PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Akintayo, A; Mayoral, J; Asada, M; Tang, J; Sundaram, S; Stanley, P				Akintayo, Ayodele; Mayoral, Joshua; Asada, Masahiro; Tang, Jian; Sundaram, Subha; Stanley, Pamela			Point mutations that inactivate MGAT4D-L, an inhibitor of MGAT1 and complex N-glycan synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						MGAT1; MGAT4D-L; N-glycans; GNA; mutational analysis; glycosyltransferase; glycosylation inhibitor; mutagenesis; flow cytometry; lectin; MGAT4D	LINKED OLIGOSACCHARIDES; GLYCOSYLATION MUTANTS; KIN RECOGNITION; MEDIAL-GOLGI; CELL MUTANTS; EXPRESSION; GENE; PROTEINS; ENCODES; CLONING	The membrane-bound, long form of MGAT4D, termed MGAT4D-L, inhibits MGAT1 activity in transfected cells and reduces the generation of complexN-glycans. MGAT1 is the GlcNAc-transferase that initiates complex and hybridN-glycan synthesis. We show here thatDrosophilaMGAT1 was also inhibited by MGAT4D-L in S2 cells. In mammalian cells, expression of MGAT4D-L causes the substrate of MGAT1 (Man(5)GlcNAc(2)Asn) to accumulate on glycoproteins, a change that is detected by the lectinGalanthus nivalisagglutinin (GNA). Using GNA binding as an assay for the inhibition of MGAT1 in MGAT4D-L transfectants, we performed site-directed mutagenesis to determine requirements for MGAT1 inhibition. Deletion of 25 amino acids (aa) from the C terminus inactivated MGAT4D-L, but deletion of 20 aa did not. Conversion of the five key amino acids (PSLFQ) to Ala, or deletion of PSLFQ in the context of full-length MGAT4D-L, also inactivated MGAT1 inhibitory activity. Nevertheless, mutant, inactive MGAT4D-L interacted with MGAT1 in co-immuno-precipitation experiments. The PSLFQ sequence also occurs in MGAT4A and MGAT4B GlcNAc-transferases. However, neither inhibited MGAT1 in transfected CHO cells. MGAT4D-L inhibitory activity could be partially transferred by attaching PSLFQ or the 25-aa C terminus of MGAT4D-L to the C terminus of MGAT1. Mutation of each amino acid in PSLFQ to Ala identified both Leu and Phe as independently essential for MGAT4D-L activity. Thus, replacement of either Leu-395 or Phe-396 with Ala led to inactivation of MGAT4D-L inhibitory activity. These findings provide new insights into the mechanism of inhibition of MGAT1 by MGAT4D-L, and for the development of small molecule inhibitors of MGAT1.	[Akintayo, Ayodele; Mayoral, Joshua; Asada, Masahiro; Tang, Jian; Sundaram, Subha; Stanley, Pamela] Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA; [Mayoral, Joshua] Albert Einstein Coll Med, Dept Pathol, New York, NY USA; [Asada, Masahiro] Natl Inst Adv Ind Sci & Technol, Cellular & Mol Biotechnol Res Inst, Tsukuba Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki, Japan; [Tang, Jian] Elstar Therapeut, Cambridge, MA USA	Yeshiva University; Yeshiva University; National Institute of Advanced Industrial Science & Technology (AIST)	Stanley, P (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA.	pamela.stanley@einsteinmed.org		Akintayo, Ayodele/0000-0003-3366-4447; Stanley, Pamela/0000-0001-5704-3747	National Institutes of Health NIGMS [RO1 GM-105399]; National Institutes of Health NCI Grant [PO1 NCI-13330]	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health NCI Grant	This work was supported by National Institutes of Health NIGMS Grant RO1 GM-105399 (to P. S.) and Einstein Core Facilities funded by National Institutes of Health NCI Grant PO1 NCI-13330 (to I. David Goldman). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akintayo A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58923-6; Au CE, 2015, MOL BIOL CELL, V26, P4015, DOI 10.1091/mbc.E14-12-1632; Batista F, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098103; BIERHUIZEN MFA, 1989, GLYCOCONJUGATE J, V6, P195, DOI 10.1007/BF01050648; Biswas B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20465-3; CHANEY W, 1986, J BIOL CHEM, V261, P551; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Chia J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214118; Cummings R. D., 2015, ESSENTIALS GLYCOBIOL, P611, DOI [DOI 10.1101/GLYCOBIOLOGY.3E.048, 10.1101/glycobiology.3e.048]; Geisler C, 2008, J BIOL CHEM, V283, P11330, DOI 10.1074/jbc.M710279200; Gonzalez M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00075; HOWARD DR, 1987, J BIOL CHEM, V262, P16830; Huang HH, 2015, ELIFE, V4, DOI 10.7554/eLife.08916; Huang HH, 2010, J CELL BIOL, V190, P893, DOI 10.1083/jcb.201004102; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; KUMAR R, 1991, J BIOL CHEM, V266, P21777; Liu J, 1996, J BIOL CHEM, V271, P33639, DOI 10.1074/jbc.271.52.33639; Mabashi-Asazuma H, 2015, ACS CHEM BIOL, V10, P2199, DOI 10.1021/acschembio.5b00340; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; Neelamegham S, 2019, GLYCOBIOLOGY, V29, P620, DOI 10.1093/glycob/cwz045; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Opat AS, 2000, J BIOL CHEM, V275, P11836, DOI 10.1074/jbc.275.16.11836; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Patnaik SK, 2000, ARCH BIOCHEM BIOPHYS, V375, P322, DOI 10.1006/abbi.1999.1693; RIPKA J, 1986, SOMAT CELL MOLEC GEN, V12, P51, DOI 10.1007/BF01560727; Sen J, 2000, DEVELOPMENT, V127, P5541; Song YH, 2010, CANCER RES, V70, P3361, DOI 10.1158/0008-5472.CAN-09-2719; Stanley P, 2017, ESSENTIALS GLYCOBIOL, P99; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Yamaji T, 2010, J BIOL CHEM, V285, P35505, DOI 10.1074/jbc.M110.154229; Yoshida A, 1998, GLYCOCONJUGATE J, V15, P1115, DOI 10.1023/A:1006951519522; Yoshida A, 1999, GLYCOBIOLOGY, V9, P303, DOI 10.1093/glycob/9.3.303; Zhong XT, 2012, BIOTECHNOL BIOENG, V109, P1723, DOI 10.1002/bit.24448	36	1	1	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2020	295	41					14053	14064		10.1074/jbc.RA120.014784	http://dx.doi.org/10.1074/jbc.RA120.014784			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OG1HE	32763972	Green Published, hybrid			2022-12-26	WOS:000581643400009
J	Huang, LS; Kotha, SR; Avasarala, S; VanScoyk, M; Winn, RA; Pennathur, A; Yashaswini, PS; Bandela, M; Salgia, R; Tyurina, YY; Kagan, VE; Zhu, XD; Reddy, SP; Sudhadevi, T; Punathil-Kannan, PK; Harijith, A; Ramchandran, R; Bikkavilli, RK; Natarajan, V				Huang, Long Shuang; Kotha, Sainath R.; Avasarala, Sreedevi; VanScoyk, Michelle; Winn, Robert A.; Pennathur, Arjun; Yashaswini, Puttaraju S.; Bandela, Mounica; Salgia, Ravi; Tyurina, Yulia Y.; Kagan, Valerian E.; Zhu, Xiangdong; Reddy, Sekhar P.; Sudhadevi, Tara; Punathil-Kannan, Prasanth-Kumar; Harijith, Anantha; Ramchandran, Ramaswamy; Bikkavilli, Rama Kamesh; Natarajan, Viswanathan			Lysocardiolipin acyltransferase regulates NSCLC cell proliferation and migration by modulating mitochondrial dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						non-small-cell lung cancer; lysocardiolipin acyltransferase; cardiolipin; cell motility; cell proliferation; cell cycle; cell migration; LYCAT; NSCLC	DIFFERENTIAL EXPRESSION ANALYSIS; CARDIOLIPIN; CANCER; DYSFUNCTION; INHIBITION; FISSION; BIOLOGY; ALCAT1	Lysocardiolipin acyltransferase (LYCAT), a cardiolipin (CL)-remodeling enzyme, is crucial for maintaining normal mitochondrial function and vascular development. Despite the well-characterized role for LYCAT in the regulation of mitochondrial dynamics, its involvement in lung cancer, if any, remains incompletely understood. In this study,in silicoanalysis of TCGA lung cancer data sets revealed a significant increase in LYCAT expression, which was later corroborated in human lung cancer tissues and immortalized lung cancer cell lines via indirect immunofluorescence and immunoblotting, respectively. Stable knockdown of LYCAT in NSCLC cell lines not only reduced CL and increased monolyso-CL levels but also reduced in vivo tumor growth, as determined by xenograft studies in athymic nude mice. Furthermore, blocking LYCAT activity using a LYCAT mimetic peptide attenuated cell migration, suggesting a novel role for LYCAT activity in promoting NSCLC. Mechanistically, the pro-proliferative effects of LYCAT were mediated by an increase in mitochondrial fusion and a G(1)/S cell cycle transition, both of which are linked to increased cell proliferation. Taken together, these results demonstrate a novel role for LYCAT in promoting NSCLC and suggest that targeting LYCAT expression or activity in NSCLC may provide new avenues for the therapeutic treatment of lung cancer.	[Huang, Long Shuang; Kotha, Sainath R.; Yashaswini, Puttaraju S.; Punathil-Kannan, Prasanth-Kumar; Ramchandran, Ramaswamy; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA; [Avasarala, Sreedevi; VanScoyk, Michelle; Bandela, Mounica; Bikkavilli, Rama Kamesh; Natarajan, Viswanathan] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Reddy, Sekhar P.; Sudhadevi, Tara; Harijith, Anantha] Univ Illinois, Dept Pediat, Chicago, IL USA; [Zhu, Xiangdong] Univ Illinois, Ctr Cardiovasc Res, Chicago, IL USA; [Zhu, Xiangdong] Univ Illinois, Dept Emergency Med, Chicago, IL USA; [Winn, Robert A.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA; [Pennathur, Arjun] Univ Pittsburgh, Dept Cardiothorac Surg, Med Ctr, Pittsburgh, PA USA; [Salgia, Ravi] City Hope Natl Med Ctr, Beckman Res Inst, Los Angeles, CA USA; [Tyurina, Yulia Y.; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Kagan, Valerian E.] Univ Pittsburgh, Dept Chem Pharmacol & Chem Biol, Pittsburgh, PA USA; [Kagan, Valerian E.] IM Sechenov Moscow State Med Univ, Lab Nav Redox Lipid, Moscow, Russia	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; City of Hope; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Sechenov First Moscow State Medical University	Natarajan, V (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA.; Bikkavilli, RK; Natarajan, V (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	visnatar@uic.edu; kamesh@uic.edu	S, Tara/AAL-5053-2021; Harijith, Anantha/AAA-5708-2021	S, Tara/0000-0001-6966-6298; Winn, Robert A/0000-0001-5948-9291; Van Scoyk, Michelle/0000-0001-6631-8300; BANDELA, MOUNICA/0000-0002-7839-0948	NHLBI, National Institutes of Health [P01HL126609, RO1HL127342, P01HL060678]; UIC College of Medicine Research Funds; NIH [CA165065, CA243142, HL114453, AI145406, GM113908]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); UIC College of Medicine Research Funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by NHLBI, National Institutes of Health, Grants P01HL126609, RO1HL127342, and P01HL060678 and UIC College of Medicine Research Funds (to V. N.) and NIH grants CA165065, CA243142, HL114453, AI145406 and GM113908 (to V. E. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badia R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005829; Bandela M, 2019, AM J RESP CRIT CARE, V199; Barroso B, 2005, J CHROMATOGR B, V814, P21, DOI 10.1016/j.jchromb.2004.07.044; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buckland AG, 1998, BBA-LIPID LIPID MET, V1390, P65, DOI 10.1016/S0005-2760(97)00170-7; Cao JS, 2009, AM J PHYSIOL-ENDOC M, V296, pE647, DOI 10.1152/ajpendo.90761.2008; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Fiske CH, 1929, SCIENCE, V70, P381, DOI 10.1126/science.70.1816.381-a; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Horbay R, 2016, APOPTOSIS, V21, P1327, DOI 10.1007/s10495-016-1295-5; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang LS, 2017, FREE RADICAL BIO MED, V112, P162, DOI 10.1016/j.freeradbiomed.2017.07.023; Huang LS, 2014, AM J RESP CRIT CARE, V189, P1402, DOI 10.1164/rccm.201310-1917OC; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kameoka S, 2018, TRENDS CELL BIOL, V28, P67, DOI 10.1016/j.tcb.2017.08.011; Keith RL, 2010, LUNG CANCER, V70, P37, DOI 10.1016/j.lungcan.2010.01.004; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lennon FE, 2014, EXPERT OPIN INV DRUG, V23, P675, DOI 10.1517/13543784.2014.899350; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McMillin JB, 2002, BBA-MOL CELL BIOL L, V1585, P97, DOI 10.1016/S1388-1981(02)00329-3; Mejia Edgard M., 2014, Cardiovascular & Hematological Disorders - Drug Targets, V14, P98; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Santucci R, 2014, CURR MED CHEM, V21, P2702, DOI 10.2174/0929867321666140414112156; Sapandowski A, 2015, MOL CELL BIOCHEM, V410, P175, DOI 10.1007/s11010-015-2549-1; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen ZN, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/891707; Shi YG, 2010, J BIOMED RES, V24, P6, DOI 10.1016/S1674-8301(10)60003-6; Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011; Tilokani L, 2018, ESSAYS BIOCHEM, V62, P341, DOI 10.1042/EBC20170104; To MD, 2013, ONCOGENE, V32, P4028, DOI 10.1038/onc.2012.404; Wang CY, 2007, BLOOD, V110, P3601, DOI 10.1182/blood-2007-04-086827; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898; Yu MF, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126915; Zhang JL, 2016, CANCER RES, V76, P6588, DOI 10.1158/0008-5472.CAN-16-1545	43	9	10	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13393	13406		10.1074/jbc.RA120.012680	http://dx.doi.org/10.1074/jbc.RA120.012680			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32732285	hybrid, Green Published			2022-12-26	WOS:000574483500021
J	Benucci, GMN; Rennick, B; Bonito, G				Benucci, Gian Maria Niccolo; Rennick, Bryan; Bonito, Gregory			Patient propagules: Do soil archives preserve the legacy of fungal and prokaryotic communities?	PLOS ONE			English	Article							ENZYME-ACTIVITY; STORAGE; DIVERSITY; SEQUENCES; IDENTIFICATION; PATTERNS; DNA	Soil archives are an important resource in agronomic and ecosystem sciences. If microbial communities could be reconstructed from archived soil DNA, as prehistoric plant communities are reconstructed via pollen data, soil archive resources would assume even greater value for reconstructing land-use history, forensic science, and biosphere modelling. Yet, the effects of long-term soil archival on the preservation of microbial DNA is still largely unknown. To address this, we assessed the capacity of high-throughput sequencing (Illumina MiSeq) of ITS (internal transcribed spacer) and prokaryotic 16S rRNA genes for reconstructing soil microbial communities across a 20 years time-series. We studied air-dried soil archives and fresh soil samples taken fromPopulusbioenergy and deciduous forest research plots at the Kellogg Biological Station. Habitat and archival time explained significant amounts of variation in soil microbial alpha- and beta-diversity both in fungal and prokaryotic communities. We found that microbial richness, diversity, and abundance generally decreased with storage time, but varied between habitat and taxonomic groups. The high relative abundance of ectomycorrhizal species includingHebelomaandCortinariusdetected in older soil archives raises questions regarding traits such as long-term persistence and viability of ectomycorrhizal propagules in soils, with relevance to forest health and ecosystem succession.Talaromyces,PaecilomycesandEpicoccumspp. were detected in fresh and across 20-year-old archived soils and were also cultured from these soils demonstrating their long-term spore viability. In summary, we found that microbial DNA in air-dried soils archived over the past 20 years degraded with time, in a manner that differed between soil types and phylogenetic groups of microbes.	[Benucci, Gian Maria Niccolo; Rennick, Bryan; Bonito, Gregory] Michigan State Univ, Plant Soil & Microbial Sci Dept, E Lansing, MI 48824 USA; [Benucci, Gian Maria Niccolo; Bonito, Gregory] Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; United States Department of Energy (DOE)	Benucci, GMN (corresponding author), Michigan State Univ, Plant Soil & Microbial Sci Dept, E Lansing, MI 48824 USA.; Benucci, GMN (corresponding author), Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA.	benucci@msu.edu		Rennick, Bryan/0000-0002-0742-2279; Benucci, Gian Maria Niccolo/0000-0003-1589-947X	AgBioResearch NIFA [MICL02416, MICL08541]; Great Lakes Bioenergy Research Center, U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DESC0018409]	AgBioResearch NIFA; Great Lakes Bioenergy Research Center, U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This research was supported through AgBioResearch NIFA, projects MICL02416 and MICL08541, and the Great Lakes Bioenergy Research Center, U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, under award number DESC0018409.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Benucci GMN, 2019, PEERJ, V7, DOI 10.7717/peerj.7744; Bonito G, 2016, FUNGAL ECOL, V22, P35, DOI 10.1016/j.funeco.2016.04.007; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Bruns TD, 2009, NEW PHYTOL, V181, P463, DOI 10.1111/j.1469-8137.2008.02652.x; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carini P, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.242; Cary SC, 2014, NAT REV MICROBIOL, V12, P789, DOI 10.1038/nrmicro3382; Chambers J. M, 1998, PROGRAMMING DATA GUI; Clark IM, 2008, SOIL BIOL BIOCHEM, V40, P1090, DOI 10.1016/j.soilbio.2007.11.021; Clemmensen KE, 2015, NEW PHYTOL, V205, P1525, DOI 10.1111/nph.13208; Collins SL, 2000, OIKOS, V91, P285, DOI 10.1034/j.1600-0706.2000.910209.x; Cui H, 2014, EUR J SOIL BIOL, V63, P55, DOI 10.1016/j.ejsobi.2014.05.006; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dolfing J, 2004, SCIENCE, V306, P813; Dolfing J, 2015, NAT REV MICROBIOL, V13, DOI 10.1038/nrmicro3382-c1; Edgar R. C., 2016, BIORXIV, DOI DOI 10.1101/074252; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Egerton-Warburton LM, 2001, P ROY SOC B-BIOL SCI, V268, P2479, DOI 10.1098/rspb.2001.1844; Feofilova EP, 2012, APPL BIOCHEM MICRO+, V48, P1, DOI 10.1134/S0003683812010048; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gdanetz K, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1952-x; Gellie NJC, 2017, MOL ECOL, V26, P2895, DOI 10.1111/mec.14081; Hallett LM, 2016, METHODS ECOL EVOL, V7, P1146, DOI 10.1111/2041-210X.12569; Ivanova EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173901; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Longley R, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz215; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; McLaren MR, 2019, ELIFE, V8, DOI 10.7554/eLife.46923; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Moon-van der Staay SY, 2006, FEMS MICROBIOL ECOL, V57, P420, DOI 10.1111/j.1574-6941.2006.00130.x; Nguyen NH, 2016, FUNGAL ECOL, V20, P241, DOI 10.1016/j.funeco.2015.06.006; Noel ZA, 2020, APPL SOIL ECOL, V150, DOI 10.1016/j.apsoil.2019.103435; Oksanen J., 2019, R PACKAGE VERSION; Oliver AK, 2015, FOREST ECOL MANAG, V345, P1, DOI 10.1016/j.foreco.2015.02.020; Peoples MS, 2012, APPL SOIL ECOL, V62, P98, DOI 10.1016/j.apsoil.2012.08.002; Pietramellara G, 2009, BIOL FERT SOILS, V45, P219, DOI 10.1007/s00374-008-0345-8; Rawlence NJ, 2014, J QUATERNARY SCI, V29, P610, DOI 10.1002/jqs.2740; Raynaud X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087217; Rubin BER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070460; Sirois SH, 2019, ENV MICROBIOL REP, V11, P173, DOI 10.1111/1758-2229.12725; Steen AD, 2019, ISME J, V13, P3126, DOI 10.1038/s41396-019-0484-y; Tierney L., 2012, LECT NOTES STAT, V435-447, DOI [10.1007/978-1-4614-3520-4_41, DOI 10.1007/978-1-4614-3520-4_41]; Tzeneva VA, 2009, RES MICROBIOL, V160, P89, DOI 10.1016/j.resmic.2008.12.001; Voroney R.P., 2015, SOIL MICROBIOLOGY EC, P15, DOI [10.1016/B978-0-12-415955-6.00002-5, DOI 10.1016/B978-0-12-415955-6.00002-5]; Wallenius K, 2010, J MICROBIOL METH, V81, P48, DOI 10.1016/j.mimet.2010.01.021; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wickham H., 2016, J APPL COMPUTATIONAL, V5, P1, DOI [10.4172/2168-9679.1000321, DOI 10.4172/2168-9679.1000321]; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	60	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237368	10.1371/journal.pone.0237368	http://dx.doi.org/10.1371/journal.pone.0237368			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780777	gold, Green Published			2022-12-26	WOS:000562664700012
J	Chang, MC; Wu, MT; Weng, KP; Chien, KJ; Lin, CC; Su, MY; Lin, KL; Chang, MH; Peng, HH				Chang, Meng-Chu; Wu, Ming-Ting; Weng, Ken-Pen; Chien, Kuang-Jen; Lin, Chu-Chuan; Su, Mao-Yuan; Lin, Ko-Long; Chang, Ming-Hua; Peng, Hsu-Hsia			Biventricular myocardial adaptation in patients with repaired tetralogy of Fallot: Mechanistic insights from magnetic resonance imaging tissue phase mapping	PLOS ONE			English	Article							OUTFLOW TRACT OBSTRUCTION; RIGHT-VENTRICULAR SIZE; PULMONARY REGURGITATION; QRS DURATION; VELOCITIES; IMPACT; MOTION; DEATH	Background The myocardial adaptive mechanism in patients with repaired tetralogy of Fallot (rTOF) is less understood. We aimed to investigate biventricular myocardial adaptive remodeling in rTOF patients. Methods We recruited 32 rTOF patients and 38 age- and sex-matched normal controls. The pulmonary stenosis of rTOF patients was measured using catheterized pressure gradient between right ventricle (RV) and pulmonary artery (PG(RVPA)). rTOF patients with PG(RVPA)< 15 mmHg and >= 15 mmHg were classified as low pulmonary stenosis (rTOF(low), n = 19) and high pulmonary stenosis (rTOF(high), n = 13) subgroups, respectively. Magnetic resonance imaging tissue phase mapping was employed to evaluate the voxelwise biventricular myocardial motion in longitudinal (Vz), radial (Vr), and circumferential (V phi) directions. Results The rTOF(low)subgroup presented higher pulmonary regurgitation fraction than rTOF(high)subgroup (p< 0.001). Compared with the normal group, only rTOF(low)subgroup presented a decreased RV ejection fraction (RVEF) (p< 0.05). The rTOF(low)subgroup showed decreased systolic and diastolic Vz in RV and LV, whereas rTOF(high)subgroup showed such change only in RV. In rTOF(low)subgroup, RVEF significantly correlated with RV systolic Vr (r = 0.56,p< 0.05), whereas LVEF correlated with LV systolic Vz (r = 0.51,p= 0.02). Prolonged QRS correlated with RV systolic Vr (r = -0.58,p< 0.01) and LV diastolic Vr (r = 0.81,p< 0.001). No such correlations occurred in rTOF(high)subgroup. Conclusions The avoidance of unfavorable functional interaction in RV and LV in rTOF(high)subgroup suggested that adequate pulmonary stenosis (PG(RVPA)>= 15 mmHg in this sereis) has a protective effect against pulmonary regurgitation.	[Chang, Meng-Chu; Peng, Hsu-Hsia] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Wu, Ming-Ting; Chang, Ming-Hua] Kaohsiung Vet Gen Hosp, Dept Radiol, Kaohsiung, Taiwan; [Wu, Ming-Ting; Weng, Ken-Pen] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan; [Weng, Ken-Pen; Chien, Kuang-Jen; Lin, Chu-Chuan] Kaohsiung Vet Gen Hosp, Dept Pediat, Kaohsiung, Taiwan; [Weng, Ken-Pen] Shu Zen Coll Med & Management, Dept Phys Therapy, Kaohsiung, Taiwan; [Su, Mao-Yuan] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Lin, Ko-Long] Kaohsiung Vet Gen Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan	National Tsing Hua University; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; Kaohsiung Veterans General Hospital	Peng, HH (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.; Weng, KP (corresponding author), Natl Yang Ming Univ, Fac Med, Taipei, Taiwan.; Weng, KP (corresponding author), Kaohsiung Vet Gen Hosp, Dept Pediat, Kaohsiung, Taiwan.; Weng, KP (corresponding author), Shu Zen Coll Med & Management, Dept Phys Therapy, Kaohsiung, Taiwan.	kenpenweng@yahoo.com.tw; hhpeng@mx.nthu.edu.tw		SU, MAO-YUAN/0000-0002-6699-2298	Veterans General Hospitals and University System of Taiwan Joint Research Program [VGHUST103-G3-1-1, VGHUST103-G3-1-2, VGHUST104-G7-71, VGHUST104-G7-7-2, VGHUST104-G7-7-3, VGHUST105-G3-1-1, VGHUST105-G3-1-2, VGHUST105-G3-1-3]; Ministry of Science and Technology in Taiwan [MOST 104-2314-B-075B-007, NSC 102-2320-B-007003-MY3, MOST 103-2314-B-010-018-MY3, MOST 105-2314-B-007-003, MOST 106-2314-B-007-006-MY3]	Veterans General Hospitals and University System of Taiwan Joint Research Program; Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This study has received funding by the Veterans General Hospitals and University System of Taiwan Joint Research Program (VGHUST103-G3-1-1, VGHUST103-G3-1-2, VGHUST104-G7-71, VGHUST104-G7-7-2, VGHUST104-G7-7-3, VGHUST105-G3-1-1, VGHUST105-G3-1-2, VGHUST105-G3-1-3 (recipient: KPW)). This study was also supported in part by Ministry of Science and Technology in Taiwan (MOST 104-2314-B-075B-007 (recipient: KPW); NSC 102-2320-B-007003-MY3, MOST 103-2314-B-010-018-MY3, MOST 105-2314-B-007-003, MOST 106-2314-B-007-006-MY3 (recipient: HHP)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonow RO, 2014, BRAUNWALDS HEART DIS, V10th, P364; BRUCE RA, 1974, AM J CARDIOL, V33, P715, DOI 10.1016/0002-9149(74)90211-2; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chang MC, 2018, EUR RADIOL, V28, P104, DOI 10.1007/s00330-017-4908-7; Chen CA, 2014, AM HEART J, V167, P555, DOI 10.1016/j.ahj.2013.12.026; D'Andrea A, 2004, Eur J Echocardiogr, V5, P123, DOI 10.1016/S1525-2167(03)00053-2; Davlouros PA, 2002, J AM COLL CARDIOL, V40, P2044, DOI 10.1016/S0735-1097(02)02566-4; Delfino JG, 2006, J MAGN RESON IMAGING, V24, P304, DOI 10.1002/jmri.20641; Foell D, 2013, J MAGN RESON IMAGING, V37, P119, DOI 10.1002/jmri.23803; Foll D, 2010, CIRC-CARDIOVASC IMAG, V3, P54, DOI 10.1161/CIRCIMAGING.108.813857; Foll D, 2009, J MAGN RESON IMAGING, V29, P1043, DOI 10.1002/jmri.21634; Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8; GATZOULIS MA, 1995, CIRCULATION, V92, P231, DOI 10.1161/01.CIR.92.2.231; Geva T, 2004, J AM COLL CARDIOL, V43, P1068, DOI 10.1016/j.jacc.2003.10.045; Geva T, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-9; Ghonim S, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00030; Grothoff M, 2006, CLIN RES CARDIOL, V95, P643, DOI 10.1007/s00392-006-0440-5; Helbing WA, 1996, J AM COLL CARDIOL, V28, P1827, DOI 10.1016/S0735-1097(96)00387-7; Jayasuriya S, 2009, EXP CLIN CARDIOL, V14, pE17; Jung B, 2008, J MAGN RESON IMAGING, V28, P1226, DOI 10.1002/jmri.21561; Kempny A, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-32; Latus H, 2013, PEDIATR CARDIOL, V34, P424, DOI 10.1007/s00246-012-0476-4; Menza M, 2018, MAGN RESON MATER PHY, V31, P61, DOI 10.1007/s10334-017-0661-9; Mueller M, 2010, EUR J ECHOCARDIOGR, V11, P786, DOI 10.1093/ejechocard/jeq067; Salerno D, 2006, QUESTION, V1; SanchezQuintana D, 1996, HEART, V76, P280, DOI 10.1136/hrt.76.3.280; Spiewak M, 2011, J MAGN RESON IMAGING, V33, P1040, DOI 10.1002/jmri.22532; Srichai MB, 2009, AM J ROENTGENOL, V192, P662, DOI 10.2214/AJR.07.3744; Steeden JA, 2014, MAGN RESON MED, V71, P145, DOI 10.1002/mrm.24646; Valente AM, 2014, HEART, V100, P247, DOI 10.1136/heartjnl-2013-304958; van Huysduynen BH, 2005, EUR HEART J, V26, P928, DOI 10.1093/eurheartj/ehi140; Weng KP, 2018, J CHIN MED ASSOC, V81, P170, DOI 10.1016/j.jcma.2017.09.012; Yoo BW, 2012, J THORAC CARDIOV SUR, V143, P1299, DOI 10.1016/j.jtcvs.2011.12.033	33	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237193	10.1371/journal.pone.0237193	http://dx.doi.org/10.1371/journal.pone.0237193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780780	Green Published, gold			2022-12-26	WOS:000562664700027
J	van Herwijnen, IR; Corbee, RJ; Endenburg, N; Beerda, B; van der Borg, JAM				van Herwijnen, Ineke R.; Corbee, Ronald J.; Endenburg, Nienke; Beerda, Bonne; van der Borg, Joanne A. M.			Permissive parenting of the dog associates with dog overweight in a survey among 2,303 Dutch dog owners	PLOS ONE			English	Article							BODY CONDITION; RISK-FACTORS; PERCEIVED OBESITY; FELINE OBESITY; FEEDING STYLE; CANINE; FAT; PREVALENCE; CHILDHOOD; BEHAVIORS	Overweight/obese dogs are at increased risk of health issues and it is up to the dog owner to uphold successful weight management. In children, overweight relates to their parent's permissive style of parenting. We predicted that permissive dog-directed parenting likewise associates with a dog being overweight (including obesity). If styles in parenting dogs indeed associate with a dog's overweight, these may provide action points for effective weight management. For 2,303 Dutch dog owners, answers on their dog's (nine-point scale) body condition scores were compared to ways of parenting the dog. We used an adapted version of the 32-item Parenting Styles and Dimensions Questionnaire and compared the distributions of dog counts across aggregated body condition score categories of underweight (scores one to three), healthy-weight (scores four and five) and overweight/obese (scores six to nine) with Chi-square tests across the quartiles of a given parenting style. Overweight/obese dogs were overrepresented in the quartile of dog owners with the highest level of permissive parenting, which is in line with findings on parenting styles and overweight/obesity in children. Supplementary logistic regression analyses on the likelihood of dogs being overweight/obese (i.e. having a body condition score of six or higher) confirmed the importance of parenting and identified the risk factors of dogs having little exercise, being of older age, neutered or owned by someone with lower level education. Our results indicate that strategies to promote proper weight management in dogs could benefit from addressing especially a dog owner's permissiveness in parenting his/her dog.	[van Herwijnen, Ineke R.; Beerda, Bonne] Wageningen Univ & Res, Dept Anim Sci, Behav Ecol Grp, Wageningen, Netherlands; [Corbee, Ronald J.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Endenburg, Nienke; van der Borg, Joanne A. M.] Univ Utrecht, Fac Vet Med, Dept Populat Hlth, Unit Anim Sci & Soc, Utrecht, Netherlands	Wageningen University & Research; Utrecht University; Utrecht University	van Herwijnen, IR (corresponding author), Wageningen Univ & Res, Dept Anim Sci, Behav Ecol Grp, Wageningen, Netherlands.	ineke.vanherwijnen@wur.nl	van+Herwijnen, Ineke/AAN-9135-2021	van der Borg, Joanne A.M./0000-0003-1052-2817				Barradas DT, 2007, J PEDIATR-US, V151, P369, DOI 10.1016/j.jpeds.2007.04.069; Baumrind D., 2013, AUTHORITATIVE PARENT, P11; Bland IM, 2009, PREV VET MED, V92, P333, DOI 10.1016/j.prevetmed.2009.08.016; Blissett J, 2011, APPETITE, V57, P826, DOI 10.1016/j.appet.2011.05.318; Burkholder WJ, 2000, J AM VET MED ASSOC, V217, P650, DOI 10.2460/javma.2000.217.650; Chandler M, 2017, J COMP PATHOL, V156, P296, DOI 10.1016/j.jcpa.2017.03.006; Collins C, 2014, J HUM NUTR DIET, V27, P557, DOI 10.1111/jhn.12192; Courcier EA, 2011, PREV VET MED, V102, P66, DOI 10.1016/j.prevetmed.2011.06.010; Courcier EA, 2010, J SMALL ANIM PRACT, V51, P362, DOI 10.1111/j.1748-5827.2010.00933.x; Eastland-Jones RC, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.25; Endenburg N, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1531-z; Francis LA, 2009, ARCH PEDIAT ADOL MED, V163, P297, DOI 10.1001/archpediatrics.2008.579; German AJ, 2012, VET J, V192, P65, DOI 10.1016/j.tvjl.2011.04.001; German AJ, 2006, J NUTR, V136, p2031S, DOI 10.1093/jn/136.7.2031S; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; German AJ, 2017, J NUTR SCI, V6, DOI 10.1017/jns.2017.5; German AJ, 2015, BRIT J NUTR, V113, pS72, DOI 10.1017/S0007114514002335; German AJ, 2010, VET J, V185, P4, DOI 10.1016/j.tvjl.2010.04.004; German AJ, 2010, AM J VET RES, V71, P393, DOI 10.2460/ajvr.71.4.393; Grolnick W.S., 2002, HDB PARENTING PRACTI, VVol. 5, P89; Hughes SO, 2008, J DEV BEHAV PEDIATR, V29, P403, DOI 10.1097/DBP.0b013e318182a976; Inglis IR, 1997, ANIM BEHAV, V53, P1171, DOI 10.1006/anbe.1996.0320; Jago R, 2011, PEDIATRICS, V128, pE572, DOI [10.1542/peds.2010-3664, 10.1542/peds.2011-1818]; Kienzle E, 1998, J NUTR, V128, p2609S, DOI [10.1093/jn/128.12.2609S, 10.1093/jn/128.12.2598S, 10.1093/jn/128.12.2680S]; Kimiecik JC, 2012, PSYCHOL SPORT EXERC, V13, P10, DOI 10.1016/j.psychsport.2011.08.004; Linder DE, 2013, AM J VET RES, V74, P1400, DOI 10.2460/ajvr.74.11.1400; Loftus JP, 2015, VET MED-RES REP, V6, P49, DOI 10.2147/VMRR.S40868; Lopez NV, 2018, APPETITE, V128, P205, DOI 10.1016/j.appet.2018.06.021; Lund E. M., 2006, International Journal of Applied Research in Veterinary Medicine, V4, P177; Mawby DI, 2004, J AM ANIM HOSP ASSOC, V40, P109, DOI 10.5326/0400109; McGowan RTS, 2014, ANIM COGN, V17, P577, DOI 10.1007/s10071-013-0688-x; McGreevy PD, 2005, VET REC, V156, P695, DOI 10.1136/vr.156.22.695; Moilanen KL, 2015, J RES ADOLESCENCE, V25, P246, DOI 10.1111/jora.12125; Munoz-Prieto A, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Olivari MG, 2013, MARRIAGE FAM REV, V49, P465, DOI 10.1080/01494929.2013.770812; Olvera N, 2010, J PEDIATR PSYCHOL, V35, P243, DOI 10.1093/jpepsy/jsp071; Rhee K, 2008, ANN AM ACAD POLIT SS, V615, P12, DOI 10.1177/0002716207308400; Rhee KE, 2006, PEDIATRICS, V117, P2047, DOI 10.1542/peds.2005-2259; Robertson ID, 2003, PREV VET MED, V58, P75, DOI 10.1016/S0167-5877(03)00009-6; ROBINSON CC, 1995, PSYCHOL REP, V77, P819, DOI 10.2466/pr0.1995.77.3.819; Sallander M, 2010, PREV VET MED, V96, P132, DOI 10.1016/j.prevetmed.2010.05.004; Sandoe P, 2014, VET REC, V175, P610, DOI 10.1136/vr.g7521; Santarossa A, 2017, JAVMA-J AM VET MED A, V251, P521, DOI 10.2460/javma.251.5.521; Schary DP, 2012, EARLY CHILD DEV CARE, V182, P1015, DOI 10.1080/03004430.2012.678596; Sharpe D., 2015, PRACTICAL ASSESSMENT, V20, DOI DOI 10.7275/TBFA-X148; Shloim N, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01849; Sokol RL, 2017, OBES REV, V18, P281, DOI 10.1111/obr.12497; Tsukayama E, 2010, ARCH PEDIAT ADOL MED, V164, P631, DOI 10.1001/archpediatrics.2010.97; van Herwijnen IR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193471; Ventura AK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-15; Vollmer RL, 2013, APPETITE, V71, P232, DOI 10.1016/j.appet.2013.08.015; White GA, 2011, J SMALL ANIM PRACT, V52, P622, DOI 10.1111/j.1748-5827.2011.01138.x; Yam PS, 2016, PREV VET MED, V127, P64, DOI 10.1016/j.prevetmed.2016.03.013	53	3	3	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237429	10.1371/journal.pone.0237429	http://dx.doi.org/10.1371/journal.pone.0237429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NE5TX	32780776	gold, Green Published			2022-12-26	WOS:000562664700010
J	Li, HB; Dai, CG; Hu, Y				Li, Hong-Bo; Dai, Chang-Geng; Hu, Yang			Characterization and expression analysis of genes encoding three small heat shock proteins in the oriental armyworm,Mythimna separata (Walker)	PLOS ONE			English	Article							DENSITY-DEPENDENT PROPHYLAXIS; COMMON CUTWORM; DISEASE RESISTANCE; SPODOPTERA-EXEMPTA; IMMUNE-RESPONSE; THERMAL-STRESS; EVOLUTIONARY; CLONING; IMPACT; POPULATIONS	Small heat shock proteins (sHsps) function in the response of insects to abiotic stress; however, their role in response to biotic stress has been under-investigated.Mythimna separata, the oriental armyworm, is polyphenetic and exhibits gregarious and solitary phases in response to high and low population density, respectively. In this study, three genes were identified encoding sHsps, namelyMsHsp19.7,MsHsp19.8andMsHsp21.4, and expression levels in solitary and gregariousM.separatawere compared. The deduced protein sequences of the threeMsHspshad molecular weights of 19.7, 19.8 and 21.4 kDa, respectively, and contained a conserved alpha-crystalline domain. Real-time PCR analyses revealed that the threesHspswere transcribed in all developmental stages and were dramatically up-regulated at the 6(th)larval stage in gregarious individuals. Expression of the threeMsHspswas variable in different tissues of 6(th)instar larvae, but exhibited consistent up- and down-regulation in the hindgut and Malpighian tubules of gregarious individuals, respectively. In addition,MsHsp19.7andMsHsp19.8were significantly induced when solitary forms were subjected to crowding for 36 h, but all threeMsHspswere down-regulated when gregarious forms were isolated. Our findings suggest that population density functions as a stress factor and impactsMsHspsexpression inM.separata.	[Li, Hong-Bo; Dai, Chang-Geng; Hu, Yang] Guizhou Acad Agr Sci, Inst Plant Protect, Guiyang, Peoples R China	Guizhou Academy of Agricultural Sciences	Li, HB (corresponding author), Guizhou Acad Agr Sci, Inst Plant Protect, Guiyang, Peoples R China.	gzlhb2017@126.com		Li, Hongboo/0000-0002-5860-9746	National Natural Science Foundation of China [31601633]; National Key Research and Development Programme of China [2018YFD0200700]; Talent Foundation of Guizhou Academy of Agricultural Science [201301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Programme of China; Talent Foundation of Guizhou Academy of Agricultural Science	This researchwas surproted by the National Natural Science Foundation of China (31601633), the National Key Research and Development Programme of China (2018YFD0200700),Talent Foundation of Guizhou Academy of Agricultural Science(201301).	ALBRECHT FO, 1959, NATURE, V184, P103, DOI 10.1038/184103a0; Ananthakrishnan T.N., 2009, PHENOTYPIC PLASTICIT, P137, DOI DOI 10.1201/B10201-7; Bai YF, 2010, THESIS; Bailey NW, 2008, EVOL ECOL RES, V10, P599; Barnes AI, 2000, P ROY SOC B-BIOL SCI, V267, P177, DOI 10.1098/rspb.2000.0984; Chapuis MP, 2011, J INSECT PHYSIOL, V57, P1562, DOI 10.1016/j.jinsphys.2011.08.011; Collett M, 1998, P NATL ACAD SCI USA, V95, P13052, DOI 10.1073/pnas.95.22.13052; Cotter SC, 2004, J ANIM ECOL, V73, P283, DOI 10.1111/j.0021-8790.2004.00806.x; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Franck E, 2004, J MOL EVOL, V59, P792, DOI 10.1007/s00239-004-0013-z; Gu J, 2012, INSECT MOL BIOL, V21, P535, DOI 10.1111/j.1365-2583.2012.01158.x; Huang LH, 2009, J INSECT PHYSIOL, V55, P279, DOI 10.1016/j.jinsphys.2008.12.004; Jiang Xing-Fu, 2014, Chinese Journal of Applied Entomology, V51, P1444, DOI 10.7679/j.issn.2095-1353.2014.168; King AM, 2015, ANNU REV ENTOMOL, V60, P59, DOI 10.1146/annurev-ento-011613-162107; Kong Hai-Long, 2011, Acta Entomologica Sinica, V54, P1384; Kong HL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20711-8; Lee KP, 2004, J INSECT PHYSIOL, V50, P1171, DOI 10.1016/j.jinsphys.2004.10.009; Li AQ, 2007, J INSECT PHYSIOL, V53, P385, DOI 10.1016/j.jinsphys.2007.01.003; Li HB, 2019, J ECON ENTOMOL, V112, P2381, DOI 10.1093/jee/toz163; Li Hong-Bo, 2018, Chinese Journal of Applied Entomology, V55, P825, DOI 10.7679/j.issn.2095-1353.2018.099; Li HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195096; Li ZW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-215; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu QN, 2013, J INVERTEBR PATHOL, V114, P313, DOI 10.1016/j.jip.2013.09.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu MX, 2014, CELL STRESS CHAPERON, V19, P91, DOI 10.1007/s12192-013-0437-8; Luo Lizhi, 1995, Acta Entomologica Sinica, V38, P428; Moller AP, 2003, AM NAT, V161, P657, DOI 10.1086/367879; Morimoto J, 2019, FRONT ZOOL, V16, DOI 10.1186/s12983-019-0302-4; Morrow G, 2004, J BIOL CHEM, V279, P43382, DOI 10.1074/jbc.C400357200; PENER MP, 1991, ADV INSECT PHYSIOL, V23, P1, DOI 10.1016/S0065-2806(08)60091-0; Quan GX, 2018, CELL STRESS CHAPERON, V23, P1247, DOI 10.1007/s12192-018-0931-0; Reeson AF, 1998, P ROY SOC B-BIOL SCI, V265, P1787, DOI 10.1098/rspb.1998.0503; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Shen Y, 2014, J INSECT PHYSIOL, V61, P34, DOI 10.1016/j.jinsphys.2013.12.007; Shen Y, 2011, J INSECT PHYSIOL, V57, P908, DOI 10.1016/j.jinsphys.2011.03.026; Silva FWS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061582; Sorensen JG, 2001, J INSECT PHYSIOL, V47, P1301, DOI 10.1016/S0022-1910(01)00119-6; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Sun Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160200; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; Walsh RK, 2011, J VECTOR ECOL, V36, P300, DOI 10.1111/j.1948-7134.2011.00170.x; Wang HS, 2007, INSECT MOL BIOL, V16, P207, DOI 10.1111/j.1365-2583.2006.00715.x; Wang HD, 2004, P NATL ACAD SCI USA, V101, P12610, DOI 10.1073/pnas.0404648101; Wilson K, 2002, P NATL ACAD SCI USA, V99, P5471, DOI 10.1073/pnas.082461999; Wilson K, 2001, ECOL LETT, V4, P637, DOI 10.1046/j.1461-0248.2001.00279.x; Xie J, 2019, INSECT SCI, V26, P263, DOI 10.1111/1744-7917.12543; Youn H, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.169342; Zhang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132700	51	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0235912	10.1371/journal.pone.0235912	http://dx.doi.org/10.1371/journal.pone.0235912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776931	gold, Green Published			2022-12-26	WOS:000561393800046
J	Lin, YH; Wang, YC; Wu, MS; Lu, KC; Lin, HY; Kuo, HS; Chang, GD; Lin, CM; Hsiao, CAL				Lin, Yuan-Hau; Wang, Ying-Chi; Wu, Mai-Szu; Lu, Kuo-Cheng; Lin, Hsin-Yi; Kuo, Hsien-Shou; Chang, Geen-Dong; Lin, Chun-Mao; Hsiao, Chiaolong			The study of isotopic enrichment of water in human plasma and erythrocyte	FASEB JOURNAL			English	Article						blood plasma; end-stage renal disease; erythrocyte; stable isotope hydrogen and oxygen; water	RED-BLOOD-CELL; HUMAN URINE; AQUAPORIN-1; TRANSPORT; MEMBRANE; KIDNEY; EXPRESSION; DEUTERIUM; CHANNELS; HYDROGEN	Life does not sustain without water. For water, there is a natural abundance of stable isotope hydrogen and oxygen. Water molecules get across cell membranes through a plasma membrane protein, named aquaporin. Moreover, the kidney is the main organ to maintain water homeostasis. Here, we study the stable isotopic ratios of hydrogen and oxygen in human blood plasma and erythrocyte corresponding to kidney functions. We extract waters from human plasma and erythrocyte, collected from 110 participants, including 51 clinically stable outpatients with end-stage renal disease (ESRD) and 59 subjects with normal renal function (NRF). We observed that (i) both extracellular (blood plasma) and intracellular (erythrocyte) biology waters are isotopic differences between the ESRD and NRF participants, (ii) the natural abundance of isotopic waters of ESRD is hypo-isotopic, and (iii) the isotopic enrichment of water between erythrocyte and blood plasma are distinct. In addition, we introduce an empirical formula using entropy transformation to describe isotopic water enrichment for biology. Accordingly, the natural abundance of stable isotope water of blood plasma and erythrocyte may be possibly put in practice a new sign for assessments of kidney dysfunctions.	[Lin, Yuan-Hau; Wu, Mai-Szu; Kuo, Hsien-Shou; Lin, Chun-Mao] Taipei Med Univ, Coll Med, 250 Wuxing St, Taipei 11031, Taiwan; [Wang, Ying-Chi; Lin, Hsin-Yi; Chang, Geen-Dong; Hsiao, Chiaolong] Natl Taiwan Univ, Inst Biochem Sci, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan; [Wang, Ying-Chi; Lin, Hsin-Yi; Hsiao, Chiaolong] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Wu, Mai-Szu] Taipei Med Univ, Div Nephrol, Shuang Ho Hosp, Taipei, Taiwan; [Lu, Kuo-Cheng] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan	Taipei Medical University; National Taiwan University; Academia Sinica - Taiwan; Taipei Medical University; Shuang Ho Hospital; Fu Jen Catholic University	Lin, CM (corresponding author), Taipei Med Univ, Coll Med, 250 Wuxing St, Taipei 11031, Taiwan.; Hsiao, CAL (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	chiaolong@ntu.edu.tw			Ministry of Science and Technology, Taiwan (MOST) [MOST-105-2628-B-002-020-MY3, MOST 108-2628-B-002-012-]; National Taiwan University (NTU) [NTU-109L7729]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); National Taiwan University (NTU)(National Taiwan UniversityNanyang Technological University)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST-105-2628-B-002-020-MY3 and MOST 108-2628-B-002-012-; National Taiwan University (NTU), Grant/Award Number: NTU-109L7729	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; AGRE P, 1993, AM J PHYSIOL, V265, pF463; BAERTSCHI P, 1976, EARTH PLANET SC LETT, V31, P341, DOI 10.1016/0012-821X(76)90115-1; Bekheirnia MR, 2006, CURR OPIN PHARMACOL, V6, P202, DOI 10.1016/j.coph.2005.09.008; BENGA G, 1986, BIOCHEMISTRY-US, V25, P1535, DOI 10.1021/bi00355a011; BENGA G, 1988, PROG BIOPHYS MOL BIO, V51, P193, DOI 10.1016/0079-6107(88)90002-8; Berdea P, 2001, STUD U BABES BOLYAI, V1, P256; Berman ESF, 2015, EUR J CLIN NUTR, V69, P1091, DOI 10.1038/ejcn.2015.10; Berman ESF, 2012, ANAL CHEM, V84, P9768, DOI 10.1021/ac3016642; Bianconi E, 2013, ANN HUM BIOL, V40, P463, DOI 10.3109/03014460.2013.807878; BODNER GM, 1986, J CHEM EDUC, V63, P673, DOI 10.1021/ed063p673; Cadnapaphornchai MA, 2001, CARDIOLOGY, V96, P122, DOI 10.1159/000047396; Chao CY, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.247801; CRAIG H, 1961, SCIENCE, V133, P1833, DOI 10.1126/science.133.3467.1833; Crisp RL, 2016, ANN HEMATOL, V95, P1595, DOI 10.1007/s00277-016-2757-0; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Duncan D, 2006, BRIT J ANAESTH, V96, P590, DOI 10.1093/bja/ael064; Evans BC, 2013, JOVE-J VIS EXP, DOI 10.3791/50166; Feynman RP, 1963, FEYNMAN LECT PHYS, pc1963; HAGEMANN R, 1970, TELLUS, V22, P712, DOI 10.1111/j.2153-3490.1970.tb00540.x; HAINES TH, 1994, FEBS LETT, V346, P115, DOI 10.1016/0014-5793(94)00470-6; Hasler CR, 1998, NEPHROL DIAL TRANSPL, V13, P3132, DOI 10.1093/ndt/13.12.3132; Hobson KA, 1999, P NATL ACAD SCI USA, V96, P8003, DOI 10.1073/pnas.96.14.8003; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; Johansen KL, 2009, ADV CHRONIC KIDNEY D, V16, P501, DOI 10.1053/j.ackd.2009.07.007; Kalantar-Zadeh K, 2009, CIRCULATION, V119, P671, DOI 10.1161/CIRCULATIONAHA.108.807362; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; King LS, 2002, TRENDS ENDOCRIN MET, V13, P355, DOI 10.1016/S1043-2760(02)00665-3; Kreuzer-Martin HW, 2005, P NATL ACAD SCI USA, V102, P17337, DOI 10.1073/pnas.0506531102; Kuchel PW, 2005, BIOSYSTEMS, V82, P189, DOI 10.1016/j.biosystems.2005.07.002; Kuo TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032137; Li H, P NAT ACAD SCI US, V113, P5862; Lloyd S., 2003, IEEE T INFORM THEORY, V28, P129; LOGE JP, 1958, AM J MED, V24, P4, DOI 10.1016/0002-9343(58)90357-7; Lohmann K, 1934, BIOCHEM Z, V273, P60; Maunsbach AB, 1997, J AM SOC NEPHROL, V8, P1; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; O'Brien DM, 2007, RAPID COMMUN MASS SP, V21, P2422, DOI 10.1002/rcm.3108; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1994, SCIENCE, V265, P1585, DOI 10.1126/science.7521540; Roudier N, 2002, J BIOL CHEM, V277, P45854, DOI 10.1074/jbc.M208999200; Roudier N, 1998, J BIOL CHEM, V273, P8407, DOI 10.1074/jbc.273.14.8407; SOMLYAI G, 1993, FEBS LETT, V317, P1, DOI 10.1016/0014-5793(93)81479-J; SZENTGYORGYI A, 1971, PERSPECT BIOL MED, V14, P239; Tea I, 2017, METHOD ENZYMOL, V596, P113, DOI 10.1016/bs.mie.2017.07.020; Tea I, 2016, SCI REP-UK, V6, DOI 10.1038/srep34251; TRANSONTAY R, 1990, J BIOMECH ENG-T ASME, V112, P257, DOI 10.1115/1.2891182; Trevisan R, 2006, J AM SOC NEPHROL, V17, pS145, DOI 10.1681/ASN.2005121320; Visconti L, 2016, J CLIN TRANSL ENDOCR, V6, P8, DOI 10.1016/j.jcte.2016.08.002; Wassenaar LI, 2016, RAPID COMMUN MASS SP, V30, P415, DOI 10.1002/rcm.7459; WESTHEIMER FH, 1961, CHEM REV, V61, P265, DOI 10.1021/cr60211a004; Wiback SJ, 2002, BIOPHYS J, V83, P808, DOI 10.1016/S0006-3495(02)75210-7; Xi G, 2008, MOL ENDOCRINOL, V22, P2162, DOI 10.1210/me.2008-0079; Yang BX, 2001, J BIOL CHEM, V276, P624, DOI 10.1074/jbc.M008664200; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zeuthen T, 1999, J BIOL CHEM, V274, P21631, DOI 10.1074/jbc.274.31.21631	57	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					13049	13062		10.1096/fj.202000388RR	http://dx.doi.org/10.1096/fj.202000388RR		AUG 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32779304	hybrid			2022-12-26	WOS:000558379800001
J	Moeng-Mahlangu, LT; Monyeki, MA; Reilly, JJ; Mchiza, ZJ; Moleah, T; Loechr, CU; Kruger, HS				Moeng-Mahlangu, Lynn T.; Monyeki, Makama A.; Reilly, John J.; Mchiza, Zandile J.; Moleah, Thabisile; Loechr, Cornelia U.; Kruger, Herculina S.			Level of agreement between objectively determined body composition and perceived body image in 6-to 8-year-old South African children: The Body Composition-Isotope Technique study	PLOS ONE			English	Article							FAT-FREE BODY; WEIGHT STATUS; CHILDHOOD OBESITY; MASS INDEX; METABOLIC SYNDROME; PERCEPTION; ADOLESCENTS; RISK; CONSEQUENCES; ASSOCIATION	To assess the level of agreement between body size self-perception and actual body size determined by body mass index (BMI) z-score and body fatness measured by the deuterium dilution method (DDM) in South African children aged 6-8 years. A cross-sectional sample of 202 children (83 boys and 119 girls) aged 6-8 years from the Body Composition-Isotope Technique study (BC-IT) was taken. Subjective measures of body image (silhouettes) were compared with the objective measures of BMI z-score and body fatness measured by the DDM. The World Health Organization BMI z-scores were used to classify the children as underweight, normal, overweight, or obese. DDM-measured fatness was classified based on the McCarthy centile curves set at 2nd, 85th and 95th in conjunction with fatness cut-off points of 25% in boys and 30% in girls. Data were analyzed using SPSS v26. Of 202 children, 32.2%, 55.1%, 8.8%, and 2.4% perceived their body size as underweight, normal, overweight, and obese, respectively. Based on BMI z-score, 18.8%, 72.8%, 6.9%, and 1.5% were classified as underweight, normal, overweight, and obese, respectively. Body fatness measurement showed that 2.5%, 48.0%, 21.8%, and 29.7% were underweight, normal weight, overweight, and obese, respectively. The application of silhouettes and BMI z-scores resulted in either overestimation or underestimation of own body size. Overall, the levels of agreements (kappa, kappa) between body size perception, body fatness, and BMI for age respectively, were small (kappa = 0.083, p = 0.053 and kappa = 0.154, p<0.001). Level of agreement between body size perception, body fatness, and BMI z-score was poor. The use of silhouettes made children either overestimate their own body size while being underweight or underestimate their own body size while being overweight or obese. Given the potential health implications associated with misclassification of body size during childhood, correct self-assessment of body size is important, and may be key to the adoption of weight control strategies directed at curbing the escalating obesity epidemic in the country. Scalable measures to allow for more accurate self-assessment are urgently needed-one approach is behavior change communication at all levels.	[Moeng-Mahlangu, Lynn T.; Monyeki, Makama A.] North West Univ, Fac Hlth Sci, Phys Act Sport & Recreat Res Focus Area, Potchefstroom, South Africa; [Reilly, John J.] Univ Strathclyde, Sch Psychol Sci & Hlth, Phys Act Hlth Grp, Glasgow, Lanark, Scotland; [Mchiza, Zandile J.] Univ Western Cape, Sch Publ Hlth SoPH, Cape Town, South Africa; [Moleah, Thabisile; Loechr, Cornelia U.] Vienna Int Ctr, Div Human Hlth, Int Atom Energy Agcy IAEA, Vienna, Austria; [Kruger, Herculina S.] North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa	North West University - South Africa; University of Strathclyde; University of the Western Cape; International Atomic Energy Agency; North West University - South Africa	Monyeki, MA (corresponding author), North West Univ, Fac Hlth Sci, Phys Act Sport & Recreat Res Focus Area, Potchefstroom, South Africa.	andries.monyeki@nwu.ac.za		Monyeki, Makama Andries/0000-0002-4156-8394	South African Medical Research Council (SA MRC) Extra Mural Unit; National Research Foundation (NRF) of South Africa for Incentive Funding for Researchers [PR_IFR190115408089]; SA MRC under the Self-Initiated Research Grants Programme; North-West University; IAEA [SAF6020]	South African Medical Research Council (SA MRC) Extra Mural Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation (NRF) of South Africa for Incentive Funding for Researchers; SA MRC under the Self-Initiated Research Grants Programme; North-West University; IAEA(International Atomic Energy Agency)	The BC-IT study is financially supported by the South African Medical Research Council (SA MRC) Extra Mural Unit and the National Research Foundation (NRF) of South Africa for Incentive Funding for Researchers (Unique Identification Number: PR_IFR190115408089). Research reported in this paper was supported by the SA MRC under the Self-Initiated Research Grants Programme. Financial support received from North-West University in the establishment of the stable isotope laboratory for the determination of body composition within the PhASReC research entity, is greatly appreciated. Additionally, we would like to thank the IAEA for financial support (TC project SAF6020). Additionally, we would like to thank the IAEA for capacity building and financial support (Technical Cooperation project SAF6020). The views and opinions expressed are those of the authors and do not necessarily represent the official views of the SA MRC or the NRF. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors, and therefore the NRF does not accept any liability in this regard.	[Anonymous], 2016, END CHILDH OB; Assaad S, 2018, CHILD CARE HLTH DEV, V44, P124, DOI 10.1111/cch.12512; Berry KJ, 2009, BEHAV RES METHODS, V41, P1144, DOI 10.3758/BRM.41.4.1144; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Brener ND, 2004, OBES RES, V12, P1866, DOI 10.1038/oby.2004.232; Caprio S, 2002, J PEDIATR ENDOCR MET, V15, P487; Cash Thomas F, 2004, Body Image, V1, P1, DOI 10.1016/S1740-1445(03)00011-1; Caraza KLC, 2016, ARCH ARGENT PEDIATR, V114, P237, DOI [10.5546/aap.2016.237, 10.5546/aap.2016.eng.237]; Chung AE, 2013, ACAD PEDIATR, V13, P371, DOI 10.1016/j.acap.2013.04.011; Chung ST, 2018, ANN NY ACAD SCI, V1411, P166, DOI 10.1111/nyas.13602; De Giuseppe R, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00123; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Deschamps V, 2015, PEDIATR OBES, V10, P15, DOI 10.1111/j.2047-6310.2013.00211.x; Dietz WH, 1998, PEDIATRICS, V101, P518; Diouf A, 2018, B WORLD HEALTH ORGAN, V96, P772, DOI 10.2471/BLT.17.205948; Falkner NH, 2001, OBES RES, V9, P32, DOI 10.1038/oby.2001.5; FRENCH SA, 1995, OBES RES, V3, P479, DOI 10.1002/j.1550-8528.1995.tb00179.x; Gardner RM, 1999, PERCEPT MOTOR SKILL, V89, P981, DOI 10.2466/PMS.89.7.981-993; Gonzalez-Zapata LI, 2019, PUBLIC HLTH NUT, DOI [10.1017/51368980018004020, DOI 10.1017/51368980018004020]; Graham L, 2018, S AFR J CHILD HEALTH, V12, P90, DOI [10.7196/sajch.2018.v12i3.1455, 10.7196/SAJCH.2018.v12i3.1455]; Gualdi-Russo E, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-85; Gurnani M, 2015, PEDIATR CLIN N AM, V62, P821, DOI 10.1016/j.pcl.2015.04.001; Heshmat R, 2015, QUAL LIFE RES, V24, P263, DOI 10.1007/s11136-014-0757-x; International Atomic Energy Agency (IAEA), 2010, INT AT EN AG IAEA HU, V12; International Atomic Energy Agency (IAEA), 2009, INT AT EN AG IAEA HU, V3; Jimenez-Flores P, 2017, NUTR HOSP, V34, P479, DOI 10.20960/nh.455; Kelishadi R, 2007, EPIDEMIOL REV, V29, P62, DOI 10.1093/epirev/mxm003; Kelsey JL., 1996, METHODS OBSERVATIONA; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liu AL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-500; Lizana PA, 2015, NUTR HOSP, V31, P698, DOI 10.3305/nh.2015.31.2.7794; Lombardo C, 2014, EAT WEIGHT DISORD-ST, V19, P329, DOI 10.1007/s40519-013-0085-0; Markey CN, 2010, J YOUTH ADOLESCENCE, V39, P1387, DOI 10.1007/s10964-010-9510-0; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; Mchiza ZJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2324-y; Mchiza ZJ, 2016, HUMAN SCI RES COUNCI; Mchiza ZJ, 2008, THESIS; Monro F, 2005, INT J EAT DISORDER, V38, P85, DOI 10.1002/eat.20153; MOORE FD, 1963, ANN NY ACAD SCI, V110, P62, DOI 10.1111/j.1749-6632.1963.tb17072.x; Mulasi-Pokhriyal U, 2010, BODY IMAGE, V7, P341, DOI 10.1016/j.bodyim.2010.08.002; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; National Department of Health (NDoH) Statistics South Africa (Stats SA) South African Medical Research & Council (SAMRC) & ICF, 2019, S AFR DEM HLTH SURV; O'Haver Judith, 2009, J Pediatr Nurs, V24, P474, DOI 10.1016/j.pedn.2008.06.011; Pasch LA, 2016, MATERN CHILD HLTH J, V20, P1842, DOI 10.1007/s10995-016-1987-z; Pedro TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154784; Poti JM, 2017, CURR OBES REP, V6, P420, DOI 10.1007/s13679-017-0285-4; Puoane T, 2010, ETHNIC DIS, V20, P29; Shisana O, 2014, S AFRICAN NATL HLTH; Stevens J, 1999, OBES RES, V7, P34, DOI 10.1002/j.1550-8528.1999.tb00388.x; STUART A, 1953, BIOMETRIKA, V40, P105, DOI 10.2307/2333101; Sullivan K.M., 2004, EPIDEMIOL MONIT, V25, P3; Tatangelo GL, 2013, BODY IMAGE, V10, P591, DOI 10.1016/j.bodyim.2013.07.006; ter Bogt TFM, 2006, J ADOLESCENT HEALTH, V39, P27, DOI 10.1016/j.jadohealth.2005.09.007; Velasquez Milagros Marcia, 2002, Food and Nutrition Bulletin, V23, P250; Voelker DK, 2015, ADOLESC HEALTH MED T, V6, P149, DOI 10.2147/AHMT.S68344; Vohr BR, 2008, J MATERN-FETAL NEO M, V21, P149, DOI 10.1080/14767050801929430; Wang YF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-183; Wang Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194237; Wang ZM, 1999, AM J CLIN NUTR, V69, P833; WILLIAMS DP, 1992, AM J PUBLIC HEALTH, V82, P358, DOI 10.2105/AJPH.82.3.358; Xie B, 2006, PREV MED, V42, P229, DOI 10.1016/j.ypmed.2005.12.013; Xu FR, 2018, J OBES, V2018, DOI 10.1155/2018/3547856; Young-Hyman D, 2003, J PEDIATR PSYCHOL, V28, P463, DOI 10.1093/jpepsy/jsg037	64	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237399	10.1371/journal.pone.0237399	http://dx.doi.org/10.1371/journal.pone.0237399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC7KJ	32777810	Green Accepted, Green Published, gold			2022-12-26	WOS:000561393800021
J	Krumkamp, R; Oppong, K; Hogan, B; Strauss, R; Frickmann, H; Wiafe-Akenten, C; Boahen, KG; Rickerts, V; Smith, IM; Gross, U; Schulze, M; Jaeger, A; Loderstadt, U; Sarpong, N; Owusu-Dabo, E; May, J; Dekker, D				Krumkamp, Ralf; Oppong, Kwabena; Hogan, Benedikt; Strauss, Ricardo; Frickmann, Hagen; Wiafe-Akenten, Charity; Boahen, Kennedy G.; Rickerts, Volker; McCormick Smith, Ilka; Gross, Uwe; Schulze, Marco; Jaeger, Anna; Loderstaedt, Ulrike; Sarpong, Nimako; Owusu-Dabo, Ellis; May, Juergen; Dekker, Denise			Spectrum of antibiotic resistant bacteria and fungi isolated from chronically infected wounds in a rural district hospital in Ghana	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; PSEUDOMONAS-AERUGINOSA; AGENTS	Background Chronic infected wounds are generally difficult to manage and treatment can be particularly challenging in resource-limited settings where diagnostic testing is not readily available. In this study, the epidemiology of microbial pathogens in chronically infected wounds in rural Ghana was assessed to support therapeutic choices for physicians. Methods Culture-based bacterial diagnostics including antimicrobial resistance testing were performed on samples collected from patients with chronic wounds at a hospital in Asante Akim North Municipality, Ghana. Fungal detection was performed by broad-range fungal PCR and sequencing of amplicons. Results In total, 105 patients were enrolled in the study, from which 207 potential bacterial pathogens were isolated.Enterobacteriaceae(n = 84, 41%) constituted the most frequently isolated group of pathogens. On species level,Pseudomonas aeruginosa(n = 50, 24%) andStaphylococcus aureus(n = 28, 14%) were predominant. High resistance rates were documented, comprising 29% methicillin resistance inS.aureusas well as resistance to 3(rd)generation cephalosporins and fluoroquinolones in 33% and 58% ofEnterobacteriaceae, respectively. OneP.aeruginosastrain with carbapenem resistance was identified. The most frequently detected fungi wereCandida tropicalis. Conclusions The pathogen distribution in chronic wounds in rural Ghana matched the internationally observed patterns with a predominance ofP.aeruginosaandS.aureus. Very high resistance rates discourage antibiotic therapy but suggest an urgent need for microbiological diagnostic approaches, including antimicrobial resistance testing to guide the management of patients with chronic wounds in Ghana.	[Krumkamp, Ralf; Hogan, Benedikt; Strauss, Ricardo; Jaeger, Anna; Loderstaedt, Ulrike; May, Juergen; Dekker, Denise] Bernhard Nocht Inst Trop Med BNITM, Dept Infect Dis Epidemiol, Hamburg, Germany; [Krumkamp, Ralf; Dekker, Denise] German Ctr Infect Res DZIF, Hamburg, Germany; [Oppong, Kwabena; Wiafe-Akenten, Charity; Boahen, Kennedy G.; Sarpong, Nimako; Owusu-Dabo, Ellis] Kumasi Ctr Collaborat Res Trop Med KCCR, Kumasi, Ghana; [Frickmann, Hagen] Bundeswehr Hosp Hamburg, Bernhard Nocht Inst, Dept Trop Med, Hamburg, Germany; [Rickerts, Volker; McCormick Smith, Ilka] Robert Koch Inst RKI, Dept Mycot & Parasit Agents & Mycobacteria, Berlin, Germany; [Gross, Uwe; Schulze, Marco] Univ Med Ctr Gottingen UMG, Inst Med Microbiol, Gottingen, Germany	German Center for Infection Research; Kumasi Center for Collaborative Research; Bernhard Nocht Institut fur Tropenmedizin; Robert Koch Institute	Dekker, D (corresponding author), Bernhard Nocht Inst Trop Med BNITM, Dept Infect Dis Epidemiol, Hamburg, Germany.; Dekker, D (corresponding author), German Ctr Infect Res DZIF, Hamburg, Germany.	dekker@bnitm.de	Akenten, CHARITY Wiafe/GNP-5249-2022; oppong, kwabena/AAO-5163-2021	Akenten, CHARITY Wiafe/0000-0001-6113-7391; oppong, kwabena/0000-0001-5473-9378				Aldrich C, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007485; Bessa LJ, 2015, INT WOUND J, V12, P47, DOI 10.1111/iwj.12049; Codjoe FS, 2019, MICROB DRUG RESIST, V25, P1449, DOI 10.1089/mdr.2018.0278; DeLeon S, 2014, INFECT IMMUN, V82, P4718, DOI 10.1128/IAI.02198-14; Frickmann H, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1448-0; Frickmann H, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9395420; Frickmann H, 2017, EUR J MICROBIOL IMMU, V7, P284, DOI 10.1556/1886.2017.00030; Frickmann H, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/938721; Han A, 2011, WOUND REPAIR REGEN, V19, P532, DOI 10.1111/j.1524-475X.2011.00720.x; Janssen H, 2018, EMERG INFECT DIS, V24, P916, DOI 10.3201/eid2405.171506; Kalan L, 2016, MBIO, V7, DOI [10.1128/mBio.01058-16, 10.1128/mbio.01058-16]; Kassam Nancy A, 2017, BMC Res Notes, V10, P757, DOI 10.1186/s13104-017-3092-9; Kazimoto T, 2018, ACTA TROP, V186, P102, DOI 10.1016/j.actatropica.2018.07.007; Kirketerp-Moller K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08; Kumburu HH, 2017, TROP MED INT HEALTH, V22, P454, DOI 10.1111/tmi.12836; Lai PS, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000475; Mama M, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-14; Micheel V, 2015, EUR J MICROBIOL IMMU, V5, P116, DOI [10.1556/EuJMI-D-15-00001, 10.1556/EUJMI-D-15-00001]; Moremi Nyambura, 2014, BMC Res Notes, V7, P211, DOI 10.1186/1756-0500-7-211; Murray CK, 2006, MIL MED, V171, P821, DOI 10.7205/MILMED.171.9.821; Ntirenganya C, 2015, AM J TROP MED HYG, V92, P865, DOI 10.4269/ajtmh.14-0607; Nunan R, 2014, DIS MODEL MECH, V7, P1205, DOI 10.1242/dmm.016782; Oli AN, 2017, PAN AFR MED J, V27, DOI 10.11604/pamj.2017.27.66.10226; Queiroz-Telles F, 2017, LANCET INFECT DIS, V17, pE367, DOI 10.1016/S1473-3099(17)30306-7; Rahman GA, 2010, ANN AFR MED, V9, P1, DOI 10.4103/1596-3519.62615; Rantala S, 2014, EUR J CLIN MICROBIOL, V33, P1303, DOI 10.1007/s10096-014-2092-0; Rooms I, 2019, EMERG INFECT DIS, V25, P1750, DOI 10.3201/eid2509.181234; Serra R, 2015, EXPERT REV ANTI-INFE, V13, P605, DOI 10.1586/14787210.2015.1023291; Zijlstra EE, 2016, LANCET INFECT DIS, V16, P100, DOI 10.1016/S1473-3099(15)00359-X	29	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237263	10.1371/journal.pone.0237263	http://dx.doi.org/10.1371/journal.pone.0237263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764812	gold, Green Submitted, Green Published			2022-12-26	WOS:000561029000005
J	Lau, Q; Igawa, T; Ogino, H; Katsura, Y; Ikemura, T; Satta, Y				Lau, Quintin; Igawa, Takeshi; Ogino, Hajime; Katsura, Yukako; Ikemura, Toshimichi; Satta, Yoko			Heterogeneity of synonymous substitution rates in the Xenopus frog genome	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; TRANSPOSABLE ELEMENTS; DROSOPHILA-MELANOGASTER; RECOMBINATION RATES; CLAWED FROGS; HYBRIDIZATION; POLYMORPHISM; CHROMOSOMES; DIVERSITY; SELECTION	With the increasing availability of high quality genomic data, there is opportunity to deeply explore the genealogical relationships of different gene loci between closely related species. In this study, we utilized genomes ofXenopus laevis(XLA, a tetraploid species with (L) and (S) sub-genomes) andX.tropicalis(XTR, a diploid species) to investigate whether synonymous substitution rates among orthologous or homoeologous genes displayed any heterogeneity. From over 1500 orthologous/homoeologous genes collected, we calculated proportion of synonymous substitutions between genomes/sub-genomes (k) and found variation within and between chromosomes. Within most chromosomes, we identified higherkwith distance from the centromere, likely attributed to higher substitution rates and recombination in these regions. Using maximum likelihood methods, we identified further evidence supporting rate heterogeneity, and estimated species divergence times and ancestral population sizes. Estimated species divergence times (XLA.L-XLA.S: similar to 25.5 mya; XLA-XTR: similar to 33.0 mya) were slightly younger compared to a past study, attributed to consideration of population size in our study. Meanwhile, we found very large estimated population size in the ancestral populations of the two species (N-A= 2.55 x 10(6)). Local hybridization and population structure, which have not yet been well elucidated in frogs, may be a contributing factor to these possible large population sizes.	[Lau, Quintin; Satta, Yoko] Sokendai Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan; [Igawa, Takeshi; Ogino, Hajime] Hiroshima Univ, Amphibian Res Ctr, Higashihiroshima, Hiroshima, Japan; [Katsura, Yukako] Kyoto Univ, Primate Res Inst, Dept Cellular & Mol Biol, Inuyama, Aichi, Japan; [Ikemura, Toshimichi] Nagahama Inst Biosci & Technol, Dept Biosci, Nagahama, Japan	Graduate University for Advanced Studies - Japan; Hiroshima University; Kyoto University	Lau, Q (corresponding author), Sokendai Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan.	quintin@soken.ac.jp	Igawa, Takeshi/E-2881-2014; Ogino, Hajime/G-5279-2019	Igawa, Takeshi/0000-0001-6880-6180; Ogino, Hajime/0000-0003-2707-2330	Goho Life Sciences International Fund	Goho Life Sciences International Fund	QL was supported by Goho Life Sciences International Fund.	[Anonymous], 2021, LANG ENV STAT COMP; Axelsson E, 2005, GENOME RES, V15, P120, DOI 10.1101/gr.3021305; Bewick AJ, 2012, SYST BIOL, V61, P913, DOI 10.1093/sysbio/sys039; Cannatella D, 2015, CYTOGENET GENOME RES, V145, P283, DOI 10.1159/000438910; CHARLESWORTH B, 1992, GENET RES, V60, P115, DOI 10.1017/S0016672300030809; Chen C, 2020, SCIENCE, V367, P1377, DOI 10.1126/science.aaz5109; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Crawford AJ, 2003, J MOL EVOL, V57, P636, DOI 10.1007/s00239-003-2513-7; Edwards NS, 2005, MOL BIOL CELL, V16, P1800, DOI 10.1091/mbc.e04-09-0788; Evans BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142823; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Fang L, 2008, CHINESE SCI BULL, V53, P746, DOI 10.1007/s11434-008-0159-y; Fischer WJ, 2000, J ZOOL, V252, P99, DOI 10.1017/S0952836900009110; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Furman BLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01104-9; Hellmann I, 2003, AM J HUM GENET, V72, P1527, DOI 10.1086/375657; Hellsten U, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-31; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Jones MR, 2018, SCIENCE, V360, P1355, DOI 10.1126/science.aar5273; Khokha MK, 2009, DEV DYNAM, V238, P1398, DOI 10.1002/dvdy.21965; Knytl M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177087; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; NEI M, 1984, EVOL BIOL, V17, P73; O'hUigin C, 2002, MOL BIOL EVOL, V19, P1501, DOI 10.1093/oxfordjournals.molbev.a004213; Oziolor EM, 2019, SCIENCE, V364, P455, DOI 10.1126/science.aav4155; Rizzon C, 2002, GENOME RES, V12, P400, DOI 10.1101/gr.210802; Satta Y, 2000, MOL PHYLOGENET EVOL, V14, P259, DOI 10.1006/mpev.2000.0704; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Shen JSJ, 2013, GENOME BIOL EVOL, V5, P998, DOI 10.1093/gbe/evt065; Soderlund C, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr123; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Uno Y, 2013, HEREDITY, V111, P430, DOI 10.1038/hdy.2013.65; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	35	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0236515	10.1371/journal.pone.0236515	http://dx.doi.org/10.1371/journal.pone.0236515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764757	gold, Green Published			2022-12-26	WOS:000561029000051
J	Silva, BD; Pacheco, MVC; Godoi, LA; Alhadas, HM; Pereira, JMV; Renno, LN; Detmann, E; Paulino, PVR; Schoonmaker, JP; Valadares, SD				Silva, Breno de Castro; Pacheco, Marcos Vinicius Carneiro; Godoi, Leticia Artuzo; Alhadas, Herlon Menegueli; Pereira, Jessica Marcela Vieira; Renno, Luciana Navajas; Detmann, Edenio; Paulino, Pedro Veiga Rodrigues; Schoonmaker, Jon Patrick; Valadares Filho, Sebastiao de Campos			Reconstituted and ensiled corn or sorghum grain: Impacts on dietary nitrogen fractions, intake, and digestion sites in young Nellore bulls	PLOS ONE			English	Article							POLYCLONAL ANTIBODY PREPARATION; SUBACUTE RUMINAL ACIDOSIS; BLOOD-GAS PROFILE; NUTRITIONAL RECOMMENDATIONS; CARCASS CHARACTERISTICS; FINISHING PERFORMANCE; FEEDLOT PERFORMANCE; PROCESSING METHOD; FEEDING-BEHAVIOR; STARCH DIGESTION	Two experiments were conducted: (1) to evaluate the effect of ensiling time and grain source on dietary nitrogen fractions; and (2) to verify the influence of concentrate level, processing method and grain source on intake, microbial efficiency, and digestibility by young Nellore bulls. In Experiment 1, corn and sorghum grains were milled, reconstituted to 35% moisture, and ensiled in a bag silo for 10 different times. There were three replications per ensiling time and grain source. Samples from each replication were analyzed in triplicate for total nitrogen (N), non-protein nitrogen (NPN), soluble N, insoluble N, and neutral detergent insoluble nitrogen (NDIN). In Experiment 2, five Nellore bulls were used in a 5 x 5 Latin square design. Four diets were comprised of 28.4% corn silage, 10.7% supplement, and 60.9% dry ground corn, dry ground sorghum, reconstituted and ensiled corn, or reconstituted and ensiled ground sorghum. An additional diet comprised of 45% corn silage, 10.7% supplement, and 44.3% dry ground corn (Roughage+) was used. Each experimental period lasted 22 days, with an adaptation period of 14 days followed by 5 days of total feces and urine collection and 3 days of collecting omasal samples. Data were analyzed using the MIXED procedure of SAS 9.4. The reconstitution and ensiling process reduced (P< 0.05) the insoluble N fraction, increased (P< 0.05) non-protein nitrogen of corn and sorghum grains, tended (P= 0.052) to increase microbial efficiency, and increased (P< 0.05) intestinal and total digestion of dry matter (DM), organic matter (OM), crude protein (CP), and starch. The concentrate level affected neither (P> 0.05) DM intake nor rumen pH. On the other hand, bulls fed diets based on 72% concentrate showed greater (P< 0.05) DM, OM, and CP digestibility compared with those fed a diet based on 55% concentrate. In addition, animals fed diets based on corn grains (both reconstituted and ensiled or dry) presented greater (P< 0.05) intestinal and total starch digestion compared to those fed sorghum grain. Therefore, the reconstitution process can reduce the insoluble N fraction and increase nutrient availability.	[Silva, Breno de Castro; Pacheco, Marcos Vinicius Carneiro; Godoi, Leticia Artuzo; Alhadas, Herlon Menegueli; Pereira, Jessica Marcela Vieira; Renno, Luciana Navajas; Detmann, Edenio; Valadares Filho, Sebastiao de Campos] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Paulino, Pedro Veiga Rodrigues] Cargill Anim Nutr Nutron, Campinas, SP, Brazil; [Schoonmaker, Jon Patrick] Purdue Univ, Dept Anim Sci, Creighton Hall Anim Sci, W Lafayette, IN 47907 USA	Universidade Federal de Vicosa; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Silva, BD (corresponding author), Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil.	breno.castro@ufv.br	Filho, Jurandir Pereira/K-2375-2012; Rennó, Luciana Navajas/AAX-9399-2021; Pereira, Jessica Marcela Vieira/GVS-3159-2022	Filho, Jurandir Pereira/0000-0002-7166-458X; Rennó, Luciana Navajas/0000-0002-7125-7781; Pereira, Jessica Marcela Vieira/0000-0002-4731-7633; de Castro Silva, Breno/0000-0002-6855-5550	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Institute Nacional de Cienciae Tecnologia - Ciencia Animal (INCT-CA); Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Institute Nacional de Cienciae Tecnologia - Ciencia Animal (INCT-CA); Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES)	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -http Anpq br (CNPq), the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais http/Avvvw taper-nig br (FAPEM IG), the Institute Nacional de Cienciae Tecnologia -Ciencia Animal (I NCT-CA) -http//inct mpg brAveb/inct ca, and Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior - littp //www capes gov br (CAPES). The Cargill Animal Nutrition/Nutron Company provided support for the study in the form of salary for author PVRP. The Cargill Animal Nutrition/ Nutron Company also donated the grains used in the study. The specific roles of the authors are articulated in the 'author contributions' section. The funding agencies had no other role in the study design, data collection, and analyses, decision to publish, or preparation of the manuscript.	Allen MS, 2014, ANIM PROD SCI, V54, P1513, DOI 10.1071/AN14478; AOAC, 2006, OFFICIAL METHODS ANA; AOAC, 2012, OFFICIAL METHODS ANA; Arcari MA, 2016, ANIM FEED SCI TECH, V221, P167, DOI 10.1016/j.anifeedsci.2016.08.005; Barbosa AM, 2011, J ANIM SCI, V89, P510, DOI 10.2527/jas.2009-2366; Bauer ML, 2001, J ANIM SCI, V79, P1917; Beauchemin KA, 2003, J DAIRY SCI, V86, P630, DOI 10.3168/jds.S0022-0302(03)73641-8; Benedeti PD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198963; Caetano M, 2019, ANIM FEED SCI TECH, V251, P166, DOI 10.1016/j.anifeedsci.2019.03.006; Caetano M, 2015, J ANIM SCI, V93, P4023, DOI 10.2527/jas.2015-9051; Chen X.B., 1995, ESTIMATION MICROBIAL; Cooper RJ, 2002, J ANIM SCI, V80, P797; Detmann E, 2010, ARQ BRAS MED VET ZOO, V62, P980, DOI 10.1590/S0102-09352010000400030; Dijkstra J., 2005, Quantitative aspects of ruminant digestion and metabolism, DOI 10.1079/9780851998145.0000; DOMBRINKKURTZMAN MA, 1993, CEREAL CHEM, V70, P105; FRANCE J, 1986, J THEOR BIOL, V121, P105, DOI 10.1016/S0022-5193(86)80031-5; Granja-Salcedo YT, 2016, ARCH ANIM NUTR, V70, P17, DOI 10.1080/1745039X.2015.1117562; Hoffman PC, 2011, J DAIRY SCI, V94, P2465, DOI 10.3168/jds.2010-3562; Huhtanen P, 1997, J ANIM SCI, V75, P1380; Junges D, 2017, J DAIRY SCI, V100, P9048, DOI 10.3168/jds.2017-12943; Krause KM, 2006, ANIM FEED SCI TECH, V126, P215, DOI 10.1016/j.anifeedsci.2005.08.004; Lechner-Doll M, 1991, FACTORS AFFECTING ME; Licitra G, 1996, ANIM FEED SCI TECH, V57, P347, DOI 10.1016/0377-8401(95)00837-3; Machado MG, 2016, ANIM FEED SCI TECH, V222, P132, DOI 10.1016/j.anifeedsci.2016.10.009; MCALLISTER TA, 1990, CAN J ANIM SCI, V70, P571, DOI 10.4141/cjas90-069; Mertens DR, 2002, J AOAC INT, V85, P1217; Millen DD, 2015, J ANIM SCI, V93, P4387, DOI 10.2527/jas.2015-9227; Mombach MA, 2019, ARQ BRAS MED VET ZOO, V71, P959, DOI 10.1590/1678-4162-9676; Moya D, 2011, J ANIM SCI, V89, P520, DOI 10.2527/jas.2010-3045; Ngu NT, 2019, J ANIM PLANT SCI, V29, P1247; Oba M, 2003, J DAIRY SCI, V86, P184, DOI 10.3168/jds.S0022-0302(03)73599-1; Oliveira CA, 2014, ANIM FEED SCI TECH, V197, P64, DOI 10.1016/j.anifeedsci.2014.08.010; Owens C. E., 2016, Professional Animal Scientist, V32, P531, DOI 10.15232/pas.2016-01510; Owens FN, 1998, J ANIM SCI, V76, P275; OWENS FN, 1986, J ANIM SCI, V63, P1634, DOI 10.2527/jas1986.6351634x; Pacheco RDL, 2012, J ANIM SCI, V90, P1898, DOI 10.2527/jas.2010-3521; Valente TNP, 2011, REV BRAS ZOOTECN, V40, P666, DOI 10.1590/S1516-35982011000300027; Pinto ACJ, 2019, CAN J ANIM SCI, V99, P392, DOI 10.1139/cjas-2018-0031; Plaizier JC, 2008, VET J, V176, P21, DOI 10.1016/j.tvjl.2007.12.016; REIS W., 2001, REV BRAS ZOOTECN, V30, P1308; ROONEY LW, 1986, J ANIM SCI, V63, P1607, DOI 10.2527/jas1986.6351607x; Rotta PP, 2014, J ANIM SCI, V92, P2996, DOI 10.2527/jas.2013-7364; Samuelson KL, 2016, J ANIM SCI, V94, P2648, DOI 10.2527/jas.2016-0282; Silva BC, 2020, J AGR SCI-CAMBRIDGE, V158, P150, DOI 10.1017/S0021859620000271; Silva B. de C., 2018, THESIS; Silva BC, 2016, 6 INT S BEEF CATTL P; Silva BD, 2019, METHODSX, V6, P2322, DOI 10.1016/j.mex.2019.09.040; UDEN P, 1980, J SCI FOOD AGR, V31, P625, DOI 10.1002/jsfa.2740310702; Valadares Filho S.C., 2016, BR CORTE 30 NUTRIENT, DOI [10.5935/978-85-8179-111-1.2016B002, DOI 10.5935/978-85-8179-111-1.2016B002]	49	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237381	10.1371/journal.pone.0237381	http://dx.doi.org/10.1371/journal.pone.0237381			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764802	gold, Green Published			2022-12-26	WOS:000561029000001
J	Kang, WS; Chen, LJ; Wang, YY; Zhu, XF; Liu, XY; Fan, HY; Duan, YX				Kang, Wen-shu; Chen, Li-jie; Wang, Yuan-yuan; Zhu, Xiao-feng; Liu, Xiao-yu; Fan, Hai-yan; Duan, Yu-xi			Bacillus simplex treatment promotes soybean defence against soybean cyst nematodes: A metabolomics study using GC-MS	PLOS ONE			English	Article							ROOT-KNOT NEMATODE; ARABIDOPSIS-THALIANA; METABOLISM; RESISTANCE; INFECTION; BACTERIUM; INDUCTION	We aimed to profile the metabolism of soybean roots that were infected with soybean cyst nematodes and treated withBacillus simplexto identify metabolic differences that may explain nematode resistance. Compared with control soybean roots,B.simplex-treated soybean roots contained lower levels of glucose, fructose, sucrose, and trehalose, which reduced the nematodes' food source. Furthermore, treatment withB.simplexled to higher levels of melibiose, gluconic acid, lactic acid, phytosphingosine, and noradrenaline in soybean roots, which promoted nematocidal activity. The levels of oxoproline, maltose, and galactose were lowered afterB.simplextreatment, which improved disease resistance. Collectively, this study provides insight into the metabolic alterations induced byB.simplextreatment, which affects the interactions with soybean cyst nematodes.	[Kang, Wen-shu] Shenyang Univ, Coll Environm, Shenyang, Peoples R China; [Chen, Li-jie; Zhu, Xiao-feng; Fan, Hai-yan; Duan, Yu-xi] Shenyang Agr Univ, Coll Plant Protect, Shenyang, Peoples R China; [Wang, Yuan-yuan] Shenyang Agr Univ, Coll Biotechnol, Shenyang, Peoples R China; [Liu, Xiao-yu] Shenyang Agr Univ, Coll Sci, Shenyang, Peoples R China	Shenyang University; Shenyang Agricultural University; Shenyang Agricultural University; Shenyang Agricultural University	Duan, YX (corresponding author), Shenyang Agr Univ, Coll Plant Protect, Shenyang, Peoples R China.	duanyx6407@163.com	Zhu, Xiaofeng/AFT-5278-2022		National Natural Science Foundation of China [313300630]; China Agriculture Research System [CARS-04-PS13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This work was supported by the National Natural Science Foundation of China (grant number: 313300630) and China Agriculture Research System (No. CARS-04-PS13).	Aballay A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003433; Abdel-Rahman FH, 2008, J ENVIRON SCI HEAL B, V43, P680, DOI 10.1080/03601230802388751; Afzal AJ, 2009, PLANT PHYSIOL, V151, P1264, DOI 10.1104/pp.109.138149; Bali S, 2017, PROTOPLASMA, P1; Bockenhoff A, 1996, PLANT PHYSIOL, V112, P1421, DOI 10.1104/pp.112.4.1421; Cabello S, 2014, J EXP BOT, V65, P201, DOI 10.1093/jxb/ert359; Cheng JJ, 2003, MOL CELL BIOL, V23, P163, DOI 10.1128/MCB.23.1.163-177.2003; Choudhary DK, 2009, MICROBIOL RES, V164, P493, DOI 10.1016/j.micres.2008.08.007; Danchin EGJ, 2016, MOL BIOL EVOL, V33, P1571, DOI 10.1093/molbev/msw041; Eloh K, 2016, J AGR FOOD CHEM, V64, P5963, DOI 10.1021/acs.jafc.6b02181; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Gao H, 2016, SCI REPORTS, V6; Golinowski W, 1996, PROTOPLASMA, V194, P103, DOI 10.1007/BF01273172; Grundler FMW, 1998, EUR J PLANT PATHOL, V104, P545, DOI 10.1023/A:1008692022279; Hofmann J, 2007, J EXP BOT, V58, P1591, DOI 10.1093/jxb/erl285; Kihika R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02379-8; Lee YS, 2014, J MICROBIOL BIOTECHN, V24, P1510, DOI 10.4014/jmb.1405.05014; Li MT, 2019, AGING MENT HEALTH, V23, P205, DOI 10.1080/13607863.2017.1399349; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu J, 2012, INT J SYST EVOL MICR, V62, P1809, DOI 10.1099/ijs.0.033670-0; MACGUIDWIN AE, 1985, J NEMATOL, V17, P389; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Saint-Mezard P, 2003, J IMMUNOL, V171, P4073, DOI 10.4049/jimmunol.171.8.4073; Singh S, 2016, MICROBIAL MEDIATED I, P57, DOI DOI 10.1007/978-981-10-0388-2_5; Wuyts N, 2006, J EXP BOT, V57, P2825, DOI 10.1093/jxb/erl044; Xiang N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154818; [项鹏 Xiang Peng], 2013, [中国生物防治学报, Chinese Journal of Biological Control], V29, P661; Yang LL, 2012, ANTON LEEUW INT J G, V102, P53, DOI 10.1007/s10482-012-9712-4	28	4	4	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237194	10.1371/journal.pone.0237194	http://dx.doi.org/10.1371/journal.pone.0237194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760135	gold, Green Published			2022-12-26	WOS:000561027200027
J	Peterman, DJ; Mikami, T; Inoue, S				Peterman, David J.; Mikami, Tomoyuki; Inoue, Shinya			The balancing act ofNipponites mirabilis(Nostoceratidae, Ammonoidea): Managing hydrostatics throughout a complex ontogeny	PLOS ONE			English	Article							FUNCTIONAL-MORPHOLOGY; LIFE ORIENTATION; FAR-EAST; HETEROMORPH; AMMONITES; SAKHALIN; MODEL	Nipponitesis a heteromorph ammonoid with a complex and unique morphology that obscures its mode of life and ethology. The seemingly aberrant shell of this Late Cretaceous nostoceratid seems deleterious. However, hydrostatic simulations suggest that this morphology confers several advantages for exploiting a quasi-planktic mode of life. Virtual, 3D models ofNipponites mirabiliswere used to compute various hydrostatic properties through 14 ontogenetic stages. At each stage,Nipponiteshad the capacity for neutral buoyancy and was not restricted to the seafloor. Throughout ontogeny, horizontally facing to upwardly facing soft body orientations were preferred at rest. These orientations were aided by the obliquity of the shell's ribs, which denote former positions of the aperture that were tilted from the growth direction of the shell. Static orientations were somewhat fixed, inferred by stability values that are slightly higher than extantNautilus. The initial open-whorled, planispiral phase is well suited to horizontal backwards movement with little rocking.Nipponitesthen deviated from this bilaterally symmetric coiling pattern with a series of alternating U-shaped bends in the shell. This modification allows for proficient rotation about the vertical axis, while possibly maintaining the option for horizontal backwards movement by redirecting its hyponome. These particular hydrostatic properties likely result in a tradeoff between hydrodynamic streamlining, suggesting thatNipponitesassumed a low energy lifestyle of slowly pirouetting in search for planktic prey. Each computed hydrostatic property influences the others in some way, suggesting thatNipponitesmaintained a delicate hydrostatic balancing act throughout its ontogeny in order to facilitate this mode of life.	[Peterman, David J.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Mikami, Tomoyuki] Univ Tokyo, Dept Biol Sci, Tokyo, Japan; [Inoue, Shinya] Hokkaido Univ, Shumanokai, Hokkaido, Japan	Utah System of Higher Education; University of Utah; University of Tokyo; Hokkaido University	Peterman, DJ (corresponding author), Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA.	sphenodiscus24@gmail.com		Peterman, David/0000-0002-6609-8544; Mikami, Tomoyuki/0000-0002-0507-6819	National Science Foundation (NSF-EAR-PF) [1952756]; Masason Foundation; ANRI fellowship; JSPS (Japan Society for the Promotion of Science) KAKENHI [18J21859]	National Science Foundation (NSF-EAR-PF)(National Science Foundation (NSF)); Masason Foundation; ANRI fellowship; JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	DP thanks the National Science Foundation (NSF-EAR-PF, #1952756) for some research materials and publication fees. SI and TM thank the Masason Foundation, the ANRI fellowship, and the JSPS (Japan Society for the Promotion of Science) KAKENHI (#18J21859) for funding a portion of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autodesk Inc, 2017, NETF 2017 3; Autodesk Inc, 2017, MESHM 3 3; Berry EW, 1928, Q REV BIOL, V3, P92, DOI 10.1086/394295; Blender Online Community, 2017, BLENF 3D MOD REND PA; Cecca Fabrizio, 1998, Atti della Accademia Nazionale dei Lincei Classe di Scienze Fisiche Matematiche e Naturali Rendiconti Lincei Scienze Fisiche e Naturali, V9, P213; Chamberlain J.A. Jr, 1981, Systematics Association Special Volume Series, P289; Cignoni P., 2014, MESHLAB VERSION 1 3; Clements R, 2008, BIOL LETTERS, V4, P179, DOI 10.1098/rsbl.2007.0602; Dacque E., 1935, ORGANISCHE MORPHOLOG; Diener C., 1912, NEUES JB MINERALOGIE, V2, P67; EBEL K, 1992, LETHAIA, V25, P179, DOI 10.1111/j.1502-3931.1992.tb01383.x; Erben H.K., 1950, HEIMAT, V58, P116; Greenwald L., 1987, NAUTILUS BIOL PALEOB; Hasegawa T, 2003, PALAEOGEOGR PALAEOCL, V189, P97, DOI 10.1016/S0031-0182(02)00634-X; Higashiura Kouhei, 2012, Fossils (Tokyo), P19; Hirano H., 1982, P GEOLOGISTS ASS, V93, P213; Hoffmann R, 2014, BIOGEOSCIENCES, V11, P2721, DOI 10.5194/bg-11-2721-2014; Hoffmann R., 2011, IAMG 2011, DOI [10.5242/iamg.2011.0163:506-516, DOI 10.5242/IAMG.2011.0163:506-516]; Hoffmann R., 2020, BIOL REV; Hoffmann R, 2018, PALAEONTOLOGY, V61, P89, DOI 10.1111/pala.12328; Hoffmann R, 2015, TOP GEOBIOL, V43, P613, DOI 10.1007/978-94-017-9630-9_16; ILLERT C, 1990, NUOVO CIMENTO D, V12, P1405, DOI 10.1007/BF02452108; Inoue S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33689; JACOBS DK, 1993, LETHAIA, V26, P101, DOI 10.1111/j.1502-3931.1993.tb01799.x; Kaplan P., 2002, JAHRB GEOL BUNDESANS, V57, P751; Klinger H.C., 1980, AMMONOIDEA, V18, P337; Klug C, 2004, ACTA PALAEONTOL POL, V49, P235; Klug C, 2001, LETHAIA, V34, P215, DOI 10.1080/002411601316981179; Klug C, 2015, AMMONOID PALEOBIOLOG, V44, P515; Klug C, 2012, PALAEONTOLOGY, V55, P1307, DOI 10.1111/j.1475-4983.2012.01196.x; Kruta I, 2010, J PALEONTOL, V84, P556, DOI 10.1666/09-110.1; Landman NH, 2015, TOP GEOBIOL, V44, P497, DOI 10.1007/978-94-017-9633-0_19; Landman NH, 2012, GEOBIOS-LYON, V45, P87, DOI 10.1016/j.geobios.2011.11.006; Lemanis R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151404; Lemanis R, 2015, PALEOBIOLOGY, V41, P313, DOI 10.1017/pab.2014.17; Lukeneder A, 2015, TOP GEOBIOL, V43, P689, DOI 10.1007/978-94-017-9630-9_18; MATSUMOTO T, 1984, Bulletin of the Geological Society of Denmark, V33, P171; Matsumoto T., 1977, MEMOIRS FS KYUSHU D, V23, P303; Mikhailova IA, 2009, PALEONTOL J+, V43, P527, DOI 10.1134/S0031030109050086; Monks Neale, 1998, Palaeontologia Electronica, V1, pUnpaginated; Moore R.C, 1952, INVERTEBRATE FOSSILS; Moron-Alfonso DA, 2019, PALAEONTOL ELECTRON, V22, DOI 10.26879/1007; Muller A.H., 1955, GROBABLAUF STAMMESGE; Naglik C, 2015, TOP GEOBIOL, V43, P649, DOI 10.1007/978-94-017-9630-9_17; Naglik C, 2016, LETHAIA, V49, P3, DOI 10.1111/let.12125; Naglik C, 2015, LETHAIA, V48, P29, DOI 10.1111/let.12085; OKAMOTO T, 1988, PALAEONTOLOGY, V31, P281; OKAMOTO T, 1988, PALEOBIOLOGY, V14, P272, DOI 10.1017/S0094837300012008; OKAMOTO T, 1989, Transactions and Proceedings of the Palaeontological Society of Japan New Series, P117; OKAMOTO T, 1988, PALAEONTOLOGY, V31, P35; OKAMOTO T., 1984, PALAEONTOLOGICAL SOC, V36, P37, DOI DOI 10.14825/KASEKI.36.0_37; Okamoto Takashi, 1996, Topics in Geobiology, V13, P225; PACKARD A, 1980, J MAR BIOL ASSOC UK, V60, P313, DOI 10.1017/S0025315400028368; PACKARD A, 1972, BIOL REV, V47, P241, DOI 10.1111/j.1469-185X.1972.tb00975.x; Palaeontological Society of Japan, 2019, DIG REF COMP TOM NIP; Peterman D.J., 2020, PROJECT NIPPONITES M; Peterman D.J., 2020, J MOLLUS STUD, DOI [10.1093/mollus/eyz035, DOI 10.1093/MOLLUS/EYZ035]; Peterman DJ, 2020, GEOBIOS-LYON, V60, P79, DOI 10.1016/j.geobios.2020.04.004; Peterman DJ, 2020, PALEOBIOLOGY, V46, P237, DOI 10.1017/pab.2020.14; Peterman DJ, 2019, ACTA PALAEONTOL POL, V64, P441, DOI 10.4202/app.00595.2019; Peterman DJ, 2019, PALAEONTOL ELECTRON, V22, DOI 10.26879/884; Peterman DJ, 2019, LETHAIA, V52, P77, DOI 10.1111/let.12291; Raup D. M., 1967, Journal of Paleontology, V41, P43; RAUP DAVID M., 1967, J PALEONTOL, V41, P566; SAUNDERS WB, 1986, PALEOBIOLOGY, V12, P64, DOI 10.1017/S0094837300002980; Schindewolf O. H., 1945, Arb Ungar Biol Forschungsinst, V16, P104; Schindewolf O. H., 1936, PALAONTOLOGIE ENTWIC, pvii; Schindewolf O.H., 1950, GRUNDFRUGEN PALAONTO; Schmidt H., 1930, Palaeontologische Zeitschrift Berlin, V12, P194; Seilacher A, 1995, PALAIOS, V10, P493, DOI 10.2307/3515089; Seilacher A., 2015, MORPHODYNAMICS; Seilacher A, 2013, PALAEONTOLOGY, V56, P1273, DOI 10.1111/pala.12073; Swinnerton H.H., 1930, OUTLINES PALAEONTOLO; Tajika A, 2015, HIST BIOL, V27, P181, DOI 10.1080/08912963.2013.872097; TANABE K, 1981, Transactions and Proceedings of the Palaeontological Society of Japan New Series, P215; Tasch P., 1973, PALEOBIOLOGY INVERTE; Tendler A, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0149-z; Trueman AE., 1940, Q J GEOL SOC LOND, V96, P339, DOI DOI 10.1144/GSL.JGS.1940.096.01-04.14; WARD P, 1979, PALEOBIOLOGY, V5, P415, DOI 10.1017/S0094837300016912; WARD PD, 1977, J PALEONTOL, V51, P367; Westermann Gerd E.G., 1996, Topics in Geobiology, V13, P607; Westermann Gerd E.G., 1999, P299; White Rabbit Co. Ltd, 2019, MOLCER 1 51; Wiedmann J., 1969, BIOL REV CAMB PHILOS, V44, P1, DOI [10.1111/j.1469-185x.1969.tb00819.x, DOI 10.1111/J.1469-185X.1969.TB00819.X]; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Yabe H., 1904, J COLL SCI IMP U TOK, V20, P1; Yazykova EA, 2004, NEW ZEAL J GEOL GEOP, V47, P291, DOI 10.1080/00288306.2004.9515057	87	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0235180	10.1371/journal.pone.0235180	http://dx.doi.org/10.1371/journal.pone.0235180			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760063	Green Submitted, gold, Green Published			2022-12-26	WOS:000561027200048
J	Trondle, T				Troendle, Tim			Supply-side options to reduce land requirements of fully renewable electricity in Europe	PLOS ONE			English	Article							WIND TURBINES; ENERGY; IMPACT; SYSTEM; REANALYSIS; GENERATION; STORAGE; METAANALYSIS; TRANSITION; MODEL	Renewable electricity can fully decarbonise the European electricity supply, but large land requirements may cause land-use conflicts. Using a dynamic model that captures renewable fluctuations, I explore the relationship between land requirements and total system cost of different supply-side options in the future. Cost-minimal fully renewable electricity requires some 97,000 km(2)(2% of total) land for solar and wind power installations, roughly the size of Portugal, and includes large shares of onshore wind. Replacing onshore wind with offshore wind, utility-scale PV, or rooftop PV reduces land requirements drastically with only small cost penalties. Moving wind power offshore is most cost-effective and reduces land requirements by 50% for a cost penalty of only 5%. Wind power can alternatively be replaced by photovoltaics, leading to a cost penalty of 10% for the same effect. My research shows that fully renewable electricity supply can be designed with very different physical appearances and impacts on landscapes and the population, but at similar cost.	[Troendle, Tim] Inst Adv Sustainabil Studies, Potsdam, Germany; [Troendle, Tim] Swiss Fed Inst Technol, Inst Environm Decis, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Trondle, T (corresponding author), Inst Adv Sustainabil Studies, Potsdam, Germany.; Trondle, T (corresponding author), Swiss Fed Inst Technol, Inst Environm Decis, Zurich, Switzerland.	tim.troendle@iass-potsdam.de	Troendle, Tim/GPK-4826-2022	Troendle, Tim/0000-0002-3734-8284	European Research Council grant (TRIPOD) [715132]	European Research Council grant (TRIPOD)	The work of T.T. was supported by a European Research Council grant (TRIPOD, grant agreement number 715132). http://erc.europa.eu The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggreko Y., 2020, CUBE ENERGY STORAGE; [Anonymous], 2018, COM2018773; Bodis K, 2019, RENEW SUST ENERG REV, V114, DOI 10.1016/j.rser.2019.109309; Brinkley C, 2019, ENERGY RES SOC SCI, V50, P51, DOI 10.1016/j.erss.2018.11.014; Brown TW, 2018, RENEW SUST ENERG REV, V92, P834, DOI 10.1016/j.rser.2018.04.113; Bussar C, 2014, ENRGY PROCED, V46, P40, DOI 10.1016/j.egypro.2014.01.156; Caglayan DG, 2019, APPL ENERG, V255, DOI 10.1016/j.apenergy.2019.113794; Capellan-Perez I, 2017, RENEW SUST ENERG REV, V77, P760, DOI 10.1016/j.rser.2017.03.137; Child M, 2019, RENEW ENERG, V139, P80, DOI 10.1016/j.renene.2019.02.077; Connolly D, 2016, RENEW SUST ENERG REV, V60, P1634, DOI 10.1016/j.rser.2016.02.025; de Castro C, 2013, RENEW SUST ENERG REV, V28, P824, DOI 10.1016/j.rser.2013.08.040; de Vries S, 2012, LANDSCAPE URBAN PLAN, V105, P118, DOI 10.1016/j.landurbplan.2011.12.005; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Devine-Wright P, 2010, J ENVIRON PSYCHOL, V30, P271, DOI 10.1016/j.jenvp.2010.01.008; Diffendorfer JE, 2019, PEERJ, V7, DOI 10.7717/peerj.7129; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; Fthenakis V, 2009, RENEW SUST ENERG REV, V13, P1465, DOI 10.1016/j.rser.2008.09.017; Halleraker J., 2016, WORKING GROUP ECOSTA, P104, DOI DOI 10.2760/649695; Herman J., 2017, J OPEN SOURC SOFTW, V2, P97, DOI [DOI 10.21105/JOSS.00097, 10.21105/joss.00097]; Horsch J, 2018, ENERGY STRATEG REV, V22, P207, DOI 10.1016/j.esr.2018.08.012; Horsch J, 2017, INT CONF EUR ENERG, DOI 10.1109/EEM.2017.7982024; IEA, 2019, OFFSH WIND OUTL, P98; Jacobson MZ, 2017, JOULE, V1, P108, DOI 10.1016/j.joule.2017.07.005; JRC, 2014, ETRI 2014 ENERGY TEC; Knebel A., 2016, OPINIONS RENEWABLES; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; MacKay D., 2008, SUSTAINABLE ENERGY H; McKenna R, 2015, ENERGY, V83, P217, DOI 10.1016/j.energy.2015.02.016; Miller LM, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/aaf9cf; Molnarova K, 2012, APPL ENERG, V92, P269, DOI 10.1016/j.apenergy.2011.11.001; Neumann F, 2019, NEAR OPTIMAL FEASIBL; Nitsch F, 2019, ENERGY SUSTAIN SOC, V9, DOI 10.1186/s13705-019-0234-z; Palmer-Wilson K, 2019, ENERG POLICY, V129, P193, DOI 10.1016/j.enpol.2019.01.071; Pfenninger S., 2018, J OPEN SOURCE SOFTW, V3, P825, DOI [10.21105/joss.00825, DOI 10.21105/joss.00825]; Pfenninger S, 2016, ENERGY, V114, P1251, DOI 10.1016/j.energy.2016.08.060; Plessmann G, 2017, ENERGY STRATEG REV, V15, P19, DOI 10.1016/j.esr.2016.11.003; Ruiz P, 2019, ENERGY STRATEG REV, V26, DOI 10.1016/j.esr.2019.100379; Ruiz P., 2015, JRC EU TIMES MODEL B, DOI [10.2790/39014., DOI 10.2790/39014]; Sanchez-Pantoja N, 2018, RENEW SUST ENERG REV, V98, P227, DOI 10.1016/j.rser.2018.09.021; Schlachtberger DP, 2017, ENERGY, V134, P469, DOI 10.1016/j.energy.2017.06.004; Schmidt O, 2019, JOULE, V3, P81, DOI 10.1016/j.joule.2018.12.008; Setton D., 2019, CORE STATEMENTS SUMM, DOI [10.2312/iass.2019.014, DOI 10.2312/IASS.2019.014]; Smil V., 2015, POWER DENSITY KEY UN; Spath L, 2018, ENERG POLICY, V122, P429, DOI 10.1016/j.enpol.2018.07.029; Steffen B., 2019, 3373905 SOC SCI RES; Stevens L, 2017, STRATA; Stokes LC, 2016, AM J POLIT SCI, V60, P958, DOI 10.1111/ajps.12220; Trondle T, 2019, ENERGY STRATEG REV, V26, DOI 10.1016/j.esr.2019.100388; Trondle T., 2020, JOULE, DOI 10/gg8zk2; Trondle T., 2020, EURO CALLIOPE, DOI [10.5281/zenodo.3949794, DOI 10.5281/ZENODO.3949794]; Trondle T., 2020, CODE RELATED TRONDLE, DOI [10.5281/zenodo.3956531, DOI 10.5281/ZENODO.3956531]; Turney D, 2011, RENEW SUST ENERG REV, V15, P3261, DOI 10.1016/j.rser.2011.04.023; van Zalk J, 2018, ENERG POLICY, V123, P83, DOI 10.1016/j.enpol.2018.08.023; Weselek A, 2019, AGRON SUSTAIN DEV, V39, DOI 10.1007/s13593-019-0581-3; Wirth H., 2020, RECENT FACTS PHOTOVO, P98; Wirth H, 2017, AKTUELLE FAKTEN PHOT; ZSW Bosch & Partner, 2019, VORB BEGL ERST EIN E, P169	58	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236958	10.1371/journal.pone.0236958	http://dx.doi.org/10.1371/journal.pone.0236958			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2EP	32760117	Green Published, gold			2022-12-26	WOS:000561027200057
J	Fioretti, C; Magni, E; Barlocco, F; Tomberli, A; Baldini, K; Ingles, J; Smorti, A; Olivotto, I				Fioretti, Chiara; Magni, Elisa; Barlocco, Fausto; Tomberli, Alessia; Baldini, Katia; Ingles, Jodie; Smorti, Andrea; Olivotto, Iacopo			Doctor-patient care relationship in genetic cardiomyopathies: An exploratory study on clinical consultations	PLOS ONE			English	Article							ILLNESS; CLASSIFICATION; COMMUNICATION; PERCEPTIONS; MEDICINE	Background The present study aims to explore the setting of consultation and communication between physicians and patients affected by genetic cardiomyopathies, investigating how the two parts of the therapeutic relationship participate and share information. Methods and results 45 adult patients affected by various cardiomyopathies took part in a prospective case study while attending consultations at a cardiologic outpatient clinic constituting an Italian referral centre for cardiomyopathies. A researcher observed the consultations, which were audio-recorded and transcribed. Transcripts were coded and an analysis of setting, type of communication implemented and participation of doctors and patients in terms of word-count and type of questions/answers was carried out. Overall word-count was significantly higher for physicians than for patients (t(44) = 9,506;p<0.001). Doctors were prone to ask closed questions (t(44) = -11,90;p<0.001) while patients preferred open answers (t(44) = 5.58;p<0.001), enriched with subjective issues related to their illness experience. Partial correlation highlights a significant positive relation between doctors' closed question and patients' open answers (r= .838;p<0.001). Conclusions Findings emphasize patients' need for adequate time and space to share their subjective illness experience with the physician, within an approach informed by the insights and recommendations of Narrative Medicine. These findings are instrumental to improving the specific clinical setting for individuals with genetic cardiomyopathies.	[Fioretti, Chiara; Magni, Elisa; Smorti, Andrea] Univ Florence, Dept Educ Languages Intercultures Literatures & P, Florence, Italy; [Barlocco, Fausto; Tomberli, Alessia; Baldini, Katia; Olivotto, Iacopo] Univ Florence, Careggi Univ Hosp, Cardiomyopathy Unit, Florence, Italy; [Ingles, Jodie] Univ Sydney, Cardio Genom Program, Centenary Inst, Camperdown, NSW, Australia; [Ingles, Jodie] Royal Prince Alfred Hosp, Camperdown, NSW, Australia	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Sydney; Centenary Institute; University of Sydney	Fioretti, C (corresponding author), Univ Florence, Dept Educ Languages Intercultures Literatures & P, Florence, Italy.	chiara.fioretti@unifi.it	Ingles, Jodie/J-3113-2019; Olivotto, Iacopo/AAC-5950-2022	Ingles, Jodie/0000-0002-4846-7676; Olivotto, Iacopo/0000-0003-1751-9266; Fioretti, Chiara/0000-0002-1440-9398				BURY M, 1991, SOCIOL HEALTH ILL, V13, P451, DOI 10.1111/j.1467-9566.1991.tb00522.x; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Charon R., 2006, NARRATIVE MED HONORI; Easter David W, 2004, Curr Surg, V61, P313, DOI 10.1016/j.cursur.2003.12.006; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Fioretti C, 2014, COMMUNITY MED, V11, P275; Fioretti C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011220; Greenhalgh T, 1999, BRIT MED J, V318, P48; Greenhalgh T, 1999, BMJ-BRIT MED J, V318, P323, DOI 10.1136/bmj.318.7179.323; Haidet P, 2003, ARCH INTERN MED, V163, P1134, DOI 10.1001/archinte.163.10.1134; Hyden LC, 1997, SOCIOL HEALTH ILL, V19, P48, DOI 10.1111/1467-9566.00040; Ingles J, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a036558; Kambhampati S, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0729-6; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Kleinman A., 1999, ILLNESS NARRATIVES; Leckie J, 2006, PATIENT EDUC COUNS, V64, P69, DOI 10.1016/j.pec.2005.11.015; Maron BJ, 2014, J AM COLL CARDIOL, V64, P83, DOI 10.1016/j.jacc.2014.05.003; Mintz David, 1992, J Med Humanit, V13, P223, DOI 10.1007/BF01137420; Newell S, 1998, CANCER-AM CANCER SOC, V83, P1640, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1640::AID-CNCR21>3.3.CO;2-R; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Pilnick A, 2011, SOC SCI MED, V72, P1374, DOI 10.1016/j.socscimed.2011.02.033; Smagarinsky Yana, 2017, Pilot Feasibility Stud, V3, P53, DOI 10.1186/s40814-017-0205-0; Subasic K, 2013, J NURS SCHOLARSHIP, V45, P371, DOI 10.1111/jnu.12040; Thiene G, 2008, EUR HEART J, V29, P144; Tsianakas V, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-271; vanDulmen AM, 1997, PATIENT EDUC COUNS, V30, P227, DOI 10.1016/S0738-3991(96)00965-2	26	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236814	10.1371/journal.pone.0236814	http://dx.doi.org/10.1371/journal.pone.0236814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NB3DK	32756572	Green Published, gold			2022-12-26	WOS:000560393300002
J	Horns, F; Quake, SR				Horns, Felix; Quake, Stephen R.			Cloning antibodies from single cells in pooled sequence libraries by selective PCR	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; DESIGN	Antibodies function by binding to antigens. Antibodies must be cloned and expressed to determine their binding characteristics, but current methods for high-throughput antibody sequencing yield antibody DNA pooled from many cells and do not readily permit cloning of antibodies from single B cells. We present a strategy for retrieving and cloning antibody DNA from single cells within a pooled library of cells. Our strategy, called selective PCR for antibody retrieval (SPAR), takes advantage of the unique sequence barcodes attached to individual cDNA molecules during sample preparation to enable specific amplification by PCR of antibody heavy- and light-chain cDNA originating from a single cell. We show through computational analysis that most human antibodies sequenced using typical high-throughput methods can be retrieved using SPAR, and experimentally demonstrate retrieval of full-length antibody variable region cDNA from three cells within pools of similar to 5,000 cells. SPAR enables rapid low-cost cloning and expression of native human antibodies from pooled single-cell sequence libraries for functional characterization.	[Horns, Felix] Stanford Univ, Biophys Grad Program, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Quake, Stephen R.] Chan Zuckerberg Biohub, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Quake, SR (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.; Quake, SR (corresponding author), Chan Zuckerberg Biohub, Stanford, CA 94305 USA.	steve@quake-lab.org			ChanZuckerberg Biohub	ChanZuckerberg Biohub	This work was funded by the ChanZuckerberg Biohub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briney B, 2019, NATURE, V566, P393, DOI 10.1038/s41586-019-0879-y; Croote D, 2018, SCIENCE, V362, P1306, DOI 10.1126/science.aau2599; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Goldstein LD, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0551-y; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Horns F, 2020, CELL REP, V30, P905, DOI 10.1016/j.celrep.2019.12.063; Horns F, 2019, P NATL ACAD SCI USA, V116, P1261, DOI 10.1073/pnas.1814213116; Kluyver T, 2016, POSITIONING AND POWER IN ACADEMIC PUBLISHING: PLAYERS, AGENTS AND AGENDAS, P87, DOI 10.3233/978-1-61499-649-1-87; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McDaniel JR, 2016, NAT PROTOC, V11, P429, DOI 10.1038/nprot.2016.024; Ranu N, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gky856; Rosenberg AB, 2018, SCIENCE, V360, P176, DOI 10.1126/science.aam8999; Schwartz JJ, 2012, NAT METHODS, V9, P913, DOI 10.1038/nmeth.2137; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Woodruff LBA, 2017, NUCLEIC ACIDS RES, V45, P1553, DOI 10.1093/nar/gkw1226; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382	18	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236477	10.1371/journal.pone.0236477	http://dx.doi.org/10.1371/journal.pone.0236477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756607	Green Published, gold			2022-12-26	WOS:000560393300037
J	Lao, AN; Cabezas, H; Orosz, A; Friedler, F; Tan, RD				Lao, Angelyn; Cabezas, Heriberto; Orosz, Akos; Friedler, Ferenc; Tan, Raymond			Socio-ecological network structures from process graphs	PLOS ONE			English	Article							ECOSYSTEM SERVICES; THEORETIC APPROACH; HABITAT; MODEL	We propose a process graph (P-graph) approach to develop ecosystem networks from knowledge of the properties of the component species. Originally developed as a process engineering tool for designing industrial plants, the P-graph framework has key advantages over conventional ecological network analysis techniques based on input-output models. A P-graph is a bipartite graph consisting of two types of nodes, which we propose to represent components of an ecosystem. Compartments within ecosystems (e.g., organism species) are represented by one class of nodes, while the roles or functions that they play relative to other compartments are represented by a second class of nodes. This bipartite graph representation enables a powerful, unambiguous representation of relationships among ecosystem compartments, which can come in tangible (e.g., mass flow in predation) or intangible form (e.g., symbiosis). For example, within a P-graph, the distinct roles of bees as pollinators for some plants and as prey for some animals can be explicitly represented, which would not otherwise be possible using conventional ecological network analysis. After a discussion of the mapping of ecosystems into P-graph, we also discuss how this framework can be used to guide understanding of complex networks that exist in nature. Two component algorithms of P-graph, namely maximal structure generation (MSG) and solution structure generation (SSG), are shown to be particularly useful for ecological network analysis. These algorithms enable candidate ecosystem networks to be deduced based on current scientific knowledge on the individual ecosystem components. This method can be used to determine the (a) effects of loss of specific ecosystem compartments due to extinction, (b) potential efficacy of ecosystem reconstruction efforts, and (c) maximum sustainable exploitation of human ecosystem services by humans. We illustrate the use of P-graph for the analysis of ecosystem compartment loss using a small-scale stylized case study, and further propose a new criticality index that can be easily derived from SSG results.	[Lao, Angelyn] De La Salle Univ, Dept Math & Stat, Manila, Philippines; [Cabezas, Heriberto] Univ Miskolc, Res Inst Appl Earth Sci, Miskolc, Hungary; [Cabezas, Heriberto; Friedler, Ferenc] Pazmany Peter Catholic Univ, Inst Proc Syst Engn & Sustainabil, Budapest, Hungary; [Orosz, Akos] Univ Pannonia, Dept Comp Sci & Syst Technol, Veszprem, Hungary; [Friedler, Ferenc] Szecheny Istvan Univ, Debrecen, Hungary; [Tan, Raymond] De La Salle Univ, Chem Engn Dept, Manila, Philippines	De La Salle University; University of Miskolc; University of Pannonia; De La Salle University	Lao, AN (corresponding author), De La Salle Univ, Dept Math & Stat, Manila, Philippines.	angelyn.lao@dlsu.edu.ph	Orosz, Ákos/K-7548-2019	Orosz, Ákos/0000-0001-8064-4487; Friedler, Ferenc/0000-0002-8069-8562; Lao, Angelyn/0000-0003-3028-9610	Pazmany Peter Catholic University Central Funds Program	Pazmany Peter Catholic University Central Funds Program	This work was supported by the Pazmany Peter Catholic University Central Funds Program to HC, which allowed for the conduct of discussions among the authors of this manuscript. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, CHEM ENG TRANS, DOI DOI 10.3303/CETI; Bodin O, 2019, NAT SUSTAIN, V2, P551, DOI 10.1038/s41893-019-0308-0; Cabezas H, 2007, RESOUR CONSERV RECY, V50, P122, DOI 10.1016/j.resconrec.2006.06.011; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Daily G.C., 1997, NATURES SERVICES, V3; Diaz S, 2019, SCIENCE, V366, P1327, DOI 10.1126/science.aax3100; Doshi R, 2015, CLEAN TECHNOL ENVIR, V17, P1573, DOI 10.1007/s10098-014-0889-2; Fath B, 2018, ENCY ECOLOGY, V1, P643; Fath B. D., 2017, INT J DESIGN NATURE, V12, P1, DOI [DOI 10.2495/DNE-V12-N1-1-15, 10.2495/DNE-V12-N1-1-15]; Fath BD, 2007, ECOL MODEL, V208, P49, DOI 10.1016/j.ecolmodel.2007.04.029; Fiedler AK, 2008, BIOL CONTROL, V45, P254, DOI 10.1016/j.biocontrol.2007.12.009; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; FRIEDLER F, 1992, COMPUT CHEM ENG, V16, pS313, DOI 10.1016/S0098-1354(09)80037-9; FRIEDLER F, 1992, CHEM ENG SCI, V47, P1973, DOI 10.1016/0009-2509(92)80315-4; FRIEDLER F, 1993, COMPUT CHEM ENG, V17, P929, DOI 10.1016/0098-1354(93)80074-W; Friedler F, 1996, NONCON OPTIM ITS APP, V7, P609; Friedler F, 2019, CURR OPIN CHEM ENG, V26, P58, DOI 10.1016/j.coche.2019.08.007; Ganin AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19540; HANNON B, 1973, J THEOR BIOL, V41, P535, DOI 10.1016/0022-5193(73)90060-X; Hutchinson MC, 2019, FUNCT ECOL, V33, P206, DOI 10.1111/1365-2435.13237; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jordan Ferenc, 2019, Current Opinion in Systems Biology, V13, P122, DOI 10.1016/j.coisb.2018.12.004; Jordan F, 2009, PHILOS T R SOC B, V364, P1733, DOI 10.1098/rstb.2008.0335; Kefi S., 2017, ADAPTIVE FOOD WEBS S, P73; Lakner R, 2017, LECT NOTES COMPUT SC, V10258, P309, DOI 10.1007/978-3-319-57861-3_18; Lau MK, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1900; Linkov I., 2019, SCI PRACTICE RESILIE; Orosz A, 2019, COMPUT-AIDED CHEM EN, V46, P1405, DOI 10.1016/B978-0-12-818634-3.50235-6; Pilosof S, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0101; Poisot T, 2016, FUNCT ECOL, V30, P1878, DOI 10.1111/1365-2435.12799; Remmers W, 2017, AFR J ECOL, V55, P342, DOI 10.1111/aje.12358; SAATY TL, 1990, EUR J OPER RES, V48, P9, DOI 10.1016/0377-2217(90)90057-I; Sterner R.W., 2008, ENCY ECOLOGY, P1101, DOI [10.1016/B978-008045405-4.00309-8, DOI 10.1016/B978-008045405-4.00309-8]	33	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0232384	10.1371/journal.pone.0232384	http://dx.doi.org/10.1371/journal.pone.0232384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750052	Green Submitted, gold, Green Published			2022-12-26	WOS:000560009200044
J	Stromback, M; Fjellman-Wiklund, A; Keisu, S; Sturesson, M; Eskilsson, T				Stromback, Maria; Fjellman-Wiklund, Anncristine; Keisu, Sara; Sturesson, Marine; Eskilsson, Therese			Restoring confidence in return to work: A qualitative study of the experiences of persons with exhaustion disorder after a dialogue-based workplace intervention	PLOS ONE			English	Article							SICKNESS ABSENCE; EMPLOYEES; INDIVIDUALS; DISTRESS; BURNOUT; TRIAL; WOMEN	Background Stress-induced exhaustion disorder (SED) is a primary cause for sickness absence among persons with mental health disorders in Sweden. Interventions involving the workplace, and supporting communication between the employee and the supervisor, are proposed to facilitate return to work (RTW). The aim of this study was to explore experiences of persons with SED who participated in a dialogue-based workplace intervention with a convergence dialogue meeting performed by a rehabilitation coordinator. Methods A qualitative design based on group interviews with 15 persons with SED who participated in a 24-week multimodal rehabilitation program was used. The interviews were analyzed with the methodology of grounded theory. Results The analysis resulted in a theoretical model where the core category, restoring confidence on common ground, represented a health promoting process that included three phases: emotional entrance, supportive guidance, and empowering change. The health promoting process was represented in participant experiences of personal progress and safety in RTW. Conclusions The intervention built on a health-promoting pedagogy, supported by continuous guidance from a rehabilitation coordinator and structured convergence dialogue meetings that enhanced common communication and collaboration with the supervisor and others involved in the RTW process. The intervention balanced relationships, transferred knowledge, and changed attitudes about SED among supervisors and colleagues in the workplace. The inclusion of a rehabilitation coordinator in the intervention was beneficial by enhancing RTW and bridging the gaps between healthcare, the workplace, and other organizational structures. In addition, the intervention contributed to a positive re-orientation towards successful RTW instead of an endpoint of employment. In a prolonged process, a dialogue-based workplace intervention with convergence dialogue meetings and a rehabilitation coordinator may support sustainable RTW for persons with SED.	[Stromback, Maria; Fjellman-Wiklund, Anncristine; Keisu, Sara; Eskilsson, Therese] Umea Univ, Dept Community Med & Rehabil, Physiotherapy, Umea, Sweden; [Stromback, Maria] Umea Univ, Dept Clin Sci, Psychiat, Umea, Sweden; [Sturesson, Marine] Umea Univ, Dept Community Med & Rehabil, Occupat Therapy, Umea, Sweden; [Eskilsson, Therese] Umea Univ, Dept Publ Hlth & Clin Med, Sect Sustainable Hlth, Umea, Sweden	Umea University; Umea University; Umea University; Umea University	Stromback, M (corresponding author), Umea Univ, Dept Community Med & Rehabil, Physiotherapy, Umea, Sweden.; Stromback, M (corresponding author), Umea Univ, Dept Clin Sci, Psychiat, Umea, Sweden.	maria.stromback@umu.se		Stromback, Maria/0000-0003-2597-2466	AFA Insurance; Region Vasterbotten in Sweden; AFA Insurance [150274]	AFA Insurance; Region Vasterbotten in Sweden; AFA Insurance	This work received support from AFA Insurance, and Region Vasterbotten in Sweden. TE received the award with grant number: AFA Insurance Dnr 150274. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AFA Insurance: https://www.afaforsakring.se/andrasprak/engelska/The Vasterbotten County Council: https://regionvasterbotten.se/informationsmaterialoch-riktlinjer/andra-sprak/engelska-eller-english The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MF, 2012, SCAND J WORK ENV HEA, V38, P93, DOI 10.5271/sjweh.3257; [Anonymous], 2007, QUALITATIVE METHODOL; Arends I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006389.pub2; Aronsson G, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4153-7; Aust B, 2015, SCAND J WORK ENV HEA, V41, P529, DOI 10.5271/sjweh.3528; Awa WL, 2010, PATIENT EDUC COUNS, V78, P184, DOI 10.1016/j.pec.2009.04.008; Bjork L, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5714-0; Charmaz Kathy, 2014, INTRO QUALITATIVE ME, V2nd; Cole Michael, 1985, CULTURE COMMUNICATIO, P146; Cullen KL, 2018, J OCCUP REHABIL, V28, P1, DOI 10.1007/s10926-016-9690-x; Danielsson L, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4388-3; de Weerd BJ, 2016, WORK, V54, P647, DOI 10.3233/WOR-162307; Ekberg K, 2015, J OCCUP REHABIL, V25, P627, DOI 10.1007/s10926-015-9570-9; Ekholm D., 2012, HOGRE UTBILDNING, V2, P67; Eskilsson T, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1457-1; Eurofond, 2017, EF1708; Eurofond, 2018, EF18047; Falk A., 2015, NATURE PREDICTIVE PO, V9504, P1, DOI DOI 10.2139/SSRN.2691910; Finnes A, 2019, J OCCUP HEALTH PSYCH, V24, P198, DOI 10.1037/ocp0000097; Forsakringskassan [The Social Insurance Office], 2017, KORTA ANAL, V2017, P1; Gavelin H.M., 2015, STRESS AMSTERDAM NET, P1; Glise K, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-118; Glise K, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-18; Grossi G, 2015, SCAND J PSYCHOL, V56, P626, DOI 10.1111/sjop.12251; Gunnarsson K, 2014, SMALL ENTERP RES, V21, P229, DOI 10.1080/13215906.2014.11082091; Harkness AMB, 2005, WORK STRESS, V19, P121, DOI 10.1080/02678370500160068; Hasselberg K, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-66; Henderson M, 2011, J ROY SOC MED, V104, P198, DOI 10.1258/jrsm.2011.100231; Holmgren K, 2004, DISABIL REHABIL, V26, P213, DOI 10.1080/09638280310001644898; KARLSON B, 2014, BMC PUBLIC HEALTH, V14, P67641, DOI DOI 10.1186/1471-2458-14-14; Karlson B, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-301; Long BC, 2008, QUAL HEALTH RES, V18, P1413, DOI 10.1177/1049732308322604; Lork K, 2018, WORK, V59, P479, DOI 10.3233/WOR-182697; Morgan D.L., 1998, PLANNING FOCUS GROUP; Nieuwenhuijsen K, 2004, OCCUP ENVIRON MED, V61, P817, DOI 10.1136/oem.2003.009688; Nieuwenhuijsen K, 2010, OCCUP MED-OXFORD, V60, P277, DOI 10.1093/occmed/kqq081; Nieuwenhuijsen K, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006237.pub3, 10.1002/14651858.CD006237.pub4]; Nigatu YT, 2016, PSYCHOL MED, V46, P3263, DOI 10.1017/S0033291716002269; Noordik E, 2011, DISABIL REHABIL, V33, P1625, DOI 10.3109/09638288.2010.541547; Norlund S, 2013, J OCCUP REHABIL, V23, P270, DOI 10.1007/s10926-012-9396-7; OECD, 2012, SICK JOB MYTHS REAL; Perski O, 2017, SCAND J PSYCHOL, V58, P551, DOI 10.1111/sjop.12398; Sennehed CP, 2018, PAIN, V159, P1456, DOI 10.1097/j.pain.0000000000001216; Shaw W, 2008, J OCCUP REHABIL, V18, P2, DOI 10.1007/s10926-007-9115-y; Stahl ACF, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5778-x; Stockholms lans landsting [Stockholm County Council], 2016, HLTH NAVIGATOR; Sundet Rolf, 2010, Clin Child Psychol Psychiatry, V15, P81, DOI 10.1177/1359104509341449; Sverige S, 2003, UTMATTNINGSSYNDROM S; van Oostrom SH, 2010, OCCUP ENVIRON MED, V67, P596, DOI 10.1136/oem.2009.050849; van Oostrom SH, 2009, J OCCUP REHABIL, V19, P212, DOI 10.1007/s10926-009-9170-7; Verdonk P, 2008, PATIENT EDUC COUNS, V73, P300, DOI 10.1016/j.pec.2008.06.003; Vygotskij LS, 1978, MIND SOC DEV HIGHER; Wallensten J, 2019, J REHABIL MED, V51, P331, DOI 10.2340/16501977-2545; Wertsch J. V., 1985, CULTURE COMMUNICATIO; Wood D, 1996, OXFORD REV EDUC, V22, P5, DOI 10.1080/0305498960220101; Zorga Sonja, 2002, J Interprof Care, V16, P265, DOI 10.1080/13561820220146694	56	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0234897	10.1371/journal.pone.0234897	http://dx.doi.org/10.1371/journal.pone.0234897			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NO3EK	32735586	Green Published, gold			2022-12-26	WOS:000569367100006
J	Prasai, A; Cernohorska, MS; Ruppova, K; Niederlova, V; Andelova, M; Draber, P; Stepanek, O; Huranova, M				Prasai, Avishek; Schmidt Cernohorska, Marketa; Ruppova, Klara; Niederlova, Veronika; Andelova, Monika; Draber, Peter; Stepanek, Ondrej; Huranova, Martina			The BBSome assembly is spatially controlled by BBS1 and BBS4 in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bardet-Biedl Syndrome; BBSome; assembly; cilium; ciliopathy; protein sorting; protein assembly; primary cilium; microscopic imaging; genetic disease; Bardet-Biedl syndrome	BARDET-BIEDL-SYNDROME; FLUORESCENCE CORRELATION SPECTROSCOPY; SYNDROME PROTEIN COMPLEX; RECEPTORS; FAMILY; CARGO; TRAFFICKING; MUTATIONS; INTERACT; PATHWAY	Bardet-Biedl syndrome (BBS) is a pleiotropic ciliopathy caused by dysfunction of primary cilia. More than half of BBS patients carry mutations in one of eight genes encoding for subunits of a protein complex, the BBSome, which mediates trafficking of ciliary cargoes. In this study, we elucidated the mechanisms of the BBSome assembly in living cells and how this process is spatially regulated. We generated a large library of human cell lines deficient in a particular BBSome subunit and expressing another subunit tagged with a fluorescent protein. We analyzed these cell lines utilizing biochemical assays, conventional and expansion microscopy, and quantitative fluorescence microscopy techniques: fluorescence recovery after photobleaching and fluorescence correlation spectroscopy. Our data revealed that the BBSome formation is a sequential process. We show that the pre-BBSome is nucleated by BBS4 and assembled at pericentriolar satellites, followed by the translocation of the BBSome into the ciliary base mediated by BBS1. Our results provide a framework for elucidating how BBS-causative mutations interfere with the biogenesis of the BBSome.	[Prasai, Avishek; Schmidt Cernohorska, Marketa; Ruppova, Klara; Niederlova, Veronika; Andelova, Monika; Draber, Peter; Stepanek, Ondrej; Huranova, Martina] Czech Acad Sci, Inst Mol Genet, Lab Adapt Immun, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Stepanek, O; Huranova, M (corresponding author), Czech Acad Sci, Inst Mol Genet, Lab Adapt Immun, Prague, Czech Republic.	martina.huranova@img.cas.cz; ondrej.stepanek@img.cas.cz	Draber, Peter/G-3141-2014; Niederlova, Veronika/HGA-7771-2022	Draber, Peter/0000-0001-8658-4614; Prasai, Avishek/0000-0002-5666-6691; Schmidt Cernohorska, Marketa/0000-0001-9053-8928; Stepanek, Ondrej/0000-0002-2735-3311; Niederlova, Veronika/0000-0001-8768-9039; Huranova, Martina/0000-0002-4403-1146	Czech Science Foundation [17-20613Y]; EMBO Installation Grant [3259]; Institute of Molecular Genetics of the Czech Academy of Sciences core funding [RVO 68378050]; Purkyne Fellowship by the Czech Academy of Sciences; Faculty of Science, Charles University, Prague	Czech Science Foundation(Grant Agency of the Czech Republic); EMBO Installation Grant; Institute of Molecular Genetics of the Czech Academy of Sciences core funding; Purkyne Fellowship by the Czech Academy of Sciences; Faculty of Science, Charles University, Prague	This study was supported by Czech Science Foundation Grant 17-20613Y (to M. H.). The Group of Adaptive Immunity is supported by EMBO Installation Grant 3259 (to O. S.) and Institute of Molecular Genetics of the Czech Academy of Sciences core funding (RVO 68378050). O. S. is supported by the Purkyne Fellowship provided by the Czech Academy of Sciences. A. P. and V. N. are students partially supported by the Faculty of Science, Charles University, Prague.	Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Chamling X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004083; Chou HT, 2019, STRUCTURE, V27, P1384, DOI 10.1016/j.str.2019.06.006; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Dilan TL, 2018, HUM MOL GENET, V27, P283, DOI 10.1093/hmg/ddx399; Forsythe E, 2013, EUR J HUM GENET, V21, P8, DOI 10.1038/ejhg.2012.115; Gambarotto D, 2019, NAT METHODS, V16, P71, DOI 10.1038/s41592-018-0238-1; Guo DF, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005890; Hernandez-Hernandez V, 2013, HUM MOL GENET, V22, P3858, DOI 10.1093/hmg/ddt241; Huranova M, 2016, EMBO REP, V17, P202, DOI 10.15252/embr.201540795; Huranova M, 2010, J CELL BIOL, V191, P75, DOI 10.1083/jcb.201004030; Jiang JS, 2016, J GENET GENOMICS, V43, P381, DOI 10.1016/j.jgg.2015.11.006; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Katoh Y, 2015, J CELL SCI, V128, P2351, DOI 10.1242/jcs.168740; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Klink BU, 2020, ELIFE, V9, DOI 10.7554/eLife.53910; Klink BU, 2017, ELIFE, V6, DOI 10.7554/eLife.27434; Knockenhauer KE, 2015, J BIOL CHEM, V290, P19569, DOI 10.1074/jbc.M115.649202; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Labun K, 2019, NUCLEIC ACIDS RES, V47, pW171, DOI 10.1093/nar/gkz365; Liu PW, 2018, P NATL ACAD SCI USA, V115, pE934, DOI 10.1073/pnas.1713226115; Loktev AV, 2013, CELL REP, V5, P1316, DOI 10.1016/j.celrep.2013.11.011; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Machan R., 2016, PRACTICAL MANUAL FLU, P5; Marion V, 2012, J MED GENET, V49, P317, DOI 10.1136/jmedgenet-2012-100737; McIntyre JC, 2016, METHOD CELL BIOL, V132, P35, DOI 10.1016/bs.mcb.2015.11.009; Mourao A, 2014, NAT STRUCT MOL BIOL, V21, P1035, DOI 10.1038/nsmb.2920; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2018, CURR OPIN CELL BIOL, V51, P124, DOI 10.1016/j.ceb.2018.03.004; Niederlova V, 2019, HUM MUTAT, V40, P2068, DOI 10.1002/humu.23862; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Quarantotti V, 2019, EMBO J, V38, DOI 10.15252/embj.2018101082; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Singh SK, 2020, ELIFE, V9, DOI 10.7554/eLife.53322; Stoetzel C, 2006, NAT GENET, V38, P521, DOI 10.1038/ng1771; Stoetzel C, 2007, AM J HUM GENET, V80, P1, DOI 10.1086/510256; Stowe TR, 2012, MOL BIOL CELL, V23, P3322, DOI 10.1091/mbc.E12-02-0134; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004; WIDENGREN J, 1995, J PHYS CHEM-US, V99, P13368, DOI 10.1021/j100036a009; Wingfield JL, 2018, ESSAYS BIOCHEM, V62, P753, DOI 10.1042/EBC20180030; Woodsmith J, 2017, NAT METHODS, V14, P1213, DOI [10.1038/NMETH.4464, 10.1038/nmeth.4464]; Zhang QH, 2013, J CELL SCI, V126, P2372, DOI 10.1242/jcs.111740; Zhang QH, 2012, J BIOL CHEM, V287, P20625, DOI 10.1074/jbc.M112.341487; Zhang QH, 2012, HUM MOL GENET, V21, P1945, DOI 10.1093/hmg/dds004; Zhang Y, 2014, HUM MOL GENET, V23, P40, DOI 10.1093/hmg/ddt394	50	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2020	295	42					14279	14290		10.1074/jbc.RA120.013905	http://dx.doi.org/10.1074/jbc.RA120.013905			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ON0UY	32759308	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000586428700004
J	Sisay, T; Tolessa, T; Mekonen, W				Sisay, Tariku; Tolessa, Tesfaye; Mekonen, Wondyefraw			Changes in biochemical parameters by gender and time: Effect of short-term vegan diet adherence	PLOS ONE			English	Article							POSTPRANDIAL LEG; SERUM-LIPIDS; RISK-FACTORS; HEALTH; VEGETARIAN; CHOLESTEROL; ASSOCIATION; METABOLISM; NUTRIENT; WOMEN	Background Vegetarian diets adapted for various reasons that may include religious, ethical, and health considerations have reasonable health benefits including weight loss, and favorable metabolic changes. However, studies that assessed health benefits associated with vegan diet practices during the Ethiopian Orthodox Christian (EOC) Lenten fasting remains limited. This study has, therefore, assessed how short-term vegan diet associated with metabolic traits, including weight, body mass index (BMI), circumference, blood pressure, total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C), through longitudinal cross-sectional study design. Methods Seventy-five subjects (34 females and 41 males) with a mean age of [+SD] 27.3 + 5.8 years (range, 18 and 35) took part in the study. The study followed three assessment sessions: at baseline, during the Lenten (week 7), and 7 weeks after the end of the Lenten (week 14). An automatic chemistry analyzer (Mindray, BE-2000, China) used for lipid profile analysis. We used paired sample t-test in pre and post-performance and repeated measures ANOVA with Bonferroni post hoc adjustment between time points. The statistical significance was set at p < 0.05. Results The EOC fasting with vegan diet induced significantly lower blood pressure, weight, BMI, TC, HDL-C, LDL-C, and TC: HDL-C ratios, during Lenten (that is vegan diet consumption), but a regain noted in these parameters 7-weeks after Lenten (that is omnivore diet). On gender differences, vegan diet associated with significantly lower blood pressure, TC, and LDL-C in females compared with age-matched male counterparts. Some methodological limitations of this study are discussed with particular reference to lack of a randomized control group and self-reported data that limit this study in establishing a causal relationship through observed associations. Conclusions Vegan diet consumption even for short period corroborate ideal metabolic traits, with more favorable changes noted in women than age-matched men counterparts. These findings might help to define vegetarian diets as part of religious fasting (beyond its spiritual goals) as a non-pharmacological prescription in different populations, and our findings add to growing evidence in these subjects.	[Sisay, Tariku; Tolessa, Tesfaye; Mekonen, Wondyefraw] Addis Ababa Univ, Coll Hlth Sci, Sch Med, Dept Physiol, Addis Ababa, Ethiopia; [Sisay, Tariku] Mizan Tepi Univ, Coll Hlth Sci, Dept Biomed Sci, Mizan, Ethiopia	Addis Ababa University	Sisay, T (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Sch Med, Dept Physiol, Addis Ababa, Ethiopia.; Sisay, T (corresponding author), Mizan Tepi Univ, Coll Hlth Sci, Dept Biomed Sci, Mizan, Ethiopia.	kaluptrk@gmail.com	eshete, tariku sisay/AAO-3044-2021	eshete, tariku sisay/0000-0001-7546-3147	College of Health Sciences at Addis Ababa University	College of Health Sciences at Addis Ababa University	We would like to thank all study subjects and the College of Health Sciences at Addis Ababa University for the financial support of this study.	Agrawal S, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-89; Al-Hourani H. M., 2007, SMJ Singapore Medical Journal, V48, P906; ANGEL JF, 1975, NUTR REP INT, V11, P29; Arega R., 2017, FASTING ETHIOPIAN OR; Berkow SE, 2005, NUTR REV, V63, P1, DOI [10.1301/nr.janr.1-8, 10.1111/j.1753-4887.2005.tb00104.x]; Buckingham A., 2018, J NUTR ED BEHAV, V50, P648; Chen CW, 2008, EUR J CLIN NUTR, V62, P138, DOI 10.1038/sj.ejcn.1602689; Chiu YF, 2015, BRIT J NUTR, V114, P1313, DOI 10.1017/S0007114515002937; Craig WJ, 2010, NUTR CLIN PRACT, V25, P613, DOI 10.1177/0884533610385707; Daniels TF, 2009, INT J BIOL SCI, V5, P474; Das SK, 2012, J OBES WT LOSS THER, V2, P2; De Biase SG, 2007, ARQ BRAS CARDIOL, V88, P35, DOI 10.1590/S0066-782X2007000100006; Dourado KF, 2011, NUTR HOSP, V26, P959, DOI [10.3305/nh.2011.26.5.5108, 10.1590/S0212-16112011000500006]; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fraser G, 2015, PUBLIC HEALTH NUTR, V18, P537, DOI 10.1017/S1368980014000263; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GRUNDY SM, 1990, J LIPID RES, V31, P1149; Hjorth MF, 2018, ANNU REV NUTR, V38, P245, DOI 10.1146/annurev-nutr-082117-051606; Horton TJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1192, DOI 10.1152/ajpendo.00164.2002; Huang YW, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-55; Jensen KO, 1999, EUR J CLIN NUTR, V53, P351, DOI 10.1038/sj.ejcn.1600767; Koufakis T, 2017, EUR J NUTR, V56, P2439, DOI 10.1007/s00394-017-1534-8; Le LT, 2014, NUTRIENTS, V6, P2131, DOI 10.3390/nu6062131; Li D, 1999, EUR J CLIN NUTR, V53, P612, DOI 10.1038/sj.ejcn.1600817; Marz W, 2017, CLIN RES CARDIOL, V106, P663, DOI 10.1007/s00392-017-1106-1; Mahan L, FOOD NUTR CARE PROCE; Morcos N. Y., 2013, INT J NUTR PHARM NEU, V3, P375, DOI DOI 10.4103/2231-0738.119853; Nestle M, 1999, P NUTR SOC, V58, P211, DOI 10.1017/S0029665199000300; Nguyen TT, 1996, AM J PHYSIOL-ENDOC M, V271, pE965, DOI 10.1152/ajpendo.1996.271.6.E965; Papadaki A, 2008, PUBLIC HEALTH NUTR, V11, P1022, DOI 10.1017/S1368980007001498; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Sacks FM, 2006, ARTERIOSCL THROM VAS, V26, P1689, DOI 10.1161/01.ATV.0000227471.00284.ef; Sanders TAB, 1999, P NUTR SOC, V58, P265, DOI 10.1017/S0029665199000361; Sarri KO, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-16; Sobal J, 2005, FOOD FOODWAYS, V13, P135, DOI 10.1080/07409710590915409; Suhr J, 2017, EUR J CLIN NUTR, V71, P959, DOI 10.1038/ejcn.2017.12; Toohey ML, 1998, J AM COLL NUTR, V17, P425, DOI 10.1080/07315724.1998.10718789; Wang XW, 2011, J CLIN ENDOCR METAB, V96, P885, DOI 10.1210/jc.2010-2061; Yokoyama Y, 2014, CARDIOVASC DIAGN THE, V4, P373, DOI 10.3978/j.issn.2223-3652.2014.10.04	39	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2020	15	8							e0237065	10.1371/journal.pone.0237065	http://dx.doi.org/10.1371/journal.pone.0237065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ND3HD	32785233	gold, Green Published			2022-12-26	WOS:000561793900002
J	Liu, N; Sun, QQ; Xu, H; Yu, XJ; Chen, WT; Wei, HQ; Jiang, J; Xu, YZ; Lu, WJ				Liu, Ning; Sun, Qianqian; Xu, Hu; Yu, Xiaojuan; Chen, Wentong; Wei, Hongquan; Jiang, Jie; Xu, Youzhi; Lu, Wenjie			Hyperuricemia induces lipid disturbances mediated by LPCAT3 upregulation in the liver	FASEB JOURNAL			English	Article						lipidomics; SREBP-1c; STAT3	SERUM URIC-ACID; INSULIN-RESISTANCE; HEPATIC STEATOSIS; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; BLOOD-PRESSURE; POTENTIAL-ROLE; RECEPTOR LXR; ER STRESS; KAPPA-B	Potential underlying molecular mechanisms for uric acid-induced lipid metabolic disturbances had not been elucidated clearly. This study investigated the effects and underlying mechanisms of uric acid on the development of lipid metabolic disorders. We collected blood samples from 100 healthy people and 100 patients with hyperuricemia for whom serum lipid analysis was performed. Meanwhile, a mouse model of hyperuricemia was generated, and lipidomics was performed on liver tissues, comparing control and hyperuricemia groups, to analyze lipid profiles and key metabolic enzymes. Uric acid directly induced serum lipid metabolic disorders in both humans and mice based on triglycerides, total cholesterol, and low-density lipoprotein cholesterol. Through lipidomic analysis, 46 lipids were differentially expressed in hyperuricemic mouse livers, and the phosphatidylcholine composition was altered, which was mediated by LPCAT3 upregulation. High-uric acid levels-induced p-STAT3 inhibition and SREBP-1c activation in vivo and in vitro. Moreover, LPCAT3-knockdown significantly attenuated uric acid-induced p-STAT3 inhibition, SREBP-1c activation, and lipid metabolic disorders in L02 cells. In conclusion, uric acid induces lipid metabolic disturbances through LPCAT3-mediated p-STAT3 inhibition and SREBP-1c activation. LPCAT3 could be a key regulatory factor linking hyperuricemia and lipid metabolic disorders. These results might provide novel insights into the clinical treatment of hyperuricemia.	[Liu, Ning; Sun, Qianqian; Xu, Hu; Yu, Xiaojuan; Chen, Wentong; Wei, Hongquan; Jiang, Jie; Xu, Youzhi; Lu, Wenjie] Anhui Med Univ, Basic Med Coll, 81 Mei Shan Rd, Hefei 230032, Peoples R China; [Jiang, Jie] Anhui Med Univ, Coll Pharm, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University	Xu, YZ; Lu, WJ (corresponding author), Anhui Med Univ, Basic Med Coll, 81 Mei Shan Rd, Hefei 230032, Peoples R China.	xuyouzhi@ahmu.edu.cn; wenjie63136@163.com		LIU, NING/0000-0003-2822-0577	National Natural Science Foundation of China (NSFC) [81700763, 81402947]; Natural Science Foundation of Anhui Province (Anhui Provincial Natural Science Foundation) [1608085QH209]; China Postdoctoral Science Foundation [2015M581974]; Postdoctoral Science Foundation of Anhui Province [2017B162]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province (Anhui Provincial Natural Science Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Science Foundation of Anhui Province	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81700763 and 81402947; Natural Science Foundation of Anhui Province (Anhui Provincial Natural Science Foundation), Grant/Award Number: 1608085QH209; China Postdoctoral Science Foundation, Grant/Award Number: 2015M581974; Postdoctoral Science Foundation of Anhui Province, Grant/Award Number: 2017B162	Bovenga F, 2015, CELL METAB, V21, P517, DOI 10.1016/j.cmet.2015.03.002; Chini LSN, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20176048, 10.1590/1414-431x20176048]; Choi YJ, 2014, LAB INVEST, V94, P1114, DOI 10.1038/labinvest.2014.98; Choi YJ, 2014, FASEB J, V28, P3197, DOI 10.1096/fj.13-247148; Cintra DEC, 2006, NUTRITION, V22, P197, DOI 10.1016/j.nut.2005.09.003; Civantos Modino Soralla, 2012, Endocrinol Nutr, V59, P533, DOI 10.1016/j.endonu.2012.06.010; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; Drake TA, 2007, J LIPID RES, V48, P1, DOI 10.1194/jlr.R600027-JLR200; Gicquel T, 2015, FASEB J, V29, P4162, DOI 10.1096/fj.14-267393; Guo Shuyuan, 2018, Cardiovascular & Hematological Disorders - Drug Targets, V18, P27, DOI 10.2174/1871529X18666180302113713; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hu W, 2018, PROG LIPID RES, V70, P17, DOI 10.1016/j.plipres.2018.04.002; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Jurowski K, 2017, CRIT REV ANAL CHEM, V47, P418, DOI 10.1080/10408347.2017.1310613; Kinoshita Shinichi, 2008, Kobe J Med Sci, V54, pE200; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Liu XY, 2020, ENDOCRINE, V68, P71, DOI 10.1007/s12020-019-02176-5; Lu J, 2019, NAT REV RHEUMATOL, V15, P413, DOI 10.1038/s41584-019-0222-x; Lu WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12144; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; Meikle PJ, 2014, PHARMACOL THERAPEUT, V143, P12, DOI 10.1016/j.pharmthera.2014.02.001; Mortada I, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0770-x; Peng T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/735056; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Puchades-Carrasco L, 2015, CURR OPIN BIOTECH, V35, P73, DOI 10.1016/j.copbio.2015.04.004; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rong X, 2017, J CLIN INVEST, V127, P3640, DOI 10.1172/JCI93616; Rong X, 2015, ELIFE, V4, DOI 10.7554/eLife.06557; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Shimano H, 2017, NAT REV ENDOCRINOL, V13, P710, DOI 10.1038/nrendo.2017.91; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Stelmach MJ, 2015, IRISH J MED SCI, V184, P463, DOI 10.1007/s11845-014-1146-8; Thomas C, 2018, ATHEROSCLEROSIS, V275, P409, DOI 10.1016/j.atherosclerosis.2018.05.023; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Vekic J, 2009, ATHEROSCLEROSIS, V203, P236, DOI 10.1016/j.atherosclerosis.2008.05.047; Wan XY, 2016, J HEPATOL, V64, P925, DOI 10.1016/j.jhep.2015.11.022; Wang B, 2019, ANNU REV PHYSIOL, V81, P165, DOI 10.1146/annurev-physiol-020518-114444; Wang B, 2018, NAT REV ENDOCRINOL, V14, P452, DOI 10.1038/s41574-018-0037-x; Wang B, 2018, CELL STEM CELL, V22, P206, DOI 10.1016/j.stem.2017.12.017; Wang M, 2016, BIOMED PHARMACOTHER, V83, P975, DOI 10.1016/j.biopha.2016.07.025; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu LQ, 2003, J BIOL CHEM, V278, P15565, DOI 10.1074/jbc.M301311200; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang DM, 2012, FOOD CHEM, V134, P2184, DOI 10.1016/j.foodchem.2012.04.026; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	56	8	8	3	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13474	13493		10.1096/fj.202000950R	http://dx.doi.org/10.1096/fj.202000950R		AUG 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32780898				2022-12-26	WOS:000558417500001
J	Xie, YQ; Liu, J; Wang, H; Luo, JY; Chen, T; Xi, QY; Zhang, YL; Sun, JJ				Xie, Yueqin; Liu, Jie; Wang, Huan; Luo, Junyi; Chen, Ting; Xi, Qianyun; Zhang, Yongliang; Sun, Jiajie			Effects of fermented feeds and ginseng polysaccharides on the intestinal morphology and microbiota composition of Xuefeng black-bone chicken	PLOS ONE			English	Article							GROWTH-PERFORMANCE; CARCASS CHARACTERISTICS; NUTRIENT DIGESTIBILITY; BACTEROIDES-VULGATUS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; MEAT QUALITY; PROBIOTICS; IMMUNITY; ACID	Fermented feeds contain abundant organic acids, amino acids, and small peptides, which improve the nutritional status as well as the morphology and microbiota composition of the intestine. Ginseng polysaccharides exhibit several biological activities and contribute to improving intestinal development. Here, Xuefeng black-bone chickens were fed a basal diet fermented byBacillus subtilis,Saccharomyces cerevisiae,Lactobacillus plantarum, andEnterococcus faecium, with or without ginseng polysaccharides. The 100% microbially fermented feed (Fe) and 100% microbially fermented feed and ginseng polysaccharide (FP) groups showed significantly increased villus height and villus height to crypt depth ratio, and decreased crypt depth in the jejunum. In the 100% complete feed and ginseng polysaccharide (Po) group, the villus height to crypt depth ratio was significantly increased, crypt depth was reduced, and villus height remained unaffected. Next, we studied the intestinal microbial composition of 32 Xuefeng black-bone chickens. A total of 10 phyla and 442 genera were identified, among whichFirmicutes,Proteobacteria, andBacteroideteswere the most dominant phyla. At the genus level,SutterellaandAsteroleplasmaabundance increased and decreased, respectively, in the FP and Po groups.Sutterellaabundance was positively correlated to villus height and villus height to crypt depth ratio, and negatively correlated to crypt depth, andAsteroleplasmaabundance was positively correlated to crypt depth and negatively correlated to villus height to crypt depth ratio. At the species level, the FP group showed significantly increasedBacteroides_vulgatusandEubacterium_tortuosumand decreasedMycoplasma_gallinarumandAsteroleplasma_anaerobiumabundance, and the Po group showed significantly increasedMycoplasma_gallinarumandAsteroleplasma_anaerobiumabundance. Moreover, bacterial abundance was closely related to the jejunum histomorphology.Asteroleplasma_anaerobiumabundance was positively correlated with crypt depth and negatively correlated with villus height to crypt depth ratio.Mycoplasma_gallinarumabundance was positively correlated to villus height, andBacteroides_vulgatusandEubacterium_tortuosumabundance was positively correlated with villus height to crypt depth ratio and negatively correlated with crypt depth. Therefore, fermented feeds with ginseng polysaccharides may be used as effective alternatives to antibiotics for improving intestinal morphology and microbial composition.	[Xie, Yueqin; Liu, Jie; Wang, Huan; Luo, Junyi; Chen, Ting; Xi, Qianyun; Zhang, Yongliang; Sun, Jiajie] South China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Anim Nutr Control, Guangdong Lab Lingnan Modern Agr, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Zhang, YL; Sun, JJ (corresponding author), South China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Anim Nutr Control, Guangdong Lab Lingnan Modern Agr, Guangzhou, Guangdong, Peoples R China.	zhangyl@scau.edu.cn; jiajiesun@scau.edu.cn	xie, yueqin/AAS-5304-2021		Technical System of Modern Agricultural Industry in Guangdong Province [2018LM1121, 2018LM2158]	Technical System of Modern Agricultural Industry in Guangdong Province	This study was supported by the Technical System of Modern Agricultural Industry in Guangdong Province [2018LM1121, 2018LM2158].	Akhter KF, 2018, INT J BIOL MACROMOL, V109, P254, DOI 10.1016/j.ijbiomac.2017.12.050; Aliakbarpour HR, 2012, ASIAN AUSTRAL J ANIM, V25, P1285, DOI 10.5713/ajas.2012.12110; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Cheng GY, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00217; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fujita H, 2002, J GASTROENTEROL, V37, P509, DOI 10.1007/s005350200079; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hackmann TJ, 2017, ENVIRON MICROBIOL, V19, P4670, DOI 10.1111/1462-2920.13929; Hiippala K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01706; Jamshidparvar A, 2017, ENVIRON SCI POLLUT R, V24, P23571, DOI 10.1007/s11356-017-9983-4; Jayaraman S, 2013, POULTRY SCI, V92, P370, DOI 10.3382/ps.2012-02528; Jiang RR, 2011, J ANIM PHYSIOL AN N, V95, P137, DOI 10.1111/j.1439-0396.2010.01031.x; Jiang S, 2020, POULTRY SCI, V99, P142, DOI 10.3382/ps/pez571; Kleven SH, 1998, POULTRY SCI, V77, P1146, DOI 10.1093/ps/77.8.1146; Liu HW, 2011, AGR SCI CHINA, V10, P1262, DOI 10.1016/S1671-2927(11)60118-1; Liu XL, 2011, FISH SHELLFISH IMMUN, V30, P495, DOI 10.1016/j.fsi.2010.11.018; Long SF, 2018, ANIM FEED SCI TECH, V235, P23, DOI 10.1016/j.anifeedsci.2017.08.018; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Min B.R., 2015, AGR FOOD ANAL BACTER, V5, P153; Mingmongkolchai S, 2018, J APPL MICROBIOL, V124, P1334, DOI 10.1111/jam.13690; Montagne L, 2003, ANIM FEED SCI TECH, V108, P95, DOI 10.1016/S0377-8401(03)00163-9; Park SH, 2010, KOREAN J FOOD SCI AN, V30, P504, DOI 10.5851/kosfa.2010.30.3.504; Pirarat N, 2011, RES VET SCI, V91, pE92, DOI 10.1016/j.rvsc.2011.02.014; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Samuel KG, 2017, POULTRY SCI, V96, P2768, DOI 10.3382/ps/pex091; Sun JJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41403; TADAYON RA, 1980, AM J VET RES, V41, P798; Thompson KL, 2006, POULTRY SCI, V85, P1535, DOI 10.1093/ps/85.9.1535; Waidmann M, 2003, GASTROENTEROLOGY, V125, P162, DOI 10.1016/S0016-5085(03)00672-3; Wang JW, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1340; Wang L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-42; Wang W, 2013, INT J BIOL MACROMOL, V58, P127, DOI 10.1016/j.ijbiomac.2013.03.062; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wu W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197762; Xia YL, 2017, GENES DIS, V4, P138, DOI 10.1016/j.gendis.2017.06.001; Yan L, 2011, ASIAN AUSTRAL J ANIM, V24, P258, DOI 10.5713/ajas.2011.10222; Yun W, 2017, J APPL POULTRY RES, V26, P584, DOI 10.3382/japr/pfx033; Zahran E, 2014, FISH SHELLFISH IMMUN, V38, P149, DOI 10.1016/j.fsi.2014.03.002; Zhang ZF, 2014, POULTRY SCI, V93, P364, DOI 10.3382/ps.2013-03314; Zhao X, 2011, CHINA POULTRY, V33, P29	43	10	11	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237357	10.1371/journal.pone.0237357	http://dx.doi.org/10.1371/journal.pone.0237357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780763	Green Published, gold			2022-12-26	WOS:000562664700034
J	Yildirim, A; Uskudarli, S				Yildirim, Ahmet; Uskudarli, Suzan			Microblog topic identification using Linked Open Data	PLOS ONE			English	Article							LOCATION PREDICTION; SHORT TEXT; WEB; INFORMATION; EXTRACTION; LINKING	Much valuable information is embedded in social media posts (microposts) which are contributed by a great variety of persons about subjects that of interest to others. The automated utilization of this information is challenging due to the overwhelming quantity of posts and the distributed nature of the information related to subjects across several posts. Numerous approaches have been proposed to detect topics from collections of microposts, where the topics are represented by lists of terms such as words, phrases, or word embeddings. Such topics are used in tasks like classification and recommendations. The interpretation of topics is considered a separate task in such methods, albeit they are becoming increasingly human-interpretable. This work proposes an approach for identifying machine-interpretable topics of collective interest. We define topics as a set of related elements that are associated by having posted in the same contexts. To represent topics, we introduce an ontology specified according to the W3C recommended standards. The elements of the topics are identified via linking entities to resources published on Linked Open Data (LOD). Such representation enables processing topics to provide insights that go beyond what is explicitly expressed in the microposts. The feasibility of the proposed approach is examined by generating topics from more than one million tweets collected from Twitter during various events. The utility of these topics is demonstrated with a variety of topic-related tasks along with a comparison of the effort required to perform the same tasks with words-list-based representations. Manual evaluation of randomly selected 36 sets of topics yielded 81.0% and 93.3% for the precision and F1 scores respectively.	[Yildirim, Ahmet; Uskudarli, Suzan] Bogazici Univ, Dept Comp Engn, Complex Syst Res Lab, Istanbul, Turkey	Bogazici University	Yildirim, A (corresponding author), Bogazici Univ, Dept Comp Engn, Complex Syst Res Lab, Istanbul, Turkey.	ahmet.yil@boun.edu.tr	Uskudarli, S/A-8015-2017	Uskudarli, S/0000-0002-0106-0182	Turkish Ministry of Development under the TAM Project [DPT2007K120610]	Turkish Ministry of Development under the TAM Project(Turkiye Cumhuriyeti Kalkinma Bakanligi)	AY is supported by the Turkish Ministry of Development under the TAM Project, number DPT2007K120610. This work is researched and developed in the SosLab at Bogazici University, Istanbul, Turkey.	Abebe MA, 2020, KNOWL-BASED SYST, V188, DOI 10.1016/j.knosys.2019.06.025; Alvanaki F., 2012, P 15 INT C EXT DAT T, P336, DOI DOI 10.1145/2247596.2247636; [Anonymous], 2011, P 20 ACM INT C INF K; [Anonymous], 2002, P 3 INT C LANG RES E; Antoniou Grigoris, 2012, SEMANTIC WEB PRIMER, V3rd; Bailey F., 2018, PHIREHOSE; Barbieri D.F., 2009, P 18 INT C WORLD WID, P1061, DOI [10.1145/1526709.1526856, DOI 10.1145/1526709.1526856]; Bauer S, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P348, DOI 10.1109/SocialCom-PASSAT.2012.107; Bicalho P, 2017, INFORM SCIENCES, V393, P66, DOI 10.1016/j.ins.2017.02.007; Bizer C, 2011, SEMANTIC SERVICES, INTEROPERABILITY AND WEB APPLICATIONS: EMERGING CONCEPTS, P205, DOI 10.4018/978-1-60960-593-3.ch008; Bizer C, 2009, J WEB SEMANT, V7, P154, DOI 10.1016/j.websem.2009.07.002; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bonte P, 2019, DEBS'19: PROCEEDINGS OF THE 13TH ACM INTERNATIONAL CONFERENCE ON DISTRIBUTED AND EVENT-BASED SYSTEMS, P103, DOI 10.1145/3328905.3329502; Brickley D., 2014, FOAF VOCABULARY SPEC; Cataldi M., 2010, P 10 INT WORKSH MULT, V1-4, P10; Celebi A, 2018, J ASSOC INF SCI TECH, V69, P675, DOI 10.1002/asi.23989; Celebi HB, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P605, DOI 10.1109/SocialCom-PASSAT.2012.124; Chen WZ, 2015, PROCEEDINGS OF THE 53RD ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL) AND THE 7TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (IJCNLP), VOL 2, P489; Chen Y, 2019, KNOWL-BASED SYST, V163, P1, DOI 10.1016/j.knosys.2018.08.011; Cheng XQ, 2014, IEEE T KNOWL DATA EN, V26, P2928, DOI 10.1109/TKDE.2014.2313872; Chi L, 2016, 2016 3RD INTERNATIONAL CONFERENCE ON INFORMATION SCIENCE AND CONTROL ENGINEERING (ICISCE), P226, DOI 10.1109/ICISCE.2016.57; Chiu J., 2016, T ASS COMPUTATIONAL, V4, P357, DOI [DOI 10.1162/TACL_A_00104, 10.1162/tacl_a_00104]; Chodhary S, 2016, INT J EMERGING TREND, V5; Cox S., 2020, TIME ONTOLOGY OWL; Degirmencioglu EA, 2010, WEBSCI10 EXTENDING F; Eisenstein J., 2013, P 2013 C N AM CHAPT, V2013, P359, DOI DOI 10.1109/GEOINFORMATICS.2010.5567952; Eissa AHB, 2018, COMPANION PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE 2018 (WWW 2018), P1235, DOI 10.1145/3184558.3191562; Eppstein D., 2010, CORR; Fang A., 2019, THESIS; Ferragina P, 2012, IEEE SOFTWARE, V29, P70, DOI 10.1109/MS.2011.122; Francis-Landau M., 2016, CORR; Garigliotti D, 2019, INFORM RETRIEVAL J, V22, P285, DOI 10.1007/s10791-018-9346-x; Gattani A, 2013, PROC VLDB ENDOW, V6, P1126, DOI 10.14778/2536222.2536237; Genc Y, 2011, LECT NOTES ARTIF INT, V6780, P484, DOI 10.1007/978-3-642-21852-1_55; Gottlieb SC, 2020, ENVIRON PLAN C-POLIT, V38, P484, DOI 10.1177/2399654419868465; Gruetze T, 2016, WEB SEMANTICS SCI SE, V37; Guha RV, 2016, COMMUN ACM, V59, P44, DOI 10.1145/2844544; Han H, 2019, 2019 2ND IEEE CONFERENCE ON MULTIMEDIA INFORMATION PROCESSING AND RETRIEVAL (MIPR 2019), P258, DOI 10.1109/MIPR.2019.00053; Hollink L., 2017, SEMANT WEB, V8, P271, DOI [10.3233/SW-160227, DOI 10.3233/SW-160227]; Horrocks I., 2004, W3C MEMBER SUBMISS, V21, P1; Hripcsak G, 2005, J AM MED INFORM ASSN, V12, P296, DOI 10.1197/jamia.M1733; Kalender M, 2018, MULTIMED TOOLS APPL, V77, P567, DOI 10.1007/s11042-016-4275-4; Karadeniz I, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2678-8; Kumar A, 2019, INT J DISAST RISK RE, V33, P365, DOI 10.1016/j.ijdrr.2018.10.021; Kumar VK, 2019, WEB SERVICES CONCEPT, P1068; Li CL, 2017, ACM T INFORM SYST, V36, DOI 10.1145/3091108; Li CL, 2016, SIGIR'16: PROCEEDINGS OF THE 39TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P165, DOI 10.1145/2911451.2911499; Liao XF, 2019, ACM COMPUT SURV, V52, DOI 10.1145/3324473; Lin TY, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P539, DOI 10.1145/2566486.2567980; Marcus A, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P227; Martinez-Rodriguez JL, 2019, KNOWLEDGE GRAPHS SEM, P87; Matentzoglu N, 2018, J BIOMED SEMANT, V9, DOI 10.1186/s13326-017-0172-7; Mathioudakis M., 2010, P 2010 ACM SIGMOD IN, P1155, DOI DOI 10.1145/1807167.1807306; McCrae J.P., 2020, LINKED OPEN DATA CLO; McGuinness Deborah L, 2001, ONTOLOGY DEV; McKinney J., 2014, VCARD ONTOLOGY DESCR; Mehrotra R, 2013, SIGIR'13: THE PROCEEDINGS OF THE 36TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH & DEVELOPMENT IN INFORMATION RETRIEVAL, P889; Newman D, 2007, ACM-IEEE J CONF DIG, P366, DOI 10.1145/1255175.1255248; Ngomo ACN, 2014, LECT NOTES COMPUT SC, V8714, P1, DOI 10.1007/978-3-319-10587-1_1; Ozdikis O, 2019, INFORM PROCESS MANAG, V56, P1280, DOI 10.1016/j.ipm.2019.02.013; Ozer M, 2016, PROCEEDINGS OF THE 2016 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING ASONAM 2016, P81, DOI 10.1109/ASONAM.2016.7752217; Parker J, 2013, 2013 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P562; Perez J, 2009, ACM T DATABASE SYST, V34, DOI 10.1145/1567274.1567278; Perrier A., 2015, SEGMENTATION TWITTER; Petrovi S, 2010, HUMAN LANGUAGE TECHN, P181; Pham TL, 2019, SEMANT WEB, V10, P457, DOI 10.3233/SW-180330; Prieto VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086191; Qiang J, 2019, CORR; Qiang JP, 2018, APPL INTELL, V48, P1802, DOI 10.1007/s10489-017-1055-4; Qiang JP, 2017, LECT NOTES ARTIF INT, V10235, P363, DOI 10.1007/978-3-319-57529-2_29; Qiu M., 2017, LATENT DIRICHLET ALL; R Core Team, 2021, R LANGUAGE ENV STAT; Ragunath R, 2015, ARPN J ENG APPL SCI, V10, P2638; Rospocher M, 2019, SEMANT WEB, V10, P753, DOI 10.3233/SW-180325; Sakor Ahmad, 2019, P 2019 NAACL HLT LON, V1, P2336, DOI DOI 10.18653/V1/N19-1243; Sayyadi H, 2013, ACM T INTERNET TECHN, V13, DOI 10.1145/2542214.2542215; Schmachtenberg M, 2014, ADOPTION LINKED DATA, P245; Seaborne A., 2013, SPARQL 1 1 QUERY LAN; Shadbolt N, 2006, IEEE INTELL SYST, V21, P96, DOI 10.1109/MIS.2006.62; Sharifi BP, 2014, COMPUT J, V57, P378, DOI 10.1093/comjnl/bxt109; Sonmez C., 2014, P EMNLP C, P313; Tonon A, 2016, J WEB SEMANT, V37-38, P170, DOI 10.1016/j.websem.2015.12.005; Tuarob S, 2013, ACM-IEEE J CONF DIG, P239; Vrandecic D, 2014, COMMUN ACM, V57, P78, DOI 10.1145/2629489; WANG J, 2015, T ASS COMPUTATIONAL, V3, P59; Wang W, 2017, COMM COM INF SC, V768, P18, DOI 10.1007/978-981-10-6893-5_2; Weng J., 2010, P 3 ACM INT C WEB SE, P261, DOI [10.1145/1718487.1718520, DOI 10.1145/1718487.1718520]; WHO, WHO INT CLASS DIS; Yamada I, 2016, CORR; Yi F, 2020, IEEE ACCESS, V8, P30692, DOI 10.1109/ACCESS.2020.2973207; Yin JH, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P2634, DOI 10.1145/3219819.3220094; Yin XY, 2019, IEEE ACCESS, V7, P169434, DOI 10.1109/ACCESS.2019.2955498; Yldrm A, 2018, BOUNTI SEMANTIC TOPI, DOI [10.6084/m9.figshare.7527476, DOI 10.6084/M9.FIGSHARE.7527476]; Yldrm A., S BOUNTI SEMANTIC TO, DOI [10.6084/m9.figshare.5943211, DOI 10.6084/M9.FIGSHARE.5943211]; Yldrm A, 2019, TOPICO ONTOLOGY; Yldrm A, 2016, PLOS ONE, V11, P1	98	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0236863	10.1371/journal.pone.0236863	http://dx.doi.org/10.1371/journal.pone.0236863			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780736	Green Published, Green Submitted, gold			2022-12-26	WOS:000562664700041
J	Khan, A; Hizam, H; Wahab, NIB; Othman, ML				Khan, Abdullah; Hizam, Hashim; Wahab, Noor Izzri bin Abdul; Othman, Mohammad Lutfi			Optimal power flow using hybrid firefly and particle swarm optimization algorithm	PLOS ONE			English	Article							BEE COLONY ALGORITHM	In this paper, a novel, effective meta-heuristic, population-based Hybrid Firefly Particle Swarm Optimization (HFPSO) algorithm is applied to solve different non-linear and convex optimal power flow (OPF) problems. The HFPSO algorithm is a hybridization of the Firefly Optimization (FFO) and the Particle Swarm Optimization (PSO) technique, to enhance the exploration, exploitation strategies, and to speed up the convergence rate. In this work, five objective functions of OPF problems are studied to prove the strength of the proposed method: total generation cost minimization, voltage profile improvement, voltage stability enhancement, the transmission lines active power loss reductions, and the transmission lines reactive power loss reductions. The particular fitness function is chosen as a single objective based on control parameters. The proposed HFPSO technique is coded using MATLAB software and its effectiveness is tested on the standard IEEE 30-bus test system. The obtained results of the proposed algorithm are compared to simulated results of the original Particle Swarm Optimization (PSO) method and the present state-of-the-art optimization techniques. The comparison of optimum solutions reveals that the recommended method can generate optimum, feasible, global solutions with fast convergence and can also deal with the challenges and complexities of various OPF problems.	[Khan, Abdullah; Hizam, Hashim; Wahab, Noor Izzri bin Abdul; Othman, Mohammad Lutfi] Univ Putra Malaysia, Dept Elect & Elect Engn, Seri Kembangan, Selangor, Malaysia; [Khan, Abdullah; Hizam, Hashim; Wahab, Noor Izzri bin Abdul; Othman, Mohammad Lutfi] Univ Putra Malaysia, Fac Engn, Adv Lightning Power & Energy Res ALPER, Seri Kembangan, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Khan, A; Hizam, H (corresponding author), Univ Putra Malaysia, Dept Elect & Elect Engn, Seri Kembangan, Selangor, Malaysia.; Khan, A; Hizam, H (corresponding author), Univ Putra Malaysia, Fac Engn, Adv Lightning Power & Energy Res ALPER, Seri Kembangan, Selangor, Malaysia.	gs52859@student.upm.edu.my; hhizam@upm.edu.my						Abd-Elazim SM, 2013, INT J ELEC POWER, V46, P334, DOI 10.1016/j.ijepes.2012.10.047; Abido MA, 2002, INT J ELEC POWER, V24, P563, DOI 10.1016/S0142-0615(01)00067-9; Abido MA, 2002, IEEE POWER ENG REV, DOI [10.1109/MPER.2002.4312374, DOI 10.1109/MPER.2002.4312374]; Abou El Ela AA, 2010, ELECTR POW SYST RES, V80, P878, DOI 10.1016/j.epsr.2009.12.018; Adaryani MR, 2013, INT J ELEC POWER, V53, P219, DOI 10.1016/j.ijepes.2013.04.021; ALSAC O, 1974, IEEE T POWER AP SYST, VPA93, P745, DOI 10.1109/TPAS.1974.293972; Alsac O, 1990, IEEE T POWER SYSTEMS; Arul R, 2013, ELECTR POW COMPO SYS, V41, P782, DOI 10.1080/15325008.2013.769033; Attia AF, 2012, ELECTR POW COMPO SYS, V40, P1285, DOI 10.1080/15325008.2012.689417; Aydilek IB, 2018, APPL SOFT COMPUT, V66, P232, DOI 10.1016/j.asoc.2018.02.025; Bakirtzis AG, 2002, IEEE T POWER SYST, V17, P229, DOI 10.1109/TPWRS.2002.1007886; Balachennaiah P, 2018, AIN SHAMS ENG J, V9, P89, DOI 10.1016/j.asej.2015.10.005; Bansilal Thukaram D, 1996, INT J ELECT POWER EN; Bentouati Bachir, J ELECT SYSTEMS, P716; Bhattacharya A, 2012, IET GENER TRANSM DIS, V6, P751, DOI 10.1049/iet-gtd.2011.0593; Bhattacharya A, 2011, IET GENER TRANSM DIS, V5, P70, DOI 10.1049/iet-gtd.2010.0237; Blum C, 2008, COMPUTATIONAL INTELL; Bouchekara HREH, 2016, APPL SOFT COMPUT, V42, P119, DOI 10.1016/j.asoc.2016.01.041; Bouchekara HREH, 2014, ENERG CONVERS MANAGE, V87, P58, DOI 10.1016/j.enconman.2014.06.088; Bouchekara HREH, 2014, APPL SOFT COMPUT, V24, P879, DOI 10.1016/j.asoc.2014.08.056; Bouchekara HREH, 2014, ELECTR POW SYST RES, V114, P49, DOI 10.1016/j.epsr.2014.03.032; Bouchekara HRE, 2014, ELECTR POW COMPO SYS, V42, P1683, DOI 10.1080/15325008.2014.949912; BURCHETT RC, 1984, IEEE T POWER AP SYST, V103, P3267, DOI 10.1109/TPAS.1984.318568; Christy AA, 2014, INT J ELEC POWER, V62, P344, DOI 10.1016/j.ijepes.2014.04.054; DOMMEL HW, 1968, IEEE T POWER AP SYST, VPA87, P1866, DOI 10.1109/TPAS.1968.292150; Duman S, 2012, ENERG CONVERS MANAGE, V59, P86, DOI 10.1016/j.enconman.2012.02.024; Eberhart RC, 2000, IEEE C EVOL COMPUTAT, P84, DOI 10.1109/CEC.2000.870279; El-Fergany AA, 2015, ELECTR POW COMPO SYS, V43, P1548, DOI 10.1080/15325008.2015.1041625; El-Sehiemy RA, 2014, INT J BIOINSPIRED CO; Fister I, 2013, SWARM EVOL COMPUT, V13, P34, DOI 10.1016/j.swevo.2013.06.001; Frank S, 2016, IIE TRANS, V48, P1172, DOI 10.1080/0740817X.2016.1189626; Frank S, 2012, ENERGY SYST, V3, P259, DOI 10.1007/s12667-012-0057-x; Frank S, 2012, ENERGY SYST, V3, P221, DOI 10.1007/s12667-012-0056-y; Ghanizadeh AJ, 2011, INT REV ELECT ENG; He XH, 2015, ENERGIES, V8, P2412, DOI 10.3390/en8042412; Jahan MS, 2013, IET GENER TRANSM DIS, V7, P1481, DOI 10.1049/iet-gtd.2012.0697; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kora P., 2016, INT J CARDIOVASC ACA, V2, P44, DOI [10.1016/j.ijcac.2015.12.001, DOI 10.1016/J.IJCAC.2015.12.001]; Kumar S, 2013, INT J ELEC POWER, V47, P416, DOI 10.1016/j.ijepes.2012.11.019; Kumari MS, 2010, INT J ELEC POWER, V32, P736, DOI 10.1016/j.ijepes.2010.01.010; Lai LL, 1997, INT J ELEC POWER, V19, P287, DOI 10.1016/S0142-0615(96)00051-8; Lee KY, 1985, IEEE POWER ENG REV, DOI [10.1109/MPER.1985.5526580, DOI 10.1109/MPER.1985.5526580]; Liang RH, 2011, ELECTR POW SYST RES, V81, P1466, DOI 10.1016/j.epsr.2011.02.011; Momoh JA, 1999, IEEE T POWER SYST, V14, P105, DOI 10.1109/59.744495; Momoh JA, 1997, IEEE T POWER SYST, V12, P444, DOI 10.1109/59.575768; Niknam T, 2012, IET GENER TRANSM DIS, V6, P515, DOI 10.1049/iet-gtd.2011.0851; Pulluri H, 2018, SOFT COMPUT, V22, P159, DOI 10.1007/s00500-016-2319-3; Radosavljevic J, 2015, ELECTR POW COMPO SYS, V43, P1958, DOI 10.1080/15325008.2015.1061620; Ruhela Dinesh Singh, 2014, STUDY COMPUTATIONAL; Sanseverino ER, 2015, ENERGIES, V8, P11493, DOI 10.3390/en81011493; Shaheen AM, 2016, IET GENER TRANSM DIS, V10, P1634, DOI 10.1049/iet-gtd.2015.0892; Shi Y, 1999, P 1999 C EV COMP CEC, V1999; SHOULTS RR, 1982, IEEE T POWER AP SYST, V101, P397, DOI 10.1109/TPAS.1982.317120; Sivasubramani S, 2011, INT J ELEC POWER, V33, P745, DOI 10.1016/j.ijepes.2010.12.031; SUN DI, 1984, IEEE T POWER AP SYST, V103, P2864, DOI 10.1109/TPAS.1984.318284; Thangaraj R, 2011, APPL MATH COMPUT, V217, P5208, DOI 10.1016/j.amc.2010.12.053; The MathWorks Inc., 2016, MATLAB REL 2012A; Ngo TT, 2016, J COMPUT SCI-NETH, V13, P68, DOI 10.1016/j.jocs.2016.01.004; Varadarajan M, 2008, IET GENER TRANSM DIS, V2, P720, DOI 10.1049/iet-gtd:20070457; Warid W, 2016, ENERGIES, V9, DOI 10.3390/en9090678; Yang X.S., 2013, IJSI, V1, P36, DOI [10.1504/IJSI.2013.055801, DOI 10.1504/IJSI.2013.055801]; Yang XS, 2010, INT J BIO-INSPIR COM, V2, P78, DOI 10.1504/IJBIC.2010.032124; Yang XS, 2010, RESEARCH AND DEVELOPMENT IN INTELLIGENT SYSTEMS XXVI, P209, DOI 10.1007/978-1-84882-983-1_15; Yang XS, 2009, LECT NOTES COMPUTER; Zhu J., 2009, OPTIMIZATION POWER S, V1, P315	65	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0235668	10.1371/journal.pone.0235668	http://dx.doi.org/10.1371/journal.pone.0235668			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776932	Green Published, Green Accepted, gold			2022-12-26	WOS:000561393800029
J	Martinez, ME; Harder, OE; Rosas, LE; Joseph, L; Davis, IC; Niewiesk, S				Martinez, Margaret E.; Harder, Olivia E.; Rosas, Lucia E.; Joseph, Lisa; Davis, Ian C.; Niewiesk, Stefan			Pulmonary function analysis in cotton rats after respiratory syncytial virus infection	PLOS ONE			English	Article							FORCED OSCILLATION TECHNIQUE; AIRWAY HYPERRESPONSIVENESS; LUNG-FUNCTION; ANTI-G; MONOCLONAL-ANTIBODY; MICE; RSV; PROTEIN; BRONCHIOLITIS; SENSITIZATION	The cotton rat (Sigmodon hispidus) is an excellent small animal model for human respiratory viral infections such as human respiratory syncytial virus (RSV) and human metapneumovirus (HMPV). These respiratory viral infections, as well as other pulmonary inflammatory diseases such as asthma, are associated with lung mechanic disturbances. So far, the pathophysiological effects of viral infection and allergy on cotton rat lungs have not been measured, although this information might be an important tool to determine the efficacy of vaccine and drug candidates. To characterize pulmonary function in the cotton rat, we established forced oscillation technique in uninfected, RSV infected and HDM sensitized cotton rats, and characterized pulmonary inflammation, mucus production, pulmonary edema, and oxygenation. There was a gender difference after RSV infection, with females demonstrating airway hyper-responsiveness while males did not. Female cotton rats 2dpi had a mild increase in pulmonary edema (wet: dry weight ratios). At day 4 post infection, female cotton rats demonstrated mild pulmonary inflammation, no increase in mucus production or reduction in oxygenation. Pulmonary function was not significantly impaired after RSV infection. In contrast, cotton rats sensitized to HDM demonstrated airway hyper-responsiveness with a significant increase in pulmonary inflammation, increase in baseline tissue damping, and a decrease in baseline pulmonary compliance. In summary, we established baseline data for forced oscillation technique and other respiratory measures in the cotton rat and used it to analyze respiratory diseases in cotton rats.	[Martinez, Margaret E.; Harder, Olivia E.; Rosas, Lucia E.; Joseph, Lisa; Davis, Ian C.; Niewiesk, Stefan] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Martinez, ME (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA.	Martinez.610@osu.edu			Genetech Fellowship from Genentech [GRT00044407]; National Institute of Health National Institute of Allergy and Infectious Diseases [P01AI112524]; National Institutes of Health/National Heart Lung & Blood Institute [HL137090]	Genetech Fellowship from Genentech; National Institute of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health/National Heart Lung & Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	M.E.M. was funded through the Genetech Fellowship under grant number GRT00044407 from Genentech (https://www.gene.com/).O.E.H.and S.N. were funded through grant number P01AI112524 from the National Institute of Health National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/).L.E.R., L. J. and I.C.D. were funded through grant number HL137090 from National Institutes of Health/National Heart Lung & Blood Institute (https://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeffner F, 2015, TOXICOL PATHOL, V43, P1074, DOI 10.1177/0192623315598399; Aeffner F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046660; Aeffner F, 2011, AM J PHYSIOL-LUNG C, V301, pL99, DOI 10.1152/ajplung.00398.2010; Amelia RW, 2011, ANIMAL MODELS RESP S; Boukhvalova MS, 2013, CURR TOP MICROBIOL, V372, P347, DOI 10.1007/978-3-642-38919-1_17; Boyoglu-Barnum S, 2015, VIROLOGY, V483, P117, DOI 10.1016/j.virol.2015.02.035; Boyoglu-Barnum S, 2013, J VIROL, V87, P10955, DOI 10.1128/JVI.01164-13; Broughton S, 2007, PEDIATR INFECT DIS J, V26, P1019, DOI 10.1097/INF.0b013e318126bbb9; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Chi XY, 2011, ASIAN PAC J ALLERGY, V29, P176; Collins RA, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-142; Dakhama A, 2005, J IMMUNOL, V175, P1876, DOI 10.4049/jimmunol.175.3.1876; Domachowske Joseph B, 2004, Pediatr Infect Dis J, V23, pS228, DOI 10.1097/01.inf.0000144672.81955.a4; Drysdale SB, 2011, THORAX, V66, P468, DOI 10.1136/thx.2010.148023; Green MG, 2018, COMPARATIVE MED, V68, P31; Hall CB, 2013, CURR TOP MICROBIOL, V372, P39, DOI 10.1007/978-3-642-38919-1_2; HALL CB, 1979, AM J DIS CHILD, V133, P798, DOI 10.1001/archpedi.1979.02130080038006; Han JY, 2014, AM J RESP CELL MOL, V51, P143, DOI 10.1165/rcmb.2013-0360OC; Hofer CC, 2015, AM J PHYSIOL-LUNG C, V308, pL628, DOI 10.1152/ajplung.00373.2014; Jiang XB, 2012, EXP LUNG RES, V38, P453, DOI 10.3109/01902148.2012.723240; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; Kittel B, 2004, EXP TOXICOL PATHOL, V55, P413, DOI 10.1078/0940-2993-00349; Lundblad LKA, 2007, EUR RESPIR J, V30, P805, DOI 10.1183/09031936.00091307; Makela MJ, 2002, AM J RESP CRIT CARE, V165, P824, DOI 10.1164/rccm.2105062; Makela MJ, 2003, J ALLERGY CLIN IMMUN, V112, P861, DOI 10.1067/mai.2003.1768; McGovern TK, 2013, JOVE-J VIS EXP, DOI 10.3791/50172; Mejias A, 2004, ANTIMICROB AGENTS CH, V48, P1811, DOI 10.1128/AAC.48.5.1811-1822.2004; Moore ML, 2009, J VIROL, V83, P4185, DOI 10.1128/JVI.01853-08; Mori H, 2013, CLIN SCI, V125, P565, DOI 10.1042/CS20130098; Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232; Parameswaran H, 2017, METHODS MOL BIOL, V1639, P77, DOI 10.1007/978-1-4939-7163-3_8; Peebles RS, 2000, J INFECT DIS, V182, P671; Peebles RS, 1999, J MED VIROL, V57, P186, DOI 10.1002/(SICI)1096-9071(199902)57:2<186::AID-JMV17>3.0.CO;2-Q; Peebles RS, 2001, J INFECT DIS, V184, P1374; Peebles RS, 2001, J MED VIROL, V63, P178, DOI 10.1002/1096-9071(20000201)63:2<178::AID-JMV1013>3.3.CO;2-F; Reddy AT, 2012, JOVE-J VIS EXP, DOI 10.3791/3771; Robichaud A, 2015, EXP LUNG RES, V41, P84, DOI 10.3109/01902148.2014.971921; Saravia J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005217; Schwarze J, 2004, THORAX, V59, P517, DOI 10.1136/thx.2003.017343; Shalaby KH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-82; Skylogianni E, 2016, PAEDIATR RESPIR REV, V18, P46, DOI 10.1016/j.prrv.2015.11.001; Song WF, 2015, AM J PHYSIOL-LUNG C, V309, pL205, DOI 10.1152/ajplung.00159.2015; Stein RT, 2017, PEDIATR PULM, V52, P556, DOI 10.1002/ppul.23570; Stokes KL, 2011, J VIROL, V85, P5782, DOI 10.1128/JVI.01693-10; Traylor ZP, 2010, AM J PHYSIOL-LUNG C, V298, pL437, DOI 10.1152/ajplung.00363.2009; Tripp RA, 2003, J VIROL, V77, P6580, DOI 10.1128/JVI.77.11.6580-6584.2003; Urbankowski Tomasz, 2016, Pneumonol Alergol Pol, V84, P134, DOI 10.5603/PiAP.2016.0014; Wennergren G, 2001, EUR RESPIR J, V18, P1044, DOI 10.1183/09031936.01.00254101; Wethington D, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0389; Wu Y, 2015, J CONTROL RELEASE, V203, P140, DOI 10.1016/j.jconrel.2015.02.016; Zomer-Kooijker K, 2014, EUR RESPIR J, V44, P666, DOI 10.1183/09031936.00009314; Zysman-Colman Z, 2016, PAEDIATR RESPIR REV, V19, P39, DOI 10.1016/j.prrv.2015.11.008	52	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237404	10.1371/journal.pone.0237404	http://dx.doi.org/10.1371/journal.pone.0237404			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776985	Green Published, gold			2022-12-26	WOS:000561393800030
J	Ritscher, S; Hoyer, M; Georges, C; Wunder, C; Wallemacq, P; Persu, A; Obermuller, N; Toennes, SW				Ritscher, Sabrina; Hoyer, Milena; Georges, Coralie; Wunder, Cora; Wallemacq, Pierre; Persu, Alexandre; Obermueller, Nicholas; Toennes, Stefan W.			Benefit of serum drug monitoring complementing urine analysis to assess adherence to antihypertensive drugs in first-line therapy	PLOS ONE			English	Article							CALCIUM-CHANNEL ANTAGONISTS; HUMAN PLASMA; HEALTHY-VOLUNTEERS; LC-MS/MS; PHARMACOKINETICS; TELMISARTAN; AMLODIPINE; SAFETY; BIOAVAILABILITY; LERCANIDIPINE	With obesity having doubled in the last decade, hypertension is on the rise. In one-third of hypertensive patients the metabolic syndrome is present. This might be one factor for the increasing number of prescriptions for angiotensin receptor blockers and calcium-channel blockers besides a more favorable risk-to-benefit ratio. The aim of the present study was to evaluate a therapeutic drug monitoring (TDM) method for assessment of adherence based on cut-offs in inpatients and to compare it to an established urine drug screening in outpatients. A method for quantification of calcium-channel blockers and angiotensin receptor blockers using high-performance liquid chromatography-tandem mass spectrometric analysis (LC-MS/MS) was developed and validated. The method was applied to serum samples of 32 patients under supervised medication to establish cut-off values for adherence assessment based on dose-related concentrations (DRC, calculated from pharmacokinetic data). Furthermore, corresponding urine and blood samples of 42 outpatients without supervised medication were analysed and the results compared with regard to adherence assessment. All serum concentrations measured for amlodipine (n = 40), lercanidipine (n = 14), candesartan (n = 10), telmisartan (n = 4) and valsartan (n = 10) in inpatients were above the patient specific lower DRC confirming adherence. Of 42 outpatients the identification of analytes in urine as well as the quantification in serum exhibited differing results. According to urinalysis, adherence was demonstrated in only 87.0% of prescriptions, compared to 91.3% for serum analyses. Differences were observed for amlodipine, lercanidipine and candesartan which can be explained by a higher specificity of the serum analysis approach due to pharmacokinetics. The present study confirms that assessing adherence based on serum drug concentrations with individually calculated lower DRCs is more accurate than using qualitative urine analysis. In particular, drugs with low bioavailability, low renal excretion or high metabolism rate such as lercanidipine and candesartan may lead to underestimation of adherence via urine analysis.	[Ritscher, Sabrina; Wunder, Cora; Toennes, Stefan W.] Goethe Univ, Univ Hosp, Inst Legal Med, Dept Forens Toxicol, Frankfurt, Germany; [Hoyer, Milena; Obermueller, Nicholas] Goethe Univ, Univ Hosp, Dept Nephrol, Med Clin 3, Frankfurt, Germany; [Georges, Coralie; Persu, Alexandre] Catholic Univ Louvain, Div Cardiol, Clin Univ St Luc, Brussels, Belgium; [Wallemacq, Pierre] Clin Univ St Luc, Clin Chem Dept, Brussels, Belgium; [Wallemacq, Pierre] Catholic Univ Louvain, Ctr Toxicol & Appl Pharmacol, Brussels, Belgium; [Persu, Alexandre] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Cardiovasc Res, Brussels, Belgium	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Universite Catholique Louvain	Ritscher, S (corresponding author), Goethe Univ, Univ Hosp, Inst Legal Med, Dept Forens Toxicol, Frankfurt, Germany.	ritscher@med.uni-frankfurt.de						Baranda AB, 2006, FORENSIC SCI INT, V156, P23, DOI 10.1016/j.forsciint.2004.11.014; Baranda AB, 2005, THER DRUG MONIT, V27, P44, DOI 10.1097/00007691-200502000-00010; Barchielli M, 1997, J CARDIOVASC PHARM, P1; Berra E, 2016, HYPERTENSION, V68, P297, DOI 10.1161/HYPERTENSIONAHA.116.07464; Carvalho M, 2001, BIOPHARM DRUG DISPOS, V22, P383, DOI 10.1002/bdd.282; Chaudhary DV, 2016, J PHARM ANAL, V6, P87, DOI 10.1016/j.jpha.2015.09.001; De Geest Sabina, 2003, Eur J Cardiovasc Nurs, V2, P323; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Eskas PA, 2016, BLOOD PRESSURE, V25, P199, DOI 10.3109/08037051.2015.1121706; FAULKNER JK, 1986, BRIT J CLIN PHARMACO, V22, P21, DOI 10.1111/j.1365-2125.1986.tb02874.x; Flesch G, 1997, EUR J CLIN PHARMACOL, V52, P115, DOI 10.1007/s002280050259; Gundersen POM, 2018, J CHROMATOGR B, V1089, P84, DOI 10.1016/j.jchromb.2018.04.038; Hiemke C, 2018, PHARMACOPSYCHIATRY, V51, pE1, DOI [10.1055/s-0037-1600991, 10.1055/s-0043-116492]; Hoogkamer JFW, 1998, EUR J CLIN PHARMACOL, V54, P341, DOI 10.1007/s002280050471; Israili ZH, 2000, J HUM HYPERTENS, V14, pS73, DOI 10.1038/sj.jhh.1000991; KOLB M, 1993, ACTA HYDROCH HYDROB, V21, P308, DOI 10.1002/aheh.19930210603; Mueller CA, 2004, J MASS SPECTROM, V39, P639, DOI 10.1002/jms.630; Peters F.T., 2009, REQUIREMENTS VALIDAT; Rahimi K, 2015, CIRC RES, V116, P925, DOI 10.1161/CIRCRESAHA.116.304723; Ravi Vasu Babu, 2012, J Pharm Anal, V2, P319, DOI 10.1016/j.jpha.2012.03.008; Riddell JG, 1997, J HUM HYPERTENS, V11, pS29; Ritscher S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52164-y; Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z; Salem H, 2018, J AM COLL CARDIOL, V71, P1819, DOI 10.1016/S0735-1097(18)32360-X; Schmieder RE, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002343; Schulz M, 2012, CRIT CARE, V16, DOI 10.1186/cc11441; Schwabe U, 2018, ARZNEIVERORDNUNGS RE; Schwabe U., 2015, ARZNEIVERORDNUNGS RE, V1, DOI [10.1007/978-3-662-47186-9_1, DOI 10.1007/978-3-662-47186-9_1]; Smith DHG, 2000, J CLIN PHARMACOL, V40, P1380; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Stangier J, 2000, J CLIN PHARMACOL, V40, P1355; Stangier J, 2000, J INT MED RES, V28, P149, DOI 10.1177/147323000002800401; THIJS L, 1992, J HYPERTENS, V10, P1103, DOI 10.1097/00004872-199210000-00001; Tomaszewski M, 2014, HEART, V100, P855, DOI 10.1136/heartjnl-2013-305063; Williams B, 2018, J HYPERTENS, V36, P1953, DOI 10.1097/HJH.0000000000001940; Wunder C, 2019, BLOOD PRESSURE, V28, P168, DOI 10.1080/08037051.2019.1599814; Zaid Abdel Naser, 2011, Sci Pharm, V79, P123, DOI 10.3797/scipharm.1009-01	37	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237383	10.1371/journal.pone.0237383	http://dx.doi.org/10.1371/journal.pone.0237383			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776967	Green Published, gold			2022-12-26	WOS:000561393800001
J	Yamahachi, H; Zai, AT; Tachibana, RO; Stepien, AE; Rodrigues, DI; Cave-Lopez, S; Lorenz, C; Arneodo, EM; Giret, N; Hahnloser, RHR				Yamahachi, Homare; Zai, Anja T.; Tachibana, Ryosuke O.; Stepien, Anna E.; Rodrigues, Diana, I; Cave-Lopez, Sophie; Lorenz, Corinna; Arneodo, Ezequiel M.; Giret, Nicolas; Hahnloser, Richard H. R.			Undirected singing rate as a non-invasive tool for welfare monitoring in isolated male zebra finches	PLOS ONE			English	Article							STRESS; SONG; VARIABILITY; EVOLUTION; BIRDSONG; BEHAVIOR; CIRCUIT; MODEL; FOOD	Research on the songbird zebra finch (Taeniopygia guttata)has advanced our behavioral, hormonal, neuronal, and genetic understanding of vocal learning. However, little is known about the impact of typical experimental manipulations on the welfare of these birds. Here we explore whether the undirected singing rate can be used as an indicator of welfare. We tested this idea by performing a post hoc analysis of singing behavior in isolated male zebra finches subjected to interactive white noise, to surgery, or to tethering. We find that the latter two experimental manipulations transiently but reliably decreased singing rates. By contraposition, we infer that a high-sustained singing rate is suggestive of successful coping or improved welfare in these experiments. Our analysis across more than 300 days of song data suggests that a singing rate above a threshold of several hundred song motifs per day implies an absence of an acute stressor or a successful coping with stress. Because singing rate can be measured in a completely automatic fashion, its observation can help to reduce experimenter bias in welfare monitoring. Because singing rate measurements are non-invasive, we expect this study to contribute to the refinement of the current welfare monitoring tools in zebra finches.	[Yamahachi, Homare; Zai, Anja T.; Tachibana, Ryosuke O.; Stepien, Anna E.; Rodrigues, Diana, I; Cave-Lopez, Sophie; Lorenz, Corinna; Arneodo, Ezequiel M.; Hahnloser, Richard H. R.] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Yamahachi, Homare; Zai, Anja T.; Tachibana, Ryosuke O.; Stepien, Anna E.; Rodrigues, Diana, I; Cave-Lopez, Sophie; Lorenz, Corinna; Arneodo, Ezequiel M.; Hahnloser, Richard H. R.] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Yamahachi, Homare; Zai, Anja T.; Tachibana, Ryosuke O.; Stepien, Anna E.; Rodrigues, Diana, I; Cave-Lopez, Sophie; Lorenz, Corinna; Arneodo, Ezequiel M.; Hahnloser, Richard H. R.] Swiss Fed Inst Technol, Zurich, Switzerland; [Lorenz, Corinna; Giret, Nicolas] Univ Paris Saclay, Inst Neurosci Paris Saclay, CNRS, UMR 9197, Orsay, France	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Hahnloser, RHR (corresponding author), Univ Zurich, Inst Neuroinformat, Zurich, Switzerland.; Hahnloser, RHR (corresponding author), Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland.; Hahnloser, RHR (corresponding author), Swiss Fed Inst Technol, Zurich, Switzerland.	rich@ini.ethz.cz	Arneodo, Ezequiel/AHA-0237-2022; Tachibana, Ryosuke/Q-2510-2019	Arneodo, Ezequiel/0000-0002-7125-4919; Tachibana, Ryosuke/0000-0002-4766-4504; Hahnloser, Richard/0000-0002-4039-7773; Giret, Nicolas/0000-0001-7139-6231; Lorenz, Corinna/0000-0001-5869-1017; Zai, Anja Tamara/0000-0002-0460-0850	Swiss National Science Foundation [31003A_156976/1, 31003A_182638]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation, www.snf.ch, Project 31003A_156976/1 and 31003A_182638 (RHRH).	Anisimov VN, 2014, NAT METHODS, V11, P1135, DOI [10.1038/NMETH.3114, 10.1038/nmeth.3114]; Banerjee SB, 2011, HORM BEHAV, V60, P233, DOI 10.1016/j.yhbeh.2011.05.011; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; Brainard MS, 2013, ANNU REV NEUROSCI, V36, P489, DOI 10.1146/annurev-neuro-060909-152826; Brawn TP, 2015, CURR TOP BEHAV NEURO, V25, P207, DOI 10.1007/7854_2014_349; BROOM DM, 1986, BRIT VET J, V142, P524, DOI 10.1016/0007-1935(86)90109-0; Brown Margaret E., 1996, V13, P67; Canopoli A, 2014, J NEUROSCI, V34, P7018, DOI 10.1523/JNEUROSCI.0266-14.2014; Carstens E, 2000, ILAR J, V41, P62; Clayton NS, 2015, NEURON, V86, P1330, DOI 10.1016/j.neuron.2015.04.024; Collins Sarah, 2004, P39, DOI 10.1016/B978-012473070-0/50005-0; Dickens MJ, 2009, P R SOC B, V276, P2051, DOI 10.1098/rspb.2008.1778; Dickens MJ, 2009, GEN COMP ENDOCR, V160, P76, DOI 10.1016/j.ygcen.2008.10.023; Dunn AM, 1996, ETHOLOGY, V102, P529; Edwards KL, 2019, ADV EXP MED BIOL, V1200, P91, DOI 10.1007/978-3-030-23633-5_5; Elemans CPH, 2014, CURR OPIN NEUROBIOL, V28, P172, DOI 10.1016/j.conb.2014.07.022; Fee MS, 2001, J NEUROSCI METH, V112, P83, DOI 10.1016/S0165-0270(01)00426-5; Gadagkar V, 2016, SCIENCE, V354, P1278, DOI 10.1126/science.aah6837; George JM, 2019, P NATL ACAD SCI US, DOI [10.1073/pnas.182084111631332005, DOI 10.1073/PNAS.182084111631332005]; Gill LF, 2016, METHODS ECOL EVOL, V7, P1349, DOI 10.1111/2041-210X.12610; Giret N, 2014, P NATL ACAD SCI USA, V111, P6063, DOI 10.1073/pnas.1317087111; Goymann W, 2005, ANN NY ACAD SCI, V1046, P35, DOI 10.1196/annals.1343.005; Greggor AL, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00323; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hall ML, 2009, J AVIAN BIOL, V40, P217, DOI 10.1111/j.1600-048X.2009.04540.x; JACOBS H, 1995, ANIM WELFARE, V4, P3; Jerem P, 2015, JOVE-J VIS EXP, DOI 10.3791/53184; Jovalekic A, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa5848; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Krause ET, 2016, APPL ANIM BEHAV SCI, V182, P80, DOI 10.1016/j.applanim.2016.06.003; Lipkind D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01436-0; Manteuffel G, 2004, APPL ANIM BEHAV SCI, V88, P163, DOI 10.1016/j.applanim.2004.02.012; Marchetti K, 1998, ANIM BEHAV, V55, P361, DOI 10.1006/anbe.1997.0586; Mooney R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0179; Murdoch D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25112-5; Narula G, 2015, SOC NEUR M WASH DC, P260; Nystrom KGK, 1997, CAN J ZOOL, V75, P47, DOI 10.1139/z97-006; Perez EC, 2012, HORM BEHAV, V61, P573, DOI 10.1016/j.yhbeh.2012.02.004; Petkov Christopher I, 2012, Front Evol Neurosci, V4, P12, DOI 10.3389/fnevo.2012.00012; Rashotte ME, 2001, PHYSIOL BEHAV, V74, P533, DOI 10.1016/S0031-9384(01)00600-X; Riters LV, 2019, BEHAV PROCESS, V163, P91, DOI 10.1016/j.beproc.2017.10.002; Riters LV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115285; Romero LM, 2016, COMP BIOCHEM PHYS A, V202, P112, DOI 10.1016/j.cbpa.2016.05.002; Scharff C, 2013, CURR OPIN NEUROBIOL, V23, P29, DOI 10.1016/j.conb.2012.10.001; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; SLATER PJB, 1972, BEHAVIOUR, V43, P248; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; THORPE W. H., 1958, IBIS, V100, P535, DOI 10.1111/j.1474-919X.1958.tb07960.x; Tilgar V, 2010, HORM BEHAV, V57, P481, DOI 10.1016/j.yhbeh.2010.02.006; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; van Hoek Caroline S., 1998, Journal of Applied Animal Welfare Science, V1, P51, DOI 10.1207/s15327604jaws0101_5; Vyssotski AL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000317; Woolley SC, 2015, NEUROSCIENCE, V296, P39, DOI 10.1016/j.neuroscience.2014.10.010; Yamahachi H, 2017, BIORXIV, DOI [10.1101/154567, DOI 10.1101/154567]; Zai AT, 2019, INFERRING TRIAL TRIA, DOI [10.3929/ethz-b-000382074, DOI 10.3929/ETHZ-B-000382074]	56	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0236333	10.1371/journal.pone.0236333	http://dx.doi.org/10.1371/journal.pone.0236333			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776943	Green Published, gold			2022-12-26	WOS:000561393800009
J	Link, TI				Link, Tobias I.			Testing reference genes for transcript profiling inUromyces appendiculatusduring urediospore infection of common bean	PLOS ONE			English	Article							UROMYCES-APPENDICULATUS; PHAKOPSORA-PACHYRHIZI; MODEL; NORMALIZATION	Uromyces appendiculatusis a major pathogen on common bean. Like other rust fungi, it uses effectors to influence its host plant. Effectors are assumed to possess characteristic expression profiles, reflecting their activity during the infection process. In order to determine expression profiles using RT-qPCR, stably expressed reference genes are necessary for normalization. These reference genes need to be tested. Using samples representing seven different developmental stages of the urediospore-based infection process we employed RT-qPCR to measure the expression of 14 candidate reference genes and determined the most suitable ones based on the range of Cq values and comparative calculations using the geNorm and NormFinder algorithms. Among the tested genesRPS14had the smallest Cq range, followed byElf1aandElf3; geNorm ratedTubandUbcE2best withCytBas a third and NormFinder foundUbcE2,TubandElf3as best reference genes. Combining these findings using equal weight for the rankingsUbcE2,Elf3andTubcan be considered the best reference genes. A combination of either two reference genes,UbcE2andTubor three reference genes,UbcE2,Tub, andElf3is recommended for normalization. However, differences between most genes were relatively small, so all tested genes can be considered suitable for normalization with the exception ofRPS9,SDH,UbcandPDK.	[Link, Tobias I.] Univ Hohenheim, Fac Agr Sci, Inst Phytomed, Dept Phytopathol, Stuttgart, Germany	University Hohenheim	Link, TI (corresponding author), Univ Hohenheim, Fac Agr Sci, Inst Phytomed, Dept Phytopathol, Stuttgart, Germany.	tobias.link@uni-hohenheim.de						Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Borges A, 2012, PLANT CELL REP, V31, P827, DOI 10.1007/s00299-011-1204-x; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cooper B, 2017, PHYTOPATHOLOGY, V107, P920, DOI [10.1094/phyto-03-17-0095-r, 10.1094/PHYTO-03-17-0095-R]; Cooper B, 2016, PHYTOPATHOLOGY, V106, P491, DOI 10.1094/PHYTO-11-15-0310-R; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Hacquard S, 2011, PHYSIOL MOL PLANT P, V75, P106, DOI 10.1016/j.pmpp.2010.10.003; Hirschburger D, 2015, INT J MOL SCI, V16, P23057, DOI 10.3390/ijms160923057; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Liebenberg MM, 2010, COMMON BEAN RUST PAT; Link TI, 2014, MOL PLANT PATHOL, V15, P379, DOI 10.1111/mpp.12099; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puthoff DP, 2008, PHYTOPATHOLOGY, V98, P1126, DOI 10.1094/PHYTO-98-10-1126; Qi MS, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01182; Schmitz HK, 2014, PEST MANAG SCI, V70, P378, DOI 10.1002/ps.3562; Song X, 2011, PROTEOMICS, V11, P944, DOI 10.1002/pmic.201000014; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vieira A, 2011, FUNGAL BIOL-UK, V115, P891, DOI 10.1016/j.funbio.2011.07.002; Voegele, 2009, PLANT RELATIONSHIPS, P79	22	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237273	10.1371/journal.pone.0237273	http://dx.doi.org/10.1371/journal.pone.0237273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760134	gold, Green Published			2022-12-26	WOS:000561027200029
J	Witte, C; Hungerford, LL; Rideout, BA; Papendick, R; Fowler, JH				Witte, Carmel; Hungerford, Laura L.; Rideout, Bruce A.; Papendick, Rebecca; Fowler, James H.			Spatiotemporal network structure among "friends of friends" reveals contagious disease process	PLOS ONE			English	Article							AVIUM SUBSP-AVIUM; MYCOBACTERIUM-AVIUM; SOCIAL NETWORK; AVIAN MYCOBACTERIOSIS; INFECTION; TRANSMISSION; TUBERCULOSIS; DYNAMICS; BIRDS; CORRELATE	Disease transmission can be identified in a social network from the structural patterns of contact. However, it is difficult to separate contagious processes from those driven by homophily, and multiple pathways of transmission or inexact information on the timing of infection can obscure the detection of true transmission events. Here, we analyze the dynamic social network of a large, and near-complete population of 16,430 zoo birds tracked daily over 22 years to test a novel "friends-of-friends" strategy for detecting contagion in a social network. The results show that cases of avian mycobacteriosis were significantly clustered among pairs of birds that had been in direct contact. However, since these clusters might result due to correlated traits or a shared environment, we also analyzed pairs of birds that had never been in direct contact but were indirectly connected in the network via other birds. The disease was also significantly clustered among these friends of friends and a reverse-time placebo test shows that homophily could not be causing the clustering. These results provide empirical evidence that at least some avian mycobacteriosis infections are transmitted between birds, and provide new methods for detecting contagious processes in large-scale global network structures with indirect contacts, even when transmission pathways, timing of cases, or etiologic agents are unknown.	[Witte, Carmel; Rideout, Bruce A.; Papendick, Rebecca] San Diego Zoo Global, Dis Invest, San Diego, CA 92101 USA; [Witte, Carmel] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Witte, Carmel] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Hungerford, Laura L.] Virginia Maryland Coll Vet Med, Dept Populat Hlth Sci, Blacksburg, VA USA; [Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; [Fowler, James H.] Univ Calif San Diego, Div Global Publ Hlth, La Jolla, CA 92093 USA	University of California System; University of California San Diego; California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego	Witte, C (corresponding author), San Diego Zoo Global, Dis Invest, San Diego, CA 92101 USA.; Witte, C (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.; Witte, C (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA.	cwitte@sandiegozoo.org		Witte, Carmel/0000-0001-9086-3333				Ashour N., 1972, Acta Veterinaria, Brno, V41, P421; Beller K., 1930, ARCH F GEFLUGELKDE, V4, P453; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948; Craft ME, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0107; Cross PC, 2004, ANN ZOOL FENN, V41, P879; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; De Groote MA, 2006, APPL ENVIRON MICROB, V72, P7602, DOI 10.1128/AEM.00930-06; Dvorska L, 2007, VET MICROBIOL, V119, P366, DOI 10.1016/j.vetmic.2006.09.010; Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x; Falkinham Joseph O 3rd, 2016, Curr Environ Health Rep, V3, P161, DOI 10.1007/s40572-016-0086-z; Farine DR, 2017, METHODS ECOL EVOL, V8, P1309, DOI 10.1111/2041-210X.12772; Feldman WH., 1938, AVIAN TUBERCULOSIS I; Friend M., 1999, FIELD MANUAL WILDLIF, P93; Fulton RM., 2013, DIS POULTRY, V13th, P1008; Godfrey Stephanie S., 2013, International Journal for Parasitology Parasites and Wildlife, V2, P235, DOI 10.1016/j.ijppaw.2013.09.001; Goodman M, 2014, INT J ENV RES PUB HE, V11, P1479, DOI 10.3390/ijerph110201479; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Grear DA, 2013, ECOL APPL, V23, P1906, DOI 10.1890/13-0907.1; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hinshaw HR., 1927, J AM VET MED ASSOC, V71, P764; Holme P, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046119; Johnson GD, 2006, AM J EPIDEMIOL, V163, P171, DOI 10.1093/aje/kwj023; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kauppinen J, 2001, VET MICROBIOL, V81, P41, DOI 10.1016/S0378-1135(01)00330-3; Kossinets G, 2009, AM J SOCIOL, V115, P405, DOI 10.1086/599247; Ledwon A, 2008, AVIAN PATHOL, V37, P59, DOI 10.1080/03079450701802255; Lloyd AL, 2006, CONTEMP MATH, V410, P209; Mansfield KG, 1997, J INFECT DIS, V175, P184, DOI 10.1093/infdis/175.1.184; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Montali RJ, 1998, J INFECT DIS, V178, P1719, DOI 10.1086/314517; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; PAVLAS M, 1983, ACTA VET BRNO, V52, P163, DOI 10.2754/avb198352030163; Pfeiffer W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173464; PORPHYRE T, 2008, VET RES, V39, DOI DOI 10.1051/VETRES:200801618346451; Sax H, 2015, CLIN INFECT DIS, V61, P67, DOI 10.1093/cid/civ198; Schalk AF, TECHNICAL B N DAKOTA, V1935279, P46; Schrenzel M, 2008, VET MICROBIOL, V126, P122, DOI 10.1016/j.vetmic.2007.06.016; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Shitaye JE, 2008, VET MICROBIOL, V127, P155, DOI 10.1016/j.vetmic.2007.07.026; Sommerstein R, 2017, INFECT CONT HOSP EP, V38, P103, DOI 10.1017/ice.2016.283; Tell LA, 2003, AVIAN DIS, V47, P433, DOI 10.1637/0005-2086(2003)047[0433:AMOAMC]2.0.CO;2; Thomas AC, 2011, CENSORING OUTDEGREE, P22; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Van Es L, 1914, B N DAKOTA AGR EXPT, P94; von Bornstedt S., 1932, ARCH F GEFLUGELK, V41, P241; Watts DJ, 1999, AM J SOCIOL, V105, P493, DOI 10.1086/210318; Weber N, 2013, CURR BIOL, V23, pR915, DOI 10.1016/j.cub.2013.09.011; Witte CL, 2010, JAVMA-J AM VET MED A, V236, P211, DOI 10.2460/javma.236.2.211; Witte CL, 2008, J VET DIAGN INVEST, V20, P186, DOI 10.1177/104063870802000207	53	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237168	10.1371/journal.pone.0237168	http://dx.doi.org/10.1371/journal.pone.0237168			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2EP	32760155	Green Published, gold			2022-12-26	WOS:000561027200066
J	Bayraktarov, E; Banaszak, AT; Maya, PM; Kleypas, J; Arias-Gonzalez, JE; Blanco, M; Calle-Trivino, J; Charuvi, N; Cortes-Useche, C; Galvan, V; Salgado, MAG; Gnecco, M; Guendulain-Garcia, SD; Delgado, EAH; Moraga, JAM; Maya, MF; Quiroz, SM; Cervantes, SM; Morikawa, M; Nava, G; Pizarro, V; Sellares-Blasco, RI; Ramos, SES; Cubero, TV; Villalpando, MF; Frias-Torres, S				Bayraktarov, Elisa; Banaszak, Anastazia T.; Maya, Phanor Montoya; Kleypas, Joanie; Arias-Gonzalez, Jesus E.; Blanco, Macarena; Calle-Trivino, Johanna; Charuvi, Nufar; Cortes-Useche, Camilo; Galvan, Victor; Garcia Salgado, Miguel A.; Gnecco, Mariana; Guendulain-Garcia, Sergio D.; Hernandez Delgado, Edwin A.; Marin Moraga, Jose A.; Fernanda Maya, Maria; Mendoza Quiroz, Sandra; Mercado Cervantes, Samantha; Morikawa, Megan; Nava, Gabriela; Pizarro, Valeria; Sellares-Blasco, Rita, I; Suleiman Ramos, Samuel E.; Villalobos Cubero, Tatiana; Villalpando, Maria F.; Frias-Torres, Sarah			Coral reef restoration efforts in Latin American countries and territories	PLOS ONE			English	Article							CONSERVATION; MANAGEMENT; NURSERIES; TRANSPLANTATION; MOTIVATIONS; RESILIENCE; SUCCESS; COST	Coral reefs worldwide are degrading due to climate change, overfishing, pollution, coastal development, coral bleaching, and diseases. In areas where the natural recovery of an ecosystem is negligible or protection through management interventions insufficient, active restoration becomes critical. The Reef Futures symposium in 2018 brought together over 400 reef restoration experts, businesses, and civil organizations, and galvanized them to save coral reefs through restoration or identify alternative solutions. The symposium highlighted that solutions and discoveries from long-term and ongoing coral reef restoration projects in Spanish-speaking countries in the Caribbean and Eastern Tropical Pacific were not well known internationally. Therefore, a meeting of scientists and practitioners working in these locations was held to compile the data on the extent of coral reef restoration efforts, advances and challenges. Here, we present unpublished data from 12 coral reef restoration case studies from five Latin American countries, describe their motivations and techniques used, and provide estimates on total annual project cost per unit area of reef intervened, spatial extent as well as project duration. We found that most projects used direct transplantation, the coral gardening method, micro-fragmentation or larval propagation, and aimed to optimize or scale-up restoration approaches (51%) or provide alternative, sustainable livelihood opportunities (15%) followed by promoting coral reef conservation stewardship and re-establishing a self-sustaining, functioning reef ecosystems (both 13%). Reasons for restoring coral reefs were mainly biotic and experimental (both 42%), followed by idealistic and pragmatic motivations (both 8%). The median annual total cost from all projects was $93,000 USD (range: $10,000 USD-$331,802 USD) (2018 dollars) and intervened a median spatial area of 1 ha (range: 0.06 ha-8.39 ha). The median project duration was 3 years; however, projects have lasted up to 17 years. Project feasibility was high with a median of 0.7 (range: 0.5-0.8). This study closes the knowledge gap between academia and practitioners and overcomes the language barrier by providing the first comprehensive compilation of data from ongoing coral reef restoration efforts in Latin America.	[Bayraktarov, Elisa] Univ Queensland, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia; [Banaszak, Anastazia T.; Guendulain-Garcia, Sergio D.; Mendoza Quiroz, Sandra] Univ Nacl Autonoma Mexico, Invest Integral Conservac Arrecifes, Puerto Morelos, Quintana Roo, Mexico; [Maya, Phanor Montoya; Gnecco, Mariana; Fernanda Maya, Maria] Corales Paz, Cali, Colombia; [Kleypas, Joanie; Marin Moraga, Jose A.; Villalobos Cubero, Tatiana] Ctr Invest Ciencias Mar & Limnol CIMAR, Raising Coral Costa Rica, San Pedro, Costa Rica; [Arias-Gonzalez, Jesus E.; Calle-Trivino, Johanna; Cortes-Useche, Camilo] Inst Politecn Nacl, Dept Recursos Mar, Ctr Invest & Estudios Avanzados, Merida, Yucatan, Mexico; [Blanco, Macarena; Calle-Trivino, Johanna; Morikawa, Megan] Wave Change, Iberostar Hotels & Resorts, Santo Domingo, Dominican Rep; [Calle-Trivino, Johanna; Cortes-Useche, Camilo; Sellares-Blasco, Rita, I; Villalpando, Maria F.] Fdn Dominicana Estudios Marinos FUNDEMAR, Santo Domingo, Dominican Rep; [Charuvi, Nufar] Fdn Calipso, Taganga, Magdalena, Colombia; [Galvan, Victor; Mercado Cervantes, Samantha] Fdn Grp Puntacana FGPC, Punta Cana, La Altagracia P, Dominican Rep; [Garcia Salgado, Miguel A.; Nava, Gabriela] Oceanus AC, Chetmal, Quintana Roo, Mexico; [Hernandez Delgado, Edwin A.; Suleiman Ramos, Samuel E.] Soc Ambiente Marino SAM, San Juan, PR USA; [Hernandez Delgado, Edwin A.] Univ Puerto Rico, Dept Environm Sci, San Juan, PR 00936 USA; [Hernandez Delgado, Edwin A.] Univ Puerto Rico, Ctr Appl Trop Ecol & Conservat, San Juan, PR 00936 USA; [Mendoza Quiroz, Sandra] SECORE Int Inc, Hilliard, OH USA; [Pizarro, Valeria] Fdn Invest & Conservac Biol Marina ECOMARES, Cali, Valle Del Cauca, Colombia; [Frias-Torres, Sarah] Vulcan, Seattle, WA USA; [Frias-Torres, Sarah] Smithsonian Inst, Washington, DC 20560 USA	University of Queensland; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico; University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Rio Piedras; Smithsonian Institution	Bayraktarov, E (corresponding author), Univ Queensland, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia.	e.bayraktarov@uq.edu.au	Banaszak, Anastazia Teresa/H-6362-2019; Blanco, Macarena/AAG-4220-2021; Frias-Torres, Sarah/ABC-6366-2020	Banaszak, Anastazia Teresa/0000-0002-6667-3983; Blanco, Macarena/0000-0001-9004-1591; Frias-Torres, Sarah/0000-0002-0557-8018; Sergio, Guendulain-Garcia/0000-0002-6091-5398; Arias-Gonzalez, Jesus Ernesto/0000-0003-4601-710X; Montoya Maya, Phanor Hernando/0000-0002-6160-6175; Bayraktarov, Elisa/0000-0002-1389-7203; Villalpando, Maria Fernanda/0000-0001-9764-0706				AGRRA, 2019, CORAL DIS OUTBREAK A; Andersson AJ, 2019, REG STUD MAR SCI, V29, DOI 10.1016/j.rsma.2019.100677; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Banaszak AT., 2018, GUIA PRACTICA RESTAU; Barton JA, 2017, REV AQUACULT, V9, P238, DOI 10.1111/raq.12135; Baums IB, 2019, ECOL APPL, V29, DOI 10.1002/eap.1978; Bayraktarov E, 2019, RESTOR ECOL, V27, P981, DOI 10.1111/rec.12977; Bayraktarov E, 2016, ECOL APPL, V26, P1055, DOI 10.1890/15-1077; Beck MW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04568-z; Beher J, 2016, ENVIRON SCI POLICY, V59, P35, DOI 10.1016/j.envsci.2016.02.005; Bostrom-Einarsson L., 2018, CORAL RESTORATION CH; Bowden-Kerby A, 2001, B MAR SCI, V69, P915; Calle-Trivino J, 2018, REG STUD MAR SCI, V18, P129, DOI 10.1016/j.rsma.2018.02.002; Cellini S. R., 2010, HDB PRACTICAL PROGRA, V21, P493, DOI [DOI 10.1002/9781119171386.CH24, 10.1002/9781119171386]; Chamberland VF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17555-z; Clewell AF, 2006, CONSERV BIOL, V20, P420, DOI 10.1111/j.1523-1739.2006.00340.x; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Cortes Jorge, 2011, P351; Cortes-Useche C, 2019, REG STUD MAR SCI, V32, DOI 10.1016/j.rsma.2019.100893; dela Cruz D. W., 2017, SCI REPORTS, V7, P13; dela Cruz DW, 2015, ECOL ENG, V84, P408, DOI 10.1016/j.ecoleng.2015.09.042; Edwards AJ, 1998, MAR POLLUT BULL, V37, P474; Edwards AJ, 2010, REEF REHABILITATION; Edwards AJ, 2015, MAR ECOL PROG SER, V525, P105, DOI 10.3354/meps11171; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Ferrario F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4794; Ferse Sebastian C.A., 2009, Journal of Applied Aquaculture, V21, P31, DOI 10.1080/10454430802694538; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Field CD, 1998, MAR POLLUT BULL, V37, P383; Forsman ZH, 2015, PEERJ, V3, DOI 10.7717/peerj.1313; Frias-Torres S, 2015, AFR J MAR SCI, V37, P421, DOI 10.2989/1814232X.2015.1078259; Gillies CL, 2015, ECOL MANAG RESTOR, V16, P84, DOI 10.1111/emr.12159; Guest JR, 2014, CORAL REEFS, V33, P45, DOI 10.1007/s00338-013-1114-1; Hagger V, 2017, RESTOR ECOL, V25, P832, DOI 10.1111/rec.12503; Hein MY, 2017, RESTOR ECOL, V25, P873, DOI 10.1111/rec.12580; Hernandez-Delgado EA, 2015, MAR POLLUT BULL, V101, P5, DOI 10.1016/j.marpolbul.2015.09.018; Hernandez-Delgado E. A., 2018, CORALS CHANGING WORL, P213, DOI DOI 10.5772/INTECHOPEN.73151; Heyward AJ, 2002, MAR ECOL PROG SER, V230, P113, DOI 10.3354/meps230113; Hubbard Dennis, 2011, P338; Iacona GD, 2018, CONSERV BIOL, V32, P979, DOI 10.1111/cobi.13195; Jackson J, 2014, GLOBAL CORAL REEF MO; JACKSON JBC, 1992, AM ZOOL, V32, P719; Johnson M.E., 2011, CARIBBEAN ACROPORA R; Mbije NE, 2013, ESTUAR COAST SHELF S, V128, P41, DOI 10.1016/j.ecss.2013.04.021; McDonald T., 2016, INT STANDARDS PRACTI, DOI DOI 10.1177/; Mcleod E, 2019, J ENVIRON MANAGE, V233, P291, DOI 10.1016/j.jenvman.2018.11.034; Meyer JL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02244; Milner-Gulland EJ, 2010, ORYX, V44, P1, DOI 10.1017/S0030605309991001; Nedimyer Kenneth, 2011, AACL Bioflux, V4, P442; Ng CSL, 2015, ECOL ENG, V82, P480, DOI 10.1016/j.ecoleng.2015.05.016; Page CA, 2018, ECOL ENG, V123, P86, DOI 10.1016/j.ecoleng.2018.08.017; Perrow M. R., 2002, HDB ECOLOGICAL RESTO; Precht W., 2006, CORAL REEF RESTORATI, P55; Rinkevich B, 2005, ENVIRON SCI TECHNOL, V39, P4333, DOI 10.1021/es0482583; Rinkevich B, 2000, MAR BIOL, V136, P807, DOI 10.1007/s002270000293; Rinkevich B, 1995, RESTOR ECOL, V3, P241, DOI 10.1111/j.1526-100X.1995.tb00091.x; Rinkevich B, 2019, J MAR SCI ENG, V7, DOI 10.3390/jmse7070201; RODRIGUEZMARTIN.RE, 2014, PLOS ONE, V0009; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Ruiz-Jaen MC, 2005, RESTOR ECOL, V13, P569, DOI 10.1111/j.1526-100X.2005.00072.x; Salafsky N, 2002, CONSERV BIOL, V16, P1469, DOI 10.1046/j.1523-1739.2002.01232.x; Schwartz MW, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12385; SER, 2004, SER PRIMER ECOLOGICA; Shaish L, 2008, J EXP MAR BIOL ECOL, V358, P86, DOI 10.1016/j.jembe.2008.01.024; Steneck RS, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00265; Sunderland T, 2009, BIOTROPICA, V41, P549, DOI 10.1111/j.1744-7429.2009.00557.x; Sutherland, 2016, PLOS BIOL, V14, DOI [DOI 10.1371/JOURNAL.PBIO.2000933, 10.1371/journal.pbio.2000933]; Van Oppen MJH, 2017, GLOBAL CHANGE BIOL, V23, P3437, DOI 10.1111/gcb.13647; Walsworth TE, 2019, NAT CLIM CHANGE, V9, P632, DOI 10.1038/s41558-019-0518-5; Woodhead AJ, 2019, FUNCT ECOL, V33, P1023, DOI 10.1111/1365-2435.13331	71	27	27	8	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0228477	10.1371/journal.pone.0228477	http://dx.doi.org/10.1371/journal.pone.0228477			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756569	Green Submitted, gold, Green Published			2022-12-26	WOS:000560393300050
J	Yasui, D; Yamane, A; Itoh, H; Kobayashi, M; Kumita, S				Yasui, Daisuke; Yamane, Aya; Itoh, Hiroshi; Kobayashi, Masayuki; Kumita, Shin-ichiro			In vivo evaluation of a monodisperse solid-in-oil-in-water miriplatin/ lipiodol emulsion in transcatheter arterial chemoembolization using a rabbit VX2 tumor model	PLOS ONE			English	Article							UNRESECTABLE HEPATOCELLULAR-CARCINOMA; TRANSARTERIAL CHEMOEMBOLIZATION; CHEMOTHERAPY; EPIRUBICIN; EFFICACY; MICRODROPLETS; SAFETY; DAMAGE; TRIAL; AGENT	Transcatheter arterial chemoembolization (TACE) is a standard treatment for unresectable hepatocellular carcinoma; however, it does not always result in tumor control. Nevertheless, treatment outcome can be improved with monodisperse emulsions of anticancer agents. In this study, the distribution of a monodisperse miriplatin-Lipiodol emulsion in the tumor and its safety were evaluated in ten Japanese white rabbits. VX2 tumor was implanted into the left liver lobe. The animals were divided into control and experimental groups (of five animals each) and respectively administered a conventional miriplatin suspension or the emulsion via the left hepatic artery. Computed tomography (CT) was performed before, immediately after, and two days following TACE. All rabbits were sacrificed two days after the procedure. Each tumor was removed and cut in half for assessment of iodine concentration in one half by mass spectroscopy and evaluation of Lipiodol accumulation and adverse events in the other half. Mean Hounsfield unit (HU) values were measured using plain CT images taken before and after TACE. Iodine concentration was higher in the experimental group [1100 (750-1500) ppm, median (range)] than in the control group [840 (660-1800) ppm], although statistically not significant. Additionally, the HU value for the experimental group was higher than that for the control group immediately after [199.6 (134.0-301.7) vs. 165.3 (131.4-280.5)] and two days after [114.2 (56.1-229.8) vs. 58.3 (42.9-132.5)] TACE, although statistically not significant. Cholecystitis was observed in one rabbit in the control group. Ischemic bile duct injury was not observed in any group. The results show that Lipiodol accumulation and retention in VX2 tumor can possibly be improved with a monodisperse emulsion; however, it should be verified with a larger study. Moreover, no significant adverse events are associated with the use of the emulsion.	[Yasui, Daisuke; Kumita, Shin-ichiro] Nippon Med Sch, Dept Radiol, Tokyo, Japan; [Yamane, Aya] Nippon Med Sch, Dept Radiol, Musashi Kosugi Hosp, Kawasaki, Kanagawa, Japan; [Itoh, Hiroshi; Kobayashi, Masayuki] Adv Anim Med Ctr, Shizuoka, Shizuoka, Japan	Nippon Medical School; Nippon Medical School	Yasui, D (corresponding author), Nippon Med Sch, Dept Radiol, Tokyo, Japan.	ledhotcp@nms.ac.jp			Japan society for the promotion of science [DY 17K16489]	Japan society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	DY 17K16489 Japan society for the promotion of science https://www.jsps.go.jp/j-grantsinaid/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 2015, HEPATOL RES, V45, P663, DOI 10.1111/hepr.12403; Bannangkoon K, 2019, CLIN MOL HEPATOL, V25, P74, DOI 10.3350/cmh.2018.0072; Golfieri R, 2014, BRIT J CANCER, V111, P255, DOI 10.1038/bjc.2014.199; Hanada M, 2009, CANCER CHEMOTH PHARM, V64, P473, DOI 10.1007/s00280-008-0895-3; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Higashi S, 1999, J PHARMACOL EXP THER, V289, P816; HIGASHI S, 1995, CANCER, V75, P1245, DOI 10.1002/1097-0142(19950315)75:6<1245::AID-CNCR2820750606>3.0.CO;2-U; Ikeda M, 2018, J GASTROENTEROL, V53, P281, DOI 10.1007/s00535-017-1374-6; Irie T, 2013, CARDIOVASC INTER RAD, V36, P706, DOI 10.1007/s00270-012-0476-z; Iwazawa J, 2014, HEPATOL RES, V44, P201, DOI 10.1111/hepr.12104; Iwazawa Jin, 2012, Cancer Manag Res, V4, P113, DOI 10.2147/CMAR.S30431; Kishimoto S, 2018, ANTICANCER RES, V38, P247, DOI 10.21873/anticanres.12214; Kora S, 2013, HEPATOL RES, V43, P1100, DOI 10.1111/hepr.12050; Lammer J, 2010, CARDIOVASC INTER RAD, V33, P41, DOI 10.1007/s00270-009-9711-7; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Masada T, 2020, J VASC INTERV RADIOL, V31, P347, DOI 10.1016/j.jvir.2019.06.015; Matsui O, 2011, ABDOM IMAGING, V36, P264, DOI 10.1007/s00261-011-9685-1; Okusaka T, 2004, INVEST NEW DRUG, V22, P169, DOI 10.1023/B:DRUG.0000011793.72775.d1; Otsuji K, 2015, HEPATOL RES, V45, P514, DOI 10.1111/hepr.12376; Seko Y, 2013, HEPATOL RES, V43, P942, DOI 10.1111/hepr.12041; Yanagie H, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20170004; Yasui D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/359296	22	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0222553	10.1371/journal.pone.0222553	http://dx.doi.org/10.1371/journal.pone.0222553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756561	Green Published, Green Submitted, gold			2022-12-26	WOS:000560393300013
J	Mohammadkhani, R; Khaledi, N; Rajabi, H; Salehi, I; Komaki, A				Mohammadkhani, Reihaneh; Khaledi, Neda; Rajabi, Hamid; Salehi, Iraj; Komaki, Alireza			Influence of the maternal high-intensity-interval-training on the cardiac Sirt6 and lipid profile of the adult male offspring in rats	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; AEROBIC EXERCISE; PREGNANCY; IMPROVES; HEALTH; IMPACT; HYPERTROPHY; HOMEOSTASIS	The susceptibility to cardiovascular disease in offspring could be reduced prior to birth through maternal intervention, before and during pregnancy. We evaluated whether the initiation periods of maternal exercise in preconception and pregnancy periods induce beneficial effects in the adult male offspring. Thirty-two female rats were divided into control and exercise groups. The exercise groups involve exercise before pregnancy or the preconception periods, exercise during pregnancy, and exercise before and during pregnancy. The mothers in the exercise groups were run on the treadmill in different periods. Then the birth weight and weekly weight gain of male offspring were measured, and the blood and left ventricle tissue of samples were collected for analysis of the Sirtuin 6 (Sirt6) and insulin growth factor-2 (IGF-2) gene expression, serum levels of low-density lipoprotein (LDL), high-density lipoprotein (HDL), cholesterol (Cho), and triglycerides (TG). There was no significant difference in the birth weight of offspring groups (P = 0.246) while maternal HIIT only during pregnancy leads to reduce weekly weight gain of offspring. Our data showed that Sirt6 and IGF-2 gene expression was increased (P = 0.017) and decreased (P = 0.047) by maternal exercise prior to and during pregnancy, respectively. Also, the serum level of LDL (p = 0.002) and Cho (P = 0.007) were significantly decreased and maternal exercise leads to improves the running speed of the adult male offspring (p = 0.0176). This study suggests that maternal HIIT prior to and during pregnancy have positive intergenerational consequence in the health and physical readiness of offspring.	[Mohammadkhani, Reihaneh; Khaledi, Neda; Rajabi, Hamid] Kharazmi Univ, Fac Phys Educ & Sports Sci, Dept Exercise Physiol, Tehran, Iran; [Salehi, Iraj; Komaki, Alireza] Hamadan Univ Med Sci, Neurophysiol Res Ctr, Hamadan, Iran	Kharazmi University	Khaledi, N (corresponding author), Kharazmi Univ, Fac Phys Educ & Sports Sci, Dept Exercise Physiol, Tehran, Iran.	n.khaledi@khu.ac.ir	Rajabi, Hamid/Y-2878-2019; Salehi, Iraj/M-5556-2017; Khaledi, Neda/AAF-1982-2019; komaki, alireza/M-1255-2017	Rajabi, Hamid/0000-0002-3276-1598; Salehi, Iraj/0000-0002-7996-013X; Khaledi, Neda/0000-0002-3859-513X; 	Hamadan University of Medical Sciences, Iran	Hamadan University of Medical Sciences, Iran	This work was supported by a grant of Hamadan University of Medical Sciences, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artal R, 2003, CLIN OBSTET GYNECOL, V46, P479, DOI 10.1097/00003081-200306000-00026; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Beeson JH, 2018, MOL METAB, V16, P35, DOI 10.1016/j.molmet.2018.06.009; Blaize AN, 2015, EXERC SPORT SCI REV, V43, P198, DOI 10.1249/JES.0000000000000058; Botting KJ, 2012, CLIN EXP PHARMACOL P, V39, P814, DOI 10.1111/j.1440-1681.2011.05649.x; Brito VB, 2016, TOXICOLOGY, V368, P46, DOI 10.1016/j.tox.2016.08.017; Carter LG, 2012, AM J PHYSIOL-ENDOC M, V303, pE1061, DOI 10.1152/ajpendo.00213.2012; Chung E, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13184; da Silva SG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147200; Darby JRT, 2018, J PHYSIOL-LONDON, V596, P2345, DOI 10.1113/JP275806; Donniacuo M, 2019, LIFE SCI, V222, P140, DOI 10.1016/j.lfs.2019.03.001; Eclarinal JD, 2016, FASEB J, V30, P2541, DOI 10.1096/fj.201500018R; Freitas DA, 2018, PHYSIOL BEHAV, V184, P6, DOI 10.1016/j.physbeh.2017.10.027; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Gordon B, 2014, CURR SPORT MED REP, V13, P253, DOI 10.1249/JSR.0000000000000073; Haram PM, 2009, CARDIOVASC RES, V81, P723, DOI 10.1093/cvr/cvn332; Harris JE, 2018, TRENDS ENDOCRIN MET, V29, P164, DOI 10.1016/j.tem.2018.01.003; Harrison CL, 2016, SEMINARS REPROD MED; Hopkins SA, 2011, EXERC SPORT SCI REV, V39, P120, DOI 10.1097/JES.0b013e31821a5527; Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]; Kemi OJ, 2005, CARDIOVASC RES, V67, P161, DOI 10.1016/j.cardiores.2005.03.010; Klein CP, 2018, INT J DEV NEUROSCI, V71, P83, DOI 10.1016/j.ijdevneu.2018.08.009; Koltai E, 2010, MECH AGEING DEV, V131, P21, DOI 10.1016/j.mad.2009.11.002; Laskovsky J, 2018, UNIV DEVELOP ADMIN, P155, DOI 10.1007/978-981-10-6858-4_7; Leandro CG, 2007, J STRENGTH COND RES, V21, P751; Liu J, 2018, J STRENGTH COND RES, V32, P1391, DOI 10.1519/JSC.0000000000002416; May LE, 2014, EARLY HUM DEV, V90, P33, DOI 10.1016/j.earlhumdev.2013.11.001; Mendes OC, 2013, ARQ BRAS CARDIOL, V100, P44, DOI 10.1590/S0066-782X2012005000112; Newcomer SC, 2012, J DEV ORIG HLTH DIS, V3, P4, DOI 10.1017/S2040174411000687; Palinski W, 2001, CIRC RES, V89, P991, DOI 10.1161/hh2301.099646; Raipuria M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120980; Songstad NT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143095; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Tao RY, 2013, J BIOL CHEM, V288, P29252, DOI 10.1074/jbc.M113.481473; Valimaki IA, 2016, EUR J APPL PHYSIOL, V116, P1683, DOI 10.1007/s00421-016-3422-y; Vitiello M, 2017, AGEING RES REV, V35, P301, DOI 10.1016/j.arr.2016.10.008; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang KCW, 2015, AM J PHYSIOL-REG I, V308, pR627, DOI 10.1152/ajpregu.00346.2014; Winnik S, 2015, EUR HEART J, V36, P3404, DOI 10.1093/eurheartj/ehv290	39	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0237148	10.1371/journal.pone.0237148	http://dx.doi.org/10.1371/journal.pone.0237148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745152	Green Published, gold			2022-12-26	WOS:000560006800008
J	Mallick, I; Kirtania, P; Szabo, M; Bashir, F; Domonkos, I; Kos, PB; Vass, I				Mallick, Ivy; Kirtania, Prithwiraj; Szabo, Milan; Bashir, Faiza; Domonkos, Ildiko; Kos, Peter B.; Vass, Imre			A simple method to produce Synechocystis PCC6803 biofilm under laboratory conditions for electron microscopic and functional studies	PLOS ONE			English	Article							POLY-BETA-HYDROXYBUTYRATE; SP PCC 6803; CHLOROPHYLL FLUORESCENCE; PHOTOSYNTHESIS; CYANOBACTERIUM; ACCUMULATION; PURIFICATION; PCC-6803; GROWTH; ALGAE	Cyanobacteria can form biofilms in nature, which have ecological roles and high potential for practical applications. In order to study them we need biofilm models that contain healthy cells and can withstand physical manipulations needed for structural studies. At present, combined studies on the structural and physiological features of axenic cyanobacterial biofilms are limited, mostly due to the shortage of suitable model systems. Here, we present a simple method to establish biofilms using the cyanobacteriumSynechocystisPCC6803 under standard laboratory conditions to be directly used for photosynthetic activity measurements and scanning electron microscopy (SEM). We found that glass microfiber filters (GMF) with somewhat coarse surface features provided a suitable skeleton to formSynechocystisPCC6803 biofilms. Being very fragile, untreated GMFs were unable to withstand the processing steps needed for SEM. Therefore, we used polyhydroxybutyrate coating to stabilize the filters. We found that up to five coats resulted in GMF stabilization and made possible to obtain high resolution SEM images of the structure of the surface-attached cells and the extensive exopolysaccharide and pili network, which are essential features of biofilm formation. By using pulse-amplitude modulated variable chlorophyll fluorescence imaging, it was also demonstrated that the biofilms contain photosynthetically active cells. Therefore, theSynechocystisPCC6803 biofilms formed on coated GMFs can be used for both structural and functional investigations. The model presented here is easy to replicate and has a potential for high-throughput studies.	[Mallick, Ivy; Kirtania, Prithwiraj; Szabo, Milan; Bashir, Faiza; Domonkos, Ildiko; Kos, Peter B.; Vass, Imre] Hungarian Acad Sci, Biol Res Ctr, Inst Plant Biol, Szeged, Hungary; [Bashir, Faiza] Univ Szeged, Fac Sci & Informat, Biol PhD Sch, Szeged, Hungary; [Kos, Peter B.] Univ Szeged, Fac Sci & Informat, Dept Biotechnol, Szeged, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University; Szeged University	Vass, I (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Plant Biol, Szeged, Hungary.	vass.imre@brc.hu	Vass, Imre/AAS-6171-2021	Vass, Imre/0000-0003-4987-7842; Bashir, Faiza/0000-0001-7704-4915	Hungarian Ministry for National Economy [GINOP-2.3.2-15-2016-00058]; Hungarian Academy of Sciences; MTA Premium Postdoctoral Research Program [PREMIUM-2017-38]; National Research, Development and Innovation Office [NKFIH FK 128977]	Hungarian Ministry for National Economy; Hungarian Academy of Sciences(Hungarian Academy of Sciences); MTA Premium Postdoctoral Research Program; National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	I.M., P.K., F.B., P.B.K., and I.V. were supported by the Hungarian Ministry for National Economy (https://www.kormany.hu/en) GINOP2.3.2-15-2016-00001. M.S. was supported by the Hungarian Academy of Sciences (www.mta.hu), MTA Premium Postdoctoral Research Program (grant ID: PREMIUM-2017-38) and by the National Research, Development and Innovation Office (https://nkfih.gov.hu/, grant ID: NKFIH FK 128977). I.D. was supported by the Hungarian Ministry for National Economy (https://www.kormany.hu/en) GINOP-2.3.2-15-2016-00058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni M, 2016, BIOTECHNOL BIOENG, V113, P311, DOI 10.1002/bit.25712; Allen R, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02192-18; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Barros AC, 2019, J APPL PHYCOL, V31, P375, DOI 10.1007/s10811-018-1582-3; Besemer K, 2015, RES MICROBIOL, V166, P774, DOI 10.1016/j.resmic.2015.05.006; Bilal Muhammad, 2017, Front Biosci (Schol Ed), V9, P319; Branco Dos Santos Filipe, 2014, Front Bioeng Biotechnol, V2, P36, DOI 10.3389/fbioe.2014.00036; Bruno L, 2012, J APPL MICROBIOL, V113, P1052, DOI 10.1111/j.1365-2672.2012.05416.x; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Cuellar-Bermudez SP, 2017, ALGAL RES, V24, P438, DOI 10.1016/j.algal.2016.08.018; Cuellar-Bermudez SP, 2015, MICROB BIOTECHNOL, V8, P190, DOI 10.1111/1751-7915.12167; David C, 2015, J IND MICROBIOL BIOT, V42, P1083, DOI 10.1007/s10295-015-1626-5; Dong Z, 2013, FASEB J S, V27, P605; Gambino M, 2019, SCI TOTAL ENVIRON, V659, P342, DOI 10.1016/j.scitotenv.2018.12.358; Gaylarde CC, 2004, BIOFOULING, V20, P71, DOI 10.1080/08927010410001681237; Gomes LC, 2017, SCANNING, DOI 10.1155/2017/2960194; Guzzon A, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7080252; Halan B, 2012, TRENDS BIOTECHNOL, V30, P453, DOI 10.1016/j.tibtech.2012.05.003; Hamilton TL, 2016, ENVIRON MICROBIOL, V18, P325, DOI 10.1111/1462-2920.13118; Hoschek A, 2019, BIORESOURCE TECHNOL, V282, P171, DOI 10.1016/j.biortech.2019.02.093; Ikeuchi M, 2001, PHOTOSYNTH RES, V70, P73, DOI 10.1023/A:1013887908680; Johnson TJ, 2018, BIOTECHNOL PROGR, V34, P811, DOI 10.1002/btpr.2628; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kera K, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00664-17; Koerdt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014104; Mallick I, 2018, SCI TOTAL ENVIRON, V610, P1239, DOI 10.1016/j.scitotenv.2017.07.234; MARCUS Y, 1992, PLANTA, V187, P511, DOI 10.1007/BF00199970; Marcus Y, 2011, J EXP BOT, V62, P4173, DOI 10.1093/jxb/err116; McCormick AJ, 2011, ENERG ENVIRON SCI, V4, P4699, DOI 10.1039/c1ee01965a; Miranda AF, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0798-9; Mohit V, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0024-3; Nedbal L, 2004, ADV PHOTOSYNTHESIS R, P19, DOI [10.1007/978-1-4020-3218-9_14, DOI 10.1007/978-1-4020-3218-9_14]; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Panda B, 2007, LETT APPL MICROBIOL, V44, P194, DOI 10.1111/j.1472-765X.2006.02048.x; Schlebusch M, 2010, APPL ENVIRON MICROB, V76, P6101, DOI 10.1128/AEM.00484-10; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; Shimakawa G, 2015, PLANT PHYSIOL, V167, P472, DOI 10.1104/pp.114.249987; Shishatskaya EI, 2008, J MATER SCI-MATER M, V19, P2493, DOI 10.1007/s10856-007-3345-6; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Wenzel T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03320-x; Wu GF, 2001, BIORESOURCE TECHNOL, V76, P85, DOI 10.1016/S0960-8524(00)00099-7; Yu Y, 2013, MAR DRUGS, V11, P2894, DOI 10.3390/md11082894	43	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236842	10.1371/journal.pone.0236842	http://dx.doi.org/10.1371/journal.pone.0236842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730363	Green Published, gold, Green Accepted			2022-12-26	WOS:000556884700051
J	Zhao, ZR; Chen, AN; Hou, W; Graham, JM; Li, HF; Richman, PS; Thode, HC; Singer, AJ; Duong, TQ				Zhao, Zirun; Chen, Anne; Hou, Wei; Graham, James M.; Li, Haifang; Richman, Paul S.; Thode, Henry C.; Singer, Adam J.; Duong, Tim Q.			Prediction model and risk scores of ICU admission and mortality in COVID-19	PLOS ONE			English	Article							PROCALCITONIN; DIAGNOSIS	This study aimed to develop risk scores based on clinical characteristics at presentation to predict intensive care unit (ICU) admission and mortality in COVID-19 patients. 641 hospitalized patients with laboratory-confirmed COVID-19 were selected from 4997 persons under investigation. We performed a retrospective review of medical records of demographics, comorbidities and laboratory tests at the initial presentation. Primary outcomes were ICU admission and death. Logistic regression was used to identify independent clinical variables predicting the two outcomes. The model was validated by splitting the data into 70% for training and 30% for testing. Performance accuracy was evaluated using area under the curve (AUC) of the receiver operating characteristic analysis (ROC). Five significant variables predicting ICU admission were lactate dehydrogenase, procalcitonin, pulse oxygen saturation, smoking history, and lymphocyte count. Seven significant variables predicting mortality were heart failure, procalcitonin, lactate dehydrogenase, chronic obstructive pulmonary disease, pulse oxygen saturation, heart rate, and age. The mortality group uniquely contained cardiopulmonary variables. The risk score model yielded good accuracy with an AUC of 0.74 ([95% CI, 0.63-0.85], p = 0.001) for predicting ICU admission and 0.83 ([95% CI, 0.73-0.92], p<0.001) for predicting mortality for the testing dataset. This study identified key independent clinical variables that predicted ICU admission and mortality associated with COVID-19. This risk score system may prove useful for frontline physicians in clinical decision-making under time-sensitive and resource-constrained environment.	[Zhao, Zirun; Chen, Anne; Hou, Wei; Graham, James M.; Li, Haifang; Duong, Tim Q.] SUNY Stony Brook, Renaissance Sch Med, Dept Radiol, Stony Brook, NY 11794 USA; [Richman, Paul S.] SUNY Stony Brook, Dept Med, Renaissance Sch Med, Div Pulm Crit Care & Sleep Med, Stony Brook, NY 11794 USA; [Thode, Henry C.; Singer, Adam J.] SUNY Stony Brook, Dept Emergency Med, Renaissance Sch Med, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Duong, TQ (corresponding author), SUNY Stony Brook, Renaissance Sch Med, Dept Radiol, Stony Brook, NY 11794 USA.	tim.duong@stonybrookmedicine.edu	hou, wei/GWM-4800-2022; Duong, Tim/AAL-8357-2021; Singer, Adam/ABG-4506-2021	Duong, Tim/0000-0001-6403-2827; 				Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; China NHaHCo, 2020, DIAGN TREATM PROT NO; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Erez A, 2014, ISR MED ASSOC J, V16, P439; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Han Y, 2020, LACTATE DEHYDROGENAS, DOI [10.1101/2020.03.24.20040162, DOI 10.1101/2020.03.24.20040162]; Hu H, 2020, ACAD EMERGENCY MED; Ji D, 2020, CLIN INFECT DIS, V71, P1393, DOI 10.1093/cid/ciaa414; Kumar Pradeep, 2018, Journal of Entomology and Zoology Studies, V6, P181; Leung K, 2020, LANCET, V395, P1382, DOI 10.1016/S0140-6736(20)30746-7; Lippi G, 2020, CLIN CHIM ACTA, V505, P190, DOI 10.1016/j.cca.2020.03.004; Liu J, 2020, LONGITUDINAL CHARACT, DOI [10.1016/j.ebiom.2020.102763, 10.1101/2020.02.16.20023671., DOI 10.1016/J.EBIOM.2020.102763]; Lu J., 2020, ACP RISK GRADE SIMPL, DOI [10.1101/2020.02.20.20025510, DOI 10.1101/2020.02.20.20025510]; Pareek M, 2020, LANCET, V395, P1421, DOI 10.1016/S0140-6736(20)30922-3; Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623; Singer A, 2020, ANN EMERGENCY MED; Singer AJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009409; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Tang X, 2020, CHEST, V158, P195, DOI 10.1016/j.chest.2020.03.032; Wadhera RK, 2020, JAMA-J AM MED ASSOC, V323, P2192, DOI 10.1001/jama.2020.7197; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; World Health Organization, COR DIS 2019 COVID 1; Xie J, DEV EXTERNAL VALIDAT; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yelin I, 2020, CLIN INFECT DIS, V71, P2073, DOI 10.1093/cid/ciaa531; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou YW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233328; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	31	113	115	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236618	10.1371/journal.pone.0236618	http://dx.doi.org/10.1371/journal.pone.0236618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730358	Green Published, gold			2022-12-26	WOS:000556884700003
J	Ditiatkovski, M; Mukhamedova, N; Dragoljevic, D; Hoang, A; Low, H; Pushkarsky, T; Fu, Y; Carmichael, I; Hill, AF; Murphy, AJ; Bukrinsky, M; Sviridov, D				Ditiatkovski, Michael; Mukhamedova, Nigora; Dragoljevic, Dragana; Hoang, Anh; Low, Hann; Pushkarsky, Tatiana; Fu, Ying; Carmichael, Irena; Hill, Andrew F.; Murphy, Andrew J.; Bukrinsky, Michael; Sviridov, Dmitri			Modification of lipid rafts by extracellular vesicles carrying HIV-1 protein Nef induces redistribution of amyloid precursor protein and Tau, causing neuronal dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HIV-associated neurocognitive disorders; neurodegeneration; cholesterol; lipid raft; amyloid; Tau; lipid raft; human immunodeficiency virus (HIV)	CHOLESTEROL EFFLUX; PLASMA; BRAIN; NEURODEGENERATION; PATHOGENESIS; MICRODOMAINS; IMPAIRMENT; CELLS	HIV-associated neurocognitive disorders (HANDs) are a frequent outcome of HIV infection. Effective treatment of HIV infection has reduced the rate of progression and severity but not the overall prevalence of HANDs, suggesting ongoing pathological process even when viral replication is suppressed. In this study, we investigated how HIV-1 protein Nef secreted in extracellular vesicles (exNef) impairs neuronal functionality. ExNef were rapidly taken up by neural cellsin vitro, reducing the abundance of ABC transporter A1 (ABCA1) and thus cholesterol efflux and increasing the abundance and modifying lipid rafts in neuronal plasma membranes. ExNef caused a redistribution of amyloid precursor protein (APP) and Tau to lipid rafts and increased the abundance of these proteins, as well as of A beta(42). ExNef further potentiated phosphorylation of Tau and activation of inflammatory pathways. These changes were accompanied by neuronal functional impairment. Disruption of lipid rafts with cyclodextrin reversed the phenotype. Short-term treatment of C57BL/6 mice with either purified recombinant Nef or exNef similarly resulted in reduced abundance of ABCA1 and elevated abundance of APP in brain tissue. The abundance of ABCA1 in brain tissue of HIV-infected human subjects diagnosed with HAND was lower, and the abundance of lipid rafts was higher compared with HIV-negative individuals. Levels of APP and Tau in brain tissue correlated with the abundance of Nef. Thus, modification of neuronal cholesterol trafficking and of lipid rafts by Nef may contribute to early stages of neurodegeneration and pathogenesis in HAND.	[Ditiatkovski, Michael; Mukhamedova, Nigora; Dragoljevic, Dragana; Hoang, Anh; Low, Hann; Fu, Ying; Murphy, Andrew J.; Sviridov, Dmitri] Baker Heart & Diabet Inst, Melbourne, Vic, Australia; [Pushkarsky, Tatiana; Bukrinsky, Michael] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Carmichael, Irena] Monash Univ, Dept Micro Imaging, Melbourne, Vic, Australia; [Hill, Andrew F.] Louisiana Trobe Univ, Louisiana Trobe Inst Mol Sci, Dept Biochem & Genet, Bundoora, Vic, Australia; [Sviridov, Dmitri] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Baker Heart and Diabetes Institute; George Washington University; Monash University; Monash University	Sviridov, D (corresponding author), Baker Heart & Diabet Inst, Melbourne, Vic, Australia.; Sviridov, D (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	Dmitri.Sviridov@Baker.edu.au	Hill, Andrew F./GZL-4124-2022; Hill, Andrew F./AAH-2854-2020	Hill, Andrew F./0000-0001-5581-2354; Mukhamedova, Nigora/0000-0002-5924-1816; fu, ying/0000-0002-1261-3336	National Institutes of Health [HL131473, NS102163]; Victorian Government's Operational Infrastructure Support Program; District of Columbia Centre for AIDS Research, a National Institutes of Health-funded program [P30AI117970]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victorian Government's Operational Infrastructure Support Program; District of Columbia Centre for AIDS Research, a National Institutes of Health-funded program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants HL131473 (to M. B. and D. S.) and NS102163 (to M. B.) and supported in part by funds from the Victorian Government's Operational Infrastructure Support Program (to D. S.) and Grant P30AI117970 from the District of Columbia Centre for AIDS Research, a National Institutes of Health-funded program (to M. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bjorkhem I, 2010, J LIPID RES, V51, P2489, DOI 10.1194/jlr.R006338; Borjabad A, 2012, J NEUROIMMUNE PHARM, V7, P914, DOI 10.1007/s11481-012-9409-5; Brew BJ, 2009, J NEUROIMMUNE PHARM, V4, P163, DOI 10.1007/s11481-008-9143-1; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cui HHL, 2014, FASEB J, V28, P2828, DOI 10.1096/fj.13-246876; Cui HHL, 2014, J BIOL CHEM, V289, P789, DOI 10.1074/jbc.M113.535807; Cysique LA, 2011, J NEUROVIROL, V17, P176, DOI 10.1007/s13365-011-0021-x; Dubrovsky L, 2020, MBIO, V11, DOI 10.1128/mBio.02956-19; Ferdin J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191613; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Fulop T, 2019, J NEUROVIROL, V25, P634, DOI 10.1007/s13365-019-00732-3; Furler RL, 2010, IMMUNOL RES, V48, P99, DOI 10.1007/s12026-010-8170-1; Gluck JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010081; Grassi S, 2020, J LIPID RES, V61, P636, DOI 10.1194/jlr.TR119000427; Ito A, 2015, ELIFE, V4, DOI 10.7554/eLife.08009; Kaul M, 2008, FRONT BIOSCI-LANDMRK, V13, P2484, DOI 10.2741/2860; Khan MB, 2016, J NEUROVIROL, V22, P179, DOI 10.1007/s13365-015-0383-6; Lamers SL, 2018, J NEUROVIROL, V24, P1, DOI 10.1007/s13365-017-0586-0; Lee JH, 2016, EBIOMEDICINE, V6, P103, DOI 10.1016/j.ebiom.2016.03.004; Low H, 2016, CELL REP, V16, P186, DOI 10.1016/j.celrep.2016.05.070; Low H, 2012, JOVE-J VIS EXP, DOI 10.3791/3810; Madhusudan A, 2009, EUR J NEUROSCI, V30, P1064, DOI 10.1111/j.1460-9568.2009.06884.x; Mujawar Z, 2006, PLOS BIOL, V4, P1970, DOI 10.1371/journal.pbio.0040365; Mukhamedova N, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007907; Qi HL, 2016, J BIOL CHEM, V291, P7742, DOI 10.1074/jbc.M115.700914; Raymond AD, 2016, J NEUROVIROL, V22, P129, DOI 10.1007/s13365-015-0397-0; Raymond AD, 2011, AIDS RES HUM RETROV, V27, P167, DOI 10.1089/aid.2009.0170; Raymond A. D., 2019, PLASMA DERIVED HIV N, DOI [10.1101/708719, DOI 10.1101/708719]; Saeedi S, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0459-9; Saribas AS, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.467; Saylor D, 2016, NAT REV NEUROL, V12, P234, DOI [10.1038/nrneurol.2016.27, 10.1038/nrneurol.2016.53]; Schengrund CL, 2010, BRAIN RES BULL, V82, P7, DOI 10.1016/j.brainresbull.2010.02.013; Sonnino S, 2014, MOL NEUROBIOL, V50, P130, DOI 10.1007/s12035-013-8614-4; Sorci-Thomas MG, 2016, CIRC RES, V118, P679, DOI 10.1161/CIRCRESAHA.115.306246; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Tzschentke TM, 2002, AMINO ACIDS, V23, P147, DOI 10.1007/s00726-001-0120-8; Waheed AA, 2009, VIRUS RES, V143, P162, DOI 10.1016/j.virusres.2009.04.007; Wong ME, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01435; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	43	10	10	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13377	13392		10.1074/jbc.RA120.014642	http://dx.doi.org/10.1074/jbc.RA120.014642			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32732283	Green Published, hybrid			2022-12-26	WOS:000574483500020
J	Ekman, B; Nero, H; Lohmander, LS; Dahlberg, LE				Ekman, B.; Nero, H.; Lohmander, L. S.; Dahlberg, L. E.			Costing analysis of a digital first-line treatment platform for patients with knee and hip osteoarthritis in Sweden	PLOS ONE			English	Article							MANAGEMENT; RECOMMENDATIONS; PROGRAM; BURDEN; IMPACT	Osteoarthritis (OA) constitutes a major and increasing burden on patients, health care systems and the broader society. It is estimated that around a quarter of the adult population is affected by OA in the knee and hip and that the prevalence of OA will increase over the coming decades largely due to aging and adverse life-style factors. Prevention and effective care are critical to manage the challenges posed by OA. Digital technologies offer opportunities to deliver cost-effective care for chronic diseases, including for OA. We report the results of a costing analysis of a new digital platform for delivering first-line care including disease information and physiotherapy to patients with OA and compare this with an existing face-to-face model of treatment. Both models are in accordance with National Treatment Guidelines in Sweden. The results show that overall the digital model costs around 25% of the existing face-to-face model of care. Based on existing evidence on the effects of these models, our findings also suggest that the digital platform offers a cost-effective alternative to the existing model of OA care. Depending on the extent to which the digital model substitutes for the existing model of care, significant resources can be saved.	[Ekman, B.] Lund Univ, Dept Clin Sci, Malmo IKVM, Lund, Sweden; [Nero, H.; Lohmander, L. S.; Dahlberg, L. E.] Lund Univ, Dept Clin Sci, Lund IKVL, Orthoped, Lund, Sweden; [Nero, H.; Lohmander, L. S.; Dahlberg, L. E.] Arthro Therapeut, Malmo, Sweden	Lund University; Lund University	Nero, H (corresponding author), Lund Univ, Dept Clin Sci, Lund IKVL, Orthoped, Lund, Sweden.; Nero, H (corresponding author), Arthro Therapeut, Malmo, Sweden.	hakan.nero@med.lu.se	Lohmander, Stefan/AAL-8314-2021	Lohmander, Stefan/0000-0002-5424-9448; Nero, Hakan/0000-0002-3850-7283	Vinnova -Sweden's Innovation Agency [2016-04187]; Stiftelsen for Bistand at Rorelsehindrade i Skane [2019-0120]	Vinnova -Sweden's Innovation Agency(Vinnova); Stiftelsen for Bistand at Rorelsehindrade i Skane	This study was financed by research grant funds from Vinnova -Sweden's Innovation Agency (grant number: 2016-04187, www.vinnova.se) and Stiftelsen for Bistand at Rorelsehindrade i Skane (grant number: 2019-0120, www.stiftbistandskane.se) to LED at the Department of Clinical Sciences, Lund, Orthopaedics, Lund University, Sweden. Arthro Therapeutics (R) (AT), the owner of Joint Academy (R), provided part of the data and information used in the analysis. The funder AT provided support in the form of salaries for authors [HN, LSL, LED], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abimbola S, 2019, HEALTH ECON REV, V9, DOI 10.1186/s13561-019-0239-5; Ackerman Ilana N, 2020, Osteoarthr Cartil Open, V2, P100070, DOI 10.1016/j.ocarto.2020.100070; Bitton Ryan, 2009, Am J Manag Care, V15, pS230; Bozic KJ, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-73; Cronstrom A, 2020, OSTEOARTHRITIS CARTI; Cronstrom A, 2019, ARTHRIT CARE RES, V71, P1194, DOI 10.1002/acr.23772; Cronstrom A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028388; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Dahlberg LE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229783; Dahlberg LE, 2016, JMIR RES PROTOC, V5, DOI [10.2196/resprot.5665, 10.2196/resprot.5881]; Deyle GD, 2020, NEW ENGL J MED, V382, P1420, DOI 10.1056/NEJMoa1905877; Drummond MF, 2015, METHODS EC EVALUATIO; Dullet NW, 2017, VALUE HEALTH, V20, P542, DOI 10.1016/j.jval.2017.01.014; Elbert NJ, 2014, J MED INTERNET RES, V16, P182, DOI 10.2196/jmir.2790; Ferket BS, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1131; Fernandes L, 2013, ANN RHEUM DIS, V72, P1125, DOI 10.1136/annrheumdis-2012-202745; Hunter DJ, 2019, LANCET, V393, P1745, DOI 10.1016/S0140-6736(19)30417-9; Husereau D, 2013, INT J TECHNOL ASSESS, V29, P117, DOI 10.1017/S0266462313000160; Jonsson T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222657; Kolasinski SL, 2020, ARTHRITIS RHEUMATOL, V72, P220, DOI [10.1002/acr.24131, 10.1002/art.41142]; Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7; Litwic A, 2013, BRIT MED BULL, V105, P185, DOI 10.1093/bmb/lds038; McKinsey & Company, 2016, VARDET DIGITAL TEKNI; Nemes S, 2014, ACTA ORTHOP, V85, P238, DOI 10.3109/17453674.2014.913224; Nero H, 2020, OSTEOARTHR CARTILAGE, V28, pS31; Nero H, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.9255; Riksrevisionen, 2014, PRIM STYRN EFT BEH E; Roos EM, 2020, OSTEOARTHR CARTILAGE, V28, pS165; Salmon JH, 2016, OSTEOARTHR CARTILAGE, V24, P1500, DOI 10.1016/j.joca.2016.03.012; Schwartz AL, 2014, JAMA INTERN MED, V174, P1067, DOI 10.1001/jamainternmed.2014.1541; Siemieniuk RAC, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1982; Singh JA, 2019, J RHEUMATOL, V46, P1134, DOI 10.3899/jrheum.170990; Skou ST, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1439-y; Skou ST, 2015, NEW ENGL J MED, V373, P1597, DOI 10.1056/NEJMoa1505467; Statistics Sweden, SAL SEARCH; Svensson G, 2018, BOA YEARLY REPORT; Sweet CMC, 2018, J AGING HEALTH, V30, P692, DOI 10.1177/0898264316688791; The Swedish National Board of Health and Welfare, NATL GUIDELINES MUSC; Thorlund JB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2747; Toelle TR, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0109-x; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	41	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2020	15	8							e0236342	10.1371/journal.pone.0236342	http://dx.doi.org/10.1371/journal.pone.0236342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ND3HD	32785226	gold, Green Published			2022-12-26	WOS:000561793900038
J	Kuang, HY; Duan, YW; Li, D; Xu, YW; Ai, WX; Li, W; Wang, Y; Liu, S; Li, MS; Liu, XQ; Shao, MQ				Kuang, Hongying; Duan, Yuwei; Li, Dan; Xu, Yanwen; Ai, Wenxia; Li, Wei; Wang, Ying; Liu, Sha; Li, Mushan; Liu, Xiaoqiu; Shao, Manqi			The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; DAMAGE; RESISTANCE	Objective To study the role of selected serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome (PCOS). Methods Selected serum inflammatory cytokines were analyzed in the particle cells, which were interfered by berberine, from 78 infertile women who were to be treated with In Vitro Fertilization (IVF) /Intracytoplasmic Sperm Injection-Embryo Transfer (icsi-et). Among them, 49 patients had PCOS infertility, and 29 were non-PCOS patients whose infertility resulted from fallopian tube and male factors. The elisa method was used to detect the changes in the expression levels of inflammatory factors in the cells. The correlations between the serum inflammatory cytokine expression levels and the corresponding clinical hormones were analyzed. The changes in the expression (mRNA and protein) levels of the serum inflammatory cytokines were studied by real-time quantitative PCR and protein printing. Fluorescence microscope and flow cytometry were used to detect the glucose uptake capacity of ovarian granulosa cells in PCOS patients under the action of insulin after berberine. Results In the PCOS group, IL-17a (P = 0.001), IL-1Ra (P<0.0001), and IL-6 (P = 0.035) were significantly higher than those in the non-PCOS group. In the non-PCOS group, AMH level was negatively correlated with inflammatory cytokines IL-17a (r = -0.819;P = 0.004), IL-1a (r = -0.716;P = 0.0.02), IL-1b (r = -0.678;P = 0.031), IL-2 (r = -0.765;P = 0.01), and IL-8 (r = -0.705;P = 0.023). However, in the PCOS group, AMH levels were not significantly correlated with the levels of the examined inflammatory cytokines. Berberine significantly reduced the expression level of mTOR mRNA (P = 0.001), and increased the expression level of IRS-1 mRNA (P = 0.009) in the PCOS granule cells. Conclusion In this study, we find that the elevated levels of serum inflammatory factors IL-17a, IL-1Ra, and IL-6 cause women to be in a subclinical inflammatory state for a long time. Abnormal changes in inflammatory factors alter their original negative correlations with AMH levels, thereby weakening the metabolism of glycolipids, promoting insulin resistance, destroying the normal ovulation and fertilization system of women, leading to polycystic ovary syndrome characterized by menstrual thinning and abnormal ovulation. Berberine can improve the sensitivity of insulin by regulating the signal pathway of insulin receptor substrate-1 (IRS-1) and mammalian target of rapamycin (mTOR) in PCOS patients and achieve a therapeutic effect of treating PCOS.	[Kuang, Hongying; Li, Wei; Wang, Ying] Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Harbin, Peoples R China; [Kuang, Hongying; Ai, Wenxia; Liu, Sha; Li, Mushan; Liu, Xiaoqiu; Shao, Manqi] Heilongjiang Univ Chinese Med, Harbin, Peoples R China; [Duan, Yuwei; Li, Dan; Xu, Yanwen] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China; [Duan, Yuwei; Xu, Yanwen] Guangdong Prov Key Lab Reprod Med, Guangzhou, Peoples R China; [Li, Dan] Beijing Univ Chinese Med, Affiliated Hosp 3, Dept Acupuncture, Beijing, Peoples R China; [Xu, Yanwen] Sun Yat Sen Univ, Affiliated Hosp 1, Reprod Med Ctr, Guangzhou, Guangdong, Peoples R China	Heilongjiang University of Chinese Medicine; Heilongjiang University of Chinese Medicine; Sun Yat Sen University; Beijing University of Chinese Medicine; Sun Yat Sen University	Li, D; Xu, YW (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China.; Xu, YW (corresponding author), Guangdong Prov Key Lab Reprod Med, Guangzhou, Peoples R China.; Li, D (corresponding author), Beijing Univ Chinese Med, Affiliated Hosp 3, Dept Acupuncture, Beijing, Peoples R China.; Xu, YW (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Reprod Med Ctr, Guangzhou, Guangdong, Peoples R China.	3509437@qq.com; Xuyanwen@live.com			Outstanding talents funding project of Heilongjiang University of Chinese Medicine, China [2018JC05]; Foundation for young academic leaders of Heilongjiang University of Chinese Medicine, China [2018RCD08]; Foundation for Heilongjiang Province Postdoctoral Research Startup, China [LBHQ18119]; Project of Undergraduate Colleges and Universities Youth Innovation Talents by Education Department of Heilongjiang Province, China [UNPYST-2018227]; Natural Science Foundation of Heilongjiang Province, China [H2016083]	Outstanding talents funding project of Heilongjiang University of Chinese Medicine, China; Foundation for young academic leaders of Heilongjiang University of Chinese Medicine, China; Foundation for Heilongjiang Province Postdoctoral Research Startup, China; Project of Undergraduate Colleges and Universities Youth Innovation Talents by Education Department of Heilongjiang Province, China; Natural Science Foundation of Heilongjiang Province, China(Natural Science Foundation of Heilongjiang Province)	This work was supported by the Outstanding talents funding project of Heilongjiang University of Chinese Medicine, China [grant number 2018JC05]; the Foundation for young academic leaders of Heilongjiang University of Chinese Medicine, China [grant number 2018RCD08]; and the Foundation for Heilongjiang Province Postdoctoral Research Startup, China [grant number LBHQ18119]; the Project of Undergraduate Colleges and Universities Youth Innovation Talents by Education Department of Heilongjiang Province, China [grant number UNPYST-2018227]; the Natural Science Foundation of Heilongjiang Province, China [grant number H2016083]	[Anonymous], 2017, AM J CANC RES, V7, P383; Benson S, 2008, BRAIN BEHAV IMMUN, V22, P177, DOI 10.1016/j.bbi.2007.07.003; Bhide P, 2017, GYNECOL ENDOCRINOL, V33, P801, DOI 10.1080/09513590.2017.1320377; Burhans WC, 2007, NUCLEIC ACIDS RES, V35, P7545, DOI 10.1093/nar/gkm1059; Chen CH, 2010, BIOCHEM BIOPH RES CO, V397, P543, DOI 10.1016/j.bbrc.2010.05.153; Chhabra Neeti, 2018, J Hum Reprod Sci, V11, P348, DOI 10.4103/jhrs.JHRS_59_17; Chueh WH, 2012, INT IMMUNOPHARMACOL, V12, P534, DOI 10.1016/j.intimp.2012.01.003; Chueh WH, 2011, J AGR FOOD CHEM, V59, P8021, DOI 10.1021/jf201627w; Denes A, 2011, CEREBROVASC DIS, V32, P517, DOI 10.1159/000332205; Derosa G, 2012, EXPERT OPIN BIOL TH, V12, P1113, DOI 10.1517/14712598.2012.704014; Front Endocrinol (Lausanne), 2019, FRONT ENDOCRINOL, V10, P692; Halicka HD, 2012, AGING-US, V4, P952, DOI 10.18632/aging.100521; Halicka HD, 2012, AGING-US, V4, P270, DOI 10.18632/aging.100450; Hehenkamp WJK, 2006, J CLIN ENDOCR METAB, V91, P4057, DOI 10.1210/jc.2006-0331; Hesampour F, 2019, IRAN J ALLERGY ASTHM, V18, P91; Imenshahidi M, 2019, PHYTOTHER RES, V33, P504, DOI 10.1002/ptr.6252; Kong WJ, 2009, METABOLISM, V58, P109, DOI 10.1016/j.metabol.2008.08.013; LI M F, 2018, EFFECT BERBERINE POL, V2018; Li MF, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/2532935; Li W, 2020, BIOMED PHARMACOTHER, V121, DOI 10.1016/j.biopha.2019.109563; Neagu M, 2012, J Med Life, V5, P462; Rehman K, 2017, CRIT REV EUKAR GENE, V27, P229, DOI 10.1615/CritRevEukaryotGeneExpr.2017019712; Rondanelli M, 2020, ARCH GYNECOL OBSTET, V301, P53, DOI 10.1007/s00404-020-05450-4; Singh IP, 2013, EXPERT OPIN THER PAT, V23, P215, DOI 10.1517/13543776.2013.746314; TarkunI Cetin Arslan B, 2006, METAB SYNDRRELAT DIS, V4, P122; Tata B, 2018, NAT MED, V24, P834, DOI 10.1038/s41591-018-0035-5; Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41; Vuddanda PR, 2010, EXPERT OPIN INV DRUG, V19, P1297, DOI 10.1517/13543784.2010.517745; Wattegedera SR, 2017, VET RES, V48, DOI 10.1186/s13567-017-0426-5; Xu J, 2018, BIOL REPROD, V98, P197, DOI 10.1093/biolre/iox181; Yang J, 2012, EVID-BASED COMPL ALT, V2012, DOI DOI 10.1155/2012/363845; Yang Y H, 2012, MED INNOVAT CHINA, V9, P1; YIN SG, 2019, BIOMED PHARMACOTHER, V0120, DOI DOI 10.1016/J.BIOPHA.2019.108687; Zhang FF, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00175	34	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2020	15	8							e0235404	10.1371/journal.pone.0235404	http://dx.doi.org/10.1371/journal.pone.0235404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ND3HD	32785222	Green Published, gold			2022-12-26	WOS:000561793900008
J	Xiong, XF; Cui, DR; Bi, YL; Sun, Y; Zhao, YC				Xiong, Xiufang; Cui, Danrui; Bi, Yanli; Sun, Yi; Zhao, Yongchao			Neddylation modification of ribosomal protein RPS27L or RPS27 by MDM2 or NEDP1 regulates cancer cell survival	FASEB JOURNAL			English	Article						MDM2; NEDD8; Neddylation; NEDP1; RPS27; RPS27L	NEDD8-ACTIVATING ENZYME; P53; INHIBITOR	Neddylation plays a distinct role in stabilization of a subset of ribosomal proteins. Whether the family of ribosomal proteins S27 (RPS27 and RPS27-like) is subjected to neddylation regulation with associated biological consequence is totally unknown. Here, we report that both family members are subjected to neddylation by MDM2 E3 ubiquitin ligase, and deneddylation by NEDP1. Blockage of neddylation with MLN4924, a small molecule inhibitor of neddylation-activating enzyme, destabilizes RPS27L and RPS27 by shortening their protein half-lives. Biologically, knockdown of RPS27L and RPS27 sensitizes, whereas ectopic expression of RPS27L and RPS27 desensitizes cancer cells to MLN4924-induced apoptosis. Taken together, our study demonstrates that neddylation stabilizes RPS27L and RPS27 to confer the survival of cancer cells.	[Xiong, Xiufang; Sun, Yi] Zhejiang Univ, Canc Inst, Affiliated Hosp 2, Sch Med, 268 Kai Xuan Rd, Hangzhou 310029, Zhejiang, Peoples R China; [Cui, Danrui; Bi, Yanli; Zhao, Yongchao] Zhejiang Univ, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat, Minist Publ Hlth,Sch Med, 79 Qing Chun Rd, Hangzhou 310003, Zhejiang, Peoples R China; [Xiong, Xiufang; Cui, Danrui; Bi, Yanli; Sun, Yi; Zhao, Yongchao] Zhejiang Univ, Inst Translat Med, Sch Med, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Sun, Y (corresponding author), Zhejiang Univ, Canc Inst, Affiliated Hosp 2, Sch Med, 268 Kai Xuan Rd, Hangzhou 310029, Zhejiang, Peoples R China.; Zhao, YC (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat, Minist Publ Hlth,Sch Med, 79 Qing Chun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	yisun@zju.edu.cn; yongchao@zju.edu.cn		Xiong, Xiufang/0000-0001-6842-3673	National Key R&D Program of China [2016YFA0501800]; National Natural Science Foundation of China [81672728, 81972591, 81721091, 81974429, 81572708]; Natural Science Foundation of Zhejiang Province [LR16C050001]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	National Key R&D Program of China, Grant/Award Number: 2016YFA0501800; National Natural Science Foundation of China, Grant/Award Number: 81672728, 81972591, 81721091, 81974429 and 81572708; Natural Science Foundation of Zhejiang Province, Grant/Award Number: LR16C050001	Barbier-Torres L, 2015, ONCOTARGET, V6, P2509, DOI 10.18632/oncotarget.3191; Cui DR, 2020, CELL REP, V30, P497, DOI 10.1016/j.celrep.2019.12.032; Cui DR, 2020, CELL DEATH DIFFER, V27, P1119, DOI 10.1038/s41418-019-0402-x; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; He H, 2007, ONCOGENE, V26, P2707, DOI 10.1038/sj.onc.1210073; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li J, 2007, CANCER RES, V67, P11317, DOI 10.1158/0008-5472.CAN-07-1088; Li LH, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju083; Maghames CM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06365-0; Milhollen MA, 2012, CANCER CELL, V21, P388, DOI 10.1016/j.ccr.2012.02.009; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Toth JI, 2012, CELL REP, V1, P309, DOI 10.1016/j.celrep.2012.02.006; Watson IR, 2010, ONCOGENE, V29, P297, DOI 10.1038/onc.2009.314; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Xie P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4733; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Xiong XF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1168-7; Xiong XF, 2014, ELIFE, V3, DOI 10.7554/eLife.02236; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Xu XL, 2016, SCI CHINA LIFE SCI, V59, P656, DOI 10.1007/s11427-016-0018-0; Zhang J, 2014, ONCOGENE, V33, P246, DOI 10.1038/onc.2012.560; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhao Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.125; Zhao YC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0192-3; Zhao YC, 2014, ANTIOXID REDOX SIGN, V21, P2383, DOI 10.1089/ars.2013.5795; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029; Zhou LS, 2018, CELL SIGNAL, V44, P92, DOI 10.1016/j.cellsig.2018.01.009	31	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13419	13429		10.1096/fj.202000530RRR	http://dx.doi.org/10.1096/fj.202000530RRR		AUG 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32779270	hybrid			2022-12-26	WOS:000558415900001
J	Perez-Gonzalez, R; Kim, Y; Miller, C; Pacheco-Quinto, J; Eckman, EA; Levy, E				Perez-Gonzalez, Rocio; Kim, Yohan; Miller, Chelsea; Pacheco-Quinto, Javier; Eckman, Elizabeth A.; Levy, Efrat			Extracellular vesicles: where the amyloid precursor protein carboxyl-terminal fragments accumulate and amyloid-beta oligomerizes	FASEB JOURNAL			English	Article						A beta oligomers; Alzheimer's disease; APP-CTFs; APP metabolism; exosomes	IMPAIR SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; MOUSE MODEL; A-BETA; DOWN-SYNDROME; LYSOSOMAL DYSFUNCTION; IN-VIVO; SECRETASE CLEAVAGE; MEMORY DEFICITS; GM1 GANGLIOSIDE	Pleiotropic roles are proposed for brain extracellular vesicles (EVs) in the development of Alzheimer's disease (AD). Our previous studies have suggested a beneficial role for EVs in AD, where the endosomal system in vulnerable neurons is compromised, contributing to the removal of accumulated material from neurons. However, the involvement of EVs in propagating AD amyloidosis throughout the brain has been considered because the amyloid-beta precursor protein (APP), APP metabolites, and key APP cleaving enzymes were identified in association with EVs. Here, we undertook to determine whether the secretase machinery is actively processing APP in EVs isolated from the brains of wild-type and APP overexpressing Tg2576 mice. We found that full-length APP is cleaved in EVs incubated in the absence of cells. The resulting metabolites, both alpha- and beta-APP carboxyl-terminal fragments and APP intracellular domain accumulate in EVs over time and amyloid-beta dimerizes. Thus, EVs contribute to the removal from neurons and transport of APP-derived neurotoxic peptides. While this is potentially a venue for propagation of the pathology throughout the brain, it may contribute to efficient removal of neurotoxic peptides from the brain.	[Perez-Gonzalez, Rocio; Kim, Yohan; Miller, Chelsea; Levy, Efrat] Nathan S Kline Inst, Ctr Dementia Res, Orangeburg, NY USA; [Perez-Gonzalez, Rocio; Kim, Yohan; Levy, Efrat] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Pacheco-Quinto, Javier; Eckman, Elizabeth A.] Biomed Res Inst New Jersey Cedar Knolls & Atlanti, Morristown, NJ USA; [Levy, Efrat] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Levy, Efrat] NYU, Sch Med, Neurosci Inst, New York, NY USA; [Perez-Gonzalez, Rocio] Hosp Santa Creu & Sant Pau, St Pau Biomed Res Inst IIB St Pau, Ctr Networked Biomed Res Neurodegenerat Dis CIBER, Barcelona, Spain; [Perez-Gonzalez, Rocio] Hosp Santa Creu & Sant Pau, Dept Neurol, Barcelona, Spain	Nathan Kline Institute for Psychiatric Research; New York University; New York University; New York University; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau	Perez-Gonzalez, R (corresponding author), St Pau Biomed Res Inst IIB St Pau, St Quinti 77-79, Barcelona 08041, Spain.	rperezgo@santpau.cat	Perez-Gonzalez, Rocio/GQH-7068-2022; Eckman, Elizabeth/AAL-7316-2021	Perez-Gonzalez, Rocio/0000-0002-0641-2001; Eckman, Elizabeth/0000-0002-5391-4960; Kim, Yohan/0000-0003-2550-8751	Alzheimer's Association [NIRG-14-316622]; National Institute on Aging [AG017617, AG056732]	Alzheimer's Association(Alzheimer's Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Alzheimer's Association, Grant/Award Number: NIRG-14-316622; National Institute on Aging, Grant/Award Number: AG017617 and AG056732	Baghallab I, 2018, J ALZHEIMERS DIS, V66, P1235, DOI 10.3233/JAD-180582; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Cataldo AM, 2008, AM J PATHOL, V173, P370, DOI 10.2353/ajpath.2008.071053; Colacurcio DJ, 2018, FREE RADICAL BIO MED, V114, P40, DOI 10.1016/j.freeradbiomed.2017.10.001; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; D'Acunzo P, 2019, DEV NEUROBIOL, V79, P656, DOI 10.1002/dneu.22708; Deyts C, 2012, J NEUROSCI, V32, P1714, DOI 10.1523/JNEUROSCI.5433-11.2012; Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Escrevente C, 2008, BBA-GEN SUBJECTS, V1780, P905, DOI 10.1016/j.bbagen.2008.03.004; Fahrenholz F, 2000, ANN NY ACAD SCI, V920, P215; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Gauthier SA, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0466-0; Ghosal K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011866; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Jiang Y, 2019, J NEUROSCI, V39, P5255, DOI 10.1523/JNEUROSCI.0578-19.2019; Jiang Y, 2016, NEUROBIOL AGING, V39, P90, DOI 10.1016/j.neurobiolaging.2015.11.013; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Joshi P, 2014, CELL DEATH DIFFER, V21, P582, DOI 10.1038/cdd.2013.180; Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197; Kaur G, 2017, MOL PSYCHIATR, V22, P981, DOI 10.1038/mp.2016.189; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Laulagnier K, 2018, CELL MOL LIFE SCI, V75, P757, DOI 10.1007/s00018-017-2664-0; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lauritzen I, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0176-6; Lauritzen I, 2016, ACTA NEUROPATHOL, V132, P257, DOI 10.1007/s00401-016-1577-6; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lauritzen L, 2019, CURR ALZHEIMER RES, V16, P453, DOI 10.2174/1567205016666190325092841; Mathews PM, 2002, J BIOL CHEM, V277, P36415, DOI 10.1074/jbc.M205208200; McPhie DL, 2001, MOL BRAIN RES, V97, P103, DOI 10.1016/S0169-328X(01)00294-7; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Neve RL, 1998, TRENDS NEUROSCI, V21, P15, DOI 10.1016/S0166-2236(97)01168-5; Nixon RA, 2017, FASEB J, V31, P2729, DOI 10.1096/fj.201700359; OsterGranite ML, 1996, J NEUROSCI, V16, P6732; Pacheco-Quinto J, 2019, FASEB J, V33, P3758, DOI 10.1096/fj.201801319R; Pardossi-Piquard R, 2016, CURR ALZHEIMER RES, V13, P942, DOI 10.2174/1567205013666160404120106; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Peng KY, 2019, BRAIN, V142, P163, DOI 10.1093/brain/awy289; Perez-Gonzalez R, 2019, NEUROBIOL AGING, V84, P26, DOI 10.1016/j.neurobiolaging.2019.07.016; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Portelius E, 2013, J ALZHEIMERS DIS, V33, P85, DOI 10.3233/JAD-2012-120994; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sanderson RD, 2019, MATRIX BIOL, V75-76, P160, DOI 10.1016/j.matbio.2017.10.007; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Sinha MS, 2018, ACTA NEUROPATHOL, V136, P41, DOI 10.1007/s00401-018-1868-1; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Welzel AT, 2014, BIOCHEMISTRY-US, V53, P3908, DOI 10.1021/bi5003053; Wolfe MS, 2008, CURR TOP MED CHEM, V8, P2, DOI 10.2174/156802608783334024; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yuyama K, 2008, J NEUROCHEM, V105, P217, DOI 10.1111/j.1471-4159.2007.05128.x; Yuyama K, 2015, FEBS LETT, V589, P84, DOI 10.1016/j.febslet.2014.11.027; Yuyama K, 2014, J BIOL CHEM, V289, P24488, DOI 10.1074/jbc.M114.577213; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Zott B, 2019, SCIENCE, V365, P559, DOI 10.1126/science.aay0198	77	18	18	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12922	12931		10.1096/fj.202000823R	http://dx.doi.org/10.1096/fj.202000823R		AUG 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32772431	Green Published, hybrid			2022-12-26	WOS:000560235000001
J	Abu-El-Rub, E; Sareen, N; Sequiera, GL; Ammar, HI; Yan, WA; ShamsEldeen, AM; Rubinchik, I; Moudgil, M; Shokry, HS; Rashed, LA; Dhingra, S				Abu-El-Rub, Ejlal; Sareen, Niketa; Sequiera, Glen Lester; Ammar, Hania, I; Yan, Weiang; ShamsEldeen, Asmaa M.; Rubinchik, Ilan; Moudgil, Meenal; Shokry, Heba S.; Rashed, Laila A.; Dhingra, Sanjiv			Hypoxia-induced increase in Sug1 leads to poor post-transplantation survival of allogeneic mesenchymal stem cells	FASEB JOURNAL			English	Article						immunogenicity; MHC-II; MSCs	STROMAL CELLS; MYOCARDIAL-INFARCTION; IMMUNOGENICITY; EXPRESSION; BENEFITS; ATPASE; REPAIR	Allogeneic mesenchymal stem cells (MSCs) from young and healthy donors are immunoprivileged and have the potential to treat numerous degenerative diseases. However, recent reviews of clinical trials report poor long-term survival of transplanted cells in the recipient that turned down the enthusiasm regarding MSC therapies. Increasing evidence now confirm that though initially immunoprivileged, MSCs eventually become immunogenic after transplantation in the ischemic or hypoxic environment of diseased tissues and are rejected by the host immune system. We performed in vitro (in rat and human cells) and in vivo (in a rat model) investigations to understand the mechanisms of the immune switch in the phenotype of MSCs. The immunoprivilege of MSCs is preserved by the absence of cell surface immune antigen, major histocompatibility complex II (MHC-II) molecule. We found that the ATPase subunit of 19S proteasome "Sug1" regulates MHC-II biosynthesis in MSCs. Exposure to hypoxia upregulates Sug1 in MSCs and its binding to class II transactivator (CIITA), a coactivator of MHC-II transcription. Sug1 binding to CIITA in hypoxic MSCs promotes the acetylation and K63 ubiquitination of CIITA leading to its activation and translocation to the nucleus, and ultimately MHC-II upregulation. In both rat and human MSCs, knocking down Sug1 inactivated MHC-II and preserved immunoprivilege even following hypoxia. In a rat model of myocardial infarction, transplantation of Sug1-knockdown MSCs in ischemic heart preserved immunoprivilege and improved the survival of transplanted cells. Therefore, the current study provides novel mechanisms of post-transplantation loss of immunoprivilege of MSCs. This study may help in facilitating better planning for future clinical trials.	[Abu-El-Rub, Ejlal; Sareen, Niketa; Sequiera, Glen Lester; Yan, Weiang; Rubinchik, Ilan; Moudgil, Meenal; Dhingra, Sanjiv] St Boniface Gen Hosp, Inst Cardiovasc Sci, Regenerat Med Program, Albrechtsen Res Ctr, Winnipeg, MB, Canada; [Abu-El-Rub, Ejlal; Sareen, Niketa; Sequiera, Glen Lester; Yan, Weiang; Rubinchik, Ilan; Moudgil, Meenal; Dhingra, Sanjiv] Univ Manitoba, Coll Med, Fac Hlth Sci, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada; [Ammar, Hania, I; ShamsEldeen, Asmaa M.; Shokry, Heba S.; Rashed, Laila A.] Cairo Univ, Fac Med, Dept Physiol & Biochem, Giza, Egypt	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Egyptian Knowledge Bank (EKB); Cairo University	Dhingra, S (corresponding author), St Boniface Gen Hosp, Inst Cardiovasc Sci, Regenerat Med Program, Res Ctr, R-3028-2,351 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	sdhingra@sbrc.ca	Shamseldeen, Asmaa/AAR-2357-2020; Shams, A/HHZ-1192-2022; Dhingra, Sanjiv/D-8766-2014	Shamseldeen, Asmaa/0000-0002-4250-0818; Dhingra, Sanjiv/0000-0002-2664-7633; Yan, Weiang/0000-0002-1065-4847	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR) [PJT156148]; Yarmouk University; Research Manitoba	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Yarmouk University; Research Manitoba	Gouvernement du Canada vertical bar Canadian Institutes of Health Research (CIHR), Grant/Award Number: PJT156148; Yarmouk University; Research Manitoba	Abu-El-Rub E, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1359-x; Ammar HI, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0142-x; Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; Axelrod ML, 2019, CLIN CANCER RES, V25, P2392, DOI 10.1158/1078-0432.CCR-18-3200; Badiavas AR, 2011, EXPERT OPIN BIOL TH, V11, P1447, DOI 10.1517/14712598.2011.606212; Bagno L, 2018, MOL THER, V26, P1610, DOI 10.1016/j.ymthe.2018.05.009; Berglund AK, 2017, STEM CELL RES THER, V8, P1; Bocelli-Tyndall C, 2007, RHEUMATOLOGY, V46, P403, DOI 10.1093/rheumatology/kel267; Chidgey AP, 2008, CELL STEM CELL, V3, P357, DOI 10.1016/j.stem.2008.09.011; Consentius C, 2015, REGEN MED, V10, P305, DOI [10.2217/rme.15.14, 10.2217/RME.15.14]; Das R, 2010, TISSUE ENG PART B-RE, V16, P159, DOI 10.1089/ten.TEB.2009.0296; Dhingra S, 2013, CIRCULATION, V128, pS69, DOI 10.1161/CIRCULATIONAHA.112.000324; Drozina G, 2005, CURR TOP MICROBIOL, V290, P147; Eggenhofer E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00148; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Girdlestone J, 2016, IMMUNOTHERAPY-UK, V8, P1405, DOI 10.2217/imt-2016-0098; Griffin MD, 2013, IMMUNOL CELL BIOL, V91, P40, DOI 10.1038/icb.2012.67; Gu LH, 2015, CELL MOL IMMUNOL, V12, P444, DOI 10.1038/cmi.2014.70; Holzwarth C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-11; Huang XP, 2016, FASEB J, V30, P3069, DOI 10.1096/fj.201600331R; Inostroza-Nieves Y, 2012, IMMUNOL LETT, V147, P67, DOI 10.1016/j.imlet.2012.06.005; Jabrane-Ferrat N, 2003, INT IMMUNOL, V15, P467, DOI 10.1093/intimm/dxg048; Jacobs SA, 2013, IMMUNOL CELL BIOL, V91, P32, DOI 10.1038/icb.2012.64; Koues OI, 2008, MOL CELL BIOL, V28, P5837, DOI 10.1128/MCB.00535-08; Kurihara T, 2016, ELIFE, V5, DOI 10.7554/eLife.14319; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Liehn EA, 2011, J AM COLL CARDIOL, V58, P2357, DOI 10.1016/j.jacc.2011.08.034; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Lohan P, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01626; Lukomska B, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/9628536; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Majka M, 2017, STEM CELL TRANSL MED, V6, P1859, DOI 10.1002/sctm.16-0484; Mazza D, 2013, CELL DEATH DIFFER, V20, P1688, DOI 10.1038/cdd.2013.120; Morgan J, 2018, ORYX, V52, P744, DOI 10.1017/S003060531700031X; Morgan JE, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150091; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Olaitan AO, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007693; Oliveira RL, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/9824698; Perico N, 2018, J AM SOC NEPHROL, V29, P362, DOI 10.1681/ASN.2017070781; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Rad F, 2019, MOL BIOL REP, V46, P1533, DOI 10.1007/s11033-019-04588-y; Rameshwar P, 2009, MOL THER, V17, P216, DOI 10.1038/mt.2008.296; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Roux C, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01991; Sareen N, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0867-4; Soland MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036163; Takeda A, 2012, CLIN TRANSPLANT, V26, P43, DOI 10.1111/j.1399-0012.2012.01642.x; Tanaka S., 2016, RENAL REPLACE THER, V2, P25, DOI DOI 10.1186/S41100-016-0038-Y; Tompkins BA, 2017, J GERONTOL A-BIOL, V72, P1513, DOI 10.1093/gerona/glx137; Tsai CC, 2012, AM J BLOOD RES, V2, P148; Volkman R, 2017, STEM CELLS, V35, P1867, DOI 10.1002/stem.2651; Wu XY, 2009, MOL CELL BIOL, V29, P5639, DOI 10.1128/MCB.00661-09; Yin JQ, 2019, NAT BIOMED ENG, V3, P90, DOI 10.1038/s41551-018-0325-8; Zhang J, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0240-9; Zhao LF, 2019, J CELL MOL MED, V23, P720, DOI 10.1111/jcmm.14035; Zhao L, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0816-2	56	5	5	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12860	12876		10.1096/fj.202000454R	http://dx.doi.org/10.1096/fj.202000454R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32770803				2022-12-26	WOS:000558807800001
J	Liu, PJ; Zhang, XF; Meng, RJ; Liu, C; Li, M; Zhang, T				Liu, Panjing; Zhang, Xiaofang; Meng, Runjie; Liu, Chang; Li, Min; Zhang, Tao			Identification of chemosensory genes from the antennal transcriptome ofSemiothisa cinerearia	PLOS ONE			English	Article							ODORANT-BINDING-PROTEINS; NEURON MEMBRANE-PROTEINS; SEX-PHEROMONE COMPONENTS; ECTROPIS-OBLIQUA PROUT; MOLECULAR CHARACTERIZATION; CNAPHALOCROCIS-MEDINALIS; OLFACTORY RECEPTORS; EXPRESSION PATTERN; ANNOTATION; ARCHITECTURE	Olfaction plays vital roles in the survival and reproduction of insects. The completion of olfactory recognition requires the participation of various complex protein families. However, little is known about the olfactory-related proteins inSemiothisa cinereariaBremer et Grey, an important pest of Chinese scholar tree. In this study, we sequenced the antennal transcriptome ofS.cinereariaand identified 125 olfactory-related genes, including 25 odorant-binding proteins (OBPs), 15 chemosensory proteins (CSPs), two sensory neuron membrane proteins (SNMPs), 52 odorant receptors (ORs), eight gustatory receptors (GRs) and 23 ionotropic receptors (IRs). BLASTX best hit results and phylogenetic analyses indicated that these genes were most identical to their respective orthologs fromEctropis obliqua. Further quantitative real-time PCR (qRT-PCR) analysis revealed that three ScinOBPs and three ScinORs were highly expressed in male antennae, while seven ScinOBPs and twelve ScinORs were female-specifically expressed. Our study will be useful for the elucidation of olfactory mechanisms inS.cinerearia.	[Liu, Panjing; Zhang, Xiaofang; Li, Min; Zhang, Tao] Hebei Acad Agr & Forestry Sci, Integrated Pest Management Ctr Hebei Prov, Key Lab IPM Crops Northern Reg North China, Minist Agr,Inst Plant Protect, Baoding, Peoples R China; [Meng, Runjie] Baoding Vocat & Tech Coll, Baoding, Peoples R China; [Liu, Chang] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Peoples R China	Hebei Academy of Agricultural & Forestry Sciences; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Zhang, T (corresponding author), Hebei Acad Agr & Forestry Sci, Integrated Pest Management Ctr Hebei Prov, Key Lab IPM Crops Northern Reg North China, Minist Agr,Inst Plant Protect, Baoding, Peoples R China.	cauzht@163.com			HAAFS Agriculture Science and Technology Innovation Project [2019-1-2-2]; HAAFS Research and Development Program [2018120304]; Hebei Province Research and Development Program [20326518D]	HAAFS Agriculture Science and Technology Innovation Project; HAAFS Research and Development Program; Hebei Province Research and Development Program	This study was supported by: TZ: HAAFS Agriculture Science and Technology Innovation Project (2019-1-2-2) and HAAFS Research and Development Program (2018120304). This study was also supported by Hebei Province Research and Development Program 20326518D.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Ando T, 2004, TOP CURR CHEM, V239, P51, DOI 10.1007/b95449; Breer H., 2019, OLFACTORY CONCEPTS I, V2, P93; Briand L, 2002, EUR J BIOCHEM, V269, P4586, DOI 10.1046/j.1432-1033.2002.03156.x; Brito NF, 2016, J INSECT PHYSIOL, V95, P51, DOI 10.1016/j.jinsphys.2016.09.008; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chang HT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179243; Chang HT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13093; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Cui GZ, 2016, J CHEM ECOL, V42, P557, DOI 10.1007/s10886-016-0731-x; Davidson NM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0410-6; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Dong XL, 2013, J INSECT PHYSIOL, V59, P26, DOI 10.1016/j.jinsphys.2012.11.004; Fan XL, 2014, MYCOSCIENCE, V55, P252, DOI 10.1016/j.myc.2013.10.001; Fleischer J, 2018, CELL MOL LIFE SCI, V75, P485, DOI 10.1007/s00018-017-2627-5; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu SH, 2013, J INSECT PHYSIOL, V59, P430, DOI 10.1016/j.jinsphys.2013.02.003; Gu XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125159; Guo F, 2019, FLA ENTOMOL, V102, P549, DOI 10.1653/024.102.0318; He P, 2017, INSECT MOL BIOL, V26, P687, DOI 10.1111/imb.12328; He P, 2014, INSECT MOL BIOL, V23, P475, DOI 10.1111/imb.12095; He P, 2018, PEST MANAG SCI, V74, P2156, DOI 10.1002/ps.4912; Honson NS, 2005, RECENT ADV PHYTOCHEM, V39, P227; Howlett N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-211; Jeong YT, 2013, NEURON, V79, P725, DOI 10.1016/j.neuron.2013.06.025; Jia XJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189889; Kulmuni J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063688; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Li XM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2236-3; Li ZQ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00953; Li ZM, 1993, CHINESE J CHEM, V11, P251, DOI 10.1002/cjoc.19930110309; Liu CC, 2014, ARCH INSECT BIOCHEM, V85, P114, DOI 10.1002/arch.21150; Liu HM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38896-x; Liu S, 2013, J INTEGR AGR, V12, P1816, DOI 10.1016/S2095-3119(13)60501-8; Liu S, 2013, ANN ENTOMOL SOC AM, V106, P378, DOI 10.1603/AN12099; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombarkia N, 2008, ENTOMOL EXP APPL, V128, P57, DOI 10.1111/j.1570-7458.2008.00741.x; MA L, 2018, FRONT PHYSIOL, V9, DOI DOI 10.3389/FPHYS.2018.0053429867573; Ma L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149591; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Megido RC, 2013, BIOTECHNOL AGRON SOC, V17, P475; Missbach C, 2015, CHEM SENSES, V40, P615, DOI 10.1093/chemse/bjv050; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Ozaki M., 2019, OLFACTORY CONCEPTS I, V2, P187; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18103248; Picimbon JF, 2019, OLFACTORY CONCEPTS I, P234, DOI [10.1007/978-3-030-05165-5_10, DOI 10.1007/978-3-030-05165-5_10]; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Seppey M, 2019, METHODS MOL BIOL, V1962, P227, DOI 10.1007/978-1-4939-9173-0_14; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Sun L, 2019, J INSECT PHYSIOL, V116, P17, DOI 10.1016/j.jinsphys.2019.04.005; Sun L, 2017, ARCH INSECT BIOCHEM, V94, DOI 10.1002/arch.21383; Sun MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062098; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 1999, CHEM SENSES, V24, P481, DOI 10.1093/chemse/24.5.481; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wanner KW, 2005, INSECT MOL BIOL, V14, P289, DOI 10.1111/j.1365-2583.2005.00559.x; Watanabe Hayaki, 2007, Invertebrate Neuroscience, V7, P109, DOI 10.1007/s10158-007-0046-2; Watanabe K, 2011, BEHAV GENET, V41, P746, DOI 10.1007/s10519-011-9461-6; Wu JD, 2017, APPL ENTOMOL ZOOL, V52, P623, DOI 10.1007/s13355-017-0516-x; Xiao SK, 2019, ELIFE, V8, DOI 10.7554/eLife.51040; Yang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121261; Yuan H, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6208-x; Zeng FF, 2013, BIOCHEM BIOPH RES CO, V433, P463, DOI 10.1016/j.bbrc.2013.03.038; Zhang HJ, 2020, INSECT BIOCHEM MOLEC, V118, DOI 10.1016/j.ibmb.2020.103313; Zhang SF, 2014, J CHEM ECOL, V40, P396, DOI 10.1007/s10886-014-0412-6; Zhang TT, 2013, J INTEGR AGR, V12, P853, DOI 10.1016/S2095-3119(13)60304-4; Zhang YL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030875; Zhang YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069715; Zhang Z, 2013, ADV MATER RES-SWITZ, V726-731, P4678, DOI 10.4028/www.scientific.net/AMR.726-731.4678; Zhao YJ, 2020, GENOMICS, V112, P2713, DOI 10.1016/j.ygeno.2020.03.005; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zuckerkandl E, 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	82	4	4	7	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237134	10.1371/journal.pone.0237134	http://dx.doi.org/10.1371/journal.pone.0237134			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764791	gold, Green Published			2022-12-26	WOS:000561029000075
J	Ramos, ACV; Gomes, D; Neto, MS; Berra, TZ; de Assis, IS; Yamamura, M; Crispim, JD; Martoreli, JF; Bruce, ATI; dos Santos, FL; Souza, LLL; Alves, YM; de Andrade, HLP; Arcoverde, MAM; Pieri, FM; Arcencio, RA				Ramos, Antonio Carlos Vieira; Gomes, Dulce; Santos Neto, Marcelino; Berra, Thais Zamboni; de Assis, Ivaneliza Simionato; Yamamura, Mellina; Crispim, Juliane de Almeida; Martoreli Junior, Jose Francisco; Bruce, Alexandre Tadashi Inomata; dos Santos, Felipe Lima; Souza, Ludmilla Leidianne Limirio; Alves, Yan Mathias; de Andrade, Hamilton Leandro Pinto; Arcoverde, Marcos Augusto Moraes; Pieri, Flavia Meneguetti; Arcencio, Ricardo Alexandre			Trends and forecasts of leprosy for a hyperendemic city from Brazil's northeast: Evidence from an eleven-year time-series analysis	PLOS ONE			English	Article							PHYSICAL-DISABILITIES; POPULATION; DISEASE; COHORT; REGION	This study's objective was to estimate the temporal trends of leprosy according to sex and age groups, as well as to estimate and predict the progression of the disease in a hyperendemic city located in the northeast of Brazil. This ecological time-series study was conducted in Imperatriz, Maranhao, Brazil. Leprosy cases diagnosed between 2006 and 2016 were included. Detection rates stratified by sex and age groups were estimated. The study of temporal trends was accomplished using the Seasonal-Trend Decomposition method and temporal modeling of detection rates using linear seasonal autoregressive integrated moving average model according to Box and Jenkins method. Trend forecasts were performed for the 2017-2020 period. A total of 3,212 cases of leprosy were identified, the average incidence among men aged between 30 and 59 years old was 201.55/100,000 inhabitants and among women in the same age group was 135.28/100,000 inhabitants. Detection rates in total and by sex presented a downward trend, though rates stratified according to sex and age presented a growing trend among men aged less than 15 years old and among women aged 60 years old or over. The final models selected in the time-series analysis show the forecasts of total detection rates and rates for men and women presented a downward trend for the 2017-2020 period. Even though the forecasts show a downward trend in Imperatriz, the city is unlikely to meet a significant decrease of the disease burden by 2020.	[Ramos, Antonio Carlos Vieira; Berra, Thais Zamboni; Crispim, Juliane de Almeida; Martoreli Junior, Jose Francisco; Bruce, Alexandre Tadashi Inomata; dos Santos, Felipe Lima; Souza, Ludmilla Leidianne Limirio; Alves, Yan Mathias; de Andrade, Hamilton Leandro Pinto; Arcencio, Ricardo Alexandre] Univ Sao Paulo Ribeirao Preto, Coll Nursing, Dept Maternal Infant Nursing & Publ Hlth, Ribeirao Preto, SP, Brazil; [Gomes, Dulce] Univ Evora, Dept Math, Evora, Portugal; [Santos Neto, Marcelino] Univ Fed Maranhao, Ctr Social Sci Hlth & Technol, Imperatriz, Maranhao, Brazil; [de Assis, Ivaneliza Simionato] Univ Ctr Dinam Cataratas, Foz Do Iguacu, Parana, Brazil; [Yamamura, Mellina] Univ Fed Sao Carlos, Dept Nursing, Sao Carlos, SP, Brazil; [Arcoverde, Marcos Augusto Moraes] Western Parana State Univ, Ctr Educ Letters & Hlth, Foz Do Iguacu, Parana, Brazil; [Pieri, Flavia Meneguetti] Univ Estadual Londrina, Dept Nursing, Londrina, Parana, Brazil	Universidade de Sao Paulo; University of Evora; Universidade Federal do Maranhao; Universidade Federal de Sao Carlos; Centro Universitario La Salle; Universidade Estadual do Oeste do Parana; Universidade Estadual de Londrina	Ramos, ACV (corresponding author), Univ Sao Paulo Ribeirao Preto, Coll Nursing, Dept Maternal Infant Nursing & Publ Hlth, Ribeirao Preto, SP, Brazil.	antonio.vieiraramos@outlook.com	Santos, Felipe Lima dos/AAC-3102-2021; Arcoverde, Marcos/AAB-2892-2019; Alves, Yan Mathias/GLU-0281-2022; Ramos, Antônio Carlos Vieira/AAK-2095-2020; Yamamura, Mellina/J-7852-2015; Yamamura, Mellina/AAJ-2596-2021; Inomata Bruce, Alexandre Tadashi/GPK-2777-2022; Arcêncio, Ricardo Alexandre/B-9520-2012; Inomata Bruce, Alexandre Tadashi/ABA-8987-2021	Santos, Felipe Lima dos/0000-0001-5606-9478; Arcoverde, Marcos/0000-0001-5104-559X; Alves, Yan Mathias/0000-0002-5596-0047; Yamamura, Mellina/0000-0001-5228-8788; Yamamura, Mellina/0000-0001-5228-8788; Inomata Bruce, Alexandre Tadashi/0000-0002-7008-8023; Arcêncio, Ricardo Alexandre/0000-0003-4792-8714; 	Coordenacao de Aperfeigoamento de Pessoal de Nivel Superior Brasil (CAPES) [001]; CAPES [001]	Coordenacao de Aperfeigoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in part by the Coordenacao de Aperfeigoamento de Pessoal de Nivel Superior Brasil (CAPES) Finance Code 001. ACVR received financial assistance from the CAPES, Financing Code 001. Website: htips://wwvi capes goy br/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ribeiro MDA, 2018, REV PANAM SALUD PUBL, V42, DOI 10.26633/RPSP.2018.42; Anchieta Jefferson de Jesus Silva, 2019, Rev. Saúde Pública, V53, P61, DOI [10.11606/S1518-8787.2019053000752, 10.11606/s1518-8787.2019053000752]; [Anonymous], 2019, Weekly Epidemiological Record, V94, P389; [Anonymous], 2017, GUID DIAGN TREATM PR; [Anonymous], 2005, THESIS; [Anonymous], SIST INF AGR NOT SIN; Barbosa CC, 2018, TROP MED INT HEALTH, V23, P748, DOI 10.1111/tmi.13067; Blok DJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1143-4; Box G. E. P., 2015, TIME SERIES ANAL FOR; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Brockwell PJ, 2006, INTRO TIME SERIES FO; Cabral-Miranda W, 2014, TROP MED INT HEALTH, V19, P1504, DOI 10.1111/tmi.12389; Chaptini C, 2015, LEPROSY REV, V86, P307; Cleveland R.B., 1990, J OFF STAT, V6, P3; Oliveira JSD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007709; Dijkstra JIR, 2017, LEPROSY REV, V88, P419; Lana FCF, 2007, REV BRAS ENFERM, V60, P696, DOI 10.1590/S0034-71672007000600014; Figueiredo Wagner, 2005, Ciênc. saúde coletiva, V10, P105, DOI 10.1590/S1413-81232005000100017; Flores LPO, 2015, REDECA, V2, P86; Freitas LRS, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1798-2; Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390; Guerrero MI, 2013, REV PANAM SALUD PUBL, V33, P137, DOI 10.1590/S1020-49892013000200009; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2019, PAN MUN IMP MA; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Koba A, 2009, LEPROSY REV, V80, P432; Liu YY, 2018, INT J DERMATOL, V57, P1492, DOI 10.1111/ijd.14148; Matos TS, 2019, AN BRAS DERMATOL, V94, P243, DOI 10.1590/abd1806-4841.20198067; Meima A, 2002, INT J EPIDEMIOL, V31, P991, DOI 10.1093/ije/31.5.991; Menezes MLN, 2017, ARQ CIENC SAUDE UNIP, V10, P1, DOI DOI 10.25110/ARQSAUDE.V21I1.2017.6072; Ministerio da Saude, 2016, MAN VIG PREV CONTR Z; Ministerio da Saude, 2016, B EPIDEMIOLOGICO, V47; Ministerio da Saude. Departamento de Informatica do SUS (DATASUS), 2020, AC DAD HANS MAR 2001; Ministerio da Saude. Departamento de Informatica do SUS (DATASUS), 2020, EST EST POP MUN ID S; Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doencas Transmissiveis, 2017, COORD GER HANS DOENC; Mitja O, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005136; Monteiro LD, 2013, CAD SAUDE PUBLICA, V29, P909, DOI 10.1590/S0102-311X2013000500009; de Alencar CHM, 2008, REV BRAS ENFERM, V61, P694, DOI 10.1590/S0034-71672008000700007; Murto C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002422; Nery JS, 2019, LANCET GLOB HEALTH, V7, pE1226, DOI [10.1016/s2214-109x(19)30260-8, 10.1016/S2214-109X(19)30260-8]; Nicchio MVC, 2016, ACTA TROP, V163, P38, DOI 10.1016/j.actatropica.2016.07.019; Nobre ML, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005364; Oliveira, 1998, Cad Saude Publica, V14, P51, DOI 10.1590/S0102-311X1998000100013; Pereira TM, 2019, REV BRAS ENFERM, V72, P1356, DOI 10.1590/0034-7167-2018-0682; Price VG, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1360550; Rodrigues RN, 2017, REME REV MIN ENFERM, V2, DOI [10.5935/1415-2762.20170007, DOI 10.5935/1415-2762.20170007]; Sarkar Rashmi, 2016, Int J Womens Dermatol, V2, P117, DOI 10.1016/j.ijwd.2016.09.001; Schreuder PAM, 2016, CLIN DERMATOL, V34, P24, DOI 10.1016/j.clindermatol.2015.11.001; SIMOES T, 2018, PLOS NEGLECT TROP D, V12, DOI DOI 10.1371/JOURNAL.PNTD.000640729624595; Smith WC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003658; Marciano LHSC, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00197216, 10.1590/0102-311X00197216]; Souza EA, 2018, CAD SAUDE PUBLICA, V34, P1, DOI [10.1590/0102-311X00196216 29412328, DOI 10.1590/0102-311X00196216 29412328]; Souza EA, 2018, REV SAUDE PUBL, V52, P1; Ramos ACV, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005381; World Health Organization, 2014, ENH GLOB STRAT FURTH; World Health Organization, LEPR EL; World Health Organization, 2016, GLOB LEPR STRAT 2016	56	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237165	10.1371/journal.pone.0237165	http://dx.doi.org/10.1371/journal.pone.0237165			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764785	gold, Green Published			2022-12-26	WOS:000561029000057
J	Foverskov, E; Glymour, MM; Mortensen, EL; Osler, M; Okholm, GT; Lund, R				Foverskov, Else; Glymour, M. Maria; Mortensen, Erik Lykke; Osler, Merete; Okholm, Gunhild Tidemann; Lund, Rikke			Education and adolescent cognitive ability as predictors of dementia in a cohort of Danish men	PLOS ONE			English	Article							LIFE-COURSE; INTELLIGENCE; CHILDHOOD; HEALTH; RISK	Background An association between education and dementia is well-established but it is unclear whether education is associated with dementia after accounting for early life cognitive ability and whether there is a joint effect, such that the risk associated with one of the exposures depends on the value of the other. We examined separate and joint associations of adolescent cognitive ability and educational attainment with risk of dementia among Danish men born between 1939 and 1959. Methods Men (N = 477,421) from the Danish Conscription Database were followed for dementia from the age 60 for up to 17 years via patient and prescription registry linkages. Exposure measures included cognitive ability assessed at the conscript board examination around age 18 and highest educational level (low: 0-10 year, medium: 10-13 years, high: >= 13 years) at age 30 from registry records. Associations with dementia diagnosis were estimated in Cox proportional hazards models adjusted for birth year and age at conscript board examination. Interaction was assessed on the multiplicative scale by including a product term between the two exposure measures and on the additive scale by calculating relative excess risk due to interaction (RERI) between different levels of the exposure measures. Results Compared to men in the high education group hazard ratio [HR] for men in the medium and low group were 1.21 (95% confidence interval [CI]: 1.13, 1.30) and 1.34 (95% CI: 1.24, 1.45), respectively when not adjusting for cognitive ability. Additional adjustment for cognitive ability attenuated the magnitude of the associations, but they remained significant (education medium: HR = 1.10, 95% CI: 1.02, 1.19 and education low: HR = 1.12, 95% CI: 1.02, 1.22). A 10% higher cognitive ability score was associated with a 3.8% lower hazard of dementia (HR = 0.962; 95% CI: 0.957, 0.967), and the magnitude of the association only changed marginally after adjustment for education. Men in the low education group with relatively low cognitive ability were identified as a high-risk subgroup for dementia. The increased risk associated with exposure to both risk factors did, however, not significantly depart from the sum of risk experienced by men only exposed to one of the risk factors (estimates of RERI were not significantly different from 0) and no significant evidence of either additive or multiplicative interactions was found. Conclusions In conclusion, the results suggest that education and cognitive ability protect against the risk of dementia independently of one another and that increases in educational attainment may at least partially offset dementia risk due to low cognitive ability.	[Foverskov, Else; Mortensen, Erik Lykke; Osler, Merete; Okholm, Gunhild Tidemann; Lund, Rikke] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Foverskov, Else; Mortensen, Erik Lykke; Lund, Rikke] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Glymour, M. Maria] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Osler, Merete; Okholm, Gunhild Tidemann] Bispebjerg & Frederiksberg Hosp, Ctr Clin Res & Prevent, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of California System; University of California San Francisco; University of Copenhagen; Bispebjerg Hospital	Foverskov, E (corresponding author), Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.; Foverskov, E (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark.	elfo@sund.ku.dk		Foverskov, Else/0000-0003-4407-0759; Lund, Rikke/0000-0002-0381-4291; Okholm, Gunhild Tidemann/0000-0001-9729-708X	Social Inequalities in Ageing (SIA) project; NordForsk [74637]; Center for Healthy Aging, University of Copenhagen - Nordea Foundation [1070011004]; NordForsk; Center of Healthy Aging, University of Copenhagen; Nordea Foundation	Social Inequalities in Ageing (SIA) project; NordForsk; Center for Healthy Aging, University of Copenhagen - Nordea Foundation; NordForsk; Center of Healthy Aging, University of Copenhagen; Nordea Foundation	This work was supported by the Social Inequalities in Ageing (SIA) project (http://www.siaproject.se/), funded by NordForsk (grant number 74637) and the Center for Healthy Aging, University of Copenhagen (https://healthyaging.ku.dk/) funded by the Nordea Foundation (grant number 1070011004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank K. Christensen, D. Molbo and T.I.A. Sorensen who together with E.L. Mortensen and M. Osler established the Danish Conscription Database. The research leading to these results was carried out as part of the Social Inequalities in Aging (SIA) project, funded by NordForsk. The research was additionally supported by the Center of Healthy Aging, University of Copenhagen, sponsored by The Nordea Foundation.	Amjad H, 2018, J GEN INTERN MED, V33, P1131, DOI 10.1007/s11606-018-4377-y; Christensen GT, 2015, INT J EPIDEMIOL, V44, P432, DOI 10.1093/ije/dyu114; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Deary IJ, 2010, INT J EPIDEMIOL, V39, P1362, DOI 10.1093/ije/dyq072; Dekhtyar S, 2016, INT J EPIDEMIOL, V45, P1207, DOI 10.1093/ije/dyw008; Dekhtyar S, 2015, AM J GERIAT PSYCHIAT, V23, P885, DOI 10.1016/j.jagp.2015.02.002; Greenland S., 2008, MODERN EPIDEMIOLOGY; Hahn RA, 2015, INT J HEALTH SERV, V45, P657, DOI 10.1177/0020731415585986; Hamad R, 2018, SOC SCI MED, V212, P168, DOI 10.1016/j.socscimed.2018.07.016; Huizink AC, 2006, NEUROSCI BIOBEHAV R, V30, P24, DOI 10.1016/j.neubiorev.2005.04.005; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Kivipelto M, 2018, NAT REV NEUROL, V14, P653, DOI 10.1038/s41582-018-0070-3; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Lang LD, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-011146; Li JH, 2015, SOC SCI MED, V127, P83, DOI 10.1016/j.socscimed.2014.07.021; Li RL, 2007, ANN EPIDEMIOL, V17, P227, DOI 10.1016/j.annepidem.2006.10.009; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; McDowell I, 2007, J CLIN EXP NEUROPSYC, V29, P127, DOI 10.1080/13803390600582420; McGurn B, 2008, NEUROLOGY, V71, P1051, DOI 10.1212/01.wnl.0000319692.20283.10; Meng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038268; Mielke Michelle M, 2018, Psychiatr Times, V35, P14; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; MORTENSEN EL, 1989, SCAND J PSYCHOL, V30, P315, DOI 10.1111/j.1467-9450.1989.tb01094.x; Nguyen TT, 2016, ANN EPIDEMIOL, V26, P71, DOI 10.1016/j.annepidem.2015.10.006; Osler M, 2017, ALZHEIMERS DEMENT, V13, P1355, DOI 10.1016/j.jalz.2017.04.003; Park C, 2008, J HEALTH ECON, V27, P1516, DOI 10.1016/j.jhealeco.2008.07.005; Phung TKT, 2007, DEMENT GERIATR COGN, V24, P220, DOI 10.1159/000107084; Pottegard A, 2017, INT J EPIDEMIOL, V46, P798, DOI 10.1093/ije/dyw213; Rantalainen V, 2018, NEUROLOGY, V91, pE171, DOI [10.1212/WNL.0000000000005757, 10.1212/wnl.0000000000005757]; Riley KP, 2005, NEUROBIOL AGING, V26, P341, DOI 10.1016/j.neurobiolaging.2004.06.019; Ritchie SJ, 2018, PSYCHOL SCI, V29, P1358, DOI 10.1177/0956797618774253; Romeo RR, 2018, PSYCHOL SCI, V29, P700, DOI 10.1177/0956797617742725; Rothman K, 1986, MODERN EPIDEMIOLOGY; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Salem LC, 2012, DEMENT GERIATR COGN, V34, P292, DOI 10.1159/000345485; Savva GM, 2015, AGE AGEING, V44, P642, DOI 10.1093/ageing/afv020; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; SIBBETT RA, 2017, BMC PSYCHIATRY, V0017; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Teasdale TW, 2009, SCAND J PSYCHOL, V50, P633, DOI 10.1111/j.1467-9450.2009.00789.x; VanderWeele TJ, 2014, EPIDEMIOL METHODS, V3, P33, DOI [DOI 10.1515/EM-2013-0005, 10.1515/em-2013-0005]; Whalley LJ, 2000, NEUROLOGY, V55, P1455, DOI 10.1212/WNL.55.10.1455; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6; who, DEMENTIA	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0235781	10.1371/journal.pone.0235781	http://dx.doi.org/10.1371/journal.pone.0235781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2EP	32760096	Green Published, gold			2022-12-26	WOS:000561027200058
J	Andreae, MO; Al-Amri, A; Andreae, TW; Garfinkel, A; Haug, G; Jochum, KP; Stoll, B; Weis, U				Andreae, Meinrat O.; Al-Amri, Abdullah; Andreae, Tracey W.; Garfinkel, Alan; Haug, Gerald; Jochum, Klaus Peter; Stoll, Brigitte; Weis, Ulrike			Geochemical studies on rock varnish and petroglyphs in the Owens and Rose Valleys, California	PLOS ONE			English	Article							DESERT VARNISH; ENVIRONMENTAL-CHANGE; MOJAVE DESERT; SAUDI-ARABIA; INYO-COUNTY; ART; ASCENDANCE; BASALT; DUST; SHUWAYMIS	We investigated rock varnish, a thin, manganese- and iron-rich, dark surface crust, on basaltic lava flows and petroglyphs in the Owens and Rose Valleys (California) by portable X-ray fluorescence (pXRF) and femtosecond laser-ablation inductively-coupled-plasma mass spectrometry (fs-LA-ICPMS). The major element composition of the varnish was consistent with a mixture of Mn-Fe oxyhydroxides and clay minerals. As expected, it contained elevated concentrations of elements that are typically enriched in rock varnish, e.g., Mn, Pb, Ba, Ce, and Co, but also showed unusually high enrichments in U, Cu, and Th. The rare earth and yttrium (REY) enrichment pattern revealed a very strong positive cerium (Ce) anomaly and distinct negative europium (Eu) and Y anomalies. The light rare earth elements (REE) were much more strongly enriched than the heavy REY. These enrichment patterns are consistent with a formation mechanism by leaching of Mn and trace elements from aeolian dust, reprecipitation of Mn and Fe as oxyhydroxides, and scavenging of trace elements by these oxyhydroxides. We inferred accumulation rates of Mn and Fe in the varnish from their areal densities measured by pXRF and the known ages of some of the lava flow surfaces. The areal densities of Mn and Fe, as well as their accumulation rates, were comparable to our previous results from the desert of Saudi Arabia. There was a moderate dependence of the Mn areal density on the inclination of the rock surfaces, but no relationship to its cardinal orientation. We attempted to use the degree of varnish regrowth on the rock art surfaces as an estimate of their age. While an absolute dating of the petroglyphs was not possible because of the lack of suitable calibration surfaces and a considerable amount of variability, the measured degree of varnish regrowth on the various petroglyphs was consistent with chronologies based on archeological and other archaeometric techniques. In particular, our results suggest that rock art creation in the study area continued over an extended period of time, possibly starting around the Pleistocene/Holocene transition and extending into the last few centuries.	[Andreae, Meinrat O.; Andreae, Tracey W.; Haug, Gerald; Jochum, Klaus Peter; Stoll, Brigitte; Weis, Ulrike] Max Planck Inst Chem, Mainz, Germany; [Andreae, Meinrat O.; Al-Amri, Abdullah] King Saud Univ, Dept Geol & Geophys, Riyadh, Saudi Arabia; [Andreae, Meinrat O.] UCSD, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Garfinkel, Alan] Calif Rock Art Fdn, Bakersfield, CA USA	Max Planck Society; King Saud University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Andreae, MO (corresponding author), Max Planck Inst Chem, Mainz, Germany.; Andreae, MO (corresponding author), King Saud Univ, Dept Geol & Geophys, Riyadh, Saudi Arabia.; Andreae, MO (corresponding author), UCSD, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	m.andreae@mpic.de	Andreae, Meinrat O./B-1068-2008	Andreae, Meinrat O./0000-0003-1968-7925; Weis, Ulrike/0000-0002-4931-0371; Jochum, Klaus Peter/0000-0002-0135-4578	German Max Planck Society; King Saud University	German Max Planck Society(Max Planck Society); King Saud University(King Saud University)	MOA received support from the German Max Planck Society (https://www.mpg.de/en) and from King Saud University (https://ksu.edu.sa/en/).No specific grant numbers were assigned. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J.A.S., 1959, PHYS CHEM EARTH, V3, P298, DOI [10.1016/0079-1946(59)90008-4, DOI 10.1016/0079-1946(59)90008-4]; Baeten J, 2012, ERCIM NEWS, P11; Bard JC., 1979, DEV PATINATION DATIN; Bau M, 2014, CHEM GEOL, V381, P1, DOI 10.1016/j.chemgeo.2014.05.004; Bednarik R. C., 2016, PALAEOART MAT SCI ST; Bednarik RG, 2017, MEDITERR ARCHAEOL AR, V17, P43, DOI 10.5281/zenodo.893192; Bednarik RG, 2017, ROCK ART RES, V34, P179; Bednarik RG, 2010, ROCK ART RES, V27, P217; Bednarik RG, 2009, ROCK ART RES, V26, P55; Belzoni Giovanni, 1820, NARRATIVE OPERATIONS; Bergametti G, 2014, MINERAL DUST KEY PLA, P179, DOI [DOI 10.1007/978-94-017-8978-3_8, 10.1007/978-94-017-8978-3_8]; Bishop JL, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001581; Bretney JC, 2012, ROCK ART LITTLE LAKE, P93; BROECKER W. S., 2001, GSA TODAY, V11, P4, DOI DOI 10.1130/1052-5173(2001)011; Byers DA, 2004, AM ANTIQUITY, V69, P235, DOI 10.2307/4128418; Cantrell CA, 2008, ATMOS CHEM PHYS, V8, P5477, DOI 10.5194/acp-8-5477-2008; CERLING TE, 1990, QUATERNARY RES, V33, P148, DOI 10.1016/0033-5894(90)90015-D; Codding BF, 2007, AM ANTIQUITY, V72, P349, DOI 10.2307/40035818; Danskin WR, 1998, 2370 US GEOL SURV; DORN RI, 1982, PROG PHYS GEOG, V6, P317, DOI 10.1177/030913338200600301; Dorn RI, 1998, ROCK COATINGS; Dorn RI., 2007, GEOCHEMICAL SEDIMENT, P246; Dorn RI, 2018, PROG PHYS GEOG, V42, P566, DOI 10.1177/0309133318795839; Dorn RI, 2013, AEOLIAN RES, V10, P61, DOI 10.1016/j.aeolia.2013.04.005; Dorn RI, 2011, GEOMORPHOLOGY, V130, P91, DOI 10.1016/j.geomorph.2011.02.002; DUFFIELD WA, 1980, J GEOPHYS RES, V85, P2381, DOI 10.1029/JB085iB05p02381; EGGLETON RA, 1987, CLAY CLAY MINER, V35, P161, DOI 10.1346/CCMN.1987.0350301; ENGEL CG, 1958, GEOL SOC AM BULL, V69, P487, DOI 10.1130/0016-7606(1958)69[487:CDODV]2.0.CO;2; Francis A., 2004, ANCIENT VISIONS PETR; Garfinkel AP, 2006, N AM ARCHAEOL, V27, P203, DOI 10.2190/A334-6127-H785-6716; Garfinkel AP, 2010, J ARCHAEOL SCI, V37, P42, DOI 10.1016/j.jas.2009.08.010; Garfinkel AP., 2007, MATURANGO MUSEUM PUB; Giambastiani MA, 2007, PCAS Q, V43, P50; Gilreath A. J., 2008, J CALIFORNIA GREAT B, V28, P1; Glazner AF, 2012, ROCK ART LITTLE LAKE, P3; Goldsmith, 2011, CHARACTERIZING ROCK; Goldsmith Y, 2014, GEOCHIM COSMOCHIM AC, V126, P97, DOI 10.1016/j.gca.2013.10.040; Grant C, 1968, MATURANGO MUSEUM PUB, V4; Guagnin M, 2017, ARAB ARCHAEOL EPIGR, V28, P138, DOI 10.1111/aae.12089; Guagnin M, 2016, HOLOCENE, V26, P1822, DOI 10.1177/0959683616645949; Guagnin M, 2015, ARCHAEOL RES ASIA, V4, P3, DOI 10.1016/j.ara.2015.08.001; Heizer Robert E, 1962, PREHISTORIC ROCK ART; Hildebrandt WR, 2016, AM ANTIQUITY, V81, P764, DOI 10.7183/0002-7316.81.4.764; Hildebrandt WR, 2002, AM ANTIQUITY, V67, P231, DOI 10.2307/2694565; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Khan M., 2005, ROCK ART RES, V22, P49, DOI DOI 10.1006/JASC.2001.0711; Khan M., 2007, ROCK ART SAUDI ARABI; Krinsley D, 2013, PHYS GEOGR, V34, P159, DOI 10.1080/02723646.2013.830926; Krinsley DH, 2017, J GEOL, V125, P317, DOI 10.1086/691147; Krinsley DH, 2012, GEOMORPHOLOGY, V138, P339, DOI 10.1016/j.geomorph.2011.09.022; Lanza NL, 2014, GEOPHYS RES LETT, V41, P5755, DOI 10.1002/2014GL060329; LARSEN ES, 1960, AM J SCI, V258, P151; Lebedeva MP, 2019, B SOC GEOL MEX, V71, P21, DOI [10.18268/bsgm2019v71n1a3, 10.18268/BSGM2019v71n1a3]; Lettis, 2013, QUAT GEOCHRONOL, P241; Liefert DT, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2019GL086412; Liu TZ, 2013, GEOPHYS RES LETT, V40, P2229, DOI 10.1002/grl.50492; Liu TZ, 2013, GEOMORPHOLOGY, V187, P38, DOI 10.1016/j.geomorph.2012.12.034; Liu TH, 2000, GEOLOGY, V28, P183, DOI 10.1130/0091-7613(2000)28<183:HFDRVG>2.0.CO;2; Liu TZ, 2000, PALAEOGEOGR PALAEOCL, V161, P423, DOI 10.1016/S0031-0182(00)00097-3; Liu TZ, 2003, GEOMORPHOLOGY, V53, P209, DOI 10.1016/S0169-555X(02)00331-8; Liu TZ, 1996, ANN ASSOC AM GEOGR, V86, P187, DOI 10.1111/j.1467-8306.1996.tb01750.x; Lytle F, 2008, EXPT TECHNIQUE MEASU; Macholdt DS, 2017, CHEM GEOL, V459, P91, DOI 10.1016/j.chemgeo.2017.04.009; Macholdt DS, 2019, HOLOCENE, V29, P1377, DOI 10.1177/0959683619846979; Macholdt DS, 2018, HOLOCENE, V28, P1495, DOI 10.1177/0959683618777075; Macholdt DS, 2017, ATMOS ENVIRON, V171, P205, DOI 10.1016/j.atmosenv.2017.10.022; McGuire KR, 2005, AM ANTIQUITY, V70, P695, DOI 10.2307/40035870; McNeil J., 2010, UTAH ROCK ART, P9; Miller DM, 2010, QUATERN INT, V215, P45, DOI 10.1016/j.quaint.2009.10.001; Moratto MJ, 2018, CALIF ARCHAOL, V10, P27, DOI 10.1080/1947461X.2017.1391476; Olsen SL., 2013, STORIES ROCKS EXPLOR; Otter LM, 2020, CHEM GEOLOGY; Palme H., 2003, TREAT GEOCHEM, V2, P1, DOI DOI 10.1016/B978-0-08-095975-7.00201-1; Perry Randall S., 2005, Proceedings of the SPIE - The International Society for Optical Engineering, V5906, p59060V, DOI 10.1117/12.626547; POTTER RM, 1979, CHEM GEOL, V25, P79, DOI 10.1016/0009-2541(79)90085-8; POTTER RM, 1977, SCIENCE, V196, P1446, DOI 10.1126/science.196.4297.1446; Prudencio MI, 2002, CATENA, V49, P77, DOI 10.1016/S0341-8162(02)00018-8; RENEAU SL, 1992, AM J SCI, V292, P684, DOI 10.2475/ajs.292.9.684; RENEAU SL, 1993, QUATERNARY RES, V40, P309, DOI 10.1006/qres.1993.1084; Robin C., 2018, ACT C VIE CLIM HES M, V29, P319; ROBIN C. J., 2016, ALPHABETS TEXTS ARTE, P312; Rogers AK., 2010, AM INDIAN ROCK ART, V36, P23; Rosenthal J. S., 2012, PLEISTOCENE HOLOCENE, P67; Rudnick, 2003, TREATISE GEOCHEMISTR, V3, P1, DOI [10.1016/B0-08-043751-6/03016-4, DOI 10.1016/B0-08-043751-6/03016-4, 10.1016/B978-0-08-095975-7.00301-6.]; Santos V, 2018, ROCK ART RES, V35, P85; Schroth AB, 1994, THESIS; SINGER A, 1970, ISRAEL J CHEM, V8, P459, DOI 10.1002/ijch.197000052; Stein P, 2013, ARAB ARCHAEOL EPIGR, V24, P186, DOI 10.1111/aae.12024; Steward J. H., 1929, U CALIFORNIA PUBLICA, V24, P47; Stumm W., 1981, AQUATIC CHEM; Sudarchikova N, 2015, CLIM PAST, V11, P765, DOI 10.5194/cp-11-765-2015; Sutton MarkQ., 2017, PACIFIC COAST ARCHAE, V53, P1; Tang HS, 2017, ROCK ART RES, V34, P40; Thiagarajan N, 2004, EARTH PLANET SC LETT, V224, P131, DOI 10.1016/j.epsl.2004.04.038; Thompson RS, 1993, GLOBAL CLIMATES LAST, V18, P468; Van Horn LF, 1995, NATIVE AM CONSULTATI; Van Slyke N, 2012, ROCK ART LITTLE LAKE, P119; Van Tilburg JA., 2012, ROCK ART LITTLE LAKE, P11; Vazquez JA, 2015, GEOCHEM GEOPHY GEOSY, V16, P2812, DOI 10.1002/2015GC005889; von Humboldt A, 1819, VOYAGE REGIONS EQUIN, VII, P299; Wayne DM, 2006, APPL GEOCHEM, V21, P1410, DOI 10.1016/j.apgeochem.2006.04.005; Whitley D.S., 2013, J ARCHAEOLOGY, V2013, DOI [10.1155/2013/713159, DOI 10.1155/2013/713159]; WHITLEY DS, 1994, WORLD ARCHAEOL, V25, P356, DOI 10.1080/00438243.1994.9980251; Whitley DS., 2007, PACIFIC COAST ARCHAE, V43, P135; Whitley DS, 2012, COMPANION ROCK ART, P605; Whitley DS, 1998, COSO ROCK ART NEW PE, P109; Willbold M, 2005, GEOSTAND GEOANAL RES, V29, P63, DOI 10.1111/j.1751-908X.2005.tb00656.x; WOLLENBERG HA, 1995, J VOLCANOL GEOTH RES, V67, P171, DOI 10.1016/0377-0273(94)00103-N; Xu XM, 2019, CHEM GEOL, V522, P55, DOI 10.1016/j.chemgeo.2019.05.016; Yohe RM., 1998, J CALIFORNIA GREAT B, V20, P26	110	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0235421	10.1371/journal.pone.0235421	http://dx.doi.org/10.1371/journal.pone.0235421			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NB3DK	32756552	Green Published, gold			2022-12-26	WOS:000560393300038
J	Hartill, EC; Waller, RG; Auster, PJ				Hartill, Elise C.; Waller, Rhian G.; Auster, Peter J.			Deep coral habitats of Glacier Bay National Park and Preserve, Alaska	PLOS ONE			English	Article							FJORDS; SEA; ASSEMBLAGES; ABUNDANCE; HISTORY; INLET; SOUTH; GULF; AGE	Glacier Bay National Park and Preserve (GBNPP) in Southeast Alaska is a system of glaciated fjords with a unique and recent history of deglaciation. As such, it can serve as a natural laboratory for studying patterns of distribution in marine communities with proximity to glacial influence. In order to examine the changes in fjord-based coral communities, underwater photo-quadrats were collected during multipurpose dives with a remotely operated vehicle (ROV) in March of 2016. Ten sites were chosen to represent the geochronological and oceanographic gradients present in GBNPP. Each site was surveyed vertically between 100 and 420 meters depth and photo-quadrats were extracted from the video strip transects for analysis. The ROV was equipped with onboard CTD which recorded environmental data (temperature and salinity), in order to confirm the uniformity of these characteristics at depth across the fjords. The percent cover and diversity of species were lowest near the glaciated heads of the fjords and highest in the Central Channel and at the mouths of the fjords. Diversity is highest where characteristics such as low sedimentation and increased tidal currents are predominant. The diverse communities at the mouths of the fjords and in the Central Channel were dominated by large colonies of the Red Tree Coral,Primnoa pacifica, as well as sponges, brachiopods, multiple species of cnidarians, echinoderms, molluscs and arthropods. The communities at the heads of the fjords were heavily dominated by pioneering species such as brachiopoda, hydrozoan turf, the encrusting stoloniferan coralSarcodyction incrustans, and smaller colonies ofP.pacifica. This research documents a gradient of species dominance from the Central Channel to the heads of the glaciated fjords, which is hypothesized to be driven by a combination of physical and biological factors such as glacial sedimentation, nutrient availability, larval dispersal, and competition.	[Hartill, Elise C.; Waller, Rhian G.] Univ Maine, Darling Marine Ctr, Sch Marine Sci, Walpole, ME 04573 USA; [Waller, Rhian G.] Univ Gothenburg, Sven Loven Ctr, Tjarno, Stromstad, Sweden; [Auster, Peter J.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Auster, Peter J.] Myst Aquarium Sea Res Fdn, Mystic, CT USA	University of Maine System; University of Maine Orono; University of Gothenburg; University of Connecticut	Hartill, EC (corresponding author), Univ Maine, Darling Marine Ctr, Sch Marine Sci, Walpole, ME 04573 USA.	elise.hartill@maine.edu	Auster, Peter/ABI-3568-2020	Hartill, Elise/0000-0002-0047-3161	NOAA Ocean Exploration and Research [NA140AR0110267]	NOAA Ocean Exploration and Research	RGW; PJA Grant #NA140AR0110267, NOAA Ocean Exploration and Research https://oceanexplorer.noaa.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; AHRENS WH, 1990, WEED SCI, V38, P452, DOI 10.1017/S0043174500056824; Aksnes DL, 2009, MAR ECOL PROG SER, V387, P39, DOI 10.3354/meps08120; Andrews AH, 2002, HYDROBIOLOGIA, V471, P101, DOI 10.1023/A:1016501320206; Brewin PE, 2003, THESIS; Buhl-Mortensen L, 2005, COLD WATER CORALS EC; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Buhl-Mortensen P., 2016, MARINE ANIMAL FOREST; BUHLMORTENSEN L, 1993, MAR ECOL PROG SER, V97, P209, DOI 10.3354/meps097209; Cairns SD, 2005, B MAR SCI, V77, P225; Carney D, 1999, POLAR BIOL, V22, P38, DOI 10.1007/s003000050388; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Cowan E.A., 1991, GLACIAL MARINE SEDIM, V261, DOI [10.1130/SPE261-p61, DOI 10.1130/SPE261-P61]; Cowan EA, 2010, GEOL SOC AM BULL, V122, P1067, DOI 10.1130/B26595.1; Crowell AL, 2013, AM ANTIQUITY, V78, P3, DOI 10.7183/0002-7316.78.1.3; Etherington LL, 2007, ESTUAR COAST, V30, P927, DOI 10.1007/BF02841386; Foersterra G., 2003, Zoologische Verhandelingen (Leiden), V345, P117; Forsterra G, 2008, MAR ECOL-EVOL PERSP, V29, P342, DOI 10.1111/j.1439-0485.2008.00240.x; Fossa JH, 2005, ERLANGEN EARTH C SER, P359, DOI 10.1007/3-540-27673-4_18; Freiwald A, 2005, ERLANGEN EARTH C SER; Gorley C.K., 2006, GETTING STARTED PRIM; Graham NAJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15863-z; GRANGE KR, 1991, HYDROBIOLOGIA, V216, P297, DOI 10.1007/BF00026478; GRANGE KR, 1988, NEW ZEAL J ZOOL, V15, P481, DOI 10.1080/03014223.1988.10422628; Grange LJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0077917, 10.1371/journal.pone.0084448]; Hampton MA, 1987, GULF ALASKA PHYS ENV; Harney JN, 2005, 20061081 US GEOL SUR; HECKER B, 1990, DEEP-SEA RES, V37, P37, DOI 10.1016/0198-0149(90)90028-T; Heifetz J, 2002, HYDROBIOLOGIA, V471, P19, DOI 10.1023/A:1016528631593; Hill DF, 2009, ESTUAR COAST SHELF S, V82, P95, DOI 10.1016/j.ecss.2008.12.019; Holme N A, 1971, IBP HDB, V16; Hooge PN, 2002, FJORD OCEANOGRAPHIC; Horton JM, 2016, ARCT ANTARCT ALP RES, V48, P253, DOI 10.1657/AAAR0015-038; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Krieger KJ, 2002, HYDROBIOLOGIA, V471, P83, DOI 10.1023/A:1016597119297; Mackovjak J., 2010, TROUBLED WATERS 1; Mellin C, 2020, ECOL APPL, V30, DOI 10.1002/eap.2122; Meyer KS, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00022; Michaelis R, 2019, CONT SHELF RES, V175, P30, DOI 10.1016/j.csr.2019.01.011; Miller RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033885; Mortensen J, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006528; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Murray C, 2015, ESTUAR COAST SHELF S, V163, P72, DOI 10.1016/j.ecss.2015.05.041; Nordstog T, 2017, P IEEE SEMICOND THER, P235, DOI 10.1109/SEMI-THERM.2017.7896936; O'Neel S, 2015, BIOSCIENCE, V65, P499, DOI 10.1093/biosci/biv027; Piepenburg D, 2005, POLAR BIOL, V28, P733, DOI 10.1007/s00300-005-0013-5; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Roy V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100900; Stone R.P., 2017, DEEP SEA CORAL TAXA; Stone Robert P., 2018, NOAA Professional Paper NMFS, V20, P1; Stone RP, 2015, ICES J MAR SCI, V72, P900, DOI 10.1093/icesjms/fsu190; Stone RP, 2005, ABSTRACTS OF THE THI, P221; THAYER CW, 1985, SCIENCE, V228, P1527, DOI 10.1126/science.228.4707.1527; Thurber AR, 2014, BIOGEOSCIENCES, V11, P3941, DOI 10.5194/bg-11-3941-2014; TUNNICLIFFE V, 1988, MAR ECOL PROG SER, V47, P117, DOI 10.3354/meps047117; Tunnicliffe V, 1981, NATURE, V294, P354, DOI 10.1038/294354a0; Waller RG, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00709; Waller RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090893; Wating L, 2011, ADV MAR BIOL, V60, P41, DOI 10.1016/B978-0-12-385529-9.00002-0; Wlodarska-Kowalczuk M, 2012, MAR ECOL PROG SER, V463, P73, DOI 10.3354/meps09858	60	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0236945	10.1371/journal.pone.0236945	http://dx.doi.org/10.1371/journal.pone.0236945			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750086	gold, Green Published			2022-12-26	WOS:000560009200029
J	Lin, RZ; Xu, JF; Ma, Q; Chen, MH; Wang, L; Wen, S; Yang, CX; Ma, C; Wang, Y; Luo, Q; Zhu, N				Lin, Ruizhu; Xu, Jianfeng; Ma, Qi; Chen, Meihua; Wang, Lei; Wen, Sha; Yang, Caixia; Ma, Chuan; Wang, Yue; Luo, Qiang; Zhu, Ning			Alterations in the fecal microbiota of patients with spinal cord injury	PLOS ONE			English	Article							GUT MICROBIOTA	Objectives Spinal cord injury (SCI) is associated with severe autonomic dysfunction. Patients with SCI often suffer from a lack of central nervous system control over the gastrointestinal system. Therefore, we hypothesized that patients with SCI would cause intestinal flora imbalance. We investigated alterations in the fecal microbiome in a group of patients with SCI. Methods Microbial communities in the feces of 23 patients and 23 healthy controls were investigated using high-throughput Illumina Miseq sequencing targeting the V3-V4 region of the 16S ribosomal RNA (rRNA) gene. The relative abundances between the fecal microbiota at the genus level in patients with SCI and healthy individuals were determined using cluster analysis. Results The structure and quantity of fecal microbiota differed significantly between patients with SCI and healthy controls, but the richness and diversity were not significantly different. A two-dimensional heatmap showed that the relative abundances of forty-five operational taxonomic units (OTUs) were significantly enriched either in SCI or healthy samples. Among these, 18 OTUs were more abundant in healthy controls than in patients with SCI, and 27 OTUs were more abundant in the SCI group than in healthy controls. Conclusion Our study showed that patients with SCI exhibited microbiome dysbiosis.	[Lin, Ruizhu; Ma, Qi; Wen, Sha; Zhu, Ning] Ningxia Med Univ, Dept Rehabil Med, Gen Hosp, Yinchuan, Ningxia, Peoples R China; [Lin, Ruizhu; Chen, Meihua; Wang, Lei; Yang, Caixia; Ma, Chuan; Luo, Qiang] Ningxia Med Univ, Dept Rehabil 2, Designated Rehabil Cooperat Hosp, Gen Hosp, Yinchuan, Ningxia, Peoples R China; [Xu, Jianfeng; Wang, Yue] Ningxia Med Univ, Tradit Chinese Med & Traumatol, Yinchuan, Ningxia, Peoples R China	Ningxia Medical University; Ningxia Medical University; Ningxia Medical University	Zhu, N (corresponding author), Ningxia Med Univ, Dept Rehabil Med, Gen Hosp, Yinchuan, Ningxia, Peoples R China.	TY18209503174@163.com			Research and Development Plan of the 13th five-year of Ningxia Autonomous Region (major ST projects) [2016BZ02]; First Class Discipline Construction Project in Colleges and Universities of Ningxia [NXYLXK2017A05]; Project of General Hospital of Ningxia Medical University [2015026, 2015030]	Research and Development Plan of the 13th five-year of Ningxia Autonomous Region (major ST projects); First Class Discipline Construction Project in Colleges and Universities of Ningxia; Project of General Hospital of Ningxia Medical University	This study was supported by Research and Development Plan of the 13th five-year of Ningxia Autonomous Region (the major S&T projects; Grant No.: 2016BZ02); The First Class Discipline Construction Project in Colleges and Universities of Ningxia (Grant No.: NXYLXK2017A05); and Project of General Hospital of Ningxia Medical University (Grant Nos.: 2015026 and 2015030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aw W, 2015, ROLE INTEGRATED OMIC; Bok CW, 2009, SINGAP MED J, V50, pE393; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484; Chen Yuying, 2013, Top Spinal Cord Inj Rehabil, V19, P1, DOI 10.1310/sci1901-1; Cottle L, 2008, J INFECTION, V56, P401, DOI 10.1016/j.jinf.2008.02.005; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Escobar JS, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0311-6; Fehlings MG, 2011, NEUROTHERAPEUTICS, V8, P704, DOI 10.1007/s13311-011-0076-7; Forsythe P, 2013, CELL MOL LIFE SCI, V70, P55, DOI 10.1007/s00018-012-1028-z; Gungor B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145878; Hopkinson N, 2001, QJM-MON J ASSOC PHYS, V94, P465, DOI 10.1093/qjmed/94.9.465; Joly F, 2010, BIOCHIMIE, V92, P753, DOI 10.1016/j.biochi.2010.02.015; Kigerl KA, 2016, J EXP MED, V213, P2603, DOI 10.1084/jem.20151345; Lin XY, 2016, CELL TRANSPLANT, V25, P1425, DOI 10.3727/096368916X690836; Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Morresey PR, 2011, EQUINE VET EDUC, V23, P398, DOI 10.1111/j.2042-3292.2010.00119.x; Nicholson SE, 2018, AM J SURG, V216, P699, DOI 10.1016/j.amjsurg.2018.07.026; Paillard D, 2007, ANTON LEEUW INT J G, V91, P417, DOI 10.1007/s10482-006-9121-7; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; SALTZSTEIN RJ, 1995, AM J PHYS MED REHAB, V74, P339; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Shi ZJ, 2018, J CELL MOL MED, V22, P2055, DOI 10.1111/jcmm.13515; Tate DG, 2016, ARCH PHYS MED REHAB, V97, P1679, DOI 10.1016/j.apmr.2016.03.019; Wang Changxing, 2017, Neurosignals, V25, P1, DOI 10.1159/000471828; Zhang C, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1735-9	28	8	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0236470	10.1371/journal.pone.0236470	http://dx.doi.org/10.1371/journal.pone.0236470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750057	Green Published, gold			2022-12-26	WOS:000560009200005
J	Andersson, T; Pikkemaat, M; Schioler, L; Hjerpe, P; Carlsson, AC; Wandell, P; Manhem, K; Kahan, T; Hasselstrom, J; Bostrom, KB				Andersson, Tobias; Pikkemaat, Miriam; Schioler, Linus; Hjerpe, Per; Carlsson, Axel C.; Wandell, Per; Manhem, Karin; Kahan, Thomas; Hasselstrom, Jan; Bengtsson Bostrom, Kristina			The impact of diabetes, education and income on mortality and cardiovascular events in hypertensive patients: A cohort study from the Swedish Primary Care Cardiovascular Database (SPCCD)	PLOS ONE			English	Article							NEIGHBORHOOD SOCIOECONOMIC-STATUS; ATRIAL-FIBRILLATION; RISK-FACTORS; MYOCARDIAL-INFARCTION; DISEASE; MELLITUS; OUTCOMES; INEQUALITIES; ASSOCIATION; STROKE	Objective In this study we aimed to estimate the effect of diabetes, educational level and income on the risk of mortality and cardiovascular events in primary care patients with hypertension. Methods We followed 62,557 individuals with hypertension diagnosed 2001-2008, in the Swedish Primary Care Cardiovascular Database. Study outcomes were death, myocardial infarction, and ischemic stroke, assessed using national registers until 2012. Cox regression models were used to estimate adjusted hazard ratios of outcomes according to diabetes status, educational level, and income. Results During follow-up, 13,231 individuals died, 9981 were diagnosed with diabetes, 4431 with myocardial infarction, and 4433 with ischemic stroke. Hazard ratios (95% confidence intervals) for diabetes versus no diabetes: mortality 1.57 (1.50-1.65), myocardial infarction 1.24 (1.14-1.34), and ischemic stroke 1.17 (1.07-1.27). Hazard ratios for diabetes and <= 9 years of school versus no diabetes and >12 years of school: mortality 1.56 (1.41-1.73), myocardial infarction 1.36 (1.17-1.59), and ischemic stroke 1.27 (1.08-1.50). Hazard ratios for diabetes and income in the lowest fifth group versus no diabetes and income in the highest fifth group: mortality 3.82 (3.36-4.34), myocardial infarction 2.00 (1.66-2.42), and ischemic stroke 1.91 (1.58-2.31). Conclusions Diabetes combined with low income was associated with substantial excess risk of mortality, myocardial infarction and ischemic stroke among primary care patients with hypertension.	[Andersson, Tobias; Schioler, Linus; Hjerpe, Per; Bengtsson Bostrom, Kristina] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Sch Publ Hlth & Community Med, Gothenburg, Sweden; [Andersson, Tobias] Narhalsan Norrmalm Hlth Ctr, Skovde, Sweden; [Pikkemaat, Miriam] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Hjerpe, Per; Bengtsson Bostrom, Kristina] R&D Ctr Skaraborg Primary Care, Malmo, Sweden; [Carlsson, Axel C.; Wandell, Per; Hasselstrom, Jan] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Family Med & Primary Care, Stockholm, Sweden; [Manhem, Karin] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Kahan, Thomas] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Cardiovasc Med, Stockholm, Sweden; [Hasselstrom, Jan] Acad Primary Care Ctr, Stockholm, Sweden	University of Gothenburg; Lund University; Karolinska Institutet; University of Gothenburg; Danderyds Hospital; Karolinska Institutet	Andersson, T (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Sch Publ Hlth & Community Med, Gothenburg, Sweden.; Andersson, T (corresponding author), Narhalsan Norrmalm Hlth Ctr, Skovde, Sweden.	tobias.e.andersson@vgregion.se	Andersson, Tobias/AAP-6903-2021; Kahan, Thomas/CAE-8515-2022; Hasselström, Jan/AAL-2826-2021	Andersson, Tobias/0000-0003-1419-8460; Carlsson, Axel C/0000-0001-6113-0472	Skaraborg Research and Development Council; R&D Centre Skaraborg Primary Care; Skaraborg Institute for Research and Development; Lennander foundation; Swedish Heart-Lung Foundation; Swedish government; Swedish county councils, the ALF-agreement	Skaraborg Research and Development Council; R&D Centre Skaraborg Primary Care; Skaraborg Institute for Research and Development; Lennander foundation; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish government; Swedish county councils, the ALF-agreement	This work was supported by grants from the Skaraborg Research and Development Council (TA), R&D Centre Skaraborg Primary Care (TA), the Skaraborg Institute for Research and Development (TA), the Lennander foundation (MP), the Swedish Heart-Lung Foundation (TK), and Grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (TK, KM, TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes TA, 2007, HYPERTENSION, V50, P467, DOI 10.1161/HYPERTENSIONAHA.106.085654; Almgren T, 2007, J HYPERTENS, V25, P1311, DOI 10.1097/HJH.0b013e328122dd58; Anell A, 2015, NEW ENGL J MED, V372, P1, DOI 10.1056/NEJMp1411430; [Anonymous], 2017, LANCET, V389, P10064; Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1; Carlsson AC, 2017, INT J STROKE, V12, P815, DOI 10.1177/1747493017702663; Cefalu WT, 2019, DIABETES CARE, V42, pS103, DOI 10.2337/dc19S010; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Dalsgaard EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124829; Danaei G, 2014, LANCET DIABETES ENDO, V2, P634, DOI 10.1016/S2213-8587(14)70102-0; de Lucia C, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00253; Forssas E, 2012, EUR J PUBLIC HEALTH, V22, P305, DOI 10.1093/eurpub/ckr044; Gaede P, 2019, DIABETOLOGIA, V62, P1575, DOI 10.1007/s00125-019-4920-3; Gregg EW, 2016, LANCET DIABETES ENDO, V4, P537, DOI 10.1016/S2213-8587(16)30010-9; Gudbjornsdottir S, NDR REPORT 2018; Hasselstrom J, 2014, BLOOD PRESSURE, V23, P116, DOI 10.3109/08037051.2013.814829; Hjerpe P, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-23; Jackson CA, 2012, DIABETOLOGIA, V55, P2938, DOI 10.1007/s00125-012-2667-1; Jansson SPO, 2015, DIABETIC MED, V32, P1319, DOI 10.1111/dme.12716; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lip S, 2016, EUR HEART J, V37, P968, DOI 10.1093/eurheartj/ehv557; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Mackenbach JP, 2000, EUR HEART J, V21, P1141, DOI 10.1053/euhj.1999.1990; Marfella R, 2018, DIABETES OBES METAB, V20, P723, DOI 10.1111/dom.13122; Marfella R, 2013, J AM COLL CARDIOL, V62, P525, DOI 10.1016/j.jacc.2013.02.091; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Qvarnstrom M, 2013, EUR J CLIN PHARMACOL, V69, P1955, DOI 10.1007/s00228-013-1555-z; Rawshani A, 2018, NEW ENGL J MED, V379, P633, DOI 10.1056/NEJMoa1800256; Rawshani A, 2016, JAMA INTERN MED, V176, P1146, DOI 10.1001/jamainternmed.2016.2940; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Rosengren A, 2019, LANCET GLOB HEALTH, V7, pE748, DOI 10.1016/S2214-109X(19)30045-2; Safar ME, 2017, HYPERTENSION, V69, P1029, DOI [10.1161/hypertensionaha.116.08962, 10.1161/HYPERTENSIONAHA.116.08962]; Sardu C, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0931-0; Sardu C, 2019, DIABETES CARE, V42, P1946, DOI 10.2337/dc18-2356; SBU, 2007, MOD EL BLOOD PRESS; van Oort FVA, 2005, J EPIDEMIOL COMMUN H, V59, P214, DOI 10.1136/jech.2003.016493; Wandell P, 2016, INT J CARDIOL, V202, P776, DOI 10.1016/j.ijcard.2015.09.027; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Zhou Z, 2005, AM J EPIDEMIOL, V162, P1016, DOI 10.1093/aje/kwi307	41	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0237107	10.1371/journal.pone.0237107	http://dx.doi.org/10.1371/journal.pone.0237107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA7OS	32745121	gold, Green Published			2022-12-26	WOS:000560006800007
J	De Pascalis, R; Rossi, AP; Mittereder, L; Takeda, K; Akue, A; Kurtz, SL; Elkins, KL				De Pascalis, Roberto; Rossi, Amy P.; Mittereder, Lara; Takeda, Kazuyo; Akue, Adovi; Kurtz, Sherry L.; Elkins, Karen L.			Production of IFN-gamma by splenic dendritic cells during innate immune responses against Francisella tularensis LVS depends on MyD88, but not TLR2, TLR4, or TLR9	PLOS ONE			English	Article							LIVE VACCINE STRAIN; BACTERIAL-GROWTH; T-CELLS; ACTIVATION; INTERFERON; INFECTION; SURVIVAL; INFLAMMASOME; RECRUITMENT; EXPRESSION	Production of IFN-gamma is a key innate immune mechanism that limits replication of intracellular bacteria such asFrancisella tularensis(Ft) until adaptive immune responses develop. Previously, we demonstrated that the host cell types responsible for IFN-gamma production in response to murineFrancisellainfection include not only natural killer (NK) and T cells, but also a variety of myeloid cells. However, production of IFN-gamma by mouse dendritic cells (DC) is controversial. Here, we directly demonstrated substantial production of IFN-gamma by DC, as well as hybrid NK-DC, from LVS-infected wild type C57BL/6 or Rag1 knockout mice. We demonstrated that the numbers of conventional DC producing IFN-gamma increased progressively over the course of 8 days of LVS infection. In contrast, the numbers of conventional NK cells producing IFN-gamma, which represented about 40% of non-B/T IFN-gamma-producing cells, peaked at day 4 after LVS infection and declined thereafter. This pattern was similar to that of hybrid NK-DC. To further confirm IFN-gamma production by infected cells, DC and neutrophils were sorted from naive and LVS-infected mice and analyzed for gene expression. Quantification of LVS by PCR revealed the presence ofFtDNA not only in macrophages, but also in highly purified, IFN-gamma producing DC and neutrophils. Finally, production of IFN-gamma by infected DC was confirmed by immunohistochemistry and confocal microscopy. Notably, IFN-gamma production patterns similar to those in wild type mice were observed in cells derived from LVS-infected TLR2, TLR4, and TLR2xTLR9 knockout (KO) mice, but not from MyD88 KO mice. Taken together, these studies demonstrate the pivotal roles of DC and MyD88 in IFN-gamma production and in initiating innate immune responses to this intracellular bacterium.	[De Pascalis, Roberto; Rossi, Amy P.; Mittereder, Lara; Kurtz, Sherry L.; Elkins, Karen L.] US FDA, Div Bacterial Parasit & Allergen Prod, Lab Mucosal Pathogens & Cellular Immunol, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Takeda, Kazuyo] US FDA, Microscopy & Imaging Core, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Akue, Adovi] US FDA, Flow Cytometry Core, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Rossi, Amy P.] Univ Cincinnati, Coll Med, Grad Program Immunol, Cincinnati, OH USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); University of Cincinnati	De Pascalis, R; Elkins, KL (corresponding author), US FDA, Div Bacterial Parasit & Allergen Prod, Lab Mucosal Pathogens & Cellular Immunol, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	roberto.depascalis@fda.hhs.gov; karen.elkins@fda.hhs.gov		De Pascalis, Roberto/0000-0002-9663-7756; Kurtz, Sherry/0000-0002-2281-8984	NIGMS NIH HHS [T32 GM063483] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abplanalp AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007920; Ashtekar AR, 2008, J LEUKOCYTE BIOL, V84, P1434, DOI 10.1189/jlb.0308215; BAKER CN, 1985, J CLIN MICROBIOL, V22, P212, DOI 10.1128/JCM.22.2.212-215.1985; Bar-Haim E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000211; Bedoui S, 2010, J IMMUNOL, V184, P2237, DOI 10.4049/jimmunol.0902871; Belhocine K, 2012, CELL MICROBIOL, V14, P71, DOI 10.1111/j.1462-5822.2011.01700.x; Bosio CM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00009; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Caminschi I, 2007, J EXP MED, V204, P2579, DOI 10.1084/jem.20071351; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Chang SR, 2007, INFECT IMMUN, V75, P1167, DOI 10.1128/IAI.01026-06; Chase JC, 2010, INFECT IMMUN, V78, P154, DOI 10.1128/IAI.00750-09; Collazo CM, 2006, MICROBES INFECT, V8, P779, DOI 10.1016/j.micinf.2005.09.014; De Pascalis R, 2008, INFECT IMMUN, V76, P4311, DOI 10.1128/IAI.00514-08; De Pascalis R, 2016, INFECT IMMUN, V84, P1054, DOI 10.1128/IAI.01348-15; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Fabrik I, 2018, MOL CELL PROTEOMICS, V17, P95, DOI 10.1074/mcp.RA117.000160; Fabrik I, 2013, CELL MICROBIOL, V15, P1473, DOI 10.1111/cmi.12160; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Fricke I, 2006, J IMMUNOL, V176, P5173, DOI 10.4049/jimmunol.176.9.5173; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Gillette DD, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00045; Golovliov I, 1996, FEMS IMMUNOL MED MIC, V13, P239, DOI 10.1111/j.1574-695X.1996.tb00244.x; Goodyear A, 2012, INFECT IMMUN, V80, P110, DOI 10.1128/IAI.05819-11; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Harding JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15248; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Hole CR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10486-5; Hong KJ, 2007, INFECT IMMUN, V75, P5338, DOI 10.1128/IAI.00561-07; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Kim BH, 2016, NAT IMMUNOL, V17, P481, DOI 10.1038/ni.3440; Kolb-Maurer A, 2000, INFECT IMMUN, V68, P3680, DOI 10.1128/IAI.68.6.3680-3688.2000; Kubicka-Sierszen A, 2015, ARCH MED SCI, V11, P1044, DOI 10.5114/aoms.2015.54860; Kuoppa K, 2001, FEMS MICROBIOL LETT, V205, P77, DOI 10.1111/j.1574-6968.2001.tb10928.x; Leisewitz AL, 2004, INFECT IMMUN, V72, P4233, DOI 10.1128/IAI.72.7.4233-4239.2004; Lewis SM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6085; Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100; Metzger DW, 2007, ANN NY ACAD SCI, V1105, P266, DOI 10.1196/annals.1409.007; Mitchell JL, 2010, MOL CELL PROBE, V24, P72, DOI 10.1016/j.mcp.2009.10.004; Moretto MM, 2007, J IMMUNOL, V179, P2485, DOI 10.4049/jimmunol.179.4.2485; Ohteki T, 1999, J EXP MED, V189, P1981, DOI 10.1084/jem.189.12.1981; Orozco SL, 2019, CELL REP, V28, P2275, DOI 10.1016/j.celrep.2019.07.077; Periasamy S, 2011, J LEUKOCYTE BIOL, V90, P493, DOI 10.1189/jlb.0411197; Pietila TE, 2005, J LEUKOCYTE BIOL, V78, P909, DOI 10.1189/jlb.1204721; Pietras EM, 2011, CELL RES, V21, P1068, DOI 10.1038/cr.2011.59; Prendergast KA, 2013, TUBERCULOSIS, V93, P115, DOI 10.1016/j.tube.2012.10.008; Putzova D, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12769; Radomski N, 2020, INFECT IMMUN, V88, DOI 10.1128/IAI.00541-19; Ray HJ, 2009, CLIN VACCINE IMMUNOL, V16, P444, DOI 10.1128/CVI.00405-08; Rizzello V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/473097; Russo BC, 2013, AM J PATHOL, V183, P1223, DOI 10.1016/j.ajpath.2013.06.013; Franco MMSC, 2019, MICROBES INFECT, V21, P85, DOI 10.1016/j.micinf.2018.09.001; Skyberg JA, 2017, J LEUKOCYTE BIOL, V102, P1441, DOI 10.1189/jlb.4A0517-179R; Versage JL, 2003, J CLIN MICROBIOL, V41, P5492, DOI 10.1128/JCM.41.12.5492-5499.2003; Westcott MM, 2010, INFECT IMMUN, V78, P2956, DOI 10.1128/IAI.01027-09; Wick MJ, 2007, IMMUNOL LETT, V112, P68, DOI 10.1016/j.imlet.2007.07.007; Xia CQ, 2007, BIOCHEM BIOPH RES CO, V352, P960, DOI 10.1016/j.bbrc.2006.11.136; Zhang BN, 1997, J EXP MED, V186, P1677, DOI 10.1084/jem.186.10.1677	58	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0237034	10.1371/journal.pone.0237034	http://dx.doi.org/10.1371/journal.pone.0237034			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745117	gold, Green Published			2022-12-26	WOS:000560006800027
J	Noriega, DD; Arraes, FBM; Antonino, JD; Macedo, LLP; Fonseca, FCA; Togawa, RC; Grynberg, P; Silva, MCM; Negrisoli, AS; Morgante, CV; Grossi-de-Sa, MF				Noriega, Daniel D.; Arraes, Fabricio B. M.; Antonino, Jose Dijair; Macedo, Leonardo L. P.; Fonseca, Fernando C. A.; Togawa, Roberto C.; Grynberg, Priscila; Silva, Maria C. M.; Negrisoli, Aldomario S., Jr.; Morgante, Carolina V.; Grossi-de-Sa, Maria F.			Comparative gut transcriptome analysis of Diatraea saccharalis in response to the dietary source	PLOS ONE			English	Article							GENERALIST INSECT HERBIVORES; PLUTELLA-XYLOSTELLA; ABC TRANSPORTERS; AMINOPEPTIDASE-N; HOST-PLANT; LEPIDOPTERA; MIDGUT; GENOME; TOOL; RESISTANCE	The sugarcane borer (Diatraea saccharalis, Fabricius,1794) is a devastating pest that causes millions of dollars of losses each year to sugarcane producers by reducing sugar and ethanol yields. The control of this pest is difficult due to its endophytic behavior and rapid development. Pest management through biotechnological approaches has emerged in recent years as an alternative to currently applied methods. Genetic information about the target pests is often required to perform biotechnology-based management. The genomic and transcriptomic data forD.saccharalisare very limited. Herein, we report a tissue-specific transcriptome ofD.saccharalislarvae and a differential expression analysis highlighting the physiological characteristics of this pest in response to two different diets: sugarcane and an artificial diet. Sequencing was performed on the Illumina HiSeq 2000 platform, and ade novoassembly was generated. A total of 27,626 protein-coding unigenes were identified, among which 1,934 sequences were differentially expressed between treatments. Processes such as defence, digestion, detoxification, signaling, and transport were highly represented among the differentially expressed genes (DEGs). Furthermore, seven aminopeptidase genes were identified as candidates to encode receptors of Cry proteins, which are toxins ofBacillus thuringiensisused to control lepidopteran pests. Since plant-insect interactions have produced a considerable number of adaptive responses in hosts and herbivorous insects, the success of phytophagous insects relies on their ability to overcome challenges such as the response to plant defences and the intake of nutrients. In this study, we identified metabolic pathways and specific genes involved in these processes. Thus, our data strongly contribute to the knowledge advancement of insect transcripts, which can be a source of target genes for pest management.	[Noriega, Daniel D.; Arraes, Fabricio B. M.; Antonino, Jose Dijair; Macedo, Leonardo L. P.; Fonseca, Fernando C. A.; Togawa, Roberto C.; Grynberg, Priscila; Silva, Maria C. M.; Morgante, Carolina V.; Grossi-de-Sa, Maria F.] Embrapa Genet Resources & Biotechnol, Brasilia, DF, Brazil; [Noriega, Daniel D.; Fonseca, Fernando C. A.] Univ Brasilia, Dept Cellular Biol, Brasilia, DF, Brazil; [Noriega, Daniel D.; Grossi-de-Sa, Maria F.] Univ Catolica Brasilia, Brasilia, DF, Brazil; [Arraes, Fabricio B. M.] Univ Fed Rio Grande do Sul, Biotechnol Ctr, Porto Alegre, RS, Brazil; [Antonino, Jose Dijair] Univ Fed Rural Pernambuco, Dept Agron Entomol, Recife, PE, Brazil; [Negrisoli, Aldomario S., Jr.] Embrapa Tabuleiros Costeiros, Aracaju, Sergipe Se, Brazil; [Morgante, Carolina V.] Embrapa Semi Arid, Petrolina, PE, Brazil; [Grossi-de-Sa, Maria F.] EMBRAPA, INCT PlantStress Biotech, Natl Inst Sci & Technol, Brasilia, DF, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidade Catolica de Brasilia; Universidade Federal do Rio Grande do Sul; Universidade Federal Rural de Pernambuco (UFRPE); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Noriega, DD; Grossi-de-Sa, MF (corresponding author), Embrapa Genet Resources & Biotechnol, Brasilia, DF, Brazil.; Noriega, DD (corresponding author), Univ Brasilia, Dept Cellular Biol, Brasilia, DF, Brazil.; Noriega, DD; Grossi-de-Sa, MF (corresponding author), Univ Catolica Brasilia, Brasilia, DF, Brazil.; Grossi-de-Sa, MF (corresponding author), EMBRAPA, INCT PlantStress Biotech, Natl Inst Sci & Technol, Brasilia, DF, Brazil.	fatima.grossi@embrapa.br; daniel.nv07@gmail.com	de Souza, Jose Dijair Antonino/I-1028-2014; Grynberg, Priscila/AAX-3019-2020; Arraes, Fabrício B. M./G-9621-2014; Fonseca, Fernando/AAX-6839-2021; Grossi-de-Sa, Maria Fatima/N-7856-2017	de Souza, Jose Dijair Antonino/0000-0002-4992-0698; Grynberg, Priscila/0000-0003-4009-9538; Arraes, Fabrício B. M./0000-0001-9735-9025; Fonseca, Fernando/0000-0001-6434-5954; Togawa, Roberto/0000-0001-7179-3210				Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Botelho JF, 2006, CONTROLE PRAGAS CANA, P25; Crava CM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3348-0; Crava CM, 2010, INSECT BIOCHEM MOLEC, V40, P506, DOI 10.1016/j.ibmb.2010.04.010; Crusoe Michael R, 2015, F1000Res, V4, P900, DOI 10.12688/f1000research.6924.1; Ferreira Carlos Alberto da Silva, 2018, Arq. Inst. Biol., V85, pe0042017, DOI 10.1590/1808-1657000042017; Melo ALD, 2016, CRIT REV BIOTECHNOL, V36, P317, DOI 10.3109/07388551.2014.960793; Fonseca FCD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118231; Denecke S, 2017, INSECT BIOCHEM MOLEC, V91, P1, DOI 10.1016/j.ibmb.2017.09.017; Feeny P., 1976, BIOCH INTERACTION PL, P1, DOI [DOI 10.1007/978-1-4684-2646-5_1, 10.1007/978-1-4684-2646-5_1]; Ganbaatar O, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0328-7; Gazara RK, 2017, GENE, V627, P85, DOI 10.1016/j.gene.2017.06.008; Gershenzon J., 2017, INSECT PLANT INTERAC, P121; Ghosh SKB, 2017, EUR J ENTOMOL, V114, P170, DOI 10.14411/eje.2017.022; Goebel FR, 2011, CURR OPIN ENV SUST, V3, P81, DOI 10.1016/j.cosust.2010.12.005; Govind G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008735; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gschloessl B, 2018, DATA BRIEF, V17, P781, DOI 10.1016/j.dib.2018.01.073; Guo W, 2019, J INSECT PHYSIOL, V117, DOI 10.1016/j.jinsphys.2019.103897; Guo YQ, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iex014; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hellemans J, 2014, METHODS MOL BIOL, V1160, P19, DOI 10.1007/978-1-4939-0733-5_3; Herde M, 2014, INSECT BIOCHEM MOLEC, V50, P58, DOI 10.1016/j.ibmb.2014.03.013; Huang XB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186397; Huang XB, 2017, J ECON ENTOMOL, V110, P1831, DOI 10.1093/jee/tox128; Hughes AL, 2014, MOL PHYLOGENET EVOL, V76, P127, DOI 10.1016/j.ympev.2014.03.014; Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelkenberg M, 2015, INSECT BIOCHEM MOLEC, V56, P21, DOI 10.1016/j.ibmb.2014.11.005; Lara FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134779; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Martinez AM, 2004, BIOCONTROL SCI TECHN, V14, P193, DOI 10.1080/09583150310001655675; Merlin BL, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01106; Merzendorfer H, 2014, ADV INSECT PHYSIOL, V46, P1, DOI 10.1016/B978-0-12-417010-0.00001-X; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Nakanishi K, 2002, FEBS LETT, V519, P215, DOI 10.1016/S0014-5793(02)02708-4; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Onofre J, 2017, PEPTIDES, V98, P93, DOI 10.1016/j.peptides.2017.01.006; Oppenheim SJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191061; Pan ZZ, 2017, INT J BIOL MACROMOL, V105, P516, DOI 10.1016/j.ijbiomac.2017.07.070; Perera OP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128563; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Rispe C, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2530-8; Rivera-Vega LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182636; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rossato JADR, 2013, AGRON J, V105, P643, DOI 10.2134/agronj2012.0309; Roy A, 2016, INSECT BIOCHEM MOLEC, V71, P91, DOI 10.1016/j.ibmb.2016.02.006; Sato R, 2019, TOXINS, V11, DOI 10.3390/toxins11020124; Schoonhoven L. M., 2005, Insect-plant biology; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Singh S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49997-y; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tellam R. L., 1996, P86; Terra W. R., 1996, P153; Tian K, 2017, PESTIC BIOCHEM PHYS, V138, P51, DOI 10.1016/j.pestbp.2017.02.006; Vacari AM, 2012, BRAGANTIA, V71, P355, DOI 10.1590/S0006-87052012005000033; Valencia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151001; Vogel H, 2014, ANNU PLANT REV, V47, P197, DOI 10.1002/9781118472507.ch6; Wang J, 2017, INSECT BIOCHEM MOLEC, V87, P147, DOI 10.1016/j.ibmb.2017.07.002; Xiang M, 2018, ARCH INSECT BIOCHEM, V97, DOI 10.1002/arch.21427; Yang YL, 2010, INSECT BIOCHEM MOLEC, V40, P592, DOI 10.1016/j.ibmb.2010.05.006; Ye C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39837-4; Yi X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00403-5; Yoshinaga N, 2018, CHEMICAL ECOLOGY OF INSECTS: APPLICATIONS AND ASSOCIATIONS WITH PLANTS AND MICROBES, P28; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang JB, 2019, PESTIC BIOCHEM PHYS, V160, P20, DOI 10.1016/j.pestbp.2019.06.001; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhong HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14137-x; Zhu B, 2019, PEST MANAG SCI, V75, P1951, DOI 10.1002/ps.5308	73	3	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0235575	10.1371/journal.pone.0235575	http://dx.doi.org/10.1371/journal.pone.0235575			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745084	Green Published, gold			2022-12-26	WOS:000560006800028
J	Glowania, C; Plaisier, MA; Ernst, MO; Van Dam, LCJ				Glowania, Catharina; Plaisier, Myrthe A.; Ernst, Marc O.; Van Dam, Loes C. J.			No need to touch this: Bimanual haptic slant adaptation does not require touch	PLOS ONE			English	Article							SOMATOSENSORY CORTEX; CALLOSAL CONNECTIONS; CURVATURE; DISCRIMINATION; RESPONSES; SYMMETRY; POSITION; NEURONS	In our daily life, we often interact with objects using both hands raising the question the question to what extent information between the hands is shared. It has, for instance, been shown that curvature adaptation aftereffects can transfer from the adapted hand to the non-adapted hand. However, this transfer only occurred for dynamic exploration, e.g. by moving a single finger over a surface, but not for static exploration when keeping static contact with the surface and combining the information from different parts of the hand. This raises the question to what extent adaptation to object shape is shared between the hands when both hands are used in static fashion simultaneously and the object shape estimates require information from both hands. Here we addressed this question in three experiments using a slant adaptation paradigm. In Experiment 1 we investigated whether an aftereffect of static bimanual adaptation occurs at all and whether it transfers to conditions in which one hand was moving. In Experiment 2 participants adapted either to a felt slanted surface or simply be holding their hands in mid-air at similar positions, to investigate to what extent the effects of static bimanual adaptation are posture-based rather than object based. Experiment 3 further explored the idea that bimanual adaptation is largely posture based. We found that bimanual adaptation using static touch did lead to aftereffects when using the same static exploration mode for testing. However, the aftereffect did not transfer to any exploration mode that included a dynamic component. Moreover, we found similar aftereffects both with and without a haptic surface. Thus, we conclude that static bimanual adaptation is of proprioceptive nature and does not occur at the level at which the object is represented.	[Glowania, Catharina; Ernst, Marc O.; Van Dam, Loes C. J.] Bielefeld Univ, Cognit Neurosci Dept, Bielefeld, Germany; [Glowania, Catharina; Ernst, Marc O.; Van Dam, Loes C. J.] Bielefeld Univ, Cognit Interact Technol Ctr Excellence, Bielefeld, Germany; [Plaisier, Myrthe A.] Eindhoven Univ Technol, Dept Mech Engn, Dynam & Control Grp, Eindhoven, Netherlands; [Ernst, Marc O.] Ulm Univ, Inst Psychol, Appl Cognit Psychol, Ulm, Germany; [Van Dam, Loes C. J.] Univ Essex, Dept Psychol, Colchester, Essex, England	University of Bielefeld; University of Bielefeld; Eindhoven University of Technology; Ulm University; University of Essex	Glowania, C (corresponding author), Bielefeld Univ, Cognit Neurosci Dept, Bielefeld, Germany.; Glowania, C (corresponding author), Bielefeld Univ, Cognit Interact Technol Ctr Excellence, Bielefeld, Germany.	catharina.glowania@uni-bielefeld.de		van Dam, Loes/0000-0003-0590-9347; Ernst, Marc/0000-0003-4197-8569	Cluster of Excellence Cognitive Interaction Technology 'CITEC' at Bielefeld University - German Research Foundation (DFG) [EXC 277]; Deutsche Forschungsgemeinschaft; Bielefeld University	Cluster of Excellence Cognitive Interaction Technology 'CITEC' at Bielefeld University - German Research Foundation (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bielefeld University	Author CG was supported by the Cluster of Excellence Cognitive Interaction Technology 'CITEC' (EXC 277) at Bielefeld University, which is funded by the German Research Foundation (DFG). We acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crook MN, 1935, AM J PSYCHOL, V47, P301, DOI 10.2307/1415834; Denisova K, 2014, IEEE T HAPTICS, V7, P61, DOI 10.1109/TOH.2013.63; Dupin L, 2015, P NATL ACAD SCI USA, V112, P619, DOI 10.1073/pnas.1419539112; GARDNER EP, 1981, BRAIN RES, V214, P301, DOI 10.1016/0006-8993(81)91196-3; Gescheider G. A., 1976, PSYCHOPHYSICS METHOD; GOODWIN AW, 1991, EXP BRAIN RES, V86, P663; GREGORY JE, 1988, J NEUROPHYSIOL, V59, P1220, DOI 10.1152/jn.1988.59.4.1220; GREGORY JE, 1986, J NEUROPHYSIOL, V56, P451, DOI 10.1152/jn.1986.56.2.451; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Han J, 2013, EXP BRAIN RES, V226, P313, DOI 10.1007/s00221-013-3437-0; HANNAH RE, 1984, ARCH PHYS MED REHAB, V65, P155; Iwamura Y, 2001, NEUROSCIENTIST, V7, P419, DOI 10.1177/107385840100700511; Iwamura Y, 2000, PHILOS T R SOC B, V355, P267, DOI 10.1098/rstb.2000.0563; KELSO JAS, 1981, B PSYCHONOMIC SOC, V18, P63; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Machilsen B, 2009, J VISION, V9, DOI 10.1167/9.12.11; Maravita A, 1997, NEUROREPORT, V8, P1671, DOI 10.1097/00001756-199705060-00022; Pont SC, 1997, PERCEPT PSYCHOPHYS, V59, P1225, DOI 10.3758/BF03214210; Pont SC, 1999, PERCEPT PSYCHOPHYS, V61, P874, DOI 10.3758/BF03206903; Proske U, 2006, MUSCLE NERVE, V34, P545, DOI 10.1002/mus.20627; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Proske U, 2009, J PHYSIOL-LONDON, V587, P4139, DOI 10.1113/jphysiol.2009.175372; PRUDHOMME MJL, 1994, J NEUROPHYSIOL, V72, P2280, DOI 10.1152/jn.1994.72.5.2280; Rhodes G, 1998, PSYCHON B REV, V5, P659, DOI 10.3758/BF03208842; Tame L, 2016, COGN NEUROPSYCHOL, V33, P48, DOI 10.1080/02643294.2016.1159547; Tame L, 2015, HUM BRAIN MAPP, V36, P1506, DOI 10.1002/hbm.22719; Tillery SIH, 1996, J NEUROPHYSIOL, V76, P2423, DOI 10.1152/jn.1996.76.4.2423; van Dam LCJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34412; van der Horst BJ, 2008, NEUROPSYCHOLOGIA, V46, P2966, DOI 10.1016/j.neuropsychologia.2008.06.003; van der Horst BJ, 2008, EXP BRAIN RES, V187, P491, DOI 10.1007/s00221-008-1390-0; Vogels IMLC, 1996, PERCEPTION, V25, P109, DOI 10.1068/p250109; Vogels IMLC, 1997, PERCEPTION, V26, P101, DOI 10.1068/p260101; VOGELS IMLC, 1995, STUD PERCEPT ACTION, V3, P319; WALKER JT, 1974, J EXP PSYCHOL, V103, P668, DOI 10.1037/h0037136; White O, 2009, EXP BRAIN RES, V192, P113, DOI 10.1007/s00221-008-1561-z	36	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236824	10.1371/journal.pone.0236824	http://dx.doi.org/10.1371/journal.pone.0236824			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NO3EK	32735569	Green Published, gold, Green Accepted			2022-12-26	WOS:000569367100049
J	Lehmann, AP; Camelier, P; Zanata, A				Lehmann, Pablo A.; Camelier, Priscila; Zanata, Angela			Parotocinclus nandae, a new distinctive colored catfish (Loricariidae: Hypoptopomatinae) from the upper Rio Paraguacu, Bahia State, northeastern Brazil	PLOS ONE			English	Article							SILURIFORMES LORICARIIDAE	A new species of Parotocinclus from the upper Rio Paraguacu, Bahia, Brazil, is described. The new species is distinguished from all congeners by its unique color pattern, with irregular dark blotches resulting in a somewhat marble-spotted pattern on head and trunk of most specimens and dorsum of head with a conspicuous V-shaped light mark from tip of snout to nares. The new species is also distinguished from congeners by having the lower lip elongated posteriorly and reaching or surpassing the anterior margin of cleithrum on the pectoral girdle, the canal cheek plate on the ventral surface of the head reduced and with a slightly concave margin, and abdomen covered by small embedded platelets, without contact with each other and not arranged in a line between the pectoral-fin axilla and pelvic-fin origin. The presence of a thick and rough skin in the interradial membrane of pelvic fin exclusively in the females of P. nandae is reported by the first time to occurs in Siluriformes.	[Lehmann, Pablo A.] Univ Vale Rio dos Sinos, Lab Ictiol, Sao Leopoldo, RS, Brazil; [Camelier, Priscila; Zanata, Angela] Univ Fed Bahia, Inst Biol, Programa Posgrad Biodiversidade & Evolucao, Salvador, BA, Brazil	Universidade do Vale do Rio dos Sinos (Unisinos); Universidade Federal da Bahia	Lehmann, AP (corresponding author), Univ Vale Rio dos Sinos, Lab Ictiol, Sao Leopoldo, RS, Brazil.	lehmanncatfish@gmail.com	de Assis Cardoso, Priscila Camelier/W-3740-2017	de Assis Cardoso, Priscila Camelier/0000-0002-1228-0076; Lehmann A., Pablo/0000-0002-8884-4827	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [476495/2010-5, 309993/2016-4, 423760/2018-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2016/19075-9, 2017/09321-5]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Authors are partially funded for field activities to collect the specimens, by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq http://www.cnpq.br/(AMZ #476495/2010-5; #309993/2016-4, and PC #423760/2018-1) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP http://www.fapesp.br/(PC grants #2016/19075-9 and #2017/09321-5).The authors received no specific funding for this work. There was no additional external funding received for this study.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; BGE, 1803, HIST NATURELLE POISS, V5; Birindelli JLO, 2007, NEOTROP ICHTHYOL, V5, P271, DOI 10.1590/S1679-62252007000300006; Boeseman M., 1968, ZOOLOGISCHE VERHANDE, P1; Cramer CA, 2011, MOL PHYLOGENET EVOL, V59, P43, DOI 10.1016/j.ympev.2011.01.002; Santos ACD, 2007, BRAZ ARCH BIOL TECHN, V50, P663, DOI 10.1590/S1516-89132007000400012; de Miranda Ribeiro A., 1918, REV MUS PAULISTA, V10, P631; Delapieve MLS, 2017, NEOTROP ICHTHYOL, V15, DOI 10.1590/1982-0224-20170079; Eigenmann C. H., 1889, Proceedings of the California Academy of Sciences, V(2), P28; Fricke R, 2019, CATALOG FISHES GENER; GARAVELLO J C, 1977, Arquivos de Zoologia (Sao Paulo), V28, P1; Gauger Marco F. W., 2005, Neotrop. ichthyol., V3, P509, DOI 10.1590/S1679-62252005000400008; Lehmann P, 2006, NEOTROP ICHTHYOL, V4, P379, DOI 10.1590/S1679-62252006000400001; Lehmann P, 2013, COPEIA, P435, DOI 10.1643/CI-13-004; Lehmann AP, 2018, ZOOTAXA, V4521, P584, DOI 10.11646/zootaxa.4521.4.7; Lehmann AP, 2015, NEOTROP ICHTHYOL, V13, P47, DOI 10.1590/1982-0224-20140113; Lehmann AP, 2014, NEOTROP ICHTHYOL, V12, P27, DOI 10.1590/S1679-62252014000100002; Lehmann AP, 2012, ZOOTAXA, P56; Lima Flavio C.T., 2001, Ichthyological Exploration of Freshwaters, V12, P105; Pereira A, 2019, LECT N MECH ENG, P107, DOI 10.1007/978-3-030-18682-1_9; Pereira EHL, 2017, ZOOTAXA, V4264, P1, DOI 10.11646/zootaxa.4264.1.1; Pereira EHL, 2014, COPEIA, P673, DOI 10.1643/CI-14-075; Pereira EHL, 2014, NEOTROP ICHTHYOL, V12, P35, DOI 10.1590/S1679-62252014000100003; Reis RE, 2017, 2 INT S PHYL CLASS N; Roxo FF, 2017, ZOOTAXA, V4232, P260, DOI 10.11646/zootaxa.4232.2.9; Roxo FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105564; Santos A, 2001, ACTA HORTIC, P97, DOI 10.17660/ActaHortic.2001.556.12; Schaefer SA, 1997, P ACAD NAT SCI PHILA, V148, P1; Steindachner F., 1877, MATH NATURWISSENSCHA, V76, P217; TAYLOR W R, 1985, Cybium, V9, P107; Zanata AM, 2013, NEOTROP ICHTHYOL, V11, P247, DOI 10.1590/S1679-62252013000200002	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236690	10.1371/journal.pone.0236690	http://dx.doi.org/10.1371/journal.pone.0236690			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735598	Green Published, gold			2022-12-26	WOS:000569367100039
J	Hao, DD; Wang, Y; Li, LY; Qian, G; Liu, J; Li, MM; Zhang, YH; Zhou, RX; Yan, DP				Hao, Doudou; Wang, Yu; Li, Liuyan; Qian, Gui; Liu, Jing; Li, Manman; Zhang, Yihua; Zhou, Ruixue; Yan, Dapeng			SHP-1 suppresses the antiviral innate immune response by targeting TRAF3	FASEB JOURNAL			English	Article						immune signaling transduction; immunoregulation; protein-protein interaction; type I interferon; virus infection	CYCLIC GMP-AMP; NEGATIVE REGULATION; IFN-BETA; ACTIVATION; PROTEIN; UBIQUITINATION; PHOSPHATASES; EXPRESSION; INDUCTION; SENSOR	Type I interferons play a pivotal role in innate immune response to virus infection. The protein tyrosine phosphatase SHP-1 was reported to function as a negative regulator of inflammatory cytokine production by inhibiting activation of NF-kappa B and MAPKs during bacterial infection, however, the role of SHP-1 in regulating type I interferons remains unknown. Here, we demonstrated that knockout or knockdown of SHP-1 in macrophages promoted both HSV-1- and VSV-induced antiviral immune response. Conversely, overexpression of SHP-1 in L929 cells suppressed the HSV-1- and VSV-induced immune response; suppression was directly dependent on phosphatase activity. We identified a direct interaction between SHP-1 and TRAF3; the association between these two proteins resulted in diminished recruitment of CK1 epsilon to TRAF3 and inhibited its K63-linked ubiquitination; SHP-1 inhibited K63-linked ubiquitination of TRAF3 by promoting dephosphorylation at Tyr116 and Tyr446. Taken together, our results identify SHP-1 as a negative regulator of antiviral immunity and suggest that SHP-1 may be a target for intervention in acute virus infection.	[Hao, Doudou; Li, Liuyan; Qian, Gui; Liu, Jing; Li, Manman; Zhang, Yihua; Zhou, Ruixue; Yan, Dapeng] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Dongan Rd 130, Shanghai 200032, Peoples R China; [Hao, Doudou; Li, Liuyan; Qian, Gui; Liu, Jing; Li, Manman; Zhang, Yihua; Zhou, Ruixue; Yan, Dapeng] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dongan Rd 130, Shanghai 200032, Peoples R China; [Wang, Yu] Army Med Univ, Coll Pharm, Natl Engn Res Ctr Immunol Prod, Dept Microbiol & Biochem Pharm, Chongqing, Peoples R China; [Wang, Yu] Army Med Univ, NCO Sch, Dept Basic Courses, Shijiazhuang, Hebei, Peoples R China	Fudan University; Fudan University; Army Medical University; Army Medical University	Yan, DP (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Immunol, Dongan Rd 130, Shanghai 200032, Peoples R China.; Yan, DP (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dongan Rd 130, Shanghai 200032, Peoples R China.	dapengyan@fudan.edu.cn			National Natural Science Foundation of China (NSFC) [31972900, 31670901, 81871249]; Shanghai Institutions of Higher Learning [TP2016007]; Outstanding Youth Training Program of Shanghai Municipal Commission of Health and Family Planning [2017YQ012]; National Key Research and Development Program of China [2016YFC1305103, 2018YFC1705505]; National Megaproject on Key Infectious Diseases [2017ZX10202102]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Institutions of Higher Learning; Outstanding Youth Training Program of Shanghai Municipal Commission of Health and Family Planning; National Key Research and Development Program of China; National Megaproject on Key Infectious Diseases	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31972900, 31670901 and 81871249; Shanghai Institutions of Higher Learning, Grant/Award Number: TP2016007; Outstanding Youth Training Program of Shanghai Municipal Commission of Health and Family Planning, Grant/Award Number: 2017YQ012; National Key Research and Development Program of China, Grant/Award Number: 2016YFC1305103 and 2018YFC1705505; National Megaproject on Key Infectious Diseases, Grant/Award Number: 2017ZX10202102	Abram CL, 2017, J LEUKOCYTE BIOL, V102, P657, DOI 10.1189/jlb.2MR0317-105R; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; [Anonymous], 2020, LANCET, V395, P311, DOI 10.1016/S0140-6736(20)30186-0; Chen XJ, 2014, PROTEIN CELL, V5, P369, DOI 10.1007/s13238-014-0026-3; Christophi GP, 2009, LAB INVEST, V89, P742, DOI 10.1038/labinvest.2009.32; Davis ME, 2015, VIROLOGY, V479, P52, DOI 10.1016/j.virol.2015.02.033; Doyle T, 2015, NAT REV MICROBIOL, V13, P403, DOI 10.1038/nrmicro3449; Garg M, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2019.09.006; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Holshue Michelle L, 2020, N Engl J Med, V382, P929, DOI 10.1056/NEJMoa2001191; Hutchinson EC, 2018, TRENDS MICROBIOL, V26, P809, DOI 10.1016/j.tim.2018.05.013; Khoury JD, 2004, BLOOD, V104, P1580, DOI 10.1182/blood-2004-03-1151; Kim SSY, 2014, J IMMUNOL, V193, P840, DOI 10.4049/jimmunol.1301601; Li HY, 2015, MICROBES INFECT, V17, P109, DOI 10.1016/j.micinf.2014.11.012; Liu JG, 2015, SCIENCE, V347, DOI 10.1126/science.1258832; Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; Mao HT, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050146; Matthys VS, 2014, J VIROL, V88, P2246, DOI 10.1128/JVI.02647-13; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Nandan D, 2000, J LEUKOCYTE BIOL, V67, P464, DOI 10.1002/jlb.67.4.464; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshiumi H, 2012, J BIOCHEM, V151, P5, DOI 10.1093/jb/mvr111; Radoshevich L, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00313; Rikihisa Y, 2010, CURR OPIN MICROBIOL, V13, P59, DOI 10.1016/j.mib.2009.12.008; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Towers GJ, 2014, CELL HOST MICROBE, V16, P10, DOI 10.1016/j.chom.2014.06.009; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Varble AJ, 2016, VIROLOGY, V499, P99, DOI 10.1016/j.virol.2016.09.009; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Wang S, 2013, J VIROL, V87, P11851, DOI 10.1128/JVI.01211-13; Watson NB, 2015, J IMMUNOL, V194, P2796, DOI 10.4049/jimmunol.1402210; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yan DP, 2012, NAT IMMUNOL, V13, P1063, DOI 10.1038/ni.2417; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang CG, 2019, NATURE, V567, P394, DOI 10.1038/s41586-019-1000-2; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhang LP, 2018, SCI CHINA TECHNOL SC, V6, P1; Zhang Q, 2005, P NATL ACAD SCI USA, V102, P6948, DOI 10.1073/pnas.0501959102; Zhao BY, 2016, P NATL ACAD SCI USA, V113, pE3403, DOI 10.1073/pnas.1603269113; Zhao W, 2013, FEBS LETT, V587, P542, DOI 10.1016/j.febslet.2013.01.052; Zhou RX, 2019, EMERG MICROBES INFEC, V8, P734, DOI 10.1080/22221751.2019.1620589; Zhou Y, 2016, NAT IMMUNOL, V17, P397, DOI 10.1038/ni.3395; Zhu Z, 2010, IMMUNOL RES, V47, P3, DOI 10.1007/s12026-009-8134-5	48	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12392	12405		10.1096/fj.202000600RR	http://dx.doi.org/10.1096/fj.202000600RR		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32779804	Green Published			2022-12-26	WOS:000555047300001
J	Lewis, TR; Smith, J; Griffin, K; Aguiar, S; Rueb, KF; Holmberg-Douglas, N; Sampson, EM; Tomasetti, S; Rodriguez, S; Stachura, DL; Arpin, CC				Lewis, Tina R.; Smith, Jesse; Griffin, Kallie; Aguiar, Stephanie; Rueb, Kristen F.; Holmberg-Douglas, Natalie; Sampson, Ellen M.; Tomasetti, Skylar; Rodriguez, Sofia; Stachura, David L.; Arpin, Carolynn C.			NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; ABL TYROSINE KINASE; PHILADELPHIA-CHROMOSOME; POT SYNTHESIS; SH2 DOMAIN; BCR; ZEBRAFISH; RAS; QUINOXALINES; BCR/ABL	The majority of chronic myeloid leukemia (CML) cases are caused by a chromosomal translocation linking the breakpoint cluster region (BCR) gene to the Abelson murine leukemia viral oncogene-1 (ABL1), creating the mutant fusion protein BCR-ABL1. Downstream of BCR-ABL1 is growth factor receptor-bound protein-2 (GRB2), an intracellular adapter protein that binds to BCR-ABL1 via its src-homology-2 (SH2) domain. This binding constitutively activates growth pathways, downregulates apoptosis, and leads to an over proliferation of immature and dysfunctional myeloid cells. Utilizing novel synthetic methods, we developed four furo-quinoxaline compounds as GRB2 SH2 domain antagonists with the goal of disrupting this leukemogenic signaling. One of the four antagonists, NHD2-15, showed a significant reduction in proliferation of K562 cells, a human BCR-ABL1(+)leukemic cell line. To elucidate the mode of action of these compounds, various biophysical,in vitro, andin vivoassays were performed. Surface plasmon resonance (SPR) assays indicated that NHD2-15 antagonized GRB2, binding with aK(D)value of 119 +/- 2 mu M. Cellulose nitrate (CN) assays indicated that the compound selectively bound the SH2 domain of GRB2. Western blot assays suggested the antagonist downregulated proteins involved in leukemic transformation. Finally, NHD2-15 was nontoxic to primary cells and adult zebrafish, indicating that it may be an effective clinical treatment for CML.	[Lewis, Tina R.; Smith, Jesse; Griffin, Kallie; Aguiar, Stephanie; Rueb, Kristen F.; Tomasetti, Skylar; Rodriguez, Sofia; Stachura, David L.] Calif State Univ Chico, Dept Biol Sci, Chico, CA 95929 USA; [Lewis, Tina R.; Holmberg-Douglas, Natalie; Sampson, Ellen M.; Arpin, Carolynn C.] Calif State Univ Chico, Dept Chem & Biochem, Chico, CA 95929 USA	California State University System; California State University Chico; California State University System; California State University Chico	Stachura, DL (corresponding author), Calif State Univ Chico, Dept Biol Sci, Chico, CA 95929 USA.; Arpin, CC (corresponding author), Calif State Univ Chico, Dept Chem & Biochem, Chico, CA 95929 USA.	dstachura@csuchico.edu; carpin@csuchico.edu		Stachura, David/0000-0002-8993-0938; Rueb, Kristen/0000-0003-4513-9228	CSU Program for Education and Research in Biotechnology (CSUPERB); CSUPERB President's Commission Scholar Awards; California State University Chico Internal Research Grant; California State University, Chico	CSU Program for Education and Research in Biotechnology (CSUPERB); CSUPERB President's Commission Scholar Awards; California State University Chico Internal Research Grant; California State University, Chico	This research was supported by the CSU Program for Education and Research in Biotechnology (CSUPERB) (New Investigator Awards to D.L.S. and C.C.A.), CSUPERB President's Commission Scholar Awards (to N.H.D. and E.M.S.), a California State University Chico Internal Research Grant (to D.L.S. and C.C.A.), and Student Research and Creativity Awards from California State University, Chico (to T.R.L. and J. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON HT, 1970, CANCER RES, V30, P2213; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Aljaar N, 2012, J ORG CHEM, V77, P7793, DOI 10.1021/jo3014275; Ambaye ND, 2011, BIOORGAN MED CHEM, V19, P693, DOI 10.1016/j.bmc.2010.10.030; Bambino K, 2017, CURR TOP DEV BIOL, V124, P331, DOI 10.1016/bs.ctdb.2016.10.007; BARTRAM CR, 1983, NATURE, V306, P277, DOI 10.1038/306277a0; BIBBINS KB, 1993, MOL CELL BIOL, V13, P7278, DOI 10.1128/MCB.13.12.7278; Brummer T, 2010, FEBS J, V277, P4356, DOI 10.1111/j.1742-4658.2010.07865.x; CARVER DR, 1982, J ORG CHEM, V47, P1036, DOI 10.1021/jo00345a028; Casciati F, 2004, COMPUT METH APPL SCI, P1; Chan WW, 2011, CANCER CELL, V19, P556, DOI 10.1016/j.ccr.2011.03.003; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Deveau AP, 2017, EXP HEMATOL, V45, P1, DOI 10.1016/j.exphem.2016.09.012; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Eaves CJ, 2015, BLOOD, V125, P2605, DOI 10.1182/blood-2014-12-570200; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Holyoake TL, 2017, BLOOD, V129, P1595, DOI 10.1182/blood-2016-09-696013; IIJIMA C, 1977, YAKUGAKU ZASSHI, V97, P712, DOI 10.1248/yakushi1947.97.7_712; Ismail MMF, 2005, ARZNEIMITTEL-FORSCH, V55, P738; Kumar KS, 2012, BIOORGAN MED CHEM, V20, P1711, DOI 10.1016/j.bmc.2012.01.012; La Rosee P, 2008, HAEMATOLOGICA, V93, P765, DOI 10.3324/haematol.12186; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; Li JJ, 2003, BIOORGAN MED CHEM, V11, P3777, DOI 10.1016/S0968-0896(03)00399-7; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MAIGNAN S, 1995, SCIENCE, V268, P291, DOI 10.1126/science.7716522; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; MARENGERE LEM, 1994, J CELL SCI, P97; MARU Y, 1991, CELL, V67, P459, DOI 10.1016/0092-8674(91)90521-Y; Maruyama IN, 2014, CELLS-BASEL, V3, P304, DOI 10.3390/cells3020304; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; Million RP, 2000, BLOOD, V96, P664; Nakhi A, 2013, ORG BIOMOL CHEM, V11, P4930, DOI 10.1039/c3ob41069b; Nioche P, 2002, J MOL BIOL, V315, P1167, DOI 10.1006/jmbi.2001.5299; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; O'Hare T, 2011, CLIN CANCER RES, V17, P212, DOI 10.1158/1078-0432.CCR-09-3314; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Paik EJ, 2010, ZEBRAFISH, V7, P61, DOI 10.1089/zeb.2009.0643; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; PUIL L, 1994, EMBO J, V13, P764, DOI 10.1002/j.1460-2075.1994.tb06319.x; Ridges S, 2012, BLOOD, V119, P5621, DOI 10.1182/blood-2011-12-398818; Rosti G, 2017, NAT REV CLIN ONCOL, V14, P141, DOI 10.1038/nrclinonc.2016.139; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Roy P, 2010, BEILSTEIN J ORG CHEM, V6, DOI 10.3762/bjoc.6.52; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; SAWYERS CL, 1995, J EXP MED, V181, P307, DOI 10.1084/jem.181.1.307; SKORSKI T, 1995, BLOOD, V86, P726, DOI 10.1182/blood.V86.2.726.bloodjournal862726; Stachura DL, 2009, BLOOD, V114, P279, DOI 10.1182/blood-2009-02-203638; Suryawanshi M.R., 2011, ARCH APPL SCI RES, V3, P380; Thiesing JT, 2000, BLOOD, V96, P3195, DOI 10.1182/blood.V96.9.3195.h8003195_3195_3199; Vidal M, 1998, J BIOL CHEM, V273, P5343, DOI 10.1074/jbc.273.9.5343; Wang JYJ, 2014, MOL CELL BIOL, V34, P1188, DOI 10.1128/MCB.01454-13; Westerfield M., 2007, GUIDE LAB USE ZEBRAF; Yeh JRJ, 2009, NAT CHEM BIOL, V5, P236, DOI 10.1038/nchembio.147; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	58	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0236839	10.1371/journal.pone.0236839	http://dx.doi.org/10.1371/journal.pone.0236839			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780746	gold, Green Published			2022-12-26	WOS:000562664700008
J	Mychek-Londer, JG; Chaganti, SR; Heath, DD				Mychek-Londer, Justin G.; Chaganti, Subba Rao; Heath, Daniel D.			Metabarcoding of native and invasive species in stomach contents of Great Lakes fishes	PLOS ONE			English	Article							ALEWIFE ALOSA-PSEUDOHARENGUS; DREISSENID MUSSEL INVASIONS; SMELT OSMERUS-MORDAX; FOOD-WEB CHANGES; RAINBOW SMELT; BYTHOTREPHES-LONGIMANUS; BENTHIVOROUS FISHES; CERCOPAGIS-PENGOI; FEEDING ECOLOGY; DIET SHIFTS	As aquatic invasive species (AIS) proliferate worldwide, a better understanding of their roles in invaded habitats is needed to inform management and introduction prevention strategies and priorities. Metabarcoding of stomach content DNA (scDNA) shows considerable promise in such regard. We thus metabarcoded scDNA from two non-native fish species (alewife (Alosa pseudoharengus) and rainbow smelt (Osmerus mordax)), and three native ones (bloater (Coregonus hoyi), ninespine stickleback (Pungitius pungitius), and slimy sculpin (Cottus cognatus)). Fishes (N = 376) were sampled in spring 2009 and 2010 from 73-128 m depths at three Lake Michigan sites. Four mitochondrial cytochrome oxidase 1 (CO1) primer sets designed to target five potential AIS prey, and a universal aquatic invertebrate CO1 primer set targeting both native and AIS prey were used. Quality controlled prey amplicons were matched to three AIS prey:Bythotrephes longimanus(mean percent frequency occurrence, all samples = 7%),Cercopagis pengoi(5%), andDreissena rostriformis bugensis(11%). Neither invasive preyDreissena polymorphanorHemimysis anomalawere detected. Native preyLeptodiaptomus sicilis,Limnocalanus macrurus, andMysis diluvianawere relatively common in scDNA (respective mean percent occurrences, all samples: 48%, 25%, 42%). Analysis of variation in prey occurrences for sample site, predator species, sample year, sample depth, and predator total length (TL) indicated site and predator species were most important. However,B.longimanusoccurrence in scDNA depended upon predator TL, perhaps indicative of its unique defensive spine limiting susceptibility to predation until fishes exceed species-specific gape-based limitations. Our analysis of native and invasive prey species indicated possible indirect AIS impacts such as native predators switching their diet due to AIS-driven losses of preferred native prey. Metabarcoding demonstrated that AIS are integrated components of the offshore Lake Michigan food web, with both native and non-native predators, and both invasive and native prey are affecting species interactions across multiple trophic levels.	[Mychek-Londer, Justin G.; Chaganti, Subba Rao; Heath, Daniel D.] Univ Windsor, Great Lakes Inst Environm Res GLIER, Windsor, ON, Canada; [Heath, Daniel D.] Univ Windsor, Dept Integrat Biol, Windsor, ON, Canada; [Mychek-Londer, Justin G.] J Londer Labs, Detroit, MI 48226 USA; [Chaganti, Subba Rao] Cooperat Inst Great Lakes Res CIGLR, Ann Arbor, MI USA; [Chaganti, Subba Rao] Univ Michigan, Ann Arbor, MI 48109 USA	University of Windsor; University of Windsor; University of Michigan System; University of Michigan	Mychek-Londer, JG (corresponding author), Univ Windsor, Great Lakes Inst Environm Res GLIER, Windsor, ON, Canada.; Mychek-Londer, JG (corresponding author), J Londer Labs, Detroit, MI 48226 USA.	jglonder@gmail.com	Chaganti, Subba Rao/AAO-8118-2020	Chaganti, Subba Rao/0000-0001-9796-3986	Ontario Trillium Scholarships Program [10415192]; Natural Sciences and Engineering Council of Canada (NSERC) Strategic Partnership Grant for Networks (CAISN) [811083]; NSERC [814014]	Ontario Trillium Scholarships Program; Natural Sciences and Engineering Council of Canada (NSERC) Strategic Partnership Grant for Networks (CAISN); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this project came from the Ontario Trillium Scholarships Program Grant no. 10415192 to JGM, a Natural Sciences and Engineering Council of Canada (NSERC) Strategic Partnership Grant for Networks (CAISN) no. 811083 to DDH, and an NSERC Discovery Grant no. 814014 to DDH.	Barbiero RP, 2004, CAN J FISH AQUAT SCI, V61, P2111, DOI 10.1139/f04-149; BAREL CDN, 1985, NATURE, V315, P19, DOI 10.1038/315019a0; BARNHISEL DR, 1995, CAN J FISH AQUAT SCI, V52, P768, DOI 10.1139/f95-076; Bially A, 2000, FRESHWATER BIOL, V43, P85, DOI 10.1046/j.1365-2427.2000.00526.x; Bourdeau PE, 2011, BIOL INVASIONS, V13, P2533, DOI 10.1007/s10530-011-0073-0; Branstrator DK, 2005, J PLANKTON RES, V27, P569, DOI 10.1093/plankt/fbi033; Briski E, 2011, BIOL INVASIONS, V13, P1325, DOI 10.1007/s10530-010-9892-7; Brown SB, 2005, J AQUAT ANIM HEALTH, V17, P113, DOI 10.1577/H04-015.1; Bunnell DB, 2015, J GREAT LAKES RES, V41, P161, DOI 10.1016/j.jglr.2015.07.011; Bunnell DB, 2014, ECOL FRESHW FISH, V23, P604, DOI 10.1111/eff.12112; Bunnell DB, 2011, FRESHWATER BIOL, V56, P1281, DOI 10.1111/j.1365-2427.2010.02568.x; Bunnell DB, 2009, J GREAT LAKES RES, V35, P74, DOI 10.1016/j.jglr.2008.10.002; Bushnoe TM, 2003, J GREAT LAKES RES, V29, P205, DOI 10.1016/S0380-1330(03)70427-4; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Comtet T, 2015, BIOL INVASIONS, V17, P905, DOI 10.1007/s10530-015-0854-y; Darling JA, 2011, ENVIRON RES, V111, P978, DOI 10.1016/j.envres.2011.02.001; Deagle BE, 2018, MOL EC; Devlin SP, 2017, ECOSYSTEMS, V20, P183, DOI 10.1007/s10021-016-0023-x; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Folino-Rorem NC, 2009, BIOL INVASIONS, V11, P1869, DOI 10.1007/s10530-008-9365-4; Gamble AE, 2011, J GREAT LAKES RES, V37, P550, DOI 10.1016/j.jglr.2011.06.008; Garrison LP, 2000, MAR ECOL PROG SER, V202, P231, DOI 10.3354/meps202231; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hondorp DW, 2005, T AM FISH SOC, V134, P588, DOI 10.1577/T04-107.1; Honeyfield DC, 2005, J AQUAT ANIM HEALTH, V17, P1, DOI 10.1577/H04-012.1; Hussey NE, 2011, CAN J FISH AQUAT SCI, V68, P2029, DOI 10.1139/F2011-115; Hyatt Kim D., 2018, Open Fish Science Journal, V11, P1; IUCN International Union for Conservation of Nature, 2010, CERC PENG GLOB INV S; Jackson JK, 2014, FRESHW SCI, V33, P312, DOI 10.1086/675225; Jarnagin ST, 2004, LIMNOL OCEANOGR, V49, P1317, DOI 10.4319/lo.2004.49.4_part_2.1317; Johnson TB, 2005, J GREAT LAKES RES, V31, P238, DOI 10.1016/S0380-1330(05)70317-8; KAUFMAN L, 1992, BIOSCIENCE, V42, P846, DOI 10.2307/1312084; Keeler KM, 2015, J GREAT LAKES RES, V41, P150, DOI 10.1016/j.jglr.2015.07.010; Kemp JS, 2018, J MOLLUS STUD, V84, P175, DOI 10.1093/mollus/eyy006; Kerfoot WC, 2011, BIOL INVASIONS, V13, P2513, DOI 10.1007/s10530-011-0078-8; Krueger CC, 1995, J GREAT LAKES RES, V21, P458, DOI 10.1016/S0380-1330(95)71117-0; Krylov PI, 1998, ERGEB LIMNOL, V52, P383; Legler ND, 2010, T AM FISH SOC, V139, P868, DOI 10.1577/T09-212.1; LEHMAN JT, 1988, NATURE, V332, P537, DOI 10.1038/332537a0; LEHMAN JT, 1993, LIMNOL OCEANOGR, V38, P879, DOI 10.4319/lo.1993.38.4.0879; LEHMAN JT, 1991, J GREAT LAKES RES, V17, P437, DOI 10.1016/S0380-1330(91)71379-8; Leray M, 2015, PEERJ, V3, DOI 10.7717/peerj.1047; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Link J, 2008, FISH RES, V93, P229, DOI 10.1016/j.fishres.2008.04.011; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; LOFTUS DH, 1986, CAN J FISH AQUAT SCI, V43, P812, DOI 10.1139/f86-100; Londer J., 2011, THESIS; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; MacIsaac HJ, 1999, CAN J FISH AQUAT SCI, V56, P1, DOI 10.1139/cjfas-56-1-1; Madenjian CP, 2008, N AM J FISH MANAGE, V28, P263, DOI 10.1577/M07-012.1; Madenjian CP, 2015, J GREAT LAKES RES, V41, P217, DOI 10.1016/j.jglr.2015.08.009; Manca MM, 2007, J PLANKTON RES, V29, P515, DOI 10.1093/plankt/fbm033; Miehls ALJ, 2014, EVOLUTION, V68, P2633, DOI 10.1111/evo.12472; MILLS EL, 1993, J GREAT LAKES RES, V19, P1, DOI 10.1016/S0380-1330(93)71197-1; Mills EL, 1996, AM ZOOL, V36, P271; MUMBY JA, 2017, CANADIAN J FISHERIES, V75, P759; Mychek-Londer JG, 2019, ENV DNA, DOI [10.1002/edn3.56, DOI 10.1002/EDN3.56]; Mychek-Londer JG, 2018, THESIS; Mychek-Londer JG, 2013, J GREAT LAKES RES, V39, P327, DOI 10.1016/j.jglr.2013.03.007; Mychek-Londer JG, 2013, T AM FISH SOC, V142, P492, DOI 10.1080/00028487.2012.756431; Myers JT, 2009, T AM FISH SOC, V138, P1352, DOI 10.1577/T08-131.1; Nalepa TF, 2013, VARIATION QUAGGA MUS, P315; Nalepa TF, 2009, FRESHWATER BIOL, V54, P466, DOI 10.1111/j.1365-2427.2008.02123.x; Nickum J, 2004, FISHERIES, V29, P26; O'Malley BP, 2017, J GREAT LAKES RES, V43, P813, DOI 10.1016/j.jglr.2017.02.003; O'Malley BP, 2014, J PLANKTON RES, V36, P989, DOI 10.1093/plankt/fbu038; Owens Randall W., 2003, Aquatic Ecosystem Health & Management, V6, P311, DOI 10.1080/14634980301487; Paterson G, 2014, FRESHWATER BIOL, V59, P2150, DOI 10.1111/fwb.12418; Pochon X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073935; Pothoven SA, 2008, N AM J FISH MANAGE, V28, P308, DOI 10.1577/M07-022.1; Pothoven SA, 2018, ENVIRON BIOL FISH, V101, P1161, DOI 10.1007/s10641-018-0766-7; Pothoven SA, 2012, J GREAT LAKES RES, V38, P134, DOI 10.1016/j.jglr.2011.10.003; Pothoven SA, 2009, J GREAT LAKES RES, V35, P190, DOI 10.1016/j.jglr.2008.11.011; Pu RL, 2018, INT WORKS EARTH OB, P1; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ricciardi A, 2000, TRENDS ECOL EVOL, V15, P62, DOI 10.1016/S0169-5347(99)01745-0; Ricciardi A, 1998, J ANIM ECOL, V67, P613, DOI 10.1046/j.1365-2656.1998.00220.x; Ricciardi A, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P211; Rush SA, 2012, FRESHWATER BIOL, V57, P2342, DOI 10.1111/fwb.12014; Schooley JD, 2008, T AM FISH SOC, V137, P1044, DOI 10.1577/T07-169.1; Shortridge MG, THESIS; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Spikkeland I, 2016, FAUNA NORV, V36, P51, DOI [10.5324/fn.v36i0.1994, DOI 10.5324/FN.V36I0.1994]; Staton JM, 2014, J GREAT LAKES RES, V40, P139, DOI 10.1016/j.jglr.2014.02.021; Stewart TJ, 2009, J GREAT LAKES RES, V35, P241, DOI 10.1016/j.jglr.2008.12.010; Stoeckmann A, 2003, CAN J FISH AQUAT SCI, V60, P126, DOI 10.1139/F03-005; Storch AJ, 2007, CAN J FISH AQUAT SCI, V64, P1314, DOI 10.1139/F07-096; Sutela T, 2000, T AM FISH SOC, V129, P545, DOI 10.1577/1548-8659(2000)129&lt;0545:VROZPT&gt;2.0.CO;2; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tyus HM, 2000, FISHERIES, V25, P17, DOI 10.1577/1548-8446(2000)025<0017:NFCAEF>2.0.CO;2; USGS. Cercopagis pengoi: U.S. Geological Survey, NON AQ SPEC DAT; Vander Zanden MJ, 2010, J GREAT LAKES RES, V36, P199, DOI 10.1016/j.jglr.2009.11.002; Waraniak JM, 2019, ECOL EVOL, V9, P1410, DOI 10.1002/ece3.4857; Wells L, 1973, LAKE MICHIGAN MANS E; WINEMILLER KO, 1989, ENVIRON BIOL FISH, V26, P177, DOI 10.1007/BF00004815; Yan ND, 1998, HYDROBIOLOGIA, V361, P157; Yurista PM, 1997, J GREAT LAKES RES, V23, P202, DOI 10.1016/S0380-1330(97)70897-9; YURISTA PM, 1992, CAN J FISH AQUAT SCI, V49, P1118, DOI 10.1139/f92-124; Zhan AB, 2013, METHODS ECOL EVOL, V4, P558, DOI 10.1111/2041-210X.12037	103	6	6	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0236077	10.1371/journal.pone.0236077	http://dx.doi.org/10.1371/journal.pone.0236077			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780731	Green Published, gold			2022-12-26	WOS:000562664700014
J	Yang, MC; Zhang, DQ; Zhao, ZF; Sit, JL; Saint-Sume, M; Shabandri, O; Zhang, KZ; Yin, L; Tong, X				Yang, Meichan; Zhang, Deqiang; Zhao, Zifeng; Sit, Julian; Saint-Sume, Mischael; Shabandri, Omar; Zhang, Kezhong; Yin, Lei; Tong, Xin			Hepatic E4BP4 induction promotes lipid accumulation by suppressing AMPK signaling in response to chemical or diet-induced ER stress	FASEB JOURNAL			English	Article						de novo lipogenesis; ER stress; high-fat; low-methionine; and choline-deficient diet; lipid accumulation; lipid droplet	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; LIVER-INJURY; CELL-DEATH; INSULIN-RESISTANCE; METABOLISM; ACTIVATION; STEATOSIS; KINASE; STEATOHEPATITIS	Prolonged ER stress has been known to be one of the major drivers of impaired lipid homeostasis during the pathogenesis of non-alcoholic liver disease (NAFLD). However, the downstream mediators of ER stress pathway in promoting lipid accumulation remain poorly understood. Here, we present data showing the b-ZIP transcription factor E4BP4 in both the hepatocytes and the mouse liver is potently induced by the chemical ER stress inducer tunicamycin or by high-fat, low-methionine, and choline-deficient (HFLMCD) diet. We showed that such an induction is partially dependent on CHOP, a known mediator of ER stress and requires the E-box element of theE4bp4promoter. Tunicamycin promotes the lipid droplet formation and alters lipid metabolic gene expression in primary mouse hepatocytes fromE4bp4(flox/flox)but notE4bp4 liver-specific KO(E4bp4-LKO) mice. Compared withE4bp4(flox/flox)mice,E4bp4-LKOfemale mice exhibit reduced liver lipid accumulation and partially improved liver function after 10-week HFLMCD diet feeding. Mechanistically, we observed elevated AMPK activity and the AMPK beta 1 abundance in the liver ofE4bp4-LKOmice. We have evidence supporting that E4BP4 may suppress the AMPK activity via promoting the AMPK beta 1 ubiquitinationanddegradation. Furthermore, acute depletion of theAmpk beta 1subunit restores lipid droplet formation inE4bp4-LKOprimary mouse hepatocytes. Our study highlighted hepatic E4BP4 as a key factor linking ER stress and lipid accumulation in the liver. Targeting E4BP4 in the liver may be a novel therapeutic avenue for treating NAFLD.	[Yang, Meichan; Zhang, Deqiang; Sit, Julian; Shabandri, Omar; Yin, Lei; Tong, Xin] Univ Michigan, Dept Mol & Integrat Physiol, Med Sch, 1137 Catherine St,Med Sci 2 7712, Ann Arbor, MI 48109 USA; [Yang, Meichan] Cent South Univ, Xiangya Hosp 2, Dept Infect Dis, Changsha, Peoples R China; [Zhao, Zifeng] China Pharmaceut Univ, Sch Tradit Chinese Pharm, Dept Pharmacol Chinese Mat, Nanjing, Peoples R China; [Saint-Sume, Mischael] Howard Univ, Dept Biol, Washington, DC 20059 USA; [Zhang, Kezhong] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA	University of Michigan System; University of Michigan; Central South University; China Pharmaceutical University; Howard University; Wayne State University	Yin, L; Tong, X (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Med Sch, 1137 Catherine St,Med Sci 2 7712, Ann Arbor, MI 48109 USA.	leiyin@umich.edu; xintong@umich.edu		TONG, XIN/0000-0002-4832-8940	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK121170, DK077449, DK099593, DK090313, DK089503, DK020572, DK034933]	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK121170, DK077449, DK099593, DK090313, DK089503, DK089503, DK020572, DK034933 and DK020572	Bandla H, 2018, HEPATOL RES, V48, P479, DOI 10.1111/hepr.13052; Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Byun S, 2017, EMBO J, V36, P1755, DOI 10.15252/embj.201695500; Chikka MR, 2013, J BIOL CHEM, V288, P4405, DOI 10.1074/jbc.M112.432344; Cho EJ, 2014, DIGEST DIS SCI, V59, P1461, DOI 10.1007/s10620-014-3217-0; Deng M, 2016, MOL CELL, V61, P614, DOI 10.1016/j.molcel.2016.01.010; Flowers MI, 2009, BBA-MOL CELL BIOL L, V1791, P85, DOI 10.1016/j.bbalip.2008.12.011; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Han CY, 2018, CELL REP, V24, P2985, DOI 10.1016/j.celrep.2018.07.068; Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Henkel A, 2013, SEMIN LIVER DIS, V33, P321, DOI 10.1055/s-0033-1358522; Iracheta-Vellve A, 2016, J BIOL CHEM, V291, P26794, DOI 10.1074/jbc.M116.736991; Kang G, 2017, METABOLISM, V77, P13, DOI 10.1016/j.metabol.2017.08.007; Keniry Megan, 2014, Discoveries (Craiova), V2, pe15; Khoury T, 2015, WORLD J GASTROENTERO, V21, P7443, DOI 10.3748/wjg.v21.i24.7443; Kim SJ, 2016, MOL CELL BIOL, V36, P1961, DOI 10.1128/MCB.00244-16; Kostrzewski T, 2018, J IMMUNOL, V200, P1370, DOI 10.4049/jimmunol.1700981; Kwon E, 2019, FASEB J, V33, P6539, DOI 10.1096/fj.201801766RRR; Lee JS, 2012, AM J TRANSL RES, V4, P102; Lee MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05721-4; Li YY, 2017, MOL ONCOL, V11, P1806, DOI 10.1002/1878-0261.12151; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Liu XY, 2015, AM J PHYSIOL-GASTR L, V309, pG965, DOI 10.1152/ajpgi.00132.2015; Miyazaki M, 2009, BIOCHEM BIOPH RES CO, V380, P818, DOI 10.1016/j.bbrc.2009.01.183; Noureddin Mazen, 2018, Curr Hepatol Rep, V17, P350, DOI 10.1007/s11901-018-0425-7; Ohta Y, 2017, EBIOMEDICINE, V18, P146, DOI 10.1016/j.ebiom.2017.03.040; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Palmisano BT, 2018, MOL METAB, V15, P45, DOI 10.1016/j.molmet.2018.05.008; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Qiu Bo, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.1912; Rahman K, 2016, LAB INVEST, V96, P895, DOI 10.1038/labinvest.2016.61; Rahman SM, 2007, HEPATOLOGY, V45, P1108, DOI 10.1002/hep.21614; Ren LP, 2013, INT J MOL MED, V32, P1029, DOI 10.3892/ijmm.2013.1493; Rinella Mary E, 2011, Hepatology, V54, P1600, DOI 10.1002/hep.24553; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Santhekadur PK, 2018, J HEPATOL, V68, P230, DOI 10.1016/j.jhep.2017.10.031; Smith BK, 2017, CURR OPIN CLIN NUTR, V20, P248, DOI 10.1097/MCO.0000000000000380; Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016; So JS, 2012, CELL METAB, V16, P487, DOI 10.1016/j.cmet.2012.09.004; Song MJ, 2019, PHARMACOL THERAPEUT, V203, DOI 10.1016/j.pharmthera.2019.107401; Tong X, 2016, J LIPID RES, V57, P1219, DOI 10.1194/jlr.M067181; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; Vila IK, 2017, CANCER CELL, V31, P208, DOI 10.1016/j.ccell.2017.01.003; Wang YH, 2017, SCIENCE, V357, P913, DOI 10.1126/science.aan0677; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Woods A, 2017, CELL REP, V18, P3043, DOI 10.1016/j.celrep.2017.03.011; Xu G, 2018, CURR MED CHEM, V25, P889, DOI 10.2174/0929867324666170404142450; Xu YQ, 2015, BBA-GEN SUBJECTS, V1850, P2552, DOI 10.1016/j.bbagen.2015.09.008; Yang FJ, 2019, CELL IMMUNOL, V336, P40, DOI 10.1016/j.cellimm.2018.12.008; Yoo J, 2018, TOXICOL APPL PHARM, V360, P18, DOI 10.1016/j.taap.2018.09.032; Zhang W, 2013, GENE DEV, V27, P441, DOI 10.1101/gad.201731.112; Zheng Z, 2016, DIABETES, V65, P3369, DOI 10.2337/db16-0298; Zhu L, 2018, MOL METAB, V8, P106, DOI 10.1016/j.molmet.2017.12.012	62	5	5	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13533	13547		10.1096/fj.201903292RR	http://dx.doi.org/10.1096/fj.201903292RR		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32780887	Green Accepted, Green Submitted			2022-12-26	WOS:000558418200001
J	Hwang, JT; Yoon, KJ; Park, CH; Choi, JH; Park, HJ; Park, YS; Lee, YT				Hwang, Jin Tae; Yoon, Kyung Jae; Park, Chul-Hyun; Choi, Jae Hyeoung; Park, Hee-Jin; Park, Young Sook; Lee, Yong-Taek			Follow-up of clinical and sonographic features after extracorporeal shock wave therapy in painful plantar fibromatosis	PLOS ONE			English	Article							DUPUYTRENS DISEASE; PEYRONIES-DISEASE; FASCIITIS; MANAGEMENT; METAANALYSIS; ULTRASOUND	Background Extracorporeal shock wave therapy (ESWT) has been used as a safe alternative treatment for refractory musculoskeletal diseases, such as plantar fasciitis, Achilles tendinopathy and gluteal tendinopathy, and various forms of fibromatosis including palmar or penile fibromatosis. However, there is limited published data for clinical and sonographic features of plantar fibromatosis after ESWT. The purpose of this study was to evaluate the long-term clinical outcome of ESWT in ultrasonography-confirmed plantar fibromatosis and ultrasonographic changes of plantar fibroma after ESWT. Methods Medical charts of 26 patients (30 feet) with plantar fibromatosis confirmed by ultrasonography were reviewed. Finally, a total of 10 feet who underwent ESWT for "Poor" or "Fair" grade of Roles-Maudsley Score (RMS) and symptoms persisted for >6 months were included in this study. Short-term follow-up was conducted one week after ESWT and long-term follow-up time averaged 34.0 months. The Numerical Rating Scale (NRS) and RMS were collected for the evaluation of clinical features. Follow-up ultrasonography was conducted at long-term follow-up and changes of plantar fibroma was assessed. A greater than 50% reduction in the NRS and achievement of a "good" or "excellent" grade in the RMS were regarded as treatment success. Additionally, medical charts of 144 patients (168 feet) with plantar fasciitis confirmed by ultrasonography were reviewed and subsequently, 42 feet who underwent ESWT with the same protocol were included for the comparison of clinical features. Results In plantar fibromatosis, baseline NRS (6.2 +/- 1.3) and RMS (3.5 +/- 0.5) were significantly improved at short-term follow-up (NRS, 1.8 +/- 1.0; RMS, 2.0 +/- 0.8,P< .001, respectively) and long-term follow-up (NRS, 0.6 +/- 1.1; RMS, 1.4 +/- 0.8,P< .001, respectively). Treatment success was recorded in seven feet (70.0%) at short-term follow-up and 8 feet (80%) at long-term follow-up, which is comparable to that of the plantar fasciitis group (28 feet, 66.7%; 35 feet, 83.3%, respectively). In long-term follow-up ultrasonography, mean fibroma thickness was reduced from 4.4 +/- 1.0 to 2.6 +/- 0.8 mm (P= .003); however, length and width were not significantly changed. There were no serious adverse effects. Conclusion While these are preliminary findings, and must be confirmed in a randomized placebo control study, ESWT can have a beneficial long-term effect on pain relief and functional outcomes in painful plantar fibromatosis. However, ESWT is unlikely to affect the ultrasonographic morphology of plantar fibroma, with the exception of reducing the thickness.	[Hwang, Jin Tae; Yoon, Kyung Jae; Park, Chul-Hyun; Choi, Jae Hyeoung; Lee, Yong-Taek] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Phys & Rehabil Med, Sch Med, Seoul, South Korea; [Park, Hee-Jin] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Radiol, Sch Med, Seoul, South Korea; [Park, Young Sook] Sungkyunkwan Univ, Samsung Changwon Hosp, Dept Phys & Rehabil Med, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, YT (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Phys & Rehabil Med, Sch Med, Seoul, South Korea.	yongtaek1.lee@gmail.com	Lee, Yong-Taek/ABB-3200-2020; Yoon, Kyung Jae/ABB-3785-2021	Lee, Yong-Taek/0000-0001-6611-0999				Abdulsalam AJ, 2019, EUR J PHYS REHAB MED, V55, P862, DOI 10.23736/S1973-9087.18.05498-9; Ahn J, 2010, ANN REHABIL MED-ARM, V34, P565; Aqil A, 2013, CLIN ORTHOP RELAT R, V471, P3645, DOI 10.1007/s11999-013-3132-2; Bedi DG, 2001, J CLIN ULTRASOUND, V29, P499, DOI 10.1002/jcu.10014; Capogrosso P, 2019, J SEX MED, V16, P1490, DOI 10.1016/j.jsxm.2019.07.016; Cohen BE, 2018, J ULTRAS MED, V37, P2725, DOI 10.1002/jum.14615; de Bree E, 2004, AM J SURG, V187, P33, DOI 10.1016/j.amjsurg.2002.11.002; Espert M, 2018, FOOT ANKLE INT, V39, P751, DOI 10.1177/1071100718768051; Fausto de Souza Dominique, 2010, J Clin Aesthet Dermatol, V3, P45; Fojecki GL, 2017, WORLD J UROL, V35, P1, DOI 10.1007/s00345-016-1834-2; Frairia Roberto, 2011, Muscles Ligaments Tendons J, V1, P138; Frizziero A, 2017, JCR-J CLIN RHEUMATOL, V23, P63, DOI 10.1097/RHU.0000000000000462; Gudmundsson KG, 2013, FOOT ANKLE INT, V34, P841, DOI 10.1177/1071100713475352; Hatzichristodoulou G, 2013, J SEX MED, V10, P2815, DOI 10.1111/jsm.12275; Hatzimouratidis K, 2012, EUR UROL, V62, P543, DOI 10.1016/j.eururo.2012.05.040; Husain J, 2000, BJU INT, V86, P466, DOI 10.1046/j.1464-410X.2000.00827.x; Knobloch Karsten, 2012, BMC Res Notes, V5, P542, DOI 10.1186/1756-0500-5-542; Knobloch K, 2011, MED HYPOTHESES, V76, P635, DOI 10.1016/j.mehy.2011.01.018; Lebret T, 2002, UROLOGY, V59, P657, DOI 10.1016/S0090-4295(02)01527-3; Lee JY, 2017, ANN REHABIL MED-ARM, V41, P42, DOI 10.5535/arm.2017.41.1.42; Lou J, 2017, AM J PHYS MED REHAB, V96, P529, DOI 10.1097/PHM.0000000000000666; McMillan AM, 2009, J FOOT ANKLE RES, V2, DOI 10.1186/1757-1146-2-32; Mohseni-Bandpei MA, 2014, ULTRASOUND MED BIOL, V40, P1737, DOI 10.1016/j.ultrasmedbio.2014.03.001; Notarnicola A, 2017, J BIOL REG HOMEOS AG, V31, P775; Ogden JA, 2001, CLIN ORTHOP RELAT R, P22; Palmieri A, 2009, EUR UROL, V56, P363, DOI 10.1016/j.eururo.2009.05.012; Park JW, 2014, ANN REHABIL MED-ARM, V38, P534, DOI 10.5535/arm.2014.38.4.534; Reilly JM, 2018, PM&R, V10, P1385, DOI 10.1016/j.pmrj.2018.05.007; Schmitz C, 2013, J ORTHOP SURG RES, V8, DOI 10.1186/1749-799X-8-31; Seo KH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197460; Tsai WC, 2000, SCAND J RHEUMATOL, V29, P255; van der Veer WM, 2008, PLAST RECONSTR SURG, V122, P486, DOI 10.1097/PRS.0b013e31817d61ab; Veith NT, 2013, FOOT ANKLE INT, V34, P1742, DOI 10.1177/1071100713505535; Wang CJ, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-11; Yoon K., 2002, J KOREAN ACAD REHABI, V26, P181; Young JR, 2019, ORTHOP RES REV, V11, P1, DOI 10.2147/ORR.S154289	36	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237447	10.1371/journal.pone.0237447	http://dx.doi.org/10.1371/journal.pone.0237447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776988	gold, Green Published			2022-12-26	WOS:000561393800036
J	Werner, SJ; Fischer, JW; Hobson, KA				Werner, Scott J.; Fischer, Justin W.; Hobson, Keith A.			Multi-isotopic (delta 2H,delta 13C,delta 15N) tracing of molt origin for European starlings associated with US dairies and feedlots	PLOS ONE			English	Article							STABLE-CARBON; BIRD DAMAGE; RATIOS; AGE	Introduced bird species can become invasive in agroecosystems and their management is inhibited if their origin and movements are not well understood. Stable isotope measurements of feathers can be used to infer molt origins and interstate movements in North America. We analyzed stable-hydrogen (delta H-2), carbon (delta C-13) and nitrogen (delta N-15) isotope ratios in feathers to better understand the molt origin of European starlings (Sturnus vulgaris) collected at dairies and feedlots throughout the United States. Primary feathers were used from 596 adult and 90 juvenile starlings collected during winter at dairies and feedlots that experience starling damages in Arizona, California, Colorado, Idaho, Illinois, Iowa, Kansas, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, Oregon, Texas, Vermont, Washington and Wisconsin. The best-fit model indicated that the combination of feather delta H-2,delta C-13 and delta N-15 values best predicted the state where samples were collected and thus supported use of this approach for tracing molt origins in European starlings. Interestingly, molt origins of starlings collected at dairies and feedlots generally west of & x2d7;90 degrees longitude (i.e. 11 of 15 states west of the Mississippi River, including Wisconsin) were assigned to the collection state and/or the state adjacent to the collection state. In contrast, molt origins of starlings collected generally east of & x2d7;90 degrees longitude (four of five eastern states) were not assigned to the collection state and/or the state adjacent to the collection state. Among all starlings (N= 686), 23% were assigned to the collection state and 19% were assigned to the state adjacent to the collection state. Among all males (N= 489) and all females (N= 197), 23% and 26% were assigned to the collection state and 19% and 13% were assigned to the state adjacent to the collection state, respectively. We observed a greater proportion (88%) of juvenile starlings assigned to states other than their collection state (i.e. potentially a result of natal dispersal) than that proportion (76%) in adult starlings. This study included an unprecedented sample of feather isotopes from European starlings throughout the United States. As a novel contribution to the ecology and management of invasive and migratory passerines, we demonstrate how such feather isoscapes can be used to predict molt origin and, potentially, interstate movements of European starlings for subsequent ecological and management investigations.	[Werner, Scott J.; Fischer, Justin W.] USDA, Anim & Plant Hlth Inspect Serv, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO 80526 USA; [Hobson, Keith A.] Univ Western Ontario, Dept Biol, London, ON, Canada; [Hobson, Keith A.] Univ Western Ontario, Environm & Climate Change Canada, London, ON, Canada	United States Department of Agriculture (USDA); Western University (University of Western Ontario); Environment & Climate Change Canada; Western University (University of Western Ontario)	Werner, SJ (corresponding author), USDA, Anim & Plant Hlth Inspect Serv, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO 80526 USA.	Scott.J.Werner@usda.gov		Fischer, Justin/0000-0002-9472-8945	USDA's National Wildlife Research Center; University of Western Ontario	USDA's National Wildlife Research Center; University of Western Ontario	This research was supported by USDA's National Wildlife Research Center and the University of Western Ontario.	Anderson A, 2013, CROP PROT, V52, P103, DOI 10.1016/j.cropro.2013.05.019; AVMA, AM VET MED ASS GUID; Cabe P. R., 1993, BIRDS N AM; Cabe PR, 1999, CONDOR, V101, P451, DOI 10.2307/1370014; Carlson JC, 2018, J DAIRY SCI, V101, P1777, DOI 10.3168/jds.2017-12858; Carlson JC, 2013, APPL ANIM BEHAV SCI, V145, P26, DOI 10.1016/j.applanim.2013.01.011; Carlson JC, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-9; Carlson JC, 2011, J APPL ECOL, V48, P479, DOI 10.1111/j.1365-2664.2010.01935.x; DICKERSON L. M., 1938, CONDOR, V40, P118, DOI 10.2307/1363826; DOLBEER RA, 1982, J FIELD ORNITHOL, V53, P28; Hache S, 2012, CAN J ZOOL, V90, P722, DOI 10.1139/Z2012-039; Hobson K.A., 2019, TRACKING ANIMAL MIGR, VSecond; Hobson KA, 1999, CONDOR, V101, P799, DOI 10.2307/1370067; Hobson KA, 2018, ECOL ENTOMOL, V43, P332, DOI 10.1111/een.12505; Hobson KA, 2014, J FIELD ORNITHOL, V85, P237, DOI 10.1111/jofo.12065; Hofmeister NR, 2019, BIORXIV; Jewett S. G., 1946, The Starling in Oregon Condor, V48, P245; Jewett Stanley G., 1942, CONDOR, V44, P79; Kessel B., 1953, Condor, V55, P49, DOI 10.2307/1365026; KESSEL B., 1951, BIRD BANDING, V22, P16; Linz G, 2018, ECOLOGY MANAGEMENT T, P333, DOI [10.1201/9781315157078-15, DOI 10.1201/9781315157078-15]; Lopez Calderon C, 2019, ECOSPHERE, DOI [10.1002/ecs2.2855, DOI 10.1002/ECS2.2855]; McCue MD, 2020, METHODS ECOL EVOL, V11, P196, DOI 10.1111/2041-210X.13327; Munro JA, 1947, CONDOR, V49, P130; Shannon JP, 2003, ISOT ENVIRON HEALT S, V39, P1, DOI 10.1080/1025601031000102215; THOMAS EDWARD S., 1934, BIRD BANDING [BOSTON], V5, P118, DOI 10.2307/4509309; Wassenaar LI, 2000, ECOL APPL, V10, P911, DOI 10.1890/1051-0761(2000)010[0911:SCAHIR]2.0.CO;2; Werner SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165996; Wing L., 1943, CONDOR, V45, P159; Yerkes T, 2008, J WILDLIFE MANAGE, V72, P715, DOI 10.2193/2007-115	30	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237137	10.1371/journal.pone.0237137	http://dx.doi.org/10.1371/journal.pone.0237137			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32777811	gold, Green Published			2022-12-26	WOS:000561393800051
J	Abdullah, I; Jafta, AD; Chapanduka, ZC				Abdullah, Ibtisam; Jafta, Andrea D.; Chapanduka, Zivanai C.			The impact of physician education regarding the importance of providing complete clinical information on the request forms of thrombophilia-screen tests at Tygerberg hospital in South Africa	PLOS ONE			English	Article							PULMONARY-EMBOLISM; GUIDELINES; QUALITY	Background Thrombophilia-screen tests are specialised haemostasis tests that are affected by numerous unique patient variables including the presence of acute thrombosis, the concomitant use of medication and patient demographics. Complete information on the request form is therefore crucial for the haematological pathologist to make patient-specific interpretation of patients' results. Objectives To assess the completeness of thrombophilia-screen test request forms and determine the impact of provision of incomplete information, on the interpretive comments generated by reporting haematological pathologists. To assess the impact of an educational session given to clinicians on the importance of providing all the relevant information on the request forms. Method Two retrospective audits, each covering 3 months, were performed to evaluate the completeness of demographic and clinical information on thrombophilia-screen request forms and its impact on the quality of the interpretive comments before and after an educational intervention. Results One hundred and seventy-one request forms were included in the first audit and 146 in the second audit. The first audit revealed that all 171 thrombophilia-screen request forms had complete patient demographic information but none had clinical information. Haematological pathologists only made generic comments which could not be applied to a specific patient. The second audit, conducted after a physician educational session, did not reveal any improvement in the clinical information provision by the test-ordering physicians. This was reportedly due to the lack of space on the request form. The interpretive comments therefore remained generic and not patient-specific. Conclusion Physicians' failure to provide relevant clinical information made it impossible for pathologists to make patient-specific interpretation of the results. A single physician education session did not change the practice, reportedly due to the inappropriate design of the test request form. Further studies are required to investigate the impact of an improved request form and the planned electronic test requesting.	[Abdullah, Ibtisam; Chapanduka, Zivanai C.] Stellenbosch Univ, Tygerberg Hosp, Natl Hlth Lab Serv, Cape Town, South Africa; [Abdullah, Ibtisam; Jafta, Andrea D.; Chapanduka, Zivanai C.] Stellenbosch Univ, Fac Med & Hlth Sci, Div Haematol Pathol, Cape Town, South Africa; [Jafta, Andrea D.] Stellenbosch Univ, Fac Med & Hlth Sci, AMPATH Labs, Cape Town, South Africa	Stellenbosch University; Tygerberg Hospital; Stellenbosch University; Stellenbosch University	Chapanduka, ZC (corresponding author), Stellenbosch Univ, Tygerberg Hosp, Natl Hlth Lab Serv, Cape Town, South Africa.; Chapanduka, ZC (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Div Haematol Pathol, Cape Town, South Africa.	zivanai@sun.ac.za	Chapanduka, zivanai/AAE-5631-2022	Chapanduka, zivanai/0000-0002-5489-8392; Abdullah, Ibtisam/0000-0001-6152-5730				ADEGOKE OA, 2011, AFR J BIOCH RES, V5, P82; Al Dogether M, 2016, J INFECT PUBLIC HEAL, V9, P749, DOI 10.1016/j.jiph.2016.09.003; Baglin T, 2010, BRIT J HAEMATOL, V149, P209, DOI 10.1111/j.1365-2141.2009.08022.x; Bailey J, 2005, J CLIN PATHOL, V58, P853, DOI 10.1136/jcp.2004.023101; Bain B. J, 2016, DACIE LEWIS PRACTICA; Becattini C, 2017, SEMIN RESP CRIT CARE, V38, P94, DOI 10.1055/s-0036-1597557; Burnett L, 2004, ANN CLIN BIOCHEM, V41, P53, DOI 10.1258/000456304322664708; Couturaud F, 2015, JAMA-J AM MED ASSOC, V314, P31, DOI 10.1001/jama.2015.7046; Einhaupl K, 2010, EUR J NEUROL, V17, P1229, DOI 10.1111/j.1468-1331.2010.03011.x; Erasmus RT, 2009, J CLIN PATHOL, V62, P593, DOI 10.1136/jcp.2008.056929; Igwebuikw, 2012, CLIN AUDIT, V4, P9; Keeling D, 2012, BRIT J HAEMATOL, V157, P47, DOI 10.1111/j.1365-2141.2012.09037.x; Kwon AJ, 2016, J THROMB HAEMOST, V14, P982, DOI 10.1111/jth.13284; Mackie I, 2013, INT J LAB HEMATOL, V35, P1, DOI 10.1111/ijlh.12004; Nutt L, 2008, ANN CLIN BIOCHEM, V45, P463, DOI 10.1258/acb.2008.007252; Olayemi E, 2011, PAN AFR MED J, V8; Osegbe ID, 2016, ANN MED HEALTH SCI R, V6, P90, DOI 10.4103/2141-9248.181834; Oyedeji OA, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.287.5273; Schettini Daniel Almeida, 2012, An. Bras. Dermatol., V87, P115, DOI 10.1590/S0365-05962012000100014; Singh S, 2015, J CHITWAN MED COLL, V5, P18; Tripodi A, 2001, CLIN CHEM, V47, P1597; Zemlin AE, 2009, SAMJ S AFR MED J, V99, P668	22	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0235826	10.1371/journal.pone.0235826	http://dx.doi.org/10.1371/journal.pone.0235826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760142	gold, Green Published			2022-12-26	WOS:000561027200055
J	Tran, VT; Ravaud, P				Tran, Viet-Thi; Ravaud, Philippe			COVID-19-related perceptions, context and attitudes of adults with chronic conditions: Results from a cross-sectional survey nested in the ComPaRe e-cohort	PLOS ONE			English	Article								Background To avoid a surge of demand on the healthcare system due to the COVID-19 pandemic, we must reduce transmission to individuals with chronic conditions who are at risk of severe illness with COVID-19. We aimed at understanding the perceptions, context and attitudes of individuals with chronic conditions during the COVID-19 pandemic to clarify their potential risk of infection. Methods A cross-sectional survey was nested in ComPaRe, an e-cohort of adults with chronic conditions, in France. It assessed participants' perception of their risk of severe illness with COVID-19; their context (i.e., work, household, contacts with external people); and their attitudes in situations involving frequent or occasional contacts with symptomatic or asymptomatic people. Data were collected from March 23 to April 2, 2020, during the lockdown in France. Analyses were weighted to represent the demographic characteristics of French patients with chronic conditions. The subgroup of participants at high risk according to the recommendations of the French High Council for Public Health was examined. Results Among the 7169 recruited participants, 63% patients felt at risk because of severe illness. About one quarter (23.7%) were at risk of infection because they worked outside home, had a household member working outside home or had regular visits from external contacts. Less than 20% participants refused contact with symptomatic people and <20% used masks when in contact with asymptomatic people. Among patients considered at high risk according to the recommendations of the French High Council for Public Health, 20% did not feel at risk, which led to incautious attitudes. Conclusion Individuals with chronic conditions have distorted perceptions of their risk of severe illness with COVID-19. In addition, they are exposed to COVID-19 due to their context or attitudes.	[Tran, Viet-Thi; Ravaud, Philippe] Univ Paris, CRESS, INSERM, INRA, Paris, France; [Tran, Viet-Thi; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, Paris, France; [Ravaud, Philippe] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Columbia University	Tran, VT (corresponding author), Univ Paris, CRESS, INSERM, INRA, Paris, France.; Tran, VT (corresponding author), Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, Paris, France.	thi.tran-viet@aphp.fr	Tran, Viet-Thi/F-1023-2018; Tran, Viet-Thi/Q-2789-2019	Tran, Viet-Thi/0000-0003-1863-6739; Tran, Viet-Thi/0000-0003-1863-6739	Assistance Publique Hopitaux de Paris; Universite de Paris	Assistance Publique Hopitaux de Paris; Universite de Paris	ComPaRe was funded by the Assistance Publique Hopitaux de Paris and the Universite de Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alqahtani JS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233147; [Anonymous], 2017, DIR RECH EV STAT ET; Cao JL, 2020, CLIN INFECT DIS, V71, P748, DOI 10.1093/cid/ciaa243; Cao JL, 2020, INTENS CARE MED, V46, P851, DOI 10.1007/s00134-020-05987-7; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; ETSAD, 2016, THES; European Centre for Disease Prevention and Control, 2020, DAT GEOGR DISTR COVI; Fosbol EL, 2020, JAMA-J AM MED ASSOC, V324, P168, DOI 10.1001/jama.2020.11301; France SP, 2020, COVID 19; Franceinfo, 2020, COR E MACR ANN SER M; Grasselli G, 2020, JAMA INTERN MED, V180, P1345, DOI 10.1001/jamainternmed.2020.3539; Haut Conseil de la Sante Publique, 2020, AV PROV PAT RISQ FOR; Institut National de la Statistique et des etudes economiques, 2018, MACRO SAS CALMAR I N; Jordan RE, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1198; Kongsved SM, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.3.e25; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Machida M, 2020, INT J INFECT DIS, V94, P139, DOI 10.1016/j.ijid.2020.04.014; Mauvais-Jarvis F, 2020, DIABETES, V69, P1857, DOI 10.2337/dbi19-0023; Nelson LM, 2020, JAMA INTERN MED, V180, P1020, DOI 10.1001/jamainternmed.2020.1369; Petrilli C, FACTORS ASS HOSPITAL; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Schiotz M, 2012, CHRONIC ILLN, V8, P56, DOI 10.1177/1742395311413307; Sun YXH, 2020, CLIN INFECT DIS, V71, P786, DOI 10.1093/cid/ciaa322; Tran VT, 2020, J CLIN EPIDEMIOL, V124, P139, DOI 10.1016/j.jclinepi.2020.04.021; Wang ZL, 2020, J INFECTION, V81, P179, DOI 10.1016/j.jinf.2020.03.040; Watkins J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m810; WHO, 2003, INT CLASSIFICATION P, V2nd; Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239; World Health Organisation (WHO), 2020, NOV COR COVID 19 SIT; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	32	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237296	10.1371/journal.pone.0237296	http://dx.doi.org/10.1371/journal.pone.0237296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760127	Green Published, gold			2022-12-26	WOS:000561027200068
J	Hocker, JR; Lerner, M; Lightfoot, SA; Peyton, MD; Thompson, JL; Deb, S; Reinersman, M; Hanas, RJ; Postier, RG; Edil, BH; Burkhart, HM; Hanas, JS				Hocker, James R.; Lerner, Megan; Lightfoot, Stan A.; Peyton, Marvin D.; Thompson, Jess L.; Deb, Subrato; Reinersman, Mathew; Hanas, R. Jane; Postier, Russel G.; Edil, Barish H.; Burkhart, Harold M.; Hanas, Jay S.			Serum discrimination and phenotype assessment of coronary artery disease patents with and without type 2 diabetes prior to coronary artery bypass graft surgery	PLOS ONE			English	Article							HEART-DISEASE; CANCER; BIOMARKERS; CORIN	Diabetes Mellitus (DM) accelerates coronary artery disease (CAD) and atherosclerosis, the causes of most heart attacks. The biomolecules involved in these inter-related disease processes are not well understood. This study analyzes biomolecules in the sera of patients with CAD, with and without type (T) 2DM, who are about to undergo coronary artery bypass graft (CABG) surgery. The goal is to develop methodology to help identify and monitor CAD patients with and without T2DM, in order to better understand these phenotypes and to glean relationships through analysis of serum biomolecules. Aorta, fat, muscle, and vein tissues from CAD T2DM patients display diabetic-related histologic changes (e.g., lipid accumulation, fibrosis, loss of cellularity) when compared to non-diabetic CAD patients. The patient discriminatory methodology utilized is serum biomolecule mass profiling. This mass spectrometry (MS) approach is able to distinguish the sera of a group of CAD patients from controls (pvalue 10(-15)), with the CAD group containing both T2DM and non-diabetic patients. This result indicates the T2DM phenotype does not interfere appreciably with the CAD determination versus control individuals. Sera from a group of T2DM CAD patients however are distinguishable from non-T2DM CAD patients (p value 10(-8)), indicating it may be possible to examine the T2DM phenotype within the CAD disease state with this MS methodology. The same serum samples used in the CAD T2DM versus non-T2DM binary group comparison were subjected to MS/MS peptide structure analysis to help identify potential biochemical and phenotypic changes associated with CAD and T2DM. Such peptide/protein identifications could lead to improved understanding of underlying mechanisms, additional biomarkers for discriminating and monitoring these disease conditions, and potential therapeutic targets. Bioinformatics/systems biology analysis of the peptide/protein changes associated with CAD and T2DM suggested cell pathways/systems affected include atherosclerosis, DM, fibrosis, lipogenesis, loss of cellularity (apoptosis), and inflammation.	[Hocker, James R.; Hanas, R. Jane; Hanas, Jay S.] Univ Oklahoma, Ctr Hlth Sci, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA; [Lerner, Megan; Peyton, Marvin D.; Thompson, Jess L.; Deb, Subrato; Reinersman, Mathew; Postier, Russel G.; Edil, Barish H.; Burkhart, Harold M.] Univ Oklahoma, Ctr Hlth Sci, Dept Surg, Oklahoma City, OK USA; [Lightfoot, Stan A.] Univ Oklahoma, Ctr Hlth Sci, Dept Med, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Hanas, JS (corresponding author), Univ Oklahoma, Ctr Hlth Sci, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA.	Jay-Hanas@ouhsc.edu	Hocker, James Randolph Sanders/AAV-4893-2020; Reinersman, Matthew/ABE-3551-2020; Hocker, James R.S./G-7217-2018	Hocker, James Randolph Sanders/0000-0002-7111-9119; Reinersman, Matthew/0000-0002-4458-0743; Hocker, James R.S./0000-0002-7111-9119	Department of Surgery, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK	Department of Surgery, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK	The study was funded by the General Research Fund of the Department of Surgery, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104. Coauthors James Hocker and Megan Lerner received salary compensation from this Research Fund for this study.	Dato VA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061780; Adela R, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-018-1755-5; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Aronson D, 2014, CARDIOL CLIN, V32, P439, DOI 10.1016/j.ccl.2014.04.001; Baker Stuart G, 2002, BMC Med Res Methodol, V2, P4, DOI 10.1186/1471-2288-2-4; Berry C, 2007, J AM COLL CARDIOL, V49, P643, DOI 10.1016/j.jacc.2006.09.045; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Dittmar GAG, 2002, SCIENCE, V295, P2442, DOI 10.1126/science.1069989; Dolan H, 2010, ANN NEUROL, V68, P231, DOI 10.1002/ana.22055; Dong NZ, 2010, CIRC-HEART FAIL, V3, P207, DOI 10.1161/CIRCHEARTFAILURE.109.903849; Eriksson A, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0151-9; Fassett JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073887; Fathy SA, 2015, BIOMARKERS, V20, P460, DOI 10.3109/1354750X.2015.1093032; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Guan W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-259; Hanas JS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215762; Hanas JS, 2018, EXP PARASITOL, V192, P98, DOI 10.1016/j.exppara.2018.07.015; Herder C, 2011, CLIN PHARMACOL THER, V90, P52, DOI 10.1038/clpt.2011.93; Hocker JR, 2017, CANCER INVEST, V35, P573, DOI 10.1080/07357907.2017.1373120; Hocker JR, 2015, CANCER LETT, V359, P314, DOI 10.1016/j.canlet.2015.01.035; Hocker JR, 2012, CANCER INVEST, V30, P180, DOI 10.3109/07357907.2011.633294; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kraja AT, 2014, MOL GENET METAB, V112, P317, DOI 10.1016/j.ymgme.2014.04.007; Lehto S, 2000, DIABETOLOGIA, V43, P148, DOI 10.1007/s001250050023; Llacer P, 2019, MED CLIN-BARCELONA, V152, P266, DOI 10.1016/j.medcli.2018.08.020; MATSUKURA M, 1988, GENE, V72, P343, DOI 10.1016/0378-1119(88)90161-8; Postier RG, 2003, J HISTOCHEM CYTOCHEM, V51, P303, DOI 10.1177/002215540305100305; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Sanjurjo L, 2015, J LEUKOCYTE BIOL, V98, P173, DOI 10.1189/jlb.3RU0215-074R; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Soper D.S., 2021, POSTHOC STAT POWER C; Sridhar GR, 2015, WORLD J DIABETES, V6, P744, DOI 10.4239/wjd.v6.i5.744; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Vachani A, 2015, J THORAC ONCOL, V10, P629, DOI 10.1097/JTO.0000000000000447; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Xian XD, 2017, ELIFE, V6, DOI 10.75549/eLife.29292; Zeadin MG, 2013, CAN J DIABETES, V37, P345, DOI 10.1016/j.jcjd.2013.06.001; Zhao JQ, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0459-8	42	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0234539	10.1371/journal.pone.0234539	http://dx.doi.org/10.1371/journal.pone.0234539			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756554	gold, Green Published			2022-12-26	WOS:000560393300026
J	Zacheja, T; Toth, A; Harami, GM; Yang, QL; Schwindt, E; Kovacs, M; Paeschke, K; Burkovics, P				Zacheja, Theresa; Toth, Agnes; Harami, Gabor M.; Yang, Qianlu; Schwindt, Eike; Kovacs, Mihaly; Paeschke, Katrin; Burkovics, Peter			Mgs1 protein supports genome stability via recognition of G-quadruplex DNA structures	FASEB JOURNAL			English	Article						DNA replication; genome stability; G-quadruplex; helicase; protein-DNA interaction	SACCHAROMYCES-CEREVISIAE HOMOLOG; STALLED REPLICATION FORKS; RECQ HELICASES; IN-VITRO; PIF1; SGS1; INSTABILITY; GENE; MAINTENANCE; WRNIP1	The integrity of the genetic material is crucial for every organism. One intrinsic attack to genome stability is stalling of the replication fork which can result in DNA breakage. Several factors, such as DNA lesions or the formation of stable secondary structures (eg, G-quadruplexes) can lead to replication fork stalling. G-quadruplexes (G4s) are well-characterized stable secondary DNA structures that can form within specific single-stranded DNA sequence motifs and have been shown to block/pause the replication machinery. In most genomes several helicases have been described to regulate G4 unfolding to preserve genome integrity, however, different experiments raise the hypothesis that processing of G4s during DNA replication is more complex and requires additional, so far unknown, proteins. Here, we show that theSaccharomyces cerevisiaeMgs1 protein robustly binds to G4 structures in vitro and preferentially acts at regions with a strong potential to form G4 structures in vivo. Our results suggest that Mgs1 binds to G4-forming sites and has a role in the maintenance of genome integrity.	[Zacheja, Theresa; Schwindt, Eike; Paeschke, Katrin] Univ Hosp Bonn, Dept Oncol Hematol & Rheumatol, Bonn, Germany; [Toth, Agnes; Burkovics, Peter] Biol Res Ctr, Inst Genet, Temesvari Krt 62, H-6726 Szeged, Hungary; [Toth, Agnes] Univ Szeged, Fac Sci & Informat, Doctoral Sch Biol, Szeged, Hungary; [Harami, Gabor M.; Kovacs, Mihaly] Eotvos Lorand Univ, Dept Biochem, EITE MTA Momentum Motor Enzymol Res Grp, Budapest, Hungary; [Yang, Qianlu; Paeschke, Katrin] Univ Wurzburg, Dept Biochem, Bioctr, Wurzburg, Germany; [Yang, Qianlu] Nanjing Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Nanjing, Peoples R China; [Kovacs, Mihaly] Eotvos Lorand Univ, MTA ELTE Motor Pharmacol Res Grp, Dept Biochem, Budapest, Hungary	University of Bonn; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University; Eotvos Lorand University; University of Wurzburg; Nanjing Medical University; Eotvos Lorand University	Burkovics, P (corresponding author), Biol Res Ctr, Inst Genet, Temesvari Krt 62, H-6726 Szeged, Hungary.; Paeschke, K (corresponding author), Univ Klin Bonn, Med Klin 3, Venusberg Campus 1,Gebaude 13,3OG029, H-53127 Bonn, Hungary.	katrin.paeschke@ukbonn.de; burkovics.peter@brc.hu		Kovacs, Mihaly/0000-0002-1200-4741	Emmy-Noether Program of the Deutsche Forschungsgemeinschaft; EC | European Research Council (ERC) [638988-G4DSB]; NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) [31700716]; Nemzeti Kutatasi, Fejlesztesi es Innovacios Hivatal (NKFI Office) [119361, 116072, ERC_ HU117680, 123989]; Eotvos Lorand Tudomanyegyetem (ELTE) [4.2.1/BOP 6072]	Emmy-Noether Program of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EC | European Research Council (ERC); NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund); Nemzeti Kutatasi, Fejlesztesi es Innovacios Hivatal (NKFI Office); Eotvos Lorand Tudomanyegyetem (ELTE)	Emmy-Noether Program of the Deutsche Forschungsgemeinschaft; EC | European Research Council (ERC), Grant/Award Number: 638988-G4DSB; NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund), Grant/Award Number: 31700716; Nemzeti Kutatasi, Fejlesztesi es Innovacios Hivatal (NKFI Office), Grant/Award Number: 119361, 116072, ERC_ HU117680 and 123989; Eotvos Lorand Tudomanyegyetem (ELTE), Grant/Award Number: 4.2.1/BOP 6072	Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; Barbour L, 2003, MUTAT RES-FUND MOL M, V532, P137, DOI 10.1016/j.mrfmmm.2003.08.014; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bosch PC, 2014, EMBO J, V33, P2521, DOI 10.15252/embj.201488663; Branzei D, 2002, MOL GENET GENOMICS, V268, P371, DOI 10.1007/s00438-002-0757-3; Branzei D, 2002, DNA REPAIR, V1, P671, DOI 10.1016/S1568-7864(02)00073-3; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Buzovetsky O, 2017, CELL REP, V21, P1707, DOI 10.1016/j.celrep.2017.10.079; Byrd AK, 2015, J BIOL CHEM, V290, P6482, DOI 10.1074/jbc.M114.630749; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Dahan D, 2018, NUCLEIC ACIDS RES, V46, P11847, DOI 10.1093/nar/gky1065; Day HA, 2014, BIOORGAN MED CHEM, V22, P4407, DOI 10.1016/j.bmc.2014.05.047; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Duan XL, 2015, J BIOL CHEM, V290, P7722, DOI 10.1074/jbc.M114.628008; Eddy S, 2014, NUCLEIC ACIDS RES, V42, P3272, DOI 10.1093/nar/gkt1314; Estep KN, 2017, CURR MED CHEM, P2881; Garcia-Rodriguez N, 2018, NUCLEIC ACIDS RES, V46, P8347, DOI 10.1093/nar/gky648; Gotz S, 2019, MOLECULES, V24, DOI 10.3390/molecules24091774; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; Gyimesi M, 2016, METHODS, V108, P24, DOI 10.1016/j.ymeth.2016.04.028; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Hishida T, 2002, EMBO J, V21, P2019, DOI 10.1093/emboj/21.8.2019; Hishida T, 2001, P NATL ACAD SCI USA, V98, P8283, DOI 10.1073/pnas.121009098; Hishida T, 2006, MOL CELL BIOL, V26, P5509, DOI 10.1128/MCB.00307-06; Hou XM, 2015, BIOCHEM J, V466, P189, DOI 10.1042/BJ20140997; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Kawabe Y, 2001, J BIOL CHEM, V276, P20364, DOI 10.1074/jbc.C100035200; Kawabe YI, 2006, DNA REPAIR, V5, P816, DOI 10.1016/j.dnarep.2006.04.006; Kim JH, 2005, NUCLEIC ACIDS RES, V33, P6137, DOI 10.1093/nar/gki900; Kitts C, 2012, IEEE-ASME T MECH, V17, P1, DOI 10.1109/TMECH.2011.2177855; Kopylov M, 2019, MOLECULES, V24, DOI 10.3390/molecules24101988; LAHAYE A, 1993, J BIOL CHEM, V268, P26155; Larsen NB, 2013, ADV EXP MED BIOL, V973, P161, DOI 10.1007/978-1-4614-5037-5_8; Lee JY, 2008, J BIOL CHEM, V283, P29847, DOI 10.1074/jbc.M804760200; Lerner LK, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020095; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Marsico G, 2019, NUCLEIC ACIDS RES, V47, P3862, DOI 10.1093/nar/gkz179; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Monchaud D, 2008, BIOCHIMIE, V90, P1207, DOI 10.1016/j.biochi.2008.02.019; Motegi A, 2007, METHODS, V41, P168, DOI 10.1016/j.ymeth.2006.07.025; Motlagh NDV, 2006, DNA REPAIR, V5, P1459, DOI 10.1016/j.dnarep.2006.07.006; Moye AL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8643; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Noer SL, 2016, NUCLEIC ACIDS RES, V44, P464, DOI 10.1093/nar/gkv1320; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Paeschke K, 2008, NAT STRUCT MOL BIOL, V15, P598, DOI 10.1038/nsmb.1422; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Putnam C. D., 2010, COLD SPRING HARB PRO, V2010; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rogers CM, 2017, NUCLEIC ACIDS RES, V45, P5217, DOI 10.1093/nar/gkx151; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi SE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07378-5; Rossi SE, 2015, CELL REP, V13, P80, DOI 10.1016/j.celrep.2015.08.073; Sabouri N, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0101-5; Sauer M, 2017, BIOCHEM SOC T, V45, P1173, DOI 10.1042/BST20170097; Saugar I, 2012, NUCLEIC ACIDS RES, V40, P245, DOI 10.1093/nar/gkr738; Schmidt KH, 2006, MOL CELL BIOL, V26, P5406, DOI 10.1128/MCB.00161-06; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Shibata T, 2005, GENES CELLS, V10, P181, DOI 10.1111/j.1365-2443.2005.00831.x; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith JS, 2011, NAT STRUCT MOL BIOL, V18, P478, DOI 10.1038/nsmb.2033; Spell RM, 2004, GENETICS, V168, P1855, DOI 10.1534/genetics.104.032771; Suhasini AN, 2013, MUTAT RES-REV MUTAT, V752, P138, DOI 10.1016/j.mrrev.2012.12.004; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; Todd AK, 2011, NUCLEIC ACIDS RES, V39, P4917, DOI 10.1093/nar/gkr104; Tsurimoto T, 2005, GENES CELLS, V10, P13, DOI 10.1111/j.1365-2443.2004.00812.x; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; van Wietmarschen N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02760-1; Wanzek K, 2017, NUCLEIC ACIDS RES, V45, P7796, DOI 10.1093/nar/gkx467; Watt PM, 1996, GENETICS, V144, P935; Wu CG, 2016, NUCLEIC ACIDS RES, V44, P8742, DOI 10.1093/nar/gkw574; Yoshida W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21514-7; Yoshimura A, 2017, CELL CYCLE, V16, P515, DOI 10.1080/15384101.2017.1282585; You J, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170771; Zeraati M, 2018, NAT CHEM, V10, P631, DOI 10.1038/s41557-018-0046-3	89	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12646	12662		10.1096/fj.202000886R	http://dx.doi.org/10.1096/fj.202000886R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32748509	Green Accepted, hybrid			2022-12-26	WOS:000558208300001
J	Guo, JX; Lei, GH				Guo, Jianxiang; Lei, Guohui			Application of ultrasound to enhance the silt drying process: An experimental study	PLOS ONE			English	Article							LIQUID BRIDGES; DEHYDRATION; SLUDGE; APPLE; TIME	Scientific and reasonable treatment of dredged silt can not only protect the ecological environment but also play an essential role in the utilization of silt resources. Due to high water content, low permeability and high organic matter content of the silt, a large amount of bacteria and harmful gases are often produced during the process of silt sedimentation. Thermal drying has been taken as a technically attractive method for harmless treatment of contaminated dredged silt. In this study, ultrasound technology is introduced to shorten the time needed for silt drying. A preliminary laboratory study is carried out to assess the effectiveness of ultrasound on thermal drying. A series of thermal drying tests, with and without ultrasound, were conducted on kaolin soil specimens that were prepared by settling and self-weight consolidation. The test results show that the length of drying time can be shortened by increasing temperature and ultrasound power. The drying time plays a dominant role in the determination of the total energy consumption. This is because reduction of drying time leads to significant decrease in energy consumption for thermal drying, and the energy consumption for additional ultrasound is relatively marginal. For thermal drying at temperatures 60 and 100 degrees C, when combined with 100 W ultrasound, the length of drying time was shortened by 44.19% and 45.16%, and the energy consumption was saved by 30.07% and 38.16%, respectively; when combined with 60 W ultrasound, the length of drying time was shortened by 4.65% and 6.45%, but the energy consumption was increased by 9.79% and 0.48%, respectively. The combination of thermal drying and 100 W ultrasound is found to be optimal in terms of drying rate and energy consumption for silt drying.	[Guo, Jianxiang; Lei, Guohui] Hohai Univ, Minist Educ Geomech & Embankment Engn, Key Lab, Nanjing, Peoples R China	Hohai University	Guo, JX (corresponding author), Hohai Univ, Minist Educ Geomech & Embankment Engn, Key Lab, Nanjing, Peoples R China.	gjx9669@163.com			Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX18_0554, 2018B669X14]; National Natural Science Foundation of China [51578213]	Postgraduate Research & Practice Innovation Program of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors gratefully acknowledge supports provided by the Postgraduate Research & Practice Innovation Program of Jiangsu Province (Project No. KYCX18_0554, 2018B669X14) and the National Natural Science Foundation of China (Project No. 51578213).	Chikouche MA, 2016, CONSTR BUILD MATER, V106, P330, DOI 10.1016/j.conbuildmat.2015.12.128; de Sarabia ERF, 2000, ULTRASONICS, V38, P642, DOI 10.1016/S0041-624X(99)00129-8; Dejam M, 2014, J HYDROL, V519, P3520, DOI 10.1016/j.jhydrol.2014.10.050; Dejam M, 2011, AICHE J, V57, P286, DOI 10.1002/aic.12262; FAIRBANKS HV, 1970, ULTRASONICS, V8, P165, DOI 10.1016/0041-624X(70)90615-3; FAIRBANKS HV, 1984, POWDER TECHNOL, V40, P257, DOI 10.1016/0032-5910(84)85071-8; Gallego-Juarez JA, 2003, ULTRASONICS, V41, P255, DOI 10.1016/S0041-624X(02)00449-3; Garcia-Noguera J, 2010, DRY TECHNOL, V28, P294, DOI 10.1080/07373930903530402; Garcia-Perez JV, 2011, DRY TECHNOL, V29, P1499, DOI 10.1080/07373937.2011.576321; Gat AD, 2012, J FLUID MECH, V703, P315, DOI 10.1017/jfm.2012.218; Hursthouse AS, 2001, J ENVIRON MONITOR, V3, P49, DOI 10.1039/b006132h; Kim YU, 2012, JPN J APPL PHYS, V51, P220; Kowalski SJ, 2015, J FOOD ENG, V156, P1, DOI 10.1016/j.jfoodeng.2015.01.023; Lemanowicz M, 2011, CHEM ENG J, V168, P159, DOI 10.1016/j.cej.2010.12.057; Meegoda JN, 2002, SOIL SEDIMENT CONTAM, V11, P91, DOI 10.1080/20025891106718; Meriggi R, 2010, PROC INST CIV ENG-GR, V163, P141, DOI 10.1680/grim.2010.163.3.141; MURALIDHARA HS, 1985, DRY TECHNOL, V3, P529, DOI 10.1080/07373938508916296; Otsuka T., 1976, 1976 Ultrasonics Symposium Proceedings, P119, DOI 10.1109/ULTSYM.1976.196645; REDDI LN, 1993, J ENVIRON ENG-ASCE, V119, P746, DOI 10.1061/(ASCE)0733-9372(1993)119:4(746); Schossler K, 2012, J FOOD ENG, V108, P103, DOI 10.1016/j.jfoodeng.2011.07.018; Simal S, 1998, J FOOD ENG, V36, P323, DOI 10.1016/S0260-8774(98)00053-3; Tabachnick B.G., 2007, EXPT DESIGNS USING A; Tao Y, 2014, ULTRASON SONOCHEM, V21, P1461, DOI 10.1016/j.ultsonch.2014.01.029; TING CMR, 1994, GEOTECHNIQUE, V44, P101, DOI 10.1680/geot.1994.44.1.101; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; WAN PJ, 1992, J AM OIL CHEM SOC, V69, P876, DOI 10.1007/BF02636336; Yao Y, 2011, ENERG CONVERS MANAGE, V52, P3319, DOI 10.1016/j.enconman.2011.06.002; Yu YH, 2002, ENERGY, V27, P457, DOI 10.1016/S0360-5442(01)00097-4; Zhang XY, 2016, FUEL, V171, P108, DOI 10.1016/j.fuel.2015.12.052	29	0	0	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236492	10.1371/journal.pone.0236492	http://dx.doi.org/10.1371/journal.pone.0236492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735613	gold, Green Published			2022-12-26	WOS:000569367100025
J	McFarlanE, M; MozdiaK, E; Daulton, E; Arasaradnam, R; Covington, J; Nwokolo, C				McFarlanE, Michael; MozdiaK, Ella; Daulton, Emma; Arasaradnam, Ramesh; Covington, James; Nwokolo, Chuka			Pre-analytical and analytical variables that influence urinary volatile organic compound measurements	PLOS ONE			English	Article							ELECTRONIC-NOSE; NONINVASIVE DIAGNOSIS; STABILITY; CANCER; AGES; TOOL	There has been rapidly accelerating interest in the utilization of volatile organic compounds (VOCs) as non-invasive methods for rapid point-of-care medical diagnostics. There is widespread variation in analytical methods and protocols, with little understanding of the effects of sample storage on VOC profiles. This study aimed to determine the effects on VOC profiles of different storage times, at room temperature, prior to freezing, of sealed urine samples from healthy individuals. Analysis using Field Asymmetric Ion Motility Spectrometry (FAIMS) determined the alterations in VOC and total ion count profiles as a result of increasing room temperature storage times. Results indicated that increasing exposure time to room temperature prior to freezing had a threefold effect. Firstly, increased urinary VOC profile variability, with a plateau phase between 12 and 48 hours, before further degradation. Secondly, an increase in total ion count with time exposed to room temperature. Finally, a deterioration in VOCs with each sample run during the analysis process. This provides new insight into the effect of storage of urine samples for VOC analysis using FAIMS technology. Results of this study provide a recommendation for a 12-hour maximum duration at room temperature prior to storage.	[McFarlanE, Michael; MozdiaK, Ella; Arasaradnam, Ramesh; Nwokolo, Chuka] Univ Hosp Coventry & Warwickshire, Dept Gastroenterol, Coventry, W Midlands, England; [Daulton, Emma; Covington, James] Univ Warwick, Sch Engn, Coventry, W Midlands, England; [Arasaradnam, Ramesh] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Arasaradnam, Ramesh] Univ Coventry, Fac Hlth Sci, Coventry, W Midlands, England	University of Warwick; University of Warwick; University of Leicester; Coventry University	McFarlanE, M (corresponding author), Univ Hosp Coventry & Warwickshire, Dept Gastroenterol, Coventry, W Midlands, England.	mmcf1982@doctors.org.uk	Covington, James A./Q-1934-2018	Covington, James A./0000-0003-1307-6488; Arasaradnam, Ramesh/0000-0002-2231-3062				Arasaradnam RP, 2016, J BREATH RES, V10, DOI 10.1088/1752-7155/10/1/016012; Arasaradnam RP, 2014, ALIMENT PHARM THER, V39, P780, DOI 10.1111/apt.12657; Arasaradnam RP, 2018, GASTROENTEROLOGY, V154, P485, DOI 10.1053/j.gastro.2017.09.054; Arasaradnam RP, 2016, DIGEST LIVER DIS, V48, P148, DOI 10.1016/j.dld.2015.10.013; Arasaradnam RP, 2015, J GASTROINTEST LIVER, V24, P197, DOI 10.15403/jgld.2014.1121.242.ury; Arasaradnam RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108750; Arasaradnam RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107312; Arasaradnam RP, 2013, INFLAMM BOWEL DIS, V19, P999, DOI 10.1097/MIB.0b013e3182802b26; Costello BD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/1/014001; Covington JA, 2015, ANALYST, V14, P6775, DOI 10.1039/c5an00868a; Covington JA, 2013, SENSORS-BASEL, V13, P11899, DOI 10.3390/s130911899; Covington JA, 2012, SENSORS-BASEL, V12, P13002, DOI 10.3390/s121013002; DAMICO A, 2013, EXPERT OPIN MED DIAG, V6, P175; Dunn WB, 2008, INT J EPIDEMIOL, V37, P23, DOI 10.1093/ije/dym281; Esfahani S, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8040121; Esfahani S, 2016, BIOSENSORS-BASEL, V6, DOI 10.3390/bios6010004; Gika HG, 2008, J CHROMATOGR A, V1189, P314, DOI 10.1016/j.chroma.2007.10.066; Kogan MI, 2015, UROL INT, V94, P445, DOI 10.1159/000369631; Kwak J, 2013, J CHROMATOGR B, V941, P50, DOI 10.1016/j.jchromb.2013.09.040; Kwak J, 2013, PHYSIOL BEHAV, V120, P211, DOI 10.1016/j.physbeh.2013.08.011; McFarlane M, 2019, COLORECTAL DIS, V21, P1259, DOI 10.1111/codi.14739; Montuschi P, 2013, RESPIRATION, V85, P72, DOI 10.1159/000340044; Saude EJ, 2007, METABOLOMICS, V3, P19, DOI 10.1007/s11306-006-0042-2; Tiele A, BIOSENSORS BASEL; Tiele Akira, 2019, Future Healthc J, V6, P79, DOI 10.7861/futurehosp.6-1-s79; Widlak MM, 2017, ALIMENT PHARM THER, V45, P354, DOI 10.1111/apt.13865; Wilson AD, 2011, SENSORS-BASEL, V11, P1105, DOI 10.3390/s110101105	27	8	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236591	10.1371/journal.pone.0236591	http://dx.doi.org/10.1371/journal.pone.0236591			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735600	Green Published, gold			2022-12-26	WOS:000569367100030
J	Pukos, N; McTigue, DM				Pukos, Nicole; McTigue, Dana M.			Delayed short-term tamoxifen treatment does not promote remyelination or neuron sparing after spinal cord injury	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; CELLULAR INFLAMMATORY RESPONSE; IMPROVES LOCOMOTOR RECOVERY; AXONAL PHYSIOLOGY; PROGENITOR CELLS; BREAST-CANCER; OLIGODENDROCYTE; ESTROGEN; EXPRESSION; CONTUSION	The tamoxifen-dependent Cre/lox system in transgenic mice has become an important research tool across all scientific disciplines for manipulating gene expression in specific cell types. In these mouse models, Cre-recombination is not induced until tamoxifen is administered, which allows researchers to have temporal control of genetic modifications. Interestingly, tamoxifen has been identified as a potential therapy for spinal cord injury (SCI) and traumatic brain injury patients due to its neuroprotective properties. It is also reparative in that it stimulates oligodendrocyte differentiation and remyelination after toxin-induced demyelination. However, it is unknown whether tamoxifen is neuroprotective and neuroreparative when administration is delayed after SCI. To properly interpret data from transgenic mice in which tamoxifen treatment is delayed after SCI, it is necessary to identify the effects of tamoxifen alone on anatomical and functional recovery. In this study, female and male mice received a moderate mid-thoracic spinal cord contusion. Mice were then gavaged with corn oil or a high dose of tamoxifen from 19-22 days post-injury, and sacrificed 42 days post-injury. All mice underwent behavioral testing for the duration of the study, which revealed that tamoxifen treatment did not impact hindlimb motor recovery. Similarly, histological analyses revealed that tamoxifen had no effect on white matter sparing, total axon number, axon sprouting, glial reactivity, cell proliferation, oligodendrocyte number, or myelination, but tamoxifen did decrease the number of neurons in the dorsal and ventral horn. Semi-thin sections confirmed that axon demyelination and remyelination were unaffected by tamoxifen. Sex-specific responses to tamoxifen were also assessed, and there were no significant differences between female and male mice. These data suggest that delayed tamoxifen administration after SCI does not change functional recovery or improve tissue sparing in female or male mice.	[Pukos, Nicole] Ohio State Univ, Neurosci Grad Program, Columbus, OH 43210 USA; [Pukos, Nicole; McTigue, Dana M.] Ohio State Univ, Belford Ctr Spinal Cord Injury, Columbus, OH 43210 USA; [McTigue, Dana M.] Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University	McTigue, DM (corresponding author), Ohio State Univ, Belford Ctr Spinal Cord Injury, Columbus, OH 43210 USA.; McTigue, DM (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA.	Dana.McTigue@osumc.edu		Pukos, Nicole/0000-0002-2441-5820	National Institute of Neurological Disorders and Stroke [NS100522, P30 NS104177]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The grants NS100522 and P30 NS104177 were awarded to DMM from the National Institute of Neurological Disorders and Stroke (https://www.ninds.nih.gov/) and funded this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00282; Arancibia-Carcamo IL, 2014, ACTA NEUROPATHOL, V128, P161, DOI 10.1007/s00401-014-1305-z; Arvanian VL, 2009, EXP NEUROL, V216, P471, DOI 10.1016/j.expneurol.2009.01.004; Assinck P, 2017, J NEUROSCI, V37, P8635, DOI 10.1523/JNEUROSCI.2409-16.2017; Azcoitia I, 2019, FRONT NEUROENDOCRIN, V55, DOI 10.1016/j.yfrne.2019.100787; Bao YJ, 2011, MOL CELL NEUROSCI, V48, P185, DOI 10.1016/j.mcn.2011.07.004; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Behjati S, 2009, CURR MED CHEM, V16, P3076, DOI 10.2174/092986709788803042; Biegon A, 1996, CANCER RES, V56, P4328; Buss A, 2003, GLIA, V42, P424, DOI 10.1002/glia.10220; Buss A, 2004, BRAIN, V128, P356; Church JS, 2017, GLIA, V65, P883, DOI 10.1002/glia.23132; Clarke LE, 2012, J NEUROSCI, V32, P8173, DOI 10.1523/JNEUROSCI.0928-12.2012; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Colon JM, 2018, EXP NEUROL, V299, P109, DOI 10.1016/j.expneurol.2017.10.006; Colon JM, 2016, NEURAL REGEN RES, V11, P1208, DOI 10.4103/1673-5374.189164; Colon JM, 2016, J NEUROTRAUM, V33, P1696, DOI 10.1089/neu.2015.4111; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Datto JP, 2015, J NEUROTRAUM, V32, P1146, DOI 10.1089/neu.2014.3702; de la Torre Valdovinos B, 2016, J VET MED, V2016, P1; Denk F, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0255-6; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Duncan GJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05473-1; Dutertre M, 2000, J PHARMACOL EXP THER, V295, P431; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Farooque M, 2006, SPINAL CORD, V44, P182, DOI 10.1038/sj.sc.3101816; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gallo MA, 1997, SEMIN ONCOL S1, V24; GLEDHILL RF, 1973, EXP NEUROL, V38, P472, DOI 10.1016/0014-4886(73)90169-6; Gonzalez GA, 2016, SCI REP-UK, V6, DOI 10.1038/srep31599; Greenhalgh AD, 2014, J NEUROSCI, V34, P6316, DOI 10.1523/JNEUROSCI.4912-13.2014; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Guptarak J, 2014, J NEUROTRAUM, V31, P268, DOI 10.1089/neu.2013.3108; Hesp ZC, 2015, J NEUROSCI, V35, P1274, DOI 10.1523/JNEUROSCI.2568-14.2015; Horky LL, 2006, J COMP NEUROL, V498, P525, DOI 10.1002/cne.21065; Horner PJ, 2000, J NEUROSCI, V20, P2218; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Jordan VC, 2003, NAT REV DRUG DISCOV, V2, P205, DOI 10.1038/nrd1031; Karimi-Abdolrezaee S, 2004, EUR J NEUROSCI, V19, P577, DOI 10.1111/j.0953-816X.2004.03164.x; Karki P, 2014, MOL CELL ENDOCRINOL, V389, P58, DOI 10.1016/j.mce.2014.01.010; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kim IY, 1996, CLIN CANCER RES, V2, P1255; Kim LA, 2014, INVEST OPHTH VIS SCI, V55, P4747, DOI 10.1167/iovs.13-13662; Kimelberg HK, 2000, NEUROREPORT, V11, P2675, DOI 10.1097/00001756-200008210-00014; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Latourelle JC, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-23; Lee JY, 2012, ENDOCRINOLOGY, V153, P3815, DOI 10.1210/en.2012-1068; Lim SW, 2018, WORLD NEUROSURG, V112, pE278, DOI 10.1016/j.wneu.2018.01.036; Marin MA, 2017, NEURAL REGEN RES, V12, P1276, DOI 10.4103/1673-5374.213543; Marin-Husstege M, 2004, DEV NEUROSCI-BASEL, V26, P245, DOI 10.1159/000082141; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Mickley KR, 2004, NEUROENDOCRINOLOGY, V79, P305, DOI 10.1159/000079710; Mosquera L, 2014, BRAIN RES, V1561, P11, DOI 10.1016/j.brainres.2014.03.002; Nashmi R, 2000, EUR J NEUROSCI, V12, P491, DOI 10.1046/j.1460-9568.2000.00926.x; Nashmi R, 2001, NEUROSCIENCE, V104, P235, DOI 10.1016/S0306-4522(01)00009-4; National Spinal Cord Injury Statistical Center, 2019, FACTS FIG GLANC; Pfaffl MW, 2001, APMIS, V109, P345, DOI 10.1034/j.1600-0463.2001.090503.x; POPOVICH PG, 1993, J NEUROTRAUM, V10, P37, DOI 10.1089/neu.1993.10.37; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; QIN MM, 1994, P NATL ACAD SCI USA, V91, P1706, DOI 10.1073/pnas.91.5.1706; Rabchevsky AG, 2007, GLIA, V55, P831, DOI 10.1002/glia.20508; Rasband MN, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020495; Schonberg DL, 2007, J NEUROPATH EXP NEUR, V66, P1124, DOI 10.1097/nen.0b013e31815c2530; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; Sun F, 2010, GLIA, V58, P1304, DOI 10.1002/glia.21009; Sun LM, 2016, QJM-INT J MED, V109, P103, DOI 10.1093/qjmed/hcv072; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tee MK, 2004, MOL BIOL CELL, V15, P1262, DOI 10.1091/mbc.E03-06-0360; Tian DS, 2009, J NEUROCHEM, V109, P1658, DOI 10.1111/j.1471-4159.2009.06077.x; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Tripathi R, 2007, GLIA, V55, P698, DOI 10.1002/glia.20491; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Tsai YT, 2014, J SURG RES, V189, P106, DOI 10.1016/j.jss.2014.02.009; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; WADE GN, 1993, AM J PHYSIOL, V264, pR1219, DOI 10.1152/ajpregu.1993.264.6.R1219; WALLACE MC, 1987, SURG NEUROL, V27, P209, DOI 10.1016/0090-3019(87)90031-0; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Yang G, 2013, PHARMACOL THERAPEUT, V139, P392, DOI 10.1016/j.pharmthera.2013.05.005; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zai LJ, 2005, GLIA, V50, P247, DOI 10.1002/glia.20176; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002	93	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0235232	10.1371/journal.pone.0235232	http://dx.doi.org/10.1371/journal.pone.0235232			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735618	gold, Green Published			2022-12-26	WOS:000569367100009
J	Rhee, J; Lee, D; Suh, MW; Lee, JH; Hong, YC; Oh, SH; Park, MK				Rhee, Jihye; Lee, Dongwook; Suh, Myung Whan; Lee, Jun Ho; Hong, Yun-Chul; Oh, Seung Ha; Park, Moo Kyun			y Prevalence, associated factors, and comorbidities of tinnitus in adolescents	PLOS ONE			English	Article							HIDDEN HEARING-LOSS; RISK-FACTORS; NATIONAL-HEALTH; MENTAL-HEALTH; DISORDERS; SYMPTOMS; STUDENTS; BEHAVIOR; EXPOSURE; CHILDREN	The aim of this study was to investigate the prevalence of tinnitus among adolescents, and the factors known or hypothesized to be associated with tinnitus. Based on random sampling of school types and regions, a nationwide hearing survey of the first-year middle and high school students of South Korea was performed. The subjects underwent an otologic examination followed by pure tone audiometry up to 8 kHz. Questionnaires about the factors associated with hearing and tinnitus were completed by the students and their parents. Among the 1,593 subjects who completed the questionnaire and underwent pure tone audiometry, the prevalence of tinnitus was 46.0% and that of severe tinnitus was 9.1%. Tinnitus was associated with age, female gender, history of ear infection and sinusitis, leisure noise exposure due to karaoke and local-area-network gaming, alcohol consumption, and cigarette smoking. Noticeable hearing loss was not detected but participants with tinnitus complained of difficulty with sound localization, hearing in noise, and verbal working memory and were more susceptible to fatigue. The subjects with tinnitus also suffered more physical and mental health problems than did those without tinnitus. Thus, protection of the ears from noise and appropriate counseling should be considered for adolescents with tinnitus.	[Rhee, Jihye] Vet Hlth Serv Med Ctr, Dept Otorhinolaryngol, Seoul, South Korea; [Lee, Dongwook; Hong, Yun-Chul] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Suh, Myung Whan; Lee, Jun Ho; Oh, Seung Ha; Park, Moo Kyun] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Lee, Jun Ho; Oh, Seung Ha; Park, Moo Kyun] Seoul Natl Univ, Sensory Organ Res Inst, Med Res Ctr, Seoul, South Korea	Veterans Health Service Medical Center; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Park, MK (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea.; Park, MK (corresponding author), Seoul Natl Univ, Sensory Organ Res Inst, Med Res Ctr, Seoul, South Korea.	aseptic@snu.ac.kr		Suh, Myung-Whan/0000-0003-1301-2249; Park, Moo Kyun/0000-0002-8635-797X; park, moo kyun/0000-0002-3621-4524; Lee, Dong-Wook/0000-0002-4023-3269	Korean society of otolaryngology-head and neck surgery [2016KORL0645]; Korean otology society	Korean society of otolaryngology-head and neck surgery; Korean otology society	Initials of the authors who received each award: S.H.O Financial Disclosure: 1. Korean society of otolaryngology-head and neck surgery Grant number: 2016KORL0645 URL: http://www.korl.or.kr/Role: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2. Korean otology society Grant number: N/A URL: http://www.otologicalsociety.or.kr/Role: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarhus L, 2015, JAMA OTOLARYNGOL, V141, P983, DOI 10.1001/jamaoto.2015.2378; Aksoy S, 2007, INT J PEDIATR OTORHI, V71, P263, DOI 10.1016/j.ijporl.2006.10.008; An YH, 2012, OTOL NEUROTOL, V33, P692, DOI 10.1097/MAO.0b013e31825952e9; Attanasio G, 2013, EAR HEARING, V34, P503, DOI 10.1097/AUD.0b013e31827bc436; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Baguley D, 2013, LANCET, V382, P1600, DOI 10.1016/S0140-6736(13)60142-7; Barbee Christi M, 2018, Semin Hear, V39, P172, DOI 10.1055/s-0038-1641743; Bhatt IS, 2018, EAR HEARING, V39, P517, DOI 10.1097/AUD.0000000000000503; Bhatt JM, 2017, LARYNGOSCOPE, V127, P466, DOI 10.1002/lary.26107; Brunnberg E, 2008, INT J AUDIOL, V47, P688, DOI 10.1080/14992020802233915; Coelho CB, 2007, PROG BRAIN RES, V166, P179, DOI 10.1016/S0079-6123(07)66016-6; Deas D, 2006, J CLIN PSYCHIAT, V67, P18, DOI 10.4088/JCP.0706e02; Degeest S, 2014, NOISE HEALTH, V16, P26, DOI 10.4103/1463-1741.127850; Eley TC, 1999, CHILD DEV, V70, P155, DOI 10.1111/1467-8624.00012; Genc GA, 2013, AURIS NASUS LARYNX, V40, P154, DOI 10.1016/j.anl.2012.06.002; Gilles A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00288; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; Kim JS, 2018, CENT EUR J PUBL HEAL, V26, P65, DOI 10.21101/cejph.a4514; Kim SY, 2017, LARYNGOSCOPE, V127, P2113, DOI 10.1002/lary.26334; Kujawa SG, 2015, HEARING RES, V330, P191, DOI 10.1016/j.heares.2015.02.009; Landalv D, 2013, NOISE HEALTH, V15, P347, DOI 10.4103/1463-1741.116584; Langguth B, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/797416; Lee DY, 2018, LARYNGOSCOPE, V128, P1462, DOI 10.1002/lary.26924; LEWIS JE, 1994, CLIN OTOLARYNGOL, V19, P50, DOI 10.1111/j.1365-2273.1994.tb01147.x; Liberman MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162726; Mahboubi H, 2013, LARYNGOSCOPE, V123, P2001, DOI 10.1002/lary.24015; Mandelli L, 2015, EUR PSYCHIAT, V30, P665, DOI 10.1016/j.eurpsy.2015.04.007; Marmut Z, 2014, NOISE HEALTH, V16, P73, DOI 10.4103/1463-1741.132080; Martinez C, 2015, EAR HEARING, V36, pE69, DOI 10.1097/AUD.0000000000000121; Newman C W, 1998, J Am Acad Audiol, V9, P153; Newman C W, 1997, J Am Acad Audiol, V8, P143; Nondahl DM, 2011, INT J AUDIOL, V50, P313, DOI 10.3109/14992027.2010.551220; Park B, 2014, OTOL NEUROTOL, V35, P1218, DOI 10.1097/MAO.0000000000000472; Park KH, 2014, J EPIDEMIOL; Park KH, 2014, J EPIDEMIOL, V24, P417, DOI 10.2188/jea.JE20140024; PENNER M J, 1992, British Journal of Audiology, V26, P115, DOI 10.3109/03005369209077879; Rhee J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209254; Rosing SN, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010596; Sahin C, 2016, EUR ARCH OTO-RHINO-L, V273, P3603, DOI 10.1007/s00405-016-3968-7; Savastano M, 2007, EUR J PEDIATR, V166, P797, DOI 10.1007/s00431-006-0320-z; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; statista, 2019, ENR RAT HIGH SCH S K; TONNDORF J, 1987, HEARING RES, V28, P271, DOI 10.1016/0378-5955(87)90054-2; Williams W, 2017, INT J AUDIOL, V56, P219, DOI 10.1080/14992027.2016.1250961; Zoger S, 2006, PSYCHOSOMATICS, V47, P282, DOI 10.1176/appi.psy.47.4.282	46	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236723	10.1371/journal.pone.0236723	http://dx.doi.org/10.1371/journal.pone.0236723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735626	Green Published, gold			2022-12-26	WOS:000569367100042
J	Schilling, KG; Blaber, J; Hansen, C; Cai, LO; Rogers, B; Anderson, AW; Smith, S; Kanakaraj, P; Rex, T; Resnick, SM; Shafer, AT; Cutting, LE; Woodward, N; Zald, D; Landman, BA				Schilling, Kurt G.; Blaber, Justin; Hansen, Colin; Cai, Leon; Rogers, Baxter; Anderson, Adam W.; Smith, Seth; Kanakaraj, Praitayini; Rex, Tonia; Resnick, Susan M.; Shafer, Andrea T.; Cutting, Laurie E.; Woodward, Neil; Zald, David; Landman, Bennett A.			Distortion correction of diffusion weighted MRI without reverse phase-encoding scans or field-maps	PLOS ONE			English	Article								Diffusion magnetic resonance images may suffer from geometric distortions due to susceptibility induced off resonance fields, which cause geometric mismatch with anatomical images and ultimately affect subsequent quantification of microstructural or connectivity indices. State-of-the art diffusion distortion correction methods typically require data acquired with reverse phase encoding directions, resulting in varying magnitudes and orientations of distortion, which allow estimation of an undistorted volume. Alternatively, additional field maps acquisitions can be used along with sequence information to determine warping fields. However, not all imaging protocols include these additional scans and cannot take advantage of state-of-the art distortion correction. To avoid additional acquisitions, structural MRI (undistorted scans) can be used as registration targets for intensity driven correction. In this study, we aim to (1) enable susceptibility distortion correction with historical and/or limited diffusion datasets that do not include specific sequences for distortion correction and (2) avoid the computationally intensive registration procedure typically required for distortion correction using structural scans. To achieve these aims, we use deep learning (3D U-nets) to synthesize an undistorted b0 image that matches geometry of structural T1w images and intensity contrasts from diffusion images. Importantly, the training dataset is heterogenous, consisting of varying acquisitions of both structural and diffusion. We apply our approach to a withheld test set and show that distortions are successfully corrected after processing. We quantitatively evaluate the proposed distortion correction and intensity-based registration against state-of-the-art distortion correction (FSL topup). The results illustrate that the proposed pipeline results in b0 images that are geometrically similar to non-distorted structural images, and more closely match state-of-the-art correction with additional acquisitions. In addition, we show generalizability of the proposed approach to datasets that were not in the original training / validation / testing datasets. These datasets included varying populations, contrasts, resolutions, and magnitudes and orientations of distortion and show efficacious distortion correction. The method is available as a Singularity container, source code, and an executable trained model to facilitate evaluation.	[Schilling, Kurt G.; Rogers, Baxter; Anderson, Adam W.; Smith, Seth; Landman, Bennett A.] Vanderbilt Univ, Med Ctr, Radiol & Radiol Sci, Nashville, TN 37232 USA; [Schilling, Kurt G.; Rogers, Baxter; Anderson, Adam W.; Smith, Seth; Landman, Bennett A.] Vanderbilt Univ, Inst Imaging Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Blaber, Justin; Kanakaraj, Praitayini; Landman, Bennett A.] Vanderbilt Univ, Elect Engn, 221 Kirkland Hall, Nashville, TN 37235 USA; [Hansen, Colin; Anderson, Adam W.; Smith, Seth] Vanderbilt Univ, Comp Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Cai, Leon] Vanderbilt Univ, Biomed Engn, 221 Kirkland Hall, Nashville, TN 37235 USA; [Rex, Tonia] Vanderbilt Univ, Vanderbilt Eye Inst, Med Ctr, Nashville, TN USA; [Resnick, Susan M.; Shafer, Andrea T.] NIA, Lab Behav Neurosci, NIH, Baltimore, MD 21224 USA; [Cutting, Laurie E.] Vanderbilt Univ, Special Educ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Woodward, Neil] Vanderbilt Univ, Psychiat & Behav Sci, Med Ctr, Nashville, TN USA; [Zald, David] Vanderbilt Univ, Neurosci, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Vanderbilt University; Vanderbilt University; Vanderbilt University	Schilling, KG (corresponding author), Vanderbilt Univ, Med Ctr, Radiol & Radiol Sci, Nashville, TN 37232 USA.; Schilling, KG (corresponding author), Vanderbilt Univ, Inst Imaging Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	kurt.g.schilling@vanderbilt.edu	Landman, Bennett A/A-2343-2009	Landman, Bennett A/0000-0001-5733-2127; Rogers, Baxter/0000-0002-5666-2797	NIMH [NIMH R03MH096321, K23MH087770]; CHDI Foundation, Inc.; NIH [R01NS050568]; NINDS [NS40068, R01 NS054893]; 16 NIH Institutes and Centers [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University [1U54MH091657]; National Institutes of Health [R01EB017230, T32EB001628]; ViSE/VICTR [VR3029]; National Center for Research Resources [UL1 RR024975-01]; Department of Defense [W81XWH17-2-055]; Intramural Research Program, National Institute on Aging, NIH	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); CHDI Foundation, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); 16 NIH Institutes and Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Clinical Center (CC)); McDonnell Center for Systems Neuroscience at Washington University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ViSE/VICTR; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Defense(United States Department of Defense); Intramural Research Program, National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was conducted in part using the resources of the Advanced Computing Center for Research and Education at Vanderbilt University, Nashville, TN. We acknowledge the data provided by several initiatives: ABIDE: Primary support for the work by Adriana Di Martino was provided by the (NIMH K23MH087770) and the Leon Levy Foundation. Primary support for the work by Michael P. Milham and the INDI team was provided by gifts from Joseph P. Healy and the Stavros Niarchos Foundation to the Child Mind Institute, as well as by an NIMH award to MPM (NIMH R03MH096321). DWI Traveling Human Phantom: This work was supported, in part, by awards from CHDI Foundation, Inc.; NIH R01NS050568; NINDS NS40068 Neurobiological Predictors of Huntington's Disease; and NINDS R01 NS054893 Cognitive and Functional Brain Changes in Preclinical HD HCP: Data were provided [in part] by the Human Connectome Project, WUMinn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. This work was supported by the National Institutes of Health under award numbers R01EB017230, and T32EB001628, and in part by ViSE/VICTR VR3029 and the National Center for Research Resources, Grant UL1 RR024975-01, and Department of Defense award number W81XWH17-2-055. This research was conducted with the support from Intramural Research Program, National Institute on Aging, NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. We gratefully acknowledge the support of NVIDIA Corporation with the donation of the Titan Xp GPU used for this research.	Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Avants BB., 2009, INSIGHT J, V2, P1, DOI DOI 10.54294/UVNHIN; Bastiani M, 2019, NEUROIMAGE, V184, P801, DOI 10.1016/j.neuroimage.2018.09.073; Bhushan C, 2012, IEEE T SIGNAL INFORM, P1, DOI [DOI 10.1177/0963721412473755, 10.1177/0963721412473755]; Brun L, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00536; Cicek Ozgun, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P424, DOI 10.1007/978-3-319-46723-8_49; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Fan QY, 2016, NEUROIMAGE, V124, P1108, DOI 10.1016/j.neuroimage.2015.08.075; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Froeling M, 2017, MAGN RESON MED, V77, P1797, DOI 10.1002/mrm.26259; Gorgolewski KJ, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005209; Graham MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185647; Harms MP, 2018, NEUROIMAGE, V183, P972, DOI 10.1016/j.neuroimage.2018.09.060; Irfanoglu MO, 2019, MAGN RESON MED, V81, P2774, DOI 10.1002/mrm.27577; Irfanoglu MO, 2015, NEUROIMAGE, V106, P284, DOI 10.1016/j.neuroimage.2014.11.042; Irfanoglu MO, 2017, P 25 ANN M ISMRM INT; Karayanidis F, 2016, NEUROIMAGE, V124, P1137, DOI 10.1016/j.neuroimage.2015.04.047; Landman BA, 2011, NEUROIMAGE, V54, P2854, DOI 10.1016/j.neuroimage.2010.11.047; Liu C-F, 2019, MAGN RESON IMAGING; Magnotta VA, 2012, BRAIN CONNECT, V2, P345, DOI 10.1089/brain.2012.0112; Mascalchi M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200258; Nath V, 2018, INT C MED IM COMP AS, P193; Paszke A., 2017, AUTOMATIC DIFFERENTI, P1; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Schilling KG, 2019, MAGN RESON IMAGING; Schilling KG, 2019, MAGN RESON IMAGING, V64, P62, DOI 10.1016/j.mri.2019.05.008; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Snoussi H, 2019, IEEE INT S BIOM IM I; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Usman M, 2019, MAGN RESON MED, V81, P1979, DOI 10.1002/mrm.27547; Wu M, 2008, LECT NOTES COMPUT SC, V5242, P321, DOI 10.1007/978-3-540-85990-1_39	33	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236418	10.1371/journal.pone.0236418	http://dx.doi.org/10.1371/journal.pone.0236418			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735601	Green Submitted, gold, Green Published			2022-12-26	WOS:000569367100022
J	Prytz, KL; Prag, M; Fredlund, H; Magnuson, A; Sundqvist, M; Kallman, J				Prytz, Karolina Liljedahl; Prag, Marten; Fredlund, Hans; Magnuson, Anders; Sundqvist, Martin; Kallman, Jan			Antibiotic treatment with one single dose of gentamicin at admittance in addition to a beta-lactam antibiotic in the treatment of community-acquired bloodstream infection with sepsis	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS; ACUTE KIDNEY INJURY; SEPTIC SHOCK; AMINOGLYCOSIDE NEPHROTOXICITY; ANTIMICROBIAL THERAPY; COMBINATION; PROPENSITY; SURVIVAL; MORTALITY; SYNERGISM	Background Combination therapy in the treatment of sepsis, especially the value of combining a beta-Lactam antibiotic with an aminoglycoside, has been discussed. This retrospective cohort study including patients with sepsis or septic shock aimed to investigate whether one single dose of gentamicin at admittance (SGA) added to beta-Lactam antibiotic could result in a lower risk of mortality than beta-Lactam monotherapy, without exposing the patient to the risk of nephrotoxicity. Methods and findings All patients with positive blood cultures were evaluated for participation (n = 1318). After retrospective medical chart review, a group of patients with community-acquired sepsis with positive blood cultures who received beta-Lactam antibiotic with or without the addition of SGA (n = 399) were included for the analysis. Mean age was 74.6 yrs. (range 19-98) with 216 (54%) males. Sequential Organ Failure Assessment score (SOFA score) median was 3 (interquartile range [IQR] 2-5) and the median Charlson Comorbidity Index for the whole group was 2 (IQR 1-3). Sixty-seven (67) patients (17%) had septic shock. The 28-day mortality in the combination therapy group was 10% (20 of 197) and in the monotherapy group 22% (45 of 202), adjusted HR 3.5 (95% CI (1.9-6.2),p= < 0.001. No significant difference in incidence of acute kidney injury (AKI) was detected. Conclusion This retrospective observational study including patients with community-acquired sepsis or septic shock and positive blood cultures, who meet Sepsis-3 criteria, shows that the addition of one single dose of gentamicin to beta-lactam treatment at admittance was associated with a decreased risk of mortality and was not associated with AKI. This antibiotic regime may be an alternative to broad-spectrum antibiotic treatment of community-acquired sepsis. Further prospective studies are warranted to confirm these results.	[Prytz, Karolina Liljedahl; Prag, Marten; Kallman, Jan] Orebro Univ, Fac Med & Hlth, Dept Infect Dis, Orebro, Sweden; [Fredlund, Hans; Sundqvist, Martin] Orebro Univ, Fac Med & Hlth, Dept Clin Microbiol, Orebro, Sweden; [Magnuson, Anders] Orebro Univ, Sch Med Sci, Clin Epidemiol & Biostat, Orebro, Sweden	Orebro University; Orebro University; Orebro University	Prytz, KL (corresponding author), Orebro Univ, Fac Med & Hlth, Dept Infect Dis, Orebro, Sweden.	karolina.liljedhal-prytz@regionorebrolan.se						Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Barnes AI, 2005, INT J ANTIMICROB AG, V26, P146, DOI 10.1016/j.ijantimicag.2005.04.014; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cobussen M, 2016, INFECT DIS-NOR, V48, P274, DOI 10.3109/23744235.2015.1109136; Daniels R, 2011, J ANTIMICROB CHEMOTH, V66, pII11, DOI 10.1093/jac/dkq515; Davey PG, 2008, CLIN MICROBIOL INFEC, V14, P15, DOI 10.1111/j.1469-0691.2008.01959.x; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Drusano GL, 2007, CLIN INFECT DIS, V45, P753, DOI 10.1086/520991; Durante-Mangoni E, 2009, INT J ANTIMICROB AG, V33, P201, DOI 10.1016/j.ijantimicag.2008.09.001; ELIOPOULOS GM, 1982, REV INFECT DIS, V4, P282; FINER N, 1992, J ROY SOC MED, V85, P530; GIAMARELLOU H, 1986, AM J MED, V80, P126, DOI 10.1016/0002-9343(86)90490-0; Goscinski G, 2003, SCAND J INFECT DIS, V35, P40, DOI 10.1080/0036554021000026983; Goulden R, 2018, EMERG MED J, V35, P345, DOI 10.1136/emermed-2017-207120; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Hanberger H, 2013, SCAND J INFECT DIS, V45, P161, DOI 10.3109/00365548.2012.747694; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Keep JW, 2016, EMERG MED J, V33, P37, DOI 10.1136/emermed-2014-204465; Kumar A, 2010, CRIT CARE MED, V38, P1773, DOI 10.1097/CCM.0b013e3181eb3ccd; Kumar A, 2010, CRIT CARE MED, V38, P1651, DOI 10.1097/CCM.0b013e3181e96b91; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Leibovici L, 2009, J ANTIMICROB CHEMOTH, V63, P246, DOI 10.1093/jac/dkn469; Leone M, 2003, CRIT CARE MED, V31, P462, DOI 10.1097/01.CCM.0000050298.59549.4A; LERNER SA, 1986, AM J MED, V80, P98, DOI 10.1016/0002-9343(86)90486-9; Lopes JA, 2013, CLIN KIDNEY J, V6, P8, DOI 10.1093/ckj/sfs160; Lopez-Novoa JM, 2011, KIDNEY INT, V79, P33, DOI 10.1038/ki.2010.337; Macdonald SPJ, 2014, ACAD EMERG MED, V21, P1257, DOI 10.1111/acem.12515; Mellhammar L., 2016, OPEN FORUM INFECT DI, V3, DOI [10.1093/ofid/ofw207, DOI 10.1093/OFID/OFW207]; MOELLERING RC, 1979, J INFECT DIS, V140, P639, DOI 10.1093/infdis/140.4.639; Ong DSY, 2017, CLIN INFECT DIS, V64, P1731, DOI 10.1093/cid/cix186; Paul Mical, 2014, Cochrane Database Syst Rev, pCD003344, DOI 10.1002/14651858.CD003344.pub3; Paul M, 2010, ANTIMICROB AGENTS CH, V54, P4851, DOI 10.1128/AAC.00627-10; Picard W, 2014, ANTIMICROB AGENTS CH, V58, P7468, DOI 10.1128/AAC.03750-14; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Saied T, 2011, AM J INFECT CONTROL, V39, pE61, DOI 10.1016/j.ajic.2011.04.009; Sanz F, 2015, RESPIROLOGY, V20, P813, DOI 10.1111/resp.12560; Saxena S, 2019, J INFECT PUBLIC HEAL, V12, P695, DOI 10.1016/j.jiph.2019.03.014; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Spagnolli W, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.12934; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; TABLAN OC, 1984, J INFECT DIS, V149, P257, DOI 10.1093/infdis/149.2.257; Taccone FS, 2010, CRIT CARE, V14, DOI 10.1186/cc8945; Tian L, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6013-5; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; Weiss E, 2015, CLIN MICROBIOL INFEC, V21, pE81, DOI [10.1016/j.cmi.2015.03.013, 10.1016/j.cmi.2015.07.010]; Yokota PKO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104475	49	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236864	10.1371/journal.pone.0236864	http://dx.doi.org/10.1371/journal.pone.0236864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730359	gold, Green Published			2022-12-26	WOS:000556884700030
J	Brix, N; Rosthoj, S; Glerup, M; Hasle, H; Herlin, T				Brix, Ninna; Rosthoj, Steen; Glerup, Mia; Hasle, Henrik; Herlin, Troels			Identifying acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis in children	PLOS ONE			English	Article							ANTINUCLEAR ANTIBODIES; CHILDHOOD LEUKEMIA; RHEUMATOID-ARTHRITIS; MANIFESTATIONS; ASSOCIATION; FREQUENCY; ONSET; PAIN	Objective Acute lymphoblastic leukemia (ALL) may present with arthritis implying the risk of being misdiagnosed as juvenile idiopathic arthritis (JIA). The aim of this study was to identify predictors for ALL based on clinical and laboratory information. Methods This cross-sectional, retrospective study compared clinical presentation and laboratory results of 26 children with ALL and arthritis versus 485 children with JIA (433 non-systemic, 52 systemic JIA). Using a Bayesian score approach the findings were evaluated by calculating odds ratios (OR) and lnOR as a measure of diagnostic weight. Results Distinction on clinical grounds was difficult, as even a high number of joints involved did not exclude ALL. One or more hematologic cell counts were low (Hb <10 g/dL, platelet count <100 x 10(9)/L, neutrophil count < 1.0 x 10(9)/L) in 92% with ALL, 25% with systemic JIA and 10% with non-systemic JIA. Neutropenia and thrombocytopenia had the highest ORs of 128 (95% CI 43-387) and 129 (95% CI 26-638), each giving a diagnostic weight of 4. The estimated risks of ALL were 0.2% with normal cell counts and 9%, 67% and 100% when one, two or three cell lines were affected. Conclusion A simple count of cell lines with low counts can serve as a basic diagnostic strategy. Children with tri- or bilinear involvement should be referred to a bone marrow, and those with unilinear involvement a thorough screen for further evidence of ALL (organomegaly, ESR, LDH, uric acid, and blood smear).	[Brix, Ninna; Glerup, Mia; Hasle, Henrik; Herlin, Troels] Aarhus Univ Hosp, Dept Pediat & Adolescent Med, Aarhus, Denmark; [Brix, Ninna; Rosthoj, Steen] Aalborg Univ Hosp, Dept Pediat & Adolescent Med, Aalborg, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital	Brix, N (corresponding author), Aarhus Univ Hosp, Dept Pediat & Adolescent Med, Aarhus, Denmark.; Brix, N (corresponding author), Aalborg Univ Hosp, Dept Pediat & Adolescent Med, Aalborg, Denmark.	ninna.brix@rn.dk		Brix, Ninna/0000-0003-2538-1834	Arvid Nilsson's Foundation [DKK 647.500, 1780631]; Danish Childhood Cancer Foundation [DKK 500.000, 2017-1945]; Olufgard Memorial Fund [DKK 130.000, 25734]	Arvid Nilsson's Foundation; Danish Childhood Cancer Foundation; Olufgard Memorial Fund	The authors have no financial disclosures relevant to this article. No sponsors or funders (other than the named authors) played any role in study design, data collevtion and analysis, decision to publish or preparation of the manuscript. Funding source: Arvid Nilsson's Foundation has granted DKK 647.500 to PhD student Ninna Brix, grant number 1780631. Danish Childhood Cancer Foundation has granted DKK 500.000 to PhD student Ninna Brix, grant number 2017-1945. Olufgard Memorial Fund has granted DKK 130.000 to PhD student, MD Ninna Brix, grant number 25734.	Agodi A, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-15; ARROYAVE CM, 1988, J ALLERGY CLIN IMMUN, V82, P741, DOI 10.1016/0091-6749(88)90073-5; Berntson L, 2003, J RHEUMATOL, V30, P2275; Biswas S, 2009, ASIAN PAC J CANCER P, V10, P903; Brix N, 2015, ARCH DIS CHILD, V100, P821, DOI 10.1136/archdischild-2014-307751; Cabral DA, 1999, J PEDIATR-US, V134, P53, DOI 10.1016/S0022-3476(99)70372-0; CABRAL DA, 1992, PEDIATRICS, V89, P441; Clarke RT, 2016, ARCH DIS CHILD, V101, P894, DOI 10.1136/archdischild-2016-311251; COSTELLO PB, 1983, J RHEUMATOL, V10, P753; DEANE PMG, 1995, PEDIATRICS, V95, P892; Edslev PW, 2007, BRIT J HAEMATOL, V138, P513, DOI 10.1111/j.1365-2141.2007.06682.x; Glerup M, 2017, CLIN RHEUMATOL, V36, P671, DOI 10.1007/s10067-017-3540-x; Gupta D, 2010, RHEUMATOL INT, V30, P767, DOI 10.1007/s00296-009-1064-7; Hjalgrim LL, 2003, J NATL CANCER I, V95, P1539, DOI 10.1093/jnci/djg064; Jones OY, 2006, PEDIATRICS, V117, pE840, DOI 10.1542/peds.2005-1515; JONSSON OG, 1990, J PEDIATR-US, V117, P233, DOI 10.1016/S0022-3476(05)80535-9; Kirubakaran C, 2002, J INDIAN MED ASSOC, V109, P568; Kirubakaran C, 2002, J INDIAN MED ASSOC, V109, P566; Lau M, 2019, PEDIATR BLOOD CANCER, V66; Lucking V, 2013, PEDIATR HEMAT ONCOL, V30, P131, DOI 10.3109/08880018.2012.748111; Malleson PN, 1997, ARCH DIS CHILD, V77, P299, DOI 10.1136/adc.77.4.299; Marwaha RK, 2010, ANN HEMATOL, V89, P249, DOI 10.1007/s00277-009-0826-3; MENON S, 1995, ANN RHEUM DIS, V54, P787, DOI 10.1136/ard.54.10.787; OSBORN TG, 1984, ARTHRITIS RHEUM, V27, P1286, DOI 10.1002/art.1780271111; OSTROV BE, 1993, J PEDIATR-US, V122, P595, DOI 10.1016/S0022-3476(05)83543-7; Petty RE, 2004, J RHEUMATOL, V31, P390; Ravelli A, 2007, LANCET, V369, P767, DOI 10.1016/S0140-6736(07)60363-8; REVESZ T, 1985, CANCER, V55, P1637, DOI 10.1002/1097-0142(19850415)55:8<1637::AID-CNCR2820550804>3.0.CO;2-H; Riise OR, 2008, PEDIATRICS, V121, pE299, DOI 10.1542/peds.2007-0291; Sinigaglia R, 2008, J PEDIATR ORTHOPED, V28, P20, DOI 10.1097/BPO.0b13e31815ff350; Tafaghodi F, 2009, CLIN RHEUMATOL, V28, P1253, DOI 10.1007/s10067-009-1221-0; Tamashiro MS, 2011, CLINICS, V66, P1665, DOI 10.1590/S1807-59322011001000001; Tsujioka T, 2017, MOD RHEUMATOL, V28, P1, DOI [10.1080/14397595.2017.1352477, DOI 10.1080/14397595.2017.1352477]; Wallendal M, 1996, ARCH PEDIAT ADOL MED, V150, P70, DOI 10.1001/archpedi.1996.02170260074012; Zombori L, 2013, PEDIATR RHEUMATOL, V11, DOI 10.1186/1546-0096-11-20	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237530	10.1371/journal.pone.0237530	http://dx.doi.org/10.1371/journal.pone.0237530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780759	Green Published, gold			2022-12-26	WOS:000562664700045
J	Kua, JA; Pang, JX				Kua, Jo Ann; Pang, Junxiong			The epidemiological risk factors of hand, foot, mouth disease among children in Singapore: A retrospective case-control study	PLOS ONE			English	Article							BASIC REPRODUCTION NUMBER; ENTEROVIRUS 71; COXSACKIEVIRUS A16; OUTBREAK; CHINA; TRANSMISSION; HERPANGINA; INFECTIONS; INFANTS; JIANGSU	The incidence of hand, foot, and mouth disease (HFMD) is increasing over the years despite current prevention and control policies in Singapore. A retrospective case-control study was conducted among parents whose children attended childcare centres in Singapore to assess the epidemiological risk factors associated with HFMD among children below 7 years old. Parents of 363 children with HFMD (as cases) and 362 children without HFMD (as controls) were enrolled from 22 childcare centres. Data of potential risk factors were collected through a standardised self-administered questionnaire from parents which include demographics and hygiene practices. Multivariate analysis were adjusted for age group, parent's education level, mother's age, HFMD-infected siblings, and preschool admission period. Child's age between 1.5 and 4.9 years, child who had been in childcare for more than 1.9years, having HFMD-infected siblings, two or more children in a family, higher educated parents, parents who had HFMD episode previously, wash toys with soap once every two to three weeks, sanitise toys once every two to three weeks, out-sourced cleaner in childcare centre, no domestic helper at home and more than 22 children in a classroom were independent risk factors of HFMD. These evidence provide crucial implications to guide more effective prevention and control of HFMD in Singapore.	[Kua, Jo Ann; Pang, Junxiong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Kua, Jo Ann; Pang, Junxiong] Natl Univ Hlth Syst, Singapore, Singapore; [Pang, Junxiong] Natl Univ Singapore, Ctr Infect Dis Epidemiol & Res, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Pang, JX (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Pang, JX (corresponding author), Natl Univ Hlth Syst, Singapore, Singapore.; Pang, JX (corresponding author), Natl Univ Singapore, Ctr Infect Dis Epidemiol & Res, Singapore, Singapore.	pangv@hotmail.com	Pang, Junxiong/AAI-5115-2021	Pang, Junxiong, Vincent/0000-0002-9788-701X	Singapore Children's Society; Saw Swee Hock School of Public Health; Singapore Children's Society of National University of Singapore (NUS); Saw Swee Hock School of Public Health of National University of Singapore (NUS)	Singapore Children's Society; Saw Swee Hock School of Public Health; Singapore Children's Society of National University of Singapore (NUS); Saw Swee Hock School of Public Health of National University of Singapore (NUS)	JAK-Singapore Children's Society (https://www.childrensociety.org.sg/researchgrants) JAK-Saw Swee Hock School of Public Health (https://sph.nus.edu.sg/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the parents and senior management of the childcare centres for their support and participation in this study. We are also thankful to Singapore Children's Society & Saw Swee Hock School of Public Health of National University of Singapore (NUS) for their financial support.	Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; Ang LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127999; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Bian LL, 2019, EXPERT REV ANTI-INFE, V17, P233, DOI 10.1080/14787210.2019.1585242; Centers for Disease Control and Prevention CDC, 2002, MORBIDITY MORTALITY, V51; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan Y F, 2005, Med J Malaysia, V60, P246; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chang SC, 2013, J HOSP INFECT, V83, P288, DOI 10.1016/j.jhin.2012.12.010; Chang YK, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860070, 10.1590/s1678-9946201860070]; Chew SP, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1195-2; Chia MY, 2014, PEDIATR NEONATOL, V55, P243, DOI 10.1016/j.pedneo.2013.07.007; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; Chua L, 2013, STAT SINGAPORE NEWSL; Communicable Diseases Division MOH, 2018, COMM DIS SURV SING 2; Communicable Diseases Division MOH, 2018, WEEKLY INFECT DIS B, V15; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; Duong V, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.101; GOH KT, 1982, B WORLD HEALTH ORGAN, V60, P965; Guo NN, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013144; Guo SF, 2013, B WORLD HEALTH ORGAN, V91, P322, DOI 10.2471/BLT.12.111310; Han J, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-178; JENISTA JA, 1984, J PEDIATR-US, V104, P685, DOI 10.1016/S0022-3476(84)80944-0; Kadurugamuwa JL, 2011, AM J INFECT CONTROL, V39, P788, DOI 10.1016/j.ajic.2011.01.015; Koh WM, 2016, PEDIATR INFECT DIS J, V35, pE285, DOI 10.1097/INF.0000000000001242; Lanigan JA, 2001, EUR J CLIN NUTR, V55, P309, DOI 10.1038/sj.ejcn.1601168; Li JS, 2013, IEEE T AUTOM SCI ENG, V10, P1, DOI 10.1109/TASE.2012.2227582; Li RW, 2005, NUTR REV, V63, P103, DOI 10.1111/j.1753-4887.2005.tb00128.x; LI W, 2016, SCI REP, V6, DOI DOI 10.1038/SREP3538827752104; Li YP, 2016, PEDIATR INFECT DIS J, V35, P353, DOI 10.1097/INF.0000000000001001; Li YP, 2013, EUR J PEDIATR, V172, P661, DOI 10.1007/s00431-013-1939-1; Lim CTK, 2016, EPIDEMIOL INFECT, V144, P1028, DOI 10.1017/S0950268815002137; LIN HJ, 2014, BMC INFECT DIS, V14, DOI DOI 10.1186/1471-2334-14-1; Liu SL, 2015, REV MED VIROL, V25, P115, DOI 10.1002/rmv.1827; Liu XN, 2019, J INFECTION, V78, P19, DOI 10.1016/j.jinf.2018.08.009; Ma E, 2011, PEDIATR INFECT DIS J, V30, P675, DOI 10.1097/INF.0b013e3182116e95; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; Ministry of Health MOH, 2012, INF CONTR GUID SCH C; Nguyen NTB, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-341; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; Park SK, 2010, J KOREAN MED SCI, V25, P677, DOI 10.3346/jkms.2010.25.5.677; Repass GL, 2014, CLEV CLIN J MED, V81, P537, DOI 10.3949/ccjm.81a.13132; Ruan F, 2011, PEDIATRICS, V127, pE898, DOI 10.1542/peds.2010-1497; Sadeharju K, 2007, PEDIATRICS, V119, P941, DOI 10.1542/peds.2006-0780; Shah VA, 2003, ANN ACAD MED SINGAP, V32, P381; Siegel K, 2017, J PUBLIC HEALTH POL, V38, P271, DOI 10.1057/s41271-017-0066-z; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Strunk T, 2011, J MATERN-FETAL NEO M, V24, P25, DOI 10.3109/14767058.2010.482605; Sun LM, 2016, AM J INFECT CONTROL, V44, pE13, DOI 10.1016/j.ajic.2015.04.202; Suzuki Y, 2010, PEDIATR INT, V52, P203, DOI 10.1111/j.1442-200X.2009.02937.x; Tay CH, 1974, SINGAP MED J, V15, P174; Teng Shu, 2013, Zhonghua Er Ke Za Zhi, V51, P787; Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745; Witso E, 2010, INT J EPIDEMIOL, V39, P459, DOI 10.1093/ije/dyp333; Wood A, 1998, J HOSP INFECT, V38, P283, DOI 10.1016/S0195-6701(98)90077-9; World Health Organization WHO, 1995, COMPL FEED INF YOUNG; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Xie Jing, 2015, Bing Du Xue Bao, V31, P500; Xu W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-8; Yao X, 2017, HUM VACC IMMUNOTHER, V13, P823, DOI 10.1080/21645515.2016.1236879; Zhang DY, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01237; Zhu Q, 2012, EUR J CLIN MICROBIOL, V31, P2197, DOI 10.1007/s10096-012-1555-4	65	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0236711	10.1371/journal.pone.0236711	http://dx.doi.org/10.1371/journal.pone.0236711			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780749	Green Published, gold			2022-12-26	WOS:000562664700007
J	Partyka, A; Zagorska, A; Kotanska, M; Walczak, M; Jastrzebska-Wiesek, M; Knutelska, J; Bednarski, M; Gluch-Lutwin, M; Mordyl, B; Janiszewska, P; Wesolowska, A				Partyka, Anna; Zagorska, Agnieszka; Kotanska, Magdalena; Walczak, Maria; Jastrzebska-Wiesek, Magdalena; Knutelska, Joanna; Bednarski, Marek; Gluch-Lutwin, Monika; Mordyl, Barbara; Janiszewska, Paulina; Wesolowska, Anna			Antidepressant-like activity and safety profile evaluation of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione derivatives as 5-HT(1A)receptor partial agonists	PLOS ONE			English	Article							RECEPTOR ANTAGONIST; DEPRESSIVE DISORDER; PREFRONTAL CORTEX; ERK ACTIVATION; BODY-WEIGHT; MAP KINASE; 5-HT7; AUGMENTATION; PHARMACOLOGY; LIGANDS	Current antidepressant therapy has several disadvantages related to the properties of antidepressants. Considering their unfavourable features, the process of searching for new antidepressant drugs with better safety and tolerability requires consistent efforts and many complementary studies. Serotonin 5-HT(1A)receptor is considered as an interesting target of antidepressant therapy. In the present study, the intrinsic activity at different signaling pathways coupled to serotonin 5-HT(1A)receptor, antidepressant-like and pharmacokinetic properties, and the safety profile of two novel imidazopurine-2,4-dione derivatives, namely compounds AZ-853 (8-(4-(4-(2-fluorophenyl)piperazin-1-yl)butyl)-1,3-dimethyl-1H- imidazo[2,1-f]purine-2,4(3H,8H)-dione) and AZ-861 (1,3-dimethyl-8-(4-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)butyl)-1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione), were studied in animal models throughin vitroandin vivoexperiments. We demonstrated that AZ-853 and AZ-861, which structurally differ by one substituent and its placement in the phenyl ring, showed varied functional, pharmacological, and pharmacokinetic properties as well as side effect profiles. AZ-861 exhibited stronger agonistic action in all functional assays. After acute and repeated administration in mice, both compounds showed antidepressant-like activity in the forced swim test, which was partially mediated by 5-HT(1A)receptor activation. AZ-853 showed a more potent antidepressant-like effect, presumably due to its better penetration into brain structures. Both compounds did not show anticholinergic properties, but after repeated administration, they induced weak sedation and lipid metabolism disturbances without affecting serum glucose level. The stronger alpha(1)-adrenolytic effect of AZ-853 is responsible for decreased systolic blood pressure, and in contrast to AZ-861, AZ-853 induced weight gain in mice. The interesting comparative pharmacological profiles of AZ-853 and AZ-861 encourage to conduct further experiments to fully understand their mechanisms and differences in action.	[Partyka, Anna; Jastrzebska-Wiesek, Magdalena; Wesolowska, Anna] Jagiellonian Univ, Fac Pharm, Dept Clin Pharm, Coll Med, Krakow, Poland; [Zagorska, Agnieszka] Jagiellonian Univ, Fac Pharm, Dept Med Chem, Coll Med, Krakow, Poland; [Kotanska, Magdalena; Knutelska, Joanna; Bednarski, Marek] Jagiellonian Univ, Fac Pharm, Dept Pharmacol Screening, Coll Med, Krakow, Poland; [Walczak, Maria; Janiszewska, Paulina] Jagiellonian Univ, Fac Pharm, Chair & Dept Toxicol, Coll Med, Krakow, Poland; [Gluch-Lutwin, Monika; Mordyl, Barbara] Jagiellonian Univ, Fac Pharm, Dept Pharmacobiol, Coll Med, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Partyka, A (corresponding author), Jagiellonian Univ, Fac Pharm, Dept Clin Pharm, Coll Med, Krakow, Poland.	annairena.partyka@uj.edu.pl	Mordyl, Barbara/AAD-8247-2019; Partyka, Anna/AAZ-8648-2020; Zagórska, Agnieszka/ABH-3725-2020; Kotańska, Magdalena/AAX-5140-2021	Mordyl, Barbara/0000-0001-7906-0353; Zagórska, Agnieszka/0000-0003-2510-7237; Kotańska, Magdalena/0000-0002-3946-1192; Jastrzebska-Wiesek, Magdalena/0000-0002-5388-1214; Knutelska, Joanna/0000-0002-2480-1617; Wesolowska, Anna/0000-0003-2383-3278; Partyka, Anna/0000-0001-9606-5228; Gluch-Lutwin, Monika/0000-0003-1632-6569	Jagiellonian University Medical College [N42/DBS/000104]	Jagiellonian University Medical College	This study was supported by Jagiellonian University Medical College grant number N42/DBS/000104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AI, 2009, PSYCHOPHARMACOLOGY, V205, P119, DOI 10.1007/s00213-009-1521-8; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Audet N, 2005, J BIOL CHEM, V280, P7808, DOI 10.1074/jbc.M411695200; Berman RM, 2009, CNS SPECTRUMS, V14, P197, DOI 10.1017/S1092852900020216; Bonaventure P, 2012, J PHARMACOL EXP THER, V342, P429, DOI 10.1124/jpet.112.193995; Bourin M, 2004, HUM PSYCHOPHARM CLIN, V19, P135, DOI 10.1002/hup.561; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3638; CARRUTHERS SG, 1994, DRUG SAFETY, V11, P12, DOI 10.2165/00002018-199411010-00003; Carvalho AF, 2016, PSYCHOTHER PSYCHOSOM, V85, P270, DOI 10.1159/000447034; Celada P, 2013, CNS DRUGS, V27, P703, DOI 10.1007/s40263-013-0071-0; Chilmonczyk Z, 2015, INT J MOL SCI, V16, P18474, DOI 10.3390/ijms160818474; D'Agostino Andrew, 2015, P T, V40, P36; da Rocha MB, 2012, FITOTERAPIA, V83, P1286, DOI 10.1016/j.fitote.2012.05.010; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dudek M, 2016, EUR J PHARMACOL, V776, P146, DOI 10.1016/j.ejphar.2016.02.047; Dudek M, 2015, METAB BRAIN DIS, V30, P1487, DOI 10.1007/s11011-015-9736-3; Dudek M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141327; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Dwivedi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2338, DOI 10.1038/sj.npp.1301372; Emdin M, 2005, CIRCULATION, V112, P2078, DOI 10.1161/CIRCULATIONAHA.105.571919; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gbahou F, 2003, P NATL ACAD SCI USA, V100, P11086, DOI 10.1073/pnas.1932276100; Hilas Olga, 2014, Consult Pharm, V29, P124, DOI 10.4140/TCP.n.2014.124; Himmerich H, 2015, ENDOCR METAB IMMUNE, V15, P252, DOI 10.2174/1871530315666150623092031; Intagliata S, 2017, BIOORGAN MED CHEM, V25, P1250, DOI 10.1016/j.bmc.2016.12.039; Ishibashi T, 2010, J PHARMACOL EXP THER, V334, P171, DOI 10.1124/jpet.110.167346; Kahl KG, 2017, VASC PHARMACOL, V96-98, P11, DOI 10.1016/j.vph.2017.07.004; Khawam EA, 2006, CLEV CLIN J MED, V73, P351, DOI 10.3949/ccjm.73.4.351; Leem YH, 2014, NEUROSCI LETT, V580, P163, DOI 10.1016/j.neulet.2014.08.001; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Lewer D, 2015, BRIT J PSYCHIAT, V207, P221, DOI 10.1192/bjp.bp.114.156786; LIPSITZ LA, 1989, NEW ENGL J MED, V321, P952; Masaki T, 2006, TRENDS PHARMACOL SCI, V27, P279, DOI 10.1016/j.tips.2006.03.008; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mociski M, 2012, CARDIOL J, V7, P60; Modica MN, 2018, J MED CHEM, V61, P8475, DOI 10.1021/acs.jmedchem.7b01898; Modica MN, 2015, BIOORG MED CHEM LETT, V25, P1427, DOI 10.1016/j.bmcl.2015.02.042; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Planchez B, 2019, J NEURAL TRANSM, V126, P1383, DOI 10.1007/s00702-019-02084-y; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Pytka K, 2018, FRONT PHARMACOL, V9, P1, DOI [10.3389/fphar.2018.00001, DOI 10.3389/FPHAR.2018.00001]; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; REMICK RA, 1988, PROG NEURO-PSYCHOPH, V12, P225, DOI 10.1016/0278-5846(88)90039-5; Ribeiro CAS, 2015, EUR J PHARMACOL, V750, P39, DOI 10.1016/j.ejphar.2015.01.010; RICHELSON E, 1994, MAYO CLIN PROC, V69, P1069, DOI 10.1016/S0025-6196(12)61375-5; Sahli ZT, 2016, EXPERT OPIN DRUG DIS, V11, P515, DOI 10.1517/17460441.2016.1160051; Serretti A, 2010, J CLIN PSYCHIAT, V71, P1259, DOI 10.4088/JCP.09r05346blu; Sniecikowska J, 2019, CURR TOP MED CHEM, V19, P2393, DOI 10.2174/1568026619666190911122040; Stroth N, 2015, BIOORGAN MED CHEM, V23, P4824, DOI 10.1016/j.bmc.2015.05.042; Thomas DR, 2004, CNS NEUROL DISORD-DR, V3, P81, DOI 10.2174/1568007043482633; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Werry TD, 2005, J NEUROCHEM, V93, P1603, DOI 10.1111/j.1471-4159.2005.03161.x; Wesolowska A, 2020, EXPERT OPIN DRUG DIS, V15, P279, DOI 10.1080/17460441.2020.1682994; Wesolowska A, 2006, NEUROPHARMACOLOGY, V51, P578, DOI 10.1016/j.neuropharm.2006.04.017; Whale R, 2010, J PSYCHOPHARMACOL, V24, P513, DOI 10.1177/0269881108097714; Yanai K, 2017, PHARMACOL THERAPEUT, V178, P148, DOI 10.1016/j.pharmthera.2017.04.004; YANKELEVITCHYAHAV, 2015, JOVE J VIS EXP MAR, DOI DOI 10.3791/52587; Zagorska A, 2018, CURR MED CHEM, V25, P3455, DOI 10.2174/0929867325666180309110629; Zagorska A, 2016, J ENZYM INHIB MED CH, V31, P10, DOI 10.1080/14756366.2016.1198902; Zmudzka E, 2018, LIFE SCI, V210, P106, DOI 10.1016/j.lfs.2018.08.050	61	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237196	10.1371/journal.pone.0237196	http://dx.doi.org/10.1371/journal.pone.0237196			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764777	gold, Green Published			2022-12-26	WOS:000561029000027
J	Tamminen, A; Happonen, P; Barth, D; Holmstrom, S; Wiebe, MG				Tamminen, Anu; Happonen, Petrus; Barth, Dorothee; Holmstrom, Sami; Wiebe, Marilyn G.			High throughput, small scale methods to characterise the growth of marine fungi	PLOS ONE			English	Article							FILAMENTOUS FUNGI; BIOSCREEN-C; TRICHODERMA STRAINS; ACID PRODUCTION; CARBON; CULTURE; PLATES; COMMUNITIES; MORPHOLOGY; PHYSIOLOGY	Various marine fungi have been shown to produce interesting, bioactive compounds, but scaling up the production of these compounds can be challenging, particularly because little is generally known about how the producing organisms grow. Here we assessed the suitability of using 100-well BioScreen plates or 96-well plates incubated in a robot hotel to cultivate eight filamentous marine fungi, six sporulating and two non-sporulating, to obtain data on growth and substrate (glucose, xylose, galactose or glycerol) utilisation in a high throughput manner. All eight fungi grew in both cultivation systems, but growth was more variable and with more noise in the data in the Cytomat plate hotel than in the BioScreen. Specific growth rates between 0.01 (no added substrate) and 0.07 h(-1)were measured for strains growing in the BioScreen and between 0.01 and 0.27 h(-1)for strains in the plate hotel. Three strains,Dendryphiella salinaLF304,Penicillium chrysogenumKF657 andPenicillium pinophilumLF458, consistently had higher specific growth rates on glucose and xylose in the plate hotel than in the BioScreen, but otherwise results were similar in the two systems. However, because of the noise in data from the plate hotel, the data obtained from it could only be used to distinguish between substrates which did or did not support growth, whereas data from BioScreen also provided information on substrate preference. Glucose was the preferred substrate for all strains, followed by xylose and galactose. Five strains also grew on glycerol. Therefore it was important to minimise the amount of glycerol introduced with the inoculum to avoid misinterpreting the results for growth on poor substrates. We concluded that both systems could provide physiological data with filamentous fungi, provided sufficient replicates are included in the measurements.	[Tamminen, Anu; Happonen, Petrus; Barth, Dorothee; Holmstrom, Sami; Wiebe, Marilyn G.] VTT Tech Res Ctr Finland Ltd, Espoo, Finland; [Holmstrom, Sami] Solar Foods Oy, Lappeenranta, Finland	VTT Technical Research Center Finland	Wiebe, MG (corresponding author), VTT Tech Res Ctr Finland Ltd, Espoo, Finland.	Marilyn.wiebe@vtt.fi		Barth, Dorothee/0000-0001-9575-905X	Academy of Finland [289055]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland (https//www aka tien/), project No. 289055, Carbohydrate metabolism of marine fungi. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. VII (with funds from the Academy of Finland) provided support in the form of salaries [AT, DB, SH, MGM or stipend [PH] for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abarca ML, 2014, FOOD MICROBIOL, V44, P243, DOI 10.1016/j.fm.2014.06.014; Agrawal S, 2018, PHYTOCHEM LETT, V23, P15, DOI 10.1016/j.phytol.2017.11.003; Amend A, 2019, MBIO, V10, DOI 10.1128/mBio.01189-18; Balabanova L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01527; BANERJEE UC, 1993, BIOTECHNOL TECH, V7, P313, DOI 10.1007/BF00150905; Bhadury P, 2006, J IND MICROBIOL BIOT, V33, P325, DOI 10.1007/s10295-005-0070-3; Bills GF, 2008, J APPL MICROBIOL, V104, P1644, DOI 10.1111/j.1365-2672.2008.03735.x; Blasi B, 2016, GEOMICROBIOL J, V33, P308, DOI 10.1080/01490451.2015.1052118; Bonugli-Santos RC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00269; Bringmann G, 2007, MAR DRUGS, V5, P23, DOI 10.3390/md502023; Bull A T, 1977, Adv Microb Physiol, V15, P1, DOI 10.1016/S0065-2911(08)60314-8; Buyer JS, 2001, J MICROBIOL METH, V45, P53, DOI 10.1016/S0167-7012(01)00221-4; Cacho RA, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00774; Cai MH, 2011, BIORESOURCE TECHNOL, V102, P3584, DOI 10.1016/j.biortech.2010.10.052; CALDWELL IY, 1973, T BRIT MYCOL SOC, V61, P411, DOI 10.1016/S0007-1536(73)80111-1; Cullings K, 2005, APPL ENVIRON MICROB, V71, P1996, DOI 10.1128/AEM.71.4.1996-2000.2005; Dana CM, 2014, BIOTECHNOL BIOENG, V111, P842, DOI 10.1002/bit.25178; Debbab A, 2012, FUNGAL DIVERS, V57, P45, DOI 10.1007/s13225-012-0191-8; Derntl C, 2017, P NATL ACAD SCI USA, V114, pE560, DOI 10.1073/pnas.1609348114; Deshmukh SK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02536; Fraser M, 2017, CAN J PLANT SCI, V97, P83, DOI 10.1139/cjps-2015-0382; Fuentes ME, 2016, MYCOLOGIA, V108, P1069, DOI 10.3852/15-338; Galkiewicz JP, 2012, DEEP-SEA RES PT I, V67, P12, DOI 10.1016/j.dsr.2012.05.001; Simoes MLG, 2009, AFR J BIOTECHNOL, V8, P6317; GAUNT DM, 1984, T BRIT MYCOL SOC, V83, P575, DOI 10.1016/S0007-1536(84)80177-1; Giese H, 2014, J BIOSCI BIOENG, V118, P702, DOI 10.1016/j.jbiosc.2014.05.016; Guo JH, 2012, BIOENGINEERED, V3, P104, DOI 10.4161/bbug.19624; Hevekerl A, 2014, APPL MICROBIOL BIOT, V98, P6983, DOI 10.1007/s00253-014-5743-2; Huth I, 2017, ENG LIFE SCI, V17, P1064, DOI 10.1002/elsc.201700041; Jones EBG, 2011, FUNGAL DIVERS, V50, P73, DOI 10.1007/s13225-011-0119-8; JONES P, 1988, T BRIT MYCOL SOC, V90, P577, DOI 10.1016/S0007-1536(88)80062-7; Kahm M, 2010, J STAT SOFTW, V33, P1; Kiuru P, 2014, PLANTA MED, V80, P1234, DOI 10.1055/s-0034-1383001; Knapp DG, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw190; Kosa G, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0716-7; Kramer A, 2016, MAR BIOTECHNOL, V18, P466, DOI 10.1007/s10126-016-9707-7; Kramer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103320; Kubicek CP, 2003, FUNGAL GENET BIOL, V38, P310, DOI 10.1016/S1087-1845(02)00583-2; Landowski CP, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0508-5; Langvad F, 1999, J MICROBIOL METH, V37, P97, DOI 10.1016/S0167-7012(99)00053-6; Le Ker C, 2011, MAR DRUGS, V9, P82, DOI 10.3390/md9010082; Lee MH, 2011, INT J FOOD MICROBIOL, V150, P157, DOI 10.1016/j.ijfoodmicro.2011.07.031; Linde T, 2014, LETT APPL MICROBIOL, V59, P224, DOI 10.1111/lam.12268; Loesch A, 2010, J INVERTEBR PATHOL, V104, P58, DOI 10.1016/j.jip.2010.01.007; Mania D, 2010, APPL ENVIRON MICROB, V76, P7102, DOI 10.1128/AEM.01560-10; Marchese P, 2020, J APPL MICROBIOL, V129, P612, DOI 10.1111/jam.14659; Medina A, 2012, FUNGAL BIOL-UK, V116, P161, DOI 10.1016/j.funbio.2011.11.001; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P478, DOI 10.1128/JCM.39.2.478-484.2001; Mowat E, 2007, J MED MICROBIOL, V56, P1205, DOI 10.1099/jmm.0.47247-0; Oliveira EN, 2012, BRAZ J MICROBIOL, V43, P800, DOI 10.1590/S1517-83822012000200046; Omero C, 2001, J MICROBIOL METH, V43, P165, DOI 10.1016/S0167-7012(00)00213-X; OSZUST K, 2018, FRONT MICROBIOL, V9, DOI DOI 10.3389/FMICB.2018.00001; Overy DP, 2019, MAR DRUGS, V17, DOI 10.3390/md17010042; Paasikallio T, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0736-3; Pang KL, 2016, FUNGAL BIOL REV, V30, P163, DOI 10.1016/j.fbr.2016.08.001; Patel MI, 2005, BIOTECHNOL LETT, V27, P805, DOI 10.1007/s10529-005-5803-x; Polli F, 2016, FUNGAL GENET BIOL, V89, P62, DOI 10.1016/j.fgb.2015.12.003; Pomponi SA, 1999, J BIOTECHNOL, V70, P5, DOI 10.1016/S0168-1656(99)00053-X; Raghukumar C, 2008, FUNGAL DIVERS, V31, P19; Rampersad SN, 2011, PLANT DIS, V95, P248, DOI 10.1094/PDIS-10-10-0725; Rice AV, 2005, STUD MYCOL, P75; Rossi-Rodrigues BC, 2009, BRAZ J MICROBIOL, V40, P404, DOI [10.1590/S1517-83822009000200035, 10.1590/S1517-838220090002000035]; Shin WS, 2017, J MICROBIOL BIOTECHN, V27, P101, DOI 10.4014/jmb.1610.10037; Silber J, 2016, MAR DRUGS, V14, DOI 10.3390/md14070137; Singh MP, 2009, J MICROBIOL METH, V77, P102, DOI 10.1016/j.mimet.2009.01.014; Slawecki RA, 2002, APPL ENVIRON MICROB, V68, P597, DOI 10.1128/AEM.68.2.597-601.2002; Stevenson K, 2016, SCI REP, V6, P4; Tamminen A, 2020, ZENODO, DOI [10.5281/zenodo.3670890, DOI 10.5281/ZENODO.3670890]; Tamminen A, 2015, MAR DRUGS, V13, P3992, DOI 10.3390/md13073992; Tamminen A, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-89; Tauk-Tornisielo SM, 2009, BRAZ J MICROBIOL, V40, P342, DOI [10.1590/S1517-83822009000200025, 10.1590/S1517-838220090002000025]; Tauk-Tornisielo SM, 2007, BRAZ J MICROBIOL, V38, P113, DOI 10.1590/S1517-83822007000100024; Thornton HA, 2008, BIOCONTROL SCI TECHN, V18, P391, DOI 10.1080/09583150801966028; TRINCI APJ, 1983, T BRIT MYCOL SOC, V81, P408, DOI 10.1016/S0007-1536(83)80098-9; TRINCI APJ, 1972, T BRIT MYCOL SOC, V58, P467, DOI 10.1016/S0007-1536(72)80095-0; Trincone A, 2010, J MOL CATAL B-ENZYM, V66, P241, DOI 10.1016/j.molcatb.2010.06.004; Veiter L, 2018, APPL MICROBIOL BIOT, V102, P2997, DOI 10.1007/s00253-018-8818-7; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; WAGNERDOBLER I, 2000, ADV BIOCHEM ENG BIOT, V74, P207; Witkowska D, 2017, POL J MICROBIOL, V66, P181, DOI 10.5604/01.3001.0010.4361; Youssef FS, 2019, MAR DRUGS, V17, DOI 10.3390/md17100559; Zhang C, 2010, MAR DRUGS, V8, P1920, DOI 10.3390/md8061920; Zhou WQ, 2013, J IND MICROBIOL BIOT, V40, P1131, DOI 10.1007/s10295-013-1314-2	83	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0236822	10.1371/journal.pone.0236822	http://dx.doi.org/10.1371/journal.pone.0236822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764772	Green Published, gold			2022-12-26	WOS:000561029000033
J	Witkiewicz, J; Klimza, H; Piersiala, K; Jackowska, J; Wierzbicka, M				Witkiewicz, Joanna; Klimza, Hanna; Piersiala, Krzysztof; Jackowska, Joanna; Wierzbicka, Malgorzata			The usefulness of the narrow band imaging (NBI) in decision-making process regarding second look procedure (SL) in laryngeal cancer follow-up after transoral laser microsurgery	PLOS ONE			English	Article							MARGIN STATUS; GLOTTIC CANCER; RESECTION; HEAD	Background The prognostic value of positive surgical margins after transoral laser microsurgery (TOLM) is still under debate. In case of positive superficial margins, some experts recommend a second-look surgery (SL) and some recommend wait and watch approach with close observation. Narrow band imaging (NBI) is an advanced imaging system used to enhance visualization of mucosal vascular pattern. In laryngology, NBI is used to improve the detection of premalignant, dysplastic and malignant lesions. Aim To assess the usefulness of NBI imaging in guiding clinical decision making regarding follow-up plan and SL after TOLM. Materials and methods A prospective cohort of 127 patients was divided into three groups based on the histology results and NBI vascular pattern of the mucosa. Group A (24/127, 18.90%) consisted of patients with suspicious vascular pattern in NBI or/and with positive deep margin. Group B (52/127, 40.94%) consisted of patients with positive or uncertain superficial margins and non-suspicious vascular pattern in NBI. Group C (51/127, 40.15%) had non-suspicious vascular NBI pattern and all negative margins. Results After the first TOLM procedure, 9/24 (37.5%) patients had positive deep margins, 1/24 (4.2%) had uncertain deep margin and 1/24 patient (4.2%) had both positive deep margin and suspicious vascular pattern in NBI. The remaining 13 cases in Group A had a suspicious NBI finding only during the first follow-up. All of the 24 patients (Group A) underwent a second look surgery. The final histology after SL showed squamous cell carcinoma in 10/24 (41.7%) patients. All 10 patients had suspicious vascular pattern in NBI and one patient had both a positive deep margins after the first TOLM and positive NBI finding. None of Group B and C subjects developed an early recurrence. Conclusions Our study provides evidence that NBI imaging will be a useful adjunct to margin status after TOLM and will facilitate clinical decision-making regarding performing the SL in patients with positive or uncertain superficial surgical margins in the first TOLM procedure. However, additional investigation with more subjects is required at this time to further validate this technique and change the standard of care.	[Witkiewicz, Joanna; Klimza, Hanna; Jackowska, Joanna; Wierzbicka, Malgorzata] Poznan Univ Med Sci, Dept Otolaryngol Head & Neck Surg, Poznan, Poland; [Piersiala, Krzysztof] Karolinska Inst, Div ENT Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Piersiala, Krzysztof] Karolinska Univ Hosp, Dept Otorhinolaryngol, Stockholm, Sweden; [Wierzbicka, Malgorzata] Polish Acad Sci, Inst Human Genet, Poznan, Poland	Poznan University of Medical Sciences; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences	Wierzbicka, M (corresponding author), Poznan Univ Med Sci, Dept Otolaryngol Head & Neck Surg, Poznan, Poland.; Wierzbicka, M (corresponding author), Polish Acad Sci, Inst Human Genet, Poznan, Poland.	otosk2@ump.edu.pl	Piersiala, Krzysztof/AAC-5351-2021	Piersiala, Krzysztof/0000-0003-3844-5999				Arens C, 2016, EUR ARCH OTO-RHINO-L, V273, P1207, DOI 10.1007/s00405-015-3851-y; Campo F, 2020, LASER SURG MED, V52, P301, DOI 10.1002/lsm.23142; Crespo AN, 2006, ACTA OTO-LARYNGOL, V126, P306, DOI 10.1080/00016480500316985; Garofolo S, 2015, ANN OTO RHINOL LARYN, V124, P294, DOI 10.1177/0003489414556082; Klimza H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180590; Klimza H, 2018, BRAZ J OTORHINOLARYN; Klimza H, 2018, POL J OTOLARYNGOL, V72, P1, DOI 10.5604/01.3001.0011.7253; Kurita H, 2008, PATHOL ONCOL RES, V14, P461, DOI 10.1007/s12253-008-9074-4; Landolfo V, 2018, BRAZ J OTORHINOLAR, V84, P74, DOI 10.1016/j.bjorl.2016.11.006; Peretti G, 2000, OTOLARYNG HEAD NECK, V123, P124, DOI 10.1067/mhn.2000.104523; Peretti G, 2010, HEAD NECK-J SCI SPEC, V32, P977, DOI 10.1002/hed.21278; Petr L, 2020, LASER SURG MED, V52, P333, DOI 10.1002/lsm.23143; Piazza C, 2008, ACTA OTORHINOLARYNGO, V28, P49; Piersiala K, 2018, POL J OTOLARYNGOL, V72, P17, DOI 10.5604/01.3001.0012.0486; Sigston E, 2006, ARCH OTOLARYNGOL, V132, P147, DOI 10.1001/archotol.132.2.147; Simo R, 2014, EUR ARCH OTO-RHINO-L, V271, P2469, DOI 10.1007/s00405-014-2966-x; Slootweg PJ, 2002, ORAL ONCOL, V38, P500, DOI 10.1016/S1368-8375(01)00092-6; Stanikova L, 2017, EUR ARCH OTO-RHINO-L, V274, P355, DOI 10.1007/s00405-016-4244-6; Sun CL, 2018, OTOLARYNG HEAD NECK, V159, P17, DOI 10.1177/0194599818758302; Watanabe A, 2009, EUR ARCH OTO-RHINO-L, V266, P1017, DOI 10.1007/s00405-008-0835-1	20	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0236623	10.1371/journal.pone.0236623	http://dx.doi.org/10.1371/journal.pone.0236623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764755	Green Published, gold			2022-12-26	WOS:000561029000034
J	Cheng, XB; Chavez, RA; Stasiewicz, MJ				Cheng, Xianbin; Chavez, Ruben A.; Stasiewicz, Matthew J.			When to use one-dimensional, two-dimensional, and Shifted Transversal Design pooling in mycotoxin screening	PLOS ONE			English	Article							AFLATOXIN; STRATEGY; REDUCE; COST; CORN	While complex sample pooling strategies have been developed for large-scale experiments with robotic liquid handling, many medium-scale experiments like mycotoxin screening by Enzyme-Linked Immunosorbent Assay (ELISA) are still conducted manually in 48- and 96-well plates. At this scale, the opportunity to save on reagent costs is offset by the increased costs of labor, materials, and risk-of-error caused by increasingly complex pooling strategies. This paper compares one-dimensional (1D), two-dimensional (2D), and Shifted Transversal Design (STD) pooling to study whether pooling affects assay accuracy and experimental cost and to provide guidance for when a human experimentalist might benefit from pooling. We approximated mycotoxin contamination in single corn kernels by fitting statistical distributions to experimental data (432 kernels for aflatoxin and 528 kernels for fumonisin) and used experimentally-validated Monte-Carlo simulation (10,000 iterations) to evaluate assay sensitivity, specificity, reagent cost, and pipetting cost. Based on the validated simulation results, assay sensitivity remains 100% for all four pooling strategies while specificity decreases as prevalence level rises. Reagent cost could be reduced by 70% and 80% in 48- and 96-well plates, with 1D and STD pooling being most reagent-saving respectively. Such a reagent-saving effect is only valid when prevalence level is < 21% for 48-well plates and < 13%-21% for 96-well plates. Pipetting cost will rise by 1.3-3.3 fold for 48-well plates and 1.2-4.3 fold for 96-well plates, with 1D pooling by row requiring the least pipetting. Thus, it is advisable to employ pooling when the expected prevalence level is below 21% and when the likely savings of up to 80% on reagent cost outweighs the increased materials and labor costs of up to 4 fold increases in pipetting.	[Cheng, Xianbin; Chavez, Ruben A.; Stasiewicz, Matthew J.] Univ Illinois Urban Champaign, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Stasiewicz, MJ (corresponding author), Univ Illinois Urban Champaign, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.	mstasie@illinois.edu	Stasiewicz, Matthew Jon/A-9083-2012	Stasiewicz, Matthew Jon/0000-0003-2712-0793; Cheng, Xianbin/0000-0002-5372-4569	ADM Institute for the Prevention of Postharvest Loss, Postharvest Loss Prevention Graduate Assistantship; Lo Fellowship through the Illinois College of Agriculture, Consumer, and Environmental Sciences; USDA Cooperative State Research, Education, and Extension Service Hatch Project [ILLU-698-903]	ADM Institute for the Prevention of Postharvest Loss, Postharvest Loss Prevention Graduate Assistantship; Lo Fellowship through the Illinois College of Agriculture, Consumer, and Environmental Sciences; USDA Cooperative State Research, Education, and Extension Service Hatch Project	This study was supported by the ADM Institute for the Prevention of Postharvest Loss, Postharvest Loss Prevention Graduate Assistantship to RAC (https://postharvestinstitute.illinois.edu/), the Lo Fellowship through the Illinois College of Agriculture, Consumer, and Environmental Sciences to XC (https://fshn.illinois.edu/), and USDA Cooperative State Research, Education, and Extension Service Hatch Project ILLU-698-903 to MJS (https://nifa.usda.gov/grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARILLOT E, 1991, NUCLEIC ACIDS RES, V19, P6241, DOI 10.1093/nar/19.22.6241; Cheng XB, 2019, FOOD CONTROL, V98, P253, DOI 10.1016/j.foodcont.2018.11.037; Currie MJ, 2004, J CLIN MICROBIOL, V42, P4866, DOI 10.1128/JCM.42.10.4866-4867.2004; Dunham JP, 2013, COLD SPRING HARB PRO, V2013; EU, 2010, EUR UN COMM REG EC 1; FDA, 2019, GUID IND ACT LEV POI; Graesboll K, 2017, PREV VET MED, V139, P93, DOI 10.1016/j.prevetmed.2016.08.001; Hann M, 1999, J CHEM INF COMP SCI, V39, P897, DOI 10.1021/ci990423o; Helica Biosystems Inc., 2016, TOT AFL ASS; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2002, IARC Monogr Eval Carcinog Risks Hum, V82, P1; Jagadeesan B, 2019, INT J FOOD MICROBIOL, V289, P30, DOI 10.1016/j.ijfoodmicro.2018.08.017; Johansson AS, 2000, J AOAC INT, V83, P1264; Kainkaryam RM, 2009, CURR OPIN DRUG DISC, V12, P339; Kainkaryam RM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-256; KENNY GE, 1970, AM J EPIDEMIOL, V91, P439, DOI 10.1093/oxfordjournals.aje.a121154; Mogensen JM, 2011, FOOD ADDIT CONTAM A, P1; Motlekar N, 2008, ASSAY DRUG DEV TECHN, V6, P395, DOI 10.1089/adt.2007.110; Mutiga SK, 2014, PHYTOPATHOLOGY, V104, P1221, DOI 10.1094/PHYTO-01-14-0006-R; Pearson TC, 2001, T ASAE, V44, P1247, DOI 10.13031/2013.6418; Pohanka M, 2012, J APPL BIOMED, V10, P155, DOI 10.2478/v10136-012-0006-y; Saunders Kenneth C, 2004, Drug Discov Today Technol, V1, P373, DOI 10.1016/j.ddtec.2004.11.009; Stasiewicz MJ, 2017, FOOD CONTROL, V78, P203, DOI 10.1016/j.foodcont.2017.02.038; Thierry-Mieg N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-28; van Schalkwyk C, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3767-z; van Zyl GU, 2011, CLIN INFECT DIS, V52, P264, DOI 10.1093/cid/ciq084; Xin XF, 2009, GENOME RES, V19, P1262, DOI 10.1101/gr.090019.108; Yao H, 2010, FOOD ADDIT CONTAM A, V27, P701, DOI 10.1080/19440040903527368	27	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236668	10.1371/journal.pone.0236668	http://dx.doi.org/10.1371/journal.pone.0236668			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756571	Green Published, gold			2022-12-26	WOS:000560393300015
J	Flash, ML; Wong, ASM; Stevenson, MA; Gilkerson, JR				Flash, Meredith L.; Wong, Adelene S. M.; Stevenson, Mark A.; Gilkerson, James R.			Barriers to entering race training before 4 years of age for Thoroughbred horses born in the 2014 Australian foal crop	PLOS ONE			English	Article							MORTALITY; DEATH; DISEASE	Currently, there is a paucity of data on the barriers for Australian Thoroughbred horses transitioning from stud farm to racetrack. This paper reports the reasons why horses failed to enter race training and documents their exit destinations. Biographical records of Australian Thoroughbred horses born in 2014 were investigated to determine the number of horses that had not officially entered race training by the start of the 4-year old racing season (1 August 2018). Of the 13,677 foals born in 2014, 66% had commenced training and 51% had raced before the beginning of their 4-year-old season in Australia. A sampling frame based on the post code of the premises where foals were born and records from Racing Australia were used to select a geographically representative sample of the 2014 Australian Thoroughbred foal crop (n= 4,124). From the population eligible for sampling 1,275 horses that had not entered training were enrolled in the survey and their breeders were sent an online questionnaire with follow-up phone calls for those who had not responded. Of the 633 responses (50% of 1275) the most frequent outcomes for horses were: death (38%,n= 239), participation in the racing industry in their 4-year old racing season (24%,n= 154) and retirement (16%,n= 100) either as Australian Stud Book (ASB) bloodstock (n= 17), or as horses rehomed outside the Thoroughbred industry (n= 83). Illness or injury was the most frequent reason for horses not entering race training that were ASB bloodstock, rehomed or deceased. There was a loss of traceability at the point of sale with most horses sold at 1 year of age. This study provides important information on the reasons, alternative outcomes and gaps in traceability for horses not entering training prior to the 4-year-old racing season.	[Flash, Meredith L.; Stevenson, Mark A.; Gilkerson, James R.] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia; [Wong, Adelene S. M.] Univ Melbourne, Fac Vet & Agr Sci, Equine Ctr, Melbourne Vet Sch, Werribee, Vic, Australia	University of Melbourne; University of Melbourne	Flash, ML (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia.	flashm@student.unimelb.edu.au	Wong, Adelene/GPS-7804-2022	Gilkerson, James/0000-0003-1801-4817; Flash, Meredith/0000-0002-5120-8632	AgriFutures Australia, as part of the AgriFuturesT Thoroughbred Horses Program [PRJ-011251]	AgriFutures Australia, as part of the AgriFuturesT Thoroughbred Horses Program	This study was supported by AgriFutures Australia, as part of the AgriFuturesT Thoroughbred Horses Program (https://www.agrifutures.com.au), in the form of a grant awarded to MLF, JRG and MAS (PRJ-011251). The funders had no role in study design, data collection and analysis or preparation of the manuscript.	[Anonymous], 2019, AUSTR RULES RACING; [Anonymous], 2016, 2016 DIG BOUND ESRI; Bailey C., 1998, 9852 RIRDC; Bourke J.M., 1995, ANN SEM EQ BRANCH NZ; Burns BM, 2010, ANIM REPROD SCI, V122, P1, DOI 10.1016/j.anireprosci.2010.04.010; COHEN ND, 1994, J AM VET MED ASSOC, V204, P1644; Crettenden J., 2014, GRAIN GRAZE, P3; Galvin NP, 2010, IRISH VET J, V63, P37, DOI 10.1186/2046-0481-63-1-37; Haas SD, 1996, CAN VET J, V37, P91; IER, 2017, RAC AUSTR SIZ SCOP S; International Federation of Horseracing Authorities, 2014, IFHA ANN REP 2014 RE; JEFFCOTT LB, 1982, EQUINE VET J, V14, P185, DOI 10.1111/j.2042-3306.1982.tb02389.x; Lumley T., 2010, COMPLEX SURVEYS GUID, DOI [10.1002/9780470580066, DOI 10.1002/9780470580066]; Morley PS, 1997, EQUINE VET J, V29, P290, DOI 10.1111/j.2042-3306.1997.tb03126.x; Refshauge G, 2016, ANIM PROD SCI, V56, P726, DOI 10.1071/AN15121; Rogers CW, 2012, J VET BEHAV, V7, P375, DOI 10.1016/j.jveb.2012.01.003; Rogers CW, 2004, NEW ZEAL VET J, V52, P272, DOI 10.1080/00480169.2004.36439; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Tanner JC, 2013, EQUINE VET J, V45, P20, DOI 10.1111/j.2042-3306.2011.00534.x; Tanner JC, 2011, NEW ZEAL VET J, V59, P323, DOI 10.1080/00480169.2011.617029; TORTORA RD, 1978, AM STAT, V32, P100, DOI 10.2307/2683352; Velie BD, 2013, EQUINE VET J, V45, P410, DOI 10.1111/j.2042-3306.2012.00651.x; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	23	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0237003	10.1371/journal.pone.0237003	http://dx.doi.org/10.1371/journal.pone.0237003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756576	Green Published, gold			2022-12-26	WOS:000560393300040
J	Forsythe, ML; Alwithenani, A; Bethune, D; Castonguay, M; Drucker, A; Flowerdew, G; French, D; Fris, J; Greer, W; Henteleff, H; MacNeil, M; Marignani, P; Morzycki, W; Plourde, M; Snow, S; Xu, ZL				Forsythe, Marika L.; Alwithenani, Akram; Bethune, Drew; Castonguay, Mathieu; Drucker, Arik; Flowerdew, Gordon; French, Daniel; Fris, John; Greer, Wenda; Henteleff, Harry; MacNeil, Mary; Marignani, Paola; Morzycki, Wojciech; Plourde, Madeleine; Snow, Stephanie; Xu, Zhaolin			Molecular profiling of non-small cell lung cancer	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; ACQUIRED-RESISTANCE; PIK3CA MUTATION; EGFR MUTATIONS; OPEN-LABEL; SURVIVAL; IMPACT; OSIMERTINIB; MULTICENTER; CRIZOTINIB	Lung cancer is generally treated with conventional therapies, including chemotherapy and radiation. These methods, however, are not specific to cancer cells and instead attack every cell present, including normal cells. Personalized therapies provide more efficient treatment options as they target the individual's genetic makeup. The goal of this study was to identify the frequency of causal genetic mutations across a variety of lung cancer subtypes in the earlier stages. 833 samples of non-small cell lung cancer from 799 patients who received resection of their lung cancer, were selected for molecular analysis of six known mutations, includingEGFR,KRAS,BRAF,PIK3CA,HER2 and ALK. A SNaPshot assay was used for point mutations and fragment analysis searched for insertions and deletions.ALKwas evaluated by IHC +/- FISH. Statistical analysis was performed to determine correlations between molecular and clinical/pathological patient data. None of the tested variants were identified in most (66.15%) of cases. The observed frequencies among the total samples vs. only the adenocarcinoma cases were notable different, with the highest frequency being theKRASmutation (24.49% vs. 35.55%), followed byEGFR(6.96% vs. 10.23%),PIK3CA(1.20% vs. 0.9%),BRAF(1.08% vs. 1.62%),ALK(0.12% vs. 0.18%), while the lowest was theHER2mutation (0% for both). The statistical analysis yielded correlations between presence of a mutation with gender, cancer type, vascular invasion and smoking history. The outcome of this study will provide data that helps stratify patient prognosis and supports development of more precise treatments, resulting in improved outcomes for future lung cancer patients.	[Forsythe, Marika L.; Alwithenani, Akram; Castonguay, Mathieu; Fris, John; Greer, Wenda; Xu, Zhaolin] Dalhousie Univ Halifax, Fac Med, Dept Pathol, Halifax, NS, Canada; [Alwithenani, Akram] Umm Al Qura Univ Makkah, Fac Appl Med Sci, Dept Lab Med, Mecca, Saudi Arabia; [Bethune, Drew; French, Daniel; Henteleff, Harry; Plourde, Madeleine] Dalhousie Univ, Fac Med, Dept Surg, Halifax, NS, Canada; [Drucker, Arik; MacNeil, Mary; Morzycki, Wojciech; Snow, Stephanie] Dalhousie Univ, Fac Med, Div Med Oncol, Halifax, NS, Canada; [Flowerdew, Gordon] Dalhousie Univ, Fac Med, Dept Epidemiol, Halifax, NS, Canada; [Marignani, Paola] Dalhousie Univ, Fac Med, Dept Biochem & Mol Biol, Halifax, NS, Canada	Dalhousie University; Umm Al Qura University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	Xu, ZL (corresponding author), Dalhousie Univ Halifax, Fac Med, Dept Pathol, Halifax, NS, Canada.	zxu3@dal.ca	Snow, Stephanie/AAN-4936-2020	Snow, Stephanie/0000-0003-3847-0289; Marignani, Paola/0000-0001-8070-905X; Forsythe, Marika/0000-0002-9662-6643	Roche Canada; Pfizer Canada; Boehringer Ingelheim Canada	Roche Canada(Roche Holding); Pfizer Canada(Pfizer); Boehringer Ingelheim Canada(Boehringer Ingelheim)	The study was partially supported by Roche Canada, Pfizer Canada and Boehringer Ingelheim Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrose R, 2015, MED J DY PATIL U, V8, P447, DOI 10.4103/0975-2870.160783; [Anonymous], 2010, ROBBINS COTRAN PATHO; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Bauml J, 2013, CLIN LUNG CANCER, V14, P581, DOI 10.1016/j.cllc.2013.05.002; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Camidge DR, 2018, J CLIN ONCOL, V36, P2693, DOI 10.1200/JCO.2017.77.5841; Cataldo VD, 2011, NEW ENGL J MED, V364, P947, DOI 10.1056/NEJMct0807960; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Di Cristofaro J, 2010, J MOL DIAGN, V12, P453, DOI 10.2353/jmoldx.2010.090222; Gadgeel SM, 2016, J CLIN ONCOL, V34, P4079, DOI 10.1200/JCO.2016.68.4639; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Jackman DM, 2009, CLIN CANCER RES, V15, P5267, DOI 10.1158/1078-0432.CCR-09-0888; Johnson ML, 2013, CANCER-AM CANCER SOC, V119, P356, DOI 10.1002/cncr.27730; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; Kim DW, 2016, LANCET ONCOL, V17, P452, DOI 10.1016/S1470-2045(15)00614-2; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Kozaki KI, 2006, CANCER SCI, V97, P1351, DOI 10.1111/j.1349-7006.2006.00343.x; Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Mok TS, 2017, NEW ENGL J MED, V376, P629, DOI 10.1056/NEJMoa1612674; Nelson HH, 1999, J NATL CANCER I, V91, P2032, DOI 10.1093/jnci/91.23.2032; Peters S, 2017, NEW ENGL J MED, V377, P829, DOI 10.1056/NEJMoa1704795; Planchard D, 2016, LANCET ONCOL, V17, P984, DOI 10.1016/S1470-2045(16)30146-2; Ramalingam SS, 2018, J CLIN ONCOL, V36, P841, DOI 10.1200/JCO.2017.74.7576; Reddi HV, 2013, MUTATIONS EGFR PATHW; Sabari JK, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.72; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shaw AT, 2011, CLIN CANCER RES, V17, P2081, DOI 10.1158/1078-0432.CCR-10-1591; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Srigley JR, 2004, MODERN PATHOL, V17, P328, DOI 10.1038/modpathol.3800055; Stewart EL, 2015, TRANSL LUNG CANCER R, V4, P67, DOI 10.3978/j.issn.2218-6751.2014.11.06; Torre LA, 2016, ADV EXP MED BIOL, V893, P1, DOI 10.1007/978-3-319-24223-1_1; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Westcott PMK, 2013, CHIN J CANCER, V32, P63, DOI 10.5732/cjc.012.10098; Wu CC, 2009, LARYNGOSCOPE, V119, P2411, DOI 10.1002/lary.20621; Zappa C, 2016, TRANSL LUNG CANCER R, V5, P288, DOI 10.21037/tlcr.2016.06.07	40	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236580	10.1371/journal.pone.0236580	http://dx.doi.org/10.1371/journal.pone.0236580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756609	gold, Green Published			2022-12-26	WOS:000560393300011
J	Schillinger, M; Weigt, H; Hirsch, PE				Schillinger, Moritz; Weigt, Hannes; Hirsch, Philipp Emanuel			Environmental flows or economic woes-Hydropower under global energy market changes	PLOS ONE			English	Article							RECENT PROGRESS; SUPPORT; SCIENCE	The global energy system changes towards renewables-dominated and liberalized markets. This requires making novel trade-offs between the profitable development of hydropower and its environmental effects on the natural flow regime. Here, we used a pristine river as a model for how these future changes will affect the natural flow regime and identify future changes on previously overlooked levels. We found that damming and discharging based on market prices leads to first- and second-level deviation from natural flows. Beyond these effects, we identified a third level of distance from natural flow. This third level is created by the transition towards a renewables-dominated energy system. The volatile energy input from renewables incentivizes hydropower plant operators to discharge based on more flexible trading behavior. We conclude that novel economic models be combined with tailored implementations of environmental flows. This will allow to find novel solutions for the trade-off between market liberalization and sustainable hydropower development.	[Schillinger, Moritz; Weigt, Hannes] Univ Basel, Res Ctr Sustainable Energy & Water Supply, Basel, Switzerland; [Hirsch, Philipp Emanuel] Univ Basel, Dept Environm Sci, Program Man Soc Environm, Basel, Switzerland	University of Basel; University of Basel	Hirsch, PE (corresponding author), Univ Basel, Dept Environm Sci, Program Man Soc Environm, Basel, Switzerland.	philipp.hirsch@unibas.ch		Hirsch, Philipp Emanuel/0000-0002-6927-2368; Weigt, Hannes/0000-0002-2036-9177; Schillinger, Moritz/0000-0002-4641-4634	Swiss Commission for Technology and Innovation (CTI) [KTI. 1155000154]	Swiss Commission for Technology and Innovation (CTI)	The work was funded by the Swiss Commission for Technology and Innovation (CTI) under Grant No. KTI. 1155000154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was conducted within the SCCER CREST (Swiss Competence Center for Energy Research).	[Anonymous], 2014, BESCHREIBUNG REGELLE; [Anonymous], 2015, SWISS J EC STAT, DOI DOI 10.1007/BF03399415; [Anonymous], [No title captured]; [Anonymous], 2018, REN EL CAP GEN STAT; [Anonymous], 2018, MARK DAT DAY AH AUCT; Arthington AH, 2006, ECOL APPL, V16, P1311, DOI 10.1890/1051-0761(2006)016[1311:TCOPEF]2.0.CO;2; Barry M., 2015, FUTURE SWISS HYDROPO; Bogdanov D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08855-1; Couto TBA, 2018, FRONT ECOL ENVIRON, V16, P91, DOI 10.1002/fee.1746; Estoppey R, 2000, ANGEMESSENE RESTWASS; FOEN, 2018, HYDR DAT FOR STAT DA; Garrison TG, 2018, INCONSTANT LANDSCAPE: THE MAYA KINGDOM OF EL ZOTZ, GUATEMALA, P1, DOI 10.5876/9781607327646; Gernaat DEHJ, 2017, NAT ENERGY, V2, DOI 10.1038/s41560-017-0006-y; Griggs D.J., 2017, GUIDE SDG INTERACTIO; Grill G, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/1/015001; Hettrich R, 2011, STATUS PERSPEKTIVEN; Hirsch PE, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8090875; IEA, 2016, EL MARK SER; IEA, 2017, WORLD EN OUTL 2017; Jonker Klunne W., 2012, HYDROENERGIA; Kuittinen H, 2018, MISSION ORIENTED R I; Mannes S., 2008, REV GEOGRAPHIE ALPIN, P125, DOI [10.4000/rga, DOI 10.4000/RGA]; Markard J, 2018, NAT ENERGY, V3, P628, DOI 10.1038/s41560-018-0171-7; McManamay RA, 2016, RIVER RES APPL, V32, P1450, DOI 10.1002/rra.3004; Mitchell C., 2016, NATURE ENERGY, V1, P6586; N'Guyen A, 2016, AMBIO, V45, P280, DOI 10.1007/s13280-015-0723-z; Null SE, 2014, J ENVIRON MANAGE, V136, P121, DOI 10.1016/j.jenvman.2014.01.024; Ocker F, 2016, P 13 INT C EUR EN MA, P1, DOI DOI 10.1109/EEM.2016.7521193; OECD, 2011, WATER GOVERNANCE OEC; Olden JD, 2010, DIVERS DISTRIB, V16, P496, DOI 10.1111/j.1472-4642.2010.00655.x; Owusu AG, 2020, RIVER RES APPL, V55, P32; Poff NL, 2017, WATER FOR THE ENVIRONMENT: FROM POLICY AND SCIENCE TO IMPLEMENTATION AND MANAGEMENT, P203, DOI 10.1016/B978-0-12-803907-6.00011-5; Poff NL, 2013, CURR OPIN ENV SUST, V5, P667, DOI 10.1016/j.cosust.2013.11.006; Ramsar Secretariat, 2018, SCAL WETL CONS WIS U; Richter BD, 2012, RIVER RES APPL, V28, P1312, DOI 10.1002/rra.1511; Richter BD, 2010, RIVER RES APPL, V26, P1052, DOI 10.1002/rra.1320; Rintamaki T, 2016, ENERGY, V117, P300, DOI 10.1016/j.energy.2016.10.058; Rojanamon P, 2009, RENEW SUST ENERG REV, V13, P2336, DOI 10.1016/j.rser.2009.07.003; Ruffieux I., 2012, EUROPAS WERTVOLLSTER; Scheurer T, 2003, AQUAT SCI, V65, P183, DOI 10.1007/s00027-003-0667-4; Stoffels RJ, 2018, FRESHWATER BIOL, V63, P996, DOI 10.1111/fwb.13061; Stokstad E, 2016, SCIENCE, V351, P904, DOI 10.1126/science.351.6276.904; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Streimikiene D, 2016, RENEW SUST ENERG REV, V57, P72, DOI 10.1016/j.rser.2015.12.113; UN, 2015, UN TRANSF OUR WORLD, DOI [10.1201/b20466-7, DOI 10.1201/B20466-7]; United Nations Industrial Development Organization (UNIDO), 2016, WORLD SMALL HYDROPOW, P650; Vermeulen J, 2019, FITNESS CHECK EVALUA; Weigt H., 2017, SSRN, DOI [10.2139/ssrn.3110605, DOI 10.2139/SSRN.3110605]; WWF, 2018, FACTSH WWF GEW SENS	49	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236730	10.1371/journal.pone.0236730	http://dx.doi.org/10.1371/journal.pone.0236730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756584	gold, Green Published			2022-12-26	WOS:000560393300009
J	Ababneh, NA; Ali, D; Al-Kurdi, B; Sallam, M; Alzibdeh, AM; Salah, B; Ryalat, AT; Azab, B; Sharrack, B; Awidi, A				Ababneh, Nidaa A.; Ali, Dema; Al-Kurdi, Ban; Sallam, Malik; Alzibdeh, Abdulla M.; Salah, Bareqa; Ryalat, Abdee T.; Azab, Belal; Sharrack, Basil; Awidi, Abdalla			Identification of APTX disease-causing mutation in two unrelated Jordanian families with cerebellar ataxia and sensitivity to DNA damaging agents	PLOS ONE			English	Article								Background Ataxia with oculomotor apraxia type 1 (AOA1) is a rare autosomal recessive cerebellar ataxia, caused by mutations in theAPTXgene. The disease is characterized by early-onset cerebellar ataxia, oculomotor apraxia and severe axonal polyneuropathy. The aim of this study was to detect the disease-causing variants in two unrelated consanguineous Jordanian families with cerebellar ataxia using whole exome sequencing (WES), and to correlate the identified mutation(s) with the clinical and cellular phenotypes. Methods WES was performed in three affected individuals and segregation analysis of p.W279*APTXcandidate variant was performed. Expression levels ofAPTXwere measured in patients' skin fibroblasts and peripheral blood mononuclear cells, followed by western blot analysis in skin fibroblasts. Genotoxicity assay was performed to detect the sensitivity ofAPTXmutated cells to H2O2, MMC, MMS and etoposide. Results A recurrent homozygous nonsense variant inAPTXgene (c.837G>A, p.W279*) was revealed in all affected individuals. qRT-PCR showed normalAPTXlevels in peripheral blood and lower levels in fibroblast cells. However, western blot showed the absence ofAPTXprotein in patients' skin fibroblasts. Significant hypersensitivity to H2O2, MMC and etoposide and lack of sensitivity to MMS were noted. Conclusions This is the first study to report the identification of a nonsense variant in theAPTXgene (c.837G>A; p.W279*) in AOA1 patients within the Jordanian population. This study confirmed the need of WES to assist in the diagnosis of cerebellar ataxia and it emphasizes the importance of studying the pathophysiology of theAPTXgene.	[Ababneh, Nidaa A.; Ali, Dema; Al-Kurdi, Ban; Awidi, Abdalla] Univ Jordan, Cell Therapy Ctr, Amman, Jordan; [Sallam, Malik; Azab, Belal] Univ Jordan, Sch Med, Dept Pathol Microbiol & Forens Med, Amman, Jordan; [Sallam, Malik] Jordan Univ Hosp, Dept Clin Labs & Forens Med, Amman, Jordan; [Sallam, Malik] Lund Univ, Dept Translat Med, Fac Med, Malmo, Sweden; [Alzibdeh, Abdulla M.] Univ Jordan, Sch Med, Amman, Jordan; [Salah, Bareqa] Univ Jordan, Jordan Univ Hosp, Gen Surg Dept Plast & Reconstruct, Amman, Jordan; [Ryalat, Abdee T.] King Hussein Canc Ctr, Amman, Jordan; [Azab, Belal] Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Richmond, VA USA; [Sharrack, Basil] Royal Hallamshire Hosp, Acad Dept Neurosci, Sheffield, S Yorkshire, England; [Sharrack, Basil] Royal Hallamshire Hosp, Sheffield NIHR Neurosci BRC, Sheffield, S Yorkshire, England; [Sharrack, Basil] Univ Sheffield, Sheffield, S Yorkshire, England; [Awidi, Abdalla] Univ Jordan, Sch Med, Hemostasis & Thrombosis Lab, Amman, Jordan; [Awidi, Abdalla] Jordan Univ Hosp, Dept Hematol & Oncol, Amman, Jordan	University of Jordan; University of Jordan; University of Jordan; Lund University; University of Jordan; University of Jordan; King Hussein Cancer Center; Virginia Commonwealth University; University of Sheffield; University of Sheffield; University of Sheffield; University of Jordan; University of Jordan	Ababneh, NA; Awidi, A (corresponding author), Univ Jordan, Cell Therapy Ctr, Amman, Jordan.; Awidi, A (corresponding author), Univ Jordan, Sch Med, Hemostasis & Thrombosis Lab, Amman, Jordan.; Awidi, A (corresponding author), Jordan Univ Hosp, Dept Hematol & Oncol, Amman, Jordan.	nidaaanwar@gmail.com; abdalla.awidi@gmail.com	Sallam, Malik/O-5021-2014; Azab, Belal/AAJ-5652-2021	Sallam, Malik/0000-0002-0165-9670; Azab, Belal/0000-0003-0293-6489; Ababneh, Nidaa A/0000-0002-2155-3013; Alzibdeh, Abdulla/0000-0002-4962-8398	deanship of scientific research, University of Jordan [2018-2017/2]	deanship of scientific research, University of Jordan	This work was supported by the deanship of scientific research, University of Jordan, grant (2018-2017/2). The funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of research materials.	Ahel I, 2006, NATURE; Amouri R, 2004, NEUROLOGY; Barbot C, 2001, ARCH NEUROL; Beaudin M, 2017, CEREBELLUM ATAXIAS; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Castellotti B, 2011, NEUROGENETICS; Crimella C, 2011, HUM MUTAT; Date H, 2001, NAT GENET; Fukuhara N, 1995, J NEUROL SCI; Garcia-Diaz B, 2015, HUM MOL GENET; Gueven N, 2004, HUM MOL GENET; Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359; Hirano M, 2007, ANN NEUROL; Kiriyama T, 2008, BIOCH BIOPHYS RES CO; Le Ber I, 2003, BRAIN; Luo H, 2004, MOL CELL BIOL; Moreira MC, 2001, NAT GENET; Onodera O., 2006, NEUROPATHOLOGY; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Shimazaki H, 2002, NEUROLOGY; Tumbale P, 2014, NATURE; Tumbale P, 2018, EMBO J, V37, DOI 10.15252/embj.201798875; Yokoseki A, 2011, BRAIN; Yoon G, 2009, BMJ CASE REP; Yoon Grace, 2018, Handb Clin Neurol, V155, P105, DOI 10.1016/B978-0-444-64189-2.00007-X	25	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0236808	10.1371/journal.pone.0236808	http://dx.doi.org/10.1371/journal.pone.0236808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750061	gold, Green Published			2022-12-26	WOS:000560009200008
J	Abid, A; Jie, S; Aslam, W; Batool, S; Lili, Y				Abid, Ali; Jie, Shang; Aslam, Waqas; Batool, Saima; Lili, Yue			Application of structural equation modelling to develop a conceptual model for smallholder's credit access: The mediation of agility and innovativeness in organic food value chain finance	PLOS ONE			English	Article							PLS-SEM; INFORMATION-TECHNOLOGY; CONTRACTUAL GOVERNANCE; RELATIONAL GOVERNANCE; SUPPLY CHAINS; AGRICULTURE; FARMERS; LIVELIHOOD; CHALLENGES; SYSTEMS	Developing a conceptual model is vital for small-scale organic farmer's credit access to sustain the livelihoods. However, smallholders continually face severe problems in getting finance that lead to reduce investment and in turn, challenges the livelihoods. Therefore, the aim of the present study was to establish and empirically test a theoretical model to explore how agility and innovativeness in organic food value chain finance are achieved through ITI, TRST, CG, ICT, and IS, and how these, in turn, can accelerate financial flow in the value chain and enhance competitiveness. The present study used a survey method and collected data from small-scale farmers, traders, and financial institutions. The model and hypothesis are tested using data obtained from 331 respondents through partial least square structure equation modeling techniques. We argue that development of theoretical model show potential to increase creditworthiness of smallholders and overcome uncertainties that impede traditional value chain credit arrangement. Thus, the present study could provide new ways to integrate the value chain partners, through information and communication technology and governance arrangements in the organic food value chain financing. This study demonstrates that the mediations of innovativeness and agility significantly affect the development of new financial products to make agile the financial flow, which in turn positively influences value chain competitiveness. Significant judgments are required for trustworthy relations among the value chain partners to positively harness innovative product development for swifter value chain finance. Therefore, this theoretical model should not be regarded as a quick solution, but a process of testing, error, and learning by doing so.	[Abid, Ali; Jie, Shang; Aslam, Waqas] Northeast Forestry Univ, Coll Econ & Management, Agr Econ & Management, Harbin, Heilongjiang, Peoples R China; [Batool, Saima] Zhejiang Univ, Sch Management Tourism & Hotel Management, Hangzhou, Peoples R China; [Lili, Yue] Heilongjiang Univ Tradit Chinese Med, Resources & Dev Tradit Chinese Med, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China; Zhejiang University; Heilongjiang University of Chinese Medicine	Jie, S (corresponding author), Northeast Forestry Univ, Coll Econ & Management, Agr Econ & Management, Harbin, Heilongjiang, Peoples R China.	shangjie2005@126.com	Aslam, Waqas/GLR-1595-2022	Aslam, Waqas/0000-0003-0096-5841; Abid, Ali/0000-0002-1107-9813; Jie, Shang/0000-0002-3887-522X	Chinese Scholarship Council; Northeast Forestry University, Harbin, Heilongjiang, China	Chinese Scholarship Council(China Scholarship Council); Northeast Forestry University, Harbin, Heilongjiang, China	This work was supported by Chinese Scholarship Council and Northeast Forestry University, Harbin, Heilongjiang, China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceleanu MI, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8030245; Akram MW, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11247148; Akram MW, 2019, CUST AGRONEGOCIO, V15, P141; Ali J, 2011, INT J INFORM MANAGE, V31, P149, DOI 10.1016/j.ijinfomgt.2010.07.008; Altenbuchner C, 2018, RENEW AGR FOOD SYST, V33, P373, DOI [10.1017/S174217051700014X, 10.1017/s174217051700014x]; ANDERSON JC, 1990, J MARKETING, V54, P42, DOI 10.2307/1252172; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; [Anonymous], 2018, 2018 IEEE INT POW EL, DOI DOI 10.1109/PEAC.2018.8590330; Bakshi KA, 2016, VALUE CHAIN FINANCIN; Birthal PS, 2005, VERTICAL COORDINATIO; Brown M, 2010, J FINANC INTERMED, V19, P255, DOI 10.1016/j.jfi.2009.03.001; Cafaggi F, 2014, EUR J LAW ECON, V37, P131, DOI 10.1007/s10657-013-9421-0; Calantone RJ, 2002, IND MARKET MANAG, V31, P515, DOI 10.1016/S0019-8501(01)00203-6; Cao M, 2011, J OPER MANAG, V29, P163, DOI 10.1016/j.jom.2010.12.008; Cao Z, 2015, J OPER MANAG, V33-34, P15, DOI 10.1016/j.jom.2014.09.009; Cavenaghi E., 2014, J PAYMENTS STRATEGY, V7, P290; Chen KZ, 2015, CHINA AGR ECON REV, V7, P616, DOI 10.1108/CAER-02-2015-0016; Chin WW, 1998, QUANT METH SER, P295; Clemons E. K., 1992, Journal of Management Information Systems, V9, P9; Clemons E. K., 1993, Journal of Management Information Systems, V10, P9; Cranfield J, 2010, AGR HUM VALUES, V27, P291, DOI 10.1007/s10460-009-9222-9; Crowder DW, 2015, P NATL ACAD SCI USA, V112, P7611, DOI 10.1073/pnas.1423674112; Dar MI, 2017, PAKISTAN EC SURVEY 2; Dharani M VS, 2016, AGR FINANC REV, V76, P1; Diniz EH, 2014, J GLOB INF MANAG, V22, P34, DOI 10.4018/jgim.2014010103; Djokoto Justice G., 2016, Cogent Food & Agriculture, V2, DOI 10.1080/23311932.2016.1242181; Doney PM, 1997, J MARKETING, V61, P35, DOI 10.2307/1251829; Dubey R, 2018, MANAG DECIS; Edwardson W., 2013, ORGANIC SUPPLY CHAIN; Elahi E, 2018, LAND USE POLICY, V71, P249, DOI 10.1016/j.landusepol.2017.12.006; Ellis F., 1996, AGR POLICIES DEV COU; Enquist B, 2011, J SERV MANAGE, V22, P217, DOI 10.1108/09564231111124235; Fahad Aldosari, 2019, Journal of the Saudi Society of Agricultural Sciences, V18, P211, DOI 10.1016/j.jssas.2017.05.004; Fasnacht D., 2009, OPEN INNOVATION FINA, DOI [10.1007/978-3-319-76394-1_4, DOI 10.1007/978-3-319-76394-1_4]; Financing. Al. GM, 2017, DIFFERENT MODELS FIN, P33; Froehlich AG, 2018, ECOL ECON, V150, P307, DOI 10.1016/j.ecolecon.2018.04.022; Gallardo J, 2006, STRATEGIC ALLIANCES; Grandori A, 2019, EUR MANAG REV, V16, P413, DOI 10.1111/emre.12291; Guesmi B, 2012, SPAN J AGRIC RES, V10, P552, DOI 10.5424/sjar/2012103-462-11; Guo SL, 2019, SUSTAIN DEV, V27, P725, DOI 10.1002/sd.1937; Hair J, 2017, IND MANAGE DATA SYST, V117, P442, DOI 10.1108/IMDS-04-2016-0130; Hair JF, 2012, J ACAD MARKET SCI, V40, P414, DOI 10.1007/s11747-011-0261-6; Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202; Hair JF, 2020, J BUS RES, V109, P101, DOI 10.1016/j.jbusres.2019.11.069; Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128; Hair Jr J. F., 2016, PRIMER PARTIAL LEAST; Hammad HM, 2011, PAK J AGR SCI, V48, P97; Hanson J, 2004, RENEW AGR FOOD SYST, V19, P218, DOI [10.1079/RAFS200482, 10.1079/RAF200482]; Haq A, 2013, WHO IS ARTHI; Henseler J, 2016, IND MANAGE DATA SYST, V116, P2, DOI 10.1108/IMDS-09-2015-0382; Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8; Ho, 2014, HDB UNIVARIATE MULTI; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Hult GTM, 2004, IND MARKET MANAG, V33, P429, DOI 10.1016/j.indmarman.2003.08.015; Hurt H.T., 1977, HUM COMMUN RES, V4, P58, DOI [DOI 10.1111/J.1468-2958.1977.TB00597.X, 10.1111/j.1468-2958.1977.tb00597.x]; Husnain MIU, 2017, JAPS J ANIM PLANT SC, V27; Ihnatenko M, 2018, DEV REGIONAL PROGRAM; Imtiaz SY, 2015, TELEMAT INFORM, V32, P254, DOI 10.1016/j.tele.2014.09.002; Issa I, 2017, SUSTAINABILITY, P1; Jawadi F, 2013, SUPPLY CHAIN MANAGEM, P14; Johnston C., 2008, Enterprise Development & Microfinance, V19, P281, DOI 10.3362/1755-1986.2008.026; Jones G, 2015, AGRIC FINANCE REV, V75, P469, DOI 10.1108/AFR-01-2015-0002; Karimi H, 2019, SP PROC EARTH ENV SC, P1, DOI 10.1007/978-3-030-18641-8_1; Kaufman A, 2000, STRATEGIC MANAGE J, V21, P649, DOI 10.1002/(SICI)1097-0266(200006)21:6<649::AID-SMJ108>3.0.CO;2-U; Khanal AR, 2018, LAND USE POLICY, V78, P367, DOI 10.1016/j.landusepol.2018.07.012; Kilelu CW, 2017, EXP AGR, V53, P269, DOI 10.1017/S0014479716000375; Kim M, 2017, INT J PROD ECON, V187, P42, DOI 10.1016/j.ijpe.2017.02.007; Kirechev D., 2018, IZV J UNION SCI EC S, V7, P294; Kissoly L, 2017, FOOD SECUR, V9, P1219, DOI 10.1007/s12571-016-0642-2; Kopparthi MS, 2012, MANAG FINANC, V38, P993, DOI 10.1108/03074351211255182; Kousar R, 2019, SUSTAINABILITY, V11, P1; Lane C, 1996, ORGAN STUD, V17, P365, DOI 10.1177/017084069601700302; Lehn K, 2018, INT J ECON BUS, V25, P65, DOI 10.1080/13571516.2017.1396661; Liu WH, 2009, J SW JIAOTONG U SOCI, V4, P26; Llanto GM, 2007, ASIAN J AGRIC DEV, V4, P23; Luhmann N., 2000, TRUST MAKING BREAKIN, P94; Lyman TR, 2008, REGULATING TRANSFORM; Mani G, 2017, IND STUD BUS ECON, P3, DOI 10.1007/978-981-10-5957-5_1; Max M, 2017, FOCUS NOTE; Middelberg S. L., 2017, Enterprise Development & Microfinance, V28, P112, DOI 10.3362/1755-1986.16-00027; Miller C, 2010, AGR VALUE CHAIN FINA, P1; Miller C., 2012, AGR VALUE CHAIN FINA; Moretto A, 2019, J PURCH SUPPLY MANAG, V25, P197, DOI 10.1016/j.pursup.2018.06.004; Ngenoh E, 2019, AGR FOOD ECON, V7, DOI 10.1186/s40100-019-0122-z; Oberholster C, 2015, OUTLOOK AGR, V44, P49, DOI 10.5367/oa.2015.0197; Oladele OI, 2011, J AGRIC FOOD INF, V12, P167, DOI 10.1080/10496505.2011.563229; PAGANO M, 1993, J FINANC, V48, P1693; Panayides PM, 2009, INT J PROD ECON, V122, P35, DOI 10.1016/j.ijpe.2008.12.025; Pappa IC, 2018, J RURAL STUD, V58, P123, DOI 10.1016/j.jrurstud.2018.01.001; Poppo L, 2002, STRATEGIC MANAGE J, V23, P707, DOI 10.1002/smj.249; Qiao YH, 2019, CAN J DEV STUD, V40, P64, DOI 10.1080/02255189.2019.1520693; Ragatz GL, 1997, J PROD INNOVAT MANAG, V14, P190, DOI 10.1016/S0737-6782(97)00007-6; Ramesh R, 2017, 2017 INTERNATIONAL CONFERENCE ON NEXTGEN ELECTRONIC TECHNOLOGIES: SILICON TO SOFTWARE (ICNETS2), P10, DOI 10.1109/ICNETS2.2017.8067886; Rao P, 2005, INT J OPER PROD MAN, V25, P898, DOI 10.1108/01443570510613956; Rasul G, 2015, ECOL FOOD NUTR; Salampasis M, 2013, PROC TECH, V8, P1, DOI 10.1016/j.protcy.2013.11.001; Sanders N.R., 2005, J SUPPLY CHAIN MANAG, V41, P4, DOI [DOI 10.1111/j.1055-6001.2005.04102001.x, DOI 10.1111/J.1055-6001.2005.04102001.X]; Saqib S. E., 2018, Kasetsart Journal of Social Sciences, V39, P262, DOI 10.1016/j.kjss.2017.06.001; Scott S, 2014, FOOD POLICY, V45, P158, DOI 10.1016/j.foodpol.2013.08.002; Shahbaz B, 2010, PAK J AGR SCI, V47, P417; Simon A, 2012, IND MANAG DATA SYST; Singh A, 2016, COMPUT HUM BEHAV, V54, P290, DOI 10.1016/j.chb.2015.07.051; Song H, 2018, INT J PHYS DISTRIB L; Stroeken JHM, 2000, INT J TECHNOL MANAGE, V20, P156, DOI 10.1504/IJTM.2000.002861; Svensson G., 2001, MANAG DECIS; Swafford PM, 2008, INT J PROD ECON, V116, P288, DOI 10.1016/j.ijpe.2008.09.002; Swafford PM, 2006, INT J OPER PROD MAN; Swinnen JFM, 2007, AGR ECON-BLACKWELL, V37, P89, DOI 10.1111/j.1574-0862.2007.00237.x; Tan FTC, 2017, INFORM MANAGE-AMSTER, V54, P292, DOI 10.1016/j.im.2016.08.001; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Tyler K, 2007, J SERV MARK, V31, P334; ul Husnain MI, 2015, PUBLIC PRIVATE BENEF; Um KH, 2019, INT J PROD ECON, V217, P97, DOI 10.1016/j.ijpe.2018.03.025; van Ginkel M, 2013, FOOD SECUR, V5, P751, DOI 10.1007/s12571-013-0305-5; van Woerkum C, 2011, PLAN THEOR, V10, P144, DOI 10.1177/1473095210389651; Vieira LM, 2013, BRIT FOOD J, V115, P1454, DOI 10.1108/BFJ-06-2011-0160; Waheed S., 2016, PAK EC SOC REV, V47, P31; Wang B, 2013, IEEE IMAGE PROC, P4417, DOI 10.1109/ICIP.2013.6738910; Webber CM, 2010, AGRIC RURAL DEV, P1, DOI 10.1596/978-0-8213-7952-3; Yaseen A, 2018, J AGRIBUS DEV EMERG, V8, P579, DOI [10.1108/JADEE-07-2017-0072, 10.1108/jadee-07-2017-0072]; Zhang QY, 2002, INT J PROD RES, V40, P561, DOI 10.1080/00207540110091695; Zhao J, 2019, CHINA AGR EC REV; Zhao Q, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11051419; Zhou KZ, 2010, J INT BUS STUD, V41, P861, DOI 10.1057/jibs.2010.7	124	9	9	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0235921	10.1371/journal.pone.0235921	http://dx.doi.org/10.1371/journal.pone.0235921			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA7PQ	32750049	Green Published, gold			2022-12-26	WOS:000560009200011
J	Fukuoka, CY; Vicari, HP; Sipert, CR; Bhawal, UK; Abiko, Y; Arana-Chavez, VE; Simoes, A				Fukuoka, Cintia Yuki; Vicari, Hugo Passos; Sipert, Carla Renata; Bhawal, Ujjal Kumar; Abiko, Yoshimitsu; Arana-Chavez, Victor Elias; Simoes, Alyne			Early effect of laser irradiation in signaling pathways of diabetic rat submandibular salivary glands	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; TNF-ALPHA; THERAPY LLLT; APOPTOSIS; ACTIVATION; PHOSPHORYLATION; AUTOPHAGY; PHOTOTHERAPY; MECHANISMS; EXPRESSION	Low-power laser irradiation (LPLI) is clinically used to modulate inflammation, proliferation and apoptosis. However, its molecular mechanisms are still not fully understood. This study aimed to describe the effects of LPLI upon inflammatory, apoptotic and proliferation markers in submandibular salivary glands (SMGs) in an experimental model of chronic disorder, 24h after one time irradiation. Diabetes was induced in rats by the injection of streptozotocin. After 29 days, these animals were treated with LPLI in the SMG area, and euthanized 24h after this irradiation. Treatment with LPLI significantly decreased diabetes-induced high mobility group box 1 (HMGB1) and tumor necrosis factor alpha (TNF-alpha) expression, while enhancing the activation of the transcriptional factor cAMP response element binding (CREB) protein. LPLI also reduced the expression of bax, a mitochondrial apoptotic marker, favoring the cell survival. These findings suggest that LPLI can hamper the state of chronic inflammation and favor homeostasis in diabetic rats SMGs.	[Fukuoka, Cintia Yuki; Vicari, Hugo Passos; Arana-Chavez, Victor Elias; Simoes, Alyne] Univ Sao Paulo, Sch Dent, Dept Biomat & Oral Biol, Lab Oral Biol, Sao Paulo, Brazil; [Sipert, Carla Renata] Univ Sao Paulo, Sch Dent, Div Endodont, Dept Restorat Dent, Sao Paulo, Brazil; [Bhawal, Ujjal Kumar; Abiko, Yoshimitsu] Nihon Univ, Dept Biochem & Mol Biol, Sch Dent Matsudo, Matsudo, Chiba, Japan	Universidade de Sao Paulo; Universidade de Sao Paulo; Nihon University	Simoes, A (corresponding author), Univ Sao Paulo, Sch Dent, Dept Biomat & Oral Biol, Lab Oral Biol, Sao Paulo, Brazil.	lysimoes@usp.br	Vicari, Hugo/AAG-2503-2021; Simoes, Alyne/G-2176-2012	Simoes, Alyne/0000-0002-4873-1393; Fukuoka, Cintia Yuki/0000-0001-6140-3549; Vicari, Hugo/0000-0001-6121-3315	Brazilian Federal Agency for Support and Evaluation of Graduate Education CAPES [BEX 18807/12-7, PNPD 20131614-33002010141P2, 2014/21214-1, 2020/09547-6]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Ministry of Education, Culture, Sports, Science and Technology of Japan	Brazilian Federal Agency for Support and Evaluation of Graduate Education CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors wish to express their gratitude to the Brazilian Federal Agency for Support and Evaluation of Graduate Education CAPES, scholarship process BEX 18807/12-7, PNPD 20131614-33002010141P2 and grants no 2014/21214-1 and 2020/09547-6, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). This work was also supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Amadio EM, 2015, LASER MED SCI, V30, P1127, DOI 10.1007/s10103-015-1713-x; ANDERSON LC, 1994, MICROSC RES TECHNIQ, V27, P61, DOI 10.1002/jemt.1070270105; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Chu YH, 2018, LASER MED SCI, V33, P279, DOI 10.1007/s10103-017-2364-x; Costes S, 2004, ANN NY ACAD SCI, V1030, P230, DOI 10.1196/annals.1329.029; CUTLER LS, 1979, VIRCHOWS ARCH A, V382, P301, DOI 10.1007/BF00430406; Dalle Stephane, 2011, Curr Mol Pharmacol, V4, P187; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; de Castro JR, 2018, THESIS; de Castro JR, 2018, J BIOPHOTONICS, V11, DOI 10.1002/jbio.201700179; Desta T, 2010, J DENT RES, V89, P609, DOI 10.1177/0022034510362960; Fukuoka CY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169443; Fukuoka CY, 2016, J BIOPHOTONICS, V9, P1246, DOI 10.1002/jbio.201600175; GAUTHIER N, 2013, PLOS ONE, V0008, DOI DOI 10.1371/JOURNAL.PONE.005406723342077; Gerlo S, 2011, CELL MOL LIFE SCI, V68, P3823, DOI 10.1007/s00018-011-0757-8; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; HAND AR, 1984, LAB INVEST, V51, P429; Hudson BI, 2018, ANNU REV MED, V69, P349, DOI 10.1146/annurev-med-041316-085215; Ibuki FK, 2013, LASER MED SCI, V28, P911, DOI 10.1007/s10103-012-1173-5; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Khodeer DM, 2016, CAN J PHYSIOL PHARM, V94, P463, DOI 10.1139/cjpp-2015-0135; Lee SC, 2007, INT J BIOCHEM CELL B, V39, P497, DOI 10.1016/j.biocel.2006.09.007; Li DX, 2014, BRAZ J MED BIOL RES, V47, P1036, DOI 10.1590/1414-431X20143996; Lin HD, 2012, RHEUMATOL INT, V32, P759, DOI 10.1007/s00296-010-1629-5; Livesey KM, 2012, CANCER RES, V72, P1996, DOI 10.1158/0008-5472.CAN-11-2291; Lopes-Martins RAB, 2007, CURR RHEUMATOL REV, V3, P147, DOI 10.2174/157339707780619421; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McCubrey JA, 2007, ADV ENZYME REGUL, V47, P64, DOI 10.1016/j.advenzreg.2006.12.013; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Naqvi S, 2014, BIOCHEM J, V458, P469, DOI 10.1042/BJ20131115; Pansani TN, 2014, INT J ORAL MAX SURG, V43, P1030, DOI 10.1016/j.ijom.2014.02.011; Oliveira RG, 2013, LASER MED SCI, V28, P1519, DOI 10.1007/s10103-012-1262-5; Otrocka-Domagala I, 2015, POL J VET SCI, V18, P523, DOI 10.1515/pjvs-2015-0068; Peplow PV, 2012, PHOTOMED LASER SURG, V30, P617, DOI 10.1089/pho.2012.3312; Peplow PV, 2011, PHOTOMED LASER SURG, V29, P285, DOI 10.1089/pho.2010.2846; Petrovic A, 2017, J PHYSIOL BIOCHEM, V73, P511, DOI 10.1007/s13105-017-0574-0; Romero AC, 2012, ARCH ORAL BIOL, V57, P1189, DOI 10.1016/j.archoralbio.2012.02.016; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Simoes A, 2009, SPEC CARE DENT, V29, P134, DOI 10.1111/j.1754-4505.2009.00078.x; Simoes A, 2010, PHOTOMED LASER SURG, V28, P91, DOI 10.1089/pho.2009.2495; Simoes A, 2009, PHOTOMED LASER SURG, V27, P877, DOI 10.1089/pho.2008.2452; Simoes A, 2009, LASER SURG MED, V41, P264, DOI 10.1002/lsm.20758; Simoes A, 2009, LASER MED SCI, V24, P591, DOI 10.1007/s10103-008-0619-2; SUNG BS, 2017, EVID BASED COMPLEMEN, V2017, DOI DOI 10.1155/2017/718163728408940; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136564; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang LY, 2019, LASER MED SCI, V34, P169, DOI 10.1007/s10103-018-2673-8; Won YJ, 2009, BIOCHEM BIOPH RES CO, V380, P655, DOI 10.1016/j.bbrc.2009.01.159; Wu CZ, 2018, ONCOTARGETS THER, V11, P4501, DOI 10.2147/OTT.S167197; Yan XD, 2017, LASER MED SCI, V32, P169, DOI 10.1007/s10103-016-2099-0	51	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0236727	10.1371/journal.pone.0236727	http://dx.doi.org/10.1371/journal.pone.0236727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750068	Green Published, gold			2022-12-26	WOS:000560009200036
J	Hur, MS; Jehoon, O; Yang, HM; Kwon, HJ; Lee, S; Lim, HS; Lim, SY; Oh, CS				Hur, Mi-Sun; Jehoon, O.; Yang, Hun-Mu; Kwon, Hyun-Jin; Lee, Seunggyu; Lim, Ha Seong; Lim, So Young; Oh, Chang-Seok			Heights and spatial relationships of the facial muscles acting on the nasolabial fold by dissection and three-dimensional microcomputed tomography	PLOS ONE			English	Article							ZYGOMATICUS MAJOR MUSCLE; ANATOMIC VARIATIONS; MIDFACIAL MUSCLES; CREASE	The aim of this study was to clarify the heights and spatial relationships of the facial muscles acting on the nasolabial fold (NLF) by dissection and three-dimensional microcomputed tomography for use in aesthetic treatments. This study used 56 specimens from 34 embalmed adult Korean. A reference line (RF) was set to imitate the NLF after removing the skin, from the superior point of the alar facial crease to the lateral point of the orbicularis oris muscle at the level of the corner of the mouth. The heights and spatial relationships of the facial muscles along the RF could be categorized into five main patterns. The dominant pattern was that the levator labii superioris alaeque nasi muscle (LLSAN), levator labii superioris muscle (LLS), zygomaticus minor muscle (Zmi), and zygomaticus major muscle (Zmj) were on the medial third, medial half, middle third, and lateral third of the RF, respectively. In micro-CT imaging, beneath the skin of the medial half of the NLF, the LLSAN and Zmi fibers inserted into the dermis of the NLF and adjacent to the NLF. Beneath the skin of the middle third of the NLF, the Zmi fibers were found before the muscle inserted into the dermis of the NLF and adjacent to the NLF. Beneath the skin of the lateral third of the NLF, the lateral margin of the orbicularis oris muscle and some Zmj fibers were found at the location of the NLF. The present study utilized dissections and micro-CT to reveal the general pattern and variations of heights and spatial relationships of the facial muscles passing beneath the NLF. These findings will be useful for understanding which muscles affect specific parts of NLFs with various contours, for reducing the NLF in aesthetic treatments, and for reconstructing the NLF in cases of facial paralysis.	[Hur, Mi-Sun] Catholic Kwandong Univ, Dept Anat, Coll Med, Kangnung, South Korea; [Jehoon, O.; Yang, Hun-Mu; Kwon, Hyun-Jin] Yonsei Univ, Dept Anat, Coll Med, Seoul, South Korea; [Jehoon, O.; Yang, Hun-Mu; Kwon, Hyun-Jin] Gyeongsang Natl Univ, Dept Math, Jinju, South Korea; [Lee, Seunggyu] Gyeongsang Natl Univ, Res Inst Nat Sci, Jinju, South Korea; [Lim, Ha Seong] Areumdaunnara Dermatol Clin, Seongnam, South Korea; [Lim, So Young] Sungkyunkwan Univ, Dept Plast Surg, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Oh, Chang-Seok] Sungkyunkwan Univ, Dept Anat & Cell Biol, Sch Med, Suwon, South Korea	Catholic Kwandong University; Yonsei University; Yonsei University Health System; Gyeongsang National University; Gyeongsang National University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Oh, CS (corresponding author), Sungkyunkwan Univ, Dept Anat & Cell Biol, Sch Med, Suwon, South Korea.	changoh@skku.edu	O, Jehoon/AAG-1633-2021	O, Jehoon/0000-0003-4351-3183; Kwon, Hyun-Jin/0000-0001-7752-6172; Lee, Seunggyu/0000-0003-3141-6968; Yang, Hun-Mu/0000-0003-1954-0114	National Research Foundation of Korea (NRF) - Korea government (MSIT) [2020R1C1C1003237]	National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	HUR MS. No.2020R1C1C1003237 National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT). https://ernd.nrf.re.kr/index.do The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.dona.	Azizadeh B, 2017, MASTER TECHNIQUES FA, V2nd; Beer GM, 2013, CLIN ANAT, V26, P196, DOI 10.1002/ca.22100; Benedetto A. V., 2018, BOTULINUM TOXINS CLI, V3; de Maio M., 2007, RZANY B BOTULINUM TO; Farahvash MR, 2010, AESTHET SURG J, V30, P17, DOI 10.1177/1090820X09360703; Fay A, 2016, DIS DISORDERS ORBIT; Grablowitz D, 2019, CLIN COSMET INV DERM, V12, P857, DOI 10.2147/CCID.S211544; Hu KS, 2008, J CRANIOFAC SURG, V19, P534, DOI 10.1097/SCS.0b013e318163e400; Hur MS, 2018, CLIN ANAT, V31, P974, DOI 10.1002/ca.23272; Jin HR, 2016, AESTHETIC PLASTIC SU; Kane Michael A C, 2003, Plast Reconstr Surg, V112, p66S, DOI 10.1097/01.PRS.0000082195.44980.10; Kim H. J., 2016, CLIN ANATOMY FACE FI; Kwon HJ, 2020, PLAST RECONSTR SURG, V145, P71, DOI 10.1097/PRS.0000000000006328; Pessa JE, 1998, PLAST RECONSTR SURG, V102, P1888, DOI 10.1097/00006534-199811000-00013; PESSA JE, 1992, AESTHET PLAST SURG, V16, P167, DOI 10.1007/BF00450609; Pessa JE, 1998, CLIN ANAT, V11, P310, DOI 10.1002/(SICI)1098-2353(1998)11:5<310::AID-CA3>3.0.CO;2-T; PESSA JE, 1992, ANN PLAS SURG, V29, P23, DOI 10.1097/00000637-199207000-00006; Petitjean C, 2011, MED IMAGE ANAL, V15, P169, DOI 10.1016/j.media.2010.12.004; Pogrel MA, 1998, ORAL SURG ORAL MED O, V86, P410, DOI 10.1016/S1079-2104(98)90365-1; RUBIN LR, 1989, PLAST RECONSTR SURG, V83, P1; Seo, 2017, BOTULINUM TOXIN ASIA, P59; Shim KS, 2008, PLAST RECONSTR SURG, V121, P466, DOI 10.1097/01.prs.0000297652.29671.1a; Snider CC, 2017, AESTHET PLAST SURG, V41, P1083, DOI 10.1007/s00266-017-0889-9; Spandan V, 2017, J COMPUT PHYS, V348, P567, DOI 10.1016/j.jcp.2017.07.036; Standring S., 2016, GRAYS ANATOMY ANATOM; Wang JH, 2011, AESTHET PLAST SURG, V35, P553, DOI 10.1007/s00266-011-9662-7; Wang JY, 2014, NATIVE MACROMOLECULE; Zhang L, 2015, J PLAST RECONSTR AES, V68, P914, DOI 10.1016/j.bjps.2015.03.023; ZUFFEREY J, 1992, PLAST RECONSTR SURG, V89, P225, DOI 10.1097/00006534-199202000-00003	29	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0237043	10.1371/journal.pone.0237043	http://dx.doi.org/10.1371/journal.pone.0237043			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750081	gold, Green Published			2022-12-26	WOS:000560009200003
J	Kaufman, AR; Hersh, ED				Kaufman, Aaron R.; Hersh, Eitan D.			The political consequences of opioid overdoses	PLOS ONE			English	Article							UNITED-STATES; DRUG; MOBILIZATION; OWNERSHIP; WAR	The United States suffered a dramatic and well-documented increase in drug-related deaths from 2000 to 2018, primarily driven by prescription and non-prescription opioids, and concentrated in white and working-class areas. A growing body of research focuses on the causes, both medical and social, of this opioid crisis, but little work as yet on its larger ramifications. Using novel public records of accidental opioid deaths linked to behavioral political outcomes, we present causal analyses showing that opioid overdoses have significant political ramifications. Those close to opioid victims vote at lower rates than those less affected by the crisis, even compared to demographically-similar friends and family of other unexpected deaths. Moreover, among those friends and family affected by opioids, Republicans are 25% more likely to defect from the party than the statewide average Republican, while Democrats are no more likely to defect; Independents are moderately more likely to register as Democrats. These results illustrate an important research design for inferring the effects of tragic events and speak to the broad social and political consequences of what is becoming the largest public health crisis in modern United States history.	[Kaufman, Aaron R.] New York Univ Abu Dhabi, Div Social Sci, Abu Dhabi, U Arab Emirates; [Hersh, Eitan D.] Tufts Univ, Dept Polit Sci, Medford, MA 02155 USA	Tufts University	Kaufman, AR (corresponding author), New York Univ Abu Dhabi, Div Social Sci, Abu Dhabi, U Arab Emirates.	aaronkaufman@nyu.edu						Achen CH, 2012, WORKING PAPER; Barnett ML, 2017, NEW ENGL J MED, V376, P663, DOI 10.1056/NEJMsa1610524; Bateson R, 2012, AM POLIT SCI REV, V106, P570, DOI 10.1017/S0003055412000299; Belanger E, 2008, ELECT STUD, V27, P477, DOI 10.1016/j.electstud.2008.01.001; Bennett WL, 2008, POLIT COMMUN, V25, P269, DOI 10.1080/10584600802197434; Betz HG, 2009, PATTERNS PREJUDICE, V43, P313, DOI 10.1080/00313220903109235; Campbell J. N, 2018, TIME RELEASE HIST OP; Chein I, ROAD H NARCOTICS DEL; Crowson HM, 2009, J PSYCHOL, V143, P449, DOI 10.3200/JRL.143.5.449-463; Csete J, 2016, LANCET, V387, P1427, DOI 10.1016/S0140-6736(16)00619-X; Dancey L, 2013, AM J POLIT SCI, V57, P312, DOI 10.1111/j.1540-5907.2012.00621.x; Dasgupta N, 2018, AM J PUBLIC HEALTH, V108, P182, DOI 10.2105/AJPH.2017.304187; De Benedictis-Kessner Justin, 2019, AM POLIT SCI REV, V113, P1078, DOI 10.1017/S0003055419000443; Dowell D, 2017, JAMA-J AM MED ASSOC, V318, P1065, DOI 10.1001/jama.2017.9308; Enos RyanD., 2019, AM POLIT SCI REV, V113, P1012, DOI [10.1017/S0003055419000340, DOI 10.1017/S0003055419000340]; Goggin SN, 2017, POLIT BEHAV, V39, P675, DOI 10.1007/s11109-016-9375-3; Graves RL, 2018, SUBST USE MISUSE, V53, P2132, DOI 10.1080/10826084.2018.1458319; Hart CL, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0055; Hersh ED, 2013, P NATL ACAD SCI USA, V110, P20959, DOI 10.1073/pnas.1315043110; Huddy L, 2005, AM J POLIT SCI, V49, P593, DOI 10.2307/3647734; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Ojeda C, 2015, SOC SCI QUART, V96, P1226, DOI 10.1111/ssqu.12173; Scholl L, 2019, MMWR-MORBID MORTAL W, V67, P1419; Timberlake JM, 2003, POLICY STUD J, V31, P71, DOI 10.1111/1541-0072.00004; Vadivelu N, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0670-z; Volkow ND, 2017, NEW ENGL J MED, V377, P391, DOI 10.1056/NEJMsr1706626; Wall R, 2000, J URBAN HEALTH, V77, P688, DOI 10.1007/BF02344032; Weir HK, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160211	28	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0236815	10.1371/journal.pone.0236815	http://dx.doi.org/10.1371/journal.pone.0236815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA7PQ	32750079	gold, Green Published			2022-12-26	WOS:000560009200014
J	Munk, AJL; Schmidt, NM; Alexander, N; Henkel, K; Hennig, J				Munk, Aisha J. L.; Schmidt, Norina M.; Alexander, Nina; Henkel, Katrina; Hennig, Juergen			Covid-19-Beyond virology: Potentials for maintaining mental health during lockdown	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE INVENTORY; ANXIETY INVENTORY; RESILIENCE; PERSONALITY; VALIDATION; VERSION; DEPRESSION; OUTCOMES; TSUNAMI; STRESS	Background The current study aimed to assess prevalence of mental disorders during Covid-19 pandemic- and respective lockdown in Germany, and potential behaviors/states that can have protective functions on preventing severe mental problems. Assessing prevalence of mental disorders, as well as to find potential protective variables is very important in order to determine people's psychological suffering. It provides the basis for teaching possible coping styles in order to prevent a major breakdown on mental health. Prevalence on mental disorders was expected to increase during the pandemic, especially depression, (general-/and health-) anxiety, panic attacks- and disorder, as well as obsessive-compulsive disorder. Additionally, potentially protective variables, such as resilience and coping, were included. Methods N = 949 subjects completed an online-survey that asked for symptoms regarding depression, (health) anxiety, panic disorder, obsessive-compulsive disorder, and lock-down related behavior-starting 14 days after lockdown in Germany. Results Prevalence of mental disorders in the current sample was much higher than usual prevalence of mental disorders, with 50.6% expressing at least one mental disorder. Resilience was associated with lower risks for any mental disorder (OR = 4.23, p < .0001, 95%CI = 3.21-5.57), as well as with any other measured mental illness (all ORs between = 2.82 for obsessive-compulsive disorder and OR = 41.44 for panic disorder, all p < .001). Similar results were obtained regarding coping (focus on positive). Conclusion Results are highly relevant in order to provide a glance on what substantial influence the current pandemic- and lockdown situation has on mental health across the country, and possibly across the world. Possible ways in order to prevent deterioration and help coping with the current situation are being elaborated and discussed.	[Munk, Aisha J. L.; Schmidt, Norina M.; Henkel, Katrina; Hennig, Juergen] Justus Liebig Univ Giessen, Fac Psychol & Sport Sci, Dept Differential & Biol Psychol, Giessen, Germany; [Alexander, Nina] Med Sch Hamburg, Fac Human Sci, Dept Psychol, Hamburg, Germany	Justus Liebig University Giessen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Munk, AJL (corresponding author), Justus Liebig Univ Giessen, Fac Psychol & Sport Sci, Dept Differential & Biol Psychol, Giessen, Germany.	aisha.j.munk@psychol.uni-giessen.de		Munk, Aisha Judith Leila/0000-0003-4718-0996; /0000-0002-4066-7825				Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; Alberts NM, 2013, J ANXIETY DISORD, V27, P68, DOI 10.1016/j.janxdis.2012.10.009; Aspinwall LG, 1997, PSYCHOL BULL, V121, P417, DOI 10.1037//0033-2909.121.3.417; Austenfeld JL, 2004, J PERS, V72, P1335, DOI 10.1111/j.1467-6494.2004.00299.x; Bailer J, 2006, DTSCH MODIFIZIERTES; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Boxer P, 2012, J PSYCHOPATHOL BEHAV, V34, P405, DOI 10.1007/s10862-012-9285-6; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Chandra V, 2006, INT REV PSYCHIATR, V18, P205, DOI 10.1080/09540260600655805; Chmitorz A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192761; Davydov DM, 2010, CLIN PSYCHOL REV, V30, P479, DOI 10.1016/j.cpr.2010.03.003; Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124; Foa EB, 2002, PSYCHOL ASSESSMENT, V14, P485, DOI 10.1037//1040-3590.14.4.485; Gao J, 2020, SSRN J; Garbe L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234232; Goenner S, 2007, PSYCHOTHER PSYCH MED, V57, P395, DOI 10.1055/s-2007-970894; Hautzinger M., 2009, BDI 2 BECK DEPRESSIO; Herrero R, 2019, INTERNET INTERV, V16, P43, DOI 10.1016/j.invent.2018.03.005; Herrman H, 2011, CAN J PSYCHIAT, V56, P258, DOI 10.1177/070674371105600504; Hirai M, 2005, J TRAUMA STRESS, V18, P631, DOI 10.1002/jts.20071; Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954; Jacobi F, 2014, NERVENARZT, V85, P77, DOI 10.1007/s00115-013-3961-y; Jung YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159841; Knoll N, 2005, EUR J PERSONALITY, V19, P229, DOI 10.1002/per.546; Lazarus R. S., 1984, STRESS APPRAISAL COP; LEE SA, 2020, DEATH STUD, DOI DOI 10.1080/07481187.2020.174848132299304; Lee SA, 2020, BRAIN BEHAV IMMUN, V87, P97, DOI 10.1016/j.bbi.2020.04.067; Lin CY, 2020, SOCIAL HLTH BEHAV, V3, P1, DOI DOI 10.4103/SHB.SHB_11_20; Lin M.-W., 2020, SOC HLTH BEHAV, V3, P72, DOI [10.4103/SHB.SHB_18_20, DOI 10.4103/SHB.SHB_18_20, https://doi.org/10.4103/SHB.SHB_18_20]; Lowe B, 2002, TESTMAPPE MANUAL FRA; Maunder RG, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-72; Ng SM, 2006, COMMUNITY MENT HLT J, V42, P53, DOI 10.1007/s10597-005-9002-y; Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Rieger M., 2020, SOC HLTH BEHAV, V3, P50, DOI [10.4103/SHB.SHB_23_20, DOI 10.4103/SHB.SHB_23_20]; Sakib N, 2022, INT J MENT HEALTH AD, V20, P2623, DOI 10.1007/s11469-020-00289-x; Salkovskis PM, 2002, PSYCHOL MED, V32, P843, DOI 10.1017/S0033291702005822; Shrivastava S, 2020, SOCIAL HLTH BEHAV, V3, P70, DOI [10.4103/SHB.SHB_17_20, DOI 10.4103/SHB.SHB_17_20]; Shultz JM, 2015, JAMA-J AM MED ASSOC, V313, P567, DOI 10.1001/jama.2014.17934; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Steptoe A, 2009, J PERS, V77, P1747, DOI 10.1111/j.1467-6494.2009.00599.x; Sternthal MJ, 2010, J HEALTH SOC BEHAV, V51, P343, DOI 10.1177/0022146510378237; Sun JM, 2020, TRENDS MOL MED, V26, P483, DOI 10.1016/j.molmed.2020.02.008; Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036; Tuliao KV, 2020, J SOC PSYCHOL, V160, P624, DOI 10.1080/00224545.2020.1726857; Updegraff JA, 2008, J PERS SOC PSYCHOL, V95, P709, DOI 10.1037/0022-3514.95.3.709; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Wald J., 2006, LIT REV CONCEPTS PSY; WHO, 2019, REP WHO CHIN JOINT M; World Health Organization, 2019, WELLB MEAS PRIM HLTH; Wu G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00010; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Zimmer-Gembeck MJ., 2016, DEV PSYCHOPATHOL, DOI [10.1002/9781119125556.devpsy410, DOI 10.1002/9781119125556.DEVPSY410]	55	31	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0236688	10.1371/journal.pone.0236688	http://dx.doi.org/10.1371/journal.pone.0236688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA7PQ	32750072	gold, Green Published			2022-12-26	WOS:000560009200040
J	do Nascimento, NC; dos Santos, AP; Sivasankar, MP; Cox, A				do Nascimento, Naila Cannes; dos Santos, Andrea P.; Sivasankar, M. Preeti; Cox, Abigail			Unraveling the molecular pathobiology of vocal fold systemic dehydration using an in vivo rabbit model	PLOS ONE			English	Article							LARYNGEAL EPITHELIAL DEFENSES; GENE-EXPRESSION; RNA-SEQ; NETHERTON-SYNDROME; NUCLEAR RECEPTORS; FATIGUING TASK; E-CADHERIN; FUROSEMIDE; WATER; HYDRATION	Vocal folds are a viscoelastic multilayered structure responsible for voice production. Vocal fold epithelial damage may weaken the protection of deeper layers of lamina propria and thyroarytenoid muscle and impair voice production. Systemic dehydration can adversely affect vocal function by creating suboptimal biomechanical conditions for vocal fold vibration. However, the molecular pathobiology of systemically dehydrated vocal folds is poorly understood. We used an in vivo rabbit model to investigate the complete gene expression profile of systemically dehydrated vocal folds. The RNA-Seq based transcriptome revealed 203 differentially expressed (DE) vocal fold genes due to systemic dehydration. Interestingly, function enrichment analysis showed downregulation of genes involved in cell adhesion, cell junction, inflammation, and upregulation of genes involved in cell proliferation. RT-qPCR validation was performed for a subset of DE genes and confirmed the downregulation of DSG1, CDH3, NECTIN1, SDC1, S100A9, SPINK5, ECM1, IL1A, and IL36A genes. In addition, the upregulation of the transcription factor NR4A3 gene involved in epithelial cell proliferation was validated. Taken together, these results suggest an alteration of the vocal fold epithelial barrier independent of inflammation, which could indicate a disruption and remodeling of the epithelial barrier integrity. This transcriptome provides a first global picture of the molecular changes in vocal fold tissue in response to systemic dehydration. The alterations observed at the transcriptional level help to understand the pathobiology of dehydration in voice function and highlight the benefits of hydration in voice therapy.	[do Nascimento, Naila Cannes; Sivasankar, M. Preeti] Purdue Univ, Dept Speech Language & Hearing Sci, W Lafayette, IN 47907 USA; [dos Santos, Andrea P.; Cox, Abigail] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, PA 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	do Nascimento, NC (corresponding author), Purdue Univ, Dept Speech Language & Hearing Sci, W Lafayette, IN 47907 USA.; Cox, A (corresponding author), Purdue Univ, Dept Comparat Pathobiol, W Lafayette, PA 47907 USA.	ncannes@purdue.edu; adcox@purdue.edu		Cannes do Nascimento, Naila/0000-0001-6233-2447	National Institutes of Health/National Institute on Deafness and other Communication Disorders [R01DC015545]	National Institutes of Health/National Institute on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded by the National Institutes of Health/National Institute on Deafness and other Communication Disorders (https://www.nidcd.nih.gov/).Grant R01DC015545 was awarded to MPS and AC. MPS and AC were co-principal investigators. The funder did not play a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Jessica Engen, Taylor Bailey, and Chenwei Duan for their precious help with animal handling and samples collection. The authors also acknowledge the support of the Purdue Genomics Core Facility, especially Allison Sorg and Dr. Phillip SanMiguel, and the Bioinformatics Core at Purdue University, particularly Dr. Shaojun Xie and Dr. Jyothi Thimmapuram, for their services and support on data analysis.	Alves M, 2019, J VOICE, V33, DOI 10.1016/j.jvoice.2017.10.001; Behlau M, 2009, CURR OPIN OTOLARYNGO, V17, P149, DOI 10.1097/MOO.0b013e32832af105; BOYD JW, 1981, BRIT VET J, V137, P166, DOI 10.1016/S0007-1935(17)31734-7; Branski RC, 2005, J VOICE, V19, P283, DOI 10.1016/j.jvoice.2004.04.003; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Brozmanova A, 2006, RESP PHYSIOL NEUROBI, V150, P99, DOI 10.1016/j.resp.2005.10.008; Bulmer DM, 2010, LARYNGOSCOPE, V120, P777, DOI 10.1002/lary.20665; Butudom P, 2004, VET J, V167, P72, DOI 10.1016/S1090-0233(03)00054-6; Cheuvront SN, 2014, COMPR PHYSIOL, V4, P257, DOI 10.1002/cphy.c130017; CONTRERAS RJ, 1985, PHYSIOL BEHAV, V34, P761, DOI 10.1016/0031-9384(85)90375-0; Costa-Silva J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190152; Cox A, 2021, J VOICE, V35, P77, DOI 10.1016/j.jvoice.2019.06.009; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dowdall JR, 2015, LARYNGOSCOPE, V125, pE313, DOI 10.1002/lary.25264; DuBois BN, 2016, BASIC CLIN PHARMACOL, V118, P432, DOI 10.1111/bcpt.12523; Durkes A, 2016, LARYNGOSCOPE, V126, pE12, DOI 10.1002/lary.25478; Erickson E, 2010, LARYNGOSCOPE, V120, P1569, DOI 10.1002/lary.20983; Fillman-Holliday Denise, 2002, ILAR J, V43 Suppl, pS49; Fisher KV, 2001, J APPL PHYSIOL, V91, P1401, DOI 10.1152/jappl.2001.91.3.1401; Foote AG, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5682-5; Freedman SB, 2015, J PEDIATR-US, V166, P908, DOI 10.1016/j.jpeds.2014.12.029; Fuchs M, 2019, CELL MOL LIFE SCI, V76, P3465, DOI 10.1007/s00018-019-03083-8; Gill GA, 2005, ANN OTO RHINOL LARYN, V114, P913, DOI 10.1177/000348940511401204; Gill GA, 2005, J CLIN PATHOL, V58, P1265, DOI 10.1136/jcp.2004.016972; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; GRAY S, 1988, ANN OTO RHINOL LARYN, V97, P381, DOI 10.1177/000348948809700410; Gray SD, 2000, OTOLARYNG CLIN N AM, V33, P679, DOI 10.1016/S0030-6665(05)70237-1; Gugatschka M, 2019, MOL CELL PROTEOMICS, V18, P1511, DOI 10.1074/mcp.RA119.001272; Hartley NA, 2014, J VOICE, V28, DOI 10.1016/j.jvoice.2014.01.007; Hiwatashi N, 2017, LARYNGOSCOPE, V127, pE317, DOI 10.1002/lary.26678; Hrdlickova R, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1364; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang XH, 2016, AM J PHYSIOL-RENAL, V310, pP958, DOI 10.1152/ajprenal.00476.2015; Ivanov AI, 2013, INT REV CEL MOL BIO, V303, P27, DOI 10.1016/B978-0-12-407697-6.00002-7; Johnston N, 2003, ANN OTO RHINOL LARYN, V112, P481, DOI 10.1177/000348940311200601; Karbiener M, 2017, J PROTEOMICS, V155, P11, DOI 10.1016/j.jprot.2017.01.010; Kawai Y, 2019, LARYNGOSCOPE, V129, pE94, DOI 10.1002/lary.27464; King RE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208763; Kishimoto Y, 2019, MOL THER-NUCL ACIDS, V16, P616, DOI 10.1016/j.omtn.2019.04.014; Kishimoto Y, 2016, LAB INVEST, V96, P807, DOI 10.1038/labinvest.2016.43; Kleiner SM, 1999, J AM DIET ASSOC, V99, P200, DOI 10.1016/S0002-8223(99)00048-6; Komatsu N, 2002, J INVEST DERMATOL, V118, P436, DOI 10.1046/j.0022-202x.2001.01663.x; Kutta H, 2008, J ANAT, V213, P473, DOI 10.1111/j.1469-7580.2008.00960.x; Levendoski EE, 2014, J SPEECH LANG HEAR R, V57, P1679, DOI 10.1044/2014_JSLHR-S-13-0283; Levendoski EE, 2014, J MEMBRANE BIOL, V247, P441, DOI 10.1007/s00232-014-9651-2; Lewis JD, 2019, MOL BIOL CELL, V30, P1390, DOI 10.1091/mbc.E18-10-0649; Leydon C, 2013, TISSUE ENG PT A, V19, P2233, DOI [10.1089/ten.tea.2012.0744, 10.1089/ten.TEA.2012.0744]; Leydon C, 2011, J SPEECH LANG HEAR R, V54, P1060, DOI 10.1044/1092-4388(2010/10-0267); Leydon C, 2010, J VOICE, V24, P637, DOI 10.1016/j.jvoice.2009.06.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JL, 2018, LARYNGOSCOPE, V128, P153, DOI 10.1002/lary.26801; Lungova V, 2015, DEV BIOL, V399, P263, DOI 10.1016/j.ydbio.2014.12.037; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Miller HJ, 2015, J GERONTOL NURS, V41, P8, DOI 10.3928/00989134-20150814-02; MORTON DB, 1993, LAB ANIM, V27, P1, DOI 10.1258/002367793780745633; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Muto S, 2017, AM J PHYSIOL-RENAL, V312, pF9, DOI 10.1152/ajprenal.00204.2016; NAYLOR JRJ, 1993, J APPL PHYSIOL, V75, P1002, DOI 10.1152/jappl.1993.75.2.1002; Novaleski CK, 2017, J SPEECH LANG HEAR R, V60, P1264, DOI 10.1044/2016_JSLHR-S-16-0326; Novaleski CK, 2016, TISSUE CELL, V48, P407, DOI 10.1016/j.tice.2016.08.007; Oji V, 2010, AM J HUM GENET, V87, P274, DOI 10.1016/j.ajhg.2010.07.005; Oleson S, 2020, J SPEECH LANG HEAR R, V63, P135, DOI 10.1044/2019_JSLHR-19-00062; Popkin BM, 2010, NUTR REV, V68, P439, DOI 10.1111/j.1753-4887.2010.00304.x; Pross N, 2017, ANN NUTR METAB, V70, P30, DOI 10.1159/000463060; Reichel O, 2008, EUR ARCH OTO-RHINO-L, V265, P937, DOI 10.1007/s00405-007-0568-6; Richer SL, 2008, AM J RHINOL, V22, P228, DOI 10.2500/ajr.2008.22.3162; Richmond C A, 2001, Biol Res Nurs, V2, P277, DOI 10.1177/109980040100200407; Roush GC, 2014, J CARDIOVASC PHARM T, V19, P5, DOI 10.1177/1074248413497257; Rousseau B, 2008, ANN OTO RHINOL LARYN, V117, P598, DOI 10.1177/000348940811700809; Rousseau B, 2011, LARYNGOSCOPE, V121, P346, DOI 10.1002/lary.21364; Safe S, 2014, MOL ENDOCRINOL, V28, P157, DOI 10.1210/me.2013-1291; Sevilla LM, 2007, J CELL BIOL, V179, P1599, DOI 10.1083/jcb.200706187; Sherrill JD, 2014, MUCOSAL IMMUNOL, V7, P718, DOI 10.1038/mi.2013.90; Shiba TL, 2016, OTOLARYNG HEAD NECK, V154, P679, DOI 10.1177/0194599816628501; Sivasankar M, 2010, CURR OPIN OTOLARYNGO, V18, P171, DOI 10.1097/MOO.0b013e3283393784; Sivasankar M, 2010, OTOLARYNG HEAD NECK, V142, P79, DOI 10.1016/j.otohns.2009.09.011; Sivasankar M, 2008, J SPEECH LANG HEAR R, V51, P1494, DOI 10.1044/1092-4388(2008/07-0181); Smirnov A, 2019, EUR J DERMATOL, V29, P477, DOI 10.1684/ejd.2019.3636; Solomon NP, 2003, J VOICE, V17, P31, DOI 10.1016/S0892-1997(03)00029-8; Solomon NP, 2000, J VOICE, V14, P341; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tse JR, 2015, J ACOUST SOC AM, V138, pEL60, DOI 10.1121/1.4922765; Verdolini K, 2002, J SPEECH LANG HEAR R, V45, P268, DOI 10.1044/1092-4388(2002/021); Wang LC, 2013, ANESTHESIOLOGY, V118, P903, DOI 10.1097/ALN.0b013e31828156ff; Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Welham NV, 2015, DIS MODEL MECH, V8, P311, DOI 10.1242/dmm.018366; Welham NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017754; Welham NV, 2003, J VOICE, V17, P21, DOI 10.1016/S0892-1997(03)00033-X; Xuan Y, 2014, J SPEECH LANG HEAR R, V57, P416, DOI 10.1044/2013_JSLHR-S-13-0068; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zdolsek J, 2012, ANESTH ANALG, V115, P814, DOI 10.1213/ANE.0b013e318261f6ba; ZHAO R, 1991, Auris Nasus Larynx, V18, P55	97	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236348	10.1371/journal.pone.0236348	http://dx.doi.org/10.1371/journal.pone.0236348			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NO3EK	32735560	gold, Green Published			2022-12-26	WOS:000569367100016
J	Gildner, TE; Cepon-Robins, TJ; Liebert, MA; Urlacher, SS; Schrock, JM; Harrington, CJ; Madimenos, FC; Snodgrass, JJ; Sugiyama, LS				Gildner, Theresa E.; Cepon-Robins, Tara J.; Liebert, Melissa A.; Urlacher, Samuel S.; Schrock, Joshua M.; Harrington, Christopher J.; Madimenos, Felicia C.; Snodgrass, J. Josh; Sugiyama, Lawrence S.			Market integration and soil-transmitted helminth infection among the Shuar of Amazonian Ecuador	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; BLOOD-PRESSURE; INTESTINAL HELMINTHS; CHILDHOOD DIARRHEA; NUTRITIONAL-STATUS; HEALTH; GROWTH; EPIDEMIOLOGY; URBAN; MODERNIZATION	Background Soil-transmitted helminth (STH) infections have many negative health outcomes (e.g., diarrhea, nutritional deficiencies) that can also exacerbate poverty. These infections are generally highest among low-income populations, many of which are also undergoing market integration (MI; increased participation in a market-based economy). Yet the direct impact of MI-related social and environmental changes on STH infection patterns is poorly understood, making it unclear which lifestyle factors should be targeted to better control disease spread. This cross-sectional study examines if household infrastructure associated with greater MI is associated with lower STH burdens among Indigenous Ecuadorian Shuar. Methods Kato-Katz fecal smears were used to determine STH infection status and intensity (n = 620 participants; 308 females, 312 males, aged 6 months-86 years); Ascaris lumbricoides (ascarid) and Trichuris trichiura (whipworm) were the primary infection types detected. Structured interviews assessing lifestyle patterns (e.g., measures of household infrastructure) measured participant MI. Multilevel regression analyses and zero-inflated negative binomial regression models tested associations between MI measures and STH infection status or intensity, controlling for individual and community characteristics. Results Participants residing in more market-integrated households exhibited lower infection rates and intensities than those in less market integrated households. Parasite infection status and T. trichiura infection intensity were lower among participants living in houses with wood floors than those with dirt floors, while individuals using well or piped water from a spring exhibited lower A. lumbricoides infection intensities compared to those using river or stream water. Unexpectedly, latrine type was not significantly related to STH infection status or intensity. These results suggest that sources of exposure differ between the two helminth species. Conclusions This study documents associations between household measures and STH infection among an Indigenous population undergoing rapid MI. These findings can help healthcare programs better target interventions and reduce STH exposure among at-risk populations.	[Gildner, Theresa E.] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA; [Cepon-Robins, Tara J.] Univ Colorado, Dept Anthropol, Colorado Springs, CO 80907 USA; [Liebert, Melissa A.] No Arizona Univ, Dept Anthropol, Flagstaff, AZ 86011 USA; [Urlacher, Samuel S.] Baylor Univ, Dept Anthropol, Waco, TX 76798 USA; [Schrock, Joshua M.; Harrington, Christopher J.; Snodgrass, J. Josh; Sugiyama, Lawrence S.] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Madimenos, Felicia C.] CUNY Queens Coll, Dept Anthropol, Flushing, NY 11367 USA; [Snodgrass, J. Josh] Univ Oregon, Ctr Global Hlth, Eugene, OR 97403 USA	Dartmouth College; University of Colorado System; University of Colorado at Colorado Springs; Northern Arizona University; Baylor University; University of Oregon; City University of New York (CUNY) System; Queens College NY (CUNY); University of Oregon	Gildner, TE (corresponding author), Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA.	Theresa.E.Gildner@dartmouth.edu			Wenner-Gren Foundation for Anthropological Research [9231, 8476, 8749]; National Science Foundation [BCS-1650674, BCS1341165]; Lewis and Clark Exploration Grant; Ryoichi Sasakawa Young Leaders Fellowship Fund; Center for Latino/a and Latin American Studies; University of Oregon	Wenner-Gren Foundation for Anthropological Research; National Science Foundation(National Science Foundation (NSF)); Lewis and Clark Exploration Grant; Ryoichi Sasakawa Young Leaders Fellowship Fund; Center for Latino/a and Latin American Studies; University of Oregon	Support for the research was provided by the Wenner-Gren Foundation for Anthropological Research (Grant #9231, 8476, 8749); National Science Foundation (Doctoral Dissertation Improvement Grant #BCS-1650674, BCS1341165); Lewis and Clark Exploration Grant; Ryoichi Sasakawa Young Leaders Fellowship Fund; the Center for Latino/a and Latin American Studies; and, the University of Oregon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2011, SE ASIAN J TROP MED, V42, P527; Alexander N, 2012, TROP MED INT HEALTH, V17, P684, DOI 10.1111/j.1365-3156.2012.02987.x; [Anonymous], 2006, PREV CHEM HUM HELM C; ARMELAGOS GJ, 1991, POPUL ENVIRON, V13, P9, DOI 10.1007/BF01256568; Baker PT, 1986, CHANGING SAMOANS BEH, V5; Barreto ML, 2007, LANCET, V370, P1622, DOI 10.1016/S0140-6736(07)61638-9; Barrett R, 1998, ANNU REV ANTHROPOL, V27, P247, DOI 10.1146/annurev.anthro.27.1.247; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bindon JR, 1997, AM J PHYS ANTHROPOL, V103, P7, DOI 10.1002/(SICI)1096-8644(199705)103:1<7::AID-AJPA2>3.0.CO;2-U; Bindon JR, 1995, SOCIAL ASPECTS OBESI, P227; Blackwell AD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001218; Blackwell AD, 2010, AM J HUM BIOL, V22, P836, DOI 10.1002/ajhb.21092; Blas E, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P1; Bowles S, 1998, J ECON LIT, V36, P75; Brooker S, 2000, E AFR MED J, V77, P157; BUNDY DAP, 1988, PHILOS T ROY SOC B, V321, P405, DOI 10.1098/rstb.1988.0100; Campbell SJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004566; Centers for Disease Control and Prevention, 2011, NEGLECTED TROPICAL D; Cepon-Robins TJ, 2014, J PARASITOL, V100, P598, DOI 10.1645/13-383.1; Chipeta Michael G, 2014, BMC Res Notes, V7, P856, DOI 10.1186/1756-0500-7-856; Dold C, 2011, MICROBES INFECT, V13, P632, DOI 10.1016/j.micinf.2010.09.012; Dressler WW, 1999, HUM BIOL, V71, P583; DRESSLER WW, 1987, SOC SCI MED, V24, P679, DOI 10.1016/0277-9536(87)90311-X; DUFOUR DL, 1992, AM J HUM BIOL, V4, P197, DOI 10.1002/ajhb.1310040205; ELKINS DB, 1986, T ROY SOC TROP MED H, V80, P774, DOI 10.1016/0035-9203(86)90384-6; Farrell SH, 2018, CLIN INFECT DIS, V66, pS253, DOI 10.1093/cid/ciy002; Francis L, 2012, INT J ENV RES PUB HE, V9, P2910, DOI 10.3390/ijerph9082910; Fuhrimann S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1809-6; Fuhrimann S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004469; Genser B, 2008, INT J EPIDEMIOL, V37, P831, DOI 10.1093/ije/dyn101; Gildner TE, 2016, J PHYSIOL ANTHROPOL, V35, DOI 10.1186/s40101-016-0118-2; Godoy, 2001, INDIANS MARKETS RAIN; Godoy R, 2005, J ANTHROPOL RES, V61, P157, DOI 10.3998/jar.0521004.0061.202; Godoy R, 2000, HUM ORGAN, V59, P117, DOI 10.17730/humo.59.1.e5p11012864375q4; Gohdes D., 1995, ATLANTIC, V43, P87; Gordon CA, 2016, ADV PARASIT, V91, P311, DOI 10.1016/bs.apar.2015.12.002; Gurven M, 2008, J GERONTOL A-BIOL, V63, P196, DOI 10.1093/gerona/63.2.196; Harner Michael J., 1984, JIVARO PEOPLE SACRED; Hotez PJ, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004186; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; Hurtado A. M., 2008, TAYLOR FRANCIS, P151; Huss-Ashmore R, 1992, RES PAPERS SCI ARCHE, V9; Jourdan PM, 2018, LANCET, V391, P252, DOI 10.1016/S0140-6736(17)31930-X; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Kealey A, 2010, J HEALTH CARE POOR U, V21, P53, DOI 10.1353/hpu.0.0270; Keith T.Z., 2014, MULTIPLE REGRESSION; Lane R., 1991, MARKET EXPERIENCE; Lazear EP, 1999, J POLIT ECON, V107, pS95, DOI 10.1086/250105; Leonard W.R., 2002, HUMAN BIOL PASTORAL, P206; Liebert MA, 2013, ANN HUM BIOL, V40, P228, DOI 10.3109/03014460.2012.759621; Lu F, 2007, CURR ANTHROPOL, V48, P593, DOI 10.1086/519806; Moncayo AL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000293; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Mascie-Taylor CN, 2004, CHANGING FACE DIS IM; McDade T. W., 2010, HUMAN EVOLUTIONARY B, P581, DOI DOI 10.1017/CB09780511781193.041; McDade TW, 2001, SOC SCI MED, V53, P55, DOI 10.1016/S0277-9536(00)00313-0; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Montresor A., 1998, WORLD HLTH ORG; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Neiderud Carl-Johan, 2015, Infection Ecology & Epidemiology, V5, P27060, DOI 10.3402/iee.v5.27060; Peer Nasheeta, 2015, Trop Dis Travel Med Vaccines, V1, P6, DOI 10.1186/s40794-015-0007-4; Petney TN, 2001, INT J PARASITOL, V31, P919, DOI 10.1016/S0020-7519(01)00196-5; Pohle P., 2004, Lyonia, V7, P133; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Pullan RL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-81; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rubenstein S, 2001, ENVIRON PLANN D, V19, P263, DOI 10.1068/d236t; Sattenspiel L, 2000, YEARB PHYS ANTHROPOL, V43, P3, DOI 10.1002/1096-8644(2000)43:31+&lt;3::AID-AJPA2&gt;3.0.CO;2-Z; Scolari C, 2000, TROP MED INT HEALTH, V5, P302, DOI 10.1046/j.1365-3156.2000.00549.x; Shephard R.J., 1996, HLTH CONSEQUENCES MO, DOI [10.1017/CBO9780511983726, DOI 10.1017/CBO9780511983726]; Shieh G, 2016, BEHAV RES METHODS, V48, P994, DOI 10.3758/s13428-015-0623-y; Stein AD, 2005, MATERN CHILD NUTR, V1, P177, DOI 10.1111/j.1740-8709.2005.00021.x; Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867; Stirling MW, 1938, HIST ETHOGRAPHICAL M; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Tarafder MR, 2010, INT J PARASITOL, V40, P399, DOI 10.1016/j.ijpara.2009.09.003; Tchobanoglous G., 2003, WASTEWATER ENG TREAT, V4th; Urlacher SS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax1065; Urlacher SS, 2018, P NATL ACAD SCI USA, V115, pE3914, DOI 10.1073/pnas.1717522115; Urlacher SS, 2016, ANN HUM BIOL, V43, P316, DOI 10.1080/03014460.2016.1192219; Urlacher SS, 2016, AM J HUM BIOL, V28, P16, DOI 10.1002/ajhb.22747; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; Wood CL, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0122; World Health Organization, 1991, BAS LAB METH MED PAR; World Health Organization, 2002, PREV CONTR SCHIST SO	86	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236924	10.1371/journal.pone.0236924	http://dx.doi.org/10.1371/journal.pone.0236924			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NO3EK	32735608	Green Published, gold			2022-12-26	WOS:000569367100060
J	Cao, Q; Anderson, DH; Liang, WY; Chou, J; Saelices, L				Cao, Qin; Anderson, Daniel H.; Liang, Wilson Y.; Chou, Joshua; Saelices, Lorena			The inhibition of cellular toxicity of amyloid-beta by dissociated transthyretin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; amyloid-beta (AB); Alzheimer's disease; neuroprotection; neuroscience; cytotoxicity; peptide; transthyretin	ALZHEIMERS-DISEASE; STRUCTURAL BASIS; PROTEIN; PEPTIDE; FIBRIL; AGGREGATION; BINDING; MICE; STABILIZATION; POLYMORPHISM	The protective effect of transthyretin (TTR) on cellular toxicity of beta-amyloid (A beta) has been previously reported. TTR is a tetrameric carrier of thyroxine in blood and cerebrospinal fluid, the pathogenic aggregation of which causes systemic amyloidosis. However, studies have documented a protective effect of TTR against cellular toxicity of pathogenic A beta, a protein associated with Alzheimer's disease. TTR binds A beta, alters its aggregation, and inhibits its toxicity bothin vitroandin vivo. In this study, we investigate whether the amyloidogenic ability of TTR and its antiamyloid inhibitory effect are associated. Using protein aggregation and cytotoxicity assays, we found that the dissociation of the TTR tetramer, required for its amyloid pathogenesis, is also necessary to prevent cellular toxicity from A beta oligomers. These findings suggest that the A beta-binding site of TTR may be hidden in its tetrameric form. Aided by computational docking and peptide screening, we identified a TTR segment that is capable of altering A beta aggregation and toxicity, mimicking TTR cellular protection. EM, immune detection analysis, and assessment of aggregation and cytotoxicity revealed that the TTR segment inhibits A beta oligomer formation and also promotes the formation of nontoxic, nonamyloid amorphous aggregates, which are more sensitive to protease digestion. Finally, this segment also inhibits seeding of A beta catalyzed by A beta fibrils extracted from the brain of an Alzheimer's patient. Together, these findings suggest that mimicking the inhibitory effect of TTR with peptide-based therapeutics represents an additional avenue to explore for the treatment of Alzheimer's disease.	[Cao, Qin; Anderson, Daniel H.; Liang, Wilson Y.; Chou, Joshua; Saelices, Lorena] Univ Calif Los Angeles, Inst Mol Biol, Dept Biol Chem, Los Angeles, CA 90024 USA; [Cao, Qin; Anderson, Daniel H.; Liang, Wilson Y.; Chou, Joshua; Saelices, Lorena] Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Saelices, Lorena] Univ Texas Southwestern Med Ctr Dallas, ODonnell Brain Inst, Dept Biophys, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX 75390 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Texas System; University of Texas Southwestern Medical Center Dallas	Saelices, L (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Biol Chem, Los Angeles, CA 90024 USA.; Saelices, L (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, Los Angeles, CA 90024 USA.; Saelices, L (corresponding author), Univ Texas Southwestern Med Ctr Dallas, ODonnell Brain Inst, Dept Biophys, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX 75390 USA.	Lorena.SaelicesGomez@UTSouthwestern.edu		Saelices Gomez, Lorena/0000-0002-1904-2150	Amyloidosis Foundation [20160759, 20170827]; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under Research Executive Agency [298559]	Amyloidosis Foundation; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under Research Executive Agency	This work was supported by Amyloidosis Foundation Grants 20160759 and 20170827 (to L. S.) and the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under Research Executive Agency Grant Agreement 298559 (to L. S.)	BURDICK D, 1992, J BIOL CHEM, V267, P546; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; Cascella R, 2013, BBA-MOL BASIS DIS, V1832, P2302, DOI 10.1016/j.bbadis.2013.09.011; Cho PY, 2015, ACS CHEM NEUROSCI, V6, P778, DOI 10.1021/cn500272a; Cho PY, 2014, ACS CHEM NEUROSCI, V5, P542, DOI 10.1021/cn500014u; Choi SH, 2007, J NEUROSCI, V27, P7006, DOI 10.1523/JNEUROSCI.1919-07.2007; Coelho Teresa, 1993, Journal of Rheumatology, V20, P179; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Costa R, 2008, FEBS LETT, V582, P936, DOI 10.1016/j.febslet.2008.02.034; Du JL, 2012, PROTEIN ENG DES SEL, V25, P337, DOI 10.1093/protein/gzs026; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Finder VH, 2010, J MOL BIOL, V396, P9, DOI 10.1016/j.jmb.2009.12.016; Garai K, 2018, PROTEIN SCI, V27, P1252, DOI 10.1002/pro.3396; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hornstrup LS, 2013, ARTERIOSCL THROM VAS, V33, P1441, DOI 10.1161/ATVBAHA.113.301273; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Li XY, 2013, J NEUROSCI, V33, P19423, DOI 10.1523/JNEUROSCI.2561-13.2013; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; PIRTTILA T, 1994, J NEUROL SCI, V127, P90, DOI 10.1016/0022-510X(94)90140-6; Ribeiro CA, 2014, J ALZHEIMERS DIS, V39, P357, DOI 10.3233/JAD-131355; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Saelices L, 2019, J BIOL CHEM, V294, P6130, DOI 10.1074/jbc.RA118.005257; Saelices L, 2018, P NATL ACAD SCI USA, V115, pE6741, DOI 10.1073/pnas.1805131115; Saelices L, 2015, J BIOL CHEM, V290, P28932, DOI 10.1074/jbc.M115.659912; Sarsoza F, 2009, ACTA NEUROPATHOL, V118, P505, DOI 10.1007/s00401-009-0530-3; SCHWARZMAN AL, 1994, P NATL ACAD SCI USA, V91, P8368, DOI 10.1073/pnas.91.18.8368; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tycko R, 2014, PROTEIN SCI, V23, P1528, DOI 10.1002/pro.2544; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843	35	8	8	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2020	295	41					14015	14024		10.1074/jbc.RA120.013440	http://dx.doi.org/10.1074/jbc.RA120.013440			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OG1HE	32769117	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000581643400006
J	Feng, DX; Kang, XM; Wang, RQ; Chen, H; Zhang, K; Feng, WL; Li, HX; Zhu, YJ; Wu, SF				Feng, Dongxu; Kang, Xiaomin; Wang, Ruiqi; Chen, He; Zhang, Kun; Feng, Weilou; Li, Huixia; Zhu, Yangjun; Wu, Shufang			Progranulin modulates cartilage-specific gene expression via sirtuin 1-mediated deacetylation of the transcription factors SOX9 and P65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondrocytes; osteoarthritis; progranulin; PGRN; sirtuin 1; SIRT1; deacetylation; growth factor; cartilage; inflammation; joint disease	GRANULIN-EPITHELIN PRECURSOR; GROWTH-FACTOR; INSULIN SENSITIVITY; TNF RECEPTORS; OSTEOARTHRITIS; CHONDROCYTES; ACROGRANIN; PROTEIN; PGRN; GLYCOPROTEIN	Progranulin (PGRN) is an autocrine growth factor that exerts crucial roles within cartilage tissue; however, the molecular mechanisms underlying PGRN-mediated cartilage homeostasis remain elusive. In the present study, we investigated the role of PGRN in regulating chondrocyte homeostasis and its therapeutic potential for managing osteoarthritis (OA). We found that PGRN levels are significantly increased in human cartilage in mild OA and that its expression is decreased in the cartilage in severe OA.In vitro, treatment of primary rat chondrocytes with recombinant PGRN significantly enhanced the levels of collagen type II alpha 1 chain (COL2A1) and aggrecan, and attenuated TNF alpha-induced up-regulation of matrix metallopeptidase 13 (MMP13) and ADAM metallopeptidase with thrombospondin type 1 motif 5 (ADAMTS5) in chondrocytes. These effects were abrogated in SIRT1(-/-)cells, indicating a causative role of SIRT1 in the effects of PGRN on protein expression in chondrocytes. Mechanistically, PGRN increased SIRT1 expression and activity, which reduced the acetylation levels of SRY-box transcription factor (SOX9) and transcription factor P65 (P65) and thereby promoted nuclear translocation of SOX9 and inhibited TNF alpha-induced P65 nuclear accumulation to maintain chondrocyte homeostasis. In conclusion, our findings reveal a mechanism of action for PGRN that maintains cartilage homeostasis and supports the notion that PGRN up-regulation may be a promising strategy for managing OA.	[Feng, Dongxu; Kang, Xiaomin; Wang, Ruiqi; Chen, He; Wu, Shufang] Xi An Jiao Tong Univ, Ctr Translat Med, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Feng, Dongxu; Zhang, Kun; Feng, Weilou; Zhu, Yangjun] Xi An Jiao Tong Univ, Hong Hui Hosp, Dept Orthpaed Trauma, Sch Med, Xian, Shaanxi, Peoples R China; [Li, Huixia] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Wu, SF (corresponding author), Xi An Jiao Tong Univ, Ctr Translat Med, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China.; Zhu, YJ (corresponding author), Xi An Jiao Tong Univ, Hong Hui Hosp, Dept Orthpaed Trauma, Sch Med, Xian, Shaanxi, Peoples R China.	hhyycskzyj@163.com; shufangw@hotmail.com			First Affiliated Hospital of Xi'an Jiaotong University College of Medicine Foundation [2018QN-01]; National Natural Science Foundation of China [81672221, 30971392, 81071440/H0601]; Natural Science Basic Research Program of Shaanxi Programs [2020JM-689, 2020JQ-507]	First Affiliated Hospital of Xi'an Jiaotong University College of Medicine Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Program of Shaanxi Programs	This work was supported by the First Affiliated Hospital of Xi'an Jiaotong University College of Medicine Foundation Grant 2018QN-01, the National Natural Science Foundation of China Grant 81672221, 30971392 and 81071440/H0601 and Natural Science Basic Research Program of Shaanxi Programs 2020JM-689 and 2020JQ-507.	ANAKWE OO, 1990, BIOL REPROD, V42, P317, DOI 10.1095/biolreprod42.2.317; BABA T, 1993, MOL REPROD DEV, V34, P233, DOI 10.1002/mrd.1080340302; Bar Oz M, 2016, AGING CELL, V15, P499, DOI 10.1111/acel.12456; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Buckland Jenny, 2013, Nat Rev Rheumatol, V9, P566, DOI 10.1038/nrrheum.2013.135; Cerezo LA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/740357; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LQ, 2017, J CELL MOL MED, V21, P3347, DOI 10.1111/jcmm.13237; Chen TM, 2019, CHINESE J PHYSIOL, V62, P2, DOI 10.4103/CJP.CJP_11_19; Chen X, 2013, J NEUROSCI, V33, P9202, DOI 10.1523/JNEUROSCI.5336-12.2013; Deng ZH, 2018, OSTEOARTHR CARTILAGE, V26, P1153, DOI 10.1016/j.joca.2018.03.007; Dvir-Ginzberg M, 2011, ARTHRITIS RHEUM-US, V63, P2363, DOI 10.1002/art.30279; Dvir-Ginzberg M, 2008, J BIOL CHEM, V283, P36300, DOI 10.1074/jbc.M803196200; Elayyan J, 2017, FASEB J, V31, P3116, DOI 10.1096/fj.201601253R; Etemadi N, 2013, IMMUNOL CELL BIOL, V91, P661, DOI 10.1038/icb.2013.53; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Fujita N, 2011, J ORTHOP RES, V29, P511, DOI 10.1002/jor.21284; Furst DE, 2010, CLIN EXP RHEUMATOL, V28, pS5; Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592; Guo FJ, 2010, ARTHRITIS RHEUM-US, V62, P2023, DOI 10.1002/art.27491; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Kang XM, 2018, J BIOL CHEM, V293, P8614, DOI 10.1074/jbc.M117.809822; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim HA, 2000, J RHEUMATOL, V27, P455; Kobayashi H, 2013, J BIOL CHEM, V288, P28620, DOI 10.1074/jbc.M113.452169; Li HX, 2014, ENDOCRINOLOGY, V155, P3493, DOI 10.1210/en.2014-1058; Liu CJ, 2011, FEBS LETT, V585, P3675, DOI 10.1016/j.febslet.2011.04.065; Liu JL, 2015, MOL ENDOCRINOL, V29, P528, DOI 10.1210/me.2014-1266; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Matsushita T, 2013, J ORTHOP RES, V31, P531, DOI 10.1002/jor.22268; Matsuzaki T, 2014, ANN RHEUM DIS, V73, P1397, DOI 10.1136/annrheumdis-2012-202620; Neill T, 2016, J CELL BIOL, V215, P687, DOI 10.1083/jcb.201603079; Takayama K, 2009, ARTHRITIS RHEUM-US, V60, P2731, DOI 10.1002/art.24864; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Wei JL, 2020, ANN NY ACAD SCI, V1460, P43, DOI 10.1111/nyas.14208; Yamamoto Y, 2014, INFLAMMATION, V37, P1806, DOI 10.1007/s10753-014-9911-4; Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147; Zhao YP, 2015, ANN RHEUM DIS, V74, P2244, DOI 10.1136/annrheumdis-2014-205779; Zhao YP, 2013, BIOMATERIALS, V34, P6412, DOI 10.1016/j.biomaterials.2013.05.030; Zhou D, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1754-3; ZHOU J, 1993, J BIOL CHEM, V268, P10863	47	6	6	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2020	295	39					13640	13650		10.1074/jbc.RA119.011164	http://dx.doi.org/10.1074/jbc.RA119.011164			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NY3VI	32747445	hybrid, Green Published			2022-12-26	WOS:000576321100017
J	Bataille, CP; Chartrand, MMG; Raposo, F; St-Jean, G				Bataille, Clement P.; Chartrand, Michelle M. G.; Raposo, Francis; St-Jean, Gilles			Assessing geographic controls of hair isotopic variability in human populations: A case-study in Canada	PLOS ONE			English	Article							STABLE-ISOTOPES; SULFUR ISOTOPES; SPATIAL DISTRIBUTIONS; CARBON; NITROGEN; RATIOS; DIET; C-13; N-15; DISCRIMINATION	Studying the isotope variability in fast-growing human tissues (e.g., hair, nails) is a powerful tool to investigate human nutrition. However, interpreting the controls of this isotopic variability at the population scale is often challenging as multiple factors can superimpose on the isotopic signals of a current population. Here, we analyse carbon, nitrogen, and sulphur isotopes in hair from 590 Canadian resident volunteers along with demographics, dietary and geographic information about each participant. We use a series of machine-learning regressions to demonstrate that the isotopic values in Canadian residents' hair are not only influenced by dietary choices but by geographic controls. First, we show that isotopic values in Canadian residents' hair have a limited range of variability consistent with the homogenization of Canadian dietary habits (as in other industrialized countries). As expected, some of the isotopic variability within the population correlates with recorded individual dietary choices. More interestingly, some regional spatial patterns emerge from carbon and sulphur isotope variations. The high carbon isotope composition of the hair of eastern Canadians relative to that of western Canadians correlates with the dominance of corn in the eastern Canadian food-industry. The gradient of sulphur isotope composition in Canadian hair from coast to inland regions correlates with the increasing soil pH and decreasing deposition of marine-derived sulphate aerosols in local food systems. We conclude that part of the isotopic variability found in the hair of Canadian residents reflects the isotopic signature associated with specific environmental conditions and agricultural practices of regional food systems transmitted to humans through the high consumption rate of intra-provincial food in Canada. Our study also underscores the strong potential of sulphur isotopes as tracers of human and food provenance.	[Bataille, Clement P.; Chartrand, Michelle M. G.; Raposo, Francis; St-Jean, Gilles] Univ Ottawa, Dept Earth & Environm Sci, Ottawa, ON, Canada	University of Ottawa	Bataille, CP (corresponding author), Univ Ottawa, Dept Earth & Environm Sci, Ottawa, ON, Canada.	cbataill@uottawa.ca		Bataille, Clement P./0000-0001-8625-4658; Chartrand, Michelle/0000-0003-3398-7246	Canadian Security and Safety Program Targeted Investment [CSSP-2018-TI2385]; Chemical, Biological, Radiological and Nuclear Research & Technology Initiative [CRTI 08-0116RD]	Canadian Security and Safety Program Targeted Investment; Chemical, Biological, Radiological and Nuclear Research & Technology Initiative	Funding: C.P.B. and F.R. acknowledge funding from Canadian Security and Safety Program Targeted Investment (CSSP-2018-TI2385). G.S.J and M.M.G.C. acknowledge funding from the Chemical, Biological, Radiological and Nuclear Research & Technology Initiative (CRTI 08-0116RD). Author contributions: C.P.B. G.S.J and M.M.G.C designed the project and analyzed the data sets. C.P.B. and F.R. performed the statistical analysis and model development steps. All authors contributed to the interpretation of the results and writing of the manuscript. Competing interests: The authors declare that they have no competing interests. Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. Additional data related to this paper may be requested from the authors.	Alvarez JBR, 2019, I C HUMANOID NANOTEC, DOI 10.1109/HNICEM48295.2019.9073534; Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Bateman AS, 2007, ISOT ENVIRON HEALT S, V43, P237, DOI 10.1080/10256010701550732; Bol R, 2002, RAPID COMMUN MASS SP, V16, P2195, DOI 10.1002/rcm.706; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brooks JR, 2002, J AGR FOOD CHEM, V50, P6413, DOI 10.1021/jf020594k; Buchardt B, 2007, CHEM GEOL, V244, P316, DOI 10.1016/j.chemgeo.2007.06.022; Burke A, 2018, EARTH PLANET SC LETT, V496, P168, DOI 10.1016/j.epsl.2018.05.022; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cernusak LA, 2013, NEW PHYTOL, V200, P950, DOI 10.1111/nph.12423; Chau TH, 2017, RAPID COMMUN MASS SP, V31, P583, DOI 10.1002/rcm.7822; Choy K, 2019, J NUTR, V149, P1960, DOI 10.1093/jn/nxz144; Codron J, 2013, CAN J ZOOL, V91, P124, DOI 10.1139/cjz-2012-0155; Craine JM, 2015, PLANT SOIL, V396, P1, DOI 10.1007/s11104-015-2542-1; DeVallance E, 2019, ARTERIOSCL THROM VAS, V39; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; Edge J., 2013, CULTIVATING OPPORTUN; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fraser I, 2008, J FORENSIC SCI, V53, P95, DOI 10.1111/j.1556-4029.2007.00607.x; Genuer R, 2015, R J, V7, P19; Gordon-Larsen P, 2003, OBES RES, V11, P121, DOI 10.1038/oby.2003.20; Hengl T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169748; Hulsemann F, 2017, ISOT ENVIRON HEALT S, V53, P356, DOI 10.1080/10256016.2017.1302447; Hulsemann F, 2015, RAPID COMMUN MASS SP, V29, P2111, DOI 10.1002/rcm.7370; Huelsemann F, 2009, RAPID COMMUN MASS SP, V23, P2448, DOI 10.1002/rcm.4039; Jahren AH, 2006, AM J CLIN NUTR, V84, P1380, DOI 10.1093/ajcn/84.6.1380; Jahren AH, 2008, P NATL ACAD SCI USA, V105, P17855, DOI 10.1073/pnas.0809870105; Jarvis A, 2008, HOLE FILLED SRTM GLO; Katzenberg M.A., 1989, CAN SOC FORENSIC SCI, V22, P7, DOI DOI 10.1080/00085030.1989.10757414; Krajcarz MT, 2019, RAPID COMMUN MASS SP, V33, P1311, DOI 10.1002/rcm.8471; Kusaka S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33122; Lehn C, 2019, INT J LEGAL MED, V133, P935, DOI 10.1007/s00414-018-1866-9; Lehn C, 2015, ISOT ENVIRON HEALT S, V51, P68, DOI 10.1080/10256016.2014.995645; Lehn C, 2015, SCI JUSTICE, V55, P72, DOI 10.1016/j.scijus.2014.10.006; Lehner B., 2008, EOS T AM GEOPHYS UN, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Love HJ, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00559; LOWE LE, 1971, CAN J SOIL SCI, V51, P129, DOI 10.4141/cjss71-017; Lugli F, 2018, AM J PHYS ANTHROPOL, V167, P470, DOI 10.1002/ajpa.23643; Macko SA, 1999, PHILOS T ROY SOC B, V354, P65, DOI 10.1098/rstb.1999.0360; Mahowald NM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006653; Martinelli LA, 2011, FOOD CHEM, V127, P1712, DOI 10.1016/j.foodchem.2011.02.046; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Meier-Augenstein W, 2011, RAPID COMMUN MASS SP, V25, P3331, DOI 10.1002/rcm.5235; Miller RL, 2014, J ADV MODEL EARTH SY, V6, P441, DOI 10.1002/2013MS000266; Mizota C, 1996, GEODERMA, V71, P77, DOI 10.1016/0016-7061(95)00091-7; Nardoto GB, 2006, AM J PHYS ANTHROPOL, V131, P137, DOI 10.1002/ajpa.20409; Nardoto GB, 2011, AM J HUM BIOL, V23, P642, DOI 10.1002/ajhb.21192; Nash SH, 2012, J NUTR, V142, P84, DOI 10.3945/jn.111.147595; Naska Androniki, 2017, F1000Res, V6, P926, DOI 10.12688/f1000research.10703.1; Nehlich O, 2015, EARTH-SCI REV, V142, P1, DOI 10.1016/j.earscirev.2014.12.002; Nehlich O, 2011, GEOCHIM COSMOCHIM AC, V75, P4963, DOI 10.1016/j.gca.2011.06.009; Nimni ME, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-24; NRIAGU JO, 1992, ENVIRON SCI TECHNOL, V26, P85, DOI 10.1021/es00025a007; O'Brien DM, 2015, ANNU REV NUTR, V35, P565, DOI 10.1146/annurev-nutr-071714-034511; O'Connell TC, 2017, OECOLOGIA, V184, P317, DOI 10.1007/s00442-017-3881-9; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Petzke KJ, 2005, RAPID COMMUN MASS SP, V19, P1392, DOI 10.1002/rcm.1925; Petzke KJ, 2009, RAPID COMMUN MASS SP, V23, P2411, DOI 10.1002/rcm.4025; Potter P, 2010, EARTH INTERACT, V14, DOI 10.1175/2009EI288.1; Reitsema LJ, 2013, AM J HUM BIOL, V25, P445, DOI 10.1002/ajhb.22398; Richards MP, 2003, INT J OSTEOARCHAEOL, V13, P37, DOI 10.1002/oa.654; Richards MP, 2001, EARTH PLANET SC LETT, V191, P185, DOI 10.1016/S0012-821X(01)00427-7; SCHOELLER DA, 1986, ECOL FOOD NUTR, V18, P159, DOI 10.1080/03670244.1986.9990922; Scholze M, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002899; Schwertl M, 2003, RAPID COMMUN MASS SP, V17, P1312, DOI 10.1002/rcm.1042; Sparks JM, 2019, APPL GEOCHEM, V108, DOI 10.1016/j.apgeochem.2019.104372; Stack P, 2011, APPL GEOCHEM, V26, P1478, DOI 10.1016/j.apgeochem.2011.05.021; Szpak P, 2019, ARCHAEOL ANTHROP SCI, V11, P2989, DOI 10.1007/s12520-018-0716-5; Szpak P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00288; Tanikawa T, 2018, GEODERMA, V315, P111, DOI 10.1016/j.geoderma.2017.11.023; Tanz N, 2010, J AGR FOOD CHEM, V58, P3139, DOI 10.1021/jf903251k; Tcherkez G, 2013, NEW PHYTOL, V200, P44, DOI 10.1111/nph.12314; Thompson AH, 2010, AM J PHYS ANTHROPOL, V141, P440, DOI 10.1002/ajpa.21162; Valenzuela LO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034234; Valenzuela LO, 2011, RAPID COMMUN MASS SP, V25, P861, DOI 10.1002/rcm.4934; van Donkelaar A, 2016, ENVIRON SCI TECHNOL, V50, P3762, DOI 10.1021/acs.est.5b05833; Webb EC, 2017, SCI TECHNOL ARCHAEOL, V3, P71, DOI 10.1080/20548923.2017.1368821; Williams LJ, 2011, AM J PHYS ANTHROPOL, V145, P125, DOI 10.1002/ajpa.21479; Yoshinaga J, 1996, AM J PHYS ANTHROPOL, V100, P23; Zazzo A, 2011, RAPID COMMUN MASS SP, V25, P2371, DOI 10.1002/rcm.5131	81	8	8	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237105	10.1371/journal.pone.0237105	http://dx.doi.org/10.1371/journal.pone.0237105			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC7KJ	32776947	gold, Green Published			2022-12-26	WOS:000561393800008
J	Chen, HL; Chen, P; Zhang, Y; Xing, Y; Guan, YY; Cheng, DX; Li, XW				Chen, Hong-Li; Chen, Pei; Zhang, Yu; Xing, Ying; Guan, Yuan-Yuan; Cheng, Dao-Xiang; Li, Xian-Wen			Retention of volunteers and factors influencing program performance of the Senior Care Volunteers Training Program in Jiangsu, China	PLOS ONE			English	Article							QUALITY-OF-CARE; PALLIATIVE CARE; ATTITUDES; CLIMATE	Background As the country with the largest aging population, China faces an enormous challenge with its elderly support and care. One of the proposed solutions is the development of volunteerism for elderly care. The Senior Care Volunteers Training Program (SCVTP) was initiated by the Red Cross Society of China with the purpose of training volunteers to care for community seniors. As one of the four pilot provinces, Jiangsu Province launched the program since 2017. Aims The present study was conducted to investigate the dropout rate of trained volunteer group leaders, the characteristics of the retained trained volunteer group leaders and the activities that their groups conducted. Additionally, the exploration of the factors influencing the SCVTP's performance was listed as another aim. Methods A cross-sectional study was designed. The study used purposive sampling to select participants who meet the criteria from all the trained volunteer group leaders (n = 623). Demographic questionnaire, volunteer role identity (VRI) scale, attitude toward helping others (AHO) scale, team climate and atmosphere (TCA) scale, and volunteer program performance evaluation (VPPE) questionnaire were used to collect the data online. Descriptive statistics were used to determine the dropout rate and general characteristics of the retained volunteers and the activities. A multiple linear regression equation was developed to study the factors that influence program performance. Results In total, 307 questionnaires were valid in the study. About 67.9%, 53.7%, and 30.0% of the trained volunteer group leaders dropped out of the program in the year of 2017, 2018, and 2019, respectively. The retained trained volunteer group leaders were more likely to be females (84.7%), those in excellent health (75.2%) and with a bachelor's degree or above (87.6%). Less attention has been paid to frailty care (n = 76) than other volunteer caring activities (e.g., safe care: n = 277, diet care: n = 250, drug management care: n = 226). VRI (beta = 0.118, p = 0.017), AHO (beta = 0.134, p = 0.021), TCA (beta = 0.459, p<0.001), and financial sustainability (beta = 0.179, p<0.001) affected the SCVTP's performance significantly (adjusted R-2= 0.356). Conclusion High rate of trained volunteer group leaders' dropout should be brought to the policymaker's attention. The characteristics of the retained trained volunteer group leaders provide a useful reference for the recruitment of trainees in the future. Frailty care may need more training by the volunteer service provider. In order to enhance program performance, a better team climate and atmosphere, financial sustainability, and volunteers with appropriate attitude and role identity are also necessary for the volunteer program.	[Chen, Hong-Li; Chen, Pei; Zhang, Yu; Xing, Ying; Guan, Yuan-Yuan; Li, Xian-Wen] Nanjing Med Univ, Sch Nursing, Nanjing, Jiangsu, Peoples R China; [Cheng, Dao-Xiang] Red Cross Soc, Jiangsu Branch, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Li, XW (corresponding author), Nanjing Med Univ, Sch Nursing, Nanjing, Jiangsu, Peoples R China.	xwli0201@njmu.educn		Li, Xianwen/0000-0003-1935-2391	Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu Province [2017SJB0285]	Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu Province	This work was supported by the Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu Province (2017SJB0285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2019, TEAM ASS QUEST; Alqahtani F., 2015, INT J SCI ENG RES, V6, P670; Anunda JS, 2016, THESIS; Beleiu I., 2015, INT MANAG RES, V11, P59; Black K., 2019, BUSINESS STAT CONT D; Blair A, 2019, AUSTRALAS J AGEING, V38, P34, DOI 10.1111/ajag.12612; Bock JO, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1360-3; Bower P, 2003, QUAL SAF HEALTH CARE, V12, P273, DOI 10.1136/qhc.12.4.273; Bowling NA, 2016, J PERS SOC PSYCHOL, V111, P218, DOI 10.1037/pspp0000085; Burbeck R, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-3; CALLERO PL, 1987, SOC PSYCHOL QUART, V50, P247, DOI 10.2307/2786825; Campbell SM, 2001, BMJ-BRIT MED J, V323, P784, DOI 10.1136/bmj.323.7316.784; Candy B, 2015, INT J NURS STUD, V52, P756, DOI 10.1016/j.ijnurstu.2014.08.007; Chen Hong-Li, 2019, CHINESE HLTH SERVICE, V36, P325; Claxton-Oldfield S, 2015, PALLIAT SUPPORT CARE, V13, P809, DOI 10.1017/S1478951514000674; Das D, 2017, IIMB MANAG REV, V29, P276, DOI 10.1016/j.iimb.2017.11.005; Department of Economic and Social Affairs Population Division European Union, 2020, WORLD POP AG 2019; Department of Economic and Social Affairs Population Dynamics European Union, 2019, WORLD POP PROSP 2019, V1; Desimone JA, 2015, J ORGAN BEHAV, V36, P171, DOI 10.1002/job.1962; Essays UK, 2018, FACT WHICH INFL TEAM; Fletcher TD, 2004, SEX ROLES, V51, P109, DOI 10.1023/B:SERS.0000032319.78926.54; Ford LR, 2006, LEADERSHIP QUART, V17, P258, DOI 10.1016/j.leaqua.2006.02.005; Grube JA, 2000, PERS SOC PSYCHOL B, V26, P1108, DOI 10.1177/01461672002611007; Hartgerink JM, 2014, J ADV NURS, V70, P791, DOI 10.1111/jan.12233; Hettiarachchi H.A.H., 2014, IOSR J BUSINESS MANA, V16, P74, DOI 10.9790/487X-16447483; International Federation of the Red Cross and Red Crescent, 2011, PROJ PROGR MON EV M; Kilgore Lindsay, 2016, Home Healthc Now, V34, P115, DOI 10.1097/NHH.0000000000000345; Klein KJ, 2001, J APPL PSYCHOL, V86, P3, DOI 10.1037/0021-9010.86.1.3; Korner M, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0888-y; Latif KF, 2017, EVAL PROGRAM PLANN, V64, P20, DOI 10.1016/j.evalprogplan.2017.05.004; Lopez-Zapata E, 2019, EUR RES STUD J, V22, P68, DOI 10.35808/ersj/1457; Marta E, 2008, J ADULT DEV, V15, P35, DOI 10.1007/s10804-007-9033-4; Mugo KJ, 2013, THESIS; Muriithi CW, 2014, THESIS; National Bureau of Statistics, 2020, OV PERF NAT EC WER S; PHILLIPS JD, 1990, PERS J, V69, P58; Quinn FF, 2014, BUSINESS STUDIES J, V6, P67; Rahiman M.H.U., 2017, BRIT J EC FINANCE MA, V13, P93; Red Cross Society of China, 2017, GUID INV RED CROSS E; RENTSCH JR, 1990, J APPL PSYCHOL, V75, P668, DOI 10.1037/0021-9010.75.6.668; Riketta M, 2008, J APPL PSYCHOL, V93, P472, DOI 10.1037/0021-9010.93.2.472; Rokach A, 2009, PSYCHOL ED, V46, P7; Scott R., 2015, EUR J PALLIAT CARE, V22, P80; Shahab M.A., 2014, INT J MANAG STUD RES, V2, P69; Sharma J. P., 2010, INT B BUSINESS ADM, V9, P7; Singer E, 2013, ANN AM ACAD POLIT SS, V645, P112, DOI 10.1177/0002716212458082; Soderhamn U, 2017, BMC PALLIAT CARE, V16, DOI 10.1186/s12904-017-0193-0; Tal KN, 2005, SMALL GR RES, V36, P437, DOI [10.1177/1046496405275233, DOI 10.1177/1046496405275233]; Tapp A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218597; Tsai YF, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-98; van Ingen E, 2017, NONPROF VOLUNT SEC Q, V46, P29, DOI 10.1177/0899764016659765; Jimenez MLV, 2010, SPAN J PSYCHOL, V13, P343, DOI 10.1017/S1138741600003905; Watanabe O, 2016, J INT HLTH, V31, P1, DOI [10.11197/jaih.31.1, DOI 10.11197/JAIH.31.1]; Webb DJ, 2000, J ACAD MARKET SCI, V28, P299, DOI 10.1177/0092070300282010; Weerakkody WAS, 2013, KELANIYA J HUMAN RES, V8, P179, DOI [10.4038/kjhrm.v8i2.8, DOI 10.4038/KJHRM.V8I2.8]	55	0	0	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237390	10.1371/journal.pone.0237390	http://dx.doi.org/10.1371/journal.pone.0237390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC7KJ	32776995	gold, Green Published			2022-12-26	WOS:000561393800012
J	Finocchiaro, D; Berenato, S; Bertolini, V; Castellani, G; Lanconelli, N; Versari, A; Spezi, E; Iori, M; Fioroni, F; Grassi, E				Finocchiaro, Domenico; Berenato, Salvatore; Bertolini, Valentina; Castellani, Gastone; Lanconelli, Nico; Versari, Annibale; Spezi, Emiliano; Iori, Mauro; Fioroni, Federica; Grassi, Elisa			Comparison of different calculation techniques for absorbed dose assessment in patient specific peptide receptor radionuclide therapy	PLOS ONE			English	Article							COMPLICATION PROBABILITY; 3-DIMENSIONAL DOSIMETRY; SOMATOSTATIN ANALOGS; SOFTWARE; LU-177-DOTATATE; SPECT	Aim The present work concerns the comparison of the performances of three systems for dosimetry in RPT that use different techniques for absorbed dose calculation (organ-level dosimetry, voxel-level dose kernel convolution and Monte Carlo simulations). The aim was to assess the importance of the choice of the most adequate calculation modality, providing recommendations about the choice of the computation tool. Methods The performances were evaluated both on phantoms and patients in a multi-level approach. Different phantoms filled with a(177)Lu-radioactive solution were used: a homogeneous cylindrical phantom, a phantom with organ-shaped inserts and two cylindrical phantoms with inserts different for shape and volume. A total of 70 patients with NETs treated by PRRT with(177)Lu-DOTATOC were retrospectively analysed. Results The comparisons were performed mainly between the mean values of the absorbed dose in the regions of interest. A general better agreement was obtained between Dose kernel convolution and Monte Carlo simulations results rather than between either of these two and organ-level dosimetry, both for phantoms and patients. Phantoms measurements also showed the discrepancies mainly depend on the geometry of the inserts (e.g. shape and volume). For patients, differences were more pronounced than phantoms and higher inter/intra patient variability was observed. Conclusion This study suggests that voxel-level techniques for dosimetry calculation are potentially more accurate and personalized than organ-level methods. In particular, a voxel-convolution method provides good results in a short time of calculation, while Monte Carlo based computation should be conducted with very fast calculation systems for a possible use in clinics, despite its intrinsic higher accuracy. Attention to the calculation modality is recommended in case of clinical regions of interest with irregular shape and far from spherical geometry, in which Monte Carlo seems to be more accurate than voxel-convolution methods.	[Finocchiaro, Domenico; Bertolini, Valentina; Iori, Mauro; Fioroni, Federica; Grassi, Elisa] Azienda Unita Sanit Locale Reggio Emilia IRCCS, Med Phys Unit, Reggio Emilia, Italy; [Finocchiaro, Domenico; Castellani, Gastone; Lanconelli, Nico] Univ Bologna, Dept Phys & Astron, Bologna, Italy; [Berenato, Salvatore; Spezi, Emiliano] Velindre Canc Ctr, Dept Med Phys, Cardiff, Wales; [Versari, Annibale] Azienda Unita Sani Locale Reggio Emilia IRCCS, Nucl Med Unit, Reggio Emilia, Italy; [Spezi, Emiliano] Cardiff Univ, Sch Engn, Cardiff, Wales	University of Bologna; Velindre Cancer Centre; Cardiff University	Fioroni, F (corresponding author), Azienda Unita Sanit Locale Reggio Emilia IRCCS, Med Phys Unit, Reggio Emilia, Italy.	federica.fioroni@ausl.re.it	Finocchiaro, Domenico/AAA-8842-2022; Spezi, Emiliano/A-8917-2008; Iori, Mauro/K-2393-2018; Berenato, Salvatore/A-4275-2019	Finocchiaro, Domenico/0000-0003-4367-6951; Spezi, Emiliano/0000-0002-1452-8813; Iori, Mauro/0000-0002-8738-3352; Berenato, Salvatore/0000-0001-7721-4195	European Metrology Programme For Innovation And Research (EMPIR) from the European Union [15HLT06]; European Union's Horizon 2020 research and innovation programme; EMPIR Participating States; Cancer Research Wales [2482]	European Metrology Programme For Innovation And Research (EMPIR) from the European Union; European Union's Horizon 2020 research and innovation programme; EMPIR Participating States; Cancer Research Wales	This work was supported by the European Metrology Programme For Innovation And Research (EMPIR) joint research project 15HLT06 "Metrology for clinical implementation of dosimetry in molecular radiotherapy" (MRTDosimetry) which has received funding from the European Union. The EMPIR initiative is co funded by the European Union's Horizon 2020 research and innovation programme and the EMPIR Participating States. SB acknowledges funding from Cancer Research Wales through grant No 2482.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; [Anonymous], MIM SUREPLANTM MRT S; Barone R, 2005, J NUCL MED, V46, p99S; Bodei L, 2008, EUR J NUCL MED MOL I, V35, P1847, DOI 10.1007/s00259-008-0778-1; Bolch WE, 1999, J NUCL MED, V40, p11S; Bolch WE, 2009, J NUCL MED, V50, P477, DOI 10.2967/jnumed.108.056036; Campana D, 2013, EUR J NUCL MED MOL I, V40, P1197, DOI 10.1007/s00259-013-2402-2; Cristy M, 1987, ORNLTM8381, pV1; Dewaraja YK, 2012, J NUCL MED, V53, P1310, DOI 10.2967/jnumed.111.100123; Finocchiaro D, 2019, PHYS MEDICA, V57, P153, DOI 10.1016/j.ejmp.2018.12.029; Forrer F, 2005, EUR J NUCL MED MOL I, V32, P511, DOI 10.1007/s00259-004-1726-3; Forrer F, 2009, EUR J NUCL MED MOL I, V36, P1138, DOI 10.1007/s00259-009-1072-6; Fraass B, 1998, MED PHYS, V25, P1773, DOI 10.1118/1.598373; Gardin I, 2003, CANCER BIOTHER RADIO, V18, P109, DOI 10.1089/108497803321269386; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Grassi E, 2015, PHYS MEDICA, V31, P72, DOI 10.1016/j.ejmp.2014.10.002; Grassi E., 2017, RADIOL DIAGN IMAGING, V1, P1, DOI 10.15761/RDI.1000101; Grassi E, 2018, PHYS MEDICA, V45, P177, DOI 10.1016/j.ejmp.2017.11.021; Grimes J, 2013, MED PHYS, V40, DOI 10.1118/1.4810963; Hippelainen ET, 2017, NUCL MED COMMUN, V38, P357, DOI 10.1097/MNM.0000000000000662; ICRP, 1991, TRAINING COURSE SERI, V60; Ilan E, 2015, J NUCL MED, V56, P177, DOI 10.2967/jnumed.114.148437; Jackson PA, 2013, MED PHYS, V40, DOI 10.1118/1.4824318; Kim B, 2012, RADIAT ONCOL J, V30, P43, DOI 10.3857/roj.2012.30.1.43; Kletting P, 2015, Z MED PHYS, V25, P264, DOI 10.1016/j.zemedi.2015.01.001; Kost SD, 2015, CANCER BIOTHER RADIO, V30, P16, DOI 10.1089/cbr.2014.1713; KUTCHER GJ, 1994, MED PHYS, V21, P581, DOI 10.1118/1.597316; KUTCHER GJ, 1989, INT J RADIAT ONCOL, V16, P1623, DOI 10.1016/0360-3016(89)90972-3; Lin H, 2010, MED PHYS, V37, DOI 10.1118/1.3468142; LYMAN JT, 1985, RADIAT RES, V104, pS13, DOI 10.2307/3576626; Marcatili S, 2013, PHYS MED BIOL, V58, P2491, DOI 10.1088/0031-9155/58/8/2491; McKay E, 2003, CANCER BIOTHER RADIO, V18, P379, DOI 10.1089/108497803322285125; PLANET Dose, PLANET DOS SOFTW; QDose, QDOSE SOFTW; SGOUROS G, 1990, J NUCL MED, V31, P1884; Spezi E, 2008, RADIAT PROT DOSIM, V131, P123, DOI 10.1093/rpd/ncn277; Stabin MG, 2005, J NUCL MED, V46, P1023; Stabin MG, 2018, J NUCL MED, V59, P154, DOI 10.2967/jnumed.117.196261; Strigari L, 2011, Q J NUCL MED MOL IM, V55, P205; Strigari L, 2014, EUR J NUCL MED MOL I, V41, P1976, DOI 10.1007/s00259-014-2824-5; Strosberg J, 2017, NEW ENGL J MED, V376, P125, DOI 10.1056/NEJMoa1607427; Uribe CF, 2017, EJNMMI PHYS, V4, DOI 10.1186/s40658-016-0170-3; Vinjamuri S, 2013, BRIT J CANCER, V108, P1440, DOI 10.1038/bjc.2013.103; Yonekura Y, 2019, Ann ICRP, V48, P5, DOI 10.1177/0146645319838665; Zaknun JJ, 2013, EUR J NUCL MED MOL I, V40, P800, DOI 10.1007/s00259-012-2330-6	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0236466	10.1371/journal.pone.0236466	http://dx.doi.org/10.1371/journal.pone.0236466			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764764	Green Published, gold, Green Accepted			2022-12-26	WOS:000561029000039
J	Allais, L; Verschuere, S; Maes, T; De Smet, R; Devriese, S; Gonzales, GB; Peeters, H; Van Crombruggen, K; Bachert, C; De Vos, M; Brusselle, GG; Bracke, KR; Cuvelier, CA; Laukens, D				Allais, Liesbeth; Verschuere, Stephanie; Maes, Tania; De Smet, Rebecca; Devriese, Sarah; Gonzales, Gerard Bryan; Peeters, Harald; Van Crombruggen, Koen; Bachert, Claus; De Vos, Martine; Brusselle, Guy G.; Bracke, Ken R.; Cuvelier, Claude A.; Laukens, Debby			Translational research into the effects of cigarette smoke on inflammatory mediators and epithelial TRPV1 in Crohn's disease	PLOS ONE			English	Article							INDUCED PULMONARY INFLAMMATION; BOWEL-DISEASE; EXPERIMENTAL COLITIS; RECEPTOR; CELLS; MECHANISMS; NICOTINE; MICE; EXPOSURE; TOBACCO	Crohn's disease is a pathological condition of the gastro-intestinal tract, causing severe transmural inflammation in the ileum and/or colon. Cigarette smoking is one of the best known environmental risk factors for the development of Crohn's disease. Nevertheless, very little is known about the effect of prolonged cigarette smoke exposure on inflammatory modulators in the gut. We examined the effect of cigarette smoke on cytokine profiles in the healthy and inflamed gut of human subjects and in the trinitrobenzene sulphonic acid mouse model, which mimics distal Crohn-like colitis. In addition, the effect of cigarette smoke on epithelial expression of transient receptor potential channels and their concurrent increase with cigarette smoke-augmented cytokine production was investigated. Active smoking was associated with increasedIL-8transcription in ileum of controls (p < 0,001; n = 18-20/group). In the ileum, TRPV1 mRNA levels were decreased in never smoking Crohn's disease patients compared to healthy subjects (p <0,001; n = 20/group). In the colon, TRPV1 mRNA levels were decreased (p = 0,046) in smoking healthy controls (n = 20/group). Likewise, healthy mice chronically exposed to cigarette smoke (n = 10/group) showed elevated ilealCxcl2(p = 0,0075) and colonicKcmRNA levels (p = 0,0186), whereas TRPV1 mRNA and protein levels were elevated in the ileum (p = 0,0315). Although cigarette smoke exposure prior to trinitrobenzene sulphonic acid administration did not alter disease activity, increased pro-inflammatory cytokine production was observed in the distal colon (Kc: p = 0,0273; Cxcl2: p = 0,104; Il1-beta: p = 0,0796), in parallel with the increase ofTrpv1mRNA (p < 0,001). We infer that CS affects pro-inflammatory cytokine expression in healthy and inflamed gut, and that the simultaneous modulation of TRPV1 may point to a potential involvement of TRPV1 in cigarette smoke-induced production of inflammatory mediators.	[Allais, Liesbeth] Anim Healthcare Flanders, Torhout, Belgium; [Allais, Liesbeth; De Smet, Rebecca; Cuvelier, Claude A.] Univ Ghent, Dept Med & Forens Pathol, Ghent, Belgium; [Verschuere, Stephanie] AZ Delta, Dept Pathol, Roeselare, AZ, Belgium; [Maes, Tania; Brusselle, Guy G.; Bracke, Ken R.] Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium; [Devriese, Sarah; Gonzales, Gerard Bryan; De Vos, Martine; Laukens, Debby] Univ Ghent, Dept Gastroenterol, Ghent, Belgium; [Peeters, Harald] AZ St Lucas, Dept Gastroenterol, Ghent, Belgium; [Van Crombruggen, Koen; Bachert, Claus] Univ Ghent, Dept Otorhinolaryngol, Upper Airways Res Lab, Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University	Allais, L (corresponding author), Anim Healthcare Flanders, Torhout, Belgium.; Allais, L (corresponding author), Univ Ghent, Dept Med & Forens Pathol, Ghent, Belgium.	liesbeth.allais@gmail.com	Bracke, Ken R/GSN-7630-2022; Maes, Tania/M-8675-2016; Bachert, Claus/J-8825-2012	Bracke, Ken R/0000-0001-5906-4605; Maes, Tania/0000-0002-3037-6928; Laukens, Debby/0000-0002-1984-5850; Allais, Liesbeth/0000-0003-2663-8566; Gonzales, Gerard Bryan/0000-0001-6614-3520	Concerted Research Action of Ghent University [BOF10/GOA/021, BOF12/GOA/008]; FWO Flanders and Interuniversitary Attraction Poles Programme/Belgian Federal Science Policy [P7/30]; Special Research Fund of Ghent University [01D41012]	Concerted Research Action of Ghent University; FWO Flanders and Interuniversitary Attraction Poles Programme/Belgian Federal Science Policy; Special Research Fund of Ghent University(Ghent University)	RDS was supported by Concerted Research Action of Ghent University (BOF10/GOA/021, BOF12/GOA/008), TM and KB were supported by FWO Flanders and Interuniversitary Attraction Poles Programme/Belgian Federal Science Policy P7/30. LA was supported by a doctoral grant from the Special Research Fund of Ghent University (01D41012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar A, 2010, GUT, V59, P767, DOI 10.1136/gut.2009.194449; Allais L, 2016, PATHOBIOLOGY, V84, P1, DOI 10.1159/000446568; Allais L, 2016, ENVIRON MICROBIOL, V18, P1352, DOI 10.1111/1462-2920.12934; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Berkowitz L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00074; Bracke KR, 2006, J IMMUNOL, V177, P4350, DOI 10.4049/jimmunol.177.7.4350; Cosnes J, 2004, BEST PRACT RES CL GA, V18, P481, DOI 10.1016/j.bpg.2003.12.003; D'Aldebert E, 2011, GASTROENTEROLOGY, V140, P275, DOI 10.1053/j.gastro.2010.09.045; D'hulst AI, 2005, EUR RESPIR J, V26, P204, DOI 10.1183/09031936.05.00095204; de Jong PR, 2014, J CLIN INVEST, V124, P3793, DOI 10.1172/JCI72340; Devriese S, 2017, HISTOCHEM CELL BIOL, V148, P85, DOI 10.1007/s00418-017-1539-7; Dutra RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027122; Eliakim R, 1998, EUR J GASTROEN HEPAT, V10, P1013; Engel MA, 2011, INFLAMM BOWEL DIS, V17, P1030, DOI 10.1002/ibd.21422; Fichna J, 2012, NEUROGASTROENT MOTIL, V24, pe557, DOI 10.1111/j.1365-2982.2012.01999.x; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Galitovskiy V, 2011, J IMMUNOL, V187, P2677, DOI 10.4049/jimmunol.1002711; GIBSON P, 1995, GUT, V37, P536, DOI 10.1136/gut.37.4.536; Grimm MC, 1996, GUT, V38, P90, DOI 10.1136/gut.38.1.90; Guo X, 1999, GASTROENTEROLOGY, V117, P884, DOI 10.1016/S0016-5085(99)70347-1; Guo X, 2001, DIGESTION, V63, P180, DOI 10.1159/000051887; Herbert MK, 2002, ANASTH INTENSIV NOTF, V37, P386, DOI 10.1055/s-2002-32701; Holzer P, 2011, PHARMACOL THERAPEUT, V131, P142, DOI 10.1016/j.pharmthera.2011.03.006; Jiang WY, 2014, INFLAMM RES, V63, P943, DOI 10.1007/s00011-014-0768-7; Jin Y, 2012, J INTERFERON CYTOKIN, DOI [10.1089/jir.2012.003023030668, DOI 10.1089/JIR.2012.003023030668]; Karban A, 2007, WORLD J GASTROENTERO, V13, P2150, DOI 10.3748/wjg.v13.i15.2150; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khan WI, 2006, CLIN EXP IMMUNOL, V143, P389, DOI 10.1111/j.1365-2249.2005.02979.x; Kun J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108164; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Macdonald G, 2004, RADIOTHER ONCOL, V73, P367, DOI 10.1016/j.radonc.2004.09.002; Ananthakrishnan Ashwin N, 2013, Gastroenterol Hepatol (N Y), V9, P367; Mortensen EM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-45; MURAKAMI H, 1980, P NATL ACAD SCI-BIOL, V77, P3464, DOI 10.1073/pnas.77.6.3464; Oral H, 2013, J MOL CELL CARDIOL, V60, P1, DOI 10.1016/j.yjmcc.2013.04.006; PERSSON PG, 1990, GUT, V31, P1377, DOI 10.1136/gut.31.12.1377; Peters EMJ, 2006, J INVEST DERMATOL, V126, P1937, DOI 10.1038/sj.jid.5700429; Sher ME, 1999, INFLAMM BOWEL DIS, V5, P73, DOI 10.1097/00054725-199905000-00001; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sun YP, 2007, DIGESTION, V76, P181, DOI 10.1159/000112643; Sykes AP, 2000, INFLAMM RES, V49, P311, DOI 10.1007/s000110050597; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; van Lierop PPE, 2010, INFLAMM BOWEL DIS, V16, P442, DOI 10.1002/ibd.21073; Verschuere S, 2012, HISTOCHEM CELL BIOL, V137, P293, DOI 10.1007/s00418-011-0902-3; Verschuere S, 2012, J CROHNS COLITIS, V6, P1, DOI 10.1016/j.crohns.2011.09.006; Verschuere S, 2011, LAB INVEST, V91, P1056, DOI 10.1038/labinvest.2011.74; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	48	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236657	10.1371/journal.pone.0236657	http://dx.doi.org/10.1371/journal.pone.0236657			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760089	Green Published, gold			2022-12-26	WOS:000561027200008
J	Moura, MN; Cardoso, DC; Baldez, BCL; Cristiano, MP				Moura, Mariana Neves; Cardoso, Danon Clemes; Lima Baldez, Brenda Carla; Cristiano, Maykon Passos			Intraspecific variation in the karyotype length and genome size of fungus-farming ants (genusMycetophylax), with remarks on procedures for the estimation of genome size in the Formicidae by flow cytometry	PLOS ONE			English	Article							NUCLEAR-DNA CONTENT; HYMENOPTERA-FORMICIDAE; PARASITOIDS HYMENOPTERA; MYCETOPHYLAX EMERY; DROSOPHILA; EVOLUTION; GENUS; CHROMOSOME; ATTINI; CELLS	Ants (Formicidae) present considerable diversity in chromosome numbers, which vary from n = 1 to n = 60, although this variation is not proportional to that in genome size, for which estimates range from 0.18 pg to 0.77 pg. Intraspecific variation in the chromosome number and karyotype structure has been reported among species, although the variation among populations of the same species has received much less attention, and there are few data on genome size. Here, we studied the karyotype length and genome size of different populations of the fungus-farming antsMycetophylax conformis(Mayr, 1884) andMycetophylax morschi(Emery, 1888). We also provide remarks on procedure for the estimation of ant genome size by Flow Cytometry (FCM) analysis. Chromosome number and morphology did not vary among the populations ofM.conformisor the cytotypes ofM.morschi, but karyotype length and genome size were significantly distinct among the populations of these ants. Our results on the variation in karyotype length and genome size amongM.morschiandM.conformispopulations reveal considerable diversity that would be largely overlooked by more traditional descriptions of karyotypes, which were also supported by the estimates of genome size obtained using flow cytometry. Changes in the amount of DNA reflect variation in the fine structure of the chromosomes, which may represent the first steps of karyotype evolution and may occur previously to any changes in the chromosome number.	[Moura, Mariana Neves] Univ Fed Vicosa, Programa Posgrad Ecol, Vicosa, MG, Brazil; [Cardoso, Danon Clemes; Cristiano, Maykon Passos] Univ Fed Ouro Preto, Dept Biodiversidade Evolucao & Meio Ambiente ICEB, Ouro Preto, MG, Brazil; [Lima Baldez, Brenda Carla] Univ Fed Ouro Preto, Programa Posgrad Ecol Biomas Trop, Ouro Preto, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto	Cardoso, DC; Cristiano, MP (corresponding author), Univ Fed Ouro Preto, Dept Biodiversidade Evolucao & Meio Ambiente ICEB, Ouro Preto, MG, Brazil.	danon@ufop.edu.br; maykon@ufop.edu.br	Cardoso, Danon Clemes/D-2313-2009; Moura, Mariana Neves/AAX-2726-2020	Cardoso, Danon Clemes/0000-0002-2811-2536; 	FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [401871-2016-9]; CAPES (Coordenacao de Pessoal de Nivel Superior) [001]; CNPq [309579/2018-0]	FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico: 401871-2016-9). M.N.M thanks CAPES (Coordenacao de Pessoal de Nivel Superior: financial code: 001); and M.P. Cristiano received a Research Productivity Fellowship from CNPq (grant number: 309579/2018-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; [Anonymous], 2019, R LANG ENV STAT COMP; Ardila-Garcia AM, 2010, INSECT MOL BIOL, V19, P337, DOI 10.1111/j.1365-2583.2010.00992.x; Bennett MD, 2003, ANN BOT-LONDON, V91, P547, DOI 10.1093/aob/mcg057; Bozek M, 2012, BOT J LINN SOC, V170, P529, DOI 10.1111/j.1095-8339.2012.01314.x; Barros LAC, 2013, ANN SOC ENTOMOL FR, V49, P367, DOI 10.1080/00379271.2013.856201; Cardoso DC, 2011, INSECT SOC, V58, P427, DOI 10.1007/s00040-011-0160-3; Cardoso DC, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1247-5; Cardoso DC, 2018, MYRMECOL NEWS, V27, P87; Cardoso DC, 2017, COMP CYTOGENET, V11, P45, DOI 10.3897/CompCytogen.v11i1.10842; Cardoso DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087473; Cardoso DC, 2012, CR BIOL, V335, P619, DOI 10.1016/j.crvi.2012.09.012; Chenais B, 2012, GENE, V509, P7, DOI 10.1016/j.gene.2012.07.042; Crawley MJ, 2013, R BOOK, P557; Cristiano MP, 2017, INSECTS, V8, DOI 10.3390/insects8040114; Cristiano MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059784; CROSLAND MWJ, 1986, SCIENCE, V231, P1278, DOI 10.1126/science.231.4743.1278; CROZIER RH, 1970, CAN J GENET CYTOL, V12, P109, DOI 10.1139/g70-018; Dolezel J, 2005, ANN BOT-LONDON, V95, P99, DOI 10.1093/aob/mci005; DOLEZEL J, 1989, BIOL PLANTARUM, V31, P113, DOI 10.1007/BF02907241; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; DOLEZEL J, 1995, CYTOMETRY, V19, P103, DOI 10.1002/cyto.990190203; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Ellis LL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004522; Mariano CDF, 2008, INSECT CONSERV DIVER, V1, P161, DOI 10.1111/j.1752-4598.2008.00022.x; Galbraith D W, 2001, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0706s02; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Gokhman VE, 2017, COMP CYTOGENET, V11, P97, DOI 10.3897/CompCytogen.v11i1.10872; Gokhman VE, 2011, COMP CYTOGENET, V5, P211, DOI 10.3897/CompCytogen.v5i3.1435; Graur D, 2016, MOL GENOME EVOLUTION; Gregory TR, 2008, HEREDITY, V101, P228, DOI 10.1038/hdy.2008.49; Gregory T. Ryan, 2005, P3; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; IMAI HT, 1988, JPN J GENET, V63, P159, DOI 10.1266/jjg.63.159; Jeffery NW, 2016, GENOME, V59, P393, DOI 10.1139/gen-2015-0206; Jennings BH, 2011, MATER TODAY, V14, P190, DOI 10.1016/S1369-7021(11)70113-4; Johnston JS, 2004, INSECT MOL BIOL, V13, P581, DOI 10.1111/j.0962-1075.2004.00514.x; Klingenberg C, 2009, ZOOTAXA, P1; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lopes DM, 2009, APIDOLOGIE, V40, P517, DOI 10.1051/apido/2009030; Lorite P, 1996, CARYOLOGIA, V49, P199, DOI 10.1080/00087114.1996.10797364; Lorite Pedro, 1998, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Biologica, V94, P23; Lorite P, 2010, MYRMECOL NEWS, V13, P89; Loureiro J, 2006, ANN BOT-LONDON, V98, P679, DOI 10.1093/aob/mcl141; Mariano Clea dos Santos Ferreira, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/973897; Mayhe-Nunes AJ, 2005, SOCIOBIOLOGY, V45, P271; Menezes RST, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07776-7; Micolino R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55135-5; Micolino R, 2019, CYTOGENET GENOME RES, V159, P151, DOI 10.1159/000503913; MULLIGAN PK, 1980, HISTOCHEMISTRY, V66, P11, DOI 10.1007/BF00493241; Nardon C, 2005, MOL ECOL, V14, P869, DOI 10.1111/j.1365-294X.2005.02457.x; Otto F, 1990, Methods Cell Biol, V33, P105; Otto F, 1992, FLOW CYTOMETRY CELL, P101, DOI 10.1007/978-3-662-02785-1_8; PALOMEQUE T, 1988, CARYOLOGIA, V41, P289, DOI 10.1080/00087114.1988.10797869; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; Pereira TTP, 2018, COMP CYTOGENET, V12, P13, DOI 10.3897/CompCytogen.v12i1.21799; RASCH EM, 1971, CHROMOSOMA, V33, P1, DOI 10.1007/BF00326379; Stolle E, 2019, MOL BIOL EVOL, V36, P553, DOI 10.1093/molbev/msy236; Tavares MG, 2012, APIDOLOGIE, V43, P731, DOI 10.1007/s13592-012-0145-x; Tavares MG, 2010, APIDOLOGIE, V41, P636, DOI 10.1051/apido/20010023; Tsutsui ND, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-64; Vieira C, 2002, MOL BIOL EVOL, V19, P1154, DOI 10.1093/oxfordjournals.molbev.a004173; Wang XH, 2011, PLANT CELL REP, V30, P955, DOI 10.1007/s00299-011-1020-3	63	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237157	10.1371/journal.pone.0237157	http://dx.doi.org/10.1371/journal.pone.0237157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760102	gold, Green Published			2022-12-26	WOS:000561027200045
J	Ohsugi, Y; Katagiri, S; Hirota, T; Niimi, H; Hatasa, M; Watanabe, K; Shimohira, T; Mizutani, K; Kitazawa, M; Matsuzawa, A; Kadokura, H; Yokose, S; Iwata, T; Aoki, A				Ohsugi, Yujin; Katagiri, Sayaka; Hirota, Tomomitsu; Niimi, Hiromi; Hatasa, Masahiro; Watanabe, Kazuki; Shimohira, Tsuyoshi; Mizutani, Koji; Kitazawa, Moe; Matsuzawa, Ayumi; Kadokura, Hiroshi; Yokose, Satoshi; Iwata, Takanori; Aoki, Akira			Laser irradiation decreases sclerostin expression in bone and osteogenic cells	FASEB JOURNAL			English	Article						bone; Er; YAG laser; microarray; osteogenic cell; sclerostin	ER-YAG LASER; TARGETED DELETION; WNT; OSTEOBLASTS; DIFFERENTIATION; CATENIN; TISSUE; GENE; SOST; PROLIFERATION	Anti-sclerostin monoclonal antibody romosozumab, a treatment for osteoporosis, reduced vertebral fracture risk and clinical fracture. Laser irradiation triggers various effects, including bio-stimulation, which can induce beneficial therapeutic effects and biological responses. Originally, we performed in vivo experiments to clarify the mechanism of better bone healing in laser-ablated bone. Here, we evaluated comprehensive and sequential gene expression in Er:YAG laser-ablated, bur-drilled, and nontreated control bones, and found laser irradiation suppressedSost(coding protein: sclerostin) expression in the bone, possibly via stimulation of mechanotransducers. Surprisingly, bio-stimulation effect of laser suppressedSostexpression in the primary osteogenic cells. Decreased sclerostin expression after laser irradiation was also validated both in vivo and in vitro. In addition, sequential microarray analysis revealed that the gene expression pattern was clearly different at 24 hours after bone ablation between bur-drilled and laser-ablated bones. The Hippo signaling pathway was significantly enriched, whereas inflammation-related pathways were not affected at 6 hours after the laser ablation, indicating that laser irradiation caused mechanical stimulation. Only bur-drilled bone showed enriched inflammation-related gene sets and pathways at 24 hours, not in the laser-ablated bone. Our study suggests that laser irradiation may become a new treatment modality for osteoporosis, by inhibiting sclerostin expression without inducing inflammation.	[Ohsugi, Yujin; Katagiri, Sayaka; Niimi, Hiromi; Hatasa, Masahiro; Watanabe, Kazuki; Shimohira, Tsuyoshi; Mizutani, Koji; Iwata, Takanori; Aoki, Akira] Tokyo Med & Dent Univ TMDU, Grad Sch Med & Dent Sci, Dept Periodontol, Tokyo, Japan; [Hirota, Tomomitsu] Jikei Univ, Res Ctr Med Sci, Div Mol Genet, Sch Med, Tokyo, Japan; [Kitazawa, Moe; Matsuzawa, Ayumi] Tokyo Med & Dent Univ TMDU, Med Res Inst, Dept Epigenet, Tokyo, Japan; [Kadokura, Hiroshi; Yokose, Satoshi] Meikai Univ, Sch Dent, Dept Restorat & Biomat Sci, Div Endodont & Operat Dent, Saitama, Japan	Tokyo Medical & Dental University (TMDU); Jikei University; Tokyo Medical & Dental University (TMDU); Meikai University	Katagiri, S; Aoki, A (corresponding author), Tokyo Med & Dent Univ TMDU, Grad Sch Med & Dent Sci, Dept Periodontol, Bunkyo Ku, 1-5-45 Yushima, Tokyo, Japan.	katagiri.peri@tmd.ac.jp; aoperi@tmd.ac.jp		Ohsugi, Yujin/0000-0002-2843-173X	Japan Society for the Promotion of Science KAKENHI [16K11825, 20K09971, 20K18501]; Academy of Laser Dentistry; Nanken-Kyoten, TMDU	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Academy of Laser Dentistry; Nanken-Kyoten, TMDU	This work was supported by the Japan Society for the Promotion of Science KAKENHI (16K11825 and 20K09971 to AA, and 20K18501 to YO) and Dr. Eugene Seidner Research Grants from the Academy of Laser Dentistry to SK. This study was supported by Nanken-Kyoten, TMDU. The authors would like to appreciate Drs. Masahiro Noda, Taichen Lin, Toru Takagi, Sho Kakizaki, Yutaro Kitanaka, Naoki Sasaki, and Rina Komazaki at Department of Periodontology, TMDU, and Mayumi Tamari at Division of Molecular Genetics, Research Center for Medical Science, The Jikei University School of Medicine for their kind support, and the staff at TMDU's experimental animal center.	Aoki A, 2015, PERIODONTOL 2000, V68, P217, DOI 10.1111/prd.12080; de Mello EDA, 2008, LASER MED SCI, V23, P253, DOI 10.1007/s10103-007-0475-5; Baek K, 2014, J CELL PHYSIOL, V229, P640, DOI 10.1002/jcp.24487; Baht GS, 2018, CURR OSTEOPOROS REP, V16, P138, DOI 10.1007/s11914-018-0423-2; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Caverzasio J, 2009, IBMS BONEKEY, V6, P9; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Collette NM, 2012, P NATL ACAD SCI USA, V109, P14092, DOI 10.1073/pnas.1207188109; Compton JT, 2014, J BONE JOINT SURG AM, V96A, P1659, DOI 10.2106/JBJS.M.01096; Cosman F, 2016, NEW ENGL J MED, V375, P1532, DOI 10.1056/NEJMoa1607948; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; ERIKSSON AR, 1983, J PROSTHET DENT, V50, P101, DOI 10.1016/0022-3913(83)90174-9; Evenepoel P, 2014, NEW ENGL J MED, V370, P1664, DOI 10.1056/NEJMc1402396; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gu GL, 2006, CELL TISSUE RES, V323, P263, DOI 10.1007/s00441-005-0066-3; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Izumi Y, 2011, PERIODONTOL 2000, V56, P166, DOI 10.1111/j.1600-0757.2010.00366.x; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kong S, 2018, J BIOPHOTONICS, V11, DOI 10.1002/jbio.201700157; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Liu F, 2008, CELL SIGNAL, V20, P999, DOI 10.1016/j.cellsig.2007.11.011; Luger EJ, 1998, LASER SURG MED, V22, P97, DOI 10.1002/(SICI)1096-9101(1998)22:2<97::AID-LSM5>3.3.CO;2-E; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; Niimi H, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00459; Ohsugi Y, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201800245; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Perussi LR, 2012, LASER MED SCI, V27, P95, DOI 10.1007/s10103-011-0920-3; Piters E, 2008, ARCH BIOCHEM BIOPHYS, V473, P112, DOI 10.1016/j.abb.2008.03.006; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Pourzarandian A, 2004, PHOTOMED LASER SURG, V22, P342, DOI 10.1089/1549541041797913; Ransom RC, 2018, NATURE, V563, P514, DOI 10.1038/s41586-018-0650-9; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saag KG, 2017, NEW ENGL J MED, V377, P1417, DOI 10.1056/NEJMoa1708322; Sebastian A, 2017, BONE, V96, P76, DOI 10.1016/j.bone.2016.10.009; Seo J, 2018, BMB REP, V51, P151, DOI 10.5483/BMBRep.2018.51.3.012; Shimohira T, PHOTOBIOMOD PHOTOMED; Shippy R, 2006, NAT BIOTECHNOL, V24, P1123, DOI 10.1038/nbt1241; Stein A, 2005, PHOTOMED LASER SURG, V23, P161, DOI 10.1089/pho.2005.23.161; Stuebinger S, 2007, J PERIODONTOL, V78, P2389, DOI 10.1902/jop.2007.070162; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Wang L, 2014, J AM SOC NEPHROL, V25, P1226, DOI 10.1681/ASN.2013060665; Wenzel PL, 2011, DEV BIOL, V351, P35, DOI 10.1016/j.ydbio.2010.12.025; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yokose S, 1996, ENDOCRINOLOGY, V137, P469, DOI 10.1210/en.137.2.469; Yokose S, 2013, J BIOINTEG, V3, P8, DOI DOI 10.32176/BIOINTEG.3.1_53; You L, 2015, BIOCHEM BIOPH RES CO, V456, P598, DOI 10.1016/j.bbrc.2014.11.120; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112	56	4	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12877	12893		10.1096/fj.202001032R	http://dx.doi.org/10.1096/fj.202001032R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32757452				2022-12-26	WOS:000558305000001
J	Steinert, RE; Rehman, A; Lima, EJS; Agamennone, V; Schuren, FHJ; Gero, D; Schreiner, P; Vonlanthen, R; Ismaeil, A; Tzafos, S; Hosa, H; Vetter, D; Misselwitz, B; Bueter, M				Steinert, Robert E.; Rehman, Ateequr; Lima, Everton Job Souto; Agamennone, Valeria; Schuren, Frank H. J.; Gero, Daniel; Schreiner, Phillip; Vonlanthen, Rene; Ismaeil, Aiman; Tzafos, Stefanos; Hosa, Hanna; Vetter, Diana; Misselwitz, Benjamin; Bueter, Marco			Roux-en-Y gastric bypass surgery changes fungal and bacterial microbiota in morbidly obese patients-A pilot study	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; BARIATRIC SURGERY; WEIGHT-LOSS; IMPACT; INFLAMMATION; ADAPTATION; DYSBIOSIS; RICHNESS; HEALTH	The Roux-en-Y gastric bypass (RYGB) remains the most effective treatment for morbidly obese patients to lower body weight and improve glycemic control. There is recent evidence that the mycobiome (fungal microbiome) can aggravate disease severity in a number of diseases including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and hepatitis; moreover, a dysbiotic fungal microbiota has been reported in the obese. We characterized fungal and bacterial microbial composition in fecal samples of 16 morbidly obese patients before and three months after RYGB surgery and compared with nine healthy controls. We found that RYGB surgery induced a clear alteration in structure and composition of the gut fungal and bacterial microbiota. Beta diversity analysis revealed significant differences in bacterial microbiota between obese patients before surgery and healthy controls (P < 0.005) and a significant, unidirectional shift in RYGB patients after surgery (P < 0.001 vs. before surgery). In contrast, there was no significant difference in fungal microbiota between groups but individually specific changes after RYGB surgery. Interestingly, RYGB surgery induced a significant reduction in fungal alpha diversity namely Chao1, Sobs, and Shannon diversity index (P<0.05, respectively) which contrasts the trend for uniform changes in bacteria towards increased richness and diversity post-surgery. We did not observe any inter-kingdom relations in RYGB patients but in the healthy control cohort and there were several correlations between fungi and bacteria and clinical parameters (P<0.05, respectively) that warrant further research. Our study identifies changes in intestinal fungal communities in RYGB patients that are distinct to changes in the bacterial microbiota.	[Steinert, Robert E.; Gero, Daniel; Schreiner, Phillip; Vonlanthen, Rene; Ismaeil, Aiman; Tzafos, Stefanos; Hosa, Hanna; Vetter, Diana; Bueter, Marco] Univ Hosp Zurich, Dept Surg, Zurich, Switzerland; [Rehman, Ateequr] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Lima, Everton Job Souto; Agamennone, Valeria; Schuren, Frank H. J.] Netherlands Org Appl Sci Res TNO, Microbiol & Syst Biol, Zeist, Netherlands; [Ismaeil, Aiman] Aswan Univ, Dept Surg, Tingar, Egypt; [Misselwitz, Benjamin] Inselspital Bern, Div Visceral Surg & Med, Bern, Switzerland; [Misselwitz, Benjamin] Bern Univ, Bern, Switzerland	University of Zurich; University Zurich Hospital; University of Kiel; Netherlands Organization Applied Science Research; Egyptian Knowledge Bank (EKB); Aswan University; University of Bern; University Hospital of Bern; University of Bern	Steinert, RE (corresponding author), Univ Hosp Zurich, Dept Surg, Zurich, Switzerland.	re.steinert@gmail.com	Misselwitz, Benjamin/L-7193-2016; Agamennone, Valeria/CAA-3892-2022	Misselwitz, Benjamin/0000-0002-8719-5175; Gero, Daniel/0000-0003-2941-9801	University of Zurich; OlgaMayenfisch-Foundation, Zurich, Switzerland; UNISCIENTIA STIFTUNG, VADUZ, Zurich, Switzerland	University of Zurich; OlgaMayenfisch-Foundation, Zurich, Switzerland; UNISCIENTIA STIFTUNG, VADUZ, Zurich, Switzerland	MB: Assistant-professorship research grant by the University of Zurich and OlgaMayenfisch-Foundation, Zurich, Switzerland. RES: UNISCIENTIA STIFTUNG, VADUZ, Zurich, Switzerland The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TD, 2017, NEW ENGL J MED, V377, P1143, DOI 10.1056/NEJMoa1700459; [Anonymous], 2018, GUT; Aron-Wisnewsky J, 2019, GUT, V68, P70, DOI 10.1136/gutjnl-2018-316103; Botschuijver S, 2017, GASTROENTEROLOGY, V153, P1026, DOI 10.1053/j.gastro.2017.06.004; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Celiker H, 2017, MED HYPOTHESES, V107, P81, DOI 10.1016/j.mehy.2017.08.012; Chen Y, 2011, DIAGN MICR INFEC DIS, V70, P492, DOI 10.1016/j.diagmicrobio.2010.04.005; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Crommen S, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010010; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Ejtahed HS, 2018, MICROB PATHOGENESIS, V116, P13, DOI 10.1016/j.micpath.2017.12.074; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Gosiewski T, 2014, GUT PATHOG, V6, DOI 10.1186/s13099-014-0043-z; Gouba N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059474; Guo Y, 2018, EUR J ENDOCRINOL, V178, P43, DOI [10.1530/EJE-17-0403, 10.1530/eje-17-0403]; Hallen-Adams HE, 2015, FUNGAL ECOL, V15, P9, DOI 10.1016/j.funeco.2015.01.006; Hartman AL, 2009, P NATL ACAD SCI USA, V106, P17187, DOI 10.1073/pnas.0904847106; Huseyin CE, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01432; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kong LC, 2013, AM J CLIN NUTR, V98, P16, DOI 10.3945/ajcn.113.058743; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Ladirat SE, 2013, J MICROBIOL METH, V92, P387, DOI 10.1016/j.mimet.2012.12.011; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Li QR, 2014, J CLIN GASTROENTEROL, V48, P513, DOI 10.1097/MCG.0000000000000035; Magouliotis DE, 2017, OBES SURG, V27, P1345, DOI 10.1007/s11695-017-2595-8; Rodriguez MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14600; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; MASON EE, 1976, AM J SURG, V131, P162, DOI 10.1016/0002-9610(76)90090-8; Mukherjee PK, 2015, NAT REV GASTRO HEPAT, V12, P77, DOI 10.1038/nrgastro.2014.188; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Peterli R, 2012, OBES SURG, V22, P740, DOI 10.1007/s11695-012-0622-3; Pournaras DJ, 2012, ENDOCRINOLOGY, V153, P3613, DOI 10.1210/en.2011-2145; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; R Core Team, 2018, R LANG ENV STAT COMP; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sinclair P, 2018, NAT REV GASTRO HEPAT, V15, P606, DOI 10.1038/s41575-018-0057-y; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Standaert-Vitse A, 2009, AM J GASTROENTEROL, V104, P1745, DOI 10.1038/ajg.2009.225; Steinert RE, 2017, PHYSIOL REV, V97, P411, DOI 10.1152/physrev.00031.2014; Strati F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01227; Tremaroli V, 2015, CELL METAB, V22, P228, DOI 10.1016/j.cmet.2015.07.009; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wickham H, 2016, ELEGANT GRAPHICS DAT, VSecond; Yoav BHY, 1995, J ROYAL STAT SOC B, V57	46	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236936	10.1371/journal.pone.0236936	http://dx.doi.org/10.1371/journal.pone.0236936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735609	Green Published, gold, Green Accepted			2022-12-26	WOS:000569367100062
J	Dohrke, JN; Watson, JF; Birchall, K; Greger, IH				Dohrke, Jan-Niklas; Watson, Jake F.; Birchall, Kristian; Greger, Ingo H.			Characterizing the binding and function of TARP gamma 8-selective AMPA receptor modulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; GENERAL FORCE-FIELD; MOLECULAR-MECHANISM; SOFTWARE NEWS; DATABASE; DYNAMICS; GAMMA-8; DETERMINANTS; OPTIMIZATION; ARCHITECTURE	alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid(AMPA)-type glutamate receptors (AMPARs) are the predominant excitatory neurotransmitter receptors in the brain, where they mediate synaptic transmission and plasticity. Excessive AMPAR activation leads to diseases such as epilepsy. AMPAR properties are modulated by auxiliary proteins and foremost by the transmembrane AMPAR regulatory proteins (TARPs). These distribute in unique expression patterns across the brain, rendering AMPAR/TARP complexes promising targets for region-specific therapeutic intervention. TARP gamma 8 is predominantly expressed in the forebrain and is enriched in the hippocampus, a region associated with temporal lobe epilepsy. Recent high-throughput medicinal chemistry screens have identified multiple promising compounds that selectively target AMPARs associated with gamma 8 and hold promise for epilepsy treatment. However, how these modulators target the receptor complex is currently unknown. Here, we use a combination of ligand docking, molecular dynamics simulations, and electrophysiology to address this question. We identify a conserved oxindole isostere, shared between three structurally diverse modulators (LY-3130481, JNJ-55511118, and JNJ-61432059) as the major module engaging gamma 8 by an H-bond to Asn-172 (gamma 8). The remaining variable region of each molecule likely targets the receptor complex in ligand-selective modes. Functional data reveal parallels in the underlying modulatory action of two prominent compounds. This work will aid development of refined AMPAR epilepsy therapeutics and facilitate to uncover the mechanisms by which TARPs modulate the receptor.	[Dohrke, Jan-Niklas; Watson, Jake F.; Greger, Ingo H.] MRC, Neurobiol Div, Lab Mol Biol, Cambridge, England; [Birchall, Kristian] LifeArc, Open Innovat Campus, Stevenage, Herts, England; [Dohrke, Jan-Niklas] Heidelberg Inst Theoret Studies, Schloss Wolfsbrunnenweg 35, Heidelberg, Germany	MRC Laboratory Molecular Biology; Heidelberg Institute for Theoretical Studies	Greger, IH (corresponding author), MRC, Neurobiol Div, Lab Mol Biol, Cambridge, England.	ig@mrc-lmb.cam.ac.uk		Watson, Jake/0000-0002-8698-3823; Greger, Ingo/0000-0002-7291-2581	Medical Research Council [MC_U105174197]; Erasmus Grant [2019-DE01-KA103-004550]; MRC [MC_U105174197] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Erasmus Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Medical Research Council Grant MC_U105174197 and Erasmus Grant 2019-DE01-KA103-004550 (to J. N. D.).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azumaya CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174742; Balannik V, 2005, NEURON, V48, P279, DOI 10.1016/j.neuron.2005.09.024; Ben-Yaacov A, 2017, NEURON, V93, P1126, DOI 10.1016/j.neuron.2017.01.032; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bowie D, 2008, CNS NEUROL DISORD-DR, V7, P129, DOI 10.2174/187152708784083821; Carbone AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10178; Carrillo E, 2020, J GEN PHYSIOL, V152, DOI 10.1085/jgp.201912451; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; Corradi V, 2018, ACS CENTRAL SCI, V4, P709, DOI 10.1021/acscentsci.8b00143; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Garcia-Nafria J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27459; Gardinier KM, 2016, J MED CHEM, V59, P4753, DOI 10.1021/acs.jmedchem.6b00125; Gill MB, 2011, J NEUROSCI, V31, P6928, DOI 10.1523/JNEUROSCI.6271-10.2011; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Greger IH, 2017, NEURON, V94, P713, DOI 10.1016/j.neuron.2017.04.009; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hawken NM, 2017, J PHYSIOL-LONDON, V595, P6517, DOI 10.1113/JP274897; Herguedas B, 2019, SCIENCE, V364, P352, DOI 10.1126/science.aav9011; Herguedas B, 2013, PROG MOL BIOL TRANSL, V117, P361, DOI 10.1016/B978-0-12-386931-9.00013-1; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Ishii T, 2020, MOL PHARMACOL, V97, P336, DOI 10.1124/mol.119.118554; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jeffery G.A., 1997, INTRO HYDROGEN BONDI; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kato AS, 2018, BIOCHEM PHARMACOL, V151, P263, DOI 10.1016/j.bcp.2018.01.018; Kato AS, 2016, NAT MED, V22, P1496, DOI 10.1038/nm.4221; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; Kato AS, 2010, TRENDS NEUROSCI, V33, P241, DOI 10.1016/j.tins.2010.02.004; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Knopp KL, 2019, J PHARMACOL EXP THER, V369, P345, DOI 10.1124/jpet.118.250126; Lee J, 2019, J CHEM THEORY COMPUT, V15, P775, DOI 10.1021/acs.jctc.8b01066; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lee MR, 2017, ACS CHEM NEUROSCI, V8, P2631, DOI 10.1021/acschemneuro.7b00186; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Lynch G, 2004, CURR OPIN PHARMACOL, V4, P4, DOI 10.1016/j.coph.2003.09.009; Maher MP, 2017, NEURON, V96, P989, DOI 10.1016/j.neuron.2017.10.001; Maher MP, 2016, J PHARMACOL EXP THER, V357, P394, DOI 10.1124/jpet.115.231712; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Partin KM, 2015, CURR OPIN PHARMACOL, V20, P46, DOI 10.1016/j.coph.2014.11.002; Ravula S, 2018, ACS MED CHEM LETT, V9, P821, DOI 10.1021/acsmedchemlett.8b00215; Rogawski MA, 2013, ACTA NEUROL SCAND, V127, P9, DOI 10.1111/ane.12099; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Sayall BM, 2019, ACS MED CHEM LETT, V10, P267, DOI 10.1021/acsmedchemlett.8b00599; Schrodinger L. L. C., 2019, SCHROD REL 2019 3; Schwenk J, 2014, NEURON, V84, P41, DOI 10.1016/j.neuron.2014.08.044; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shi Y, 2009, NEURON, V62, P633, DOI 10.1016/j.neuron.2009.05.016; Straub C, 2012, CURR OPIN NEUROBIOL, V22, P488, DOI 10.1016/j.conb.2011.09.005; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Twomey EC, 2016, SCIENCE, V353, P83, DOI 10.1126/science.aaf8411; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Yamazaki M, 2010, EUR J NEUROSCI, V31, P2204, DOI 10.1111/j.1460-9568.2010.07254.x; Yelshanskaya MV, 2016, NEURON, V91, P1305, DOI 10.1016/j.neuron.2016.08.012; Yu WB, 2012, J COMPUT CHEM, V33, P2451, DOI 10.1002/jcc.23067; Zhao Y, 2016, NATURE, V536, P108, DOI 10.1038/nature18961	68	11	12	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2020	295	43					14565	14577		10.1074/jbc.RA120.014135	http://dx.doi.org/10.1074/jbc.RA120.014135			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OP9LU	32747446	Green Published, hybrid			2022-12-26	WOS:000588412800005
J	Shimonaka, S; Matsumoto, SE; Elahi, M; Ishiguro, K; Hasegawa, M; Hattori, N; Motoi, Y				Shimonaka, Shotaro; Matsumoto, Shin-Ei; Elahi, Montasir; Ishiguro, Koichi; Hasegawa, Masato; Hattori, Nobutaka; Motoi, Yumiko			Asparagine residue 368 is involved in Alzheimer's disease tau strain-specific aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tau protein; tauopathy; protein aggregation; protein misfolding; prion; neurodegenerative disease; seed; tau strain; seed	PAIRED HELICAL FILAMENTS; NEUROFIBRILLARY TANGLES; ALPHA-SYNUCLEIN; FINE-STRUCTURE; PROTEIN-TAU; MUTATIONS; TAUOPATHY; BRAIN; PHOSPHORYLATION; PROPAGATION	In tauopathies, tau forms pathogenic fibrils with distinct conformations (termed "tau strains") and acts as an aggregation "seed" templating the conversion of normal tau into isomorphic fibrils. Previous research showed that the aggregation core of tau fibril covers the C-terminal region (243-406 amino acids (aa)) and differs among the diseases. However, the mechanisms by which distinct fibrous structures are formed and inherited via templated aggregation are still unknown. Here, we sought to identify the key sequences of seed-dependent aggregation. To identify sequences for which deletion reduces tau aggregation, SH-SY5Y cells expressing a series of 10 partial deletion (Del 1-10, covering 244-400 aa) mutants of tau-CTF24 (243-441 aa) were treated with tau seeds prepared from a different tauopathy patient's brain (Alzheimer's disease, progressive supranuclear palsy, and corticobasal degeneration) or recombinant tau, and then seed-dependent tau aggregation was assessed biochemically. We found that the Del 8 mutant lacking 353-368 aa showed significantly decreased aggregation in both cellular andin vitromodels. Furthermore, to identify the minimum sequence responsible for tau aggregation, we systematically repeated cellular tau aggregation assays for the delineation of shorter deletion sites and revealed that Asn-368 mutation suppressed tau aggregation triggered by an AD tau seed, but not using other tauopathy seeds. Our study suggested that 353-368 aa is a novel aggregation-responsible sequence other than PHF6 and PHF6*, and within this sequence, the Asn-368 residue plays a role in strain-specific tau aggregation in different tauopathies.	[Shimonaka, Shotaro; Hattori, Nobutaka] Juntendo Univ, Grad Sch Med, Res Inst Dis Old Age, Tokyo, Japan; [Shimonaka, Shotaro; Elahi, Montasir; Motoi, Yumiko] Juntendo Univ, Sch Med, Dept Diagnosis Prevent & Treatment Dementia, Tokyo, Japan; [Elahi, Montasir; Ishiguro, Koichi; Hattori, Nobutaka; Motoi, Yumiko] Juntendo Univ, Sch Med, Dept Neurol, Tokyo, Japan; [Matsumoto, Shin-Ei] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Immunol, Kagoshima, Japan; [Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dementia Res Project, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Kagoshima University; Tokyo Metropolitan Institute of Medical Science	Motoi, Y (corresponding author), Juntendo Univ, Sch Med, Dept Diagnosis Prevent & Treatment Dementia, Tokyo, Japan.; Motoi, Y (corresponding author), Juntendo Univ, Sch Med, Dept Neurol, Tokyo, Japan.	motoi@juntendo.ac.jp	Hattori, Nobutaka/ACR-0069-2022; Elahi, Montasir/DVV-6789-2022	Elahi, Montasir/0000-0002-6201-290X; Matsumoto, Shin-Ei/0000-0002-4283-202X; Hattori, Nobutaka/0000-0002-2034-2556	MEXT KAKENHI Grant [17K15606]; Research Institute for Diseases of Old Age at the Juntendo University School of Medicine	MEXT KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Institute for Diseases of Old Age at the Juntendo University School of Medicine	This work was supported by MEXT KAKENHI Grant 17K15606 (to S. S.) and grants-in-aid from the Research Institute for Diseases of Old Age at the Juntendo University School of Medicine.	Agadjanyan MG, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0172-1; Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Arakhamia T, 2020, CELL, V180, P633, DOI 10.1016/j.cell.2020.01.027; Arima K, 2006, NEUROPATHOLOGY, V26, P475, DOI 10.1111/j.1440-1789.2006.00669.x; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Congdon EE, 2009, J BIOL CHEM, V284, P20830, DOI 10.1074/jbc.M109.016089; Dan A, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-54; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, ACTA NEUROPATHOL, V136, P699, DOI 10.1007/s00401-018-1914-z; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fichou Y, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0682-x; Fischer D, 2007, BIOCHEMISTRY-US, V46, P2574, DOI 10.1021/bi061318s; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Geng JH, 2015, J MOL NEUROSCI, V55, P251, DOI 10.1007/s12031-014-0314-7; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2018, COLD SH Q B, V83, P163, DOI 10.1101/sqb.2018.83.037580; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Goedert M, 2017, BRAIN, V140, P266, DOI 10.1093/brain/aww230; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; Grover A, 2002, NEUROSCI LETT, V323, P33, DOI 10.1016/S0304-3940(02)00124-6; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hosokawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052389; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Kontsekova E, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt278; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Litersky JM, 1996, BIOCHEM J, V316, P655, DOI 10.1042/bj3160655; Liu F, 2002, FEBS LETT, V512, P101, DOI 10.1016/S0014-5793(02)02228-7; Mancini RS, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00735; Margittai M, 2006, J BIOL CHEM, V281, P37820, DOI 10.1074/jbc.M605336200; Matsumoto SE, 2015, HUM MOL GENET, V24, P6403, DOI 10.1093/hmg/ddv351; Momeni P, 2010, CLIN NEUROL NEUROSUR, V112, P917, DOI 10.1016/j.clineuro.2010.07.015; Morozova OA, 2013, BIOCHEMISTRY-US, V52, P6960, DOI 10.1021/bi400866w; Motoi Yumiko, 2010, Biomol Concepts, V1, P131, DOI 10.1515/bmc.2010.017; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Okuda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117511; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Rossi G, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00192; Rossi G, 2014, NEUROBIOL AGING, V35, P408, DOI 10.1016/j.neurobiolaging.2013.08.004; Rossi G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.008; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Seidler PM, 2018, NAT CHEM, V10, P170, DOI [10.1038/nchem.2889, 10.1038/NCHEM.2889]; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Takahashi M, 2015, ACTA NEUROPATHOL, V129, P895, DOI 10.1007/s00401-015-1415-2; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Taniguchi-Watanabe S, 2016, ACTA NEUROPATHOL, V131, P267, DOI 10.1007/s00401-015-1503-3; TERRY RD, 1963, J NEUROPATH EXP NEUR, V22, P629, DOI 10.1097/00005072-196310000-00005; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Watanabe A, 1999, J BIOL CHEM, V274, P7368, DOI 10.1074/jbc.274.11.7368; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; YAGISHITA S, 1981, ACTA NEUROPATHOL, V54, P239, DOI 10.1007/BF00687747; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046; Yoshida H, 2002, J NEUROCHEM, V80, P548, DOI 10.1046/j.0022-3042.2001.00729.x; Yu KC, 2018, TRANSL NEUROSCI, V9, P54, DOI 10.1515/tnsci-2018-0010; Zhang WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.43584; Zhang WJ, 2020, NATURE, V580, P283, DOI 10.1038/s41586-020-2043-0; Zheng J, 2011, J AM CHEM SOC, V133, P3144, DOI 10.1021/ja110545h; Zilka N, 2006, FEBS LETT, V580, P3582, DOI 10.1016/j.febslet.2006.05.029	70	5	5	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2020	295	41					13996	14014		10.1074/jbc.RA120.013271	http://dx.doi.org/10.1074/jbc.RA120.013271			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OG1HE	32759167	Green Published, hybrid			2022-12-26	WOS:000581643400005
J	Zheng, M; Williams, EP; Malireddi, RKS; Karki, R; Banoth, B; Burton, A; Webby, R; Channappanavar, R; Jonsson, CB; Kanneganti, TD				Zheng, Min; Williams, Evan Peter; Malireddi, R. K. Subbarao; Karki, Rajendra; Banoth, Balaji; Burton, Amanda; Webby, Richard; Channappanavar, Rudragouda; Jonsson, Colleen Beth; Kanneganti, Thirumala-Devi			Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						coronavirus; mouse hepatitis virus (MHV); NLRP3; gasdermin D; caspase-8; RIPK3; inflammasome; caspase-1; pyroptosis; necroptosis; apoptosis; PANoptosis; RNA virus; plus-stranded RNA virus; infection; infectious disease; host defense	RESPIRATORY SYNDROME CORONAVIRUS; MOUSE HEPATITIS-VIRUS; GASDERMIN D; IMMUNE-RESPONSES; CYTOKINE STORM; E PROTEIN; SARS-COV; ACTIVATION; APOPTOSIS; PYROPTOSIS	Coronaviruses have caused several zoonotic infections in the past two decades, leading to significant morbidity and mortality globally. Balanced regulation of cell death and inflammatory immune responses is essential to promote protection against coronavirus infection; however, the underlying mechanisms that control these processes remain to be resolved. Here we demonstrate that infection with the murine coronavirus mouse hepatitis virus (MHV) activated the NLRP3 inflammasome and inflammatory cell death in the form of PANoptosis. Deleting NLRP3 inflammasome components or the downstream cell death executioner gasdermin D (GSDMD) led to an initial reduction in cell death followed by a robust increase in the incidence of caspase-8- and receptor-interacting serine/threonine-protein kinase 3 (RIPK3)-mediated inflammatory cell deathafter coronavirus infection. Additionally, loss of GSDMD promoted robust NLRP3 inflammasome activation. Moreover, the amounts of some cytokines released during coronavirus infection were significantly altered in the absence of GSDMD. Altogether, our findings show that inflammatory cell death, PANoptosis, is induced by coronavirus infection and that impaired NLRP3 inflammasome function or pyroptosis can lead to negative consequences for the host. These findings may have important implications for studies of coronavirus-induced disease.	[Zheng, Min; Malireddi, R. K. Subbarao; Karki, Rajendra; Banoth, Balaji; Burton, Amanda; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Webby, Richard] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Williams, Evan Peter; Channappanavar, Rudragouda; Jonsson, Colleen Beth] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Channappanavar, Rudragouda] Univ Tennessee, Ctr Hlth Sci, Dept Acute & Tertiary Care, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Jonsson, Colleen/GPC-4424-2022; Kanneganti, Thirumala-Devi/Y-2503-2019; Banoth, Balaji/ABF-7350-2020; Karki, Rajendra/H-6647-2019	Jonsson, Colleen/0000-0002-2640-7672; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Karki, Rajendra/0000-0003-4436-9128; Williams, Evan/0000-0003-4506-115X; Banoth, Balaji/0000-0002-7467-2198	United States National Institutes of Health [AI101935, AI124346, AR056296, CA253095]; American Lebanese Syrian Associated Charities	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	Work from our laboratory is supported by the United States National Institutes of Health Grants AI101935, AI124346, AR056296, and CA253095 (to T.-D. K.) and by the American Lebanese Syrian Associated Charities (to T.-D. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; An SW, 1999, J VIROL, V73, P7853, DOI 10.1128/JVI.73.9.7853-7859.1999; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P373; Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011; Belyavskyi M, 1998, VIROLOGY, V250, P41, DOI 10.1006/viro.1998.9356; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Brownlie J, 2017, FENNER'S VETERINARY VIROLOGY, 5TH EDITION, P435, DOI 10.1016/B978-0-12-800946-8.00024-6; C.Shen, 2020, medRxiv, DOI 10.1101/2020.03.02.20029975; Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14; Chen IY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00050; Chen KW, 2019, EMBO J, V38, DOI 10.15252/embj.2019101638; Cho SJ, 2018, AM J PHYSIOL-LUNG C, V314, pL372, DOI 10.1152/ajplung.00393.2017; Christgen S, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00237; DANIEL C, 1990, VIROLOGY, V174, P87, DOI 10.1016/0042-6822(90)90057-X; De Diego ML, 2014, VIRUS RES, V194, P124, DOI 10.1016/j.virusres.2014.07.024; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5; Fujikura D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072065; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Galluzzi L, 2014, CELL RES, V24, P139, DOI 10.1038/cr.2014.8; Grunewald ME, 2018, VIROLOGY, V517, P62, DOI 10.1016/j.virol.2017.11.020; Guo S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005155; Gurung P, 2016, P NATL ACAD SCI USA, V113, P4452, DOI 10.1073/pnas.1601636113; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Herold S, 2015, EUR RESPIR J, V45, P1463, DOI 10.1183/09031936.00186214; Hocke AC, 2013, AM J RESP CRIT CARE, V188, P882, DOI 10.1164/rccm.201305-0954LE; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255; Jaimes JA, 2020, J MOL BIOL, V432, P3309, DOI 10.1016/j.jmb.2020.04.009; Jiang YT, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010039; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Karki R, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.136720; Karki R, 2018, CELL, V173, P920, DOI 10.1016/j.cell.2018.02.055; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kesavardhana S, 2020, ANNU REV IMMUNOL, V38, P567, DOI 10.1146/annurev-immunol-073119-095439; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Lavi E, 1996, VIROLOGY, V221, P325, DOI 10.1006/viro.1996.0382; Liu J, 2020, J MED VIROL, V92, P491, DOI 10.1002/jmv.25709; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Lukens JR, 2014, NATURE, V516, P246, DOI 10.1038/nature13788; Luo W, 2020, CLIN PATHOLOGY CRITI, DOI 10.13140/RG.2.2.22934.29762; Malireddi RKS, 2020, J EXP MED, V217, DOI 10.1084/jem.20191644; Malireddi RKS, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00406; Malireddi RKS, 2018, J EXP MED, V215, P1023, DOI 10.1084/jem.20171922; Malireddi RKS, 2010, J IMMUNOL, V185, P3127, DOI 10.4049/jimmunol.1001512; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Nicholls J, 2003, RESPIROLOGY, V8, pS6, DOI 10.1046/j.1440-1843.2003.00517.x; Nieto-Torres JL, 2015, VIROLOGY, V485, P330, DOI 10.1016/j.virol.2015.08.010; Nieto-Torres JL, 2015, VIRUSES-BASEL, V7, P3552, DOI 10.3390/v7072786; Nieto-Torres JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004077; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732; Piasecka B, 2018, P NATL ACAD SCI USA, V115, pE488, DOI 10.1073/pnas.1714765115; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Prompetchara E, 2020, ASIAN PAC J ALLERGY, V38, P1, DOI 10.12932/AP-200220-0772; Rogers C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14128; Samir P, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00238; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Sariol A, 2020, IMMUNITY, V53, P248, DOI 10.1016/j.immuni.2020.07.005; Schickli JH, 1997, J VIROL, V71, P9499, DOI 10.1128/JVI.71.12.9499-9507.1997; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Shi CS, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0181-7; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Siu KL, 2019, FASEB J, V33, P8865, DOI 10.1096/fj.201802418R; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Stout-Delgado HW, 2012, J IMMUNOL, V188, P2815, DOI 10.4049/jimmunol.1103051; Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009; Tsuchiya K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09753-2; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; WILLIAMS RK, 1991, P NATL ACAD SCI USA, V88, P5533, DOI 10.1073/pnas.88.13.5533; World Health Organization, 2019, WHO E MED REG OFF ME; Yue Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0917-y; Zheng M, 2020, CELL, V181, P674, DOI 10.1016/j.cell.2020.03.040; Zhou HX, 2010, MBIO, V1, DOI 10.1128/mBio.00219-10; Zhou M, 2020, FRONT MED-PRC, V14, P126, DOI 10.1007/s11684-020-0767-8; Zhou ZW, 2020, SCIENCE, V368, P965, DOI 10.1126/science.aaz7548	94	82	85	9	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2020	295	41					14040	14052		10.1074/jbc.RA120.015036	http://dx.doi.org/10.1074/jbc.RA120.015036			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OG1HE	32763970	hybrid, Green Published			2022-12-26	WOS:000581643400008
J	Hounkpe, BW; Benatti, RD; Carvalho, BD; De Paula, EV				Hounkpe, Bidossessi Wilfried; Benatti, Rafaela de Oliveira; Carvalho, Benilton de Sa; De Paula, Erich Vinicius			Identification of common and divergent gene expression signatures in patients with venous and arterial thrombosis using data from public repositories	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; SICKLE-CELL-DISEASE; ISCHEMIC-STROKE; R/BIOCONDUCTOR PACKAGE; TISSUE FACTOR; THROMBOEMBOLISM; ATHEROSCLEROSIS; ASSOCIATION; NEUTROPHIL; ASPIRIN	Cardiovascular disease (CVD) and venous thromboembolism (VTE) figure among the main causes of morbidity and mortality in modern societies. Although associated with distinct pathogenic mechanisms, epidemiological, experimental and clinical trial data suggest that the mechanisms responsible for arterial and venous thrombosis are at least partially overlapped. Herein we aimed to explore shared and discordant pathways involved in the pathogenesis of VTE and CVD at the transcriptomic level and to validate the results in independent cohorts. Five public datasets of gene expression data from VTE and CVD (myocardial infarction, peripheral arterial occlusive disease and stroke) patients were analyzed using an integrative bioinformatic strategy. A machine/statistical learning method was used to derive classifiers for the discrimination of VTE and CVD, and tested in independent datasets. Two sets of genes that were commonly (n = 472) or divergently (n = 124) expressed in CVD and VTE were identified. Genes and pathways associated with innate immune function were over-represented in both conditions, along with pathways associated with complement and hemostasis. Pathways associated with neutrophil activation and with IL-1 signaling were also enriched in CVD compared to VTE. The gene expression signature of VTE more closely resembled the pattern of cardioembolic stroke than the patterns of acute myocardial infarction, ischemic stroke and peripheral arterial occlusive disease. Classifiers derived from these gene lists accurately discriminated patients with VTE and CVD from independent cohorts. In conclusion, our results add a new set of data at the transcriptomic level for future studies between arterial and venous thrombosis. Strengths and limitations of this study Our results represent the first comparison of venous and arterial thrombosis at the transcriptomic level. Our main result was the demonstration that immunothrombosis pathways are important to the pathophysiology of these conditions, also at the transcriptomic level. A specific signature for venous and arterial thrombosis was described, and validated in independent cohorts. The limited number of public repositories with gene expression data from patients with venous thromboembolism limits the representation of these patients in our analyses. In order to gather a meaningful number of studies with gene expression data we had to include patients in different time-points since the index thrombotic event, which might have increased the heterogeneity of our population.	[Hounkpe, Bidossessi Wilfried; Benatti, Rafaela de Oliveira; De Paula, Erich Vinicius] Univ Estadual Campinas, Sch Med Sci, Campinas, SP, Brazil; [Carvalho, Benilton de Sa] Univ Estadual Campinas, Inst Math Stat & Sci Comp, Dept Stat, Campinas, SP, Brazil; [De Paula, Erich Vinicius] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas	De Paula, EV (corresponding author), Univ Estadual Campinas, Sch Med Sci, Campinas, SP, Brazil.; De Paula, EV (corresponding author), Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil.	erich@unicamp.br	Hounkpe, Bidossessi/ABD-9587-2021; Carvalho, Benilton/G-1868-2012; De Paula, Erich V/C-5943-2012	Hounkpe, Bidossessi/0000-0002-9992-1939; Carvalho, Benilton/0000-0001-5122-5646; De Paula, Erich V/0000-0003-1539-7912	Sao Paulo Research Foundation [2016/14172 6, 2014/0984 3, 2015/24666 3]; CNPq Brazil [309317/2016, 405497/2016 4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) [001]; GCRF/UKRI [BB/P027849/1]; BBSRC [BB/P027849/1] Funding Source: UKRI	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); GCRF/UKRI; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was financially supported by the Sao Paulo Research Foundation. grants #2016/14172 6, 2014/0984 3 and 2015/24666 3; CNPq Brazil, grant #309317/2016; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) Finance Code 001. BSC was funded by CNPq Brazil, grant #405497/2016 4 and GCRF/UKRI, grant #BB/P027849/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; Alavi-Majd H, 2014, GENE, V534, P383, DOI 10.1016/j.gene.2013.08.063; Albayati MA, 2015, SEMIN THROMB HEMOST, V41, P615, DOI 10.1055/s-0035-1556726; Atai NA, 2011, IMMUNOLOGY, V132, P39, DOI 10.1111/j.1365-2567.2010.03335.x; Baker M, 2012, NATURE, V487, P282, DOI 10.1038/487282a; Becattini C, 2010, J THROMB HAEMOST, V8, P891, DOI 10.1111/j.1538-7836.2010.03777.x; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384; Camacho DM, 2018, CELL, V173, P1581, DOI 10.1016/j.cell.2018.05.015; Campello E, 2018, THROMB HAEMOSTASIS, V118, P251, DOI 10.1160/TH17-08-0596; Campo G, 2012, BLOOD COAGUL FIBRIN, V23, P680, DOI 10.1097/MBC.0b013e328355111f; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Corsetti JP, 2016, ATHEROSCLEROSIS, V250, P1, DOI 10.1016/j.atherosclerosis.2016.04.017; de Souza GR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176505; Del Carratore F, 2017, BIOINFORMATICS, V33, P2774, DOI 10.1093/bioinformatics/btx292; Di Nisio M, 2016, LANCET, V388, P3060, DOI 10.1016/S0140-6736(16)30514-1; Diaz-Canestro C, 2019, STROKE, V50, P469, DOI 10.1161/STROKEAHA.118.023739; Doran AC, 2010, CIRC RES, V106, P1303, DOI 10.1161/CIRCRESAHA.109.210294; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eikelboom JW, 2017, NEW ENGL J MED, V377, P1319, DOI 10.1056/NEJMoa1709118; Eliasson A, 2006, J THROMB HAEMOST, V4, P1897, DOI 10.1111/j.1538-7836.2006.02152.x; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Fernandez-Sanles A, 2018, ARTERIOSCL THROM VAS, V38, P645, DOI 10.1161/ATVBAHA.117.310340; Frieler RA, 2017, EXP NEUROL, V298, P104, DOI 10.1016/j.expneurol.2017.08.016; Garcia D, 2018, NEW ENGL J MED, V378, P2010, DOI 10.1056/NEJMra1705454; Gollomp K, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99445; Grover SP, 2018, ARTERIOSCL THROM VAS, V38, P709, DOI 10.1161/ATVBAHA.117.309846; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hou Q, 2018, EBIOMEDICINE, V32, P234, DOI 10.1016/j.ebiom.2018.05.010; Hounkpe BW, 2015, SCI REP-UK, V5, DOI 10.1038/srep17822; Jenny NS, 2014, J THROMB HAEMOST, V12, P999, DOI 10.1111/jth.12557; Jenny NS, 2009, ARTERIOSCL THROM VAS, V29, P594, DOI 10.1161/ATVBAHA.108.178947; Jiang YM, 2017, EBIOMEDICINE, V22, P78, DOI 10.1016/j.ebiom.2017.06.028; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Kessler C, 2008, ROM J MORPHOL EMBRYO, V49, P27; Kodama K, 2015, DIABETES, V64, P867, DOI 10.2337/db14-0149; Kremers BMM, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00033; Krug T, 2012, J CEREBR BLOOD F MET, V32, P1061, DOI 10.1038/jcbfm.2012.24; Larsen HG, 2019, ATHEROSCLEROSIS, V287, P16, DOI 10.1016/j.atherosclerosis.2019.05.020; Lewis DA, 2015, THROMB RES, V135, P659, DOI 10.1016/j.thromres.2015.02.003; Lewis DA, 2011, THROMB RES, V128, P536, DOI 10.1016/j.thromres.2011.06.003; Li HY, 2011, DIABETES, V60, P993, DOI 10.2337/db10-0607; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lim MY, 2013, CURR OPIN HEMATOL, V20, P472, DOI 10.1097/MOH.0b013e328363442f; Lippi G, 2018, SEMIN THROMB HEMOST, V44, P239, DOI 10.1055/s-0037-1607202; Fiusa MML, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0327-2; Maas C, 2018, BLOOD, V131, P1903, DOI 10.1182/blood-2017-04-569111; Maciejak A, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0149-z; Mackman N, 2012, J CLIN INVEST, V122, P2331, DOI 10.1172/JCI60229; Manichaikul A, 2016, J LIPID RES, V57, P433, DOI 10.1194/jlr.M064592; Manichaikul A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090222; Masud Rizwan, 2012, J Clin Bioinforma, V2, P6, DOI 10.1186/2043-9113-2-6; Milan M, 2014, THROMB RES, V134, P1028, DOI 10.1016/j.thromres.2014.09.007; Misra S, 2018, GENE, V672, P180, DOI 10.1016/j.gene.2018.06.027; Murga C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00112; Mutch DM, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-17; Noubouossie D, 2016, BLOOD REV, V30, P245, DOI 10.1016/j.blre.2015.12.003; Noubouossie DF, 2019, BLOOD, V133, P2186, DOI 10.1182/blood-2018-10-862243; PAN Y, 2019, SCI REP UK, V0009; Pancioli AM, 2008, STROKE, V39, P3268, DOI 10.1161/STROKEAHA.108.517656; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Prandoni P, 2015, VENOUS ARTERIAL THRO, DOI [10.17554/j.issn.2409-3548.2015.01.4, DOI 10.17554/J.ISSN.2409-3548.2015.01.4]; R. Core Team, 2019, R FDN STAT COMP, V10, P11, DOI [10.1108/eb003648, DOI 10.1108/EB003648]; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Raskob GE, 2014, ARTERIOSCL THROM VAS, V34, P2363, DOI 10.1161/ATVBAHA.114.304488; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ristagno G, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00823; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; Saleh Moussa, 2018, F1000Res, V7, DOI 10.12688/f1000research.15096.1; Saraiva SD, 2015, THROMB RES, V136, P1174, DOI 10.1016/j.thromres.2015.10.029; Sathipati SY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34604-3; Schonfelder T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21273-5; Shimizu H, 2019, EBIOMEDICINE, V46, P150, DOI 10.1016/j.ebiom.2019.07.046; Shiotsu Y, 2011, CLIN J AM SOC NEPHRO, V6, P718, DOI 10.2215/CJN.08310910; Sorensen HT, 2007, LANCET, V370, P1773, DOI 10.1016/S0140-6736(07)61745-0; Sparkenbaugh EM, 2015, HAEMATOLOGICA, V100, P308, DOI 10.3324/haematol.2014.114728; Spronk HMH, 2018, THROMB HAEMOSTASIS, V118, P229, DOI 10.1160/TH17-07-0492; Stamova B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102550; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suresh R, 2014, J MOL CELL CARDIOL, V74, P13, DOI 10.1016/j.yjmcc.2014.04.017; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011; Virchow R, 1856, GESAMMELTE ABH, P219; Wang B, 2015, BIOINFORMATICS, V31, P3043, DOI 10.1093/bioinformatics/btv289; Wang XK, 2003, MOL PHARMACOL, V64, P833, DOI 10.1124/mol.64.4.833; Wang ZX, 2018, EBIOMEDICINE, V32, P93, DOI 10.1016/j.ebiom.2018.05.024; Wendelboe AM, 2016, CIRC RES, V118, P1340, DOI 10.1161/CIRCRESAHA.115.306841; Wolberg AS, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.6; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887; Wu W, 2014, CARDIOVASC RES, V102, P46, DOI 10.1093/cvr/cvu007; Yan Jingwen, 2018, Brief Bioinform, V19, P1370, DOI 10.1093/bib/bbx066	97	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0235501	10.1371/journal.pone.0235501	http://dx.doi.org/10.1371/journal.pone.0235501			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780732	Green Published, gold			2022-12-26	WOS:000562664700006
J	Ahinkorah, BO; Budu, E; Seidu, AA; Hagan, JE; Agbaglo, E; Hormenu, T; Schack, T; Yaya, S				Ahinkorah, Bright Opoku; Budu, Eugene; Seidu, Abdul-Aziz; Hagan, John Elvis, Jr.; Agbaglo, Ebenezer; Hormenu, Thomas; Schack, Thomas; Yaya, Sanni			Consistent condom use among men who pay for sex in sub-Saharan Africa: Empirical evidence from Demographic and Health Surveys	PLOS ONE			English	Article							COMMERCIAL SEX; HIV-INFECTION; TRANSACTIONAL SEX; NATIONAL-SURVEY; WORKERS; RISK; ADULTS; DETERMINANTS; PREVENTION; UNIVERSITY	Background Paying for sex has often been associated with risky sexual behavior among heterosexual men, and men who pay for sex are considered as a bridging population for sexually transmitted infections. Consistent condom use during paid sex is essential for reducing sexually transmitted infections, including HIV/AIDS. In this study, we assessed the prevalence and predictors of consistent condom use among men who pay for sex in sub-Saharan Africa. Materials and methods We pooled data from 29 sub-Saharan African countries' Demographic and Health Surveys. A total of 3,353 men in sub-Saharan Africa who had paid for sex in the last 12 months preceding the surveys and had complete information on all the variables of interest were used in this study. The outcome variable for the study was consistent condom use for every paid sex in the last 12 months. Both bivariate and multivariable logistic regression analyses were carried out. Results were presented as adjusted odds ratios with their corresponding 95% confidence intervals. Statistical significance was declared at p< 0.05. Results Overall, the prevalence of consistent condom use during paid sex in sub-Saharan Africa was 83.96% (CI = 80.35-87.56), ranging from 48.70% in Benin to 98% in Burkina Faso. Men aged 35-44 [AOR, 1.39 CI = 1.04-1.49], men in the richest wealth quintile [AOR, 1.96 CI = 1.30-3.00], men with secondary level of education [AOR, 1.69 CI = 1.17-2.44], and men in Burkina Faso [AOR = 67.59, CI = 8.72-523.9] had higher odds of consistent condom use during paid sex, compared to men aged 15-19, those in the poorest wealth quintile, those with no formal education, and men in Benin respectively. Conversely, Muslim men had lower odds [AOR = 0.71, CI = 0.53-0.95] of using condom consistently during paid sex, compared to Christian men. Conclusion Empirical evidence from this study suggests that consistent condom use during paid sex encompasses complex social and demographic characteristics. The study also revealed that demographic characteristics such as age, wealth quintile, education, and religion were independently related to consistent condom use for paid sex among men. With sub-Saharan Africa having the highest sexual and reproductive health burden in the world, continuous application of evidence-based interventions (e.g., educational and entrepreneurial training) that account for behavioural and social vulnerabilities are required.	[Ahinkorah, Bright Opoku] Univ Technol Sydney, Fac Hlth, Australian Ctr Publ & Populat Hlth Res ACPPHR, Sydney, NSW, Australia; [Budu, Eugene; Seidu, Abdul-Aziz] Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana; [Seidu, Abdul-Aziz] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Hagan, John Elvis, Jr.; Hormenu, Thomas] Univ Cape Coast, Dept Hlth Phys Educ & Recreat, Cape Coast, Ghana; [Hagan, John Elvis, Jr.; Schack, Thomas] Bielefeld Univ, Fac Psychol & Sport Sci, Neurocognit & Act Biomech Res Grp, Bielefeld, Germany; [Agbaglo, Ebenezer] Univ Cape Coast, Dept English, Cape Coast, Ghana; [Yaya, Sanni] Univ Ottawa, Sch Int Dev & Global Studies, Ottawa, ON, Canada; [Yaya, Sanni] Univ Oxford, George Inst Global Hlth, Oxford, England	University of Technology Sydney; University of Cape Coast; James Cook University; University of Cape Coast; University of Bielefeld; University of Cape Coast; University of Ottawa; University of Oxford	Hagan, JE (corresponding author), Univ Cape Coast, Dept Hlth Phys Educ & Recreat, Cape Coast, Ghana.; Hagan, JE (corresponding author), Bielefeld Univ, Fac Psychol & Sport Sci, Neurocognit & Act Biomech Res Grp, Bielefeld, Germany.	elvis.hagan@ucc.edu.gh	Agbaglo, Ebenezer/AAN-5804-2021	Seidu, Abdul-Aziz/0000-0001-9734-9054; Hagan Jnr., Dr. John Elvis/0000-0003-3530-6133	German Research Foundation through the Neurocognition and Action-Biomechanics Research Group, Bielefeld University, Germany	German Research Foundation through the Neurocognition and Action-Biomechanics Research Group, Bielefeld University, Germany	We sincerely thank the German Research Foundation through the Neurocognition and Action-Biomechanics Research Group, Bielefeld University, Germany for providing financial support for the publication of this research.	Adu-Oppong A, 2007, AIDS EDUC PREV, V19, P160, DOI 10.1521/aeap.2007.19.2.160; Ajayi AI, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7543-1; Aklilu M, 2001, AIDS, V15, P87, DOI 10.1097/00002030-200101050-00013; Aliaga A, 2006, DHS WORKING PAPERS, V30; Amo-Adjei J, 2014, HEALTH EDUC, V114, P473, DOI 10.1108/HE-02-2014-0013; Bekker LG, 2018, LANCET, V392, P312, DOI [10.1016/s0140-6736(18)31070-5, 10.1016/S0140-6736(18)31070-5]; Blanc A., 2000, RELATIONSHIP BETWEEN; Magalhaes RDB, 2019, REV LAT-AM ENFERM, V27, DOI 10.1590/1518-8345.2951.3226; Campbell C, 2001, AM J PUBLIC HEALTH, V91, P1978, DOI 10.2105/AJPH.91.12.1978; Campbell C., 2003, LETTING DIE WHY HIV; Chen XS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-84; Choudhry V, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.27249; Corsi DJ, 2012, INT J EPIDEMIOL, V41, P1602, DOI 10.1093/ije/dys184; Curtis SL, 2004, SEX TRANSM INFECT, V80, P22, DOI 10.1136/sti.2004.011650; Eshetu T, 2017, ETHIOP J HEALTH SCI, V27, P411, DOI 10.4314/ejhs.v27i4.12; Giano Z, 2021, J HOMOSEXUAL, V68, P872, DOI 10.1080/00918369.2019.1667159; Gibbs A, 2015, J COMMUNITY APPL SOC, V25, P110, DOI 10.1002/casp.2199; Goldenberg SM, 2011, HEALTH PLACE, V17, P748, DOI 10.1016/j.healthplace.2011.01.012; Hill AO, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122815; Ingham R., 1995, SOC AS AIDS, P43; Januraga PP, 2018, LANCET HIV, V5, pE560, DOI 10.1016/S2352-3018(18)30148-6; Karamouzian Mohammad, 2017, J Int Assoc Provid AIDS Care, V16, P572, DOI 10.1177/2325957417732834; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; Krueger A, 2016, AIDS BEHAV, V20, P2961, DOI 10.1007/s10461-016-1293-1; Lagarde E, 2001, AIDS, V15, P1399, DOI 10.1097/00002030-200107270-00009; Lawoyin TO, 2001, INT J STD AIDS, V12, P63, DOI 10.1258/0956462011923967; Lefkowitz ES, 2004, J SEX RES, V41, P150, DOI 10.1080/00224490409552223; Ma Y, 2016, BIOMED RES INT, V2016; Matseke G, 2012, SCI WORLD J, DOI 10.1100/2012/501807; MEHRYAR A, 1995, SOC AS AIDS, P124; Nagot N, 2002, J ACQ IMMUN DEF SYND, V29, P517, DOI 10.1097/00126334-200204150-00013; Nasrullah M, 2017, J SEX MED, V14, P541, DOI 10.1016/j.jsxm.2017.02.015; Nations United, 2015, SUST DEV GOALS; Newman P A, 2008, J LGBT Health Res, V4, P81; Ni M, 2015, CHIN HLTH CARE WOMEN, V30, P1078; Noar SM, 2006, ARCH SEX BEHAV, V35, P327, DOI 10.1007/s10508-006-9028-4; Ochako R, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0316-3; Protogerou C, 2018, HEALTH PSYCHOL, V37, P586, DOI 10.1037/hea0000604; Ramanathan S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-827; Rastogi S, 2014, J SEXUALLY TRANSMITT, V2014; Reynolds HW, 2013, AIDS CARE, V25, P592, DOI 10.1080/09540121.2012.726340; Rissel C, 2017, SEX RES SOC POLICY, V14, P81, DOI 10.1007/s13178-016-0225-1; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Ruisenor-Escudero H, 2015, GLOB MENT HEALTH, V2, DOI 10.1017/gmh.2015.7; Saag MS, 2018, JAMA-J AM MED ASSOC, V320, P379, DOI 10.1001/jama.2018.8431; Sarkar NN, 2008, EUR J CONTRACEP REPR, V13, P114, DOI 10.1080/13625180802011302; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; Seidu AA, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2019.100459; Silan V, WHY WE ARE NOT USING; Siziya Seter, 2008, BMC Res Notes, V1, P123, DOI 10.1186/1756-0500-1-123; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; Talukdar A, 2007, AIDS, V21, P2231, DOI 10.1097/QAD.0b013e3282e9a718; Tong WWY, 2013, AIDS, V27, P2233, DOI 10.1097/QAD.0b013e3283633111; Tran TN, 2006, AIDS BEHAV, V10, P159, DOI 10.1007/s10461-005-9061-7; Ulibarri MD, 2012, INT J STD AIDS, V23, P229, DOI 10.1258/ijsa.2011.011184; Ulibarri MD, 2010, PSYCHOL TRAUMA-US, V2, P318, DOI 10.1037/a0017500; UNAIDS, 2020, GLOB AIDS MON 2020; Wamoyi J, 2019, JAIDS-J ACQ IMM DEF, V80, P367, DOI [10.1097/QAI.0000000000001928, 10.1097/qai.0000000000001928]; Wang L, 2015, CHIN J AIDS STDS, V21, P791; Webb D., 1997, HIV AIDS AFRICA; Wee S, 2004, SEX TRANSM INFECT, V80, P310, DOI 10.1136/sti.2003.008342; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Yang SJ, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010250; Yang Y, 2016, AIDS BEHAV, V20, P2309, DOI 10.1007/s10461-015-1239-z; YI SY, 2015, BMC PUBLIC HEALTH, V15, P11942, DOI DOI 10.1186/S12879-015-0954-4	65	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0236552	10.1371/journal.pone.0236552	http://dx.doi.org/10.1371/journal.pone.0236552			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC7KJ	32776965	Green Accepted, Green Published, gold			2022-12-26	WOS:000561393800034
J	Bou-Dargham, MJ; Sang, QXA				Bou-Dargham, Mayassa J.; Sang, Qing-Xiang Amy			Secretome analysis reveals upregulated granzyme B in human androgen-repressed prostate cancer cells with mesenchymal and invasive phenotype	PLOS ONE			English	Article							STATISTICAL-MODEL; CARCINOMA; TRANSITION; GROWTH; MASS; LYMPHOCYTES; COMPLEMENT; EXPRESSION; MANAGEMENT; LYMPHOMA	Epithelial-mesenchymal transition (EMT) is a critical early step in cancer metastasis and a complex process that involves multiple factors. In this study, we used proteomics approaches to investigate the secreted proteins (secretome) of paired human androgen-repressed prostate cancer (ARCaP) cell lines, representing the epithelial (ARCaP-E) and mesenchymal (ARCaP-M) phenotypes. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analyses showed high levels of proteins involved in bone remodeling and extracellular matrix degradation in the ARCaP-M cells, consistent with the bone metastasis phenotype. Furthermore, LC-MS/MS showed a significantly higher level of the serine protease granzyme B (GZMB) in ARCaP-M conditioned media (CM) compared to that of ARCaP-E. Using quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) to detect mRNA and Western blot to detect protein expression, we further demonstrated that the GZMB gene was expressed by ARCaP-M and the protein was secreted extracellularly. ARCaP-M cells with GZMB gene knockdown using small interfering RNA (siRNA) have markedly reduced invasiveness as demonstrated by theMatrigelinvasion assay in comparison with the scrambled siRNA negative control. This study reports that GZMB secretion by mesenchymal-like androgen-repressed human prostate cancer cells promotes invasion, suggesting a possible extracellular role for GZMB in addition to its classic role in immune cell-mediated cytotoxicity.	[Bou-Dargham, Mayassa J.; Sang, Qing-Xiang Amy] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Sang, Qing-Xiang Amy] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Sang, QXA (corresponding author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.; Sang, QXA (corresponding author), Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.	qxsang@chem.fsu.edu		Sang, Qing-Xiang (Amy)/0000-0001-8828-0569; Bou-Dargham, Mayassa/0000-0002-1551-8887	CRC Multidisciplinary Support (MDS) grant from the Florida State University	CRC Multidisciplinary Support (MDS) grant from the Florida State University	This work was supported in part by CRC Multidisciplinary Support (MDS) grant from the Florida State University and an Endowed Chair Professorship in Cancer Research from anonymous donors to QXAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Afshar-Kharghan V, 2017, J CLIN INVEST, V127, P780, DOI 10.1172/JCI90962; Asano N, 2006, J CLIN ONCOL, V24, P4626, DOI 10.1200/JCO.2006.06.5342; Belfort-Mattos PN, 2010, EUR J GYNAECOL ONCOL, V31, P459; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Cao Zheng, 2016, Critical Reviews in Oncogenesis, V21, P155, DOI 10.1615/CritRevOncog.2016016955; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chung L W, 1997, Hinyokika Kiyo, V43, P815; Chung LWK, 2006, CLIN GENITOURIN CANC, V5, P162, DOI 10.3816/CGC.2006.n.034; D'Eliseo D, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0302-6; D'Eliseo D, 2012, J NUTR BIOCHEM, V23, P452, DOI 10.1016/j.jnutbio.2011.01.010; D'Eliseo D, 2010, INT J CANCER, V127, P1283, DOI 10.1002/ijc.25135; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Dong L, 2019, ASIAN J UROL, V6, P26, DOI 10.1016/j.ajur.2018.11.005; Ewen CL, 2012, CELL DEATH DIFFER, V19, P28, DOI 10.1038/cdd.2011.153; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Fridman WH, 2012, NAT REV CANCER, DOI [10.1038/nrc3245.22419253, DOI 10.1038/NRC3245.22419253]; Froelich CJ, 2009, TRENDS IMMUNOL, V30, P117, DOI 10.1016/j.it.2009.01.002; Grindel B, 2016, ONCOTARGET, V7, P10433, DOI 10.18632/oncotarget.7197; Guzman VB, 2008, CANCER INVEST, V26, P499, DOI 10.1080/07357900701805678; Handy CE, 2018, FUTURE ONCOL, V14, P907, DOI 10.2217/fon-2017-0531; Hotte SJ, 2010, CURR ONCOL, V17, pS72; Jennbacken K, 2009, PROSTATE, V69, P1164, DOI 10.1002/pros.20965; Joeckel LT, 2014, BIOL CHEM, V395, P181, DOI 10.1515/hsz-2013-0238; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Li YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033011; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nuhn P, 2019, EUR UROL, V75, P88, DOI 10.1016/j.eururo.2018.03.028; Oudejans JJ, 2002, J PATHOL, V198, P468, DOI 10.1002/path.1236; Pio R, 2014, ADV EXP MED BIOL, V772, P229, DOI 10.1007/978-1-4614-5915-6_11; Saad F, 2015, UROLOGY, V86, P852, DOI 10.1016/j.urology.2015.07.034; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Stewart PA, 2017, ONCOTARGET, V8, P39209, DOI 10.18632/oncotarget.16835; ten Berge RL, 2001, LEUKEMIA, V15, P458, DOI 10.1038/sj.leu.2402045; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tu S-M, 2004, CLIN ASPECTS BONE ME, P23, DOI [10.1007/978-1-4419-9129-4_2, DOI 10.1007/978-1-4419-9129-4_2]; Van Damme P, 2009, MOL CELL PROTEOMICS, V8, P258, DOI 10.1074/mcp.M800060-MCP200; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Wang X, 2011, J PROTEOME RES, V10, P3920, DOI 10.1021/pr2000144; Wells A, 2011, FRONT BIOSCI-LANDMRK, V16, P815, DOI 10.2741/3722; Yao DB, 2011, MOL CANCER RES, V9, P1608, DOI 10.1158/1541-7786.MCR-10-0568; Zhao YG, 2003, J BIOL CHEM, V278, P15056, DOI 10.1074/jbc.M210975200; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1; Zhau HYE, 1996, P NATL ACAD SCI USA, V93, P15152, DOI 10.1073/pnas.93.26.15152	46	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237222	10.1371/journal.pone.0237222	http://dx.doi.org/10.1371/journal.pone.0237222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764784	Green Published, gold			2022-12-26	WOS:000561029000023
J	Jones, EJ; Poole, KC; Sollini, J; Town, SM; Bizley, JK				Jones, Eleanor J.; Poole, Katarina C.; Sollini, Joseph; Town, Stephen M.; Bizley, Jennifer K.			Seasonal weight changes in laboratory ferrets	PLOS ONE			English	Article							MUSTELA-PUTORIUS-FURO; BODY-WEIGHT; SOUND LOCALIZATION; FEMALE FERRETS; CYCLES; GROWTH; FOOD; REPRODUCTION; DURATION; LESIONS	Ferrets (Mustela putorius furo) are a valuable animal model used in biomedical research. Like many animals, ferrets undergo significant variation in body weight seasonally, affected by photoperiod, and these variations complicate the use weight as an indicator of health status. To overcome this requires a better understanding of these seasonal weight changes. We provide a normative weight data set for the female ferret accounting for seasonal changes, and also investigate the effect of fluid regulation on weight change. Female ferrets (n = 39) underwent behavioural testing from May 2017 to August 2019 and were weighed daily, while housed in an animal care facility with controlled light exposure. In the winter (October to March), animals experienced 10 hours of light and 14 hours of dark, while in summer (March to October), this contingency was reversed. Individual animals varied in their body weight from approximately 700 to 1200 g. However, weights fluctuated with light cycle, with animals losing weight in summer, and gaining weight in winter such that they fluctuated between approximately 80% and 120% of their long-term average. Ferrets were weighed as part of their health assessment while experiencing water regulation for behavioural training. Water regulation superimposed additional weight changes on these seasonal fluctuations, with weight loss during the 5-day water regulation period being greater in summer than winter. Analysing the data with a Generalised Linear Model confirmed that the percentage decrease in weight per week was relatively constant throughout the summer months, while the percentage increase in body weight per week in winter decreased through the season. Finally, we noted that the timing of oestrus was reliably triggered by the increase in day length in spring. These data establish a normative benchmark for seasonal weight variation in female ferrets that can be incorporated into the health assessment of an animal's condition.	[Jones, Eleanor J.; Poole, Katarina C.; Sollini, Joseph; Town, Stephen M.; Bizley, Jennifer K.] UCL, Ear Inst, London, England; [Jones, Eleanor J.] Univ Nottingham, Nottingham Biomed Res Ctr, Natl Inst Hlth Res NIHR, Clin Metab & Mol Physiol,MRCARUK Ctr Musculoskele, Nottingham, England; [Sollini, Joseph] Univ Nottingham, Div Clin Neurosci, Hearing Sci, Sch Med, Nottingham, England	University of London; University College London; University of Nottingham; University of Nottingham	Bizley, JK (corresponding author), UCL, Ear Inst, London, England.	j.bizley@ucl.ac.uk	Jones, Eleanor/AAK-9657-2021; Sollini, Joseph/M-2106-2017	Jones, Eleanor/0000-0003-3261-3787; Bizley, Jennifer/0000-0001-6605-2362; Poole, Katarina/0000-0002-7101-7294; Town, Stephen/0000-0003-1375-7769; Sollini, Joseph/0000-0002-1974-4291	Wellcome Trust; Royal Society Sir Henry Dale Fellowship [098418/Z/12/Z]; BBSRC [BB/R004420/1, BB/N001818/1]; ERC [Cog-771550 SOUNDSCENE]; BBSRC [BB/H016813/2] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society Sir Henry Dale Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Wellcome Trust and Royal Society Sir Henry Dale Fellowship to JKB (098418/Z/12/Z) www.welicome.ac.uk The BBSRC (grant reference numbers BB/R004420/1 and BB/N001818/1), The ERC (Cog-771550 SOUNDSCENE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakthavatchalu V, 2016, VET PATHOL, V53, P349, DOI 10.1177/0300985815623621; Ball RS, 2006, ILAR J, V47, P348, DOI 10.1093/ilar.47.4.348; BARTNESS TJ, 1985, NEUROSCI BIOBEHAV R, V9, P599, DOI 10.1016/0149-7634(85)90006-5; BERNSTEIN IS, 1989, AM J PRIMATOL, V18, P251, DOI 10.1002/ajp.1350180309; Bissonnette TH, 1935, J EXP BIOL, V12, P315; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; Bizley JK, 2013, J ACOUST SOC AM, V133, P365, DOI 10.1121/1.4768798; Blanco-Melo D, 2020, BIORXIV, DOI [10.1101/2020.06.19.15493032607507, DOI 10.1101/2020.06.19.15493032607507]; DONOVAN BT, 1967, J ENDOCRINOL, V39, P105, DOI 10.1677/joe.0.0390105; DONOVAN BT, 1986, J REPROD FERTIL, V76, P491, DOI 10.1530/jrf.0.0760491; Duque A, 2010, CEREB CORTEX, V20, P1020, DOI 10.1093/cercor/bhp164; Fox JG, 2014, BIOLOGY AND DISEASES OF THE FERRET, 3RD EDITION, P1, DOI 10.1002/9781118782699; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Gad SC, 2000, INT J TOXICOL, V19, P149, DOI 10.1080/10915810050074928; Gehrt SD, 1999, AM MIDL NAT, V141, P19, DOI 10.1674/0003-0031(1999)141[0019:GRAIVI]2.0.CO;2; Gorman MR, 2001, MAMMALIAN PHOTOPERIO, P481, DOI [10.1007/978-1-4615-1201-1_19, DOI 10.1007/978-1-4615-1201-1_19]; Grassel SM, 2016, WEST N AM NATURALIST, V76, P405, DOI 10.3398/064.076.0403; HABVEY N. E., 1958, Australian Journal of Biological Sciences, V11, P187; Jha SK, 2006, BEHAV BRAIN RES, V172, P106, DOI 10.1016/j.bbr.2006.05.001; KAVANAGH GL, 1988, J NEUROPHYSIOL, V60, P879, DOI 10.1152/jn.1988.60.3.879; KORHONEN H, 1990, J ANIM PHYSIOL AN N, V63, P109, DOI 10.1111/j.1439-0396.1990.tb00123.x; KORHONEN H, 1986, PHYSIOL BEHAV, V37, P777, DOI 10.1016/0031-9384(86)90184-8; LAW MI, 1988, J COMP NEUROL, V278, P157, DOI 10.1002/cne.902780202; Lempel AA, 2019, CURR BIOL, V29, P179, DOI 10.1016/j.cub.2018.11.017; Lindeberg H, 2008, REPROD DOMEST ANIM, V43, P150, DOI 10.1111/j.1439-0531.2008.01155.x; LYNCH GR, 1978, PHYSIOL ZOOL, V51, P289, DOI 10.1086/physzool.51.3.30155746; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Marks GA, 1996, SLEEP, V19, P83, DOI 10.1093/sleep/19.2.83; MENDOZA SP, 1978, HORM BEHAV, V11, P295, DOI 10.1016/0018-506X(78)90033-8; Morgan PJ, 2003, J ENDOCRINOL, V177, P27, DOI 10.1677/joe.0.1770027; NIXON AJ, 1995, J EXP ZOOL, V272, P435, DOI 10.1002/jez.1402720605; Nodal FR, 2010, J NEUROPHYSIOL, V103, P1209, DOI 10.1152/jn.00991.2009; Paquette SG, 2014, VIROLOGY, V464, P177, DOI 10.1016/j.virol.2014.07.013; Parsons CH, 1999, J NEUROPHYSIOL, V82, P2294, DOI 10.1152/jn.1999.82.5.2294; SCHNEIDER JE, 1986, PHYSIOL BEHAV, V38, P119, DOI 10.1016/0031-9384(86)90141-1; Sellers KK, 2016, CELL REP, V16, P2864, DOI 10.1016/j.celrep.2016.08.055; SHUMP AU, 1978, LAB ANIM SCI, V28, P89; Stepien RL, 1999, VET RADIOL ULTRASOUN, V40, P606, DOI 10.1111/j.1740-8261.1999.tb00886.x; THORNTON PC, 1979, LAB ANIM, V13, P119, DOI 10.1258/002367779780943422; THORPE PA, 1976, J ENDOCRINOL, V70, P255, DOI 10.1677/joe.0.0700255; Toth LA, 2000, CONTEMP TOP LAB ANIM, V39, P9; Yoshimura A T., 2006, COMP BIOCH PHYSL	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0232733	10.1371/journal.pone.0232733	http://dx.doi.org/10.1371/journal.pone.0232733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764762	Green Submitted, Green Published, gold			2022-12-26	WOS:000561029000010
J	Wen, YX; Shi, HS; Wu, ZX; Xiao, H; Wang, H; Chen, LB				Wen, Yinxian; Shi, Huasong; Wu, Zhixin; Xiao, Hao; Wang, Hui; Chen, Liaobin			GR/Sp3/HDAC1/UGDH signaling participated in the maternal dexamethasone-induced dysplasia of the rat fetal growth plate	FASEB JOURNAL			English	Article						fetal growth plate; histone acetylation; maternal dexamethasone; proteoglycan; UDP-glucose dehydrogenase	UDP-GLUCOSE DEHYDROGENASE; GLUCOCORTICOID-RECEPTOR; DEVELOPMENTAL TOXICITY; HISTONE DEACETYLASES; GENE-EXPRESSION; CARTILAGE; EXPOSURE; CORTICOSTEROIDS; INHIBITION; MATRIX	Maternal dexamethasone decreases the body length of the newborn. However, whether dexamethasone inhibits the development of the growth plate of the fetal long bone is still unknown. Here, we found that lengths of fetal femur and growth plate were both shorter in the fetuses with maternal dexamethasone (0.2 mg/kg.d from gestation day 9 to 20), with a decreased proteoglycan content of the growth plate in the fetal rat. Notable decreases in both the gene expression and H3K9 acetylation of UDP-glucose dehydrogenase (Ugdh) gene, which codes a key enzyme in the proteoglycan biosynthesis in the chondrocyte, were also observed. Meanwhile, up-regulation of glucocorticoid receptor (GR), specific protein 3 (Sp3), and histone deacetylase 1 (Hdac1) gene expression were detected in the fetal growth plate. Similar changes were also observed in the chondrogenic rat bone marrow stromal cells (BMSCs) with excessive exogenous dexamethasone. However, antagonizing GR with RU486 and silencingHdac1orSp3with specific siRNAs could all stimulate the H3K9 acetylation and gene expression ofUgdhpreviously inhibited by dexamethasone. Meanwhile, dexamethasone also induced the nuclear translocation of GR, which further directly bound to theUgdhpromoter and interacted with HDAC1 and Sp3, respectively. Collectively, our study revealed that maternal dexamethasone induced the direct binding of GR to theUgdhpromoter of the chondrocyte in the rat fetal growth plate, which recruited HDAC1 and Sp3, induced deacetylation of the H3K9, and subsequently inhibitedUgdhgene expression. Such changes further led to attenuated proteoglycan synthesis in the developing chondrocyte and therefore disrupted the development of growth plate and fetal long bone.	[Wen, Yinxian; Shi, Huasong; Wu, Zhixin; Xiao, Hao; Chen, Liaobin] Wuhan Univ, Zhongnan Hosp, Dept Joint Surg & Sports Med, Wuhan 430071, Peoples R China; [Wen, Yinxian; Wang, Hui; Chen, Liaobin] Hubei Prov Key Lab Dev Originated Dis, Wuhan, Peoples R China; [Wang, Hui] Wuhan Univ, Basic Med Sch, Dept Pharmacol, Wuhan 430071, Peoples R China	Wuhan University; Wuhan University	Chen, LB (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Joint Surg & Sports Med, Wuhan 430071, Peoples R China.; Wang, H (corresponding author), Wuhan Univ, Basic Med Sch, Dept Pharmacol, Wuhan 430071, Peoples R China.	wanghui19@whu.edu.cn; lbchen@whu.edu.cn			National Natural Science Foundation of China [81603214, 81673490, 81673524]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81603214, 81673490 and 81673524	Beauchef G, 2005, BIOCHEM BIOPH RES CO, V333, P1123, DOI 10.1016/j.bbrc.2005.06.020; Bontemps Y, 2003, J BIOL CHEM, V278, P21566, DOI 10.1074/jbc.M209366200; Bradley EW, 2015, PHYSIOL REV, V95, P1359, DOI 10.1152/physrev.00004.2015; Chen Z, 2018, TOXICOL APPL PHARM, V351, P12, DOI 10.1016/j.taap.2018.05.005; Chen Z, 2018, TOXICOL LETT, V286, P1, DOI 10.1016/j.toxlet.2018.01.008; Clarkin CE, 2011, J CELL PHYSIOL, V226, P749, DOI 10.1002/jcp.22393; Crowther CA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003935.pub3; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Hansen DK, 1999, TOXICOL SCI, V48, P230, DOI 10.1093/toxsci/48.2.230; Huan YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129803; Islam KN, 2008, MOL ENDOCRINOL, V22, P585, DOI 10.1210/me.2007-0412; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Kiani C, 2002, CELL RES, V12, P19, DOI 10.1038/sj.cr.7290106; LABORDE JB, 1992, FUND APPL TOXICOL, V19, P545, DOI 10.1016/0272-0590(92)90093-W; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lemke U, 2008, CELL METAB, V8, P212, DOI 10.1016/j.cmet.2008.08.001; Liu CJ, 2004, J BIOL CHEM, V279, P47081, DOI 10.1074/jbc.M405288200; Lv F, 2018, ENDOCRINOLOGY, V159, P1401, DOI 10.1210/en.2018-00044; Melrose J, 2016, MATRIX BIOL, V52-54, P363, DOI 10.1016/j.matbio.2016.01.008; Minina E, 2001, DEVELOPMENT, V128, P4523; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P403, DOI 10.1038/nrendo.2014.74; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P391, DOI 10.1038/nrendo.2014.73; Murphy KE, 2012, OBSTET GYNECOL, V119, P917, DOI 10.1097/AOG.0b013e31825189dc; Paine-Saunders S, 2000, DEV BIOL, V225, P179, DOI 10.1006/dbio.2000.9831; Pan JM, 2019, J RECEPT SIG TRANSD, V39, P80, DOI 10.1080/10799893.2019.1625061; Prydz K, 2000, J CELL SCI, V113, P193; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Sun H, 2008, MOL ENDOCRINOL, V22, P2076, DOI 10.1210/me.2007-0302; Tan KS, 2000, AM J MED, V109, P727, DOI 10.1016/S0002-9343(00)00615-X; Tomaszewska E, 2013, J ANIM PHYSIOL AN N, V97, P785, DOI 10.1111/j.1439-0396.2012.01319.x; Vatsyayan J, 2005, J BIOCHEM, V137, P703, DOI 10.1093/jb/mvi082; Viviano BL, 2005, DEV BIOL, V282, P152, DOI 10.1016/j.ydbio.2005.03.003; Wen YX, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0484-2; Xiao H, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0701-z; Zhang XR, 2016, BRIT J PHARMACOL, V173, P2250, DOI 10.1111/bph.13506	38	2	2	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12834	12846		10.1096/fj.202000106R	http://dx.doi.org/10.1096/fj.202000106R		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32767431				2022-12-26	WOS:000558271200001
J	Dibar, DT; Zhang, K; Yuan, SQ; Zhang, JY; Zhou, ZZ; Ye, XX				Dibar, Dagne Tafa; Zhang, Kun; Yuan, Suqiang; Zhang, Jinyu; Zhou, Zhongze; Ye, Xiaoxin			Ecological stoichiometric characteristics of Carbon (C), Nitrogen (N) and Phosphorus (P) in leaf, root, stem, and soil in four wetland plants communities in Shengjin Lake, China	PLOS ONE			English	Article							FRESH-WATER; NUTRIENT AVAILABILITY; AQUATIC MACROPHYTES; LIMITATION; PATTERNS; FORESTS; GROWTH; STOCKS	Ecological stoichiometric should be incorporated into management and nutrient impacted ecosystems dynamic to understand the status of ecosystems and ecological interaction. The present study focused on ecological stoichiometric characteristics of soil, and leaves, stems, and roots of different macrophytes after the banning of seine fishing in Shengjin Lake. For C, N, and P analysis from leaves, stems, roots, and soil to explore their stoichiometric ratio and deriving environmental forces, four dominant plant communities (Vallisneria natans, Zizanialatifolia,Trapa natans and Carex schmidtii) were collected. The concentration of C, N, P and C: N: P ratio in leaves, stems, roots, and soil among the plant communities varied significantly. Along the depth gradient high C: N was measured inC.schmidtiisoil (7.08 +/- 1.504) but not vary significantly (P>0.05). High C: P result was found inT.natans(81.14 +/- 43.88) and inV.natanssoil (81.40 +/- 42.57) respectively with no significant difference (p>0.05). Besides, N: P ratio measured high inV.natans(13.7 +/- 4.05) and showed significant variation (P<0.05). High leaf C: N and N: P ratio was measured inC.schmidtiiandV.natansrespectively. Nevertheless, high leaf C: P ratio was measured inZ.latifolia. From the three studied organs, leaf C: N and N: P ratio showed high values compared to root and stems. The correlation analysis result showed that at 0-10cm depth soil organic carbon (SOC) correlated negatively with stem total phosphorus (STP), and root total nitrogen (RTN) (P<0.05) but positively strongly with leaf total phosphorus (LTP) and leaf total nitrogen (LTN) (P<0.01) respectively. Soil total nitrogen (STN) at 0-10cm strongly positively correlated with leaf total phosphorus (LTP) (P<0.01) and positively with RN: P and leaf total carbon (LTC) (P<0.05). Soil basic properties such as soil moisture content (SMC), bulky density (BD) and pH positively correlated with soil ecological stoichiometric characteristics. Redundancy analysis (RDA) result showed available nitrogen (AN), soil total nitrogen (STN), and available phosphorus (AP) were the potential determinants variables on plants stoichiometric characteristics.	[Dibar, Dagne Tafa; Zhang, Kun; Yuan, Suqiang; Zhang, Jinyu; Zhou, Zhongze; Ye, Xiaoxin] Anhui Univ, Sch Resources & Environm Engn, Hefei, Peoples R China	Anhui University	Dibar, DT (corresponding author), Anhui Univ, Sch Resources & Environm Engn, Hefei, Peoples R China.	dagnet346@gmail.com	Ye, Xiaoxin/HGU-2549-2022	Dibar, Dagne Tafa/0000-0002-3018-7537	National Natural Science Foundation of China (NFSC) [31800346]	National Natural Science Foundation of China (NFSC)(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (NFSC) [31800346]. The Institute who support this research has no role in design, data collection, analysis, and decision to publish this manuscript as they provide us only fund.	Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Andersen T, 2004, ECOL LETT, V7, P884, DOI 10.1111/j.1461-0248.2004.00646.x; Baldwin DS, 2006, WETLANDS, V26, P455, DOI 10.1672/0277-5212(2006)26[455:TSEOSO]2.0.CO;2; Cao T, 2011, FRESHWATER BIOL, V56, P1620, DOI 10.1111/j.1365-2427.2011.02601.x; Castle SC, 2009, ECOSYSTEMS, V12, P101, DOI 10.1007/s10021-008-9210-8; Chen XS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12688; Chen ZQ, 2016, PLANT SOIL, V398, P367, DOI 10.1007/s11104-015-2670-7; Cong WF, 2014, J ECOL, V102, P1163, DOI 10.1111/1365-2745.12280; Demars BOL, 2007, FRESHWATER BIOL, V52, P2073, DOI 10.1111/j.1365-2427.2007.01817.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Estefan G., 2013, METHODS SOIL PLANT W, V3rd, P84; Feng DF, 2017, J SOIL SEDIMENT, V17, P2054, DOI 10.1007/s11368-017-1665-9; Gao Y, 2013, ECOL ENG, V57, P366, DOI 10.1016/j.ecoleng.2013.04.011; Greenway M, 1997, WATER SCI TECHNOL, V35, P135, DOI 10.1016/S0273-1223(97)00062-0; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hansson LA, 2005, FRESHWATER BIOL, V50, P705, DOI 10.1111/j.1365-2427.2005.01352.x; He WM, 2010, ECOL RES, V25, P967, DOI 10.1007/s11284-010-0724-0; Hessen DO, 2013, LIMNOL OCEANOGR, V58, P2219, DOI 10.4319/lo.2013.58.6.2219; Hu MJ, 2018, PLANT SOIL, V431, P273, DOI 10.1007/s11104-018-3759-6; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Li LP, 2014, AQUAT BOT, V112, P84, DOI 10.1016/j.aquabot.2013.08.002; Li L, 2016, CAN J SOIL SCI, V96, P461, DOI 10.1139/cjss-2015-0122; Liu FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138169; Lu Q, 2018, PHYS CHEM EARTH A, P9, DOI [10.1016/j.pce.04.001, DOI 10.1016/J.PCE.04.001]; Madsen TV, 2002, FRESHWATER BIOL, V47, P283, DOI 10.1046/j.1365-2427.2002.00802.x; Mao R, 2016, SCI TOTAL ENVIRON, V559, P1, DOI 10.1016/j.scitotenv.2016.03.158; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Meng Renxian, 1979, J ANHUI U NATURAL SC; Mi ZR, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0981; Minden V, 2014, PLANT BIOLOGY, V16, P897, DOI 10.1111/plb.12155; Moorthi SD, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0270; Paul E., 2014, SOIL MICROBIOLOGY EC; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; Romanya J, 2017, SOIL BIOL BIOCHEM, V113, P250, DOI 10.1016/j.soilbio.2017.06.015; Sardans J, 2014, ECOHYDROLOGY, V7, P1, DOI 10.1002/eco.1459; Sato S, 2005, REV BRAS CIENC SOLO, V29, P685, DOI 10.1590/S0100-06832005000500004; Schmidt SK, 2016, ECOSYSTEMS, V19, P1164, DOI 10.1007/s10021-016-9992-z; Shang B, 2018, ENVIRON POLLUT, V234, P136, DOI 10.1016/j.envpol.2017.11.056; Shang ZH, 2013, ECOL ENG, V58, P170, DOI 10.1016/j.ecoleng.2013.06.035; Sperfeld E, 2017, FUNCT ECOL, V31, P286, DOI 10.1111/1365-2435.12707; Tashi S, 2016, GLOBAL CHANGE BIOL, V22, P2255, DOI 10.1111/gcb.13234; Urbina I, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1801; Wang JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21137; Wu TG, 2012, BIOCHEM SYST ECOL, V44, P255, DOI 10.1016/j.bse.2012.06.002; Xia CX, 2014, ECOL ENG, V70, P406, DOI 10.1016/j.ecoleng.2014.06.018; Yang XX, 2016, BIOGEOSCI DISCUSS, V12, P18973, DOI DOI 10.5194/BG/13-4429; Yu JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep37940; Yu Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032162, 10.1371/journal.pone.0050902]; Zechmeister-Boltenstern S, 2015, ECOL MONOGR, V85, P133, DOI 10.1890/14-0777.1; Zhang C, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002296; ZHANG HX, 2017, ECOLOGICAL ENG, P00153, DOI DOI 10.1016/J.ECOLENG.12.036; Zhang W, 2015, PLANT SOIL, V391, P77, DOI 10.1007/s11104-015-2406-8; Zhang ZH, 2013, J SOIL SEDIMENT, V13, P140, DOI [10.1007/s11368-012-0571-4, 10.1007/s11368-013-0693-3]; Zhang ZS, 2017, CHINESE GEOGR SCI, V27, P507, DOI 10.1007/s11769-017-0884-8	54	6	7	8	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0230089	10.1371/journal.pone.0230089	http://dx.doi.org/10.1371/journal.pone.0230089			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760138	Green Submitted, gold, Green Published			2022-12-26	WOS:000561027200034
J	Rungrojcharoenkit, K; Sunintaboon, P; Ellison, D; Macareo, L; Midoeng, P; Chaisuwirat, P; Fernandez, S; Ubol, S				Rungrojcharoenkit, Kamonthip; Sunintaboon, Panya; Ellison, Damon; Macareo, Louis; Midoeng, Panuwat; Chaisuwirat, Preamrudee; Fernandez, Stefan; Ubol, Sukathida			Development of an adjuvanted nanoparticle vaccine against influenza virus, anin vitrostudy	PLOS ONE			English	Article							N-TRIMETHYL CHITOSAN; NUCLEOPROTEIN GENE; EPITHELIAL-CELLS; DENDRITIC CELLS; NASAL DELIVERY; PROTECTS MICE; HA2 SUBUNIT; HEMAGGLUTININ; RESPONSES; IMMUNOGENICITY	Influenza is an infectious respiratory illness caused by influenza viruses. Despite yearly updates, the efficacy of influenza vaccines is significantly curtailed by the virus antigenic drift and antigenic shift. These constant changes to the influenza virus make-up also challenge the development of a universal flu vaccine, which requires conserved antigenic regions shared by influenza viruses of different subtypes. We propose that it is possible to bypass these challenges by the development of an influenza vaccine based on conserved proteins delivered in an adjuvanted nanoparticle system. In this study, we generated influenza nanoparticle constructs using trimethyl chitosan nanoparticles (TMC nPs) as the carrier of recombinant influenza hemagglutinin subunit 2 (HA2) and nucleoprotein (NP). The purified HA2 and NP recombinant proteins were encapsulated into TMC nPs to form HA2-TMC nPs and NP-TMC nPs, respectively. Primary human intranasal epithelium cells (HNEpCs) were used as anin vitromodel to measure immunity responses. HA2-TMC nPs, NP-TMC nPs, and HA2-NP-TMC nPs (influenza nanoparticle constructs) showed no toxicity in HNEpCs. The loading efficiency of HA2 and NP into the TMC nPs was 97.9% and 98.5%, respectively. HA2-TMC nPs and NP-TMC nPs more efficiently delivered HA2 and NP proteins to HNEpCs than soluble HA2 and NP proteins alone. The induction of various cytokines and chemokines was more evident in influenza nanoparticle construct-treated HNEpCs than in soluble protein-treated HNEpCs. In addition, soluble factors secreted by influenza nanoparticle construct-treated HNEpCs significantly induced MoDCs maturation markers (CD80, CD83, CD86 and HLA-DR), as compared to soluble factors secreted by protein-treated HNEpCs. HNEpCs treated with the influenza nanoparticle constructs significantly reduced influenza virus replication in anin vitrochallenge assay. The results indicate that TMC nPs can be used as influenza vaccine adjuvants and carriers capable of delivering HA2 and NP proteins to HNEpCs.	[Rungrojcharoenkit, Kamonthip; Ubol, Sukathida] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand; [Rungrojcharoenkit, Kamonthip; Ellison, Damon; Macareo, Louis; Fernandez, Stefan] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok, Thailand; [Sunintaboon, Panya] Mahidol Univ, Fac Sci, Dept Chem, Bangkok, Thailand; [Midoeng, Panuwat; Chaisuwirat, Preamrudee] Phramongkutklao Hosp, Army Inst Pathol, Div Pathol, Bangkok, Thailand	Mahidol University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Mahidol University; Phramongkutklao Hospital	Ubol, S (corresponding author), Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand.; Fernandez, S (corresponding author), Armed Forces Res Inst Med Sci, Dept Virol, Bangkok, Thailand.	stefan.fernandez.mil@mail.mil; sukathida.ubo@mahidol.ac.th			Global Emerging Infections Surveillance; National Vaccine Institute, Thailand [2561.1/1]	Global Emerging Infections Surveillance; National Vaccine Institute, Thailand	This work was supported by the Global Emerging Infections Surveillance to KR and by the National Vaccine Institute, Thailand (grant#2561.1/1 to SU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Disclaimer: Material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the author, and are not to be construed as official, or as reflecting true views of the Department of the Army or the Department of Defense.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; ALMEIDA AJ, 1993, J PHARM PHARMACOL, V45, P198, DOI 10.1111/j.2042-7158.1993.tb05532.x; ALPAR HO, 1994, J DRUG TARGET, V2, P147, DOI 10.3109/10611869409015903; Amidi M, 2006, J CONTROL RELEASE, V111, P107, DOI 10.1016/j.jconrel.2005.11.014; Amidi M, 2007, VACCINE, V25, P144, DOI 10.1016/j.vaccine.2006.06.086; Amidi M, 2010, ADV DRUG DELIVER REV, V62, P59, DOI 10.1016/j.addr.2009.11.009; Athmaram TN, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-524; Bottcher-Friebertshauser E, 2013, PATHOG DIS, V69, P87, DOI 10.1111/2049-632X.12053; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Brooking J, 2001, J DRUG TARGET, V9, P267, DOI 10.3109/10611860108997935; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; CATE TR, 1983, REV INFECT DIS, V5, P737; Centers for Disease Control and Prevention, LIV INTR INFL VIS; Centers for Disease Control and Prevention. Influenza (Flu), ANT DRUG RES INFL VI; Chadwick S, 2010, ADV DRUG DELIVER REV, V62, P394, DOI 10.1016/j.addr.2009.11.012; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Cheung RCF, 2015, MAR DRUGS, V13, P5156, DOI 10.3390/md13085156; CLEMENTS ML, 1986, J CLIN MICROBIOL, V23, P66, DOI 10.1128/JCM.23.1.66-72.1986; Csaba Noemi, 2006, Expert Opin Drug Deliv, V3, P463, DOI 10.1517/17425247.3.4.463; Csaba N, 2009, ADV DRUG DELIVER REV, V61, P140, DOI 10.1016/j.addr.2008.09.005; Donovan MD, 1998, ADV DRUG DELIVER REV, V29, P147, DOI 10.1016/S0169-409X(97)00066-5; DURRER C, 1994, PHARMACEUT RES, V11, P680, DOI 10.1023/A:1018920128007; ENDO A, 1991, J GEN VIROL, V72, P699, DOI 10.1099/0022-1317-72-3-699; Fan X, 2015, MUCOSAL IMMUNOL, V8, P211, DOI 10.1038/mi.2014.59; Foged C, 2005, INT J PHARMACEUT, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035; Guo LN, 2010, ARCH VIROL, V155, P1765, DOI 10.1007/s00705-010-0756-3; Hagenaars N, 2010, J CONTROL RELEASE, V144, P17, DOI 10.1016/j.jconrel.2010.01.027; Hagenaars N, 2009, PHARM RES-DORDR, V26, P1353, DOI 10.1007/s11095-009-9845-y; Hashem AM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/414637; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Huang BY, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-322; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Issa Mohamed M, 2005, Drug Discov Today Technol, V2, P1, DOI 10.1016/j.ddtec.2005.05.008; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Kanchan V, 2007, BIOMATERIALS, V28, P5344, DOI 10.1016/j.biomaterials.2007.08.015; Khanna M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/546274; Kotze AF, 1999, EUR J PHARM SCI, V7, P145, DOI 10.1016/S0928-0987(98)00016-5; Kotze AF, 1997, PHARMACEUT RES, V14, P1197, DOI 10.1023/A:1012106907708; Lee Jong-Soo, 2013, J Virol Methods, V194, P280, DOI 10.1016/j.jviromet.2013.08.022; Liang Ming Tao, 2006, Current Drug Delivery, V3, P379; Lippi G, 2010, EUR J INTERN MED, V21, P70, DOI 10.1016/j.ejim.2009.12.001; MacLeod MKL, 2011, P NATL ACAD SCI USA, V108, P7914, DOI 10.1073/pnas.1104588108; Mallajosyula VVA, 2014, P NATL ACAD SCI USA, V111, pE2514, DOI 10.1073/pnas.1402766111; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Moghimi SM, 2006, ADV DRUG DELIVER REV, V58, P1451, DOI 10.1016/j.addr.2006.09.010; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Nantachit N, 2017, MICROBIOL IMMUNOL, V61, P305, DOI 10.1111/1348-0421.12497; Nantachit N, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0598-z; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roose K, 2009, DRUG NEWS PERSPECT, V22, P80, DOI 10.1358/dnp.2009.22.2.1334451; SHU LL, 1993, J VIROL, V67, P2723, DOI 10.1128/JVI.67.5.2723-2729.1993; Sinha VR, 2004, INT J PHARMACEUT, V274, P1, DOI 10.1016/j.ijpharm.2003.12.026; Slutter B, 2008, J DRUG TARGET, V16, P1, DOI [10.1080/10611860701637966, 10.1080/10611860701637966 ]; Slutter B, 2010, VACCINE, V28, P6282, DOI 10.1016/j.vaccine.2010.06.121; Snyman D, 2003, DRUG DEV IND PHARM, V29, P61, DOI 10.1081/DDC-120016684; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sun J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00038; Thorlund K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-134; Thueng-In K, 2010, VACCINE, V28, P6765, DOI 10.1016/j.vaccine.2010.07.065; To KKW, 2015, ARCH VIROL, V160, P777, DOI 10.1007/s00705-014-2314-x; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Whitehouse M, 2012, LUPUS, V21, P217, DOI 10.1177/0961203311429818; WHO Global Influenza Surveillance Network, MAN LAB DIAGN VIR SU; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; World Health Organization, INFL SEAS	71	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237218	10.1371/journal.pone.0237218	http://dx.doi.org/10.1371/journal.pone.0237218			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760143	gold, Green Published			2022-12-26	WOS:000561027200073
J	Stellavato, A; Abate, L; Vassallo, V; Donniacuo, M; Rinaldi, B; Schiraldi, C				Stellavato, Antonietta; Abate, Lucrezia; Vassallo, Valentina; Donniacuo, Maria; Rinaldi, Barbara; Schiraldi, Chiara			An in vitro study to assess the effect of hyaluronan-based gels on muscle-derived cells: Highlighting a new perspective in regenerative medicine	PLOS ONE			English	Article							HYBRID COMPLEXES; OXIDATIVE STRESS; SKELETAL-MUSCLE; ATROPHY; ACID	Hyaluronan (HA) is a nonsulfated glycosaminoglycan that has been widely used for biomedical applications. Here, we have analyzed the effect of HA on the rescue of primary cells under stress as well as its potential to recover muscle atrophy and validated the developed modelin vitrousing primary muscle cells derived from rats. The potentials of different HAs were elucidated through comparative analyses using pharmaceutical grade a) high (HHA) and b) low molecular weight (LHA) hyaluronans, c) hybrid cooperative complexes (HCC) of HA in three experimental set-ups. The cells were characterized based on the expression of myogenin, a muscle-specific biomarker, and the proliferation was analyzed using Time-Lapse Video Microscopy (TLVM). Cell viability in response to H(2)O(2)challenge was evaluated by 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay, and the expression of the superoxide dismutase enzyme (SOD-2) was assessed by western blotting. Additionally, in order to establish anin vitromodel of atrophy, muscle cells were treated with tumor necrosis factor-alpha (TNF-alpha), along with hyaluronans. The expression of Atrogin, MuRF-1, nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-kB), and Forkhead-box-(Fox)-O-3 (FoxO3a) was evaluated by western blotting to elucidate the molecular mechanism of atrophy. The results showed that HCC and HHA increased cell proliferation by 1.15 and 2.3 folds in comparison to un-treated cells (control), respectively. Moreover, both pre- and post-treatments of HAs restored the cell viability, and the SOD-2 expression was found to be reduced by 1.5 fold in HA-treated cells as compared to the stressed condition. Specifically in atrophic stressed cells, HCC revealed a noteworthy beneficial effect on the myogenic biomarkers indicating that it could be used as a promising platform for tissue regeneration with specific attention to muscle cell protection against stressful agents.	[Stellavato, Antonietta; Abate, Lucrezia; Vassallo, Valentina; Schiraldi, Chiara] Univ Campania Luigi Vanvitelli, Sch Med, Dept Expt Med, Via L De Crecchio, Naples, Italy; [Donniacuo, Maria; Rinaldi, Barbara] Univ Campania Luigi Vanvitelli, Dept Expt Med, Unit Pharmacol, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Stellavato, A (corresponding author), Univ Campania Luigi Vanvitelli, Sch Med, Dept Expt Med, Via L De Crecchio, Naples, Italy.	antonietta.stellavato@unicampania.it; chiara.schiraldi@unicampania.it	Vassallo, Valentina/AAC-7742-2021	Vassallo, Valentina/0000-0001-6891-9724; STELLAVATO, Antonietta/0000-0003-1635-2724	National grant MIUR "Sviluppo e sperimentazione di molecole ad azione nutraceutica e cosmeceutica" MIUR Ministero dell'Universita e della Ricerca Scientifica. Regional Competence Center in Industrial Biotechnologies (Bioteknet) S.C.P.A [PON03PE_00060_3]	National grant MIUR "Sviluppo e sperimentazione di molecole ad azione nutraceutica e cosmeceutica" MIUR Ministero dell'Universita e della Ricerca Scientifica. Regional Competence Center in Industrial Biotechnologies (Bioteknet) S.C.P.A	National grant MIUR PON03PE_00060_3 "Sviluppo e sperimentazione di molecole ad azione nutraceutica e cosmeceutica" MIUR Ministero dell'Universita e della Ricerca Scientifica. Regional Competence Center in Industrial Biotechnologies (Bioteknet) S.C.P.A funded short term grants for A. S. and L.A.	Alessio N, 2018, AGING-US, V10, P1575, DOI 10.18632/aging.101493; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Bonnevie ED, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216702; Brocca L, 2010, EXP PHYSIOL, V95, P331, DOI 10.1113/expphysiol.2009.050245; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cho S, 2018, J ETHNOPHARMACOL, V213, P328, DOI 10.1016/j.jep.2017.10.008; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Cui W, 2019, TOXICOL APPL PHARM, V378, DOI 10.1016/j.taap.2019.114625; D'Agostino A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194727; D'Agostino A, 2017, CARBOHYD POLYM, V157, P21, DOI 10.1016/j.carbpol.2016.07.125; D'Agostino A, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0064-6; De Rosa M, 2012, WO Patent, Patent No. [WO/2012/032,151, 032151]; Fakhari A, 2013, ACTA BIOMATER, V9, P7081, DOI 10.1016/j.actbio.2013.03.005; Fallacara A, 2017, FACIAL PLAST SURG, V33, P87, DOI [10.1055/s-0036-1597685, 10.1055/s-0037-1601851]; Ishikawa T, 2005, CONNECT TISSUE RES, V46, P101, DOI 10.1080/03008200590954131; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kaur N, 2019, J CELL PHYSIOL, V234, P6194, DOI 10.1002/jcp.27348; Kim H, 2017, BIOMATERIALS, V123, P155, DOI 10.1016/j.biomaterials.2017.01.029; Kinoshita H, 2019, SPINE, V44, pE446, DOI 10.1097/BRS.0000000000002891; Lawler JM, 2006, MUSCLE NERVE, V33, P200, DOI 10.1002/mus.20454; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mendoza G, 2009, MINI-REV MED CHEM, V9, P1479, DOI 10.2174/138955709790361494; Miki Y, 2019, BIOCHEM BIOPH RES CO, V516, P951, DOI 10.1016/j.bbrc.2019.06.143; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mirzoev TM, 2018, BIOCHEMISTRY-MOSCOW+, V83, P1299, DOI 10.1134/S0006297918110020; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Musaro A, 2010, CURR OPIN CLIN NUTR, V13, P236, DOI 10.1097/MCO.0b013e3283368188; Paulin D, 2004, EXP CELL RES, V301, P1, DOI 10.1016/j.yexcr.2004.08.004; Rinaldi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069954; Ryu Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194955; Salwowska NM, 2016, J COSMET DERMATOL-US, V15, P520, DOI 10.1111/jocd.12237; Sandri M, 2013, BIOGERONTOLOGY, V14, P303, DOI 10.1007/s10522-013-9432-9; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schiraldi C, 2016, CLIN CASES MINER BON, V13, P36, DOI 10.11138/ccmbm/2016.13.1.036; Spinelli FM, 2019, FEBS J, V286, P3433, DOI 10.1111/febs.14871; Stellavato A, 2016, J BIOL REG HOMEOS AG, V30, P7; Stellavato A, 2019, ADV THER, V36, P3221, DOI 10.1007/s12325-019-01064-8; Stellavato A, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4328219; Stellavato A, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8481243; Stellavato A, 2017, CELL PHYSIOL BIOCHEM, V44, P1078, DOI 10.1159/000485414; Stellavato A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163510	43	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236164	10.1371/journal.pone.0236164	http://dx.doi.org/10.1371/journal.pone.0236164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760085	Green Published, gold			2022-12-26	WOS:000561027200078
J	Karabachev, AD; Martini, DJ; Hermel, DJ; Solcz, D; Richardson, ME; Pesaran, T; Sarkar, IN; Greenblatt, MS				Karabachev, Alexander D.; Martini, Dylan J.; Hermel, David J.; Solcz, Dana; Richardson, Marcy E.; Pesaran, Tina; Sarkar, Indra Neil; Greenblatt, Marc S.			Curated multiple sequence alignment for the Adenomatous Polyposis Coli (APC) gene and accuracy of in silico pathogenicity predictions	PLOS ONE			English	Article							UNKNOWN CLINICAL-SIGNIFICANCE; MISSENSE SUBSTITUTIONS; VARIANTS; BRCA1; CLASSIFICATION; GUIDELINES; MUTATIONS; TOOLS	Computational algorithms are often used to assess pathogenicity of Variants of Uncertain Significance (VUS) that are found in disease-associated genes. Most computational methods include analysis of protein multiple sequence alignments (PMSA), assessing interspecies variation. Careful validation of PMSA-based methods has been done for relatively few genes, partially because creation of curated PMSAs is labor-intensive. We assessed how PMSA-based computational tools predict the effects of the missense changes in theAPCgene, in which pathogenic variants cause Familial Adenomatous Polyposis. Most Pathogenic or Likely Pathogenic APC variants are protein-truncating changes. However, public databases now contain thousands of variants reported as missense. We created a curated APC PMSA that contained >3 substitutions/site, which is large enough for statistically robustin silicoanalysis. The creation of the PMSA was not easily automated, requiring significant querying and computational analysis of protein and genome sequences. Of 1924 missense APC variants in the NCBI ClinVar database, 1800 (93.5%) are reported as VUS. All but two missense variants listed as P/LP occur at canonical splice or Exonic Splice Enhancer sites. Pathogenicity predictions by five computational tools (Align-GVGD, SIFT, PolyPhen2, MAPP, REVEL) differed widely in their predictions of Pathogenic/Likely Pathogenic (range 17.5-75.0%) and Benign/Likely Benign (range 25.0-82.5%) forAPCmissense variants in ClinVar. When applied to 21 missense variants reported in ClinVar and securely classified as Benign, the five methods ranged in accuracy from 76.2-100%. Computational PMSA-based methods can be an excellent classifier for variants of some hereditary cancer genes. However, there may be characteristics of theAPCgene and protein that confound the results ofin silicoalgorithms. A systematic study of these features could greatly improve the automation of alignment-based techniques and the use of predictive algorithms in hereditary cancer genes.	[Karabachev, Alexander D.; Martini, Dylan J.; Hermel, David J.; Solcz, Dana; Greenblatt, Marc S.] Univ Vermont, Dept Med, Larner Coll Med, Burlington, VT 05405 USA; [Richardson, Marcy E.; Pesaran, Tina] Ambry Genet, Aliso Viejo, CA USA; [Sarkar, Indra Neil] Brown Univ, Ctr Biomed Informat, Providence, RI 02912 USA; [Sarkar, Indra Neil] Rhode Isl Qual Inst, Providence, RI USA; [Martini, Dylan J.] Emory Univ, Sch Med, Atlanta, GA USA; [Hermel, David J.] Scripps Clin, La Jolla, CA 92037 USA	University of Vermont; Brown University; Emory University; Scripps Research Institute	Greenblatt, MS (corresponding author), Univ Vermont, Dept Med, Larner Coll Med, Burlington, VT 05405 USA.	Marc.Greenblatt@uvmhealth.org		Martini, Dylan/0000-0002-0843-1222; Karabachev, Alexander/0000-0003-1747-1194	INS [U54 GM115677]; National Institutes of Health	INS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	INS U54 GM115677 National Institutes of Health The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkevich V, 2004, J MED GENET, V41, P492, DOI 10.1136/jmg.2003.015867; Adebali O, 2016, GENET MED, V18, P1029, DOI 10.1038/gim.2015.208; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Cooper GM, 2003, GENOME RES, V13, P813, DOI 10.1101/gr.1064503; Dommering CJ, 2014, J MED GENET, V51, P366, DOI 10.1136/jmedgenet-2014-102264; Drost M, 2018, GENETICS MED; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Goldgar DE, 2008, HUM MUTAT, V29, P1265, DOI 10.1002/humu.20897; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Grandval P, 2014, HUM MUTAT, V35, P532, DOI 10.1002/humu.22539; Greenblatt MS, 2003, ONCOGENE, V22, P1150, DOI 10.1038/sj.onc.1206101; Grimm DG, 2015, HUM MUTAT, V36, P513, DOI 10.1002/humu.22768; Hansford S, 2015, JAMA ONCOL, V1, P23, DOI 10.1001/jamaoncol.2014.168; Hermel D., 2016, FAM CANCER, V16, P159; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Ioannidis NM, 2016, AM J HUM GENET, V99, P877, DOI 10.1016/j.ajhg.2016.08.016; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Lee K, 2018, HUM MUTAT, V39, P1553, DOI 10.1002/humu.23650; Maddison W.P., 2018, MESQUITE MODULAR SYS; Menendez M, 2008, GASTROENTEROLOGY, V134, P56, DOI 10.1053/j.gastro.2007.10.009; Miller PJ, 2011, HUM MUTAT, V32, P900, DOI 10.1002/humu.21504; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ortuno FM, 2013, BIOINFORMATICS, V29, P2112, DOI 10.1093/bioinformatics/btt360; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rishishwar L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042336; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tavtigian SV, 2008, HUM MUTAT, V29, P1327, DOI 10.1002/humu.20892; Tavtigian SV, 2008, HUM MUTAT, V29, P1342, DOI 10.1002/humu.20896; Tavtigian SV, 2018, GENET MED, V20, P1054, DOI 10.1038/gim.2017.210; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Tavtigian SV, 2006, FAM CANCER, V5, P77, DOI 10.1007/s10689-005-2578-0; Thompson BA, 2013, HUM MUTAT, V34, P255, DOI 10.1002/humu.22214; Weber W, 2005, HERED CANCER CLIN PR, V3, P81, DOI 10.1186/1897-4287-3-2-81; Yurgelun MB, 2015, GASTROENTEROLOGY, V149, P604, DOI 10.1053/j.gastro.2015.05.006	40	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0233673	10.1371/journal.pone.0233673	http://dx.doi.org/10.1371/journal.pone.0233673			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750050	Green Submitted, Green Published, gold			2022-12-26	WOS:000560009200042
J	Kashongwe, IM; Mawete, F; Mbulula, L; Nsuela, DJ; Losenga, L; Anshambi, N; Aloni, M; Kaswa, M; Kayembe, JMN; Umba, P; Lepira, FB; Kashongwe, ZM				Kashongwe, Innocent Murhula; Mawete, Fina; Mbulula, Leopoldine; Nsuela, Don Jean; Losenga, Luc; Anshambi, Nicole; Aloni, Murielle; Kaswa, Michel; Kayembe, Jean Marie Ntumba; Umba, Pierre; Lepira, Francois Bompeka; Kashongwe, Zacharie Munogolo			Outcomes and adverse events of pre- and extensively drug-resistant tuberculosis patients in Kinshasa, Democratique Republic of the Congo: A retrospective cohort study	PLOS ONE			English	Article							DIABETES-MELLITUS; BEDAQUILINE; TB; REGIMEN	Background Extensively drug-resistant tuberculosis (XDR TB) is a very serious form of tuberculosis that is burdened with a heavy mortality toll, especially before the advent of new TB drugs. The Democratic Republic of the Congo (DRC) is among the countries most affected by this new epidemic. Methods A retrospective analysis was performed of the records of all patients with pre- and extensively drug-resistant tuberculosis hospitalized from January 1, 2015 to December 31, 2017 and monitored for at least 6 months to one year after the end of their treatment in Kinshasa; an individualized therapeutic regimen with bedaquiline for 20 months was built for each patient. The adverse effects were systematically monitored. Results Of the 40 laboratory-confirmed patients, 32 (80%) patients started treatment, including 29 preXRB and 3 XDR TB patients. In the eligible group, 3 patients (9.4%) had HIV-TB coinfections. The therapeutic success rate was 53.2%, and the mortality rate was 46.8% (15/32); there were no relapses, failures or losses to follow-up. All coinfected HIV-TB patients died during treatment. The cumulative patient survival rate was 62.5% at 3 months, 53.1% at 6 months and 53.1% at 20 months. The most common adverse events were vomiting, Skin rash, anemia and peripheral neuropathy. Conclusion The new anti-tuberculosis drugs are a real hope for the management of Drug Resistant tuberculosis patient and other new therapeutic combinations may improve favorable outcomes.	[Kashongwe, Innocent Murhula; Kayembe, Jean Marie Ntumba; Lepira, Francois Bompeka; Kashongwe, Zacharie Munogolo] Kinshasa Univ Hosp, Pulmonol Unit, Internal Med, Kinshasa, DEM REP CONGO; [Kashongwe, Innocent Murhula; Mbulula, Leopoldine; Nsuela, Don Jean; Losenga, Luc; Umba, Pierre] Damian Fdn, Drug Resistant TB Unit, Ctr Excellence Damien, Kinshasa, DEM REP CONGO; [Kashongwe, Innocent Murhula; Mawete, Fina; Kaswa, Michel] Natl TB Program Democrat Republ Congo, Kinshasa, DEM REP CONGO; [Anshambi, Nicole] Prov Coordinat TB Control, Kinshasa, DEM REP CONGO; [Aloni, Murielle] Natl Lab Mycobacteria, Kinshasa, DEM REP CONGO		Kashongwe, IM (corresponding author), Kinshasa Univ Hosp, Pulmonol Unit, Internal Med, Kinshasa, DEM REP CONGO.; Kashongwe, IM (corresponding author), Damian Fdn, Drug Resistant TB Unit, Ctr Excellence Damien, Kinshasa, DEM REP CONGO.; Kashongwe, IM (corresponding author), Natl TB Program Democrat Republ Congo, Kinshasa, DEM REP CONGO.	innokash@yahoo.fr		Kaswa, Michel/0000-0003-3260-7248				Agence Publique Francaise de Recherches sur le Sida et les Hepatitis Virales, 2003, ECH ANRS COT GRAV EV; [Anonymous], 2019, GLOB TUB REP 2019; [Anonymous], 2018, LANCET; BORISOV SE, 2017, EUR RESPIR J, V0049; Caminero J., 2013, GUIDELINES CLIN OPER; CONRADIE F, 2020, NEW ENGL J MED, V0382, P00893; COX V, 2018, INT J TUBERC LUNG D, V0022, P00407; FALZON D, 2016, EUR RESPIR J, V0048, DOI DOI 10.1183/13993003.CONGRESS-2016.PA1903; GANDHI NR, 2010, LANCET, V0375, P01830; HEWISON C, 2018, INT J TUBERC LUNG D, V0022, P00766; JACOBSON KR, 2010, CLIN INFECT DIS, V0051, P00006; Kashongwe IM, 2019, J PULM MED RESP CARE, V1, P5; Kashongwe MI, 2018, J TUBERC RES, V6, P125; KUABAN C, 2015, INT J TUBERC LUNG D, V0019, P00517; LANGE C, 2019, INT J TUBERC LUNG D, V0023, P00645; LATIF A, 2018, PUBLIC HEALTH ACTION, V0008, P00014; MIGLIORI GB, 2013, EUR RESPIR J, V0042, P00169; MIOTTO P, 2017, EUR RESPIR J, V0050; NAHID P, 2019, AM J RESP CRIT CARE, V0200, pE  9, DOI DOI 10.1164/RCCM.201909-1874ST31729908; National Tuberculosis Program of DR Congo, 2016, RAPP GROUP THEM TUB; NDJEKA N, 2018, EUR RESPIR J, V0052; NDJEKA N, 2015, INT J TUBERC LUNG D, V0019, P00979; OLARU ID, 2015, EUR RESPIR J, V0045, P01119; PALMERO D, 2015, ARCH BRONCONEUMOL, V0051, pe  49; PETERSON ML, 2019, INT J TUBERC LUNG D, V0023, P00720; REUTER A, 2017, INT J TUBERC LUNG DI, V0021, P01114, DOI DOI 10.5588/IJTLD.17.046829037291; Riccardi N, 2018, RECENT PAT ANTIINFEC, V13; RICCARDI N, 2019, BMC INFECT DIS, V0019; SCHNIPPEL K, 2018, LANCET RESP MED, V0006, P00699; SOTGIU G, 2015, EUR RESPIR J, V0045, P00025; TANG SJ, 2015, EUR RESPIR J, V0045, P00161; TANG SJ, 2011, EMERG INFECT DIS, V0017, P00558; VANDEUN A, 2018, INT J TUBERC LUNG D, V0022, P00239; VINEY K, 2019, INT J TUBERC LUNG D, V0023, P01055; WHO, 2014, **NON-TRADITIONAL**; WHO, 2013, **NON-TRADITIONAL**; WHO-World Health Organization, 2016, GLOB DIFF EHEALTH MA; World Health Organization, 2006, WHO LIB CAT I N PUBL; World Health Organization, 2016, WHOHTMTB201604; World Health Organization, 2018, RAP COMM KEY CHANG T; World Health Organization, 2019, WORLD MALARIA REPORT; World Health Organization, 2018, INT CLASS FUNCT DIS; World Health Organization, 2011, BURDEN DIS ENV NOISE; World Health Organization, 2018, WHO TREATM GUID MULT; World Health Organization, 2014, WHOHTMTB201423; World Health Organization ( WHO), Q A COVID 19 PREGN C	46	3	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0236264	10.1371/journal.pone.0236264	http://dx.doi.org/10.1371/journal.pone.0236264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750060	gold, Green Published			2022-12-26	WOS:000560009200039
J	Sanchis, AC; Gallego, J; Hernandez, R; Arrazubi, V; Custodio, A; Cano, JM; Aguado, G; Macias, I; Lopez, C; Lopez, F; Visa, L; Garrido, M; Lago, NM; Montes, AF; Limon, ML; Azkarate, A; Pimentel, P; Reguera, P; Ramchandani, A; Cacho, JD; Carnicero, AM; Granja, M; Richard, MM; Perez, CH; Hurtado, A; Serra, O; Buxo, E; Tocino, RV; Jimenez-Fonseca, P; Carmona-Bayonas, A				Cotes Sanchis, Almudena; Gallego, Javier; Hernandez, Raquel; Arrazubi, Virginia; Custodio, Ana; Maria Cano, Juana; Aguado, Gema; Macias, Ismael; Lopez, Carlos; Lopez, Flora; Visa, Laura; Garrido, Marcelo; Martinez Lago, Nieves; Fernandez Montes, Ana; Luisa Limon, Maria; Azkarate, Aitor; Pimentel, Paola; Reguera, Pablo; Ramchandani, Avinash; Diego Cacho, Juan; Martin Carnicero, Alfonso; Granja, Monica; Martin Richard, Marta; Hernandez Perez, Carolina; Hurtado, Alicia; Serra, Olbia; Buxo, Elvira; Vidal Tocino, Rosario; Jimenez-Fonseca, Paula; Carmona-Bayonas, Alberto			Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry	PLOS ONE			English	Article							GASTROESOPHAGEAL JUNCTION CANCER; RANDOMIZED PHASE-III; SUPPORTIVE CARE; DOUBLE-BLIND; OPEN-LABEL; RAMUCIRUMAB MONOTHERAPY; 1ST-LINE CHEMOTHERAPY; PLUS PACLITAXEL; ADENOCARCINOMA; SURVIVAL	Background Second-line treatments boost overall survival in advanced gastric cancer (AGC). However, there is a paucity of information as to patterns of use and the results achieved in actual clinical practice. Materials and methods The study population comprised patients with AGC in the AGAMENON registry who had received second-line. The objective was to describe the pattern of second-line therapies administered, progression-free survival following second-line (PFS-2), and post-progression survival since first-line (PPS). Results 2311 cases with 2066 progression events since first-line (89.3%) were recorded; 245 (10.6%) patients died during first-line treatment and 1326/2066 (64.1%) received a second-line. Median PFS-2 and PPS were 3.1 (95% CI, 2.9-3.3) and 5.8 months (5.5-6.3), respectively. The most widely used strategies were monoCT (56.9%), polyCT (15.0%), ramucirumab+CT (12.6%), platinum-reintroduction (8.3%), trastuzumab+CT (6.1%), and ramucirumab (1.1%). PFS-2/PPS medians gradually increased in monoCT, 2.6/5.1 months; polyCT 3.4/6.3 months; ramucirumab+CT, 4.1/6.5 months; platinum-reintroduction, 4.2/6.7 months, and for the HER2+ subgroup in particular, trastuzumab+CT, 5.2/11.7 months. Correlation between PFS since first-line and OS was moderate in the series as a whole (Kendall's tau = 0.613), lower in those subjects who received second-line (Kendall's tau = 0.539), especially with ramucirumab+CT (Kendall's tau = 0.413). Conclusion This analysis reveals the diversity in second-line treatment for AGC, highlighting the effectiveness of paclitaxel-ramucirumab and, for a selected subgroup of patients, platinum reintroduction; both strategies endorsed by recent clinical guidelines.	[Cotes Sanchis, Almudena] Hosp Gen Univ Elda, Med Oncol Dept, Alicante, Spain; [Gallego, Javier] Hosp Gen Univ Elche, Med Oncol Dept, Elche, Spain; [Hernandez, Raquel] Hosp Univ Canarias, Med Oncol Dept, Tenerife, Spain; [Arrazubi, Virginia] Complejo Hosp Navarra, Med Oncol Dept, Pamplona, Spain; [Custodio, Ana] Hosp Univ La Paz, Med Oncol Dept, CIBERONC CB 16 12 00398, Madrid, Spain; [Maria Cano, Juana] Hosp Gen Univ Ciudad Real, Med Oncol Dept, Ciudad Real, Spain; [Aguado, Gema] Hosp Univ Gregorio Maranon, Med Oncol Dept, Madrid, Spain; [Macias, Ismael] Hosp Univ Parc Tauli, Med Oncol Dept, Sabadell, Spain; [Lopez, Carlos; Diego Cacho, Juan] Hosp Univ Marques de Valdecilla, Med Oncol Dept, IDIVAL, Santander, Spain; [Lopez, Flora] Hosp Univ Doce Octubre, Med Oncol Dept, Madrid, Spain; [Visa, Laura] Hosp Univ El Mar, Med Oncol Dept, Barcelona, Spain; [Garrido, Marcelo] Pontificia Univ Catolica Chile, Med Oncol Dept, Santiago, Chile; [Martinez Lago, Nieves] Complejo Hosp Univ A Coruna, Med Oncol Dept, La Coruna, Spain; [Fernandez Montes, Ana] Complejo Hosp Orense, Med Oncol Dept, Orense, Spain; [Luisa Limon, Maria] Hosp Univ Virgen del Rocio, Med Oncol Dept, Seville, Spain; [Azkarate, Aitor] Hosp Univ Son Espases, Med Oncol Dept, Mallorca, Spain; [Pimentel, Paola] Hosp Santa Lucia, Med Oncol Dept, Cartagena, Spain; [Reguera, Pablo] Hosp Univ Ramon y Cajal, Med Oncol Dept, Madrid, Spain; [Ramchandani, Avinash] Hosp Univ Insular Gran Canaria, Med Oncol Dept, Las Palmas Gran Canaria, Spain; [Martin Carnicero, Alfonso] Hosp San Pedro, Med Oncol Dept, Logrono, Spain; [Granja, Monica] Hosp Univ Clin San Carlos Madrid, Med Oncol Dept, Madrid, Spain; [Martin Richard, Marta] Hosp Univ Santa Creu & St Pau, Med Oncol Dept, Barcelona, Spain; [Hernandez Perez, Carolina] Hosp Univ Nuestra Senora Candelaria, Med Oncol Dept, Tenerife, Spain; [Hurtado, Alicia] Hosp Univ Fdn Alcorcon, Med Oncol Dept, Madrid, Spain; [Serra, Olbia] Catalan Inst Oncol, Med Oncol Dept, Lhospitalet De Llobregat, Spain; [Buxo, Elvira] Hosp Univ Vall dHebron, Med Oncol Dept, Barcelona, Spain; [Vidal Tocino, Rosario] Complejo Asistencial Univ Salamanca, Med Oncol Dept, IBSAL, Salamanca, Spain; [Jimenez-Fonseca, Paula] Hosp Univ Cent Asturias, Med Oncol Dept, ISPA, Oviedo, Spain; [Carmona-Bayonas, Alberto] Univ Murcia, Hosp Univ Morales Meseguer, Hematol & Med Oncol Dept, IMIB, Murcia, Spain	Universidad de la Laguna; Servicio Navarro de Salud - Osasunbidea; Hospital Universitario La Paz; General University Gregorio Maranon Hospital; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario 12 de Octubre; Pontificia Universidad Catolica de Chile; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Complexo Hospitalario Universitario de Ourense, Verin e O Barco de Valdeorras; Virgen del Rocio University Hospital; Hospital Universitari Son Espases; Hospital Universitario Ramon y Cajal; Alcorcon Foundation University Hospital; Catalan Institute of Oncology; Hospital Universitari Vall d'Hebron; Central University Hospital Asturias; Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA); Meseguer General University Hospital Morales; University of Murcia	Gallego, J (corresponding author), Hosp Gen Univ Elche, Med Oncol Dept, Elche, Spain.	j.gallegoplazas@gmail.com		Martinez-Lago, Nieves/0000-0002-0408-6871; Carmona-Bayonas, Alberto/0000-0002-1930-9660; Martin Carnicero, Alfonso/0000-0002-8564-2875	IRICOM S.A.	IRICOM S.A.	We thank Priscilla Chase Duran for editing the manuscript, Natalia Cateriano, Miguel Vaquero, and IRICOM S.A. for supporting the registry website. We are indebted to all patients, as well as to AGAMENON centres and investigators who particpated in this research and made it possible.	Al-Batran S-E, 2016 ASCO ANN M CHIC; Bang YJ, 2010, LANCET, V376, P1302; Begg CB, 2013, JNCI-J NATL CANCER I, V105, P1594, DOI 10.1093/jnci/djt289; Carmona-Bayonas A, 2018, GASTRIC CANCER, V21, P96, DOI 10.1007/s10120-017-0718-5; Carmona-Bayonas A, 2019, THROMB HAEMOSTASIS, V119, P1849, DOI 10.1055/s-0039-1694012; Carmona-Bayonas A, 2018, EJSO-EUR J SURG ONC, V44, P1191, DOI 10.1016/j.ejso.2018.03.019; Carmona-Bayonas A, 2016, J NATL COMPR CANC NE, V14, P1379, DOI 10.6004/jnccn.2016.0148; Choi IS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205853; Custodio A, 2017, BRIT J CANCER, V116, P1526, DOI 10.1038/bjc.2017.122; De Vita F, 2019, FUTURE ONCOL, V15, P2723, DOI 10.2217/fon-2019-0243; Di Bartolomeo M, 2018, TARGET ONCOL, V13, P227, DOI 10.1007/s11523-018-0562-5; Emura T, 2010, COMPUT STAT DATA AN, V54, P3033, DOI 10.1016/j.csda.2010.03.013; Fanotto V, 2017, GASTRIC CANCER, V20, P825, DOI 10.1007/s10120-016-0681-6; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ford HER, 2014, LANCET ONCOL, V15, P78, DOI 10.1016/S1470-2045(13)70549-7; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Harrell FE., 2015, PACKAGE RMS, P229; Harrell FE, 2015, SPRINGER SER STAT, P1, DOI 10.1007/978-3-319-19425-7_1; Hironaka S, 2013, J CLIN ONCOL, V31, P4438, DOI 10.1200/JCO.2012.48.5805; Janowitz T, 2016, BRIT J CANCER, V114, P381, DOI 10.1038/bjc.2015.452; Fonseca PJ, 2017, BRIT J CANCER, V117, P775, DOI 10.1038/bjc.2017.245; Jimenez-Fonseca P, 2017, GASTRIC CANCER, V20, P465, DOI 10.1007/s10120-016-0639-8; Jung M, 2018, GASTRIC CANCER, V21, P819, DOI 10.1007/s10120-018-0806-1; Kang JH, 2012, J CLIN ONCOL, V30, P1513, DOI 10.1200/JCO.2011.39.4585; Kang YK, 2017, LANCET, V390, P2461, DOI 10.1016/S0140-6736(17)31827-5; Kojima T, 2019, 2019 ASCO ANN M CHIC; Lee KW, 2019, ONCOLOGIST, V24, P18, DOI 10.1634/theoncologist.2018-0142; Li J, 2016, J CLIN ONCOL, V34, P1448, DOI 10.1200/JCO.2015.63.5995; Li Q, 2016, ONCOTARGET, V7, P50656, DOI 10.18632/oncotarget.10456; Liu LY, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S82365; Muro K, 2018, ANN ONCOL, V29, P16; National Comprehensive Cancer Network (NCCN), 2020, CLIN PRACT GUID ONC; Nevala-Plagemann C, 2019, ESMO OPEN, V4, DOI 10.1136/esmoopen-2019-000539; Okines AFC, 2010, ONCOLOGY-BASEL, V79, P150, DOI 10.1159/000322114; Paoletti X, 2013, JNCI-J NATL CANCER I, V105, P1667, DOI 10.1093/jnci/djt269; Park SR, 2017, EUR J CANCER, V83, P32, DOI 10.1016/j.ejca.2017.06.008; Paulson AS, 2018, GASTRIC CANCER, V21, P831, DOI 10.1007/s10120-018-0796-z; Satoh T, 2014, J CLIN ONCOL, V32, P2039, DOI 10.1200/JCO.2013.53.6136; Shitara K, 2018, LANCET ONCOL, V19, P1437, DOI 10.1016/S1470-2045(18)30739-3; Shitara K, 2018, LANCET, V392, P123, DOI 10.1016/S0140-6736(18)31257-1; Shitara K, 2012, INVEST NEW DRUG, V30, P1224, DOI 10.1007/s10637-011-9648-y; Smyth EC, 2016, ANN ONCOL, V27, pv38, DOI 10.1093/annonc/mdw350; Thuss-Patience PC, 2017, LANCET ONCOL, V18, P640, DOI 10.1016/S1470-2045(17)30111-0; Thuss-Patience PC, 2011, EUR J CANCER, V47, P2306, DOI 10.1016/j.ejca.2011.06.002; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Visa L, 2018, J GERIATR ONCOL, V9, P254, DOI 10.1016/j.jgo.2017.11.008; Viudez A, 2019, CLIN TRANSL ONCOL, P1; Wagner AD, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub4; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6; Yamada Y, 2019, LANCET GASTROENTEROL, V4, P501, DOI 10.1016/S2468-1253(19)30083-4; Yoshikawa T, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8243; Zhang Yong, 2016, Medicine (Baltimore), V95, pe2792, DOI 10.1097/MD.0000000000002792; Zhu XF, 2017, GASTRIC CANCER, V20, P646, DOI 10.1007/s10120-016-0656-7	53	11	11	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0235848	10.1371/journal.pone.0235848	http://dx.doi.org/10.1371/journal.pone.0235848			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735623	Green Published, gold			2022-12-26	WOS:000569367100012
J	Harumoto, T; Sato, A; Takayama, Y; Miyagi, H; Saito, J; Shinohara, F				Harumoto, Toshimasa; Sato, Atsuko; Takayama, Yuki; Miyagi, Hikaru; Saito, Jun-ichi; Shinohara, Fumikazu			Structure-guided screening strategy combining surface plasmon resonance with nuclear magnetic resonance for identification of small-molecule Argonaute 2 inhibitors	PLOS ONE			English	Article							MICRORNAS; RNAS	Argonaute (AGO) proteins are the key component of the RNA interference machinery that suppresses gene expression by forming an RNA-induced silencing complex (RISC) with microRNAs (miRNAs). Each miRNA is involved in various cellular processes, such as development, differentiation, tumorigenesis, and viral infection. Thus, molecules that regulate miRNA function are expected to have therapeutic potential. In addition, the biogenesis of miRNA is a multistep process involving various proteins, although the complete pathway remains to be elucidated. Therefore, identification of molecules that can specifically modulate each step will help understand the mechanism of gene suppression. To date, several AGO2 inhibitors have been identified. However, these molecules were identified through a single screening method, and no studies have specifically evaluated a combinatorial strategy. Here, we demonstrated a combinatorial screening (SCR) approach comprising an in silico molecular docking study, surface plasmon resonance (SPR) analysis, and nuclear magnetic resonance (NMR) analysis, focusing on the strong binding between the 5'-terminal phosphate of RNA and the AGO2 middle (MID) domain. By combining SPR and NMR, we identified binding modes of amino acid residues binding to AGO2. First, using a large chemical library (over 6,000,000 compounds), 171 compounds with acidic functional groups were screened using in silico SCR. Next, we constructed an SPR inhibition system that could analyze only the 5'-terminal binding site of RNA, and nine molecules that strongly bound to the AGO2 MID domain were selected. Finally, using NMR, three molecules that bound to the desired site were identified. The RISC inhibitory ability of the "hit" compounds was analyzed in human cell lysate, and all three hit compounds strongly inhibited the binding between double-stranded RNA and AGO2.	[Harumoto, Toshimasa; Miyagi, Hikaru] Kyowa Kirin Co Ltd, Res Funct Unit, R&D Div, Machida, Tokyo, Japan; [Sato, Atsuko; Takayama, Yuki; Saito, Jun-ichi] Kyowa Kirin Co Ltd, Res Funct Unit, R&D Div, Nagaizumi, Shizuoka, Japan; [Shinohara, Fumikazu] Kyowa Kirin Co Ltd, Res Funct Unit, R&D Div, Chiyoda Ku, Otemachi, Tokyo, Japan	Kyowa Kirin Ltd; Kyowa Kirin Ltd; Kyowa Kirin Ltd	Harumoto, T (corresponding author), Kyowa Kirin Co Ltd, Res Funct Unit, R&D Div, Machida, Tokyo, Japan.	toshimasa.harumoto.w9@kyowakirin.com			Kyowa Kirin Co., Ltd.	Kyowa Kirin Co., Ltd.	This work was supported by Kyowa Kirin Co., Ltd. The sponsor provided support in the form of salaries for authors TH, AS, YT, HM, JS, and FS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso N, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv069; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; De N, 2013, MOL CELL, V50, P344, DOI 10.1016/j.molcel.2013.04.001; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Goddard T. D., SPARKY 3; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hengel SR, 2016, ELIFE, V5, DOI 10.7554/eLife.14740; Iosue I, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.452; Kirsch P, 2019, MOLECULES, V24, DOI 10.3390/molecules24234309; Kobayashi H, 2016, BBA-GENE REGUL MECH, V1859, P71, DOI 10.1016/j.bbagrm.2015.08.007; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Madsen C, 2014, ANTIVIR RES, V112, P26, DOI 10.1016/j.antiviral.2014.10.002; Masciarelli S, 2014, ACS CHEM BIOL, V9, P1674, DOI 10.1021/cb500286b; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Suzuki HI, 2011, J BIOCHEM, V149, P15, DOI 10.1093/jb/mvq113; Tan GS, 2012, ACS CHEM BIOL, V7, P402, DOI 10.1021/cb200253h; Watashi K, 2010, J BIOL CHEM, V285, P24707, DOI 10.1074/jbc.M109.062976; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733	25	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236710	10.1371/journal.pone.0236710	http://dx.doi.org/10.1371/journal.pone.0236710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735606	Green Published, gold			2022-12-26	WOS:000569367100041
J	Sozzi, S; Nardone, A; Schieppati, M				Sozzi, Stefania; Nardone, Antonio; Schieppati, Marco			Adaptation of balancing behaviour during continuous perturbations of stance. Supra-postural visual tasks and platform translation frequency modulate adaptation rate	PLOS ONE			English	Article							CENTER-OF-MASS; PREPARATORY CORTICAL ACTIVITY; PARKINSONS-DISEASE; 1ST TRIAL; SENSORIMOTOR INTEGRATION; OLDER-ADULTS; TIME-COURSE; HEAD STABILIZATION; PROCESSING TIME; MOVING PLATFORM	When humans are administered continuous and predictable perturbations of stance, an adaptation period precedes the steady state of balancing behaviour. Little information is available on the modulation of adaptation by vision and perturbation frequency. Moreover, performance of supra-postural tasks may modulate adaptation in as yet unidentified ways. Our purpose was to identify differences in adaptation associated to distinct visual tasks and perturbation frequencies. Twenty non-disabled adult volunteers stood on a platform translating 10 cm in antero-posterior (AP) direction at low (LF, 0.18 Hz) and high frequency (HF, 0.56 Hz) with eyes open (EO) and closed (EC). Additional conditions were reading a text fixed to platform (EO-TP) and reading a text stationary on ground (EO-TG). Peak-to-peak (PP) displacement amplitude and AP position of head and pelvis markers were computed for each of 27 continuous perturbation cycles. The time constant and extent of head and pelvis adaptation and the cross-correlation coefficients between head and pelvis were compared across visual conditions and frequencies. Head and pelvis mean positions in space varied little across conditions and perturbation cycles but the mean head PP displacements changed over time. On average, at LF, the PP displacement of the head and pelvis increased progressively. Adaptation was rapid or ineffective with EO, but slower with EO-TG, EO-TP, EC. At HF, the head PP displacement amplitude decreased progressively with fast adaptation rates, while the pelvis adaptation was not apparent. The results show that visual tasks can modulate the adaptation rate, highlight the effect of the perturbation frequency on adaptation and provide evidence of priority assigned to pelvis stabilization over visual tasks at HF. The effects of perturbation frequency and optic flow and their interaction with other sensory inputs and cognitive tasks on the adaptation strategies should be investigated in impaired individuals and considered in the design of rehabilitation protocols.	[Sozzi, Stefania] Inst Pavia, Ctr Studi Att Motorie, IRCCS, ICS Maugeri SPA SB, Pavia, Italy; [Nardone, Antonio] Univ Pavia, Dept Clin Surg Diagnost & Paediat Sci, Pavia, Italy; [Nardone, Antonio] IRCCS Inst Pavia, Neurorehabil Unit, ICS Maugeri SPA SB, Pavia, Italy; [Nardone, Antonio] IRCCS Inst Pavia, Spinal Unit, ICS Maugeri SPA SB, Pavia, Italy; [Schieppati, Marco] Inst Pavia, IRCCS, ICS Maugeri SPA SB, Pavia, Italy	Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia	Nardone, A (corresponding author), Univ Pavia, Dept Clin Surg Diagnost & Paediat Sci, Pavia, Italy.; Nardone, A (corresponding author), IRCCS Inst Pavia, Neurorehabil Unit, ICS Maugeri SPA SB, Pavia, Italy.; Nardone, A (corresponding author), IRCCS Inst Pavia, Spinal Unit, ICS Maugeri SPA SB, Pavia, Italy.	marco.schieppati@icsmaugeri.it	Nardone, Antonio/J-8733-2016; Schieppati, Marco/O-2138-2019; Schieppati, Marco/K-5171-2016; Nardone, Antonio/ABH-1196-2020; Stefania, Sozzi/K-3924-2016	Nardone, Antonio/0000-0002-9547-1774; Schieppati, Marco/0000-0002-0630-0819; Schieppati, Marco/0000-0002-0630-0819; Nardone, Antonio/0000-0002-9547-1774; Stefania, Sozzi/0000-0002-6837-651X	Ministry of Health, Italy	Ministry of Health, Italy(Ministry of Health, Italy)	All Authors are employed by a commercial company. The ICS Maugeri SPA SB is the company that owns several hospitals in Italy, including the Istituto Scientifico in Pavia. Stefania Sozzi and Marco Schieppati have a temporary employment (coordinated collaboration) and their salaries are paid by the ICS Maugeri. Antonio Nardone is at the ICS Maugeri on the basis of a formal agreement between ICS Maugeri and the University of Pavia, where he is Professor of PM&R. This study was supported by the 'Ricerca Corrente' funding scheme of the Ministry of Health, Italy. The Ministry of Health had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study."The organization ICS Maugeri provided support in the form of salaries for the authors SS, AN and MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Allum JHJ, 2011, HUM MOVEMENT SCI, V30, P279, DOI 10.1016/j.humov.2010.11.009; Angelaki DE, 2014, COLD SH Q B, V79, P141, DOI 10.1101/sqb.2014.79.024638; Asslaender L, 2020, EXP BRAIN RES, V238, P465, DOI 10.1007/s00221-020-05723-z; Asslander L, 2016, J NEUROPHYSIOL, V116, P272, DOI 10.1152/jn.01145.2015; Asslander L, 2015, HUM MOVEMENT SCI, V41, P147, DOI 10.1016/j.humov.2015.02.010; Ballenghein U, 2019, COGN PROCESS, V20, P371, DOI 10.1007/s10339-018-0894-1; Barra J, 2013, NEUROPHYSIOL CLIN, V43, P197, DOI 10.1016/j.neucli.2013.02.001; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; Bekkers EMJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00540; Berthoz A, 1979, Prog Brain Res, V50, P197; Bhatt T, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0510-3; Blouin JS, 2003, EXP BRAIN RES, V150, P458, DOI 10.1007/s00221-003-1466-9; Bonnet CT, 2019, NEUROSCIENCE, V416, P177, DOI 10.1016/j.neuroscience.2019.07.031; Bonnet CT, 2016, GAIT POSTURE, V50, P120, DOI 10.1016/j.gaitpost.2016.08.030; Bonnet CT, 2016, GAIT POSTURE, V48, P57, DOI 10.1016/j.gaitpost.2016.04.016; Bove M, 2009, NEUROSCIENCE, V164, P1601, DOI 10.1016/j.neuroscience.2009.09.053; Bril B, 1998, NEUROSCI BIOBEHAV R, V22, P555, DOI 10.1016/S0149-7634(97)00044-4; Bronstein AM, 2016, HAND CLINIC, V137, P57, DOI 10.1016/B978-0-444-63437-5.00004-2; Buch ER, 2003, LEARN MEMORY, V10, P55, DOI 10.1101/lm.50303; Buchanan JJ, 2003, BEHAV BRAIN RES, V143, P121, DOI 10.1016/S0166-4328(03)00038-X; Buchanan JJ, 2001, EXP BRAIN RES, V139, P482, DOI 10.1007/s002210100798; Buchanan JJ, 1999, J NEUROPHYSIOL, V81, P2325, DOI 10.1152/jn.1999.81.5.2325; Camernik J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00486; Campbell AD, 2013, J NEUROPHYSIOL, V110, P2236, DOI 10.1152/jn.00766.2012; Castro P, 2019, GAIT POSTURE, V68, P538, DOI 10.1016/j.gaitpost.2018.12.043; Catena RD, 2017, J BIOMECH, V59, P23, DOI 10.1016/j.jbiomech.2017.05.007; Chelazzi L, 2019, CURR OPIN PSYCHOL, V29, P135, DOI 10.1016/j.copsyc.2019.02.004; Cleworth TW, 2016, NEUROSCI LETT, V620, P127, DOI 10.1016/j.neulet.2016.03.032; Coelho DB, 2018, NEUROSCI LETT, V685, P167, DOI 10.1016/j.neulet.2018.08.043; Coelho DB, 2017, EXP BRAIN RES, V235, P2375, DOI 10.1007/s00221-017-4980-x; Contreras-Vidal JL, 2003, EXP BRAIN RES, V150, P25, DOI 10.1007/s00221-003-1403-y; Corna S, 1999, EXP BRAIN RES, V124, P331, DOI 10.1007/s002210050630; Corna S, 2003, ARCH PHYS MED REHAB, V84, P1173, DOI 10.1016/S0003-9993(03)00130-8; Cromwell RL, 2004, J VESTIBUL RES-EQUIL, V14, P367; Cromwell RL, 2001, J VESTIBUL RES-EQUIL, V11, P105; Day BL, 2007, J PHYSIOL-LONDON, V582, P153, DOI 10.1113/jphysiol.2007.132092; Day BL, 2016, J PHYSIOL-LONDON, V594, P5661, DOI 10.1113/JP271813; De Nunzio AM, 2007, BRAIN RES BULL, V74, P258, DOI 10.1016/j.brainresbull.2007.06.020; De Nunzio AM, 2010, CLIN NEUROPHYSIOL, V121, P240, DOI 10.1016/j.clinph.2009.10.018; De Nunzio AM, 2008, MOVEMENT DISORD, V23, P2186, DOI 10.1002/mds.22201; De Nunzio AM, 2007, EXP BRAIN RES, V178, P18, DOI 10.1007/s00221-006-0708-z; De Nunzio AM, 2005, EXP BRAIN RES, V165, P261, DOI 10.1007/s00221-005-2297-7; Dichgans Johannes, 1978, PERCEPTION, P755, DOI DOI 10.1007/978-3-642-46354-9_25; Dijkstra BW, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00201; Dutt-Mazumder A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29844-2; Dutt-Mazumder A, 2017, HUM MOVEMENT SCI, V52, P24, DOI 10.1016/j.humov.2017.01.006; Farkhatdinov I, 2019, P ROY SOC A-MATH PHY, V475, DOI 10.1098/rspa.2018.0010; Fujiwara Katsuo, 2007, Journal of Physiological Anthropology, V26, P485, DOI 10.2114/jpa2.26.485; Fukuchi RK, 2010, J BIOMECH, V43, P592, DOI 10.1016/j.jbiomech.2009.09.050; Galletti C, 2018, CORTEX, V98, P203, DOI 10.1016/j.cortex.2017.01.009; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Geurts P., 2002, THESIS; Ghai S, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9245310; Ghai S, 2017, CLIN INTERV AGING, V12, P557, DOI 10.2147/CIA.S125201; Giardini M, 2018, GAIT POSTURE, V66, pS19; Giardini M, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/5614242; Gilaie-Dotan S, 2016, NEUROPSYCHOLOGIA, V89, P378, DOI 10.1016/j.neuropsychologia.2016.07.018; Goodworth AD, 2009, J NEUROPHYSIOL, V102, P496, DOI 10.1152/jn.00118.2009; Guerraz M, 2001, COGNITIVE BRAIN RES, V11, P259, DOI 10.1016/S0926-6410(00)00080-X; Happee R, 2017, J BIOMECH, V58, P203, DOI 10.1016/j.jbiomech.2017.05.005; Henry M, 2019, J NEUROPHYSIOL, V122, P525, DOI 10.1152/jn.00067.2019; Hettich G, 2011, MULTIBODY DYNAMICS 2; Hill CM, 2018, J ELECTROMYOGR KINES, V41, P96, DOI 10.1016/j.jelekin.2018.05.007; HOCHERMAN S, 1988, EXP NEUROL, V99, P388, DOI 10.1016/0014-4886(88)90156-2; Honeine JL, 2017, J NEUROPHYSIOL, V117, P777, DOI 10.1152/jn.00725.2016; Honeine JL, 2015, J NEUROPHYSIOL, V114, P3097, DOI 10.1152/jn.00618.2015; Honeine JL, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00190; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; HORAK FB, 1989, J NEUROPHYSIOL, V62, P841, DOI 10.1152/jn.1989.62.4.841; Hwang S, 2016, EXP BRAIN RES, V234, P2369, DOI 10.1007/s00221-016-4642-4; Izawa J, 2012, AUTISM RES, V5, P124, DOI 10.1002/aur.1222; Jeong B, 2018, GAIT POSTURE, V62, P333, DOI 10.1016/j.gaitpost.2018.03.048; Jilk DJ, 2014, EXP BRAIN RES, V232, P169, DOI 10.1007/s00221-013-3729-4; Jimenez L, 2011, J EXP PSYCHOL HUMAN, V37, P222, DOI 10.1037/a0020378; Kanekar N, 2014, AGE, V36, P1067, DOI 10.1007/s11357-014-9621-8; KESHNER EA, 1987, EXP BRAIN RES, V69, P77; Kiemel T, 2011, J NEUROSCI, V31, P15144, DOI 10.1523/JNEUROSCI.1013-11.2011; Ko JH, 2015, J MOTOR BEHAV, V47, P415, DOI 10.1080/00222895.2014.1003781; Krakauer JW, 2019, COMPR PHYSIOL, V9, P613, DOI 10.1002/cphy.c170043; Krause A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01075; Lee IC, 2018, GAIT POSTURE, V59, P117, DOI 10.1016/j.gaitpost.2017.09.014; Legge GE, 2001, VISION RES, V41, P725, DOI 10.1016/S0042-6989(00)00295-9; Lehnen N, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00562; Loschky LC, 2017, J VISION, V17, DOI 10.1167/17.1.6; Masani K, 2016, J PHYSIOL-LONDON, V594, P5365, DOI 10.1113/JP272597; McCrum C, 2017, EUR REV AGING PHYS A, V14, DOI 10.1186/s11556-017-0173-7; Mergner T, 2010, ANNU REV CONTROL, V34, P177, DOI 10.1016/j.arcontrol.2010.08.001; Mohapatra S, 2013, EXP BRAIN RES, V224, P25, DOI 10.1007/s00221-012-3286-2; Nanhoe-Mahabier W, 2012, NEUROSCIENCE, V217, P123, DOI 10.1016/j.neuroscience.2012.03.064; Nardone A, 2014, RESTOR NEUROL NEUROS, V32, P233, DOI 10.3233/RNN-130315; Nardone A, 2010, ARCH PHYS MED REHAB, V91, P1869, DOI 10.1016/j.apmr.2010.09.011; Nijhuis LBO, 2010, J NEUROPHYSIOL, V104, P2704, DOI 10.1152/jn.01080.2009; Norrie RG, 2002, EXP BRAIN RES, V146, P315, DOI 10.1007/s00221-002-1172-z; O'Connell C, 2017, EXP BRAIN RES, V235, P3261, DOI 10.1007/s00221-017-5045-x; Patel P, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12247; Patel PJ, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01181; Perrin P, 1998, NEUROSCI LETT, V245, P155, DOI 10.1016/S0304-3940(98)00208-0; Peterka RJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01045; Peterka RJ, 2018, HAND CLINIC, V159, P27, DOI 10.1016/B978-0-444-63916-5.00002-1; Polskaia N, 2015, GAIT POSTURE, V41, P454, DOI 10.1016/j.gaitpost.2014.11.009; Pozzo T., 1990, NORMAL SUBJECTS, V82, P97, DOI [DOI 10.1007/BF00230842, DOI 10.1007/BF00230842)]; Rabin E, 2006, EXP BRAIN RES, V170, P122, DOI 10.1007/s00221-006-0348-3; Raffi M, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9050934; Rasman BG, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00899; Rasouli O, 2017, EXP BRAIN RES, V235, P2301, DOI 10.1007/s00221-017-4972-x; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Richer N, 2017, GAIT POSTURE, V54, P45, DOI 10.1016/j.gaitpost.2017.02.022; Rogers MW, 2018, HAND CLINIC, V159, P85, DOI 10.1016/B978-0-444-63916-5.00005-7; Ruffieux J, 2017, J NEGAT RESULTS BIOM, V16, DOI 10.1186/s12952-017-0076-1; SCHIEPPATI M, 1994, ELECTROEN CLIN NEURO, V93, P286, DOI 10.1016/0168-5597(94)90031-0; Schieppati M, 2002, EXP BRAIN RES, V144, P200, DOI 10.1007/s00221-002-1028-6; SCHIEPPATI M, 1995, J PHYSIOL-LONDON, V487, P787, DOI 10.1113/jphysiol.1995.sp020918; Schmid M, 2008, NEUROSCIENCE, V153, P1079, DOI 10.1016/j.neuroscience.2008.03.024; Schmid M, 2007, BRAIN, V130, P2097, DOI 10.1093/brain/awm157; Schmid M, 2016, NEUROSCI LETT, V628, P110, DOI 10.1016/j.neulet.2016.06.021; Schmid M, 2011, HUM MOVEMENT SCI, V30, P262, DOI 10.1016/j.humov.2011.02.002; Schnitzer BS, 2006, VISION RES, V46, P1611, DOI 10.1016/j.visres.2005.09.023; Schut IM, 2019, IEEE T NEUR SYS REH, V27, P2336, DOI 10.1109/TNSRE.2019.2943206; Schwabe A, 2004, GAIT POSTURE, V19, P16, DOI 10.1016/S0966-6362(03)00006-7; Selinger JC, 2015, CURR BIOL, V25, P2452, DOI 10.1016/j.cub.2015.08.016; Siegmund GP, 2008, EXERC SPORT SCI REV, V36, P76, DOI 10.1097/JES.0b013e318168f1ce; Sienko KH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00944; Smith BA, 2014, J NEUROL PHYS THER, V38, P207, DOI 10.1097/NPT.0000000000000058; Smith BA, 2012, EXP BRAIN RES, V222, P455, DOI 10.1007/s00221-012-3232-3; Sozzi S, 2012, NEUROSCIENCE, V212, P59, DOI 10.1016/j.neuroscience.2012.03.044; Sozzi S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00748; Sozzi S, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00419; Sozzi S, 2011, HUM MOVEMENT SCI, V30, P172, DOI 10.1016/j.humov.2010.06.002; Stark-Inbar A, 2017, J NEUROPHYSIOL, V117, P412, DOI 10.1152/jn.01141.2015; Steiner KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163598; Tagliabue M, 2013, NEUROSCIENCE, V248, P88, DOI 10.1016/j.neuroscience.2013.05.051; Timmann D, 1997, BRAIN, V120, P327, DOI 10.1093/brain/120.2.327; Tisserand R, 2016, GAIT POSTURE, V48, P64, DOI 10.1016/j.gaitpost.2016.04.032; Toth AJ, 2017, EXP BRAIN RES, V235, P407, DOI 10.1007/s00221-016-4801-7; van der Kooij H, 2007, J NEUROPHYSIOL, V98, P730, DOI 10.1152/jn.00457.2006; van Drunen P, 2015, EXP BRAIN RES, V233, P735, DOI 10.1007/s00221-014-4151-2; Van Ooteghem K, 2008, EXP BRAIN RES, V187, P603, DOI 10.1007/s00221-008-1329-5; Van Ooteghem K, 2017, GAIT POSTURE, V57, P299, DOI 10.1016/j.gaitpost.2017.06.021; Venkatakrishnan A, 2011, HUM MOVEMENT SCI, V30, P760, DOI 10.1016/j.humov.2010.08.020; Vuillerme N, 2006, EXP BRAIN RES, V169, P130, DOI 10.1007/s00221-005-0124-9; Welch TDJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096440; Wulf G, 2009, PHYS THER, V89, P162, DOI 10.2522/ptj.20080045; Yang F, 2014, J BIOMECH, V47, P3807, DOI 10.1016/j.jbiomech.2014.10.027; Zanetti C, 2007, EUR J APPL PHYSIOL, V100, P331, DOI 10.1007/s00421-007-0434-7	144	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236702	10.1371/journal.pone.0236702	http://dx.doi.org/10.1371/journal.pone.0236702			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NO3EK	32735602	Green Published, gold			2022-12-26	WOS:000569367100040
J	Wood, KA; Rowlands, CF; Thomas, HB; Woods, S; O'Flaherty, J; Douzgou, S; Kimber, SJ; Newman, WG; O'Keefe, RT				Wood, Katherine A.; Rowlands, Charlie F.; Thomas, Huw B.; Woods, Steven; O'Flaherty, Julieta; Douzgou, Sofia; Kimber, Susan J.; Newman, William G.; O'Keefe, Raymond T.			Modelling the developmental spliceosomal craniofacial disorder Burn-McKeown syndrome using induced pluripotent stem cells	PLOS ONE			English	Article							TREACHER-COLLINS-SYNDROME; CHOANAL ATRESIA; DEFECTS; IDENTIFICATION; EXPRESSION; MUTATIONS; PATHOGENESIS; VERTEBRATES; PRIMERBANK; GENERATION	The craniofacial developmental disorder Burn-McKeown Syndrome (BMKS) is caused by biallelic variants in the pre-messenger RNA splicing factor gene TXNL4A/DIB1. The majority of affected individuals with BMKS have a 34 base pair deletion in the promoter region of one allele of TXNL4A combined with a loss-of-function variant on the other allele, resulting in reduced TXNL4A expression. However, it is unclear how reduced expression of this ubiquitously expressed spliceosome protein results in craniofacial defects during development. Here we reprogrammed peripheral mononuclear blood cells from a BMKS patient and her unaffected mother into induced pluripotent stem cells (iPSCs) and differentiated the iPSCs into induced neural crest cells (iNCCs), the key cell type required for correct craniofacial development. BMKS patient-derived iPSCs proliferated more slowly than both mother- and unrelated control-derived iPSCs, and RNA-Seq analysis revealed significant differences in gene expression and alternative splicing. Patient iPSCs displayed defective differentiation into iNCCs compared to maternal and unrelated control iPSCs, in particular a delay in undergoing an epithelial-to-mesenchymal transition (EMT). RNA-Seq analysis of differentiated iNCCs revealed widespread gene expression changes and mis-splicing in genes relevant to craniofacial and embryonic development that highlight a dampened response to WNT signalling, the key pathway activated during iNCC differentiation. Furthermore, we identified the mis-splicing of TCF7L2 exon 4, a key gene in the WNT pathway, as a potential cause of the downregulated WNT response in patient cells. Additionally, mis-spliced genes shared common sequence properties such as length, branch point to 3' splice site (BPS-3'SS) distance and splice site strengths, suggesting that splicing of particular subsets of genes is particularly sensitive to changes in TXNL4A expression. Together, these data provide the first insight into how reduced TXNL4A expression in BMKS patients might compromise splicing and NCC function, resulting in defective craniofacial development in the embryo.	[Wood, Katherine A.; Rowlands, Charlie F.; Thomas, Huw B.; Douzgou, Sofia; Newman, William G.; O'Keefe, Raymond T.] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Evolut & Genom Sci, Manchester, Lancs, England; [Wood, Katherine A.; Rowlands, Charlie F.; Douzgou, Sofia; Newman, William G.] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Ctr Genom Med, Manchester, Lancs, England; [Woods, Steven; O'Flaherty, Julieta; Kimber, Susan J.] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	O'Keefe, RT (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Evolut & Genom Sci, Manchester, Lancs, England.	rokeefe@manchester.ac.uk	Houge, Sofia Douzgou/I-2049-2019	Houge, Sofia Douzgou/0000-0001-8890-7544; Wooods, Steven/0000-0001-6873-5722; Wood, Katherine/0000-0002-6459-2127; Newman, William/0000-0002-6382-4678; Thomas, Huw/0000-0001-9626-9706; O'Flaherty, Julieta/0000-0003-3387-9149; O'Keefe, Raymond/0000-0001-8764-1289	Biotechnology and Biological Sciences Research Council [BB/N000258/1]; National Institute for Health Manchester Biomedical Research Centre [IS-BRC-1215-20007]; Medical Research Council studentship [1916606]; Medical Research Council industrial Collaborative Awards in Science and Engineering (iCASE) studentship [1926882]; QIAGEN; European Union SYBIL European Community's Seventh Framework Programme (FP7/2007-2013) [60230]; BBSRC [BB/N000358/1] Funding Source: UKRI; MRC [1926882, MR/L011840/1, MR/S002553/1, 1916606] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Manchester Biomedical Research Centre; Medical Research Council studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council industrial Collaborative Awards in Science and Engineering (iCASE) studentship; QIAGEN; European Union SYBIL European Community's Seventh Framework Programme (FP7/2007-2013); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: The research of WGN and RTO was supported by the Biotechnology and Biological Sciences Research Council (BB/N000258/1) (bbsrc.ukri.org). WGN was supported by National Institute for Health Manchester Biomedical Research Centre funding (IS-BRC-1215-20007) (manchesterbrc.nihr.ac.uk). KAW was supported by a Medical Research Council studentship (1916606) (mrc.ukri.org). CFR was supported by a Medical Research Council industrial Collaborative Awards in Science and Engineering (iCASE) studentship (1926882) with QIAGEN (mrc.ukri. org). SW and SJK were supported by the European Union SYBIL European Community's Seventh Framework Programme (FP7/2007-2013, 60230) (ec.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; [Anonymous], 2014, BMC BIOINF, DOI [DOI 10.1186/1471-2105-12-323, DOI 10.1201/B16589]; Atale N, 2014, J MICROSC-OXFORD, V255, P7, DOI 10.1111/jmi.12133; Banovich NE, 2018, GENOME RES, V28, P122, DOI 10.1101/gr.224436.117; Barrell WB, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00139; Beauchamp MC, 2020, DEV DYNAM, V249, P924, DOI 10.1002/dvdy.183; Beauchamp MC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219280; Bebee TW, 2015, ELIFE, V4, DOI 10.7554/eLife.08954; Bhatt S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008326; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burn J, 1992, Clin Dysmorphol, V1, P137; Chae YK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21061-1; Chambers SM, 2016, METHODS MOL BIOL, V1307, P329, DOI 10.1007/7651_2013_59; Cho N, 2019, EXP MOL PATHOL, V109, P36, DOI 10.1016/j.yexmp.2019.104264; Clay MR, 2014, DEVELOPMENT, V141, P2506, DOI 10.1242/dev.105551; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; Corvelo A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001016; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Deml B, 2015, BIRTH DEFECTS RES A, V103, P630, DOI 10.1002/bdra.23397; Devotta A, 2016, DEV BIOL, V415, P371, DOI 10.1016/j.ydbio.2016.02.010; Dixon J, 2000, HUM MOL GENET, V9, P1473, DOI 10.1093/hmg/9.10.1473; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Goos JAC, 2017, EUR J HUM GENET, V25, P1126, DOI 10.1038/ejhg.2017.107; Gordon CT, 2012, J MED GENET, V49, P737, DOI 10.1136/jmedgenet-2012-101173; Gottgens EL, 2016, INT REV CEL MOL BIO, V327, P163, DOI 10.1016/bs.ircmb.2016.06.003; Green SA, 2015, NATURE, V520, P474, DOI 10.1038/nature14436; Hall BK, 1999, NEURAL CREST DEV EVO, DOI [10.1007/978-1-4757-3064-7, DOI 10.1007/978-1-4757-3064-7]; Jeong HM, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.89; Jin T, 2008, MOL ENDOCRINOL, V22, P2383, DOI 10.1210/me.2008-0135; Kandul NP, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-67; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Le Bras GF, 2012, CELL ADHES MIGR, V6, P365, DOI 10.4161/cam.21326; Lehalle D, 2015, CLIN GENET, V88, P405, DOI 10.1111/cge.12596; Lei L, 2017, NUCLEIC ACIDS RES, V45, P3422, DOI 10.1093/nar/gkw1043; Leung AW, 2016, DEVELOPMENT, V143, P398, DOI 10.1242/dev.130849; Li LM, 2018, AM J PATHOL, V188, P1882, DOI 10.1016/j.ajpath.2018.04.012; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marques F, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006307; Matsuda Yoko, 2012, Patholog Res Int, V2012, P574768, DOI 10.1155/2012/574768; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mill C, 2012, CARDIOVASC RES, V95, P233, DOI 10.1093/cvr/cvs141; Miller EE, 2017, HUM MOL GENET, V26, P2177, DOI 10.1093/hmg/ddx078; Morders D., 2009, MOL VIS, V12, P1259, DOI DOI 10.1055/S-0029-1237430; Murdoch B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041089; Narayanan DL, 2020, AM J MED GENET A, V182, P1313, DOI 10.1002/ajmg.a.61554; Parmeggiani F, 2011, CURR GENOMICS, V12, P236, DOI 10.2174/138920211795860080; Pla P, 2001, J CELL PHYSIOL, V189, P121, DOI 10.1002/jcp.10008; Pradella D, 2017, MOL CANCER, V16, DOI 10.1186/s12943-016-0579-2; Rasband W.-S., 2012, ARXIV; Reuter K, 1999, J MOL BIOL, V294, P515, DOI 10.1006/jmbi.1999.3258; Revil T, 2013, DEV DYNAM, V242, P281, DOI 10.1002/dvdy.23918; Richter J, 2017, CRIT REV BIOCHEM MOL, V52, P414, DOI 10.1080/10409238.2017.1325828; Rogers CD, 2012, WIRES DEV BIOL, V1, P52, DOI 10.1002/wdev.8; Ruzickova S, 2017, RNA BIOL, V14, P544, DOI 10.1080/15476286.2016.1191735; Sanchez E, 2020, GENET MED, V22, P547, DOI 10.1038/s41436-019-0669-9; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schreib CC, 2018, J MOL BIOL, V430, P1640, DOI 10.1016/j.jmb.2018.04.027; Serrano F, 2019, STEM CELLS DEV, V28, P81, DOI 10.1089/scd.2017.0234; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Simoes-Costa M, 2013, GENOME RES, V23, P1069, DOI 10.1101/gr.157586.113; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stevens SW, 2001, RNA, V7, P1543; Strang-Karisson S, 2017, CLIN DYSMORPHOL, V26, P193, DOI 10.1097/MCD.0000000000000175; Stuhlmiller TJ, 2012, CELL MOL LIFE SCI, V69, P3715, DOI 10.1007/s00018-012-0991-8; Stuhlmiller TJ, 2012, DEVELOPMENT, V139, P289, DOI 10.1242/dev.070276; Tabaglio T, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800157; Tanackovic G, 2011, HUM MOL GENET, V20, P2116, DOI 10.1093/hmg/ddr094; Taneyhill L.A., 2014, NEURAL CREST CELLS E, P51, DOI DOI 10.1016/B978-0-12-401730-6.00003-X; Taneyhill LA, 2008, CELL ADHES MIGR, V2, P223, DOI 10.4161/cam.2.4.6835; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Tobin JL, 2008, P NATL ACAD SCI USA, V105, P6714, DOI 10.1073/pnas.0707057105; Toriello HV, 1999, CLIN DYSMORPHOL, V8, P143; Trainor PA, 2010, AM J MED GENET A, V152A, P2984, DOI 10.1002/ajmg.a.33454; Trede NS, 2007, P NATL ACAD SCI USA, V104, P6608, DOI 10.1073/pnas.0701919104; Urano-Morisawa E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174940; Van Otterloo E, 2016, DEV BIOL, V415, P171, DOI 10.1016/j.ydbio.2016.01.017; Vitale AM, 2012, STEM CELL TRANSL MED, V1, P641, DOI 10.5966/sctm.2012-0043; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Weise A, 2010, NUCLEIC ACIDS RES, V38, P1964, DOI 10.1093/nar/gkp1197; Wieczorek D, 2003, CLIN DYSMORPHOL, V12, P171, DOI 10.1097/01.mcd.0000072163.33788.c4; Wieczorek D, 2014, AM J HUM GENET, V95, P698, DOI 10.1016/j.ajhg.2014.10.014; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wood KA, 2019, HUM MOL GENET, V28, P3704, DOI 10.1093/hmg/ddz169; Wu G, 2018, RNA, V24, P1056, DOI 10.1261/rna.065383.117; Wu J, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-019-0238-y; Xu MC, 2017, AM J HUM GENET, V100, P592, DOI 10.1016/j.ajhg.2017.02.008; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang Y, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.919460; Zhang YZ, 1999, PHYSIOL GENOMICS, V1, P109, DOI 10.1152/physiolgenomics.1999.1.3.109; Zhang YZ, 2000, GENE, V257, P33, DOI 10.1016/S0378-1119(00)00372-3	98	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0233582	10.1371/journal.pone.0233582	http://dx.doi.org/10.1371/journal.pone.0233582			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735620	gold, Green Published, Green Submitted			2022-12-26	WOS:000569367100003
J	Smith, CD; Schmidt, CA; Lin, CT; Fisher-Wellman, KH; Neufer, PD				Smith, Cody D.; Schmidt, Cameron A.; Lin, Chien-Te; Fisher-Wellman, Kelsey H.; Neufer, P. Darrell			Flux through mitochondrial redox circuits linked to nicotinamide nucleotide transhydrogenase generates counterbalance changes in energy expenditure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondrial metabolism; nicotinamide nucleotide transhydrogenase (NNT); energy metabolism; bioenergetics; electron transport system (ETS); beta-oxidation; redox regulation; redox buffering circuits; hydrogen sulfide; nicotinamide nucleotide transhydrogenase	FATTY-ACID OXIDATION; SKELETAL-MUSCLE; HYDROGEN-PEROXIDE; SUPEROXIDE; MECHANISM; C57BL/6J; SITES; LIVER; EFFICIENCY; DELETION	Compensatory changes in energy expenditure occur in response to positive and negative energy balance, but the underlying mechanism remains unclear. Under low energy demand, the mitochondrial electron transport system is particularly sensitive to added energy supply (i.e. reductive stress), which exponentially increases the rate of H2O2 (JH(2)O(2)) production. H2O2 is reduced to H2O by electrons supplied by NADPH. NADP(+) is reduced back to NADPH by activation of mitochondrial membrane potential-dependent nicotinamide nucleotide transhydrogenase (NNT). The coupling of reductive stress-induced JH(2)O(2) production to NNT-linked redox buffering circuits provides a potential means of integrating energy balance with energy expenditure. To test this hypothesis, energy supply was manipulated by varying flux rate through beta-oxidation in muscle mitochondria minus/plus pharmacological or genetic inhibition of redox buffering circuits. Here we show during both non-ADP- and low-ADP-stimulated respiration that accelerating flux through beta-oxidation generates a corresponding increase in mitochondrial JH(2)O(2) production, that the majority (similar to 70-80%) of H2O2 produced is reduced to H2O by electrons drawn from redox buffering circuits supplied by NADPH, and that the rate of electron flux through redox buffering circuits is directly linked to changes in oxygen consumption mediated by NNT. These findings provide evidence that redox reactions within beta-oxidation and the electron transport system serve as a barometer of substrate flux relative to demand, continuously adjusting JH(2)O(2) production and, in turn, the rate at which energy is expended via NNT-mediated proton conductance. This variable flux through redox circuits provides a potential compensatory mechanism for fine-tuning energy expenditure to energy balance in real time.	[Smith, Cody D.; Schmidt, Cameron A.; Lin, Chien-Te; Fisher-Wellman, Kelsey H.; Neufer, P. Darrell] East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27858 USA; [Smith, Cody D.; Schmidt, Cameron A.; Lin, Chien-Te; Fisher-Wellman, Kelsey H.; Neufer, P. Darrell] East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Neufer, PD (corresponding author), East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27858 USA.; Neufer, PD (corresponding author), East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27858 USA.	neuferp@ecu.edu		Fisher-Wellman, Kelsey/0000-0002-0300-829X	National Institutes of Health [R01 DK096907, R01 DK110656]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01 DK096907 and R01 DK110656 (to P. D. N.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Belanger A. J., 1988, FRAMINGHAM STUDY EPI; Brand MD, 2016, FREE RADICAL BIO MED, V100, P14, DOI 10.1016/j.freeradbiomed.2016.04.001; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brookes PS, 1998, COMP BIOCHEM PHYS B, V119, P325, DOI 10.1016/S0305-0491(97)00357-X; Dey S, 2016, J BIOL CHEM, V291, P11185, DOI 10.1074/jbc.M116.726968; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; DONTSOV AE, 1972, J BIOENERG, V3, P277, DOI 10.1007/BF01515975; Fisher-Wellman KH, 2018, CELL REP, V24, P3593, DOI 10.1016/j.celrep.2018.08.091; Fisher-Wellman KH, 2016, DIABETES, V65, P3249, DOI 10.2337/db16-0291; Fisher-Wellman KH, 2015, BIOCHEM J, V467, P271, DOI 10.1042/BJ20141447; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Go YM, 2013, J BIOL CHEM, V288, P26512, DOI 10.1074/jbc.R113.464131; Goldberg EJ, 2019, BIOCHEM J, V476, P1521, DOI 10.1042/BCJ20190182; Goldsmith R, 2010, AM J PHYSIOL-REG I, V298, pR79, DOI 10.1152/ajpregu.00053.2009; Jackson JB, 2015, FEBS LETT, V589, P2027, DOI 10.1016/j.febslet.2015.06.027; Jogl G, 2004, ANN NY ACAD SCI, V1033, P17, DOI 10.1196/annals.1320.002; Jones DP, 2015, ANTIOXID REDOX SIGN, V23, P734, DOI 10.1089/ars.2015.6247; Kakimoto PAHB, 2015, REDOX BIOL, V4, P375, DOI 10.1016/j.redox.2015.02.003; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Lark DS, 2016, AM J PHYSIOL-CELL PH, V311, pC239, DOI 10.1152/ajpcell.00124.2016; Lark DS, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00332; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NICHOLLS DG, 2013, BIOENERGETICS; Park EA, 1998, MOL CELL BIOCHEM, V180, P27, DOI 10.1023/A:1006874503379; Perevoshchikova IV, 2013, FREE RADICAL BIO MED, V61, P298, DOI 10.1016/j.freeradbiomed.2013.04.006; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Rodrigues JV, 2012, FREE RADICAL BIO MED, V53, P12, DOI 10.1016/j.freeradbiomed.2012.04.016; Rolfe DFS, 1999, AM J PHYSIOL-CELL PH, V276, pC692, DOI 10.1152/ajpcell.1999.276.3.C692; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Rosenbaum M, 2000, AM J CLIN NUTR, V71, P1421; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Rosenbaum M, 2018, AM J PHYSIOL-ENDOC M, V315, pE771, DOI 10.1152/ajpendo.00116.2018; Rydstrom J, 2006, BBA-BIOENERGETICS, V1757, P721, DOI 10.1016/j.bbabio.2006.03.010; Schonfeld P, 2012, BBA-BIOENERGETICS, V1817, P410, DOI 10.1016/j.bbabio.2011.12.009; SCHULZ H, 1994, J NUTR, V124, P165, DOI 10.1093/jn/124.2.165; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Willis WT, 2016, MED SCI SPORT EXER, V48, P990, DOI 10.1249/MSS.0000000000000884; Zhang QH, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01089	49	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16207	16216		10.1074/jbc.RA120.013899	http://dx.doi.org/10.1074/jbc.RA120.013899			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32747443	hybrid, Green Published			2022-12-26	WOS:000598519500003
J	Immarigeon, C; Bernat-Fabre, S; Guillou, E; Verger, A; Prince, E; Benmedjahed, MA; Payet, A; Couralet, M; Monte, D; Villeret, V; Bourbon, HM; Boube, M				Immarigeon, Clement; Bernat-Fabre, Sandra; Guillou, Emmanuelle; Verger, Alexis; Prince, Elodie; Benmedjahed, Mohamed A.; Payet, Adeline; Couralet, Marie; Monte, Didier; Villeret, Vincent; Bourbon, Henri-Marc; Boube, Muriel			Mediator complex subunit Med19 binds directly GATA transcription factors and is required with Med1 for GATA-driven gene regulationin vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GATA transcription factors; Serpent; Srp; Pannier; Pnr; mediator complex; Med19; Med1; cofactor; Drosophila development; thoracic closure; DNA-binding domain; Activation domain; GATA transcription factor; gene regulation; transcription coregulator; transcription regulation; drosophila genetics	TERMINAL ZINC-FINGER; DROSOPHILA; CELL; PANNIER; DNA; EXPRESSION; PROTEIN; ROLES; COREGULATOR; INVOLVEMENT	The evolutionarily conserved multiprotein Mediator complex (MED) serves as an interface between DNA-bound transcription factors (TFs) and the RNA Pol II machinery. It has been proposed that each TF interacts with a dedicated MED subunit to induce specific transcriptional responses. But are these binary partnerships sufficient to mediate TF functions? We have previously established that the Med1 Mediator subunit serves as a cofactor of GATA TFs inDrosophila, as shown in mammals. Here, we observe mutant phenotype similarities between another subunit, Med19, and theDrosophilaGATA TF Pannier (Pnr), suggesting functional interaction. We further show that Med19 physically interacts with the Drosophila GATA TFs, Pnr and Serpent (Srp),in vivoandin vitrothrough their conserved C-zinc finger domains. Moreover, Med19 loss of function experimentsin vivoorin celluloindicate that it is required for Pnr- and Srp-dependent gene expression, suggesting general GATA cofactor functions. Interestingly, Med19 but not Med1 is critical for the regulation of all tested GATA target genes, implying shared or differential use of MED subunits by GATAs depending on the target gene. Lastly, we show a direct interaction between Med19 and Med1 by GST pulldown experiments indicating privileged contacts between these two subunits of the MED middle module. Together, these findings identify Med19/Med1 as a composite GATA TF interface and suggest that binary MED subunit-TF partnerships are probably oversimplified models. We propose several mechanisms to account for the transcriptional regulation of GATA-targeted genes.	[Immarigeon, Clement; Bernat-Fabre, Sandra; Guillou, Emmanuelle; Prince, Elodie; Benmedjahed, Mohamed A.; Payet, Adeline; Couralet, Marie; Bourbon, Henri-Marc; Boube, Muriel] Univ Toulouse, Ctr Biol Integrat CBD, UMR5547, CNRS UPS, Toulouse, France; [Verger, Alexis; Monte, Didier; Villeret, Vincent] Univ Lille, Inserm, CHU Lille, Inst Pasteur Lille,CNRS,ERL 9002 Integrat Struct, Lille, France; [Prince, Elodie] Univ Nice Sophia Antipolis, Inst Biol Valrose, Batiment Biochim,Parc Valrose, Nice, France; [Couralet, Marie] Inst Pharmacol Mol & Cellulaire, UMR7275, Valbonne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur	Boube, M (corresponding author), Univ Toulouse, Ctr Biol Integrat CBD, UMR5547, CNRS UPS, Toulouse, France.	muriel.boube-trey@univ-tlse3.fr	Couralet, Marie/AAN-1697-2021	Couralet, Marie/0000-0002-4581-8418; Prince, Elodie/0000-0001-7361-1396; verger, alexis/0000-0002-0299-2344; IMMARIGEON, Clement/0000-0001-7985-5885; monte, didier/0000-0002-0613-6203	French Ministere de l'Enseignement et de la Recherche; Ligue Nationale contre le Cancer; Association pour la Recherche sur le Cancer Grant [ARC PJA 20141201932]; Agence Nationale de Recherche [ANR-16 CE12-0021-01]; Centre National de Recherche Scientifique (CNRS); Toulouse III University	French Ministere de l'Enseignement et de la Recherche; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer Grant; Agence Nationale de Recherche(French National Research Agency (ANR)); Centre National de Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Toulouse III University	This work was supported by French Ministere de l'Enseignement et de la Recherche (to C. I.), the Ligue Nationale contre le Cancer (to C. I. and A. P.), the Association pour la Recherche sur le Cancer Grant ARC PJA 20141201932, and the Agence Nationale de Recherche Grant ANR-16 CE12-0021-01. This work was also supported by the Centre National de Recherche Scientifique (CNRS) and Toulouse III University.	Arnold CD, 2018, EMBO J, V37, DOI 10.15252/embj.201798896; Asmar J, 2008, DEV BIOL, V316, P487, DOI 10.1016/j.ydbio.2008.01.040; Baidoobonso SM, 2007, J BIOL CHEM, V282, P5551, DOI 10.1074/jbc.M609484200; Berk AJ, 2012, P NATL ACAD SCI USA, V109, P19519, DOI 10.1073/pnas.1217267109; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Boube M, 2000, GENE DEV, V14, P2906, DOI 10.1101/gad.17900; Boube M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004303; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chlon TM, 2012, DEVELOPMENT, V139, P3905, DOI 10.1242/dev.080440; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; Crawford SE, 2002, J BIOL CHEM, V277, P3585, DOI 10.1074/jbc.M107995200; Crona F, 2015, DEV BIOL, V407, P173, DOI 10.1016/j.ydbio.2015.08.005; Ding N, 2009, J BIOL CHEM, V284, P2648, DOI 10.1074/jbc.M806514200; El Khattabi L, 2019, CELL, V178, P1145, DOI 10.1016/j.cell.2019.07.011; Fondell JD, 2013, BBA-GEN SUBJECTS, V1830, P3867, DOI 10.1016/j.bbagen.2012.02.012; Garcia-Garcia MJ, 1999, DEVELOPMENT, V126, P3523; Ge K, 2008, MOL CELL BIOL, V28, P1081, DOI 10.1128/MCB.00967-07; Ghirlando R, 2003, J BIOL CHEM, V278, P45620, DOI 10.1074/jbc.M306410200; Gobert V, 2010, MOL CELL BIOL, V30, P2837, DOI 10.1128/MCB.01625-09; Grants JM, 2015, NUCLEIC ACIDS RES, V43, P2442, DOI 10.1093/nar/gkv037; Haenlin M, 1997, GENE DEV, V11, P3096, DOI 10.1101/gad.11.22.3096; Heitzler P, 1996, GENETICS, V143, P1271; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hu C.-D., 2005, ANAL CURR PROTOC CEL, V29, P2131, DOI 10.1002/0471143030.cb2103s29; Jeronimo C, 2017, TRENDS CELL BIOL, V27, P765, DOI 10.1016/j.tcb.2017.07.001; Kato Y, 2002, NATURE, V418, P641, DOI 10.1038/nature00969; Kuuluvainen E, 2014, J BIOL CHEM, V289, P16252, DOI 10.1074/jbc.M113.541904; Liu Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11149; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; Lowry JA, 2000, J MOL EVOL, V50, P103, DOI 10.1007/s002399910012; Malik N, 2017, CRIT REV BIOCHEM MOL, V52, P475, DOI 10.1080/10409238.2017.1325830; Mojica-Vazquez LH, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006718; Newton A, 2001, J BIOL CHEM, V276, P35794, DOI 10.1074/jbc.M106256200; Pope NJ, 2013, MOL CELL BIOL, V33, P1938, DOI 10.1128/MCB.00141-13; Pope NJ, 2010, NUCLEIC ACIDS RES, V38, P2190, DOI 10.1093/nar/gkp1159; RAMAIN P, 1993, DEVELOPMENT, V119, P1277; Robinson PJ, 2015, ELIFE, V4, DOI 10.7554/eLife.08719; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Sato M, 2000, MECH DEVELOP, V93, P127, DOI 10.1016/S0925-4773(00)00282-3; Schiano C, 2014, BBA-REV CANCER, V1845, P66, DOI 10.1016/j.bbcan.2013.12.001; Sorrentino RP, 2005, SEMIN CELL DEV BIOL, V16, P107, DOI 10.1016/j.semcdb.2004.10.005; Soutourina J, 2019, CELL, V178, P1036, DOI 10.1016/j.cell.2019.07.040; Soutourina J, 2018, NAT REV MOL CELL BIO, V19, P262, DOI 10.1038/nrm.2017.115; Stumpf M, 2006, P NATL ACAD SCI USA, V103, P18504, DOI 10.1073/pnas.0604494103; Stumpf M, 2010, P NATL ACAD SCI USA, V107, P21541, DOI 10.1073/pnas.1005794107; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Verger A, 2019, BIOCHEM SOC T, V47, P399, DOI 10.1042/BST20180608; VISVADER JE, 1995, MOL CELL BIOL, V15, P634; Waltzer L, 2002, EMBO J, V21, P5477, DOI 10.1093/emboj/cdf545; WHYATT DJ, 1993, EMBO J, V12, P4993, DOI 10.1002/j.1460-2075.1993.tb06193.x; Wilkinson-White L, 2011, P NATL ACAD SCI USA, V108, P14443, DOI 10.1073/pnas.1105898108; Yin JW, 2014, DEVELOPMENT, V141, P977, DOI 10.1242/dev.098392; Zhou HY, 2006, MOL CELL BIOL, V26, P8667, DOI 10.1128/MCB.00443-06	58	6	6	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2020	295	39					13617	13629		10.1074/jbc.RA120.013728	http://dx.doi.org/10.1074/jbc.RA120.013728			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NY3VI	32737196	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000576321100015
J	O'Donovan, SD; Driessens, K; Lopatta, D; Wimmenauer, F; Lukas, A; Neeven, J; Stumm, T; Smirnov, E; Lenz, M; Ertaylan, G; Jennen, DGJ; van Riel, NAW; Cavill, R; Peeters, RLM; de Kok, TMCM				O'Donovan, Shauna D.; Driessens, Kurt; Lopatta, Daniel; Wimmenauer, Florian; Lukas, Alexander; Neeven, Jelmer; Stumm, Tobias; Smirnov, Evgueni; Lenz, Michael; Ertaylan, Gokhan; Jennen, Danyel G. J.; van Riel, Natal A. W.; Cavill, Rachel; Peeters, Ralf L. M.; de Kok, Theo M. C. M.			Use of deep learning methods to translate drug-induced gene expression changes from rat to human primary hepatocytes	PLOS ONE			English	Article							NONGENOTOXIC CARCINOGENS; REPRESENTATIONS; TOXICOGENOMICS; MECHANISMS; TOXICOLOGY; TOXICITY	In clinical trials, animal and cell line models are often used to evaluate the potential toxic effects of a novel compound or candidate drug before progressing to human trials. However, relating the results of animal andin vitromodel exposures to relevant clinical outcomes in the humanin vivosystem still proves challenging, relying on often putative orthologs. In recent years, multiple studies have demonstrated that the repeated dose rodent bioassay, the current gold standard in the field, lacks sufficient sensitivity and specificity in predicting toxic effects of pharmaceuticals in humans. In this study, we evaluate the potential of deep learning techniques to translate the pattern of gene expression measured following an exposure in rodents to humans, circumventing the current reliance on orthologs, and also fromin vitrotoin vivoexperimental designs. Of the applied deep learning architectures applied in this study the convolutional neural network (CNN) and a deep artificial neural network with bottleneck architecture significantly outperform classical machine learning techniques in predicting the time series of gene expression in primary human hepatocytes given a measured time series of gene expression from primary rat hepatocytes following exposurein vitroto a previously unseen compound across multiple toxicologically relevant gene sets. With a reduction in average mean absolute error across 76 genes that have been shown to be predictive for identifying carcinogenicity from 0.0172 for a random regression forest to 0.0166 for the CNN model (p < 0.05). These deep learning architecture also perform well when applied to predict time series ofin vivogene expression given measured time series ofin vitrogene expression for rats.	[O'Donovan, Shauna D.; Lenz, Michael; Ertaylan, Gokhan; van Riel, Natal A. W.; Peeters, Ralf L. M.; de Kok, Theo M. C. M.] Maastricht Univ, Maastricht Ctr Syst Biol MaCSBio, Maastricht, Netherlands; [O'Donovan, Shauna D.] Wageningen Univ & Res, Div Human Nutr & Hlth, Wageningen, Netherlands; [Driessens, Kurt; Lopatta, Daniel; Wimmenauer, Florian; Lukas, Alexander; Neeven, Jelmer; Stumm, Tobias; Smirnov, Evgueni; Cavill, Rachel; Peeters, Ralf L. M.] Maastricht Univ, Dept Data Sci & Knowledge Engn, Maastricht, Netherlands; [Lenz, Michael] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut, Mainz, Germany; [Lenz, Michael] Johannes Gutenberg Univ Mainz, Prevent Cardiol & Preventat Med Ctr Cardiol, Univ Med Ctr, Mainz, Germany; [Ertaylan, Gokhan] Flemish Inst Technol Res VITO, Mol, Belgium; [Jennen, Danyel G. J.; de Kok, Theo M. C. M.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Toxicogen, Maastricht, Netherlands; [van Riel, Natal A. W.] Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands	Maastricht University; Wageningen University & Research; Maastricht University; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; VITO; Maastricht University; Eindhoven University of Technology	O'Donovan, SD (corresponding author), Maastricht Univ, Maastricht Ctr Syst Biol MaCSBio, Maastricht, Netherlands.; O'Donovan, SD (corresponding author), Wageningen Univ & Res, Div Human Nutr & Hlth, Wageningen, Netherlands.	shauna.odonovan@wur.nl	van Riel, Natal/J-5319-2013	van Riel, Natal/0000-0001-9375-4730; O'Donovan, Shauna/0000-0003-2253-4903; Ertaylan, Gokhan/0000-0001-5602-6435	Dutch Province of Limburg	Dutch Province of Limburg	The research in this paper was supported by a grant from the Dutch Province of Limburg awarded to T.d.K, R.P, and N.v.R.	Aliper A, 2016, MOL PHARMACEUT, V13, P2524, DOI 10.1021/acs.molpharmaceut.6b00248; Angermueller C, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156651; Baskin I.I., 2018, METHODS MOL BIOL, V1800; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Caiment F, 2014, CARCINOGENESIS, V35, P201, DOI 10.1093/carcin/bgt278; Chai X, 2016, COMPUT BIOL MED, V79, P205, DOI 10.1016/j.compbiomed.2016.10.019; Chen YF, 2016, BIOINFORMATICS, V32, P1832, DOI 10.1093/bioinformatics/btw074; CHHABRA RS, 1990, ENVIRON HEALTH PERSP, V86, P313, DOI 10.2307/3430970; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Dutil F, 2018, ARXIV180606975V1; Ellinger-Ziegelbauer H, 2009, TOXICOL LETT, V186, P36, DOI 10.1016/j.toxlet.2008.08.017; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Ganter B, 2005, J BIOTECHNOL, V119, P219, DOI 10.1016/j.jbiotec.2005.03.022; Glorot X., 2011, P 14 INT C ART INT S, P315; Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a; Herndon N, 2014, COMM COM INF SC, V452, P191, DOI 10.1007/978-3-662-44485-6_14; Herndon N, 2014, BIOINFORMATICS 2014: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON BIOINFORMATICS MODELS, METHODS AND ALGORITHMS, P57; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hu T, 2007, MUTAT RES, V619, P16; Idakwo G, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01044; Igarashi Y, 2015, NUCLEIC ACIDS RES, V43, pD921, DOI 10.1093/nar/gku955; Jover R, 1998, FEBS LETT, V431, P227, DOI 10.1016/S0014-5793(98)00746-7; Jung D, 2007, LIVER INT, V27, P137, DOI 10.1111/j.1478-3231.2006.01393.x; Kingma D., 2014, P 3 INT C LEARNING R, DOI DOI 10.1038/S41598-021-83424-5; Le Fevre AC, 2007, MUTAT RES-FUND MOL M, V619, P16, DOI 10.1016/j.mrfmmm.2006.12.007; Lee H, 2011, COMMUN ACM, V54, P95, DOI 10.1145/2001269.2001295; Li HH, 2007, MUTAT RES-FUND MOL M, V623, P98, DOI 10.1016/j.mrfmmm.2007.03.013; Liu J, 2014, TOXICOL SCI, V141, P538, DOI 10.1093/toxsci/kfu151; Magkoufopoulou C, 2012, CARCINOGENESIS, V33, P1421, DOI 10.1093/carcin/bgs182; Mathijs K, 2010, MUTAGENESIS, V25, P561, DOI 10.1093/mutage/geq040; Mayr A, 2016, FRONT ENV SCI-SWITZ, V3, DOI 10.3389/fenvs.2015.00080; Mourragui S, 2019, PRECISE DOMAIN ADAPT, DOI [10.1101/536797, DOI 10.1101/536797]; Nair V., 2010, P 27 INT C INT C MAC, P807; Pu LM, 2019, BMC PHARMACOL TOXICO, V20, DOI 10.1186/s40360-018-0282-6; Rodriguez-Antona C, 2002, XENOBIOTICA, V32, P505, DOI 10.1080/00498250210128675; Rosenblatt F., 1957, 854601 CORN AER LAB; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707; Ryaboshapkina M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10930-w; Singh R, 2016, BIOINFORMATICS, V32, P639, DOI 10.1093/bioinformatics/btw427; Socher R, 2011, INT C MACHINE LEARNI; Stein-O'Brien GL, 2019, CELL SYST, V8, P395, DOI 10.1016/j.cels.2019.04.004; Sutskever I, 2014, ADV NEUR IN, V27; Taroni JN, 2019, CELL SYST, V8, P380, DOI 10.1016/j.cels.2019.04.003; Tsujimura K, 2006, CANCER SCI, V97, P1002, DOI 10.1111/j.1349-7006.2006.00280.x; van Delft JHM, 2005, MUTAT RES-FUND MOL M, V575, P17, DOI 10.1016/j.mrfmmm.2005.02.006; van Delft JHM, 2004, CARCINOGENESIS, V25, P1265, DOI 10.1093/carcin/bgh108; van Delft J, 2014, TOXICOGENOMICS-BASED CELLULAR MODELS: ALTERNATIVES TO ANIMAL TESTING FOR SAFETY ASSESSMENT, P193; Vinken M, 2013, TOXICOL SCI, V136, P97, DOI 10.1093/toxsci/kft177; Wang H, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00042; Weng J. J., 1993, [1993] Proceedings Fourth International Conference on Computer Vision, P121, DOI 10.1109/ICCV.1993.378228; Xu YJ, 2015, J CHEM INF MODEL, V55, P2085, DOI 10.1021/acs.jcim.5b00238; Yuan Y, 2019, P NATL ACAD SCI USA, V116, P27151, DOI 10.1073/pnas.1911536116	55	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0236392	10.1371/journal.pone.0236392	http://dx.doi.org/10.1371/journal.pone.0236392			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780735	Green Published, gold			2022-12-26	WOS:000562664700001
J	Taylor, CE; Drew, AJ; Zhang, Y; Qiu, YQ; Bachus, KN; Foreman, KB; Henninger, HB				Taylor, Carolyn E.; Drew, Alex J.; Zhang, Yue; Qiu, Yuqing; Bachus, Kent N.; Foreman, K. Bo; Henninger, Heath B.			Upper extremity prosthetic selection influences loading of transhumeral osseointegrated systems	PLOS ONE			English	Article							BONE INGROWTH; STABILITY; FIXATION; IMPLANTS	Percutaneous osseointegrated (OI) implants are increasingly viable as an alternative to socket suspension of prosthetic limbs. Upper extremity prostheses have also become more complex to better replicate hand and arm function and attempt to recreate pre-amputation functional levels. With more functionality comes heavier devices that put more stress on the bone-implant interface, which could be an issue for implant stability. This study quantified transhumeral loading at defined amputation levels using four simulated prosthetic limb-types: (1) body powered hook, (2) myoelectric hook, (3) myoelectric hand, and (4) advanced prosthetic limb. Computational models were constructed to replicate the weight distribution of each prosthesis type, then applied to motion capture data collected during Advanced Activities of Daily Living (AADLs). For activities that did not include a handheld weight, the body powered prosthesis bending moments were 13-33% (range of means for each activity across amputation levels) of the intact arm moments (reference 100%), torsional moments were 12-15%, and axial pullout forces were 30-40% of the intact case (p <= 0.001). The myoelectric hook and hand bending moments were 60-99%, torsional moments were 44-97%, and axial pullout forces were 62-101% of the intact case. The advanced prosthesis bending moments were 177-201%, torsional moments were 164-326%, and axial pullout forces were 133-185% of the intact case (p <= 0.001). The addition of a handheld weight for briefcase carry and jug lift activities reduced the overall impact of the prosthetic model itself, where the body powered forces and moments were much closer to those of the intact model, and more complex prostheses further increased forces and moments beyond the intact arm levels. These results reveal a ranked order in loading magnitude according to complexity of the prosthetic device, and highlight the importance of considering the patient's desired terminal device when planning post-operative percutaneous OI rehabilitation and training.	[Taylor, Carolyn E.; Bachus, Kent N.; Henninger, Heath B.] Univ Utah, Dept Orthopaed, Salt Lake City, UT 84112 USA; [Taylor, Carolyn E.; Bachus, Kent N.; Henninger, Heath B.] Univ Utah, Dept Biomed Engn, Salt Lake City, UT 84112 USA; [Drew, Alex J.] DJO Surg, Austin, TX USA; [Zhang, Yue; Qiu, Yuqing] Univ Utah, Dept Epidemiol, Salt Lake City, UT USA; [Bachus, Kent N.; Foreman, K. Bo] Univ Utah, Dept Vet Affairs, Salt Lake City, UT USA; [Foreman, K. Bo] Univ Utah, Dept Phys Therapy & Athlet Training, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Henninger, HB (corresponding author), Univ Utah, Dept Orthopaed, Salt Lake City, UT 84112 USA.; Henninger, HB (corresponding author), Univ Utah, Dept Biomed Engn, Salt Lake City, UT 84112 USA.	heath.henninger@utah.edu		Taylor, Carolyn/0000-0002-1862-4773	US Army Medical Research and Materiel Command [W81XWH-15-C-0058]; United States Department of Veterans Affairs Rehabilitation Research and Development Service [I01RX001246]; NIH NIAMS [R01 AR067196]; NIH National Center for Research Resources; National Center for Advancing Translational Sciences [UL1TR002538]	US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); United States Department of Veterans Affairs Rehabilitation Research and Development Service; NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	KB received a grant from US Army Medical Research and Materiel Command (W81XWH-15-C-0058) and they United States Department of Veterans Affairs Rehabilitation Research and Development Service (I01RX001246). HH received a grant from the NIH NIAMS (R01 AR067196). YZ is a member of the Study Design and Biostatistics Center that received a grant from the NIH National Center for Research Resources and the National Center for Advancing Translational Sciences (UL1TR002538). DJO Surgical provided support for this study in the form of salary for AJD. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cordella F, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00209; Drew AJ, 2020, CLIN BIOMECH, V72, P108, DOI 10.1016/j.clinbiomech.2019.12.005; Drew AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189418; DUCHEYNE P, 1977, J BIOMED MATER RES, V11, P811, DOI 10.1002/jbm.820110603; ENGH CA, 1992, CLIN ORTHOP RELAT R, P13; Holt BM, 2013, J BIOMED MATER RES A, V101, P2075, DOI 10.1002/jbm.a.34510; Hoyt BW, 2020, EXPERT REV MED DEVIC, V17, P17, DOI 10.1080/17434440.2020.1704623; Jeyapalina S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221850; Jeyapalina S, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-017-5980-x; Jeyapalina S, 2014, CLIN ORTHOP RELAT R, V472, P2966, DOI 10.1007/s11999-014-3523-z; Jeyapalina S, 2014, CLIN ORTHOP RELAT R, V472, P2957, DOI 10.1007/s11999-013-3381-0; Jeyapalina S, 2012, ANAT REC, V295, P1437, DOI 10.1002/ar.22533; Jeyapalina S, 2012, J ORTHOP RES, V30, P1304, DOI 10.1002/jor.22081; Jonsson S, 2011, PROSTHET ORTHOT INT, V35, P190, DOI 10.1177/0309364611409003; Kang NV, 2010, J HAND SURG-AM, V35A, P1130, DOI 10.1016/j.jhsa.2010.03.037; Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3; MARTENS M, 1980, ARCH ORTHOP TRAUM SU, V97, P111, DOI 10.1007/BF00450933; McFarland LV, 2010, J REHABIL RES DEV, V47, P299, DOI 10.1682/JRRD.2009.03.0027; Metzger AJ, 2012, ARCH PHYS MED REHAB, V93, P2029, DOI 10.1016/j.apmr.2012.03.011; PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108; R Core Team, 2020, R LANG ENV STAT COMP; Resnik L, 2012, ARCH PHYS MED REHAB, V93, P710, DOI 10.1016/j.apmr.2011.11.010; Stenlund P, 2019, ANN BIOMED ENG, V47, P1369, DOI 10.1007/s10439-019-02244-x; Tsikandylakis G, 2014, CLIN ORTHOP RELAT R, V472, P2947, DOI 10.1007/s11999-014-3695-6; Webster J.B., 2017, FULL STRIDE ADV STAT, P167, DOI [10.1007/978-1-4939-7247-0_10, DOI 10.1007/978-1-4939-7247-0_10]; Welke B, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-70; WRIGHT TW, 1995, J HAND SURG-AM, V20A, P619, DOI 10.1016/S0363-5023(05)80278-3	27	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237179	10.1371/journal.pone.0237179	http://dx.doi.org/10.1371/journal.pone.0237179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760149	gold, Green Published			2022-12-26	WOS:000561027200089
J	Galerneau, LM; Bailly, S; Borel, JC; Jullian-Desayes, I; Joyeux-Faure, M; Benmerad, M; Bonsignore, MR; Tamisier, R; Pepin, JL				Galerneau, Louis-Marie; Bailly, Sebastien; Borel, Jean-Christian; Jullian-Desayes, Ingrid; Joyeux-Faure, Marie; Benmerad, Meriem; Bonsignore, Marisa R.; Tamisier, Renaud; Pepin, Jean-Louis			Long-term variations of arterial stiffness in patients with obesity and obstructive sleep apnea treated with continuous positive airway pressure	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; EXPERT CONSENSUS DOCUMENT; AORTIC STIFFNESS; CARDIOVASCULAR EVENTS; PULMONARY-DISEASE; BLOOD-PRESSURE; RISK-FACTOR; ALL-CAUSE; CPAP; HYPERTENSION	Background Obstructive sleep apnea (OSA) is associated with cardiovascular co-morbidities and mortality. Arterial stiffness is an independent predictor of cardiovascular risk and mortality, and is influenced by the presence of OSA and related comorbidities. There is a paucity of data regarding long-term evolution of arterial stiffness in CPAP-treated OSA patients.We aimed to prospectively study long term PWV variations and determinants of PWV deterioration. Methods In a prospective obese OSA cohort, at time of diagnosis and after several years of follow-up we collected arterial stiffness measured by carotid-femoral pulse wave velocity (PWV), clinical and metabolic parameters, and CPAP adherence.Univariate and multivariate analyses were performed in order to determine contributing factors. Results Seventy two OSA patients (men: 52.8%, median age: 55.8 years and median BMI of 38.5 kg/m(2)) with a prevalence of hypertension: 58.3%, type 2 diabetes: 20.8%, hypercholesterolemia: 33.3%, current or past smoking: 59.7%, were evaluated after a median follow-up of 7.4 [5.8; 8.3] years. Over the period of follow-up, the median increase in PWV was 1.34 [0.10; 2.37] m/s. In multivariate analysis, the increase in PWV was associated with older age (10 extra years was associated with a 5.24 [1.35; 9.12] % increase in PWV) and hypertension (a significant increase in PWV of 8.24 [1.02; 15.57] %). No impact of CPAP adherence on PWV evolution was found. Conclusion PWV progression in CPAP-treated OSA patients is mainly related to pre-existing cardio-metabolic comorbidities and not influenced by CPAP adherence. In this high cardiovascular risk population, it is crucial to associated weight management and exercise with CPAP treatment.	[Galerneau, Louis-Marie; Bailly, Sebastien; Borel, Jean-Christian; Jullian-Desayes, Ingrid; Joyeux-Faure, Marie; Benmerad, Meriem; Tamisier, Renaud; Pepin, Jean-Louis] Univ Grenoble Alpes, HP2 Lab, INSERM U1042, Grenoble, France; [Galerneau, Louis-Marie; Bailly, Sebastien; Borel, Jean-Christian; Jullian-Desayes, Ingrid; Joyeux-Faure, Marie; Benmerad, Meriem; Tamisier, Renaud; Pepin, Jean-Louis] Grenoble Alpes Univ Hosp, EFCR Lab, Thorax & Vessels, Grenoble, France; [Bonsignore, Marisa R.] Univ Palermo, PROMISE Dept, Div Resp Med, Palermo, Italy; [Bonsignore, Marisa R.] IBIM CNR, Palermo, Italy	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR)	Galerneau, LM (corresponding author), Univ Grenoble Alpes, HP2 Lab, INSERM U1042, Grenoble, France.; Galerneau, LM (corresponding author), Grenoble Alpes Univ Hosp, EFCR Lab, Thorax & Vessels, Grenoble, France.	LMgalerneau@chu-grenoble.fr	Bonsignore, Maria/U-6440-2017; Stefanadis, Christodoulos/ABH-2232-2020; BAILLY, Sébastien SB/H-4648-2013; Borel, Jean Christian/AAC-5950-2019	Bonsignore, Maria/0000-0002-4875-7796; Stefanadis, Christodoulos/0000-0001-5974-6454; BAILLY, Sébastien SB/0000-0002-2179-4650; Borel, Jean Christian/0000-0003-4140-6210	French National Research Agency [ANR-12-TECS-0010, ANR-15-IDEX-02]; "e-health and integrated care" Chair of excellence of the University Grenoble Alpes Foundation; endowment fund "Agir pour les maladies chroniques"; ORKYN Society; Perimetre Association	French National Research Agency(French National Research Agency (ANR)); "e-health and integrated care" Chair of excellence of the University Grenoble Alpes Foundation; endowment fund "Agir pour les maladies chroniques"; ORKYN Society; Perimetre Association	This study was funded by an unrestricted grant from the French National Research Agency (ANR-12-TECS-0010) in the framework of the "Investissements d'avenir" program (ANR-15-IDEX-02), the "e-health and integrated care" Chair of excellence of the University Grenoble Alpes Foundation and the endowment fund "Agir pour les maladies chroniques". This study was funded in part by OYRKYN Society and Pe ' rimetre Association.	[Anonymous], 2014, INT CLASSIFICATION S; Aron-Wisnewsky J, 2016, METABOLISM, V65, P1124, DOI 10.1016/j.metabol.2016.05.004; ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485; Berry RB, 2017, J CLIN SLEEP MED, V13, P665, DOI 10.5664/jcsm.6576; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bratton DJ, 2015, JAMA-J AM MED ASSOC, V314, P2280, DOI 10.1001/jama.2015.16303; Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653; Chirinos JA, 2014, NEW ENGL J MED, V370, P2265, DOI 10.1056/NEJMoa1306187; Chung S, 2010, RESPIRATION, V79, P363, DOI 10.1159/000228905; Doonan RJ, 2011, HYPERTENS RES, V34, P23, DOI 10.1038/hr.2010.200; Drager LF, 2007, CHEST, V131, P1379, DOI 10.1378/chest.06-2703; Drager LF, 2017, CIRCULATION, V136, P1840, DOI 10.1161/CIRCULATIONAHA.117.029400; Drager LF, 2011, CHEST, V140, P534, DOI 10.1378/chest.10-2223; Drager LF, 2010, ATHEROSCLEROSIS, V208, P490, DOI 10.1016/j.atherosclerosis.2009.08.016; Gay P, 2006, SLEEP, V29, P381, DOI 10.1093/sleep/29.3.381; Jelic S, 2008, CIRCULATION, V117, P2270, DOI 10.1161/CIRCULATIONAHA.107.741512; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Joyeux-Faure M, 2018, THORAX, V73, P1146, DOI 10.1136/thoraxjnl-2018-211513; Kaess BM, 2012, JAMA-J AM MED ASSOC, V308, P875, DOI 10.1001/2012.jama.10503; Koivistoinen T, 2011, ANN MED, V43, P312, DOI 10.3109/07853890.2010.549145; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lee HM, 2012, CHEST, V142, P1118, DOI 10.1378/chest.11-2421; Levy P, 2009, EUR RESPIR J, V34, P243, DOI 10.1183/09031936.00166808; Levy P, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.15; Lin X, 2016, EUR ARCH OTO-RHINO-L, V273, P4081, DOI 10.1007/s00405-016-3914-8; Malhotra A, 2018, AM J RESP CRIT CARE, V197, P289, DOI 10.1164/rccm.201712-2510ST; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marin JM, 2010, AM J RESP CRIT CARE, V182, P325, DOI 10.1164/rccm.200912-1869OC; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; McEvoy RD, 2016, NEW ENGL J MED, V375, P919, DOI 10.1056/NEJMoa1606599; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Murphy AM, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01731-2016; Pepin JL, 2016, LANCET RESP MED, V4, P407, DOI 10.1016/S2213-2600(16)00054-0; Pepin JL, 2013, SLEEP MED REV, V17, P3, DOI 10.1016/j.smrv.2012.11.002; Phillips CL, 2013, SLEEP MED REV, V17, P7, DOI 10.1016/j.smrv.2012.03.002; Pietri P, 2014, HYPERTENS RES, V37, P452, DOI 10.1038/hr.2013.148; Prenner SB, 2015, ATHEROSCLEROSIS, V238, P370, DOI 10.1016/j.atherosclerosis.2014.12.023; Safar ME, 2013, J AM COLL CARDIOL, V61, P12, DOI 10.1016/j.jacc.2012.01.088; Saito T, 2010, HYPERTENS RES, V33, P844, DOI 10.1038/hr.2010.77; Sateia MJ, 2014, CHEST, V146, P1387, DOI 10.1378/chest.14-0970; Shiina K, 2012, RESP MED, V106, P1335, DOI 10.1016/j.rmed.2012.05.006; Singh D, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00164-2019; Societe de Pneumologie de Langue Francaise, 2010, Rev Mal Respir, V27, P806, DOI 10.1016/j.rmr.2010.05.011; Stone IS, 2012, HEART, V98, P1055, DOI 10.1136/heartjnl-2012-301759; Tavil Y, 2007, J AM SOC ECHOCARDIOG, V20, P366, DOI 10.1016/j.echo.2006.09.005; Tsioufis C, 2007, J HYPERTENS, V25, P141, DOI 10.1097/HJH.0b013e32801092c1; Van Bortel LM, 2012, J HYPERTENS, V30, P445, DOI 10.1097/HJH.0b013e32834fa8b0; Van Ryswyk E, 2019, AM J RESP CRIT CARE, V199, P1433, DOI 10.1164/rccm.201811-2200LE; Vanfleteren LEGW, 2014, EUR RESPIR J, V43, P1306, DOI 10.1183/09031936.00169313; Vivodtzev I, 2018, THORAX, V73, P634, DOI 10.1136/thoraxjnl-2017-211152; Vivodtzev I, 2014, CHEST, V145, P861, DOI 10.1378/chest.13-1809; Vlachantoni IT, 2013, SLEEP MED REV, V17, P19, DOI 10.1016/j.smrv.2012.01.002; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG; Weir-McCall JR, 2015, RESP MED, V109, P1381, DOI 10.1016/j.rmed.2015.06.005; Williams B, 2018, J HYPERTENS, V36, P1953, DOI 10.1097/HJH.0000000000001940; Zamarron Carlos, 2008, Int J Chron Obstruct Pulmon Dis, V3, P671	61	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236667	10.1371/journal.pone.0236667	http://dx.doi.org/10.1371/journal.pone.0236667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756570	Green Published, gold			2022-12-26	WOS:000560393300016
J	Kalra, A; Parija, D; Raizada, N; Sachdeva, KS; Rao, R; Swaminathan, S; Khanna, A; Chopra, KK; Hanif, M; Singh, V; Umadevi, KR; Sheladia, KN; Rao, R; Vasundhara, N; Anil, S; Nirmala, AR; Azeem, A; Chhajlani, V; Khurana, J; Das, NJ; Choudhury, B; Nair, SA; Mall, S; Sen, R; Chadha, SS; Denkinger, CM; Boehme, C; Sarin, S				Kalra, Aakshi; Parija, Debadutta; Raizada, Neeraj; Sachdeva, K. S.; Rao, Raghuram; Swaminathan, Soumya; Khanna, Ashwani; Chopra, Kamal Kishore; Hanif, M.; Singh, Varinder; Umadevi, K. R.; Sheladia, K. N.; Rao, Rama; Vasundhara, N.; Anil, S.; Nirmala, A. R.; Azeem, Abdul; Chhajlani, Vijay; Khurana, Jyoti; Das, N. J.; Choudhury, Bandana; Nair, Sreenivas Achuthan; Mall, Shalini; Sen, Rajashree; Chadha, Sarabjit Singh; Denkinger, Claudia M.; Boehme, Catharina; Sarin, Sanjay			Upfront Xpert MTB/RIF for diagnosis of pediatric TB-Does it work? Experience from India	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; GLOBAL BURDEN; CHILDREN; PULMONARY; ACCURACY; CULTURE; DELHI	Background Diagnosis of TB in pediatric population poses several challenges. A novel initiative was implemented in several major cities of India aimed at providing upfront access to free-of-cost Xpert MTB/RIF to presumptive pediatric TB cases. This paper aims to describe the experience of implementing this large initiative and assess feasibility of the intervention in high TB burden settings. Methods Data were drawn from the pediatric TB project implemented in 10 major cities of India between April 2014 and March 2018. In each city, providers, both public and private, were engaged and linked with a high throughput Xpert MTB/RIF lab (established in that city) through rapid specimen transportation and electronic reporting system. Rates and proportions were estimated to describe the characteristics of this cohort. Results Of the total 94,415 presumptive pediatric TB cases tested in the project, 6,270 were diagnosed positive for MTB (6.6%) on Xpert MTB/RIF (vs 2% on smear microscopy). Among MTB positives, 545 cases were rifampicin resistant (8.7%). The median duration between collection of specimens and reporting of results was 0 days (same day) and >89% cases were initiated on treatment. Approximately 50% of the specimens tested were non-sputum. The number of providers/facilities engaged under the project increased >10-fold (from 124 in Q2'14 to 1416 in Q1'18). Conclusion This project, which was one of the largest initiatives globally among pediatric population, demonstrated the feasibility of sustaining rapid and upfront access to free-of-cost Xpert MTB/RIF testing. The project underscores the efficiency of this rapid diagnostic assay in tackling several challenges in pediatric TB diagnosis, identifies opportunities for further interventions as well as brings to light scope for effective engagement with healthcare providers. The findings have facilitated a policy decision by National TB Programme mandating the use of Xpert MTB/RIF as a primary diagnostic tool for TB diagnosis in children, which is being scaled-up.	[Kalra, Aakshi; Parija, Debadutta; Raizada, Neeraj; Mall, Shalini; Sen, Rajashree; Chadha, Sarabjit Singh; Sarin, Sanjay] Fdn Innovat New Diagnost, New Delhi, India; [Sachdeva, K. S.; Rao, Raghuram] Govt India, Cent TB Div, New Delhi, India; [Swaminathan, Soumya] WHO, Geneva, Switzerland; [Khanna, Ashwani] Govt Natl Capital Terr, State TB Off, Delhi, India; [Chopra, Kamal Kishore] New Delhi TB Ctr, New Delhi, India; [Hanif, M.; Singh, Varinder] Lady Hardinge Med Coll & Hosp, New Delhi, India; [Hanif, M.; Singh, Varinder] Assoc Kalawati Saran Childrens Hosp, New Delhi, India; [Umadevi, K. R.] Natl Inst Res TB, Chennai, Tamil Nadu, India; [Sheladia, K. N.] Surat Municipal Corp, Dist TB Ctr, Surat, Gujarat, India; [Rao, Rama] State TB Off, Vijayawada, Andhra Pradesh, India; [Vasundhara, N.] Dist TB Ctr, Visakhapatnam, Andhra Pradesh, India; [Anil, S.; Nirmala, A. R.; Azeem, Abdul] State TB Training & Demonstrat Ctr, Intermediate Reference Lab, Bangalore, Karnataka, India; [Chhajlani, Vijay] Dist TB Ctr, Indore, Madhya Pradesh, India; [Khurana, Jyoti] Intermediate Reference Lab, Indore, Madhya Pradesh, India; [Das, N. J.] Directorate Hlth Serv, Off Jt Director Hlth Serv TB, Gauhati, Assam, India; [Choudhury, Bandana] Intermediate Reference Lab, Gauhati, Assam, India; [Nair, Sreenivas Achuthan] Stop TB Partnership, Geneva, Switzerland; [Denkinger, Claudia M.; Boehme, Catharina] Fdn Innovat New Diagnost, Geneva, Switzerland	Foundation For Innovative New Diagnostics; World Health Organization; Lady Hardinge Medical College & Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Foundation For Innovative New Diagnostics	Kalra, A (corresponding author), Fdn Innovat New Diagnost, New Delhi, India.	draakshikalra@gmail.com		Raizada, Neeraj/0000-0003-2116-332X; Nair, Sreenivas/0000-0002-2586-6797	Global Health Bureau, Office of Health, Infectious Diseases, US Agency for International Development (USAID) [AID-OAA-A-14-00029]	Global Health Bureau, Office of Health, Infectious Diseases, US Agency for International Development (USAID)(United States Agency for International Development (USAID))	The Global Health Bureau, Office of Health, Infectious Diseases, US Agency for International Development (USAID) financially supported these activities through Challenge TB under the terms of Agreement No. AID-OAA-A-14-00029. The funder provided support in the form of salaries for authors [AK, DP, NR, SM, RS] during project tenure, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. The authors' views expressed in this publication do not necessarily reflect the views of USAID or the US Government.	[Anonymous], 2018, IND TB REP 2018 REV; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Dodd PJ, 2017, LANCET GLOB HEALTH, V5, pE898, DOI [10.1016/S2214-109X(17)30289-9, 10.1016/s2214-109x(17)30289-9]; Dodd PJ, 2016, LANCET INFECT DIS, V16, P1193, DOI 10.1016/S1473-3099(16)30132-3; Gomez-Pastrana D, 2001, CLIN INFECT DIS, V32, P17, DOI 10.1086/317526; Jenkins HE, 2014, LANCET, V383, P1572, DOI 10.1016/S0140-6736(14)60195-1; Joshi S, 2017, INT J COMMUNITY MED, V4; Kalra A, 2017, INT J TUBERC LUNG D, V21, P645, DOI 10.5588/ijtld.16.0563; Kumar A, 2013, INDIAN PEDIATR, V50, P301, DOI 10.1007/s13312-013-0085-1; Marais BJ, 2007, PAEDIATR RESPIR REV, V8, P124, DOI 10.1016/j.prrv.2007.04.002; McDowell A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193656; Nelliyanil Maria, 2012, Indian J Tuberc, V59, P207; Raizada N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193341; Raizada N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193194; Rufai Syed Beenish, 2017, J Lab Physicians, V9, P47, DOI 10.4103/0974-2727.187927; Satyanarayana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013338; Scott LE, 2014, J CLIN MICROBIOL, V52, P1818, DOI 10.1128/JCM.03553-13; Seddon JA, 2012, CLIN INFECT DIS, V54, P157, DOI 10.1093/cid/cir772; Sharma S, 2008, INT J TUBERC LUNG D, V12, P74; Sharma Sangeeta, 2010, Indian J Tuberc, V57, P4; Swaminathan S, 2010, CLIN INFECT DIS, V50, pS184, DOI 10.1086/651490; TBC, 2011, IND MAN RNTCP YOUR A; Walzl G., 2018, LANCET INFECT DIS, V18, pE199, DOI DOI 10.1016/S1473-3099(18)30111-7; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; World Health Organization, 2014, XPERT MTB RIF IMPL M; World Health Organization, 2013, POL UPD AUT REAL TIM; World Health Organization, 2013, XPERT MTB RIF ASS DI; World Health Organization, 2014, STAND OP PROC SOP PR; World Health Organization Geneva, 2013, DEF REP FRAM TUB, V213, P3; Zeka AN, 2011, J CLIN MICROBIOL, V49, P4138, DOI 10.1128/JCM.05434-11	31	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236057	10.1371/journal.pone.0236057	http://dx.doi.org/10.1371/journal.pone.0236057			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756559	Green Accepted, gold, Green Published			2022-12-26	WOS:000560393300003
J	van Boheemen, L; van Beers-Tas, MH; Kroese, JM; van de Stadt, LA; van Schaardenburg, D; Nurmohamed, MT				van Boheemen, Laurette; van Beers-Tas, Marian H.; Kroese, Johanna M.; van de Stadt, Lotte A.; van Schaardenburg, Dirkjan; Nurmohamed, Michael T.			Cardiovascular risk in persons at risk of developing rheumatoid arthritis	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; RESTING HEART-RATE; BLOOD-DONORS; LIPID-LEVELS; INFLAMMATION; DISEASE; MORTALITY; DYSLIPIDEMIA; POPULATION; ARTHRALGIA	Background Rheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) risk which may start even before diagnosis. To explore this CVD risk prior to RA, we determined multiple risk factors and two 10-year clinical risk scores in a cohort of individuals at-risk of RA. We also analyzed associations with arthritis development and autoantibody status and compared a subset of at-risk individuals to an age and sex matched seronegative control group. Methods In a cohort of 555 consecutive arthralgia patients positive for rheumatoid factor (RF) and / or anti-citrullinated protein antibody (ACPA) we retrospectively identified patients with preclinical arthritis (i.e. those who developed arthritis), and non-arthritis patients (those without arthritis development during maximum 5 years follow up). Demographics, CVD risk factors and the 10-year cardiovascular risk according to the SCORE and QRISK3 system were determined at baseline. Results Preclinical arthritis patients (n = 188) had a higher heart rate (68 vs 63 bpm, p = 0.048) and lower cholesterol (5.2 mmol/l vs 5.5, p = 0.006), HDL (1.0 mmol/l vs 1.1, p0.003) and ApoB (0.85 g/l vs 0.91, p = 0.011) compared to non-arthritis patients (n = 367). Lipid levels were associated with ACPA status in both the preclinical arthritis and non-arthritis group. Ten-year CVD risk scores did not differ between preclinical arthritis and non-arthritis patients, in total, 7% (SCORE) and 8% (QRISK3) of seropositive arthralgia patients were classified as high risk. Seropositive at-risk patients (n = 71) had higher total cholesterol (5.4 vs 4.9, p<0.001), TC/HDL ratio (4.0 vs 3.0, p<0.001), triglycerides (1.4 vs 1.0, p = 0.001), ApoB (1.0 vs 0.9, p = 0.019) and 10-year risk scores (median SCORE 1.0 vs 0.0, p = 0.030 and median QRISK3 4.4 vs 3.1, p<0.001) compared to seronegative controls. Conclusion Our results suggest that lipid changes commence prior to RA diagnosis and that ACPAs might play a role.	[van Boheemen, Laurette; van Beers-Tas, Marian H.; van de Stadt, Lotte A.; Nurmohamed, Michael T.] Reade, Amsterdam Rheumatol & Immunol Ctr, Dept Rheumatol, Amsterdam, Netherlands; [Kroese, Johanna M.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Orofacial Pain & Dysfunct, Amsterdam, Netherlands; [Kroese, Johanna M.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Periodontol, Amsterdam, Netherlands; [Kroese, Johanna M.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands; [Kroese, Johanna M.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [van Schaardenburg, Dirkjan] Univ Amsterdam, Med Ctr, AMC, Dept Rheumatol, Amsterdam, Netherlands; [Nurmohamed, Michael T.] Univ Amsterdam, Med Ctr, VUmc, Dept Rheumatol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	van Boheemen, L (corresponding author), Reade, Amsterdam Rheumatol & Immunol Ctr, Dept Rheumatol, Amsterdam, Netherlands.	l.v.boheemen@reade.nl	van beers-tas, marian/AAB-5645-2021					Adlan AM, 2014, SEMIN ARTHRITIS RHEU, V44, P283, DOI 10.1016/j.semarthrit.2014.06.003; Alemao E, 2017, RHEUMATOLOGY, V56, P777, DOI 10.1093/rheumatology/kew440; Aydemir M, 2010, LUPUS, V19, P255, DOI 10.1177/0961203309351540; Bag-Ozbek A, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-014-0497-6; Bartoloni E, 2010, AUTOIMMUN REV, V9, P701, DOI 10.1016/j.autrev.2010.06.001; Boo S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005117; Bos WH, 2010, ANN RHEUM DIS, V69, P490, DOI 10.1136/ard.2008.105759; Cambridge G, 2013, ATHEROSCLEROSIS, V228, P243, DOI 10.1016/j.atherosclerosis.2013.02.009; Choy E, 2009, ANN RHEUM DIS, V68, P460, DOI 10.1136/ard.2008.101964; Choy E, 2014, RHEUMATOLOGY, V53, P2143, DOI 10.1093/rheumatology/keu224; Crowson CS, 2012, AM J CARDIOL, V110, P420, DOI 10.1016/j.amjcard.2012.03.044; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Drosos GC, 2021, EUR J PREV CARDIOL, V28, P346, DOI [10.1177/2047487320906650, 10.1093/eurjpc/zwaa256]; El-Barbary AM, 2011, J RHEUMATOL, V38, P828, DOI 10.3899/jrheum.101143; Engelen L, 2013, EUR HEART J, V34, P2368, DOI 10.1093/eurheartj/ehs380; England BR, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1036; ETTINGER WH, 1994, ARTERIOSCLER THROMB, V14, P8, DOI 10.1161/01.ATV.14.1.8; Fausto S, 2018, SWISS MED WKLY, V148, DOI 10.4414/smw.2018.14656; Fent G, 2019, ANN RHEUM DIS; Giraud C, 2019, J PHYSIOL BIOCHEM, V75, P453, DOI 10.1007/s13105-019-00694-4; Goodson NJ, 2002, ARTHRITIS RHEUM-US, V46, P2010, DOI 10.1002/art.10419; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Hashizume M, 2012, CYTOKINE, V58, P424, DOI 10.1016/j.cyto.2012.02.010; HIPPISLEYCOX J, 2017, BMJ BRIT MED J, V357; Hollan I, 2020, EUR HEART J-CARD PHA, V6, P104, DOI 10.1093/ehjcvp/pvz033; Holmqvist M, 2017, ANN RHEUM DIS, V76, P1642, DOI 10.1136/annrheumdis-2016-211066; Hozawa A, 2004, AM J HYPERTENS, V17, P1005, DOI 10.1016/j.amjhyper.2004.06.019; Kawai VK, 2015, ARTHRITIS RHEUMATOL, V67, P381, DOI 10.1002/art.38944; Kerola AM, 2012, ANN RHEUM DIS, V71, P1606, DOI 10.1136/annrheumdis-2012-201334; Koopman FA, 2016, EBIOMEDICINE, V6, P231, DOI 10.1016/j.ebiom.2016.02.029; Kremers HM, 2008, ARTHRITIS RHEUM-US, V58, P2268, DOI 10.1002/art.23650; Lauper K, 2017, SEMIN IMMUNOPATHOL, V39, P447, DOI 10.1007/s00281-017-0632-2; Liao KP, 2013, RHEUMATOLOGY, V52, P45, DOI 10.1093/rheumatology/kes243; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Myasoedova E, 2010, ANN RHEUM DIS, V69, P1310, DOI 10.1136/ard.2009.122374; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P2423, DOI 10.1002/art.20431; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; PIHA SJ, 1993, BRIT J RHEUMATOL, V32, P212; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Primdahl J, 2013, ANN RHEUM DIS, V72, P1771, DOI 10.1136/annrheumdis-2013-203682; Provan SA, 2018, SEMIN ARTHRITIS RHEU, V48, P134, DOI 10.1016/j.semarthrit.2017.11.010; Robertson J, 2013, NAT REV RHEUMATOL, V9, P513, DOI 10.1038/nrrheum.2013.91; Shen JY, 2018, J RHEUMATOL, V45, P218, DOI 10.3899/jrheum.170025; Toms TE, 2010, CURR VASC PHARMACOL, V8, P301; Turesson C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0804-1; Turk SA, 2017, J RHEUMATOL, V44, P580, DOI 10.3899/jrheum.161184; van de Stadt LA, 2012, ANN RHEUM DIS, V71, P1915, DOI 10.1136/annrheumdis-2012-201709; van Halm VP, 2007, ANN RHEUM DIS, V66, P184, DOI 10.1136/ard.2006.051672; Zhang DF, 2016, CAN MED ASSOC J, V188, pE53, DOI 10.1503/cmaj.150535	49	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0237072	10.1371/journal.pone.0237072	http://dx.doi.org/10.1371/journal.pone.0237072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745151	gold, Green Published			2022-12-26	WOS:000560006800015
J	Peviani, V; Bottini, G				Peviani, Valeria; Bottini, Gabriella			Proprioceptive errors in the localization of hand landmarks: What can be learnt about the hand metric representation?	PLOS ONE			English	Article							BODY MODEL; SOMATOSENSORY CORTEX; AREA 3A; POSITION; MUSCLE; ORGANIZATION; MOVEMENT; VISION; JOINT; SHAPE	Proprioception acquires a crucial role in estimating the configuration of our body segments in space when visual information is not available. Proprioceptive accuracy is assessed by asking participants to match the perceived position of an unseen body landmark through reaching movements. This task was also adopted to study the perceived hand structure by computing the relative distances between averaged proprioceptive judgments (hand Localization Task). However, the pattern of proprioceptive errors leading to the misperceived hand structure is unexplored. Here, we aimed to characterize this pattern across different hand landmarks, having different anatomo-physiological properties and cortical representations. Furthermore, we sought to describe the error consistency and its stability over time. To this purpose, we analyzed the proprioceptive errors of 43 healthy participants during the hand Localization Task. We found larger but more consistent errors for the fingertips compared to the knuckles, possibly due to poorer proprioceptive signal, compensated by other sources of spatial information. Furthermore, we found a shift (overlap effect) and a temporal drift of the hand perceived position towards the shoulder of origin, which was consistent within and between subjects. The overlap effect had a greater influence on lateral compared to medial landmarks, leading to the hand width overestimation. Our results are compatible with domain-general and body-specific spatial biases affecting the proprioceptive localization of the hand landmarks, thus the apparent hand structure misperception.	[Peviani, Valeria; Bottini, Gabriella] Max Planck Inst Empir Aesthet, Dept Neurosci, Frankfurt, Germany; [Peviani, Valeria] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy; [Bottini, Gabriella] ASST Grande Osped Metropolitano Niguarda, Cognit Neuropsychol Ctr, Milan, Italy; [Bottini, Gabriella] Milan Ctr Neurosci, NeuroMI, Milan, Italy	University of Pavia	Peviani, V (corresponding author), Max Planck Inst Empir Aesthet, Dept Neurosci, Frankfurt, Germany.; Peviani, V (corresponding author), Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy.	valeria-carmen.peviani@ae.mpg.de	Peviani, Valeria/AAR-9458-2020	Peviani, Valeria/0000-0002-9147-7845				Ashizawa Tetsuo, 2016, Continuum (Minneap Minn), V22, P1208, DOI 10.1212/CON.0000000000000362; Battaglia-Mayer A, 2019, CEREB CORTEX, V29, P716, DOI 10.1093/cercor/bhx354; Beck B, 2016, EXP BRAIN RES, V234, P1795, DOI 10.1007/s00221-016-4585-9; Bloom F, 2009, ENCY NEUROSCIENCE; BURKE D, 1988, J PHYSIOL-LONDON, V402, P347, DOI 10.1113/jphysiol.1988.sp017208; Cocchini G, 2018, Q J EXP PSYCHOL, V71, P2314, DOI 10.1177/1747021817741606; Coelho LA, 2019, EXP BRAIN RES, V237, P137, DOI 10.1007/s00221-018-5408-y; Coelho LA, 2019, PSYCHOL RES-PSYCH FO, V83, P1375, DOI 10.1007/s00426-018-1003-x; Coelho LA, 2018, PSYCHOL RES-PSYCH FO, V82, P866, DOI 10.1007/s00426-017-0870-x; de Vignemont F, 2010, NEUROPSYCHOLOGIA, V48, P669, DOI 10.1016/j.neuropsychologia.2009.09.022; Desmurget M, 2000, EXP BRAIN RES, V134, P363, DOI 10.1007/s002210000473; Duncan RO, 2007, CEREB CORTEX, V17, P2878, DOI 10.1093/cercor/bhm015; Fuentes CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076805; Ganea N, 2017, COGNITION, V162, P41, DOI 10.1016/j.cognition.2017.01.021; Haggard P, 2000, PERCEPT PSYCHOPHYS, V62, P363, DOI 10.3758/BF03205556; HEATH CJ, 1976, J PHYSIOL-LONDON, V257, P199, DOI 10.1113/jphysiol.1976.sp011364; Huffman KJ, 2001, CEREB CORTEX, V11, P849, DOI 10.1093/cercor/11.9.849; HUTTENLOCHER J, 1991, PSYCHOL REV, V98, P352, DOI 10.1037/0033-295X.98.3.352; Krubitzer L, 2004, J COMP NEUROL, V471, P97, DOI 10.1002/cne.20025; Kuling IA, 2017, EXP BRAIN RES, V235, P533, DOI 10.1007/s00221-016-4815-1; Kuling IA, 2016, ACTA PSYCHOL, V166, P31, DOI 10.1016/j.actpsy.2016.03.011; Longo MR, 2019, ACTA PSYCHOL, V196, P1, DOI 10.1016/j.actpsy.2019.03.002; Longo MR, 2018, EXP BRAIN RES, V236, P3113, DOI 10.1007/s00221-018-5360-x; Longo MR, 2015, CONSCIOUS COGN, V36, P96, DOI 10.1016/j.concog.2015.06.009; Longo MR, 2015, EUR PSYCHOL, V20, P6, DOI 10.1027/1016-9040/a000198; Longo MR, 2014, EXP BRAIN RES, V232, P1241, DOI 10.1007/s00221-014-3840-1; Longo MR, 2013, COGNITION, V126, P475, DOI 10.1016/j.cognition.2012.11.013; Longo MR, 2012, ACTA PSYCHOL, V141, P164, DOI 10.1016/j.actpsy.2012.07.015; Longo MR, 2012, PSYCHOL SCI, V23, P740, DOI 10.1177/0956797612441219; Longo MR, 2012, J EXP PSYCHOL HUMAN, V38, P9, DOI 10.1037/a0025428; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Martuzzi R, 2014, HUM BRAIN MAPP, V35, P213, DOI 10.1002/hbm.22172; Matthews PBC, 1974, MAMMALIAN MUSCLE REC, DOI [10.1111/j.1476-5381.1974.tb09610.x, DOI 10.1111/J.1476-5381.1974.TB09610.X]; Mattioni S, 2014, ACTA PSYCHOL, V153, P60, DOI 10.1016/j.actpsy.2014.09.009; Medina J, 2017, J EXP PSYCHOL HUMAN, V43, P1430, DOI 10.1037/xhp0000397; Medina J, 2016, COGN NEUROPSYCHOL, V33, P5, DOI 10.1080/02643294.2016.1188065; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paillard J., 1968, NEUROPSYCHOLOGY SPAT; Peviani V, 2020, ACTA PSYCHOL, V203, DOI 10.1016/j.actpsy.2020.103003; Peviani V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49979-0; Peviani V, 2018, J COGN PSYCHOL, V30, P880, DOI 10.1080/20445911.2018.1538154; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Rapp B, 2002, NEUROREPORT, V13, P207, DOI 10.1097/00001756-200202110-00007; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Rincon-Gonzalez L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025214; Sanchez-Panchuelo RM, 2010, J NEUROPHYSIOL, V103, P2544, DOI 10.1152/jn.01017.2009; Saulton A, 2016, ACTA PSYCHOL, V164, P103, DOI 10.1016/j.actpsy.2015.12.013; Saulton A, 2015, EXP BRAIN RES, V233, P1471, DOI 10.1007/s00221-015-4221-0; Schwoebel J, 2005, J COGNITIVE NEUROSCI, V17, P543, DOI 10.1162/0898929053467587; Steenbergen P, 2014, EXP BRAIN RES, V232, P597, DOI 10.1007/s00221-013-3768-x; Stone KD, 2018, ACTA PSYCHOL, V185, P22, DOI 10.1016/j.actpsy.2018.01.007; Stringer EA, 2011, NEUROIMAGE, V54, P1012, DOI 10.1016/j.neuroimage.2010.09.058; Tame L, 2017, ATTEN PERCEPT PSYCHO, V79, P1204, DOI 10.3758/s13414-017-1301-1; Tsay A, 2014, J PHYSIOL-LONDON, V592, P2679, DOI 10.1113/jphysiol.2013.269365; WANN JP, 1992, EXP BRAIN RES, V91, P162; Wilson ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011851	56	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236416	10.1371/journal.pone.0236416	http://dx.doi.org/10.1371/journal.pone.0236416			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NO3EK	32735572	Green Published, gold			2022-12-26	WOS:000569367100021
J	Meikle, CK; Meisler, AJ; Bird, CM; Jeffries, JA; Azeem, N; Garg, P; Crawford, EL; Kelly, CA; Gao, TZ; Wuescher, LM; Willey, JC; Worth, RG				Meikle, Claire K.; Meisler, Adam J.; Bird, Cara M.; Jeffries, Joseph A.; Azeem, Nabila; Garg, Priyanka; Crawford, Erin L.; Kelly, Clare A.; Gao, Tess Z.; Wuescher, Leah M.; Willey, James C.; Worth, Randall G.			Platelet-T cell aggregates in lung cancer patients: Implications for thrombosis	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; P-SELECTIN; TISSUE FACTOR; RISK; ACTIVATION; CHEMOTHERAPY; LYMPHOCYTE; RATIO; INFLAMMATION; NEUTROPHIL	Platelet-leukocyte aggregates (PLAs) are associated with increased thrombosis risk. The influence of PLA formation is especially important for cancer patients, since thrombosis accounts for approximately 10% of cancer-associated deaths. Our objective was to characterize and quantify PLAs in whole blood samples from lung cancer patients compared to healthy volunteers with the intent to analyze PLA formation in the context of lung cancer-associated thrombosis. Consenting lung cancer patients (57) and healthy volunteers (56) were enrolled at the Dana Cancer Center at the University of Toledo Health Science Campus. Peripheral blood samples were analyzed by flow cytometry. Patient medical history was reviewed through electronic medical records. Most importantly, we found lung cancer patients to have higher percentages of platelet-T cell aggregates (PTCAs) than healthy volunteers among both CD4+ T lymphocyte and CD8+ T lymphocyte populations. Our findings demonstrate that characterization of PTCAs may have clinical utility in differentiating lung cancer patients from healthy volunteers and stratifying lung cancer patients by history of thrombosis.	[Meikle, Claire K.; Meisler, Adam J.; Bird, Cara M.; Jeffries, Joseph A.; Azeem, Nabila; Garg, Priyanka; Kelly, Clare A.; Gao, Tess Z.; Wuescher, Leah M.; Worth, Randall G.] Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA; [Crawford, Erin L.; Willey, James C.] Univ Toledo, Coll Med & Life Sci, Dept Med, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Worth, RG (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.	randall.worth@utoledo.edu	Wuescher, Leah/ABC-8822-2020	Wuescher, Leah/0000-0002-9708-7709; Gao, Tess/0000-0001-5127-1423	NIH/NHLBI [RO1 HL-122401]; Careers in Immunology Fellowship	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Careers in Immunology Fellowship	This work was supported in part by a grant from NIH/NHLBI (RO1 HL-122401) to RGW. CM was supported by a Careers in Immunology Fellowship (No funding number provided American Association of Immunologists to RGW). There was no additional external funding received for this study.; We thank the patients and volunteers who agreed to participate in this research study, the Dana Cancer Center at the University of Toledo Medical Center for facilitating the patient consent process, the Jacobson Center for Clinical and Translational Research at the University of Toledo for assistance in institutional review board preparation, and the University of Toledo Flow Cytometry Core Facilities for support in conducting experiments.	American Cancer Society, 2016, CANC FACTS FIGURES 2; Asmis L, 2018, PLATELETS, P1; Ay C, 2008, BLOOD, V112, P2703, DOI 10.1182/blood-2008-02-142422; Berlacher MD, 2013, AM J PATHOL, V182, P244, DOI 10.1016/j.ajpath.2012.09.005; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; Borges E, 1997, J EXP MED, V185, P573, DOI 10.1084/jem.185.3.573; Borsig L, 2008, EXPERT REV ANTICANC, V8, P1247, DOI 10.1586/14737140.8.8.1247; Chee CE, 2014, BLOOD, V123, P3972, DOI 10.1182/blood-2014-01-549733; Chen M, 2006, ARCH IMMUNOL THER EX, V54, P75, DOI 10.1007/s00005-006-0010-6; Chen WH, 2015, THROMB RES, V136, P451, DOI 10.1016/j.thromres.2015.06.014; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Davila M, 2008, J THROMB HAEMOST, V6, P1517, DOI 10.1111/j.1538-7836.2008.02987.x; Emir S, 2015, EUR REV MED PHARMACO, V19, P3613; FeldingHabermann B, 1996, J BIOL CHEM, V271, P5892, DOI 10.1074/jbc.271.10.5892; Ferroni P, 2015, INT J CANCER, V136, P1234, DOI 10.1002/ijc.29076; Franco AT, 2015, BLOOD, V126, P582, DOI 10.1182/blood-2014-08-531582; Grilz E, 2018, HAEMATOLOGICA, V103, P1549, DOI 10.3324/haematol.2018.192419; Hisada Y, 2015, J THROMB HAEMOST, V13, P1372, DOI 10.1111/jth.13009; Horsted F, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001275; Jensen MK, 2001, EUR J HAEMATOL, V66, P143, DOI 10.1034/j.1600-0609.2001.00359.x; Jia J, 2015, TUMOR BIOL, V36, P9319, DOI 10.1007/s13277-015-3667-9; Jurasz P, 2001, CANC RES, V2001, P1; Kadlec B, 2014, SCI WORLD J, DOI 10.1155/2014/125706; Key NS, 2016, CANC RES, V76, P1; Khorana AA, 2007, J THROMB HAEMOST, V5, P632, DOI 10.1111/j.1538-7836.2007.02374.x; Khorana AA, 2005, CANCER-AM CANCER SOC, V104, P2822, DOI 10.1002/cncr.21496; KITAGAWA H, 1989, CANCER RES, V49, P537; Laubli H, 2010, SEMIN CANCER BIOL, V20, P169, DOI 10.1016/j.semcancer.2010.04.005; Lyman GH, 2015, J CLIN ONCOL, V33, P654, DOI 10.1200/JCO.2014.59.7351; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Meikle CKS, 2017, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00147; Messager M, 2015, EJSO-EUR J SURG ONC, V41, P1316, DOI 10.1016/j.ejso.2015.06.007; Metelli A, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0570-z; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; Miglani RK, 2013, INDIAN J SURG, V75, P4, DOI 10.1007/s12262-012-0443-6; Moore RA, 2011, J CLIN ONCOL, V29, P3466, DOI 10.1200/JCO.2011.35.5669; Navi BB, 2019, BLOOD, V133, P781, DOI 10.1182/blood-2018-06-860874; Navi BB, 2017, J AM COLL CARDIOL, V70, P927, DOI 10.1016/j.jacc.2017.06.047; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Rachidi S, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai7911; Romualdi E, 2016, THROMBOSIS RES; Salas-Perdomo A, 2018, ARTERIOSCLER THROMB, V38; Salla E, 2016, ANGIOLOGY, V67, P709, DOI 10.1177/0003319715614945; Sanchez-Salcedo P, 2016, LUNG CANCER, V97, P28, DOI 10.1016/j.lungcan.2016.04.010; Scotte F, 2019, CANCERS, V11, DOI 10.3390/cancers11010048; Simanek R, 2010, J THROMB HAEMOST, V8, P114, DOI 10.1111/j.1538-7836.2009.03680.x; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Tagalakis V, 2007, J THORAC ONCOL, V2, P729, DOI 10.1097/JTO.0b013e31811ea275; Tuzovic Mirela, 2018, Curr Treat Options Cardiovasc Med, V20, P40, DOI 10.1007/s11936-018-0635-x; van den Berg YW, 2012, BLOOD, V119, P924, DOI 10.1182/blood-2011-06-317685; van Es N, 2018, THROMB RES, V163, P41, DOI 10.1016/j.thromres.2018.01.009; van Es N, 2014, SEMIN ONCOL, V41, P311, DOI 10.1053/j.seminoncol.2014.04.015; Wang YB, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2862-4; Xu XR, 2018, BLOOD, V131, P1777, DOI 10.1182/blood-2017-05-743187; Zamora C, 2013, J LEUKOCYTE BIOL, V94, P521, DOI 10.1189/jlb.0213074; Zhang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126496; Zhou X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101119	57	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0236966	10.1371/journal.pone.0236966	http://dx.doi.org/10.1371/journal.pone.0236966			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776968	gold, Green Published			2022-12-26	WOS:000561393800042
J	Quignon, C; Beymer, M; Gauthier, K; Gauer, F; Simonneaux, V				Quignon, Clarisse; Beymer, Matthew; Gauthier, Karine; Gauer, Francois; Simonneaux, Valerie			Thyroid hormone receptors are required for the melatonin-dependent control of Rfrp gene expression in mice	FASEB JOURNAL			English	Article						deiodinase; neuropeptides; seasonal rhythms; tanycytes; TSH	TYPE-2 DEIODINASE GENE; PARS TUBERALIS; CELL-PROLIFERATION; DJUNGARIAN HAMSTER; BODY-WEIGHT; ALPHA; PHOTOPERIOD; PINEAL; RAT; REPRODUCTION	Mammals adapt to seasons using a neuroendocrine calendar defined by the photoperiodic change in the nighttime melatonin production. Under short photoperiod, melatonin inhibits thepars tuberalisproduction of TSH beta, which, in turn, acts on tanycytes to regulate the deiodinase 2/3 balance resulting in a finely tuned seasonal control of the intra-hypothalamic thyroid hormone T3. Despite the pivotal role of this T3 signaling for synchronizing reproduction with the seasons, T3 cellular targets remain unknown. One candidate is a population of hypothalamic neurons expressingRfrp, the gene encoding the RFRP-3 peptide, thought to be integral for modulating rodent's seasonal reproduction. Here we show that nighttime melatonin supplementation in the drinking water of melatonin-deficient C57BL/6J mice mimics photoperiodic variations in the expression of the genesTshb, Dio2,Dio3, andRfrp, as observed in melatonin-proficient mammals. Notably, we report that this melatonin regulation ofRfrpexpression is no longer observed in mice carrying a global mutation of the T3 receptor, TR alpha, but is conserved in mice with a selective neuronal mutation of TR alpha. In line with this observation, we find that TR alpha is widely expressed in the tanycytes. Altogether, our data demonstrate that the melatonin-driven T3 signal regulates RFRP-3 neurons through non-neuronal, possibly tanycytic, TR alpha.	[Quignon, Clarisse; Beymer, Matthew; Gauer, Francois; Simonneaux, Valerie] Univ Strasbourg, Inst Neurosci Cellulaires & Integrat, CNRS, UPR 3212, Strasbourg, France; [Gauthier, Karine] Univ Lyon, Inst Genom Fonct Lyon, ENS Lyon, INRAE,CNRS, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Simonneaux, V (corresponding author), Univ Strasbourg, Inst Neurosci Cellulaires & Integrat, 8 Allee Gen Rouvillois, F-67000 Strasbourg, France.	simonneaux@inci-cnrs.unistra.fr			Agence Nationale de la Recherche (ANR) [ANR-13-BSV1-001]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	Agence Nationale de la Recherche (ANR), Grant/Award Number: ANR-13-BSV1-001	Ancel C, 2012, ENDOCRINOLOGY, V153, P1352, DOI 10.1210/en.2011-1622; Angelopoulou E, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00183; Banares S, 2005, GENESIS, V42, P6, DOI 10.1002/gene.20117; Bank JHH, 2017, J NEUROENDOCRINOL, V29, DOI 10.1111/jne.12487; Barrett P, 2007, ENDOCRINOLOGY, V148, P3608, DOI 10.1210/en.2007-0316; Batailler M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24381-4; Bernal J, 2015, NAT REV ENDOCRINOL, V11, P406, DOI 10.1038/nrendo.2015.66; Bockmann J, 1996, ENDOCRINOLOGY, V137, P1804, DOI 10.1210/en.137.5.1804; Bothorel B, 2002, EUR J NEUROSCI, V16, P1090, DOI 10.1046/j.1460-9568.2002.02176.x; BRADLEY DJ, 1989, P NATL ACAD SCI USA, V86, P7250, DOI 10.1073/pnas.86.18.7250; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; CARLSON DJ, 1994, ENDOCRINOLOGY, V135, P1831, DOI 10.1210/en.135.5.1831; Cazarez-Marquez F, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12710; Dardente H, 2003, J NEUROENDOCRINOL, V15, P778, DOI 10.1046/j.1365-2826.2003.01060.x; Dardente H, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12729; Dardente H, 2010, CURR BIOL, V20, P2193, DOI 10.1016/j.cub.2010.10.048; de Miera CS, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.217687; Dufourny L, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12344; Freeman DA, 2007, AM J PHYSIOL-REG I, V292, pR2368, DOI 10.1152/ajpregu.00713.2006; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; Gomes FCA, 1999, GLIA, V25, P247, DOI 10.1002/(SICI)1098-1136(19990201)25:3<247::AID-GLIA5>3.0.CO;2-2; Guadano-Ferraz A, 2003, MOL PSYCHIATR, V8, P30, DOI 10.1038/sj.mp.4001196; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Hazlerigg D, 2014, KNOBIL NEILLS PHYSL, V34, P1575; Hazlerigg DG, 2013, CHRONOBIOL INT, V30, P548, DOI 10.3109/07420528.2012.754450; Helfer G, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12680; Henningsen JB, 2017, ENDOCRINOLOGY, V158, P652, DOI 10.1210/en.2016-1689; Henson JR, 2013, J BIOL RHYTHM, V28, P193, DOI 10.1177/0748730413487974; Herwig A, 2008, OBESITY FACTS, V1, P71, DOI 10.1159/000123428; Huang LY, 1998, J NEUROBIOL, V36, P410, DOI 10.1002/(SICI)1097-4695(19980905)36:3<410::AID-NEU8>3.0.CO;2-Z; Kapoor R, 2015, J NEUROCHEM, V133, P599, DOI 10.1111/jnc.13093; Kasahara T, 2010, P NATL ACAD SCI USA, V107, P6412, DOI 10.1073/pnas.0914399107; KLOSEN P, 1993, J HISTOCHEM CYTOCHEM, V41, P455, DOI 10.1177/41.3.8429209; Klosen P, 2013, FASEB J, V27, P2677, DOI 10.1096/fj.13-229559; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; MAYWOOD ES, 1993, J ENDOCRINOL, V136, P65, DOI 10.1677/joe.0.1360065; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Migaud M, 2011, J BIOL RHYTHM, V26, P486, DOI 10.1177/0748730411420062; Murphy M, 2012, ENDOCRINOLOGY, V153, P101, DOI 10.1210/en.2011-1249; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Nishiwaki-Ohkawa T, 2016, J ENDOCRINOL, V229, pR117, DOI 10.1530/JOE-16-0066; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; Prevot V, 2018, ENDOCR REV, V39, P333, DOI 10.1210/er.2017-00235; Quignodon L, 2007, MOL ENDOCRINOL, V21, P2350, DOI 10.1210/me.2007-0176; REITER RJ, 1980, INT J BIOMETEOROL, V24, P57, DOI 10.1007/BF02245542; Revel FG, 2008, ENDOCRINOLOGY, V149, P902, DOI 10.1210/en.2007-0848; Revel FG, 2006, ENDOCRINOLOGY, V147, P4680, DOI 10.1210/en.2006-0606; Revel FG, 2006, CURR BIOL, V16, P1730, DOI 10.1016/j.cub.2006.07.025; Ribelayga C, 2000, AM J PHYSIOL-REG I, V278, pR1339, DOI 10.1152/ajpregu.2000.278.5.R1339; Richard S, 2017, BEHAV BRAIN RES, V321, P18, DOI 10.1016/j.bbr.2016.12.025; ROLLAG MD, 1980, P SOC EXP BIOL MED, V165, P330, DOI 10.3181/00379727-165-40981; Simonneaux V, 2020, EUR J NEUROSCI, V51, P509, DOI 10.1111/ejn.14287; Wallis K, 2010, MOL ENDOCRINOL, V24, P1904, DOI 10.1210/me.2010-0175; Warner A, 2012, J MOL ENDOCRINOL, V49, pR29, DOI 10.1530/JME-12-0068; Watanabe M, 2004, ENDOCRINOLOGY, V145, P1546, DOI 10.1210/en.2003-1593; WITTKOWSKI W, 1988, CELL TISSUE RES, V251, P183, DOI 10.1007/BF00215463; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Yasuo S, 2005, ENDOCRINOLOGY, V146, P2551, DOI 10.1210/en.2005-0057; Yasuo S, 2009, J NEUROSCI, V29, P2885, DOI 10.1523/JNEUROSCI.0145-09.2009; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117	61	6	6	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12072	12082		10.1096/fj.202000961R	http://dx.doi.org/10.1096/fj.202000961R		AUG 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32776612	Green Submitted			2022-12-26	WOS:000558417200001
J	Esposito, M; Akman, HB; Giron, P; Ceregido, MA; Schepers, R; Paez, LRC; La Monaca, E; De Greve, J; Coux, O; De Trez, C; Lindon, C; Gutierrez, GJ				Esposito, Mara; Akman, H. Begum; Giron, Philippe; Ceregido, M. Angeles; Schepers, Rogier; Ramos Paez, Luis C.; La Monaca, Esther; De Greve, Jacques; Coux, Olivier; De Trez, Carl; Lindon, Catherine; Gutierrez, Gustavo J.			USP13 controls the stability of Aurora B impacting progression through the cell cycle	ONCOGENE			English	Article							TUMOR-SUPPRESSOR CYLD; MITOTIC KINASE; OVEREXPRESSION; ANEUPLOIDY; PHOSPHORYLATION; DEGRADATION; EXPRESSION; PREDICTION; REGULATOR; SEQUENCE	Aurora B kinase plays essential roles in mitosis. Its protein levels increase before the onset of mitosis and sharply decrease during mitosis exit. The latter decrease is due to a balance between the actions of the E3 ubiquitin ligase anaphase-promoting complex or cyclosome (activated by the Cdh1 adapter), and the deubiquitinating enzyme USP35. Aurora B also executes important functions in interphase. Abnormal modulation of Aurora B in interphase leads to cell cycle defects often linked to aberrant chromosomal condensation and segregation. Very little is however known about how Aurora B levels are regulated in interphase. Here we found that USP13-associates with and stabilizes Aurora B in cells, especially before their entry into mitosis. In order for USP13 to exert its stabilizing effect on Aurora B, their association is promoted by the Aurora B-mediated phosphorylation of USP13 at Serine 114. We also present evidence that USP13 instigates Aurora B deubiquitination and/or protect it from degradation in a non-catalytic manner. In addition, we report that genetic or chemical modulation of the cellular levels/activity of USP13 affects unperturbed cell-cycle progression. Overall our study unveils the molecular and cellular connections of the USP13-Aurora B axis, which potentially participates in the rewiring of the cell cycle happening in cancer cells.	[Esposito, Mara; Giron, Philippe; Ceregido, M. Angeles; Schepers, Rogier; Ramos Paez, Luis C.; La Monaca, Esther; Gutierrez, Gustavo J.] Vrije Univ Brussel, Fac Sci & Bioengn Sci, Dept Biol, Lab Pathophysiol Cell Signaling, Pl Laan 2, B-1050 Brussels, Belgium; [Akman, H. Begum; Lindon, Catherine] Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England; [Giron, Philippe; De Greve, Jacques] Vrije Univ Brussel, Fac Med & Pharm, Lab Mol & Med Oncol, Laarbeeklaan 103, B-1090 Brussels, Belgium; [Coux, Olivier] CNRS, CRBM, 1919 Route Mende, F-34293 Montpellier, France; [De Trez, Carl] Vrije Univ Brussel, Fac Sci & Bioengn Sci, Dept Bioengn, Lab Cellular & Mol Immunol, Pl Laan 2, B-1050 Brussels, Belgium; [Ceregido, M. Angeles] GlaxoSmithKline, Ave Pascal 2-4-6, B-1300 Wavre, Belgium; [Schepers, Rogier] VIB KU Leuven, Ctr Canc Biol, Campus Gasthuisberg,Herestr 49-B912, Leuven, Belgium; [Ramos Paez, Luis C.] Ablynx NV, Technol Pk 21, B-9052 Ghent, Belgium; [La Monaca, Esther] Janssen Pharmaceut NV, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Gutierrez, Gustavo J.] Galapagos NV, Generaal Wittelaan L11 A3, B-2800 Mechelen, Belgium	Vrije Universiteit Brussel; University of Cambridge; Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Vrije Universiteit Brussel; GlaxoSmithKline; Flanders Institute for Biotechnology (VIB); KU Leuven; Johnson & Johnson; Janssen Pharmaceuticals; Galapagos NV	Gutierrez, GJ (corresponding author), Vrije Univ Brussel, Fac Sci & Bioengn Sci, Dept Biol, Lab Pathophysiol Cell Signaling, Pl Laan 2, B-1050 Brussels, Belgium.; Gutierrez, GJ (corresponding author), Galapagos NV, Generaal Wittelaan L11 A3, B-2800 Mechelen, Belgium.	ggutierr@vub.be	Akman, H. Begum/F-8427-2012; Coux, Olivier/P-6847-2019; Gutierrez, Gustavo/AAO-9957-2021; De Greve, Jacques/J-4939-2012	Akman, H. Begum/0000-0003-4646-4225; Coux, Olivier/0000-0001-8455-3849; Gutierrez, Gustavo/0000-0001-8652-972X; De Trez, Carl/0000-0002-3899-1968; Giron, Philippe/0000-0002-1331-1890; De Greve, Jacques/0000-0002-2389-0742	FWO [G0C7514N]; BELSPO Interuniversity Attraction Poles [IAP-P7 - 07]; VUB (starting ZAP credit & Interdisciplinary Research Program for Excellence on Cancer Research); Innoviris (BB2B program); COST-EU program (Proteostasis); BBSRC [BB/R004137/1] Funding Source: UKRI; MRC [MR/M01102X/1] Funding Source: UKRI	FWO(FWO); BELSPO Interuniversity Attraction Poles; VUB (starting ZAP credit & Interdisciplinary Research Program for Excellence on Cancer Research); Innoviris (BB2B program); COST-EU program (Proteostasis); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research in GJG's laboratory was funded by grants from FWO (G0C7514N), BELSPO Interuniversity Attraction Poles (IAP-P7 - 07), VUB (starting ZAP credit & Interdisciplinary Research Program for Excellence on Cancer Research), and Innoviris (BB2B program). The collaboration between the laboratories of GJG and CL included a short-term scientific mission (ME) supported by the COST-EU program (Proteostasis). We are indebted to Yvon Elkrim for technical assistance with the flow cytometry analyses, and to Professors Luc Leyns and Peter Tompa (VUB- and VIB- Brussels, Belgium, respectively) for allowing access to some of their laboratories' equipment.	Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bonet C, 2012, J BIOL CHEM, V287, P29887, DOI 10.1074/jbc.M112.371682; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Chen BB, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.271; Chen MF, 2011, P NATL ACAD SCI USA, V108, P9119, DOI 10.1073/pnas.1100028108; Chen YJ, 2009, VIRCHOWS ARCH, V455, P431, DOI 10.1007/s00428-009-0838-3; Darling S, 2017, BIOCHEM SOC T, V45, P1125, DOI 10.1042/BST20170087; Fang XG, 2017, J EXP MED, V214, P245, DOI 10.1084/jem.20151673; Floyd S, 2013, J CELL SCI, V126, P2845, DOI 10.1242/jcs.123232; Fournane Sadek, 2012, Genes Cancer, V3, P697, DOI 10.1177/1947601912473477; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gilberto S, 2017, J CELL BIOL, V216, P2259, DOI 10.1083/jcb.201703170; Gonzalez-Loyola A, 2015, MOL CELL BIOL, V35, P3566, DOI 10.1128/MCB.01286-14; Gully CP, 2012, P NATL ACAD SCI USA, V109, pE1513, DOI 10.1073/pnas.1110287109; Han C, 2016, NAT COMMUN, V7; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hayashi-Takanaka Y, 2009, J CELL BIOL, V187, P781, DOI 10.1083/jcb.200904137; Jiao QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027646; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Krenn V, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00225; Li L, 2019, EBIOMEDICINE, V45, P553, DOI 10.1016/j.ebiom.2019.06.011; Li Y, 2017, NAT COMMUN, V8; Lindon C, 2016, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00307; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Liu Y, 2014, ELIFE, V3; Maerki S, 2009, J CELL BIOL, V187, P791, DOI 10.1083/jcb.200906117; Man XJ, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1262-4; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Morgan D. O., 2006, CELL CYCLE PRINCIPLE; Munoz-Barrera M, 2014, P NATL ACAD SCI USA, V111, pE3996, DOI 10.1073/pnas.1408017111; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ota T, 2002, CANCER RES, V62, P5168; Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138; Park J, 2018, BMB REP, V51, P261, DOI 10.5483/BMBRep.2018.51.6.110; Pinto-Fernandez A, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00592; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sahtoe DD, 2015, TRENDS BIOCHEM SCI, V40, P456, DOI 10.1016/j.tibs.2015.05.002; Scortegagna M, 2011, J BIOL CHEM, V286, P27333, DOI 10.1074/jbc.M111.218214; Song CG, 2017, CELL PHYSIOL BIOCHEM, V42, P965, DOI 10.1159/000478679; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Staibano S, 2003, HISTOPATHOLOGY, V43, P254, DOI 10.1046/j.1365-2559.2003.01706.x; Stegmeier F, 2007, P NATL ACAD SCI USA, V104, P8869, DOI 10.1073/pnas.0703268104; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Sun H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15534; Sun L, 2010, J PATHOL, V221, P425, DOI 10.1002/path.2723; Tatsuka M, 1998, CANCER RES, V58, P4811; Teng CL, 2012, CELL CYCLE, V11, P4059, DOI 10.4161/cc.22381; van der Waal MS, 2012, EXP CELL RES, V318, P1407, DOI 10.1016/j.yexcr.2012.03.015; van Leuken RJ, 2008, CELL CYCLE, V7, P2710, DOI 10.4161/cc.7.17.6553; Vischioni B, 2006, MOL CANCER THER, V5, P2905, DOI 10.1158/1535-7163.MCT-06-0301; Wu Y, 2019, BIOMED PHARMACOTHER, V114, DOI 10.1016/j.biopha.2019.108831; Xie X, 2018, J CELL SCI, V131, DOI 10.1242/jcs.210856; Yeh HM, 2013, J IMMUNOL, V191, P3328, DOI 10.4049/jimmunol.1300225; Zeng WFF, 2007, J CLIN PATHOL, V60, P218, DOI 10.1136/jcp.2006.036806; Zhang JS, 2013, NAT CELL BIOL, V15, P1486, DOI 10.1038/ncb2874; Zhang SY, 2018, INT CONF BIG DATA, P1, DOI 10.1109/BigComp.2018.00010; Zhao XS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1421; Zhou QX, 2020, J EXP MED, V217, DOI 10.1084/jem.20191779	62	10	10	1	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2020	39	37					6009	6023		10.1038/s41388-020-01396-8	http://dx.doi.org/10.1038/s41388-020-01396-8		AUG 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NM2OY	32772043				2022-12-26	WOS:000557315300001
J	Cai, J; Liu, WF; Wong, CW; Zhu, WB; Lin, Y; Hu, J; Xu, WC; Zhang, JF; Sander, M; Wang, Z; Dan, J; Zhang, JY; Liu, Y; Guo, L; Qin, Z; Liu, XC; Liu, Y; Yan, GM; Wu, SH; Liang, JK				Cai, Jing; Liu, Wenfeng; Wong, Chun Wa; Zhu, Wenbo; Lin, Yuan; Hu, Jun; Xu, Wencang; Zhang, Jifu; Sander, Max; Wang, Zhuo; Dan, Jia; Zhang, Jiayu; Liu, Yang; Guo, Li; Qin, Zhen; Liu, Xincheng; Liu, Ying; Yan, Guangmei; Wu, Sihan; Liang, Jiankai			Zinc-finger antiviral protein acts as a tumor suppressor in colorectal cancer	ONCOGENE			English	Article							MULTIPLE INTESTINAL NEOPLASIA; VIRAL MESSENGER-RNAS; ZAP; TRAIL; INTERFERONS; INHIBITION; RECEPTOR; EXPRESSION; INFECTION; CASPASE-8	Avoiding immune destruction is essential for tumorigenesis. Current research into the interaction between tumor and immunological niches complement tumor pathology beyond cancer genetics. Intrinsic host defense immunity is a specialized innate immunity component to restrict viral infection. However, whether intrinsic immunity participates in tumor pathology is unclear. Previously, we identified a zinc-finger antiviral protein ZAP that is commonly downregulated in a panel of clinical cancer specimens. However, whether ZAP has an impact on tumor development was unknown. Here we report ZAP as a genuine tumor suppressor. Pan-caner analysis with TCGA data from 712 patients and large-scale immunohistochemistry in tissue microarrays from 1552 patients reveal that ZAP is prevalently downregulated, and associated with poor survival in liver, colon, and bladder cancer patients. Ectopic over-expression of ZAP inhibits the malignant phenotypes of colorectal tumor by cell cycle arrest. Using RNA immunoprecipitation and RNA decay assays, we demonstrate that ZAP directly and specifically binds to and degrades the transcript of TRAILR4, which in turn represses TRAILR4 expression and inhibits the aggressiveness of colorectal cancer cells. Furthermore, our CRISPR-engineered mice models show that loss-of-function of ZAP synergizes with APC-deficiency to drive malignant colorectal cancer in vivo. Overall, we identify a previously unknown function of the antiviral factor ZAP in colorectal tumorigenesis, linking intrinsic immunity to tumor pathogenetics.	[Cai, Jing; Liu, Wenfeng; Wong, Chun Wa; Zhu, Wenbo; Lin, Yuan; Hu, Jun; Dan, Jia; Zhang, Jiayu; Liu, Yang; Guo, Li; Qin, Zhen; Liu, Xincheng; Yan, Guangmei; Liang, Jiankai] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510080, Peoples R China; [Xu, Wencang; Zhang, Jifu; Sander, Max] Guangzhou Virotech Pharmaceut Co Ltd, Guangzhou 510663, Peoples R China; [Wang, Zhuo] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510080, Peoples R China; [Liu, Ying] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510630, Peoples R China; [Wu, Sihan] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Liang, JK (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510080, Peoples R China.; Wu, SH (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	siw048@ucsd.edu; liangjk5@mail.sysu.edu.cn	Wu, Sihan/AAB-6812-2020	Wu, Sihan/0000-0001-8329-7492; Lin, Yuan/0000-0002-7152-0965; Wong, Chun-wa/0000-0003-3476-9283	National Natural Science Foundation of China [81872887, 81902809, 81872886, 81773751, 81973342, 81973347]; Fundamental Research Funds for the Central Universities [18ykpy37]; National Major Scientific and Technological Special Project for "Significant New Drugs Development" [2018ZXO9733002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Major Scientific and Technological Special Project for "Significant New Drugs Development"	JC: the National Natural Science Foundation of China (No. 81902809) and the Fundamental Research Funds for the Central Universities (No. 18ykpy37). WZ: the National Natural Science Foundation of China (No. 81872886). JH: the National Natural Science Foundation of China (No. 81773751). JL: the National Natural Science Foundation of China (No. 81973342). YL: the National Natural Science Foundation of China (No. 81973347). GY: the National Natural Science Foundation of China (No. `81872887) and the National Major Scientific and Technological Special Project for "Significant New Drugs Development" during the 13th Five-Year Plan Period (No. 2018ZXO9733002).	Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Charron G, 2013, P NATL ACAD SCI USA, V110, P11085, DOI 10.1073/pnas.1302564110; Chen SD, 2012, NAT STRUCT MOL BIOL, V19, P430, DOI 10.1038/nsmb.2243; Chiu HP, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007166; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Feng MY, 2019, NAT REV CANCER, V19, P568, DOI 10.1038/s41568-019-0183-z; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang Z, 2010, PROTEIN CELL, V1, P752, DOI 10.1007/s13238-010-0096-9; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Lee H, 2013, P NATL ACAD SCI USA, V110, P12379, DOI 10.1073/pnas.1310604110; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Li S, 2016, NAT IMMUNOL, V17, P241, DOI 10.1038/ni.3311; Lin Y, 2014, P NATL ACAD SCI USA, V111, pE4504, DOI 10.1073/pnas.1408759111; Liu CH, 2015, P NATL ACAD SCI USA, V112, P14048, DOI 10.1073/pnas.1509745112; MacDonald MR, 2007, J VIROL, V81, P13509, DOI 10.1128/JVI.00402-07; Mao RC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003494; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Muller S, 2007, J VIROL, V81, P2391, DOI 10.1128/JVI.01601-06; Munoz-Fontela C, 2016, NAT REV IMMUNOL, V16, P741, DOI 10.1038/nri.2016.99; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Ribas A, 2015, CANCER DISCOV, V5, P915, DOI 10.1158/2159-8290.CD-15-0563; Saito Y, 2016, SCI REP, V6; Smyth MJ, 2003, IMMUNITY, V18, P1, DOI 10.1016/S1074-7613(02)00502-2; Snell LM, 2017, TRENDS IMMUNOL, V38, P542, DOI 10.1016/j.it.2017.05.005; Spranger S, 2018, NAT REV CANCER, V18, P139, DOI 10.1038/nrc.2017.117; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Textor S, 2011, CANCER RES, V71, P5998, DOI 10.1158/0008-5472.CAN-10-3211; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Todorova T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6362; von Karstedt S, 2017, NAT REV CANCER, V17, P352, DOI 10.1038/nrc.2017.28; Vyas S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3240; Wang XS, 2019, GENOMICS, V111, P1464, DOI 10.1016/j.ygeno.2018.09.020; Xuan YF, 2012, J VIROL, V86, P12431, DOI 10.1128/JVI.01514-12; Yoon KW, 2015, SCIENCE, V349, DOI 10.1126/science.1261669; Zhu YP, 2012, EMBO J, V31, P4236, DOI 10.1038/emboj.2012.271; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	45	6	7	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2020	39	37					5995	6008		10.1038/s41388-020-01416-7	http://dx.doi.org/10.1038/s41388-020-01416-7		AUG 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NM2OY	32770142				2022-12-26	WOS:000557117100001
J	Freeman, DW; Hooten, NN; Kim, Y; Mode, NA; Ejiogu, N; Zonderman, AB; Evans, MK				Freeman, David W.; Noren Hooten, Nicole; Kim, Yoonseo; Mode, Nicolle A.; Ejiogu, Ngozi; Zonderman, Alan B.; Evans, Michele K.			Association between GDF15, poverty and mortality in urban middle-aged African American and white adults	PLOS ONE			English	Article							DIFFERENTIATION FACTOR 15; SOCIOECONOMIC-STATUS; LIFE-SPAN; RECEPTOR; HEALTH; RISK; DISPARITIES; FACTOR-15; RACE; MEN	Mortality disparities are influenced by race and poverty. There is limited information about whether poverty influences biologic markers of mortality risk. Emerging data suggests that growth differentiation factor 15 (GDF15) is associated with mortality; however, the interplay between GDF15, sociodemographic factors and mortality is not known. We sought to evaluate the interactions between GDF15 and sex, race and poverty status on mortality. Serum GDF15 was measured in 1036 African American and white middle-aged men and women above and below 125% of the Federal poverty status from the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) study. Multivariable adjusted Cox regression models were used to assess the association between log-transformed GDF15 (logGDF15) and 12-year mortality outcomes (all-cause, cardiovascular- and cancer-specific outcomes) and interactions with sex, race and poverty status. Likelihood ratio tests were used to assess significance of the interaction terms. Median GDF15 was 655.2 pg/mL (IQR = 575.1). During 12.2 years of follow-up, 331 died of which 94 cardiovascular- and 87 were cancer-specific deaths. One unit of increase in logGDF15 was associated with a hazard ratio for all-cause mortality, cardiovascular- and cancer-specific mortality of 2.26 (95% confidence interval [CI], 1.94-2.64), 2.74 (95%CI, 2.06-3.63) and 1.41 (95%CI, 1.00-2.00), respectively. There was an interaction between logGDF15 and poverty status on all-cause mortality (p<0.05). The GDF15xpoverty status interaction term improved model calibration for all-cause mortality. Our study provides the first evidence that the effect of elevated GDF15 on all-cause mortality is modified by poverty status.	[Freeman, David W.; Noren Hooten, Nicole; Kim, Yoonseo; Mode, Nicolle A.; Ejiogu, Ngozi; Zonderman, Alan B.; Evans, Michele K.] NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, IRP,NIH, Baltimore, MD 21224 USA; [Freeman, David W.] Univ Utah, Sch Med, Salt Lake City, UT USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Utah System of Higher Education; University of Utah	Evans, MK (corresponding author), NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, IRP,NIH, Baltimore, MD 21224 USA.	me42v@nih.gov	Noren Hooten, Nicole/J-5498-2019; Ezike, Ngozi/AAL-3075-2021	Noren Hooten, Nicole/0000-0002-1683-3838; Mode, Nicolle/0000-0002-8193-0554; Evans, Michele/0000-0002-8546-2831	National Institute on Aging Intramural Research Program, National Institutes of Health [09-AG -N248, AG000513]	National Institute on Aging Intramural Research Program, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funding from the National Institute on Aging Intramural Research Program, National Institutes of Health, protocol number 09-AG -N248; project number AG000513 awarded to MKE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assari S, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00040; Babic A, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/s41424-018-0008-5; CDC (Centers for Disease Control and Prevention), 2020, MORBIDITY MORTALITY; Colen CG, 2006, AM J PUBLIC HEALTH, V96, P2032, DOI 10.2105/AJPH.2005.076547; Colen CG, 2018, SOC SCI MED, V199, P167, DOI 10.1016/j.socscimed.2017.04.051; County Health Rankings & Roadmaps, MAR INC IN 2011 2015; Daniels LB, 2011, CIRCULATION, V123, P2101, DOI 10.1161/CIRCULATIONAHA.110.979740; Demler OV, 2015, STAT MED, V34, P1659, DOI 10.1002/sim.6428; Eggers KM, 2013, CLIN CHEM, V59, P1091, DOI 10.1373/clinchem.2012.201210; Emmerson PJ, 2017, NAT MED, V23, P1215, DOI 10.1038/nm.4393; Evans MK, 2010, ETHNIC DIS, V20, P267; Fontenot K., 2018, US CENSUS BUREAU CUR; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hagstrom E, 2017, CLIN CHEM, V63, P325, DOI 10.1373/clinchem.2016.260570; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Ho JY, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2562; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; Hudson DL, 2012, J MENS HEALTH, V9, P127, DOI 10.1016/j.jomh.2012.03.006; Hughes A, 2018, AM J EPIDEMIOL, V187, P2346, DOI 10.1093/aje/kwy155; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kim Y, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/8278039; Kochanek KD, 2017, MORTALITY US; Kochhar R., 2018, INCOME INEQUALITY US; Liu Z., 2018, 363291 BIORXIV, DOI [10.1101/363291, DOI 10.1101/363291]; Muhammad DA, 2017, RACIAL WEALTH DIVIDE; Mullican SE, 2018, TRENDS ENDOCRIN MET, V29, P560, DOI 10.1016/j.tem.2018.05.002; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; Needham BL, 2013, SOC SCI MED, V85, P1, DOI 10.1016/j.socscimed.2013.02.023; Rohatgi A, 2012, CLIN CHEM, V58, P172, DOI 10.1373/clinchem.2011.171926; Simons RL, 2016, SOC SCI MED, V150, P192, DOI 10.1016/j.socscimed.2015.12.001; Sloan FA, 2010, AM J PUBLIC HEALTH, V100, P357, DOI 10.2105/AJPH.2008.158188; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; Tajuddin SM, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1313-6; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Tsai VWW, 2018, CELL METAB, V28, P353, DOI 10.1016/j.cmet.2018.07.018; Wallentin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078797; Wang TJ, 2012, CIRCULATION, V126, P1596, DOI 10.1161/CIRCULATIONAHA.112.129437; Wang XY, 2014, AGING-US, V6, P690, DOI 10.18632/aging.100687; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Wollert KC, 2017, CLIN CHEM, V63, P140, DOI 10.1373/clinchem.2016.255174; Woolf SH, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3096; World Health Organization, 2013, GLOB ACT PLAN PREV C; Yang LD, 2017, NAT MED, V23, P1158, DOI 10.1038/nm.4394; Zhang MY, 2018, REDOX BIOL, V16, P87, DOI 10.1016/j.redox.2018.01.013; Zonderman AB, 2016, JAMA INTERN MED, V176, P1394, DOI 10.1001/jamainternmed.2016.3649	45	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237059	10.1371/journal.pone.0237059	http://dx.doi.org/10.1371/journal.pone.0237059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2FE	32764826	gold, Green Published			2022-12-26	WOS:000561029000068
J	Lashkari, K; Teague, GC; Beattie, U; Betts, J; Kumar, S; McLaughlin, MM; Lopez, FJ				Lashkari, Kameran; Teague, Gianna C.; Beattie, Ursula; Betts, Joanna; Kumar, Sanjay; McLaughlin, Megan M.; Lopez, Francisco J.			Plasma biomarkers of the amyloid pathway are associated with geographic atrophy secondary to age-related macular degeneration	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; ALZHEIMERS-DISEASE; INFLAMMASOME ACTIVATION; COMPLEMENT ACTIVATION; HIGH-RISK; BETA; PREVALENCE; DEPOSITS; DRUSEN; EYES	Geographic atrophy (GA) is an advanced form of dry age-related macular degeneration (AMD), in which local inflammation and hyperactivity of the complement pathway have been implicated in its pathophysiology. This study explores whether any surrogate biomarkers are specifically associated with GA. Plasma from subjects with GA, intermediate dry AMD and non-AMD control were evaluated in 2 cohorts. Cohort 1 was assayed in a 320-analyte Luminex library. Statistical analysis was performed using non-parametric and parametric methods (Kruskal-Wallis, principal component analysis, partial least squares and multivariate analysis of variance (MANOVA) and univariate ANCOVAs). Bioinformatic analysis was conducted and identified connections to the amyloid pathway. Statistically significant biomarkers identified in Cohort 1 were then re-evaluated in Cohort 2 using individual ELISA and multiplexing. Of 320 analytes in Cohort 1, 273 were rendered measurable, of which 56 were identified as changing. Among these markers, 40 were identified in univariate ANCOVAs. Serum amyloid precursor protein (sAPP) was analyzed by a separate ELISA and included in further analyses. The 40 biomarkers, sAPP and amyloid-beta (A beta) (1-42) (included for comparison) were evaluated in Cohort 2. This resulted in 11 statistically significant biomarkers, including sAPP and A beta(1-40), but not A beta(1-42). Other biomarkers identified included serum proteases- tissue plasminogen activator, tumor-associated trypsinogen inhibitor, matrix metalloproteinases 7 and 9, and non-proteases- insulin-like growth factor binding protein 6, AXL receptor tyrosine kinase, omentin, pentraxin-3 and osteopontin. Findings suggest that there is a preferential processing of APP to A beta(1-40) over A beta(1-42), and a potential role for the carboxylase activity of the gamma-secretase protein, which preferentially splices sAPP beta to A beta(1-40). Other markers are associated with the breakdown and remodeling of the extracellular matrix, and loss of homeostasis, possibly within the photoreceptor-retinal pigment epithelium-choriocapillaris complex. These data suggest novel disease pathways associated with GA pathogenesis and could provide potential novel targets for treatment of GA.	[Lashkari, Kameran; Teague, Gianna C.; Beattie, Ursula] Harvard Med Sch, Schepens Eye Res Inst Mass Eye & Ear, Boston, MA 02115 USA; [Betts, Joanna; Kumar, Sanjay; McLaughlin, Megan M.; Lopez, Francisco J.] GlaxoSmithKline, Alternat Discovery & Dev, King Of Prussia, PA USA; [Lashkari, Kameran] Univ Massachusetts, Dept Bioengn, Dartmouth, NS, Canada; [Betts, Joanna] GlaxoSmithKline, Computat Biol, Stevenage, Herts, England; [Kumar, Sanjay] GlaxoSmithKline, Novel Human Genet Res Unit, King Of Prussia, PA USA; [McLaughlin, Megan M.] GlaxoSmithKline, Dev, King Of Prussia, PA USA; [Lopez, Francisco J.] Allergan Abbvie Co, Clin Dev Ophthalmol, Irvine, CA USA	Harvard University; Harvard Medical School; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Lashkari, K (corresponding author), Harvard Med Sch, Schepens Eye Res Inst Mass Eye & Ear, Boston, MA 02115 USA.; Lashkari, K (corresponding author), Univ Massachusetts, Dept Bioengn, Dartmouth, NS, Canada.	klashkari@umassd.edu		Beattie, Ursula/0000-0002-7131-3712	GlaxoSmithKline, King of Prussia, PA, USA [4100112]; GlaxoSmithKline	GlaxoSmithKline, King of Prussia, PA, USA; GlaxoSmithKline(GlaxoSmithKline)	This work was supported by Grant 4100112, GlaxoSmithKline, King of Prussia, PA, USA (https//us gsk corn) awarded to KL. Coauthors, JB, SK, MMcLM and FJL received funding from GlaxoSmithKline in the form of salaries. The funders of this study had no role in data collection and analysis or the decision to publish. GlaxoSmithKline authors contributed to study design, the interpretation of results and preparation of the manuscript.	Almonte AG, 2011, BRAIN RES, V1407, P107, DOI 10.1016/j.brainres.2011.06.042; Anderson DH, 2004, EXP EYE RES, V78, P243, DOI 10.1016/j.exer.2003.10.011; [Anonymous], 2018, MODERN RETINA; Ardeljan D, 2011, DRUG FUTURE, V36, P713, DOI 10.1358/dof.2011.36.9.1678338; Bednar A, 2013, INVEST OPHTH VIS SCI, P54; Benjamini Y, 2001, ANN STAT, V29, P1165; Bird AC, 2014, JAMA OPHTHALMOL, V132, P338, DOI 10.1001/jamaophthalmol.2013.5799; Box GEP, 1964, J ROYAL STAT SOC B, V26, P42; Box GEPH, 1974, TECHNOMETRICS, V16, P5; Boyer DS, 2017, RETINA-J RET VIT DIS, V37, P819, DOI 10.1097/IAE.0000000000001392; C.T. R, 2013, LANG ENV STAT COMP; Campbell JC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075302 24086502, DOI 10.1371/JOURNAL.PONE.0075302 24086502]; Cha DM, 2013, INVEST OPHTH VIS SCI, V54, P7038, DOI 10.1167/iovs.13-12730; Chang SW, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00058; Crabb JW, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a017194; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Cuchillo-Ibanez I, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-2; Daigo K, 2016, IMMUNOL REV, V274, P202, DOI 10.1111/imr.12476; Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484; Demars MP, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt77; Deng L., 2019, FRONT MOL NEUROSCI, V12, P14; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fandos Noelia, 2017, Alzheimers Dement (Amst), V8, P179, DOI 10.1016/j.dadm.2017.07.004; Hernandez-Zimbron LF, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8374647; Finger RP, 2014, OPHTHALMOLOGY, V121, P1252, DOI 10.1016/j.ophtha.2013.12.034; Grassmann F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0548-0; Greferath U, 2016, OPHTHALMOLOGY, V123, P1320, DOI 10.1016/j.ophtha.2016.02.009; Holz FG, 2018, JAMA OPHTHALMOL, V136, P666, DOI 10.1001/jamaophthalmol.2018.1544; Inoue K, 2017, CELL REP, V21, P1727, DOI 10.1016/j.celrep.2017.10.075; Jeffrey Cheng QEG, 2018, OPHTHALMOLOGY RETINA, V2, P8; Johnson AJ, 2007, CLIN VACCINE IMMUNOL, V14, P1084, DOI 10.1128/CVI.00115-07; Juel HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132800; Kovacs K, 2015, INVEST OPHTH VIS SCI, V56, P6523, DOI 10.1167/iovs.15-16793; Kremlitzka M, 2018, HUM MOL GENET, V27, P2678, DOI 10.1093/hmg/ddy178; Lambert NG, 2016, PROG RETIN EYE RES, V54, P64, DOI 10.1016/j.preteyeres.2016.04.003; Lashkari K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195751; Liu RT, 2013, INVEST OPHTH VIS SCI, V54, P2225, DOI 10.1167/iovs.12-10849; Miriam F-F, 2010, BIOCHIM BIOPHYS ACTA, V1803, P3, DOI DOI 10.1016/J.BBAMCR.2009.07.004; Mo FM, 2010, INVEST OPHTH VIS SCI, V51, P4226, DOI 10.1167/iovs.09-3910; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Nielsen M.K. SY, 2019, ACTA OPHTHALMOL, V97, P7, DOI [10.1111/aos.13859, DOI 10.1111/AOS.13859]; Nita M, 2014, MED SCI MONITOR, V20, P1003, DOI 10.12659/MSM.889887; Rabenstein M, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0098-x; Rabiolo A, 2017, CLIN OPHTHALMOL, V11, P1707, DOI 10.2147/OPTH.S130165; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Rosenfeld PJ, 2018, OPHTHALMOL RETINA, V2, P1028, DOI 10.1016/j.oret.2018.03.001; Ross RJ, 2007, EXPERT REV OPHTHALMO, V2, P443, DOI 10.1586/17469899.2.3.443; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Sadda SR, 2016, RETINA-J RET VIT DIS, V36, P1806, DOI 10.1097/IAE.0000000000001283; Seddon JM, 2013, NAT GENET, V45, P1366, DOI 10.1038/ng.2741; Seth A, 2008, INVEST OPHTH VIS SCI, V49, P743, DOI 10.1167/iovs.07-1072; Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P339, DOI 10.1016/j.ophtha.2011.07.056; Song HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149269; Sunness JS, 1997, OPHTHALMOLOGY, V104, P1677, DOI 10.1016/S0161-6420(97)30079-7; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; Wang JY, 2008, J IMMUNOL, V181, P712, DOI 10.4049/jimmunol.181.1.712; Wang JY, 2009, J CELL PHYSIOL, V220, P119, DOI 10.1002/jcp.21742; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yaspan BL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf1443; Zanzottera EC, 2016, RETINA-J RET VIT DIS, V36, pS26, DOI 10.1097/IAE.0000000000001330; Zhao Q, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue5-fulltext-2; Zhao YH, 2015, MOL NEUROBIOL, V52, P533, DOI 10.1007/s12035-014-8886-3	64	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0236283	10.1371/journal.pone.0236283	http://dx.doi.org/10.1371/journal.pone.0236283			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764794	Green Published, gold			2022-12-26	WOS:000561029000064
J	Noumonvi, KD; Ferlan, M				Noumonvi, Koffi Dodji; Ferlan, Mitja			Empirical vs. light-use efficiency modelling for estimating carbon fluxes in a mid-succession ecosystem developed on abandoned karst grassland	PLOS ONE			English	Article							GROSS PRIMARY PRODUCTION; PRIMARY PRODUCTIVITY; REMOTE ESTIMATION; VEGETATION; MODIS; RESPIRATION; CANOPY; MAIZE; SOIL; PHOTOSYNTHESIS	Karst systems represent an important carbon sink worldwide. However, several phenomena such as the CO(2)degassing and the exchange of cave air return a considerable amount of CO(2)to the atmosphere. It is therefore of paramount importance to understand the contribution of the ecosystem to the carbon budget of karst areas. In this study conducted in a mid-succession ecosystem developed on abandoned karst grassland, two types of model were assessed, estimating the gross primary production (GPP) or the net ecosystem exchange (NEE) based on seven years of eddy covariance data (2013-2019): (1) a quadratic vegetation index-based empirical model with five alternative vegetation indices as proxies of GPP and NEE, and (2) the vegetation photosynthesis model (VPM) which is a light use efficiency model to estimate only GPP. The Enhanced Vegetation Index (EVI) was the best proxy for NEE whereas SAVI performed very similarly to EVI in the case of GPP in the empirical model setting. The empirical model performed better than the VPM model which tended to underestimate GPP. Therefore, for this ecosystem, we suggest the use of the empirical model provided that the quadratic relationship observed persists. However, the VPM model would be a good alternative under a changing climate, as it is rooted in the understanding of the photosynthesis process, if the scalars it involves could be improved to better estimate GPP.	[Noumonvi, Koffi Dodji; Ferlan, Mitja] Slovenian Forestry Inst, Dept Forest Ecol, Ljubljana, Slovenia	Slovenian Forestry Institute	Noumonvi, KD (corresponding author), Slovenian Forestry Inst, Dept Forest Ecol, Ljubljana, Slovenia.	noumonvikoffidodji@hotmail.fr		Noumonvi, Koffi Dodji/0000-0002-3305-174X	European Research Council under the European Union [774234]; Slovenian Research Agency [Z4-8217, J4-9297, P4-0107]	European Research Council under the European Union(European Research Council (ERC)); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This research was funded by the European Research Council under the European Union's Horizon 2020 research and innovation program under grant agreement No. 774234, and also by the Slovenian Research Agency, projects Z4-8217 and J4-9297 and research program P4-0107.	Gilabert MA, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9030193; Ardo J., 2015, CARBON BAL MANAGE, V10, P3, DOI [10.1186/s13021-015-0013-x, DOI 10.1186/S13021-015-0013-X]; Benjamin K, 2005, LANDSCAPE ECOL, V20, P627, DOI 10.1007/s10980-005-0068-2; Burnham KP, 2002, INFORM THEORETIC APP, V172, P70, DOI [10.1016/j.ecolmodel.2003.11.004, DOI 10.1016/J.ECOLMODEL.2003.11.004]; Chirici G, 2016, J GEOPHYS RES-BIOGEO, V121, P266, DOI 10.1002/2015JG003019; Cooper J, 2009, HUM FACTORS ERGON, P3; Desai AR, 2008, AGR FOREST METEOROL, V148, P821, DOI 10.1016/j.agrformet.2007.11.012; Dong JW, 2015, REMOTE SENS ENVIRON, V162, P154, DOI 10.1016/j.rse.2015.02.022; Dong TF, 2017, IEEE J-STARS, V10, P104, DOI 10.1109/JSTARS.2016.2605303; Ferlan M, 2011, AGR ECOSYST ENVIRON, V140, P199, DOI 10.1016/j.agee.2010.12.003; Ferlan M., 2013, THESIS; Ferlan M, 2016, AGR ECOSYST ENVIRON, V220, P152, DOI 10.1016/j.agee.2016.01.020; Fernandez-Martinez M, 2014, NAT CLIM CHANGE, V4, P471, DOI [10.1038/nclimate2177, 10.1038/NCLIMATE2177]; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; Gitelson AA, 1996, REMOTE SENS ENVIRON, V58, P289, DOI 10.1016/S0034-4257(96)00072-7; Gitelson AA, 2019, REMOTE SENS LETT, V10, P283, DOI 10.1080/2150704X.2018.1547445; Gitelson AA, 2012, REMOTE SENS ENVIRON, V121, P404, DOI 10.1016/j.rse.2012.02.017; Goerner A, 2009, REMOTE SENS ENVIRON, V113, P1101, DOI 10.1016/j.rse.2009.02.001; Heinsch F.A., 2003, USERS GUIDE GPP NPP, P57; Hilker T, 2008, SCI TOTAL ENVIRON, V404, P411, DOI 10.1016/j.scitotenv.2007.11.007; Huang XJ, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11151823; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; HUETE AR, 1985, REMOTE SENS ENVIRON, V17, P37, DOI 10.1016/0034-4257(85)90111-7; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Jenkins JP, 2007, AGR FOREST METEOROL, V143, P64, DOI 10.1016/j.agrformet.2006.11.008; Jia X, 2020, SCI TOTAL ENVIRON, V709, DOI 10.1016/j.scitotenv.2019.136210; Larsen KS, 2007, BIOGEOCHEMISTRY, V85, P201, DOI 10.1007/s10533-007-9129-8; Lasslop G, 2010, GLOBAL CHANGE BIOL, V16, P187, DOI 10.1111/j.1365-2486.2009.02041.x; Liu ZJ, 2014, REMOTE SENS-BASEL, V6, P10215, DOI 10.3390/rs61010215; Madani N, 2014, J GEOPHYS RES-BIOGEO, V119, P1755, DOI 10.1002/2014JG002709; Mahadevan P, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002735; MEEK DW, 1984, AGRON J, V76, P939, DOI 10.2134/agronj1984.00021962007600060018x; Nestola E, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8030260; Niu B, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8070592; Noumonvi KD, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11060649; RAICH JW, 1991, ECOL APPL, V1, P399, DOI 10.2307/1941899; Rossini M, 2012, BIOGEOSCIENCES, V9, P2565, DOI 10.5194/bg-9-2565-2012; Rouse JW, 1974, P 3 EARTH RES SAT S; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; SCHUEPP PH, 1990, BOUND-LAY METEOROL, V50, P353; Schwalm CR, 2006, AGR FOREST METEOROL, V140, P269, DOI 10.1016/j.agrformet.2006.06.010; Sjostrom M, 2013, REMOTE SENS ENVIRON, V131, P275, DOI 10.1016/j.rse.2012.12.023; Song CH, 2013, PROG PHYS GEOG, V37, P834, DOI 10.1177/0309133313507944; Stoy PC, 2013, AGR FOREST METEOROL, V171, P137, DOI 10.1016/j.agrformet.2012.11.004; Sun ZY, 2019, SCI TOTAL ENVIRON, V668, P696, DOI 10.1016/j.scitotenv.2019.03.025; Veroustraete F, 2002, REMOTE SENS ENVIRON, V83, P376, DOI 10.1016/S0034-4257(02)00043-3; White WB, 2013, ACTA CARSOLOGICA, V42, P177; Wohlfahrt G, 2010, BIOGEOSCIENCES, V7, P683, DOI 10.5194/bg-7-683-2010; Wu CY, 2010, REMOTE SENS ENVIRON, V114, P2925, DOI 10.1016/j.rse.2010.07.012; Wu CS, 2016, SCI REP-UK, V6, DOI 10.1038/srep21561; Wutzler T, 2018, BIOGEOSCIENCES, V15, P5015, DOI 10.5194/bg-15-5015-2018; Xiao XM, 2005, ECOL APPL, V15, P954, DOI 10.1890/04-0470; Xiao XM, 2004, REMOTE SENS ENVIRON, V91, P256, DOI 10.1016/j.rse.2004.03.010; Xiao XM, 2004, REMOTE SENS ENVIRON, V89, P519, DOI 10.1016/j.rse.2003.11.008; Xiao XM, 2005, REMOTE SENS ENVIRON, V95, P480, DOI 10.1016/j.rse.2004.12.009; Yan W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122486; Yu GR, 2008, GLOBAL CHANGE BIOL, V14, P2555, DOI 10.1111/j.1365-2486.2008.01663.x; Yuan WP, 2007, AGR FOREST METEOROL, V143, P189, DOI 10.1016/j.agrformet.2006.12.001; Yuan WP, 2014, AGR FOREST METEOROL, V192, P108, DOI 10.1016/j.agrformet.2014.03.007; Zhao L, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18113965; Zhou XD, 2002, INT GEOSCI REMOTE SE, P3252, DOI 10.1109/IGARSS.2002.1027146	62	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237351	10.1371/journal.pone.0237351	http://dx.doi.org/10.1371/journal.pone.0237351			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764813	Green Published, gold			2022-12-26	WOS:000561029000029
J	Zhao, SM; Liu, R; Fei, CW; Zia, AW; Jing, LX				Zhao, Shumi; Liu, Rong; Fei, Chengwei; Zia, Abdul Wasy; Jing, Lingxiao			Flexible sensor matrix film-based wearable plantar pressure force measurement and analysis system	PLOS ONE			English	Article							GAIT ANALYSIS-METHODS	Plantar pressure force data derived from gait and posture are commonly used as health indicators for foot diagnosis, injury prevention, and rehabilitation. This study developed a wearable plantar pressure force measurement and analysis (WPPFMA) system based on a flexible sensor matrix film to monitor plantar pressure force in real time. The developed system comprised a flexible sensor matrix film embedded in the insole of the shoe, a wearable data acquisition (DAQ) device with a Bluetooth module, and dedicated software with an intuitive graphical user interface for displaying the plantar pressure force data from receivers by using a terminal unit (laptop or smart-phone). The flexible sensor matrix film integrated 16 piezoresistive cell sensors to detect pressure force at different anatomical zones of the plantar and under different body positions. The signals from the flexible sensor matrix film were collected using the DAQ module embedded in the shoe and transmitted to the receivers through Bluetooth. The real-time display and analysis software can monitor, visualize, and record the detailed plantar pressure force data, such as average pressure force, maximum pressure force, and pressure force distributions and variations over time. The outcomes of the trials in which the system was worn revealed the applicability of the developed WPPFMA system for monitoring plantar pressure force under static and dynamic wearing conditions. The plantar pressure force data derived from this system provide valuable insights for personal foot care, gait analysis, and clinical diagnosis.	[Zhao, Shumi; Liu, Rong; Fei, Chengwei; Zia, Abdul Wasy; Jing, Lingxiao] Hong Kong Polytech Univ, Inst Text & Clothing, Hung Hom, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Liu, R (corresponding author), Hong Kong Polytech Univ, Inst Text & Clothing, Hung Hom, Kowloon, Hong Kong, Peoples R China.	rong.liu@polyu.edu.hk	Zia, Abdul Wasy/AAW-7664-2021; Zia, Abdul Wasy/B-3505-2012; LIU, Rong/C-2427-2017	Zia, Abdul Wasy/0000-0002-3748-4446; LIU, Rong/0000-0002-4484-5203; Zhao, Shumi/0000-0002-0204-3819	Innovation and Technology Fund of the Hong Kong SAR Government [ITP/026/17TP]	Innovation and Technology Fund of the Hong Kong SAR Government	This study was supported by Innovation and Technology Fund (ITP/026/17TP) of the Hong Kong SAR Government. RL received the award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafsha F, 2018, 2018 IEEE INT INSTR; Behrens I, 2003, J MICROMECH MICROENG, V13, pS171, DOI 10.1088/0960-1317/13/4/325; Brimacombe JM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005165; Bryant A., 1999, FOOT, V9, P115, DOI DOI 10.1054/F00T.1999.0538; Caldas R, 2017, GAIT POSTURE, V57, P204, DOI 10.1016/j.gaitpost.2017.06.019; Cheng YL, 2010, FOOTWEAR SCI, V2, P149, DOI 10.1080/19424280.2010.520678; De Silva A. H. T. E., 2018, Informatics in Medicine Unlocked, V12, P98, DOI 10.1016/j.imu.2018.07.001; Deng CR, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201801606; Gerlach C, 2015, IEEE SENS J, V15, P3647, DOI 10.1109/JSEN.2015.2392084; Hamid R, 2017, ENG MED BIOL SOC EMB; Huang HH, 2017, CONS EL GCCE 2017 IE; 배강호, 2016, [Korean Journal of Sport Biomechanics, 한국운동역학회지], V26, P115; Kim J-W, 2007, WORLD C MED PHYS BIO; Kim YT, 2012, PROSTHET ORTHOT INT, V36, P159, DOI 10.1177/0309364611433444; Lau PH, 2013, NANO LETT, V13, P3864, DOI 10.1021/nl401934a; Lin F, 2016, IEEE T IND INFORM, V12, P2281, DOI 10.1109/TII.2016.2585643; Lou CG, 2017, MATERIALS, V10, DOI 10.3390/ma10091068; Majumder A, 2014, REHABILITATION ENG A; Muro-de-la-Herran A, 2014, SENSORS-BASEL, V14, P3362, DOI 10.3390/s140203362; Neal BS, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/s13047-014-0055-4; Perumal SV, 2016, ICT EXPRESS, V2, P168, DOI 10.1016/j.icte.2016.10.005; Pothuganti Karunakar, 2014, 22311297 ISSN, V4, P655; Rajala S, 2017, IEEE SENS J, V17, P6798, DOI 10.1109/JSEN.2017.2750241; Ramirez-Bautista Julian Andres, 2017, IEEE Rev Biomed Eng, V10, P299, DOI 10.1109/RBME.2017.2747402; Razak AHA, 2012, SENSORS-BASEL, V12, P9884, DOI 10.3390/s120709884; Rim YS, 2016, ADV MATER, V28, P4415, DOI 10.1002/adma.201505118; Sabry AH, 2018, MALAYS J FUNDAM APPL, V14, P96; Shu L, 2010, IEEE T INF TECHNOL B, V14, P767, DOI 10.1109/TITB.2009.2038904; Soltanzadeh Z, 2017, J AM PODIAT MED ASSN, V107, P30, DOI 10.7547/14-085; Tan AM, 2015, PROC TECH, V20, P117, DOI 10.1016/j.protcy.2015.07.020; Teymouri M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187359; Tong JWK, 2013, J ORTHOP SPORT PHYS, V43, P700, DOI 10.2519/jospt.2013.4225; Waite LM, 2005, J NEUROL SCI, V229, P89, DOI 10.1016/j.jns.2004.11.009; Woodburn J, 1996, CLIN BIOMECH, V11, P301, DOI 10.1016/0268-0033(95)00071-2; Yang GL, 2019, CLUSTER COMPUT, V22, pS3021, DOI 10.1007/s10586-018-1830-y	35	8	8	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237090	10.1371/journal.pone.0237090	http://dx.doi.org/10.1371/journal.pone.0237090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764796	Green Published, gold			2022-12-26	WOS:000561029000065
J	Ahinkorah, BO				Ahinkorah, Bright Opoku			Predictors of unmet need for contraception among adolescent girls and young women in selected high fertility countries in sub-Saharan Africa: A multilevel mixed effects analysis	PLOS ONE			English	Article							BARRIERS; HEALTH; ACCESS; TRENDS; CARE	Introduction Despite the desire of adolescent girls and young women (AGYW) in sub-Saharan Africa (SSA) to use contraceptives, the majority of them have challenges with access to contraceptive services. This is more evident in high fertility countries in SSA. The purpose of this study was to examine the predictors of unmet need for contraception among AGYW in selected high fertility countries in SSA. Materials and methods Data from current Demographic and Health Surveys (DHS) carried out between 2010 and 2018 in 10 countries in SSA were analysed. A sample size of 24,898 AGYW who were either married or cohabiting was used. Unmet need for contraception was the outcome variable in this study. The explanatory variables were age, marital status, occupation, educational level, frequency of reading newspaper/magazine, frequency of listening to radio, frequency of watching television and parity (individual level variables) and wealth quintile, sex of household head, place of residence and decision-maker in healthcare (household/community level variables). Descriptive and multilevel logistic regression analyses were carried out. The results of the multilevel logistic regression analyses were reported using adjusted odds ratios at 95% confidence interval. Results The prevalence of unmet need for contraception in all the countries considered in this study was 24.9%, with Angola, recording the highest prevalence of 42.6% while Niger had the lowest prevalence of 17.8%. In terms of the individual level predictors, the likelihood of unmet need for contraception was low among AGYW aged 20-24 [aOR = 0.82; 95% CI = 0.76-0.88], those with primary [aOR = 1.22; 95% CI = 1.13-1.31] and secondary/higher levels of formal education [aOR = 1.18; 95% CI = 1.08-1.28, p < 0.001], cohabiting AGYW [aOR = 1.52; 95% CI = 1.42-1.63] and AGYW with three or more births [aOR = 3.41; 95% CI = 3.02-3.85]. At the household/community level, the odds of unmet need for contraception was highest among poorer AGYW [aOR = 1.36; 95% CI = 1.21-1.53], AGYW in female-headed households [aOR = 1.22; 95% CI = 1.13-1.33], urban AGYW [aOR = 1.21; 95% CI = 1.11-1.32] and AGYW who took healthcare decisions alone [aOR = 1.10; 95% CI = 1.01-1.21]. Conclusion This study has identified disparities in unmet need for contraception among AGYW in high fertility countries in SSA, with AGYW in Angola having the highest prevalence. Both individual and household/community level factors predicted unmet need for contraception among AGYW in this study. However, based on the ICC values, household/community level factors prevailed the individual level factors. Enhancing access to contraception among poorer AGYW, those in female-headed households, those in urban areas and those who take healthcare decisions alone by both governmental and non-governmental organisations in high fertility countries is recommended.	[Ahinkorah, Bright Opoku] Univ Technol Sydney, Fac Hlth, Australian Ctr Populat & Publ Hlth Res ACPPHR, Liverpool, NSW, Australia	University of Technology Sydney	Ahinkorah, BO (corresponding author), Univ Technol Sydney, Fac Hlth, Australian Ctr Populat & Publ Hlth Res ACPPHR, Liverpool, NSW, Australia.	brightahinkorah@gmail.com						Amo-Adjei J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3842-y; [Anonymous], 2020, TOTAL FERTILITY RATE; [Anonymous], 2019, FERT VER YOUNG AD; [Anonymous], 2015, UNMET NEED FAMILY PL; [Anonymous], 2012, ADOLESCENTS YOUNG PE; [Anonymous], **NON-TRADITIONAL**; Appiah F, 2020, SSM-POPUL HLTH, V10, DOI 10.1016/j.ssmph.2020.100554; Asif MF., 2019, BMC PUBLIC HEALTH, V19, P1, DOI [10.1186/s12889-018-6343-3, DOI 10.1186/S12889-018-6343-3]; Austin PC, 2017, STAT MED, V36, P3257, DOI 10.1002/sim.7336; Avogo WA, 2019, J ENVIRON PUBLIC HEA, V2019, DOI 10.1155/2019/9731756; Bankole A, 2010, STUD FAMILY PLANN, V41, P117, DOI 10.1111/j.1728-4465.2010.00232.x; Behrman JA, 2018, STUD FAMILY PLANN, V49, P319, DOI 10.1111/sifp.12075; Blum RW, 2007, J ADOLESCENT HEALTH, V41, P230, DOI 10.1016/j.jadohealth.2007.04.005; Capurchande R, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0326-2; CHANDRAMOULI V, 2014, REPROD HEALTH, V0011; Cleland J, 2014, STUD FAMILY PLANN, V45, P105, DOI 10.1111/j.1728-4465.2014.00380.x; Cornish H, 2021, CULT HEALTH SEX, V23, P19, DOI 10.1080/13691058.2019.1683229; Corsi DJ, 2012, INT J EPIDEMIOL, V41, P1602, DOI 10.1093/ije/dys184; Darroch JE, 2013, LANCET, V381, P1756, DOI 10.1016/S0140-6736(13)60597-8; Darroch JE, 2013, CONTRACEPTION, V87, P259, DOI 10.1016/j.contraception.2012.08.029; Darroch JE, 2011, CONTRACEPTIVE TECHNO, V201; Dingeta T, 2019, OPEN ACCESS J CONTR, V10, P89, DOI 10.2147/OAJC.S227260; Durojaye E, 2011, COMP INT LAW J SOUTH, V44, P1; Durowade KA, 2017, ETHIOP J HEALTH SCI, V27, P121, DOI 10.4314/ejhs.v27i2.4; FINDLEY SE, 2013, AFRICAN J REPROD HLT, V0013, DOI DOI 10.1186/1471-2458-13-1034; Geary RS, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-259; Gelman A., 2007, DATA ANAL USING REGR; Govender K, 2019, S AFR J PSYCHOL, V49, P52, DOI 10.1177/0081246318757932; Gulliford MC, 2005, J CLIN EPIDEMIOL, V58, P246, DOI 10.1016/j.jclinepi.2004.08.012; Guure C, 2019, ARCH PUBLIC HEALTH, V77, DOI 10.1186/s13690-019-0340-6; Hall Kelli Stidham, 2018, Qual Res Med Healthc, V2, P55, DOI 10.4081/qrmh.2018.7062; Huda TM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211113; Ibarra-Nava I, 2020, BMC PUBLIC HLTH, V20, P1, DOI [10.1186/s12889-019-7969-5, DOI 10.1186/S12889-019-7969-5]; Juarez F, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5439-0; Kabiru CW, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-11; Khan NF, 2011, BRIT J CANCER, V105, pS46, DOI 10.1038/bjc.2011.422; Khanam M, 2019, HEALTH SERV RES MANA, V6, DOI 10.1177/2333392819876555; Machiyama K, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0268-z; Makola L, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0861-8; Mekonnen W, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-37; Merlo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153778; Mokomane Z, 2006, J COMP FAM STUD, V37, P25, DOI 10.3138/jcfs.37.1.25; Moreau C, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001581; Naidoo K, 2019, SAGE OPEN, V9, DOI 10.1177/2158244019859951; Nzokirishaka A, 2018, CONTRACEP REPROD MED, V3, DOI 10.1186/s40834-018-0062-0; Ochako R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1483-1; Odimegwu C., 2018, S AFR J DEMOGR, V18, P111; Osamor PE, 2016, INT J WOMENS HEALTH, V8, P191, DOI 10.2147/IJWH.S105483; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Radovich E, 2018, J ADOLESCENT HEALTH, V62, P273, DOI 10.1016/j.jadohealth.2017.09.013; Ritchwood TD, 2015, CHILD YOUTH SERV REV, V52, P74, DOI 10.1016/j.childyouth.2015.03.005; Sedgh G, 2018, WORLDWIDE RALHW; Seidu AA, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2019.100459; Sidze EM, 2014, INT PERSPECT SEX R H, V40, P176, DOI 10.1363/4017614; Smith T, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1469-8; Solanke BL, 2019, CONTRACEP REPROD MED, V4, DOI 10.1186/s40834-019-0093-1; Tadele A, 2019, CONTRACEP REPROD MED, V4, DOI 10.1186/s40834-019-0087-z; Tegegn M, 2017, CONTRACEP REPROD MED, V2, DOI 10.1186/s40834-017-0048-3; Thatte N, 2016, AFR J REPROD HEALTH, V20, P53, DOI 10.29063/ajrh2016/v20i2.6; Tsui AO, 2017, POPUL DEV REV, V43, P166, DOI 10.1111/padr.12051; United Nations. Department of E Social A, 2007, WORLD YOUTH REP 2007; Westoff CF, 2012, UNMET NEED MODERN CO; Wulifan JK, 2019, CONTRACEP REPROD MED, V4, DOI 10.1186/s40834-018-0083-8; Wulifan JK, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-015-0281-3; Yaya S, 2018, PLOS ONE, V13; Yaya S, 2019, BMC INT HEALTH HUM R, V19, DOI 10.1186/s12914-019-0219-1	66	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236352	10.1371/journal.pone.0236352	http://dx.doi.org/10.1371/journal.pone.0236352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2EP	32760153	gold, Green Published			2022-12-26	WOS:000561027200060
J	Chelladurai, JRJJ; Martin, KA; Chinchilla-Vargas, K; Castro, PJD; Kaplan, RM; Brewer, MT				Jesudoss Chelladurai, Jeba R. J.; Martin, Katy A.; Chinchilla-Vargas, Krystal; Jimenez Castro, Pablo D.; Kaplan, Ray M.; Brewer, Matthew T.			Laboratory assays reveal diverse phenotypes among microfilariae ofDirofilaria immitisisolates with known macrocyclic lactone susceptibility status	PLOS ONE			English	Article							ANTHELMINTIC RESISTANCE; P-GLYCOPROTEIN; BINDING-SITES; HEARTWORM; QUANTITATION; MECHANISMS; IVERMECTIN; VIABILITY; NEMATODES; EFFICACY	Prevention of canine heartworm disease caused byDirofilaria immitisrelies on chemoprophylaxis with macrocyclic lactone anthelmintics. Alarmingly, there are increased reports ofD.immitisisolates with resistance to macrocyclic lactones and the ability to break through prophylaxis. Yet, there is not a well-established laboratory assay that can utilize biochemical phenotypes of microfilariae to predict drug resistance status. In this study we evaluated laboratory assays measuring cell permeability, metabolism, and P-glycoprotein-mediated efflux. Our assays revealed that trypan blue, propidium iodide staining, and resazurin metabolism could detect differences amongD.immitisisolates but none of these approaches could accurately predict drug susceptibility status for all resistant isolates tested. P-glycoprotein assays suggested that the repertoire of P-gp expression is likely to vary among isolates, and investigation of pharmacological differences among different P-gp genes is warranted. Further research is needed to investigate and optimize laboratory assays forD.immitismicrofilariae, and caution should be applied when adapting cell death assays to drug screening studies for nematode parasites.	[Jesudoss Chelladurai, Jeba R. J.; Martin, Katy A.; Chinchilla-Vargas, Krystal; Brewer, Matthew T.] Iowa State Univ, Coll Vet Med, Dept Vet Pathol, Ames, IA 50011 USA; [Jimenez Castro, Pablo D.; Kaplan, Ray M.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA; [Jimenez Castro, Pablo D.] Univ Nacl Colombia, Grp Parasitol Vet, Bogota, Colombia	Iowa State University; University System of Georgia; University of Georgia; Universidad Nacional de Colombia	Brewer, MT (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Pathol, Ames, IA 50011 USA.	brewermt@iastate.edu	Chelladurai, Jeba Jesudoss/AAJ-8621-2020	Chelladurai, Jeba Jesudoss/0000-0003-3077-0201; Chinchilla-Vargas, Krystal/0000-0003-0679-3542	AKC Canine Health Foundation [02458-A]; National Institutes of Health [5R21AI14449302]; USDA-NIFA [2017-04619]	AKC Canine Health Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA-NIFA(United States Department of Agriculture (USDA))	This work was supported by the AKC Canine Health Foundation grant 02458-A and National Institutes of Health grant 5R21AI14449302 to M.T.B. K.A.M. was supported by USDA-NIFA project #2017-04619. The sponsors did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader C, 2017, EXP PARASITOL, V181, P70, DOI 10.1016/j.exppara.2017.07.008; Ballesteros C, 2018, INT J PARASITOL-DRUG, V8, P596, DOI 10.1016/j.ijpddr.2018.06.006; Bourguinat C, 2016, INT J PARASITOL-DRUG, V6, P116, DOI 10.1016/j.ijpddr.2016.04.001; Bourguinat C, 2011, VET PARASITOL, V176, P374, DOI 10.1016/j.vetpar.2011.01.024; Chelladurai JJ, 2019, VET PARASITOL, V267, P75, DOI 10.1016/j.vetpar.2019.02.002; COMLEY JCW, 1989, INT J PARASITOL, V19, P77, DOI 10.1016/0020-7519(89)90024-6; DRAKE J, 2018, PARASITE VECTOR, V0011; Evans CC, 2017, VET PARASITOL, V246, P76, DOI 10.1016/j.vetpar.2017.09.003; Evans CC, 2013, INT J PARASITOL-DRUG, V3, P102, DOI 10.1016/j.ijpddr.2013.05.001; Ferreira RJ, 2013, J CHEM INF MODEL, V53, P1747, DOI 10.1021/ci400195v; Ferreira SR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/879263; Geary TG, 2011, TOP COMPANION ANIM M, V26, P186, DOI 10.1053/j.tcam.2011.09.004; Hampshire VA, 2005, VET PARASITOL, V133, P191, DOI 10.1016/j.vetpar.2005.04.004; Hu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070702; Hunt PR, 2012, FOOD CHEM TOXICOL, V50, P3280, DOI 10.1016/j.fct.2012.06.051; James CE, 2007, PARASITOL RES, V101, P975, DOI 10.1007/s00436-007-0572-1; Kerboeuf D, 2011, ANTIMICROB AGENTS CH, V55, P2224, DOI 10.1128/AAC.01477-10; Lebedeva IV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022429; Lucchetti C, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3645-y; Maclean MJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2436-6; Mani T, 2016, INT J PARASITOL, V46, P631, DOI 10.1016/j.ijpara.2016.04.004; Mansour NR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000795; Menez C, 2016, ANTIMICROB AGENTS CH, V60, P4809, DOI 10.1128/AAC.00713-16; Moorhead AR, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2441-9; Palikaras K, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2215; Paveley RA, 2013, PARASITE IMMUNOL, V35, P302, DOI 10.1111/pim.12037; Peak E, 2011, AN ACAD BRAS CIENC, V83, P649, DOI 10.1590/S0001-37652011000200024; PREMACHANDRAN D, 1988, J NEMATOL, V20, P70; Pulaski CN, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0494-6; Raza A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1806-9; Self SW, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3633-2; Silbereisen A, 2011, J MICROBIOL METH, V87, P169, DOI 10.1016/j.mimet.2011.08.009; Smith JM, 2002, J PARASITOL, V88, P612, DOI 10.1645/0022-3395(2002)088[0612:LOPGMI]2.0.CO;2; Tandon R, 2004, VET PARASITOL, V121, P125, DOI 10.1016/j.vetpar.2003.09.016; Tang FX, 2004, J PHARM SCI-US, V93, P1185, DOI 10.1002/jps.20046; Vatta AF, 2014, VET PARASITOL, V206, P38, DOI 10.1016/j.vetpar.2014.02.004; Whittaker JH, 2017, J VET PHARMACOL THER, V40, P105, DOI 10.1111/jvp.12330; WILKINS TD, 1972, ANTIMICROB AGENTS CH, V1, P451, DOI 10.1128/AAC.1.6.451; Williamson SM, 2012, J HELMINTHOL, V86, P202, DOI 10.1017/S0022149X11000216; Williamson SM, 2011, MOL BIOCHEM PARASIT, V180, P99, DOI 10.1016/j.molbiopara.2011.09.003; Wolstenholme AJ, 2015, PARASITOLOGY, V142, P1249, DOI 10.1017/S003118201500061X	41	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237150	10.1371/journal.pone.0237150	http://dx.doi.org/10.1371/journal.pone.0237150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760111	Green Published, gold			2022-12-26	WOS:000561027200028
J	Niki, M; Yoshiyama, T; Nagai, H; Miyamoto, Y; Niki, M; Oinuma, K; Tsubouchi, T; Kaneko, Y; Matsumoto, S; Sasaki, Y; Hoshino, Y				Niki, Mamikoc; Yoshiyama, Takashi; Nagai, Hideaki; Miyamoto, Yuji; Niki, Makoto; Oinuma, Ken-ichi; Tsubouchi, Taishi; Kaneko, Yukihiro; Matsumoto, Sohkichi; Sasaki, Yuka; Hoshino, Yoshihiko			Nutritional status positively impacts humoral immunity against its Mycobacterium tuberculosis, disease progression, and vaccine development	PLOS ONE			English	Article							ANTIBODY-MEDIATED IMMUNITY; C-REACTIVE PROTEIN/ALBUMIN; ACTIVE TUBERCULOSIS; FOAMY MACROPHAGES; PROGNOSTIC SCORE; IGA RESPONSES; B-CELLS; PULMONARY; MALNUTRITION; INFECTION	Nutritional status contributes to the regulation of immune responses against pathogens, and malnutrition has been considered as a risk factor for tuberculosis (TB).Mycobacterium tuberculosis(Mtb), the causative agent of TB, can modulate host lipid metabolism and induce lipid accumulation in macrophages, where the bacilli adopt a dormant phenotype. In addition, serum lipid components play dual roles in the regulation of and protection from Mtb infection. We analyzed the relationship between nutritional status and the humoral immune response in TB patients. We found that serum HDL levels are positively correlated with the serum IgA specific for Mtb antigens. Analysis of the relationship between serum nutritional parameters and clinical parameters in TB patients showed that serum albumin and CRP levels were negatively correlated before treatment. We also observed reduced serum LDL levels in TB patients following treatment. These findings may provide insight into the role of serum lipids in host immune responses against Mtb infection. Furthermore, improving the nutritional status may enhance vaccination efficacy.	[Niki, Mamikoc; Niki, Makoto; Oinuma, Ken-ichi; Tsubouchi, Taishi; Kaneko, Yukihiro] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Abeno Ku, Osaka, Japan; [Yoshiyama, Takashi; Sasaki, Yuka] Fukujuji Hosp, Japan AntiTB Assoc, Kiyose, Tokyo, Japan; [Nagai, Hideaki] Tokyo Natl Hosp, Natl Hosp Org, Kiyose, Tokyo, Japan; [Miyamoto, Yuji; Hoshino, Yoshihiko] Natl Inst Infect Dis, Leprosy Res Ctr, Dept Mycobacteriol, Aoba Ku, Higashimurayama, Tokyo, Japan; [Matsumoto, Sohkichi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Infect Dis Control & Int Med, Niigata, Japan	Osaka Metropolitan University; Fukujuji Hospital; National Institute of Infectious Diseases (NIID); Niigata University	Hoshino, Y (corresponding author), Natl Inst Infect Dis, Leprosy Res Ctr, Dept Mycobacteriol, Aoba Ku, Higashimurayama, Tokyo, Japan.	yhoshino@nih.go.jp			AMED [JP18FK0108075]; Japan Society for the Promotion of Science [16K09584, 18K08312]	AMED; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors are thankful to all healthcare workers and tuberculosis patients who participated in this study. This work was supported in part by AMED under Grant Number JP18FK0108075 (to Y. H.) and by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science for Mam. N. (16K09584) and Y. H. (18K08312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achkar JM, 2013, CELL HOST MICROBE, V13, P250, DOI 10.1016/j.chom.2013.02.009; Aguilo N, 2016, J INFECT DIS, V213, P831, DOI 10.1093/infdis/jiv503; Akpovi DC, 2013, AFR J BIOTECHNOL, V12, P6; Albers R, 2013, BRIT J NUTR, V110, pS1, DOI 10.1017/S0007114513001505; Alvarez N, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-S1-S3; Alvarez-Uria G, 2013, BIOIMPACTS, V3, P123, DOI 10.5681/bi.2013.025; Artero A, 2010, J CRIT CARE, V25, P276, DOI 10.1016/j.jcrc.2009.12.004; Baumann R, 2014, J INFECTION, V69, P581, DOI 10.1016/j.jinf.2014.05.014; Bhargava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077979; Bisaso Kuteesa R., 2014, In Silico Pharmacology, V2, P3, DOI 10.1186/s40203-014-0003-9; Caire-Brandli I, 2014, INFECT IMMUN, V82, P476, DOI 10.1128/IAI.01196-13; Casadevall A, 2003, INFECT IMMUN, V71, P4225, DOI 10.1128/IAI.71.8.4225-4228.2003; Chandra RK, 2002, EUR J CLIN NUTR, V56, pS73, DOI 10.1038/sj.ejcn.1601492; Chandrasekaran P, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01316; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Culkin SJ, 1997, J IMMUNOL, V158, P3277; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deniz O, 2007, CLIN BIOCHEM, V40, P162, DOI 10.1016/j.clinbiochem.2006.10.015; Dodd CE, 2016, J IMMUNOL, V197, P4727, DOI 10.4049/jimmunol.1600856; Gebremicael Gebremedhin, 2017, Int J Chronic Dis, V2017, P3843291, DOI 10.1155/2017/3843291; Glatman-Freedman A, 2006, TUBERCULOSIS, V86, P191, DOI 10.1016/j.tube.2006.01.008; HARRIES AD, 1985, HUM NUTR-CLIN NUTR, V39C, P361; Hoft DF, 2018, MUCOSAL IMMUNOL, V11, P486, DOI 10.1038/mi.2017.67; Inoue M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24233-1; Jacobs AJ, 2016, TUBERCULOSIS, V101, P102, DOI 10.1016/j.tube.2016.08.001; Joller N, 2010, P NATL ACAD SCI USA, V107, P20441, DOI 10.1073/pnas.1013827107; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Kim MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132109; Kinoshita A, 2015, ANN SURG ONCOL, V22, P803, DOI 10.1245/s10434-014-4048-0; Krawinkel MB, 2012, ANN NUTR METAB, V61, P39, DOI 10.1159/000345162; Lai R, 2015, EUR RESPIR REV, V24, P356, DOI 10.1183/16000617.00002515; Langhorne J, 1998, P NATL ACAD SCI USA, V95, P1730, DOI 10.1073/pnas.95.4.1730; Legesse M, 2013, SCAND J IMMUNOL, V78, P266, DOI 10.1111/sji.12080; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Maier EA, 2013, VACCINE, V32, P48, DOI 10.1016/j.vaccine.2013.10.072; Micha R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2272; Monteiro-Maia Renata, 2006, J Immune Based Ther Vaccines, V4, P4, DOI 10.1186/1476-8518-4-4; Moore SE, 2003, ACTA PAEDIATR, V92, P170, DOI 10.1111/j.1651-2227.2003.tb00522.x; MURATE T, 1992, INTERNAL MED, V31, P185, DOI 10.2169/internalmedicine.31.185; Niki M, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/4928757; Niki M, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/527395; Organization WH, 2017, GLOB TBERC REP 2017; OZ H, 2017, NUTRIENTS, V9; Palanisamy GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034148; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P9130, DOI 10.1073/pnas.0804298105; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Rho S, 2017, IMMUNOL LETT, V190, P247, DOI 10.1016/j.imlet.2017.08.025; Rodriguez A, 2005, VACCINE, V23, P2565, DOI 10.1016/j.vaccine.2004.11.032; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Santucci P, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00122; Sasaki Kosuke, 2002, Nihon Naika Gakkai Zasshi, V91 Suppl, P94; Savy M, 2009, J NUTR, V139, p2154S, DOI 10.3945/jn.109.105312; SENGUPTA SR, 1949, BRIT J NUTR, V2, P313, DOI 10.1079/BJN19480059; Siddiqi UR, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/610707; Soh AZ, 2016, J NUTR, V146, P1093, DOI 10.3945/jn.115.228049; Soriano S, 2007, CLIN NEPHROL, V67, P352; Topic RZ, 2009, ARCH MED RES, V40, P103, DOI 10.1016/j.arcmed.2008.11.001; Van der Meeren O, 2018, NEW ENGL J MED, V379, P1621, DOI 10.1056/NEJMoa1803484; Wouters-Wesseling W, 2002, J GERONTOL A-BIOL, V57, pM563, DOI 10.1093/gerona/57.9.M563; Xiao JN, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00495; Yen YF, 2017, INT J OBESITY, V41, P971, DOI 10.1038/ijo.2017.64; Zhou T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10481; Zimmermann N, 2016, EMBO MOL MED, V8, P1325, DOI 10.15252/emmm.201606330	64	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237062	10.1371/journal.pone.0237062	http://dx.doi.org/10.1371/journal.pone.0237062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760105	Green Published, gold			2022-12-26	WOS:000561027200001
J	Yang, P; Qi, J; Zhang, SH; Wang, XL; Bi, GS; Yang, Y; Sheng, B; Yang, G				Yang, Po; Qi, Jun; Zhang, Shuhao; Wang, Xulong; Bi, Gaoshan; Yang, Yun; Sheng, Bin; Yang, Geng			Feasibility study of mitigation and suppression strategies for controlling COVID-19 outbreaks in London and Wuhan	PLOS ONE			English	Article								Recent outbreaks of coronavirus disease 2019 (COVID-19) has led a global pandemic cross the world. Most countries took two main interventions: suppression like immediate lockdown cities at epicenter or mitigation that slows down but not stopping epidemic for reducing peak healthcare demand. Both strategies have their apparent merits and limitations; it becomes extremely hard to conduct one intervention as the most feasible way to all countries. Targeting at this problem, this paper conducted a feasibility study by defining a mathematical model named SEMCR, it extended traditional SEIR (Susceptible-Exposed-Infectious-Recovered) model by adding two key features: a direct connection between Exposed and Recovered populations, and separating infections into mild and critical cases. It defined parameters to classify two stages of COVID-19 control: active contain by isolation of cases and contacts, passive contain by suppression or mitigation. The model was fitted and evaluated with public dataset containing daily number of confirmed active cases including Wuhan and London during January 2020 and March 2020. The simulated results showed that 1) Immediate suppression taken in Wuhan significantly reduced the total exposed and infectious populations, but it has to be consistently maintained at least 90 days (by the middle of April 2020). Without taking this intervention, we predict the number of infections would have been 73 folders higher by the middle of April 2020. Its success requires efficient government initiatives and effective collaborative governance for mobilizing of corporate resources to provide essential goods. This mode may be not suitable to other countries without efficient collaborative governance and sufficient health resources. 2) In London, it is possible to take a hybrid intervention of suppression and mitigation for every 2 or 3 weeks over a longer period to balance the total infections and economic loss. While the total infectious populations in this scenario would be possibly 2 times than the one taking suppression, economic loss and recovery of London would be less affected. 3) Both in Wuhan and London cases, one important issue of fitting practical data was that there were a portion (probably 62.9% in Wuhan) of self-recovered populations that were asymptomatic or mild symptomatic. This finding has been recently confirmed by other studies that the seroprevalence in Wuhan varied between 3.2% and 3.8% in different sub-regions. It highlights that the epidemic is far from coming to an end by means of herd immunity. Early release of intervention intensity potentially increased a risk of the second outbreak.	[Yang, Po] Univ Sheffield, Dept Comp Sci, Sheffield, S Yorkshire, England; [Yang, Po; Yang, Geng] Zhejiang Univ, Sch Mech Engn, State Key Lab Fluid Power & Elect Syst, Hangzhou, Zhejiang, Peoples R China; [Qi, Jun] Univ Oxford, Dept Engn Sci, Oxford, England; [Qi, Jun] Xian Jiaotong Liverpool Univ, Dept Comp Sci & Software Engn, Suzhou, Peoples R China; [Zhang, Shuhao; Wang, Xulong; Bi, Gaoshan; Yang, Yun] Yunnan Univ, Sch Software, Kunming, Yunnan, Peoples R China; [Sheng, Bin] Shanghai Jiao Tong Univ, Dept Comp Sci & Engn, Shanghai, Peoples R China	University of Sheffield; Zhejiang University; University of Oxford; Xi'an Jiaotong-Liverpool University; Yunnan University; Shanghai Jiao Tong University	Yang, P (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield, S Yorkshire, England.; Yang, P (corresponding author), Zhejiang Univ, Sch Mech Engn, State Key Lab Fluid Power & Elect Syst, Hangzhou, Zhejiang, Peoples R China.; Qi, J (corresponding author), Univ Oxford, Dept Engn Sci, Oxford, England.; Qi, J (corresponding author), Xian Jiaotong Liverpool Univ, Dept Comp Sci & Software Engn, Suzhou, Peoples R China.; Yang, Y (corresponding author), Yunnan Univ, Sch Software, Kunming, Yunnan, Peoples R China.	po.yang@sheffield.ac.uk; ruth1012@live.com; yangyun@ynu.edu.cn	Yang, Po/C-9936-2011	Yang, Po/0000-0002-8553-7127	WorldWide Universities Network Special Grant Scheme at University of Sheffield; Open Foundation of the State Key Laboratory of Fluid Power and Mechatronic Systems [GZKF-201802]; National Natural Science Foundation of China [61876166, 61663046]	WorldWide Universities Network Special Grant Scheme at University of Sheffield; Open Foundation of the State Key Laboratory of Fluid Power and Mechatronic Systems; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been supported by WorldWide Universities Network Special Grant Scheme at University of Sheffield, in part by the Open Foundation of the State Key Laboratory of Fluid Power and Mechatronic Systems under Grant No: GZKF-201802, in part by the the National Natural Science Foundation of China under Grant No: 61876166 and 61663046.	Abdul Kuddus, 2014, AM J MATH STAT, V4, P231; Anderson RM, 2020, COMMENT WILL COUNTRY, V2019, P1; Bin M, 2020, FAST MULTISHOT COVID, P1; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Hethcote H.W., 1981, DIFFER EQUATIONS APP, P65; Hollingsworth TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001076; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Liu X., 2017, INFECT DIS MODELING; Meidan D, 2020, ALTERNATING QUARANTI, P1; Ning NZ, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2110-1; Pung R, 2020, LANCET, V395, P1039, DOI 10.1016/S0140-6736(20)30528-6; Rethlefsen ML, 2013, J MED LIBR ASSOC, V101, P55, DOI 10.3163/1536-5050.101.1.009; Wang JY, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P830, DOI 10.1145/3219819.3219865; Wang L, 2014, CHINESE SCI BULL, V59, P3511, DOI 10.1007/s11434-014-0499-8; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; WHO, 2020, 33 WHO; Bruce Aylward, 2019, MISSION CORONAVIRUS, V2019, P16; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Xu X, 2020, NAT MED, V26, P1193, DOI 10.1038/s41591-020-0949-6; Yang P, 2020, FEASIBILITY CONTROLL; Yang P., 2020, EFFECT MULTIPLE INTE; Yang S, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.66; Yang ZF, 2020, J THORAC DIS, V12, P165, DOI 10.21037/jtd.2020.02.64	25	17	17	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236857	10.1371/journal.pone.0236857	http://dx.doi.org/10.1371/journal.pone.0236857			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760081	gold, Green Published, Green Accepted			2022-12-26	WOS:000561027200007
J	Shinu, P; Singh, VA; Nair, A; Venugopala, KN; Akrawi, SH				Shinu, Pottathil; Singh, Varsha A.; Nair, Anroop; Venugopala, Katharigatta N.; Akrawi, Sabah H.			Papain-cetylpyridinium chloride and pepsin-cetylpyridinium chloride; two novel, highly sensitive, concentration, digestion and decontamination techniques for culturing mycobacteria from clinically suspected pulmonary tuberculosis cases	PLOS ONE			English	Article							SODIUM-HYDROXIDE; HYPERTONIC SALINE; SAMPLES; MICROSCOPY; SPECIMENS; RECOVERY	Mycobacterial culture remains the gold standard for the diagnosis of tuberculosis. However, an appropriate digestion and decontamination method (DDM) is essential for the effective recovery of tubercle bacilli in culture. Therefore, the current study was designed to compare the performance of papain-cetylpyridinium chloride [papain-CPC] and pepsin-cetylpyridinium chloride [pepsin-CPC] DDMs against N-acetyl L-Cysteine-sodium hydroxide (NALC-NaOH) DDM for recovery of mycobacteria from clinically suspected pulmonary tuberculosis cases. To evaluate papain-CPC, pepsin-CPC and NALC-NaOH DDMs, sputum samples (N = 1381) were cultured on Lowenstein-Jensen medium and the results were compared. The papain-CPC DDM showed sensitivity, specificity, positive predictive value, and negative predictive value of 100%, 93.27%, 71.7%, and 100%, respectively as compared to NALC-NaOH DDM. Similarly, pepsin-CPC DDM demonstrated sensitivity, specificity, positive predictive value and negative predictive value of 98.94%, 94.7%, 76.11%, and 99.81%, respectively. In summary, both papain-CPC and pepsin-CPC DDMs are highly sensitive and specific techniques for recovery of mycobacteria as compared to NALC-NaOH DDM. However, when the overall performances of all DDMs compared, papain-CPC DDM isolated increased number of mycobacterial isolates with comparatively higher numbers of colonies on LJ media than both pepsin-CPC and NALC-NaOH DDMs, indicating its potential to replace the NALC-NaOH DDM for recovery of mycobacteria from sputum samples.	[Shinu, Pottathil] King Faisal Univ, Coll Clin Pharm, Dept Biomed Sci, Al Hasa, Saudi Arabia; [Singh, Varsha A.] MMIMSR, Dept Microbiol, Ambala, India; [Nair, Anroop; Venugopala, Katharigatta N.; Akrawi, Sabah H.] King Faisal Univ, Coll Clin Pharm, Dept Pharmaceut Sci, Al Hasa, Saudi Arabia; [Venugopala, Katharigatta N.] Durban Univ Technol, Dept Biotechnol & Food Technol, Durban, South Africa	King Faisal University; Maharishi Markandeshwar University; King Faisal University; Durban University of Technology	Shinu, P (corresponding author), King Faisal Univ, Coll Clin Pharm, Dept Biomed Sci, Al Hasa, Saudi Arabia.	spottathail@kfu.edu.sa	Venugopala, Katharigatta N./M-4030-2016; Nair, Anroop/L-9995-2014	Venugopala, Katharigatta N./0000-0003-0680-1549; Nair, Anroop/0000-0003-2850-8669; pottathil, shinu/0000-0003-4245-0803	Deanship of Scientific research at King Faisal University [186200]	Deanship of Scientific research at King Faisal University	The authors acknowledge the Deanship of Scientific research at King Faisal University for the financial support under Nasher Track (Grant No.186200).	Ardizzoni E, 2014, INT J TUBERC LUNG D, V18, P972, DOI 10.5588/ijtld.13.0887; Biotec Laboratories, 2000, RAP BACT ASS DET MYC; Chakravorty S, 2005, J CLIN MICROBIOL, V43, P2697, DOI 10.1128/JCM.43.6.2697-2702.2005; De Bel A, 2013, J CLIN MICROBIOL, V51, P4204, DOI 10.1128/JCM.02035-13; Deshpande PS, 2007, FLUIDS BARRIERS CNS, V4, DOI 10.1186/1743-8454-4-10; FUJINAGA M, 1995, PROTEIN SCI, V4, P960; Ganoza CA, 2008, J MED MICROBIOL, V57, P1094, DOI 10.1099/jmm.0.2008/001339-0; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; Jain S, 2014, PATHOG GLOB HEALTH, V108, P118, DOI 10.1179/2047773214Y.0000000133; Jani MN, 2011, J GLOB INFECT DIS, V3, P94, DOI 10.4103/0974-777X.77305; Kassaza K, 2014, J CLIN MICROBIOL, V52, P2671, DOI 10.1128/JCM.00749-14; Kent PT, 1985, GUIDE LEVEL 3 LAB; KUBICA GP, 1963, AM REV RESPIR DIS, V87, P775; MITCHEL REJ, 1970, J BIOL CHEM, V245, P3485; Pardini M, 2005, J CLIN MICROBIOL, V43, P442, DOI 10.1128/JCM.43.1.442-444.2005; RATNAM S, 1987, J CLIN MICROBIOL, V25, P1428, DOI 10.1128/JCM.25.8.1428-1432.1987; Revised National Tuberculosis Control Programme, 2009, MAN LAB TECHN; Revised National Tuberculosis Control Programme, 2017, NAT STRAT PLAN TUB E; Ricaldi JN, 2008, TROP DOCT, V38, P97, DOI 10.1258/td.2007.070024; Sankar MM, 2009, J CLIN MICROBIOL, V47, P4189, DOI 10.1128/JCM.01295-09; Shinu P, 2016, J CLIN LAB ANAL, V30, P567, DOI 10.1002/jcla.21904; Shinu P, 2013, DIAGN MICR INFEC DIS, V77, P150, DOI 10.1016/j.diagmicrobio.2013.06.021; Shinu P, 2013, J BASIC MICROB, V53, P260, DOI 10.1002/jobm.201100519; SMITHWICK RW, 1975, J CLIN MICROBIOL, V1, P411, DOI 10.1128/JCM.1.5.411-413.1975; Williams MD, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7040079; World Health Organization, GLOB TUB REP 2016; World Health Organization, 1998, CULT 3; Yoon SH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-172	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0236700	10.1371/journal.pone.0236700	http://dx.doi.org/10.1371/journal.pone.0236700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750088	gold, Green Published			2022-12-26	WOS:000560009200032
J	Han, SJ; Kim, M; Novitsky, E; D'Agati, V; Lee, HT				Han, Sang Jun; Kim, Mihwa; Novitsky, Ella; D'Agati, Vivette; Lee, H. Thomas			Intestinal TLR9 deficiency exacerbates hepatic IR injury via altered intestinal inflammation and short-chain fatty acid synthesis	FASEB JOURNAL			English	Article						apoptosis; butyrate; inflammation; microbiome; necrosis; neutrophil; propionate; short-chain fatty acid	ISCHEMIA-REPERFUSION INJURY; ACUTE KIDNEY INJURY; RENAL ISCHEMIA; ISCHEMIA/REPERFUSION INJURY; DEPENDENT REPRESSION; LIVER ISCHEMIA; RECEPTOR 9; PROTECTS; BUTYRATE; CELLS	Mice deficient in intestinal epithelial TLR9 develop small intestinal Paneth cell hyperplasia and higher Paneth cell IL-17A levels. Since small intestinal Paneth cells and IL-17A play critical roles in hepatic ischemia reperfusion (IR) injury, we tested whether mice lacking intestinal TLR9 have increased hepatic IR injury. Mice lacking intestinal TLR9 had profoundly increased liver injury after hepatic IR compared to WT mice with exacerbated hepatocyte necrosis, apoptosis, neutrophil infiltration, and inflammatory cytokine generation. Moreover, we observed increased small intestinal inflammation and apoptosis after hepatic IR in intestinal TLR9 deficient mice. As a potential explanation for increased hepatic IR injury, fecal short-chain fatty acids butyrate and propionate levels were lower in intestinal TLR9 deficient mice. Suggesting a potential therapy for hepatic IR, exogenous administration of butyrate or propionate protected against hepatic IR injury in intestinal TLR9 deficient mice. Mechanistically, butyrate induced small intestinal IL-10 expression and downregulated the claudin-2 expression. Finally, IL-10 neutralization abolished the protective effects of butyrate against hepatic IR injury. Our studies show intestinal TLR9 deficiency results in exacerbated hepatic IR injury with increased small intestinal apoptosis and inflammation. Furthermore, short-chain fatty acids butyrate and propionate protect against hepatic IR injury and intestinal apoptosis/inflammation in intestinal TLR9 deficient mice.	[Han, Sang Jun; Kim, Mihwa; Novitsky, Ella; Lee, H. Thomas] Columbia Univ, Dept Anesthesiol, Anesthesiol Res Labs, P&S Box 46 PH-5,630 West 168th St, New York, NY 10032 USA; [D'Agati, Vivette] Columbia Univ, Dept Pathol, Coll Phys & Surg, New York, NY USA	Columbia University; Columbia University	Han, SJ; Lee, HT (corresponding author), Columbia Univ, Dept Anesthesiol, Anesthesiol Res Labs, P&S Box 46 PH-5,630 West 168th St, New York, NY 10032 USA.	sh3740@cumc.columbia.edu; tl128@columbia.edu			National Research Foundation of Korea (NRF) [NRF-2018R1A6A3A03011633]; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK-109544, DK-115694]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2018R1A6A3A03011633; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK-109544 and DK-115694	Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Asarat M, 2016, IMMUNOL INVEST, V45, P205, DOI 10.3109/08820139.2015.1122613; Bakar AM, 2012, INT J MOL SCI, V13, P977, DOI 10.3390/ijms13010977; Bakker PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137511; Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365; Bartoszek A, 2020, PHARMACOL RES, V152, DOI 10.1016/j.phrs.2019.104604; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Bhaskaran N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01995; Callahan Ben J, 2016, F1000Res, V5, P1492; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Cao ZJ, 2013, BBA-MOL BASIS DIS, V1832, P96, DOI 10.1016/j.bbadis.2012.08.008; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen SWC, 2009, TRANSPLANTATION, V87, P1478, DOI 10.1097/TP.0b013e3181a3c691; Dar WA, 2019, LIVER INT, V39, DOI 10.1111/liv.14091; De Vuyst L, 2011, INT J FOOD MICROBIOL, V149, P73, DOI 10.1016/j.ijfoodmicro.2011.03.003; Deng MH, 2018, J IMMUNOL, V200; Foureau DM, 2010, J IMMUNOL, V184, P7022, DOI 10.4049/jimmunol.0901642; Han SJ, 2019, KIDNEY INT, V95, P859, DOI 10.1016/j.kint.2018.10.035; Hart ML, 2008, FASEB J, V22, P2784, DOI 10.1096/fj.07-103911; Heller F, 2008, MUCOSAL IMMUNOL, V1, pS58, DOI 10.1038/mi.2008.46; Huang H, 2015, HEPATOLOGY, V62, P600, DOI 10.1002/hep.27841; Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501; Ju C, 2016, J MOL MED, V94, P613, DOI 10.1007/s00109-016-1408-1; Kimura I, 2020, PHYSIOL REV, V100, P171, DOI 10.1152/physrev.00041.2018; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kolachala VL, 2008, BRIT J PHARMACOL, V155, P127, DOI 10.1038/bjp.2008.227; Lee HT, 2013, AM J PHYSIOL-GASTR L, V304, pG12, DOI 10.1152/ajpgi.00201.2012; Lee HT, 2012, AM J PHYSIOL-RENAL, V303, pF1216, DOI 10.1152/ajprenal.00220.2012; Lee HT, 2009, LAB INVEST, V89, P196, DOI 10.1038/labinvest.2008.124; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106184; Lu C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000629; Luettig J, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.977176; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Mankertz J, 2009, CELL TISSUE RES, V336, P67, DOI 10.1007/s00441-009-0751-8; Vergara DM, 2017, NUTR HOSP, V34, P58, DOI 10.20960/nh.1573; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morote-Garcia JC, 2009, GASTROENTEROLOGY, V136, P607, DOI 10.1053/j.gastro.2008.10.037; Nastos C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/906965; Park J, 2015, MUCOSAL IMMUNOL, V8, P80, DOI 10.1038/mi.2014.44; Park SW, 2012, J IMMUNOL, V189, P5421, DOI 10.4049/jimmunol.1200581; Park SW, 2012, J AM SOC NEPHROL, V23, P266, DOI 10.1681/ASN.2011050503; Park SW, 2011, KIDNEY INT, V80, P1315, DOI 10.1038/ki.2011.281; Park SW, 2011, HEPATOLOGY, V53, P1662, DOI 10.1002/hep.24253; Park SW, 2009, AM J PHYSIOL-RENAL, V297, pF885, DOI 10.1152/ajprenal.00317.2009; Puertollano E, 2014, CURR OPIN CLIN NUTR, V17, P139, DOI 10.1097/MCO.0000000000000025; Qiao YL, 2014, J SURG RES, V187, P653, DOI 10.1016/j.jss.2013.08.028; Qiao YL, 2015, J SURG RES, V197, P324, DOI 10.1016/j.jss.2015.04.031; Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979; Rumio C, 2012, J CELL PHYSIOL, V227, P1107, DOI 10.1002/jcp.22830; Salzman NH, 2013, SEMIN IMMUNOL, V25, P334, DOI 10.1016/j.smim.2013.09.006; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Shaker ME, 2016, BIOCHEM PHARMACOL, V112, P90, DOI 10.1016/j.bcp.2016.05.003; Shintani Y, 2013, P NATL ACAD SCI USA, V110, P5109, DOI 10.1073/pnas.1219243110; Slone EA, 2012, AM J CLIN EXP IMMUNO, V1, P124; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Torii T, 2010, ANN CLIN BIOCHEM, V47, P447, DOI 10.1258/acb.2010.010047; TRABER PG, 1991, AM J PHYSIOL, V260, pG895, DOI 10.1152/ajpgi.1991.260.6.G895; Yap S, 2012, AM J PHYSIOL-RENAL, V302, pF1104, DOI 10.1152/ajprenal.00543.2011; Zhang MM, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0500-x; Zheng L, 2017, J IMMUNOL, V199, P2976, DOI 10.4049/jimmunol.1700105	63	4	5	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12083	12099		10.1096/fj.202000314R	http://dx.doi.org/10.1096/fj.202000314R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32738096				2022-12-26	WOS:000558164800001
J	Sentra, S; Bishnu, D; Dhali, GK; Sentra, A; Chowdhury, A				Sentra, Suman; Bishnu, Debasree; Dhali, Gopal Krishna; Sentra, Amal; Chowdhury, Abhijit			Expression of type I collagen in response to Isoniazid exposure is indirect and is facilitated by collateral induction of cytochrome P450 2E1: An in-vitro study	PLOS ONE			English	Article							INDUCED LIVER-INJURY; OXIDATIVE STRESS; CYP2E1; GLUTATHIONE; FAILURE; PREDICTORS; ACTIVATION; PROGNOSIS; APOPTOSIS; OXIDASE	We wanted to investigate whether Isoniazid (INH) can directly stimulate activation of hepatic stellate cells (HSCs) and enhance production of collagen. Treatment of human hepatic stellate cell line LX2 with or without 5 mu M INH for 24 to 72 hours was performed to look into content of cytochrome P450 2E1 (CYP2E1), activity of NADPH oxidase (NOX) and intracellular oxidative stress. Protein level as well as mRNA expression of alpha smooth muscle actin (alpha-SMA) and collagen1A1 (COL1A1) were assessed by western blot and real time PCR. In some experiments pyrazole (PY) was pre-treated to LX2 cells to induce CYP2E1 prior to INH treatment. CYP2E1 level as well as NOX activity was gradually increased with INH treatment in LX2 cells till 72 hours. Following 72 hours of INH exposure, intracellular glutathione (GSH) level was found to be reduced compared to control (p<0.01) and showed expression of alpha-SMA, indicating activation of HSC. We could not found any change in collagen expression in this experimental study. Pyrazole (PY) pre-treatment to LX2 cells caused significant increase in cellular CYP2E1 content associated with increase of NOX, intracellular reactive oxygen species (ROS), and expression of alpha-SMA and collagen1 after INH exposure. CYP2E1 is present in insignificant amount in HSCs and INH treatment could not induce collagen expression, although altered cellular oxidant levels was observed. But in LX2 cells when CYP2E1 was over-expressed by PY, INH administration provokes oxidative stress mediated stellate cells activation along with collagen type I expression.	[Sentra, Suman; Bishnu, Debasree; Dhali, Gopal Krishna; Sentra, Amal; Chowdhury, Abhijit] Inst Post Grad Med Educ & Res, Sch Digest & Liver Dis, Ctr Liver Res, Kolkata, India; [Sentra, Amal; Chowdhury, Abhijit] Indian Inst Liver & Digest Sci, JCM Ctr Liver Res & Innovat, Sonarpur, India; [Sentra, Suman] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Indiana University System; Indiana University Bloomington	Chowdhury, A (corresponding author), Inst Post Grad Med Educ & Res, Sch Digest & Liver Dis, Ctr Liver Res, Kolkata, India.; Chowdhury, A (corresponding author), Indian Inst Liver & Digest Sci, JCM Ctr Liver Res & Innovat, Sonarpur, India.	achowdhury2002@yahoo.co.in	Dhali, Gopal Krishna/AAE-5331-2022	Dhali, Gopal Krishna/0000-0002-6759-5067	Indian Council of Medical Research, New Delhi [5/4/38/2011-NCD-II]	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	This study was funded by Indian Council of Medical Research, New Delhi (Grant no.: 5/4/38/2011-NCD-II to A.C).	Andrade RJ, 2006, HEPATOLOGY, V44, P1581, DOI 10.1002/hep.21424; Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Bai JX, 2006, TOXICOL SCI, V91, P365, DOI 10.1093/toxsci/kfj165; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bolt HM, 2003, INT ARCH OCC ENV HEA, V76, P174, DOI 10.1017/s00420-002-0407-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Casini A, 1998, J HEPATOL, V28, P40, DOI 10.1016/S0168-8278(98)80200-6; Chowdhury A, 2006, J HEPATOL, V45, P117, DOI 10.1016/j.jhep.2006.01.027; Deleve LD, 1998, SEMIN LIVER DIS, V18, P403, DOI 10.1055/s-2007-1007173; Devarbhavi H, 2010, AM J GASTROENTEROL, V105, P2396, DOI 10.1038/ajg.2010.287; Ding WX, 2004, HEPATOLOGY, V40, P403, DOI 10.1002/hep.20310; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gong PF, 2003, J BIOL CHEM, V278, P29693, DOI 10.1074/jbc.M304728200; GORSKY LD, 1984, J BIOL CHEM, V259, P6812; Herrera B, 2004, FREE RADICAL BIO MED, V36, P16, DOI 10.1016/j.freeradbiomed.2003.09.020; KOOP DR, 1991, J PHARMACOL EXP THER, V258, P1072; KOOP DR, 1992, FASEB J, V6, P724, DOI 10.1096/fasebj.6.2.1537462; Kumar R, 2010, HEPATOLOGY, V51, P1665, DOI 10.1002/hep.23534; KUTHAN H, 1982, EUR J BIOCHEM, V126, P583, DOI 10.1111/j.1432-1033.1982.tb06820.x; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; MITCHELL JR, 1976, ANN INTERN MED, V84, P181, DOI 10.7326/0003-4819-84-2-181; Nieto N, 1999, HEPATOLOGY, V30, P987, DOI 10.1002/hep.510300433; Oinonen T, 1998, BIOCHEM PHARMACOL, V56, P1075, DOI 10.1016/S0006-2952(98)00062-8; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; PARK KS, 1993, EUR J PHARM-ENVIRON, V248, P7, DOI 10.1016/0926-6917(93)90019-M; Reuben A, 2010, HEPATOLOGY, V52, P2065, DOI 10.1002/hep.23937; Russo MW, 2004, LIVER TRANSPLANT, V10, P1018, DOI 10.1002/lt.20204; Slater TF, 1971, BIOCHEM J, V123, P523, DOI [10.1042/bj1230523, DOI 10.1042/BJ1230523]; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yamada T, 1997, LIFE SCI, V61, P171, DOI 10.1016/S0024-3205(97)00372-X	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236992	10.1371/journal.pone.0236992	http://dx.doi.org/10.1371/journal.pone.0236992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735603	gold, Green Published			2022-12-26	WOS:000569367100066
J	Guha, S; Herman, A; Herbertson, L; Antonino, MJ; Silverstein, JS; Cooper, J; Myers, MR				Guha, Suvajyoti; Herman, Alexander; Herbertson, Luke; Antonino, Mark J.; Silverstein, Joshua S.; Cooper, Jeffrey; Myers, Matthew R.			Technical considerations for medical device manufacturers when designing gastrostomy tubes (G-tubes) using the new ISO 80369-3 connector	PLOS ONE			English	Article								Background Gastrostomy tubes (G-tubes) are typically used when people cannot eat food by mouth. The connector section that allows G-tubes to connect to other devices, such as feeding sets or syringes, has been modified on some of the devices to reduce misconnections in hospital settings. The narrow internal diameter of the new connector, standardized under ISO 80369-3, has caused some users to express concern about a reduced flow rate. Previous studies performed on commercial devices determined that it was not conclusive how much the ISO 80369-3 connector contributed towards the reduced flow rate, because when manufacturers designed these new connector-based devices, they often changed other geometric variables (such as distal tube diameter, or length) at the same time. Thus, it became difficult isolating the effect of the connector from other geometric variables. Method The key objective of this study was to investigate how different design variables impacted the flow rate through the G-tubes. 3D-printed devices were used to assess the geometric parameters in a systematic manner. Commercial diets and Newtonian analog fluids with matched viscosities were used for testing. Results The flow path length of the "transition section" encompassing the standardized ISO 80369-3 connector in the new devices was found to cause reduced flow. Additionally, results showed that a shortened (<= 10 mm) transition section, along with a 10% increase in the distal inner diameter of large bore devices (e.g., 24 Fr), can restore flow rates to levels consistent with the previous devices prior to the connector standardization. Conclusions The strategy for restoring flow rates to previous levels may help alleviate concerns raised by multiple stakeholders such as health care professionals, patients, caregivers and device manufacturers. In addition, the approach proposed here can be used as a tool for designing future G-tube devices.	[Guha, Suvajyoti; Herman, Alexander; Herbertson, Luke; Myers, Matthew R.] US FDA, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA; [Antonino, Mark J.; Silverstein, Joshua S.; Cooper, Jeffrey] US FDA, Off Prod Evaluat & Qual, Ctr Devices & Radiol Hlth, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Guha, S (corresponding author), US FDA, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA.	Suvajyoti.Guha@fda.hhs.gov	Herman, Alexander/AAD-2113-2021	Herman, Alexander/0000-0002-8378-8184; Guha, Suvajyoti/0000-0002-7622-2721	Office of the Chief Scientist's Shared Resources program; Oak Ridge Associated Universities (ORAU)	Office of the Chief Scientist's Shared Resources program; Oak Ridge Associated Universities (ORAU)	3D Printing work was performed in the FDA Additive Manufacturing of Medical Products (AMMP) Lab, supported by the Office of the Chief Scientist's Shared Resources program.; Mr. A. Herman was funded through the Oak Ridge Associated Universities (ORAU) at the time of data collection.	Blumenstein I, 2014, WORLD J GASTROENTERO, V20, P8505, DOI 10.3748/wjg.v20.i26.8505; Cengel Y.A., 2010, FLUID MECH FUNDAMENT, V3rd ed.; Guha S, 2018, JPEN-PARENTER ENTER, V42, P1334, DOI 10.1002/jpen.1159; Hurt RT, 2016, CURR NUTR REP, V5, P240; Mundi MS, 2017, NUTR CLIN PRACT, V32, P799, DOI 10.1177/0884533617718472; Mundi MS, 2018, JPEN-PARENTER ENTER, V42, P522, DOI 10.1177/0148607117703959	6	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236644	10.1371/journal.pone.0236644	http://dx.doi.org/10.1371/journal.pone.0236644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730360	Green Published, gold			2022-12-26	WOS:000556884700102
J	Shen, QY; Hu, G; Wu, JZ; Lv, LT				Shen, Qinyan; Hu, Guinv; Wu, JinZhong; Lv, Liting			A new clinical prognostic nomogram for liver cancer based on immune score	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; PATHWAY; IMMUNOSCORE; TRANSITION; BLOCKADE; PROMOTES; GENOME; CELLS	Background Increased attention is being paid to the relationship between the immune status of the tumor microenvironment and tumor prognosis. The application of immune scoring in evaluating the clinical prognosis of liver cancer patients has not yet been explored. This study sought to clarify the association between immune score and prognosis and construct a clinical nomogram to predict the survival of patients with liver cancer. Methods A total of 346 patients were included in our analysis datasets downloaded from The Cancer Genome Atlas (TCGA) dataset. A Cox proportional-hazards regression model was used to estimate the adjusted hazard ratios (HRs). A nomogram was built based on the results of multivariate analysis and was subjected to bootstrap internal validation. The predictive accuracy and discriminative ability were measured by the concordance index (C-index) and the calibration curve. Through the functional analysis of differential expression of genes with different immune scores, the target genes were screened out. Results In comparison with patients with low immune scores, those with intermediate and high immune scores had significantly improved survival time [HR and 95% confidence interval (CI): 0.54 (0.30-0.97) and 0.51 (0.27-0.97), respectively]. The C-index for survival time prediction was 0.66 (95% CI: 0.60-0.71). The calibration plot for the probability of survival at three or five years showed good agreement between prediction by the nomogram and actual observations. The top 10 hub genes wereCXCL8(chemokine (C-X-C motif) ligand 8),SYK(spleen tyrosine kinase),CXCL12(chemokine (C-X-C motif) ligand 12),CXCL10(chemokine (C-X-C motif) ligand10),CXCL1(chemokine (C-X-C motif) ligand1),CCL5(chemokine (C-C motif) ligand 5),CCL20(chemokine (C-C motif) ligand 20),LCK,CXCL11(chemokine (C-X-C motif) ligand 11),CCR5(chemokine (C-C motif) receptor 5). More importantly, we found that the high expression ofCXCL8andCXCL1were related to the prognosis. Conclusions High and/or intermediate immune scores are significantly correlated with better survival time in patients with liver cancer. Moreover, nomograms for predicting prognosis may help to estimate the survival of patients. We also propose thatCXCL8andCXCL1may be a potential therapeutic target for liver cancer treatment.	[Shen, Qinyan; Hu, Guinv; Wu, JinZhong; Lv, Liting] Wenzhou Med Univ, Dept Surg Oncol, Affiliated Dongyang Hosp, Dongyang, Zhejiang, Peoples R China	Wenzhou Medical University	Shen, QY (corresponding author), Wenzhou Med Univ, Dept Surg Oncol, Affiliated Dongyang Hosp, Dongyang, Zhejiang, Peoples R China.	sqy198977@163.com	shen, qinyan/ABE-8181-2021					Abba MC, 2015, CANCER RES, V75, P3980, DOI 10.1158/0008-5472.CAN-15-0506; Anitei MG, 2014, CLIN CANCER RES, V20, P1891, DOI 10.1158/1078-0432.CCR-13-2830; Bie YQ, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/8023460; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Cheng HJ, 2019, AM J CANCER RES, V9, P1536; Dalin MG, 2016, CLIN CANCER RES, V22, P4623, DOI 10.1158/1078-0432.CCR-16-0637; Delire B, 2015, EUR J CLIN INVEST, V45, P609, DOI 10.1111/eci.12441; Drakes ML, 2018, CANCERS, V10, DOI 10.3390/cancers10090302; Duffy AG, 2017, J HEPATOL, V66, P545, DOI 10.1016/j.jhep.2016.10.029; Efstathiou JA, 2019, EUR UROL, V76, P59, DOI 10.1016/j.eururo.2019.01.011; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; FINN RS, 2019, J CLIN ONCOL S, V37; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Garnelo M, 2017, GUT, V66, P342, DOI 10.1136/gutjnl-2015-310814; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Huang WJ, 2015, GASTROENTEROLOGY, V149, P1053, DOI 10.1053/j.gastro.2015.05.058; Inarrairaegui M, 2018, CLIN CANCER RES, V24, P1518, DOI 10.1158/1078-0432.CCR-17-0289; Jia D, 2018, AGING-US, V10, P592, DOI 10.18632/aging.101415; Jiang H, 2017, APMIS, V125, P773, DOI 10.1111/apm.12721; Jorge NAN, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02235-w; Jusakul A, 2017, CANCER DISCOV, V7, P1116, DOI 10.1158/2159-8290.CD-17-0368; Karlsson A, 2014, CLIN CANCER RES, V20, P6127, DOI 10.1158/1078-0432.CCR-14-1087; Knall C, 1996, J BIOL CHEM, V271, P2832, DOI 10.1074/jbc.271.5.2832; Liu PF, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/3710961; Liu Q, 2016, CYTOKINE GROWTH F R, V31, P61, DOI 10.1016/j.cytogfr.2016.08.002; Longo V, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55100698; Mahajan UM, 2018, GASTROENTEROLOGY, V155, P1625, DOI 10.1053/j.gastro.2018.08.009; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Sangro B, 2013, J HEPATOL, V59, P81, DOI 10.1016/j.jhep.2013.02.022; Shen T, 2017, ONCOL REP, V37, P2095, DOI 10.3892/or.2017.5453; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tai D, 2019, CANCERS, V11, DOI 10.3390/cancers11121926; Tan YH, 2020, INT J CLIN EXP PATHO, V13, P473; Waidmann O, 2018, EXPERT OPIN BIOL TH, V18, P905, DOI 10.1080/14712598.2018.1499722; Wen Y, 2006, GROALPHA IS HIGHLY E, P5951; Yang S, 2019, CANCER SCI, V110, P3639, DOI 10.1111/cas.14216; Yau T, 2019, J HEPATOL, V71, P543, DOI 10.1016/j.jhep.2019.05.014; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Yuan M, 2016, TUMOR DERIVED CXCL1; Zeng DQ, 2019, CANCER IMMUNOL RES, V7, P737, DOI 10.1158/2326-6066.CIR-18-0436; Zhang HM, 2018, J CANCER, V9, P1773, DOI 10.7150/jca.24577; Zhong XD, 2019, PEERJ, V7, DOI 10.7717/peerj.8017; Zhou Q, 2011, FUTURE ONCOL, V7, P1149, DOI [10.2217/FON.11.95, 10.2217/fon.11.95]; Zhou R, 2019, CANCER IMMUNOL IMMUN, V68, P433, DOI 10.1007/s00262-018-2289-7; Zhu AX, 2018, LANCET ONCOL, V19, P940, DOI 10.1016/S1470-2045(18)30351-6	47	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236622	10.1371/journal.pone.0236622	http://dx.doi.org/10.1371/journal.pone.0236622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730361	Green Published, gold			2022-12-26	WOS:000556884700029
J	Alexander, KL; Serrano, CA; Chakraborty, A; Nearing, M; Council, LN; Riquelme, A; Garrido, M; Bellis, SL; Smythies, LE; Smith, PD				Alexander, Katie L.; Serrano, Carolina A.; Chakraborty, Asmi; Nearing, Marie; Council, Leona N.; Riquelme, Arnoldo; Garrido, Marcelo; Bellis, Susan L.; Smythies, Lesley E.; Smith, Phillip D.			Modulation of glycosyltransferase ST6Gal-I in gastric cancer-derived organoids disrupts homeostatic epithelial cell turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cancer biology; epithelial cell; gastric cancer; glycosylation; sialic acid; stem cells alpha-26-sialyltransferase 1 (ST6Gal-I); stem cells; beta-galactoside alpha 2; 6-sialyltransferase 1 (ST6GAL1)	HELICOBACTER-PYLORI; MEDIATED APOPTOSIS; STEM-CELLS; RECEPTOR; DEATH; SIALYLATION; TISSUE; PERSISTENCE; EXPRESSION; STOMACH	Programmed cell death promotes homeostatic cell turnover in the epithelium but is dysregulated in cancer. The glycosyltransferase ST6Gal-I is known to block homeostatic apoptosis through alpha 2,6-linked sialylation of the death receptor TNFR1 in many cell types. However, its role has not been investigated in gastric epithelial cells or gastric tumorigenesis. We determined that human gastric antral epithelium rarely expressed ST6Gal-I, but the number of ST6Gal-I-expressing epithelial cells increased significantly with advancing premalignancy leading to cancer. The mRNA expression levels ofST6GAL-IandSOX9in human gastric epithelial cells correlated positively with one another through the premalignancy cascade, indicating that increased epithelial cell expression of ST6Gal-I is associated with premalignant progression. To determine the functional impact of increased ST6Gal-I, we generated human gastric antral organoids from epithelial stem cells and differentiated epithelial monolayers from gastric organoids. Gastric epithelial stem cells strongly expressed ST6Gal-I, suggesting a novel biomarker of stemness. In contrast, organoid-derived epithelial monolayers expressed markedly reduced ST6Gal-I and underwent TNF-induced, caspase-mediated apoptosis, consistent with homeostasis. Conversely, epithelial monolayers generated from gastric cancer stem cells retained high levels of ST6Gal-I and resisted TNF-induced apoptosis, supporting prolonged survival. Protection from TNF-induced apoptosis depended on ST6Gal-I overexpression, because forced ST6Gal-I overexpression in normal gastric stem cell-differentiated monolayers inhibited TNF-induced apoptosis, and cleavage of alpha 2,6-linked sialic acids from gastric cancer organoid-derived monolayers restored susceptibility to TNF-induced apoptosis. These findings implicate up-regulated ST6Gal-I expression in blocking homeostatic epithelial cell apoptosis in gastric cancer pathogenesis, suggesting a mechanism for prolonged epithelioid tumor cell survival.	[Alexander, Katie L.; Nearing, Marie; Smythies, Lesley E.; Smith, Phillip D.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Chakraborty, Asmi; Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Council, Leona N.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Serrano, Carolina A.] Pontificia Univ Catolica Chile, Dept Pediat Gastroenterol & Nutr, Santiago, Chile; [Riquelme, Arnoldo] Pontificia Univ Catolica Chile, Dept Gastroenterol, Santiago, Chile; [Riquelme, Arnoldo] Pontificia Univ Catolica Chile, Dept Hlth Sci, Santiago, Chile; [Garrido, Marcelo] Pontificia Univ Catolica Chile, Dept Oncol, Santiago, Chile	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Smythies, LE; Smith, PD (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	lsmythies@uabmc.edu; pdsmith@uabmc.edu	chakraborty, asmi/AAX-5384-2021	chakraborty, asmi/0000-0002-6528-8602; Nearing, Marie/0000-0002-5261-4544	National Institutes of Health [HD088954, CA233581, CA225177, RR20136]; University of Alabama at Birmingham Training Program in Immunologic Diseases and Basic Immunology [2T32AI007051-41]; University of Alabama at Birmingham School of Medicine and Health Services Foundation GEF Awards; Broad Foundation, Broad Medical Research Program; Crohn's and Colitis Foundation of America; DeGregorio Family Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham Training Program in Immunologic Diseases and Basic Immunology; University of Alabama at Birmingham School of Medicine and Health Services Foundation GEF Awards; Broad Foundation, Broad Medical Research Program; Crohn's and Colitis Foundation of America; DeGregorio Family Foundation	This work was supported by National Institutes of Health Grants HD088954 (to P. D. S.), CA233581 (to S. L. B.), CA225177 (to S. L. B.), and RR20136 (to P. D. S.); University of Alabama at Birmingham Training Program in Immunologic Diseases and Basic Immunology 2T32AI007051-41 (K. L. A.); University of Alabama at Birmingham School of Medicine and Health Services Foundation GEF Awards (to L. E. S., P. D. S., Stem Cell Organogenesis Program); Broad Foundation, Broad Medical Research Program (to L. E. S.); Crohn's and Colitis Foundation of America Grant (to L. E. S.); and The DeGregorio Family Foundation Grant (to P. D. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All human specimens were obtained after written informed consent approved by the University of Alabama at Birmingham Institutional Review Board and abide by the Declaration of Helsinki Principles.	Aguilar-Medina M, 2019, J ONCOL, V2019, DOI 10.1155/2019/6754040; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Blaser MJ, 1999, P NATL ACAD SCI USA, V96, P8359, DOI 10.1073/pnas.96.15.8359; Blutt SE, 2017, EXP BIOL MED, V242, P1633, DOI 10.1177/1535370217710638; BRADLEY JR, 1995, AM J PATHOL, V146, P27; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cendrowski J, 2016, CYTOKINE GROWTH F R, V32, P63, DOI 10.1016/j.cytogfr.2016.07.002; Chakraborty A, 2018, J BIOL CHEM, V293, P984, DOI 10.1074/jbc.M117.808584; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; Costa-Nogueira C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-431; Dijkstra KK, 2018, CELL, V174, P1586, DOI 10.1016/j.cell.2018.07.009; EASTWOOD GL, 1977, GASTROENTEROLOGY, V72, P962; Elimova Elena, 2015, J Natl Compr Canc Netw, V13, pe19; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Farin HF, 2016, NATURE, V530, P340, DOI 10.1038/nature16937; Fernald K, 2013, TRENDS CELL BIOL, V23, P620, DOI 10.1016/j.tcb.2013.07.006; Ferro A, 2014, EUR J CANCER, V50, P1330, DOI 10.1016/j.ejca.2014.01.029; Fox IJ, 2014, SCIENCE, V345, P889, DOI 10.1126/science.1247391; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; Harting Matthew T, 2004, J Pediatr Surg, V39, pe8, DOI 10.1016/j.jpedsurg.2004.04.043; Hasehira K, 2012, MOL CELL PROTEOMICS, V11, P1913, DOI 10.1074/mcp.M112.020586; Holdbrooks AT, 2018, J BIOL CHEM, V293, P1610, DOI 10.1074/jbc.M117.801480; Hooi JKY, 2017, GASTROENTEROLOGY, V153, P420, DOI 10.1053/j.gastro.2017.04.022; Jones SJ, 1999, J IMMUNOL, V162, P1042; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Martin LT, 2002, J BIOL CHEM, V277, P32930, DOI 10.1074/jbc.M203362200; Matheu A, 2012, CANCER RES, V72, P1301, DOI 10.1158/0008-5472.CAN-11-3660; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Molendijk I, 2015, GASTROENTEROLOGY, V149, P918, DOI 10.1053/j.gastro.2015.06.014; Ohata H, 2004, INT J CANCER, V109, P138, DOI 10.1002/ijc.11680; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Plati J, 2008, J CELL BIOCHEM, V104, P1124, DOI 10.1002/jcb.21707; Roper J, 2018, NAT PROTOC, V13, P217, DOI 10.1038/nprot.2017.136; Rosania R, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0640-7; Ruan HH, 2017, ONCOTARGET, V8, P113163, DOI 10.18632/oncotarget.22635; Rugge M, 2017, CLIN GASTROENTEROL H, V15, P1833, DOI 10.1016/j.cgh.2017.05.023; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schneider-Brachert W, 2013, INT J MOL SCI, V14, P14475, DOI 10.3390/ijms140714475; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Schultz MJ, 2016, CANCER RES, V76, P3978, DOI 10.1158/0008-5472.CAN-15-2834; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; Serizawa T, 2016, INFECT IMMUN, V84, P562, DOI 10.1128/IAI.01437-15; Sigal M, 2017, NATURE, V548, P451, DOI 10.1038/nature23642; Subbiah V, 2011, PEDIATR BLOOD CANCER, V57, P524, DOI 10.1002/pbc.23051; Suzuki O, 2014, INT J ONCOL, V44, P1433, DOI 10.3892/ijo.2014.2319; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; UCHIDA Y, 1979, J BIOCHEM-TOKYO, V86, P1573, DOI 10.1093/oxfordjournals.jbchem.a132675; VanDussen KL, 2019, STEM CELL RES, V37, DOI 10.1016/j.scr.2019.101430; VanDussen KL, 2015, GUT, V64, P911, DOI 10.1136/gutjnl-2013-306651; Vazquez-Martin C, 2005, ONCOLOGY-BASEL, V69, P436, DOI 10.1159/000089999; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189	58	10	11	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2020	295	41					14153	14163		10.1074/jbc.RA120.014887	http://dx.doi.org/10.1074/jbc.RA120.014887			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OG1HE	32763973	Green Published, hybrid			2022-12-26	WOS:000581643400016
J	Okushin, K; Tsutsumi, T; Ikeuchi, K; Kado, A; Enooku, K; Fujinaga, H; Yamauchi, N; Ushiku, T; Moriya, K; Yotsuyanagi, H; Koike, K				Okushin, Kazuya; Tsutsumi, Takeya; Ikeuchi, Kazuhiko; Kado, Akira; Enooku, Kenichiro; Fujinaga, Hidetaka; Yamauchi, Naoko; Ushiku, Tetsuo; Moriya, Kyoji; Yotsuyanagi, Hiroshi; Koike, Kazuhiko			Heterozygous knockout ofBile salt export pumpameliorates liver steatosis in mice fed a high-fat diet	PLOS ONE			English	Article							BILE-ACID RECEPTORS; NUCLEAR RECEPTOR; HEPATOCELLULAR-CARCINOMA; OBETICHOLIC ACID; GENE; IDENTIFICATION; TRANSPORTERS; METABOLISM; EXPRESSION; LIGANDS	The incidence of nonalcoholic steatohepatitis (NASH) is increasing worldwide, including in Asian countries. We reported that the hepatic expression of bile salt export pump (BSEP) was downregulated in patients with NASH, suggesting that BSEP is involved in the pathogenesis of NASH. To identify the underlying mechanism, we analyzedBsepheterozygous knock-out (Bsep(+/-)mice) and wild-type (WT) C57BL/6J mice fed a high-fat diet (HFD) (32.0% animal fat) or normal diet. We examined histological changes, levels of hepatic lipids and hepatic bile acids, and expression of genes related to bile acid and cholesterol metabolism. HFD-fedBsep(+/-)mice exhibited milder hepatic steatosis and less weight gain, compared to HFD-fed WT mice. The concentrations of total bile acid, triglycerides, and cholesterols were reduced in the liver of HFD-fedBsep(+/-)mice. Regarding hepatic bile acid metabolism, the expression levels ofFarnesoid X receptor(Fxr) andMultidrug resistance-associated protein 2were significantly upregulated in HFD-fedBsep(+/-)mice, compared to HFD-fed WT mice. Furthermore, several alterations were observed in upstream cholesterol metabolism in the liver. The expression levels of bile acid metabolism-related genes were also altered in the intestine of HFD-fedBsep(+/-)mice. In conclusion, HFD-fedBsep(+/-)mice exhibited significant alterations of the expression levels of genes related to bile acid and lipid metabolism in both the liver and ileum, resulting in alleviated steatosis and less weight gain. These results suggest the importance of BSEP for maintenance of bile acid and cholesterol metabolism. Further investigations of the involvement of BSEP in the pathogenesis of NASH will provide greater insight and facilitate the development of novel therapeutic modalities.	[Okushin, Kazuya; Kado, Akira; Enooku, Kenichiro; Fujinaga, Hidetaka; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Okushin, Kazuya; Moriya, Kyoji] Univ Tokyo, Grad Sch Med, Dept Infect Control & Prevent, Tokyo, Japan; [Tsutsumi, Takeya; Ikeuchi, Kazuhiko; Yotsuyanagi, Hiroshi] Univ Tokyo, Adv Clin Res Ctr, Inst Med Sci, Div Infect Dis, Tokyo, Japan; [Yamauchi, Naoko; Ushiku, Tetsuo] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Koike, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	kkoike-tky@umin.ac.jp		Okushin, Kazuya/0000-0001-9584-043X; Kado, Akira/0000-0003-4477-6858	AMED [JP19fk0210040, JP20fk0210040]; JSPS KAKENHI [JP17K15929, JP20K17014]; Gilead Sciences Research Scholars Program in Liver Disease-Japan	AMED; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Gilead Sciences Research Scholars Program in Liver Disease-Japan	This independent research is supported by AMED under Grant Number JP19fk0210040 and JP20fk0210040 (to KK), JSPS KAKENHI Grant Number JP17K15929 and JP20K17014 (to KO), and the Gilead Sciences Research Scholars Program in Liver Disease-Japan (to KO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arab JP, 2016, HEPATOLOGY BALTIMORE, DOI [10.1002/hep.2870927358174, DOI 10.1002/HEP.2870927358174]; Aranha MM, 2008, EUR J GASTROEN HEPAT, V20, P519, DOI 10.1097/MEG.0b013e3282f4710a; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; CHILDS S, 1995, CANCER RES, V55, P2029; Copple BL, 2016, PHARMACOL RES, V104, P9, DOI 10.1016/j.phrs.2015.12.007; Cotter TG, 2020, GASTROENTEROLOGY, DOI [10.1053/j.gastro.2020.01.05232061595, DOI 10.1053/J.GASTRO.2020.01.05232061595]; Dasarathy S, 2011, EUR J GASTROEN HEPAT, V23, P382, DOI 10.1097/MEG.0b013e328345c8c7; de Boer JF, 2017, GASTROENTEROLOGY, V152, P1126, DOI 10.1053/j.gastro.2016.12.037; Ferslew BC, 2015, CLIN PHARMACOL THER, V97, P419, DOI 10.1002/cpt.66; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fuchs CD, 2016, SEMIN LIVER DIS, V36, P69, DOI 10.1055/s-0036-1571296; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; Karpen SJ, 2013, GASTROENTEROLOGY, V145, P508, DOI 10.1053/j.gastro.2013.07.017; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; La Frano MR, 2017, NUTR RES, V46, P11, DOI 10.1016/j.nutres.2017.07.006; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li YY, 2013, BIOCHEM PHARMACOL, V86, P1517, DOI 10.1016/j.bcp.2013.08.015; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Marrero JA, 2002, HEPATOLOGY, V36, P1349, DOI 10.1053/jhep.2002.36939; Mudaliar S, 2013, GASTROENTEROLOGY, V145, P574, DOI 10.1053/j.gastro.2013.05.042; Murakami Y, 2016, J FOOD SCI, V81, pH216, DOI 10.1111/1750-3841.13166; Musso G, 2016, NAT REV DRUG DISCOV, V15, P249, DOI 10.1038/nrd.2015.3; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Okushin K, 2016, J GASTROENTEROL, V51, P808, DOI 10.1007/s00535-015-1148-y; Okushin K, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0247-9; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pathak P, 2018, HEPATOLOGY, V68, P1574, DOI 10.1002/hep.29857; Pierre JF, 2016, AM J PHYSIOL-GASTR L, V311, pG286, DOI 10.1152/ajpgi.00202.2016; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Rubinstein E, 2008, SEMIN LIVER DIS, V28, P380, DOI 10.1055/s-0028-1091982; Satapathy SK, 2015, SEMIN LIVER DIS, V35, P221, DOI 10.1055/s-0035-1562943; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Strautnieks SS, 1997, AM J HUM GENET, V61, P630, DOI 10.1086/515501; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Sumi K, 2007, MOL CELL BIOL, V27, P4248, DOI 10.1128/MCB.01894-06; Taylor SA, 2018, HEPATOLOGY, V68, P1229, DOI 10.1002/hep.30078; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Trauner M, 2010, DIGEST DIS, V28, P220, DOI 10.1159/000282091; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang RX, 2009, HEPATOLOGY, V50, P948, DOI 10.1002/hep.23089; Wang RX, 2001, P NATL ACAD SCI USA, V98, P2011, DOI 10.1073/pnas.031465498; Younossi ZM, 2019, LANCET, V394, P2184, DOI 10.1016/S0140-6736(19)33041-7	46	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2020	15	8							e0234750	10.1371/journal.pone.0234750	http://dx.doi.org/10.1371/journal.pone.0234750			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ND3HD	32785220	Green Published, gold			2022-12-26	WOS:000561793900026
J	Kosmidis, K; Macheras, P				Kosmidis, Kosmas; Macheras, Panos			A fractal kinetics SI model can explain the dynamics of COVID-19 epidemics	PLOS ONE			English	Article							DRUG-RELEASE	The COVID-19 pandemic has already had a shocking impact on the lives of everybody on the planet. Here, we present a modification of the classical SI model, the Fractal Kinetics SI model which is in excellent agreement with the disease outbreak data available from the World Health Organization. The fractal kinetic approach that we propose here originates from chemical kinetics and has successfully been used in the past to describe reaction dynamics when imperfect mixing and segregation of the reactants is important and affects the dynamics of the reaction. The model introduces a novel epidemiological parameter, the "fractal" exponenthwhich is introduced in order to account for the self-organization of the societies against the pandemic through social distancing, lockdowns and flight restrictions.	[Kosmidis, Kosmas] Aristotle Univ Thessaloniki, Dept Phys, Div Theoret Phys, Thessaloniki, Greece; [Kosmidis, Kosmas; Macheras, Panos] Res Ctr ATHENA, PharmaInformat Unit, Athens, Greece	Aristotle University of Thessaloniki	Kosmidis, K (corresponding author), Aristotle Univ Thessaloniki, Dept Phys, Div Theoret Phys, Thessaloniki, Greece.; Kosmidis, K (corresponding author), Res Ctr ATHENA, PharmaInformat Unit, Athens, Greece.	kosmask@auth.gr	Kosmidis, Kosmas/G-4812-2011	Kosmidis, Kosmas/0000-0002-9150-5746	"Athena" Research Center	"Athena" Research Center	The authors acknowledge financial support from "Athena" Research Center for the open access publication of this work.	ANDERSON R M, 1991; Anguelova M, 2012, MATH BIOSCI, V239, P139, DOI 10.1016/j.mbs.2012.04.005; [Anonymous], 2020, PCA IRIS DATASET; Bank W, 2018, POPULATION; Brauer F., 2012, MATH MODELS POPULATI, V2; Distefano J., 2015, DYNAMIC SYSTEMS BIOL; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Inc WR, 2020, MATH VERS 12 1; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Karlsson J., 2012, IFAC PROC VOL, V45, P941, DOI 10.3182/20120711-3-BE-2027.00381; KOPELMAN R, 1988, SCIENCE, V241, P1620, DOI 10.1126/science.241.4873.1620; Kosmidis K, 2003, INT J PHARMACEUT, V254, P183, DOI 10.1016/S0378-5173(03)00030-9; Kosmidis K, 2003, J CHEM PHYS, V119, P6373, DOI 10.1063/1.1603731; Kosmidis K, 2003, PHARM RES-DORDR, V20, P988, DOI 10.1023/A:1024497920145; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Marsland S, 2015, MACHINE LEARNING ALG, DOI DOI 10.1201/B17476; Newville Matthew, 2014, Zenodo, DOI 10.5281/ZENODO.11813; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peng L., 2020, MEDRXIV, P1, DOI [10.1101/2020.02.16.20023465, DOI 10.1101/2020.02.16.20023465]; Raschka S., 2015, PYTHON MACHINE LEARN; Raue A, 2014, BIOINFORMATICS, V30, P1440, DOI 10.1093/bioinformatics/btu006; SAVAGEAU MA, 1993, J MOL RECOGNIT, V6, P149, DOI 10.1002/jmr.300060403; SAVAGEAU MA, 1995, J THEOR BIOL, V176, P115, DOI 10.1006/jtbi.1995.0181; Tableau, 2020, DAT COV 19 OUTBR; Wu J, 2020, NEUROCOMPUTING, V395, P78, DOI 10.1016/j.neucom.2020.02.017	25	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237304	10.1371/journal.pone.0237304	http://dx.doi.org/10.1371/journal.pone.0237304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780754	gold, Green Published, Green Submitted			2022-12-26	WOS:000562664700015
J	Shi, YY; Cui, XW; Sun, YL; Zhao, Q; Liu, TJ				Shi, Yongyan; Cui, Xuewei; Sun, Yanli; Zhao, Qun; Liu, Tianjing			Intestinal vitamin D receptor signaling ameliorates dextran sulfate sodium-induced colitis by suppressing necroptosis of intestinal epithelial cells	FASEB JOURNAL			English	Article						inflammatory bowel disease; necroptosis; vitamin D receptor	INFLAMMATORY-BOWEL-DISEASE; EXPRESSION; BARRIER; APOPTOSIS; NECROSIS; INJURY; DEATH	Vitamin D status is closely related to inflammatory bowel disease (IBD), but the mechanism has not been fully elucidated. This study explored the effect of intestinal vitamin D signaling on necroptosis and the underlying mechanism in colitis. Serum 25(OH)D levels and the expression of necroptotic proteins were examined in patients with IBD. Colitis was induced in an intestinal-specific hVDR transgenic model, and the gross manifestation, histological integrity, and intestinal barrier function were tested. The findings were further confirmed in vitro. Immunoprecipitation and colocalization were performed to investigate the association between the vitamin D receptor and necroptotic proteins. We found that serum 25(OH)D decreased in patients with IBD, while the expression of necroptotic proteins increased. The intestinal hVDR transgenic model could largely ameliorate the structural destruction, restore barrier dysfunction, and suppress necroptosis caused by DSS. This was probably achieved by binding to RIPK1/3 necrosomes, as we observed decreased RIPK1/3 necrosome formation and increased VDR expression in the cytosol. This study demonstrated an inhibitory effect of the intestinal vitamin D signaling pathway on necroptosis in DSS-induced colitis. The vitamin D receptor shifts from the nucleus to the cytosol to impede the formation of RIPK1/3. Our findings may offer some theoretical basis for a novel treatment of IBD in clinical practice.	[Shi, Yongyan; Cui, Xuewei] China Med Univ, Dept Pediat, Shengjing Hosp, Shenyang, Peoples R China; [Sun, Yanli] China Med Univ, Dept Pediat, Affiliated Hosp 4, Shenyang, Peoples R China; [Zhao, Qun; Liu, Tianjing] China Med Univ, Shengjing Hosp, Dept Pediat Orthoped, 36 Sanhao St, Shenyang 110004, Peoples R China	China Medical University; China Medical University; China Medical University	Liu, TJ (corresponding author), China Med Univ, Shengjing Hosp, Dept Pediat Orthoped, 36 Sanhao St, Shenyang 110004, Peoples R China.	tianjing_rat@163.com	Cui, Xuewei/HCH-4622-2022		National Natural Science Foundation of China (NSFC) [81700459, 81801500]; Natural Science Foundation of Liaoning Province (Liaoning Natural Science Foundation) [20180550562]; The 345 Talent Project of Shengjing Hospital [M0275, M0279]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province (Liaoning Natural Science Foundation); The 345 Talent Project of Shengjing Hospital	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81700459 and 81801500; Natural Science Foundation of Liaoning Province (Liaoning Natural Science Foundation), Grant/Award Number: 20180550562; The 345 Talent Project of Shengjing Hospital, Grant/Award Number: M0275 and M0279	APPLEYARD CB, 1995, AM J PHYSIOL-GASTR L, V269, pG119, DOI 10.1152/ajpgi.1995.269.1.G119; Caviezel Daniel, 2018, Inflamm Intest Dis, V2, P200, DOI 10.1159/000489010; Chen SW, 2015, TOXICOL LETT, V237, P79, DOI 10.1016/j.toxlet.2015.06.006; Cheng SL, 2016, INTERDISCIP SCI, V8, P65, DOI 10.1007/s12539-015-0106-y; COOPER HS, 1993, LAB INVEST, V69, P238; Du J, 2015, INFLAMM BOWEL DIS, V21, P2495, DOI 10.1097/MIB.0000000000000526; Golan MA, 2015, DIGEST DIS SCI, V60, P1941, DOI 10.1007/s10620-015-3634-8; Gunther C, 2013, GUT, V62, P1062, DOI 10.1136/gutjnl-2011-301364; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Hausmann J, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091319; Jeong MS, 2014, ANN DERMATOL, V26, P296, DOI 10.5021/ad.2014.26.3.296; Ko KH, 2019, INTEST RES, V17, P70, DOI 10.5217/ir.2018.00022; Li S, 2018, WORLD J CLIN CASES, V6, P745, DOI 10.12998/wjcc.v6.i14.745; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Liu TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32889; Liu WC, 2013, J CLIN INVEST, V123, P3983, DOI 10.1172/JCI65842; Liu ZY, 2015, AM J CANCER RES, V5, P3174; Moriwaki K, 2014, IMMUNITY, V41, P567, DOI 10.1016/j.immuni.2014.09.016; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Newton K, 2016, ANNU REV BIOCHEM, V85, P743, DOI 10.1146/annurev-biochem-060815-014830; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Pierdomenico M, 2014, AM J GASTROENTEROL, V109, P279, DOI 10.1038/ajg.2013.403; Quarni W, 2017, J STEROID BIOCHEM, V173, P157, DOI 10.1016/j.jsbmb.2017.01.024; Sharma D, 2017, IMMUNOL REV, V280, P57, DOI 10.1111/imr.12602; Su LP, 2013, GASTROENTEROLOGY, V145, P407, DOI 10.1053/j.gastro.2013.04.011; Tabatabaeizadeh SA, 2018, J RES MED SCI, V23, DOI 10.4103/jrms.JRMS_606_17; Wang F, 2017, ENDOCRINOLOGY, V158, P1951, DOI 10.1210/en.2016-1913; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wu TL, 2019, ANN PALLIAT MED, V8, P483, DOI 10.21037/apm.2019.07.04; Zammit SC, 2018, EUR J GASTROEN HEPAT, V30, P1297, DOI 10.1097/MEG.0000000000001238; Zhang C, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1580-7; Zhang J, 2019, MOL IMMUNOL, V107, P132, DOI 10.1016/j.molimm.2019.01.018; Zhao GX, 2019, J CLIN INVEST, V129, P972, DOI 10.1172/JCI122779; Zhu T, 2015, INT J MOL MED, V35, P1213, DOI 10.3892/ijmm.2015.2150	34	7	7	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13494	13506		10.1096/fj.202000143RRR	http://dx.doi.org/10.1096/fj.202000143RRR		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32779265	hybrid			2022-12-26	WOS:000558416600001
J	Muhr, LSA; Lagheden, C; Hassan, SS; Kleppe, SN; Hultin, E; Dillner, J				Arroyo Muhr, Laila Sara; Lagheden, Camilla; Hassan, Sadaf Sakina; Kleppe, Sara Nordqvist; Hultin, Emilie; Dillner, Joakim			De novo sequence assembly requires bioinformatic checking of chimeric sequences	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS-DNA	De novo assembly of sequence reads from next generation sequencing platforms is a common strategy for detecting presence and sequencing of viruses in biospecimens. Amplification artifacts and presence of several related viruses in the same specimen can lead to assembly of erroneous, chimeric sequences. We now report that such chimeras can also occur between viral and non-viral biological sequences incorrectly joined together which may cause erroneous detection of viruses, highlighting the importance of performing a chimera checking step in bioinformatics pipelines. Using Illumina NextSeq and metagenomic sequencing, we analyzed 80 consecutive non-melanoma skin cancers (NMSCs) from 11 immunosuppressed patients together with 11 NMSCs from patients who had only developed 1 NMSC. We aligned high-quality reads against a Human Papillomavirus (HPV) database and found HPV sequences in 9/91 specimens. A previous bioinformatic analysis of the same crude sequencing data from some of these samples had found an additional 3 specimens to be HPV-positive after performing de novo assembly. The reason for the discrepancy was investigated and found to be mostly caused by chimeric sequences containing both viral and non-viral sequences. Non-viral sequences were present in these 3 samples. To avoid erroneous detection of HPV when performing sequencing, we thus developed a novel script to identify HPV chimeric sequences.	[Arroyo Muhr, Laila Sara; Lagheden, Camilla; Hassan, Sadaf Sakina; Kleppe, Sara Nordqvist; Hultin, Emilie; Dillner, Joakim] Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet	Muhr, LSA (corresponding author), Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden.	sara.arroyo.muhr@ki.se		Arroyo Muhr, Laila Sara/0000-0003-2498-5206; Nordqvist Kleppe, Sara/0000-0002-8892-7497	Swedish Research Council [K2015-57X21044-07-3]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by the Swedish Research Council (author: JD, grant number K2015-57X21044-07-3, url:www.vr.se).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo Muhr LS, 2019, J GEN VIROL; Asgari MM, 2008, J INVEST DERMATOL, V128, P1409, DOI 10.1038/sj.jid.5701227; AYLING M, 2019, BRIEF BIOINFORM; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bzhalava D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065953; Duhaime MB, 2012, ENVIRON MICROBIOL, V14, P2526, DOI 10.1111/j.1462-2920.2012.02791.x; Dzunkova M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00955; Forslund O, 2004, J INVEST DERMATOL, V123, P388, DOI 10.1111/j.0022-202X.2004.23205.x; Forslund O, 2003, J CUTAN PATHOL, V30, P423, DOI 10.1034/j.1600-0560.2003.00092.x; Goodacre N, 2018, MSPHERE, V3, DOI 10.1128/mSphereDirect.00069-18; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; LI YB, 2016, SCI REP UK, V6; Lu Z., 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.013985726440104, DOI 10.1371/JOURNAL.PONE.013985726440104]; Mackintosh LJ, 2009, BRIT J DERMATOL, V161, P56, DOI 10.1111/j.1365-2133.2009.09146.x; Muhr LSA, 2015, INT J CANCER, V136, P2546, DOI 10.1002/ijc.29325; Muhr LSA, 2019, INT J CANCER, V145, P3181, DOI 10.1002/ijc.32645; Muhr LSA, 2017, INT J CANCER, V141, P2498, DOI 10.1002/ijc.31017; Muhr LSA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172308; Muhr LSA, 2015, VIROLOGY, V485, P283, DOI 10.1016/j.virol.2015.07.023; Olson ND, 2019, BRIEF BIOINFORM, V20, P1140, DOI 10.1093/bib/bbx098; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Rampelli S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2446-3; Roux S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-76; Saiki R K, 1992, Biotechnology, V24, P476; Sedlazeck FJ, 2013, BIOINFORMATICS, V29, P2790, DOI 10.1093/bioinformatics/btt468; Weissenborn SJ, 2005, J INVEST DERMATOL, V125, P93, DOI 10.1111/j.0022-202X.2005.23733.x; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078470; Zheng Y, 2017, VIROLOGY, V500, P130, DOI 10.1016/j.virol.2016.10.017	28	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237455	10.1371/journal.pone.0237455	http://dx.doi.org/10.1371/journal.pone.0237455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32777809	Green Published, gold			2022-12-26	WOS:000561393800048
J	Hassane-Harouna, S; Cherif, GF; Ortuno-Gutierrez, N; Cisse, D; Camara, LM; Diallo, BD; Camara, S; Bangoura, AM; Lynen, L; Decroe, T				Hassane-Harouna, Souleymane; Cherif, Gba-Foromo; Ortuno-Gutierrez, Nimer; Cisse, Diao; Camara, Lansana Mady; Diallo, Boubacar Djelo; Camara, Souleymane; Bangoura, Adama Marie; Lynen, Lutgarde; Decroe, Tom			Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: A retrospective cohort study	PLOS ONE			English	Article							GATIFLOXACIN; MOXIFLOXACIN	Setting Since August 2016, after the Ebola outbreak, the Guinean National Tuberculosis Programme and Damien Foundation implemented the shorter treatment regimen (STR) for multidrug-resistant tuberculosis (MDR-TB) in the three MDR-TB sites of Conakry. Previously, the longer regimen was used to treat MDR-TB. Objectives In a post-Ebola context, with a weakened health system, we describe the MDR-TB treatment uptake, patients characteristics, treatment outcomes and estimate the effect of using the longer versus STR on having a programmatically adverse outcome. Design This is a retrospective cohort study in RR-TB patients treated with either the longer regimen or STR. Results In Conakry, in 2016 and 2017, 131 and 219 patients were diagnosed with rifampicin-resistant tuberculosis (RR-TB); and 108 and 163 started treatment, respectively. Of 271 patients who started treatment, 75 were treated with the longer regimen and 196 with the STR. Patients characteristics were similar regardless of the regimen except that the median age was higher among those treated with a longer regimen (30 years (IQR:24-38) versus 26 years (IQR:21-39) for the STR. Patients treated with a STR were more likely to obtain a programmatically favorable outcome (74.0% vs 58.7%, p = 0.01) as lost to follow up was higher among those treated with a longer regimen (20.0% vs 8.2%, p = 0.006). Patients on a longer regimen were more than 2 times more likely (aOR: 2.5; 95%CI:1.3,4.7) to have a programmatically adverse outcome as well as being 45 years or older (aOR: 2.8; 95%CI:1.3,6.2), HIV positive (aOR:3.3; 95%CI:1.6,6.6) and attendance at a clinic without NGO support (aOR:3.0; 95%:1.6,5.7). Conclusion In Guinea, patients treated with the STR were more likely to have a successful outcome than those treated with the longer MDR-TB treatment regimen. Lost to follow-up was higher in patients on the longer regimen. However, STR treatment outcomes were less good than those reported in the region.	[Hassane-Harouna, Souleymane; Cherif, Gba-Foromo; Cisse, Diao] Act Damien, Conakry, Guinea; [Ortuno-Gutierrez, Nimer] Res Dept Brussels, Act Damien, Brussels, Belgium; [Camara, Lansana Mady] Gamal Abdel Nasser Univ, Conakry, Guinea; [Camara, Lansana Mady; Diallo, Boubacar Djelo] Hop Univ Ignace Deen, Pneumo Phtisiol, Conakry, Guinea; [Camara, Souleymane; Bangoura, Adama Marie] Natl TB Control Program, Conakry, Guinea; [Lynen, Lutgarde; Decroe, Tom] Inst Trop Med, Antwerp, Belgium; [Decroe, Tom] Res Fdn Flanders, Brussels, Belgium	Institute of Tropical Medicine (ITM)	Hassane-Harouna, S (corresponding author), Act Damien, Conakry, Guinea.	hassoul20@yahoo.fr	Decroo, Tom/AAV-7208-2020; Lynen, Lutgarde/A-1212-2014; Lynen, Lutgarde/AAT-9180-2020	Decroo, Tom/0000-0002-1205-1484; Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895; HASSANE HAROUNA, Souleymane/0000-0002-9950-5660				Abidi S, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01467-2019; Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100; Chiang CY, 2016, INT J TUBERC LUNG D, V20, P1143, DOI 10.5588/ijtld.15.0884; Gumbo T, 2004, J INFECT DIS, V190, P1642, DOI 10.1086/424849; Khan FA, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00061-2017; Kuaban C, 2015, INT J TUBERC LUNG D, V19, P517, DOI 10.5588/ijtld.14.0535; Loveday M, 2019, LANCET, V393, P351; Nunn AJ, 2019, NEW ENGL J MED, V380, P1201, DOI 10.1056/NEJMoa1811867; Ortuno-Gutierrez N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157296; Piubello A, 2014, INT J TUBERC LUNG D, V18, P1188, DOI 10.5588/ijtld.13.0075; Trebucq A, 2018, INT J TUBERC LUNG D, V22, P17, DOI 10.5588/ijtld.17.0498; Van Deun A, 2019, INT J TUBERC LUNG D, V23, P965, DOI 10.5588/ijtld.19.0053; WHO, 2019, GLOB TUB REP, P1; World Health Organization, 2016, WHOHTMTB201604159; World Health Organization, 2019, WHO HQ REP; World Health Organization, 2013, WHOHTMTB20132140; World Health Organization, 2019, MULT RES TUB FACTSH; World Health Organization, 2019, CONS GUID DRUG RES T	18	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237355	10.1371/journal.pone.0237355	http://dx.doi.org/10.1371/journal.pone.0237355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776969	Green Published, gold			2022-12-26	WOS:000561393800022
J	Koper, LM; Bode, C; Bender, A; Reimer, I; Heberer, T; Wallmann, J				Koeper, Lydia M.; Bode, Christoph; Bender, Alice; Reimer, Inke; Heberer, Thomas; Wallmann, Juergen			Eight years of sales surveillance of antimicrobials for veterinary use in Germany-What are the perceptions?	PLOS ONE			English	Article							ANTIBIOTIC USE; PUBLIC-HEALTH; RESISTANCE; ANIMALS; FOOD; HUMANS; MRSA; MECHANISMS; REDUCTION; EMERGENCE	A surveillance system for sales volumes of antimicrobial agents for veterinary use was established in Germany in 2011. Since then, pharmaceutical companies and wholesalers have been legally obliged to report annual volumes of veterinary antimicrobial products sold to veterinary practices or clinics located in Germany. The evaluation of sales volumes for eight consecutive years resulted in a considerable total decrease by 58% from 1706 tons to 722 tons. During the investigation period, two legally binding measures to control the risk of antimicrobial resistance resulting from the veterinary use of antimicrobials were introduced, a) the German treatment frequencies benchmarking in 2014 and b) the obligation to conduct susceptibility testing for the use of cephalosporins of the 3(rd)and 4(th)generation and of fluoroquinolones in 2018. Both had a marked impact on sales volumes. Nonetheless, the category of Critically Important Antimicrobials as defined by the World Health Organization kept accounting for the highest share on sales volumes in Germany in 2018 with 403 tons, despite an overall reduction by 53%. Sales surveillance is considered essential for data retrieval on a global scale and inter-country comparison. However, the usability of a surveillance system based on sales data for risk management of antimicrobial resistance has limitations. The German system does not include off-label use of antimicrobial products authorized for human medicine and does not allow for identification of areas of high risk according to animal species, farm and production types and indications for treatment. For further reduction and enhanced promotion of a prudent use of antimicrobials, targeted measures would be required that could only be deducted from use data collected at farm or veterinary practice level. A surveillance system based on use data is currently lacking in Germany but will be established according to Regulation (EU) 2019/6 on veterinary medicinal products.	[Koeper, Lydia M.; Bode, Christoph; Bender, Alice; Reimer, Inke; Heberer, Thomas; Wallmann, Juergen] Fed Off Consumer Protect & Food Safety BVL, Dept Vet Drugs, Berlin, Germany		Koper, LM (corresponding author), Fed Off Consumer Protect & Food Safety BVL, Dept Vet Drugs, Berlin, Germany.	lydia.koeper@bvl.bund.de						Aidara-Kane A, 2012, REV SCI TECH OIE, V31, P277; Aidara-Kane A, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-017-0294-9; Al-Tawfiq JA, 2017, INT J INFECT DIS, V54, P77, DOI 10.1016/j.ijid.2016.11.415; Alhashem F, 2017, WORLD J CLIN CASES, V5, P324, DOI 10.12998/wjcc.v5.i8.324; [Anonymous], 2019, EUROPEAN PHARMACOPOE, V10; [Anonymous], 2019, BELG VET SURV ANT CO; Asif M, 2018, INFECT DRUG RESIST, V11, P1249, DOI 10.2147/IDR.S166750; Bondt N, 2013, PREV VET MED, V108, P10, DOI 10.1016/j.prevetmed.2012.07.009; Carmo LP, 2017, EUROSURVEILLANCE, V22, P29, DOI [10.2807/1560-7917.ES.2017.22.6.30458, 10.2807/1560-7917.es.2017.22.6.30458]; Chatterjee A, 2018, LANCET INFECT DIS, V18, pE368, DOI 10.1016/S1473-3099(18)30296-2; Chavin C, 2001, VET RES, V32, P533, DOI 10.1051/vetres:2001145; Collignon PC, 2016, CLIN INFECT DIS, V63, P1087, DOI 10.1093/cid/ciw475; Collineau L, 2017, ZOONOSES PUBLIC HLTH, V64, P165, DOI 10.1111/zph.12298; Coyne LA, 2018, PREV VET MED, V161, P115, DOI 10.1016/j.prevetmed.2018.10.021; Cuny C, 2013, INT J MED MICROBIOL, V303, P331, DOI 10.1016/j.ijmm.2013.02.010; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Daeseleire E, 2016, DRUG TEST ANAL, V8, P549, DOI 10.1002/dta.2010; Dahms C, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0053-3; De Briyne N, 2014, VET REC, V175, DOI 10.1136/vr.102462; Dohmen W, 2015, CLIN MICROBIOL INFEC, V21, P917, DOI 10.1016/j.cmi.2015.05.032; Dupont N, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0208-5; European Food Safety Authority, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5077; European Medicines Agency, 2015, EMACVMPAWP4017402013; European Medicines Agency, SAL VET ANT AG 31 EU; European Surveillance of Antimicrobial Consumption Network, 2019, ANT CONS EU EAA ANN; Evans BR, 2014, REV SCI TECH OIE, V33, P413, DOI 10.20506/rst.33.2.2298; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Federal Office of Consumer Protection and Food Safety, 2019, 137 BVL FED OFF CONS; Federal Office of Consumer Protection and Food Safety, 2016, REPORT CONSUMPTION A; Ferreira JP, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00213; Food and Agriculture Organization of the United Nations Ministry of Environment and Food of Denmark-Danish veterinary and Food Administration, TACKL ANT US RES PIG; French Ministry of Agriculture and Food, 2017, ECOANTIBIO2 FRENCH N; Gastmeier P, 2009, INFECT CONT HOSP EP, V30, P993, DOI 10.1086/605720; Gastmeier P, 2008, J HOSP INFECT, V70, P11, DOI 10.1016/S0195-6701(08)60005-5; Gaynes R, 2001, EMERG INFECT DIS, V7, P295, DOI 10.3201/eid0702.010230; Gentilini F, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02872; German Federal Ministry of Health, 2008, GERM ANT RES STRAT; Grave K, 2014, J ANTIMICROB CHEMOTH, V69, P2284, DOI 10.1093/jac/dku106; Guardabassi L, 2013, VET REC, V173, P599, DOI 10.1136/vr.f7276; Hansen S, 2018, EUROSURVEILLANCE, V23, P24, DOI 10.2807/1560-7917.ES.2018.23.21.1700513; Hassoun A, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1801-3; Hauck R, 2014, BERL MUNCH TIERARZTL, V127, P359, DOI 10.2376/0005-9366-127-359; Helke KL, 2017, CRIT REV FOOD SCI, V57, P472, DOI 10.1080/10408398.2016.1230088; HM Government, 2019, TACKL ANT RES 2019 2; Hoelzer K, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1131-3; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Hopman NEM, 2018, PREV VET MED, V158, P106, DOI 10.1016/j.prevetmed.2018.07.013; Kadlec K, 2018, ANTIMICROBIAL RESISTANCE IN BACTERIA FROM LIVESTOCK AND COMPANION ANIMALS, P365, DOI 10.1128/9781555819804.ch16; Kasabova S, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00116; Kock R, 2014, BERL MUNCH TIERARZTL, V127, P384, DOI 10.2376/0005-9366-127-384; Lekagul A, 2018, PREV VET MED, V160, P85, DOI 10.1016/j.prevetmed.2018.09.016; Lhermie G, 2020, J ANTIMICROB CHEMOTH, V75, P1671, DOI 10.1093/jac/dkaa104; Lhermie G, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02114; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mevius D, 2014, J VERBRAUCH LEBENSM, V9, P177, DOI 10.1007/s00003-014-0874-z; Mukerji S, 2017, ESSAYS BIOCHEM, V61, P23, DOI 10.1042/EBC20160055; National Institute for Public Health and the Environment Dutch Foundation of the Working Party on Antibiotic Policy Wangeningen Bioveterinary Research Netherlands Food and Consumer Product Safety Authority Netherlands Veterinary Medicines Institute. Nethmap Maran, 2018, CONS ANT AG ANT RES; Netherlands Veterinary Medicines Institute, 2019, TRENDS BENCHM LIV FA; NORM and NORM-Vet, 2019, US ANT AG OCC ANT RE; OIE World Organization for Animal Health, 2021, ANN REP ANT AG INT U; Pantosti A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00127; Poirel L, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.ARBA-0026-2017; Pulss S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01265; Saraiva MMS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203158; Schar D, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002521; Schmidt VM, 2018, J ANTIMICROB CHEMOTH, V73, P3305, DOI 10.1093/jac/dky352; Scott AM, 2018, INT J ANTIMICROB AG, V52, P316, DOI 10.1016/j.ijantimicag.2018.04.005; Scott HM, 2019, ANN NY ACAD SCI, V1441, P8, DOI 10.1111/nyas.14058; Smith A, 2019, J VET INTERN MED, V33, P1677, DOI 10.1111/jvim.15522; Speksnijder DC, 2015, ZOONOSES PUBLIC HLTH, V62, P79, DOI 10.1111/zph.12167; Statens Serum Institut National Food Institute Technical University of Denmark, 2019, DANMAP 2018 US ANT A; Tang KL, 2017, LANCET PLANET HEALTH, V1, pE316, DOI 10.1016/S2542-5196(17)30141-9; The German Federal Government, 2015, FIGHT ANT RES GOOD B; U.S. Food and Drug Administration, 2019, 2018 SUMM REP AT SOL; U.S. Government Accountability Office, 2017, GAO17192; Van Boeckel TP, 2017, SCIENCE, V357, P1350, DOI 10.1126/science.aao1495; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; Venter H, 2017, ESSAYS BIOCHEM, V61, P1, DOI 10.1042/EBC20160053; World Health Organization, 2018, RANK MED IMP ANT RIS, V6th; World Health Organization, 2005, CRIT IMP ANT AG HUM; World Organization for Animal Health (OIE), 2019, OIE LIST ANT AG VET	83	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237459	10.1371/journal.pone.0237459	http://dx.doi.org/10.1371/journal.pone.0237459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776971	Green Published, gold			2022-12-26	WOS:000561393800044
J	Lee, HJ; Kim, CO; Lee, DC				Lee, Hye Jun; Kim, Choon Ok; Lee, Duk Chul			Association between daily sunlight exposure duration and diabetic retinopathy in Korean adults with diabetes: A nationwide population-based cross-sectional study	PLOS ONE			English	Article							INDUCED ACTIVATION; OXIDATIVE STRESS; RISK-FACTORS; UV-A; TYPE-2; COMPLICATIONS; RETINA; PREVALENCE; CELLS	Purpose To investigate the association between daily sunlight exposure duration and diabetic retinopathy in Korean adults with diabetes. Methods This study used data from the 2008-2011 Korea National Health and Nutrition Examination Survey. Overall, 1,089 patients with diabetes aged >40 years were included. The duration of daily sunlight exposure was assessed via health interviews. Comprehensive ophthalmic evaluations, including standard retinal fundus photography after pupil dilation, were conducted. Diabetic retinopathy was graded using the modified Airlie House Classification. Multivariate logistic regression analysis was performed to analyze the association between daily sunlight exposure duration and the diagnosis of diabetic retinopathy and non-proliferative diabetic retinopathy. Results The risk of diabetic retinopathy was 2.66 times higher in the group with >= 5 h of daily sunlight exposure than in the group with less exposure after adjusting for risk factors such as duration of diabetes, serum hemoglobin A1c level, hypertension, and dyslipidemia (P= 0.023). Furthermore, the risk of non-proliferative diabetic retinopathy was 3.13 times higher in the group with >= 5 h of daily sunlight exposure than in the group with less exposure (P= 0.009). In patients with diabetes for <10 years, the risks of diabetic retinopathy and non-proliferative diabetic retinopathy were 4.26 and 4.82 times higher in the group with >= 5 h of daily sunlight exposure than the group with less exposure, respectively (P< 0.05). Conclusions This study revealed that sunlight exposure for >= 5 h a day was significantly associated with an increased risk of diabetic retinopathy and non-proliferative diabetic retinopathy in Korean patients with diabetes. The risks were significantly higher in patients with diabetes for <10 years. Therefore, reducing daily sunlight exposure could be an early preventive strategy against diabetic retinopathy in people with diabetes.	[Lee, Hye Jun; Lee, Duk Chul] Yonsei Univ, Coll Med, Dept Family Med, Seoul, South Korea; [Kim, Choon Ok] Yonsei Univ Hlth Syst, Severance Hosp, Dept Clin Pharmacol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, DC (corresponding author), Yonsei Univ, Coll Med, Dept Family Med, Seoul, South Korea.; Kim, CO (corresponding author), Yonsei Univ Hlth Syst, Severance Hosp, Dept Clin Pharmacol, Seoul, South Korea.	delivery98@yuhs.ac; faith@yuhs.ac		Lee, Duk Chul/0000-0001-9166-1813; Lee, HyeJun/0000-0001-5810-9787; Kim, Choon Ok/0000-0002-2319-1108				Amutha A, 2017, DIABETES RES CLIN PR, V123, P1, DOI 10.1016/j.diabres.2016.11.006; Atlasz T, 2011, J MOL NEUROSCI, V43, P51, DOI 10.1007/s12031-010-9392-3; Berkowitz BA, 2015, INVEST OPHTH VIS SCI, V56, P606, DOI 10.1167/iovs.14-15687; Busch EM, 1999, VISION RES, V39, P1233, DOI 10.1016/S0042-6989(98)00233-8; Cusi K, 2011, AM J MED, V124, pS2, DOI 10.1016/j.amjmed.2011.07.017; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Grandahl K, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0410-3; Group DRS, 1981, INVEST OPHTHALMOL, V21, P6; Hanus J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.478; Hillier TA, 2003, DIABETES CARE, V26, P2999, DOI 10.2337/diacare.26.11.2999; KAGAN VE, 1973, BIOCHIM BIOPHYS ACTA, V330, P76, DOI 10.1016/0005-2736(73)90285-X; Kim YJ, 2014, J KOREAN MED SCI, V29, P1699, DOI 10.3346/jkms.2014.29.12.1699; Kowluru RA, 2003, FREE RADICAL RES, V37, P1169, DOI 10.1080/10715760310001604189; Kowluru RA, 2002, FREE RADICAL RES, V36, P993, DOI 10.1080/1071576021000006572; LEE T H, 1987, Korean Journal of Internal Medicine, V2, P42; LERMAN S, 1991, PHOTOCHEM PHOTOBIOL, V53, P243, DOI 10.1111/j.1751-1097.1991.tb03929.x; Maser R E, 1999, Del Med J, V71, P287; Melo T, 2013, J MASS SPECTROM, V48, P68, DOI 10.1002/jms.3129; Miyamoto S., 2003, J AM CHEM SOC, V125, P61; Oduntan OA., 2011, S AFR OPTOM, V70, P191, DOI 10.4102/aveh.v70i4.116; Park CY, 2012, BRIT J OPHTHALMOL, V96, P151, DOI 10.1136/bjo.2010.198275; Roduit R, 2008, APOPTOSIS, V13, P343, DOI 10.1007/s10495-008-0179-8; Song SH, 2009, QJM-INT J MED, V102, P799, DOI 10.1093/qjmed/hcp121; Tidake P., 2018, IOSR J DENT MED SCI, V17, P25; Tringali G, 2016, MOL MED REP, V14, P3485, DOI 10.3892/mmr.2016.5649; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Yang JY, 2013, DIABETES RES CLIN PR, V102, P218, DOI 10.1016/j.diabres.2013.10.016	27	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237149	10.1371/journal.pone.0237149	http://dx.doi.org/10.1371/journal.pone.0237149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764774	gold, Green Published			2022-12-26	WOS:000561029000012
J	Nagayama, Y; Isoo, N; Nakashima, A; Suzuki, K; Yamano, M; Nariyama, T; Yagame, M; Matsui, K				Nagayama, Yoshikuni; Isoo, Naoyuki; Nakashima, Ayaka; Suzuki, Kengo; Yamano, Mizuki; Nariyama, Tomoyuki; Yagame, Motoka; Matsui, Katsuyuki			Renoprotective effects of paramylon, a beta-1,3-D-Glucan isolated from Euglena gracilis Z in a rodent model of chronic kidney disease	PLOS ONE			English	Article							SUPERFINE DISPERSED LENTINAN; GUT MICROBIOTA; BETA-GLUCAN; MACROPHAGES; ACTIVATION; EFFICACY; ISOFORMS	Paramylon is a novel beta-glucan that is stored byEuglena gracilis Z, which is a unicellular photosynthesizing green alga with characteristics of both animals and plants. Recent studies have indicated that paramylon functions as an immunomodulator or a dietary fiber. Currently, chronic kidney disease (CKD) is a global health problem, and there is no effective preventive treatment for CKD progression. However, paramylon may suppress the progression of CKD via the elimination of uremic toxins or modulation of gut microbiota, leading to the alleviation of inflammation. The aim of this study was to evaluate the effect of paramylon in CKD rat model. Eight-week-old male Wistar rats with a 5/6 nephrectomy were given either a normal diet or a diet containing 5% paramylon for 8 weeks. Proteinuria was measured intermittently. Serum and kidney tissues were harvested after sacrifice. We performed a renal molecular and histopathological investigation, serum metabolome analysis, and gut microbiome analysis. The results showed that paramylon attenuated renal function, glomerulosclerosis, tubulointerstitial injury, and podocyte injury in the CKD rat model. Renal fibrosis, tubulointerstitial inflammatory cell infiltration, and proinflammatory cytokine gene expression levels tended to be suppressed with paramylon treatment. Further, paramylon inhibited the accumulation of uremic toxins, including tricarboxylic acid (TCA) cycle-related metabolites and modulated a part of CKD-related gut microbiota in the CKD rat model. In conclusion, we suggest that paramylon mainly inhibited the absorption of non-microbiota-derived uremic solutes, leading to protect renal injury via anti-inflammatory and anti-fibrotic effects. Paramylon may be a novel compound that can act against CKD progression.	[Nagayama, Yoshikuni; Isoo, Naoyuki; Yamano, Mizuki; Nariyama, Tomoyuki; Yagame, Motoka; Matsui, Katsuyuki] Teikyo Univ, Sch Med, Univ Hosp, Dept Internal Med 4, Kawasaki, Kanagawa, Japan; [Nakashima, Ayaka; Suzuki, Kengo] Euglena Co Ltd, Tokyo, Japan	Teikyo University	Nagayama, Y (corresponding author), Teikyo Univ, Sch Med, Univ Hosp, Dept Internal Med 4, Kawasaki, Kanagawa, Japan.	ynaga@med.teikyo-u.ac.jp		Nakashima, Ayaka/0000-0001-7474-406X				Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Carvalho A, 2012, CELL MOL IMMUNOL, V9, P276, DOI 10.1038/cmi.2012.1; Castillo-Rodriguez E, 2018, TOXINS, V10, DOI 10.3390/toxins10070300; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Hisada T, 2015, ARCH MICROBIOL, V197, P919, DOI 10.1007/s00203-015-1125-0; Isoda N, 2009, HEPATO-GASTROENTEROL, V56, P437; Kawano, 1987, NIPPON EIYO SHOKURYO, V40, P193, DOI [10.4327/jsnfs.40.193, DOI 10.4327/JSNFS.40.193]; Kluger MA, 2013, KIDNEY INT, V83, P865, DOI 10.1038/ki.2012.483; Kofuji Kyoko, 2012, ISRN Pharm, V2012, P125864, DOI 10.5402/2012/125864; KOIZUMI N, 1993, ANTIVIR RES, V21, P1, DOI 10.1016/0166-3542(93)90063-O; KONDO Y, 1992, J PHARMACOBIO-DYNAM, V15, P617, DOI 10.1248/bpb1978.15.617; Koppe L, 2015, KIDNEY INT, V88, P958, DOI 10.1038/ki.2015.255; Lekawanvijit S, 2012, CIRC RES, V111, P1470, DOI 10.1161/CIRCRESAHA.112.278457; Mishima E, 2017, KIDNEY INT, V92, P634, DOI 10.1016/j.kint.2017.02.011; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nagayama Y, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1574-9; Nagayama Y, 2014, AM J PHYSIOL-RENAL, V307, pF346, DOI 10.1152/ajprenal.00620.2013; Nakashima A, 2018, J NUTR SCI VITAMINOL, V64, P8, DOI 10.3177/jnsv.64.8; Nakashima A, 2017, BIOCHEM BIOPH RES CO, V494, P379, DOI 10.1016/j.bbrc.2017.09.167; Nemoto Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38389-3; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Reyna-Villasmil Nadia, 2007, Am J Ther, V14, P203, DOI 10.1097/01.pap.0000249917.96509.e7; SAKAGAMI H, 1991, In Vivo (Attiki), V5, P101; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; SHIH W, 1988, KIDNEY INT, V33, P1113, DOI 10.1038/ki.1988.119; Shimada R, 2016, FOOD FUNCT, V7, P4655, DOI [10.1039/c6fo00606j, 10.1039/C6FO00606J]; Shimizu K, 2009, HEPATO-GASTROENTEROL, V56, P240; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Sugiyama A, 2010, J VET MED SCI, V72, P755, DOI 10.1292/jvms.09-0526; Sugiyama A, 2009, J VET MED SCI, V71, P885, DOI 10.1292/jvms.71.885; Suzuki K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191462; Tada R, 2009, IMMUNOL LETT, V123, P144, DOI 10.1016/j.imlet.2009.03.005; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Tanaka S, 2018, KIDNEY INT, V94, P912, DOI 10.1016/j.kint.2018.04.025; Tian X, 2014, J CLIN INVEST, V124, P1098, DOI 10.1172/JCI69778; Van Hung T, 2018, J NUTR, V148, P552, DOI 10.1093/jn/nxy008; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Wang XF, 2020, GUT, V69, P2131, DOI 10.1136/gutjnl-2019-319766; White RWD, 2002, UROLOGY, V60, P640, DOI 10.1016/S0090-4295(02)01856-3; Wilkins LJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49452-y	46	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237086	10.1371/journal.pone.0237086	http://dx.doi.org/10.1371/journal.pone.0237086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764782	gold, Green Published			2022-12-26	WOS:000561029000042
J	Santana, FM; Feitosa, LM; Lessa, RP				Santana, Francisco Marcante; Feitosa, Leonardo Manir; Lessa, Rosangela Paula			From plentiful to critically endangered: Demographic evidence of the artisanal fisheries impact on the smalltail shark (Carcharhinus porosus) from Northern Brazil	PLOS ONE			English	Article							DAGGERNOSE SHARK; LIFE-HISTORY; ISOGOMPHODON-OXYRHYNCHUS; GALEOCERDO-CUVIER; TIGER SHARK; REPRODUCTIVE-BIOLOGY; AGE-DETERMINATION; BLACKNOSE SHARK; EXTINCTION RISK; GROWTH	The smalltail shark,Carcharhinus porosus, was the most abundant elasmobranch species in fisheries off Brazil's northern coast (BNC) in the 1980s, but its population has been declining since the 1990s. For this reason, a demographic analysis is necessary to determine the extent of this decline and the fishing effect on the BNC's population. Therefore, we performed a stochastic demographic analysis of the population in the BNC, and considered its global center of abundance. Smalltail shark specimens (n= 937) were collected with gillnets in Maranhao state, eastern BNC, in the 1980s with sizes ranging between 29.6 and 120.0 cm total length. Most of the individuals (90.6%) caught were juveniles (< 6 years-old), and the mortality and exploitation rates showed that the species was overexploited (92.3% above the fishing mortality corresponding to the population equilibrium threshold). The smalltail shark's biological characteristics, such as slow growth and low fecundity, demonstrate that it is one of the least resilient species among similar sized coastal sharks in the region. All these factors yielded an annual decrease of 28% in the intrinsic population growth rate, resulting in a population decline of more than 90% in only 10 years, and much higher for the current period. This set of features comprising fishing recruitment occurring upon juveniles, overfishing, and intrinsically low resilience make the population unable to sustain fishing pressure and severely hamper biological recruitment, thus causing this drastic population decline. Furthermore, several local extinctions for this species in the northeastern and southeastern regions of Brazil highlight its concerning conservation scenario. Therefore, since similar fisheries characteristics occur throughout its distribution range,C.porosusfits the criteria E of the IUCN Red List for a critically endangered species and urgent conservation measures are needed to prevent its extinction in the near future.	[Santana, Francisco Marcante] Univ Fed Rural Pernambuco UFRPE, Unidade Acad Serra Talhada UAST, Lab Dinam Populacoes Aquat DAQUA, Serra Talhada, PE, Brazil; [Santana, Francisco Marcante; Feitosa, Leonardo Manir; Lessa, Rosangela Paula] Univ Fed Rural Pernambuco UFRPE, Dept Pesca & Aquicultura DEPAq, Lab Dinam Populacoes Marinhas DIMAR, Recife, PE, Brazil; [Feitosa, Leonardo Manir; Lessa, Rosangela Paula] Univ Fed Pernambuco UFPE, Programa Posgrad Biol Anim, Recife, PE, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal de Pernambuco	Santana, FM (corresponding author), Univ Fed Rural Pernambuco UFRPE, Unidade Acad Serra Talhada UAST, Lab Dinam Populacoes Aquat DAQUA, Serra Talhada, PE, Brazil.; Santana, FM (corresponding author), Univ Fed Rural Pernambuco UFRPE, Dept Pesca & Aquicultura DEPAq, Lab Dinam Populacoes Marinhas DIMAR, Recife, PE, Brazil.	framarsantana@yahoo.com.br	Santana, Francisco/ABG-2693-2020; Manir Feitosa, Leonardo/P-7077-2017	Santana, Francisco/0000-0002-3225-8861; Manir Feitosa, Leonardo/0000-0002-1988-5326	Secretaria Interministerial para os Recursos do Mar SECIRM; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) [IBPG-0089-2.05/17]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [301048/86-OC]	Secretaria Interministerial para os Recursos do Mar SECIRM; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The Project "Elasmobranchs of Maranhao's Coast" was funded by Secretaria Interministerial para os Recursos do Mar SECIRM. Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) provided a master's degree scholarship to LMF (Proc. IBPG-0089-2.05/17). Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq provided a Research Grant to RPL (Proc. 301048/86-OC).	[Anonymous], 2011, RELATORIO GRUPO TECN; [Anonymous], 2014, PESCA MARINHA ESTUAR; [Anonymous], 2014, PESCA MARINHA ESTUAR; AragAo JAN, 2001, B TECNICO CIENTIFICO, V1, P7; Martins APB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193969; Barbosa Martins Ana Paula, 2015, Univ. Sci., V20, P297, DOI 10.11144/Javeriana.SC20-3.sdos; Barreto RR, 2017, MAR POLICY, V85, P114, DOI 10.1016/j.marpol.2017.08.016; Barreto RR, 2011, FISH RES, V110, P170, DOI 10.1016/j.fishres.2011.04.003; Beerkircher L, 2003, FISH B-NOAA, V101, P168; Beverton RJ, 2012, DYNAMICS EXPLOITED F, V11th; BRANSTETTER S, 1987, ENVIRON BIOL FISH, V20, P169, DOI 10.1007/BF00004952; BRANSTETTER S, 1990, NOAA Technical Report NMFS, P17; Brewster-Geisz KK, 2000, FISH B-NOAA, V98, P236; Carlson JD, 2003, FISH B-NOAA, V101, P281; Castro Jose I., 2011, Aqua, V17, P1; CHEN S, 1989, NIPPON SUISAN GAKK, V55, P205; COMPAGNO L J V, 1984, FAO (Food and Agriculture Organization of the United Nations) Fisheries Synopsis, P1; CORTES E, 1995, FISH B-NOAA, V93, P57; Cortes E, 2002, CONSERV BIOL, V16, P1048, DOI 10.1046/j.1523-1739.2002.00423.x; Rodrigues LFD, 2020, FISH RES, V223, DOI 10.1016/j.fishres.2019.105407; de Kroon H, 2000, ECOLOGY, V81, P607, DOI 10.1890/0012-9658(2000)081[0607:EAROMA]2.0.CO;2; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Dulvy NK, 2004, FISH FISH, V5, P255, DOI 10.1111/j.1467-2679.2004.00158.x; Ebert D.A., 2013, FAO SPECIES CATALOGU, V7, P56; Feitosa LM, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00125; Feitosa LM, 2019, FISHERIES, V44, P144, DOI 10.1002/fsh.10205; Feitosa LM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21683-5; Feitosa LM, 2017, ENDANGER SPECIES RES, V34, P229, DOI 10.3354/esr00852; Feitosa LM, 2020, AQUAT CONSERV MAR FR, V31, P1; Feldheim KA, 2004, EVOLUTION, V58, P2332, DOI 10.1111/j.0014-3820.2004.tb01607.x; Furtado-Junior I., 2002, B TECNICO CIENTIFICO, V3, P147; Garcia VB, 2008, P ROY SOC B-BIOL SCI, V275, P83, DOI 10.1098/rspb.2007.1295; GARRICK J A F, 1982, NOAA (National Oceanic and Atmospheric Administration) Technical Report NMFS (National Marine Fisheries Service) Circular, P1; Gedamke T, 2007, N AM J FISH MANAGE, V27, P605, DOI 10.1577/M05-157.1; Grant MI, 2020, ICES J MAR SCI, V77, P241, DOI 10.1093/icesjms/fsz196; Hazin FHV, 2013, AN ACAD BRAS CIENC, V85, P1053, DOI 10.1590/S0001-37652013005000055; Hazin FHV, 2002, FISH B-NOAA, V100, P143; Hewitt DA, 2005, FISH B-NOAA, V103, P433; Hoenig JM, 1982 U RHOD GRAD SCH, V82-3; Hood GM, 2006, POPTOOLS; IBAMA-Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renovaveis, 2011, PROP PLAN GEST US SU, P154; ICMBIO-INSTITUTO CHICO MENDES DE CONSERVACAO DA BIODIVERSIDADE, 2018, LIVRO VERMELHO FAUNA, VIII; Isaac VJ, 2009, J APPL ICHTHYOL, V25, P244, DOI 10.1111/j.1439-0426.2009.01274.x; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Jensen AL, 1996, CAN J FISH AQUAT SCI, V53, P820, DOI 10.1139/cjfas-53-4-820; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; Lessa R, 1999, MAR FRESHWATER RES, V50, P383, DOI 10.1071/MF98127; Lessa R, 1998, MAR FRESHWATER RES, V49, P705, DOI 10.1071/MF98019; Lessa R, 1999, B MAR SCI, V64, P115; Lessa R, 2000, MAR FRESHWATER RES, V51, P339, DOI 10.1071/MF99125; Lessa R, 2006, IUCN RED LIST THREAT, P8235; Lessa R., 1997, B LAB HIDROBIOLOGIA, V10, P19; Lessa R, 1999, BIODIVERSIDADE ELASM, P1; LESSA R P, 1988, Revista Brasileira de Biologia, V48, P721; LESSA R P, 1986, Acta Amazonica, V16-17, P73; Lessa R.P., 1986, B LAB HIDROBIOLOGIA, V7, P27; Lessa R, 2016, GLOB ECOL CONSERV, V7, P70, DOI 10.1016/j.gecco.2016.04.003; Lessa Rosangela, 2009, Pan-American Journal of Aquatic Sciences, V4, P532; Lessa Rosangela, 1997, Cybium, V21, P123; Lessa RPT, 2018, LIVRO VERMELHO FAUNA, VVI, P950; Machado MRB, 2000, B LAB HIDROBIOL SAO, V13, P51; Marceniuk A. P., 2019, REV NORDESTINA BIOL, V27, P120; Palmeira CAM, 2013, FOOD CONTROL, V34, P249, DOI 10.1016/j.foodcont.2013.04.017; Menni Roberto C., 1998, Acta Zoologica Lilloana, V44, P69; MMA, 2004, INSTR NORM 05 2004; MMA, 2005, INSTR NORM 52; Mollet HF, 2002, MAR FRESHWATER RES, V53, P503, DOI 10.1071/MF01083; Oliver S, 2015, MAR POLICY, V54, P86, DOI 10.1016/j.marpol.2014.12.017; Otway NM, 2004, BIOL CONSERV, V119, P341, DOI 10.1016/j.biocon.2003.11.017; PAIVA KS, 2009, B TEC CIENT CEPNO BE, V9, P25; PARSONS GR, 1993, MAR BIOL, V117, P23, DOI 10.1007/BF00346422; Pauly D., 1980, FAO FISH CIRC, V729, P54; PETERSON I, 1984, CAN J FISH AQUAT SCI, V41, P1117, DOI 10.1139/f84-131; Pirog A, 2019, J FISH BIOL, V95, P1195, DOI 10.1111/jfb.14118; Ricker WE, 1980, CALCUL INTERPRETATIO; Rikhter VA, 1976, I CNAF RES DOCUMENT, P1; SADOWSKY V, 1967, Beitraege zur Neotropischen Fauna, V5, P71; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Salas S., 2011, COASTAL FISHERIES LA; Santana FM, 2009, FISH RES, V100, P210, DOI 10.1016/j.fishres.2009.07.009; Simpfendorfer C.A., 2005, MANAGEMENT TECHNIQUE, P143; Smart JJ, 2018, ECOL APPL, V28, P1520, DOI 10.1002/eap.1687; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Stride RK, 1992, PESCA EXPT TUBARAO C, V3rd; Tavares W, 2013, BIOCHEM SYST ECOL, V49, P21, DOI 10.1016/j.bse.2013.02.004; White WT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209387; White WT, 2012, ZOOTAXA, P1; White WT, 2014, ZOOTAXA, V3821, P71, DOI 10.11646/zootaxa.3821.1.5; Whitney NM, 2007, MAR BIOL, V151, P63, DOI 10.1007/s00227-006-0476-0; Wintner SP, 2000, MAR FRESHWATER RES, V51, P43, DOI 10.1071/MF99077	90	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236146	10.1371/journal.pone.0236146	http://dx.doi.org/10.1371/journal.pone.0236146			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760084	gold, Green Published			2022-12-26	WOS:000561027200044
J	Singh, KK; Graether, SP				Singh, Karamjeet K.; Graether, Steffen P.			Conserved sequence motifs in the abiotic stress response protein late embryogenesis abundant 3	PLOS ONE			English	Article							LEA PROTEINS; GENE FAMILY; ARABIDOPSIS; IDENTIFICATION; REVEALS; GENOME; MITOCHONDRIA; BIOLOGY; SCALE; DNA	LEA3 proteins, a family of abiotic stress proteins, are defined by the presence of a tryptophan-containing motif, which we name the W-motif. We use Pfam LEA3 sequences to search the Phytozome database to create a W-motif definition and a LEA3 sequence dataset. A comprehensive analysis of these sequences revealed four N-terminal motifs, as well as two previously undiscovered C-terminal motifs that contain conserved acidic and hydrophobic residues. The general architecture of the LEA3 sequences consisted of an N-terminal motif with a potential mitochondrial transport signal and the twin-arginine motif cut-site, followed by a W-motif and often a C-terminal motif. Analysis of species distribution of the motifs showed that one architecture was found exclusively in Commelinids, while two were distributed fairly evenly over all species. The physiochemical properties of the different architectures showed clustering in a relatively narrow range compared to the previously studied dehydrins. The evolutionary analysis revealed that the different sequences grouped into clades based on architecture, and that there appear to be at least two distinct groups of LEA3 proteins based on their architectures and physiochemical properties. The presence of LEA3 proteins in non-vascular plants but their absence in algae suggests that LEA3 may have arisen in the evolution of land plants.	[Singh, Karamjeet K.; Graether, Steffen P.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Graether, Steffen P.] Univ Guelph, Grad Program Bioinformat, Guelph, ON, Canada	University of Guelph; University of Guelph	Graether, SP (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada.; Graether, SP (corresponding author), Univ Guelph, Grad Program Bioinformat, Guelph, ON, Canada.	graether@uoguelph.ca	Graether, Steffen P./AAR-8849-2021; Graether, Steffen P./AFU-0892-2022	Graether, Steffen P./0000-0002-2356-3936; Graether, Steffen P./0000-0002-2356-3936	National Research and Engineering Council (Canada); Ontario Graduate Scholarship	National Research and Engineering Council (Canada); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by a National Research and Engineering Council (Canada) grant to SPG and an Ontario Graduate Scholarship to KKS.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altunoglu YC, 2016, PLANT GROWTH REGUL, V80, P225, DOI 10.1007/s10725-016-0160-4; Amara I., 2014, American Journal of Plant Sciences, V5, P3440; Atici O, 2003, PHYTOCHEMISTRY, V64, P1187, DOI 10.1016/S0031-9422(03)00420-5; Babu RC, 2001, PLANT BREEDING, V120, P233, DOI 10.1046/j.1439-0523.2001.00578.x; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bardel J, 2002, PROTEOMICS, V2, P880, DOI 10.1002/1615-9861(200207)2:7<880::AID-PROT880>3.0.CO;2-0; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Borrell A, 2002, PLANT MOL BIOL, V50, P249, DOI 10.1023/A:1016084615014; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Campos F, 2013, MOL GENET GENOMICS, V288, P503, DOI 10.1007/s00438-013-0768-2; Candat A, 2014, PLANT CELL, V26, P3148, DOI 10.1105/tpc.114.127316; Charfeddine S, 2015, MOL BIOL REP, V42, P1163, DOI 10.1007/s11033-015-3853-2; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dolev M, 2006, ANNU REV BIOCHEM, V85, P515; Dong CN, 2002, PLANT PHYSIOL, V129, P1368, DOI 10.1104/pp.001925; Eriksson SK, 2011, ECOL STUD-ANAL SYNTH, V215, P289, DOI 10.1007/978-3-642-19106-0_14; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; FRANZ G, 1989, MOL GEN GENET, V218, P143, DOI 10.1007/BF00330577; Furuki T., 2011, BIOCHEMISTRY-US, V50, P1083; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Graether SP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00576; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Huang SB, 2009, PLANT PHYSIOL, V150, P1272, DOI 10.1104/pp.109.137885; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Jaspard E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036968; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Kozlov AM, 2019, BIOINFORMATICS, V35, P4453, DOI 10.1093/bioinformatics/btz305; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lan T, 2013, TREE GENET GENOMES, V9, P253, DOI 10.1007/s11295-012-0551-2; Liang Y, 2016, NAT PUBL GR, V6, P1; LIN CT, 1992, PLANT PHYSIOL, V99, P519, DOI 10.1104/pp.99.2.519; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Malik AA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00709; Menze MA, 2009, J BIOL CHEM, V284, P10714, DOI 10.1074/jbc.C900001200; Mowla SB, 2006, PLANT J, V48, P743, DOI 10.1111/j.1365-313X.2006.02911.x; Olsen JL, 2016, NATURE, V530, P331, DOI 10.1038/nature16548; Olvera-Carrillo Y, 2010, PLANT PHYSIOL, V154, P373, DOI 10.1104/pp.110.158964; Pedrosa AM, 2015, PLOS ONE, V10, P1; Poltronieri P., 2011, Ratarstvo i Povrtarstvo, V48, P15; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; R Core Team, 2021, R LANGUAGE ENV STAT; Riera M, 2004, P NATL ACAD SCI USA, V101, P9879, DOI 10.1073/pnas.0306154101; Riley AC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211813; ROBERTS JK, 1993, PLANT CELL, V5, P769, DOI 10.1105/tpc.5.7.769; Salleh FM, 2012, PLANT CELL ENVIRON, V35, P418, DOI 10.1111/j.1365-3040.2011.02394.x; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sjoling S, 1998, TRENDS PLANT SCI, V3, P136, DOI 10.1016/S1360-1385(98)01212-6; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Ukaji N, 2001, PLANT PHYSIOL, V126, P1588, DOI 10.1104/pp.126.4.1588; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Van Oosten M.J., 2016, DROUGHT STRESS TOLER, V2, P39, DOI [10.1007/978-3-319-32423-4_2, DOI 10.1007/978-3-319-32423-4, DOI 10.1007/978-3-319-32423-4_2]; Wang XS, 2007, PLANT SCI, V172, P414, DOI 10.1016/j.plantsci.2006.10.004	58	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237177	10.1371/journal.pone.0237177	http://dx.doi.org/10.1371/journal.pone.0237177			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760115	Green Published, gold			2022-12-26	WOS:000561027200085
J	Wagner, L; Geiling, L; Hauth, C; Hocke, T; Plontke, S; Rahne, T				Wagner, Luise; Geiling, Lukas; Hauth, Christopher; Hocke, Thomas; Plontke, Stefan; Rahne, Torsten			Improved binaural speech reception thresholds through small symmetrical separation of speech and noise	PLOS ONE			English	Article							INTERAURAL LEVEL DIFFERENCES; COCHLEAR IMPLANT; HEARING-LOSS; INTELLIGIBILITY; STIMULATION; PERCEPTION; BENEFITS; MASKING; HEAD	Speech perception in noise is challenging and is improved by binaural hearing. Since signal processing of assistive hearing devices often modifies or masks the peripheral binaural head-shadow or better-ear effects, central binaural processing should be measured separately. In a prospective study, 10 listeners with normal hearing were tested with the German matrix sentence test in a set-up with two loudspeakers located at opposite angles in the horizontal plane with respect to S0N0. The speech reception threshold (SRT) was investigated depending on the separation angle between speech and noise. The lowest (best) SRT was obtained for a separation of target and interfering source from S(0)N(0)at an angle of about S +/- 60 degrees N -/+ 60 degrees. The derived normative curve was comparable to SRTs predicted by the binaural-speech-intelligibility-model. The systematic separation of signal and noise showed a significant improvement in speech intelligibility for normal-hearing people even for small separation angles. This experimental setting was verified. This study aimed to assess the effect of small sound source separation on binaural hearing and speech perception.	[Wagner, Luise; Geiling, Lukas; Plontke, Stefan; Rahne, Torsten] Martin Luther Univ Halle Wittenberg, Univ Med Halle, Dept Otorhinolaryngol Head & Neck Surg, Halle, Germany; [Hauth, Christopher] Carl von Ossietzky Univ Oldenburg, Dept Med Phys & Cluster Excellence Hearing4All, Oldenburg, Germany; [Hocke, Thomas] Cochlear Deutschland GmbH & Co KG, Hannover, Germany	Martin Luther University Halle Wittenberg; Carl von Ossietzky Universitat Oldenburg; Cochlear	Wagner, L (corresponding author), Martin Luther Univ Halle Wittenberg, Univ Med Halle, Dept Otorhinolaryngol Head & Neck Surg, Halle, Germany.	luise.wagner@uk-halle.de	Rahne, Torsten/AAD-1369-2021		Cochlear Deutschland GmbH Co. KG	Cochlear Deutschland GmbH Co. KG	TH is an employee of Cochlear Deutschland GmbH & Co. KG. The specific roles of all authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Mr. Baranowski and his staff for building the setup. We thank Jesko Verhey and Jan Hots (Otto-von-Guericke University Magdeburg) for assistance using the head simulator and Cochlear Deutschland GmbH & Co. KG for the financial support.	American National Standards Institute, 1997, METH CALC SPEECH INT; Bernstein JGW, 2016, EAR HEARING, V37, P289, DOI 10.1097/AUD.0000000000000284; Beutelmann R, 2010, J ACOUST SOC AM, V127, P2479, DOI 10.1121/1.3295575; Brand T, 2002, J ACOUST SOC AM, V111, P2801, DOI 10.1121/1.1479152; BRONKHORST AW, 1988, J ACOUST SOC AM, V83, P1508, DOI 10.1121/1.395906; DUBNO JR, 1984, J ACOUST SOC AM, V76, P87, DOI 10.1121/1.391011; DURLACH NI, 1963, J ACOUST SOC AM, V35, P1206, DOI 10.1121/1.1918675; Freyman RL, 1999, J ACOUST SOC AM, V106, P3578, DOI 10.1121/1.428211; Gabriel P, 2011, Z AUDIOL, V50, P50; Hauth CF, 2018, TRENDS HEAR, V22, DOI 10.1177/2331216517753547; HELFER KS, 1990, J SPEECH HEAR RES, V33, P149, DOI 10.1044/jshr.3301.149; Hey M, 2014, INT J AUDIOL, V53, P895, DOI 10.3109/14992027.2014.938368; Hohmann V, 2002, ACTA ACUST UNITED AC, V88, P433; Holube I, 1993, EXPT MODELLVORSTELLU; Hoppe U, 2018, ACTA OTO-LARYNGOL, V138, P713, DOI 10.1080/00016489.2018.1444281; Jones HG, 2016, EAR HEARING, V37, pE341, DOI 10.1097/AUD.0000000000000297; Kraaijenga VJC, 2016, OTOL NEUROTOL, V37, P1300, DOI 10.1097/MAO.0000000000001185; Laszig R, 2004, OTOL NEUROTOL, V25, P958, DOI 10.1097/00129492-200411000-00016; Lingner A, 2016, JARO-J ASSOC RES OTO, V17, P461, DOI 10.1007/s10162-016-0575-7; Litovsky R.Y., 2012, ACOUST TODAY, V8, P18, DOI [10.1121/1.4729575, DOI 10.1121/1.4729575]; Martin RL, 2012, J ACOUST SOC AM, V131, P378, DOI 10.1121/1.3669994; Moore BCJ, 2016, J ACOUST SOC AM, V140, P2817, DOI 10.1121/1.4965299; Neher T, 2017, HEARING RES, V353, P36, DOI 10.1016/j.heares.2017.07.014; PLOMP R, 1981, ACUSTICA, V48, P325; PLOMP R, 1978, J ACOUST SOC AM, V63, P533, DOI 10.1121/1.381753; Potts WB, 2019, TRENDS HEAR, V23, DOI 10.1177/2331216519831492; Rader T, 2013, EAR HEARING, V34, P324, DOI 10.1097/AUD.0b013e318272f189; Rennies J, 2014, J ACOUST SOC AM, V135, P1556, DOI 10.1121/1.4863197; SHAW EAG, 1974, J ACOUST SOC AM, V56, P1848, DOI 10.1121/1.1903522; Van Eeckhoutte M, 2018, TRENDS HEAR, V22, DOI 10.1177/2331216518805363; van Hoesel RJM, 2012, HEARING RES, V288, P100, DOI 10.1016/j.heares.2011.11.014; Wagener K.C., 1999, Z AUDIOL, V38, P4; Weigerber T, 2019, HNO, V67, P265, DOI [10.1007/s00106-019-0635-530859252, DOI 10.1007/S00106-019-0635-530859252]; Williges B, 2019, TRENDS HEAR, V23, DOI 10.1177/2331216519858311	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236469	10.1371/journal.pone.0236469	http://dx.doi.org/10.1371/journal.pone.0236469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756594	Green Published, gold			2022-12-26	WOS:000560393300017
J	Ngwaga, T; Kong, L; Lin, D; Schoborg, C; Taylor, LE; Mayer, KH; Klein, RS; Celentano, DD; Sobel, JD; Jamieson, DJ; King, CC; Tavis, JE; Blackard, JT				Ngwaga, Tshegofatso; Kong, Ling; Lin, Derrick; Schoborg, Cassandra; Taylor, Lynn E.; Mayer, Kenneth H.; Klein, Robert S.; Celentano, David D.; Sobel, Jack D.; Jamieson, Denise J.; King, Caroline C.; Tavis, John E.; Blackard, Jason T.			Diversity of the hepatitis C virus NS5B gene during HIV co-infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HYPERVARIABLE REGION 1; DEPENDENT RNA-POLYMERASE; COMPENSATORY MUTATIONS; SECONDARY STRUCTURES; LIVER-DAMAGE; RESISTANCE; GENOTYPE; IDENTIFICATION; INFECTION	Viral diversity is an important feature of hepatitis C virus (HCV) infection and an important predictor of disease progression and treatment response. HIV/HCV co-infection is associated with enhanced HCV replication, increased fibrosis, and the development of liver disease. HIV also increases quasispecies diversity of HCV structural genes, although limited data are available regarding the impact of HIV on non-structural genes of HCV, particularly in the absence of direct-acting therapies. The genetic diversity and presence of drug resistance mutations within the RNA-dependent RNA polymerase (NS5B) gene were examined in 3 groups of women with HCV genotype 1a infection, including those with HCV mono-infection, antiretroviral (ART)-naive women with HIV/HCV co-infection and CD4 cell count <350 cells/mm(3), and ART-naive women with HIV/HCV co-infection and CD4 cell count >= 350 cells/mm(3). None had ever been treated for HCV infection. There was evidence of significant diversity across the entire NS5B gene in all women. There were several nucleotides and amino acids with distinct distributions across the three study groups, although no obvious clustering of NS5B sequences was observed based on HIV co-infection or CD4 cell count. Polymorphisms at amino acid positions associated with resistance to dasabuvir and sofosbuvir were limited, although the Q309R variant associated with ribavirin resistance was present in 12 individuals with HCV mono-infection, 8 HIV/HCV co-infected individuals with CD4 <350 cells/mm(3), and 12 HIV/HCV co-infected individuals with CD4 >= 350 cells/mm(3). Previously reported fitness altering mutations were rare. CD8(+)T cell responses against the human leukocyte antigen (HLA) B57-restricted epitopes NS5B(2629-2637)and NS5B(2936-2944)are critical for HCV control and were completely conserved in 44 (51.8%) and 70 (82.4%) study participants. These data demonstrate extensive variation across the NS5B gene. Genotypic variation may have a profound impact on HCV replication and pathogenesis and deserves careful evaluation.	[Ngwaga, Tshegofatso; Kong, Ling; Lin, Derrick; Schoborg, Cassandra; Blackard, Jason T.] Univ Cincinnati, Coll Med, Div Digest Dis, Cincinnati, OH 45221 USA; [Taylor, Lynn E.] Brown Univ, Miriam Hosp, Providence, RI USA; [Taylor, Lynn E.] Brown Univ, Dept Med, Providence, RI 02912 USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Mayer, Kenneth H.] Fenway Inst, Boston, MA USA; [Klein, Robert S.] Hudson Infect Dis Associates, Briarcliff Manor, NY USA; [Celentano, David D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Sobel, Jack D.] Wayne State Univ, Sch Med, Div Infect Dis, Detroit, MI USA; [Jamieson, Denise J.; King, Caroline C.] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA; [Jamieson, Denise J.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA USA; [Tavis, John E.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA	University System of Ohio; University of Cincinnati; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Brown University; Harvard University; Beth Israel Deaconess Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Wayne State University; Centers for Disease Control & Prevention - USA; Emory University; Saint Louis University	Blackard, JT (corresponding author), Univ Cincinnati, Coll Med, Div Digest Dis, Cincinnati, OH 45221 USA.	jason.blackard@uc.edu		Mayer, Kenneth/0000-0001-7460-733X; Taylor, Lynn/0000-0002-0472-8125; Ngwaga, Tshegofatso/0000-0003-3568-9090	National Institute of General Medical Sciences [GM105414]; NIEHS [P30 ES006096]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the National Institute of General Medical Sciences (award GM105414 to JTB). Amplicon-seq was conducted by the Genomics, Epigenomics and Sequencing Core at the Department of Environmental Health within University of Cincinnati College of Medicine and is supported in part by NIEHS P30 ES006096).	Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Asahina Y, 2005, J HEPATOL; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Bagaglio S, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1054-z; Beld M, 1998, VIROLOGY, V244, P504, DOI 10.1006/viro.1998.9130; Blackard JT, 2012, J MED VIROL, V84, P242, DOI 10.1002/jmv.22269; Blackard JT, 2011, CLIN INFECT DIS, V52, P674, DOI 10.1093/cid/ciq199; Blackard JT, 2010, J CLIN MICROBIOL, V48, P4256, DOI 10.1128/JCM.01613-10; Brambilla S, 1998, HEPATOLOGY, V27, P1678, DOI 10.1002/hep.510270629; Cannon NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002123; Cao F, 2011, J VIRAL HEPATITIS, V18, P349, DOI 10.1111/j.1365-2893.2010.01316.x; Chung RT, 2002, AIDS, V16, P1915, DOI 10.1097/00002030-200209270-00008; Curran R, 2002, J GEN VIROL, V83, P11, DOI 10.1099/0022-1317-83-1-11; Domingo E, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008271; Donlin MJ, 2007, J VIROL, V81, P8211, DOI 10.1128/JVI.00487-07; Donlin MJ, 2012, J VIROL, V86, P3050, DOI 10.1128/JVI.06857-11; Donlin MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009032; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Gaudieri S, 2009, HEPATOLOGY, V49, P1069, DOI 10.1002/hep.22773; Gretch DR, 1996, J VIROL, V70, P7622, DOI 10.1128/JVI.70.11.7622-7631.1996; Guettouche T, 2005, ANTIVIR THER, V10, P593; Hamano K, 2005, J GASTROEN HEPATOL, V20, P1401, DOI 10.1111/j.1440-1746.2005.04024.x; Hayashi J, 2000, J INFECT DIS, V181, P1523, DOI 10.1086/315431; Hmwe SS, 2010, ANTIVIR RES, V85, P520, DOI 10.1016/j.antiviral.2009.12.008; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Layden-Almer JE, 2005, J INFECT DIS, V192, P1078, DOI 10.1086/432760; Leveque VJP, 2002, CELL MOL LIFE SCI, V59, P909, DOI 10.1007/s00018-002-8478-7; Nguyen LT, 2016, ANTIVIR THER, V21, P447, DOI 10.3851/IMP3025; Lohmann V, 2000, J VIRAL HEPATITIS, V7, P167; Manzin A, 1998, J VIROL, V72, P6271, DOI 10.1128/JVI.72.7.6271-6276.1998; MARTELL M, 1994, J VIROL, V68, P3425, DOI 10.1128/JVI.68.5.3425-3436.1994; Mayer KH, 2003, JAIDS-J ACQ IMM DEF, V33, P614, DOI 10.1097/00126334-200308150-00011; Murayama A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000885; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nagayama K, 1999, VIROLOGY, V263, P244, DOI 10.1006/viro.1999.9924; Neumann-Haefelin C, 2011, HEPATOLOGY, V54, P1157, DOI 10.1002/hep.24541; Oniangue-Ndza C, 2011, J VIROL, V85, P11883, DOI 10.1128/JVI.00779-11; Pawlotsky JM, 2000, HEPATOLOGY, V32, P889, DOI 10.1053/jhep.2000.19150; Pawlotsky JM, 2003, ANTIVIR RES, V59, P1, DOI 10.1016/S0166-3542(03)00088-3; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; Ramezani A, 2019, CLIN RES HEPATOL GAS, V43, P594, DOI 10.1016/j.clinre.2019.01.011; Ray SC, 1999, J VIROL, V73, P2938, DOI 10.1128/JVI.73.4.2938-2946.1999; Romero-Lopez C, 2011, CELLULAR MOL LIFE SC, V2011; Romero-Lopez C, 2009, RNA, V15, P1740, DOI 10.1261/rna.1680809; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; Ruhl M, 2012, J VIROL, V86, P991, DOI 10.1128/JVI.05603-11; Sherman KE, 1999, HEPATOLOGY, V30, P265, DOI 10.1002/hep.510300131; Shire NJ, 2006, HEPATOLOGY, V44, P1146, DOI 10.1002/hep.21374; Smith DK, 1997, AM J EPIDEMIOL, V146, P459, DOI 10.1093/oxfordjournals.aje.a009299; Stover CT, 2003, J INFECT DIS, V187, P1388, DOI 10.1086/374649; Sullivan DG, 1998, J VIROL, V72, P10036, DOI 10.1128/JVI.72.12.10036-10043.1998; Tedaldi EM, 2003, CLIN INFECT DIS, V36, P363, DOI 10.1086/345953; Thomas DL, 2001, J INFECT DIS, V183, P973, DOI 10.1086/319256; Tuplin A, 2004, J GEN VIROL, V85, P3037, DOI 10.1099/vir.0.80141-0; Tuplin A, 2002, RNA, V8, P824, DOI 10.1017/S1355838202554066; Vaughan R, 2012, RNA, V18, P1541, DOI 10.1261/rna.031914.111; World Health Organization, HEP C 2019; Wu RH, 2019, INFECT DRUG RESIST, V12, P2987, DOI 10.2147/IDR.S218584; Yang S, 2018, ARCH VIROL, V163, P467, DOI 10.1007/s00705-017-3640-6; Yokozaki S, 2000, BLOOD, V96, P4293; Young KC, 2003, HEPATOLOGY, V38, P869, DOI 10.1053/jhep.2003.50445	66	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0237162	10.1371/journal.pone.0237162	http://dx.doi.org/10.1371/journal.pone.0237162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750098	gold, Green Published			2022-12-26	WOS:000560009200001
J	Kapaya, H; Jacques, R; Almond, T; Rosser, MH; Anumba, D				Kapaya, Habiba; Jacques, Richard; Almond, Thomas; Rosser, Miss Hilary; Anumba, Dilly			Is short-term-variation of fetal-heart-rate a better predictor of fetal acidaemia in labour? A feasibility study	PLOS ONE			English	Article							EPIDURAL ANALGESIA; RELIABILITY; ACCURACY; SIGNAL	Background Continuous intrapartum fetal monitoring is challenging and its clinical benefits are debated. The project evaluated whether short-term-variation (STV) and other computerised fetal heart rate (FHR) parameters (baseline FHR, long-term-variation, accelerations and decelerations) predicted acidaemia at birth. The aims of the study were to assess the changes in FHR pattern during labour and determine the feasibility of undertaking a definitive trial by reporting the practicalities of using the monitoring device, participant recruitment, data collection and staff training. Methods 200 high-risk women carrying a term singleton, non-anomalous fetus, requiring continuous FHR monitoring in labour were consented to participate from the Jessop Wing maternity unit, Sheffield, UK. The trans-abdominal fetal ECG monitor was placed as per clinical protocol. During the monitoring session, clinicians were blinded to the computerised FHR parameters. We analysed the last hour of the FHR and its ability to predict umbilical arterial blood pH <7.20 using receiver operator characteristics (ROC) curves. Results Of 200 women, 137 cases were excluded as either the monitor did not work from the onset of labour (n = 30), clinical staff did not return or used the monitor on another patient (n = 37), umbilical cord blood not obtained (n = 25), FHR data not recorded within an hour of birth (n = 34) and other reasons (n = 11). In 63 cases included in the final analysis, the computer-derived FHR parameters did not show significant correlation with umbilical artery cord pH <7.20. Labour was associated with a significant increase in short and long term variation of FHR and number of deceleration (P<0.001). However, baseline FHR decreased significantly before delivery (P<0.001). Conclusions The project encountered a number of challenges, with learning points crucial to informing the design of a large study to evaluate the potential place of intrapartum computerised FHR parameters, using abdominal fetal ECG monitor before its clinical utility and more widespread adoption can be ascertained.	[Kapaya, Habiba] NHS Fdn Trust, Sheffield Teaching Hosp, Sheffield, S Yorkshire, England; [Jacques, Richard] Univ Sheffield, Sch Hlth & Related Res ScHARR, Med Stat Grp, Sheffield, S Yorkshire, England; [Almond, Thomas; Rosser, Miss Hilary] NHS Fdn Trust, Sheffield Teaching Hosp, Obstet & Gynaecol, Sheffield, S Yorkshire, England; [Anumba, Dilly] Univ Sheffield, Acad Unit Reprod & Dev Med, Sheffield, S Yorkshire, England	Oxford University Hospitals NHS Foundation Trust; University of Sheffield; University of Sheffield; Oxford University Hospitals NHS Foundation Trust; University of Sheffield; University of Sheffield	Kapaya, H (corresponding author), NHS Fdn Trust, Sheffield Teaching Hosp, Sheffield, S Yorkshire, England.	h.kapaya@sheffield.ac.uk	Jacques, Richard/A-2410-2010; Professor Dilly Anumba MBBS, FWACS/A-6358-2011	Jacques, Richard/0000-0001-6710-5403; Professor Dilly Anumba MBBS, FWACS/0000-0003-2502-3033; kapaya, habiba/0000-0001-6218-1781	Yorkshire and Humber Clinical Research Network; National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme [PB-PG-1215-20010]	Yorkshire and Humber Clinical Research Network; National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme(National Institute for Health Research (NIHR))	The Yorkshire and Humber Clinical Research Network provided additional support to the study. We would like to thank Mr James Bushby for the technical support in kind for the study and Professor Tracey Young for reading the final version of the manuscript.; The paper presents independent research funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-PG-1215-20010. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.	Alfirevic Z, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066; Annunziata ML, 2016, J OBSTET GYNAECOL RE, V42, P258, DOI 10.1111/jog.12908; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bowler T, 2014, AUST NZ J OBSTET GYN, V54, P79, DOI 10.1111/ajo.12144; Brocklehurst P, 2017, LANCET, V389, P1719, DOI 10.1016/S0140-6736(17)30568-8; Cohen WR, 2014, ACTA OBSTET GYN SCAN, V93, P590, DOI 10.1111/aogs.12387; Cohen WR, 2012, ACTA OBSTET GYN SCAN, V91, P1306, DOI 10.1111/j.1600-0412.2012.01533.x; Georgieva A, 2014, BJOG-INT J OBSTET GY, V121, P889, DOI 10.1111/1471-0528.12568; Georgieva A, 2019, ACTA OBSTET GYN SCAN, V98, P1207, DOI 10.1111/aogs.13639; Graatsma EM, 2009, BJOG-INT J OBSTET GY, V116, P334, DOI 10.1111/j.1471-0528.2008.01951.x; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hayes-Gill BR, 2020, ACTA OBSTET GYN SCAN, V99, P413, DOI 10.1111/aogs.13760; Kapaya H, 2016, J MATERN-FETAL NEO M, P1; Kapaya H, 2014, J MATERN-FETAL NEO M, P1; Kapaya H, 2019, J OBSTET GYNAECOL, V39, P1081, DOI 10.1080/01443615.2019.1587394; Kapaya H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193908; Kumar S, 2010, EARLY HUM DEV, V86, P339, DOI 10.1016/j.earlhumdev.2010.05.009; Leighton BL, 2002, AM J OBSTET GYNECOL, V186, pS69, DOI 10.1067/mob.2002.121813; Lieberman E, 2002, AM J OBSTET GYNECOL, V186, pS31, DOI 10.1067/mob.2002.122522; Nijhuis IJM, 2000, EUR J OBSTET GYN R B, V89, P27, DOI 10.1016/S0301-2115(99)00162-1; Nunes I, 2017, OBSTET GYNECOL, V129, P83, DOI 10.1097/AOG.0000000000001799; Pardey J, 2002, AM J OBSTET GYNECOL, V186, P1095, DOI 10.1067/mob.2002.122447; Pinheiro J, R PACKAGE VERSION; R Core Team, 2021, R LANGUAGE ENV STAT; Reynolds F, 2011, INT J OBSTET ANESTH, V20, P38, DOI 10.1016/j.ijoa.2010.08.004; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Seliger G, 2017, J PERINATOL, V37, P231, DOI 10.1038/jp.2016.202; Thornton CE, 2010, AUST NZ J OBSTET GYN, V50, P456, DOI 10.1111/j.1479-828X.2010.01211.x; van Laar JOEH, 2010, BJOG-INT J OBSTET GY, V117, P429, DOI 10.1111/j.1471-0528.2009.02456.x; Waterman EJ, 2004, HYPERTENS PREGNANCY, V23, P155, DOI 10.1081/PRG-120028291; Westgate JA, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.063; Weyrich J, 2020, ARCH GYNECOL OBSTET, V301, P137, DOI 10.1007/s00404-019-05419-y; White CRH, 2012, BJOG-INT J OBSTET GY, V119, P857, DOI 10.1111/j.1471-0528.2012.03308.x; Wretler S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0845-8; Yeh P, 2012, BJOG-INT J OBSTET GY, V119, P824, DOI 10.1111/j.1471-0528.2012.03335.x	35	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236982	10.1371/journal.pone.0236982	http://dx.doi.org/10.1371/journal.pone.0236982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745099	gold, Green Published, Green Accepted			2022-12-26	WOS:000560006800030
J	Chen, CH; Wu, MJ; Wen, MC; Tsai, SF				Chen, Cheng-Hsu; Wu, Ming-Ju; Wen, Mei-Chin; Tsai, Shang-Feng			Crescents formations are independently associated with higher mortality in biopsy-confirmed immunoglobulin A nephropathy	PLOS ONE			English	Article							LONG-TERM OUTCOMES; IGA NEPHROPATHY; RENAL-DISEASE; CARDIOVASCULAR-DISEASE; KIDNEY-DISEASE; MULTICENTER; VALIDATION; RISK	Background and objectives Immunoglobulin A Nephropathy (IgAN) is the most common type of glomerulonephritis with variable renal outcome. The association between IgAN and patient survival is limited. The effect of crescents on patient survival was never studied. Materials We conducted a retrospective cohort study between January 2003 and December 2013. All patients with the biopsy-proved IgAN was enrolled for the analysis of patient survival and renal survival. Cox regression model was used analyze the associated factors for patient survival. Results All 388 participants with IgAN were enrolled, in which 45 patients with crescents. The mean percentage of glomeruli involvement was 23 +/- 18.9%. After long-term follow-up, crescents group had both worse renal (p = 0.034) and patient survivals (p = 0.016). In univariate Cox regression model, the age (HR = 1.08, 95% CI = 1.05-1.12, p < 0.001), crescents (HR = 3.93, 95% CI = 1.18-13.07, p = 0.025), serum albumin (HR = 0.023, 95%CI = 0.11-0.50, p < 0.001), blood total protein (HR = 0.46, 95%CI = 0.28-0.75, p = 0.002), HDL (HR = 0.95, 95%CI = 0.91-0.99, p = 0.009), daily urine protein (HR = 1.14, 95%CI = 1.01-1.29, p = 0.038), urine PCR (HR = 1.07, 95%CI = 1.02-1.12, p = 0.003), serum IgM (HR = 0.98, 95%CI = 0.96-1.00, p = 0.036), BUN (HR = 1.02, 95%CI = 1.01-1.02, p = 0.005), and eGFR (HR = 0.097, 95%CI = 0.94-0.99, p = 0.0011) were associated with patient survival. After multivariate Cox regression analysis, age (HR = 1.08, 95%CI = 1.01-1.13, p = 0.013), crescents (HR = 5.57, 95%CI = 1.14-29.05, p = 0.034), and HDL (HR = 0.94, 95%CI = 0.90-0.99, p = 0.026) were associated with patient survival. Crescents IgAN is with the highest risk (up to 5.75 of HR) for patient mortality. Conclusions The major strengths of the present study is that crescents IgAN had worse patient survival compared to non-crescents IgAN. Clinicians should be more careful to care patients with crescents IgAN.	[Chen, Cheng-Hsu; Wu, Ming-Ju; Tsai, Shang-Feng] Taichung Vet Gen Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan; [Chen, Cheng-Hsu; Tsai, Shang-Feng] Tunghai Univ, Dept Life Sci, Taichung, Taiwan; [Wen, Mei-Chin] Taichung Vet Gen Hosp, Dept Pathol, Taichung, Taiwan; [Tsai, Shang-Feng] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan	Taichung Veterans General Hospital; Tunghai University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Tsai, SF (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan.; Tsai, SF (corresponding author), Tunghai Univ, Dept Life Sci, Taichung, Taiwan.; Tsai, SF (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	s881056@gmail.com			Taichung Veterans General Hospital [TCVGH1093605D, TCVGH-1093602B]	Taichung Veterans General Hospital	This study was supported by Grants from Taichung Veterans General Hospital: TCVGH1093605D and TCVGH-1093602B.	Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Bjorneklett R, 2012, NEPHROL DIAL TRANSPL, V27, P1485, DOI 10.1093/ndt/gfr446; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gutierrez E, 2012, J AM SOC NEPHROL, V23, P1753, DOI 10.1681/ASN.2012010063; Gutierrez OM, 2013, JAMA-J AM MED ASSOC, V310, P706, DOI 10.1001/jama.2013.8777; Haas M, 2017, J AM SOC NEPHROL, V28, P691, DOI 10.1681/ASN.2016040433; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Jacob Churg JB, 1995, IGA NEPHROPATHY; Jarrick S, 2019, J AM SOC NEPHROL, V30, P866, DOI 10.1681/ASN.2018101017; Knoop T, 2013, AM J KIDNEY DIS, V62, P883, DOI 10.1053/j.ajkd.2013.04.019; Komatsu H, 2013, KIDNEY BLOOD PRESS R, V37, P649, DOI 10.1159/000355745; Lee H, 2013, AM J NEPHROL, V37, P74, DOI 10.1159/000345960; Lee HJ, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-143; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 1998, AM J KIDNEY DIS, V32, P853, DOI 10.1016/S0272-6386(98)70145-3; Lv JC, 2017, JAMA-J AM MED ASSOC, V318, P432, DOI 10.1001/jama.2017.9362; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Menon V, 2008, KIDNEY INT, V73, P1310, DOI 10.1038/ki.2008.67; Park S, 2019, KIDNEY BLOOD PRESS R, V44, P22, DOI 10.1159/000497808; Rauen T, 2015, NEW ENGL J MED, V373, P2225, DOI 10.1056/NEJMoa1415463; Rodrigues JC, 2017, CLIN J AM SOC NEPHRO, V12, P677, DOI 10.2215/CJN.07420716; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Tan M, 2015, KIDNEY BLOOD PRESS R, V40, P200, DOI 10.1159/000368495; Thomas B, 2017, J AM SOC NEPHROL, V28, P2167, DOI 10.1681/ASN.2016050562; Trimarchi H, 2017, KIDNEY INT, V91, P1014, DOI 10.1016/j.kint.2017.02.003; Tsai SF, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060848; Walsh M, 2010, CLIN J AM SOC NEPHRO, V5, P425, DOI 10.2215/CJN.06530909; Zhang W, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006190	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0237075	10.1371/journal.pone.0237075	http://dx.doi.org/10.1371/journal.pone.0237075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735632	Green Published, gold			2022-12-26	WOS:000569367100068
J	St Clair, CR; Head, GP; Gassmann, AJ				St Clair, Coy R.; Head, Graham P.; Gassmann, Aaron J.			Western corn rootworm abundance, injury to corn, and resistance to Cry3Bb1 in the local landscape of previous problem fields	PLOS ONE			English	Article							DIABROTICA-VIRGIFERA-VIRGIFERA; INSECT RESISTANCE; TRANSGENIC CROPS; HELICOVERPA-ZEA; MATING-BEHAVIOR; FITNESS COSTS; BT COTTON; COLEOPTERA; CHRYSOMELIDAE; EVOLUTION	Western corn rootworm, Diabrotica virgifera virgifera LeConte (Coleoptera: Chrysomelidae), is a major pest of corn in the United States. Transgenic corn expressing insecticidal proteins derived from the bacterium Bacillus thuringiensis (Bt) is an important tool used to manage rootworm populations. However, field-evolved resistance to Bt threatens this technology. In areas where resistance is present, resistant individuals may travel from one field to a neighboring field, spreading resistance alleles. An important question that remains to be answered is the extent to which greater-than-expected root injury (i.e., >1 node of injury) to Cry3Bb1 corn from western corn rootworm is associated with rootworm abundance, root injury, and levels of resistance in neighboring fields. To address this question, fields with a history of greater-than-expected injury to Cry3Bb1 corn (focal fields) and surrounding fields (< 2.2 km from focal fields) were examined to quantify rootworm abundance, root injury, and resistance to Cry3Bb1 corn. Additionally, use of Bt corn and soil insecticide use for the previous six years were quantified for each field. Resistance to Cry3Bb1 was present in all fields assayed, even though focal fields had grown more Cry3 corn and less non-Bt corn than surrounding fields. This finding implies that some movement of resistance alleles had occurred between focal fields and surrounding fields. Overall, our data suggest that resistance to Cry3Bb1 in the landscape has been influenced by both local rootworm movement and field-level management tactics.	[St Clair, Coy R.; Gassmann, Aaron J.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA; [Head, Graham P.] Bayer Crop Sci, Resistance Management, Chesterfield, MO USA	Iowa State University; Bayer AG; Bayer CropScience	St Clair, CR (corresponding author), Iowa State Univ, Dept Entomol, Ames, IA 50011 USA.	cstclair@iastate.edu	St Clair, Coy/GQZ-4601-2022	St Clair, Coy/0000-0002-9590-973X; Head, Graham/0000-0003-0521-0616	Bayer Crop Science	Bayer Crop Science(Bayer AG)	This work was supported with funding from Bayer Crop Science (https://www.cropscience.bayer.com) to AJG. The funder provided support in the form of salaries for authors CRS and GPH. GPH, as a scientist at Bayer Crop Science and a coauthor of this study, provided input on the design of the study and provided comments on a completed draft of the manuscript. Aside from these interactions, the funding agency had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Abendroth L., 2011, CORN GROWTH DEV; Ali MI, 2006, J ECON ENTOMOL, V99, P164, DOI 10.1603/0022-0493(2006)099[0164:SOHZAH]2.0.CO;2; Andow DA, 2016, J ECON ENTOMOL, V109, P1, DOI 10.1093/jee/tov238; Beckler AA, 2004, AGR FOREST ENTOMOL, V6, P129, DOI 10.1111/j.1461-9563.2004.00213.x; Carpenter JE, 2010, NAT BIOTECHNOL, V28, P319, DOI 10.1038/nbt0410-319; Carriere Y, 2001, P ROY SOC B-BIOL SCI, V268, P1475, DOI 10.1098/rspb.2001.1689; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Dalecky A, 2006, PLOS BIOL, V4, P1048, DOI 10.1371/journal.pbio.0040181; Downes S, 2017, PEST MANAG SCI, V73, P485, DOI 10.1002/ps.4461; Dun Z, 2010, J APPL ENTOMOL, V134, P409, DOI 10.1111/j.1439-0418.2009.01487.x; Dunbar MW, 2016, J ECON ENTOMOL, V109, P2096, DOI 10.1093/jee/tow163; Dunbar MW, 2013, J ECON ENTOMOL, V106, P168, DOI 10.1603/EC11291; Edgerton MD, 2012, NAT BIOTECHNOL, V30, P493, DOI 10.1038/nbt.2259; Gassmann AJ, 2016, J ECON ENTOMOL, V109, P1872, DOI 10.1093/jee/tow110; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Gassmann Aaron J, 2012, GM Crops Food, V3, P235, DOI 10.4161/gmcr.20744; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Hammack L, 2003, J ECON ENTOMOL, V96, P1153, DOI 10.1603/0022-0493-96.4.1153; Hoffmann AM, 2015, J APPL ENTOMOL, V139, P403, DOI 10.1111/jen.12209; Ingber DA, 2015, J ECON ENTOMOL, V108, P2421, DOI 10.1093/jee/tov199; Ives AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169167; Jakka SRK, 2016, SCI REP-UK, V6, DOI 10.1038/srep27860; Levay N, 2015, CEREAL RES COMMUN, V43, P155, DOI 10.1556/CRC.2014.0020; LEW AC, 1979, ANN ENTOMOL SOC AM, V72, P391, DOI 10.1093/aesa/72.3.391; Marquardt PT, 2009, ENVIRON ENTOMOL, V38, P176, DOI 10.1603/022.038.0122; Martinez JC, 2016, ENVIRON ENTOMOL, V45, P747, DOI 10.1093/ee/nvw015; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Miller NJ, 2017, CURR OPIN INSECT SCI, V21, P68, DOI 10.1016/j.cois.2017.04.005; NARANJO SE, 1994, ANN ENTOMOL SOC AM, V87, P383, DOI 10.1093/aesa/87.3.383; Oleson JD, 2005, J ECON ENTOMOL, V98, P1, DOI 10.1603/0022-0493-98.1.1; Paolino AR, 2017, TOXINS, V9, DOI 10.3390/toxins9050159; Parry HR, 2017, ECOL MODEL, V365, P129, DOI 10.1016/j.ecolmodel.2017.10.004; Reindere JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208266; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Shrestha RB, 2018, J APPL ENTOMOL, V142, P937, DOI 10.1111/jen.12505; Shrestha RB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200156; Siegfried Blair D, 2012, GM Crops Food, V3, P184, DOI 10.4161/gmcr.20715; Sisterson MS, 2005, J ECON ENTOMOL, V98, P1751, DOI 10.1603/0022-0493-98.6.1751; Sokal R.R., 2012, BIOMETRY; Spencer JL, 2009, AGR FOREST ENTOMOL, V11, P9, DOI 10.1111/j.1461-9563.2008.00399.x; St Clair CR, 2020, J ECON ENTOMOL, V113, P1839, DOI 10.1093/jee/toaa106; Storer NP, 2003, J ECON ENTOMOL, V96, P156, DOI 10.1603/0022-0493-96.1.156; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2017, NAT BIOTECHNOL, V35, P926, DOI 10.1038/nbt.3974; Tabashnik Bruce E, 2012, GM Crops Food, V3, P194, DOI 10.4161/gmcr.20329; Tabashnik BE, 2012, J ECON ENTOMOL, V105, P767, DOI 10.1603/EC12080; Tinsley NA, 2013, J APPL ENTOMOL, V137, P161, DOI 10.1111/j.1439-0418.2012.01736.x; U.S. Environmental Protection Agency, 2011, 2009 RES MON REV CRY; U.S. Environmental Protection Agency, 2003, BIOP REG ACT DOC EV; Wangila DS, 2015, J ECON ENTOMOL, V108, P742, DOI 10.1093/jee/tou063; Yu EY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212696	54	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0237094	10.1371/journal.pone.0237094	http://dx.doi.org/10.1371/journal.pone.0237094			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735582	gold, Green Published			2022-12-26	WOS:000569367100070
J	Garrido, F; Morales, C				Garrido, Francisco; Morales, Catalina			Using oxygen 18 isotope to problematize the presence of resettled laborers in the far provinces of the Inca empire	PLOS ONE			English	Article							BONE PHOSPHATE; STABLE-ISOTOPE; FRACTIONATION; SETTLEMENT; ARTIFACTS; CONFLICT; POTTERY; ATACAMA; ENAMEL; VALUES	Resettlement, as a major imperial policy in the Inca empire, appears to have been a widespread mechanism for labor mobilization and the dismantling of rebellions. While multiple ethnohistorical references exist regarding resettlement in the central Andes, the extent of this policy in the imperial provinces is still unknown, especially in cases of economic intensification that might have required more labor force. The delta O-18 isotope is a good proxy for human mobility when comparing the childhood isotopic signature in the teeth enamel and the local water signature at the place of death. If applied to the study of an archaeological sequence, we can observe the expansion or reduction of a population's displacement within a territory, if they received foreigners, and in general, how their social interaction and networks changed over time. In a marginal provincial setting of the Inca empire, such as Copiapo valley in Chile, the study of delta O-18 isotope can enable us to observe if the alleged economic intensification in metallurgical production implied the massive arrival of foreign populations. Significantly, the Late Horizon does not evidence a great change in terms of mobility, compared to previous periods in Copiapo valley. Thus, the isotopic evidence can more clearly illuminate the social and political dynamics of an imperial provincial setting, where economic activities demanded by the Inca state were mainly carried out by the local labor force.	[Garrido, Francisco; Morales, Catalina] Museo Nacl Hist Nat, Santiago, Chile		Garrido, F (corresponding author), Museo Nacl Hist Nat, Santiago, Chile.	francisco.garrido@mnhn.gob.cl		Garrido, Francisco/0000-0001-8979-2670	Fondecyt, Agencia Nacional de Investigacion (ANID), Chile [11170010]; Museo Regional de Atacama; Museo Nacional de Historia Natural in Chile	Fondecyt, Agencia Nacional de Investigacion (ANID), Chile; Museo Regional de Atacama; Museo Nacional de Historia Natural in Chile	This work was financially supported by Fondecyt (Grant No. 11170010), Agencia Nacional de Investigacion (ANID), Chile. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the sponsorship of the Museo Regional de Atacama and Museo Nacional de Historia Natural in Chile. We also acknowledge the work of Dr. Alexander Cherkinsky, who was in charge of the AMS and isotope analysis of the samples presented in this paper, and the work of the reviewers that helped improving this paper. Finally, we thank Pilar Rivas and Pablo Diaz for providing us with the data of individuals 14 and 16.	Aguirre I, 1999, ESTUDIO HIDROGEOLOGI; Alatawi E, 2018, 2018 25TH AUSTRALASIAN SOFTWARE ENGINEERING CONFERENCE (ASWEC), P41, DOI 10.1109/ASWEC.2018.00014; Arkush E, 2005, CURR ANTHROPOL, V46, P3, DOI 10.1086/425660; Arkush E., 2015, HILLFORTS ANCIENT AN; Berenguer J., 2009, IMPERIO HABSBURGO; Bray TL, 2005, J ANTHROPOL ARCHAEOL, V24, P82, DOI 10.1016/j.jaa.2004.11.001; Brettell R, 2012, J ANAL ATOM SPECTROM, V27, P778, DOI 10.1039/c2ja10335d; Britton K, 2015, AM J PHYS ANTHROPOL, V157, P226, DOI 10.1002/ajpa.22704; Cantarutti G., 2013, MINING QUARRYING ANC, P185, DOI DOI 10.1007/978-1-4614-5200-3_9; Castillo G, 1996, SHINCAL, V6, P193; Chenery CA, 2012, RAPID COMMUN MASS SP, V26, P309, DOI 10.1002/rcm.5331; Costin Cathy L., 1996, CRAFT SPECIALIZATION, P211; Covey RA, 2015, INKA EMPIRE MULTIDIS, P83; dAltroy Terence, 2015, INCAS; DALTROY TN, 1985, CURR ANTHROPOL, V26, P187, DOI 10.1086/203249; Daux V, 2008, J HUM EVOL, V55, P1138, DOI 10.1016/j.jhevol.2008.06.006; Diaz P, 2017, CASERONES; Gagnon CM, 2015, J ARCHAEOL SCI-REP, V4, P174, DOI 10.1016/j.jasrep.2015.09.008; Garrido F, 2020, ETHNOHISTORY, V67, P127, DOI 10.1215/00141801-7888777; Garrido F, 2019, LAT AM ANTIQ, V30, P606, DOI 10.1017/laq.2019.48; Garrido F, 2017, AM ANTHROPOL, V119, P631, DOI 10.1111/aman.12924; Garrido F, 2017, ARCHAEOL ANTHROP SCI, V9, P935, DOI 10.1007/s12520-016-0315-2; Garrido F, 2016, J ANTHROPOL ARCHAEOL, V43, P94, DOI 10.1016/j.jaa.2016.06.001; Gil AF, 2014, INT J OSTEOARCHAEOL, V24, P31, DOI 10.1002/oa.1304; Haun SJ, 2010, DISTANT PROVINCES IN, P193; Hermes T.R., 2018, ISOTOPIC INVESTIGATI, P57, DOI DOI 10.4324/9781315143026-5; Hu D, 2019, ANTIQUITY, V93, P990, DOI 10.15184/aqy.2019.82; Hu D, 2018, J ARCHAEOL SCI-REP, V18, P213, DOI 10.1016/j.jasrep.2018.01.018; Julien C., 2012, HIGHWAYS BYWAYS ROAD, P147; Katzenberg M.A., 2019, BIOL ANTHR HUMAN SKE, V3rd ed., P469; Knudson KJ, 2009, INT J OSTEOARCHAEOL, V19, P171, DOI 10.1002/oa.1042; Krivoruchko K, 2014, LECT N EARTH SYST SC, P61, DOI 10.1007/978-3-642-32408-6_15; La Lone D., 1982, CONTEXTS PREHISTORIC, P291; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; Lorandi A. M., 1991, ANTHROPOLOGICA, V9, P211; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; McEwan Gordon F., 2006, INCAS NEW PERSPECTIV; Museo Chileno de Arte Precolombino, 2001, TRAS HUELLA INKA CHI, P74; Nielsen Axel E., 2015, CORPUS ARCHIVOS VIRT, V5, P1; Niemeyer H., 1998, CULTURAS PREHISTORIC, P61; Niemeyer H., 1994, CORDILLERA ANDES RUT, P23; Niemeyer H, 1986, REV COMECHINGONIA, V4, P165; Niemeyer H., 1998, CULTURAS PREHISTORIC, P115; Niemeyer Hans, 1998, CULTURAS PREHISTORIC, P163; Pellegrini M, 2011, PALAEOGEOGR PALAEOCL, V310, P71, DOI 10.1016/j.palaeo.2011.02.023; Pestle WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102844; Pilz J, 2008, STOCH ENV RES RISK A, V22, P621, DOI 10.1007/s00477-007-0165-7; Pollard AM, 2011, AM J PHYS ANTHROPOL, V145, P499, DOI 10.1002/ajpa.21524; Raffino R, 2004, B ARQUEOLOGIA PUCP, V8, P247; Rostorowski M., 2008, HIST TAHUANTINSUYU; Salazar D, 2013, CHUNGARA, V45, P83, DOI 10.4067/S0717-73562013000100004; Shinoda K., 2015, INKA EMPIRE MULTIDIS, P55; Sociedad Chilena de Arqueologia, 1993, P 12 C NAC ARQ CHIL, P333; Sociedad Chilena de Arqueologia, 1972, P 6 C NAC ARQ CHIL, P229; Sociedad Geologica de Chile, 1997, SOC GEOLOGICA CHILE, P610; Topic J, 1987, ORIGINS DEV ANDEAN S, P47; Troncoso A., 2013, REV CHILENA ANTROPOL, V27, P101; Troncoso R., 2012, EVALUACION HIDROGEOL; Turner BL, 2009, J ARCHAEOL SCI, V36, P317, DOI 10.1016/j.jas.2008.09.018; Turner TF, 2010, ECOLOGY, V91, P2227, DOI 10.1890/09-1454.1; Ugan A, 2012, J ARCHAEOL SCI, V39, P2752, DOI 10.1016/j.jas.2012.04.013; Uribe M., 2016, PREHISTORIA CHILE SU, P529; Williams VI, 2016, J ARCHAEOL SCI-REP, V9, P481, DOI 10.1016/j.jasrep.2016.08.028; Wilson AS, 2007, P NATL ACAD SCI USA, V104, P16456, DOI 10.1073/pnas.0704276104; Wright LE, 1998, AM J PHYS ANTHROPOL, V106, P1; Zori C, 2019, J ARCHAEOL RES, V27, P501, DOI 10.1007/s10814-019-09128-7; Zori C, 2013, J ARCHAEOL SCI, V40, P1165, DOI 10.1016/j.jas.2012.09.012	67	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237532	10.1371/journal.pone.0237532	http://dx.doi.org/10.1371/journal.pone.0237532			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC7KJ	32776982	Green Published, gold			2022-12-26	WOS:000561393800049
J	Ko, CJ; Hsu, TW; Wu, SR; Lan, SW; Hsiao, TF; Lin, HY; Lin, HH; Tu, HF; Lee, CF; Huang, CC; Chen, MJM; Hsiao, PW; Huang, HP; Lee, MS				Ko, Chun-Jung; Hsu, Ting-Wei; Wu, Shang-Ru; Lan, Shao-Wei; Hsiao, Ting-Feng; Lin, Hsin-Ying; Lin, Hsin-Hsien; Tu, Hsin-Fang; Lee, Cheng-Fan; Huang, Cheng-Chung; Chen, Mei-Ju May; Hsiao, Pei-Wen; Huang, Hsiang-Po; Lee, Ming-Shyue			Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis	ONCOGENE			English	Article							HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR; ANCHORED SERINE-PROTEASE; PERICELLULAR PROTEOLYSIS; SWISS-MODEL; MATRIPTASE; EXPRESSION; CLUSPRO; TISSUE; MET	TMPRSS2 is an important membrane-anchored serine protease involved in human prostate cancer progression and metastasis. A serine protease physiologically often comes together with a cognate inhibitor for execution of proteolytically biologic function; however, TMPRSS2's cognate inhibitor is still elusive. To identify the cognate inhibitor of TMPRSS2, in this study, we applied co-immunoprecipitation and LC/MS/MS analysis and isolated hepatocyte growth factor activator inhibitors (HAIs) to be potential inhibitor candidates for TMPRSS2. Moreover, the recombinant HAI-2 proteins exhibited a better inhibitory effect on TMPRSS2 proteolytic activity than HAI-1, and recombinant HAI-2 proteins had a high affinity to form a complex with TMPRSS2. The immunofluorescence images further showed that TMPRSS2 was co-localized to HAI-2. Both KD1 and KD2 domain of HAI-2 showed comparable inhibitory effects on TMPRSS2 proteolytic activity. In addition, HAI-2 overexpression could suppress the induction effect of TMPRSS2 on pro-HGF activation, extracellular matrix degradation and prostate cancer cell invasion. We further determined that the expression levels of TMPRSS2 were inversely correlated with HAI-2 levels during prostate cancer progression. In orthotopic xenograft animal model, TMPRSS2 overexpression promoted prostate cancer metastasis, and HAI-2 overexpression efficiently blocked TMPRSS2-induced metastasis. In summary, the results together indicate that HAI-2 can function as a cognate inhibitor for TMPRSS2 in human prostate cancer cells and may serve as a potential factor to suppress TMPRSS2-mediated malignancy.	[Ko, Chun-Jung; Hsu, Ting-Wei; Wu, Shang-Ru; Lan, Shao-Wei; Lin, Hsin-Ying; Lin, Hsin-Hsien; Tu, Hsin-Fang; Lee, Cheng-Fan; Huang, Cheng-Chung; Lee, Ming-Shyue] Natl Taiwan Univ, Coll Med, Dept Biochem & Mol Biol, Taipei, Taiwan; [Ko, Chun-Jung] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Hsiao, Ting-Feng] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Hsiao, Ting-Feng] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan; [Chen, Mei-Ju May] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Hsiao, Pei-Wen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan; [Huang, Hsiang-Po] Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei, Taiwan	National Taiwan University; University of Texas System; UTMD Anderson Cancer Center; Chang Gung University; Chang Gung University; University of Texas System; UTMD Anderson Cancer Center; Academia Sinica - Taiwan; National Taiwan University	Lee, MS (corresponding author), Natl Taiwan Univ, Coll Med, Dept Biochem & Mol Biol, Taipei, Taiwan.	mslee2006@ntu.edu.tw	Ko, Chun-Jung/AAA-6187-2022; Tu, Hsin-Fang/HGA-9284-2022	Ko, Chun-Jung/0000-0001-6565-7060; HUANG, HSIANG-PO/0000-0002-3382-305X; Hsiao, Ting-Feng/0000-0003-4074-9019	Ministry of Science and Technology [MOST 104-2320-B-002-044-MY3, MOST 105-2911-I-002-521, MOST 106-2320-B-002-046-MY3, MOST 108-2320-B-002-024-MY3]; National Health Research Institutes Grant [NHRI-EX106-10401BI, NHRI-EX109-10725BI]; National Taiwan University [NTU-CESRP-104R7602C4, NTU105R89612, NYU107L890504]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes Grant; National Taiwan University(National Taiwan University)	This study was supported by Ministry of Science and Technology Grants MOST 104-2320-B-002-044-MY3, MOST 105-2911-I-002-521, MOST 106-2320-B-002-046-MY3 and MOST 108-2320-B-002-024-MY3, National Health Research Institutes Grant NHRI-EX106-10401BI and NHRI-EX109-10725BI, and National Taiwan University Grant NTU-CESRP-104R7602C4, NTU105R89612 and NYU107L890504 to M.S. Lee. We appreciate the service of the First Core Laboratory of National Taiwan University College of Medicine. We thank Dr. Chen-Yong Lin at the Georgetown University for his gifts of antibodies. We would like to acknowledge Dr. Chia-Jung Yu (Chang Gung University, Taoyuan, Taiwan; Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan) and the Proteomics Core Laboratory of Chang Gung University for providing proteomics technical support.	Aalinkeel R, 2004, CANCER RES, V64, P5311, DOI 10.1158/0008-5472.CAN-2506-2; Benaud CM, 2002, CLIN EXP METASTAS, V19, P639, DOI 10.1023/A:1020985632550; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Chen YW, 2010, AM J PATHOL, V176, P2986, DOI 10.2353/ajpath.2010.090665; Chou FP, 2013, AM J PATHOL, V183, P1306, DOI 10.1016/j.ajpath.2013.06.024; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Delaria KA, 1997, J BIOL CHEM, V272, P12209, DOI 10.1074/jbc.272.18.12209; Dozmorov MG, 2009, PROSTATE, V69, P1077, DOI 10.1002/pros.20960; Eder T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091458; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Garten W, 2015, EUR J CELL BIOL, V94, P375, DOI 10.1016/j.ejcb.2015.05.013; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Humphrey PA, 2006, CLIN GENITOURIN CANC, V4, P269, DOI 10.3816/CGC.2006.n.006; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin JS, 2007, HISTOL HISTOPATHOL, V22, P305, DOI 10.14670/HH-22.305; Kang JY, 2003, CANCER RES, V63, P1101; Kawaguchi M, 2014, CANCERS, V6, P1890, DOI 10.3390/cancers6041890; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Ko CJ, 2015, CANCER RES, V75, P2949, DOI 10.1158/0008-5472.CAN-14-3297; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Kumar D, 2018, CANCER RES, V78, P3769, DOI 10.1158/0008-5472.CAN-17-1076; Lai YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127293; Lam DK, 2015, PAIN, V156, P923, DOI 10.1097/j.pain.0000000000000130; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Lucas J, 2008, J PATHOL, V215, P118, DOI 10.1002/path.2330; Lucas JM, 2014, CANCER DISCOV, V4, P1310, DOI 10.1158/2159-8290.CD-13-1010; Maurer E, 2013, BIOCHEM J, V450, P583, DOI 10.1042/BJ20121518; Mestres J, 2008, NAT BIOTECHNOL, V26, P983, DOI 10.1038/nbt0908-983; Mierke CT, 2013, EUR J CELL BIOL, V92, P89, DOI 10.1016/j.ejcb.2012.12.002; Miyazawa K, 2010, FEBS J, V277, P2208, DOI 10.1111/j.1742-4658.2010.07637.x; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; PISTERS LL, 1995, J UROLOGY, V154, P293, DOI 10.1016/S0022-5347(01)67297-5; Qin L, 1998, FEBS LETT, V436, P111, DOI 10.1016/S0014-5793(98)01105-3; Roversi FM, 2018, BIOMED PHARMACOTHER, V101, P278, DOI 10.1016/j.biopha.2018.02.100; Russo AL, 2009, CLIN CANCER RES, V15, P4292, DOI 10.1158/1078-0432.CCR-09-0599; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Sevenich L, 2014, GENE DEV, V28, P2331, DOI 10.1101/gad.250647.114; Shen CA-SaMM, 2000, GENE DEV, V14, P26; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Stowell SR, 2015, ANNU REV PATHOL-MECH, V10, P473, DOI 10.1146/annurev-pathol-012414-040438; Tao LL, 2017, ONCOL LETT, V14, P2611, DOI 10.3892/ol.2017.6497; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tsai CH, 2014, ONCOGENE, V33, P4643, DOI 10.1038/onc.2013.412; Vogel LK, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-176; Wilson S, 2005, BIOCHEM J, V388, P967, DOI 10.1042/BJ20041066; Wu SR, 2019, BRIT J CANCER, V120, P499, DOI 10.1038/s41416-019-0400-2	58	15	15	5	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2020	39	37					5950	5963		10.1038/s41388-020-01413-w	http://dx.doi.org/10.1038/s41388-020-01413-w		AUG 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NM2OY	32778768	Green Published, Bronze			2022-12-26	WOS:000558201400002
J	Huong, NQ; Nga, NTT; Long, NV; Luu, BD; Latinne, A; Pruvot, M; Phuong, NT; Quang, LTV; Hung, VV; Lan, NT; Hoa, NT; Minh, PQ; Diep, NT; Tung, N; Ky, VD; Roberton, SI; Thuy, HB; Gilbert, M; Wicker, L; Mazet, JAK; Johnson, CK; Goldstein, T; Tremeau-Bravard, A; Ontiveros, V; Joly, DO; Walzer, C; Fine, AE; Olson, SH				Nguyen Quynh Huong; Nguyen Thi Thanh Nga; Nguyen Van Long; Bach Duc Luu; Latinne, Alice; Pruvot, Mathieu; Nguyen Thanh Phuong; Le Tin Vinh Quang; Vo Van Hung; Nguyen Thi Lan; Nguyen Thi Hoa; Phan Quang Minh; Nguyen Thi Diep; Nguyen Tung; Van Dang Ky; Roberton, Scott, I; Hoang Bich Thuy; Gilbert, Martin; Wicker, Leanne; Mazet, Jonna A. K.; Johnson, Christine Kreuder; Goldstein, Tracey; Tremeau-Bravard, Alex; Ontiveros, Victoria; Joly, Damien O.; Walzer, Chris; Fine, Amanda E.; Olson, Sarah H.			Coronavirus testing indicates transmission risk increases along wildlife supply chains for human consumption in Viet Nam, 2013-2014	PLOS ONE			English	Article							BAT CORONAVIRUSES; MEKONG DELTA; INFECTION; TRADE; GUANO	Outbreaks of emerging coronaviruses in the past two decades and the current pandemic of a novel coronavirus (SARS-CoV-2) that emerged in China highlight the importance of this viral family as a zoonotic public health threat. To gain a better understanding of coronavirus presence and diversity in wildlife at wildlife-human interfaces in three southern provinces in Viet Nam 2013-2014, we used consensus Polymerase Chain Reactions to detect coronavirus sequences. In comparison to previous studies, we observed high proportions of positive samples among field rats (34.0%, 239/702) destined for human consumption and insectivorous bats in guano farms (74.8%, 234/313) adjacent to human dwellings. Most notably among field rats, the odds of coronavirus RNA detection significantly increased along the supply chain from field rats sold by traders (reference group; 20.7% positivity, 39/188) by a factor of 2.2 for field rats sold in large markets (32.0%, 116/363) and 10.0 for field rats sold and served in restaurants (55.6%, 84/151). Coronaviruses were also detected in rodents on the majority of wildlife farms sampled (60.7%, 17/28). These coronaviruses were found in the Malayan porcupines (6.0%, 20/331) and bamboo rats (6.3%, 6/96) that are raised on wildlife farms for human consumption as food. We identified six known coronaviruses in bats and rodents, clustered in threeCoronaviridaegenera, including theAlpha-,Beta-, andGammacoronaviruses. Our analysis also suggested either mixing of animal excreta in the environment or interspecies transmission of coronaviruses, as both bat and avian coronaviruses were detected in rodent feces on wildlife farms. The mixing of multiple coronaviruses, and their apparent amplification along the wildlife supply chain into restaurants, suggests maximal risk for end consumers and likely underpins the mechanisms of zoonotic spillover to people.	[Nguyen Quynh Huong; Nguyen Thi Thanh Nga; Latinne, Alice; Roberton, Scott, I; Hoang Bich Thuy; Wicker, Leanne; Fine, Amanda E.] Wildlife Conservat Soc, Viet Nam Country Program, Hanoi, Vietnam; [Nguyen Van Long; Bach Duc Luu; Phan Quang Minh; Nguyen Thi Diep; Nguyen Tung; Van Dang Ky] Minist Agr & Rural Dev Viet Nam, Dept Anim Hlth, Hanoi, Vietnam; [Latinne, Alice; Pruvot, Mathieu; Gilbert, Martin; Joly, Damien O.; Walzer, Chris; Fine, Amanda E.; Olson, Sarah H.] Wildlife Conservat Soc, Hlth Program, Bronx, NY 10460 USA; [Latinne, Alice] EcoHlth Alliance, New York, NY USA; [Nguyen Thanh Phuong; Le Tin Vinh Quang; Vo Van Hung] Reg Anim Hlth Off 6, Ho Chi Minh City, Vietnam; [Nguyen Thi Lan; Nguyen Thi Hoa] Viet Nam Natl Univ Agr, Fac Vet Med, Hanoi, Vietnam; [Mazet, Jonna A. K.; Johnson, Christine Kreuder; Goldstein, Tracey; Tremeau-Bravard, Alex; Ontiveros, Victoria] Univ Calif Davis, Hlth Inst 1, Sch Vet Med, Davis, CA 95616 USA; [Walzer, Chris] Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria; [Van Dang Ky] Anim Asia Fdn Viet Nam, Hanoi, Vietnam; [Gilbert, Martin] Cornell Univ, Coll Vet Med, Cornell Wildlife Hlth Ctr, Ithaca, NY 14853 USA; [Wicker, Leanne] Zoos Victoria, Healesville Sanctuary, Australian Wildlife Hlth Ctr, Healesville, Vic, Australia; [Joly, Damien O.] British Columbia Minist Environm & Climate Change, Victoria, BC, Canada	Wildlife Conservation Society; EcoHealth Alliance; Vietnam National University Hanoi; Vietnam National University of Agriculture (VNUA); University of California System; University of California Davis; University of Veterinary Medicine Vienna; Cornell University	Fine, AE (corresponding author), Wildlife Conservat Soc, Viet Nam Country Program, Hanoi, Vietnam.; Fine, AE (corresponding author), Wildlife Conservat Soc, Hlth Program, Bronx, NY 10460 USA.	afine@wcs.org		Gilbert, Martin/0000-0002-9930-4383; Walzer, Chris/0000-0002-0437-5147; Pruvot, Mathieu/0000-0001-9325-3960	United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT project [GHN-A-OO-09-00010-00, AID-OAA-A-14-00102]; USAID Emerging Pandemic Threats Program [EPT-1, EPT-2]	United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT project(United States Agency for International Development (USAID)); USAID Emerging Pandemic Threats Program(United States Agency for International Development (USAID))	This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT project (cooperative agreement numbers GHN-A-OO-09-00010-00 [J.A.K.M., C.K.J., T.G., D. O.J.] and AID-OAA-A-14-00102 [J.A.K.M, C.K.J., T. G., A.E.F, S.H.O.]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The URL to the USAID Emerging Pandemic Threats Program (EPT-1 and 2) is https://www.usaid.gov/ept2.	Achenbach JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017643; Amman BR, 2014, EMERG INFECT DIS, V20, P1761, DOI 10.3201/eid2010.140696; Anthony SJ, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex012; Aplin KP, 2003, ACIA MONOGR; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bell D, 2004, PHILOS T R SOC B, V359, P1107, DOI 10.1098/rstb.2004.1492; Berto A, 2018, ZOONOSES PUBLIC HLTH, V65, P30, DOI 10.1111/zph.12362; Bosco-Lauth AM, 2016, VIROLOGY, V495, P161, DOI 10.1016/j.virol.2016.04.032; Breed AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061316; CBNRM Learning Institute, 2009, EM TRENDS CHALL INN; Chhay S., 2012, CAMBODIAN J NAT HIST, V2012; Chu DKW, 2008, J GEN VIROL, V89, P1282, DOI 10.1099/vir.0.83605-0; Corman VM, 2015, J VIROL, V89, P11858, DOI 10.1128/JVI.01755-15; Corman VM, 2014, J VIROL, V88, P11297, DOI 10.1128/JVI.01498-14; CRANDALL KA, 1993, GENETICS, V134, P959; Drexler JF, 2014, ANTIVIR RES, V101, P45, DOI 10.1016/j.antiviral.2013.10.013; FAO (Food and Agriculture Organization of the United Nations), 2014, WILDL FARM VIET NAM; Francisco L, 2018, LIVING SAFELY BATS; Furey NM, 2012, BATS, V30, P7; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Greatorex ZF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150666; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698; HUBER N, 2019, FRONT VET SCI, V6, DOI DOI 10.3389/FVETS.2019.0000130723724; Huynh J, 2012, J VIROL, V86, P12816, DOI 10.1128/JVI.00906-12; Jackson J.K., 2021, C RES SERV; Jing L, 2011, J ENVIRON INFORM, V17, P36, DOI 10.3808/jei.201100185; Khiem N.T., 2003, RATS MICE PEOPLE ROD, P543; Knober S, 2004, LEARNING SARS PREPAR; Lacroix A, 2017, INFECT GENET EVOL, V48, P10, DOI 10.1016/j.meegid.2016.11.029; Li X, 2020, LECT NOTES ELECTR EN, V574, P1, DOI [10.1007/978-981-13-9718-9_1, 10.1126/sciadv.abb9153, 10.1101/2020.03.20.000885]; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Cuong NV, 2015, VECTOR-BORNE ZOONOT, V15, P65, DOI 10.1089/vbz.2014.1603; Quan PL, 2010, MBIO, V1, DOI 10.1128/mBio.00208-10; R Core Team, 2021, R LANGUAGE ENV STAT; Roberton SI, 2003, HUNTING TRADING WILD; Rourke KO, 2014, MARKET CHAIN ANAL CR; Runfola D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231866; Son NT, 2014, TAP CHI SINH HOC, V31, P52, DOI [10.15625/0866-7160/v31n3.4946, DOI 10.15625/0866-7160/V31N3.4946]; Sothearen T., 2014, Journal of Tropical Agriculture, V52, P169; Springer MS, 2013, CURR BIOL, V23, pR999, DOI 10.1016/j.cub.2013.09.053; Srilopan S, 2018, ACTA CHIROPTEROL, V20, P207, DOI 10.3161/15081109ACC2018.20.1.016; Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003; Swift L, 2007, ECOHEALTH, V4, P25, DOI 10.1007/s10393-006-0076-y; Valitutto MT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230802; Wacharapluesadee S, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0950-6; Wacharapluesadee S, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0289-1; Wacharapluesadee S, 2013, EMERG INFECT DIS, V19, P1349, DOI 10.3201/eid1908.130119; Wang N, 2018, VIROL SIN, V33, P104, DOI 10.1007/s12250-018-0012-7; Wang W, 2015, VIROLOGY, V474, P19, DOI 10.1016/j.virol.2014.10.017; Watanabe S, 2010, EMERG INFECT DIS, V16, P1217, DOI 10.3201/eid1608.100208; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; WHO, 2019, REP WHO CHIN JOINT M; Wildlife Conservation Society Department VFP, 2008, COMM WILDL FARMS VIE; World Health Organization, SUMM PROB SARS CAS O	56	38	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237129	10.1371/journal.pone.0237129	http://dx.doi.org/10.1371/journal.pone.0237129			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776964	Green Submitted, Green Published, gold			2022-12-26	WOS:000561393800032
J	Qi, JL; Liu, XH; Gao, HT; Sun, XK				Qi, Junlong; Liu, Xianghua; Gao, Haitao; Sun, Xiangkun			Research on the deformation law for flat rolling of a core filled tube based on the slab method	PLOS ONE			English	Article							POWDER; WIRES	The deformation law for axisymmetric deformation during the drawing of a core filled tube (CORFT) has been studied. However, the results of such studies could not be used in the flat rolling process of the CORFT, which is a plan deformation condition. In this paper, the inner core material and outer steel tube were successively analyzed based on the slab method during the flat rolling process (plan deformation) of the CORFT, and equations for wall thickness, core density, and roll force have been developed. The theoretical results solved by the developed equations were compared with the experimental results, revealing adequate accuracy for engineering requirements. The influences of rolling parameters on the roll force and the ultimate value of the relative density of the core material were studied, and the limiting condition for a larger roll force or higher value for relative density was obtained.	[Qi, Junlong; Liu, Xianghua; Gao, Haitao; Sun, Xiangkun] Northeastern Univ, State Key Lab Rolling & Automat, Shenyang, Peoples R China; [Liu, Xianghua] Key Lab Lightweight Struct Mat, Shenyang, Liaoning, Peoples R China	Northeastern University - China	Liu, XH (corresponding author), Northeastern Univ, State Key Lab Rolling & Automat, Shenyang, Peoples R China.; Liu, XH (corresponding author), Key Lab Lightweight Struct Mat, Shenyang, Liaoning, Peoples R China.	liuxh@mail.neu.edu.cn						Cavaliere MA, 2001, COMPUT STRUCT, V79, P2075, DOI 10.1016/S0045-7949(01)00055-4; Han Z, 1997, SUPERCOND SCI TECH, V10, P371, DOI 10.1088/0953-2048/10/6/001; He K, 2017, RENEW SUST ENERG REV, V70, P1022, DOI 10.1016/j.rser.2016.12.007; Hosono H, 2018, MATER TODAY, V21, P278, DOI 10.1016/j.mattod.2017.09.006; Huang H, 2018, IEEE T APPL SUPERCON, V28, DOI 10.1109/TASC.2017.2779751; Jiang ZY, 2004, TRIBOL INT, V37, P185, DOI 10.1016/S0301-679X(03)00049-5; KORZEKWA DA, 1994, APPL SUPERCOND, V2, P261, DOI 10.1016/0964-1807(94)90012-4; Liang XP, 2014, MAT SCI ENG A-STRUCT, V619, P265, DOI 10.1016/j.msea.2014.09.091; Liu XH, 2014, KIND CORE FILLED TUB; Liu XH, 2017, KIND CORE FILLED TUB; Liu Y, 2019, COMPOS STRUCT, V211, P273, DOI 10.1016/j.compstruct.2018.12.027; Lu YJ, 2017, AER ADV ENG RES, V128, P233; Lu YJ, 2009, CHIN J MECH ENG-EN, V22, P890, DOI 10.3901/CJME.2009.06.890; Nagasekhar AV, 2006, APPL PHYS A-MATER, V85, P185, DOI 10.1007/s00339-006-3677-y; Pandheeradi M, 2001, J MANUF SCI E-T ASME, V123, P665, DOI 10.1115/1.1371929; Qi JL, 2020, INT J MECH SCI, V165, DOI 10.1016/j.ijmecsci.2019.105152; Razani NA, 2018, INT J ADV MANUF TECH, V94, P175, DOI 10.1007/s00170-017-0801-4; Rowe GW., 1979, ELEMENTS METALWORKIN; Sun JL, 2017, INT J MECH SCI, V133, P720, DOI 10.1016/j.ijmecsci.2017.09.025; Wang HY, 2016, INT J MECH SCI, V106, P194, DOI 10.1016/j.ijmecsci.2015.12.021; Zhang SN, 2020, IEEE T APPL SUPERCON, V30, DOI 10.1109/TASC.2020.2978784	21	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237039	10.1371/journal.pone.0237039	http://dx.doi.org/10.1371/journal.pone.0237039			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776956	gold, Green Published			2022-12-26	WOS:000561393800018
J	Tsushima, Y; Okada, S; Kawai, Y; Sumita, A; Ando, H; Miki, M				Tsushima, Yoshiaki; Okada, Sho; Kawai, Yuka; Sumita, Akio; Ando, Hiroshi; Miki, Mitsunori			Effect of illumination on perceived temperature	PLOS ONE			English	Article							APPARENT WARMTH; INFORMATION; VISION; COOL	The widely known hue-heat effect, a multisensory phenomenon between vision and thermal sensing, is a hypothesis based on the idea that light and colors affect perceived temperature. However, the application of this effect has not been prevalent in our daily lives. To work towards developing more practical use of the hue-heat effect, we conducted a series of psychophysical experiments to investigate the relationship between perceived temperature and illumination in a well-controlled experimental environment. The results showed that illumination had three types of effects to change our sense of coolness/warmness: creating, eliminating, and exchanging effects. Furthermore, we confirmed the existence of two distinctive time courses for the three effects: creating effect started immediately, but the eliminating effect takes time. These findings provide us with a better understanding of the hue-heat effect and enable us to apply it in everyday life. Paired with the new technologies it can also help with energy conservation.	[Tsushima, Yoshiaki; Ando, Hiroshi] Natl Inst Informat & Commun Technol NICT, Ctr Informat & Neural Networks CiNet, Kyoto, Japan; [Okada, Sho; Kawai, Yuka; Miki, Mitsunori] Doshisha Univ, Fac Sci & Engn, Kyoto, Japan; [Sumita, Akio] Kimura Kohki Co Ltd, Osaka, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Doshisha University	Tsushima, Y (corresponding author), Natl Inst Informat & Commun Technol NICT, Ctr Informat & Neural Networks CiNet, Kyoto, Japan.	tsushima@nict.go.jp		Tsushima, Yoshiaki/0000-0001-7818-4602	JST (Japan Science and Technology Agency) project "Keihanna Research Complex"; Kimura Kohki Co. Ltd.	JST (Japan Science and Technology Agency) project "Keihanna Research Complex"; Kimura Kohki Co. Ltd.	This work was partially supported by a JST (Japan Science and Technology Agency) project "Keihanna Research Complex". This work was also supported by Kimura Kohki Co. Ltd. Kimura Kohki Co. Ltd. The funder provided support in the form of salaries for an author [A.S.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section.	BENNETT CA, 1972, HUM FACTORS, V14, P149, DOI 10.1177/001872087201400204; BERRY PC, 1961, J APPL PSYCHOL, V45, P248, DOI 10.1037/h0040221; Chen Y.-C, 2017, FRONT PSYCHOL, V8; ENGEL GR, 1971, NATURE, V234, P308, DOI 10.1038/234308a0; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fenko A, 2010, MATER DESIGN, V31, P1325, DOI 10.1016/j.matdes.2009.09.008; Fujisaki W, 2009, EXP BRAIN RES, V198, P245, DOI 10.1007/s00221-009-1870-x; Gepshtein S, 2003, CURR BIOL, V13, P483, DOI 10.1016/S0960-9822(03)00133-7; GREENE TC, 1980, ERGONOMICS, V23, P949, DOI 10.1080/00140138008924804; Hardin CL, 2000, J CONSCIOUSNESS STUD, V7, P113; HEIJS W, 1988, J ENVIRON PSYCHOL, V8, P235, DOI 10.1016/S0272-4944(88)80012-4; Helbig HB, 2007, EXP BRAIN RES, V179, P595, DOI 10.1007/s00221-006-0814-y; Ho HN, 2014, SCI REP-UK, V4, DOI 10.1038/srep05527; Ho HN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091854; Ministry of the Environment of Japan, 2016, APP GLOB WARM CONTR, P150; Mogensen M.F., 1926, AM J PSYCHOL; Mounia Z., 2016, LECT NOTES COMPUTER, V9774; Richard FD, 2003, REV GEN PSYCHOL, V7, P331, DOI 10.1037/1089-2680.7.4.331; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Spence C., 2020, TEMPERATURE BASED CR, P1; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Tinker MA, 1938, AM J PSYCHOL, V51, P532, DOI 10.2307/1416154; Westfall J, 2016, PANGEA POWER ANALYSI; Winzen J, 2014, LIGHTING RES TECHNOL, V46, P465, DOI 10.1177/1477153513484028; WRIGHT B, 1962, AM J PSYCHOL, V75, P232, DOI 10.2307/1419606; Zampini M, 2005, ACTA PSYCHOL, V118, P277, DOI 10.1016/j.actpsy.2004.10.017	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0236321	10.1371/journal.pone.0236321	http://dx.doi.org/10.1371/journal.pone.0236321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC7KJ	32776987	gold, Green Published			2022-12-26	WOS:000561393800047
J	De Leon, LF; Cornejo, A; Gavilan, RG; Aguilar, C				De Leon, Luis F.; Cornejo, Aydee; Gavilan, Ronnie G.; Aguilar, Celestino			Hidden biodiversity in Neotropical streams: DNA barcoding uncovers high endemicity of freshwater macroinvertebrates at small spatial scales	PLOS ONE			English	Article							ASSEMBLAGE STRUCTURE; SPECIES-DIVERSITY; EXTRAPOLATION; RAREFACTION; PERFORMANCE; ECOSYSTEMS; MODELS; ORGANIZATION; COMMUNITY; RICHNESS	Aquatic macroinvertebrates play a crucial role in freshwater ecosystems, but their diversity remains poorly known, particularly in the tropics. This "taxonomic void" limits our understanding of biodiversity patterns and processes in freshwater ecosystems, and the scale at which they operate. We used DNA barcoding to estimate lineage diversity (and the diversity of unique haplotypes) in 224 specimens of freshwater macroinvertebrates at a small spatial scale within the Panama Canal Watershed (PCW). In addition, we compiled available barcoding data to assess macroinvertebrate diversity at a broader spatial scale spanning the Isthmus of Panama. Consistently across two species delimitation algorithms (i.e., ABGD and GMYC), we found high lineage diversity within the PCW, with similar to 100-106 molecular operational taxonomic units (MOTUs) across 168 unique haplotypes. We also found a high lineage diversity along the Isthmus of Panama, but this diversity peaked within the PCW. However, our rarefaction/extrapolation approach showed that this diversity remains under-sampled. As expected, these results indicate that the diversity of Neotropical freshwater macroinvertebrates is higher than previously thought, with the possibility of high endemicity even at narrow spatial scales. Consistent with previous work on aquatic insects and other freshwater taxa in this region, geographic isolation is likely a main factor shaping these patterns of diversity. However, other factors such as habitat variability and perhaps local adaptation might be reshaping these patterns of diversity at a local scale. Although further research is needed to better understand the processes driving diversification in freshwater macroinvertebrates, we suggest that Neotropical streams hold a high proportion of hidden biodiversity. Understanding this diversity is crucial in the face of increasing human disturbance.	[De Leon, Luis F.] Univ Massachusetts Boston, Dept Biol, Boston, MA USA; [De Leon, Luis F.; Aguilar, Celestino] Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ctr Biodiversidad & Descubrimiento Drogas, Panama City, Panama; [De Leon, Luis F.; Aguilar, Celestino] Smithsonian Trop Res Inst, Balboa, Panama; [Cornejo, Aydee] Inst Conmemorat Gorgas Estudios Salud, Panama City, Panama; [Gavilan, Ronnie G.] Inst Nacl Salud, Ctr Nacl Salud Publ, Lima, Peru; [Gavilan, Ronnie G.] Univers Privada San Juan Bautista, Escuela Profes Med Humana, Lima, Peru	University of Massachusetts System; University of Massachusetts Boston; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Smithsonian Institution; Smithsonian Tropical Research Institute; Instituto Conmemorativo Gorgas de Estudios de la Salud; Instituto Nacional de Salud - Peru	De Leon, LF (corresponding author), Univ Massachusetts Boston, Dept Biol, Boston, MA USA.; De Leon, LF (corresponding author), Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ctr Biodiversidad & Descubrimiento Drogas, Panama City, Panama.; De Leon, LF (corresponding author), Smithsonian Trop Res Inst, Balboa, Panama.	luis.deleonreyna@umb.edu	Cornejo, Aydeé/ACU-1078-2022; De Leon, Luis F/H-1112-2011	Cornejo, Aydeé/0000-0001-6789-5847; Aguilar, Celestino/0000-0003-1627-0374; Gavilan, Ronnie/0000-0003-1437-5607; De Leon, Luis F/0000-0001-9317-420X	Consortium for the Barcode of Life; Secretaria Nacional de Ciencia, Tecnologia e Innovacion (SENACYT) [ITE12-002, Fl D16-116]; Sistema Nacional de Investigacion (SNI); University of Massachusetts Boston	Consortium for the Barcode of Life(Smithsonian InstitutionSmithsonian National Museum of Natural History); Secretaria Nacional de Ciencia, Tecnologia e Innovacion (SENACYT); Sistema Nacional de Investigacion (SNI); University of Massachusetts Boston	Financial support was provided by a grant from the Consortium for the Barcode of Life to L. F. De Leon. Additional funding was provided by Secretaria Nacional de Ciencia, Tecnologia e Innovacion (SENACYT; Grants No. ITE12-002 and Fl D16-116 to L. F. De LeOn), Sistema Nacional de Investigacion (SNI; to C. Aguilar), and the University of Massachusetts Boston (to Luis F. De Leon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Avelar C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50241-w; Al-Shami SA, 2014, J TROP ECOL, V30, P335, DOI 10.1017/S0266467414000200; Amouroux P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01997-6; Barley AJ, 2016, MOL ECOL, V25, P1944, DOI 10.1111/mec.13590; Beermann AJ, 2018, ENVIRON SCI EUR, V30, DOI 10.1186/s12302-018-0157-x; Bojsen BH, 2003, ARCH HYDROBIOL, V158, P317, DOI 10.1127/0003-9136/2003/0158-0317; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Boyero L, 2002, MAR FRESHWATER RES, V53, P753, DOI 10.1071/MF01232; Boyero L, 2001, HYDROBIOLOGIA, V464, P219, DOI 10.1023/A:1013922307096; Boyero L, 2012, GLOBAL ECOL BIOGEOGR, V21, P134, DOI 10.1111/j.1466-8238.2011.00673.x; Boyero L, 2009, J N AM BENTHOL SOC, V28, P397, DOI 10.1899/08-146.1; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Castillo AM, 2018, HYDROBIOLOGIA, V807, P1, DOI 10.1007/s10750-017-3403-0; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Collen B, 2014, GLOBAL ECOL BIOGEOGR, V23, P40, DOI 10.1111/geb.12096; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Cornejo A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220528; Covich AP, 1999, BIOSCIENCE, V49, P119, DOI 10.2307/1313537; Covich AP, 2004, BIOSCIENCE, V54, P767, DOI 10.1641/0006-3568(2004)054[0767:TROBIT]2.0.CO;2; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dijkstra KDB, 2014, ANNU REV ENTOMOL, V59, P143, DOI 10.1146/annurev-ento-011613-161958; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; De Leon LF, 2016, BIODIVERS CONSERV, V25, P2821, DOI 10.1007/s10531-016-1197-4; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; FLOWERS RW, 1991, J N AM BENTHOL SOC, V10, P322, DOI 10.2307/1467605; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Garcia-Lopez A, 2013, J BIOGEOGR, V40, P2134, DOI 10.1111/jbi.12148; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Havemann N, 2018, PEERJ, V6, DOI 10.7717/peerj.4577; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Holzenthal RW, 2007, ORDER TRICHOPTERA KI, V1813; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jacobsen D, 1997, FRESHWATER BIOL, V38, P247, DOI 10.1046/j.1365-2427.1997.00210.x; Jacobsen D, 2008, AQUAT ECOL-SAN DIEGO, P65, DOI 10.1016/B978-012088449-0.50006-6; Jones M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019259; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Ligeiro R, 2010, FRESHWATER BIOL, V55, P424, DOI 10.1111/j.1365-2427.2009.02291.x; Lin XL, 2018, INSECT SYST EVOL, V49, P329, DOI 10.1163/1876312X-00002172; Malmqvist B, 2002, ENVIRON CONSERV, V29, P134, DOI 10.1017/S0376892902000097; Martinez C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148040; Mayhew PJ, 2007, BIOL REV, V82, P425, DOI 10.1111/j.1469-185X.2007.00018.x; Melo AS, 2001, J N AM BENTHOL SOC, V20, P1, DOI 10.2307/1468184; Merritt R.W., 1996, INTRO AQUATIC INSECT; Miller M.A., 2010, P GAT COMP ENV WORKS; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Murria C, 2015, DIVERS DISTRIB, V21, P938, DOI 10.1111/ddi.12343; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Posada-Garcia J. A., 2003, CALDASIA, P169; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Purez G.R, 1988, GUIA ESTUDIO MACROIN; Quintero DA, 1992, INSECTS PANAMA MESOA; Rambaut A., 2014, TRACER V1 6; Rambaut A, 2013, LOGCOMBINER V1 8 2; Ramirez A, 2000, REV BIOL TROP, V48, P247; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Righi-Cavallaro Karina Ocampo, 2010, Acta Limnol. Bras., V22, P306, DOI 10.4322/actalb.02203007; Roldan-Perez G., 1988, GUIA ESTUDIO MACROIN; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sharpe DMT, 2017, ECOLOGY, V98, P412, DOI 10.1002/ecy.1648; Smith SA, 2005, J BIOGEOGR, V32, P1835, DOI 10.1111/j.1365-2699.2005.01317.x; Springer M., 2006, CLAVE TAXONOMICA LAR, V1, P273; Springer M., 2008, BIOL TROPICAL S4, V56, P273; Streelman JT, 2004, MOL ECOL, V13, P2471, DOI 10.1111/j.1365-294X.2004.02240.x; Wallace JB, 1996, ANNU REV ENTOMOL, V41, P115, DOI 10.1146/annurev.en.41.010196.000555; Wantzen KM, 2006, J N AM BENTHOL SOC, V25, P61, DOI 10.1899/0887-3593(2006)25[61:NVINSE]2.0.CO;2; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Xia XH, 2017, J HERED, V108, P431, DOI 10.1093/jhered/esx033	73	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0231683	10.1371/journal.pone.0231683	http://dx.doi.org/10.1371/journal.pone.0231683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764752	gold, Green Submitted, Green Published			2022-12-26	WOS:000561029000025
J	Tassone, LM; Benitez, FUA; Rochon, D; Martinez, PB; Bonilla, M; Leon, CS; Muchnik, C; Solis, P; Medel, N; Kochen, S; Brusco, LI; Moyano, MD; Forcato, C				Tassone, Leonela M.; Urreta Benitez, Facundo A.; Rochon, Delfina; Martinez, Paula B.; Bonilla, Matias; Leon, Candela S.; Muchnik, Carolina; Solis, Patricia; Medel, Nancy; Kochen, Silvia; Brusco, Luis I.; Moyano, Malen D.; Forcato, Cecilia			Memory reconsolidation as a tool to endure encoding deficits in elderly	PLOS ONE			English	Article							COGNITIVE RESERVE; PREFRONTAL CORTEX; EPISODIC MEMORIES; PROTEIN-SYNTHESIS; OLDER-ADULTS; RETRIEVAL; DYNAMICS; REMINDER; PLASTICITY; CONTEXT	Normal aging involves changes in the ability to acquire, consolidate and recall new information. It has been recently proposed that the reconsolidation process is also affected in older adults. Reconsolidation is triggered after reminder presentation, allowing memories to be modified: they can be impaired, strengthened or changed in their content. In young adults it was previously shown that the presentation of repetitive reminders induces memory strengthening one day after reactivation and the presentation of at least one reminder increases memory persistence several days after reactivation. However, until now this process has remained elusive in older adults. We hypothesize that older adults need a stronger reminder to induce memory strengthening through the reconsolidation process than young adults. To test this, we perform a three-day experiment. On day 1, participants learned 15 sound-word associations, on day 2 they received no reminders (NR group), one reminder (R group) or two rounds of reactivations (Rx2 group). Finally, they were tested on day 7. We found that, contrary to our hypothesis, older adults show a memory improvement triggered by repeated labilization/reconsolidation processes to an equal extent than young adults. These results open new perspectives into the use of reconsolidation to improve daily acquired information and the development of therapeutic home used tools to produce memory enhancement in healthy older adults or those with cognitive decline.	[Tassone, Leonela M.; Urreta Benitez, Facundo A.; Rochon, Delfina; Martinez, Paula B.; Bonilla, Matias; Leon, Candela S.; Moyano, Malen D.; Forcato, Cecilia] Inst Tecnol Buenos Aires ITBA, Dept Ciencias Vida, Lab Sueno & Memoria, Buenos Aires, DF, Argentina; [Tassone, Leonela M.; Urreta Benitez, Facundo A.; Kochen, Silvia; Moyano, Malen D.; Forcato, Cecilia] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Muchnik, Carolina; Brusco, Luis I.] Univ Buenos Aires, Fac Ciencias Med, Ctr Neuropsiquiatria & Neurol Conducta CENECON, Buenos Aires, DF, Argentina; [Solis, Patricia; Medel, Nancy; Kochen, Silvia] Univ Nacl Arturo Jauretche, Hosp El Cruce Nestor Kirchner, CONICET, Unidad Ejecutora Estudios Neurociencias & Sistema, Florencio Varela, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Forcato, C (corresponding author), Inst Tecnol Buenos Aires ITBA, Dept Ciencias Vida, Lab Sueno & Memoria, Buenos Aires, DF, Argentina.; Forcato, C (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	cforcato@itba.edu.ar		FORCATO, CECILIA/0000-0002-5954-4008	AGENCIA [PICT 2016 N 0229]	AGENCIA	This work was supported by AGENCIA (PICT 2016 N 0229 to CF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokhin KV, 2002, EUR J NEUROSCI, V15, P1759, DOI 10.1046/j.1460-9568.2002.02023.x; Balota D. A., 2000, OXFORD HDB MEMORY, P395, DOI DOI 10.1037/A0015086; Bavassi L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37089-2; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Butman J, 2000, MEDICINA-BUENOS AIRE, V60, P561; Chalfonte BL, 1996, MEM COGNITION, V24, P403, DOI 10.3758/BF03200930; Colombel F, 2016, PSYCHOL AGING, V31, P239, DOI 10.1037/pag0000086; Craik FIM, 2012, NEUROSCI BIOBEHAV R, V36, P1729, DOI 10.1016/j.neubiorev.2011.11.007; CRAIK FIM, 1987, J EXP PSYCHOL LEARN, V13, P474, DOI 10.1037/0278-7393.13.3.474; Dudai Y., 2002, MEMORY KEYWORDS CONC; Forcato C, 2007, LEARN MEMORY, V14, P295, DOI 10.1101/lm.486107; Forcato C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061688; Forcato C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023305; Forcato C, 2010, NEUROBIOL LEARN MEM, V93, P77, DOI 10.1016/j.nlm.2009.08.006; Foricato C, 2009, NEUROBIOL LEARN MEM, V91, P50, DOI 10.1016/j.nlm.2008.09.011; Froger C, 2014, ANN PSYCHOL, V114, P355; Glisky EL, 2001, J EXP PSYCHOL LEARN, V27, P1131, DOI 10.1037//0278-7393.27.5.1131; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Howe ML, 2020, MEMORY, V28, P839, DOI 10.1080/09658211.2019.1705489; Hupbach A, 2008, LEARN MEMORY, V15, P574, DOI 10.1101/lm.1022308; Hupbach A, 2007, LEARN MEMORY, V14, P47, DOI 10.1101/lm.365707; Inda MC, 2011, J NEUROSCI, V31, P1635, DOI 10.1523/JNEUROSCI.4736-10.2011; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Jones BJ, 2015, NEUROBIOL LEARN MEM, V120, P7, DOI 10.1016/j.nlm.2015.02.003; Kindt M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03659-1; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Miller SL, 2008, P NATL ACAD SCI USA, V105, P2181, DOI 10.1073/pnas.0706818105; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; NAVEHBENJAMIN M, 1995, PSYCHOL AGING, V10, P284, DOI 10.1037/0882-7974.10.2.284; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Sandrini M, 2003, J COGNITIVE NEUROSCI, V15, P855, DOI 10.1162/089892903322370771; Sandrini M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00289; Sandrini M, 2013, CURR BIOL, V23, P2181, DOI 10.1016/j.cub.2013.08.045; Sangha S, 2003, J NEUROSCI, V23, P8034; SCHACTER DL, 1991, PSYCHOL AGING, V6, P559, DOI 10.1037/0882-7974.6.4.559; Schwabe L, 2008, NEUROBIOL LEARN MEM, V90, P44, DOI 10.1016/j.nlm.2008.02.002; Schwabe L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007519; Sevenster D, 2013, SCIENCE, V339, P830, DOI 10.1126/science.1231357; Shing YL, 2010, NEUROSCI BIOBEHAV R, V34, P1080, DOI 10.1016/j.neubiorev.2009.11.002; Sanjurjo NS, 2019, APPL NEUROPSYCH-ADUL, V26, P331, DOI 10.1080/23279095.2018.1427096; Sinclair AH, 2019, TRENDS NEUROSCI, V42, P727, DOI 10.1016/j.tins.2019.08.007; St Jacques PL, 2015, MEMORY, V23, P876, DOI 10.1080/09658211.2014.933241; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Strange BA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00175; Torralva T, 2011, NEUROLOGIA, V26, P351, DOI 10.1016/j.nrl.2010.10.013; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Wingfield A, 2002, CAN J EXP PSYCHOL, V56, P187, DOI 10.1037/h0087396	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237361	10.1371/journal.pone.0237361	http://dx.doi.org/10.1371/journal.pone.0237361			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2FE	32764815	gold, Green Published			2022-12-26	WOS:000561029000045
J	Hristovska, I; Verdonk, F; Comte, JC; Tsai, ES; Desestret, V; Honnorat, J; Chretien, F; Pascual, O				Hristovska, Ines; Verdonk, Franck; Comte, Jean-Christophe; Tsai, Eileen S.; Desestret, Virginie; Honnorat, Jerome; Chretien, Fabrice; Pascual, Olivier			Ketamine/xylazine and barbiturates modulate microglial morphology and motility differently in a mouse model	PLOS ONE			English	Article							NEURONAL NMDA RECEPTORS; GENERAL-ANESTHESIA; ACTIVATION; KETAMINE; RELEASE; ATP; HIPPOCAMPAL; EXPRESSION; XYLAZINE; CELLS	Microglia, the resident immune cells of the brain, are highly ramified and motile and their morphology is strongly linked to their function. Microglia constantly monitor the brain parenchyma and are crucial for maintaining brain homeostasis and fine-tuning neuronal networks. Besides affecting neurons, anesthetics may have wide-ranging effects mediated by non-neuronal cells and in particular microglia. We thus examined the effect of two commonly used anesthetic agents, ketamine/xylazine and barbiturates, on microglial motility and morphology. A combination of two-photonin vivoimaging and electroencephalography (EEG) recordings in unanesthetized and anesthetized mice as well as automated analysis ofex vivosections were used to assess morphology and dynamics of microglia. We found that administration of ketamine/xylazine and pentobarbital anesthesia resulted in quite distinct EEG profiles. Both anesthetics reduced microglial motility, but only ketamine/xylazine administration led to reduction of microglial complexityin vivo. The change of cellular dynamicsin vivowas associated with a region-dependent reduction of several features of microglial cellsex vivo, such as the complexity index and the ramification length, whereas thiopental altered the size of the cytoplasm. Our results show that anesthetics have considerable effects on neuronal activity and microglial morphodynamics and that barbiturates may be a preferred anesthetic agent for the study of microglial morphology. These findings will undoubtedly raise compelling questions about the functional relevance of anesthetics on microglial cells in neuronal physiology and anesthesia-induced neurotoxicity.	[Hristovska, Ines; Desestret, Virginie; Honnorat, Jerome; Pascual, Olivier] Inst NeuroMyoGene, Equipe Synaptopathies & Autoanticorps SynatAc, INSERM U1217, UMR CNRS 5310, Lyon, France; [Hristovska, Ines; Comte, Jean-Christophe; Desestret, Virginie; Honnorat, Jerome; Pascual, Olivier] Univ Claude Bernard Lyon 1, Univ Lyon, Lyon, France; [Verdonk, Franck; Chretien, Fabrice] Inst Pasteur, Dept Infect & Epidemiol, Unite Neuropathol Expt, Paris, France; [Verdonk, Franck] Hop St Antoine, AP HP, Dept Anesthesiol & Soins Intensifs, Paris, France; [Verdonk, Franck] Sorbonne Univ, Paris, France; [Verdonk, Franck; Tsai, Eileen S.] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA; [Comte, Jean-Christophe] CRNL, Equipe Proc Oubli & Dynam Corticale, INSERM U1028, CNRS UMR5292, Lyon, France; [Desestret, Virginie; Honnorat, Jerome] Hosp Civils Lyon, Ctr Malad Rares Syndromes Neurol Paraneoplas, Lyon, France; [Chretien, Fabrice] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Chretien, Fabrice] Lab Hosp Univ Neuropathol, Ctr Hosp St Anne, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Stanford University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite	Pascual, O (corresponding author), Inst NeuroMyoGene, Equipe Synaptopathies & Autoanticorps SynatAc, INSERM U1217, UMR CNRS 5310, Lyon, France.; Pascual, O (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, Lyon, France.; Chretien, F (corresponding author), Inst Pasteur, Dept Infect & Epidemiol, Unite Neuropathol Expt, Paris, France.; Chretien, F (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.; Chretien, F (corresponding author), Lab Hosp Univ Neuropathol, Ctr Hosp St Anne, Paris, France.	fabrice.chretien@pasteur.fr; olivier.pascual@inserm.fr	Pascual, Olivier/AAE-1449-2020; Verdonk, Franck/AAG-8997-2021	Pascual, Olivier/0000-0002-5730-9880; Verdonk, Franck/0000-0001-7061-5594	French ministry for research; Foundation des Gueules Cassees; SFAR (Societe Francaise d'Anesthesie-Reanimation); ANR MICROMEM [R17136CC]; INSERM	French ministry for research(Ministry of Research, France); Foundation des Gueules Cassees; SFAR (Societe Francaise d'Anesthesie-Reanimation); ANR MICROMEM(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	IH was funded by the French ministry for research. This work was also supported by the Foundation des Gueules Cassees and the SFAR (Societe Francaise d'Anesthesie-Reanimation), ANR MICROMEM #R17136CC and INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi R, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0088-18.2018; Boucsein C, 2003, EUR J NEUROSCI, V17, P2267, DOI 10.1046/j.1460-9568.2003.02663.x; Chauvette S, 2011, J NEUROSCI, V31, P14998, DOI 10.1523/JNEUROSCI.2339-11.2011; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DAVIS EJ, 1994, BRAIN RES BULL, V34, P73, DOI 10.1016/0361-9230(94)90189-9; De Biase LM, 2017, NEURON, V95, P341, DOI 10.1016/j.neuron.2017.06.020; Dissing-Olesen L, 2014, J NEUROSCI, V34, P10511, DOI 10.1523/JNEUROSCI.0405-14.2014; Eyo UB, 2014, J NEUROSCI, V34, P10528, DOI 10.1523/JNEUROSCI.0416-14.2014; Fontainhas AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015973; Garcia PS, 2010, CURR NEUROPHARMACOL, V8, P2, DOI 10.2174/157015910790909502; GOLDSTEIN A, 1960, J PHARMACOL EXP THER, V128, P1; Gomez-Nicola D, 2015, NEUROSCIENTIST, V21, P169, DOI 10.1177/1073858414530512; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; GREEN CJ, 1981, LAB ANIM, V15, P163, DOI 10.1258/002367781780959107; Guneykaya D, 2018, CELL REP, V24, P2773, DOI 10.1016/j.celrep.2018.08.001; Gyoneva S, 2013, J BIOL CHEM, V288, P15291, DOI 10.1074/jbc.M113.458901; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Hanisch UK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00065; Hantal G, 2019, BBA-BIOMEMBRANES, V1861, P594, DOI 10.1016/j.bbamem.2018.12.008; Hellwig S, 2016, BRAIN BEHAV IMMUN, V55, P126, DOI 10.1016/j.bbi.2015.11.008; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Kaindl AM, 2012, ANN NEUROL, V72, P536, DOI 10.1002/ana.23626; Kannan G, 2017, J CONTROL RELEASE J; Kenny JD, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00237; Kubota T, 1999, PSYCHOPHARMACOLOGY, V146, P335, DOI 10.1007/s002130051125; Kuhn SA, 2004, MOL CELL NEUROSCI, V25, P312, DOI 10.1016/j.mcn.2003.10.023; Liu YU, 2019, NAT NEUROSCI, V22, P1771, DOI 10.1038/s41593-019-0511-3; Loscher W, 2012, EPILEPSIA, V53, P12, DOI 10.1111/epi.12025; Lukatch HS, 2005, CEREB CORTEX, V15, P1322, DOI 10.1093/cercor/bhi015; Lydic R, 2002, SLEEP, V25, P617; MacIver MB, 1996, ANESTHESIOLOGY, V84, P1411, DOI 10.1097/00000542-199606000-00018; Madry C, 2018, NEURON, V97, P299, DOI 10.1016/j.neuron.2017.12.002; NACCARATO EF, 1979, LAB ANIM, V13, P317, DOI 10.1258/002367779780943314; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Nakki R, 1996, EXP NEUROL, V137, P234, DOI 10.1006/exnr.1996.0022; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Raj DDA, 2014, NEUROBIOL AGING, V35, P2147, DOI 10.1016/j.neurobiolaging.2014.03.025; Setiawan E, 2018, LANCET PSYCHIAT, V5, P339, DOI 10.1016/S2215-0366(18)30048-8; Sipe GO, 2016, NAT COMMUN, P7; Stowell RD, 2019, NAT NEUROSCI, V22, P1782, DOI 10.1038/s41593-019-0514-0; Sun WL, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00421; Thrane AS, 2012, P NATL ACAD SCI USA, V109, P18974, DOI 10.1073/pnas.1209448109; TICKU MK, 1992, EPILEPSY RES, P57; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Ulmann L, 2013, GLIA, V61, P1306, DOI 10.1002/glia.22516; Verdonk F, 2019, BRAIN BEHAV IMMUN; Verdonk F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0614-7; Vutskits L, 2016, NAT REV NEUROSCI, V17, P705, DOI 10.1038/nrn.2016.128; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wu LJ, 2007, GLIA, V55, P810, DOI 10.1002/glia.20500; Yamakura T, 2000, ANESTHESIOLOGY, V92, P1144, DOI 10.1097/00000542-200004000-00033; Zhao YH, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/3271579; Zhou Cheng, 2012, World J Crit Care Med, V1, P80, DOI 10.5492/wjccm.v1.i3.80; Zhu HC, 1997, ANESTHESIOLOGY, V87, P944, DOI 10.1097/00000542-199710000-00030	57	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236594	10.1371/journal.pone.0236594	http://dx.doi.org/10.1371/journal.pone.0236594			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760073	gold, Green Published			2022-12-26	WOS:000561027200059
J	Olsson, K; Eriksson, JS; Rosdahl, H; Schantz, P				Olsson, Karin; Salier Eriksson, Jane; Rosdahl, Hans; Schantz, Peter			Are heart rate methods based on ergometer cycling and level treadmill walking interchangeable?	PLOS ONE			English	Article							MAXIMAL OXYGEN-UPTAKE; ENERGY-EXPENDITURE; PHYSICAL-ACTIVITY; METABOLIC SYSTEM; PULSE-RATE; EXERCISE; EFFICIENCY; WORK; INTENSITY; FREQUENCY	Introduction The heart rate (HR) method is a promising approach for evaluating oxygen uptake ((V) over dot O-2), energy demands and exercise intensities in different forms of physical activities. It would be valuable if the HR method, established on ergometer cycling, is interchangeable with other regular activities, such as level walking. This study therefore aimed to examine the interchangeability of the HR method when estimating(V) over dot O-2 for ergometer cycling and level treadmill walking in submaximal conditions. Methods Two models ofHR-(V) over dot O-2 regression equations for cycle ergometer exercise (CEE) and treadmill exercise (TE) were established with 34 active commuters. Model 1 consisted of three submaximal intensities of ergometer cycling or level walking, model 2 included also one additional workload of maximal ergometer cycling or running. The regression equations were used for estimating(V) over dot O-2 with seven individual HR values based on 25-85% of HR reserve (HRR). The(V) over dot O-2 estimations were compared between CEE and TE, within and between each model. Results Only minor, and in most cases non-significant, average differences were observed when comparing the estimated(V) over dot O-2 levels between CEE and TE. Model 1 ranged from -0.4 to 4.8% (n.s.) between 25-85% HRR. In model 2, the differences between 25-65% HRR ranged from 1.3 to -2.7% (n.s.). At the two highest intensities, 75 and 85% HRR,(V) over dot O-2 was slightly lower (3.7%, 4.4%; P < 0.05), for CEE than TE. The inclusion of maximal exercise in the HR-(V) over dot O-2 relationships reduced the individual(V) over dot O-2 variations between the two exercise modalities. Conclusion The HR methods, based on submaximal ergometer cycling and level walking, are interchangeable for estimating mean(V) over dot O-2 levels between 25-85% of HRR. Essentially, the same applies when adding maximal exercise in the HR-(V) over dot O-2 relationships. The inter-individual(V) over dot O-2 variation between ergometer cycling and treadmill exercise is reduced when using the HR method based on both submaximal and maximal workloads.	[Olsson, Karin; Salier Eriksson, Jane; Rosdahl, Hans; Schantz, Peter] GIH, Swedish Sch Sport & Hlth Sci, Astrand Lab, Res Unit Movement Hlth & Environm, Stockholm, Sweden; [Olsson, Karin; Salier Eriksson, Jane; Rosdahl, Hans; Schantz, Peter] GIH, Swedish Sch Sport & Hlth Sci, Lab Appl Sport Sci, Stockholm, Sweden	Swedish School of Sport & Health Sciences; Swedish School of Sport & Health Sciences	Schantz, P (corresponding author), GIH, Swedish Sch Sport & Hlth Sci, Astrand Lab, Res Unit Movement Hlth & Environm, Stockholm, Sweden.	peter.schantz@gih.se		Schantz, Peter/0000-0003-3547-425X	Public Health Funds of the Stockholm County Council [LS0401-0158]; Research Funds of the Swedish Transport Administration [TRV:2017/63917-6522]; Swedish School of Sport and Health Sciences, GIH	Public Health Funds of the Stockholm County Council; Research Funds of the Swedish Transport Administration; Swedish School of Sport and Health Sciences, GIH	This work was funded by The Public Health Funds of the Stockholm County Council (LS0401-0158)(to PS), The Research Funds of the Swedish Transport Administration (TRV:2017/63917-6522)(to PS) and the Swedish School of Sport and Health Sciences, GIH (to PS, JSE and HR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes C, 2012, INT J SPORTS MED, V33, P26, DOI 10.1055/s-0031-1285928; Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; ASTRAND I, 1961, ACTA PHYSIOL SCAND, V50, P294, DOI 10.1111/j.1748-1716.1960.tb00183.x; ASTRAND I, 1971, AM J CLIN NUTR, V24, P1471; ASTRAND PO, 1954, J APPL PHYSIOL, V7, P218, DOI 10.1152/jappl.1954.7.2.218; ASTRAND PO, 1976, PROG CARDIOVASC DIS, V19, P51, DOI 10.1016/0033-0620(76)90008-6; BERGGREN G, 1950, Arbeitsphysiologie, V14, P255; BERRY MJ, 1993, MED SCI SPORT EXER, V25, P1031; Bjorkman FME, 2017, THESIS GYMNASTIK OCH; Boothby WM, 1915, AM J PHYSIOL, V37, P383, DOI 10.1152/ajplegacy.1915.37.2.383; BOOYENS J, 1960, CAN J BIOCHEM PHYS, V38, P1301, DOI 10.1139/o60-162; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Carpenter TM., 1964, TABLES FACTORS FORMU; CHRISTENSEN CC, 1983, AM J CLIN NUTR, V37, P468, DOI 10.1093/ajcn/37.3.468; COTES EJ, 1969, ERGONOMICS, V12, P415, DOI 10.1080/00140136908931065; Coyle E F, 2001, Exerc Sport Sci Rev, V29, P88, DOI 10.1097/00003677-200104000-00009; COYLE EF, 1992, MED SCI SPORT EXER, V24, P782; EKBLOM B, 1968, J APPL PHYSIOL, V25, P124, DOI 10.1152/jappl.1968.25.2.124; Ekelund U, 2001, EUR J APPL PHYSIOL, V85, P244, DOI 10.1007/s004210100436; Eriksson JS, 2012, EUR J APPL PHYSIOL, V112, P345, DOI 10.1007/s00421-011-1985-1; Eston R G, 1986, Br J Sports Med, V20, P4; FAIRBARN MS, 1994, CHEST, V105, P1365, DOI 10.1378/chest.105.5.1365; Farinatti PTV, 2009, EUR J APPL PHYSIOL, V107, P625, DOI 10.1007/s00421-009-1162-y; Foss O, 2005, INT J SPORTS MED, V26, P569, DOI 10.1055/s-2004-821317; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Green JA, 2011, COMP BIOCHEM PHYS A, V158, P287, DOI 10.1016/j.cbpa.2010.09.011; HERMANSE.L, 1969, J APPL PHYSIOL, V26, P31, DOI 10.1152/jappl.1969.26.1.31; HERMANSEN L, 1970, J APPL PHYSIOL, V29, P82, DOI 10.1152/jappl.1970.29.1.82; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Iannetta D, 2020, MED SCI SPORT EXER, V52, P466, DOI 10.1249/MSS.0000000000002147; Jones AM, 2011, MED SCI SPORT EXER, V43, P2046, DOI 10.1249/MSS.0b013e31821fcfc1; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Krogh A, 1917, J PHYSIOL-LONDON, V51, P182; Lafortuna CL, 2010, SCAND J MED SCI SPOR, V20, P630, DOI 10.1111/j.1600-0838.2009.00975.x; Lafortuna CL, 2009, J ENDOCRINOL INVEST, V32, P647, DOI 10.1007/BF03345735; Lafortuna CL, 2006, EUR J APPL PHYSIOL, V97, P16, DOI 10.1007/s00421-006-0137-5; Lafortuna CL, 2008, EUR J APPL PHYSIOL, V103, P707, DOI 10.1007/s00421-008-0758-y; LI RW, 1993, AM J CLIN NUTR, V58, P602, DOI 10.1093/ajcn/58.5.602; McCrory MA, 1997, AM J CLIN NUTR, V66, P18, DOI 10.1093/ajcn/66.1.18; Midgley AW, 2007, SPORTS MED, V37, P1019, DOI 10.2165/00007256-200737120-00002; Montero D, 2017, J PHYSIOL-LONDON, V595, P3377, DOI 10.1113/JP273480; Montoye HJ, 1996, MEASURING PHYS ACTIV; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Poole DC, 2016, MED SCI SPORT EXER, V48, P2320, DOI 10.1249/MSS.0000000000000939; Ross R, 2001, MED SCI SPORT EXER, V33, pS521, DOI 10.1097/00005768-200106001-00023; RYHMING I, 1953, Arbeitsphysiologie, V15, P235; Schantz P, 2018, THESIS; Schantz P, 2019, EUR J APPL PHYSIOL, V119, P2655, DOI 10.1007/s00421-019-04236-0; Schantz P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219741; Shephard RJ, 2012, EUR J APPL PHYSIOL, V112, P2785, DOI 10.1007/s00421-011-2268-6; SPURR GB, 1988, AM J CLIN NUTR, V48, P552, DOI 10.1093/ajcn/48.3.552; Stigell E, 2015, INT J ENV RES PUB HE, V12, P15626, DOI 10.3390/ijerph121215008; strand P-O, 1952, THESIS; Sun XG, 2002, AM J RESP CRIT CARE, V166, P1443, DOI 10.1164/rccm.2202033; VOKAC Z, 1975, J APPL PHYSIOL, V39, P54, DOI 10.1152/jappl.1975.39.1.54; WENGER HA, 1986, SPORTS MED, V3, P346, DOI 10.2165/00007256-198603050-00004; Zuccarelli L, 2018, MED SCI SPORT EXER, V50, P1649, DOI 10.1249/MSS.0000000000001612	59	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237388	10.1371/journal.pone.0237388	http://dx.doi.org/10.1371/journal.pone.0237388			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760167	gold, Green Published			2022-12-26	WOS:000561027200026
J	Qin, X; Yu, P; Li, HL; Hu, Y; Li, XH; Wang, Q; Lin, L; Tian, L				Qin, Xia; Yu, Pin; Li, Huiling; Hu, Yan; Li, Xuehua; Wang, Qin; Lin, Lu; Tian, Li			Integrating the "best" evidence into nursing of venous thromboembolism in ICU patients using the i-PARIHS framework	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; KNOWLEDGE TRANSLATION; HEALTH-CARE; IMPLEMENTATION; MORTALITY	Objectives To explore how to integrate the "best" practice into nursing of venous thromboembolism (VTE) based on the integrated-Promoting Action on Research Implementation in Health Services (i-PARIHS) framework. Methods A mixed-methods design was used. A steering group for clinical evidence implementation (EI) was established to conduct pre-implementation baseline surveys, a thorough analysis of the evidence, and an analysis of the survey results. The hindering and enabling factors associated with the clinical implementation of the evidence were analysed based on the three core elements of i-PARIHS, to formulate the clinical implementation plan for VTE nursing evidence. On-site expert reviews and focus group interviews were used to evaluate the feasibility of the draft plan, make adjustments, and finalize the evidence-based practice plan, which was then put into practice and evaluated. Results A new nursing process, a health education manual and a nursing quality checklist on VTE has been established and proved to be appropriate through the implementation. Compliance with evidence related to VTE nursing increased significantly in the two units, with better compliance in unit B than unit A. The knowledge, attitude and behaviour scores for VTE nursing increased substantially in both nurses and patients. Conclusion The EI programme of incorporating the "best" evidence on VTE nursing into clinical practice using the i-PARIHS framework demonstrated feasibility, appropriateness and effectiveness and could serve as a reference.	[Qin, Xia; Li, Xuehua; Wang, Qin] First Peoples Hosp Kunshan, Suzhou, Peoples R China; [Yu, Pin; Lin, Lu; Tian, Li] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China; [Li, Huiling; Lin, Lu; Tian, Li] Soochow Univ, Med Coll, Sch Nursing, Suzhou, Peoples R China; [Hu, Yan] Fudan Univ, Sch Nursing, Shanghai, Peoples R China	Soochow University - China; Soochow University - China; Fudan University	Lin, L; Tian, L (corresponding author), Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China.; Lin, L; Tian, L (corresponding author), Soochow Univ, Med Coll, Sch Nursing, Suzhou, Peoples R China.	linlu@suda.edu.cn; tianlisz@suda.edu.cn		, Li/0000-0002-6243-6331; Li, Huiling/0000-0001-9025-436X	Humanity and Social Science Youth Foundation of Ministry of Education of China [18YJCZH164]	Humanity and Social Science Youth Foundation of Ministry of Education of China	This study was funded by the Humanity and Social Science Youth Foundation of Ministry of Education of China (Project No. 18YJCZH164).	Aitken LM, 2011, AUST CRIT CARE, V24, P244, DOI 10.1016/j.aucc.2011.01.004; Bernardi R, 2017, J ASSOC INF SYST, V18, P81, DOI 10.17705/1jais.00451; BOX GEP, 1986, TECHNOMETRICS, V28, P11, DOI 10.2307/1269599; Bucknall Tracey, 2006, J Healthc Qual, V28, P12; Cook D, 2005, CRIT CARE MED, V33, P1565, DOI 10.1097/01.CCM.0000171207.95319.B2; Eccles M, 2005, J CLIN EPIDEMIOL, V58, P107, DOI 10.1016/j.jclinepi.2004.09.002; Essam A, 2011, ANN THORAC MED, V6, P193, DOI 10.4103/1817-1737.84772; Estabrooks CA, 2006, J CONTIN EDUC HEALTH, V26, P25, DOI 10.1002/chp.48; Flottorp SA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-35; Gill H, 2016, IMPLEMENT SCI, V11, P33; Greenhalgh T, 2004, SPREAD GOOD IDEAS SY; Harvey G, 2002, J ADV NURS, V37, P577, DOI 10.1046/j.1365-2648.2002.02126.x; Harvey G., 2015, IMPLEMENTING EVIDENC; Harvey G, 2015, INT J HEALTH POLICY, V4, P123, DOI 10.15171/ijhpm.2015.54; Ho KM, 2011, CHEST, V140, P1436, DOI 10.1378/chest.11-1444; HUANG S, 2017, CHIN J EVID BASED PE, DOI DOI 10.1186/S13018-017-0605-0; Kitson A, 1998, QUAL HEALTH CARE, V7, P149, DOI 10.1136/qshc.7.3.149; Kitson AL, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-1; Kitson AL, 2016, J NURS SCHOLARSHIP, V48, P294, DOI 10.1111/jnu.12206; Palinkas LA, 2011, ADM POLICY MENT HLTH, V38, P44, DOI 10.1007/s10488-010-0314-z; Pannucci CJ, 2014, J AM COLL SURGEONS, V218, P898, DOI 10.1016/j.jamcollsurg.2014.01.046; Peters DH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6753; Qin X., 2017, IMPLEMENTATION EVIDE; Rycroft-Malone J, 2004, J ADV NURS, V47, P81, DOI 10.1111/j.1365-2648.2004.03068.x; Rycroft-Malone J, 2002, QUAL SAF HEALTH CARE, V11, P174, DOI 10.1136/qhc.11.2.174; Rycroft-Malone J, 2007, NURS RES, V56, pS78, DOI 10.1097/01.NNR.0000280631.48407.9b; Rycroft-Malone J, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-28; Tabak RG, 2012, AM J PREV MED, V43, P337, DOI 10.1016/j.amepre.2012.05.024; Tian L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187257; Titchen A., 2018, IMPLEMENTATION SCI, V3, P1; Ullrich PM, 2014, WORLDV EVID-BASED NU, V11, P26, DOI 10.1111/wvn.12016; Waltz C. F., 2016, MEASUREMENT NURSING, DOI DOI 10.1891/9780826170620	32	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237342	10.1371/journal.pone.0237342	http://dx.doi.org/10.1371/journal.pone.0237342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2EP	32760163	gold, Green Published			2022-12-26	WOS:000561027200022
J	Badran, A; tul-Wahab, A; Zafar, H; Mohammad, N; Imad, R; Khan, MA; Baydoun, E; Choudhary, MI				Badran, Adnan; tul-Wahab, Atia; Zafar, Humaira; Mohammad, Nayab; Imad, Rehan; Ashfaq Khan, Mariam; Baydoun, Elias; Choudhary, M. Iqbal			Antipsychotics drug aripiprazole as a lead against breast cancer cell line (MCF-7) in vitro	PLOS ONE			English	Article								Breast cancer is the second leading cause of death among women globally. The existing treatment options for breast cancer are largely associated with severe toxicities, and lower efficacies. Therefore, there is an urgent need for the development of non-toxic effective drugs against breast cancer. For this purpose, drug repositioning strategy was used to evaluate the anti-cancer potential of a library of heterocyclic drugs. The major advantage of drug repurposing is that the pharmacokinetic, pharmacodynamic, and toxicity profiles of drugs are well documented. In the current study, we screened 97 drugs of different chemical classes, and among them aripiprazole, an antipsychotic drug, was found to be sufficiently active against breast cancer cell line MCF-7. Aripiprazole showed a cytotoxicity (IC50= 12.1 +/- 0.40 mu M) to MCF-7 cells, comparable to the standard anticancer drug doxorubicin (IC50= 1.25 +/- 0.34 mu M). Aripiprazole was also found to be active against other cancer cell lines, including MDA-MB-231 (IC50= 19.83 +/- 0.27 mu M), AU565 (IC50= 18.02 +/- 0.44 mu M), and BT-474 (IC50= 36.42 +/- 0.12 mu M). Aripiprazole significantly inhibited the cell cycle progression at subG(0)G(1)phase, and enhanced apoptosis in MCF-7 breast cancer cells. The drug was also able to significantly increase the nuclear condensation, and modulated the expression of certain genes involved in breast cancer, such as caspases 3, and 9, BAK-1, C-MYC, BCL2L1, BCL-10, and BCL-2. Further studies are needed to explore the effect of aripiprazole on intrinsic and extrinsic pathways of apoptosis in cancer cells.	[Badran, Adnan] Univ Petra, Fac Pharm & Med Sci, Amman, Jordan; [tul-Wahab, Atia; Zafar, Humaira; Mohammad, Nayab; Imad, Rehan; Ashfaq Khan, Mariam; Choudhary, M. Iqbal] Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Int Ctr Chem & Biol Sci, Karachi, Pakistan; [Baydoun, Elias] Amer Univ Beirut, Dept Biol, Beirut, Lebanon; [Choudhary, M. Iqbal] Univ Karachi, HEJ Res Inst Chem, Int Ctr Chem & Biol Sci, Karachi, Pakistan; [Choudhary, M. Iqbal] Univ Airlangga, Fac Sci & Technol, Dept Chem, Surabaya, Indonesia	Petra University; University of Karachi; American University of Beirut; University of Karachi; Airlangga University	Choudhary, MI (corresponding author), Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Int Ctr Chem & Biol Sci, Karachi, Pakistan.; Choudhary, MI (corresponding author), Univ Karachi, HEJ Res Inst Chem, Int Ctr Chem & Biol Sci, Karachi, Pakistan.; Choudhary, MI (corresponding author), Univ Airlangga, Fac Sci & Technol, Dept Chem, Surabaya, Indonesia.	iqbal.choudhary@iccs.edu	Choudhary, M. Iqbal/C-8633-2012	Choudhary, M. Iqbal/0000-0001-5356-3585	University of Petra, Amman, Jordan under project entitled, "Synthesis of new compounds of breast cancer treatment by targeting aromatase"; URB of the American University of Beirut	University of Petra, Amman, Jordan under project entitled, "Synthesis of new compounds of breast cancer treatment by targeting aromatase"; URB of the American University of Beirut	Yes, this is funded. Authors acknowledge the enabling role of the University of Petra, Amman, Jordan, through a financial support under project entitled, "Synthesis of new compounds of breast cancer treatment by targeting aromatase". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Authors acknowledge the enabling role of the University of Petra, Amman, Jordan, through a financial support under project entitled, "Synthesis of new compounds of breast cancer treatment by targeting aromatase". EB would like to thank the URB of the American University of Beirut for financial support.	Al Dhaheri Y., 2013, PLOS ONE, V8; American Cancer Society, 2019, BREAST CANC FACTS FI; [Anonymous], 2017, BREAST CANC FACTS FI; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; Casey AB, 2017, ACS CHEM NEUROSCI, V8, P1135, DOI 10.1021/acschemneuro.7b00087; Chen XP, 2007, DRUG DISCOV THER, V1, P23; Cui JH, 2017, ONCOTARGET, V8, P1007, DOI 10.18632/oncotarget.13537; Das S., 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.004664123077516, DOI 10.1371/JOURNAL.PONE.004664123077516]; Di Sciascio G, 2015, NEUROPSYCH DIS TREAT, V11, P2635, DOI 10.2147/NDT.S88117; Dilly SJ, 2017, CANCER LETT, V393, P16, DOI 10.1016/j.canlet.2017.01.042; EICHENBERGER T, 1989, CLIN INVEST MED, V12, P363; Etti IC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182357; JULIUS MH, 1972, P NATL ACAD SCI USA, V69, P1934, DOI 10.1073/pnas.69.7.1934; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; Kim S. H., 2014, P ANN M AM ASS CANC, V74; Ko Eun-Yi, 2015, J Cancer Prev, V20, P223, DOI 10.15430/JCP.2015.20.4.223; Koohpar ZK, 2015, IRAN J CANCER PREV, V8, DOI 10.17795/ijcp2331; Lecoeur H, 2002, EXP CELL RES, V277, P1, DOI 10.1006/excr.2002.5537; Lekka E., 2012, DRUG DISCOVERY TODAY, V8, P103, DOI DOI 10.1016/J.DDSTR.2011.06.005; Leo CP, 2020, NAT REV DRUG DISCOV, V19, P11, DOI 10.1038/d41573-019-00201-w; Manoharan KP, 2007, MED CHEM, V3, P121; O'Connor KA, 2005, NAT REV DRUG DISCOV, V4, P1005, DOI 10.1038/nrd1900; Shim JS, 2014, INT J BIOL SCI, V10, P654, DOI 10.7150/ijbs.9224; Siddiqui RA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-418; Sobis J, 2015, PHARMACOL REP, V67, P353, DOI 10.1016/j.pharep.2014.09.007; Tong CWS, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00227; Ukaji T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137663; Vega-Avila Elisa, 2011, Proc West Pharmacol Soc, V54, P10	28	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0235676	10.1371/journal.pone.0235676	http://dx.doi.org/10.1371/journal.pone.0235676			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32746451	Green Published, gold			2022-12-26	WOS:000560006800052
J	Bang, S; Kim, H; Jang, K; Paik, SS; Shin, SJ				Bang, Seongsik; Kim, Hyunsung; Jang, Kiseok; Paik, Seung Sam; Shin, Su-Jin			The loss of nuclear expression of single-stranded DNA binding protein 2 of gastric adenocarcinoma and its prognostic role: Analysis of molecular subtype	PLOS ONE			English	Article							PROMOTER METHYLATION; TUMOR-SUPPRESSOR; CANCER INCIDENCE; SSBP2; GENE; DIFFERENTIATION; GROWTH; KOREA; LDB1	Single-stranded DNA binding protein 2 (SSBP2) is ubiquitously expressed, with several studies reporting it to be a tumor suppressor. We investigated SSBP2 expression and its clinicopathological significance in gastric cancer. SSBP2 expression was examined by immunohistochemistry in 539 gastric cancer sections. The cases were divided into three subtypes, namely, Epstein-Barr virus-associated (EBV), microsatellite unstable, and others (microsatellite stable and EBV negative), based on the molecular classification of The Cancer Genome Atlas (TCGA). Cases were also divided into two subgroups according to the amplification status of human epidermal growth factor receptor 2 (HER2). Most cases showed SSBP2 positivity, and only 24 (4.5%) cases displayed negative nuclear expression. Loss of nuclear expression correlated significantly with high pT category (P= 0.001), nodal metastasis (P= 0.002), and stage of progression (P= 0.005), with no correlation between molecular characteristics and SSBP2 expression. All HER2 amplification cases displayed positive SSBP2 expression. Negative SSBP2 cases showed significantly shorter recurrence-free survival (RFS) compared to positive SSBP2 cases (P= 0.008). Loss of nuclear expression of SSBP2 was significantly associated with shorter RFS in the microsatellite stable and EBV negative groups (P= 0.002), as well as the HER2 negative group (P= 0.007). However, there were no statistically significant differences in multivariate analyses. Loss of nuclear expression of SSBP2 was a poor prognostic factor, associated with stage of progression and recurrence, and showed no significant difference in molecular characteristics, including TCGA subtype and HER2 status.	[Bang, Seongsik; Kim, Hyunsung; Jang, Kiseok; Paik, Seung Sam] Hanyang Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Shin, Su-Jin] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Pathol, Seoul, South Korea	Hanyang University; Yonsei University; Yonsei University Health System	Shin, SJ (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Pathol, Seoul, South Korea.	charm@yuhs.ac			National Research Foundation of Korea(NRF) - Korea government(MSIT) [2017R1C1B5017930]	National Research Foundation of Korea(NRF) - Korea government(MSIT)	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIT) (2017R1C1B5017930).	Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Boku N, 2014, GASTRIC CANCER, V17, P1, DOI 10.1007/s10120-013-0252-z; Brait M, 2017, ONCOTARGET, V8, P15431, DOI 10.18632/oncotarget.14873; Brait M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070878; Caputo L, 2015, CELL STEM CELL, V17, P287, DOI 10.1016/j.stem.2015.08.007; Castro P, 2002, GENOMICS, V80, P78, DOI 10.1006/geno.2002.6805; Dey-Guha I, 2009, INT J BIOL SCI, V5, P686; Eom BW, 2018, CANCER RES TREAT, V50, P1343, DOI 10.4143/crt.2017.464; Garcia SA, 2016, ONCOTARGET, V7, P84258, DOI 10.18632/oncotarget.12481; Hu B, 2012, J GASTROINTEST ONCOL, V3, P251, DOI 10.3978/j.issn.2078-6891.2012.021; Huang YP, 2011, INT J CANCER, V128, P2261, DOI 10.1002/ijc.25569; Jung KW, 2017, CANCER RES TREAT, V49, P306, DOI 10.4143/crt.2017.130; Kagohara LT, 2015, FUTURE ONCOL, V11, P233, DOI [10.2217/fon.14.165, 10.2217/FON.14.165]; KIM H, 2018, BMC CANC, V0018, DOI DOI 10.1186/S12885-018-5158-Z30541499; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Li J, 2014, J IMMUNOL, V193, P4654, DOI 10.4049/jimmunol.1300337; Liang H, 2005, ONCOGENE, V24, P2625, DOI 10.1038/sj.onc.1208167; Liu JW, 2008, CLIN CANCER RES, V14, P3754, DOI 10.1158/1078-0432.CCR-07-4763; Maldonado L, 2014, J UROLOGY, V192, P1542, DOI 10.1016/j.juro.2014.04.082; Michailidi C, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/597164; Park SC, 2013, GUT LIVER, V7, P385, DOI 10.5009/gnl.2013.7.4.385; Sohn BH, 2017, CLIN CANCER RES, V23, P4441, DOI 10.1158/1078-0432.CCR-16-2211; Song ZY, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317714626; Wang Y, 2010, ONCOGENE, V29, P3044, DOI 10.1038/onc.2010.78	24	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236896	10.1371/journal.pone.0236896	http://dx.doi.org/10.1371/journal.pone.0236896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745119	gold, Green Published			2022-12-26	WOS:000560006800011
J	Diem, K; Fauler, M; Fois, G; Hellmann, A; Winokurow, N; Schumacher, S; Kranz, C; Frick, M				Diem, Kathrin; Fauler, Michael; Fois, Giorgio; Hellmann, Andreas; Winokurow, Natalie; Schumacher, Stefan; Kranz, Christine; Frick, Manfred			Mechanical stretch activates piezo1 in caveolae of alveolar type I cells to trigger ATP release and paracrine stimulation of surfactant secretion from alveolar type II cells	FASEB JOURNAL			English	Article						lung; mechanobiology; piezo-1; purinergic signaling	DEFORMATION-INDUCED INJURY; LUNG EPITHELIAL-CELLS; CA2+ ENTRY; IMMOBILIZATION MATRIX; VESICULAR P2X(4); EXOCYTOSIS; STRAIN; RECEPTORS; POLY(BENZOXAZINE); PATHOPHYSIOLOGY	Secretion of pulmonary surfactant in the alveoli of the lungs is essential to maintain lung function. Stretching of alveoli during lung inflation is the main trigger for surfactant secretion. Yet, the molecular mechanisms how mechanical distension of alveoli results in surfactant secretion are still elusive. The alveolar epithelium consists of alveolar epithelial type I (ATI) and surfactant secreting type II (ATII) cells. ATI, but not ATII cells, express caveolae, small plasma membrane invaginations that can respond to plasma membrane stresses and serve mechanotransductive roles. Within this study, we investigated the role of caveolae as mechanosensors in the alveolus. We generated a human caveolin-1 knockout ATI cell (hAELVi(cav-/-)) using CRISPR/Cas9. Wildtype (hAELVi(wt)) and hAELVi(cav-/-)cells grown on flexible membranes responded to increasing stretch amplitudes with rises in intracellular Ca2+. The response was less frequent and started at higher stretch amplitudes in hAELVi(cav-/-)cells. Stretch-induced Ca2+-signals depended on Ca2+-entry via piezo1 channels, localized within caveolae in hAELVi(wt)and primary ATI cells. Ca2+-entry via piezo1 activated pannexin-1 hemichannels resulting in ATP release from ATI cells. ATP release was reduced in hAELVi(cav-/-)cells. In co-cultures resembling the alveolar epithelium, released ATP stimulated Ca(2+)signals and surfactant secretion from neighboring ATII cells when co-cultured with hAELVi(wt)but not hAELVi(cav-/-)cells. In summary, we propose that caveolae in ATI cells are mechanosensors within alveoli regulating stretch-induced surfactant secretion from ATII cells.	[Diem, Kathrin; Fauler, Michael; Fois, Giorgio; Frick, Manfred] Ulm Univ, Inst Gen Physiol, Albert Einstein Allee 11, D-89081 Ulm, Germany; [Hellmann, Andreas; Kranz, Christine] Ulm Univ, Inst Analyt & Bioanalyt Chem, Ulm, Germany; [Winokurow, Natalie; Schumacher, Stefan] Ulm Univ, Inst Mol & Cellular Anat, Ulm, Germany	Ulm University; Ulm University; Ulm University	Frick, M (corresponding author), Ulm Univ, Inst Gen Physiol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	manfred.frick@uni-ulm.de	Frick, Manfred/E-1374-2012; Fois, Giorgio/AAD-5657-2022	Frick, Manfred/0000-0002-4763-1104; Fois, Giorgio/0000-0001-5414-1149	Deutsche Forschungsgemeinschaft [278012962, 251293561, 175083951]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft, Grant/Award Number: 278012962, 251293561 and 175083951	Andreeva AV, 2007, AM J PHYSIOL-LUNG C, V293, pL259, DOI 10.1152/ajplung.00112.2007; Andronescu C, 2014, ELECTROCHEM COMMUN, V41, P12, DOI 10.1016/j.elecom.2014.01.015; Arold SP, 2009, AM J PHYSIOL-LUNG C, V296, pL574, DOI 10.1152/ajplung.90454.2008; Ashino Y, 2000, AM J PHYSIOL-LUNG C, V279, pL5, DOI 10.1152/ajplung.2000.279.1.L5; Bachofen H, 2001, COMP BIOCHEM PHYS A, V129, P183, DOI 10.1016/S1095-6433(01)00315-4; Belete HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027469; Belete HA, 2010, CELL PHYSIOL BIOCHEM, V25, P71, DOI 10.1159/000272052; Bove PF, 2010, J BIOL CHEM, V285, P34939, DOI 10.1074/jbc.M110.162933; Boyce AKJ, 2015, BIOCHEM J, V470, P319, DOI 10.1042/BJ20141551; Brunello CA, 2016, SCI REP-UK, V6, DOI 10.1038/srep30498; Brunschweiger A, 2006, CURR MED CHEM, V13, P289, DOI 10.2174/092986706775476052; Campbell L, 1999, BIOCHEM BIOPH RES CO, V262, P744, DOI 10.1006/bbrc.1999.1280; Cheng JPX, 2016, TRENDS CELL BIOL, V26, P177, DOI 10.1016/j.tcb.2015.10.010; Chiu YH, 2018, J GEN PHYSIOL, V150, P19, DOI 10.1085/jgp.201711888; Coste B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8223; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; DeLalio LJ, 2019, J BIOL CHEM, V294, P6940, DOI 10.1074/jbc.RA118.006982; DeLalio LJ, 2018, ARTERIOSCL THROM VAS, V38, P2065, DOI 10.1161/ATVBAHA.118.311290; Dietl P, 2004, BIOL NEONATE, V85, P299, DOI 10.1159/000078176; Dietl P, 2001, NEWS PHYSIOL SCI, V16, P239; Dietl P, 2012, CELL CALCIUM, V52, P296, DOI 10.1016/j.ceca.2012.04.010; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Edwards YS, 1999, FEBS LETT, V448, P127, DOI 10.1016/S0014-5793(99)00357-9; Edwards YS, 2001, COMP BIOCHEM PHYS A, V129, P245, DOI 10.1016/S1095-6433(01)00321-X; Fernandez-Rojo MA, 2013, CELL REP, V4, P238, DOI 10.1016/j.celrep.2013.06.017; Fois G, 2018, J GEN PHYSIOL, V150, P277, DOI 10.1085/jgp.201711870; Fois G, 2012, BIOMECH MODEL MECHAN, V11, P959, DOI 10.1007/s10237-011-0365-4; Frick M, 2004, AM J PHYSIOL-LUNG C, V286, pL210, DOI 10.1152/ajplung.00332.2003; Frick M, 2001, AM J RESP CELL MOL, V25, P306, DOI 10.1165/ajrcmb.25.3.4493; Furuya K, 2016, AM J PHYSIOL-LUNG C, V311, pL956, DOI 10.1152/ajplung.00425.2015; Gehi R, 2011, J BIOL CHEM, V286, P27639, DOI 10.1074/jbc.M111.260711; Gerstmair A, 2009, J APPL PHYSIOL, V107, P613, DOI 10.1152/japplphysiol.00012.2009; Gervasio OL, 2011, J CELL SCI, V124, P3581, DOI 10.1242/jcs.084376; Godecke S, 2012, AM J PHYSIOL-CELL PH, V302, pC915, DOI 10.1152/ajpcell.00283.2010; Gosens R, 2008, CURR MOL MED, V8, P741, DOI 10.2174/156652408786733720; Gunther A, 1999, EUR RESPIR J, V14, P565, DOI 10.1034/j.1399-3003.1999.14c14.x; Haller T, 1999, AM J PHYSIOL-LUNG C, V277, pL893, DOI 10.1152/ajplung.1999.277.5.L893; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Isakson BE, 2003, AM J RESP CELL MOL, V29, P552, DOI 10.1165/rcmb.2002-0281OC; Isakson BE, 2001, AM J PHYSIOL-LUNG C, V280, pL221, DOI 10.1152/ajplung.2001.280.2.L221; Isshiki M, 2003, TRAFFIC, V4, P717, DOI 10.1034/j.1600-0854.2003.00130.x; Knudsen L, 2018, HISTOCHEM CELL BIOL, V150, P661, DOI 10.1007/s00418-018-1747-9; Kuehn A, 2016, ALTEX-ALTERN ANIM EX, V33, P251, DOI 10.14573/altex.1511131; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Lazarowski ER, 2011, ADV PHARMACOL, V61, P221, DOI 10.1016/B978-0-12-385526-8.00008-4; LAZAROWSKI ER, 1995, BRIT J PHARMACOL, V116, P1619, DOI 10.1111/j.1476-5381.1995.tb16382.x; Le Lay S, 2005, BBA-MOL CELL RES, V1746, P322, DOI 10.1016/j.bbamcr.2005.06.001; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Lopez-Rodriguez E, 2016, AM J PHYSIOL-LUNG C, V310, pL1260, DOI 10.1152/ajplung.00065.2016; Martin C, 1996, EUR RESPIR J, V9, P2479, DOI 10.1183/09031936.96.09122479; Mendoza-Topaz C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205306; Miklavc P, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00171; Miklavc P, 2011, P NATL ACAD SCI USA, V108, P14503, DOI 10.1073/pnas.1101039108; Miklavc P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010982; Mishra A, 2011, J CELL SCI, V124, P657, DOI 10.1242/jcs.066977; Moreno-Vicente R, 2018, CELL REP, V25, P1622, DOI 10.1016/j.celrep.2018.10.024; Nassoy P, 2012, TRENDS CELL BIOL, V22, P381, DOI 10.1016/j.tcb.2012.04.007; Newman GR, 1999, CELL TISSUE RES, V295, P111, DOI 10.1007/s004410051217; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Parton RG, 2018, CURR BIOL, V28, pR402, DOI 10.1016/j.cub.2017.11.075; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Patel AS, 2005, AM J PHYSIOL-LUNG C, V289, pL489, DOI 10.1152/ajplung.00074.2005; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; Perlman CE, 2007, J APPL PHYSIOL, V103, P1037, DOI 10.1152/japplphysiol.00160.2007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rausch V, 2019, CURR BIOL, V29, P242, DOI 10.1016/j.cub.2018.11.066; Ravasio A, 2011, AM J PHYSIOL-CELL PH, V300, pC1456, DOI 10.1152/ajpcell.00427.2010; Roan E, 2011, AM J PHYSIOL-LUNG C, V301, pL625, DOI 10.1152/ajplung.00105.2011; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seminario-Vidal L, 2009, J BIOL CHEM, V284, P20638, DOI 10.1074/jbc.M109.004762; Sengupta P, 2008, J CELL SCI, V121, P1363, DOI 10.1242/jcs.020081; Shvets E, 2014, CURR OPIN CELL BIOL, V29, P99, DOI 10.1016/j.ceb.2014.04.011; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Steffen L, 2017, AM J PHYSIOL-LUNG C, V313, pL313, DOI 10.1152/ajplung.00033.2017; Tan JJ, 2020, AM J PHYSIOL-LUNG C, V318, pL49, DOI 10.1152/ajplung.00321.2019; Thompson MA, 2014, EXPERT REV RESP MED, V8, P111, DOI 10.1586/17476348.2014.855610; Torday JS, 2002, AM J PHYSIOL-LUNG C, V283, pL130, DOI 10.1152/ajplung.00380.2001; Tschumperlin DJ, 2000, AM J RESP CRIT CARE, V162, P357, DOI 10.1164/ajrccm.162.2.9807003; Tschumperlin DJ, 1999, J APPL PHYSIOL, V86, P2026, DOI 10.1152/jappl.1999.86.6.2026; Tschumperlin DJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1173, DOI 10.1152/ajplung.1998.275.6.L1173; Waters CM, 2012, COMPR PHYSIOL, V2, P1, DOI 10.1002/cphy.c100090; WIRTZ HRW, 1990, SCIENCE, V250, P1266, DOI 10.1126/science.2173861; Yamamoto K, 2011, J CELL SCI, V124, P3477, DOI 10.1242/jcs.087221; Ziller C, 2017, CHEMELECTROCHEM, V4, P864, DOI 10.1002/celc.201600765	90	35	35	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12785	12804		10.1096/fj.202000613RRR	http://dx.doi.org/10.1096/fj.202000613RRR		AUG 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32744386	hybrid, Green Published			2022-12-26	WOS:000557254400001
J	Chen, Y; Wang, YF; Liu, X; Xu, J; Zhang, MQ				Chen, Yong; Wang, Yunfei; Liu, Xin; Xu, Jian; Zhang, Michael Q.			Model-based analysis of chromatin interactions from dCas9-Based CAPTURE-3C-seq	PLOS ONE			English	Article							CHROMOSOME CONFORMATION; 3D GENOME; FUNCTIONAL-ORGANIZATION; TRANSCRIPTION; RESOLUTION; PRINCIPLES; DOMAINS; 5C	Deciphering long-range chromatin interactions is critical for understanding temporal and tissue-specific gene expression regulated by cis- and trans-acting factors. By combining the chromosome conformation capture (3C) and biotinylated dCas9 system, we previously established a method CAPTURE-3C-seq to unbiasedly identify high-resolution and locus-specific long-range DNA interactions. Here we present the statistical model and a flexible pipeline, C3S, for analysing CAPTURE-3C-seq or similar experimental data from raw sequencing reads to significantly interacting chromatin loci. C3S provides all steps for data processing, quality control and result illustration. It can automatically define the bin size based on the binding peak of the dCas9-targeted regions. Furthermore, it supports the analysis of intra- and inter-chromosomal interactions for different mammalian cell types. We successfully applied C3S across multiple datasets in human K562 cells and mouse embryonic stem cells (mESC) for detecting known and new chromatin interactions at multiple scales. Integrative and topological analysis of the interacted loci at the human beta-globin gene cluster provides new insights into mechanisms in developmental gene regulation and network structure in local chromosomal architecture. Furthermore, computational results in mESCs reveal a role for chromatin interacting loops between enhancers and promoters in regulating alternative transcripts of the pluripotency gene OCT4.	[Chen, Yong] Rowan Univ, Dept Mol & Cellular Biosci, Glassboro, NJ 08028 USA; [Chen, Yong; Zhang, Michael Q.] Univ Texas Dallas, Ctr Syst Biol, Dept Biol Sci, Richardson, TX 75083 USA; [Wang, Yunfei] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Liu, Xin; Xu, Jian] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr Res Inst, Dept Pediat, Dallas, TX 75390 USA; [Zhang, Michael Q.] Tsinghua Univ, MOE Key Lab Bioinformat, Beijing, Peoples R China; [Zhang, Michael Q.] Tsinghua Univ, Bioinformat Div & Ctr Synthet & Syst Biol, BNRist, Beijing, Peoples R China; [Zhang, Michael Q.] Tsinghua Univ, Dept Automat, Beijing, Peoples R China	Rowan University; University of Texas System; University of Texas Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Tsinghua University; Tsinghua University; Tsinghua University	Chen, Y (corresponding author), Rowan Univ, Dept Mol & Cellular Biosci, Glassboro, NJ 08028 USA.; Chen, Y; Zhang, MQ (corresponding author), Univ Texas Dallas, Ctr Syst Biol, Dept Biol Sci, Richardson, TX 75083 USA.; Zhang, MQ (corresponding author), Tsinghua Univ, MOE Key Lab Bioinformat, Beijing, Peoples R China.; Zhang, MQ (corresponding author), Tsinghua Univ, Bioinformat Div & Ctr Synthet & Syst Biol, BNRist, Beijing, Peoples R China.; Zhang, MQ (corresponding author), Tsinghua Univ, Dept Automat, Beijing, Peoples R China.	chenyong@rowan.edu; Michael.zhang@utdallas.edu		CHEN, YONG/0000-0001-6827-4321	NIH [R01MH109616]; Cecil H. and Ida Green Endowment; SKRDPC grant [2017YFA0505503]; American Heart Association [18POST34060219]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cecil H. and Ida Green Endowment; SKRDPC grant; American Heart Association(American Heart Association)	MQZ was supported by the NIH grant R01MH109616, the Cecil H. and Ida Green Endowment, and the SKR&DPC grant (2017YFA0505503). XL was supported by the American Heart Association postdoctoral fellowship (18POST34060219).	Arzate-Mejia RG, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.137729; Babu D, 2015, NUCLEUS-PHILA, V6, P382, DOI 10.1080/19491034.2015.1106676; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Davies JOJ, 2016, NAT METHODS, V13, P74, DOI [10.1038/NMETH.3664, 10.1038/nmeth.3664]; de Laat W, 2007, CURR OPIN GENET DEV, V17, P456, DOI 10.1016/j.gde.2007.07.009; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Haraksingh RR, 2013, J MOL BIOL, V425, P3970, DOI 10.1016/j.jmb.2013.07.015; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Huang JL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03279-9; Huang JL, 2016, DEV CELL, V36, P9, DOI 10.1016/j.devcel.2015.12.014; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Jansma JM, 2013, J NEUROSCI METH, V215, P190, DOI 10.1016/j.jneumeth.2013.02.017; Jian X, 2018, P NATL ACAD SCI USA, V115, pE4633, DOI 10.1073/pnas.1803146115; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li XW, 2017, NAT PROTOC, V12, P899, DOI 10.1038/nprot.2017.012; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Liu XP, 2018, J CELL PHYSIOL, V233, P5468, DOI 10.1002/jcp.26411; Liu Xin, 2018, Curr Protoc Mol Biol, V123, pe64, DOI 10.1002/cpmb.64; Liu X, 2017, CELL, V170, P1028, DOI 10.1016/j.cell.2017.08.003; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Maass PG, 2019, J CELL BIOL, V218, P27, DOI 10.1083/jcb.201806052; Monahan K, 2019, NATURE, V565, P448, DOI 10.1038/s41586-018-0845-0; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI 10.1038/nmeth.3999; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Quinodoz SA, 2018, CELL, V174, P744, DOI 10.1016/j.cell.2018.05.024; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sandhu KS, 2012, CELL REP, V2, P1207, DOI 10.1016/j.celrep.2012.09.022; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Spielmann M, 2018, NAT REV GENET, V19, P453, DOI 10.1038/s41576-018-0007-0; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; van Berkum NL, 2009, METHODS MOL BIOL, V567, P189, DOI 10.1007/978-1-60327-414-2_13; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zeitz MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073974; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Xin, 2012, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1010s40	47	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236666	10.1371/journal.pone.0236666	http://dx.doi.org/10.1371/journal.pone.0236666			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735574	Green Published, gold			2022-12-26	WOS:000569367100038
J	Martin-Mora, E; Ellis, S; Page, LM				Martin-Mora, Elizabeth; Ellis, Shari; Page, Lawrence M.			Use of web-based species occurrence information systems by academics and government professionals	PLOS ONE			English	Article							ECOLOGICAL DATA; BIODIVERSITY INFORMATION; OBSERVATIONAL DATA; SEEKING BEHAVIOR; RATING-SCALES; MANN-WHITNEY; T-TEST; SCIENTISTS; SCIENCE; NEEDS	Web-based information systems designed to increase access to species occurrence data for use in research and natural resource decision-making have become more prevalent over the past few decades. The effectiveness of these systems depends on their usability and extent of use by their intended audiences. We conducted an online survey of academics and government professionals in the United States to compare their species occurrence data needs and their perceptions and use of web-based species occurrence information systems. Our results indicate that although views and perceptions held by academics and government professionals about the importance, usefulness, and ease of use of these information systems tend to be similar, there were differences in their use of species occurrence data and web-based species occurrence information systems. The baseline information obtained in this study will help inform future directions for improvements in species occurrence information systems.	[Martin-Mora, Elizabeth] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA; [Ellis, Shari; Page, Lawrence M.] Univ Florida, iDigBio, Gainesville, FL USA; [Ellis, Shari; Page, Lawrence M.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Martin-Mora, Elizabeth] US Geol Survey, Gainesville, FL 32653 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of the Interior; United States Geological Survey	Martin-Mora, E (corresponding author), Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA.; Martin-Mora, E (corresponding author), US Geol Survey, Gainesville, FL 32653 USA.	elizabeth_martin@usgs.gov		Martin, Elizabeth/0000-0002-5808-6156	iDigBio by US National Science Foundation [DBI 1115210, DBI 1547229]	iDigBio by US National Science Foundation(National Science Foundation (NSF))	The authors received no specific funding for this work. EM participation in this study was self-funded and conducted on personal time outside of her primary employment with USGS. SE and LMP participation in this study was funded as part of iDigBio by US National Science Foundation awards DBI 1115210 and DBI 1547229.	AAPOR, 2016, ENCY SURVEY RES METH; ARINO AH, 2013, BIODIVERS INFORM, V8, P59; Arzberger P., 2004, DATA SCI J, V3, P135, DOI DOI 10.2481/DSJ.3.135; Baker K.S., 2015, INT J DIGITAL CURATI, V10, P110, DOI [10.2218/ijdc.v10i2.346, DOI 10.2218/IJDC.V10I2.346]; Ball-Damerow JE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215794; Berman KS, 2017, NEW PUB SCHOLARSHIP, P177; Bethlehem J, 2010, INT STAT REV, V78, P161, DOI 10.1111/j.1751-5823.2010.00112.x; Bingham H., 2017, RES IDEAS OUTCOMES, V3, DOI DOI 10.3897/RIO.3.E14059; Bird TJ, 2014, BIOL CONSERV, V173, P144, DOI 10.1016/j.biocon.2013.07.037; Bishara AJ, 2012, PSYCHOL METHODS, V17, P399, DOI 10.1037/a0028087; Bishop BW, 2019, P ASS INFORM SCI TEC, V56, P21, DOI [10.1002/pra2.4, DOI 10.1002/PRA2.4]; Bowker GC, 2000, SOC STUD SCI, V30, P643, DOI 10.1177/030631200030005001; Bradley J, 2010, INTEGR SER INFORM SY, V28, P19, DOI 10.1007/978-1-4419-6108-2_2; Canhos V.P., 2004, Biodiversity Informatics, V1, P1; Carlson KA, 2017, INTRO STAT ACTIVE LE, V656, P399, DOI [10.1037/a0028087, DOI 10.1037/A0028087]; Chapman A., 2005, PRINCIPLES METHODS D; Constable H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000309; CULLEN P, 1990, FRESHWATER BIOL, V24, P201, DOI 10.1111/j.1365-2427.1990.tb00319.x; Cullen P, 2001, KNOWL SEEK STRAT NAT; Curty RG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189288; Davis MLES, 2014, ENVIRON MANAGE, V53, P690, DOI 10.1007/s00267-014-0229-7; DeLone WH, 2003, J MANAGE INFORM SYST, V19, P9, DOI 10.1080/07421222.2003.11045748; Edwards JL, 2004, BIOSCIENCE, V54, P485; FAITH DP, 2013, BIODIVERS INFORM, V8, P41; Faniel I., 2017, CURATING RES DATA VO, P103; Faniel IM, 2016, J ASSOC INF SCI TECH, V67, P1404, DOI 10.1002/asi.23480; Faniel IM, 2010, COMPUT SUPP COOP W J, V19, P355, DOI 10.1007/s10606-010-9117-8; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; Fornwall Mark, 2000, Oceanography, V13, P31; Fricker R.D., 2002, FIELD METHOD, V14, P347, DOI DOI 10.1177/152582202237725; Gewin V., 2012, NATURE NEWS; Gould CC, 1991, INFORM NEEDS SCI ASS; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Gregory K, 2019, ARXIV190900464V2; Gregory K, 2019, J ASSOC INF SCI TECH, V70, P419, DOI 10.1002/asi.24165; Gregory KM, 2020, J INF SCI, V46, P459, DOI 10.1177/0165551519837182; Haywood BK, 2014, PUBLIC UNDERST SCI, V23, P92, DOI 10.1177/0963662513494560; Hemminger BM, 2007, J AM SOC INF SCI TEC, V58, P2205, DOI 10.1002/asi.20686; HERNER S, 1954, IND ENG CHEM, V46, P228, DOI 10.1021/ie50529a065; Hudson MAR, 2017, CONDOR, V119, P526, DOI 10.1650/CONDOR-17-62.1; IBM Corp. Released, 2017, IBM SPSS STAT WIND V; Indiana University Center for Postsecondary Research, 2016, CARN CLASS I HIGH ED; Jamali HR, 2010, ONLINE INFORM REV, V34, P282, DOI 10.1108/14684521011036990; Kim SS, 2005, DECISION SCI, V36, P187, DOI 10.1111/j.1540-5915.2005.00070.x; Kneisel AN, 2020, J GREAT LAKES RES, V46, P910, DOI 10.1016/j.jglr.2020.01.006; Krosnick JA, 1997, WILEY SER PROB STAT, P141; Krosnick JA, 2010, SURV RES METHODS-GER, V4, P61, DOI [10.18148/srm/2010.v4i1.2682, DOI 10.18148/SRM/2010.V4I1.2682, DOI 10.18148/SRM/2010]; Krosnick JA, 2010, HANDBOOK OF SURVEY RESEARCH, 2ND EDITION, P263; Kuruppu PU, 2006, J ACAD LIBR, V32, P609, DOI 10.1016/j.acalib.2006.08.001; La Salle J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0337; Landry R, 2003, PUBLIC ADMIN REV, V63, P192, DOI 10.1111/1540-6210.00279; Li L., 2010, C P; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Mahmood MA, 2000, INT J HUM-COMPUT ST, V52, P751, DOI 10.1006/ijhc.1999.0353; McHugh ML, 2013, BIOCHEM MEDICA, V23, P143, DOI 10.11613/BM.2013.018; Michener WK, 2015, ECOL INFORM, V29, P33, DOI 10.1016/j.ecoinf.2015.06.010; Millar MM, 2011, PUBLIC OPIN QUART, V75, P249, DOI 10.1093/poq/nfr003; Musnik N., 2012, P AM SOC INFORM SCI, V49, DOI [10.1002/meet.14504901088, DOI 10.1002/MEET.14504901088]; Nachar N, 2008, TUTOR QUANT METHODS, V4, P13, DOI 10.20982/tqmp.04.1.p013; National Science Board, 2014, SCI ENG IND 2014; National Science Foundation National Center for Science and Engineering Statistics, 2019, 19304 NSF; Nelson G, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2017.0391; Nicholas D, 2007, J ACAD LIBR, V33, P629, DOI 10.1016/j.acalib.2007.09.001; Niu X, 2012, J AM SOC INF SCI TEC, V63, P336, DOI 10.1002/asi.21669; Niu X, 2010, J AM SOC INF SCI TEC, V61, P869, DOI 10.1002/asi.21307; Oding-Smee L., 2007, NATURE, DOI [10.1038/news070508-7, DOI 10.1038/NEWS070508-7]; Osawa T, 2019, ECOL RES, V34, P446, DOI 10.1111/1440-1703.12023; Pasquetto I., 2017, DATA SCI J, V16, DOI [10.5334/dsj-2017-008, DOI 10.5334/DSJ-2017-008]; Peng L, 2008, MARK INTELL PLAN, V26, P649, DOI 10.1108/02634500810902884; Preston CC, 2000, ACTA PSYCHOL, V104, P1, DOI 10.1016/S0001-6918(99)00050-5; Puth MT, 2015, ANIM BEHAV, V102, P77, DOI 10.1016/j.anbehav.2015.01.010; Qualtrics, 2017, QUAL SURV SOFTW VERS; Ruscio J, 2008, J MOD APPL STAT METH, V7, P416; Scholes RJ, 2012, CURR OPIN ENV SUST, V4, P139, DOI 10.1016/j.cosust.2011.12.005; Schwartz D, 1987, CONCEPT TESTING TEST; Seavy NE, 2010, BIODIVERS CONSERV, V19, P1261, DOI 10.1007/s10531-009-9752-x; SKELTON B, 1973, J LIBR, V5, P138, DOI 10.1177/096100067300500205; Smithsonian Institution National Museum of Natural History, 2019, ENC LIF EOL; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; Somerville MM, 2013, COLLABORATIVE LIB, V5, P29; Sullivan BL, 2017, BIOL CONSERV, V208, P5, DOI 10.1016/j.biocon.2016.04.031; Tenopir C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134826; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; Thornhill I, 2016, BIOSCIENCE, V66, P720, DOI 10.1093/biosci/biw089; U.S. Geological Survey, 2019, BIOD INF SERV OUR NA; Underwood E., 2018, RES IDEAS OUTCOMES, V4, DOI DOI 10.3897/RIO.4.E28045; United States Census Bureau, 2020, CENS BUR REG DIV STA; Usman M., 2016, IOSR J MATH IOSR JM, V12, P22, DOI DOI 10.9790/5728-1204052227; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Vissers J, 2017, PHYTOKEYS, P37, DOI 10.3897/phytokeys.78.10936; Waide RB, 2017, BIOSCIENCE, V67, P1044, DOI 10.1093/biosci/bix117; Weber N.M., 2013, P AM SOC INFORM SCI, V49, P1, DOI [DOI 10.1002/MEET.14504901168, 10.1002/meet.14504901168]; Williams MD, 2009, J INF TECHNOL, V24, P1, DOI 10.1057/jit.2008.30; Yitzhaki M, 2004, J AM SOC INF SCI TEC, V55, P832, DOI 10.1002/asi.20026; Yocum HM, 2019, REG ENVIRON CHANGE, V19, P1187, DOI 10.1007/s10113-019-01474-y; Yoon A, 2019, ONLINE INFORM REV, V43, P1245, DOI 10.1108/OIR-01-2019-0014; Yoon A, 2017, J ASSOC INF SCI TECH, V68, P946, DOI 10.1002/asi.23730; Zibran M. F., 2007, CHI SQUARED TEST; Zimmerman A, 2007, INT J DIGIT LIBRARIE, V7, P5, DOI 10.1007/s00799-007-0015-8; Zimmerman AS, 2008, SCI TECHNOL HUM VAL, V33, P631, DOI 10.1177/0162243907306704; Zimmerman AS, 2003, THESIS; ZIMMERMAN DW, 1987, J EXP EDUC, V55, P171, DOI 10.1080/00220973.1987.10806451	102	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236556	10.1371/journal.pone.0236556	http://dx.doi.org/10.1371/journal.pone.0236556			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NO3EK	32735594	Green Published, gold			2022-12-26	WOS:000569367100027
J	Steele, EM; Khandpur, N; Louzada, MLD; Monteiro, CA				Steele, Euridice Martinez; Khandpur, Neha; da Costa Louzada, Maria Laura; Monteiro, Carlos Augusto			Association between dietary contribution of ultra-processed foods and urinary concentrations of phthalates and bisphenol in a nationally representative sample of the US population aged 6 years and older	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; CONSUMPTION; PRODUCTS; EXPOSURE; HEALTH; TRENDS; ENERGY; VARIABILITY; METABOLITES; PREDICTORS	Ultra-processed food consumption has been associated with several health outcomes such as obesity, hypertension, cardiovascular disease and cancer. The deleterious nutrient profile of these products, and the presence of food additives, neoformed contaminants and contact materials such as phthalates and bisphenol may be some of the potential pathways through which ultra-processed food influences disease outcomes. The aim of this study was to examine the association between dietary contribution of ultra-processed foods and urinary biomarker concentrations of parent compounds or their metabolites including Di(2-ethylhexyl) phthalate (SDEHP), Di-isononyl phthalate (SDiNP), Monocarboxynonyl phthalate (mCNP), Mono (3-carboxypropyl) phthalate (mCPP), Monobenzyl phthalate (mBzP), Bisphenol A (BPA), Bisphenol F (BPF) and Bisphenol S (BPS), in the US. Participants from the cross-sectional 2009-2016 National Health and Nutrition Examination Survey, aged 6+ years, with urinary measures and with one 24-hour dietary recall were included in the study. Ultra-processed foods were identified based on the NOVA classification system, a four-group food classification based on the extent and purpose of industrial food processing. Linear regression was used to compare average urinary creatinine-standardized concentrations across quintiles of energy contribution of ultra-processed foods. Models incorporated survey sample weights and were adjusted for different sociodemographic and life-style variables. Adjusted geometric means of SDiNP, mCNP, mCPP, mBzP and BPF increased monotonically from the lowest to the highest quintile of ultra-processed food consumption. As both phthalates/bisphenol and ultra-processed foods have been previously associated with insulin resistance, diabetes, general/abdominal obesity and hypertension, our results suggest the possibility of contact materials in ultra-processed foods as one link between ultra-processed food and these health outcomes. Future studies could confirm findings and further explore these mechanisms of action.	[Steele, Euridice Martinez; Khandpur, Neha; da Costa Louzada, Maria Laura; Monteiro, Carlos Augusto] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil; [Steele, Euridice Martinez; Khandpur, Neha; da Costa Louzada, Maria Laura; Monteiro, Carlos Augusto] Univ Sao Paulo, Ctr Epidemiol Studies Hlth & Nutr, Sao Paulo, Brazil; [Khandpur, Neha] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Harvard University; Harvard T.H. Chan School of Public Health	Steele, EM (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil.; Steele, EM (corresponding author), Univ Sao Paulo, Ctr Epidemiol Studies Hlth & Nutr, Sao Paulo, Brazil.	emar_steele@hotmail.com	Monteiro, Carlos Augusto/F-9892-2012; Steele, Eurídice Martinez/AAP-9903-2021	Monteiro, Carlos Augusto/0000-0002-3777-1533; Khandpur, Neha/0000-0002-4766-8361	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2015/14900-9]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Processo FAPESP) [2018/17972-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Processo FAPESP)	This research received funding from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Processo no 2015/14900-9) to CAM and from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Processo FAPESP no 2018/17972-9) to EMS.	[Anonymous], 2010, 91 FAO FOOD NUTR; [Anonymous], 2008, P FULL REP ALL NUTR, P1; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Blanco-Rojo R, 2019, MAYO CLIN PROC, V94, P2178, DOI 10.1016/j.mayocp.2019.03.035; Blanton CA, 2006, J NUTR, V136, P2594, DOI 10.1093/jn/136.10.2594; Martins APB, 2013, REV SAUDE PUBL, V47, P656, DOI 10.1590/S0034-8910.2013047004968; Braun JM, 2012, ENVIRON HEALTH PERSP, V120, P739, DOI 10.1289/ehp.1104139; Buckley JP, 2019, ENVIRON INT, V131, DOI 10.1016/j.envint.2019.105057; Calafat AM, 2015, ENVIRON HEALTH PERSP, V123, pA166, DOI 10.1289/ehp.1510041; Canhada, 2019, PHN; Cao XL, 2011, FOOD ADDIT CONTAM A, V28, P791, DOI 10.1080/19440049.2010.513015; Cao XL, 2019, FOOD ADDIT CONTAM A, DOI 10.1080/19440049.2019.1643042; Cao XL, 2010, COMPR REV FOOD SCI F, V9, P21, DOI 10.1111/j.1541-4337.2009.00093.x; Centers for Disease Control and Prevention. National Center for Health Statistics. National Health and Nutrition Examination Survey, ANTHR PROC MAN 2009; Centers for Disease Control and Prevention. National Center for Health Statistics. National Health and Nutrition Examination Survey. Laboratory Procedure Manual, 2015, MET PHTHAL PHTHAL AL; Centers for Disease Control and Prevention. National Center for Health Statistics. National Health and Nutrition Examination Survey. Laboratory Procedure Manual, 2015, PERS CAR CONS PROD C; Mendonca RD, 2017, AM J HYPERTENS, V30, P358, DOI 10.1093/ajh/hpw137; Mendonca RD, 2016, AM J CLIN NUTR, V104, P1433, DOI 10.3945/ajcn.116.135004; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Fardet A, 2016, FOOD FUNCT, V7, P2338, DOI [10.1039/c6fo00107f, 10.1039/C6FO00107F]; Fiolet T, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k322; Geens T, 2012, FOOD CHEM TOXICOL, V50, P3725, DOI 10.1016/j.fct.2012.07.059; Gore AC, 2015, ENDOCR REV, V36, pE1, DOI 10.1210/er.2015-1010; Hall KD, 2019, CELL METAB, V30, P67, DOI 10.1016/j.cmet.2019.05.008; Harrell FE, 2001, REGRESSION MODELING; Johns LE, 2015, ENVIRON INT, V85, P27, DOI 10.1016/j.envint.2015.08.005; Juul F, 2018, BRIT J NUTR, V120, P90, DOI [10.1017/S0007114518001046, 10.1017/s0007114518001046]; Juul F, 2015, PUBLIC HEALTH NUTR, V18, P3096, DOI 10.1017/S1368980015000506; Kim H, 2019, PUBLIC HEALTH NUTR, V22, P1777, DOI [10.1017/S1368980018003890, 10.1017/s1368980018003890]; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Laboratory Procedure Manual, 2011, UR CREAT; Lopez-Espinosa MJ, 2007, FOOD ADDIT CONTAM A, V24, P95, DOI 10.1080/02652030600936375; Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107; Monteiro C. A., 2019, ULTRA PROCESSED FOOD; Monteiro CA, 2019, PUBLIC HEALTH NUTR, V22, P936, DOI 10.1017/S1368980018003762; Monteiro CA, 2018, PUBLIC HEALTH NUTR, V21, P5, DOI 10.1017/S1368980017000234; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Moreira MA, 2014, INT J ENV RES PUB HE, V11, P507, DOI 10.3390/ijerph110100507; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Moubarac JC, 2014, CAN J DIET PRACT RES, V75, P15, DOI 10.3148/75.1.2014.15; National Health and Nutrition Examination Survey, 2018, AN GUID 2011 2014 20; NHANES, 2009, MEC PERS DIET INT PR; NHANES, 2009, PHON FOLL DIET INT P; NTP (National Toxicology Program), 2016, REP CARC; Pacyga DC, 2019, ADV NUTR, V10, P803, DOI 10.1093/advances/nmz029; *PAHO, 2015, ULTR FOOD DRINK PROD; Polinski KJ, 2018, ENVIRON RES, V162, P308, DOI 10.1016/j.envres.2018.01.025; Prentice RL, 2011, AM J EPIDEMIOL, V174, P591, DOI 10.1093/aje/kwr140; Radke EG, 2019, ENVIRON INT, V132, DOI 10.1016/j.envint.2019.04.040; Ranciere F, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0036-5; Rauber F, 2015, NUTR METAB CARDIOVAS, V25, P116, DOI 10.1016/j.numecd.2014.08.001; Rico-Campa A, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1949; Rumpler WV, 2008, EUR J CLIN NUTR, V62, P544, DOI 10.1038/sj.ejcn.1602742; Serrano SE, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-43; Shoshtari-Yeganeh B, 2019, ENVIRON SCI POLLUT R, V26, P9435, DOI 10.1007/s11356-019-04373-1; Srour B, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1451; Srour Bernard, ULTRAPROCESSED FOOD; Steele EM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009892; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; US Department of Agriculture, USDA FOOD NUTR DAT D; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; Vandevijvere S, 2019, OBES REV, V20, P10, DOI 10.1111/obr.12860; Watkins DJ, 2014, ENVIRON SCI TECHNOL, V48, P8881, DOI 10.1021/es501744v; World Health Organization, 2016, BMI CLASSIFICATION; Zinocker MK, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030365; Zota AR, 2016, ENVIRON HEALTH PERSP, V124, P1521, DOI 10.1289/ehp.1510803; Zota AR, 2014, ENVIRON HEALTH PERSP, V122, P235, DOI 10.1289/ehp.1306681	67	37	37	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236738	10.1371/journal.pone.0236738	http://dx.doi.org/10.1371/journal.pone.0236738			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735599	Green Published, gold			2022-12-26	WOS:000569367100043
J	Gschwind, R; Fournier, T; Kennedy, S; Tsatsaris, V; Cordier, AG; Barbut, F; Butel, MJ; Wydau-Dematteis, S				Gschwind, Remi; Fournier, Thierry; Kennedy, Sean; Tsatsaris, Vassilis; Cordier, Anne-Gael; Barbut, Frederic; Butel, Marie-Jose; Wydau-Dematteis, Sandra			Evidence for contamination as the origin for bacteria found in human placenta rather than a microbiota	PLOS ONE			English	Article							MEMBRANES; TERM; DNA	Until recently thein uteroenvironment of pregnant women was considered sterile. Recent high-sensitivity molecular techniques and high-throughput sequencing lead to some evidence for a low-biomass microbiome associated with the healthy placenta. Other studies failed to reveal evidence for a consistent presence of bacteria using either culture or molecular based techniques. Comparing conflicting "placental microbiome" studies is complicated by the use of varied and inconsistent protocols. Given this situation, we undertook an evaluation of thein uteroenvironment sterility using several controlled methods, in the same study, to evaluate the presence or absence of bacteria and to explain contradictions present in the literature. Healthy pregnant women (n = 38) were recruited in three maternity wards. Placenta were collected after cesarean section with or without Alexis(R)and vaginal delivery births. For this study we sampled fetal membranes, umbilical cord and chorionic villi. Bacterial presence was analyzed using bacterial culture and qPCR on 34 fetal membranes, umbilical cord and chorionic villi samples. Shotgun metagenomics was performed on seven chorionic villi samples. We showed that the isolation of meaningful quantities of viable bacteria or bacterial DNA was possible only outside the placenta (fetal membranes and umbilical cords) highlighting the importance of sampling methods in studying thein uteroenvironment. Bacterial communities described by metagenomics analysis were similar in chorionic villi samples and in negative controls and were dependent on the database chosen for the analysis. We conclude that the placenta does not harbor a specific, consistent and functional microbiota.	[Gschwind, Remi; Fournier, Thierry; Tsatsaris, Vassilis; Cordier, Anne-Gael; Barbut, Frederic; Butel, Marie-Jose; Wydau-Dematteis, Sandra] Univ Paris, INSERM UMR S 1139 3PHM, Paris, France; [Gschwind, Remi; Fournier, Thierry; Tsatsaris, Vassilis; Cordier, Anne-Gael; Barbut, Frederic; Butel, Marie-Jose; Wydau-Dematteis, Sandra] Hosp Univ Dept Risks Pregnancy, Paris, France; [Fournier, Thierry; Tsatsaris, Vassilis; Cordier, Anne-Gael; Barbut, Frederic; Butel, Marie-Jose; Wydau-Dematteis, Sandra] PremUp Fdn, Paris, France; [Kennedy, Sean] Inst Pasteur, Dept Computat Biol, USR 3756, CNRS, Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wydau-Dematteis, S (corresponding author), Univ Paris, INSERM UMR S 1139 3PHM, Paris, France.; Wydau-Dematteis, S (corresponding author), Hosp Univ Dept Risks Pregnancy, Paris, France.; Wydau-Dematteis, S (corresponding author), PremUp Fdn, Paris, France.	sandra.wydau@parisdescartes.fr	GSCHWIND, Rémi/AAC-9863-2022; Barbut, frederic/AAF-4952-2021	Wydau-Dematteis, Sandra/0000-0003-2023-3656; Kennedy, Sean/0000-0002-3932-8922	PRIDE grant from the hospital-university department "Risks in Pregnancy"; Paris Descartes university	PRIDE grant from the hospital-university department "Risks in Pregnancy"; Paris Descartes university	This work was supported by a PRIDE grant from the hospital-university department "Risks in Pregnancy" and by Paris Descartes university. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Amarasekara R, 2015, J OBSTET GYNAECOL RE, V41, P662, DOI 10.1111/jog.12619; Antony KM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.041; Bassols J, 2016, PEDIATR RES, V80, P777, DOI 10.1038/pr.2016.155; Borghi E, 2019, REPROD SCI, V26, P1045, DOI 10.1177/1933719118804411; Breitwieser FP, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1568-0; Breitwieser FP, 2019, BIOINFORMATICS; Collado MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23129; de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5; de Goffau MC, 2018, NAT MICROBIOL, V3, P851, DOI 10.1038/s41564-018-0202-y; Dong XD, 2015, CAN J INFECT DIS MED, V26, P90, DOI 10.1155/2015/737294; Doyle RM, 2014, PLACENTA, V35, P1099, DOI 10.1016/j.placenta.2014.10.007; Doyle RM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180167; Eisenhofer R, 2019, TRENDS MICROBIOL, V27, P105, DOI 10.1016/j.tim.2018.11.003; Glassing A, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0103-7; GOMEZARANGO LF, 2017, SCI REP UK, V7; Hiergeist A, 2015, ILAR J, V56, P228, DOI 10.1093/ilar/ilv017; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Karstens L, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00290-19; Kliman HJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009864; Kuperman A, 2020, BJOG-INT J OBSTET GY, V127, P159, DOI 10.1111/1471-0528.15896; Lagier JC, 2018, NAT REV MICROBIOL, V16, P540, DOI 10.1038/s41579-018-0041-0; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lauder AP, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0172-3; Leiby JS, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0575-4; Leon LJ, 2018, APPL ENVIRON MICROB, V84, P14; Malmuthuge N, 2018, VET IMMUNOL IMMUNOP, V204, P59, DOI 10.1016/j.vetimm.2018.09.005; Moreno I, 2016, AM J OBSTET GYNECOL, V215, P684, DOI 10.1016/j.ajog.2016.09.075; Nasko DJ, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1554-6; Parnell LA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11514-4; Pettker CM, 2007, OBSTET GYNECOL, V109, P739, DOI 10.1097/01.AOG.0000255663.47512.23; Satokari R, 2009, LETT APPL MICROBIOL, V48, P8, DOI 10.1111/j.1472-765X.2008.02475.x; Seferovic MD, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.04.036; Shin HD, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0126-1; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; Theis KR, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2018.10.018; Tuominen H, 2019, J ORAL MICROBIOL, V11, DOI 10.1080/20002297.2019.1663084; Verstraelen H, 2016, PEERJ, V4, DOI 10.7717/peerj.1602; Willyard C, 2018, NATURE, V553, P264, DOI 10.1038/d41586-018-00664-8; Younge N, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127806; ZHENG J, 2017, FRONT PHYSIOL, V0008; Zheng J, 2017, ONCOTARGET, V8, P82314, DOI 10.18632/oncotarget.19319; Zheng J, 2015, NUTRIENTS, V7, P6924, DOI 10.3390/nu7085315; 2018, LANCET INFECT DIS, V0018, P00925, DOI DOI 10.1016/S1473-3099(18)30503-630152348	44	20	20	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237232	10.1371/journal.pone.0237232	http://dx.doi.org/10.1371/journal.pone.0237232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776951	gold, Green Published			2022-12-26	WOS:000561393800019
J	Silveira, WA; Goncalves, DA; Machado, J; Lautherbach, N; Lustrino, D; Paula-Gomes, S; Pereira, MG; Miyabara, EH; Sandri, M; Kettelhut, IC; Navegantes, LC				Silveira, Wilian A.; Goncalves, Dawit A.; Machado, Juliano; Lautherbach, Natalia; Lustrino, Danilo; Paula-Gomes, Silvia; Pereira, Marcelo G.; Miyabara, Elen H.; Sandri, Marco; Kettelhut, Isis C.; Navegantes, Luiz C.			cAMP-dependent protein kinase inhibits FoxO activity and regulates skeletal muscle plasticity in mice	FASEB JOURNAL			English	Article						adrenergic signaling; protein metabolism; skeletal muscle atrophy; skeletal muscle plasticity; ubiquitin-proteasome system	ACETYLTRANSFERASE ACTIVITY; HEPATIC GLUCONEOGENESIS; ERK1/2 ACTIVATION; UBIQUITIN LIGASES; ATROPHY; PROTEOLYSIS; PGC-1-ALPHA; RECEPTOR; SUPPRESSES; CREB	Although we have shown that catecholamines suppress the activity of the Ubiquitin-Proteasome System (UPS) and atrophy-related genes expression through a cAMP-dependent manner in skeletal muscle from rodents, the underlying mechanisms remain unclear. Here, we report that a single injection of norepinephrine (NE; 1 mg kg(-1); s.c) attenuated the fasting-induced up-regulation of FoxO-target genes in tibialis anterior (TA) muscles by the stimulation of PKA/CREB and Akt/FoxO1 signaling pathways. In addition, muscle-specific activation of PKA by the overexpression of PKA catalytic subunit (PKAcat) suppressed FoxO reporter activity induced by (1) a wild-type; (2) a non-phosphorylatable; (3) a non-phosphorylatable and non-acetylatable forms of FoxO1 and FoxO3; (4) downregulation of FoxO protein content, and probably by (5) PGC-1 alpha up-regulation. Consistently, the overexpression of the PKAcat inhibitor (PKI) up-regulated FoxO activity and the content of Atrogin-1 and MuRF1, as well as induced muscle fiber atrophy, the latter effect being prevented by the overexpression of a dominant negative (d. n.) form of FoxO (d.n.FoxO). The sustained overexpression of PKAcat induced fiber-type transition toward a smaller, slower, and more oxidative phenotype and improved muscle resistance to fatigue. Taken together, our data provide the first evidence that endogenous PKA activity is required to restrain the basal activity of FoxO and physiologically important to maintain skeletal muscle mass.	[Silveira, Wilian A.; Goncalves, Dawit A.; Machado, Juliano; Lautherbach, Natalia; Lustrino, Danilo; Kettelhut, Isis C.; Navegantes, Luiz C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Physiol, Sao Paulo, Brazil; [Silveira, Wilian A.] Fed Univ Trifingulo Mineiro UFTM, Inst Biol & Nat Sci, Uberaba, Brazil; [Goncalves, Dawit A.; Paula-Gomes, Silvia; Kettelhut, Isis C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem, Sao Paulo, Brazil; [Goncalves, Dawit A.; Paula-Gomes, Silvia; Kettelhut, Isis C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Immunol, Sao Paulo, Brazil; [Goncalves, Dawit A.] Fed Univ Minas Gerais UFMG, Dept Phys Educ, Sch Phys Educ Physiotherapy & Occupat Therapy, Belo Horizonte, MG, Brazil; [Goncalves, Dawit A.; Sandri, Marco] Univ Padua, Dept Biomed Sci, Padua, Italy; [Goncalves, Dawit A.; Sandri, Marco] Venetian Inst Mol Med, Padua, Italy; [Machado, Juliano] Helmholtz Ctr Munich, Inst Diabet & Canc IDC, Neuherberg, Germany; [Pereira, Marcelo G.; Miyabara, Elen H.] Univ Sao Paulo, Dept Anat Inst Biomed Sci, Sao Paulo, Brazil; [Sandri, Marco] Univ Padua, Myol Ctr, Padua, Italy; [Lustrino, Danilo] Univ Fed Sergipe, Dept Physiol, Aracaju, Brazil; [Paula-Gomes, Silvia] Univ Fed Ouro Preto, Inst Exact & Biol Sci, Dept Biol Sci, Ouro Preto, Brazil; [Pereira, Marcelo G.] Univ Sao Paulo, Sch Phys Educ & Sport, Dept Biodynam Human Body Movement, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Minas Gerais; University of Padua; Veneto Institute Molecular Medicine; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Universidade de Sao Paulo; University of Padua; Universidade Federal de Sergipe; Universidade Federal de Ouro Preto; Universidade de Sao Paulo	Navegantes, LC (corresponding author), Univ Sao Paulo, Dept Physiol, Ribeirao Preto Med Sch, BR-14049900 Ribeirao Preto, SP, Brazil.	navegantes@fmrp.usp.br	Gonçalves, Dawit A/S-3648-2016; Gomes Pereira, Marcelo/D-7324-2015; Lustrino, Danilo/ABC-2635-2021; Miyabara, Elen/E-8143-2012; Kettelhut, Isis do Carmo/I-4839-2012	Gonçalves, Dawit A/0000-0003-2621-3330; Lustrino, Danilo/0000-0001-7118-743X; Miyabara, Elen/0000-0002-2325-9571; Kettelhut, Isis do Carmo/0000-0002-9034-5357; A. Silveira, Wilian/0000-0002-6171-7940; Navegantes, Luiz/0000-0002-9870-9469; Gomes Pereira, Marcelo/0000-0002-6670-8031	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [12/18861-0, 15/21112-7, 12/24524-6, 18/10089-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [PNPD20131672, 233261/2014-1, 306624/2015-0]; AFM-Telethon [19524]; Italian Ministry of Education (MiUR) [PRIN 2010/2011]; Foundation Leducq; AIRC [17388]; RISE [645648]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; AFM-Telethon; Italian Ministry of Education (MiUR)(Ministry of Education, Universities and Research (MIUR)); Foundation Leducq; AIRC; RISE	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Grant/Award Number: 12/18861-0, 15/21112-7, 12/24524-6 and 18/10089-2; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Grant/Award Number: PNPD20131672, 233261/2014-1 and 306624/2015-0; AFM-Telethon, Grant/ Award Number: 19524; Italian Ministry of Education (MiUR), Grant/Award Number: PRIN 2010/2011; Foundation Leducq, AIRC, Grant/Award Number: 17388; RISE, Grant/Award Number: 645648	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Baviera AM, 2007, AM J PHYSIOL-ENDOC M, V292, pE702, DOI 10.1152/ajpendo.00147.2006; Baviera AM, 2010, MOL CELL ENDOCRINOL, V315, P104, DOI 10.1016/j.mce.2009.09.028; Beehler BC, 2006, EXP BIOL MED, V231, P335; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Berdeaux R, 2012, AM J PHYSIOL-ENDOC M, V303, pE1, DOI 10.1152/ajpendo.00555.2011; Bertaggia E, 2012, AM J PHYSIOL-CELL PH, V302, pC587, DOI 10.1152/ajpcell.00142.2011; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bok J, 2003, J NEUROSCI, V23, P777; Brouillard F, 2003, J BIOL CHEM, V278, P39509, DOI 10.1074/jbc.M307123200; Bruno NE, 2014, EMBO J, V33, P1027, DOI 10.1002/embj.201386145; Chen M, 2009, AM J PHYSIOL-CELL PH, V296, pC930, DOI 10.1152/ajpcell.00443.2008; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Geng TY, 2011, AM J PATHOL, V178, P1738, DOI 10.1016/j.ajpath.2011.01.005; Goncalves DA, 2019, J CACHEXIA SARCOPENI, V10, P455, DOI 10.1002/jcsm.12395; Goncalves DAP, 2012, AM J PHYSIOL-ENDOC M, V302, pE123, DOI 10.1152/ajpendo.00188.2011; Goncalves DAP, 2009, ENDOCRINOLOGY, V150, P5395, DOI 10.1210/en.2009-0428; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Graca FA, 2013, AM J PHYSIOL-ENDOC M, V305, pE1483, DOI 10.1152/ajpendo.00267.2013; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Harcourt LJ, 2007, NEUROMUSCULAR DISORD, V17, P47, DOI 10.1016/j.nmd.2006.08.012; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Khan MM, 2016, P NATL ACAD SCI USA, V113, P746, DOI 10.1073/pnas.1524272113; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kline WO, 2007, J APPL PHYSIOL, V102, P740, DOI 10.1152/japplphysiol.00873.2006; Lee JW, 2011, J BIOL CHEM, V286, P6423, DOI 10.1074/jbc.M110.180661; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lira EC, 2011, MUSCLE NERVE, V44, P371, DOI 10.1002/mus.22066; Lira EC, 2007, SHOCK, V27, P687, DOI 10.1097/SHK.0b013e31802e43a6; Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007; Mahendra VP, 2019, J FUNCT FOODS, V56, P110, DOI 10.1016/j.jff.2019.02.047; MCELLIGOTT MA, 1987, AM J PHYSIOL, V253, pE370, DOI 10.1152/ajpendo.1987.253.4.E370; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Navegantes LCC, 1999, AM J PHYSIOL-ENDOC M, V277, pE883, DOI 10.1152/ajpendo.1999.277.5.E883; Navegantes LCC, 2000, AM J PHYSIOL-ENDOC M, V279, pE663, DOI 10.1152/ajpendo.2000.279.3.E663; Pereira MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085283; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Raffaello A, 2010, J CELL BIOL, V191, P101, DOI 10.1083/jcb.201001136; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Ryall JG, 2007, J GERONTOL A-BIOL, V62, P813, DOI 10.1093/gerona/62.8.813; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Senf SM, 2011, AM J PHYSIOL-CELL PH, V300, pC1490, DOI 10.1152/ajpcell.00255.2010; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Silveira WA, 2014, J APPL PHYSIOL, V117, P11, DOI 10.1152/japplphysiol.01055.2013; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; SUGANO T, 1982, J BIOCHEM-TOKYO, V92, P111, DOI 10.1093/oxfordjournals.jbchem.a133907; Voltarelli VA, 2012, SCAND J MED SCI SPOR, V22, pe125, DOI 10.1111/j.1600-0838.2012.01519.x; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; WING SS, 1995, BIOCHEM J, V307, P639, DOI 10.1042/bj3070639; Yang JH, 2014, J MOL CELL CARDIOL, V66, P83, DOI 10.1016/j.yjmcc.2013.11.001; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yimlamai T, 2005, J APPL PHYSIOL, V99, P71, DOI 10.1152/japplphysiol.00448.2004; Yuan YA, 2011, MOL CELL BIOCHEM, V348, P77, DOI 10.1007/s11010-010-0640-1; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	63	12	12	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12946	12962		10.1096/fj.201902102RR	http://dx.doi.org/10.1096/fj.201902102RR		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32772437				2022-12-26	WOS:000558817100001
J	Baruti, K; Lentz, K; Anderson, M; Ajibola, G; Phinius, BB; Choga, WT; Mbangiwa, T; Powis, KM; Sebunya, T; Blackard, JT; Lockman, S; Moyo, S; Shapiro, R; Gaseitsiwe, S				Baruti, Kabo; Lentz, Kayla; Anderson, Motswedi; Ajibola, Gbolahan; Phinius, Bonolo B.; Choga, Wonderful T.; Mbangiwa, Tshepiso; Powis, Kathleen M.; Sebunya, Theresa; Blackard, Jason T.; Lockman, Shahin; Moyo, Sikhulile; Shapiro, Roger; Gaseitsiwe, Simani			Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana	PLOS ONE			English	Article							INFECTION; INFANTS	Background Botswana introduced the HBV vaccine at birth for all newborns in 2000. To the best of our knowledge, since the introduction of HBV vaccination, there have been limited data for vaccine response to HBV and its impact on early childhood HBV infections among children HIV exposed but uninfected in Botswana. Aims To determine the prevalence of hepatitis B surface antigen (HBsAg) and HBV vaccine response in 18 months old children HIV exposed but uninfected in Botswana. Methods Stored plasma samples from 304 children at 18 months of age and 287 mothers from delivery were tested for HBsAg. Mothers with positive HBsAg had HBV DNA level tested, and their HBV genotypes were determined by amplifying a 415-base pair (bp) region of the surface gene. Plasma samples from children exposed to HIV were tested for hepatitis B surface antibody (anti-HBs) titers. Results No children (0 of 304) were positive for HBsAg at 18 months while 5 (1.74%) of 287 HIV-positive mothers were HBsAg positive. Four of the HBsAg positive mothers were infected with genotype A1, while 1 was infected with genotype E. The median anti-HBs titer in children was 174 mIU/mL [QR: 70, 457]. Three (1.1%) of 269 children had an inadequate vaccine response (<10 mIU/mL), while 266 (98.9%) of 269 had protective immunity. However, when using the >= 100mIU/mL threshold, only 170 (63.2%) of 269 children had complete protection. Conclusion No HBsAg positivity was identified in a cohort of children HIV exposed but uninfected. The absence of HBsAg positives was associated with good HBV vaccine responses and low maternal HBsAg prevalence in Botswana.	[Baruti, Kabo; Sebunya, Theresa] Univ Botswana, Dept Biol Sci, Fac Sci, Gaborone, Botswana; [Baruti, Kabo; Anderson, Motswedi; Ajibola, Gbolahan; Phinius, Bonolo B.; Choga, Wonderful T.; Mbangiwa, Tshepiso; Powis, Kathleen M.; Lockman, Shahin; Moyo, Sikhulile; Shapiro, Roger; Gaseitsiwe, Simani] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Lentz, Kayla] Harvard Univ, Cambridge, MA USA; [Mbangiwa, Tshepiso] Univ Cape Town, Fac Hlth Sci, Dept Pathol, Cape Town, South Africa; [Powis, Kathleen M.; Lockman, Shahin; Moyo, Sikhulile; Shapiro, Roger; Gaseitsiwe, Simani] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Powis, Kathleen M.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Blackard, Jason T.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Lockman, Shahin] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	University of Botswana; Botswana-Harvard AIDS Institute Partnership; Harvard University; University of Cape Town; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital	Gaseitsiwe, S (corresponding author), Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana.; Gaseitsiwe, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	sgaseitsiwe@bhp.org.bw	Powis, Kathleen/AAU-5123-2021; Moyo, Sikhulile/E-1464-2015; CHOGA, Wonderful T./ABB-4787-2021	Moyo, Sikhulile/0000-0003-3821-4592; CHOGA, Wonderful T./0000-0001-7606-0569; Baruti, Kabo/0000-0002-1592-7533; Phinius, Bonolo Bonita/0000-0002-0180-2705; Powis, Kathleen/0000-0002-4478-4471; Ajibola, Gbolahan/0000-0002-5408-4823	sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [DEL-15-006]; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107752/Z/15/Z]; United Kingdom government	sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom government	This work was supported by the sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative (grant DEL-15-006 to M.A, S.M, and S.G.),. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (grant 107752/Z/15/Z) and the United Kingdom government.	Anderson M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1096-4; [Anonymous], 2016, GREEN BOOK IMMUNISAT, P161; [Anonymous], HBV DATABASE; Breakwell Lucy, 2017, Pan Afr Med J, V27, P17, DOI 10.11604/pamj.supp.2017.27.3.11981; Chotun N, 2015, VACCINE, V33, P4618, DOI 10.1016/j.vaccine.2015.06.076; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hesseling A.C., 2017, INT J TUBERC LUND DI, V90, P1172, DOI [10.1016/j.physbeh.2017.03.040, DOI 10.1016/J.PHYSBEH.2017.03.040]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li ZX, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.30; Lockman S, 2017, LANCET GLOB HEALTH, V5, pE491, DOI 10.1016/s2214-109x(17)30143-2; Mancinelli S, 2018, J MED VIROL, V90, P1172, DOI 10.1002/jmv.25049; Matthews PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134037; Mbangiwa T, 2018, GENES-BASEL, V9, DOI 10.3390/genes9050259; Mendy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058029; Moskosky S. B., 2011, Morbidity and Mortality Weekly Report, V60, P1; Moturi Edna, 2018, J Immunol Sci, VSuppl, P31; Ndubuka J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003749; Patel P, 2011, AM J TROP MED HYG, V85, P390, DOI 10.4269/ajtmh.2011.10-0510; Sunbul M, 2014, WORLD J GASTROENTERO, V20, P5427, DOI 10.3748/wjg.v20.i18.5427	20	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237252	10.1371/journal.pone.0237252	http://dx.doi.org/10.1371/journal.pone.0237252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764801	Green Published, gold			2022-12-26	WOS:000561029000063
J	Sutin, AR; Luchetti, M; Aschwanden, D; Lee, JH; Sesker, AA; Strickhouser, JE; Stephan, Y; Terracciano, A				Sutin, Angelina R.; Luchetti, Martina; Aschwanden, Damaris; Lee, Ji Hyun; Sesker, Amanda A.; Strickhouser, Jason E.; Stephan, Yannick; Terracciano, Antonio			Change in five-factor model personality traits during the acute phase of the coronavirus pandemic	PLOS ONE			English	Article							LIFE EVENTS; IMPACT; AGE	The rapid spread of the coronavirus and the strategies to slow it have disrupted just about every aspect of our lives. Such disruption may be reflected in changes in psychological function. The present study used a pre-posttest design to test whether Five Factor Model personality traits changed with the coronavirus outbreak in the United States. Participants (N= 2,137) were tested in early February 2020 and again during the President's 15 Days to Slow the Spread guidelines. In contrast to the preregistered hypotheses, Neuroticism decreased across these six weeks, particularly the facets of Anxiety and Depression, and Conscientiousness did not change. Interestingly, there was some evidence that the rapid changes in the social context had changed the meaning of an item. Specifically, an item about going to work despite being sick was a good indicator of conscientiousness before COVID-19, but the interpretation of it changed with the pandemic. In sum, the unexpected small decline in Neuroticism suggests that, during the acute phase of the coronavirus outbreak, feelings of anxiety and distress may be attributed more to the pandemic than to one's personality.	[Sutin, Angelina R.; Luchetti, Martina; Lee, Ji Hyun; Sesker, Amanda A.; Strickhouser, Jason E.] Florida State Univ, Coll Med, Dept Behav Sci & Social Med, Tallahassee, FL 32306 USA; [Aschwanden, Damaris; Terracciano, Antonio] Florida State Univ, Coll Med, Dept Geriatr, Tallahassee, FL 32306 USA; [Stephan, Yannick] Univ Montpellier, Euromov, Montpellier, France	State University System of Florida; Florida State University; State University System of Florida; Florida State University; Universite de Montpellier	Sutin, AR (corresponding author), Florida State Univ, Coll Med, Dept Behav Sci & Social Med, Tallahassee, FL 32306 USA.	angelina.sutin@med.fsu.edu	Luchetti, Martina/A-4530-2017; Sesker, Amanda A./AAS-9647-2021; Terracciano, Antonio/H-7403-2019	Luchetti, Martina/0000-0002-7370-8443; Sesker, Amanda A./0000-0003-1247-6463; Terracciano, Antonio/0000-0001-5799-8885; Lee, Ji Hyun/0000-0003-3810-9186	National Institute on Aging of the National Institutes of Health [R01AG053297]	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG053297 to ARS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, J Pers, V60, P175; [Anonymous], 2020, FACT SHEET DHS NOTIC; Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE256, DOI 10.1016/S2468-2667(20)30061-X; Associated Press, 2020, US NEWS WORLD REPORT; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Denissen JJA, 2019, J PERS SOC PSYCHOL, V116, P612, DOI 10.1037/pspp0000196; Gold J, 2020, KAISER HLTH NEWS; Imbert F., 2020, CNBC; Jeronimus BF, 2013, PSYCHOL MED, V43, P2403, DOI 10.1017/S0033291713000159; Kaplan J., 2020, BUSINESS INSIDER; Karsten J, 2012, J PSYCHIATR RES, V46, P644, DOI 10.1016/j.jpsychires.2012.01.024; Lee A, 2020, CNN 0407; Lockenhoff CE, 2009, J TRAUMA STRESS, V22, P53, DOI 10.1002/jts.20385; McCrae RR, 2010, NEOINVENTORIES NEOPE; McCrae RR, 2003, PERSONALITY ADULTHOO, DOI DOI 10.4324/9780203428412; McGinty EE, 2020, JAMA-J AM MED ASSOC, V324, P93, DOI 10.1001/jama.2020.9740; Milojev P, 2014, SOC PSYCHOL PERS SCI, V5, P760, DOI 10.1177/1948550614528545; Ogle CM, 2014, J PERS, V82, P93, DOI 10.1111/jopy.12037; Rakich N., 2020, FIVETHIRTYEIGHT 0320; Roberts BW, 2017, PSYCHOL BULL, V143, P117, DOI 10.1037/bul0000088; Roberts BW, 2005, PERS PSYCHOL, V58, P103, DOI 10.1111/j.1744-6570.2005.00301.x; Soto CJ, 2017, J PERS SOC PSYCHOL, V113, P117, DOI 10.1037/pspp0000096; Specht J, 2011, J PERS SOC PSYCHOL, V101, P862, DOI 10.1037/a0024950; STEPHAN Y, 2020, AM PSYCHOL, DOI DOI 10.1037/AMP000069032567879; Terracciano A, 2005, PSYCHOL AGING, V20, P493, DOI 10.1037/0882-7974.20.3.493; Terracciano A, 2006, PERS SOC PSYCHOL B, V32, P999, DOI 10.1177/0146167206288599; The White House, 2020, 15 DAYS SLOW SPREAD; WHO, 2020, WEEKLY EPIDEMIOLOGIC; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Xiang YT, 2020, JAMA PSYCHIAT, V77, P989, DOI 10.1001/jamapsychiatry.2020.1057	30	30	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237056	10.1371/journal.pone.0237056	http://dx.doi.org/10.1371/journal.pone.0237056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2EP	32760108	Green Published, gold			2022-12-26	WOS:000561027200083
J	Chi, HC; Tsai, CY; Wang, CS; Yang, HY; Lo, CH; Wang, WJ; Lee, KF; Lai, LY; Hong, JH; Chang, YF; Tsai, MM; Yeh, CT; Wu, CH; Hsieh, CC; Wang, LH; Chen, WJ; Lin, KH				Chi, Hsiang-Cheng; Tsai, Chung-Ying; Wang, Chia-Siu; Yang, Huang-Yu; Lo, Chien-Hui; Wang, Won-Jing; Lee, Kam-Fai; Lai, Li-Yin; Hong, Ji-Hong; Chang, Yen-Fang; Tsai, Ming-Ming; Yeh, Chau-Ting; Wu, Cheng Heng; Hsieh, Ching-Chuan; Wang, Lu-Hai; Chen, Wei-Jan; Lin, Kwang-Huei			DOCK6 promotes chemo- and radioresistance of gastric cancer by modulating WNT/beta-catenin signaling and cancer stem cell traits	ONCOGENE			English	Article							BETA-CATENIN; RAC1; EXPRESSION; MIGRATION; CARCINOMA; COMPLEX	Gastric cancer (GC) is the third leading cause of cancer-related mortality worldwide and prognosis after potentially curative gastrectomy remains poor. Administration of GC-targeting molecules in combination with adjuvant chemo- or radiotherapy following surgical resection has been proposed as a potentially effective treatment option. Here, we have identified DOCK6, a guanine nucleotide exchange factor (GEF) for Rac1 and CDC42, as an independent biomarker for GC prognosis. Clinical findings indicate the positive correlation of higher DOCK6 expression with tumor size, depth of invasion, lymph node metastasis, vascular invasion, and pathological stage. Furthermore, elevated DOCK6 expression was significantly associated with shorter cumulative survival in both univariate and multivariate analyses. Gene ontology analysis of three independent clinical GC cohorts revealed significant involvement of DOCK6-correlated genes in the WNT/beta-catenin signaling pathway. Ectopic expression of DOCK6 promoted GC cancer stem cell (CSC) characteristics and chemo- or radioresistance concomitantly through Rac1 activation. Conversely, depletion of DOCK6 suppressed CSC phenotypes and progression of GC, further demonstrating the pivotal role of DOCK6 in GC progression. Our results demonstrate a novel mechanistic link between DOCK6, Rac1, and beta-catenin in GCCSC for the first time, supporting the utility of DOCK6 as an independent marker of GC	[Chi, Hsiang-Cheng] Chang Gung Univ, Chang Gung Mem Hosp, Inst Radiol Res, Radiat Biol Res Ctr, Taoyuan, Taiwan; [Chi, Hsiang-Cheng; Wu, Cheng Heng; Lin, Kwang-Huei] Chang Gung Univ, Dept Biochem, Coll Med, Taoyuan, Taiwan; [Chi, Hsiang-Cheng; Wang, Lu-Hai] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Tsai, Chung-Ying] Chang Gung Mem Hosp, Dept Nephrol, Kidney Res Ctr, Taoyuan, Taiwan; [Wang, Chia-Siu; Tsai, Ming-Ming; Hsieh, Ching-Chuan] Chang Gung Mem Hosp, Dept Gen Surg, Chiayi, Taiwan; [Yang, Huang-Yu] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Kidney Res Inst,Nephrol Dept, Taoyuan, Taiwan; [Yang, Huang-Yu; Chang, Yen-Fang] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan; [Yang, Huang-Yu] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Lo, Chien-Hui; Wang, Won-Jing] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Coll Life Sci, Taipei, Taiwan; [Lo, Chien-Hui; Wang, Won-Jing] Natl Yang Ming Univ, Taiwan Int Grad Program TIGP Mol Med, Taipei, Taiwan; [Lo, Chien-Hui; Wang, Won-Jing] Acad Sinica, Taipei, Taiwan; [Lee, Kam-Fai] Chang Gung Mem Hosp, Dept Pathol, Chiayi, Taiwan; [Lai, Li-Yin] Natl Taiwan Univ, Dept Microbiol & Internal Med, Taipei, Taiwan; [Hong, Ji-Hong] Chang Gung Mem Hosp Linkou, Inst Radiol Res, Dept Radiat Oncol, Taoyuan, Taiwan; [Tsai, Ming-Ming] Chang Gung Univ Sci & Technol, Dept Nursing, Taoyuan, Taiwan; [Tsai, Ming-Ming; Lin, Kwang-Huei] Chang Gung Univ Sci & Technol, Coll Human Ecol, Res Ctr Chinese Herbal Med, Taoyuan, Taiwan; [Yeh, Chau-Ting; Lin, Kwang-Huei] Chang Gung Mem Hosp, Liver Res Ctr, Taoyuan, Taiwan; [Wang, Lu-Hai] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli County, Taiwan; [Chen, Wei-Jan] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Div Cardiol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; China Medical University Taiwan; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Chang Gung Memorial Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung University	Lin, KH (corresponding author), Chang Gung Univ, Dept Biochem, Coll Med, Taoyuan, Taiwan.; Wang, LH (corresponding author), China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan.; Lin, KH (corresponding author), Chang Gung Univ Sci & Technol, Coll Human Ecol, Res Ctr Chinese Herbal Med, Taoyuan, Taiwan.; Lin, KH (corresponding author), Chang Gung Mem Hosp, Liver Res Ctr, Taoyuan, Taiwan.; Wang, LH (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli County, Taiwan.; Chen, WJ (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Div Cardiol, Taoyuan, Taiwan.	lu-hai.wang@nhri.org.tw; wjchen@adm.cgmh.org.tw; khlin@mail.cgu.edu.tw	Lai, Li-Yin/ABD-8471-2021	Lai, Li-Yin/0000-0003-0244-6834; Tsai, Chung-Ying/0000-0002-1444-5647; Chi, Hsiang Cheng/0000-0001-5691-2453; Wang, Won-Jing/0000-0001-9733-0839; YANG, HUANG-YU/0000-0001-6826-9717	Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPD1H0631-0632, CMRPD1G0421-0423, CMRPD1J0051, NMRPD1G0942, NMRPD1G0951, CMRPG6F0621-0623, NMRPG6G0051]; Ministry of Science and Technology of the Republic of China [MOST 106-2320-B-182-031-MY3, 106-2320-B-182-032-MY3, 106-2314-B-182A-130, MOST 105-2321-B-182 -002-MY3, 107-2320-B-182-025]	Chang Gung Memorial Hospital, Taoyuan, Taiwan(Chang Gung Memorial Hospital); Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Chang Gung Memorial Hospital, Taoyuan, Taiwan (CMRPD1H0631-0632, CMRPD1G0421-0423, CMRPD1J0051, NMRPD1G0942, and NMRPD1G0951 to K-HL; CMRPG6F0621-0623 and NMRPG6G0051 to C-SW) and the Ministry of Science and Technology of the Republic of China (MOST 106-2320-B-182-031-MY3 and 106-2320-B-182-032-MY3 to K-HL, 106-2314-B-182A-130 to C-SW, and MOST 105-2321-B-182 -002-MY3 and 107-2320-B-182-025 to H-CC).	Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Baniak N, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0969-3; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Buongiorno P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-73; Chahdi A, 2013, J BIOL CHEM, V288, P34019, DOI 10.1074/jbc.M113.480103; Chen G, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2994; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Chi HC, 2017, ONCOGENE, V36, P5274, DOI 10.1038/onc.2017.136; Chi HC, 2016, AUTOPHAGY, V12, P2271, DOI 10.1080/15548627.2016.1230583; Chi HC, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.227; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Debruyne DN, 2018, ONCOGENE, V37, P241, DOI 10.1038/onc.2017.323; Gadea G, 2014, EUR J CELL BIOL, V93, P466, DOI 10.1016/j.ejcb.2014.06.003; Gilles C, 2003, CANCER RES, V63, P2658; Gotoh K, 2008, BLOOD, V111, P2973, DOI 10.1182/blood-2007-09-112169; Han ME, 2011, CELL MOL LIFE SCI, V68, P3589, DOI 10.1007/s00018-011-0672-z; Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019; Jamieson C, 2015, J CELL SCI, V128, P3933, DOI 10.1242/jcs.167742; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI [DOI 10.1007/PL00011681, DOI 10.1007/S101209800016]]; Kwon KJ, 2014, GASTRIC CANCER, V17, P43, DOI 10.1007/s10120-013-0234-1; Li XW, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0729-z; Lou H, 2007, ONCOGENE, V26, P1357, DOI 10.1038/sj.onc.1210200; Mao J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.515; McNiven MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1944, DOI 10.2741/1348; Miyamoto Y, 2007, EXP CELL RES, V313, P791, DOI 10.1016/j.yexcr.2006.11.017; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; O'Dwyer D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027718; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Saegusa M, 2005, LAB INVEST, V85, P768, DOI 10.1038/labinvest.3700273; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Shaheen R, 2011, AM J HUM GENET, V89, P328, DOI 10.1016/j.ajhg.2011.07.009; Shi Lei, 2013, Commun Integr Biol, V6, pe26839, DOI 10.4161/cib.26839; Stamos JL, 2013, COLD SPRING HARB PER, V5, DOI DOI 10.1101/CSHPERSPECT.A007898; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Tsai CY, 2018, FASEB J, V32, P2601, DOI 10.1096/fj.201700094R; Tsai MM, 2016, EUR J CANCER, V64, P137, DOI 10.1016/j.ejca.2016.05.007; Upadhyay G, 2008, ONCOGENE, V27, P5845, DOI 10.1038/onc.2008.202; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Vojnits K, 2015, SCI REP-UK, V5, DOI 10.1038/srep17355; Wang Q, 2012, MED ONCOL, V29, P77, DOI 10.1007/s12032-010-9766-y; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yamauchi J, 2008, J CELL BIOL, V181, P351, DOI 10.1083/jcb.200709033; Yoon CH, 2011, FEBS LETT, V585, P2331, DOI 10.1016/j.febslet.2011.05.070	47	14	14	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2020	39	37					5933	5949		10.1038/s41388-020-01390-0	http://dx.doi.org/10.1038/s41388-020-01390-0		AUG 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NM2OY	32753649				2022-12-26	WOS:000555747100002
J	Qi, L; Wang, ZY; Shao, XR; Li, M; Chen, SN; Liu, XQ; Yan, S; Zhang, B; Zhang, XD; Li, X; Zhao, WX; Pan, JA; Zhao, B; Zhang, XD				Qi, Lin; Wang, Zhong-Yong; Shao, Xin-Rong; Li, Miao; Chen, Shu-Na; Liu, Xue-Qi; Yan, Shi; Zhang, Bo; Zhang, Xu-Dong; Li, Xin; Zhao, Wenxue; Pan, Ji-An; Zhao, Bo; Zhang, Xing-Ding			ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma	ONCOGENE			English	Article							GRADE II; RADIOTHERAPY; TEMOZOLOMIDE; PROGRESSION; MECHANISMS; CYTOKINE; SURVIVAL; GLIOMAS; GROWTH; CANCER	Oligodendroglioma is an important type of lower-grade glioma (LGG), which is a slowly progressing brain tumor. Many LGGs eventually transform into a more aggressive or malignant type. Enhanced angiogenesis is a characteristic of malignantly transformed oligodendroglioma (m-oligodendroglioma). However, the pathogenesis and signaling pathways associated with angiogenesis and proliferation in m-oligodendroglioma are not well understood. In this study, we identified that Insulin Gene Enhancer Protein (ISL2) and its angiogenic capacity were inversely related to survival according to LGG patient data from an online database, and this was further confirmed with pathological LGG patient samples, including malignantly transformed samples, by detecting the expression of ISL2, the angiogenic markers vascular endothelial growth factor (VEGFA) and CD31 and the proliferation marker Ki-67. We then established novel oligodendroglioma patient tumor-derived orthotopic xenograft mouse models and cell lines to verify the role of ISL2 in regulating angiogenesis to promote oligodendroglioma growth and malignant transformation. Furthermore, ISL2 regulated ANGPT2 transcription by binding to the ANGPT2 promoter. Then, ANGPT2, a downstream gene, activated angiogenesis through VEGFA to promote oligodendroglioma malignant transformation. Finally, combining AAV-ISL2-shRNA with temozolomide suppressed oligodendroglioma progression more effectively than either monotherapy in vivo and in vitro. Thus, hypoxia-induced ISL2 regulated ANGPT2, which subsequently induced angiogenesis to promote oligodendroglioma growth and malignant transformation. Malignancy was accompanied by worsened hypoxia inside the tumor mass, creating a positive feedback loop. In conclusion, this study suggests that ISL2 is a biomarker for oligodendroglioma progression and that anti-ISL2 therapy may offer a potential clinical strategy for treating m-oligodendroglioma.	[Qi, Lin; Shao, Xin-Rong; Li, Miao; Chen, Shu-Na; Liu, Xue-Qi; Zhang, Xu-Dong; Li, Xin; Zhao, Wenxue; Pan, Ji-An; Zhao, Bo; Zhang, Xing-Ding] Sun Yat Sen Univ, Sch Med, Dept Pharmacol, Mol Canc Res Ctr, Shenzhen, Peoples R China; [Qi, Lin] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; [Wang, Zhong-Yong] Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou, Peoples R China; [Yan, Shi] Univ Vet Med Vienna, Inst Parasitol, Dept Pathobiol, Vienna, Austria; [Zhang, Bo] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Intervent Radiol, Guangzhou, Peoples R China	Sun Yat Sen University; Northwestern University; Feinberg School of Medicine; Soochow University - China; University of Veterinary Medicine Vienna; Sun Yat Sen University	Qi, L; Zhang, XD (corresponding author), Sun Yat Sen Univ, Sch Med, Dept Pharmacol, Mol Canc Res Ctr, Shenzhen, Peoples R China.; Qi, L (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA.	qilin23@mail.sysu.edu.cn; zhangxd39@mail.sysu.edu.cn	zhang, xu/GRX-9733-2022; zhang, xian/GYA-0290-2022; Zhao, Bo/GVT-7665-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GYE-3558-2022; Li, Xin/A-4137-2011; Yan, Shi/H-9091-2013	Zhao, Bo/0000-0002-2163-6484; WANG, ZHONGYONG/0000-0003-1131-3849; Li, Xin/0000-0001-8328-4894; Yan, Shi/0000-0003-4949-9140; Liu, Xueqi/0000-0002-8295-032X	National Natural Science Foundation of China [81970191, 31971161, 31971224, 81301978]; Guangdong Natural Science Foundation of China [2018A0303130090, 2019A1515011332]; Youth Medical Doctors Project of Jiangsu Province of China [QNRC2016870]; Fundamental Research Funds for the Central Universities of China [19ykpy149]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Youth Medical Doctors Project of Jiangsu Province of China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported in part by the National Natural Science Foundation of China (grant nos. 81970191, 31971161, 31971224, and 81301978), the Guangdong Natural Science Foundation of China (grant nos. 2018A0303130090 and 2019A1515011332), the Youth Medical Doctors Project of Jiangsu Province of China (QNRC2016870), and the Fundamental Research Funds for the Central Universities of China (grant no. 19ykpy149).	Alfonso JCL, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0490; Bachy I, 2002, NEUROREPORT, V13, pA23, DOI 10.1097/00001756-200202110-00002; Chaudhry IH, 2001, HISTOPATHOLOGY, V39, P409, DOI 10.1046/j.1365-2559.2001.01230.x; Chen Z, 2016, GUT, V65, P925, DOI 10.1136/gutjnl-2014-308416; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Edqvist PHD, 2006, EUR J HISTOCHEM, V50, P147; Esencay M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-347; Feller C, 2020, ACTA NEUROPATHOL, V139, P211, DOI 10.1007/s00401-019-02096-8; Fischer I, 2005, BRAIN PATHOL, V15, P297; Fuchs Q, 2020, CANCERS, V12, DOI 10.3390/cancers12040979; Gagliardi F, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104705; Gill Gordon N, 2003, Trans Am Clin Climatol Assoc, V114, P179; Heindryckx F, 2015, WORLD J HEPATOL, V7, P165, DOI 10.4254/wjh.v7.i2.165; Karamysheva AF, 2008, BIOCHEMISTRY-MOSCOW+, V73, P751, DOI 10.1134/S0006297908070031; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Kay RB, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00073; Krenzlin H, 2019, J CLIN INVEST, V129, P1671, DOI 10.1172/JCI123375; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Martinez-Gonzalez A, 2016, ADV EXP MED BIOL, V936, P11, DOI 10.1007/978-3-319-42023-3_2; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Onishi M, 2011, BRAIN TUMOR PATHOL, V28, P13, DOI 10.1007/s10014-010-0007-z; Osterberg N, 2016, NEURO-ONCOLOGY, V18, P939, DOI 10.1093/neuonc/now005; Podbielska M, 2016, J LIPID RES, V57, P2028, DOI 10.1194/jlr.M070664; POST GR, 1992, MOL CHEM NEUROPATHOL, V16, P303, DOI 10.1007/BF03159976; Qi L, 2015, PLOS ONE, V10; Reyes-Botero G, 2018, ONCOLOGIST, V23, P524, DOI 10.1634/theoncologist.2017-0689; Schiffer D, 2018, NEUROL SCI, V39, P1161, DOI 10.1007/s10072-018-3408-0; Scholz A, 2015, ANN NY ACAD SCI, V1347, P45, DOI 10.1111/nyas.12726; Seano G, 2020, ANGIOGENESIS, V23, P9, DOI 10.1007/s10456-019-09691-z; Shim WSN, 2007, MOL CANCER RES, V5, P655, DOI 10.1158/1541-7786.MCR-07-0072; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Vallee A, 2018, REV NEUROSCIENCE, V29, P71, DOI 10.1515/revneuro-2017-0032; van den Bent MJ, 2018, LANCET ONCOL, V19, P1170, DOI 10.1016/S1470-2045(18)30362-0; van den Bent MJ, 2018, NEUROL CLIN, V36, P467, DOI 10.1016/j.ncl.2018.04.005; Wang ML, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0533-1; Wang X, 2014, ONCOL REP, V31, P1975, DOI 10.3892/or.2014.3112; Weller M, 2017, LANCET ONCOL, V18, pE315, DOI 10.1016/S1470-2045(17)30194-8; Weller M, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.17; Wesseling P, 2015, ACTA NEUROPATHOL, V129, P809, DOI 10.1007/s00401-015-1424-1; Yazdani Yasaman, 2016, Asian Pac J Cancer Prev, V17, P5303; Zhang XD, 2016, CANCER CELL, V29, P639, DOI 10.1016/j.ccell.2016.03.026	46	9	9	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2020	39	37					5964	5978		10.1038/s41388-020-01411-y	http://dx.doi.org/10.1038/s41388-020-01411-y		AUG 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NM2OY	32753650				2022-12-26	WOS:000555747100004
J	Rose, P; Schleimer, JH; Schreiber, S				Rose, Pia; Schleimer, Jan-Hendrik; Schreiber, Susanne			Modifications of sodium channel voltage dependence induce arrhythmia-favouring dynamics of cardiac action potentials	PLOS ONE			English	Article							HUMAN VENTRICULAR TISSUE; WAVE-PROPAGATION; PATHOPHYSIOLOGY; MUTATION; SCN5A; MODEL	Heart arrhythmia is a pathological condition where the sequence of electrical impulses in the heart deviates from the normal rhythm. It is often associated with specific channelopathies in cardiac tissue, yet how precisely the changes in ionic channels affect the electrical activity of cardiac cells is still an open question. Even though sodium channel mutations that underlie cardiac syndromes like the Long-Q-T and the Brugada-syndrome are known to affect a number of channel parameters simultaneously, previous studies have predominantly focused on the persistent late component of the sodium current as the causal explanation for an increased risk of heart arrhythmias in these cardiac syndromes. A systematic analysis of the impact of other important sodium channel parameters is currently lacking. Here, we investigate the reduced ten-Tusscher-model for single human epicardium ventricle cells and use mathematical bifurcation analysis to predict the dependence of the cardiac action potential on sodium channel activation and inactivation time-constants and voltage dependence. We show that, specifically, shifts of the voltage dependence of activation and inactivation curve can lead to drastic changes in the action potential dynamics, inducing oscillations of the membrane potential as well as bistability. Our results not only demonstrate a new way to induce multiple co-existing states of excitability (biexcitability) but also emphasize the critical role of the voltage dependence of sodium channel activation and inactivation curves for the induction of heart-arrhythmias.	[Rose, Pia; Schleimer, Jan-Hendrik; Schreiber, Susanne] Humboldt Univ, Inst Theoret Biol, Berlin, Germany; [Schleimer, Jan-Hendrik; Schreiber, Susanne] Bernstein Ctr Computat Neurosci, Berlin, Germany	Humboldt University of Berlin	Schreiber, S (corresponding author), Humboldt Univ, Inst Theoret Biol, Berlin, Germany.; Schreiber, S (corresponding author), Bernstein Ctr Computat Neurosci, Berlin, Germany.	s.schreiber@hu-berlin.de		Rose, Pia/0000-0001-6757-8083	German Federal Ministry of Education and Research (BMBF) [01GQ1403]; German Research Foundation (DFG); Open Access Publication Fund of Humboldt-Universitat zu Berlin	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of Humboldt-Universitat zu Berlin	S.S. received funding for this work from the German Federal Ministry of Education and Research (BMBF, 01GQ1403), https://www.bmbf.de. We acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Fund of Humboldt-Universitat zu Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsayed M, 2015, J PHYSIOL-LONDON, V593, P4201, DOI 10.1113/JP270139; Amin AS, 2010, PFLUG ARCH EUR J PHY, V460, P223, DOI 10.1007/s00424-009-0761-0; [Anonymous], 2012, CLIN ARRHYTHMOLOGY E; Beuter A., 2003, NONLINEAR DYNAMICS P; Chadda KR, 2017, PFLUG ARCH EUR J PHY, V469, P629, DOI 10.1007/s00424-017-1959-1; Chang MG, 2012, HEART RHYTHM, V9, P115, DOI 10.1016/j.hrthm.2011.08.014; CRANEFIELD PF, 1977, CIRC RES, V41, P415, DOI 10.1161/01.RES.41.4.415; Fernandez-Falgueras A, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010007; GADSBY DC, 1977, J GEN PHYSIOL, V70, P725, DOI 10.1085/jgp.70.6.725; Horvath B, 2014, ESC HEART FAIL, V1, P26, DOI 10.1002/ehf2.12003; Hsu EJ, 2017, J GEN PHYSIOL, V149, P389, DOI 10.1085/jgp.201611678; Lowe JS, 2012, CARDIOVASC RES, V95, P300, DOI 10.1093/cvr/cvs160; Makita N, 2008, J CLIN INVEST, V118, P2219, DOI [10.1172/JCl34057, 10.1172/JCI34057]; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Moreno JD, 2012, J MOL CELL CARDIOL, V52, P608, DOI 10.1016/j.yjmcc.2011.12.003; Noble D, 2006, HEART, V92, P1, DOI 10.1136/hrt.2005.078782; Qu ZL, 2015, ANNU REV PHYSIOL, V77, P29, DOI 10.1146/annurev-physiol-021014-071622; Santana LF, 2010, J MOL CELL CARDIOL, V49, P901, DOI 10.1016/j.yjmcc.2010.09.005; Sheets MF, 2010, TRENDS CARDIOVAS MED, V20, P16, DOI 10.1016/j.tcm.2010.03.002; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Swan H, 2014, CIRC-CARDIOVASC GENE, V7, P771, DOI 10.1161/CIRCGENETICS.114.000703; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; Ten Tusscher KHWJ, 2006, PHYS MED BIOL, V51, P6141, DOI 10.1088/0031-9155/51/23/014; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; VERMEULEN JT, 1994, CARDIOVASC RES, V28, P1547, DOI 10.1093/cvr/28.10.1547	25	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0236949	10.1371/journal.pone.0236949	http://dx.doi.org/10.1371/journal.pone.0236949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750067	Green Published, gold			2022-12-26	WOS:000560009200034
J	Nuryawan, A; Hutauruk, NO; Purba, EYS; Masruchin, N; Batubara, R; Risnasari, I; Satrio, FK; Rahmawaty; Basyuni, M; McKay, D				Nuryawan, Arif; Hutauruk, Nova O.; Purba, Esra Yunita S.; Masruchin, Nanang; Batubara, Ridwanti; Risnasari, Iwan; Satrio, Fatih Khusno; Rahmawaty; Basyuni, Mohammad; McKay, Deirdre			Properties of wood composite plastics made from predominant Low Density Polyethylene (LDPE) plastics and their degradability in nature	PLOS ONE			English	Article							WATER-ABSORPTION; MECHANICAL-PROPERTIES; BEHAVIOR; HDPE; RESISTANCE; EXTRUSION; WASTE; FLOUR	To address concerns over plastics in the global environment, this project produced three wood plastics composites (WPCs) which could divert plastics from the waste stream into new materials. The three materials made had a ratio of 85%:15%, 90%:10%, and 95%:5% low density polyethylene (LDPE) to wood powder and were produced using the dissolution method. Physical and mechanical properties of each WPC were evaluated according to Japanese Industrial Standard (JIS) A 5908:2003. Their degradation in nature was evaluated through a graveyard test and assay test conducted inCoptotermes curvignathustermites. Results showed that density, moisture content, thickness swelling and water absorption of the WPCs fulfilled the JIS standard. The mechanical properties of these composites also met the JIS standard, particularly their modulus of elasticity (MOE). Modulus of rupture (MOR) and internal bonding (IB) showed in lower values, depending on the proportion of wood filler they contained. Discoloration of the WPCs was observed after burial in the soil with spectra alteration of attenuated transmission reflectance (ATR) in the band of 500-1000 cm(-1)which could be assigned to detach the interphase between wood and plastics. As termite bait, the WPCs decreased in weight, even though the mass loss was comparatively small. Micro Confocal Raman Imaging Spectrometer revealed that termite guts from insects feeding on WPCs contained small amounts of LDPE. This indicated termite can consume plastics in the form of WPCs. Thus WPCs made predominantly of plastics can be degraded in nature. While producing WPCs can assist in decreasing plastics litter in the environment, the eventual fate of the LDPE in termites is still unknown.	[Nuryawan, Arif; Hutauruk, Nova O.; Purba, Esra Yunita S.; Batubara, Ridwanti; Risnasari, Iwan] Univ Sumatera Utara, Dept Forest Prod Technol, Fac Forestry, Medan, North Sumatra, Indonesia; [Masruchin, Nanang] Indonesian Inst Sci LIPI, Res Ctr Biomat, Cibinong, West Java, Indonesia; [Satrio, Fatih Khusno] PT Horiba Indonesia, Tangerang, Banten, Indonesia; [Rahmawaty] Univ Sumatera Utara, Dept Forest Management, Fac Forestry, Medan, North Sumatra, Indonesia; [Basyuni, Mohammad] Univ Sumatera Utara, Dept Silviculture, Fac Forestry, Medan, North Sumatra, Indonesia; [McKay, Deirdre] Keele Univ, Sch Geog Geol & Environm, Keele, Staffs, England; [Nuryawan, Arif; Batubara, Ridwanti; Risnasari, Iwan; Basyuni, Mohammad] Univ Sumatera Utara, Ctr Excellence Mangrove, Medan, North Sumatra, Indonesia	University of North Sumatra; Indonesian Institute of Sciences; University of North Sumatra; University of North Sumatra; Keele University; University of North Sumatra	Nuryawan, A (corresponding author), Univ Sumatera Utara, Dept Forest Prod Technol, Fac Forestry, Medan, North Sumatra, Indonesia.; Nuryawan, A (corresponding author), Univ Sumatera Utara, Ctr Excellence Mangrove, Medan, North Sumatra, Indonesia.	arif5@usu.ac.id	Risnasari, Iwan/AAC-2270-2021; Masruchin, Nanang/HGU-6093-2022; Basyuni, Mohammad/D-8537-2015; Nuryawan, Arif/AAR-7179-2020; , Rahmawaty/AAV-8902-2020	Risnasari, Iwan/0000-0003-2178-162X; Masruchin, Nanang/0000-0003-0866-754X; Basyuni, Mohammad/0000-0003-1120-8571; Nuryawan, Arif/0000-0002-4525-6937; , Rahmawaty/0000-0002-2052-2813; Batubara, Ridwanti/0000-0003-2476-7989	Universitas Sumatera Utara (USU) [2590/UN5.1.R/PPM/2018]	Universitas Sumatera Utara (USU)	AN thanks to Universitas Sumatera Utara (USU) for funding this research under scheme of Penelitian Terapan TALENTA-USU year of 2018, contract number 2590/UN5.1.R/PPM/2018 date of March 16, 2018. FKS is employed by and receives salary from PT.Horiba Indonesia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AP, 2014, RSC ADV, V4, P40421, DOI 10.1039/c4ra06220e; Achilias DS, 2007, J HAZARD MATER, V149, P536, DOI 10.1016/j.jhazmat.2007.06.076; [Anonymous], 2006, 017207 SNI NAT STAND; Antriana N., 2014, SAINTIFIKA, V6.; Atli A, 2018, INT J CHEM MOL NUCL, V12, P226; Aydemir D, 2019, DRVNA IND, V70, P279, DOI 10.5552/drvind.2019.1851; Baeza J, 2001, CHEM CHARACTERIZATIO, P275; Burke J., 1984, SOLUBILITY PARAMETER, P13; Chen Y, 2016, MATERIALS, V9, DOI 10.3390/ma9080610; Chen Y, 2014, WOOD SCI TECHNOL, V48, P137, DOI 10.1007/s00226-013-0582-3; Clemons C, 2002, FOREST PROD J, V52, P10; Essabir H, 2016, CARBOHYD POLYM, V143, P70, DOI 10.1016/j.carbpol.2016.02.002; Feng Jing, 2014, Journal of Applied Sciences, V14, P776; Flores-Hernandez MA, 2014, J COMPOS MATER, V48, P209, DOI 10.1177/0021998312470149; Gao X, 2018, POLYM COMPOSITE, V39, P3236, DOI 10.1002/pc.24336; Guidigo J, 2017, INT J SCI RES, V6, P1069; Gulitah V., 2019, INT J BIOBASED PLAST, V1, P22, DOI [10.1080/24759651.2019.1631242, DOI 10.1080/24759651.2019.1631242]; Hadi AJ, 2019, THEOR FOUND CHEM EN+, V53, P115, DOI 10.1134/S0040579519010068; Handayani S, 2019, MATEC WEB CONF, V258, DOI 10.1051/matecconf/201925801022; Hatakeyama T., 1999, THERMAL ANAL FUNDAME; Hopewell J, 2009, PHILOS T R SOC B, V364, P2115, DOI 10.1098/rstb.2008.0311; Hunter Lab, 2008, HUNT LAB COL SCAL; Il'yasova AN, 2016, POLYM SCI SER A+, V58, P1017, DOI 10.1134/S0965545X16060092; Jam NJ, 2007, J THERMOPLAST COMPOS, V20, P439, DOI 10.1177/0892705707082324; Japanese Industrial Standards, 2015, A5908 JIS; Karami A, 2017, SCI REPORTS, P46173; Karami A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05828-6; Khalil HPSA, 2002, POLYM-PLAST TECHNOL, V41, P453, DOI 10.1081/PPT-120004362; Kim BormJune, 2014, Mokchae Konghak = Journal of the Korean Wood Science and Technology, V42, P499; Kim JW, 2008, WOOD FIBER SCI, V40, P519; King AM, 2006, SUSTAIN DEV, V14, P257, DOI 10.1002/sd.271; Lukmandaru G., 2009, J FORESTRY, V3; Morrell JJ, 2010, 10 INT C WOOD BIOF P, P71; Muthusamy M. S., 2019, CURR WORLD ENVIRON, V14, P49, DOI DOI 10.12944/CWE.14.1.07; Najafi SK, 2008, J COMPOS MATER, V42, P993, DOI 10.1177/0021998307088608; Nuryawan A, 2019, INT C SCI TECHN ENG; Nygard P, 2008, COMPOS SCI TECHNOL, V68, P3418, DOI 10.1016/j.compscitech.2008.09.029; Onggo D, 1999, J MATER SCI, V4, P13; Pandey KK, 1999, J APPL POLYM SCI, V71, P1969, DOI 10.1002/(SICI)1097-4628(19990321)71:12<1969::AID-APP6>3.0.CO;2-D; Rao JP, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10030266; Ritchie R, 2020, PLASTIC POLLUTION; da Luz JMR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069386; Schirp A, 2008, AM CHEM SOC ACS S SE; Segerholm BK, 2013, P IRG ANN M IRG WP 1; Singh AP, 2013, MICRON, V54-55, P87, DOI 10.1016/j.micron.2013.08.011; Stark NM, 2007, POLYM DEGRAD STABIL, V92, P1883, DOI 10.1016/j.polymdegradstab.2007.06.017; Sykacek E, 2009, COMPOS PART A-APPL S, V40, P1272, DOI 10.1016/j.compositesa.2009.05.023; Tshabalala MA, 2005, HANDBOOK OF WOOD CHEMISTRY AND WOOD COMPOSITES, P187; Turku I, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00559; Ulyshen MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101867; Vasile C, 2013, COMPOS PART B-ENG, V55, P314, DOI 10.1016/j.compositesb.2013.06.008; Yang HS, 2006, COMPOS STRUCT, V72, P429, DOI 10.1016/j.compstruct.2005.01.013; Zhao YB, 2018, CHEMOSPHERE, V209, P707, DOI 10.1016/j.chemosphere.2018.06.095	53	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236406	10.1371/journal.pone.0236406	http://dx.doi.org/10.1371/journal.pone.0236406			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745098	Green Accepted, gold, Green Published			2022-12-26	WOS:000560006800045
J	Fortuin, AS; Philips, BWJ; van der Leest, MMG; Ladd, ME; Orzada, S; Maas, MC; Scheenen, TWJ				Fortuin, Ansje S.; Philips, Bart W. J.; van der Leest, Marloes M. G.; Ladd, Mark E.; Orzada, Stephan; Maas, Marnix C.; Scheenen, Tom W. J.			Magnetic resonance imaging at ultra-high magnetic field strength: An in vivo assessment of number, size and distribution of pelvic lymph nodes	PLOS ONE			English	Article							TIME-INTERLEAVED ACQUISITION; CLINICAL-PRACTICE GUIDELINES; PROSTATE-CANCER PATIENTS; RADICAL PROSTATECTOMY; NODAL METASTASES; MR LYMPHOGRAPHY; LYMPHADENECTOMY; DISSECTION; DIAGNOSIS; ACCURACY	Objective The definition of an in vivo nodal anatomical baseline is crucial for validation of representative lymph node dissections and accompanying pathology reports of pelvic cancers, as well as for assessing a potential therapeutic effect of extended lymph node dissections. Therefore the number, size and distribution of lymph nodes in the pelvis were assessed with high-resolution, large field-of-view, 7 Tesla (T) magnetic resonance imaging (MRI) with frequency-selective excitation. Materials and methods We used 7 T MRI for homogeneous pelvic imaging in 11 young healthy volunteers. Frequency-selective imaging of water and lipids was performed to detect nodal structures in the pelvis. Number and size of detected nodes was measured and size distribution per region was assessed. An average volunteer-normalized nodal size distribution was determined. Results In total, 564 lymph nodes were detected in six pelvic regions. Mean number was 51.3 with a wide range of 19-91 lymph nodes per volunteer. Mean diameter was 2.3 mm with a range of 1 to 7 mm. 69% Was 2 mm or smaller. The overall size distribution was very similar to the average volunteer-normalized nodal size distribution. Conclusions The amount of in vivo visible lymph nodes varies largely between subjects, whereas the normalized size distribution of nodes does not. The presence of many small lymph nodes (<= 2mm) renders representative or complete removal of pelvic lymph nodes to be very difficult. 7T MRI may shift the in vivo detection limits of lymph node metastases in the future.	[Fortuin, Ansje S.; Philips, Bart W. J.; van der Leest, Marloes M. G.; Maas, Marnix C.; Scheenen, Tom W. J.] Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Nijmegen, Netherlands; [Fortuin, Ansje S.] Ziekenhuis Gelderse Vallei, Dept Radiol, Ede, Netherlands; [Ladd, Mark E.] German Canc Res Ctr, Med Phys Radiol, Heidelberg, Germany; [Ladd, Mark E.] Heidelberg Univ, Fac Phys & Astron, Heidelberg, Germany; [Ladd, Mark E.] Heidelberg Univ, Fac Med, Heidelberg, Germany; [Ladd, Mark E.; Orzada, Stephan; Scheenen, Tom W. J.] Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany	Radboud University Nijmegen; Gelderse Vallei Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Duisburg Essen	Scheenen, TWJ (corresponding author), Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Nijmegen, Netherlands.; Scheenen, TWJ (corresponding author), Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany.	Tom.Scheenen@radboudumc.nl	Ladd, Mark E./B-3285-2011; Orzada, Stephan/H-6745-2019; Scheenen, Tom W.J./I-5921-2013	Orzada, Stephan/0000-0001-9784-4354; Fortuin, Ansje/0000-0003-1372-3294; Ladd, Mark/0000-0002-4128-9440	Dutch Cancer Society [KUN 2014-6624]; European Research Council under the European Union [291903]	Dutch Cancer Society(KWF Kankerbestrijding); European Research Council under the European Union(European Research Council (ERC))	The research leading to these results has received funding from the Dutch Cancer Society (Bart Philips, KUN 2014-6624) and the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement n. 291903 MRexcite (Mark Ladd). There are no other disclosures to acknowledge for all authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellomi M, 2005, EUR RADIOL, V15, P2469, DOI 10.1007/s00330-005-2847-1; Brown G, 2003, RADIOLOGY, V227, P371, DOI 10.1148/radiol.2272011747; Canessa CE, 2001, DIS COLON RECTUM, V44, P1333, DOI 10.1007/BF02234794; Chand M, 2013, COLORECTAL DIS, V15, P1201, DOI 10.1111/codi.12435; Conti A, 2017, WORLD J UROL, V35, P517, DOI 10.1007/s00345-015-1752-8; Dorin RP, 2011, EUR UROL, V60, P946, DOI 10.1016/j.eururo.2011.07.012; Fortuin AS, 2018, WIRES NANOMED NANOBI, V10, DOI 10.1002/wnan.1471; Fortuin AS, 2012, INT J RADIAT ONCOL, V84, P712, DOI 10.1016/j.ijrobp.2011.12.093; Fossati N, 2017, EUR UROL, V72, P84, DOI 10.1016/j.eururo.2016.12.003; Fransen van de Putte EE, 2015, UROL ONCOL, V33; Frost JA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007585.pub4; Ganswindt U, 2011, INT J RADIAT ONCOL, V79, P1364, DOI 10.1016/j.ijrobp.2010.01.012; Glynne-Jones R, 2017, ANN ONCOL, V28, P22, DOI 10.1093/annonc/mdx224; Heesakkers RAM, 2009, RADIOLOGY, V251, P408, DOI 10.1148/radiol.2512071018; Hilton S, 1997, AM J ROENTGENOL, V169, P521, DOI 10.2214/ajr.169.2.9242768; Hope TA, 2019, J NUCL MED, V60, P786, DOI 10.2967/jnumed.118.219501; Hovels AM, 2008, CLIN RADIOL, V63, P387, DOI 10.1016/j.crad.2007.05.022; Joniau S, 2013, EUR UROL, V63, P450, DOI 10.1016/j.eururo.2012.06.057; Koh DM, 2006, ABDOM IMAGING, V31, P632, DOI 10.1007/s00261-006-9022-2; McMahon CJ, 2010, RADIOLOGY, V254, P31, DOI 10.1148/radiol.2541090361; Meijer HJM, 2013, RADIOTHER ONCOL, V106, P59, DOI 10.1016/j.radonc.2012.10.021; Meijer HJM, 2012, INT J RADIAT ONCOL, V82, P1405, DOI 10.1016/j.ijrobp.2011.04.054; Montironi R, 2014, HUM PATHOL, V45, P2059, DOI 10.1016/j.humpath.2014.06.023; Morikawa LK, 2011, INT J RADIAT ONCOL, V80, P6, DOI 10.1016/j.ijrobp.2010.11.074; Netter FH, 2014, ATLAS HUMAN ANATOMY; Oldenburg J, 2013, ANN ONCOL, V24, P125, DOI 10.1093/annonc/mdt304; Orzada S, 2012, MAGN RESON MED, V67, P1033, DOI 10.1002/mrm.23081; Orzada S, 2010, MAGN RESON MED, V64, P327, DOI 10.1002/mrm.22527; Parker C, 2015, ANN ONCOL, V26, pV69, DOI 10.1093/annonc/mdv222; Philips BWJ, 2017, MAGN RESON MED, V78, P1020, DOI 10.1002/mrm.26498; Ramirez M, 2016, SURG RADIOL ANAT, V38, P425, DOI 10.1007/s00276-015-1581-x; Schiavina Riccardo, 2015, Clin Genitourin Cancer, V13, pe55, DOI 10.1016/j.clgc.2014.08.004; Stijns R, 2019, INVEST RADIOL, V54, P645, DOI 10.1097/RLI.0000000000000581; Thakur S, 2011, INT J SURG PATHOL, V19, P315, DOI 10.1177/1066896910393242; Topor B, 2003, DIS COLON RECTUM, V46, P779, DOI 10.1007/s10350-004-6656-4; von Eyben FE, 2018, EUR UROL FOCUS, V4, P686, DOI 10.1016/j.euf.2016.11.002; Weingartner K, 1996, J UROLOGY, V156, P1969, DOI 10.1016/S0022-5347(01)65406-5; Wu LC, 2011, EUR J RADIOL, V80, P582, DOI 10.1016/j.ejrad.2009.11.027; Yuan Y, 2012, EUR J RADIOL, V81, P1002, DOI 10.1016/j.ejrad.2011.01.112; Zheng YC, 2007, J SURG ONCOL, V96, P213, DOI 10.1002/jso.20826	40	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236884	10.1371/journal.pone.0236884	http://dx.doi.org/10.1371/journal.pone.0236884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735614	Green Published, gold			2022-12-26	WOS:000569367100055
J	Khadka, J; Raviv, B; Swetha, B; Grandhi, R; Singiri, JR; Novoplansky, N; Gutterman, Y; Galis, I; Huang, ZY; Grafi, G				Khadka, Janardan; Raviv, Buzi; Swetha, Bupur; Grandhi, Rohith; Singiri, Jeevan R.; Novoplansky, Nurit; Gutterman, Yitzchak; Galis, Ivan; Huang, Zhenying; Grafi, Gideon			Maternal environment alters dead pericarp biochemical properties of the desert annual plant Anastatica hierochuntica L.	PLOS ONE			English	Article							POLYGALACTURONASE-INHIBITING PROTEINS; STRESS TOLERANCE; GERMINATION INHIBITORS; SEEDBED ECOLOGY; DROUGHT STRESS; SALT TOLERANCE; ARABIDOPSIS; DORMANCY; TEMPERATURE; EXPRESSION	The dead organs enclosing embryos (DOEEs) emerge as central components of the dispersal unit (DU) capable for long-term storage of active proteins and other substances that affect seed performance and fate. We studied the effect of maternal environment (salt and salt+heat) on progeny DU (dry indehiscent fruit) focusing on pericarp properties of Anastatica hierochuntica. Stressed plants displayed increased seed abortion and low level and rate of germination. Hydrated pericarps released antimicrobial factors and allelopathic substances that inhibit germination of heterologous species. Proteome analysis of dead pericarps revealed hundreds of proteins, among them nucleases, chitinases and proteins involved in reactive oxygen species detoxification and cell wall modification. Salt treatment altered the composition and level of proteins stored in the pericarp. We observed changes in protein profile released from seeds of salt-treated plants with a notable increase in a small anti-fungal protein, defensin. The levels of phytohormones including IAA, ABA and salicylic acid were reduced in dead pericarps of stressed plants. The data presented here highlighted the predominant effects of maternal environment on progeny DUs of the desert plant A. hierochuntica, particularly on pericarp properties, which in turn might affect seed performance and fate, soil fertility and consequently plant biodiversity.	[Khadka, Janardan; Raviv, Buzi; Swetha, Bupur; Grandhi, Rohith; Singiri, Jeevan R.; Novoplansky, Nurit; Gutterman, Yitzchak; Grafi, Gideon] Ben Gurion Univ Negev, French Associates Inst Agr & Biotechnol Drylands, Jacob Blaustein Inst Desert Res, Midreshet Ben Gurion, Israel; [Galis, Ivan] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan; [Huang, Zhenying] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Ben Gurion University; Okayama University; Chinese Academy of Sciences; Institute of Botany, CAS	Grafi, G (corresponding author), Ben Gurion Univ Negev, French Associates Inst Agr & Biotechnol Drylands, Jacob Blaustein Inst Desert Res, Midreshet Ben Gurion, Israel.	ggrafi@bgu.ac.il	Khadka, Janardan/AAW-7293-2021	Khadka, Janardan/0000-0002-2672-4678; Galis, Ivan/0000-0001-9840-8845	Joint NSFC-ISF Research Grant [2456/18, 31861143024]; Joint Usage/Research Center, Institute of Plant Science and Resources, Okayama University, Japan	Joint NSFC-ISF Research Grant; Joint Usage/Research Center, Institute of Plant Science and Resources, Okayama University, Japan	The work was supported by a Joint NSFC-ISF Research Grant to GG (grant no. 2456/18) and ZH (grant no. 31861143024). This work was partly supported by the Joint Usage/Research Center, Institute of Plant Science and Resources, Okayama University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins SW, 2002, EUPHYTICA, V126, P13, DOI 10.1023/A:1019623706427; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Benikhlef L, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-133; Berardini TZ, 2004, PLANT PHYSIOL, V2, P1; Bernoux M, 2008, PLANT CELL, V20, P2252, DOI 10.1105/tpc.108.058685; Bhatt A, 2020, BOTANY, V98, P117, DOI 10.1139/cjb-2019-0096; Booth D. T., 1990, Journal of Seed Technology, V14, P61; BOOTH DT, 1989, J RANGE MANAGE, V42, P178, DOI 10.2307/3899467; BOOTH DT, 1983, J RANGE MANAGE, V36, P387, DOI 10.2307/3898495; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Cai YM, 2018, NEW PHYTOL, V218, P1143, DOI 10.1111/nph.14676; Cantero A, 2006, PLANT PHYSIOL BIOCH, V44, P13, DOI 10.1016/j.plaphy.2006.02.002; Chassot C, 2008, PLANT J, V55, P555, DOI 10.1111/j.1365-313X.2008.03540.x; Che-Othman MH, 2017, PLANT CELL ENVIRON, V40, P2875, DOI 10.1111/pce.13034; Chen M, 2014, P NATL ACAD SCI USA, V111, P18787, DOI 10.1073/pnas.1412274111; CLIPSON NJW, 1985, PLANTA, V165, P392, DOI 10.1007/BF00392237; Rodriguez-Gacio MD, 2009, PLANT SIGNAL BEHAV, V4, P1035, DOI 10.4161/psb.4.11.9902; Di CX, 2012, GENE, V506, P150, DOI 10.1016/j.gene.2012.06.085; Doungous O, 2018, ENVIRON SCI POLLUT R, V25, P25327, DOI 10.1007/s11356-018-2591-0; El-Keblawy A, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8090322; El-Keblawy A, 2016, J ARID LAND, V8, P254, DOI 10.1007/s40333-015-0023-2; Eshel G, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01992; EVENARI M, 1949, BOT REV, V15, P153, DOI 10.1007/BF02861721; Federici L, 2006, TRENDS PLANT SCI, V11, P65, DOI 10.1016/j.tplants.2005.12.005; Fenner M., 1991, Seed Science Research, V1, P75, DOI 10.1017/S0960258500000696; Ferrari S, 2012, PLANT BIOLOGY, V14, P31, DOI 10.1111/j.1438-8677.2011.00449.x; Finkelstein Ruth R., 2002, Plant Cell, V14, pS15; FRIEDMAN J, 1981, OECOLOGIA, V51, P400, DOI 10.1007/BF00540912; Fukumoto K, 2013, J INTEGR PLANT BIOL, V55, P775, DOI 10.1111/jipb.12057; Gatford KT, 2002, FUNCT PLANT BIOL, V29, P881, DOI 10.1071/PP01011; Gaudet DA, 2003, PHYSIOL PLANTARUM, V117, P195, DOI 10.1034/j.1399-3054.2003.00041.x; Godwin J, 2017, PLANTS-BASEL, V6, DOI 10.3390/plants6040064; Grafi G, 2019, ISR J PLANT SCI, V66, P52, DOI 10.1163/22238980-00001048; Grover A, 2012, CRIT REV PLANT SCI, V31, P57, DOI 10.1080/07352689.2011.616043; Gupta A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03907-2; Gutterman Y., 1978, Journal of Arid Environments, V1, P141; GUTTERMAN Y, 1972, J ECOL, V60, P713, DOI 10.2307/2258561; Gutterman Y., 1978, ACTA HORTIC, V83, P49, DOI DOI 10.17660/ACTAHORTIC.1978.83.6; HARPER SHT, 1980, NEW PHYTOL, V84, P473, DOI 10.1111/j.1469-8137.1980.tb04554.x; Hatzig SV, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1531-y; Hsu FC, 2013, PLANT CELL, V25, P2699, DOI 10.1105/tpc.113.114447; Huang ZY, 2016, ECOLOGY, V97, P250, DOI 10.1890/15-0744.1; Hyun TK, 2015, TRANSGENIC RES, V24, P651, DOI 10.1007/s11248-015-9868-6; Hyun TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112946; Konopka-Postupolska D, 2009, PLANT PHYSIOL, V150, P1394, DOI 10.1104/pp.109.135228; Li R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01411; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047682; Liu YH, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00938; MacGregor DR, 2015, NEW PHYTOL, V205, P642, DOI 10.1111/nph.13090; Maitra N., 1998, PLANT PHYSIOL, V118, P1536; MIYAMOTO T, 1961, PLANT PHYSIOL, V36, P739, DOI 10.1104/pp.36.6.739; Muller K, 2013, PLANT PHYSIOL, V161, P305, DOI 10.1104/pp.112.205724; Patton T, 2006, J MICROBIOL METH, V64, P84, DOI 10.1016/j.mimet.2005.04.007; Penfield S, 2017, J EXP BOT, V68, P819, DOI 10.1093/jxb/erw436; Perez-Amador MA, 2000, PLANT PHYSIOL, V122, P169, DOI 10.1104/pp.122.1.169; Raviv B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082455; Raviv B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181102; Raviv B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177537; Reef R, 2012, FUNCT PLANT BIOL, V39, P1038, DOI 10.1071/FP12178; Ren CW, 2000, PLANT PHYSIOL, V124, P231, DOI 10.1104/pp.124.1.231; Richards SL, 2015, J EXP BOT, V66, P37, DOI 10.1093/jxb/eru398; Sah SK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00571; SANKARY MN, 1972, ECOLOGY, V53, P1155, DOI 10.2307/1935429; Sathoff AE, 2019, MOL PLANT MICROBE IN, V32, P507, DOI 10.1094/MPMI-08-18-0229-CR; Scheler C, 2015, PLANT PHYSIOL, V167, P200, DOI 10.1104/pp.114.247429; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Singh P, 2014, PLANT CELL, V26, P2676, DOI 10.1105/tpc.114.123356; SROELOV Rachel., 1940, Palestine Journal of Botany, V2, P33; Steinbrecher T, 2017, J EXP BOT, V68, P765, DOI 10.1093/jxb/erw428; Sun K, 2004, PLANT PHYSIOL, V135, P2358, DOI 10.1104/pp.104.043091; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Tielborger K, 2014, PROG BOT, V75, P377, DOI 10.1007/978-3-642-38797-5_12; Ueno K, 2005, EUPHYTICA, V143, P271, DOI 10.1007/s10681-005-7880-2; Vandvik V, 2016, OIKOS, V125, P218, DOI 10.1111/oik.02022; Varga M., 1966, ACTA BIOL, V10, P65; Verbon EH, 2016, TRENDS PLANT SCI, V21, P218, DOI 10.1016/j.tplants.2016.01.013; Vriens K, 2014, MOLECULES, V19, P12280, DOI 10.3390/molecules190812280; Wijewardana C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214977; WURZBURGER J, 1969, NEW PHYTOL, V68, P337, DOI 10.1111/j.1469-8137.1969.tb06445.x; Young LW, 2004, J EXP BOT, V55, P485, DOI 10.1093/jxb/erh038; Zamioudis C, 2012, MOL PLANT MICROBE IN, V25, P139, DOI 10.1094/MPMI-06-11-0179	82	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0237045	10.1371/journal.pone.0237045	http://dx.doi.org/10.1371/journal.pone.0237045			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735576	Green Published, gold			2022-12-26	WOS:000569367100067
J	Canabarro, A; Tenorio, E; Martins, R; Martins, L; Brito, S; Chaves, R				Canabarro, Askery; Tenorio, Elayne; Martins, Renato; Martins, Lais; Brito, Samurai; Chaves, Rafael			Data-driven study of the COVID-19 pandemic via age-structured modelling and prediction of the health system failure in Brazil amid diverse intervention strategies	PLOS ONE			English	Article								In this work we propose a data-driven age-structured census-based SIRD-like epidemiological model capable of forecasting the spread of COVID-19 in Brazil. We model the current scenario of closed schools and universities, social distancing of people above sixty years old and voluntary home quarantine to show that it is still not enough to protect the health system by explicitly computing the demand for hospital intensive care units. We also show that an urgent intense quarantine might be the only solution to avoid the collapse of the health system and, consequently, to minimize the quantity of deaths. On the other hand, we demonstrate that the relaxation of the already imposed control measures in the next days would be catastrophic.	[Canabarro, Askery; Brito, Samurai; Chaves, Rafael] Univ Fed Rio Grande do Norte, Int Inst Phys, Natal, RN, Brazil; [Canabarro, Askery] Univ Fed Alagoas, Nucleo Ciencias Exatas NCEx, Grp Fis Mat Condensada, Campus Arapiraca, Arapiraca, AL, Brazil; [Tenorio, Elayne] Hosp Santa Casa Misericordia Maceio, Maceio, AL, Brazil; [Martins, Renato] HIV AIDS Testing & Counseling Ctr, Itaberaba, BA, Brazil; [Martins, Lais] Super Sch Hlth Sci, Brasilia, DF, Brazil; [Chaves, Rafael] Univ Fed Rio Grande do Norte, Sch Sci & Technol, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal de Alagoas; Universidade Federal do Rio Grande do Norte	Canabarro, A (corresponding author), Univ Fed Rio Grande do Norte, Int Inst Phys, Natal, RN, Brazil.; Canabarro, A (corresponding author), Univ Fed Alagoas, Nucleo Ciencias Exatas NCEx, Grp Fis Mat Condensada, Campus Arapiraca, Arapiraca, AL, Brazil.	askery.canabarro@arapiraca.ufal.br	De Aguiar Brito, Samuraí Gomes/AAG-5625-2020; Chaves, Rafael/H-4725-2016; Canabarro, Askery/F-3213-2012	De Aguiar Brito, Samuraí Gomes/0000-0002-0131-1949; Chaves, Rafael/0000-0001-8493-4019; Canabarro, Askery/0000-0001-5048-2317				Anastassopoulou C, 2020, PLOS ONE, DOI [10.1101/2020.02.11.20022186, DOI 10.1101/2020.02.11.20022186, DOI 10.1371/JOURNAL.PONE.0230405, 10.1371/journal.pone.0230405]; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Arenas A, 2020, PHYS REV X, DOI DOI 10.1103/PHYSREVX.10.041055; Arenas A., 2020, DERIVATION EFFECTIVE, DOI [10.1101/2020.04.06.20054320., DOI 10.1101/2020.04.06.20054320, 10.1101/2020.04.06.20054320]; Caccavo D., 2020, CHINESE ITALIAN COVI, DOI 10.1101/2020.03.19.20039388; Canabarro AA, 2004, PHYSICA A, V342, P234, DOI 10.1016/j.physa.2004.04.083; Castellano C, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.011070; Chang SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19393-6; Gleria I, 2015, BRAZ J PHYS, V45, P450, DOI 10.1007/s13538-015-0339-6; Gonzalez RI, 2020, IS COVID19 QUARANTIN; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Imai N, 2020, REPORT 9 IMPACT NON, DOI 10.25561/77482; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lyra1 W, 2020, EFFECT VERTICAL CONF, DOI [10.1101/2020.04.09.20060053, DOI 10.1101/2020.04.09.20060053]; Messias D, 2018, PHYSICA A, V492, P215, DOI 10.1016/j.physa.2017.09.088; Miller A., 2020, MEDRXIV, DOI 10.1101/2020.03.24.20042937; Moore S, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.068301; Nowak MA., 2000, VIRUS DYNAMICS MATH; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Prem K, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005697; Rackauckas C., 2017, J OPEN RES STW, V5, P15, DOI 10.5334/jors.151; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Scabini LFS, 2020, SOCIAL INTERACTION L; TSALLIS C, 2020, PREDICTING COVID 19; Vattay G., 2020, PREDICTING ULTIMATE; Verity R, 2020, ESTIMATES SEVERITY C, DOI DOI 10.1101/2020.03.09.20033357; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xue J, 2020, REINFECTION COULD NO, DOI [10.1101/2020.03.13.990226v2, DOI 10.1101/2020.03.13.990226V1, 10.1101/2020.03.13.990226]; Zhou T, 2006, PROG NAT SCI-MATER, V16, P452	29	18	19	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236310	10.1371/journal.pone.0236310	http://dx.doi.org/10.1371/journal.pone.0236310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730352	Green Published, Green Submitted, gold			2022-12-26	WOS:000556884700039
J	Maity, S; Das, F; Kasinath, BS; Ghosh-Choudhury, N; Choudhury, GG				Maity, Soumya; Das, Falguni; Kasinath, Balakuntalam S.; Ghosh-Choudhury, Nandini; Ghosh Choudhury, Goutam			TGF beta acts through PDGFR beta to activate mTORC1 via the Akt/PRAS40 axis and causes glomerular mesangial cell hypertrophy and matrix protein expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; diabetic nephropathy; Akt (protein kinase B); mTOR complex (mTORC); PDGFR&#946; diabetic nephropathy; transforming growth factor-&#946; (TGF&#946; )	GROWTH-FACTOR-BETA; MESSENGER-RNA TRANSLATION; DIABETIC-NEPHROPATHY; MAMMALIAN TARGET; HIGH GLUCOSE; PHOSPHATIDYLINOSITOL 3-KINASE; EXPERIMENTAL GLOMERULONEPHRITIS; FIBRONECTIN EXPRESSION; MESENCHYMAL TRANSITION; RAPAMYCIN COMPLEXES	Interaction of transforming growth factor-beta (TGF beta)-induced canonical signaling with the noncanonical kinase cascades regulates glomerular hypertrophy and matrix protein deposition, which are early features of glomerulosclerosis. However, the specific target downstream of the TGF beta receptor involved in the noncanonical signaling is unknown. Here, we show that TGF beta increased the catalytic loop phosphorylation of platelet-derived growth factor receptor beta (PDGFR beta), a receptor tyrosine kinase expressed abundantly in glomerular mesangial cells. TGF beta increased phosphorylation of the PI 3-kinase-interacting Tyr-751 residue of PDGFR beta, thus activating Akt. Inhibition of PDGFR beta using a pharmacological inhibitor and siRNAs blocked TGF beta-stimulated phosphorylation of proline-rich Akt substrate of 40 kDa (PRAS40), an intrinsic inhibitory component of mTORC1, and prevented activation of mTORC1 in the absence of any effect on Smad 2/3 phosphorylation. Expression of constitutively active myristoylated Akt reversed the siPDGFR beta-mediated inhibition of mTORC1 activity; however, co-expression of the phospho-deficient mutant of PRAS40 inhibited the effect of myristoylated Akt, suggesting a definitive role of PRAS40 phosphorylation in mTORC1 activation downstream of PDGFR beta in mesangial cells. Additionally, we demonstrate that PDGFR beta-initiated phosphorylation of PRAS40 is required for TGF beta-induced mesangial cell hypertrophy and fibronectin and collagen I (alpha 2) production. Increased activating phosphorylation of PDGFR beta is also associated with enhanced TGF beta expression and mTORC1 activation in the kidney cortex and glomeruli of diabetic mice and rats, respectively. Thus, pursuing TGF beta noncanonical signaling, we identified how TGF beta receptor I achieves mTORC1 activation through PDGFR beta-mediated Akt/PRAS40 phosphorylation to spur mesangial cell hypertrophy and matrix protein accumulation. These findings provide support for targeting PDGFR beta in TGF beta-driven renal fibrosis.	[Maity, Soumya; Das, Falguni; Kasinath, Balakuntalam S.; Ghosh Choudhury, Goutam] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Ghosh Choudhury, Goutam] US Dept Vet Affairs, Res, San Antonio, TX 78229 USA; [Kasinath, Balakuntalam S.; Ghosh Choudhury, Goutam] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Choudhury, GG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.; Choudhury, GG (corresponding author), US Dept Vet Affairs, Res, San Antonio, TX 78229 USA.; Choudhury, GG (corresponding author), South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu			Department of Veterans Affairs Biomedical Laboratory Research and Development Service Merit Review Award [2I01 BX000926, IK6BX00361]; Department of Veterans Affairs Biomedical Laboratory Research and Development Service	Department of Veterans Affairs Biomedical Laboratory Research and Development Service Merit Review Award; Department of Veterans Affairs Biomedical Laboratory Research and Development Service(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs Biomedical Laboratory Research and Development Service Merit Review Award 2I01 BX000926 to G. G.-C. G. G.-C. is a recipient of Research Career Scientist Award IK6BX00361 from the Department of Veterans Affairs Biomedical Laboratory Research and Development Service.	Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bera A, 2017, AM J PHYSIOL-CELL PH, V313, pC430, DOI 10.1152/ajpcell.00081.2017; Boor P, 2014, NEPHROL DIAL TRANSPL, V29, pI45, DOI 10.1093/ndt/gft273; BORDER WA, 1990, NATURE, V346, P371, DOI 10.1038/346371a0; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Charbonneau M, 2016, J IMMUNOL, V196, P3264, DOI 10.4049/jimmunol.1500502; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Chen JK, 2005, J AM SOC NEPHROL, V16, P1384, DOI 10.1681/ASN.2004100894; Chen S, 2004, KIDNEY INT, V65, P1191, DOI 10.1111/j.1523-1755.2004.00492.x; Chern JJ, 2002, DEVELOPMENT, V129, P4005; CHOUDHURY GG, 1994, KIDNEY INT, V46, P37, DOI 10.1038/ki.1994.242; CHOUDHURY GG, 1993, AM J PHYSIOL, V265, pF634, DOI 10.1152/ajprenal.1993.265.5.F634; Choudhury GG, 2004, CELL SIGNAL, V16, P31, DOI 10.1016/S0898-6568(03)00094-9; Choudhury GG, 2003, CELL SIGNAL, V15, P161, DOI 10.1016/S0898-6568(02)00057-8; Choudhury GG, 2000, KIDNEY INT, V57, P908, DOI 10.1046/j.1523-1755.2000.00907.x; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Das F, 2019, J BIOL CHEM, V294, P9440, DOI 10.1074/jbc.RA118.007023; Das F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109608; Das F, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.605196; Das F, 2013, J CELL PHYSIOL, V228, P1617, DOI 10.1002/jcp.24327; Das F, 2013, J BIOL CHEM, V288, P7756, DOI 10.1074/jbc.M113.455782; Das F, 2012, J BIOL CHEM, V287, P3808, DOI 10.1074/jbc.M111.246397; Davidsohn N, 2019, P NATL ACAD SCI USA, V116, P23505, DOI 10.1073/pnas.1910073116; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042316; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; Eid AA, 2013, DIABETES, V62, P2935, DOI 10.2337/db12-1504; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Hathaway CK, 2015, P NATL ACAD SCI USA, V112, P5815, DOI 10.1073/pnas.1504777112; Heldin CH, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022053; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kato M, 2014, NAT REV NEPHROL, V10, P517, DOI 10.1038/nrneph.2014.116; Kato M, 2012, SEMIN NEPHROL, V32, P253, DOI 10.1016/j.semnephrol.2012.04.004; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim HW, 2004, KIDNEY INT, V66, P1859, DOI 10.1111/j.1523-1755.2004.00959.x; Kopp JB, 1996, LAB INVEST, V74, P991; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Langham RG, 2003, NEPHROL DIAL TRANSPL, V18, P1392, DOI 10.1093/ndt/gfg177; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Liang XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155534; Lindahl P, 1998, DEVELOPMENT, V125, P3313; Liu F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060972; Liu N, 2015, J AM SOC NEPHROL, V26, P2716, DOI 10.1681/ASN.2014080793; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Maity S, 2019, FEBS LETT, V593, P2261, DOI 10.1002/1873-3468.13505; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; MCGLADE CJ, 1992, MOL CELL BIOL, V12, P991, DOI 10.1128/MCB.12.3.991; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; OKUDA S, 1990, J CLIN INVEST, V86, P453, DOI 10.1172/JCI114731; Porsch H, 2014, J BIOL CHEM, V289, P19747, DOI 10.1074/jbc.M114.547273; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Sakaguchi M, 2006, BIOCHEM BIOPH RES CO, V340, P296, DOI 10.1016/j.bbrc.2005.12.012; Samarakoon R, 2013, CELL SIGNAL, V25, P2198, DOI 10.1016/j.cellsig.2013.07.007; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; SCHLONDORFF D, 1987, FASEB J, V1, P272, DOI 10.1096/fasebj.1.4.3308611; Sharma K, 1996, DIABETES, V45, P522, DOI 10.2337/diabetes.45.4.522; Sharma K, 1997, DIABETES, V46, P854, DOI 10.2337/diabetes.46.5.854; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; SHULTZ PJ, 1988, AM J PHYSIOL, V255, pF674, DOI 10.1152/ajprenal.1988.255.4.F674; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Uehara Goro, 2004, Clin Exp Nephrol, V8, P36, DOI 10.1007/s10157-003-0265-8; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; van Roeyen CRC, 2012, EUR J CELL BIOL, V91, P542, DOI 10.1016/j.ejcb.2011.07.003; Vega G, 2016, CYTOKINE, V88, P115, DOI 10.1016/j.cyto.2016.08.019; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Volkers M, 2014, EMBO MOL MED, V6, P57, DOI 10.1002/emmm.201303183; Wang YH, 2009, MECH DEVELOP, V126, P781, DOI 10.1016/j.mod.2009.08.005; Wang ZF, 2003, J AM SOC NEPHROL, V14, P3147, DOI 10.1097/01.ASN.0000098681.56240.1A; Xu SZ, 2020, J CELL MOL MED, V24, P5224, DOI 10.1111/jcmm.15175; YOSHIOKA K, 1993, LAB INVEST, V68, P154; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zeng FH, 2009, EXP CELL RES, V315, P602, DOI 10.1016/j.yexcr.2008.08.005; Zheng SR, 2004, DIABETES, V53, P3248, DOI 10.2337/diabetes.53.12.3248; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	97	9	9	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2020	295	42					14262	14278		10.1074/jbc.RA120.014994	http://dx.doi.org/10.1074/jbc.RA120.014994			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ON0UY	32732288	Green Published, hybrid			2022-12-26	WOS:000586428700003
J	Matsubara, S; Wakisaka, S; Aoyama, K; Seaborn, K; Hiyama, A; Inami, M				Matsubara, Seito; Wakisaka, Sohei; Aoyama, Kazuma; Seaborn, Katie; Hiyama, Atsushi; Inami, Masahiko			Perceptual simultaneity and its modulation during EMG-triggered motion induction with electrical muscle stimulation	PLOS ONE			English	Article							ARTIFICIAL MUSCLE; SELF-AGENCY; RECALIBRATION; SENSE	When human movement is assisted or controlled with a muscle actuator, such as electrical muscle stimulation, a critical issue is the integration of such induced movement with the person's motion intention and how this movement then affects their motor control. Towards achieving optimal integration and reducing feelings of artificiality and enforcement, we explored perceptual simultaneity through electrical muscle stimulation, which involved changing the interval between intentional and induced movements. We report on two experiments in which we evaluated the ranges between detection and stimulus for perceptual simultaneity achievable with an electromyography-triggered electrical muscle stimulation system. We found that the peak range was approximately 80-160 ms, with the timing of perceptual simultaneity shifting according to different adaptation states. Our results indicate that perceptual simultaneity is controllable using this adaptation strategy.	[Matsubara, Seito; Aoyama, Kazuma] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo, Japan; [Wakisaka, Sohei; Hiyama, Atsushi; Inami, Masahiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Aoyama, Kazuma] Univ Tokyo, Virtual Real Educ Res Ctr, Tokyo, Japan; [Seaborn, Katie] Tokyo Inst Technol, Dept Ind Engn & Econ, Tokyo, Japan; [Hiyama, Atsushi] RIKEN, Ctr Adv Intelligence Project, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Tokyo Institute of Technology; RIKEN	Matsubara, S (corresponding author), Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo, Japan.	matsubara@star.rcast.u-tokyo.ac.jp	Seaborn, Katie/GNP-8102-2022	Seaborn, Katie/0000-0002-7812-9096; Matsubara, Seito/0000-0003-0622-8797	JST CREST, Japan [JPMJCR16E1]; JST ERATO [JPMJER1701]	JST CREST, Japan(Core Research for Evolutional Science and Technology (CREST)); JST ERATO(Japan Science & Technology Agency (JST))	This work was supported by JST CREST Grant Number JPMJCR16E1, Japan and JST ERATO Grant Number JPMJER1701 (Inami JIZAI Body Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2007, J MOTOR BEHAV, V39, P162, DOI 10.3200/JMBR.39.3.162-168; Baecker Ronald M., 2012, Interactions, V19, P32, DOI 10.1145/2168931.2168940; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Carson RG, 2021, J PHYSIOL-LONDON, V599, P2375, DOI 10.1113/JP278298; Cauraugh J, 2000, STROKE, V31, P1360, DOI 10.1161/01.STR.31.6.1360; CAVANAGH PR, 1979, EUR J APPL PHYSIOL, V42, P159, DOI 10.1007/BF00431022; Christie BP, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab154c; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; HAMPEL FR, 1974, J AM STAT ASSOC, V69, P383, DOI 10.2307/2285666; Hara Y, 2006, AM J PHYS MED REHAB, V85, P977, DOI 10.1097/01.phm.0000247853.61055.f8; Hayashi T, 2005, 2005 6TH INTERNATIONAL CONFERENCE ON ASIC PROCEEDINGS, BOOKS 1 AND 2, P639; Hug F, 2009, J ELECTROMYOGR KINES, V19, P182, DOI 10.1016/j.jelekin.2007.10.010; Imaizumi S, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00035; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Kasahara S, 2019, P 2019 CHI C HUM FAC, P643; Kuroda T, 2014, ACOUST SCI TECHNOL, V35, P1, DOI 10.1250/ast.35.1; Lopes P, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P939, DOI 10.1145/2702123.2702461; Lopes P, 2016, UIST 2016: PROCEEDINGS OF THE 29TH ANNUAL SYMPOSIUM ON USER INTERFACE SOFTWARE AND TECHNOLOGY, P207, DOI 10.1145/2984511.2984530; MacIntyre NJ, 1996, NEUROREPORT, V7, P1513; Maekawa A., 2019, P 10 AUGMENTED HUMAN, P1; Muraoka Yoshihiro, 2001, Frontiers of Medical and Biological Engineering, V11, P323, DOI 10.1163/156855701321138969; Nishida J, 2017, PROCEEDINGS OF THE 2017 ACM SIGCHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'17), P3316, DOI 10.1145/3025453.3025829; Ogawa K, 2017, ADV ROBOTICS, V31, P1135, DOI 10.1080/01691864.2017.1392345; Phinyomark A, 2012, EXPERT SYST APPL, V39, P7420, DOI 10.1016/j.eswa.2012.01.102; Sato A, 2005, COGNITION, V94, P241, DOI 10.1016/j.cognition.2004.04.003; Shimada S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006185; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Takahashi N, 2019, P 2019 IEEE C VIRTUA, P1568; Timm J, 2014, CONSCIOUS COGN, V23, P42, DOI 10.1016/j.concog.2013.11.002; Tondu B, 2012, J INTEL MAT SYST STR, V23, P225, DOI 10.1177/1045389X11435435; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023536; Yamamoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029414	37	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2020	15	8							e0236497	10.1371/journal.pone.0236497	http://dx.doi.org/10.1371/journal.pone.0236497			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ND3HD	32785230	Green Published, gold			2022-12-26	WOS:000561793900015
J	Sehlin, D; Stocki, P; Gustavsson, T; Hultqvist, G; Walsh, FS; Rutkowski, JL; Syvanen, S				Sehlin, Dag; Stocki, Pawel; Gustavsson, Tobias; Hultqvist, Greta; Walsh, Frank S.; Rutkowski, J. Lynn; Syvanen, Stina			Brain delivery of biologics using a cross-species reactive transferrin receptor 1 VNAR shuttle	FASEB JOURNAL			English	Article						Alzheimer's disease (AD); amyloid-beta (A beta); antibody; blood-brain barrier (BBB); positron emission tomography (PET); receptor mediated transcytosis	ALZHEIMERS-DISEASE; BARRIER; ANTIBODIES; PENETRATION	Transferrin receptor 1 (TfR1) mediated transcytosis is an attractive strategy to enhance brain uptake of protein drugs, but translation remains a challenge. Here, a single domain shark antibody VNAR fragment (TXB2) with similar affinity to murine and human TfR1 was used to shuttle protein cargo into the brain. TXB2 was fused to a human IgG1 Fc domain (hFc) or to the amyloid-beta (A beta) antibody bapineuzumab (Bapi). TXB2-hFc displayed 20-fold higher brain concentrations compared with a control VNAR-hFc at 18 hours post-injection in wt mice. At the same time point, brain concentrations of Bapi-TXB2 was threefold higher than Bapi. In transgenic mice overexpressing human A beta, the brain-to-blood concentration ratio increased with time due to interaction with intracerebral A beta deposits. The relatively stable threefold difference between Bapi-TXB2 and Bapi was observed for up to 6 days after injection. PET imaging and ex vivo autoradiography revealed more parenchymal distribution of Bapi-TXB2 compared with Bapi. In conclusion, the TXB2 VNAR shuttle markedly increased brain uptake of protein cargo and increased brain concentrations of the A beta binding antibody Bapi.	[Sehlin, Dag; Gustavsson, Tobias; Syvanen, Stina] Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, S-75185 Uppsala, Sweden; [Stocki, Pawel; Walsh, Frank S.; Rutkowski, J. Lynn] Ossianix Inc, Gunnels Wood Rd, Stevenage, Herts, England; [Stocki, Pawel; Walsh, Frank S.; Rutkowski, J. Lynn] Ossianix Inc, Philadelphia, PA USA; [Hultqvist, Greta] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden	Uppsala University; Uppsala University	Sehlin, D (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, S-75185 Uppsala, Sweden.; Stocki, P (corresponding author), Ossianix Inc, Gunnels Wood Rd, Stevenage, Herts, England.	dag.sehlin@pubcare.uu.se; pawel@ossianix.com	Gustavsson, Tobias/AFK-4025-2022; Gustavsson, Tobias/AAG-2820-2022	Sehlin, Dag/0000-0002-9430-3859; Hultqvist, Greta/0000-0002-4136-6792; Syvanen, Stina/0000-0002-8196-4041	Vetenskapsradet (VR) [2018-02715, 2017-02413]; Alzheimerfonden; Hjarnfonden (Swedish Brain Foundation); Torsten Soderbergs Stiftelse (Torsten Soderberg Foundation); Petrus och Augusta Hedlunds Stiftelse (Hedlund Foundation); Ake Wiberg Stiftelse (Ake Wiberg Foundation); Ahlenstiftelsen (Ahlen Foundation); Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Gun och Bertil Stohnes Stiftelse (Stohnes Stiftelse); Stiftelsen for Gamla Tjanarinnor (Foundation for Old Servants); Stiftelsen Sigurd and Elsa Goljes Minne	Vetenskapsradet (VR)(Swedish Research Council); Alzheimerfonden; Hjarnfonden (Swedish Brain Foundation); Torsten Soderbergs Stiftelse (Torsten Soderberg Foundation); Petrus och Augusta Hedlunds Stiftelse (Hedlund Foundation); Ake Wiberg Stiftelse (Ake Wiberg Foundation); Ahlenstiftelsen (Ahlen Foundation); Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Gun och Bertil Stohnes Stiftelse (Stohnes Stiftelse); Stiftelsen for Gamla Tjanarinnor (Foundation for Old Servants); Stiftelsen Sigurd and Elsa Goljes Minne	Vetenskapsradet (VR), Grant/Award Number: 2018-02715 and 2017-02413; Alzheimerfonden; Hjarnfonden (Swedish Brain Foundation); Torsten Soderbergs Stiftelse (Torsten Soderberg Foundation); Petrus och Augusta Hedlunds Stiftelse (Hedlund Foundation); Ake Wiberg Stiftelse (Ake Wiberg Foundation); Ahlenstiftelsen (Ahlen Foundation); Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Gun och Bertil Stohnes Stiftelse (Stohnes Stiftelse); Stiftelsen for Gamla Tjanarinnor (Foundation for Old Servants); Stiftelsen Sigurd and Elsa Goljes Minne	Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Clark AJ, 2015, P NATL ACAD SCI USA, V112, P12486, DOI 10.1073/pnas.1517048112; Couch JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005338; Fang XTT, 2019, NEUROIMAGE, V184, P881, DOI 10.1016/j.neuroimage.2018.10.011; Gustafsson S, 2018, NEUROPHARMACOLOGY, V143, P1, DOI 10.1016/j.neuropharm.2018.09.001; Hultqvist G, 2017, THERANOSTICS, V7, P308, DOI 10.7150/thno.17155; Johnsen KB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11220-1; Lannfelt L, 2014, J INTERN MED, V275, P284, DOI 10.1111/joim.12168; Lo M, 2017, J BIOL CHEM, V292, P3900, DOI 10.1074/jbc.M116.767749; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lord A, 2009, FEBS J, V276, P995, DOI 10.1111/j.1742-4658.2008.06836.x; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Meier SR, 2018, J NUCL MED, V59, P1885, DOI 10.2967/jnumed.118.213140; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Pardridge WM, 2016, EXPERT OPIN BIOL TH, V16, P1455, DOI 10.1080/14712598.2016.1230195; Pardridge WM, 2016, EXPERT OPIN DRUG DEL, V13, P963, DOI 10.1517/17425247.2016.1171315; Philipson O, 2009, NEUROBIOL AGING, V30, P1393, DOI 10.1016/j.neurobiolaging.2007.11.022; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Sehlin D, 2019, EUR J NUCL MED MOL I, V46, P2848, DOI 10.1007/s00259-019-04426-0; Sehlin D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17358-2; Sehlin D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10759; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Stocki P., 2019, BLOOD BRAIN BARRIER, P1, DOI [10.1101/816900, DOI 10.1101/816900]; Syvanen S, 2018, ALZHEIMERS RES THER, V10, DOI [10.1186/s13195-018-0377-8, 10.1186/S13195-018-0377-8]; Wang E, 2014, NUCL MED COMMUN, V35, P767, DOI 10.1097/MNM.0000000000000117; Webster CI, 2016, FASEB J, V30, P1927, DOI 10.1096/fj.201500078; Wyatt EA, 2019, BIOENG TRANSL MED, V4, P30, DOI 10.1002/btm2.10108; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zuchero YJY, 2016, NEURON, V89, P70, DOI 10.1016/j.neuron.2015.11.024	31	18	19	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13272	13283		10.1096/fj.202000610RR	http://dx.doi.org/10.1096/fj.202000610RR		AUG 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32779267	Green Published, hybrid			2022-12-26	WOS:000558415100001
J	Tsuchihara, T; Nukada, H; Nakanishi, K; Morishita, R; Amako, M; Arino, H; Nemoto, K; Chiba, K				Tsuchihara, Toyokazu; Nukada, Hitoshi; Nakanishi, Kuniaki; Morishita, Ryuichi; Amako, Masatoshi; Arino, Hiroshi; Nemoto, Koichi; Chiba, Kazuhiro			Efficacy of nonviral gene transfer of human hepatocyte growth factor (HGF) against ischemic-reperfusion nerve injury in rats	PLOS ONE			English	Article							QUANTITATIVE ASSESSMENT; THERAPEUTIC ANGIOGENESIS; DIABETIC-NEUROPATHY; NEUROTROPHIC FACTOR; LIMB ISCHEMIA; NEUROMETER; NEOVASCULARIZATION; DEMYELINATION; PURIFICATION; CAPILLARIES	Ischemic neuropathy is common in subjects with critical limb ischemia, frequently causing chronic neuropathic pain. However, neuropathic pain caused by ischemia is hard to control despite the restoration of an adequate blood flow. Here, we used a rat model of ischemic-reperfusion nerve injury (IRI) to investigate possible effects of hepatocyte growth factor (HGF) against ischemic neuropathy. Hemagglutinating virus of Japan (HVJ) liposomes containing plasmids encoded with HGF was delivered into the peripheral nervous system by retrograde axonal transport following its repeated injections into the tibialis anterior muscle in the right hindlimb. First HGF gene transfer was done immediately after IRI, and repeated at 1, 2 and 3 weeks later. Rats with IRI exhibited pronounced mechanical allodynia and thermal hyperalgesia, decreased blood flow and skin temperature, and lowered thresholds of plantar stimuli in the hind paw. These were all significantly improved by HGF gene transfer, as also were sciatic nerve conduction velocity and muscle action potential amplitudes. Histologically, HGF gene transfer resulted in a significant increase of endoneurial microvessels in sciatic and tibial nerves and promoted nerve regeneration which were confirmed by morphometric analysis. Neovascularization was observed in the contralateral side of peripheral nerves as well. In addition, IRI elevated mRNA levels of P2X3 and P2Y1 receptors, and transient receptor potential vanilloid receptor subtype 1 (TRPV1) in sciatic nerves, dorsal root ganglia and spinal cord, and these elevated levels were inhibited by HGF gene transfer. In conclusion, HGF gene transfer is a potent candidate for treatment of acute ischemic neuropathy caused by reperfusion injury, because of robust angiogenesis and enhanced nerve regeneration.	[Tsuchihara, Toyokazu; Amako, Masatoshi; Arino, Hiroshi; Nemoto, Koichi; Chiba, Kazuhiro] Natl Def Med Coll, Dept Orthoped Surg, Tokorozawa, Saitama, Japan; [Tsuchihara, Toyokazu; Nukada, Hitoshi] Univ Otago, Dept Med, Med Sch, Dunedin, New Zealand; [Nukada, Hitoshi] Toho Univ, Dept Exploratory Med Nat Life & Man, Med Sch, Chiba, Japan; [Nakanishi, Kuniaki] Natl Def Med Coll Hosp, Dept Lab Med, Tokorozawa, Saitama, Japan; [Morishita, Ryuichi] Osaka Univ, Dept Clin Gene Therapy, Grad Sch Med, Suita, Osaka, Japan; [Tsuchihara, Toyokazu] Tsuchihara Orthopaed Clin, Yokohama, Kanagawa, Japan; [Nakanishi, Kuniaki] KKR Tachikawa Hosp, Dept Pathol, Tachikawa, Tokyo, Japan; [Arino, Hiroshi] Ota Mem Hosp, Dept Orthoped Surg, Otaru, Hokkaido, Japan; [Nemoto, Koichi] Eijinkai Iruma Heart Hosp, Dept Orthopaed, Iruma, Saitama, Japan	National Defense Medical College - Japan; University of Otago; Toho University; National Defense Medical College - Japan; Osaka University; Tachikawa Hospital	Nukada, H (corresponding author), Univ Otago, Dept Med, Med Sch, Dunedin, New Zealand.; Nukada, H (corresponding author), Toho Univ, Dept Exploratory Med Nat Life & Man, Med Sch, Chiba, Japan.	hitoshi.nukada@med.toho-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20591037, 24591307]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Toyokazu Tsuchihara (No. 20591037 and 24591307). https://www.jsps.go.jp/index.html https://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajroud-Driss S, 2013, MOL THER, V21, P1279, DOI 10.1038/mt.2013.69; American Association of Electrodiagnostic Medicine, 1999, Muscle Nerve Suppl, V8, pS247; Aoki M, 2000, J Atheroscler Thromb, V7, P71; Asbury AK, 1970, HDB CLIN NEUROLOGY; Baldanzi G, 2015, BIOMEDICINES, V3, P1, DOI 10.3390/biomedicines3010001; Becker F, 2011, EUR J VASC ENDOVASC, V42, pS4, DOI 10.1016/S1078-5884(11)60009-9; Bobek V, 2006, VASC PHARMACOL, V44, P395, DOI 10.1016/j.vph.2006.03.009; Boldyreva MA, 2018, BIOMED PHARMACOTHER, V101, P682, DOI 10.1016/j.biopha.2018.02.138; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Darling JD, 2017, J VASC SURG, V65, P695, DOI 10.1016/j.jvs.2016.09.055; Davey F, 2000, MOL CELL NEUROSCI, V15, P79, DOI 10.1006/mcne.1999.0803; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Fajardo-Puerta AB, 2016, J CLIN PATHOL, V69, P575, DOI 10.1136/jclinpath-2015-203575; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Ito K, 2016, J BIOCHEM, V160, P77, DOI 10.1093/jb/mvw037; Jensen SA, 2006, EUR J VASC ENDOVASC, V32, P60, DOI 10.1016/j.ejvs.2005.12.022; Kanzaki M, 2010, NEUROTOXICOLOGY, V31, P709, DOI 10.1016/j.neuro.2010.07.004; Kato N, 2005, DIABETES, V54, P846, DOI 10.2337/diabetes.54.3.846; Kato N, 2003, J NEUROCHEM, V85, P810, DOI 10.1046/j.1471-4159.2003.01730.x; Kessler JA, 2015, ANN CLIN TRANSL NEUR, V2, P465, DOI 10.1002/acn3.186; Kiso T, 2001, J PHARMACOL EXP THER, V297, P352; KO KR, 2018, SCI REP, V8, DOI DOI 10.1038/S41598-018-26704-X29844434; Koike H, 2003, FASEB J, V17, P779, DOI 10.1096/fj.02-0754fje; Leithead C, 2018, J VASC SURG, V67, P498, DOI 10.1016/j.jvs.2017.07.109; LIU S, 1995, ANESTHESIOLOGY, V82, P60, DOI 10.1097/00000542-199501000-00009; Maina F, 1999, NAT NEUROSCI, V2, P213, DOI 10.1038/6310; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; MASSON EA, 1991, DIABETIC MED, V8, pS63, DOI 10.1111/j.1464-5491.1991.tb02159.x; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; McDermott MM, 2015, CIRC RES, V116, P1540, DOI 10.1161/CIRCRESAHA.114.303517; Mills JL, 2014, SEMIN VASC SURG, V27, P16, DOI 10.1053/j.semvascsurg.2014.12.002; Morishita R, 2004, CURR GENE THER, V4, P199; Nakamura F, 1996, P NATL ACAD SCI USA, V93, P10465, DOI 10.1073/pnas.93.19.10465; NAKAMURA T, 1987, FEBS LETT, V224, P311, DOI 10.1016/0014-5793(87)80475-1; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588; Nho B, 2018, FASEB J, V32, P5119, DOI 10.1096/fj.201800476R; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; NUKADA H, 1986, EXP NEUROL, V92, P391, DOI 10.1016/0014-4886(86)90090-7; Nukada H, 2002, J PERIPHER NERV SYST, V7, P37, DOI 10.1046/j.1529-8027.2002.02004.x; NUKADA H, 1985, EXP NEUROL, V87, P369, DOI 10.1016/0014-4886(85)90227-4; Nukada H, 1997, J Peripher Nerv Syst, V2, P60; Nukada H, 2000, ANN NEUROL, V47, P71, DOI 10.1002/1531-8249(200001)47:1<71::AID-ANA12>3.3.CO;2-G; NUKADA H, 1988, BRAIN RES, V449, P89, DOI 10.1016/0006-8993(88)91027-X; NUKADA H, 1984, AM J PATHOL, V115, P275; NUKADA H, 1994, J ANAT, V185, P259; Okabayashi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013034; PITEI DL, 1994, DIABETIC MED, V11, P872, DOI 10.1111/j.1464-5491.1994.tb00371.x; Powell RJ, 2004, VASC MED, V9, P193, DOI 10.1191/1358863x04vm557oa; Sanada F, 2015, EXPERT OPIN BIOL TH, V15, P381, DOI 10.1517/14712598.2015.1007039; Schratzberger P, 2000, NAT MED, V6, P405, DOI 10.1038/74664; Simovic D, 2001, ARCH NEUROL-CHICAGO, V58, P761, DOI 10.1001/archneur.58.5.761; Suzuki J, 2016, HYPERTENS RES, V39, P183, DOI 10.1038/hr.2015.134; Tay B, 1997, ANESTH ANALG, V84, P1071, DOI 10.1097/00000539-199705000-00021; Tsuchihara T, 2009, MOL THER, V17, P42, DOI 10.1038/mt.2008.214; Tsuda M, 2002, EUR J NEUROSCI, V15, P1444, DOI 10.1046/j.1460-9568.2002.01982.x; Tsuda M, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0007.2000; Ueno S, 1999, BRIT J PHARMACOL, V126, P429, DOI 10.1038/sj.bjp.0702319; Ugalde V, 2001, Phys Med Rehabil Clin N Am, V12, P365; Weseley S A, 1988, ASAIO Trans, V34, P188; Yang XM, 1998, J NEUROSCI, V18, P8369	62	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237156	10.1371/journal.pone.0237156	http://dx.doi.org/10.1371/journal.pone.0237156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780756	Green Published, gold			2022-12-26	WOS:000562664700044
J	Nouraie, M; Ashley-Koch, AE; Garrett, ME; Sritharan, N; Zhang, YZ; Little, J; Gordeuk, VR; Gladwin, MT; Telen, MJ; Kato, GJ				Nouraie, Mehdi; Ashley-Koch, Allison E.; Garrett, Melanie E.; Sritharan, Nithya; Zhang, Yingze; Little, Jane; Gordeuk, Victor R.; Gladwin, Mark T.; Telen, Marilyn J.; Kato, Gregory J.			Serum albumin is independently associated with higher mortality in adult sickle cell patients: Results of three independent cohorts	PLOS ONE			English	Article							HUMAN PHYSIOLOGY; KIDNEY-DISEASE; HEART-FAILURE; RISK-FACTORS; HYPOALBUMINEMIA; PATHOPHYSIOLOGY; INFLAMMATION; SURVIVAL; DEATH	Sickle cell disease (SCD) impacts liver and kidney function as well as skin integrity. These complications, as well as the hyperinflammatory state of SCD, could affect serum albumin. Serum albumin has key roles in antioxidant, anti-inflammatory and antithrombotic pathways and maintains vascular integrity. In SCD, these pathways modulate disease severity and clinical outcomes. We used three independent SCD adult cohorts to assess clinical predictors of serum albumin as well its association with mortality. In 2553 SCD adult participants, the frequency of low (<35 g/L) serum albumin was 5%. Older age and lower hemoglobin (P <0.001) were associated with lower serum albumin in all three cohorts. In age and hemoglobin adjusted analysis, higher liver enzymes (P <0.05) were associated with lower serum albumin. In two of the three cohorts, lower kidney function as measured by Glomerular Filtration Rate (P<0.001) was associated with lower serum albumin. Lower serum albumin predicted higher risk of tricuspid regurgitation velocity >= 2.5 m/s (OR = 1.1 per g/L, P <= 0.01). In all three cohorts, patients with low serum albumin had higher mortality (adjusted HR >= 2.9, P <= 0.003). This study confirms the role of serum albumin as a biomarker of disease severity and prognosis in patients with SCD. Albumin as a biomarker and possible mediator of SCD severity should be studied further.	[Nouraie, Mehdi; Zhang, Yingze; Gladwin, Mark T.; Kato, Gregory J.] Univ Pittsburgh, Dept Med, Vasc Med Inst, Pittsburgh, PA 15260 USA; [Ashley-Koch, Allison E.; Garrett, Melanie E.; Telen, Marilyn J.] Duke Univ, Dept Med, Durham, NC USA; [Sritharan, Nithya; Gladwin, Mark T.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Little, Jane] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; [Gordeuk, Victor R.] Univ Illinois, Dept Med, Chicago, IL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Nouraie, M (corresponding author), Univ Pittsburgh, Dept Med, Vasc Med Inst, Pittsburgh, PA 15260 USA.	nouraies@upmc.edu	Nouraie, Seyed Mehdi/O-4071-2018; Kato, Gregory J/I-7615-2014	Nouraie, Seyed Mehdi/0000-0001-7465-0581; Kato, Gregory J/0000-0003-4465-3217; Telen, Marilyn/0000-0003-3809-1780	Doris Duke Charitable Foundation	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	M.J. Telen and A.E. Ashley-Koch received grants from Doris Duke Charitable Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Garcia-Bello JA, 2018, NEFROLOGIA, V38, P414, DOI 10.1016/j.nefro.2017.11.024; Ashley-Koch AE, 2011, BRIT J HAEMATOL, V155, P386, DOI 10.1111/j.1365-2141.2011.08832.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Caraceni P, 2013, EUR J INTERN MED, V24, P721, DOI 10.1016/j.ejim.2013.05.015; Cartin-Ceba R, 2019, CLIN LIVER DIS, V23, P683, DOI 10.1016/j.cld.2019.06.003; Chiu PF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003202; da Guarda CC, 2017, EXPERT REV HEMATOL, V10, P533, DOI 10.1080/17474086.2017.1327809; Danielski M, 2003, AM J KIDNEY DIS, V42, P286, DOI 10.1016/S0272-6386(03)00653-X; DOWEIKO JP, 1991, JPEN-PARENTER ENTER, V15, P207, DOI 10.1177/0148607191015002207; DOWEIKO JP, 1991, JPEN-PARENTER ENTER, V15, P476, DOI 10.1177/0148607191015004476; Drawz P, 2016, CLIN J AM SOC NEPHRO, V11, P207, DOI 10.2215/CJN.03940415; Franch-Arcas G, 2001, CLIN NUTR, V20, P265, DOI 10.1054/clnu.2001.0438; Gatta A, 2012, INTERN EMERG MED, V7, pS193, DOI 10.1007/s11739-012-0802-0; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gladwin MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099489; Gonzalez-Pacheco H, 2017, AM J CARDIOL, V119, P951, DOI 10.1016/j.amjcard.2016.11.054; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Idicula TT, 2009, CEREBROVASC DIS, V28, P13, DOI 10.1159/000215938; KATES RE, 1989, J CARDIOVASC PHARM, V13, P168; Kato GJ, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.10; Kato GJ, 2017, J CLIN INVEST, V127, P750, DOI 10.1172/JCI89741; Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414; Liu M, 2012, EUR J HEART FAIL, V14, P39, DOI 10.1093/eurjhf/hfr154; Mafra D, 2007, INT UROL NEPHROL, V39, P619, DOI 10.1007/s11255-007-9201-2; Morlese JF, 1996, AM J CLIN NUTR, V64, P952, DOI 10.1093/ajcn/64.6.952; Nouraie M, 2019, AM J HEMATOL, V94, pE312, DOI 10.1002/ajh.25624; Peterson EJ, 2018, J INT MED RES, V46, P3665, DOI 10.1177/0300060518777349; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Reid M, 2002, AM J CLIN NUTR, V76, P1409, DOI 10.1093/ajcn/76.6.1409; Rozga J, 2013, ANN TRANSPL, V18, P205, DOI 10.12659/AOT.889188; Shah Rushikesh, 2017, World J Gastrointest Pathophysiol, V8, P108, DOI 10.4291/wjgp.v8.i3.108; Sitar ME, 2013, CLIN LAB, V59, P945, DOI 10.7754/Clin.Lab.2012.121115; Smith A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00187; van Beers EJ, 2015, CIRC RES, V116, P298, DOI 10.1161/CIRCRESAHA.116.304577; Viasus D, 2013, J INFECTION, V66, P415, DOI 10.1016/j.jinf.2012.12.007; Vichinsky E, 2017, HEMATOL-AM SOC HEMAT, P435, DOI 10.1182/asheducation-2017.1.435; Wang TJ, 2019, KIDNEY BLOOD PRESS R, V44, P590, DOI 10.1159/000500782; Yap FHY, 2002, ANAESTH INTENS CARE, V30, P202, DOI 10.1177/0310057X0203000213	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237543	10.1371/journal.pone.0237543	http://dx.doi.org/10.1371/journal.pone.0237543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776978	gold, Green Published			2022-12-26	WOS:000561393800007
J	Elad, B; Koren, O; Slim, W; Turgeman, Y; Avraham, G; Schwartz, N; Elias, M				Elad, Boaz; Koren, Ofir; Slim, Wasin; Turgeman, Yoav; Avraham, Gilat; Schwartz, Naama; Elias, Mazen			Thrombin generation's role in predicting coronary disease severity	PLOS ONE			English	Article								Background Thrombin, a key enzyme of the clotting system, is involved in thrombus formation, platelet activation, and atherosclerosis, thereby possessing a central role in the pathogenesis of ischemic heart disease. Studies have shown an association between thrombin generation (TG) and cardiovascular morbidity and mortality, but results have been equivocal. Our aim was to study the predictive ability of TG assay in evaluating coronary stenosis severity. Methods In this prospective study we recruited patients with acute coronary syndrome (ACS) or acute chest pain (without evidence of myocardial injury) planned for coronary angiography. Thrombin generation was evaluated by Calibrated Automated Thrombogram (CAT) prior to angiography. Primary end points were significant coronary stenosis and the Syntax I score evaluated by coronary angiography. Results From April 2018 through September 2019, we recruited 128 patients. In the primary analysis there was no significant association between TG and significant coronary stenosis nor between TG and syntax I score, however, there was a positive correlation between peak height and troponin peak (Spearman correlation coefficient 0.194, P-value = 0.035). In sub-group analysis, the chest pain group bare no association between TG and coronary stenosis. In unstable angina group there was an association between peak height and significant coronary stenosis (P-value = 0.029), and in non ST-elevation myocardial infarction group, TG values possessed a relatively good predictive ability of significant coronary stenosis (area under the receiver operating characteristic curve of similar to 65%) and a positive correlation between both lag time and ttpeak with the syntax I score was noticed (Spearman correlation coefficient 0.31, P-value = 0.099 and Spearman correlation coefficient 0.37, P-value = 0.045 respectively). Conclusion In patients with acute chest pain, TG values, evaluated by CAT, do not predict severity of coronary stenosis, nor do they possess prognostic value. Yet, in ACS patients, TG may have the ability to predict coronary disease severity.	[Elad, Boaz; Avraham, Gilat; Elias, Mazen] Emek Med Ctr, Internal Med C, Afula, Israel; [Koren, Ofir; Turgeman, Yoav] Emek Med Ctr, Heart Inst, Afula, Israel; [Koren, Ofir; Turgeman, Yoav; Elias, Mazen] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-32000 Haifa, Israel; [Slim, Wasin] Emek Med Ctr, Emergency Dept, Afula, Israel; [Schwartz, Naama] Univ Haifa, Sch Publ Hlth, Haifa, Israel	Emek Medical Center; Emek Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Emek Medical Center; University of Haifa	Elad, B (corresponding author), Emek Med Ctr, Internal Med C, Afula, Israel.	boazelad1@gmail.com	Koren, Ofir/AAZ-8573-2021; Koren, Ofir/GYU-7333-2022	Koren, Ofir/0000-0002-8666-8276; elad, boaz/0000-0001-9253-2351				Al Dieri R, 2012, BLOOD REV, V26, P197, DOI 10.1016/j.blre.2012.06.001; Attanasio M, 2016, THROMB RES, V147, P52, DOI 10.1016/j.thromres.2016.09.020; Baglin T, 2005, BRIT J HAEMATOL, V130, P653, DOI 10.1111/j.1365-2141.2005.05612.x; Borissoff JI, 2012, JACC-CARDIOVASC IMAG, V5, P1201, DOI 10.1016/j.jcmg.2012.01.023; Campo G, 2012, BLOOD COAGUL FIBRIN, V23, P680, DOI 10.1097/MBC.0b013e328355111f; Carcaillon L, 2011, ARTERIOSCL THROM VAS, V31, P1445, DOI 10.1161/ATVBAHA.111.223453; Collet JP, 2016, EUR HEART J, V37, pE1, DOI 10.1093/eurheartj/ehv407; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Loeffen R, 2015, J GERONTOL A-BIOL, V70, P982, DOI 10.1093/gerona/glu228; Orbe J, 2008, THROMB HAEMOSTASIS, V99, P382, DOI 10.1160/TH07-07-0443; Smid M, 2011, J THROMB HAEMOST, V9, P450, DOI 10.1111/j.1538-7836.2010.04162.x; ten Cate H, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003553; van Veen JJ, 2008, BRIT J HAEMATOL, V142, P889, DOI 10.1111/j.1365-2141.2008.07267.x	13	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237024	10.1371/journal.pone.0237024	http://dx.doi.org/10.1371/journal.pone.0237024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764787	gold, Green Published			2022-12-26	WOS:000561029000022
J	Khan, S; Yousuf, M; Ikram, M				Khan, Salman; Yousuf, Mohd.; Ikram, Mohsin			Morphometric based differentiation among Trichogramma spp.	PLOS ONE			English	Article							HYMENOPTERA TRICHOGRAMMATIDAE; LEPIDOPTERA; EVANESCENS; HYM	GenusTrichogrammaWestwood is being utilized in various biological control programme worldwide.Trichogrammaspp. are egg parasitoids which lay their eggs inside the host eggs. More than 240 species are known, of which, 45 species are recorded from India. It is quite difficult to identify and differentiate among the species ofTrichogrammadue to smaller size. In present study, we hypothesized a methodology to identify theTrichogrammaspecies based on potential morphometric characteristics. The males and females of five different species ofTrichogrammanamely,T.brassicae,T.chilotraeae,T.danaidiphaga,T.danausicidaandT.dendrolimiwere morphometrically analysed. A total of 33 characters in males and 27 in females were taken into consideration for morphometric identification and analysis using principal component method. It was observed that few characters of male like body length, length of flagellar hair, maximum marginal hair length of fore wing, genitalia characters including aedeagus length, distance between chelate structure and gonoforceps, and others were identified as important morphometric characters. Similarly, in females, ovipositor length, body and head length, eye width, antennal club width and number of setae in forewings were found important for taxonomic identification. Male and female of each species are clearly identified from high definition microscopic images.	[Khan, Salman; Yousuf, Mohd.; Ikram, Mohsin] Forest Res Inst, Forest Entomol Discipline, Forest Protect Div, Dehra Dun, Uttarakhand, India; [Khan, Salman] Forest Survey India, Seminary Hills, Nagpur, Maharashtra, India	Indian Council of Forestry Research & Education (ICFRE); Forest Research Institute (FRI); Forest Survey of India	Khan, S (corresponding author), Forest Res Inst, Forest Entomol Discipline, Forest Protect Div, Dehra Dun, Uttarakhand, India.; Khan, S (corresponding author), Forest Survey India, Seminary Hills, Nagpur, Maharashtra, India.	salman1315@gmail.com	; KHAN, SALMAN/A-2175-2017	Ikram, Dr. Mohsin/0000-0002-2040-1923; KHAN, SALMAN/0000-0002-8070-6577				Alba M. C., 1988, Philippine Entomologist, V7, P253; [Anonymous], 1999, MEMOIRS ENTOMOLOGICA; Ashmead W. H., 1888, Canadian Entomologist, Vxx, P101; Bezdenko T. T., 1968, BIOL CONTROL METHOD; Bohinc Tanja, 2015, Acta Agriculturae Slovenica, V105, P323, DOI 10.14720/aas.2015.105.2.15; Burks Roger A., 2002, Journal of Hymenoptera Research, V11, P167; Chan Mei-Ling, 2000, Chinese Journal of Entomology, V20, P135; Chiriac Ion, 2005, Journal of the Entomological Research Society, V7, P35; DeBach P, 1991, BIOL CONTROL NATURAL, P440; del Pino M, 2013, ARTHROPOD SYST PHYLO, V71, P169; DOUTT R L, 1968, Proceedings of the California Academy of Sciences, V35, P477; Foerster A., 1856, HYMENOPTEROLOGISCHE, V2, P1; Fursov V. N., 2016, UKRAINSKA ENTOMOFAUN, V7, P95; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Hassan Ehtashamul, 2007, Indian Journal of Entomology, V69, P58; Honda JY, 2006, APPL ENTOMOL ZOOL, V41, P247, DOI 10.1303/aez.2006.247; Jalali S. K., 2003, USDA TECHNICAL B; Khan Salman, 2019, Proceedings of the Zoological Society (Calcutta), V72, P187, DOI 10.1007/s12595-018-0260-4; Knutson A, 2005, B6071 TEX AGR EXT SE, P5; KOSTADINOV D, 1991, ANN SOC ENTOMOL FR, V27, P393; Lewis WJ, 1997, P NATL ACAD SCI USA, V94, P12243, DOI 10.1073/pnas.94.23.12243; Lin Naiquan, 1994, Contributions of the Biological Control Research Institute Fujian Agricultural University Special Publication, V4, P1; Matsumura S., 1926, EZHEG ZOOL MUZ, V26, P27; Mohammad Yousuf, 2008, Journal of Tropical Forestry, V24, P69; Mohd. Yousuf, 2015, Indian Forester, V141, P806; Nagaraja H., 2007, Journal of Biological Control, V21, P291; Nagaraja H., 2010, Journal of Biological Control, V24, P297; Nagaraja H., 2010, Journal of Biological Control, V24, P203; Nagaraja H., 2008, Colemania Insect Biosystematics, V4, P1; NAGARAJA H, 1973, Oriental Insects, V7, P275; NAGARAJA H, 1969, Entomophaga, V14, P393, DOI 10.1007/BF02390544; NAGARKATTI S, 1977, ANNU REV ENTOMOL, V22, P157, DOI 10.1146/annurev.en.22.010177.001105; NAGARKATTI S, 1971, B ENTOMOL RES, V6, P13, DOI 10.1017/S0007485300057412; Nathan SS, 2006, CROP PROT, V25, P287, DOI 10.1016/j.cropro.2005.03.023; O'Higgins P, 1998, J ANAT, V193, P251, DOI 10.1046/j.1469-7580.1998.19320251.x; PIMENTEL D, 1992, BIOSCIENCE, V42, P354, DOI 10.2307/1311782; PINTO JD, 1985, P ENTOMOL SOC WASH, V87, P176; PINTUREAU B, 1980, ENTOMOPHAGA, V25, P431, DOI 10.1007/BF02374706; Platner GR, 1999, ENTOMOL NEWS, V110, P56; Polaszek A, 2012, BIOCONTROL, V57, P21, DOI 10.1007/s10526-011-9361-y; Poorani J., 2013, TRICHOGRAMMATIDS HYM; Rao V. P., 1971, TECHNICAL COMMUNICAT; Ruiz A. E.R., 1979, Revista Peruana de Entomologia, V22, P1; SCHOLLER M, 1995, COLLOQ INRA, P33; Sokal R. R, 1973, PRINCIPLES PRACTICE, P1; Taylor L, 2005, ANN ENTOMOL SOC AM, V98, P291, DOI 10.1603/0013-8746(2005)098[0291:ANSOTH]2.0.CO;2; TAYLOR S, 2002, THESIS, P1; Thiruvengadam V, 2016, BIOL CONTROL, V101, P130, DOI 10.1016/j.biocontrol.2016.07.005; VIGGIANI G, 1989, Bollettino del Laboratorio di Entomologia Agraria Filippo Silvestri, V46, P107; Viggiani G., 1971, PORTICI, V29, P181; Yousuf M., 2012, ANN ENTOMOLOGY, V30, P1; Yousuf M., 1988, INDIAN J SYST ENTOMO, V4, P55; Yousuf M., 2004, CONT TRENDS INSECT S, P307	53	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236422	10.1371/journal.pone.0236422	http://dx.doi.org/10.1371/journal.pone.0236422			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760075	Green Published, gold			2022-12-26	WOS:000561027200043
J	Lin, FC; Chang, WL; Chiang, NJ; Lin, MY; Chung, TJ; Pao, TH; Lai, WW; Tseng, YL; Yen, YT; Sheu, BS				Lin, Forn-Chia; Chang, Wei-Lun; Chiang, Nai-Jung; Lin, Meng-Ying; Chung, Ta-Jung; Pao, Tzu-Hui; Lai, Wu-Wei; Tseng, Yau-Lin; Yen, Yi-Ting; Sheu, Bor-Shyang			Radiation dose escalation can improve local disease control and survival among esophageal cancer patients with large primary tumor volume receiving definitive chemoradiotherapy	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TREATMENT RESPONSE; THERAPY; CHEMORADIATION; CISPLATIN; SURGERY	Background This study aimed to investigate the correlation between primary tumor volume and cancer failure patterns in esophageal squamous cell carcinoma (ESCC) treated with definitive concurrent chemoradiotherapy (CCRT) and examine whether increasing radiation dose can improve the outcome. Methods We retrospectively reviewed 124 patients with stage III ESCC treated by definitive CCRT. The primary tumor volume calculated from the radiotherapy planning computed tomography scans was correlated to treatment response, time to disease progression, and overall survival. We further analyzed whether a higher radiation dose correlated with better disease control and patient survival. Results Patients with poor CCRT response had a larger primary tumor volume than those with good response (97.9vs64.3 cm(3),P= 0.032). The optimal cutoff value to predict CCRT response was 55.3 cm(3). Large primary tumor volume (>= 55.3 cm(3)) correlated with shorter time to tumor progression in the esophagus (13.6vs48.6 months,P= 0.033) compared with small tumor volume (< 55.3 cm(3)). For the large esophageal tumors (>= 55.3 cm(3)), radiation dose > 60 gray significantly prolonged the time to tumor progression in esophagus (20.3vs10.1 months,P= 0.036) and overall survival (12.2vs8.0 months,P= 0.030), compared with dose <= 60 gray. In contrast, higher radiation dose did not benefit local disease control or overall survival in the small esophageal tumors (< 55.3 cm(3)). Conclusion Large primary tumor volume correlates with poor local control and overall survival in ESCC treated with definitive CCRT. Radiation dose > 60 gray can improve the outcomes in patients with large primary tumor. Further prospective dose escalation trials are warranted.	[Lin, Forn-Chia; Pao, Tzu-Hui] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Radiat Oncol, Tainan, Taiwan; [Chang, Wei-Lun; Chiang, Nai-Jung; Lin, Meng-Ying; Sheu, Bor-Shyang] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med, Tainan, Taiwan; [Chiang, Nai-Jung] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Chung, Ta-Jung] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Diagnost Radiol, Tainan, Taiwan; [Lai, Wu-Wei; Tseng, Yau-Lin; Yen, Yi-Ting] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Surg, Tainan, Taiwan; [Sheu, Bor-Shyang] Kaohsiung Med Univ, Coll Med, Inst Clin Med, Kaohsiung, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University	Sheu, BS (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med, Tainan, Taiwan.; Sheu, BS (corresponding author), Kaohsiung Med Univ, Coll Med, Inst Clin Med, Kaohsiung, Taiwan.	sheubs@mail.nuku.edu.tw		Sheu, Bor-Shyang/0000-0002-1500-6929	Ministry of Science and Technology of Taiwan [MOST 1052314-B-006-030, 105-2314-B-006-045MY2]; National Cheng Kung University Hospital of Taiwan [NCKUH-10902063]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital of Taiwan	This study was supported by the Ministry of Science and Technology of Taiwan [MOST 1052314-B-006-030 to BSS and 105-2314-B-006-045MY2 to FCL] and National Cheng Kung University Hospital of Taiwan [NCKUH-10902063 to FCL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedenne L, 2007, J CLIN ONCOL, V25, P1160, DOI 10.1200/JCO.2005.04.7118; Boggs Drexell Hunter, 2015, J Gastrointest Cancer, V46, P131, DOI 10.1007/s12029-015-9699-y; Bradley JD, 2002, INT J RADIAT ONCOL, V52, P49, DOI 10.1016/S0360-3016(01)01772-2; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chang WL, 2017, J GASTROENTEROL, V52, P705, DOI 10.1007/s00535-016-1265-2; Chang WL, 2015, J GASTROEN HEPATOL, V30, P463, DOI 10.1111/jgh.12683; Chen J, 2018, DIS ESOPHAGUS, V31, DOI 10.1093/dote/doy043; Chen MQ, 2019, RADIAT ONCOL, V14, DOI 10.1186/s13014-019-1258-4; Conroy T, 2014, LANCET ONCOL, V15, P305, DOI 10.1016/S1470-2045(14)70028-2; Huang JW, 2015, J CHIN MED ASSOC, V78, P229, DOI 10.1016/j.jcma.2014.11.003; Hulshof MCCM, 2020, J CLIN ONCOL, V38; Ilson DH, 2018, GASTROENTEROLOGY, V154, P437, DOI 10.1053/j.gastro.2017.09.048; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Nguyen NP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-265; Ota M, 2005, DIG ENDOSC, V17, P59, DOI DOI 10.1111/J.1443-1661.2005.00458.X; PAO TH, 2020, RAD ONCOLOGY LONDON, V0015, DOI DOI 10.1186/S13014-020-01498-332103779; Stahl M, 2005, J CLIN ONCOL, V23, P2310, DOI 10.1200/JCO.2005.00.034; Strongin A, 2012, INT J RADIAT ONCOL, V82, P1823, DOI 10.1016/j.ijrobp.2010.10.053; Suntharalingam M, 2017, JAMA ONCOL, V3, P1520, DOI 10.1001/jamaoncol.2017.1598; Werner-Wasik M, 2008, INT J RADIAT ONCOL, V70, P385, DOI 10.1016/j.ijrobp.2007.06.034	20	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237114	10.1371/journal.pone.0237114	http://dx.doi.org/10.1371/journal.pone.0237114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760099	Green Published, gold			2022-12-26	WOS:000561027200039
J	Federman, DG; Gupta, S; Stack, G; Campbell, SM; Peaper, DR; Dembry, LM; Fisher, A; Tarabar, AF; Kozal, M; Ruser, CB				Federman, Daniel G.; Gupta, Shaili; Stack, Gary; Campbell, Sheldon M.; Peaper, David R.; Dembry, Louise M.; Fisher, Ann; Tarabar, Asim F.; Kozal, Michael; Ruser, Christopher B.			SARS-CoV-2 detection in setting of viral swabs scarcity: Are MRSA swabs and viral swabs equivalent?	PLOS ONE			English	Article								Background The global pandemic of Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV2) has resulted in unprecedented challenges for healthcare systems. One barrier to widespread testing has been a paucity of traditional respiratory viral swab collection kits relative to the demand. Whether other sample collection kits, such as widely available MRSA nasal swabs can be used to detect SARS-CoV-2 is unknown. Methods We compared simultaneous nasal MRSA swabs (COPAN ESwabs(R)480C flocked nasal swab in 1mL of liquid Amies medium) and virals wabs (BD H192(07) flexible mini-tip flocked nasopharyngeal swabs in 3mL Universal Transport Medium) for SARS-CoV-2 PCR testing using Simplexa COVID-19 Direct assay on patients over a 4-day period. When the results were discordant, the viral swab sample was run again on the Cepheid Xpert Xpress(R)SARS-CoV-2 assay. Results Of the 81 included samples, there were 19 positives and 62 negatives in viral media and 18 positives and 63 negative in the MRSA swabs. Amongst all included samples, there was concordance between the COPAN ESwabs(R)480C and the viral swabs in 78 (96.3%). Conclusion We found a high rate of concordance in test results between COPAN ESwabs(R)480C in Amies solution and BD H192(07) nasopharyngeal swabs in in 3 mL of Universal Viral Transport medium viral media. Clinicians and laboratories should feel better informed and assured using COPAN ESwabs(R)480C to help in the diagnosis of COVID-19.	[Federman, Daniel G.; Gupta, Shaili; Stack, Gary; Campbell, Sheldon M.; Peaper, David R.; Dembry, Louise M.; Fisher, Ann; Tarabar, Asim F.; Kozal, Michael; Ruser, Christopher B.] VA Connecticut Healthcare Syst, West Haven, CT 06516 USA; [Federman, Daniel G.; Gupta, Shaili; Stack, Gary; Campbell, Sheldon M.; Peaper, David R.; Dembry, Louise M.; Fisher, Ann; Tarabar, Asim F.; Kozal, Michael; Ruser, Christopher B.] Yale Univ, Sch Med, New Haven, CT 06520 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Federman, DG (corresponding author), VA Connecticut Healthcare Syst, West Haven, CT 06516 USA.; Federman, DG (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	Daniel.federman@va.gov		, Michael/0000-0002-7719-7396; Federman, Daniel/0000-0001-9253-8630				Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Haffajee RL, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006740; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Meyer M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062200; Rogers AA, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00708-20; Spencer S, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00027-19; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	7	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0237127	10.1371/journal.pone.0237127	http://dx.doi.org/10.1371/journal.pone.0237127			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756602	Green Submitted, Green Published, gold			2022-12-26	WOS:000560393300033
J	Mizuno, M; Endo, K; Katano, H; Tsuji, A; Kojima, N; Watanabe, K; Shimizu, N; Morio, T; Sekiya, I				Mizuno, Mitsuru; Endo, Kentaro; Katano, Hisako; Tsuji, Ayako; Kojima, Naomi; Watanabe, Ken; Shimizu, Norio; Morio, Tomohiro; Sekiya, Ichiro			The environmental risk assessment of cell-processing facilities for cell therapy in a Japanese academic institution	PLOS ONE			English	Article							PSOCOPTERA LIPOSCELIDIDAE; MICROBIAL-CONTAMINATION; CONSTANT TEMPERATURES; POPULATION-GROWTH; STEM-CELLS; AIR; COMMUNITY; BACTERIA; INSECTS; WATER	Cell therapy is a promising treatment. One of the key aspects of cell processing products is ensuring sterility of cell-processing facilities (CPFs). The objective of this study was to assess the environmental risk factors inside and outside CPFs. We monitored the temperature, humidity, particle number, colony number of microorganisms, bacteria, fungi, and harmful insects in and around our CPF monthly over one year. The temperature in the CPF was constant but the humidity fluctuated depending on the humidity outside. The particle number correlated with the number of entries to the room. Except for winter, colonies of microorganisms and harmful insects were detected depending on the cleanliness of the room. Seven bacterial and two fungal species were identified by PCR analyses. Psocoptera and Acari each accounted for 41% of the total trapped insects. These results provide useful data for taking the appropriate steps to keep entire CPFs clean.	[Mizuno, Mitsuru; Endo, Kentaro; Katano, Hisako; Kojima, Naomi; Watanabe, Ken; Shimizu, Norio; Sekiya, Ichiro] Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Bunkyo Ku, Tokyo, Japan; [Mizuno, Mitsuru; Katano, Hisako; Tsuji, Ayako; Shimizu, Norio; Morio, Tomohiro; Sekiya, Ichiro] Tokyo Med & Dent Univ, Ctr Transfus Med & Cell Therapy, Bunkyo Ku, Tokyo, Japan; [Morio, Tomohiro] Tokyo Med & Dent Univ, Grad Sch, Dept Pediat & Dev Biol, Bunkyo Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Sekiya, I (corresponding author), Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Bunkyo Ku, Tokyo, Japan.; Sekiya, I (corresponding author), Tokyo Med & Dent Univ, Ctr Transfus Med & Cell Therapy, Bunkyo Ku, Tokyo, Japan.	sekiya.arm@tmd.ac.jp	Mitsuru, Mizuno/K-3962-2017; Endo, Kentaro/M-9427-2019	Mitsuru, Mizuno/0000-0002-4410-3621; Endo, Kentaro/0000-0003-4790-4632	Japan Agency for Medical Research and Development (AMED) [JP18bk0104065]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	The Research Project for Practical Applications of Regenerative Medicine (JP18bk0104065) supported IS from the Japan Agency for Medical Research and Development (AMED) to complete this study.	AHEARN DG, 1991, J IND MICROBIOL, V8, P277, DOI 10.1007/BF01576067; Balasubramanian R, 2012, AEROBIOLOGIA, V28, P375, DOI 10.1007/s10453-011-9242-y; Baz A., 2008, ENCY ENTOMOLOGY, P381, DOI 10.1007/0-306-48380-7_416; Chaves F, 2005, J CLIN MICROBIOL, V43, P4877, DOI 10.1128/JCM.43.9.4877-4879.2005; Cobo F, 2007, LETT APPL MICROBIOL, V44, P379, DOI 10.1111/j.1472-765X.2006.02095.x; Cooley JD, 1998, OCCUP ENVIRON MED, V55, P579, DOI 10.1136/oem.55.9.579; Damani N., 2019, MANUAL INFECT PREVEN; Gautam SG, 2010, J ECON ENTOMOL, V103, P1920, DOI 10.1603/EC10127; Gomez-Silvan C, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0453-0; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Gunar OV, 2011, PHARM CHEM J+, V45, P93, DOI 10.1007/s11094-011-0568-0; Gurung K, 2019, ENTOMOL EXP APPL, V167, P156, DOI 10.1111/eea.12768; Hamdy AM, 2018, OMICS, V22, P133, DOI 10.1089/omi.2017.0091; Hara A, 2014, THER INNOV REGUL SCI, V48, P681, DOI 10.1177/2168479014526877; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kelley ST, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-202; Koenig DW, 1997, WATER SCI TECHNOL, V35, P59, DOI 10.1016/S0273-1223(97)00235-7; Konomi K, 2015, CELL STEM CELL, V16, P350, DOI 10.1016/j.stem.2015.03.012; Kubota H, 2012, APPL ENVIRON MICROB, V78, P3317, DOI 10.1128/AEM.07816-11; Landrin A, 2005, J HOSP INFECT, V61, P27, DOI 10.1016/j.jhin.2005.03.002; Leong LEX, 2018, EMERG INFECT DIS, V24, P2109, DOI 10.3201/eid2411.171929; Lestan D, 1999, WORLD J MICROB BIOT, V15, P349, DOI 10.1023/A:1008983521015; Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368; Merino N, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-018-5389-z; Mirhoseini SH, 2015, ANN AGR ENV MED, V22, P670, DOI 10.5604/12321966.1185772; Mizutani M, 2016, REGEN THER, V5, P25, DOI 10.1016/j.reth.2016.06.004; Mora M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01573; Nadarasah G, 2011, FEMS MICROBIOL REV, V35, P555, DOI 10.1111/j.1574-6976.2011.00264.x; Novotny C, 2000, APPL MICROBIOL BIOT, V54, P850, DOI 10.1007/s002530000432; Ogawa Y, 2019, REGEN THER, V12, P36, DOI 10.1016/j.reth.2019.04.002; Opit GP, 2009, J ECON ENTOMOL, V102, P1360, DOI 10.1603/029.102.0364; Pacchioni F, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1267-8; Park HK, 2014, J APPL MICROBIOL, V116, P718, DOI 10.1111/jam.12416; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prussin AJ, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0144-z; Ruiu L, 2015, INSECTS, V6, P352, DOI 10.3390/insects6020352; Ryan MP, 2010, J HOSP INFECT, V75, P153, DOI 10.1016/j.jhin.2010.03.007; Ryan MP, 2006, J HOSP INFECT, V62, P278, DOI 10.1016/j.jhin.2005.08.015; Sandle T., 2015, PHARM MICROBIOLOGY; Sandle Tim, 2011, PDA J Pharm Sci Technol, V65, P392, DOI 10.5731/pdajpst.2011.00765; Scaltriti S, 2007, J HOSP INFECT, V66, P320, DOI 10.1016/j.jhin.2007.05.019; Schroeder Hilke, 2003, Leg Med (Tokyo), V5 Suppl 1, pS372; Sekiya I, 2019, CELL TRANSPLANT, V28, P1445, DOI 10.1177/0963689719863793; Sekiya I, 2015, CLIN ORTHOP RELAT R, V473, P2316, DOI 10.1007/s11999-015-4324-8; Stocks GW, 2010, AM J INFECT CONTROL, V38, P199, DOI 10.1016/j.ajic.2009.07.006; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Tse H, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0052809 23285189, DOI 10.1371/JOURNAL.PONE.0052809 23285189]; Vijayakumar R, 2019, J APPL MICROBIOL, V126, P1011, DOI 10.1111/jam.14118; Whyte W, 1981, J Parenter Sci Technol, V35, P255; Yano T, 2013, MICROBES ENVIRON, V28, P87, DOI 10.1264/jsme2.ME12146; Zhao GZ, 2009, INT J SYST EVOL MICR, V59, P2383, DOI 10.1099/ijs.0.010256-0	52	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236600	10.1371/journal.pone.0236600	http://dx.doi.org/10.1371/journal.pone.0236600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756610	Green Published, gold			2022-12-26	WOS:000560393300060
J	Giani, S; Silletti, S; Gavazzi, F; Morello, L; Spinsanti, G; Parati, K; Breviario, D				Giani, Silvia; Silletti, Silvia; Gavazzi, Floriana; Morello, Laura; Spinsanti, Giacomo; Parati, Katia; Breviario, Diego			aTBP: A versatile tool for fish genotyping	PLOS ONE			English	Article							BARCODE	Animal Tubulin-Based-Polymorphism (aTBP), an intron length polymorphism method recently developed for vertebrate genotyping, has been successfully applied to the identification of several fish species. Here, we report data that demonstrate the ability of the aTBP method to assign a specific profile to fish species, each characterized by the presence of commonly shared amplicons together with additional intraspecific polymorphisms. Within each aTBP profile, some fragments are also recognized that can be attributed to taxonomic ranks higher than species, e.g. genus and family. Versatility of application across different taxonomic ranks combined with the presence of a significant number of DNA polymorphisms, makes the aTBP method an additional and useful tool for fish genotyping, suitable for different purposes such as species authentication, parental recognition and detection of allele variations in response to environmental changes.	[Giani, Silvia; Silletti, Silvia; Gavazzi, Floriana; Morello, Laura; Breviario, Diego] CNR, Dept Scie Bioagroalimentari, Ist Biol Biotecnol Agr, Milan, Italy; [Spinsanti, Giacomo] Univ Siena, Dept Life Sci, Siena, Italy; [Parati, Katia] Ist Sperimentale Italiano Lazzaro Spallanzani, Rivolta Dadda, CR, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Siena; IRCCS Lazzaro Spallanzani	Breviario, D (corresponding author), CNR, Dept Scie Bioagroalimentari, Ist Biol Biotecnol Agr, Milan, Italy.	diego.breviario@ibba.cnr.it	Gianì, Silvia/AAV-3716-2020; Gavazzi, Floriana/AAC-4544-2022; Morello, Laura/ABF-9139-2022	Morello, Laura/0000-0002-8854-1770; Parati, Katia/0000-0003-3570-4641; Breviario, Diego/0000-0002-3062-7598; GIANI, SILVIA/0000-0001-8740-1787	FHfFC (Future Home for Future Communications) project - Regione Lombardia; Future Home for Future Communities (FHfFC) project - Regione Lombardia	FHfFC (Future Home for Future Communications) project - Regione Lombardia; Future Home for Future Communities (FHfFC) project - Regione Lombardia	This work was partially supported by the FHfFC (Future Home for Future Communications) project funded by Regione Lombardia. DB was the recipient. GA: FHfFC 2016 There was no additional external funding received for this study and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by the Future Home for Future Communities (FHfFC) project funded by Regione Lombardia. There was no additional external funding received for this study and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballin NZ, 2019, FOOD CONTROL, V105, P141, DOI 10.1016/j.foodcont.2019.05.022; Braglia L., 2017, American Journal of Plant Sciences, V8, P3475, DOI 10.4236/ajps.2017.813234; Jennings WB, 2019, GENOME, V62, P77, DOI 10.1139/gen-2018-0145; Congiu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018249; Detrich HW, 1997, COMP BIOCHEM PHYS A, V118, P501, DOI 10.1016/S0300-9629(97)00012-1; DETRICH HW, 1987, J BIOL CHEM, V262, P8360; Du K, 2020, NAT ECOL EVOL, V4, P841, DOI 10.1038/s41559-020-1166-x; Evans ML, 2009, MOL ECOL, V18, P4716, DOI 10.1111/j.1365-294X.2009.04374.x; Faulks L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152732; Galal-Khallaf A, 2014, FOOD CONTROL, V46, P441, DOI 10.1016/j.foodcont.2014.06.016; Galli A, 2011, J APPL ICHTHYOL, V27, P651, DOI 10.1111/j.1439-0426.2011.01709.x; Gavazzi F, 2012, ELECTROPHORESIS, V33, P2840, DOI 10.1002/elps.201200144; Giani S, 2020, FOOD CONTROL, V110, DOI 10.1016/j.foodcont.2019.107010; Haddeland PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122032; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Lehnert SJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10972-w; Lehnert SJ, 2016, MOL ECOL, V25, P1259, DOI 10.1111/mec.13560; Mitchell JK, 2016, FOOD ANAL METHOD, V9, P2711, DOI 10.1007/s12161-016-0460-3; Parati K, 2011, CONSERV GENET RESOUR, V3, P83, DOI 10.1007/s12686-010-9296-0; Parati K, 2013, QUAD RIC REG LOMB DI; Reilly Alan, 2018, 1165 FAO UN, V2018; Shokralla S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15894; Sultana S, 2018, FOOD RES INT, V105, P19, DOI 10.1016/j.foodres.2017.10.065; Vandeputte M, 2009, AQUACULTURE, V286, P20, DOI 10.1016/j.aquaculture.2008.09.008; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Zhou Li, 2017, Aquaculture and Fisheries, V2, P103, DOI 10.1016/j.aaf.2017.04.003	28	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0237111	10.1371/journal.pone.0237111	http://dx.doi.org/10.1371/journal.pone.0237111			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750100	gold, Green Published			2022-12-26	WOS:000560009200045
J	Heyde, BJ; Barthel, A; Siemens, J; Mulder, I				Heyde, Benjamin Justus; Barthel, Anne; Siemens, Jan; Mulder, Ines			A fast and robust method for the extraction and analysis of quaternary alkyl ammonium compounds from soil and sewage sludge	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; CATIONIC SURFACTANTS; MASS-SPECTROMETRY; COMPOUNDS QACS; WATER; IDENTIFICATION; DEGRADATION; SEDIMENTS; TOXICITY; BIOCIDES	Alkyltrimethylammonium compounds (ATMACs), dialkyldimethylammonium compounds (DADMACs) and benzylalkyldimethylethylammonium compounds (BACs) are quaternary alkylammonium compounds (QAAC), which are released into the environment in large quantities after their use in cleaning agents and disinfectants. Despite their potential role as selective agents promoting resistance against QAACs as well as antibiotics, there is a lack of data for QAACs in soil due to the lack of sensitive analytical methods. Therefore, we present a robust and fast method for the extraction and quantification of concentrations of these compounds in soil and sewage sludge. The method is based on ultrasonic extraction (USE) with a mixture of acetonitrile and HCl followed by a solid phase extraction (SPE) cleaning step and a subsequent quantification of concentrations with high performance liquid chromatography with mass spectrometry (HPLC-MS/MS) in multi mass reaction mode (MRM). The proposed method is suitable for the quantification of ATMACs (chain length C-8 to C-16), BACs (C-8 to C-18) and DADMACs (C-8 to C-16). The achieved limits of quantification (LOQ) range from 0.1 mu g kg(-1)to 2.1 mu g kg(-1). The recovery rates of spiked soil samples for non-deuterated homologues were between 47% and 57%. The analysis of sewage sludge samples and soil samples revealed that BAC-C12 was the most abundant QAAC with concentrations up to 38600 mu g kg(-1)in sewage sludge and up to 81 mu g kg(-1)in a Mexican soil that was irrigated with wastewater. Overall, the presented methods open perspectives for effectively studying fate and effects of QAACs in soils.	[Heyde, Benjamin Justus; Barthel, Anne; Siemens, Jan; Mulder, Ines] Justus Liebig Univ Giessen, Inst Soil Sci & Soil Conservat, iFZ Res Ctr BioSyst Land Use & Nutr, Giessen, Germany	Justus Liebig University Giessen	Heyde, BJ (corresponding author), Justus Liebig Univ Giessen, Inst Soil Sci & Soil Conservat, iFZ Res Ctr BioSyst Land Use & Nutr, Giessen, Germany.	bheyd@envr.jlug.de	Heyde, Benjamin Justus/ABD-9823-2020; Mulder, Ines/ACL-4606-2022	Heyde, Benjamin/0000-0002-1192-1708	DFG [MU3988/2-1]	DFG(German Research Foundation (DFG))	This work was supported by DFG research project MU3988/2-1 (IM), https://www.dfg.de/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGE A, 2016, J CHROMATOGR A, V1450, P00064; CLARA M, 2007, WATER RES, V0041, P04339; DAVISON AS, 2013, ANN CLIN BIOCHEM, V0050, P00274; DOMAGK G, 1935, DEUT MED WOCHENSCH 1, V0061, P00829; EURL, 2016, AN QUAT AMM COMP QAC; FERNANDEZ P, 1996, ANAL CHEM, V0068, P00921; FERRER I, 2001, ENVIRON SCI TECHNOL, V0035, P02583; FERRER I, 2002, ANAL CHEM, V0074, P01275; GARCIA MT, 2000, CHEMOSPHERE, V0041, P00705; GERIKE P, 1994, WATER RES, V0028, P00147; GILLINGS MR, 2009, FEMS MICROBIOLOGY LE, V0296, P00282, DOI DOI 10.1111/J.1574-6968.2009.01646.X; GRIGSON SJW, 2000, RAPID COMMUN MASS SP, V0014, P02210, DOI DOI 10.1002/1097-0231(20001215)14:233.0.CO;2-8; Kaj L, 2014, QUATERNARY AMMONIUM; KANG HI, 2016, B KOREAN CHEM SOC, V0037, P01219, DOI DOI 10.1002/BKCS.10842; LARAMARTIN PA, 2010, ENVIRON SCI TECHNOL, V0044, P07569, DOI DOI 10.1021/ES101169A; LI XL, 2009, ANAL CHEM, V0081, P07926; MARTINEZCARBALLO E, 2007, ENV POLLUTION BARKIN, V0146, P00543, DOI DOI 10.1016/J.ENVPOL.2006.07.016; MERINO F, 2003, J CHROMATOGR A, V0998, P00143, DOI DOI 10.1016/S0021-9673(03)00565-X; MULDER I, 2018, REV ENV SCI BIOTECHN, V0017, P00159, DOI DOI 10.1007/S11157-017-9457-7; NUNEZ O, 2004, J CHROMATOGR A, V1058, P00089, DOI DOI 10.1016/J.CHROMA.2004.08.085; OSTMAN M, 2017, WATER RES, V0115, P00318; RUAN T, 2014, ENVIRON SCI TECHNOL, V0048, P04289, DOI DOI 10.1007/S11157-017-9457-7.PDF; TANDUKAR M, 2013, ENV SCI TECHNOLOGY, V0047, P09730, DOI DOI 10.1021/ES401507K; VIDAL JLM, 2004, J CHROMATOGR A, V1050, P00179; XIANG L, 2015, J AGR FOOD CHEM, V0063, P06689; YING GG, 2006, ENVIRON INT, V0032, P00417; ZHANG C, 2015, SCI TOTAL ENVIRON, V0518, P00352	27	9	9	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0237020	10.1371/journal.pone.0237020	http://dx.doi.org/10.1371/journal.pone.0237020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750078	Green Published, gold			2022-12-26	WOS:000560009200002
J	Lopes, RF; Minuzzi, LG; Figueiredo, AJ; Goncalves, C; Tessitore, A; Capranica, L; Teixeira, AM; Rama, L				Lopes, Renata Fiedler; Minuzzi, Luciele Guerra; Figueiredo, Antonio Jose; Goncalves, Carlos; Tessitore, Antonio; Capranica, Laura; Teixeira, Ana Maria; Rama, Luis			Upper respiratory symptoms (URS) and salivary responses across a season in youth soccer players: A useful and non-invasive approach associated to URS susceptibility and occurrence in young athletes	PLOS ONE			English	Article							AMERICAN-COLLEGE; TRACT INFECTION; IMMUNE FUNCTION; ALPHA-AMYLASE; EXERCISE; IGA; SPORT; CORTISOL; COMPETITION; PARAMETERS	This study examined the effect of a competitive season on salivary responses [cortisol (sC), testosterone (sT), Testosterone/Cortisol ratio (sT/C), Immunoglobulin A (sIgA), sIgA secretion rate (srIgA), alpha-amylase (sAA)] and upper respiratory symptoms (URS) occurrence in three teams of male soccer players (Under-15, Under-17 and Under-19 yrs.). Training and competition volumes, salivary biomarkers and URS were determined monthly. No differences were found for monthly training volume between teams. Incidence of URS was higher for the U15 (44.9% of the total cases). Higher sT and srIgA were observed for the U19, lower sC were found for the U17 and sAA showed higher values for the U15 throughout the season. In the U15, significant difference (p= .023) was found for sIgA concentration with higher concentration values in January compared to December (-42.7%;p= .008) and the sT showed seasonal variation (p< .001) with the highest value in January significantly different from October (-40.2%;p= .035), November (-38.5%;p= 0.022) and December (-51.6%;p= .008). The U19 presented an increase in sC in March compared to February (-66.1%,p= .018), sT/C were higher in February compared to March (-58.1%;p= .022) and sAA increased in March compared to September (-20.5%;p= .037). Negative correlations, controlled for age group, were found between URS occurrence and srIgA (r = -0.170, p = .001), sAA (r = -0.179, p = .001) and sT (r = -0.107, p = .047). Monitoring salivary biomarkers provides information on mucosal immunity with impact in URS occurrence. Coaches could manipulate training loads to attenuate the physical stressors imposed on athletes, especially at demanding and stressful periods.	[Lopes, Renata Fiedler; Minuzzi, Luciele Guerra; Figueiredo, Antonio Jose; Goncalves, Carlos; Teixeira, Ana Maria; Rama, Luis] Univ Coimbra, Fac Sport Sci & Phys Educ, Res Ctr Sport & Phys Act, Coimbra, Portugal; [Minuzzi, Luciele Guerra] Sao Paulo State Univ, Fac Sci & Technol, Dept Phys Educ, Exercise & Immunometab Res Grp, Presidente Prudente, SP, Brazil; [Tessitore, Antonio; Capranica, Laura] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy	Universidade de Coimbra; Universidade Estadual Paulista; Foro Italico University of Rome	Rama, L (corresponding author), Univ Coimbra, Fac Sport Sci & Phys Educ, Res Ctr Sport & Phys Act, Coimbra, Portugal.	luisrama@fcdef.uc.pt	Laura, Capranica/AFW-3460-2022; Minuzzi, Luciele Guerra/B-9776-2016; Teixeira, Ana Maria/O-3427-2018	Minuzzi, Luciele Guerra/0000-0002-9342-5563; Teixeira, Ana Maria/0000-0003-1498-949X; Figueiredo, Antonio/0000-0001-6956-0514	CAPES -Ministry of Education -Brazil [BEX:1417/13-4]	CAPES -Ministry of Education -Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	LGM are financed by a grant from CAPES -Ministry of Education -Brazil, reference code BEX:1417/13-4. (http://www.capes.gov.br).AMT and LM are registered at Research Center for Sport and Physical Activity -CIDAF (UID/PTD/04213/2016). (https://www.uc.pt/fcdef/Investigacao/in_ english/CIDAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgrove JE, 2008, J SPORT SCI, V26, P653, DOI 10.1080/02640410701716790; Barrett B, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-76; Bishop N.C., 2006, IMMUNE FUNCT SPORT E, P1; Capranica L, 2011, INT J SPORT PHYSIOL, V6, P572, DOI 10.1123/ijspp.6.4.572; Clemente FM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225522; Cormack SJ, 2008, INTJ SPORT PHYSIOL, V3, P439, DOI 10.1123/ijspp.3.4.439; Coutts AJ, 2007, EUR J APPL PHYSIOL, V99, P313, DOI 10.1007/s00421-006-0345-z; Cox AJ, 2008, CLIN J SPORT MED, V18, P438, DOI 10.1097/JSM.0b013e318181e501; Cunniffe B, 2011, MED SCI SPORT EXER, V43, P388, DOI 10.1249/MSS.0b013e3181ef9d6b; Diaz MM, 2013, INT J SPORTS MED, V34, P8, DOI 10.1055/s-0032-1316318; Djaoui L, 2017, PHYSIOL BEHAV, V181, P86, DOI 10.1016/j.physbeh.2017.09.004; Edmonds R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127749; Elloumi M, 2003, EUR J APPL PHYSIOL, V90, P23, DOI 10.1007/s00421-003-0868-5; Fahlman MM, 2005, MED SCI SPORT EXER, V37, P374, DOI 10.1249/01.MSS.0000155432.67020.88; Figueiredo AJ, 2014, INT J SPORT PHYSIOL, V9, P540, DOI 10.1123/IJSPP.2014_0023; Filaire E, 2003, PERCEPT MOTOR SKILL, V97, P1061, DOI 10.2466/PMS.97.8.1061-1072; Filaire E, 2001, EUR J APPL PHYSIOL, V86, P179, DOI 10.1007/s004210100512; Gill SK, 2014, INT J SPORTS MED, V35, P966, DOI 10.1055/s-0033-1358479; Gleeson M, 2000, IMMUNOL CELL BIOL, V78, P536, DOI 10.1046/j.1440-1711.2000.00956.x; Gleeson M, 2007, J APPL PHYSIOL, V103, P693, DOI 10.1152/japplphysiol.00008.2007; Guiomar R., 2016, PROGRAMA NACL VIGILA; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Iorgulescu Gabriela, 2009, J Med Life, V2, P303; Koch A.J., 2010, BRAZILIAN J BIOMOTRI, V4, P92; Koibuchi E, 2014, EXP THER MED, V7, P773, DOI 10.3892/etm.2014.1497; Kraemer RR, 2014, HORM METAB RES, V46, P150, DOI 10.1055/s-0033-1355381; Locke S, 2011, SCAND J MED SCI SPOR, V21, P90, DOI 10.1111/j.1600-0838.2009.00983.x; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; Miletic ID, 1996, PHYSIOL BEHAV, V60, P243, DOI 10.1016/0031-9384(95)02161-2; Minuzzi LG, 2019, J CELL BIOCHEM, V120, P5551, DOI 10.1002/jcb.27839; Moreira A, 2014, J STRENGTH COND RES, V28, P467, DOI 10.1519/JSC.0b013e31829b5512; Morgado JM, 2012, EUR J APPL PHYSIOL, V112, P471, DOI 10.1007/s00421-011-1966-4; Morgans R, 2014, RES SPORTS MED, V22, P346, DOI 10.1080/15438627.2014.944641; Mortatti AL, 2012, J STRENGTH COND RES, V26, P1396, DOI 10.1519/JSC.0b013e31822e7b63; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Nieman DC, 1997, J ATHL TRAINING, V32, P344; Nieman DC, 1997, J APPL PHYSIOL, V82, P1385, DOI 10.1152/jappl.1997.82.5.1385; Owen AL, 2016, J STRENGTH COND RES, V30, P2460, DOI 10.1519/JSC.0000000000000380; Papacosta E, 2011, J SCI MED SPORT, V14, P424, DOI 10.1016/j.jsams.2011.03.004; Penailillo L, 2015, J SPORT SCI, V33, P2080, DOI 10.1080/02640414.2015.1064151; Putlur P, 2004, J SPORT SCI MED, V3, P234; Rama L, 2013, EUR J APPL PHYSIOL, V113, P859, DOI 10.1007/s00421-012-2490-x; Rosa L, 2014, ORAL DIS, V20, P186, DOI 10.1111/odi.12088; Spence L, 2007, MED SCI SPORT EXER, V39, P577, DOI 10.1249/mss.0b013e31802e851a; Takai N, 2004, ARCH ORAL BIOL, V49, P963, DOI 10.1016/j.archoralbio.2004.06.007; TOMASI TB, 1982, J CLIN IMMUNOL, V2, P173, DOI 10.1007/BF00915219; Valente-dos-Santos J, 2014, INT J SPORTS MED, V35, P762, DOI 10.1055/s-0033-1358469; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64	48	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0236669	10.1371/journal.pone.0236669	http://dx.doi.org/10.1371/journal.pone.0236669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750092	Green Published, gold			2022-12-26	WOS:000560009200030
J	de Oliveira, CM; Tureck, LV; Alvares, D; Liu, CY; Horimoto, ARVR; Balcells, M; Alvim, RD; Krieger, JE; Pereira, AC				de Oliveira, Camila Maciel; Viater Tureck, Luciane; Alvares, Danilo; Liu, Chunyu; Horimoto, Andrea Roseli Vancan Russo; Balcells, Mercedes; de Oliveira Alvim, Rafael; Krieger, Jose Eduardo; Pereira, Alexandre Costa			Relationship between marital status and incidence of type 2 diabetes mellitus in a Brazilian rural population: The Baependi Heart Study	PLOS ONE			English	Article							SOCIOECONOMIC POSITION; HEALTH BEHAVIORS; MORTALITY; PREVALENCE; GENDER; TRENDS; PROTECTION; MARRIAGE	Many factors influence the incidence of type 2 diabetes mellitus (T2DM). Here, we investigated the associations between socio-demographic characteristics and familial history with the 5-year incidence of T2DM in a family-based study conducted in Brazil. T2DM was defined as baseline fasting blood glucose >= 126 mg/dL or the use of any hypoglycaemic drug. We excluded individuals with T2DM at baseline or if they did not attend two examination cycles. After exclusions, we evaluated a sample of 1,125 participants, part of the Baependi Heart Study (BHS). Mixed-effects logistic regression models were used to assess T2DM incident given different characteristics. At the 5-year follow-up, the incidence of T2DM was 6.7% (7.2% men and 6.3% women). After adjusting for age, sex, and education status, the model that combined marital and occupation status, skin color, and familial history of T2DM provided the best prediction for T2DM incidence. Only marital status was independently associated with T2DM incidence. Individuals that remained married, despite having significantly increased their weight, were significantly less likely to develop diabetes than their divorced counterparts.	[de Oliveira, Camila Maciel; Horimoto, Andrea Roseli Vancan Russo; de Oliveira Alvim, Rafael; Krieger, Jose Eduardo; Pereira, Alexandre Costa] Univ Sao Paulo, Lab Genet & Mol Cardiol, Heart Inst InCor, Sch Med, Sao Paulo, Brazil; [de Oliveira, Camila Maciel] Univ Fed Parana, Dept Integrat Med, Curitiba, Parana, Brazil; [de Oliveira, Camila Maciel; Balcells, Mercedes] MIT, Inst Med Engn & Sci, Global CoCreat Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Viater Tureck, Luciane] Univ Fed Parana, Dept Genet, Curitiba, Parana, Brazil; [Alvares, Danilo] Pontificia Univ Catolica Chile, Dept Stat, Santiago, Chile; [Liu, Chunyu] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Liu, Chunyu] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Balcells, Mercedes] Ramon Llull Univ, Inst Quim de Sarria, Bioengn Dept, Barcelona, Spain; [de Oliveira Alvim, Rafael] Univ Fed Amazonas, Dept Physiol Sci, Manaus, Amazonas, Brazil	Universidade de Sao Paulo; Universidade Federal do Parana; Massachusetts Institute of Technology (MIT); Universidade Federal do Parana; Pontificia Universidad Catolica de Chile; Framingham Heart Study; Boston University; Universitat Ramon Llull; Institut Quimic de Sarria; Universidade Federal de Amazonas	de Oliveira, CM; Pereira, AC (corresponding author), Univ Sao Paulo, Lab Genet & Mol Cardiol, Heart Inst InCor, Sch Med, Sao Paulo, Brazil.; de Oliveira, CM (corresponding author), Univ Fed Parana, Dept Integrat Med, Curitiba, Parana, Brazil.; de Oliveira, CM (corresponding author), MIT, Inst Med Engn & Sci, Global CoCreat Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cmaciel@mit.edu; alexandre.pereira@incor.usp.br	Alvares, Danilo/AAO-6491-2021; Pereira, Alexandre/HHN-1038-2022; Alvim, Rafael/ABA-7823-2021	Alvares, Danilo/0000-0003-3764-0397; Alvim, Rafael/0000-0003-3150-4239; de Oliveira, Camila Maciel/0000-0001-6823-7395	Sao Paulo Research Foundation (FAPESP); Hospital Samaritano Society through the Ministry of Health [25000.180.664/2011-35]; Fundacion Empreses IQS; Global Co-Creation Lab;  [SAF2017-84773-C2-1-R]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Hospital Samaritano Society through the Ministry of Health; Fundacion Empreses IQS; Global Co-Creation Lab; 	The current research was supported by grants from the Sao Paulo Research Foundation (FAPESP). This work was supported by Hospital Samaritano Society (grant no. 25000.180.664/2011-35), through the Ministry of Health to Support Program Institutional Development of the Unified Health System (SUS-PROADI). M.B. was partially funded by Spain Minister of Economy (SAF2017-84773-C2-1-R), Fundacion Empreses IQS and the Global Co-Creation Lab.	Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Alvim RO, 2017, J HYPERTENS, V35, P105, DOI 10.1097/HJH.0000000000001133; ANNESI I, 1989, STAT MED, V8, P1515, DOI 10.1002/sim.4780081211; Boehme MWJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2188-1; Camelo LV, 2016, ANN EPIDEMIOL, V26, P858, DOI 10.1016/j.annepidem.2016.09.014; Cornelis MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106720; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; de Oliveira CM, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-32; Emmerick ICM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017308; Eng PM, 2005, J EPIDEMIOL COMMUN H, V59, P56, DOI 10.1136/jech.2004.020073; Escolar-Pujolar A, 2018, ENDOCRINOL DIAB NUTR, V65, P21, DOI 10.1016/j.endinu.2017.10.006; Espinosa J, 2008, J HEALTH ECON, V27, P1326, DOI 10.1016/j.jhealeco.2008.04.001; Flor Luisa Sorio, 2017, Rev. bras. epidemiol., V20, P16, DOI 10.1590/1980-5497201700010002; Fox CS, 2006, CIRCULATION, V113, P2914, DOI 10.1161/CIRCULATIONAHA.106.613828; Haines L, 2018, HEALTH EDUC BEHAV, V45, P668, DOI 10.1177/1090198117752783; Johnson NJ, 2000, ANN EPIDEMIOL, V10, P224, DOI 10.1016/S1047-2797(99)00052-6; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; LUNDQUIST J, 2014, DEMOGRAPHY STUDY HUM; Manzoli L, 2007, SOC SCI MED, V64, P77, DOI 10.1016/j.socscimed.2006.08.031; Meiners Micheline Marie Milward de Azevedo, 2017, Rev. bras. epidemiol., V20, P445, DOI 10.1590/1980-5497201700030008; Metsa-Simola N, 2013, POP STUD-J DEMOG, V67, P97, DOI 10.1080/00324728.2012.746386; Iser BPM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108044; Murray JE, 2000, DEMOGRAPHY, V37, P511, DOI 10.1353/dem.2000.0010; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Peters SAE, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005663; Ramezankhani A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215593; Sommer I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2227-y; Tamayo T, 2016, DTSCH ARZTEBL INT, V113, P177, DOI 10.3238/arztebl.2016.0177; Tuoyire DA, 2019, J BIOSOC SCI, V51, P313, DOI 10.1017/S0021932018000147; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; Vega T, 2015, J DIABETES, V7, P411, DOI 10.1111/1753-0407.12183; Whisman MA, 2014, HEALTH PSYCHOL, V33, P832, DOI 10.1037/hea0000064; Williams ED, 2010, DIABETOLOGIA, V53, P2538, DOI 10.1007/s00125-010-1888-4; WYKE S, 1992, SOC SCI MED, V34, P523, DOI 10.1016/0277-9536(92)90208-8; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	35	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236869	10.1371/journal.pone.0236869	http://dx.doi.org/10.1371/journal.pone.0236869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA7OS	32745127	gold, Green Published			2022-12-26	WOS:000560006800022
J	Park, MG; Choi, J; Hong, YS; Park, CG; Kim, BG; Lee, SY; Lim, HJ; Mo, HH; Lim, E; Cha, W				Park, Min-Goo; Choi, Jungmi; Hong, Young-Seoub; Park, Chung Gyoo; Kim, Byoung-Gwon; Lee, Se-Young; Lim, Hyoun-Ju; Mo, Hyoung-ho; Lim, Eunjo; Cha, Wonseok			Negative effect of methyl bromide fumigation work on the central nervous system	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ANOPLOPHORA-GLABRIPENNIS COLEOPTERA; EEG ALPHA-RHYTHM; ETHYL FORMATE; ALZHEIMERS-DISEASE; QUANTITATIVE EEG; RESTING EEG; FREQUENCY; ELECTROENCEPHALOGRAPHY; INTELLIGENCE	Methyl bromide (MB) is a fumigant that has been widely used for killing pests on plants in trade, soils, and structures worldwide due to its excellent permeability and insecticidal effect; however, MB should be replaced because it is an ozone-depleting substance. It is well-known that MB is highly toxic and hazardous to workers, but the effects of exposure in asymptomatic workers have not been explored. The purpose of this study is to investigate the impact of MB fumigation on the health of fumigators at a sensitive level. The electroencephalogram (EEG) and urinary bromide ion levels of 44 fumigators (the study group) and 20 inspectors (the control) were measured before and after fumigation work from February to August 2019 in Busan, Korea. The mean post-work concentration of bromide ion (18.311 mu g/mg CRE) in the fumigators was significantly increased from the pre-work level (7.390 mu g/mg CRE) (P<0.001). The fumigator post-work median frequencies (MDF) and alpha-to-theta ratios (ATR) of EEG index were significantly decreased compared to the pre-work values (P<0.05 for all indices). In contrast, there were no significant differences in inspector EEG indices and urinary bromide ion. The urinary bromide ion levels in all the subjects were negatively correlated with MDF (P= 0.032). In conclusion, fumigators' EEG indices and urinary bromide ion suggested that occupational exposure to MB negatively affected the health of workers, although the workers were asymptomatic.	[Park, Min-Goo; Mo, Hyoung-ho] Anim & Plant Quarantine Agcy APQA, Div Pest Control, Dept Plant Quarantine, Gimcheon Si, Gyeongsangbuk D, South Korea; [Park, Min-Goo; Park, Chung Gyoo] Gyeongsang Natl Univ, Inst Life Sci, Program BK21, Jinju, Gyeongnam, South Korea; [Choi, Jungmi; Lim, Eunjo; Cha, Wonseok] Human Antiaging Stand Res Inst, Uiryeong Gun, Gyeongsangnam D, South Korea; [Hong, Young-Seoub; Kim, Byoung-Gwon] Dong A Univ, Coll Med, Dept Prevent Med, Busan, South Korea; [Hong, Young-Seoub; Kim, Byoung-Gwon; Lee, Se-Young; Lim, Hyoun-Ju] Dong A Univ, Heavy Met Exposure Environm Hlth Ctr, Busan, South Korea	Animal & Plant Quarantine Agency; Gyeongsang National University; Dong A University; Dong A University	Park, MG (corresponding author), Anim & Plant Quarantine Agcy APQA, Div Pest Control, Dept Plant Quarantine, Gimcheon Si, Gyeongsangbuk D, South Korea.; Park, MG (corresponding author), Gyeongsang Natl Univ, Inst Life Sci, Program BK21, Jinju, Gyeongnam, South Korea.	pmg@korea.kr	Park, Min-Goo/AAV-5273-2020	Park, Min-Goo/0000-0003-2479-3693; Choi, Jungmi/0000-0002-5287-7942; Cha, Wonseok/0000-0002-3625-2723	APQA	APQA	This study was carried out with funding of research on the plant quarantine technology development project of APQA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Kyung-won Kim, an officer in pest control division of APQA, for helping the subjects join this study and organizing the schedule. We also thank Byung-Ho Lee, a professor of Gyeongsang National University, to advice for submitting the journal. This study was carried out with funding of research on the plant quarantine technology development project of APQA.	Adamis D, 2005, INT J GERIATR PSYCH, V20, P1038, DOI 10.1002/gps.1393; Agarwal M, 2015, J ECON ENTOMOL, V108, P2566, DOI 10.1093/jee/tov242; Agency for Toxic Substances & Disease Registry (ATSDR), 2018, TOX PROF BROM; Al-Qazzaz NK, 2016, IEEE EMBS CONF BIO, P347, DOI 10.1109/IECBES.2016.7843471; ALEXEEFF GV, 1985, J TOXICOL ENV HEALTH, V15, P109, DOI 10.1080/15287398509530639; ALLAIN P, 1990, ANALYST, V115, P813, DOI 10.1039/an9901500813; Animal and Plant Quarantine Agency, 2018, STAT IMP EXP PLANT C; Anokhin A, 1996, INTELLIGENCE, V23, P1, DOI 10.1016/S0160-2896(96)80002-X; Babiloni C, 2007, EUR J NEUROSCI, V25, P3742, DOI 10.1111/j.1460-9568.2007.05601.x; Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P1113, DOI 10.1016/j.clinph.2006.01.020; Babiloni C, 2009, NEUROIMAGE, V44, P123, DOI 10.1016/j.neuroimage.2008.08.005; Barak AV, 2006, J ECON ENTOMOL, V99, P1628, DOI 10.1603/0022-0493-99.5.1628; Baur X, 2015, J OCCUP MED TOXICOL, V10, DOI 10.1186/s12995-015-0059-4; Bond E.J., 1984, MANUAL FUMIGATION IN; Brinkmeyer J, 2004, INT J GERIATR PSYCH, V19, P749, DOI 10.1002/gps.1162; Choi J, 2020, CLIN EEG NEUROSCI, V51, P348, DOI 10.1177/1550059420914832; Choi J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46789-2; Choi KD, 2002, J KOREAN NEUROL ASS, V20, P307; Claus JJ, 1998, ALZ DIS ASSOC DIS, V12, P167, DOI 10.1097/00002093-199809000-00008; COBEN LA, 1990, ELECTROEN CLIN NEURO, V75, P148, DOI 10.1016/0013-4694(90)90168-J; de Souza A, 2013, J NEUROL SCI, V335, P36, DOI 10.1016/j.jns.2013.09.022; Deschamps FJ, 1996, OCCUP MED-OXFORD, V46, P89, DOI 10.1093/occmed/46.1.89; Doppelmayr M, 2005, NEUROSCI LETT, V381, P309, DOI 10.1016/j.neulet.2005.02.037; Dringenberg HC, 2000, BEHAV BRAIN RES, V115, P235, DOI 10.1016/S0166-4328(00)00261-8; Fields PG, 2002, ANNU REV ENTOMOL, V47, P331, DOI 10.1146/annurev.ento.47.091201.145217; Gargiulo G, 2010, CLIN NEUROPHYSIOL, V121, P686, DOI 10.1016/j.clinph.2009.12.025; Grabner RH, 2004, COGNITIVE BRAIN RES, V20, P212, DOI 10.1016/j.cogbrainres.2004.02.010; Griffin M. J., 2013, New Zealand Plant Protection, V66, P54; Huang C, 2000, CLIN NEUROPHYSIOL, V111, P1961, DOI 10.1016/S1388-2457(00)00454-5; IRISH D. D., 1940, JOUR INDUST HYG AND TOXICOL, V22, P218; Jackson CE, 2008, ALZHEIMERS DEMENT, V4, pS137, DOI 10.1016/j.jalz.2007.10.008; Jelic V, 2000, NEUROBIOL AGING, V21, P533, DOI 10.1016/S0197-4580(00)00153-6; Jelic V, 2009, CLIN EEG NEUROSCI, V40, P129, DOI 10.1177/155005940904000211; Karunaratne C, 1997, POSTHARVEST BIOL TEC, V10, P255, DOI 10.1016/S0925-5214(97)01406-3; KATO N, 1986, Industrial Health, V24, P87; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; KOGA M, 1991, Journal of UOEH, V13, P19; Kwak YT, 2006, J CLIN NEUROPHYSIOL, V23, P456; Lee BH, 2016, J ECON ENTOMOL, V109, P143, DOI 10.1093/jee/tov289; Lee Byung-Ho, 2007, Journal of Asia-Pacific Entomology, V10, P369, DOI 10.1016/S1226-8615(08)60378-7; Lee J-S, 2001, J KOREAN SOC CCCUPAT, V11, P212; Luckhaus C, 2008, INT J GERIATR PSYCH, V23, P1148, DOI 10.1002/gps.2042; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; MBTOC, 2010, 2010 REP METH BROM T; MBTOC, 2014, 2014 REP METH BROM T; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; Moretti DV, 2007, CLIN NEUROPHYSIOL, V118, P2716, DOI 10.1016/j.clinph.2007.09.059; Moretti DV, 2004, CLIN NEUROPHYSIOL, V115, P299, DOI 10.1016/S1388-2457(03)00345-6; Muller M, 1999, TOXICOL LETT, V107, P155, DOI 10.1016/S0378-4274(99)00042-9; Noh GJ, 2006, ANESTHESIOLOGY, V104, P921, DOI 10.1097/00000542-200605000-00006; NOLING JW, 1994, J NEMATOL, V26, P573; Park TH, 2000, KOREAN J OCCUP ENV M, V12, P547; PENTTILA M, 1985, ELECTROEN CLIN NEURO, V60, P1, DOI 10.1016/0013-4694(85)90942-3; Preisser AM, 2012, INT MARIT HEALTH, V63, P133; PRICHEP LS, 1994, NEUROBIOL AGING, V15, P85, DOI 10.1016/0197-4580(94)90147-3; PRINZ PN, 1989, ELECTROEN CLIN NEURO, V73, P427, DOI 10.1016/0013-4694(89)90092-8; Ren YL, 2006, J ECON ENTOMOL, V99, P308, DOI 10.1603/0022-0493-99.2.308; Ren YL, 2011, J STORED PROD RES, V47, P63, DOI 10.1016/j.jspr.2010.04.006; Rogers JM, 2016, INT J PSYCHOPHYSIOL, V106, P87, DOI 10.1016/j.ijpsycho.2016.06.006; Rossini PM, 2006, NEUROSCIENCE, V143, P793, DOI 10.1016/j.neuroscience.2006.08.049; Schreckenberger M, 2004, NEUROIMAGE, V22, P637, DOI 10.1016/j.neuroimage.2004.01.047; Shin HU, 2016, J KOR OPHTHALMOL SOC, V57, P1987, DOI 10.3341/jkos.2016.57.12.1987; 이현석, 2008, [Journal of Korean Society of Occupational and Environmental Hygiene, 한국산업보건학회지], V18, P32; SOININEN H, 1992, NEUROSCI LETT, V137, P5, DOI 10.1016/0304-3940(92)90285-F; Sterman MB, 1996, BIOFEEDBACK SELF-REG, V21, P3, DOI 10.1007/BF02214147; Suwanlaong Kanokrat, 2008, Journal of the Medical Association of Thailand, V91, P421; SZELIES B, 1994, ELECTROEN CLIN NEURO, V91, P131, DOI 10.1016/0013-4694(94)90034-5; TANAKA S, 1991, IND HEALTH, V29, P11, DOI 10.2486/indhealth.29.11; Thier R, 1999, ARCH TOXICOL, V73, P489, DOI 10.1007/s002040050640; Tomlin, 1997, PESTICIDE MANUAL; UNEP, 2018, HDB MONTR PROT SUBST, Vtwelfth; van der Hiele K, 2007, CLIN NEUROPHYSIOL, V118, P1931, DOI 10.1016/j.clinph.2007.05.070; van der Hiele K, 2007, NEUROBIOL AGING, V28, P1322, DOI 10.1016/j.neurobiolaging.2006.06.006; VERBERK MM, 1979, BRIT J IND MED, V36, P59; Wang KE, 2008, ANAL SCI, V24, P509, DOI 10.2116/analsci.24.509; WYERS H, 1945, BRIT J IND MED, V2, P24; Yamano Y, 2011, IND HEALTH, V49, P133, DOI 10.2486/indhealth.MS1143; Yang J, 2016, J ECON ENTOMOL, V109, P2355, DOI 10.1093/jee/tow222; Yi J, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224325; Zoefel B, 2011, NEUROIMAGE, V54, P1427, DOI 10.1016/j.neuroimage.2010.08.078	80	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236694	10.1371/journal.pone.0236694	http://dx.doi.org/10.1371/journal.pone.0236694			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA7OS	32745138	gold, Green Published			2022-12-26	WOS:000560006800010
J	Winnay, JN; Solheim, MH; Sakaguchi, M; Njolstad, PR; Kahn, CR				Winnay, Jonathon N.; Solheim, Marie H.; Sakaguchi, Masaji; Njolstad, Pal R.; Kahn, C. Ronald			Inhibition of the PI 3-kinase pathway disrupts the unfolded protein response and reduces sensitivity to ER stress-dependent apoptosis	FASEB JOURNAL			English	Article						Apoptosis; ER stress; PI 3-kinase; SHORT Syndrome; Unfolded Protein Response	ENDOPLASMIC-RETICULUM STRESS; REGULATORY SUBUNIT; PHOSPHOINOSITIDE 3-KINASE; PIK3R1 MUTATIONS; PARTIAL LIPODYSTROPHY; POSITIVE REGULATION; INSULIN ACTION; SHORT STATURE; P85 ALPHA; P85-ALPHA	Class Ia phosphoinositide 3-kinases (PI3K) are critical mediators of insulin and growth factor action. We have demonstrated that the p85 alpha regulatory subunit of PI3K modulates the unfolded protein response (UPR) by interacting with and regulating the nuclear translocation of XBP-1s, a transcription factor essential for the UPR. We now show that PI3K activity is required for full activation of the UPR. Pharmacological inhibition of PI3K in cells blunts the ER stress-dependent phosphorylation of IRE1 alpha and PERK, decreases induction of ATF4, CHOP, and XBP-1 and upregulates UPR target genes. Cells expressing a human p85 alpha mutant (R649W) previously shown to inhibit PI3K, exhibit decreased activation of IRE1 alpha and PERK and reduced induction of CHOP and ATF4. Pharmacological inhibition of PI3K, overexpression of a mutant of p85 alpha that lacks the ability to interact with the p110 alpha catalytic subunit ( increment p85 alpha) or expression of mutant p85 alpha (R649W) in vivo, decreased UPR-dependent induction of ER stress response genes. Acute tunicamycin treatment of R649W(+/-)mice revealed reduced induction of UPR target genes in adipose tissue, whereas chronic tunicamycin exposure caused sustained increases in UPR target genes in adipose tissue. Finally, R649W(+/-)cells exhibited a dramatic resistance to ER stress-dependent apoptosis. These data suggest that PI3K pathway dysfunction causes ER stress that may drive the pathogenesis of several diseases including Type 2 diabetes and various cancers.	[Winnay, Jonathon N.; Solheim, Marie H.; Sakaguchi, Masaji; Kahn, C. Ronald] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA 02215 USA; [Solheim, Marie H.; Njolstad, Pal R.] Univ Bergen, KG Jebsen Ctr Diabet Res, Dept Clin Sci, Bergen, Norway; [Sakaguchi, Masaji] Kumamoto Univ, Dept Metab Med, Kumamoto, Japan; [Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, Bergen, Norway; [Winnay, Jonathon N.] Sana Biotechnol, Cambridge, MA USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Bergen; Kumamoto University; University of Bergen; Haukeland University Hospital	Kahn, CR (corresponding author), Harvard Med Sch, Joslin Diabet Ctr, Sect Integrat Physiol & Metab, One Joslin Pl, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK055545]; EC \ FP7 \ FP7 Ideas: European Research Council (FP7 Ideas) [29357]	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); EC \ FP7 \ FP7 Ideas: European Research Council (FP7 Ideas)	HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: R01 DK055545; EC vertical bar FP7 vertical bar FP7 Ideas: European Research Council (FP7 Ideas), Grant/Award Number: 29357	AARSKOG D, 1983, AM J MED GENET, V15, P29, DOI 10.1002/ajmg.1320150104; Agouni A, 2011, BIOCHEM J, V438, P369, DOI 10.1042/BJ20110373; Avila M, 2016, CLIN GENET, V89, P501, DOI 10.1111/cge.12688; Barcena C, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-51; Bettaieb A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034412; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Chudasama KK, 2013, AM J HUM GENET, V93, P150, DOI 10.1016/j.ajhg.2013.05.023; Chung BK, 2014, CLIN GENET, V85, P228, DOI 10.1111/cge.12262; Cui WJ, 2011, ACTA CRYSTALLOGR D, V67, P423, DOI 10.1107/S0907444911006445; Fruman DA, 2014, NEW ENGL J MED, V370, P1061, DOI 10.1056/NEJMe1400055; Gockeritz E, 2015, INT J CANCER, V137, P2234, DOI 10.1002/ijc.29579; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hawkes CP, 2013, EUR J PEDIATR, V172, P1255, DOI 10.1007/s00431-013-2007-6; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hosoi T, 2007, BRAIN RES, V1152, P27, DOI 10.1016/j.brainres.2007.03.052; Inukai I, 2001, FEBS LETT, V490, P32, DOI 10.1016/S0014-5793(01)02132-9; Inukai K, 1997, J BIOL CHEM, V272, P7873, DOI 10.1074/jbc.272.12.7873; Inukai K, 1996, J BIOL CHEM, V271, P5317, DOI 10.1074/jbc.271.10.5317; Klatka M, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0362-z; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; LIPSON AH, 1989, J MED GENET, V26, P473, DOI 10.1136/jmg.26.7.473; Lu G, 2013, MOL METAB, V2, P405, DOI 10.1016/j.molmet.2013.07.005; Matsumoto M, 1996, FEBS LETT, V395, P143, DOI 10.1016/0014-5793(96)01016-2; Mayer IA, 2016, ANNU REV MED, V67, P11, DOI 10.1146/annurev-med-062913-051343; Mounir Z, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001630; Oakes SA, 2020, AM J PATHOL, V190, P934, DOI 10.1016/j.ajpath.2020.01.010; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Prischi F., 2014, NAT COMMUN, V5, P1; Ravichandran LV, 2001, MOL ENDOCRINOL, V15, P1768, DOI 10.1210/me.15.10.1768; Ren SX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111606; Sakaue H, 1997, MOL ENDOCRINOL, V11, P1552, DOI 10.1210/me.11.10.1552; Solheim MH, 2017, INVEST OPHTH VIS SCI, V58, P3100, DOI 10.1167/iovs.16-21347; Sorge G, 1996, AM J MED GENET, V61, P178, DOI 10.1002/(SICI)1096-8628(19960111)61:2<178::AID-AJMG16>3.0.CO;2-R; Taniguchi CM, 2007, MOL CELL BIOL, V27, P2830, DOI 10.1128/MCB.00079-07; Taniguchi CM, 2006, P NATL ACAD SCI USA, V103, P12093, DOI 10.1073/pnas.0604628103; Thauvin-Robinet C, 2013, AM J HUM GENET, V93, P141, DOI 10.1016/j.ajhg.2013.05.019; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Urra H, 2016, TRENDS CANCER, V2, P252, DOI 10.1016/j.trecan.2016.03.007; Winnay JN, 2016, J CLIN INVEST, V126, P1401, DOI 10.1172/JCI84005; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000	45	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12521	12532		10.1096/fj.202000892R	http://dx.doi.org/10.1096/fj.202000892R		AUG 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32744782				2022-12-26	WOS:000557255100001
J	Klimont, M; Oronowicz-Jaskowiak, A; Flieger, M; Rzeszutek, J; Juszkat, R; Jonczyk-Potoczna, K				Klimont, Michal; Oronowicz-Jaskowiak, Agnieszka; Flieger, Mateusz; Rzeszutek, Jacek; Juszkat, Robert; Jonczyk-Potoczna, Katarzyna			Deep learning for cerebral angiography segmentation from non-contrast computed tomography	PLOS ONE			English	Article								Cerebral computed tomography angiography is a widely available imaging technique that helps in the diagnosis of vascular pathologies. Contrast administration is needed to accurately assess the arteries. On non-contrast computed tomography, arteries are hardly distinguishable from the brain tissue, therefore, radiologists do not consider this imaging modality appropriate for the evaluation of vascular pathologies. There are known contraindications to administering iodinated contrast media, and in these cases, the patient has to undergo another examination to visualize cerebral arteries, such as magnetic resonance angiography. Deep learning for image segmentation has proven to perform well on medical data for a variety of tasks. The aim of this research was to apply deep learning methods to segment cerebral arteries on non-contrast computed tomography scans and consequently, generate angiographies without the need for contrast administration. The dataset for this research included 131 patients who underwent brain non-contrast computed tomography directly followed by computed tomography with contrast administration. Then, the segmentations of arteries were generated and aligned with non-contrast computed tomography scans. A deep learning model based on the U-net architecture was trained to perform the segmentation of blood vessels on non-contrast computed tomography. An evaluation was performed on separate test data, as well as using cross-validation, reaching Dice coefficients of 0.638 and 0.673, respectively. This study proves that deep learning methods can be leveraged to quickly solve problems that are difficult and time-consuming for a human observer, therefore providing physicians with additional information on the patient. To encourage the further development of similar tools, all code used for this research is publicly available.	[Klimont, Michal; Juszkat, Robert] Poznan Univ Med Sci, Dept Radiol, Poznan, Poland; [Klimont, Michal; Oronowicz-Jaskowiak, Agnieszka; Flieger, Mateusz; Rzeszutek, Jacek] Fast Radiol, Poznan, Poland; [Oronowicz-Jaskowiak, Agnieszka] Natl Inst Oncol, Dept Radiol 1, Warsaw, Poland; [Jonczyk-Potoczna, Katarzyna] Poznan Univ Med Sci, Dept Paediat Radiol, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences	Klimont, M (corresponding author), Poznan Univ Med Sci, Dept Radiol, Poznan, Poland.; Klimont, M (corresponding author), Fast Radiol, Poznan, Poland.	klimont.md@gmail.com	Katarzyna, Jończyk - Potoczna/AAU-2901-2021	Katarzyna, Jończyk - Potoczna/0000-0002-9412-8931; Klimont, Michal/0000-0002-9063-2516				Aitken A, 2017, ARXIV170702937CS; [Anonymous], 2015, ARXIV151203385CS; [Anonymous], 2020, FAST RADIOLOGY ARTIF; Avendi MR, 2016, MED IMAGE ANAL, V30, P108, DOI 10.1016/j.media.2016.01.005; Brant WE, 2012, FUNDAMENTALS DIAGNOS; Brox T, 2015, P LECT NOTES COMPUTE, DOI DOI 10.1007/978-3-319-24574-428; Chu B, 2017, ARXIV170102362CS; Dill T, 2008, HEART, V94, P943, DOI 10.1136/hrt.2007.125039; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gong E, 2018, J MAGN RESON IMAGING, V48, P330, DOI 10.1002/jmri.25970; Hedblom A, 2013, THESIS; KATZ DA, 1995, RADIOLOGY, V195, P445, DOI 10.1148/radiology.195.2.7724764; Kingma D. P., 2017, ADAM METHOD STOCHAST; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kong C, 2017, ARXIV171202502CS; Lesage D, 2009, MED IMAGE ANAL, V13, P819, DOI 10.1016/j.media.2009.07.011; Lundervold AS, 2019, Z MED PHYS, V29, P102, DOI 10.1016/j.zemedi.2018.11.002; Manninen AL, 2012, AM J NEURORADIOL, V33, P2038, DOI 10.3174/ajnr.A3123; Moccia S, 2018, COMPUT METH PROG BIO, V158, P71, DOI 10.1016/j.cmpb.2018.02.001; Oliveira FPM, 2014, COMPUT METHOD BIOMEC, V17, P73, DOI 10.1080/10255842.2012.670855; Park HJ, 2019, RADIOLOGY, V293, P565, DOI 10.1148/radiol.2019190829; Pieper S, 2004, IEEE INT S BIOMED IM, V26, P632, DOI DOI 10.1109/ISBI.2004.1398617; Raghu M., 2019, ARXIV190207208CSSTAT; Rawson JV, 2013, AM FAM PHYSICIAN, V88, P312; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Smistad E, 2015, MED IMAGE ANAL, V20, P1, DOI 10.1016/j.media.2014.10.012; Smith L. N., 2018, ARXIV180309820CSSTAT; Sudre CH, 2017, LECT NOTES COMPUT SC, V10553, P240, DOI 10.1007/978-3-319-67558-9_28; Tan C., 2018, ARXIV180801974CSSTAT; Wolny A., 2019, WOLNY PYTORCH 3DUNET; Wu YW, 2016, ANN ACAD MED SINGAP, V45, P157; Yoo TS, 2002, STUD HEALTH TECHNOL, V85, P586; Zhang B, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003170; Zhu Jun-Yan, 2018, ARXIV170310593CS	34	4	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0237092	10.1371/journal.pone.0237092	http://dx.doi.org/10.1371/journal.pone.0237092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735633	Green Published, gold			2022-12-26	WOS:000569367100069
J	Nair, AA; Velagapudi, MA; Lang, JA; Behara, L; Venigandla, R; Velagapudi, N; Fong, CT; Horibe, M; Lang, JD; Nair, BG				Nair, Akira A.; Velagapudi, Mihir A.; Lang, Jonathan A.; Behara, Lakshmana; Venigandla, Ravitheja; Velagapudi, Nishant; Fong, Christine T.; Horibe, Mayumi; Lang, John D.; Nair, Bala G.			Machine learning approach to predict postoperative opioid requirements in ambulatory surgery patients	PLOS ONE			English	Article							PAIN; CONSUMPTION; ANALGESIA	Opioids play a critical role in acute postoperative pain management. Our objective was to develop machine learning models to predict postoperative opioid requirements in patients undergoing ambulatory surgery. To develop the models, we used a perioperative dataset of 13,700 patients (>= 18 years) undergoing ambulatory surgery between the years 2016-2018. The data, comprising of patient, procedure and provider factors that could influence postoperative pain and opioid requirements, was randomly split into training (80%) and validation (20%) datasets. Machine learning models of different classes were developed to predict categorized levels of postoperative opioid requirements using the training dataset and then evaluated on the validation dataset. Prediction accuracy was used to differentiate model performances. The five types of models that were developed returned the following accuracies at two different stages of surgery: 1) Prior to surgery-Multinomial Logistic Regression: 71%, Naive Bayes: 67%, Neural Network: 30%, Random Forest: 72%, Extreme Gradient Boost: 71% and 2) End of surgery-Multinomial Logistic Regression: 71%, Naive Bayes: 63%, Neural Network: 32%, Random Forest: 72%, Extreme Gradient Boost: 70%. Analyzing the sensitivities of the best performing Random Forest model showed that the lower opioid requirements are predicted with better accuracy (89%) as compared with higher opioid requirements (43%). Feature importance (% relative importance) of model predictions showed that the type of procedure (15.4%), medical history (12.9%) and procedure duration (12.0%) were the top three features contributing to model predictions. Overall, the contribution of patient and procedure features towards model predictions were 65% and 35% respectively. Machine learning models could be used to predict postoperative opioid requirements in ambulatory surgery patients and could potentially assist in better management of their postoperative acute pain.	[Nair, Akira A.] Lakeside High Sch, Seattle, WA USA; [Velagapudi, Mihir A.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Lang, Jonathan A.] Haverford Coll, Haverford, PA 19041 USA; [Behara, Lakshmana; Venigandla, Ravitheja; Velagapudi, Nishant] Perimatics LLC, Bellevue, WA USA; [Fong, Christine T.; Lang, John D.; Nair, Bala G.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Horibe, Mayumi] VA Puget Sound Hosp, Dept Anesthesiol, Seattle, WA USA	University of California System; University of California Berkeley; Haverford College; University of Washington; University of Washington Seattle	Nair, BG (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.	nairbg@uw.edu			University of Washington; Perimatics LLC; VA Puget Sound Health System	University of Washington(University of Washington); Perimatics LLC; VA Puget Sound Health System(US Department of Veterans Affairs)	BGN owns equity in Perimatics LLC and serves as its advisor. This commercial affiliation did not play a role in the study. The University of Washington provided support in the form of salaries for some of the authors [BGN, JDL, CTF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Similarly, Perimatics LLC provided support in the form of salaries for some of the authors [NV, RV, LB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Lastly, VA Puget Sound Health System provided support in the form of salaries for the author [MH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors [AAN, MAV, JAL] were summer student interns and were unfunded. The specific roles of these authors are articulated in the `author contributions' section.	Amalakuhan B, 2012, J COMMUNITY HOSP INT, V2, DOI 10.3402/jchimp.v2i1.9915; Apfelbaum JL, 2003, ANESTH ANALG, V97, P534, DOI 10.1213/01.ANE.0000068822.10113.9E; Banka Trevor R, 2015, HSS J, V11, P71, DOI 10.1007/s11420-014-9418-4; Burbridge MA, 2019, CUREUS, V11, DOI 10.7759/cureus.3863; CDC, MORPH MILL EQ TABL; Chen GA, 2011, J THORAC ONCOL, V6, P1481, DOI 10.1097/JTO.0b013e31822918bd; Chevalier P, 2014, PAIN MANAG, V4, P267, DOI [10.2217/pmt.14.26, 10.2217/PMT.14.26]; Chirikov VV, 2017, MED CARE, V55, pE104, DOI 10.1097/MLR.0000000000000405; Chung F, 1996, CAN J ANAESTH, V43, P1121, DOI 10.1007/BF03011838; De Cosmo G, 2008, CLIN J PAIN, V24, P399, DOI 10.1097/AJP.0b013e3181671a08; Gorodeski EZ, 2011, CIRC-CARDIOVASC QUAL, V4, P521, DOI 10.1161/CIRCOUTCOMES.110.959023; Healey M, 1998, AUST NZ J OBSTET GYN, V38, P80, DOI 10.1111/j.1479-828X.1998.tb02965.x; Hsich E, 2011, CIRC-CARDIOVASC QUAL, V4, P39, DOI 10.1161/CIRCOUTCOMES.110.939371; Ip HYV, 2009, ANESTHESIOLOGY, V111, P657, DOI 10.1097/ALN.0b013e3181aae87a; Jiang F, 2017, STROKE VASC NEUROL, V2, P230, DOI 10.1136/svn-2017-000101; Kalkman CJ, 2003, PAIN, V105, P415, DOI 10.1016/S0304-3959(03)00252-5; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Lesmeister C., 2017, MASTERING MACHINE LE, V2nd. ed.; Lo-Ciganic WH, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0968; National Institutes of Health, 2003, WARR GRANT MAGN CLIN; Parthipan A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210575; Raiff Doug, 2014, Hosp Pharm, V49, P1022, DOI 10.1310/hpj4911-1022; Sullivan D, 2016, J TRAUMA NURS, V23, P361, DOI 10.1097/JTN.0000000000000250; TAENZER P, 1986, PAIN, V24, P331, DOI 10.1016/0304-3959(86)90119-3; Thottakkara P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155705; Veterans Health Administration, 2002, VHA DOD CLIN PRACT G; Watts Richard, 2017, J Anaesthesiol Clin Pharmacol, V33, P28, DOI 10.4103/0970-9185.202182; Wells N., 2008, PATIENT SAFETY QUALI, P469; Wheeler M, 2002, J PAIN, V3, P159, DOI 10.1054/jpai.2002.123652	29	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236833	10.1371/journal.pone.0236833	http://dx.doi.org/10.1371/journal.pone.0236833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735604	gold, Green Published			2022-12-26	WOS:000569367100052
J	Dobrovolny, HM				Dobrovolny, Hana M.			Modeling the role of asymptomatics in infection spread with application to SARS-CoV-2	PLOS ONE			English	Article							EPIDEMIC; WUHAN	SARS-CoV-2 started causing infections in humans in late 2019 and has spread rapidly around the world. While the number of symptomatically infected and severely ill people is high and has overwhelmed the medical systems of many countries, there is mounting evidence that some of the rapid spread of this virus has been driven by asymptomatic infections. In this study, we use a compartmental mathematical model of a viral epidemic that includes asymptomatic infection to examine the role of asymptomatic individuals in the spread of the infection. We apply the model to epidemics in California, Florida, New York, and Texas, finding that asymptomatic infections far outnumber reported symptomatic infections at the peak of the epidemic in all four states. The model suggests that relaxing of social distancing measures too quickly could lead to a rapid rise in the number of cases, driven in part by asymptomatic infections.	[Dobrovolny, Hana M.] Texas Christian Univ, Dept Phys & Astron, Ft Worth, TX 76129 USA	Texas Christian University	Dobrovolny, HM (corresponding author), Texas Christian Univ, Dept Phys & Astron, Ft Worth, TX 76129 USA.	h.dobrovolny@tcu.edu	Dobrovolny, Hana M./A-2447-2013	Dobrovolny, Hana M./0000-0003-3592-6770				Ayittey FK, 2020, J MED VIROL, V92, P473, DOI 10.1002/jmv.25706; Bendavid E, 2020, COVID 19 ANTIBODY SE, DOI [10.1101/2020.04.14.20062463, DOI 10.1101/2020.04.14.20062463]; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chisholm RH, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.172341; Dean NE, 2016, CLIN INFECT DIS, V62, P1277, DOI 10.1093/cid/ciw114; Deng YT, 2020, CAMB CHINA LIBR, P1; Du ZW, 2020, EMERG INFECT DIS, V26, P1341, DOI [10.3201/eid2606.200357, 10.1101/2020.02.19.20025452]; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Ghinai I, 2020, LANCET, V395, P1137, DOI 10.1016/S0140-6736(20)30607-3; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Hoehl S, 2020, NEW ENGL J MED, V382, P1278, DOI 10.1056/NEJMc2001899; Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4; Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Leung KY, 2018, MATH BIOSCI, V301, P190, DOI 10.1016/j.mbs.2018.04.002; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Manyombe MLM, 2016, MATH BIOSCI ENG, V13, P813, DOI 10.3934/mbe.2016019; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; Milne GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061504; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Rahman B, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2111; Roosa K, 2019, THEOR BIOL MED MODEL, V16, DOI 10.1186/s12976-018-0097-6; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Solonen A, 2013, INT J BIOMATH, V6, DOI 10.1142/S1793524513500083; Sood N, 2020, JAMA-J AM MED ASSOC, V323, P2425, DOI 10.1001/jama.2020.8279; Tanne JH, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1090; Thompson RN, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004836; Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018; Tong ZD, 2020, EMERG INFECT DIS, V26, P1052, DOI 10.3201/eid2605.200198; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Wang JL, 2018, APPL ANAL, V97, P1467, DOI 10.1080/00036811.2017.1313409; Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748; Wei WE, 2020, MMWR-MORBID MORTAL W, V69, p411e5, DOI DOI 10.15585/mmwr.mm6914e1; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yang CY, 2020, MATH BIOSCI ENG, V17, P2708, DOI 10.3934/mbe.2020148; Yu XX, 2020, INFLUENZA OTHER RESP, V14, P474, DOI 10.1111/irv.12743; Zhang JJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2817-7; Zhu YF, 2021, STAT BIOSCI, V13, P1, DOI 10.1007/s12561-020-09277-0	43	17	18	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0236976	10.1371/journal.pone.0236976	http://dx.doi.org/10.1371/journal.pone.0236976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776963	Green Published, gold			2022-12-26	WOS:000561393800003
J	Kuhnert, L; Giantin, M; Dacasto, M; Halwachs, S; Honscha, W				Kuhnert, Lydia; Giantin, Mery; Dacasto, Mauro; Halwachs, Sandra; Honscha, Walther			AhR-activating pesticides increase the bovine ABCG2 efflux activity in MDCKII-bABCG2 cells	PLOS ONE			English	Article							BLOOD-MILK BARRIER; MAMMARY-GLAND; EXPRESSION; TRANSPORTER; DIOXIN; MECHANISMS; SECRETION; RESIDUES; PATHWAY; GENE	In bovine mammary glands, the ABCG2 transporter actively secretes xenobiotics into dairy milk. This can have significant implications when cattle are exposed to pesticide residues in feed. Recent studies indicate that the fungicide prochloraz activates the aryl hydrocarbon receptor (AhR) pathway, increasing bovine ABCG2 (bABCG2) gene expression and efflux activity. This could enhance the accumulation of bABCG2 substrates in dairy milk, impacting pesticide risk assessment. We therefore investigated whether 13 commonly used pesticides in Europe are inducers of AhR and bABCG2 activity. MDCKII cells expressing mammary bABCG2 were incubated with pesticides for up to 72 h. To reflect anin vivosituation, applied pesticide concentrations corresponded to the maximum residue levels (MRLs) permitted in bovine fat or muscle. AhR activation was ascertained through CYP1A mRNA expression and enzyme activity, measured by qPCR and 7-ethoxyresorufin-omicron-deethylase (EROD) assay, respectively. Pesticide-mediated increase of bABCG2 efflux activity was assessed using the Hoechst 33342 accumulation assay. For all assays, the known AhR-activating pesticide prochloraz served as a positive control, while the non-activating tolclofos-methyl provided the negative control. At 10-fold MRL concentrations, chlorpyrifos-methyl, diflufenican, ioxynil, rimsulfuron, and tebuconazole significantly increased CYP1A1 mRNA levels, CYP1A activity, and bABCG2 efflux activity compared to the vehicle control. In contrast, dimethoate, dimethomorph, glyphosate, iprodione, methiocarb and thiacloprid had no impact on AhR-mediated CYP1A1 mRNA levels, CYP1A activity or bABCG2 efflux. In conclusion, the MDCKII-bABCG2 cell model proved an appropriate tool for identifying AhR- and bABCG2-inducing pesticides. This provides anin vitroapproach that could reduce the number of animals required in pesticide approval studies.	[Kuhnert, Lydia; Halwachs, Sandra; Honscha, Walther] Univ Leipzig, Fac Vet Med, Inst Pharmacol Pharm & Toxicol, Leipzig, Germany; [Giantin, Mery; Dacasto, Mauro] Univ Padua, Div Vet Pharmacol & Toxicol, Dept Comparat Biomed & Food Sci, Padua, Italy; [Halwachs, Sandra] MSD Anim Hlth Innovat GmbH, Schwabenheim, Germany	Leipzig University; University of Padua; Merck & Company; Intervet International B.V.	Kuhnert, L (corresponding author), Univ Leipzig, Fac Vet Med, Inst Pharmacol Pharm & Toxicol, Leipzig, Germany.	lydia.kuhnert@vetmed.uni-leipzig.de		Kuhnert, Lydia/0000-0002-9779-2440	MSD Animal Health Innovation GmbH	MSD Animal Health Innovation GmbH(Merck & CompanyIntervet International B.V.)	MSD Animal Health Innovation GmbH provided support in the form of salary for author SH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are given in the 'author contributions' section.	Ackermann T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0461-z; [Anonymous], 2006, EFSA SCI REP, V79, P1, DOI DOI 10.2903/J.EFSA.2006.79R; Ballent M, 2018, J VET PHARMACOL THER, V41, P292, DOI 10.1111/jvp.12466; Bundesamt fur Verbraucherschutz und Lebensmittelsicherheit (BVL), 2014, LIST AUTH PLANT PROT; Bundesamt fur Verbraucherschutz und Lebensmittelsicherheit (BVL), 2012, BER LEB 2011 MON GEM, DOI [10.1007/978-3-0348-0580-3, DOI 10.1007/978-3-0348-0580-3]; Bundesamt fur Verbraucherschutz und Lebensmittelsicherheit (BVL), 2014, BER LEB 2014 MON GEM, DOI [10.1007/978-3-319-26967-2, DOI 10.1007/978-3-319-26967-2]; Bundesamt fur Verbraucherschutz und Lebensmittelsicherheit (BVL), 2017, ERG MELD GEM 64 PFLA; Bundesamt fur Verbraucherschutz und Lebensmittelsicherheit (BVL), 2015, BER LEB 2013 MON GEM, DOI [10.1007/978-3-319-14658-4, DOI 10.1007/978-3-319-14658-4]; Chang TKH, 2006, CYTOCHROME P450 PROT, P85, DOI 10.1385/1592599982; Chedik L, 2018, EXPERT OPIN DRUG MET, V14, P739, DOI 10.1080/17425255.2018.1487398; DONATO MT, 1993, ANAL BIOCHEM, V213, P29, DOI 10.1006/abio.1993.1381; EFSA, 2005, EFSA SCI REPORT, P1, DOI DOI 10.2903/J.EFSA.2005.45R; EFSA Panel on Plant Protection Products and Their Residues, 2008, EFSA J, V6, P1, DOI [10.2903/j.efsa.2008.122r, DOI 10.2903/J.EFSA.2008.122R]; European Commission (COM), 2015, EU PEST DAT SESARCH; European Commission (COM), 2015, EU PEST DAT SEARCH A; European Food Safety Authority, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2219; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3233; European Food Safety Authority, 2011, EFSA Journal, V9, P2323; European Medicines Agency (EMA); Committee for Human Medicinal Products (CHMP), 2012, GUID INV DRUG INT CP; Food and Agriculture Organization of the united Nations (FAO), 1995, PEST RES FOOD 1994 E; Galea KS, 2015, J EXPO SCI ENV EPID, V25, P623, DOI 10.1038/jes.2015.54; Gianti M, 2013, RES VET SCI, V94, P90, DOI 10.1016/j.rvsc.2012.07.035; Giantin M, 2016, VET J, V212, P36, DOI 10.1016/j.tvjl.2016.03.024; Giantin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095481; Go RE, 2017, ENVIRON TOXICOL, V32, P2225, DOI 10.1002/tox.22438; Halwachs S, 2014, TOXICOL IN VITRO, V28, P432, DOI 10.1016/j.tiv.2013.12.015; Halwachs S, 2013, TOXICOL SCI, V131, P491, DOI 10.1093/toxsci/kfs304; Hamilton D, 2004, PEST MANAG SCI, V60, P311, DOI 10.1002/ps.865; Jonker JW, 2005, NAT MED, V11, P127, DOI 10.1038/nm1186; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Larigot Lucie, 2018, Biochim Open, V7, P1, DOI 10.1016/j.biopen.2018.05.001; Lewis KA, 2016, HUM ECOL RISK ASSESS, V22, P1050, DOI 10.1080/10807039.2015.1133242; Lindner S, 2013, J VET PHARMACOL THER, V36, P562, DOI 10.1111/jvp.12045; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long M, 2003, TOXICOLOGY, V194, P77, DOI 10.1016/j.tox.2003.08.001; Mackowiak B, 2016, BBA-GENE REGUL MECH, V1859, P1130, DOI 10.1016/j.bbagrm.2016.02.006; Mahnke H, 2016, DRUG METAB DISPOS, V44, P700, DOI 10.1124/dmd.115.068940; Manzini L, 2017, J VET PHARMACOL THER, V40, P591, DOI 10.1111/jvp.12397; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Mohammadi-Bardbori A, 2014, ASSAY QUANTITATIVE D, DOI [10.1038/protex.2014.043, DOI 10.1038/PROTEX.2014.043]; Mostafalou S, 2013, TOXICOL APPL PHARM, V268, P157, DOI 10.1016/j.taap.2013.01.025; Organisation for Economic Co-operation and Development (OECD), 2013, INTR OECD TEST GUID; Otero JA, 2016, J DAIRY SCI, V99, P5731, DOI 10.3168/jds.2015-10593; Pirsaheb Meghdad, 2015, Med J Islam Repub Iran, V29, P228; POLAND A, 1973, MOL PHARMACOL, V9, P736; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Real R, 2011, J VET PHARMACOL THER, V34, P313, DOI 10.1111/j.1365-2885.2010.01241.x; Schmidt H. H., 2000, Gesunde Pflanzen, V52, P172; Takeuchi S, 2008, CHEMOSPHERE, V74, P155, DOI 10.1016/j.chemosphere.2008.08.015; Tirona RG, 2011, HANDB EXP PHARMACOL, V201, P373, DOI 10.1007/978-3-642-14541-4_10; Tsiplakou E, 2010, CHEMOSPHERE, V80, P504, DOI 10.1016/j.chemosphere.2010.04.069; US Food and Drug Administration (FDA), 2017, IN VITR MET AND TRAN; Vrzal Radim, 2004, Biomedical Papers (Olomouc), V148, P3; Wassermann L, 2013, ARCH TOXICOL, V87, P1671, DOI 10.1007/s00204-013-1066-9; Wassermann L, 2013, J PHARM SCI-US, V102, P772, DOI 10.1002/jps.23399; 2011, EFSA J, V9, DOI DOI 10.1007/978-3-319-14658-4	58	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237163	10.1371/journal.pone.0237163	http://dx.doi.org/10.1371/journal.pone.0237163			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764792	gold, Green Published			2022-12-26	WOS:000561029000044
J	Matsuoka, H; Ando, K; Swayze, EJ; Unan, EC; Mathew, J; Hu, QJ; Tsuda, Y; Nakashima, Y; Saeki, H; Oki, E; Bharti, AK; Mori, M				Matsuoka, Hiroya; Ando, Koji; Swayze, Emma J.; Unan, Elizabeth C.; Mathew, Joseph; Hu, Quingjiang; Tsuda, Yasuo; Nakashima, Yuichiro; Saeki, Hiroshi; Oki, Eiji; Bharti, Ajit K.; Mori, Masaki			CTDSP1 inhibitor rabeprazole regulates DNA-PKcs dependent topoisomerase I degradation and irinotecan drug resistance in colorectal cancer	PLOS ONE			English	Article							PROTON PUMP INHIBITOR; PROTEIN-KINASE; CAMPTOTHECIN RESISTANCE; COLON-CANCER; GENE; MECHANISM; GASTRIN; OVEREXPRESSION; IDENTIFICATION; REPAIR	Irinotecan specifically targets topoisomerase I (topoI), and is used to treat various solid tumors, but only 13-32% of patients respond to the therapy. Now, it is understood that the rapid rate of topoI degradation in response to irinotecan causes irinotecan resistance. We have published that the deregulated DNA-PKcs kinase cascade ensures rapid degradation of topoI and is at the core of the drug resistance mechanism of topoI inhibitors, including irinotecan. We also identified CTD small phosphatase 1 (CTDSP1) (a nuclear phosphatase) as a primary upstream regulator of DNA-PKcs in response to topoI inhibitors. Previous reports showed that rabeprazole, a proton pump inhibitor (PPI) inhibits CTDSP1 activity. The purpose of this study was to confirm the effects of rabeprazole on CTDSP1 activity and its impact on irinotecan-based therapy in colon cancer. Using differentially expressing CTDSP1 cells, we demonstrated that CTDSP1 contributes to the irinotecan sensitivity by preventing topoI degradation. Retrospective analysis of patients receiving irinotecan with or without rabeprazole has shown the effects of CTDSP1 on irinotecan response. These results indicate that CTDSP1 promotes sensitivity to irinotecan and rabeprazole prevents this effect, resulting in drug resistance. To ensure the best chance at effective treatment, rabeprazole may not be a suitable PPI for cancer patients treated with irinotecan.	[Matsuoka, Hiroya; Ando, Koji; Hu, Quingjiang; Tsuda, Yasuo; Nakashima, Yuichiro; Oki, Eiji; Mori, Masaki] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Fukuoka, Japan; [Swayze, Emma J.; Unan, Elizabeth C.; Mathew, Joseph; Bharti, Ajit K.] Boston Univ, Sch Med, Dept Med, Div Hematol & Med Oncol, Boston, MA 02118 USA; [Saeki, Hiroshi] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma, Japan	Kyushu University; Boston University; Gunma University	Ando, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Fukuoka, Japan.	k-ando@surg2.med.kyushu-u.ac.jp						Ando K, 2017, ONCOTARGET, V8, P43733, DOI 10.18632/oncotarget.16376; BEIDLER DR, 1995, MOL PHARMACOL, V47, P907; Beusterien K, 2014, ONCOLOGIST, V19, P127, DOI 10.1634/theoncologist.2013-0359; Brangi M, 1999, CANCER RES, V59, P5938; Candeil L, 2004, INT J CANCER, V109, P848, DOI 10.1002/ijc.20032; Chan DW, 1996, BIOCHEM CELL BIOL, V74, P67, DOI 10.1139/o96-007; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; Douglas P, 2001, J BIOL CHEM, V276, P18992, DOI 10.1074/jbc.M011703200; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Goodwin JF, 2014, CANCER DISCOV, V4, P1126, DOI 10.1158/2159-8290.CD-14-0358; Graham C, 2016, CURR ONCOL, V23, pE583, DOI 10.3747/co.23.3204; Han YM, 2014, NEOPLASIA, V16, P73, DOI 10.1593/neo.131510; HSIANG YH, 1988, CANCER RES, V48, P1722; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Jette N, 2015, PROG BIOPHYS MOL BIO, V117, P194, DOI 10.1016/j.pbiomolbio.2014.12.003; Kamenski T, 2004, MOL CELL, V15, P399, DOI 10.1016/j.molcel.2004.06.035; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Lindner K, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0073-x; Liu LF, 2000, ANN NY ACAD SCI, V922, P1; Luciani F, 2004, JNCI-J NATL CANCER I, V96, P1702, DOI 10.1093/jnci/djh305; Maliepaard M, 1999, CANCER RES, V59, P4559; Mazard T, 2013, MOL CANCER THER, V12, P2121, DOI 10.1158/1535-7163.MCT-12-0966; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Meisenberg C, 2017, NUCLEIC ACIDS RES, V45, P1159, DOI 10.1093/nar/gkw1026; Mi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004395; Ng TL, 2015, ONCOLOGIST, V20, P576, DOI 10.1634/theoncologist.2014-0438; Ohashi N, 1996, JPN J CANCER RES, V87, P1280, DOI 10.1111/j.1349-7006.1996.tb03144.x; RUBIN E, 1994, J BIOL CHEM, V269, P2433; SMITH JP, 1989, DIGEST DIS SCI, V34, P171, DOI 10.1007/BF01536047; Takatani H, 1997, JPN J CANCER RES, V88, P160, DOI 10.1111/j.1349-7006.1997.tb00361.x; Tsurutani J, 2002, LUNG CANCER-J IASLC, V35, P299, DOI 10.1016/S0169-5002(01)00425-1; Wang BY, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0194-x; Wang QH, 2009, NEOPLASIA, V11, P1012, DOI 10.1593/neo.09720; WINSETT OE, 1986, SURGERY, V99, P302; WONG K, 1991, GUT, V32, P1352, DOI 10.1136/gut.32.11.1352; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Yeo M, 2005, SCIENCE, V307, P596, DOI 10.1126/science.1100801; Zhang MM, 2011, ACS CHEM BIOL, V6, P511, DOI 10.1021/cb100357t	39	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0228002	10.1371/journal.pone.0228002	http://dx.doi.org/10.1371/journal.pone.0228002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764831	Green Published, gold, Green Submitted			2022-12-26	WOS:000561029000049
J	de Souza, J; Leskinen, H; Lock, AL; Shingfield, KJ; Huhtanen, P				de Souza, J.; Leskinen, H.; Lock, A. L.; Shingfield, K. J.; Huhtanen, P.			Between-cow variation in milk fatty acids associated with methane production	PLOS ONE			English	Article							DIETARY FISH-OIL; RUMEN FERMENTATION; DAIRY-COWS; ODD-CHAIN; GENETIC-PARAMETERS; LACTATION STAGE; EMISSIONS; PREDICTION; DIGESTION; PROFILES	We evaluated the between-cow (b-cow) variation and repeatability in omasal and milk fatty acids (FA) related to methane (CH4) emission. The dataset was originated from 9 studies with rumen-cannulated dairy cows conducted using either a switch-back or a Latin square design. Production of CH(4)per mole of VFA (Y_CH(4)VFA) was calculated based on VFA stoichiometry. Experiment, diet within experiment, period within experiment, and cow within experiment were considered as random factors. Empirical models were developed between the variables of interest by univariate and bivariate mixed model regression analysis. The variation associated with diet was higher than the b-cow variation with low repeatability (< 0.25) for milk odd- and branch-chain FA (OBCFA). Similarly, for de novo synthesized milk FA, diet variation was similar to 3-fold greater than the b-cow variation; repeatability for these FA was moderate to high (0.34-0.58). Also, for bothcis-9 C18:1 andcis-9cis-12cis-15 C18:3 diet variation was more than double the b-cow variation, but repeatability was moderate. Among the de novo milk FA, C4:0 was positively related with stoichiometric Y_CH(4)VFA, while for OBCFA,anteisoC15:0 and C15:0 were negatively related with it. Notably, when analyzing the relationship between omasal FA and milk FA we observed positive intercept estimates for all the OBCFA, which may indicate endogenous post-ruminal synthesis of these FA, most likely in the mammary gland. For milkisoC13:0,isoC15:0,anteisoC15:0, and C15:0 were positively influenced by omasal proportion of their respective FA and by energy balance. In contrast, the concentration of milk C17:0,isoC18:0, C18:0,cis-11 C18:1, andcis-9cis-12cis-15 C18:3 were positively influenced by omasal proportion of their respective FA but negatively related to calculated energy balance. Our findings demonstrate that for most milk FA examined, a larger variation is attributed to diet than b-cow differences with low to moderate repeatability. While some milk FA were positively or negatively related with Y_CH(4)VFA, there was a pronounced effect of calculated energy balance on these estimates. Additionally, even though OBCFA have been indicated as markers of rumen function, our results suggest that endogenous synthesis of these FA may occur, which therefore, may limit the utilization of milk FA as a proxy for CH(4)predictions for cows fed the same diet.	[de Souza, J.; Lock, A. L.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Leskinen, H.; Shingfield, K. J.] Nat Resources Inst Finland Luke, Prod Syst, Milk Prod, Jokioinen, Finland; [Huhtanen, P.] Swedish Univ Agr Sci, Dept Agr Res Northern Sweden, Umea, Sweden; [de Souza, J.] Perdue Agribusiness, Salisbury, MD USA	Michigan State University; Natural Resources Institute Finland (Luke); Swedish University of Agricultural Sciences	Huhtanen, P (corresponding author), Swedish Univ Agr Sci, Dept Agr Res Northern Sweden, Umea, Sweden.	Pekka.Huhtanen@slu.se	Leskinen, Heidi M/R-2269-2016; Lock, Adam/HCH-4180-2022	Leskinen, Heidi M/0000-0002-9892-5671; 	Formas (Formas is a government research council for sustainable development)	Formas (Formas is a government research council for sustainable development)	PH: Grant from Formas (Formas is a government research council for sustainable development) ((https://formas.se/en/start-page.html) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahvenjarvi S, 2000, BRIT J NUTR, V83, P67, DOI 10.1017/S0007114500000106; Bauman DE, 2011, ANNU REV NUTR, V31, P299, DOI 10.1146/annurev.nutr.012809.104648; Berthelot V, 2001, SMALL RUMINANT RES, V40, P29, DOI 10.1016/S0921-4488(00)00217-0; Bittante G, 2018, J DAIRY SCI, V101, P1752, DOI 10.3168/jds.2017-13472; BODY DR, 1988, PROG LIPID RES, V27, P39, DOI 10.1016/0163-7827(88)90004-5; Cabezas-Garcia EH, 2017, J DAIRY SCI, V100, P4409, DOI 10.3168/jds.2016-12206; Castro-Montoya JM, 2016, J AGR SCI-CAMBRIDGE, V154, P515, DOI 10.1017/S0021859615001215; Castro-Montoyaa JM, 2017, ANIMAL, V11, P1153, DOI [10.1017/S1751731116002627, 10.1017/s1751731116002627]; Chilliard Y, 2009, J DAIRY SCI, V92, P5199, DOI 10.3168/jds.2009-2375; Craninx M, 2008, J DAIRY SCI, V91, P2662, DOI 10.3168/jds.2007-0656; DeVries TJ, 2005, J DAIRY SCI, V88, P625, DOI 10.3168/jds.S0022-0302(05)72726-0; Dewhurst RJ, 2007, J DAIRY SCI, V90, P1775, DOI 10.3168/jds.2006-715; Dijkstra J, 2011, ANIM FEED SCI TECH, V166-67, P590, DOI 10.1016/j.anifeedsci.2011.04.042; Ellis JL, 2007, J DAIRY SCI, V90, P3456, DOI 10.3168/jds.2006-675; Fievez V, 2012, ANIM FEED SCI TECH, V172, P51, DOI 10.1016/j.anifeedsci.2011.12.008; FRANCE J, 1986, J THEOR BIOL, V121, P105, DOI 10.1016/S0022-5193(86)80031-5; French EA, 2012, J DAIRY SCI, V95, P2015, DOI 10.3168/jds.2011-4827; Garnsworthy PC, 2012, J DAIRY SCI, V95, P3166, DOI 10.3168/jds.2011-4605; Halmemies-Beauchet-Filleau A, 2014, J DAIRY SCI, V97, P3761, DOI 10.3168/jds.2013-7358; Halmemies-Beauchet-Filleau A, 2013, J DAIRY SCI, V96, P5882, DOI 10.3168/jds.2013-6872; Halmemies-Beauchet-Filleau A, 2013, J DAIRY SCI, V96, P5267, DOI 10.3168/jds.2013-6571; Halmemies-Beauchet-Filleau A, 2013, J DAIRY SCI, V96, P2428, DOI 10.3168/jds.2012-6043; Halmemies-Beauchet-Filleau A, 2011, J DAIRY SCI, V94, P4413, DOI 10.3168/jds.2010-3885; Hristov AN, 2013, J ANIM SCI, V91, P5045, DOI 10.2527/jas.2013-6583; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Kairenius P, 2018, J DAIRY SCI, V101, P3021, DOI 10.3168/jds.2017-13776; Kairenius P, 2015, J DAIRY SCI, V98, P5653, DOI 10.3168/jds.2015-9548; Kairenius P, 2009, P 11 INT S RUM PHYS; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Leskinen H, 2019, J DAIRY SCI, V102, P5148, DOI 10.3168/jds.2018-15860; LUKE, 2010, FINN FEED TABL FEED; MASSARTLEEN AM, 1983, J DAIRY SCI, V66, P1445, DOI 10.3168/jds.S0022-0302(83)81958-4; Mele M, 2009, J DAIRY SCI, V92, P392, DOI 10.3168/jds.2008-1445; Mohammed R, 2011, J DAIRY SCI, V94, P6057, DOI 10.3168/jds.2011-4369; Montoya JC, 2011, ANIM FEED SCI TECH, V166-67, P596, DOI 10.1016/j.anifeedsci.2011.04.080; Negussie E, 2017, J DAIRY SCI, V100, P2433, DOI 10.3168/jds.2016-12030; Pinares-Patino CS, 2013, ANIMAL, V7, P316, DOI 10.1017/S1751731113000864; Pinares-Patino CS, 2003, J AGR SCI-CAMBRIDGE, V140, P205, DOI 10.1017/S0021859603003046; Precht D, 2000, EUR J LIPID SCI TECH, V102, P102, DOI 10.1002/(SICI)1438-9312(200002)102:2<102::AID-EJLT102>3.3.CO;2-3; Ramin M, 2013, J DAIRY SCI, V96, P2476, DOI 10.3168/jds.2012-6095; Rico DE, 2016, ANIMAL, V10, P203, DOI 10.1017/S1751731115001949; Shetty N, 2017, J DAIRY SCI, V100, P9052, DOI 10.3168/jds.2017-13014; Shingfield KJ, 2013, ANIMAL, V7, P132, DOI 10.1017/S1751731112001681; Shingfield KJ, 2012, J NUTR, V142, P1437, DOI 10.3945/jn.112.158576; Shingfield KJ, 2002, ANIM FEED SCI TECH, V97, P1, DOI 10.1016/S0377-8401(02)00006-8; Shingfield KJ, 2003, ANIM SCI, V77, P165, DOI 10.1017/S1357729800053765; Shingfield KJ, 2007, P 2 INT C CONJ LIN A; St-Pierre NR, 2001, J DAIRY SCI, V84, P741, DOI 10.3168/jds.S0022-0302(01)74530-4; Stoop WM, 2008, J DAIRY SCI, V91, P385, DOI 10.3168/jds.2007-0181; van Engelen S, 2015, J DAIRY SCI, V98, P8223, DOI 10.3168/jds.2014-8989; van Lingen HJ, 2014, J DAIRY SCI, V97, P7115, DOI 10.3168/jds.2014-8268; Vlaeminck B, 2006, J DAIRY SCI, V89, P3954, DOI 10.3168/jds.S0022-0302(06)72437-7; Vlaeminck B, 2015, J DAIRY SCI, V98, P4829, DOI 10.3168/jds.2014-9207; WOLIN MJ, 1960, J DAIRY SCI, V43, P1452, DOI 10.3168/jds.S0022-0302(60)90348-9; Yan T, 2009, ANIMAL, V3, P1455, DOI 10.1017/S175173110900473X	55	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0235357	10.1371/journal.pone.0235357	http://dx.doi.org/10.1371/journal.pone.0235357			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760112	Green Published, gold			2022-12-26	WOS:000561027200080
J	Li, TH; Che, PF; Zhang, CR; Zhang, B; Ali, A; Zang, LS				Li, Tian-Hao; Che, Peng-Fei; Zhang, Chao-Ran; Zhang, Bo; Ali, Asad; Zang, Lian-Sheng			Recycling of spent mushroom substrate: Utilization as feed material for the larvae of the yellow mealworm Tenebrio molitor (Coleoptera: Tenebrionidae)	PLOS ONE			English	Article							FOOD UTILIZATION; GROWTH	Spent mushroom substrate is made from the waste remaining after the harvest of mushrooms. Here, we evaluated the potential of five spent edible fungi (Auricularia cornea,Lentinus edodes,Pleurotus eryngii,P.citrinopileatusandP.ostreatus) substrates as feed sources forTenebrio molitorlarvae. Young larvae did not survive on any substrate except the spentL.edodessubstrate (36.7%). The survival rates in young larvae were similar among the different diets in which wheat bran or rice bran was replaced with 0, 20, 30, 40, 50, or 60% spentL.edodessubstrate. The weights of the surviving larvae were decreased only when 70% of wheat bran and > 40% of rice bran was replaced with spentL.edodessubstrate. In addition, the middle-aged larvae fed wheat bran only were significantly larger than those fed diets with 30 similar to 60% spentL.edodessubstrate in dry feed, but the larvae of all treatments failed to pupate. Whereas the green feed was added in dry feed, there were no significant differences in pupal weight, pupation rate, pupal duration, adult emergence, or deformed adults among the three treatments in middle-aged larvae that were fed on diets containing 0, 30, or 40% spentL.edodessubstrate. Collectively, these results suggest that spentL.edodessubstrate has considerable potential to be used as a partial replacement (< 40%) of conventional feed forT.molitor, and spent mushroom substrate waste may be recycled as feed material for resource insects.	[Li, Tian-Hao; Che, Peng-Fei; Zhang, Chao-Ran; Zang, Lian-Sheng] Jilin Agr Univ, Jilin Engn Res Ctr Resource Insects Ind, Changchun, Peoples R China; [Zhang, Bo] Jilin Agr Univ, Chinese Minist Educ Edible & Med Fungi, Engn Res Ctr, Changchun, Peoples R China; [Ali, Asad] Abdul Wali Khan Univ, Dept Agr, Mardan, Pakistan	Jilin Agricultural University; Jilin Agricultural University; Abdul Wali Khan University	Zang, LS (corresponding author), Jilin Agr Univ, Jilin Engn Res Ctr Resource Insects Ind, Changchun, Peoples R China.	lsz0415@163.com	Ali, Asad/GWQ-7078-2022	Ali, Asad/0000-0002-8194-5094; Li, Tian-Hao/0000-0001-7496-9277	Jilin Provincial Science and Technology Department, China [20180201074SF]; Jilin Province Development and Reform Commission, China [2019C022]; China Scholarship Council	Jilin Provincial Science and Technology Department, China; Jilin Province Development and Reform Commission, China; China Scholarship Council(China Scholarship Council)	This study was partially funded by Jilin Provincial Science and Technology Department, China (20180201074SF), Jilin Province Development and Reform Commission, China (2019C022), and China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; The authors wish to thank Dr. Xingeng Wang (USDA-ARS, Newark, Delaware) for his valuable comments on an earlier draft of this paper. We thank the Engineering Research Center of Chinese Ministry of Education for Edible and Medicinal Fungi, China, for providing spent mushroom substrates, and Dr. Xiao Li (Jilin Agricultural University, Changchun, China) for the technical assistance.	Aderemi F, 2014, AM INT J CONT RES, V4, P178; Alexopoulos C. J., 1996; [Anonymous], 2014, RES BIOTECHNOLOGY; [Anonymous], 2018, J FUNGAL RES, DOI DOI 10.1186/S12953-018-0134-8; Cai MM, 2019, WASTE BIOMASS VALORI, V10, P265, DOI 10.1007/s12649-017-0063-2; Castro R. I. Lopez, 2008, Micologia Aplicada International, V20, P17; Chen Genfu, 1992, Journal of Fujian Teachers University Natural Science, V8, P66; Dai A, 2017, NAT ENVIRON POLLUT T, V16, P643; Dai Y-C, 2018, MYCOSYSTEMA, P3; DeFoliart GR, 1997, ECOL FOOD NUTR, V36, P109, DOI 10.1080/03670244.1997.9991510; Di Gregorio S, 2016, J CHEM TECHNOL BIOT, V91, P1654, DOI 10.1002/jctb.4936; Gao B., 2019, MODERN J ANIMAL HUSB, V7, P33; Gao Hong-Li, 2006, Acta Ecologica Sinica, V26, P3258; Matute RG, 2011, WORLD J MICROB BIOT, V27, P1331, DOI 10.1007/s11274-010-0582-5; [韩素云 Han Suyun], 2014, [广东农业科学, Guangdong Agricultural Sciences], V41, P89; Hanafi FHM, 2018, J MATER CYCLES WASTE, V20, P1383, DOI 10.1007/s10163-018-0739-0; Hoornweg D, 2013, NATURE, V502, P615, DOI 10.1038/502615a; Hu ZunRui, 2017, Journal of Environmental Entomology, V39, P187; Huang Qiong, 2011, Acta Entomologica Sinica, V54, P286; Kim Sun Young, 2014, Korean Journal of Applied Entomology, V53, P367, DOI 10.5656/KSAE.2014.10.0.043; Kim YI, 2012, ASIAN AUSTRAL J ANIM, V25, P1575, DOI 10.5713/ajas.2012.12251; Kim YI, 2011, ASIAN AUSTRAL J ANIM, V24, P1560, DOI 10.5713/ajas.2011.11076; Kourimska L., 2016, NFS Journal, V4, P22, DOI 10.1016/j.nfs.2016.07.001; Lee Seul Bi, 2018, Korean Journal of Applied Entomology, V57, P97, DOI 10.5656/KSAE.2018.04.0.011; Li TH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39505-7; Liu YM, 2019, EDIBLE FUNGI CHINA, V38, P1; Moon Yea Hwang, 2012, [Journal of Mushrooms, 한국버섯학회지], V10, P236; Morales-Ramos JA, 2011, ENVIRON ENTOMOL, V40, P1285, DOI 10.1603/EN10239; Morales-Ramos JA, 2010, J ENTOMOL SCI, V45, P75, DOI 10.18474/0749-8004-45.2.75; Morales-Ramos JA, 2015, J ECON ENTOMOL, V108, P2259, DOI 10.1093/jee/tov208; Morales-Ramos JA, 2015, ANN ENTOMOL SOC AM, V108, P146, DOI 10.1093/aesa/sau049; Myers HM, 2008, ENVIRON ENTOMOL, V37, P11, DOI 10.1603/0046-225X(2008)37[11:DOBSFD]2.0.CO;2; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445; Pelletier N, 2010, P NATL ACAD SCI USA, V107, P18371, DOI 10.1073/pnas.1004659107; Ravzanaadii Nergui, 2012, International Journal of Industrial Entomology, V25, P93; Rinker DL., 2017, EDIBLE MED MUSHROOMS, P427, DOI [10.1002/9781119149446.ch20, DOI 10.1002/9781119149446.CH20]; Sheng C-g, 2014, EDIBLE FUNGI CHINA, V33, P61; Spranghers T, 2017, J SCI FOOD AGR, V97, P2594, DOI 10.1002/jsfa.8081; Tay CC, 2016, DESALIN WATER TREAT, V57, P9325, DOI 10.1080/19443994.2015.1027957; van Huis A, 2020, J INSECTS FOOD FEED, V6, P27, DOI 10.3920/JIFF2019.0017; Viji G, 2003, BIOL CONTROL, V26, P233, DOI 10.1016/S1049-9644(02)00170-6; Wang XG, 2019, BIOL CONTROL, V137, DOI 10.1016/j.biocontrol.2019.104028; Wu SQ, 2014, J ECON ENTOMOL, V107, P137, DOI 10.1603/EC13276; Xu CC, 2010, ANIM SCI J, V81, P194, DOI 10.1111/j.1740-0929.2009.00728.x; Yang Zhao-Fen, 1999, Entomological Knowledge, V36, P24; Zhang JinXia, 2015, Mycosystema, V34, P524; Zhang Y, 2018, NO HORTICULTURE, P27; Zhao Xiaoli, 2012, CHINESE EDIBLE FUNGU, V31, P1; Zhou AX, 2016, DESALIN WATER TREAT, V57, P388, DOI 10.1080/19443994.2014.979239; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; Zhu JY, 2015, J RENEW SUSTAIN ENER, V7, DOI 10.1063/1.4919404; Zhuo S, 2009, CHINA RESOURCES COMP, V27, P22	52	10	10	7	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237259	10.1371/journal.pone.0237259	http://dx.doi.org/10.1371/journal.pone.0237259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760156	gold, Green Published			2022-12-26	WOS:000561027200076
J	Romero-Severson, EO; Hengartner, N; Meadors, G; Ke, R				Romero-Severson, Ethan Obie; Hengartner, Nick; Meadors, Grant; Ke, Ruian			Change in global transmission rates of COVID-19 through May 6 2020	PLOS ONE			English	Article								We analyzed COVID-19 data through May 6th, 2020 using a partially observed Markov process. Our method uses a hybrid deterministic and stochastic formalism that allows for time variable transmission rates and detection probabilities. The model was fit using iterated particle filtering to case count and death count time series from 55 countries. We found evidence for a shrinking epidemic in 30 of the 55 examined countries. Of those 30 countries, 27 have significant evidence for subcritical transmission rates, although the decline in new cases is relatively slow compared to the initial growth rates. Generally, the transmission rates in Europe were lower than in the Americas and Asia. This suggests that global scale social distancing efforts to slow the spread of COVID-19 are effective although they need to be strengthened in many regions and maintained in others to avoid further resurgence of COVID-19. The slow decline also suggests alternative strategies to control the virus are needed before social distancing efforts are partially relaxed.	[Romero-Severson, Ethan Obie; Hengartner, Nick; Ke, Ruian] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA; [Meadors, Grant] Los Alamos Natl Lab, Computat Phys Grp, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Romero-Severson, EO (corresponding author), Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA.	eoromero@lanl.gov	Romero-Severson, Ethan Obie/ABB-1185-2021; Ke, Ruian/P-9603-2018	Meadors, Grant/0000-0001-7718-0407; Ke, Ruian/0000-0001-5307-8934	Laboratory Directed Research and Development grant from Los Alamos National Laboratory [20200002CR]	Laboratory Directed Research and Development grant from Los Alamos National Laboratory	EORS, NH, RK we funded by Laboratory Directed Research and Development grant 20200002CR from Los Alamos National Laboratory. The sponsors played no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Arel-Bundock V., 2018, J OPEN SOURCE SOFTW, V3, P848, DOI [10.21105/joss.00848, DOI 10.21105/JOSS.00848]; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dorigatti I., 2020, SEVERITY 2019 NOVEL; Flaxman S, 2020, 13 IMP COLL LOND; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Ionides EL, 2005, STAT SINICA, V15, P1003; Ke R, 2020, FAST SPREAD COVID 19; King A, 2009, POMP STAT INFERENCE; King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347; Kujawski SA, 2020, NATURE MED, P1; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Ma JL, 2020, INFECT DIS MODEL, V5, P129, DOI 10.1016/j.idm.2019.12.009; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Washington DC CIA, 2020, WORLD FACTBOOK; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x	15	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236776	10.1371/journal.pone.0236776	http://dx.doi.org/10.1371/journal.pone.0236776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760158	gold, Green Published			2022-12-26	WOS:000561027200016
J	Downe, S; Agius, JC; Balaam, MC; Frith, L				Downe, Soo; Agius, Jean Calleja; Balaam, Marie-Clare; Frith, Lucy			Understanding childbirth as a complex salutogenic phenomenon: The EU COST BIRTH Action Special Collection	PLOS ONE			English	Article								In 2014, the EU funded a four-year European Cooperation in Science and Technology (COST) Action to address the topic of childbirth. The COST Birth Action was a cross-European network, that brought together over 120 scientists, practitioners, activists and policy makers from 34 countries to work on intrapartum care. The central aim was to advance the state of research and practice in a specific area of great clinical and social importance, intrapartum care. The Action used inter and trans-disciplinary approaches to address birth from multiple perspectives and drew on complexity theory and the concept of salutogenesis (wellbeing). This special collection presents six papers produced from the Action and gives a sense of the range and depth of the work conducted. The Collection illustrates the knowledge that can be generated when a diverse group of people come together with a similar goals and perspectives.	[Downe, Soo; Balaam, Marie-Clare] UCLan, ReaCH Grp, Preston, Lancs, England; [Agius, Jean Calleja] Univ Malta, Fac Med & Surg, Dept Anat, Msida, Malta; [Frith, Lucy] Univ Liverpool, Inst Populat Hlth, Liverpool, Merseyside, England	University of Central Lancashire; University of Malta; University of Liverpool	Frith, L (corresponding author), Univ Liverpool, Inst Populat Hlth, Liverpool, Merseyside, England.	l.j.frith@liverpool.ac.uk	Frith, Lucy/AAW-6711-2020	Frith, Lucy/0000-0002-8506-0699; Balaam, Marie-Clare/0000-0003-4511-7352	COST Action BIRTH: "Building Intrapartum Research Through Health - An interdisciplinary whole system approach to understanding and contextualising physiological labour and birth" - EU COST (European Cooperation in Science and Technology) [IS1405]	COST Action BIRTH: "Building Intrapartum Research Through Health - An interdisciplinary whole system approach to understanding and contextualising physiological labour and birth" - EU COST (European Cooperation in Science and Technology)	This article is based upon work funded by the COST Action IS1405 BIRTH: "Building Intrapartum Research Through Health - An interdisciplinary whole system approach to understanding and contextualising physiological labour and birth" (http://www.cost.eu/COST_ Actions/isch/IS1405), supported by EU COST (European Cooperation in Science and Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Board, 2018, STAT HIGH LOW MAT MO; Antonovsky A., 1979, HLTH STRESS COPING; Butterfield H., 1957, ORIGINS MODERN SCI; Carmichael T, 2019 COMPLEX ADAPTIV; Childbirth Connection, 2017, CES BIRTH TRENDS US; Combellick JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33995-7; Conrad P, 2010, SOC SCI MED, V70, P1943, DOI 10.1016/j.socscimed.2010.02.019; Dahlen HG, 2013, MED HYPOTHESES, V80, P656, DOI 10.1016/j.mehy.2013.01.017; Daly D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227941; de Jonge A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180846; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000025.pub2; Gabrysch S, 2019, LANCET GLOB HEALTH, V7, pE1074, DOI 10.1016/S2214-109X(19)30165-2; Gleick J., 1987, CHAOS MAKING NEW SCI; Goffman D, 2016, SEMIN PERINATOL, V40, P96, DOI 10.1053/j.semperi.2015.11.014; Grobman G. M., 2005, Public Administration Quarterly, V29, P350; Healy M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226502; Hollowell J, 2015, HLTH SERVICES DELIVE, P36; Homer CSE, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-206; Houweling TAJ, 2007, B WORLD HEALTH ORGAN, V85, P745, DOI 10.2471/BLT.06.038588; Kasiteropoulou D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231997; Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2; Mandelbrot Benoit B., 1983, FRACTAL GEOMETRY NAT; Miller S, 2016, LANCET, V388, P2176, DOI 10.1016/S0140-6736(16)31472-6; MONTGOMERY TL, 1958, AM J OBSTET GYNECOL, V76, P706, DOI 10.1016/0002-9378(58)90002-4; Moran PS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228309; NICE, 2014, INTR CAR CAR HLTH WO; Olza I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230992; Peters LL, 2018, BIRTH-ISS PERINAT C, V45, P347, DOI 10.1111/birt.12348; Project Euro-Peristat, 2018, PROJ EUR PER; Rego-Costa A, 2018, EVOLUTION, V72, P375, DOI 10.1111/evo.13407; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Shakur H, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012964; Slingo J, 2011, PHILOS T R SOC A, V369, P4751, DOI 10.1098/rsta.2011.0161; Topalidou A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226755; UN, 2016, EV WOM EV CHILD GLOB; Uvnas-Moberg K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235806; van Baalen S, 2015, J EVAL CLIN PRACT, V21, P433, DOI 10.1111/jep.12282; Varpio L, 2017, MED EDUC, V51, P353, DOI 10.1111/medu.13160; Vogel JP, 2015, LANCET GLOB HEALTH, V3, pE260, DOI 10.1016/S2214-109X(15)70094-X; Wang R, 2017, AM J EPIDEMIOL, V185, P96, DOI 10.1093/aje/kww153; WHO, 2018, PRET BIRTH	41	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236722	10.1371/journal.pone.0236722	http://dx.doi.org/10.1371/journal.pone.0236722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756586	gold, Green Published, Green Accepted			2022-12-26	WOS:000560393300056
J	Rho, MJ; Park, J; Moon, HW; Lee, C; Nam, S; Kim, D; Kim, CS; Jeon, SS; Kane, M; Lee, JY				Rho, Mi Jung; Park, Jihwan; Moon, Hyong Woo; Lee, Chanjung; Nam, Sejin; Kim, Dongbum; Kim, Choung-Soo; Jeon, Seong Soo; Kane, Minyong; Lee, Ji Youl			Dr. Answer AI for prostate cancer: Clinical outcome prediction model and service	PLOS ONE			English	Article							EXTRACAPSULAR EXTENSION; DECISION AID; METASTASIS; NOMOGRAM; TRIAL; SMOTE	Objectives The importance of clinical outcome prediction models using artificial intelligence (AI) is being emphasized owing to the increasing necessity of developing a clinical decision support system (CDSS) employing AI. Therefore, in this study, we proposed a "Dr. Answer" AI software based on the clinical outcome prediction model for prostate cancer treated with radical prostatectomy. Methods The Dr. Answer AI was developed based on a clinical outcome prediction model, with a user-friendly interface. We used 7,128 clinical data of prostate cancer treated with radical prostatectomy from three hospitals. An outcome prediction model was developed to calculate the probability of occurrence of 1) tumor, node, and metastasis (TNM) staging, 2) extracapsular extension, 3) seminal vesicle invasion, and 4) lymph node metastasis. Random forest and k-nearest neighbors algorithms were used, and the proposed system was compared with previous algorithms. Results Random forest exhibited good performance for TNM staging (recall value: 76.98%), while k-nearest neighbors exhibited good performance for extracapsular extension, seminal vesicle invasion, and lymph node metastasis (80.24%, 98.67%, and 95.45%, respectively). The Dr. Answer AI software consisted of three primary service structures: 1) patient information, 2) clinical outcome prediction, and outcomes according to the National Comprehensive Cancer Network guideline. Conclusion The proposed clinical outcome prediction model could function as an effective CDSS, supporting the decisions of the physicians, while enabling the patients to understand their treatment outcomes. The Dr. Answer AI software for prostate cancer helps the doctors to explain the treatment outcomes to the patients, allowing the patients to be more confident about their treatment plans.	[Rho, Mi Jung] Catholic Univ Korea, Coll Med, Catholic Canc Res Inst, Seoul, South Korea; [Park, Jihwan] Catholic Univ Korea, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea; [Park, Jihwan; Moon, Hyong Woo; Lee, Ji Youl] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Urol, Seoul, South Korea; [Lee, Chanjung; Nam, Sejin; Kim, Dongbum] LifeSemantics, Seoul, South Korea; [Kim, Choung-Soo] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Urol, Seoul, South Korea; [Jeon, Seong Soo; Kane, Minyong] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Urol, Seoul, South Korea; [Kane, Minyong] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Lee, JY (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Urol, Seoul, South Korea.	uroljy@catholic.ac.kr			Institute for Information & Communications Technology Promotion (IITP) - Korean government (MSIT) [2018-2-00861]	Institute for Information & Communications Technology Promotion (IITP) - Korean government (MSIT)	This work was supported by the Institute for Information & Communications Technology Promotion (IITP) grant funded by the Korean government (MSIT) (2018-2-00861, Intelligent SW Technology Development for Medical Data Analysis). LifeSemantics provided support in the form of salaries for Chanjung Lee, Sejin Nam, Dongbum Kim. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar E, 2019, BRIT J RADIOL, V92, DOI 10.1259/bjr.20190286; Auffenberg GB, 2019, EUR UROL, V75, P901, DOI 10.1016/j.eururo.2018.09.050; Bahadori Mohammadkarim, 2017, J Educ Health Promot, V6, P21, DOI 10.4103/2277-9531.204742; Bouazza SH, 2015, 2015 INTELLIGENT SYSTEMS AND COMPUTER VISION (ISCV); Boutilier JJ, 2015, MED PHYS, V42, P1586, DOI 10.1118/1.4914140; Brower V, 2007, J NATL CANCER I, V99, P109, DOI 10.1093/jnci/djk047; Clarke G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.2.e16; Couronne R, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2264-5; Datta K, 2010, FUTURE ONCOL, V6, P823, DOI 10.2217/FON.10.33; Fernandez A, 2018, J ARTIF INTELL RES, V61, P863, DOI 10.1613/jair.1.11192; Gooch J, 2014, ANN SURG ONCOL, V21, P2897, DOI 10.1245/s10434-014-3752-0; Guinney J, 2017, LANCET ONCOL, V18, P132, DOI 10.1016/S1470-2045(16)30560-5; Han H, 2005, LECT NOTES COMPUT SC, V3644, P878, DOI 10.1007/11538059_91; Hararah MK, 2018, ORAL ONCOL, V83, P73, DOI 10.1016/j.oraloncology.2018.06.005; Jameson JL, 2010, ENDOCRINOLOGY; Jensen C, 2019, J APPL CLIN MED PHYS, V20, P146, DOI 10.1002/acm2.12542; JEWETT HJ, 1972, J UROLOGY, V107, P1034, DOI 10.1016/S0022-5347(17)61201-1; Kassan EC, 2012, J HEALTH COMMUN, V17, P677, DOI 10.1080/10810730.2011.579688; Kim JK, 2017, STUD HEALTH TECHNOL, V245, P1273, DOI 10.3233/978-1-61499-830-3-1273; Kwon H, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/10502; Lee CH, 2017, CONSULTATION TIME, V27, P39, DOI [10.4332/KJHPA.2017.27.1.39, DOI 10.4332/KJHPA.2017.27.1.39]; Liu H, 2018, PROGNOSTIC SIGNIFICA, V9, P32238; Maillo J, 2017, KNOWL-BASED SYST, V117, P3, DOI 10.1016/j.knosys.2016.06.012; Marvel MK, 1999, JAMA-J AM MED ASSOC, V281, P283, DOI 10.1001/jama.281.3.283; NIPA, 2018, DOCTOR ANSWER; Ohori M, 2004, J UROLOGY, V171, P1844, DOI 10.1097/01.ju.0000121693.05077.3d; Park J, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9152982; Potter S R, 2000, Rev Urol, V2, P190; Rho MJ, 2019, TYPES PROBLEMATIC SM, P12287; Soh JY, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.9363; Taylor KL, 2010, BEHAV MED, V36, P130, DOI 10.1080/08964289.2010.525263; Volk RJ, 2007, AM J PREV MED, V33, P428, DOI 10.1016/j.amepre.2007.07.030; Wang L, 2007, RADIOLOGY, V242, P182, DOI 10.1148/radiol.2421051254; Yadav Kamlesh K, 2018, IEEE Pulse, V9, P19, DOI 10.1109/MPUL.2018.2866354; Yang XM, 2018, INT J PARALLEL PROG, V46, P838, DOI 10.1007/s10766-017-0551-9	35	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236553	10.1371/journal.pone.0236553	http://dx.doi.org/10.1371/journal.pone.0236553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756597	Green Published, gold			2022-12-26	WOS:000560393300043
J	Nagoshi, RN; Canarte, E; Navarrete, B; Pico, J; Bravo, C; de Lopez, MA; Garces-Carrera, S				Nagoshi, Rodney N.; Canarte, Ernesto; Navarrete, Bernardo; Pico, Jimmy; Bravo, Catalina; Arias de Lopez, Myriam; Garces-Carrera, Sandra			The genetic characterization of fall armyworm populations in Ecuador and its implications to migration and pest management in the northern regions of South America	PLOS ONE			English	Article							SPODOPTERA-FRUGIPERDA LEPIDOPTERA; NOCTUIDAE HOST STRAINS; CENTRAL COLOMBIA; RICE STRAINS; PUERTO-RICO; FIELD COLLECTIONS; CORN; MAIZE; DIFFERENTIATION; SUSCEPTIBILITY	The fall armyworm (Spodoptera frugiperda) is a moth pest native to the Western Hemisphere that has recently become a global problem, invading Africa, Asia, and Australia. The species has a broad host range, long-distance migration capability, and a propensity for the generation of pesticide resistance traits that make it a formidable invasive threat and a difficult pest to control. While fall armyworm migration has been extensively studied in North America, where annual migrations of thousands of kilometers are the norm, migration patterns in South America are less understood. As a first step to address this issue we have been genetically characterizing fall armyworm populations in Ecuador, a country in the northern portion of South America that has not been extensively surveyed for this pest. These studies confirm and extend past findings indicating similarities in the fall armyworm populations from Ecuador, Trinidad-Tobago, Peru, and Bolivia that suggest substantial migratory interactions. Specifically, we found that populations throughout Ecuador are genetically homogeneous, indicating that the Andes mountain range is not a long-term barrier to fall armyworm migration. Quantification of genetic variation in an intron sequence describe patterns of similarity between fall armyworm from different locations in South America with implications for how migration might be occurring. In addition, we unexpectedly found these observations only apply to one subset of fall armyworm (the C-strain), as the other group (R-strain) was not present in Ecuador. The results suggest differences in migration behavior between fall armyworm groups in South America that appear to be related to differences in host plant preferences.	[Nagoshi, Rodney N.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA; [Canarte, Ernesto; Navarrete, Bernardo; Pico, Jimmy; Bravo, Catalina; Garces-Carrera, Sandra] Natl Inst Agr Res INIAP, Quito, Ecuador	United States Department of Agriculture (USDA)	Nagoshi, RN (corresponding author), USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.	rodney.nagoshi@ars.usda.gov		Navarrete, Bernardo/0000-0001-9200-7119; Arias, Myriam/0000-0002-3826-586X	Agricultural Research Service of the United States Department of Agriculture [6036-2200-30-00D]; USAID PASA [908-0210-012]; National Institute of Agriculture Research (INIAP), Ecuador [MAE-DNB-CM-2015-0024]	Agricultural Research Service of the United States Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USAID PASA; National Institute of Agriculture Research (INIAP), Ecuador	The author R.N.N. received support came from the Agricultural Research Service of the United States Department of Agriculture (6036-2200-30-00D) and USAID PASA (908-0210-012). The authors E.C., B.N., J.P., C.B., M.A., and S.G.C. received support from the National Institute of Agriculture Research (INIAP), Ecuador, authorized by the agreement between the INIAP and the Ministry of Environment of Ecuador reference number MAE-DNB-CM-2015-0024.	ANDREWS KL, 1988, FLA ENTOMOL, V71, P630, DOI 10.2307/3495022; Banerjee R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09866-y; Canas-Hoyos N, 2016, NEOTROP ENTOMOL, V45, P411, DOI 10.1007/s13744-016-0393-y; Canas-Hoyos N, 2014, ANN ENTOMOL SOC AM, V107, P575, DOI 10.1603/AN12154; Cano-Calle D, 2015, ANN ENTOMOL SOC AM, V108, P172, DOI 10.1093/aesa/sav001; Clark PL, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.0501; Du Plessis H, 2018, SPODOPTERA FRUGIPERD; Early R, 2018, NEOBIOTA, P25, DOI 10.3897/neobiota.40.28165; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Murua MG, 2015, J ECON ENTOMOL, V108, P2305, DOI 10.1093/jee/tov203; Groot AT, 2010, ECOL ENTOMOL, V35, P105, DOI 10.1111/j.1365-2311.2009.01138.x; Groot AT, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-20; Jeger M, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5351; Juarez ML, 2014, ENTOMOL EXP APPL, V152, P182, DOI 10.1111/eea.12215; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kost S, 2016, EVOLUTION, V70, P1418, DOI 10.1111/evo.12940; Juarez ML, 2012, J ECON ENTOMOL, V105, P573, DOI 10.1603/EC11184; Levy HC, 2002, FLA ENTOMOL, V85, P186, DOI 10.1653/0015-4040(2002)085[0186:SIOSFL]2.0.CO;2; Li XJ, 2020, PEST MANAG SCI, V76, P454, DOI 10.1002/ps.5530; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lima ER, 2009, CHEMOECOLOGY, V19, P29, DOI 10.1007/s00049-009-0005-y; LUGINBILL PHILIP, 1928, U S DEPT AGRIC TECH BULL, V34, P1; Martinelli S, 2006, J ECON ENTOMOL, V99, P519, DOI 10.1603/0022-0493-99.2.519; Meagher RL, 2004, ECOL ENTOMOL, V29, P614, DOI 10.1111/j.0307-6946.2004.00629.x; Meagher RL, 2019, ENVIRON ENTOMOL, V48, P343, DOI 10.1093/ee/nvy190; Nagoshi KL, 2019, J ECON ENTOMOL, DOI [10.1093/jee/toz344 31879767, DOI 10.1093/JEE/TOZ344 31879767]; Nagoshi RN, 2016, INSECT MOL BIOL, V25, P324, DOI 10.1111/imb.12223; Nagoshi RN, 2004, FLA ENTOMOL, V87, P440, DOI 10.1653/0015-4040(2004)087[0440:BADOTT]2.0.CO;2; Nagoshi RN, 2004, ENVIRON ENTOMOL, V33, P881, DOI 10.1603/0046-225X-33.4.881; Nagoshi RN, 2019, PLOS ONE, V14; Nagoshi RN, 2007, J ECON ENTOMOL, V100, P954, DOI 10.1603/0022-0493(2007)100[954:COHFDF]2.0.CO;2; Nagoshi RN, 2007, ANN ENTOMOL SOC AM, V100, P394, DOI 10.1603/0013-8746(2007)100[394:IACOFA]2.0.CO;2; Nagoshi RN, 2008, J ECON ENTOMOL, V101, P742, DOI 10.1603/0022-0493(2008)101[742:UHTMTM]2.0.CO;2; Nagoshi RN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222332; Nagoshi RN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44744-9; Nagoshi RN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208966; Nagoshi RN, 2017, J ECON ENTOMOL, V110, P2568, DOI 10.1093/jee/tox229; Nagoshi RN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171743; Nagoshi RN, 2015, J ECON ENTOMOL, V108, P135, DOI 10.1093/jee/tou044; Nagoshi RN, 2012, J ECON ENTOMOL, V105, P418, DOI 10.1603/EC11332; Nagoshi RN, 2010, J ECON ENTOMOL, V103, P360, DOI 10.1603/EC09253; Nagoshi RN, 2010, ANN ENTOMOL SOC AM, V103, P283, DOI 10.1603/AN09046; Niu Y, 2013, FLA ENTOMOL, V96, P701, DOI 10.1653/024.096.0302; PASHLEY DP, 1988, EVOLUTION, V42, P93, DOI 10.1111/j.1558-5646.1988.tb04110.x; PASHLEY DP, 1987, ANN ENTOMOL SOC AM, V80, P731, DOI 10.1093/aesa/80.6.731; PASHLEY DP, 1986, ANN ENTOMOL SOC AM, V79, P898, DOI 10.1093/aesa/79.6.898; Prowell DP, 2004, ANN ENTOMOL SOC AM, V97, P1034, DOI 10.1603/0013-8746(2004)097[1034:MGAOHU]2.0.CO;2; Ramirez-Cabral NYZ, 2017, J AGR SCI-CAMBRIDGE, V155, P1219, DOI 10.1017/S0021859617000314; Rios-Diez JD, 2012, SOUTHWEST ENTOMOL, V37, P281, DOI 10.3958/059.037.0304; Rios-Diez JD, 2011, J ECON ENTOMOL, V104, P1698, DOI 10.1603/EC11079; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saldamando CI, 2010, NEOTROP ENTOMOL, V39, P921, DOI 10.1590/S1519-566X2010000600012; Schofl G, 2009, J EVOLUTION BIOL, V22, P1447, DOI 10.1111/j.1420-9101.2009.01759.x; Schofl G, 2011, AM NAT, V177, P470, DOI 10.1086/658904; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Unbehend M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089255; Westbrook J, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2919; Westbrook JK, 2016, INT J BIOMETEOROL, V60, P255, DOI 10.1007/s00484-015-1022-x; YU SJ, 1991, PESTIC BIOCHEM PHYS, V39, P84, DOI 10.1016/0048-3575(91)90216-9	60	3	3	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236759	10.1371/journal.pone.0236759	http://dx.doi.org/10.1371/journal.pone.0236759			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745105	Green Published, gold			2022-12-26	WOS:000560006800036
J	Shi, LY; Zhang, L; Lu, Y				Shi, Liuyan; Zhang, Liang; Lu, Yun			Evaluating social network-based weight loss interventions in Chinese population: An agent-based simulation	PLOS ONE			English	Article								Objective The aim of this study is to assess network-based weight loss interventions in the Chinese setting using agent-based simulation. Methods An agent-based model incorporating social, environmental and personal influence is developed to simulate the obesity epidemic through an interconnected social network among a population of 2197 individuals from the nationally representative survey. Model parameters are collected from literature and existing database. To ensure the robustness of our findings, the model is validated against empirical observations and sensitivity analyses are performed on calibrated parameters. Results When compared with the baseline model, significant weight difference is detected using paired samples t tests for network-based intervention strategies (p<0.05) but no difference is observed for the two conventional intervention strategies including choosing random or high-risk individuals (p>0.05). Targeting the most connected individuals minimizes the average population weight, average BMI, and generates a reduction of 2.70% and 1.38% in overweight and obesity prevalence. Conclusions The simulations shows that targeting individuals on the basis of their social network attributes outperforms conventional targeting strategies. Future work needs to focus on how to further leverage social networks to curb obesity prevalence and enhance interventions for other chronic conditions using agent-based simulation.	[Shi, Liuyan; Zhang, Liang; Lu, Yun] China Pharmaceut Univ, Sch Int Pharmaceut Business, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Lu, Y (corresponding author), China Pharmaceut Univ, Sch Int Pharmaceut Business, Nanjing, Jiangsu, Peoples R China.	luyuncpu@163.com			National Natural Science Foundation of China [71673298]; Jiangsu Education Department (Jiangsu Province Foundation for Philosophy and Social Sciences Research in Colleges and Universities) [2017SJB0054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Education Department (Jiangsu Province Foundation for Philosophy and Social Sciences Research in Colleges and Universities)	YL received funding from the National Natural Science Foundation of China under grant number 71673298(http://www.nsfc.gov.cn/) and the Jiangsu Education Department (Jiangsu Province Foundation for Philosophy and Social Sciences Research in Colleges and Universities, http://jyt.jiangsu.gov.cn/) under grant number 2017SJB0054.	[Anonymous], 2004, OVERVIEW NUTR SCI; [Anonymous], 2008, PLA HLTH; [Anonymous], 2007, Gastroenterology clinics of North America., V36, pviii, DOI 10.1016/j.gtc.2007.01.004; Astrup A, 2000, Obes Rev, V1, P17, DOI 10.1046/j.1467-789x.2000.00004.x; Auchincloss AH, 2008, AM J EPIDEMIOL, V168, P1, DOI 10.1093/aje/kwn118; Axelrod R, 2006, HANDB ECON, V13, P1565; Bahr DB, 2009, OBESITY, V17, P723, DOI 10.1038/oby.2008.615; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; El-Sayed AM, 2013, AM J EPIDEMIOL, V178, P287, DOI 10.1093/aje/kws455; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gesell SB, 2012, J OBES, V2012, DOI 10.1155/2012/749832; Giabbanelli PJ, 2012, J COMPUT SCI-NETH, V3, P17, DOI 10.1016/j.jocs.2012.01.004; Hammond RA, 2014, ANN NY ACAD SCI, V1331, P34, DOI 10.1111/nyas.12344; Hua NG, 2013, FOOD NUTR CHINA; Kushner RF, 2007, GASTROENTEROL CLIN N, V36, P191, DOI 10.1016/j.gtc.2007.01.004; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Stafford RS, 2000, ARCH FAM MED, V9, P631, DOI 10.1001/archfami.9.7.631; Trogdon JG, 2014, ECON HUM BIOL, V15, P153, DOI 10.1016/j.ehb.2014.08.004; van Woudenberg TJ, 2019, J MED INTERNET RES, V21, DOI 10.2196/12914; WANG H, 2008, CHINESE HLTH EC, P15; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wise Jacqui, 2014, BMJ, V348, pg3582, DOI 10.1136/bmj.g3582; Wolfe AW, 1997, AM ETHNOL, V24, P219, DOI 10.1525/ae.1997.24.1.219; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Zhang J, 2015, SOC SCI MED, V125, P203, DOI 10.1016/j.socscimed.2014.05.049; 2014, LANCET LONDON ENGLAN, P00766, DOI DOI 10.1016/S0140-6736(14)60460-824880830	29	0	1	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236716	10.1371/journal.pone.0236716	http://dx.doi.org/10.1371/journal.pone.0236716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA7OS	32745125	Green Published, gold			2022-12-26	WOS:000560006800034
J	Skorka, P; Grzywacz, B; Moron, D; Lenda, M				Skorka, Piotr; Grzywacz, Beata; Moron, Dawid; Lenda, Magdalena			The macroecology of the COVID-19 pandemic in the Anthropocene	PLOS ONE			English	Article							EUROPEAN COUNTRIES; HUMAN MIGRATION; LAND-USE; EPIDEMIC; DISEASE; GLOBALIZATION; REGRESSION; MORTALITY; INVASION; ECOLOGY	Severe acute respiratory syndrome coronavirus 2, the virus that causes coronavirus disease 2019 (COVID-19), has expanded rapidly throughout the world. Thus, it is important to understand how global factors linked with the functioning of the Anthropocene are responsible for the COVID-19 outbreak. We tested hypotheses that the number of COVID-19 cases, number of deaths and growth rate of recorded infections: (1) are positively associated with population density as well as (2) proportion of the human population living in urban areas as a proxies of interpersonal contact rate, (3) age of the population in a given country as an indication of that population's susceptibility to COVID-19; (4) net migration rate and (5) number of tourists as proxies of infection pressure, and negatively associated with (5) gross domestic product which is a proxy of health care quality. Data at the country level were compiled from publicly available databases and analysed with gradient boosting regression trees after controlling for confounding factors (e.g. geographic location). We found a positive association between the number of COVID-19 cases in a given country and gross domestic product, number of tourists, and geographic longitude. The number of deaths was positively associated with gross domestic product, number of tourists in a country, and geographic longitude. The effects of gross domestic product and number of tourists were non-linear, with clear thresholds above which the number of COVID-19 cases and deaths increased rapidly. The growth rate of COVID-19 cases was positively linked to the number of tourists and gross domestic product. The growth rate of COVID-19 cases was negatively associated with the mean age of the population and geographic longitude. Growth was slower in less urbanised countries. This study demonstrates that the characteristics of the human population and high mobility, but not population density, may help explain the global spread of the virus. In addition, geography, possibly via climate, may play a role in the pandemic. The unexpected positive and strong association between gross domestic product and number of cases, deaths, and growth rate suggests that COVID-19 may be a new civilisation disease affecting rich economies.	[Skorka, Piotr; Lenda, Magdalena] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland; [Grzywacz, Beata; Moron, Dawid] Polish Acad Sci, Inst Systemat & Evolut Anim, Krakow, Poland	Polish Academy of Sciences; Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences	Skorka, P (corresponding author), Polish Acad Sci, Inst Nat Conservat, Krakow, Poland.	skorasp@gmail.com	Skórka, Piotr/B-7218-2009; Moroń, Dawid/A-8595-2010	Skórka, Piotr/0000-0002-3221-296X; Moroń, Dawid/0000-0003-3692-7855; Grzywacz, Beata/0000-0003-1222-8857; Lenda, Magdalena/0000-0001-7824-7220				Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Apolloni A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-176; Araujo Miguel B., 2020, SPREAD SARS COV 2 CO, DOI [10.1101/2020.03.12.20034728, DOI 10.1101/2020.03.12.20034728]; Ayittey FK, 2020, J MED VIROL, V92, P473, DOI 10.1002/jmv.25706; Baldi G, 2015, WEST EUR POLIT, V38, P1152, DOI 10.1080/01402382.2015.1041237; Blumenshine P, 2008, EMERG INFECT DIS, V14, P709, DOI 10.3201/eid1405.071301; Boehmke B., 2020, HANDS ON MACHINE LEA; Brainerd E, 2003, 3791 CTR EC POL RES; Brown JH, 2014, ECOL ENG, V65, P24, DOI 10.1016/j.ecoleng.2013.07.071; Buckley R, 2020, BIOL CONSERV, V247, DOI 10.1016/j.biocon.2020.108640; Bukhari Q., 2020, WILL CORONAVIRUS PAN, DOI [10.2139/ssrn.3556998, DOI 10.2139/SSRN.3556998]; Burnside WR, 2012, BIOL REV, V87, P194, DOI 10.1111/j.1469-185X.2011.00192.x; Castelli F, 2017, CLIN MICROBIOL INFEC, V23, P283, DOI 10.1016/j.cmi.2017.03.012; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Chin AWH, 2020, LANCET MICROBE, V1, pE10, DOI [10.1016/S2666-5247(20)30003-3, 10.1016/S2666-5247(20)30095-1]; Chowell G, 2008, P ROY SOC B-BIOL SCI, V275, P501, DOI 10.1098/rspb.2007.1477; Clark RP, 2000, GLOBAL LIFE SYSTEMS; Corlett RT, 2015, TRENDS ECOL EVOL, V30, P36, DOI 10.1016/j.tree.2014.10.007; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Dellicour S, 2016, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-016-0924-x; Dobson AP, 1996, BIOSCIENCE, V46, P115, DOI 10.2307/1312814; Ducharme Jamie, 2020, TIME; Egger G, 2012, ECON HUM BIOL, V10, P147, DOI 10.1016/j.ehb.2012.01.002; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fernandez RM, 2019, GOOD HLTH WELL BEING; Ferrari Matthew J, 2011, Interdiscip Perspect Infect Dis, V2011, P267049, DOI 10.1155/2011/267049; Fong IW, 2019, CHALLENGES INFECT DI; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gaston KJ, 2000, PATTERN PROCESS MACR; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; Gog JR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003635; Goldstein A, 2015, J COMPUT GRAPH STAT, V24, P44, DOI 10.1080/10618600.2014.907095; Greenwell BM, 2017, R J, V9, P421; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Hall C., 2000, TOURISM GEOGR, V2, P5, DOI [DOI 10.1080/146166800363420, 10.1080/146166800363420]; Hallatschek O, 2014, P NATL ACAD SCI USA, V111, pE4911, DOI 10.1073/pnas.1404663111; Hastings A, 2010, ECOLOGY, V91, P3471, DOI 10.1890/10-0776.1; Hochachka WM, 2000, P NATL ACAD SCI USA, V97, P5303, DOI 10.1073/pnas.080551197; Institute of Medicine (IOM), 2010, INFECT DIS MOVEMENT; Jaba E, 2014, PROC ECON FINANC, V15, P108, DOI 10.1016/S2212-5671(14)00454-7; Janssen F, 2006, SOC SCI MED, V63, P239, DOI 10.1016/j.socscimed.2005.11.040; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Kraemer Moritz U G, 2020, medRxiv, DOI 10.1101/2020.03.02.20026708; Leiva-Leon D, 2020, REAL TIME WEAKNESS G; Lenda M, 2018, J ECOL, V106, P671, DOI 10.1111/1365-2745.12827; Lenda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099786; Li AH, 2018, J AM STAT ASSOC, V113, P660, DOI 10.1080/01621459.2016.1273116; Lin G, 2019, MATH BIOSCI ENG, V16, P7562, DOI 10.3934/mbe.2019380; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Madhav N., 2017, DIS CONTROL PRIORITI, V9, P315, DOI [10.1596/978-1-4648-0527-1_ch17, DOI 10.1596/978-1-4648-0527-1]; Malhi Y, 2017, ANNU REV ENV RESOUR, V42, P77, DOI 10.1146/annurev-environ-102016-060854; Mascie-Taylor CGN, 2017, ANN HUM BIOL, V44, P427, DOI 10.1080/03014460.2017.1313448; Misra AK, 2011, J BIOL SYST, V19, P389, DOI 10.1142/S0218339011004020; Naresh R, 2011, APPL MATH COMPUT, V217, P4416, DOI 10.1016/j.amc.2010.10.036; National Research Council and Institute of Medicine, 2020, BOARD CHILDREN YOUTH; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Popa A. M., 2012, ROMANIAN J FISCAL PO, V3, P1; Quaglia A, 2005, CRIT REV ONCOL HEMAT, V54, P117, DOI 10.1016/j.critrevonc.2004.12.001; R Core Team, 2021, R LANGUAGE ENV STAT; Rizzo C, 2007, EMERG INFECT DIS, V13, P694, DOI 10.3201/eid1305.061309; Rossello J, 2017, HEALTH POLICY PLANN, V32, P538, DOI 10.1093/heapol/czw177; Sambaturu N, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006069; Satariano WA, 2012, AM J PUBLIC HEALTH, V102, P1508, DOI 10.2105/AJPH.2011.300631; Schapire R., 2002, MSRI WORKSH NONL EST, P1; Schlapfer M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0789; Smith KF, 2007, ECOLOGY, V88, P1903, DOI 10.1890/06-1052.1; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; Soto SM, 2009, CLIN MICROBIOL INFEC, V15, P26, DOI 10.1111/j.1469-0691.2008.02694.x; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001242]; TAN M, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M223732522740; Tewara MA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3534-6; Waters CN, 2016, SCIENCE, V351, P137, DOI 10.1126/science.aad2622; Wei WQ, 2017, NAT HUM BEHAV, V1, P890, DOI 10.1038/s41562-017-0240-0; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Wood CL, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0122; World Health Organisation (WHO), 2020, 151 WHO; Yu WB, 2020, ZOOL RES, V41, P247, DOI 10.24272/j.issn.2095-8137.2020.022; Zhang JJ, 2020, SCIENCE, V368, P1481, DOI 10.1126/science.abb8001; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	83	17	18	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236856	10.1371/journal.pone.0236856	http://dx.doi.org/10.1371/journal.pone.0236856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2PD	32730366	Green Published, gold			2022-12-26	WOS:000556884700001
J	Lo Cascio, F; Garcia, S; Montalbano, M; Puangmalai, N; McAllen, S; Pace, A; Piccionello, AP; Kayed, R				Lo Cascio, Filippa; Garcia, Stephanie; Montalbano, Mauro; Puangmalai, Nicha; McAllen, Salome; Pace, Andrea; Palumbo Piccionello, Antonio; Kayed, Rakez			Modulating disease-relevant tau oligomeric strains by small molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						brain-derived tau oligomers; tau aggregation; tau oligomeric strains; toxicity; tau protein; tauopathy; small molecule; protein aggregation; oligomer	ALZHEIMERS-DISEASE; AMYLOID-BETA; ALPHA-SYNUCLEIN; CURCUMIN; MECHANISMS; PATHOLOGY; PROTEIN; TAUOPATHIES; PROPAGATION; ABSORPTION	The pathological aggregation of tau plays an important role in Alzheimer's disease and many other related neurodegenerative diseases, collectively referred to as tauopathies. Recent evidence has demonstrated that tau oligomers, small and soluble prefibrillar aggregates, are highly toxic due to their strong ability to seed tau misfolding and propagate the pathology seen across different neurodegenerative diseases. We previously showed that novel curcumin derivatives affect preformed tau oligomer aggregation pathways by promoting the formation of more aggregated and nontoxic tau aggregates. To further investigate their therapeutic potential, we have extended our studies o disease-relevant brain-derived tau oligomers (BDTOs). Herein, using well-characterized BDTOs, isolated from brain tissues of different tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies, we found that curcumin derivatives modulate the aggregation state of BDTOs by reshaping them and rescue neurons from BDTO-associated toxicity. Interestingly, compound CL3 showed an effect on the aggregation pattern of BDTOs from different tauopathies, resulting in the formation of less neurotoxic larger tau aggregates with decreased hydrophobicity and seeding propensity. Our results lay the groundwork for potential investigations of the efficacy and beneficial effects of CL3 and other promising compounds for the treatment of tauopathies. Furthermore, CL3 may aid in the development of tau imaging agent for the detection of tau oligomeric strains and differential diagnosis of the tauopathies, thus enabling earlier interventions.	[Lo Cascio, Filippa; Garcia, Stephanie; Montalbano, Mauro; Puangmalai, Nicha; McAllen, Salome; Kayed, Rakez] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA; [Lo Cascio, Filippa; Garcia, Stephanie; Montalbano, Mauro; Puangmalai, Nicha; McAllen, Salome; Kayed, Rakez] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Lo Cascio, Filippa; Garcia, Stephanie; Montalbano, Mauro; Puangmalai, Nicha; McAllen, Salome; Kayed, Rakez] Univ Texas Med Branch, Dept Neurosci, Galveston, TX 77555 USA; [Lo Cascio, Filippa; Garcia, Stephanie; Montalbano, Mauro; Puangmalai, Nicha; McAllen, Salome; Kayed, Rakez] Univ Texas Med Branch, Dept Cell Biol, Galveston, TX 77555 USA; [Pace, Andrea; Palumbo Piccionello, Antonio] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, Palermo, Italy	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Palermo	Kayed, R (corresponding author), Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA.; Kayed, R (corresponding author), Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA.; Kayed, R (corresponding author), Univ Texas Med Branch, Dept Neurosci, Galveston, TX 77555 USA.; Kayed, R (corresponding author), Univ Texas Med Branch, Dept Cell Biol, Galveston, TX 77555 USA.	rakayed@utmb.edu	Piccionello, Antonio Palumbo/V-6634-2017; Puangmalai, Nicha/AAO-7521-2021; Montalbano, Mauro/AAA-6833-2021	Piccionello, Antonio Palumbo/0000-0003-4402-5798; Puangmalai, Nicha/0000-0002-1138-237X; Montalbano, Mauro/0000-0002-0456-452X; Kayed, Rakez/0000-0001-6216-8640	Mitchell Center for Neurodegenerative Diseases; Gillson Longenbaugh Foundation; National Institutes of Health [R01AG054025, R01NS094557, RFA1AG055771, R01AG060718]; American Heart Association [17CSA33620007]	Mitchell Center for Neurodegenerative Diseases; Gillson Longenbaugh Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by the Mitchell Center for Neurodegenerative Diseases; the Gillson Longenbaugh Foundation; National Institutes of Health Grants R01AG054025, R01NS094557, RFA1AG055771, and R01AG060718; and American Heart Association Collaborative Grant 17CSA33620007 (to R. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed R, 2019, CHEM SCI, V10, P6072, DOI 10.1039/c9sc01331h; Alafuzoff I, 2008, BRAIN PATHOL, V18, P484, DOI 10.1111/j.1750-3639.2008.00147.x; Bavisotto CC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020661; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Bittar A, 2019, BRAIN COMMUN, V1, DOI 10.1093/braincomms/fcz004; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Braak H, 1991, BRAIN PATHOL, V1, P213, DOI 10.1111/j.1750-3639.1991.tb00661.x; Brunello CA, 2020, CELL MOL LIFE SCI, V77, P1721, DOI 10.1007/s00018-019-03349-1; Calcul L, 2012, FUTURE MED CHEM, V4, P1751, DOI [10.4155/FMC.12.124, 10.4155/fmc.12.124]; Castillo-Carranza DL, 2018, BIOL PSYCHIAT, V84, P499, DOI 10.1016/j.biopsych.2017.12.018; Castillo-Carranza DL, 2017, AGING DIS, V8, P257, DOI 10.14336/AD.2017.0112; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Das RK, 2010, NANOMED-NANOTECHNOL, V6, P153, DOI 10.1016/j.nano.2009.05.009; Cardenas-Aguayo MD, 2014, ACS CHEM NEUROSCI, V5, P1178, DOI 10.1021/cn500148z; Douglass BJ, 2015, J AM COLL NUTR, V34, P347, DOI 10.1080/07315724.2014.950392; Eisele YS, 2015, NAT REV DRUG DISCOV, V14, P759, DOI 10.1038/nrd4593; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Gadhave K, 2016, J CELL MOL MED, V20, P1392, DOI 10.1111/jcmm.12817; Gerson JE, 2017, NEUROPROTECTION IN ALZHEIMER'S DISEASE, P97, DOI 10.1016/B978-0-12-803690-7.00006-5; Gerson J, 2016, CURR PHARM DESIGN, V22, P4028, DOI 10.2174/1381612822666160518142226; Gerson JE, 2016, CRIT REV BIOCHEM MOL, V51, P482, DOI 10.1080/10409238.2016.1226251; Gerson JE, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-73; Ghaemmaghami S, 2011, J MOL BIOL, V413, P527, DOI 10.1016/j.jmb.2011.07.021; Ghag G, 2018, PROTEIN SCI, V27, P1901, DOI 10.1002/pro.3499; Gomperts SN, 2016, JAMA NEUROL, V73, P1334, DOI 10.1001/jamaneurol.2016.3338; Graham WV, 2017, ANNU REV MED, V68, P413, DOI 10.1146/annurev-med-042915-103753; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hasanbasic S, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8613209; He ZH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13787-x; Heilbronner G, 2013, EMBO REP, V14, P1017, DOI 10.1038/embor.2013.137; Hill E, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0166-19.2019; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Holmes BB, 2012, CURR OPIN NEUROL, V25, P721, DOI 10.1097/WCO.0b013e32835a3ee0; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hu SX, 2015, EXPERT REV NEUROTHER, V15, P629, DOI 10.1586/14737175.2015.1044981; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Irwin DJ, 2016, PARKINSONISM RELAT D, V22, pS29, DOI 10.1016/j.parkreldis.2015.09.020; Iseki E, 2003, ACTA NEUROPATHOL, V105, P265, DOI 10.1007/s00401-002-0644-3; Jadhav S, 2015, TRANSL NEUROSCI, V6, P214, DOI 10.1515/tnsci-2015-0023; Jiang LL, 2019, ACTA NEUROPATHOL, V137, P259, DOI 10.1007/s00401-018-1937-5; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee HE, 2019, PHARM PAT ANAL, V8, P15, DOI 10.4155/ppa-2019-0003; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Leuzy A, 2019, MOL PSYCHIATR, V24, P1112, DOI 10.1038/s41380-018-0342-8; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lo C. H., 2019, NOVAL SMALL MOL SCRE, DOI [10.1101/510412, DOI 10.1101/510412]; Lo Cascio F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55419-w; Lo Cascio F, 2018, ACS CHEM NEUROSCI, V9, P1317, DOI 10.1021/acschemneuro.7b00501; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Maiti P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061637; Mannini B, 2014, ACS CHEM BIOL, V9, P2309, DOI 10.1021/cb500505m; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2006, J BIOL CHEM, V281, P37820, DOI 10.1074/jbc.M605336200; McAlary L, 2019, CNS DRUGS, V33, P883, DOI 10.1007/s40263-019-00657-9; Medina M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041160; Mohanty C, 2010, BIOMATERIALS, V31, P6597, DOI 10.1016/j.biomaterials.2010.04.062; Montalbano M, 2019, AGING CELL, V18, DOI 10.1111/acel.13035; Mudher A, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0488-7; Munch C, 2012, J MOL BIOL, V421, P491, DOI 10.1016/j.jmb.2011.12.061; Murray ME, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt231; Park SA, 2020, EXP MOL MED, V52, P556, DOI 10.1038/s12276-020-0418-9; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Pfeffer SR, 2017, MOL BIOL CELL, V28, P712, DOI 10.1091/mbc.E16-10-0737; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Prasad S, 2014, CANCER RES TREAT, V46, P2, DOI 10.4143/crt.2014.46.1.2; Puangmalai N, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2503-3; Purkayastha S, 2009, BRAIN RES, V1266, P130, DOI 10.1016/j.brainres.2009.01.066; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rahmani Arshad Husain, 2018, Adv Biomed Res, V7, P38, DOI 10.4103/abr.abr_147_16; Rauch JN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24904-z; Ringman JM, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt146; Salehi B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020430; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sengupta U, 2020, MOL NEUROBIOL, V57, P2741, DOI 10.1007/s12035-020-01913-6; Sengupta U, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0615-0; Sengupta U, 2018, METHODS MOL BIOL, V1779, P113, DOI 10.1007/978-1-4939-7816-8_9; Sengupta U, 2017, ANN CLIN TRANSL NEUR, V4, P226, DOI 10.1002/acn3.382; Sengupta U, 2016, EBIOMEDICINE, V6, P42, DOI 10.1016/j.ebiom.2016.03.035; Sengupta U, 2015, BIOL PSYCHIAT, V78, P672, DOI 10.1016/j.biopsych.2014.12.019; Silva MC, 2019, ELIFE, V8, DOI 10.7554/eLife.45457; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; Walker LC, 2013, JAMA NEUROL, V70, P304, DOI 10.1001/jamaneurol.2013.1453; Wang P, 2018, CHEM COMMUN, V54, P10120, DOI 10.1039/c8cc05072d; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Yavarpour-Bali H, 2019, INT J NANOMED, V14, P4449, DOI 10.2147/IJN.S208332	93	14	14	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2020	295	44					14807	14825		10.1074/jbc.RA120.014630	http://dx.doi.org/10.1074/jbc.RA120.014630			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OP9MG	32737202	Green Published, hybrid			2022-12-26	WOS:000588414100003
J	Bucko, PJ; Garcia, I; Manocha, R; Bhat, A; Wordeman, L; Scott, JD				Bucko, Paula J.; Garcia, Irvin; Manocha, Ridhima; Bhat, Akansha; Wordeman, Linda; Scott, John D.			Gravin-associated kinase signaling networks coordinate gamma-tubulin organization at mitotic spindle poles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase A anchoring protein (AKAP); protein kinase; enzyme inhibitor; protein complex; mitosis; tubulin	CELLULAR-DISTRIBUTION; CENTROSOME; INHIBITOR; PLK1; PROTEINS; EXPRESSION; NUCLEATION; CENTRIOLES; COMPLEXES; REVEALS	Mitogenic signals that regulate cell division often proceed through multienzyme assemblies within defined intracellular compartments. The anchoring protein Gravin restricts the action of mitotic kinases and cell-cycle effectors to defined mitotic structures. In this report we discover that genetic deletion of Gravin disrupts proper accumulation and asymmetric distribution of gamma-tubulin during mitosis. We utilize a new precision pharmacology tool, Local Kinase Inhibition, to inhibit the Gravin binding partner polo-like kinase 1 at spindle poles. Using a combination of gene-editing approaches, quantitative imaging, and biochemical assays, we provide evidence that disruption of local polo-like kinase 1 signaling underlies the gamma-tubulin distribution defects observed with Gravin loss. Our study uncovers a new role for Gravin in coordinating gamma-tubulin recruitment during mitosis and illuminates the mechanism by which signaling enzymes regulate this process at a distinct subcellular location.	[Bucko, Paula J.; Garcia, Irvin; Manocha, Ridhima; Bhat, Akansha; Scott, John D.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Wordeman, Linda] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Scott, JD (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	scottjdw@uw.edu		Bucko, Paula/0000-0002-0889-5465	National Institutes of Health [DK119186, DK119192]; Fibrolamellar Carcinoma Foundation (FCF)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fibrolamellar Carcinoma Foundation (FCF)	This work was supported by National Institutes of Health Grants DK119186 and DK119192 to J.D.S. Support also from the Fibrolamellar Carcinoma Foundation (FCF). This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bateman NW, 2015, J PROTEOME RES, V14, P1900, DOI 10.1021/pr5012894; Bucko PJ, 2021, ANNU REV PHARMACOL, V61, P361, DOI 10.1146/annurev-pharmtox-022420-112134; Bucko PJ, 2019, ELIFE, V8, DOI 10.7554/eLife.52220; Canton DA, 2013, CELL CYCLE, V12, P863, DOI 10.4161/cc.24192; Canton DA, 2012, MOL CELL, V48, P547, DOI 10.1016/j.molcel.2012.09.002; Caracciolo V, 2010, J CELL PHYSIOL, V223, P519, DOI 10.1002/jcp.22077; Chen D, 2004, J BIOL CHEM, V279, P4829, DOI 10.1074/jbc.M311196200; Cheng Chieh-Yuan, 2018, Oncotarget, V9, P21231, DOI 10.18632/oncotarget.25035; Chinen T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9722; Cho EH, 2010, CANCER BIOL THER, V9, P66, DOI 10.4161/cbt.9.1.10451; Choi M, 2015, CANCER LETT, V357, P591, DOI 10.1016/j.canlet.2014.12.023; Colicino EG, 2018, MOL BIOL CELL, V29, P532, DOI 10.1091/mbc.E17-08-0524; Combes G, 2017, ONCOGENE, V36, P4819, DOI 10.1038/onc.2017.113; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; Esseltine JL, 2013, TRENDS PHARMACOL SCI, V34, P648, DOI 10.1016/j.tips.2013.10.005; Friesen DE, 2012, CHEM BIOL DRUG DES, V79, P639, DOI 10.1111/j.1747-0285.2012.01340.x; Fulcher LJ, 2020, CELL CYCLE, V19, P505, DOI 10.1080/15384101.2020.1728014; Gabrovsek L., 2017, ENCY SIGNALING MOL, P1; Gelman Irwin H, 2010, Genes Cancer, V1, P1147, DOI 10.1177/1947601910392984; Gutteridge REA, 2016, MOL CANCER THER, V15, P1427, DOI 10.1158/1535-7163.MCT-15-0897; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Hehnly H, 2015, ELIFE, V4, DOI 10.7554/eLife.09384; Hendrickson TW, 2001, MOL BIOL CELL, V12, P2469, DOI 10.1091/mbc.12.8.2469; Katsetos CD, 2006, J NEUROPATH EXP NEUR, V65, P465, DOI 10.1097/01.jnen.0000229235.20995.6e; Kawashima AT, 2020, TRENDS PHARMACOL SCI, V41, P227, DOI 10.1016/j.tips.2020.02.002; Klaeger S, 2017, SCIENCE, V358, DOI 10.1126/science.aan4368; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Lattao R, 2017, GENETICS, V206, P33, DOI 10.1534/genetics.116.198168; Lee KS, 2015, TRENDS PHARMACOL SCI, V36, P858, DOI 10.1016/j.tips.2015.08.013; Leibowitz ML, 2015, ANNU REV GENET, V49, P183, DOI 10.1146/annurev-genet-120213-092228; Lemmon MA, 2016, CELL, V164, P1172, DOI 10.1016/j.cell.2016.02.047; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Manning JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009618; Maounis NF, 2012, HISTOL HISTOPATHOL, V27, P1183, DOI 10.14670/HH-27.1183; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Muller H, 2006, SCIENCE, V314, P654, DOI 10.1126/science.1132834; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Niu Y, 2009, CANCER SCI, V100, P580, DOI 10.1111/j.1349-7006.2008.01075.x; Nygren PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.30872; Parada CA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19308-y; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Smith FD, 2018, P NATL ACAD SCI USA, V115, pE11465, DOI 10.1073/pnas.1816614115; Smith FD, 2017, SCIENCE, V356, P1288, DOI 10.1126/science.aaj1669; Smith FD, 2013, ELIFE, V2, DOI 10.7554/eLife.01319; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858; Xia W, 2001, CANCER RES, V61, P5644; Xu DZ, 2011, P NATL ACAD SCI USA, V108, P11301, DOI 10.1073/pnas.1107723108; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Zhang XY, 2009, J CELL SCI, V122, P2240, DOI 10.1242/jcs.042747; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	60	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2020	295	40					13784	13797		10.1074/jbc.RA120.014791	http://dx.doi.org/10.1074/jbc.RA120.014791			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OB4MB	32732289	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000578444100007
J	Dultz, G; Shimakami, T; Schneider, M; Murai, K; Yamane, D; Marion, A; Zeitler, TM; Stross, C; Grimm, C; Richter, RM; Baumer, K; Yi, M; Biondi, RM; Zeuzem, S; Tampe, R; Antes, I; Lange, CM; Welsch, C				Dultz, Georg; Shimakami, Tetsuro; Schneider, Markus; Murai, Kazuhisa; Yamane, Daisuke; Marion, Antoine; Zeitler, Tobias M.; Stross, Claudia; Grimm, Christian; Richter, Rebecca M.; Baeumer, Katrin; Yi, MinKyung; Biondi, Ricardo M.; Zeuzem, Stefan; Tampe, Robert; Antes, Iris; Lange, Christian M.; Welsch, Christoph			Extended interaction networks with HCV protease NS3-4A substrates explain the lack of adaptive capability against protease inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatitis C virus (HCV); serine protease (NS3-4A); structure constraints; evolution; adaptation; mitochondrial antiviral signaling protein (MAVS); protease inhibitor; resistance mutation; replicative fitness; drug resistance; molecular biology; molecular dynamics; molecular adaptation	RESISTANCE-ASSOCIATED SUBSTITUTIONS; NF-KAPPA-B; HEPATITIS-C; NS3/4A PROTEASE; CELLULAR SUBSTRATE; HELICASE; MAVS; REPLICATION; INFECTION; SUBTYPES	Inhibitors against the NS3-4A protease of hepatitis C virus (HCV) have proven to be useful drugs in the treatment of HCV infection. Although variants have been identified with mutations that confer resistance to these inhibitors, the mutations do not restore replicative fitness and no secondary mutations that rescue fitness have been found. To gain insight into the molecular mechanisms underlying the lack of fitness compensation, we screened known resistance mutations in infectious HCV cell culture with different genomic backgrounds. We observed that the Q41R mutation of NS3-4A efficiently rescues the replicative fitness in cell culture for virus variants containing mutations at NS3-Asp(168). To understand how the Q41R mutation rescues activity, we performed protease activity assays complemented by molecular dynamics simulations, which showed that protease-peptide interactions far outside the targeted peptide cleavage sites mediate substrate recognition by NS3-4A and support protease cleavage kinetics. These interactions shed new light on the mechanisms by which NS3-4A cleaves its substrates, viral polyproteins and a prime cellular antiviral adaptor protein, the mitochondrial antiviral signaling protein MAVS. Peptide binding is mediated by an extended hydrogen-bond network in NS3-4A that was effectively optimized for protease-MAVS binding in Asp(168)variants with rescued replicative fitness from NS3-Q41R. In the protease harboring NS3-Q41R, the N-terminal cleavage products of MAVS retained high affinity to the active site, rendering the protease susceptible for potential product inhibition. Our findings reveal delicately balanced protease-peptide interactions in viral replication and immune escape that likely restrict the protease adaptive capability and narrow the virus evolutionary space.	[Dultz, Georg; Stross, Claudia; Grimm, Christian; Richter, Rebecca M.; Baeumer, Katrin; Biondi, Ricardo M.; Zeuzem, Stefan; Lange, Christian M.; Welsch, Christoph] Goethe Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany; [Shimakami, Tetsuro; Murai, Kazuhisa] Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Schneider, Markus; Marion, Antoine; Zeitler, Tobias M.; Antes, Iris] Tech Univ Munich, Ctr Integrated Prot Sci Munich CIPSM, Dept Life Sci, Freising Weihenstephan, Germany; [Yamane, Daisuke] Tokyo Metropolitan Inst Med Sci, Tokyo, Japan; [Yi, MinKyung] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Biondi, Ricardo M.] Max Planck Gesell, CONICET, Biomed Res Inst Buenos Aires, Partner Inst, Buenos Aires, DF, Argentina; [Zeuzem, Stefan; Welsch, Christoph] Goethe Univ Hosp Frankfurt, Univ Ctr Infect Dis, Frankfurt, Germany; [Tampe, Robert] Goethe Univ Frankfurt, Bioctr, Inst Biochem, Frankfurt, Germany; [Tampe, Robert] Goethe Univ Frankfurt, Cluster Excellence Macromol Complexes, Frankfurt, Germany; [Lange, Christian M.] Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany; [Lange, Christian M.] Univ Duisburg Essen, Essen, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Kanazawa University; Technical University of Munich; Tokyo Metropolitan Institute of Medical Science; University of Texas System; University of Texas Medical Branch Galveston; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt; University of Duisburg Essen; University of Duisburg Essen	Welsch, C (corresponding author), Goethe Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany.; Welsch, C (corresponding author), Goethe Univ Hosp Frankfurt, Univ Ctr Infect Dis, Frankfurt, Germany.	christoph.welsch@kgu.de	Marion, Antoine/AAC-4712-2019	Marion, Antoine/0000-0002-8266-8957; Biondi, Ricardo/0000-0002-8873-7167; Dultz, Georg/0000-0003-0775-0907; Richter, Rebecca M./0000-0002-3831-7666	German Research Foundation; Cluster of Excellence "Macromolecular Complexes" [CRC 807, SPP 1623, RTG 1986]; Center for Integrated Protein Science Munich [SFB 749/C8, SFB 1035, WE 4388/6-1]; IGSSE Graduate School; Goethe University-Frankfurt Tandem Research Scholarship; DAAD-JSPS; Hessian Initiative for the Development of Scientific-Economic Excellence (LOEWE), Research Center for Translational Medicine and Pharmacology; Novel Drug Targets against Poverty-Related and Neglected Tropical Infectious Diseases; Else Kroner-Fresenius Foundation, Graduate School for Translational Research Innovation-Pharma	German Research Foundation(German Research Foundation (DFG)); Cluster of Excellence "Macromolecular Complexes"; Center for Integrated Protein Science Munich; IGSSE Graduate School; Goethe University-Frankfurt Tandem Research Scholarship; DAAD-JSPS; Hessian Initiative for the Development of Scientific-Economic Excellence (LOEWE), Research Center for Translational Medicine and Pharmacology; Novel Drug Targets against Poverty-Related and Neglected Tropical Infectious Diseases; Else Kroner-Fresenius Foundation, Graduate School for Translational Research Innovation-Pharma	This work was supported by the German Research Foundation and the Cluster of Excellence "Macromolecular Complexes", CRC 807, SPP 1623, and RTG 1986 (to R. T.); the Center for Integrated Protein Science Munich (to I. A.), SFB 749/C8 (to A. M.), SFB 1035 (to M. S.), and WE 4388/6-1 (to C. W.); the IGSSE Graduate School (M. S.); a Goethe University-Frankfurt Tandem Research Scholarship (G. D.); and the DAAD-JSPS Joint Research Program (T. S. and C. W.). This work was also supported by the Hessian Initiative for the Development of Scientific-Economic Excellence (LOEWE), Research Center for Translational Medicine and Pharmacology; Novel Drug Targets against Poverty-Related and Neglected Tropical Infectious Diseases; and the Else Kroner-Fresenius Foundation, Graduate School for Translational Research Innovation-Pharma (C. M. L., C. W. and S. Z.).	Acevedo A, 2014, NATURE, V505, P686, DOI 10.1038/nature12861; Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046; Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Brenndorfer ED, 2009, HEPATOLOGY, V49, P1810, DOI 10.1002/hep.22857; Case D., 2015, AMBER, V14; Cervera H, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0984; Choi HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02624-8; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Doncheva NT, 2019, J MOL BIOL, V431, P2354, DOI 10.1016/j.jmb.2019.04.034; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Duell ER, 2016, ACS CHEM BIOL, V11, P1082, DOI 10.1021/acschembio.5b00905; Feng H, 2019, J HEPATOL, V71, P25, DOI 10.1016/j.jhep.2019.02.020; Ferreira AR, 2016, J CELL MOL MED, V20, P750, DOI 10.1111/jcmm.12801; FRIGERIO F, 1992, J MOL BIOL, V225, P107, DOI 10.1016/0022-2836(92)91029-O; Gotte M., 2017, HDB ANTIMICROBIAL RE, V1st; Grossfield A, 2009, ANN REP COMP CHEM, V5, P23, DOI 10.1016/S1574-1400(09)00502-7; Guedj J, 2010, J THEOR BIOL, V267, P330, DOI 10.1016/j.jtbi.2010.08.036; Jiang M, 2013, ANTIMICROB AGENTS CH, V57, P6236, DOI 10.1128/AAC.01578-13; Kang X, 2013, VIROLOGY, V435, P385, DOI 10.1016/j.virol.2012.10.025; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Krishnan P, 2017, J HEPATOL, V66, pS500, DOI 10.1016/S0168-8278(17)31399-5; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; McGivern DR, 2015, J VIROL, V89, P5362, DOI 10.1128/JVI.03188-14; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2002, EMBO REP, V3, P1201, DOI 10.1093/embo-reports/kvf236; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Morikawa K, 2014, HEPATOLOGY, V59, P423, DOI 10.1002/hep.26671; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Patel MR, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001282; Pawlotsky JM, 2016, GASTROENTEROLOGY, V151, P70, DOI 10.1053/j.gastro.2016.04.003; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Prongay AJ, 2007, J MED CHEM, V50, P2310, DOI 10.1021/jm060173k; Rodriguez A, 2007, J PHYS CHEM B, V111, P12909, DOI 10.1021/jp0743469; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Romano KP, 2011, J VIROL, V85, P6106, DOI 10.1128/JVI.00377-11; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Schechter I, 2012, BIOCHEM BIOPH RES CO, V425, P497, DOI 10.1016/j.bbrc.2012.08.015; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sheldon J, 2014, J VIROL, V88, P12098, DOI 10.1128/JVI.01860-14; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Taremi SS, 1998, PROTEIN SCI, V7, P2143, DOI 10.1002/pro.5560071011; Wang B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003231; Welsch C, 2015, J HEPATOL, V62, P779, DOI 10.1016/j.jhep.2014.11.009; Welzel TM, 2017, J HEPATOL, V67, P224, DOI 10.1016/j.jhep.2017.03.014; Wu RH, 2019, INFECT DRUG RESIST, V12, P2987, DOI 10.2147/IDR.S218584; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yanagi M, 1998, VIROLOGY, V244, P161, DOI 10.1006/viro.1998.9092; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi M, 2014, J VIROL, V88, P3678, DOI 10.1128/JVI.03540-13	55	4	4	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2020	295	40					13862	13874		10.1074/jbc.RA120.013898	http://dx.doi.org/10.1074/jbc.RA120.013898			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OB4MB	32747444	Green Published, hybrid			2022-12-26	WOS:000578444100013
J	Fieulaine, S; Witte, MD; Theile, CS; Ayach, M; Ploegh, HL; Jupin, I; Bressanelli, S				Fieulaine, Sonia; Witte, Martin D.; Theile, Christopher S.; Ayach, Maya; Ploegh, Hidde L.; Jupin, Isabelle; Bressanelli, Stephane			Turnip yellow mosaic virus protease binds ubiquitin suboptimally to fine-tune its deubiquitinase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						viral protease; deubiquitylation (deubiquitination); plant virus; plus-stranded RNA virus; ubiquitin; crystal structure; protein complex	PAPAIN-LIKE PROTEASE; RESPIRATORY SYNDROME CORONAVIRUS; DEPENDENT RNA-POLYMERASE; STRUCTURAL BASIS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; CROSS-REACTIVITY; CLEAVAGE SITE; DOMAIN; SPECIFICITY	Single-stranded, positive-sense RNA viruses assemble their replication complexes in infected cells from a multidomain replication polyprotein. This polyprotein usually contains at least one protease, the primary function of which is to process the polyprotein into mature proteins. Such proteases also may have other functions in the replication cycle. For instance, cysteine proteases (PRO) frequently double up as ubiquitin hydrolases (DUB), thus interfering with cellular processes critical for virus replication. We previously reported the crystal structures of such a PRO/DUB fromTurnip yellow mosaic virus(TYMV) and of its complex with one of its PRO substrates. Here we report the crystal structure of TYMV PRO/DUB in complex with ubiquitin. We find that PRO/DUB recognizes ubiquitin in an unorthodox way: It interacts with the body of ubiquitin through a split recognition motif engaging both the major and the secondary recognition patches of ubiquitin (Ile(44)patch and Ile(36)patch, respectively, including Leu(8), which is part of the two patches). However, the contacts are suboptimal on both sides. Introducing a single-point mutation in TYMV PRO/DUB aimed at improving ubiquitin-binding led to a much more active DUB. Comparison with other PRO/DUBs from other viral families, particularly coronaviruses, suggests that low DUB activities of viral PRO/DUBs may generally be fine-tuned features of interaction with host factors.	[Fieulaine, Sonia; Ayach, Maya; Bressanelli, Stephane] Univ Paris Saclay, Inst Integrat Biol Cell I2BC, CNRS, CEA, F-91198 Gif Sur Yvette, France; [Witte, Martin D.; Theile, Christopher S.; Ploegh, Hidde L.] Boston Childrens Hosp, Boston, MA USA; [Witte, Martin D.; Theile, Christopher S.; Ploegh, Hidde L.] Harvard Med Sch, Boston, MA 02115 USA; [Jupin, Isabelle] Univ Paris, Jacques Monod Inst, Lab Mol Virol, UMR,CNRS, Paris, France; [Witte, Martin D.] Stratingh Inst Chem, Fac Sci & Engn, Chem Biol 2, Groningen, Netherlands; [Theile, Christopher S.] Alnylam Pharmaceut Inc, Cambridge, MA USA	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Fieulaine, S; Bressanelli, S (corresponding author), Univ Paris Saclay, Inst Integrat Biol Cell I2BC, CNRS, CEA, F-91198 Gif Sur Yvette, France.	sonia.fieulaine@i2bc.paris-saclay.fr; stephane.bressanelli@i2bc.paris-saclay.fr		Bressanelli, Stephane/0000-0002-0921-6727	French Infrastructure for Integrated Structural Biology Grant [ANR-10-INSB-05-01]; Agence Nationale de la Recherche [ANR-11-BSV8-011, ANR-16-CE200015]	French Infrastructure for Integrated Structural Biology Grant; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work has benefited from the Core Institute for Integrative Biology of the Cell crystallization platform, supported by French Infrastructure for Integrated Structural Biology Grant ANR-10-INSB-05-01. This work and M. A. were supported by the Agence Nationale de la Recherche Contracts ANR-11-BSV8-011 "Ubi-or-not-ubi" and ANR-16-CE200015 "ViroDUB."	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akutsu M, 2011, P NATL ACAD SCI USA, V108, P2228, DOI 10.1073/pnas.1015287108; Alcaide-Loridan C, 2012, PLANT PHYSIOL, V160, P72, DOI 10.1104/pp.112.201905; Artavanis-Tsakonas K, 2010, J BIOL CHEM, V285, P6857, DOI 10.1074/jbc.M109.072405; Baez-Santos YM, 2014, J VIROL, V88, P12511, DOI 10.1128/JVI.01294-14; Bailey-Elkin BA, 2017, J MOL BIOL, V429, P3441, DOI 10.1016/j.jmb.2017.06.010; Bailey-Elkin BA, 2014, J BIOL CHEM, V289, P34667, DOI 10.1074/jbc.M114.609644; Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Bekes M, 2015, BIOCHEM J, V468, P215, DOI 10.1042/BJ20141170; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Bransom KL, 1996, VIROLOGY, V217, P404, DOI 10.1006/viro.1996.0131; Camborde L, 2010, PLANT CELL, V22, P3142, DOI 10.1105/tpc.109.072090; Capodagli GC, 2013, J VIROL, V87, P3815, DOI 10.1128/JVI.03252-12; Capodagli GC, 2011, J VIROL, V85, P3621, DOI 10.1128/JVI.02496-10; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chenon M, 2012, EMBO J, V31, P741, DOI 10.1038/emboj.2011.424; Choi AG, 2013, REV MED VIROL, V23, P85, DOI 10.1002/rmv.1725; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Cui GF, 2010, BIOCHEMISTRY-US, V49, P10198, DOI 10.1021/bi101303t; Dall'Acqua W, 2000, PROTEIN SCI, V9, P1; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DEGROOT RJ, 1991, P NATL ACAD SCI USA, V88, P8967, DOI 10.1073/pnas.88.20.8967; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Deleage G, 2017, BIOINFORMATICS, V33, P3991, DOI 10.1093/bioinformatics/btx521; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Ekkebus R, 2013, J AM CHEM SOC, V135, P2867, DOI 10.1021/ja309802n; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Golubtsov A, 2006, FEBS LETT, V580, P1502, DOI 10.1016/j.febslet.2006.01.071; Gustin JK, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00161; Hericourt F, 2000, BIOCHEM J, V349, P417, DOI 10.1042/0264-6021:3490417; Hermanns T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03148-5; Hospenthal MK, 2013, NAT STRUCT MOL BIOL, V20, P555, DOI 10.1038/nsmb.2547; Hu X, 2016, BIOCHEMISTRY-US, V55, P3007, DOI 10.1021/acs.biochem.5b00992; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Jakubiec A, 2007, J VIROL, V81, P11402, DOI 10.1128/JVI.01428-07; Jakubiec A, 2006, J BIOL CHEM, V281, P21236, DOI 10.1074/jbc.M600052200; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Jupin I, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006714; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; KADARE G, 1995, J GEN VIROL, V76, P2853, DOI 10.1099/0022-1317-76-11-2853; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kerkvliet J, 2011, J VIROL, V85, P621, DOI 10.1128/JVI.01626-10; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lei J, 2016, VIROL SIN, V31, P288, DOI 10.1007/s12250-016-3742-4; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; Lombardi C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003560; Losick VP, 2003, VIROLOGY, V309, P306, DOI 10.1016/S0042-6822(03)00071-0; Luo HL, 2016, CURR OPIN VIROL, V17, P1, DOI 10.1016/j.coviro.2015.09.005; Madala PK, 2010, CHEM REV, V110, pPR1, DOI 10.1021/cr900368a; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Moriceau L, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02138; Morrow ME, 2013, BIOCHEMISTRY-US, V52, P3564, DOI 10.1021/bi4003106; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Narwal M, 2018, INT J BIOL MACROMOL, V116, P451, DOI 10.1016/j.ijbiomac.2018.05.007; Neuman BW, 2016, ANTIVIR RES, V135, P97, DOI 10.1016/j.antiviral.2016.10.005; Perica T, 2010, CURR OPIN STRUC BIOL, V20, P367, DOI 10.1016/j.sbi.2010.03.007; Prod'homme D, 2001, VIROLOGY, V281, P88, DOI 10.1006/viro.2000.0769; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; Ratia K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004113; Rehman SAA, 2016, MOL CELL, V63, P146, DOI 10.1016/j.molcel.2016.05.009; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Robin C, 2012, ACTA CRYSTALLOGR F, V68, P486, DOI 10.1107/S1744309112008445; Russo AT, 2006, STRUCTURE, V14, P1449, DOI 10.1016/j.str.2006.07.010; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; van Kasteren PB, 2013, P NATL ACAD SCI USA, V110, pE838, DOI 10.1073/pnas.1218464110; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/nchembio.426, 10.1038/NCHEMBIO.426]; Viswanathan K, 2010, CURR OPIN MICROBIOL, V13, P517, DOI 10.1016/j.mib.2010.05.012; Wang D, 2011, J VIROL, V85, P3758, DOI 10.1128/JVI.02589-10; Wimmer P, 2015, VIRUSES-BASEL, V7, P4854, DOI 10.3390/v7092849; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17; Zhang W, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006372; Zhao C, 2013, TRENDS MICROBIOL, V21, P181, DOI 10.1016/j.tim.2013.01.005	84	5	5	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2020	295	40					13769	13783		10.1074/jbc.RA120.014628	http://dx.doi.org/10.1074/jbc.RA120.014628			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OB4MB	32732284	Green Published, hybrid			2022-12-26	WOS:000578444100006
J	Jordao, M; Pinho, MS; St Jacques, PL				Jordao, Magda; Pinho, Maria Salome; St Jacques, Peggy L.			The effects of aging and an episodic specificity induction on spontaneous task-unrelated thought	PLOS ONE			English	Article							INVOLUNTARY AUTOBIOGRAPHICAL MEMORIES; AGE-RELATED DIFFERENCES; OLDER-ADULTS; FUTURE THOUGHTS; INDIVIDUAL-DIFFERENCES; WORKING-MEMORY; MIND; YOUNG; FREQUENCY; THINKING	When voluntarily describing their past or future, older adults typically show a reduction in episodic specificity (e.g., including fewer details reflecting a specific event, time and/or place). However, aging has less impact on other types of tasks that place minimal demands on strategic retrieval such as spontaneous thoughts. In the current study, we investigated age-related differences in the episodic specificity of spontaneous thoughts using experimenter-based coding of thought descriptions. Additionally, we tested whether an episodic specificity induction, which increases episodic detail during deliberate retrieval of events in young and older adults, has the same effect under spontaneous retrieval. Twenty-four younger and 24 healthy older adults performed two counterbalanced sessions including a video, the episodic specificity or control induction, and a vigilance task. In the episodic specificity induction, participants recalled the details of the video while in the control they solved math exercises. The impact of this manipulation on the episodic specificity of spontaneous thoughts was assessed in the subsequent vigilance task, in which participants were randomly stopped to describe their thoughts and classify them as deliberate/spontaneous. We found no differences in episodic specificity between age groups in spontaneous thoughts, supporting the prediction that automatic retrieval attenuates the episodic specificity decrease in aging. The lack of age differences was present regardless of the induction, showing no interactions. For the induction, we also found no main effect, indicating that automatic retrieval bypasses event construction and accesses pre-stored events. Overall, our evidence suggests that spontaneous retrieval is a promising strategy to support episodic specificity in aging.	[Jordao, Magda; Pinho, Maria Salome] Univ Coimbra, Fac Psychol & Educ Sci, Ctr Res Neuropsychol & Cognit & Behav Intervent, Coimbra, Portugal; [St Jacques, Peggy L.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Jordao, Magda] Univ Coimbra, Fac Psicol & Ciencias Educ, Coimbra, Portugal	Universidade de Coimbra; University of Alberta; Universidade de Coimbra	Jordao, M (corresponding author), Univ Coimbra, Fac Psychol & Educ Sci, Ctr Res Neuropsychol & Cognit & Behav Intervent, Coimbra, Portugal.; Jordao, M (corresponding author), Univ Coimbra, Fac Psicol & Ciencias Educ, Coimbra, Portugal.	magda.jordao@gmail.com		Jordao, Magda/0000-0003-2108-2677; Pinho, Maria Salome/0000-0001-9786-2819	Fundacao para a Ciencia e Tecnologia through the Human Capital Operating Programme - European Social Fund [SFRH/BD/103338/2014]; Ministry for Science, Technology and Higher Education of Portugal	Fundacao para a Ciencia e Tecnologia through the Human Capital Operating Programme - European Social Fund; Ministry for Science, Technology and Higher Education of Portugal	This research was supported by a PhD grant (SFRH/BD/103338/2014) provided to MJ by the Fundacao para a Ciencia e Tecnologia (https://www.fct.pt/index.phtml.en) through the Human Capital Operating Programme supported by the European Social Fund and the Ministry for Science, Technology and Higher Education of Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2008, PSYCHOL SCI, V19, P33, DOI 10.1111/j.1467-9280.2008.02043.x; Addis DR, 2010, PSYCHOL AGING, V25, P369, DOI 10.1037/a0017280; Barzykowski K, 2019, CONSCIOUS COGN, V72, P31, DOI 10.1016/j.concog.2019.03.011; Barzykowski K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157121; Beck A. T., 1996, MANUAL BECK DEPRESSI, V1, P82; Berntsen D, 2009, INVOLUNTARY AUTOBIOGRAPHICAL MEMORIES: AN INTRODUCTION TO THE UNBIDDEN PAST, P1, DOI 10.1017/CBO9780511575921; Berntsen D, 2015, CONSCIOUS COGN, V36, P352, DOI 10.1016/j.concog.2015.07.007; Berntsen D, 2010, CURR DIR PSYCHOL SCI, V19, P138, DOI 10.1177/0963721410370301; Berntsen D, 2008, MEM COGNITION, V36, P449, DOI 10.3758/MC.36.2.449; Brewer W. F., 1996, REMEMBERING OUR STUD, P16, DOI [10.1017/cbo9780511527913.002, DOI 10.1017/CBO9780511527913.002, 10.1017/CBO9780511527913.002]; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Christoff K, 2016, NAT REV NEUROSCI, V17, P718, DOI 10.1038/nrn.2016.113; Cole S, 2021, PSYCHOL RES-PSYCH FO, V85, P464, DOI 10.1007/s00426-019-01262-7; Cole S, 2019, PSYCHOL RES-PSYCH FO, V83, P631, DOI 10.1007/s00426-019-01193-3; Cole SN, 2013, Q J EXP PSYCHOL, V66, P1687, DOI 10.1080/17470218.2012.758157; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Conway MA, 2001, PHILOS T R SOC B, V356, P1375, DOI 10.1098/rstb.2001.0940; Craik F. I. M., 1986, HUMAN MEMORY COGNITI; Craik FIM, 2020, ANNU REV PSYCHOL, V71, P1, DOI 10.1146/annurev-psych-010419-051027; Cuddy LL, 2015, ANN NY ACAD SCI, V1337, P223, DOI 10.1111/nyas.12617; De Beni R, 2013, AGING CLIN EXP RES, V25, P89, DOI 10.1007/s40520-013-0003-3; Devitt AL, 2017, MEM COGNITION, V45, P1078, DOI 10.3758/s13421-017-0716-1; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fisher RP, 1992, MEMORY ENHANCING TEC, P220; Frank DJ, 2015, PSYCHOL AGING, V30, P266, DOI 10.1037/pag0000031; Gallo DA, 2011, MEMORY, V19, P641, DOI 10.1080/09658211.2011.595723; Gardner RS, 2015, PSYCHOL AGING, V30, P209, DOI 10.1037/a0038876; Harris CB, 2015, CONSCIOUS COGN, V33, P204, DOI 10.1016/j.concog.2014.12.012; Jacques PLS, 2012, NEUROBIOL AGING, V33, P1298, DOI 10.1016/j.neurobiolaging.2010.11.007; JASP Team, 2019, JASP VERS 0 10 1; Jeunehomme O, 2016, Q J EXP PSYCHOL, V69, P254, DOI 10.1080/17470218.2014.993663; Jing HG, 2016, J EXP PSYCHOL GEN, V145, P402, DOI 10.1037/xge0000142; Jordao M, 2019, PSYCHOL AGING, V34, P531, DOI 10.1037/pag0000356; Jordao M, 2019, PSYCHOL RES-PSYCH FO, V83, P710, DOI 10.1007/s00426-019-01146-w; Kane MJ, 2017, PSYCHOL SCI, V28, P1271, DOI 10.1177/0956797617706086; Kensinger E.A., 2009, EMOTIONAL MEMORY ADU; Kirk M, 2019, MEMORY, V27, P441, DOI 10.1080/09658211.2018.1515960; Klinger E, 2018, OXFORD HDB SPONTANEO; Kvavilashvili L., 2007, INVOLUNTARY MEMORY, P87, DOI DOI 10.1002/9780470774069.CH5; Kvavilashvili L, 2020, TRENDS COGNITIVE SCI; Kyung Y, 2016, MEMORY, V24, P272, DOI 10.1080/09658211.2014.1002411; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Mace J. H., 2007, INVOLUNTARY MEMORY, P1, DOI DOI 10.1002/9780470774069.CH1; Madore KP, 2019, CONSCIOUS COGN, V68, P1, DOI 10.1016/j.concog.2018.12.001; Madore KP, 2019, MEMORY, V27, P250, DOI 10.1080/09658211.2018.1502322; Madore KP, 2016, MEM COGNITION, V44, P974, DOI 10.3758/s13421-016-0605-z; Madore KP, 2014, PSYCHOL AGING, V29, P913, DOI 10.1037/a0038209; Madore KP, 2014, J EXP PSYCHOL LEARN, V40, P609, DOI 10.1037/a0034885; Maillet D, 2017, CONSCIOUS COGN, V52, P55, DOI 10.1016/j.concog.2017.04.014; Maillet D, 2016, NEUROPSYCHOLOGIA, V80, P142, DOI 10.1016/j.neuropsychologia.2015.11.017; McCormick C, 2018, J NEUROSCI, V38, P2745, DOI 10.1523/JNEUROSCI.1812-17.2018; Michaelian K, 2011, PHILOS PSYCHOL, V24, P323, DOI 10.1080/09515089.2011.559623; MOSCOVITCH M, 1995, J CLIN EXP NEUROPSYC, V17, P276, DOI 10.1080/01688639508405123; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Oliveira-Brochado F, 2014, INSTRUMENTOS CONTEXT, P187; Palermo L, 2016, J CLIN EXP NEUROPSYC, V38, P752, DOI 10.1080/13803395.2016.1161735; Piolino P, 2002, MEMORY, V10, P239, DOI 10.1080/09658210143000353; Piolino P, 2006, PSYCHOL AGING, V21, P510, DOI 10.1037/0882-7974.21.3.510; Piolino P, 2010, NEUROPSYCHOLOGIA, V48, P429, DOI 10.1016/j.neuropsychologia.2009.09.035; Plimpton B, 2015, CONSCIOUS COGN, V33, P261, DOI 10.1016/j.concog.2015.01.014; Rasmussen A.S., 2015, PSYCHOL CONSCIOUS, V2, P185, DOI [DOI 10.1037/CNS0000042, 10.1037/cns0000042]; Rasmussen AS, 2009, APPL COGNITIVE PSYCH, V23, P1137, DOI 10.1002/acp.1615; Ros L, 2010, AGING NEUROPSYCHOL C, V17, P89, DOI 10.1080/13825580903042650; Rubin DC, 2015, PSYCHOL REV, V122, P1, DOI 10.1037/a0037907; Rubin DC, 2009, MEM COGNITION, V37, P679, DOI 10.3758/37.5.679; Rubin DC, 1995, MEMORY ORAL TRADITIO, P385; Schacter DL, 2016, MEM STUD, V9, P245, DOI 10.1177/1750698016645230; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Schlagman S, 2008, MEM COGNITION, V36, P920, DOI 10.3758/MC.36.5.920; Schlagman S, 2009, PSYCHOL AGING, V24, P397, DOI 10.1037/a0015785; Seli P, 2018, TRENDS COGN SCI, V22, P479, DOI 10.1016/j.tics.2018.03.010; Seli P, 2017, PSYCHOL AGING, V32, P315, DOI 10.1037/pag0000172; Seli P, 2015, PSYCHOL RES-PSYCH FO, V79, P750, DOI 10.1007/s00426-014-0617-x; Sheldon S, 2017, MEMORY, V25, P360, DOI 10.1080/09658211.2016.1178777; Simoes MR, 2008, MONTREAL COGNITIVE A; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Soares AP, 2017, BEHAV RES METHODS, V49, P1065, DOI 10.3758/s13428-016-0767-4; Soares AP, 2012, BEHAV RES METHODS, V44, P256, DOI 10.3758/s13428-011-0131-7; St Jacques PL, 2007, MEMORY, V15, P129, DOI 10.1080/09658210601119762; Stawarczyk D, 2011, ACTA PSYCHOL, V136, P370, DOI 10.1016/j.actpsy.2011.01.002; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Unsworth N, 2014, ACTA PSYCHOL, V150, P14, DOI 10.1016/j.actpsy.2014.04.001; Uzer T, 2012, J EXP PSYCHOL LEARN, V38, P1296, DOI 10.1037/a0028142; VANDOORN J, 2019, JASP GUIDELINES COND; Vannucci M, 2018, PERS INDIV DIFFER, V121, P57, DOI 10.1016/j.paid.2017.09.022; Vannucci M, 2017, CONSCIOUS COGN, V53, P61, DOI 10.1016/j.concog.2017.06.004; Vannucci M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089582; Warden EA, 2019, PSYCHOL RES-PSYCH FO, V83, P727, DOI 10.1007/s00426-018-1103-7; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122; Williamson VJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086170; Zavagnin M, 2016, AGING CLIN EXP RES, V28, P109, DOI 10.1007/s40520-015-0368-6	92	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237340	10.1371/journal.pone.0237340	http://dx.doi.org/10.1371/journal.pone.0237340			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC7KJ	32776948	gold, Green Published			2022-12-26	WOS:000561393800002
J	Suzuki, K; Matsumoto, M; Katoh, Y; Liu, L; Ochiai, K; Aizawa, Y; Nagatomi, R; Okuno, H; Itoi, E; Igarashi, K				Suzuki, Katsushi; Matsumoto, Mitsuyo; Katoh, Yasutake; Liu, Liang; Ochiai, Kyoko; Aizawa, Yuta; Nagatomi, Ryoichi; Okuno, Hiroshi; Itoi, Eiji; Igarashi, Kazuhiko			Bach1 promotes muscle regeneration through repressing Smad-mediated inhibition of myoblast differentiation	PLOS ONE			English	Article							MEDICAL-RESEARCH PROGRAM; SKELETAL-MUSCLE; HEME OXYGENASE-1; OXIDATIVE STRESS; PROFESSIONAL FOOTBALL; CELLULAR SENESCENCE; GENETIC ABLATION; INJURIES; CELLS; TRANSCRIPTION	It has been reported thatBach1-deficient mice show reduced tissue injuries in diverse disease models due to increased expression of heme oxygenase-1 (HO-1)that possesses an antioxidant function. In contrast, we found thatBach1deficiency in mice exacerbated skeletal muscle injury induced by cardiotoxin. Inhibition of Bach1 expression in C2C12 myoblast cells using RNA interference resulted in reduced proliferation, myotube formation, and myogenin expression compared with control cells. While the expression of HO-1 was increased by Bach1 silencing in C2C12 cells, the reduced myotube formation was not rescued by HO-1 inhibition. Up-regulations of Smad2, Smad3 and FoxO1, known inhibitors of muscle cell differentiation, were observed inBach1-deficient mice andBach1-silenced C2C12 cells. Therefore, Bach1 may promote regeneration of muscle by increasing proliferation and differentiation of myoblasts.	[Suzuki, Katsushi; Matsumoto, Mitsuyo; Katoh, Yasutake; Liu, Liang; Ochiai, Kyoko; Aizawa, Yuta; Igarashi, Kazuhiko] Tohoku Univ, Dept Biochem, Grad Sch Med, Sendai, Miyagi, Japan; [Suzuki, Katsushi; Okuno, Hiroshi; Itoi, Eiji] Tohoku Univ, Dept Orthopaed Surg, Grad Sch Med, Sendai, Miyagi, Japan; [Matsumoto, Mitsuyo; Igarashi, Kazuhiko] Tohoku Univ, Ctr Regulatory Epigenome & Dis, Grad Sch Med, Sendai, Miyagi, Japan; [Katoh, Yasutake] Japan Agcy Med Res & Dev, Chiyoda Ku, Tokyo, Japan; [Nagatomi, Ryoichi] Tohoku Univ, Dept Med & Sci Sports & Exercise, Grad Sch Med, Sendai, Miyagi, Japan; [Okuno, Hiroshi] Tohoku Rosai Hosp, Dept Orthopaed Surg, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Igarashi, K (corresponding author), Tohoku Univ, Dept Biochem, Grad Sch Med, Sendai, Miyagi, Japan.; Igarashi, K (corresponding author), Tohoku Univ, Ctr Regulatory Epigenome & Dis, Grad Sch Med, Sendai, Miyagi, Japan.	igarashi@med.tohoku.ac.jp	Nagatomi, Ryoichi/Q-8792-2016	Nagatomi, Ryoichi/0000-0003-3038-7202; Igarashi, Kazuhiko/0000-0002-2470-2475	Japan Society for the Promotion of Science [18H04021, 15H02506, 19K07680, 16K07108, 17K10918]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-inAid from the Japan Society for the Promotion of Science (18H04021 and 15H02506 to K.I., 19K07680 and 16K07108 to M.M., and 17K10918 to H.O.)	Ahmad CS, 2014, AM J SPORT MED, V42, P1464, DOI 10.1177/0363546514529083; Al-Sawaf O, 2014, J PATHOL, V234, P538, DOI 10.1002/path.4418; Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Brooks JHM, 2005, BRIT J SPORT MED, V39, P767, DOI 10.1136/bjsm.2005.018408; Cesari M, 2009, J GERONTOL A-BIOL, V64, P377, DOI 10.1093/gerona/gln031; Chan MC, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0114-6; Crisco JJ, 1996, J BIOMECH, V29, P1291, DOI 10.1016/0021-9290(96)00047-4; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Czerwinska AM, 2012, FOLIA HISTOCHEM CYTO, V50, P144, DOI [10.5603/FHC.2012.0021, 10.2478/18710]; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Disatnik MH, 1998, J NEUROL SCI, V161, P77, DOI 10.1016/S0022-510X(98)00258-5; Dohi Y, 2008, NAT STRUCT MOL BIOL, V15, P1246, DOI 10.1038/nsmb.1516; Dohl Y, 2006, ANTIOXID REDOX SIGN, V8, P60, DOI 10.1089/ars.2006.8.60; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Fletcher JE, 1996, TOXICON, V34, P1301, DOI 10.1016/S0041-0101(96)00105-5; Folker ES, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00363; Garcia-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187; GARCIACONTRERAS C, 2018, INT J MOL SCI, V0019; Garry GA, 2016, METHODS MOL BIOL, V1460, P61, DOI 10.1007/978-1-4939-3810-0_6; Gissel H, 2005, ANN NY ACAD SCI, V1066, P166, DOI 10.1196/annals.1363.013; Hama M, 2012, ARTHRITIS RHEUM-US, V64, P1518, DOI 10.1002/art.33497; Hardy D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147198; Harusato A, 2013, INFLAMM BOWEL DIS, V19, P740, DOI 10.1097/MIB.0b013e3182802968; Hawkins RD, 2001, BRIT J SPORT MED, V35, P43, DOI 10.1136/bjsm.35.1.43; Igarashi K, 2014, TOHOKU J EXP MED, V232, P229, DOI 10.1620/tjem.232.229; Inoue M, 2011, J CLIN BIOCHEM NUTR, V48, P161, DOI 10.3164/jcbn.09-122GFR; Ito M, 2017, PEDIATR RES, V81, P926, DOI 10.1038/pr.2017.17; Jazwa A, 2013, CARDIOVASC RES, V97, P115, DOI 10.1093/cvr/cvs284; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; Kaariainen M, 2000, SCAND J MED SCI SPOR, V10, P332, DOI 10.1034/j.1600-0838.2000.010006332.x; Kanezaki R, 2001, J BIOL CHEM, V276, P7278, DOI 10.1074/jbc.M004227200; Kang X, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax7863; Kanno H, 2009, J NEUROTRAUM, V26, P31, DOI 10.1089/neu.2008.0667; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kozakowska M, 2014, ANTIOXID REDOX SIGN, V20, P1827, DOI 10.1089/ars.2013.5341; Kozakowska M, 2012, ANTIOXID REDOX SIGN, V16, P113, DOI 10.1089/ars.2011.3964; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Le Roux I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9528; Matsumoto M, 2016, GENES CELLS, V21, P553, DOI 10.1111/gtc.12365; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Natsu K, 2004, TISSUE ENG, V10, P1093, DOI 10.1089/1076327041887754; Novak ML, 2014, J PATHOL, V232, P344, DOI 10.1002/path.4301; Opar DA, 2014, SCAND J MED SCI SPOR, V24, pE254, DOI 10.1111/sms.12159; Ota K, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/757901; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pajcini KV, 2010, TRANSIENT INACTIVATI, V7, P198, DOI [10.1016/j.stem.2010.05.02220682446, DOI 10.1016/J.STEM.2010.05.02220682446]; Paradis S, 2016, AM J PHYSIOL-CELL PH, V310, pC968, DOI 10.1152/ajpcell.00356.2015; Pratt SJP, 2014, J BIOL METHODS, V1, DOI [10.14440/jbm.2014.3425530979, DOI 10.14440/JBM.2014.3425530979]; Romanick M, 2013, BBA-MOL BASIS DIS, V1832, P1410, DOI 10.1016/j.bbadis.2013.03.011; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Watts R, 2013, OBESITY, V21, P525, DOI 10.1002/oby.20070; Woods C, 2004, BRIT J SPORT MED, V38, P36, DOI 10.1136/bjsm.2002.002352; Xu M, 2017, ONCOTARGET, V8, P10662, DOI 10.18632/oncotarget.12891; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yano Y, 2006, GENES CELLS, V11, P791, DOI 10.1111/j.1365-2443.2006.00979.x; Zhong JL, 2010, FREE RADICAL BIO MED, V48, P196, DOI 10.1016/j.freeradbiomed.2009.10.037; [No title captured]; [No title captured]; [No title captured]	61	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0236781	10.1371/journal.pone.0236781	http://dx.doi.org/10.1371/journal.pone.0236781			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776961	gold, Green Published			2022-12-26	WOS:000561393800017
J	Groeger, M; Spanier, G; Wolf, M; Deschner, J; Proff, P; Schroder, A; Kirschneck, C				Groeger, Marcella; Spanier, Gerrit; Wolf, Michael; Deschner, James; Proff, Peter; Schroeder, Agnes; Kirschneck, Christian			Effects of histamine on human periodontal ligament fibroblasts under simulated orthodontic pressure	PLOS ONE			English	Article							H-1 RECEPTOR ANTAGONIST; FACTOR-KAPPA-B; TOOTH MOVEMENT; HPDL CELLS; RT-QPCR; EXPRESSION; CETIRIZINE; TISSUE; OSTEOCLASTOGENESIS; INTERLEUKIN-6	As type-I-allergies show an increasing prevalence in the general populace, orthodontic patients may also be affected by histamine release during treatment. Human periodontal ligament fibroblasts (PDLF) are regulators of orthodontic tooth movement. However, the impact of histamine on PDLF in this regard is unknown. Therefore PDLF were incubated without or with an orthodontic compressive force of 2g/cm(2)with and without additional histamine. To assess the role of histamine-1-receptor (H1R) H1R-antagonist cetirizine was used. Expression of histamine receptors and important mediators of orthodontic tooth movement were investigated. PDLF expressed histamine receptors H1R, H2R and H4R, but not H3R. Histamine increased the expression of H1R, H2R and H4R as well as of interleukin-6, cyclooxygenase-2, and prostaglandin-E2 secretion even without pressure application and induced receptor activator of NF-kB ligand (RANKL) protein expression with unchanged osteoprotegerin secretion. These effects were not observed in presence of H1R antagonist cetirizine. By expressing histamine receptors, PDLF seem to be able to respond to fluctuating histamine levels in the periodontal tissue. Increased histamine concentration was associated with enhanced expression of proinflammatory mediators and RANKL, suggesting an inductive effect of histamine on PDLF-mediated osteoclastogenesis and orthodontic tooth movement. Since cetirizine inhibited these effects, they seem to be mainly mediated via histamine receptor H1R.	[Groeger, Marcella; Proff, Peter; Schroeder, Agnes; Kirschneck, Christian] Univ Hosp Regensburg, Dept Orthodont, Regensburg, Germany; [Spanier, Gerrit] Univ Hosp Regensburg, Dept Craniomaxillofacial Surg, Regensburg, Germany; [Wolf, Michael] Univ Hosp RWTH Aachen, Dept Orthodont, Aachen, Germany; [Deschner, James] Johannes Gutenberg Univ Mainz, Dept Periodontol & Operat Dent, Mainz, Germany	University of Regensburg; University of Regensburg; RWTH Aachen University; RWTH Aachen University Hospital; Johannes Gutenberg University of Mainz	Kirschneck, C (corresponding author), Univ Hosp Regensburg, Dept Orthodont, Regensburg, Germany.	christian.kirschneck@ukr.de	Schröder, Agnes/AHC-9286-2022; DESCHNER, JAMES/AAW-3998-2021	Kirschneck, Christian/0000-0001-9473-8724	Verein zur Forderung der wissenschaftlichen Zahnheilkunde in Bayern e.V. [Kirschneck 2018]; German Orthodontic Society DGKFO [Schroder 2019]	Verein zur Forderung der wissenschaftlichen Zahnheilkunde in Bayern e.V.; German Orthodontic Society DGKFO	This study was supported by the Verein zur Forderung der wissenschaftlichen Zahnheilkunde in Bayern e.V. (C.K., grant nr. Kirschneck 2018, h1lp://vvm.vtvz.de) and the German Orthodontic Society DGKFO (A.S., grant nr. Schroder 2019, bilps://www.dgklo-vorstand.de/).	Alikhani M, 2018, J WORLD FED ORTHOD, V7, P82, DOI 10.1016/j.ejwf.2018.08.001; Alsahli A, 2016, CALCIFIED TISSUE INT, V98, P511, DOI 10.1007/s00223-015-0097-z; ARRANG JM, 1987, NATURE, V327, P117, DOI 10.1038/327117a0; Bakker RA, 2001, MOL PHARMACOL, V60, P1133, DOI 10.1124/mol.60.5.1133; Bakker RA, 2008, MOL PHARMACOL, V73, P94, DOI 10.1124/mol.107.038547; BERNHEIM J, 1991, AGENT ACTION SUPPL, V34, P269; BIEGANSKI T, 1983, Acta Physiologica Polonica, V34, P139; Biosse-Duplan M, 2009, AM J PATHOL, V174, P1426, DOI 10.2353/ajpath.2009.080871; Branco ACCC, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/9524075; Cataldi M, 2014, CHEM IMMUNOL ALLERGY, V100, P214, DOI 10.1159/000358740; Graber L.W., 2017, ORTHODONTICS CURRENT, V6th; Grimm S, 2020, CLIN ORAL INVEST, V24, P343, DOI 10.1007/s00784-019-02930-z; Hattori Y, 2018, HISTAMINE HISTAMINE; Heeschen W., 1989, PATHOGENE MIKROORGAN; Hong SM, 2015, INT FORUM ALLERGY RH, V5, P923, DOI 10.1002/alr.21555; Huang H, 2014, AM J ORTHOD DENTOFAC, V146, P620, DOI 10.1016/j.ajodo.2014.07.007; Hwang S, 2020, KOREAN J ORTHOD, V50, P42, DOI 10.4041/kjod.2020.50.1.42; Jiang C, 2015, ORAL DIS, V21, P694, DOI 10.1111/odi.12273; Kanzaki H, 2002, J BONE MINER RES, V17, P210, DOI 10.1359/jbmr.2002.17.2.210; Kanzaki H, 2001, J DENT RES, V80, P887, DOI 10.1177/00220345010800030801; Kirschneck C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15281-0; Kirschneck C, 2016, ANN ANAT, V204, P93, DOI 10.1016/j.aanat.2015.11.005; KLEIN DC, 1970, ENDOCRINOLOGY, V86, P1436, DOI 10.1210/endo-86-6-1436; Koretsi V, 2015, EUR J ORTHODONT, V37, P308, DOI 10.1093/ejo/cju045; Krishnan V, 2006, AM J ORTHOD DENTOFAC, V129, P1, DOI DOI 10.1016/J.AJ0D0.2005.10.007; Kriznar I, 2008, INFLAMM RES, V57, pS29, DOI 10.1007/s00011-007-0615-1; KURIHARA N, 1990, J IMMUNOL, V144, P4226; Leurs R, 2009, BRIT J PHARMACOL, V157, P14, DOI 10.1111/j.1476-5381.2009.00250.x; Meeran Nazeer Ahmed, 2013, J Indian Soc Periodontol, V17, P16, DOI 10.4103/0972-124X.107468; Meh A, 2011, AM J ORTHOD DENTOFAC, V139, pE323, DOI 10.1016/j.ajodo.2009.11.013; Meikle MC, 2006, EUR J ORTHODONT, V28, P221, DOI 10.1093/ejo/cj1001; Moneret-Vautrin DA, 1983, CLIN REACTIONS FOOD; Muluke M, 2016, J DENT RES, V95, P223, DOI 10.1177/0022034515609882; Nam SY, 2019, BRIT J PHARMACOL, V176, P1664, DOI 10.1111/bph.14615; Niisato N, 1996, J PERIODONTAL RES, V31, P113, DOI 10.1111/j.1600-0765.1996.tb00472.x; O'Mahony L, 2011, J ALLERGY CLIN IMMUN, V128, P1153, DOI 10.1016/j.jaci.2011.06.051; Okada N, 1997, J PERIODONTAL RES, V32, P559, DOI 10.1111/j.1600-0765.1997.tb00932.x; Park IH, 2014, ALLERGY ASTHMA IMMUN, V6, P567, DOI 10.4168/aair.2014.6.6.567; Proff P, 2014, J OROFAC ORTHOP, V75, P191, DOI 10.1007/s00056-014-0212-1; Proff P, 2009, CLIN ORAL INVEST, V13, P355, DOI 10.1007/s00784-009-0268-2; Schroder A, 2019, ALCOHOL, V77, P59, DOI 10.1016/j.alcohol.2018.10.004; Schroder A, 2018, J OROFAC ORTHOP, V79, P337, DOI 10.1007/s00056-018-0145-1; Seifert R, 2013, TRENDS PHARMACOL SCI, V34, P33, DOI 10.1016/j.tips.2012.11.001; Singh M, 2013, MINI-REV MED CHEM, V13, P47, DOI 10.2174/138955713804484695; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Thangam EB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01873; Thurmond RL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00065; Woelber JP, 2016, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-016-0257-1; Wolf M, 2016, INNATE IMMUN-LONDON, V22, P674, DOI 10.1177/1753425916669417; Wolf M, 2016, CLIN ORAL INVEST, V20, P923, DOI 10.1007/s00784-015-1580-7; Yamaguchi M, 2009, ORTHOD CRANIOFAC RES, V12, P113, DOI 10.1111/j.1601-6343.2009.01444.x; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	52	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237040	10.1371/journal.pone.0237040	http://dx.doi.org/10.1371/journal.pone.0237040			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764823	Green Published, gold			2022-12-26	WOS:000561029000041
J	Vauti, F; Stegemann, LA; Vogele, V; Koster, RW				Vauti, Franz; Stegemann, Luisa A.; Voegele, Viktoria; Koester, Reinhard W.			All-age whole mountin situhybridization to reveal larval and juvenile expression patterns in zebrafish	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; GENE; HOMOLOG; PROTEIN; FISH; RNA	The zebrafishDanio reriois a valuable and common model for scientists in the fields of genetics and developmental biology. Since zebrafish are also amenable to genetic manipulation, modelling of human diseases or behavioral experiments have moved into the focus of zebrafish research. Consequently, gene expression data beyond embryonic and larval stages become more important, yet there is a dramatic knowledge gap of gene expression beyond day four of development. Like in other model organisms, the visualization of spatial and temporal gene expression by whole mountin situhybridization (ISH) becomes increasingly difficult when zebrafish embryos develop further and hence the growing tissues become dense and less permeable. Here we introduce a modified method for whole mount ISH, which overcomes these penetration and detection problem. The method is an all in one solution that enables the detection and visualization of gene expression patterns up to the late larval stage in a 3D manner without the need for tissue sectioning and offers a valuable extension for whole mount ISH by immunohistochemistry in the zebrafish field.	[Vauti, Franz; Stegemann, Luisa A.; Voegele, Viktoria; Koester, Reinhard W.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Cellular & Mol Neurobiol, Braunschweig, Germany	Braunschweig University of Technology	Vauti, F (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Cellular & Mol Neurobiol, Braunschweig, Germany.	f.vauti@tu-bs.de		Vauti, Franz/0000-0003-0275-1433	German Research Foundation (DFG) [K1949/7-2, 241961032]	German Research Foundation (DFG)(German Research Foundation (DFG))	We gratefully acknowledge funding for this work the German Research Foundation (DFG, K1949/7-2, project: 241961032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alestrom P, 2020, LAB ANIM-UK, V54, P213, DOI 10.1177/0023677219869037; Antinucci P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29490; Bae YK, 2009, DEV BIOL, V330, P406, DOI 10.1016/j.ydbio.2009.04.013; Baumann L, 2016, AQUAT TOXICOL, V172, P44, DOI 10.1016/j.aquatox.2015.12.015; Bohnsack BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022991; CONLON RA, 1993, METHOD ENZYMOL, V225, P373; Dreosti E, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00039; Elsalini OA, 2003, DEV GENES EVOL, V212, P593, DOI 10.1007/s00427-002-0279-3; Filippi A, 2012, DEV BIOL, V369, P133, DOI 10.1016/j.ydbio.2012.06.010; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Hobro AJ, 2017, VIB SPECTROSC, V91, P31, DOI 10.1016/j.vibspec.2016.10.012; Holterhoff CK, 2009, DEV DYNAM, V238, P2936, DOI 10.1002/dvdy.22123; Jin L, 1997, J CLIN LAB ANAL, V11, P2, DOI 10.1002/(SICI)1098-2825(1997)11:1<2::AID-JCLA2>3.0.CO;2-F; Karlsson J, 2001, MAR BIOTECHNOL, V3, P522, DOI 10.1007/s1012601-0053-4; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Le Guellec D, 2004, INT J DEV BIOL, V48, P217, DOI 10.1387/ijdb.15272388; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; McNicol AM, 1997, J PATHOL, V182, P250, DOI 10.1002/(SICI)1096-9896(199707)182:3<250::AID-PATH837>3.0.CO;2-S; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Pizard A, 2004, CURR PROTOC MOL BIOL, V14, p14.9, DOI 10.1002/0471142727.mb1409-66; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Sedykh I, 2018, DEV DYNAM, V247, P650, DOI 10.1002/dvdy.24613; Sire JY, 2004, INT J DEV BIOL, V48, P233, DOI 10.1387/ijdb.15272389; Thisse B, 2004, ZFIN DIRECT DATA SUB; Thisse C., 2005, ZFIN DIRECT DATA SUB; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002	29	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237167	10.1371/journal.pone.0237167	http://dx.doi.org/10.1371/journal.pone.0237167			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764780	Green Published, gold			2022-12-26	WOS:000561029000060
J	Wallis, CM; Zeilinger, AR; Sicard, A; Beal, DJ; Walker, MA; Almeida, RPP				Wallis, Christopher M.; Zeilinger, Adam R.; Sicard, Anne; Beal, Dylan J.; Walker, M. Andrew; Almeida, Rodrigo P. P.			Impact of phenolic compounds on progression ofXylella fastidiosainfections in susceptible andPdR1-locus containing resistant grapevines	PLOS ONE			English	Article							PIERCES-DISEASE; XYLELLA-FASTIDIOSA; VITIS-VINIFERA; PLANT; PATHOGEN; INFECTION	Pierce's disease is of major concern for grapevine (Vitis vinifera) production wherever the bacterial pathogenXylella fastidiosaand its vectors are present. Long-term management includes the deployment of resistant grapevines such as those containing thePdR1locus from the wild grapevine speciesVitis arizonica, which do not develop Pierce's disease symptoms upon infection. However, little is understood about how thePdR1locus functions to prevent disease symptom development. Therefore, we assessed the concentrations of plant defense-associated compounds called phenolics in healthy andX.fastidiosa-infectedPdR1-resistant and susceptible grapevine siblings over time. Soluble foliar phenolic levels, especially flavonoids, inX.fastidiosa-infectedPdR1-resistant grapevines were discovered to be significantly lower than those in infected susceptible grapevines. Therefore, it was hypothesized thatPdR1-resistant grapevines, by possessing lowered flavonoid levels, affects biofilm formation and causes reducedX.fastidiosaintra-plant colonization, thus limiting the ability to increase pathogen populations and cause Pierce's disease. These results therefore reveal that differences in plant metabolite levels might be a component of the mechanisms thatPdR1utilizes to prevent Pierce's disease.	[Wallis, Christopher M.] USDA ARS, Crop Dis Pests & Genet Res Unit, San Joaquin Valley Agr Sci Ctr, Parlier, CA 93648 USA; [Zeilinger, Adam R.; Sicard, Anne; Beal, Dylan J.; Almeida, Rodrigo P. P.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Walker, M. Andrew] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA	United States Department of Agriculture (USDA); University of California System; University of California Berkeley; University of California System; University of California Davis	Wallis, CM (corresponding author), USDA ARS, Crop Dis Pests & Genet Res Unit, San Joaquin Valley Agr Sci Ctr, Parlier, CA 93648 USA.	christopher.wallis@ars.usda.gov	Wallis, Christopher/AFO-9404-2022; Almeida, Rodrigo/GZH-0682-2022	Wallis, Christopher/0000-0003-3855-8256; Sicard, Anne/0000-0002-0575-195X	PD/GWSS Program; California Department of Food and Agriculture [2017-2035]	PD/GWSS Program; California Department of Food and Agriculture	This work was funded in part by a grant from the PD/GWSS Program (https inivvaist pdgelss.net/), California Department of Food and Agriculture (agreement number 2017-2035) (ARZ, RPPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero CB, 2005, MOL PLANT PATHOL, V6, P43, DOI 10.1111/j.1364-3703.2004.00262.x; Andreason SA, 2018, J ECON ENTOMOL, V111, P2340, DOI 10.1093/jee/toy192; Boots M, 2008, TRENDS ECOL EVOL, V23, P248, DOI 10.1016/j.tree.2008.01.006; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Chen J, 2005, PHYTOPATHOLOGY, V95, P708, DOI 10.1094/PHYTO-95-0708; Choi HK, 2013, MOL PLANT MICROBE IN, V26, P643, DOI 10.1094/MPMI-09-12-0217-R; Cushnie TPT, 2007, J APPL MICROBIOL, V103, P1562, DOI 10.1111/j.1365-2672.2007.03393.x; Dandekar AM, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00084; Dandekar AM, 2012, P NATL ACAD SCI USA, V109, P3721, DOI 10.1073/pnas.1116027109; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Gilligan CA, 2008, PHILOS T R SOC B, V363, P741, DOI 10.1098/rstb.2007.2181; Gorniak I, 2019, PHYTOCHEM REV, V18, P241, DOI 10.1007/s11101-018-9591-z; Harding SA, 2019, TREE PHYSIOL, V39, P341, DOI 10.1093/treephys/tpz005; HILL BL, 1995, PHYTOPATHOLOGY, V85, P209, DOI 10.1094/Phyto-85-209; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; Humann-Guilleminot S, 2019, J APPL ECOL, V56, P1502, DOI 10.1111/1365-2664.13392; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Krivanek A, 2006, THEOR APPL GENET, V112, P1125, DOI 10.1007/s00122-006-0214-5; Krivanek AF, 2005, PHYTOPATHOLOGY, V95, P44, DOI 10.1094/PHYTO-95-0044; Lindow S, 2014, MOL PLANT MICROBE IN, V27, P244, DOI 10.1094/MPMI-07-13-0197-FI; Perez-Donoso AG, 2007, PLANT PHYSIOL, V143, P1024, DOI 10.1104/pp.106.087023; Rapicavoli J, 2018, MOL PLANT PATHOL, V19, P786, DOI 10.1111/mpp.12585; Rapicavoli JN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02861-5; Roy R, 2018, VIRULENCE, V9, P522, DOI 10.1080/21505594.2017.1313372; Sicard A, 2018, ANNU REV PHYTOPATHOL, V56, P181, DOI 10.1146/annurev-phyto-080417-045849; Sun Q, 2013, PLANT PHYSIOL, V161, P1529, DOI 10.1104/pp.112.208157; Tumber KP, 2014, CALIF AGR, V68, P20, DOI 10.3733/ca.v068n01p20; Ulrey RK, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-499; Vikram A, 2010, J APPL MICROBIOL, V109, P515, DOI 10.1111/j.1365-2672.2010.04677.x; Wallis C, 2008, NEW PHYTOL, V177, P767, DOI 10.1111/j.1469-8137.2007.02307.x; Wallis CM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00502; Wallis CM, 2012, PHYTOPATHOLOGY, V102, P816, DOI 10.1094/PHYTO-04-12-0074-R	32	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237545	10.1371/journal.pone.0237545	http://dx.doi.org/10.1371/journal.pone.0237545			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764829	gold, Green Published			2022-12-26	WOS:000561029000013
J	Liyew, AM; Kebede, SA; Agegnehu, CD; Teshale, AB; Alem, AZ; Yeshaw, Y; Tesema, GA				Liyew, Alemneh Mekuriaw; Kebede, Sewnet Adem; Agegnehu, Chilot Desta; Teshale, Achamyeleh Birhanu; Alem, Adugnaw Zeleke; Yeshaw, Yigizie; Tesema, Getayeneh Antehunegn			Spatiotemporal patterns of anemia among lactating mothers in Ethiopia using data from Ethiopian Demographic and Health Surveys (2005, 2011 and 2016)	PLOS ONE			English	Article							HEMOGLOBIN CONCENTRATION; SYSTEMATIC ANALYSIS; PREGNANT-WOMEN; RISK-FACTOR; PREVALENCE; INDICATOR; BURDEN	Introduction Maternal anemia is a worldwide public health problem especially in developing countries including Ethiopia. The burden of anemia among lactating mothers in Ethiopia was higher than those who were neither pregnant nor breastfeeding. To date, there is limited evidence on spatiotemporal patterns of anemia among lactating mothers in the country. Exploring the spatial patterns of maternal anemia is vital to design and monitor effective intervention programs. Therefore this study aimed to explore spatiotemporal patterns of anemia among lactating mothers in Ethiopia over the past one and half-decades. Methods A total of 11,989 lactating mothers were included from the three consecutive Ethiopian Demographic and Health Surveys(2005, 2011, and 2016). The trend of anemia over the three surveys was showed. Furthermore, spatial autocorrelation analysis, cluster and outlier analysis, hotspot analysis, spatial interpolation, and spatial scan statistics were carried out to identify geographically risk areas of anemia among lactating mothers in Ethiopia. Finally, the most anemia risk areas were detected consistently by different spatial analytic methods in each survey. Results Anemia during lactation had an increasing trend from 2011 to 2016 in all regions of Ethiopia. It was also spatially clustered over three survey periods (Moran's I: 0.102-0.256, P<0.01).The hotspot areas were detected in Afar, Somali, Gambela, Dire Dawa, and Oromia regions during the last fifteen years. In 2005 and 2011, a total of 100 most likely clusters (Loglikelihood Ratio(LLR) = 8.8, P<0.05, and LLR = 45.94, P<0.001, respectively) were identified in the Afar region. However, in the 2016 survey period, primary clusters were shifted to the Somali region where 57 clusters (LLR = 72.73, P<0.001) were detected in the entire region. Besides, the risk prediction map showed that the eastern part of the country was at a higher risk of anemia during lactation. Conclusion Anemia during lactation was spatially clustered in Ethiopia. High-risk areas were detected in the eastern part of Ethiopia prominently in the Afar and Somali regions. Therefore, public health intervention activities designed in a targeted approach to impact high-risk populations in those hot spot areas wound be helpful to reduce anemia in Ethiopia.	[Liyew, Alemneh Mekuriaw; Kebede, Sewnet Adem; Teshale, Achamyeleh Birhanu; Alem, Adugnaw Zeleke; Yeshaw, Yigizie; Tesema, Getayeneh Antehunegn] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Liyew, Alemneh Mekuriaw; Kebede, Sewnet Adem; Agegnehu, Chilot Desta; Teshale, Achamyeleh Birhanu; Alem, Adugnaw Zeleke; Yeshaw, Yigizie; Tesema, Getayeneh Antehunegn] Univ Gondar, Comprehens Specialized Hosp, Gondar, Ethiopia; [Agegnehu, Chilot Desta] Univ Gondar, Coll Med & Hlth Sci, Sch Nursing, Gondar, Ethiopia; [Yeshaw, Yigizie] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Physiol, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar; University of Gondar	Liyew, AM (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia.; Liyew, AM (corresponding author), Univ Gondar, Comprehens Specialized Hosp, Gondar, Ethiopia.	alemnehmekuriawliyew@gmail.com	Teshale, Achamyeleh/HHN-8416-2022; Yeshaw, Yigizie/L-6336-2019	mekuriaw, Alemneh/0000-0001-9034-6205; Desta, Chilot/0000-0001-9407-4630				Abdurahman A., 2018, HAEMOGLOBIN CONCENTR; Abriha Abrehet, 2014, BMC Res Notes, V7, P888, DOI 10.1186/1756-0500-7-888; Aghamohammadi A, 2011, CASP J INTERN MED, V2, P194; Albacar G, 2011, J AFFECT DISORDERS, V131, P136, DOI 10.1016/j.jad.2010.11.006; [Anonymous], 2007, ASS IR STAT POP REP; Anselin L, 2007, SOC INDIC RES, V82, P287, DOI 10.1007/s11205-006-9034-x; Asres Yaregal, 2014, Int Sch Res Notices, V2014, P391580, DOI 10.1155/2014/391580; AXEMO P, 1995, GYNECOL OBSTET INVES, V39, P103, DOI 10.1159/000292389; Bates I, 2007, PLOS MED, V4, P1285, DOI 10.1371/journal.pmed.0040231; Bekele A, 2016, ANEMIA, V2016, DOI 10.1155/2016/1073192; Benoist B., 2008, WORLDWIDE PREVALENCE; Berhane G., 2011, 23 ETH INT FOOD POL; Bodnar LM, 2001, AM J OBSTET GYNECOL, V185, P438, DOI 10.1067/mob.2001.115996; Central Statistical Agency (CSA), 2011, FOOD KNOWL SURV 2011; Central Statistical Agency (CSA) and ORC Macro, 2005, ETH DEM HLTH SURV 20; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Chaya N, 2007, RES COMMENT, V2, P1; Corwin EJ, 2003, J NUTR, V133, P4139, DOI 10.1093/jn/133.12.4139; Domellof M, 2004, AM J CLIN NUTR, V79, P111; Ejigu BA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197171; Gebre A, 2017, MED RES CHRONICLES, V4, P352; Geneva S., 2011, NMHNHDMNM111; Gutema Bekele, 2014, BMC Hematol, V14, P13, DOI 10.1186/2052-1839-14-13; Haidar Jemal A, 2009, BMC Blood Disord, V9, P7, DOI 10.1186/1471-2326-9-7; Haile D, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-016-1210-7; Institute EPH, 2013, ETH NAT FOOD CONS SU; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kefiyalew Filagot, 2014, BMC Res Notes, V7, P771, DOI 10.1186/1756-0500-7-771; Kibret KT, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027276; Krivoruchko K, 2012, ARCUSER FALL, P6; Kulldorff M., 2015, TEMPORAL SPACE TIME; Lakew Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006001; Lover AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091252; Mara D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000363; Melaku Umeta, 2008, Ethiopian Journal of Health Development, V22, P252; Melku M, 2014, ANEMIA, V2014, DOI 10.1155/2014/108593; Misganaw A, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0145-1; Mitas L., 1999, GEOGRAPHICAL INFORM, V8, P481; Naish S, 2014, INT ARCH PHOTOGRAMM, V40-8, P197, DOI 10.5194/isprsarchives-XL-8-197-2014; Rahman MM, 2016, AM J CLIN NUTR, V103, P495, DOI 10.3945/ajcn.115.107896; Roba KT, 2015, NUTRITION, V31, P1213, DOI 10.1016/j.nut.2015.03.007; Ross JS, 1996, WORKING NOTES SERIES, V3; Rutstein SO., 2006, GUIDE DHS STAT, V38; Sserunjogi L, 2003, HEALTH POLICY PLANN, V18, P225, DOI 10.1093/heapol/czg027; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Strasser R, 2003, FAM PRACT, V20, P457, DOI 10.1093/fampra/cmg422; Tadesse M., 2006, ATLAS ETHIOPIAN RURA; Tay Samuel Crowther Kofi, 2017, BMC Res Notes, V10, P3, DOI 10.1186/s13104-016-2327-5; Teshale AB, 2020, MULTILEVEL ANAL; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; WHO, 2014, 2025 AN POL BRIEF; Zafar T, 2008, PROF MED J, V15, P74; Zulu LC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-285	53	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237147	10.1371/journal.pone.0237147	http://dx.doi.org/10.1371/journal.pone.0237147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2EP	32760116	Green Published, gold			2022-12-26	WOS:000561027200011
J	Bernardes, SMF; Assuncao, A; Fujao, C; Carnide, F				Fernandes Bernardes, Sarah Moreira; Assuncao, Ana; Fujao, Carlos; Carnide, Filomena			Normative reference values of the handgrip strength for the Portuguese workers	PLOS ONE			English	Article							GRIP STRENGTH; AGE; EMPLOYMENT; FRAILTY; HEALTH	Introduction The active workforce is increasingly aging. However workload, as well as working time and intensity, sometimes remains unchanged. This can be an even more critical situation in older people, since occupational exposure associated with aging, will further reduce the muscle's ability to generate energy, which in turn facilitates the development of these age-related syndromes. This study aims to identify the normative values of handgrip strength for Portuguese workers in the automotive industry. Methods About 1225 employees were invited to participate in the study. The final sample consisted of 656 employees in the assembly area. The handgrip strength was measured in kilograms (kg) using the Jamar digital dynamometer. Sex-specific profiles of handgrip strength were designed by the Ordinary Least Square regression (OLS) analysis, where height, age, age squared, and height squared are entered into the models as determining factors of the maximum grip strength in both female and male groups. Results The peak mean values of handgrip strength in the group of women was 34 kg in the age group of 35-39 years, and in the group of men the peak mean was 52 kg in the age group of 25-34 years. The most pronounced decline in the female group appears in the age of 30-34 years of about 4 kg and the male group the decline occurs at 2kg below the peak force, in the age group of 40-57 year-olds. This study used a cut-off at 2 SD below by the sex-specific peak mean. Conclusion Normative values can help delineate the career path of workers because they portray risk values according to age, height, and gender. The normative values assist health and engineering professionals and ergonomists in adjusting task demands to the morphological and strength characteristics of the workers.	[Fernandes Bernardes, Sarah Moreira; Assuncao, Ana; Carnide, Filomena] Univ Lisbon, Fac Human Kinet, Sports & Hlth Dept, Biomech & Funct Morphol Lab,CIPER, Lisbon, Portugal; [Fujao, Carlos] Volkswagen Autoeuropa, Area Ind Engn & Lean Management, Palmela, Portugal; [Fujao, Carlos] Univ Lisbon, Inst Educ & Sci, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Bernardes, SMF (corresponding author), Univ Lisbon, Fac Human Kinet, Sports & Hlth Dept, Biomech & Funct Morphol Lab,CIPER, Lisbon, Portugal.	sarah.mfber@gmail.com	Carnide, Filomena/K-5603-2013; Assuncao, Ana/L-7491-2014	Carnide, Filomena/0000-0002-0580-8637; Fujao, Carlos/0000-0002-1433-5712; Assuncao, Ana/0000-0002-9020-8045; MOREIRA FERNANDES BERNARDES, SARAH/0000-0003-1738-3661	Foundation for National Scientific Computation [UIDB/00447/2020]; Coordination of Superior Level Staff Improvement (CAPES, Brazil) [011990/2013-09]	Foundation for National Scientific Computation; Coordination of Superior Level Staff Improvement (CAPES, Brazil)	This work was partly supported by Foundation for National Scientific Computation, under Grant UIDB/00447/2020 to CIPER Interdisciplinary Center for the Study of Human Performance (unit 447), Ph.D. grant by Coordination of Superior Level Staff Improvement (CAPES, Brazil) 011990/2013-09. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.The funder (Volkswagen Autoeuropa) provided support in the form of authors' salaries and/or research materials for authors (Carlos Fujao), but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Ambrasat J, 2012, SSRN ELECT J; Bohannon RW, 2005, J HAND THER, DOI [10.1197/j.jht.2005.07.00316271690, DOI 10.1197/J.JHT.2005.07.00316271690]; Budziareck MB, 2008, CLIN NUTR, V27, P357, DOI 10.1016/j.clnu.2008.03.008; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Del Signore S, 2017, AGING CLIN EXP RES, V29, P69, DOI 10.1007/s40520-016-0710-7; Dodds R, 2013, AGE AGEING, V42, P794, DOI 10.1093/ageing/aft124; Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637; Frederiksen H, 2006, ANN EPIDEMIOL, V16, P554, DOI 10.1016/j.annepidem.2005.10.006; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gilles MA, 2003, J MOTOR BEHAV, V35, P79, DOI 10.1080/00222890309602123; Grobler CJ, 2013, OCCUP MED-OXFORD, V63, P210, DOI 10.1093/occmed/kqt007; Hutcheson GD, 1999, MULTIVARIATE SOCIAL, P289; Iavicoli I, 2018, ARCH GERONTOL GERIAT, V75, P51, DOI 10.1016/j.archger.2017.11.010; Ilmarinen J., 1997, SCANDINAVIAN J WORK; Ilmarinen JE, 2001, OCCUP ENVIRON MED, V58, P546, DOI 10.1136/oem.58.8.546; Kenny GP, 2016, APPL PHYSIOL NUTR ME, V41, pS92, DOI 10.1139/apnm-2015-0483; Kunelius A, 2007, WORK; Landau K, 2008, INT J IND ERGONOM, V38, P561, DOI 10.1016/j.ergon.2008.01.006; Lang J, 2012, SOC SCI MED, V75, P1163, DOI 10.1016/j.socscimed.2012.04.015; Luna-Heredia E, 2005, CLIN NUTR, V24, P250, DOI 10.1016/j.clnu.2004.10.007; Marfell-Jones M, 2006, INT STANDARDS ANTHRO; Martin-Ruiz C, 2014, P NUTR SOC, V73, P422, DOI 10.1017/S0029665114000147; Massy-Westropp NM, 2011, BMC RES NOTES, DOI [10.1186/1756-0500-4-12721492469, DOI 10.1186/1756-0500-4-12721492469]; Mathews T J, 2012, Natl Vital Stat Rep, V60, P1; Mathiassen SE, 2003, ERGONOMICS, V46, P800, DOI 10.1080/0014013031000090125; Mathiowetz V, 1985, ARCH PHYS MED REHAB; Mathiowetz Virgil, 2002, Occup Ther Int, V9, P201, DOI 10.1002/oti.165; Morimoto Akio, 2017, J Phys Ther Sci, V29, P1644, DOI 10.1589/jpts.29.1644; Muglich D, 2015, P 19 TRIENN C IEA AU, P1; Norheim KL, 2019, HUM MOVEMENT SCI, DOI [10.2196/resprot.819629167091, DOI 10.2196/RESPROT.819629167091]; Okunribido Olanrewaju O., 2011, Occupational Ergonomics, V10, P53, DOI 10.3233/OER-2011-0192; Palmer KT, 2017, OCCUP ENVIRON MED, V74, P476, DOI 10.1136/oemed-2016-104103; Poole CJM, 2010, OCCUP MED-OXFORD, V60, P127, DOI 10.1093/occmed/kqp170; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Rettig AC, 2009, J MUSCULOSKELET MED; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Savinainen M, 2004, ERGONOMICS, V47, P1087, DOI 10.1080/00140130410001686357; Schaub K, 2013, THEOR ISS ERGON SCI, V14, P616, DOI 10.1080/1463922X.2012.678283; Shin W, 2019, INT J OCCUP SAF ERGO, V25, P110, DOI 10.1080/10803548.2017.1373487; Sousa-Santos AR, 2018, ARCH GERONTOL GERIAT, V74, P162, DOI 10.1016/j.archger.2017.10.018; Steiber N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163917; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; World Health Organization, 2010, GLOBAL HLTH AGING	44	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236555	10.1371/journal.pone.0236555	http://dx.doi.org/10.1371/journal.pone.0236555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NB3DK	32756598	Green Submitted, Green Published, gold			2022-12-26	WOS:000560393300036
J	Sjostrom, O; Dahlin, AM; Silander, G; Syk, I; Melin, B; Hellguist, BN				Sjostrom, Olle; Dahlin, Anna M.; Silander, Gustav; Syk, Ingvar; Melin, Beatrice; Hellguist, Barbro Numan			Travel time to care does not affect survival for patients with colorectal cancer in northern Sweden: A data linkage study from the Risk North database	PLOS ONE			English	Article							COLON-CANCER; SOCIOECONOMIC-STATUS; HEALTH-CARE; DIAGNOSIS; DISTANCE; ASSOCIATION; DISEASE; ACCESS	Introduction Numerous prior studies, even from countries with free access to care, have associated long travel time to care with poor survival in patients with colorectal cancer. Methods This is a data-linkage study of all 3718 patients with colorectal cancer, diagnosed between 2007 and 2013 in Northern Sweden, one of the most sparsely populated areas in Europe. Travel time to nearest hospital was calculated based on GPS coordinates and multivariable Cox regression was used to analyse possible associations between travel time and cause-specific survival. Results No association between travel time and survival was observed, either in univariable analysis (colon HR 1.00 [95% CI 0.998-1.003]; rectal HR 0.998; [95% CI 0.995-1.002]) or in multivariable Cox regression analysis (colon HR 0.999 [95% CI 0.997-1.002]; rectal HR 0.997 [95% CI 0.992-1.002]). Conclusions In contrast to most other studies, no association between travel time and colorectal cancer survival was found; despite that longer travel time was associated with known risk factors for poorer outcome. In the Swedish health care setting, travel time does not appear to represent a barrier to care or to negatively influence outcomes.	[Sjostrom, Olle; Dahlin, Anna M.; Silander, Gustav; Melin, Beatrice; Hellguist, Barbro Numan] Umea Univ, Dept Radiat Sci, Oncol, Umea, Sweden; [Syk, Ingvar] Lund Univ, Skane Univ Hosp, Dept Surg, Malmo, Sweden	Umea University; Lund University; Skane University Hospital	Sjostrom, O (corresponding author), Umea Univ, Dept Radiat Sci, Oncol, Umea, Sweden.	olle.sjostrom@regionjh.se		Dahlin, Anna/0000-0002-6754-2571; Sjostrom, Olle/0000-0002-7277-6305	Regional Cancer Centre North (RCC Norr); County Council of Vasterbotten (ALF Grants); County Council of Jamtland-Harjedalen	Regional Cancer Centre North (RCC Norr); County Council of Vasterbotten (ALF Grants); County Council of Jamtland-Harjedalen	This study was funded with grants from Regional Cancer Centre North (RCC Norr)BNH and AD, the County Councils of Vasterbotten (ALF Grants) GS, OS and Jamtland-Harjedalen OS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggi M, 2015, ONCOLOGIST, V20, P1378, DOI 10.1634/theoncologist.2015-0110; Campbell NC, 2000, BRIT J CANCER, V82, P1863, DOI 10.1054/bjoc.1999.1079; Cavalli-Bjorkman N, 2012, BRIT J CANCER, V107, P189, DOI 10.1038/bjc.2012.186; Chow CJ, 2015, DIS COLON RECTUM, V58, P415, DOI 10.1097/DCR.0000000000000173; Crawford SM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000410; Dejardin O, 2008, ALIMENT PHARM THER, V27, P940, DOI 10.1111/j.1365-2036.2008.03673.x; England N., 2018, RAPID CANC DIAGNOSTI; Gunnarsson H, 2013, EJSO-EUR J SURG ONC, V39, P831, DOI 10.1016/j.ejso.2013.04.004; Hogan J, 2015, INT SURG, V100, P77, DOI 10.9738/INTSURG-D-13-00281.1; Johansson LA, 2009, J CLIN EPIDEMIOL, V62, P1202, DOI 10.1016/j.jclinepi.2009.01.010; Jones AP, 2008, EUR J CANCER, V44, P269, DOI 10.1016/j.ejca.2007.07.028; Kodeda K, 2013, BRIT J SURG, V100, P1100, DOI 10.1002/bjs.9166; Kravdal O, 2006, HEALTH PLACE, V12, P527, DOI 10.1016/j.healthplace.2005.08.005; Massarweh NN, 2014, J CLIN ONCOL, V32, P942, DOI 10.1200/JCO.2013.52.3845; Murage P, 2016, HEALTH PLACE, V42, P11, DOI 10.1016/j.healthplace.2016.08.014; Office for National Statistics, 2016, UK PERSP 2016 UK EUR; Olsson LI, 2014, WORLD J SURG, V38, P3265, DOI 10.1007/s00268-014-2735-4; R Foundation for Statistical Computing, 2019, R LANG ENV STAT COMP; Regional Cancer Centres in corroboration [RCC i samverkan], 2018, STAND CANC CAR PATHW; Sjostrom O, 2018, ACTA ONCOL, V57, P1622, DOI 10.1080/0284186X.2018.1497300; The Swedish Colorectal Cancer Registry, 2018, NAT QAUL REP RECT CA; The Swedish Colorectal Cancer Registry, 2018, NAT QUAL REP COL CAN; The United States Census Bureau, 2016, MEAS AM OUR CHANG LA; Turner M, 2017, BRIT J CANCER, V117, P439, DOI 10.1038/bjc.2017.180; Wasif N, 2016, ANN SURG ONCOL, V23, P3444, DOI 10.1245/s10434-016-5242-z; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816	26	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236799	10.1371/journal.pone.0236799	http://dx.doi.org/10.1371/journal.pone.0236799			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756574	gold, Green Published			2022-12-26	WOS:000560393300024
J	Desgorces, FD; Hourcade, JC; Dubois, R; Toussaint, JF; Noirez, P				Desgorces, Francois-Denis; Hourcade, Jean-Christophe; Dubois, Romain; Toussaint, Jean-Francois; Noirez, Philippe			Training load quantification of high intensity exercises: Discrepancies between original and alternative methods	PLOS ONE			English	Article							PERFORMANCE; PERCEPTION; RECOVERY; QUANTIFY	The purpose of this study was to quantify training loads (TL) of high intensity sessions through original methods (TRIMP; session-RPE; Work-Endurance-Recovery) and their updated alternatives (TRIMPcumulative; RPEalone; New-WER). Ten endurance athletes were requested to perform five sessions until exhaustion. Session 1 composed by a 800m maximal performance and four intermittent sessions performed at the 800m velocity, three sessions with 400m of interval length and work:recovery ratios of 2:1, 1:1 and 1:2 and one with 200m intervals and 1:1. Total TL were quantified from the sessions' beginning to the cool-down period and an intermediate TL (TL800) was calculated when 800m running was accumulated within the sessions. At the end of the sessions high and similar RPE were reported (effect size, eta(2)= 0.12), while, at the intermediate 800m distance, the higher interval distances and work:recovery ratios the higher the RPE (eta(2)= 0.88). Our results show marked differences in sessions' total TL between original (e.g., lowest TL for the 800m and highest for the 200m-1:1 sessions) and alternative methods (RPE(alone)and New-WER; similar TL for each session). Differences appear in TL(800)notably between TRIMP and other methods which are negatively correlated. All TL report light to moderate correlations between original methods and their alternatives, original methods are strongly correlated together, as observed for alternative methods. Differences in TL quantification between original and alternative methods underline that they are not interchangeable. Because of high exercise volume influence, original methods markedly enhance TL of sessions with higher exercise volumes although these presented the easiest interval distances and work-recovery ratios. Alternative methods based on exhaustion level (New-WER) and exertion (RPEalone) provided a new and promising point of view of TL quantification where exhaustion determines the highest TL whatever the exercise. This remains to be tested with more extended populations submitted to wider ranges of exercises.	[Desgorces, Francois-Denis; Hourcade, Jean-Christophe; Toussaint, Jean-Francois; Noirez, Philippe] Inst Natl Sport Expertise Performance, Inst Rech BioMed Epidemiol Sport, Paris, France; [Desgorces, Francois-Denis; Toussaint, Jean-Francois; Noirez, Philippe] Univ Paris, Equipe Accueil, Paris, France; [Hourcade, Jean-Christophe] Acad Conseil Preparat Athlet ACPA Performance, Gradignan, France; [Dubois, Romain] Univ Pau & Pays Adour, Equipe Accueil, Mouvement, Equilibre,Performance,Sante, Tarbes, France; [Toussaint, Jean-Francois] Hop Hotel Dieu, AP HP, Ctr Invest Med Sport, Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Pau et des Pays de l'Adour; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Desgorces, FD (corresponding author), Inst Natl Sport Expertise Performance, Inst Rech BioMed Epidemiol Sport, Paris, France.; Desgorces, FD (corresponding author), Univ Paris, Equipe Accueil, Paris, France.	francois.desgorces@unilim.fr		DESGORCES, FRANCOIS/0000-0003-2598-8599; Dubois, Romain/0000-0002-0051-244X				Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; Agostinho MF, 2015, J STRENGTH COND RES, V29, P1570, DOI 10.1519/JSC.0000000000000777; Banister EW, 1975, AUST J SPORTS MED, V7, P57; Ben Belgith A, 2012, SCI SPORT, V27, P169, DOI 10.1016/j.scispo.2011.06.012; Bourdon PC, 2017, INT J SPORT PHYSIOL, V12, P161, DOI 10.1123/IJSPP.2017-0208; Desgorces FD, 2008, PERCEPT MOTOR SKILL, V106, P104, DOI 10.2466/PMS.106.1.104-112; Desgorces FD, 2007, APPL PHYSIOL NUTR ME, V32, P762, DOI 10.1139/H07-037; Eston R, 2012, INT J SPORT PHYSIOL, V7, P175, DOI 10.1123/ijspp.7.2.175; FOSTER C, 1995, EUR J APPL PHYSIOL O, V70, P367, DOI 10.1007/BF00865035; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Garcia-Ramos A, 2015, EUR J SPORT SCI, V15, P85, DOI 10.1080/17461391.2014.922621; Halson SL, 2014, SPORTS MED, V44, pS139, DOI 10.1007/s40279-014-0253-z; Hourcade JC, 2017, SCI SPORT, V32, P221, DOI 10.1016/j.scispo.2017.03.004; Jean-Christophe H, 2018, BIOL SPORT, V35, P67, DOI 10.5114/biolsport.2018.70753; Joseph T, 2008, MED SCI SPORT EXER, V40, P381, DOI 10.1249/mss.0b013e31815a83f6; Lambert MI, 2010, INT J SPORT PHYSIOL, V5, P406, DOI 10.1123/ijspp.5.3.406; Manzi V, 2009, MED SCI SPORT EXER, V41, P2090, DOI 10.1249/MSS.0b013e3181a6a959; Morales J, 2016, INT J SPORT PHYSIOL, V11, P913, DOI 10.1123/ijspp.2015-0605; Noakes TD, 2004, J APPL PHYSIOL, V96, P1571, DOI 10.1152/japplphysiol.01124.2003; Smith DJ, 2003, SPORTS MED, V33, P1103, DOI 10.2165/00007256-200333150-00003; Stagno KM, 2007, J SPORT SCI, V25, P629, DOI 10.1080/02640410600811817; Taha T, 2003, SPORTS MED, V33, P1061, DOI 10.2165/00007256-200333140-00003; Tardieu-Berger M, 2004, EUR J APPL PHYSIOL, V93, P145, DOI 10.1007/s00421-004-1189-z	23	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0237027	10.1371/journal.pone.0237027	http://dx.doi.org/10.1371/journal.pone.0237027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745112	gold, Green Published			2022-12-26	WOS:000560006800009
J	Yan, MX; Chen, J; Jiang, H; Xie, YQ; Li, CC; Chen, LH; Yang, BB; Cao, J				Yan, Maoxiao; Chen, Jia; Jiang, Hua; Xie, Yuqiong; Li, Chunchun; Chen, Lihong; Yang, Beibei; Cao, Jiang			Effective inhibition of cancer cells by recombinant adenovirus expressing EGFR-targeting artificial microRNA and reversed-caspase-3	PLOS ONE			English	Article							NECK-CANCER; SLPI; RESISTANCE; CETUXIMAB; HEAD; CISPLATIN; CASPASE-3	The EGFR-targeting cancer therapies are commonly facing drug resistance, mostly due to mutations. Gene therapy with artificial microRNA targeting EGFR conserved sequence may avoid such problem. In this study, we constructed a recombinant adenovirus expressing EGFR-targeting artificial microRNA and active revCASP3 (Ad-EC), under the control of tumor-specific SLPI promoter, and evaluated its inhibitory effect on HEP-2 cancer cells bothin vitroandin vivo. MTT assay showed that cell growth inhibition rate at 72h was 44.0% in Ad-EC group at MOI 50, while the rate was 7.7% in the control virus Ad-GFP group and 3.6% in Cetuximab (500 mu g/ml) group respectively. Flow cytometry analysis revealed the late apoptotic cells rate was 36.1% in Ad-EC group, significantly higher than 6.5% of Ad-GFP group (p< 0.001). When Ad-EC (MOI 50) was combined with CDDP (0.25 mu g/ml), late apoptotic cells rate increased to 61.2%, significantly higher than each monotherapy group (P <0.001). The real-time xCELLigence system recorded an effective cell growth inhibition in Ad-EC and CDDP groups, and more enhanced effect in Ad-EC plus CDDP group. Western blot revealed that Ad-EC could inhibit the activation of AKT pathway and ERK1/2 pathway, while Cetuximab had the AKT pathway over-activated.In vivoexperiments with HEP-2 xenograft in nude mice confirmed the tumor inhibition in Ad-EC, CDDP and Ad-EC plus CDDP groups compared with PBS group (P <0.01). Collectively, these data support the effective inhibition of cancer cells by this novel gene therapy strategy.	[Yan, Maoxiao; Chen, Jia; Jiang, Hua; Yang, Beibei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Otorhinolaryngol, Hangzhou, Zhejiang, Peoples R China; [Xie, Yuqiong; Li, Chunchun; Chen, Lihong; Cao, Jiang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Clin Res Ctr, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yang, BB (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Otorhinolaryngol, Hangzhou, Zhejiang, Peoples R China.; Cao, J (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Clin Res Ctr, Hangzhou, Zhejiang, Peoples R China.	caoj@zju.edu.cn; 2187006@zju.edu.cn		Cao, Jiang/0000-0001-9542-5279	National Natural Science Foundation of China [81172561]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China (No.81172561, to YB), URL: http://www.nsfc.gov.cn/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardelli A, 2012, NAT MED, V18, P199, DOI 10.1038/nm.2646; Brand TM, 2014, CANC BIOL THER, V11, P777; Brand TM, 2013, RADIOTHER ONCOL, V108, P370, DOI 10.1016/j.radonc.2013.06.010; Campbell CMP, 2016, ORAL ONCOL, V55, P1, DOI 10.1016/j.oraloncology.2016.02.004; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chen J, 2012, CANCER GENE THER, V19, P328, DOI 10.1038/cgt.2012.5; Chen J, 2017, PATHOL ONCOL RES, V23, P829, DOI 10.1007/s12253-016-0160-8; Chen P, 2019, INT J CLIN EXP PATHO, V12, P1968; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Hao SH, 2018, ONCOL LETT, V15, P6503, DOI 10.3892/ol.2018.8148; Hoskins E, 2011, GYNECOL ONCOL, V122, P656, DOI 10.1016/j.ygyno.2011.04.052; Kho D, 2015, BIOSENSORS-BASEL, V5, P199, DOI 10.3390/bios5020199; Kimura H, 2007, CANCER SCI, V98, P1275, DOI 10.1111/j.1349-7006.2007.00510.x; Kozin SV, 2017, ONCOTARGET, V8, P108292, DOI 10.18632/oncotarget.22660; Luo M, 2010, CELL RES, V20, P211, DOI 10.1038/cr.2010.9; Magrini SM, 2016, J CLIN ONCOL, V34, P427, DOI 10.1200/JCO.2015.63.1671; Mok TS, 2017, NEW ENGL J MED, V376, P629, DOI 10.1056/NEJMoa1612674; Quesnelle KM, 2012, CANCER BIOL THER, V13, P935, DOI 10.4161/cbt.20846; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Sigismund S, 2018, MOL ONCOL, V12, P3, DOI 10.1002/1878-0261.12155; Srinivasula SM, 1998, J BIOL CHEM, V273, P10107, DOI 10.1074/jbc.273.17.10107; Van Cutsem E, 2015, J CLIN ONCOL, V33, P692, DOI 10.1200/JCO.2014.59.4812; Xie WT, 2019, GENE, V720, DOI 10.1016/j.gene.2019.144088; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246	26	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0237098	10.1371/journal.pone.0237098	http://dx.doi.org/10.1371/journal.pone.0237098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745124	gold, Green Published			2022-12-26	WOS:000560006800044
J	Chennen, K; Weber, T; Lornage, X; Kress, A; Bohm, J; Thompson, J; Laporte, J; Poch, O				Chennen, Kirsley; Weber, Thomas; Lornage, Xaviere; Kress, Arnaud; Bohm, Johann; Thompson, Julie; Laporte, Jocelyn; Poch, Olivier			MISTIC: A prediction tool to reveal disease-relevant deleterious missense variants	PLOS ONE			English	Article							NONSYNONYMOUS SNVS; SEQUENCE VARIANTS; GENETIC-VARIATION; HEALTH; PATHOGENICITY; ANNOTATIONS; GUIDELINES; MUTATIONS; GENOMICS; MAJORITY	The diffusion of next-generation sequencing technologies has revolutionized research and diagnosis in the field of rare Mendelian disorders, notably via whole-exome sequencing (WES). However, one of the main issues hampering achievement of a diagnosis via WES analyses is the extended list of variants of unknown significance (VUS), mostly composed of missense variants. Hence, improved solutions are needed to address the challenges of identifying potentially deleterious variants and ranking them in a prioritized short list. We present MISTIC (MISsense deleTeriousness predICtor), a new prediction tool based on an original combination of two complementary machine learning algorithms using a soft voting system that integrates 113 missense features, ranging from multi-ethnic minor allele frequencies and evolutionary conservation, to physiochemical and biochemical properties of amino acids. Our approach also uses training sets with a wide spectrum of variant profiles, including both high-confidence positive (deleterious) and negative (benign) variants. Compared to recent state-of-the-art prediction tools in various benchmark tests and independent evaluation scenarios, MISTIC exhibits the best and most consistent performance, notably with the highest AUC value (> 0.95). Importantly, MISTIC maintains its high performance in the specific case of discriminating deleterious variants from benign variants that are rare or population-specific. In a clinical context, MISTIC drastically reduces the list of VUS (< 30%) and significantly improves the ranking of "causative" deleterious variants. Pre-computed MISTIC scores for all possible human missense variants are available at http://lbgi.fr/mistic.	[Chennen, Kirsley; Weber, Thomas; Kress, Arnaud; Thompson, Julie; Poch, Olivier] Univ Strasbourg, Complex Syst & Translat Bioinformat CSTB, ICube Lab, CNRS,Federat Med Translat Strasbourg FMTS, Strasbourg, France; [Chennen, Kirsley; Lornage, Xaviere; Bohm, Johann; Laporte, Jocelyn] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS UMR7104, INSERM U1258, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Chennen, K; Poch, O (corresponding author), Univ Strasbourg, Complex Syst & Translat Bioinformat CSTB, ICube Lab, CNRS,Federat Med Translat Strasbourg FMTS, Strasbourg, France.; Chennen, K (corresponding author), Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS UMR7104, INSERM U1258, Illkirch Graffenstaden, France.	kchennen@unistra.fr; poch@unistra.fr		laporte, jocelyn/0000-0001-8256-5862; Weber, Thomas/0000-0002-0807-6363; Chennen, Kirsley/0000-0001-9268-6748; Lornage, Xaviere/0000-0002-1342-510X	Agence Nationale de la Recherche [BIPBIP: ANR-10-BINF-03-02, ReNaBiIFB: ANR-11-INBS-0013, ELIXIR-EXCELERATE: GA-676559]; CNRS; Universite de Strasbourg; Fondation Maladies Rares; Fondation pour la Recherche Medicale; Association Francaise contre les Myopathies	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; Fondation Maladies Rares; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	We thank the BISTRO and BICS bioinformatics platforms for their assistance. This work is supported by the Agence Nationale de la Recherche (BIPBIP: ANR-10-BINF-03-02; ReNaBiIFB: ANR-11-INBS-0013, ELIXIR-EXCELERATE: GA-676559), Institute funds from the CNRS, the Universite de Strasbourg and by the Fondation Maladies Rares within the frame of the Myocapture"sequencing project, the Fondation pour la Recherche Medicale, and the Association Francaise contre les Myopathies.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ainscough BJ, 2016, NAT METHODS, V13, P806, DOI 10.1038/nmeth.4000; Alirezaie N, 2018, AM J HUM GENET, V103, P474, DOI 10.1016/j.ajhg.2018.08.005; Alkan C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-963; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ameur A, 2017, EUR J HUM GENET, V25, P1253, DOI 10.1038/ejhg.2017.130; Bohm J, 2017, NEUROMUSCULAR DISORD, V27, pS195, DOI 10.1016/j.nmd.2017.06.367; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carter H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S3; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Collins M, 2002, MACH LEARN, V48, P253, DOI 10.1023/A:1013912006537; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; GOLDMAN SA, 1995, MACH LEARN, V20, P245, DOI 10.1007/BF00994017; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Grimm DG, 2015, HUM MUTAT, V36, P513, DOI 10.1002/humu.22768; Havrilla JM, 2019, NAT GENET, V51, P88, DOI 10.1038/s41588-018-0294-6; Ioannidis NM, 2016, AM J HUM GENET, V99, P877, DOI 10.1016/j.ajhg.2016.08.016; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Jagadeesh KA, 2016, NAT GENET, V48, P1581, DOI 10.1038/ng.3703; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; John SE., 2018, SCI REP, V8, P1; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; MIYAZAWA S, 1993, PROTEIN ENG, V6, P267, DOI 10.1093/protein/6.3.267; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pedersen BS, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0973-5; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rehm HL, 2017, NAT REV GENET, V18, P259, DOI 10.1038/nrg.2016.162; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rogers MF, 2018, BIOINFORMATICS, V34, P511, DOI 10.1093/bioinformatics/btx536; Samocha KE, 2017, GENOMICS, DOI [10.1101/148353, DOI 10.1101/148353]; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sundaram L, 2018, NAT GENET, V50, P1161, DOI 10.1038/s41588-018-0167-z; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Vihinen M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S2; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wright CF, 2018, NAT REV GENET, V19, P253, DOI 10.1038/nrg.2017.116; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	54	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236962	10.1371/journal.pone.0236962	http://dx.doi.org/10.1371/journal.pone.0236962			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735577	gold, Green Published			2022-12-26	WOS:000569367100065
J	Ge, ML; Li, D; Qiao, Z; Sun, Y; Kang, T; Zhu, SH; Wang, SF; Xiao, H; Zhao, CJ; Shen, SH; Xu, ZS; Liu, H				Ge, Maolin; Li, Dan; Qiao, Zhi; Sun, Yan; Kang, Ting; Zhu, Shouhai; Wang, Shifen; Xiao, Hua; Zhao, Chunjun; Shen, Shuhong; Xu, Zhenshu; Liu, Han			Restoring MLL reactivates latent tumor suppression-mediated vulnerability to proteasome inhibitors	ONCOGENE			English	Article							MULTIPLE-MYELOMA; METHYLTRANSFERASE ACTIVITY; FAMILY PROTEINS; CANCER; CELLS; GENE; BORTEZOMIB; MONOUBIQUITINATION; TRANSCRIPTION; DEGRADATION	MLL undergoes multiple distinct chromosomal translocations to yield aggressive leukemia with dismal outcomes. Besides their well-established role in leukemogenesis, MLL fusions also possess latent tumor-suppressive activity, which can be exploited as effective cancer treatment strategies using pharmacological means such as proteasome inhibitors (PIs). Here, using MLL-rearranged xenografts and MLL leukemic cells as models, we show that wild-type MLL is indispensable for the latent tumor-suppressive activity of MLL fusions. MLL dysfunction, shown as loss of the chromatin accumulation and subsequent degradation of MLL, compromises the latent tumor suppression of MLL-AF4 and is instrumental for the acquired PI resistance. Mechanistically, MLL dysfunction is caused by chronic PI treatment-induced epigenetic reprogramming through the H2Bub-ASH2L-MLL axis and can be specifically restored by histone deacetylase (HDAC) inhibitors, which induce histone acetylation and recruits MLL on chromatin to promote cell cycle gene expression. Our findings not only demonstrate the mechanism underlying the inevitable acquisition of PI resistance in MLL leukemic cells, but also illustrate that preventing the emergence of PI-resistant cells constitutes a novel rationale for combination therapy with PIs and HDAC inhibitors in MLL leukemias.	[Ge, Maolin; Li, Dan; Sun, Yan; Zhu, Shouhai; Zhao, Chunjun; Liu, Han] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hematol,Ruijin Hosp, State Key Lab Med Genom,Natl Res Ctr Translat Med, Shanghai 200025, Peoples R China; [Qiao, Zhi; Xiao, Hua] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Kang, Ting] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Oncol, Shanghai 200092, Peoples R China; [Wang, Shifen; Xu, Zhenshu] Fujian Med Univ, Union Hosp, Fujian Inst Hematol, Fujian Prov Key Lab Hematol, Fuzhou 350001, Peoples R China; [Shen, Shuhong] Shanghai Jiao Tong Univ, Key Lab Pediat Hematol & Oncol, Minist Hlth,Dept Hematol & Oncol,Sch Med, Pediat Translat Med Inst,Shanghai Childrens Med C, Shanghai 200127, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fujian Medical University; Shanghai Jiao Tong University	Liu, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hematol,Ruijin Hosp, State Key Lab Med Genom,Natl Res Ctr Translat Med, Shanghai 200025, Peoples R China.; Xu, ZS (corresponding author), Fujian Med Univ, Union Hosp, Fujian Inst Hematol, Fujian Prov Key Lab Hematol, Fuzhou 350001, Peoples R China.; Shen, SH (corresponding author), Shanghai Jiao Tong Univ, Key Lab Pediat Hematol & Oncol, Minist Hlth,Dept Hematol & Oncol,Sch Med, Pediat Translat Med Inst,Shanghai Childrens Med C, Shanghai 200127, Peoples R China.	shenshuhong@scmc.com.cn; zhenshuxu@yahoo.com; liuhan68@sjtu.edu.cn	Xiao, Hua/I-7429-2013	Xiao, Hua/0000-0002-2831-0436; Liu, Han/0000-0002-0022-1861	National Key Research and Development Program of China [2018YFA0107802]; National Natural Science Foundation of China [81973996, 81570119]; Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant [20161304]; Program of Shanghai Academic Research Leader [19XD1402500]; Shanghai Municipal Health Commission [2019CXJQ01]; Joint Funds for the Innovation of Science and Technology of Fujian Province of China [2017Y9005]; Collaborative Innovation Center of Hematology; Samuel Waxman Cancer Research Foundation	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant; Program of Shanghai Academic Research Leader; Shanghai Municipal Health Commission; Joint Funds for the Innovation of Science and Technology of Fujian Province of China; Collaborative Innovation Center of Hematology; Samuel Waxman Cancer Research Foundation	This work was supported by the National Key Research and Development Program of China (2018YFA0107802), the National Natural Science Foundation of China (81973996 and 81570119), the Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant (20161304), the Program of Shanghai Academic Research Leader (19XD1402500), the Shanghai Municipal Health Commission (2019CXJQ01), the Joint Funds for the Innovation of Science and Technology of Fujian Province of China (No.2017Y9005), the Collaborative Innovation Center of Hematology, and the Samuel Waxman Cancer Research Foundation.	Ahmad K, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.39; Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Cao F, 2014, MOL CELL, V53, P247, DOI 10.1016/j.molcel.2013.12.001; Chen YF, 2017, CANCER CELL, V31, P755, DOI 10.1016/j.ccell.2017.05.002; Drexler HG, 2004, LEUKEMIA, V18, P227, DOI 10.1038/sj.leu.2403236; Espinosa JM, 2008, GENE DEV, V22, P2743, DOI 10.1101/gad.1732108; Flavahan WA, 2017, SCIENCE, V357, DOI 10.1126/science.aal2380; Glickman MS, 2012, CELL, V148, P1089, DOI 10.1016/j.cell.2012.02.015; Goldman A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7139; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Kaldis P, 2007, CELL, V128, P241, DOI 10.1016/j.cell.2007.01.006; Koss C, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.972.972; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Li D, 2018, LEUKEMIA, V32, P2012, DOI 10.1038/s41375-018-0212-z; Liang KW, 2017, CELL, V168, P59, DOI 10.1016/j.cell.2016.12.011; Liau BB, 2017, CELL STEM CELL, V20, P233, DOI 10.1016/j.stem.2016.11.003; Liu H, 2014, CANCER CELL, V25, P530, DOI 10.1016/j.ccr.2014.03.008; Liu H, 2010, NATURE, V467, P343, DOI 10.1038/nature09350; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; Manasanch EE, 2017, NAT REV CLIN ONCOL, V14, P417, DOI [10.1007/s12079-011-0121-7, 10.1038/nrclinonc.2016.206]; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; McConkey D, 2010, BLOOD, V116, P308, DOI 10.1182/blood-2010-04-278507; Meyer C, 2018, LEUKEMIA, V32, P273, DOI 10.1038/leu.2017.213; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2010, MOL CELL, V38, P853, DOI 10.1016/j.molcel.2010.05.011; Mishra BP, 2014, CELL REP, V7, P1239, DOI 10.1016/j.celrep.2014.04.015; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Muntean AG, 2012, ANNU REV PATHOL-MECH, V7, P283, DOI 10.1146/annurev-pathol-011811-132434; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Pei XY, 2004, CLIN CANCER RES, V10, P3839, DOI 10.1158/1078-0432.CCR-03-0561; Prenzel T, 2011, CANCER RES, V71, P5739, DOI 10.1158/0008-5472.CAN-11-1896; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Riedel SS, 2016, J CLIN INVEST, V126, P1438, DOI 10.1172/JCI80825; Rushworth SA, 2011, CANCER RES, V71, P1999, DOI 10.1158/0008-5472.CAN-10-3018; Salgia R, 2018, TRENDS CANCER, V4, P110, DOI 10.1016/j.trecan.2018.01.001; San-Miguel JF, 2014, LANCET ONCOL, V15, P1195, DOI 10.1016/S1470-2045(14)70440-1; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; Wainwright EN, 2017, TRENDS CANCER, V3, P372, DOI 10.1016/j.trecan.2017.04.004; Wang E, 2013, P NATL ACAD SCI USA, V110, P3901, DOI 10.1073/pnas.1301045110; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Wu LP, 2013, MOL CELL, V49, P1108, DOI 10.1016/j.molcel.2013.01.033; Xia ZB, 2005, P NATL ACAD SCI USA, V102, P14028, DOI 10.1073/pnas.0506464102; Xu HM, 2016, CANCER CELL, V30, P863, DOI 10.1016/j.ccell.2016.10.019; Zhang QL, 2009, LEUKEMIA, V23, P1507, DOI 10.1038/leu.2009.41; Zhao ZB, 2019, GENE DEV, V33, P61, DOI 10.1101/gad.319830.118	53	4	4	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 3	2020	39	36					5888	5901		10.1038/s41388-020-01408-7	http://dx.doi.org/10.1038/s41388-020-01408-7		JUL 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NJ1HO	32733069	Green Published, hybrid			2022-12-26	WOS:000557084000001
J	Nakamura, K; Noguchi, T; Takahara, M; Omori, Y; Furukawa, T; Katoh, Y; Nakayama, K				Nakamura, Kentaro; Noguchi, Tatsuro; Takahara, Mariko; Omori, Yoshihiro; Furukawa, Takahisa; Katoh, Yohei; Nakayama, Kazuhisa			Anterograde trafficking of ciliary MAP kinase-like ICK/CILK1 by the intraflagellar transport machinery is required for intraciliary retrograde protein trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cilia; extracellular vesicle; ICK; IFT-B complex; intraflagellar transport; intracellular trafficking; protein kinase; extracellular vesicles; CRISPR; Cas	INTESTINAL-CELL KINASE; FLAGELLAR LENGTH; IFT-B; EXTRACELLULAR VESICLES; COMPLEX; ICK; CILIOGENESIS; TUBULIN; BINDING; CILIUM	ICK (also known as CILK1) is a mitogen-activated protein kinase-like kinase localized at the ciliary tip. Its deficiency is known to result in the elongation of cilia and causes ciliopathies in humans. However, little is known about how ICK is transported to the ciliary tip. We here show that the C-terminal noncatalytic region of ICK interacts with the intraflagellar transport (IFT)-B complex of the IFT machinery and participates in its transport to the ciliary tip. Furthermore, total internal reflection fluorescence microscopy demonstrated that ICK undergoes bidirectional movement within cilia, similarly to IFT particles. Analysis ofICKknockout cells demonstrated that ICK deficiency severely impairs the retrograde trafficking of IFT particles and ciliary G protein-coupled receptors. In addition, we found that inICKknockout cells, ciliary proteins are accumulated at the bulged ciliary tip, which appeared to be torn off and released into the environment as an extracellular vesicle. The exogenous expression of various ICK constructs inICKknockout cells indicated that the IFT-dependent transport of ICK, as well as its kinase activity and phosphorylation at the canonical TDY motif, is essential for ICK function. Thus, we unequivocally show that ICK transported to the ciliary tip is required for retrograde ciliary protein trafficking and consequently for normal ciliary function.	[Nakamura, Kentaro; Noguchi, Tatsuro; Takahara, Mariko; Katoh, Yohei; Nakayama, Kazuhisa] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Sakyo Ku, Kyoto, Japan; [Omori, Yoshihiro; Furukawa, Takahisa] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka, Japan; [Takahara, Mariko] Sumitomo Dainippon Pharma Co Ltd, Chuo Ku, Tokyo, Japan; [Omori, Yoshihiro] Nagahama Inst Biosci & Technol, Nagahama, Shiga, Japan	Kyoto University; Osaka University; Dainippon Sumitomo Pharmaceutical Company	Katoh, Y; Nakayama, K (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Sakyo Ku, Kyoto, Japan.	kazunaka@pharm.kyoto-u.ac.jp; ykatoh@pharm.kyoto-u.ac.jp	Nakayama, Kazuhisa/ABF-2924-2020	Furukawa, Takahisa/0000-0003-4171-220X; Katoh, Yohei/0000-0003-1649-4917; Nakayama, Kazuhisa/0000-0001-7701-7183	Japan Society for the Promotion of Science (JSPS) [15H04370, 19H00980, 18H02403, 19H03420]; JSPS International Joint Research Program grant-LEAD with UK Research and Innovation from JSPS; Uehara Memorial Foundation; Kyoto University Internal Grant ISHIZUE	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS International Joint Research Program grant-LEAD with UK Research and Innovation from JSPS; Uehara Memorial Foundation(Uehara Memorial Foundation); Kyoto University Internal Grant ISHIZUE	This work was supported in part by Japan Society for the Promotion of Science (JSPS) Grants 15H04370 and 19H00980 (to K. Nakayama), 18H02403 (to Y. K.), and 19H03420 (to Y. O.); a JSPS International Joint Research Program grant-LEAD with UK Research and Innovation from JSPS (to K. Nakayama); a Uehara Memorial Foundation grant (to Y. K.); and Kyoto University Internal Grant ISHIZUE (to K. Nakayama).	Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Asleson CM, 1998, GENETICS, V148, P693; Bailey JN, 2018, NEW ENGL J MED, V378, P1018, DOI 10.1056/NEJMoa1700175; Bangs F, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028175; Bengs F, 2005, MOL MICROBIOL, V55, P1606, DOI 10.1111/j.1365-2958.2005.04498.x; Berman SA, 2003, CURR BIOL, V13, P1145, DOI 10.1016/S0960-9822(03)00415-9; Bertiaux E, 2018, J CELL BIOL, V217, P4284, DOI 10.1083/jcb.201805030; Bhogaraju S, 2014, BIOESSAYS, V36, P463, DOI 10.1002/bies.201400007; Bhogaraju S, 2013, SCIENCE, V341, P1009, DOI 10.1126/science.1240985; Boldt K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11491; Braun DA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028191; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Broekhuis JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108470; Burghoorn J, 2007, P NATL ACAD SCI USA, V104, P7157, DOI 10.1073/pnas.0606974104; Chaya T, 2014, EMBO J, V33, P1227, DOI 10.1002/embj.201488175; Chen TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079359; Chien A, 2017, ELIFE, V6, DOI 10.7554/eLife.28606; Ferreira JP, 2013, P NATL ACAD SCI USA, V110, P11284, DOI 10.1073/pnas.1305590110; Fu Z, 2005, MOL CELL BIOL, V25, P6047, DOI 10.1128/MCB.25.14.6047-6064.2005; Fu Z, 2006, MOL CELL BIOL, V26, P8639, DOI 10.1128/MCB.00816-06; Fu Z, 2019, FEBS LETT, V593, P2990, DOI 10.1002/1873-3468.13600; Funabashi T, 2018, J CELL BIOL, V217, P2867, DOI 10.1083/jcb.201801039; Funabashi T, 2017, MOL BIOL CELL, V28, P624, DOI 10.1091/mbc.E16-09-0648; Garcia-Gonzalo FR, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028134; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hamada Y, 2018, MOL BIOL CELL, V29, P1628, DOI 10.1091/mbc.E18-03-0173; Hirano T, 2017, MOL BIOL CELL, V28, P429, DOI 10.1091/mbc.E16-11-0813; Hoang-Minh Lan B, 2018, Cilia, V7, P6, DOI 10.1186/s13630-018-0060-5; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jiang YY, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008099; Jordan MA, 2018, NAT CELL BIOL, V20, P1250, DOI 10.1038/s41556-018-0213-1; Katoh Y, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2687; Katoh Y, 2017, MOL BIOL CELL, V28, P898, DOI 10.1091/mbc.E17-01-0051; Katoh Y, 2016, J BIOL CHEM, V291, P10962, DOI 10.1074/jbc.M116.713883; Katoh Y, 2015, J CELL SCI, V128, P2351, DOI 10.1242/jcs.168740; Kubo K, 2015, BIOL OPEN, V4, P910, DOI 10.1242/bio.012146; Kubo T, 2016, J CELL SCI, V129, P2106, DOI 10.1242/jcs.187120; Kukic Ira, 2016, Cilia, V5, P23, DOI 10.1186/s13630-016-0044-2; Lahiry P, 2009, AM J HUM GENET, V84, P134, DOI 10.1016/j.ajhg.2008.12.017; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Lechtreck KF, 2015, TRENDS BIOCHEM SCI, V40, P765, DOI 10.1016/j.tibs.2015.09.003; Liang YW, 2014, DEV CELL, V30, P585, DOI 10.1016/j.devcel.2014.07.019; Liu PW, 2018, P NATL ACAD SCI USA, V115, pE934, DOI 10.1073/pnas.1713226115; McInerney-Leo A, 2015, CLIN GENET, V88, P550, DOI 10.1111/cge.12550; Mijalkovic J, 2018, CELL REP, V25, P1701, DOI 10.1016/j.celrep.2018.10.050; Moon H, 2014, P NATL ACAD SCI USA, V111, P8541, DOI 10.1073/pnas.1323161111; Mukhopadhyay S, 2014, SEMIN CELL DEV BIOL, V33, P63, DOI 10.1016/j.semcdb.2014.05.002; Nager AR, 2017, CELL, V168, P252, DOI 10.1016/j.cell.2016.11.036; Nakayama K, 2020, CRIT REV BIOCHEM MOL, V55, P179, DOI 10.1080/10409238.2020.1768206; Nakayama K, 2018, J BIOCHEM, V163, P155, DOI 10.1093/jb/mvx087; Nishijima Y, 2017, MOL BIOL CELL, V28, P1652, DOI 10.1091/mbc.E17-01-0017; Nozaki S, 2019, BIOL OPEN, V8, DOI 10.1242/bio.043786; Nozaki S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195005; Nozaki S, 2017, J CELL SCI, V130, P563, DOI 10.1242/jcs.197004; Oh YS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070677; Okamoto S, 2017, J NEUROSCI, V37, P2073, DOI 10.1523/JNEUROSCI.3067-16.2017; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Oud Machteld M, 2016, Cilia, V5, P8, DOI 10.1186/s13630-016-0029-1; Phua SC, 2017, CELL, V168, P264, DOI 10.1016/j.cell.2016.12.032; Prevo B, 2017, FEBS J, V284, P2905, DOI 10.1111/febs.14068; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Schmidts M, 2014, J PEDIATR GENET, V3, P49, DOI 10.3233/PGE-14089; Snouffer A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006912; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Takahara M, 2019, J BIOCHEM, V165, P257, DOI 10.1093/jb/mvy100; Takahara M, 2018, HUM MOL GENET, V27, P516, DOI 10.1093/hmg/ddx421; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Taschner M, 2017, J BIOL CHEM, V292, P7462, DOI 10.1074/jbc.M117.780155; Taschner M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a028092; Taschner M, 2016, EMBO J, V35, P773, DOI 10.15252/embj.201593164; Taylor SP, 2016, HUM MOL GENET, V25, P3998, DOI 10.1093/hmg/ddw240; Thomas S, 2009, J BIOL CHEM, V284, P12410, DOI 10.1074/jbc.M809746200; Togawa K, 2000, J CELL PHYSIOL, V183, P129, DOI 10.1002/(SICI)1097-4652(200004)183:1<129::AID-JCP15>3.0.CO;2-S; Toropova K, 2019, NAT STRUCT MOL BIOL, V26, P823, DOI 10.1038/s41594-019-0286-y; Tsurumi Y, 2019, MOL BIOL CELL, V30, P658, DOI 10.1091/mbc.E18-10-0678; Wang EJ, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030694; Wang J, 2014, CURR BIOL, V24, P519, DOI 10.1016/j.cub.2014.01.002; Wang W, 2020, FASEB J, V34, P6369, DOI 10.1096/fj.201902611R; Wang YR, 2019, FASEB J, V33, P6431, DOI 10.1096/fj.201802375RR; Wood CR, 2013, CURR BIOL, V23, P906, DOI 10.1016/j.cub.2013.04.019; Ye F, 2018, J CELL BIOL, V217, P1847, DOI 10.1083/jcb.201709041; Yi PS, 2018, TRAFFIC, V19, P522, DOI 10.1111/tra.12572	83	14	14	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2020	295	38					13363	13376		10.1074/jbc.RA120.014142	http://dx.doi.org/10.1074/jbc.RA120.014142			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NV7FV	32732286	hybrid, Green Published			2022-12-26	WOS:000574483500019
J	Urena-Peralta, JR; Perez-Moraga, R; Garcia-Garcia, F; Guerri, C				Urena-Peralta, Juan R.; Perez-Moraga, Raul; Garcia-Garcia, Francisco; Guerri, Consuelo			Lack of TLR4 modifies the miRNAs profile and attenuates inflammatory signaling pathways	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; TOLL-LIKE RECEPTORS; GENE SET ANALYSIS; INNATE IMMUNITY; OXIDATIVE STRESS; BRAIN-DAMAGE; KEY PLAYERS; MICRORNAS; EXPRESSION; MICE	TLR4 is a member of thes (TLR) immune family, which are activated by lipopolysaccharide, ethanol or damaged tissue, among others, by triggering proinflammatory cytokines release and inflammation. Lack of TLR4 protects against inflammatory processes and neuroinflammation linked with several neuropathologies. By considering that miRNAs are key post-transcriptional regulators of the proteins involved in distinct cellular processes, including inflammation, this study aimed to assess the impact of the miRNAs profile in mice cortices lacking the TLR4 response. Using mice cerebral cortices and next-generation sequencing (NGS), the findings showed that lack of TLR4 significantly reduced the quantity and diversity of the miRNAs expressed in WT mice cortices. The results also revealed a significant down-regulation of the miR-200 family, while cluster miR-99b/let-7e/miR-125a was up-regulated in TLR4-KO vs. WT. The bioinformatics and functional analyses demonstrated that TLR4-KO presented the systematic depletion of many pathways closely related to the immune system response, such as cytokine and interleukin signaling, MAPK and ion Channels routes, MyD88 pathways, NF-kappa beta and TLR7/8 pathways. Our results provide new insights into the molecular and biological processes associated with the protective effects of TLR-KO against inflammatory damage and neuroinflammation, and reveal the relevance of the TLR4 receptors response in many neuropathologies.	[Urena-Peralta, Juan R.; Guerri, Consuelo] Prince Felipe Res Ctr, Mol & Cellular Pathol Alcohol Lab, Valencia, Spain; [Perez-Moraga, Raul; Garcia-Garcia, Francisco] Prince Felipe Res Ctr, Bioinformat & Biostat Unit, Valencia, Spain; [Perez-Moraga, Raul] Prince Felipe Res Ctr, Biomed Imaging Unit FISABIO CIPF, Valencia, Spain	Prince Felipe Research Center; Prince Felipe Research Center; Prince Felipe Research Center	Guerri, C (corresponding author), Prince Felipe Res Ctr, Mol & Cellular Pathol Alcohol Lab, Valencia, Spain.	guerri@cipf.es	Ureña, Juan/ABC-4915-2021; Guerri, Consuelo/R-1171-2019; García-García, Francisco/N-2263-2019; Pérez-Moraga, Raúl/ABG-9831-2020	Guerri, Consuelo/0000-0001-9485-6202; García-García, Francisco/0000-0001-8354-5636; Pérez-Moraga, Raúl/0000-0002-9611-9123	Spanish Ministry of Science and Innovation [SAF2015-69187R]; Institute Carlos III; FEDER funds (RTA-Network) [RD16/0017/0004]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Institute Carlos III(Instituto de Salud Carlos III); FEDER funds (RTA-Network)	This work has been supported by grants from the Spanish Ministry of Science and Innovation (SAF2015-69187R)/(URL: http://www.ciencia.gob.es/portal/site/MICINN/?lang_choosen= en). And the Institute Carlos III and FEDER funds (RTA-Network, RD16/0017/0004)/(URL: https://www.isciii.es/Paginas/Inicio.aspx) granted to C.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alfonso-Loeches S, 2012, GLIA, V60, P948, DOI 10.1002/glia.22327; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Arroyo DS, 2011, INT IMMUNOPHARMACOL, V11, P1415, DOI 10.1016/j.intimp.2011.05.006; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Campolo M, 2019, BRAIN BEHAV IMMUN, V76, P236, DOI 10.1016/j.bbi.2018.12.003; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Chen H, 2019, SEX TRANSM INFECT, V95, P246, DOI 10.1136/sextrans-2018-053813; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cohen JL, 2017, BEHAV BRAIN RES, V319, P110, DOI 10.1016/j.bbr.2016.11.015; Coleman LG, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0799-4; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Curtale G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02037; Devaraj S, 2011, CYTOKINE, V55, P441, DOI 10.1016/j.cyto.2011.03.023; Fernandez-Lizarbe S, 2009, J IMMUNOL, V183, P4733, DOI 10.4049/jimmunol.0803590; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Fu JY, 2018, J CELL PHYSIOL, V233, P2292, DOI 10.1002/jcp.26101; Garcia-Garcia F, 2016, BIOINFORMATICS, V32, P2809, DOI 10.1093/bioinformatics/btw334; Grace PM, 2018, BRAIN RES, V1692, P9, DOI 10.1016/j.brainres.2018.04.038; Hammond SM, 2015, ADV DRUG DELIVER REV, V87, P3, DOI 10.1016/j.addr.2015.05.001; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hyakkoku K, 2010, NEUROSCIENCE, V171, P258, DOI 10.1016/j.neuroscience.2010.08.054; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kempuraj D, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00216; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lei J, 2019, J CELLULAR PHYSL; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Liu WY, 2018, J CELL BIOCHEM, V119, P2124, DOI 10.1002/jcb.26374; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Massey VL, 2018, ALCOHOL CLIN EXP RES, V42, P2107, DOI 10.1111/acer.13871; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mishra BB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-53; Montaner D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010348; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Perez-Pardo P, 2019, GUT, V68, P829, DOI 10.1136/gutjnl-2018-316844; Pers TH, 2016, HUM MOL GENET, V25, pR133, DOI 10.1093/hmg/ddw249; Petes C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01075; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pla A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.46; Pla A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153097; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenberger K, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0003-1; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Shen WS, 2017, GENE THER, V24, P353, DOI 10.1038/gt.2017.28; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Slota JA, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5020035; Sun LQ, 2018, CELL PHYSIOL BIOCHEM, V45, P458, DOI 10.1159/000486923; Suzuki M, 2010, PROCEEDINGS OF THE ASME TURBO EXPO 2010: TURBOMACHINERY: AXIAL FLOW FAN AND COMPRESSOR AERODYNAMICS DESIGN METHODS, AND CFD MODELING FOR TURBOMACHINERY, VOL 7, PTS A-C, P1011; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tran M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96094; Urena-Peralta JR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34277-y; Verma R, 2018, STROKE, V49, P1701, DOI 10.1161/STROKEAHA.118.020627; Wang J, 2018, BIOCHEM BIOPH RES CO, V505, P677, DOI 10.1016/j.bbrc.2018.09.165; Wang X, 2017, BIOMED RES INT, V2017; Wang Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/124614; Wendlandt EB, 2012, INNATE IMMUN-LONDON, V18, P846, DOI 10.1177/1753425912443903; Xiang W, 2015, REV NEUROSCIENCE, V26, P407, DOI 10.1515/revneuro-2014-0067; Xiao J, 2015, BIOCHEM J, V471, P281, DOI 10.1042/BJ20131510; Xu XM, 2017, J NEUROSCI, V37, P10498, DOI 10.1523/JNEUROSCI.1139-17.2017; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu KK, 2018, J MOL MED, V96, P65, DOI 10.1007/s00109-017-1593-6; Zhou R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002702; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59; Ziemann M, 2016, RNA, V22, P1120, DOI 10.1261/rna.055509.115	77	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237066	10.1371/journal.pone.0237066	http://dx.doi.org/10.1371/journal.pone.0237066			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780740	Green Published, gold			2022-12-26	WOS:000562664700018
J	Chuka, A; Gutema, BT; Ayele, G; Megersa, ND; Melketsedik, ZA; Zewdie, TH				Chuka, Adefris; Gutema, Befikadu Tariku; Ayele, Gistane; Megersa, Nega Degefa; Melketsedik, Zeleke Aschalew; Zewdie, Tadiwos Hailu			Prevalence of hypertension and associated factors among adult residents in Arba Minch Health and Demographic Surveillance Site, Southern Ethiopia	PLOS ONE			English	Article							BODY-MASS INDEX; BLOOD-PRESSURE; VEGETABLE CONSUMPTION; SOCIOECONOMIC-STATUS; GLOBAL BURDEN; FRUIT; RISK; COFFEE; METAANALYSIS; KHAT	Hypertension is the leading risk factor for mortality and it is also one of the major risk factors for other non-communicable diseases (NCDs). The objective of the study was to assess the prevalence of hypertension and its associated factors among adults residing in Arba Minch health and demographic surveillance site (HDSS), Southern Ethiopia. A community-based cross-sectional survey was conducted in 2017 on the estimated sample size of 3,368 adults at Arba Minch Health and Demographic Surveillance site (HDSS). Data were collected using the WHO STEPS survey tools. Bivariate analysis was done to detect candidate variables atP-valueless than 0.25 and entered into the final model to identify the independent predictors of hypertension. The prevalence of hypertension was 18.92% (95% CI: 17.63-20.28). The magnitude increase among respondents in the older age group [AOR 1.39 (95%CI: 1.05-1.84), 1.68 (95% CI: 1.26-2.23) and 2.67 (95%CI: 2.01-3.56) for age group 35-44, 45-54 and 55-64, respectively, compared to 25-34 years old group] and those with the higher wealth index [AOR 1.86 (95%CI: 1.33-2.59), 2.68 (95% CI: 1.91-3.75) and 2.97 (95%CI: 2.08-4.25) for 3(rd)quantile, 4(th)quantile and 5(th)quantile, respectively, compared to 1(st)quantile]. The odds of hypertension reduce among married participants (AOR 0.66, 95%CI: 0.51-0.85). Respondents with overweight (AOR 1.44, 95%CI: 1.02-2.02), khat chewing (AOR3.31, 95%CI: 1.94-5.64), low fruit and/or vegetable consumption (AOR 1.27, 95%CI: 1.05-1.53) and those who do not use coffee and tea (AOR 1.52, 95%CI: 1.03-2.24) had significantly higher likelihood of hypertension. Nearly one out of five participants have hypertension in this population. As hypertension is one of the silent killers, it is advisable to develop a system for enabling early detection and monitoring in the older age groups and overweight individuals.	[Chuka, Adefris] CARE Ethiopia Hawassa Project Off, Hawassa, Ethiopia; [Gutema, Befikadu Tariku; Ayele, Gistane] Arba Minch Univ, Sch Publ Hlth, Arba Minch, Ethiopia; [Gutema, Befikadu Tariku; Ayele, Gistane] Arba Minch Hlth & Demog Surveillance Syst HDSS, Arba Minch, Ethiopia; [Megersa, Nega Degefa; Melketsedik, Zeleke Aschalew] Arba Minch Univ, Sch Nursing, Arba Minch, Ethiopia; [Zewdie, Tadiwos Hailu] Arba Minch Univ, Sch Med, Arba Minch, Ethiopia	Arba Minch University; Arba Minch University; Arba Minch University	Gutema, BT (corresponding author), Arba Minch Univ, Sch Publ Hlth, Arba Minch, Ethiopia.; Gutema, BT (corresponding author), Arba Minch Hlth & Demog Surveillance Syst HDSS, Arba Minch, Ethiopia.	befikadutariku2@gmail.com	DEGEFA, NEGA/GQB-0957-2022; Gutema, Befikadu Tariku/AAD-7023-2020	DEGEFA, NEGA/0000-0002-2557-3214; Gutema, Befikadu Tariku/0000-0003-0574-6074; Chuka, Adefris/0000-0002-7919-8501	Arba Minch Demographic Surveillance and Health Research Center, Arba Minch University	Arba Minch Demographic Surveillance and Health Research Center, Arba Minch University	This study was funded by Arba Minch Demographic Surveillance and Health Research Center, Arba Minch University. The funder did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rather the funder cover the cost related to the data collection and analysis.	Abebe SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125210; Addo J, 2009, J EPIDEMIOL COMMUN H, V63, P646, DOI 10.1136/jech.2008.081828; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Al-Hebshi NN, 2005, ADDICT BIOL, V10, P299, DOI 10.1080/13556210500353020; Alonso A, 2004, BRIT J NUTR, V92, P311, DOI 10.1079/BJN20041196; AMU H, 2016, INT J HYPERTENS, V16, DOI DOI 10.1186/S12913-016-1527-Y; [Anonymous], 2003, DIET NUTR PREV CHRON; Awoke A, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-113; Bachewe F.N., 2017, RISING COSTS ANIMAL, P130; Bayray A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204879; Beusenberg M, 1994, USERS GUIDE SELF REP; Bonsa F, 2014, ETHIOP J HEALTH SCI, V24, P21, DOI 10.4314/ejhs.v24i1.3; Borgi L, 2016, HYPERTENSION, V67, P288, DOI 10.1161/HYPERTENSIONAHA.115.06497; Buford TW, 2016, AGEING RES REV, V26, P96, DOI 10.1016/j.arr.2016.01.007; Chei CL, 2018, EUR J NUTR, V57, P1333, DOI 10.1007/s00394-017-1412-4; Corsi DJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0411; CSA, 2013, POPULATION PROJECTIO; (CSA) CSA, 2016, EM OBST NEWB CAR NEE; Doll S, 2002, INT J OBESITY, V26, P48, DOI 10.1038/sj.ijo.0801854; Dua S, 2014, N AM J MED SCI, V6, P89, DOI 10.4103/1947-2714.127751; Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667; FDRE Ministry of Health, 2014, NAT STRAT ACT PLAN N; Fernald LCH, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.065219; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Getahun W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-390; Glover LM, 2020, AM J HYPERTENS, V33, P84, DOI 10.1093/ajh/hpz133; Hassan NAGM, 2000, TROP DOCT, V30, P107, DOI 10.1177/004947550003000219; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Jee SH, 1999, HYPERTENSION, V33, P647, DOI 10.1161/01.HYP.33.2.647; Jima SB, 2015, SCI J PUBL HLTH, V3, P650; Kibret KT, 2015, PUBLIC HEALTH REV, V36, DOI 10.1186/s40985-015-0014-z; Landi F, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121976; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Leng B, 2015, J HYPERTENS, V33, P221, DOI 10.1097/HJH.0000000000000428; Li BR, 2016, J CLIN HYPERTENS, V18, P468, DOI 10.1111/jch.12777; Loewe M, 2015, SUSTAINABLE DEV GOAL; Mc Causland FR, 2014, J HYPERTENS, V32, P756, DOI 10.1097/HJH.0000000000000107; Misganaw A, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0145-1; Noordzij M, 2005, LWW, DOI [10.1097/01.hjh.0000166828.94699.1d15834273, DOI 10.1097/01.HJH.0000166828.94699.1D15834273]; Nugent R., 2015, BENEFITS COSTS NONCO; Olack B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2610-8; Organization WH, 2009, GLOB HLTH RISKS MORT; Osman S, 2019, ANN GLOB HEALTH, V85, DOI 10.5334/aogh.2404; Pinto E, 2007, POSTGRAD MED J, V83, P109, DOI 10.1136/pgmj.2006.048371; Ramezankhani A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215593; Roba HS, 2019, INT J HYPERTENS, V2019, DOI 10.1155/2019/9878437; Robles TF, 2014, PSYCHOL BULL, V140, P140, DOI 10.1037/a0031859; Schmidhuber J., 2005, ACTA AGR SCAND C, V2, P150, DOI DOI 10.1080/16507540500534812; Shetty P, 2013, INDIAN J PEDIATR, V80, pS21, DOI 10.1007/s12098-013-0971-5; Tesfaye F, 2008, PREV CHRONIC DIS, V5; Uiterwaal CSPM, 2007, AM J CLIN NUTR, V85, P718, DOI 10.1093/ajcn/85.3.718; Utsugi MT, 2008, HYPERTENS RES, V31, P1435, DOI 10.1291/hypres.31.1435; Vukovic D, 2008, CROAT MED J, V49, P832, DOI 10.3325/cmj.2008.49.832; Wang L, 2012, AM J HYPERTENS, V25, P180, DOI 10.1038/ajh.2011.186; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2011, GLOBAL STATUS REPORT; WHO, 2012, WORLD HEAL ORGAN, P1; WIDLER P, 1994, CLIN PHARMACOL THER, V55, P556, DOI 10.1038/clpt.1994.69; World Health Organization, 2014, GLOB HLTH EST DEATHS, DOI 10.1371/journal.pgen.1004412.20; World Health Organization, 2014, GLOB ACT PLAN PREV C; World Health Organization, 2018, AIR POLL CHILD HLTH; World Health Organization, 2005, WHO STEPWISE APPR NO; Wu L, 2016, J HUM HYPERTENS, V30, P573, DOI 10.1038/jhh.2016.44; Zekewos A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221726	65	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237333	10.1371/journal.pone.0237333	http://dx.doi.org/10.1371/journal.pone.0237333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC7KJ	32776993	gold, Green Published			2022-12-26	WOS:000561393800053
J	Nakamori, M; Imamura, E; Fukuta, M; Tachiyama, K; Kamimura, T; Hayashi, Y; Matsushima, H; Ogawa, K; Nishino, M; Hirata, A; Mizoue, T; Wakabayashi, S				Nakamori, Masahiro; Imamura, Eiji; Fukuta, Masako; Tachiyama, Keisuke; Kamimura, Teppei; Hayashi, Yuki; Matsushima, Hayato; Ogawa, Kanami; Nishino, Masami; Hirata, Akiko; Mizoue, Tatsuya; Wakabayashi, Shinichi			Tongue thickness measured by ultrasonography is associated with tongue pressure in the Japanese elderly	PLOS ONE			English	Article							DYSPHAGIA; STRENGTH; RELIABILITY	The term "oral frailty" reflects the fact that oral health is associated with physical frailty and mortality. The gold standard methods for evaluating the swallowing function have several problems, including the need for specialized equipment, the risk of radiation exposure and aspiration, and general physicians not possessing the requisite training to perform the examination. Hence, several simple and non-invasive techniques have been developed for evaluating swallowing function, such as those for measuring tongue pressure and tongue thickness. The aim of this study was to investigate the relationship between tongue thickness ultrasonography and tongue pressure in the Japanese elderly. We evaluated 254 elderly patients, who underwent tongue ultrasonography and tongue pressure measurement. To determine tongue thickness, we measured the vertical distance from the surface of the mylohyoid muscle to the tongue dorsum using ultrasonography. The results of the analyses revealed that tongue thickness was linearly associated with tongue pressure in both sexes. In male participants, dyslipidemia, lower leg circumference, and tongue pressure were independently and significantly associated with tongue thickness. In female participants, body mass index and tongue pressure were independently and significantly associated with tongue thickness. The optimal cutoff for tongue thickness to predict the tongue pressure of < 20 kPa was 41.3 mm in males, and 39.3 mm in females. In the Japanese elderly, tongue thickness using ultrasonography is associated with tongue pressure. Tongue thickness and tongue pressure, which are sensitive markers for oral frailty, decrease with age. We conclude that tongue ultrasonography provides a less invasive technique for determining tongue thickness and predicts oral frailty for elderly patients.	[Nakamori, Masahiro; Imamura, Eiji; Tachiyama, Keisuke; Kamimura, Teppei; Hayashi, Yuki; Matsushima, Hayato] Suiseikai Kajikawa Hosp, Dept Neurol, Hiroshima, Japan; [Nakamori, Masahiro; Tachiyama, Keisuke; Kamimura, Teppei; Hayashi, Yuki] Hiroshima Univ, Dept Clin Neurosci & Therapeut, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Fukuta, Masako; Ogawa, Kanami; Nishino, Masami; Hirata, Akiko] Suiseikai Kajikawa Hosp, Dept Clin Lab, Hiroshima, Japan; [Mizoue, Tatsuya; Wakabayashi, Shinichi] Suiseikai Kajikawa Hosp, Dept Neurosurg, Hiroshima, Japan	Hiroshima University	Nakamori, M (corresponding author), Suiseikai Kajikawa Hosp, Dept Neurol, Hiroshima, Japan.; Nakamori, M (corresponding author), Hiroshima Univ, Dept Clin Neurosci & Therapeut, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	mnakamori1@gmail.com	Nakamori, Masahiro/AAD-6862-2021	Nakamori, Masahiro/0000-0002-0944-5538; Kamimura, Teppei/0000-0003-0372-7814				Adams V, 2015, DISABIL REHABIL, V37, P389, DOI 10.3109/09638288.2014.921245; Butler SG, 2011, J GERONTOL A-BIOL, V66, P452, DOI 10.1093/gerona/glq234; Cichero JAY, 2018, GERIATRICS-BASEL, V3, DOI 10.3390/geriatrics3040069; Hakeem FF, 2019, GERODONTOLOGY, V36, P205, DOI 10.1111/ger.12406; Hayashi R, 2002, INT J PROSTHODONT, V15, P385; Hiraoka A, 2017, DYSPHAGIA, V32, P542, DOI 10.1007/s00455-017-9797-z; Hirota N, 2010, STROKE, V41, P2982, DOI 10.1161/STROKEAHA.110.594960; Hudson HM, 2000, DYSPHAGIA, V15, P31, DOI 10.1007/s004559910007; Kunieda K, 2013, J PAIN SYMPTOM MANAG, V46, P201, DOI 10.1016/j.jpainsymman.2012.07.020; Machida N, 2017, GERIATR GERONTOL INT, V17, P295, DOI 10.1111/ggi.12715; Mano T, 2014, NEUROLOGY, V82, P255, DOI 10.1212/WNL.0000000000000041; Marik PE, 2003, CHEST, V124, P328, DOI 10.1378/chest.124.1.328; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nakamori M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165837; Nakamori M, 2016, CLIN NEUROPHYSIOL, V127, P1669, DOI 10.1016/j.clinph.2015.07.032; O'Connor-Reina C, 2020, SLEEP BREATH, V24, P281, DOI 10.1007/s11325-019-01952-x; Rapp L, 2017, J FRALITY AGING, V6, P154, DOI 10.14283/jfa.2017.9; Tamura F, 2012, DYSPHAGIA, V27, P556, DOI 10.1007/s00455-012-9407-z; Tanaka T, 2018, J GERONTOL A-BIOL, V73, P1661, DOI 10.1093/gerona/glx225; Tsuga K, 2011, J ORAL REHABIL, V38, P680, DOI 10.1111/j.1365-2842.2011.02202.x; Tsuga K, 2012, GERODONTOLOGY, V29, pE1078, DOI 10.1111/j.1741-2358.2011.00615.x; Van den Steen L, 2021, FOLIA PHONIATR LOGO, V73, P109, DOI 10.1159/000505153; Wang SH, 2020, AM J RESP CRIT CARE, V201, P718, DOI 10.1164/rccm.201903-0692OC; Weikamp JG, 2012, J NEUROL, V259, P2360, DOI 10.1007/s00415-012-6503-9; Yoshikawa M, 2011, DYSPHAGIA, V26, P232, DOI 10.1007/s00455-010-9291-3	25	6	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0230224	10.1371/journal.pone.0230224	http://dx.doi.org/10.1371/journal.pone.0230224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2FE	32764766	gold, Green Submitted, Green Published			2022-12-26	WOS:000561029000066
J	Yeasmeen, T; Kelaher, M; Brotherton, JML; Malloy, MJ				Yeasmeen, Tahira; Kelaher, Margaret; Brotherton, Julia M. L.; Malloy, Michael J.			Understanding the participation of breast screening among women born in predominantly Muslim countries living in Victoria, Australia from record-linkage data	PLOS ONE			English	Article							CANCER; HEALTH; KNOWLEDGE; RELIGION	Background Early detection of breast cancer can improve survival rates and decrease mortality rates. This study investigates whether there are significant differences in participation in breast screening among women born in Muslim countries compared to women born in Non-Muslim countries and Australia. Methods Screening data from January 1(st), 2000 to December 31(st), 2013 from the Breast Screen Victoria Registry (BSV) was linked with hospital records from the Victorian Admitted Episodes Dataset (VAED). Countries having more than 50% of their population as Muslim were categorised as Muslim countries. Age adjusted rates were calculated for women born in Muslim and Non-Muslim countries and compared with the Australian age adjusted rates. Logistic regression assessed the association between screening status and other factors which include country of birth, marital status, age and socio-economic status. Results Women born in Muslim countries (Odds Ratio (OR) = 0.70, 95%CI = 0.68-0.72) and in other Non-Muslim countries (OR = 0.87, 95%CI = 0.86-0.88) had lower odds of participation in breast screening than Australian born women. Women aged 60-64 years (OR = 1.42, 95%CI = 1.40-1.44) had higher odds of participation in the BreastScreen program than 50-54 age group. Conclusion This study provides valuable insights to understanding breast screening participation among women born in Muslim countries residing in Victoria. This population level study contributes to the broader knowledge of screening participation of women born in Muslim countries, an understudied population group in Australia and across the world. This study has implications for breast screening programs as it highlights the need for culturally sensitive approaches to support breast screening participation among women born in Muslim countries.	[Yeasmeen, Tahira; Kelaher, Margaret] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Hlth Policy, Parkville, Vic, Australia; [Brotherton, Julia M. L.] VCS Fdn, VCS Populat Hlth, East Melbourne, Vic, Australia; [Malloy, Michael J.] Melbourne Hlth, VICNISS, Melbourne, Vic, Australia	University of Melbourne	Yeasmeen, T (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Hlth Policy, Parkville, Vic, Australia.	tyeasmeen@student.unimelb.edu.au		Yeasmeen, Tahira/0000-0003-4427-2465	Victorian Department of Health and Human Services; University of Melbourne International student scholarship	Victorian Department of Health and Human Services; University of Melbourne International student scholarship	JL and MM received grants for this project from the Victorian Department of Health and Human Services. Mk was not funded for this study. TY was funded by the University of Melbourne International student scholarship. Grant numbers are not available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the Victorian Department of Health and Human Services. We acknowledge the role of the Victorian Data Linkage Unit in this study. We acknowledge the contribution of the chief investigators of the main data linkage study including Louise Galloway, Dorota Gertig, Genevieve Chappell and Vicki Pridmore. We acknowledge the contribution of BSV and the Victorian Department of Health and Human Service for sharing their dataset and insight with us in this project.	ABS, 2018, CENS POP HOUS 2016; [Anonymous], 2018, SIEMENS HLTH; Australian Institute of Health and Welfare, 2015, BREASTSCREEN AUSTR M; Australian Institute of Health and Welfare, 2016, BREASTSCREEN AUSTR M; Azaiza F, 2006, J WOMENS HEALTH, V15, P520, DOI 10.1089/jwh.2006.15.520; Breen N, 2001, J NATL CANCER I, V93, P1704, DOI 10.1093/jnci/93.22.1704; Federation of Ethnic Communities' Councils of Australia, 2010, CANC CULT LING DIV C; GLOBOCAN, 2012, CERV CANC EST INC MO; Hadi Muhammad A., 2010, Pharmacy Pract (Granada), V8, P29; Hasnain M, 2014, J WOMENS HEALTH, V23, P602, DOI 10.1089/jwh.2013.4569; Hassan R., 2015, AUSTR MUSLIMS DEMOGR; *INT AG RES CANC, 2018, GLOBOCAN 2018 EST CA; Islam Nadia, 2006, J Immigr Minor Health, V8, P211, DOI 10.1007/s10903-006-9325-y; Lauby-Secretan B, 2015, NEW ENGL J MED, V372, P2353, DOI 10.1056/NEJMsr1504363; Lofters A.K., 2017, CANC EPIDEMIOL PREV; Lugo L., 2011, FUTURE GLOBAL MUSLIM; Masadeh M, 2016, ACG CASE REP J, V3, DOI 10.14309/crj.2016.151; O'Hara J, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081677; Okobia Michael N, 2006, World J Surg Oncol, V4, P11, DOI 10.1186/1477-7819-4-11; Padela AI, 2015, J IMMIGR MINOR HEALT, V17, P660, DOI 10.1007/s10903-014-0014-y; Padela AI, 2013, J RELIG HEALTH, V52, P1333, DOI 10.1007/s10943-012-9620-y; Parsa P, 2008, ASIAN PAC J CANCER P, V9, P221; Pink B., 2007, AUSTR STANDARD GEOGR; Pruitt SL, 2009, CANCER EPIDEM BIOMAR, V18, P2579, DOI 10.1158/1055-9965.EPI-09-0135; Renshaw C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-157; Schoueri-Mychasiw N, 2013, J IMMIGR MINOR HEALT, V15, P149, DOI 10.1007/s10903-012-9612-8; Siahpush M, 2002, PREV MED, V35, P362, DOI 10.1006/pmed.2002.1086; Szczepura A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-346; Donnelly TT, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-49; Victoria Government, 2016, HLTH HUM SERV VICT C; Weber MF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-144; Yeasmeen T, 2019, J Cancer Policy, V22, DOI 10.1016/j.jcpo.2019.100201	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237341	10.1371/journal.pone.0237341	http://dx.doi.org/10.1371/journal.pone.0237341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764828	Green Published, gold			2022-12-26	WOS:000561029000019
J	Yu, YY; Lu, J; Oliphant, K; Gupta, N; Claud, K; Lu, L				Yu, Yueyue; Lu, Jing; Oliphant, Kaitlyn; Gupta, Nikhilesh; Claud, Katerina; Lu, Lei			Maternal administration of probiotics promotes gut development in mouse offsprings	PLOS ONE			English	Article							MUCIN GENE-EXPRESSION; NECROTIZING ENTEROCOLITIS; FECAL MICROBIOTA; PRETERM INFANTS; IMPACT; SUPPLEMENTATION; BUTYRATE	Necrotizing enterocolitis is the most common gastrointestinal disorder in premature neonates. This disease is characterized by massive epithelial necrosis, gut barrier dysfunction and improper mucosal defense development. Studies have shown that probiotic administration can decrease NEC incidence and mortality. The proposed mechanisms of probiotics for the prevention of NEC are: promotion of intestinal development; improved barrier function through decreased apoptosis and improved mucin production; decreased expression of proinflammatory cytokines IL6, IL8, and TNF alpha, and modulation of microbiota dysbiosis in preterm infants. However, reported sepsis in the immunocompromised preterm host has deterred routine prophylactic administration of probiotics in the neonatal intensive care unit. We hypothesize that maternal administration of probiotics to pregnant mouse dams can recapitulate the beneficial effects observed in neonates fed with probiotics directly. We exposed pregnant mice to the probiotics and monitored the changes in the developing intestines of the offspring. Pregnant mice were fed daily with the probioticsLactobacillus acidophilusandBifidobacterium infantis(LB) from embryonic day15 to 2-week-old postnatally. Intraperitoneal administration of IL-1 beta in the pups was used to model proinflammatory insults. Sera were collected at 2 weeks of age and evaluated for inflammatory cytokines by enzyme-linked-immunosorbent-assay and gut permeability by Fluorescein isothiocyanate-dextran tracer assay. Ileal tissues were collected for the evaluation of apoptosis and proliferation of the intestinal epithelium; as well as mucin and tight junction integrity at mucosal surface by immunofluorescent staining. We find that maternal LB exposure facilitated intestinal epithelial cell differentiation, prevented loss of mucin and preserved the intestinal integrity and barrier function and decreased serum levels of IL-1 beta, TNF-alpha and IL-6 in the preweaned offsprings. in LB exposed pups. We demonstrate that maternal probiotic supplementation promotes gut maturation in developing offspring. This is potentially a safe alternative therapy to induce intestinal maturation and prevent prematurity-associated neonatal disorders.	[Yu, Yueyue; Lu, Jing; Oliphant, Kaitlyn; Gupta, Nikhilesh; Claud, Katerina; Lu, Lei] Univ Chicago, Dept Pediat, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago	Lu, L (corresponding author), Univ Chicago, Dept Pediat, Pritzker Sch Med, Chicago, IL 60637 USA.	llu@peds.bsd.uchicago.edu		Lu, Lei/0000-0002-9253-9753	Digestive Diseases Reseach Core Center, University of Chicago	Digestive Diseases Reseach Core Center, University of Chicago	This work was supported by the Digestive Diseases Reseach Core Center, University of Chicago. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbian ME, 2019, EARLY HUM DEV, V135, P66, DOI 10.1016/j.earlhumdev.2019.05.009; Bazacliu C, 2019, CURR PEDIATR REV, V15, P68, DOI 10.2174/1573396314666181102123030; Bazanella M, 2017, AM J CLIN NUTR, V106, P1274, DOI 10.3945/ajcn.117.157529; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; Benor S, 2014, AM J PERINAT, V31, P497, DOI 10.1055/s-0033-1353490; Blackwood Brian P, 2017, J Probiotics Health, V5, DOI 10.4172/2329-8901.1000159; Borthakur A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075664; Bourriaud C, 2005, J APPL MICROBIOL, V99, P201, DOI 10.1111/j.1365-2672.2005.02605.x; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Buisine MP, 1998, GUT, V43, P519, DOI 10.1136/gut.43.4.519; Caballero-Franco C, 2007, AM J PHYSIOL-GASTR L, V292, pG315, DOI 10.1152/ajpgi.00265.2006; Caplan MS, 1999, GASTROENTEROLOGY, V117, P577, DOI 10.1016/S0016-5085(99)70450-6; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; Claud EC, 2004, P NATL ACAD SCI USA, V101, P7404, DOI 10.1073/pnas.0401710101; Claud EC, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-20; Dobbler PT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02243; Fan WG, 2014, J MICROBIOL BIOTECHN, V24, P133, DOI 10.4014/jmb.1309.09029; Hackam D, 2018, SEMIN PEDIATR SURG, V27, P11, DOI 10.1053/j.sempedsurg.2017.11.003; Halpern MD, 2015, TISSUE BARRIERS, V3, DOI 10.1080/21688370.2014.1000707; Hoyos A B, 1999, Int J Infect Dis, V3, P197, DOI 10.1016/S1201-9712(99)90024-3; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Lin HC, 2008, PEDIATRICS, V122, P693, DOI 10.1542/peds.2007-3007; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Martin R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41738-5; Moore SA, 2016, J PEDIATR SURG, V51, P1907, DOI 10.1016/j.jpedsurg.2016.09.011; Oliphant K, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0704-8; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Rautava S, 2012, NAT REV GASTRO HEPAT, V9, P565, DOI 10.1038/nrgastro.2012.144; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; Schnabl KL, 2008, WORLD J GASTROENTERO, V14, P2142, DOI 10.3748/wjg.14.2142; Shiou SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065108; Shiou SR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.154625; Stanford AH, 2019, PEDIAT RES; Sugahara H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13548; Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621; Underwood MA, 2017, SEMIN PERINATOL, V41, P41, DOI 10.1053/j.semperi.2016.09.017; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Wickramasinghe S, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0508-3; Xu LF, 2012, INFLAMMATION, V35, P308, DOI 10.1007/s10753-011-9320-x	40	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237182	10.1371/journal.pone.0237182	http://dx.doi.org/10.1371/journal.pone.0237182			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764797	gold, Green Published			2022-12-26	WOS:000561029000007
J	Asiki, G; Wanjohi, MN; Barnes, A; Bash, K; Muthuri, S; Amugsi, D; Doughman, D; Kimani, E; Vandevijvere, S; Holdsworth, M				Asiki, Gershim; Wanjohi, Milkah N.; Barnes, Amy; Bash, Kristin; Muthuri, Stella; Amugsi, Dickson; Doughman, Danielle; Kimani, Elizabeth; Vandevijvere, Stefanie; Holdsworth, Michelle			Benchmarking food environment policies for the prevention of diet-related non-communicable diseases in Kenya: National expert panel's assessment and priority recommendations	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; IMPLEMENTATION; OBESITY; SYSTEM	Introduction Unhealthy food environments drive the increase of diet-related non-communicable diseases (NCDs). Objective We aimed to examine healthy food environment policies in Kenya and identify priorities for future action. Methods Using the Healthy Food Environment Policy Index (Food-EPI) we collected evidence on the extent of government action to create healthy food environments across 13 policy and infrastructure support domains and 43 related good practice indicators between 2017 and 2018. A panel of 15 national experts rated the extent of government action on each indicator compared to the policy development cycle and international best practice respectively. Based on gaps found, actions to improve food environments in Kenya were identified and prioritized. Results In the policy development cycle, 16/43 (37%) of good practice policy indicators were judged to be in 'implementation' phase, including: food composition targets, packaged foods' ingredient lists/nutrient declarations; systems regulating health claims; restrictions on marketing breast milk substitutes; and school nutrition policies. Infrastructure support actions in 'implementation' phase included: food-based dietary guidelines; strong political support to reduce NCDs; comprehensive NCD action plan; transparency in developing food policies; and surveys monitoring nutritional status. Half (22/43) of the indicators were judged to be 'in development'. Compared to international best practice, the Kenyan Government was judged to be performing relatively well ('medium' implementation) in one policy (restrictions on marketing breast milk substitutes) and three infrastructure support areas (political leadership; comprehensive implementation plan; and ensuring all food policies are sensitive to nutrition). Implementation for 36 (83.7%) indicators were rated as 'low' or 'very little'. Taking into account importance and feasibility, seven actions within the areas of leadership, food composition, labelling, promotion, prices and health-in-all-policies were prioritized. Conclusion This baseline assessment is important in creating awareness to address gaps in food environment policy. Regular monitoring using Food-EPI may contribute to addressing the burden of diet-related NCDs in Kenya.	[Asiki, Gershim; Wanjohi, Milkah N.; Muthuri, Stella; Amugsi, Dickson; Doughman, Danielle; Kimani, Elizabeth] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Asiki, Gershim] Karolinska Inst, Dept Womens & Childrens Hlth, Solna, Sweden; [Barnes, Amy; Bash, Kristin] Univ Sheffield, Sch Hlth & Related Res ScHARR, Publ Hlth, Sheffield, S Yorkshire, England; [Vandevijvere, Stefanie] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand; [Holdsworth, Michelle] Univ Montpellier, French Natl Res Inst Sustainable Dev IRD, NUTRIPASS Unit, IRD,SupAgro, Montpellier, France	African Population & Health Research Centre; Karolinska Institutet; University of Sheffield; University of Auckland; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Asiki, G (corresponding author), African Populat & Hlth Res Ctr, Nairobi, Kenya.; Asiki, G (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Solna, Sweden.	gasiki@aphrc.org	Barnes, Amy/GWV-5027-2022; holdsworth, michelle/AAH-5400-2020; Barnes, Amy/AAA-9221-2019	Barnes, Amy/0000-0002-8122-9792; holdsworth, michelle/0000-0001-6028-885X; Barnes, Amy/0000-0002-8122-9792; Asiki, Gershim/0000-0002-9966-1153; Amugsi, DICKSON A/0000-0002-5261-8481; Doughman, Danielle/0000-0002-2052-4640	UK Medical Research Fund (MRC) - Global Challenges Research Fund (GCRF) [332:643]	UK Medical Research Fund (MRC) - Global Challenges Research Fund (GCRF)	MH, SV, EK, SM received funding from UK Medical Research Fund (MRC) - Global Challenges Research Fund (GCRF) Grant number 332:643.	Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Amugsi DA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017344; Anand SS, 2015, J AM COLL CARDIOL, V66, P1590, DOI 10.1016/j.jacc.2015.07.050; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Juma PA, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5825-7; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Malhotra A, 2015, IT IS TIME BUST MYTH; Mberu B, 2015, J URBAN HEALTH, V92, P422, DOI 10.1007/s11524-015-9943-6; Mbochi RW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-823; Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585; Ng S, 2018, PUBLIC HEALTH NUTR, V21, P3395, DOI 10.1017/S1368980018002379; Phillips-Howard PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114010; Phulkerd S, 2017, PUBLIC HEALTH NUTR, V20, P381, DOI [10.1017/s1368980016002391, 10.1017/S1368980016002391]; Piotrowicz M, 2013, PRZEGL EPIDEMIOL, V67, P151; Piotrowicz Maria, 2013, Przegl Epidemiol, V67, P69; Sacks G., 2019, POLICIES TACKLING OB; Spires M., 2016, South African Health Review, V2016, P35; Steyn NP, 2014, ANN NY ACAD SCI, V1311, P88, DOI 10.1111/nyas.12433; Steyn NP, 2011, SCAND J PUBLIC HEALT, V39, P88, DOI 10.1177/1403494810384426; Swinburn B, 2013, OBES REV, V14, P24, DOI 10.1111/obr.12073; Swinburn B, 2015, LANCET, V385, P2534, DOI 10.1016/S0140-6736(14)61747-5; Vandevijvere S, 2017, PROGR NZ GOVT IMPLEM; Vandevijvere S, 2015, B WORLD HEALTH ORGAN, V93, P294, DOI 10.2471/BLT.14.145540; WHO, 2015, US PRIC POL PROM HEA; World Health Organization, 2013, GLOB ACT PLAN PREV C	26	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236699	10.1371/journal.pone.0236699	http://dx.doi.org/10.1371/journal.pone.0236699			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760079	Green Accepted, gold, Green Published			2022-12-26	WOS:000561027200017
J	Kannampallil, TG; Goss, CW; Evanoff, BA; Strickland, JR; McAlister, RP; Duncan, J				Kannampallil, Thomas G.; Goss, Charles W.; Evanoff, Bradley A.; Strickland, Jaime R.; McAlister, Rebecca P.; Duncan, Jennifer			Exposure to COVID-19 patients increases physician trainee stress and burnout	PLOS ONE			English	Article							MEDICAL-STUDENTS; NORMATIVE DATA; SCALES DASS; DEPRESSION; VALIDITY; RESIDENT; IMPACT	The coronavirus disease 2019 (COVID-19) pandemic has put considerable physical and emotional strain on frontline healthcare workers. Among frontline healthcare workers, physician trainees represent a unique group-functioning simultaneously as both learners and caregivers and experiencing considerable challenges during the pandemic. However, we have a limited understanding regarding the emotional effects and vulnerability experienced by trainees during the pandemic. We investigated the effects of trainee exposure to patients being tested for COVID-19 on their depression, anxiety, stress, burnout and professional fulfillment. All physician trainees at an academic medical center (n= 1375) were invited to participate in an online survey. We compared the measures of depression, anxiety, stress, burnout and professional fulfillment among trainees who were exposed to patients being tested for COVID-19 and those that were not, using univariable and multivariable models. We also evaluated perceived life stressors such as childcare, home schooling, personal finances and work-family balance among both groups. 393 trainees completed the survey (29% response rate). Compared to the non-exposed group, the exposed group had a higher prevalence of stress (29.4% vs. 18.9%), and burnout (46.3% vs. 33.7%). The exposed group also experienced moderate to extremely high perceived stress regarding childcare and had a lower work-family balance. Multivariable models indicated that trainees who were exposed to COVID-19 patients reported significantly higher stress (10.96 [95% CI, 9.65 to 12.46] vs 8.44 [95% CI, 7.3 to 9.76];P= 0.043) and were more likely to be burned out (1.31 [95% CI, 1.21 to1.41] vs 1.07 [95% CI, 0.96 to 1.19];P= 0.002]. We also found that female trainees were more likely to be stressed (P= 0.043); while unmarried trainees were more likely to be depressed (P= 0.009), and marginally more likely to have anxiety (P= 0.051). To address these challenges, wellness programs should focus on sustaining current programs, develop new and targeted mental health resources that are widely accessible and devise strategies for creating awareness regarding these resources.	[Kannampallil, Thomas G.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Kannampallil, Thomas G.; Goss, Charles W.] Washington Univ, Sch Med, Inst Informat, St Louis, MO 63110 USA; [Goss, Charles W.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Evanoff, Bradley A.; Strickland, Jaime R.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [McAlister, Rebecca P.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Duncan, Jennifer] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Kannampallil, TG (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.; Kannampallil, TG (corresponding author), Washington Univ, Sch Med, Inst Informat, St Louis, MO 63110 USA.	thomas.k@wustl.edu	Goss, Charles W/R-7296-2019	Kannampallil, Thomas/0000-0003-4119-4836				Bai Y, 2004, PSYCHIAT SERV, V55, P1055, DOI 10.1176/appi.ps.55.9.1055; Bettinsoli M.L., 2020, PSYCHOL IMPACT CONTE; Carayon P., 2019, JAMA; Clara IP, 2001, J PSYCHOPATHOL BEHAV, V23, P61, DOI 10.1023/A:1011095624717; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Cutler D., 2020, JAMA HLTH FOR; De Brier N., 2020, FACTORS AFFECTING ME; Dyrbye LN, 2014, ACAD MED, V89, P443, DOI 10.1097/ACM.0000000000000134; Dzau V.J., 2020, NEJM; Ey Sydney, 2016, J Grad Med Educ, V8, P747, DOI 10.4300/JGME-D-16-00034.1; Ey Sydney, 2013, J Grad Med Educ, V5, P486, DOI 10.4300/JGME-D-12-00048.1; Galea S., JAMA INTERNAL MED; Gallagher TH, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005234; Gautam M, 2020, PSYCHOSOMATICS; Givens JL, 2002, ACAD MED, V77, P918, DOI 10.1097/00001888-200209000-00024; Guille Constance, 2010, J Grad Med Educ, V2, P210, DOI 10.4300/JGME-D-09-00086.1; Han S, 2019, ANN INTERN MED, V170, P784, DOI 10.7326/M18-1422; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Huang JZ, 2020, CHINESE J IND HYGIEN, V38, P192, DOI [DOI 10.3760/CMA.J.CN121094-20200219-00063, 10.3760/cma.j.cn121094-20200219-00063]; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lam TP, 2010, MED TEACH, V32, pE120, DOI 10.3109/01421590903449894; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lovibond S.H., 1996, MANUAL DEPRESSION AN, DOI DOI 10.1037/T01004-000; Maslach C., 1986, MASLACH BURNOUT INVE, V21; Mata DA, 2015, JAMA-J AM MED ASSOC, V314, P2373, DOI 10.1001/jama.2015.15845; Maunder R, 2003, CAN MED ASSOC J, V168, P1245; Le MTH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180557; National Academies of Sciences E. and Medicine, 2019, TAK ACT CLIN BURN SY; NIOSH (National Institute of Occupational Safety and Health), 2016, QUAL WORK LIF QUEST; Raj Kristin S, 2016, J Grad Med Educ, V8, P674, DOI 10.4300/JGME-D-15-00764.1; Rambaldini G, 2005, J GEN INTERN MED, V20, P381, DOI 10.1111/j.1525-1497.2005.0099.x; Redel-Traub G., 2020, NEW YORK MAGAZINE; Ripp J., 2020, ATTENDING EMOTIONAL; Shanafelt T., 2020, JAMA; Snyder Rebecca A, 2013, J Grad Med Educ, V5, P365, DOI 10.4300/JGME-D-12-00294.1; Trockel M, 2018, ACAD PSYCHIATR, V42, P11, DOI 10.1007/s40596-017-0849-3; Wu A.W., 2020, ANN INTERNAL MED	37	178	182	7	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237301	10.1371/journal.pone.0237301	http://dx.doi.org/10.1371/journal.pone.0237301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2EP	32760131	Green Published, gold			2022-12-26	WOS:000561027200012
J	Morelle, JM; Claquin, P; Orvain, F				Morelle, Jerome; Claquin, Pascal; Orvain, Francis			Evidence for better microphytobenthos dynamics in mixed sand/mud zones than in pure sand or mud intertidal flats (Seine estuary, Normandy, France)	PLOS ONE			English	Article							WATER MARINE HABITATS; CHLOROPHYLL-A; ECOLOGICAL ROLE; SEASONAL-VARIATIONS; LIGHT-INTENSITY; BENTHIC DIATOMS; MUSSEL CULTURE; SECRET GARDEN; SEDIMENT; BIOMASS	Understanding the dynamics of microphytobenthos biomass and photosynthetic performances in intertidal ecosystems will help advance our understanding of how trophic networks function in order to optimize ecological management and restoration projects. The main objective of this study was to investigate microphytobenthic biomass and photosynthetic performances as a function of the sedimentary and environmental variabilities in the range of intertidal habitats in the downstream Seine estuary (Normandy, France). Our results highlight higher biomass associated with more stratified biofilms and better photosynthetic performances in areas characterized by a sand/mud mixture (40-60% of mud) compared to pure sand or pure mud environments. This type of sediment probably offers an efficient trade-off between the favorable characteristics of the two types of sediments (sand and mud) with respect to light penetration and nutrient accessibility. Moreover, the large quantities of exopolysaccharides produced in sand/mud mixtures emphasizes the functional role played by microphytobenthos in promoting sediment stability against erosion. This allows us to show that despite the strong increase in sand content of the downstream Seine estuary, intertidal flats are still productive since microphytobenthic biomass, photosynthetic performances and exopolysaccharides secretion are highest in sand-mud mixtures. This study also underlines the impact of ecosystem modifications due to human disturbance and climate change on the dynamics of key primary producers in estuaries.	[Morelle, Jerome; Claquin, Pascal; Orvain, Francis] Sorbonne Univ, BOREA Biol Organismes & Ecosyst Aquat, CNRS, MNHN,UA,FRE 2030,IRD 207, Caen, France; [Morelle, Jerome; Claquin, Pascal; Orvain, Francis] Univ Caen Normandie, Normandie Univ, Caen, France; [Morelle, Jerome] CNRS, UMR 6553, ECOBIO, Rennes, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Morelle, JM (corresponding author), Sorbonne Univ, BOREA Biol Organismes & Ecosyst Aquat, CNRS, MNHN,UA,FRE 2030,IRD 207, Caen, France.; Morelle, JM (corresponding author), Univ Caen Normandie, Normandie Univ, Caen, France.; Morelle, JM (corresponding author), CNRS, UMR 6553, ECOBIO, Rennes, France.	jerome.morelle@univ-rennes1.fr	Morelle, Jérôme/ABG-3091-2021	Morelle, Jérôme/0000-0003-2167-818X; Claquin, Pascal/0000-0002-5183-203X	GIP SeineAval project PROUESSE [SAV2013PROUESSE-1]	GIP SeineAval project PROUESSE	This work was support by the GIP SeineAval project PROUESSE; Convention ID: SAV2013PROUESSE-1 https://www.seine-aval.fr/.	Barnett A, 2015, ISME J, V9, P32, DOI 10.1038/ismej.2014.105; Barranguet C, 1994, FACTORS CONTROLLING, V173; BAUDINET D, 1990, HYDROBIOLOGIA, V207, P187, DOI 10.1007/BF00041456; Billen G, 2001, ESTUARIES, V24, P977, DOI 10.2307/1353011; Blommaert L, 2018, EUR J PHYCOL, V53, P146, DOI 10.1080/09670262.2017.1397197; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROTAS V, 1995, HYDROBIOLOGIA, V300, P93, DOI 10.1007/BF00024451; Cartaxana P, 2013, AQUAT MICROB ECOL, V70, P87, DOI 10.3354/ame01648; Cartaxana P, 2003, ESTUAR COAST SHELF S, V58, P293, DOI 10.1016/S0272-7714(03)00081-7; Cloern JE, 2014, BIOGEOSCIENCES, V11, P2477, DOI 10.5194/bg-11-2477-2014; COLIJN F, 1981, MAR ECOL PROG SER, V4, P9, DOI 10.3354/meps004009; Daggers TD, 2018, REMOTE SENS ENVIRON, V211, P129, DOI 10.1016/j.rse.2018.03.037; de Brouwer JFC, 2001, MAR ECOL PROG SER, V218, P33, DOI 10.3354/meps218033; Donadi S, 2013, ECOSYSTEMS, V16, P1325, DOI 10.1007/s10021-013-9686-8; Du GY, 2018, J OCEANOL LIMNOL, V36, P293, DOI 10.1007/s00343-017-6099-0; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dupuy C, 2014, J SEA RES, V92, P56, DOI 10.1016/j.seares.2013.12.002; Frankenbach S, 2018, MAR ECOL PROG SER, V601, P41, DOI 10.3354/meps12670; Gillet P, 2008, ESTUAR COAST SHELF S, V76, P201, DOI 10.1016/j.ecss.2007.07.004; Guarini JM, 1998, MAR ECOL PROG SER, V166, P131, DOI 10.3354/meps166131; Guarini JM, 2000, CONT SHELF RES, V20, P1771, DOI 10.1016/S0278-4343(00)00047-9; Herman PMJ, 2001, CONT SHELF RES, V21, P2055, DOI 10.1016/S0278-4343(01)00042-5; JASSBY AD, 1993, MAR ECOL PROG SER, V95, P39, DOI 10.3354/meps095039; Jaud M, 2016, ISPRS INT J GEO-INF, V5, DOI 10.3390/ijgi5040050; Jesus B, 2005, ESTUAR COAST SHELF S, V65, P30, DOI 10.1016/j.ecss.2005.05.005; KUHL M, 1994, LIMNOL OCEANOGR, V39, P1368; KUHL M, 1994, MAR ECOL PROG SER, V105, P139, DOI 10.3354/meps105139; Le Hir P, 2001, ESTUARIES, V24, P950, DOI 10.2307/1353009; Le Hir P, 2011, CONT SHELF RES, V31, pS135, DOI 10.1016/j.csr.2010.12.009; Lefebvre S, 2009, ESTUAR COAST SHELF S, V82, P415, DOI 10.1016/j.ecss.2009.02.002; Lesourd S, 2003, ESTUAR COAST SHELF S, V58, P3, DOI 10.1016/S0272-7714(02)00340-2; Leynaert A, 2011, ESTUAR COAST SHELF S, V95, P59, DOI 10.1016/j.ecss.2011.08.005; Longphuirt SN, 2009, MAR ECOL PROG SER, V379, P33, DOI 10.3354/meps07852; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; MACINTYRE HL, 1995, MAR ECOL PROG SER, V122, P227, DOI 10.3354/meps122227; MacIntyre HL, 1996, ESTUARIES, V19, P186, DOI 10.2307/1352224; Meleder V, 2005, MAR ECOL PROG SER, V297, P83, DOI 10.3354/meps297083; Meleder V, 2003, REMOTE SENS ENVIRON, V88, P386, DOI 10.1016/j.rse.2003.08.009; Meybeck Michel, 1998, Hydrobiologia, V373-374, P1, DOI 10.1023/A:1017067506832; Miller DC, 1996, ESTUARIES, V19, P202, DOI 10.2307/1352225; Morelle J, 2018, ESTUARIES COASTS, V41; Morelle J, 2018, J EXP MAR BIOL ECOL, V503, P136, DOI 10.1016/j.jembe.2018.02.007; Orvain F, 2003, MICROB ECOL, V45, P237, DOI 10.1007/s00248-002-2027-7; Passarelli C, 2014, J SEA RES, V92, P92, DOI 10.1016/j.seares.2013.07.010; Perkins RG, 2003, CONT SHELF RES, V23, P575, DOI 10.1016/S0278-4343(03)00006-2; PINCKNEY J, 1993, ESTUARIES, V16, P887, DOI 10.2307/1352447; Santos PJP, 1997, OCEANOL ACTA, V20, P549; Scaps P, 2002, HYDROBIOLOGIA, V470, P203, DOI 10.1023/A:1015681605656; Sdrigotti E., 2002, ATTI ASSOCIAZIONE IT, V15, P11; Serodio J, 2004, AQUAT MICROB ECOL, V36, P137, DOI 10.3354/ame036137; Serodio J, 2012, AQUAT MICROB ECOL, V67, P161, DOI 10.3354/ame01591; Serodio J, 2011, PHOTOSYNTH RES, V108, P61, DOI 10.1007/s11120-011-9654-0; Serodio Joao, 1999, Aquatic Ecology, V33, P235, DOI 10.1023/A:1009989229098; Shnyukova E. I., 2017, International Journal on Algae, V19, P5, DOI 10.1615/InterJAlgae.v19.i1.10; Stal L. J., 2003, BERICHTE FORSCHUNGSZ, V12, P109; Thrush SF, 2012, ECOL APPL, V22, P1213, DOI 10.1890/11-1403.1; Ubertini M, 2015, J EXP MAR BIOL ECOL, V467, P52, DOI 10.1016/j.jembe.2015.02.007; Ubertini M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044155; Underwood GJC, 1999, ADV ECOL RES, V29, P93; Underwood Graham J. C., 1994, Diatom Research, V9, P451; Van De Koppel J, 2001, ECOLOGY, V82, P3449, DOI 10.1890/0012-9658(2001)082[3449:DASSOI]2.0.CO;2; van der Wal D, 2010, ECOSYSTEMS, V13, P338, DOI 10.1007/s10021-010-9322-9; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Weerman EJ, 2010, AM NAT, V176, pE15, DOI 10.1086/652991; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985	65	9	9	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237211	10.1371/journal.pone.0237211	http://dx.doi.org/10.1371/journal.pone.0237211			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760132	Green Published, gold			2022-12-26	WOS:000561027200086
J	Pongpirul, K; Kaewpoungngam, K; Chotirosniramit, K; Theprugsa, S				Pongpirul, Krit; Kaewpoungngam, Kanitha; Chotirosniramit, Korn; Theprugsa, Sinnop			Commercial airline protocol during COVID-19 pandemic: An experience of Thai Airways International	PLOS ONE			English	Article								Introduction Coronavirus disease 2019 (COVID-19) pandemic has affected the aviation industry. Existing protocols have relied on scientifically questionable evidence and might not lead to the optimal balance between public health safety and airlines' financial viability. Objective To explore the implementation feasibility of Thai Airways International protocol from the perspectives of passengers and aircrews. Design An online questionnaire survey of passengers and an in-depth interview with aircrews. Setting Two randomly selected repatriation flights operated by Thai Airways International using Boeing 777 aircraft (TG476 from Sydney and TG492 from Auckland to Bangkok) Participants 377 Thai passengers and 35 aircrews. Results The mean age of passengers was 28.14 (95%CI 26.72 to 29.55) years old; 57.03% were female. TG492 passengers were mostly students and significantly younger than that of TG476 (p<0.0001) with comparable flying experience (p = 0.1192). The average body temperature was 36.52 (95%CI 36.48 to 36.55) degrees Celsius. Passengers estimated average physical distances of 1.59 (95%CI 1.48 to 1.70), 1.41 (95%CI 1.29 to 1.53), and 1.26 (95%CI 1.12 to 1.41) meters at check-in, boarding, and in-flight, respectively. Passengers were checked for body temperature during the flight 1.97 (95%CI 1.77 to 2.18) times on average which is significantly more frequent in longer than shorter flight (p<0.0001). Passengers moved around or went to the toilet during the flight 2.00 (95%CI 1.63 to 2.37) and 2.08 (95%CI 1.73 to 2.43) times which are significantly more frequent in longer than shorter flight (p = 0.0186 and 0.0049, respectively). The aircrews were satisfied with the protocol and provided several practical suggestions. Conclusion The protocol was well received by the passengers and aircrews of the repatriation flights with some suggestions for improvement.	[Pongpirul, Krit; Chotirosniramit, Korn] Chulalongkorn Univ, Dept Prevent & Social Med, Fac Med, Bangkok, Thailand; [Pongpirul, Krit] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Pongpirul, Krit] Bumrungrad Int Hosp, Bangkok, Thailand; [Kaewpoungngam, Kanitha] Dhurakij Pundit Univ, Coll Aviat Dev & Training, Bangkok, Thailand; [Theprugsa, Sinnop] Thai Airways Int Publ Co Ltd, Bangkok, Thailand	Chulalongkorn University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Pongpirul, K (corresponding author), Chulalongkorn Univ, Dept Prevent & Social Med, Fac Med, Bangkok, Thailand.; Pongpirul, K (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.; Pongpirul, K (corresponding author), Bumrungrad Int Hosp, Bangkok, Thailand.	doctorkrit@gmail.com	Pongpirul, Krit/H-4064-2019	Pongpirul, Krit/0000-0003-3818-9761				[Anonymous], 2020, COVID 19 SCREENING Q; [Anonymous], 2020, APPL RE ENTRY PERMIT; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Cripps K., 2020, CNN, V21; Gandhi M, 2020, NEW ENGL J MED, V382, P2158, DOI 10.1056/NEJMe2009758; Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349; Sutherland W, 2020, INFORM MANAGEMENT LO	7	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237299	10.1371/journal.pone.0237299	http://dx.doi.org/10.1371/journal.pone.0237299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760126	Green Submitted, Green Published, gold			2022-12-26	WOS:000561027200087
J	Dekker, M; Waissi, F; van Bennekom, J; Silvis, MJM; Timmerman, N; Schoneveld, AH; Grobbee, DE; de Winter, RJ; Mosterd, A; Timmers, L; de Kleijn, DPV				Dekker, Mirthe; Waissi, Farahnaz; van Bennekom, Joelle; Silvis, Max J. M.; Timmerman, Nathalie; Schoneveld, Arjan H.; Grobbee, Diederick E.; de Winter, Robbert J.; Mosterd, Arend; Timmers, Leo; de Kleijn, Dominique P., V			Extracellular Vesicle cystatin c is associated with unstable angina in troponin negative patients with acute chest pain	PLOS ONE			English	Article							SENSITIVITY CARDIAC TROPONIN; CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; EARLY-DIAGNOSIS; ENDOTHELIAL MICROPARTICLES; PROTEIN-LEVELS; MANAGEMENT; RISK; BIOMARKERS; GUIDELINES	Background Despite the use of high-sensitive cardiac troponin there remains a group of high-sensitive cardiac troponin negative patients with unstable angina with a non-neglectable risk for future adverse cardiovascular events, emphasising the need for additional risk stratification. Plasma extracellular vesicles are small bilayer membrane vesicles known for their potential role as biomarker source. Their role in unstable angina remains unexplored. We investigate if extracellular vesicle proteins are associated with unstable angina in patients with chest pain and low high-sensitive cardiac troponin. Methods The MINERVA study included patients presenting with acute chest pain but no acute coronary syndrome. We performed an exploratory retrospective case-control analysis among 269 patients. Cases were defined as patients with low high-sensitive cardiac troponin and proven ischemia. Patients without ischemia were selected as controls. Blood samples were fractionated to analyse the EV proteins in three plasma-subfractions: TEX, HDL and LDL. Protein levels were quantified using electrochemiluminescence immunoassay. Results Lower levels of (adjusted) EV cystatin c in the TEX subfraction were associated with having unstable angina (OR 0.93 95% CI 0.88-0.99). Conclusion In patients with acute chest pain but low high-sensitive cardiac troponin, lower levels of plasma extracellular vesicle cystatin c are associated with having unstable angina. This finding is hypothesis generating only considering the small sample size and needs to be confirmed in larger cohort studies, but still identifies extracellular vesicle proteins as source for additional risk stratification.	[Dekker, Mirthe; Waissi, Farahnaz; van Bennekom, Joelle; Timmerman, Nathalie; de Kleijn, Dominique P., V] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Dekker, Mirthe; Waissi, Farahnaz; de Winter, Robbert J.] Amsterdam Univ Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Silvis, Max J. M.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Schoneveld, Arjan H.] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands; [Grobbee, Diederick E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Mosterd, Arend] Meander Med Ctr Amersfoort, Dept Cardiol, Amersfoort, Netherlands; [Timmers, Leo] St Antonius Hosp Nieuwegein, Dept Cardiol, Nieuwegein, Netherlands; [de Kleijn, Dominique P., V] Netherlands Heart Inst, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Meander Medisch Centrum; St. Antonius Hospital Utrecht	de Kleijn, DPV (corresponding author), Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands.; de Kleijn, DPV (corresponding author), Netherlands Heart Inst, Utrecht, Netherlands.	dkleijn@umcutrecht.nl		Dekker, Mirthe/0000-0002-9336-9469; Silvis, Max/0000-0002-7196-8049	Cardiovascular Research Netherlands (CVON) [201705]; Netherlands Heart Foundation [2017T067]	Cardiovascular Research Netherlands (CVON); Netherlands Heart Foundation(Netherlands Heart Foundation)	This study was funded by Cardiovascular Research Netherlands (CVON grant number 201705 to DdK, LT, RdW and DeG) and the Netherlands Heart Foundation (grant 2017T067 to LT).	Amabile N, 2014, EUR HEART J, V35, P2972, DOI 10.1093/eurheartj/ehu153; Amsterdam EA, 2014, CIRCULATION, V130, P2354, DOI 10.1161/CIR.0000000000000133; Bank IEM, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005373; Boulanger CM, 2017, NAT REV CARDIOL, V14, P259, DOI 10.1038/nrcardio.2017.7; Chapman AR, 2020, CIRCULATION, V141, P161, DOI 10.1161/CIRCULATIONAHA.119.042960; Chironi G, 2006, ARTERIOSCL THROM VAS, V26, P2775, DOI 10.1161/01.ATV.0000249639.36915.04; D'Souza M, 2015, AM J MED, V128, P852, DOI 10.1016/j.amjmed.2015.01.044; Hoog VC, 2013, EUR HEART J-ACUTE CA, V2, P53, DOI 10.1177/2048872612471212; Deddens JC, 2013, J CARDIOVASC TRANSL, V6, P884, DOI 10.1007/s12265-013-9493-9; Eggers KM, 2017, AM J MED, V130, P1423, DOI 10.1016/j.amjmed.2017.05.037; Eggers KM, 2016, EUR HEART J, V37, P2417, DOI 10.1093/eurheartj/ehw029; Giannitsis E, 2020, CLIN RES CARDIOL, V109, P476, DOI 10.1007/s00392-019-01529-4; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Kanhai DA, 2013, INT J CARDIOL, V168, P2358, DOI 10.1016/j.ijcard.2013.01.231; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Keller T, 2009, EUR HEART J, V30, P314, DOI 10.1093/eurheartj/ehn598; Kiyosue A, 2010, CIRC J, V74, P2441, DOI 10.1253/circj.CJ-10-0158; Loyer X, 2014, CIRC RES, V114, P345, DOI 10.1161/CIRCRESAHA.113.300858; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; Martinez MC, 2011, TRENDS PHARMACOL SCI, V32, P659, DOI 10.1016/j.tips.2011.06.005; Mendis S, 2011, INT J EPIDEMIOL, V40, P139, DOI 10.1093/ije/dyq165; Mueller C, 2014, EUR HEART J, V35, P552, DOI 10.1093/eurheartj/eht530; Negrusz-Kawecka M, 2014, ADV CLIN EXP MED, V23, P551, DOI 10.17219/acem/37222; Poldervaart JM, 2017, ANN INTERN MED, V166, P689, DOI 10.7326/M16-1600; Puelacher C, 2019, HEART, V105, P1423, DOI 10.1136/heartjnl-2018-314305; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Sanchis J, 2014, HEART, V100, P1591, DOI 10.1136/heartjnl-2013-305440; Sandoval Y, 2018, EUR HEART J-ACUTE CA, V7, P120, DOI 10.1177/2048872616658591; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Twerenbold R, 2016, EUR HEART J, V37, P3324, DOI 10.1093/eurheartj/ehw232; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wang JW, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010094; Wright RS, 2011, J AM COLL CARDIOL, V57, P1920, DOI 10.1016/j.jacc.2011.02.009; Yong PJA, 2013, EUR J PREV CARDIOL, V20, P496, DOI 10.1177/2047487312445001	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0237036	10.1371/journal.pone.0237036	http://dx.doi.org/10.1371/journal.pone.0237036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756583	gold, Green Published			2022-12-26	WOS:000560393300022
J	Fu, YT; Bhadha, JH; Rott, P; Beuzelin, JM; Kanissery, R				Fu, Yuting; Bhadha, Jehangir H.; Rott, Philippe; Beuzelin, Julien M.; Kanissery, Ramdas			Investigating the use of aquatic weeds as biopesticides towards promoting sustainable agriculture	PLOS ONE			English	Article							AMARANTHUS-PALMERI; GROWTH; GERMINATION; L.	Aquatic weeds such as muskgrass (Charaspp.), water hyacinth (Eichhornia crassipes), water lettuce (Pistia stratiotes), hydrilla (Hydrilla verticillate), filamentous algae (Lyngbya wollei), and duckweed (Lemna minor) thrive in farm canals within the Everglades Agricultural Area of South Florida. Their presence, particularly during the summer months is an environmental concern with regards to water quality, in addition to being a nuisance because of their ability to multiply and spread rapidly in open waters causing restricted drainage/irrigation flow and low dissolved oxygen levels. Chemical control is effective but can have undesirable off-target effects, so reduced herbicide use is desirable. Hence, need exists to discover ways in which these weeds could be best managed or utilized. The objective of this research was to evaluate the allelopathic effect of these weeds to determine their use as potential biopesticides. Six aqueous extracts were tested against 100 bacterial strains isolated from plants and soil to evaluate their antimicrobial activity. These extracts were also used to determine their insecticidal and antifeedant effects on fall armyworm (FAW,Spodoptera frugiperda). Both extracts and powder form of the aquatic weeds were tested for their herbicidal activity towards seed germination and growth of three common terrestrial weed species. At a dilution of 1:100 and 1:1,000, none of the aquatic weeds inhibitedin-vitrogrowth of the bacterial strains, with one exception (filamentous algae extract at 1:100 reduced growth of one bacterial isolate by 54%). Water lettuce reduced the survival rate of FAW by 14% while hydrilla and duckweed caused 11% and 9% reduction of FAW growth, respectively. Powdered duckweed inhibited the growth of nutsedge by 41%, whereas filamentous algae powder and extract reduced germination of amaranth by 20% and 28%, respectively. Harvesting these weeds and converting them into useable compounds could not only eliminate the in situ farm canal and water quality problems but also result in development of new soil amendments or biopesticides.	[Fu, Yuting; Bhadha, Jehangir H.] Univ Florida, Everglades Res & Educ Ctr, Soil & Water Sci Dept, Belle Glade, FL 33430 USA; [Rott, Philippe] Univ Florida, Everglades Res & Educ Ctr, Plant Pathol Dept, Belle Glade, FL 33430 USA; [Rott, Philippe] UMR BGPI, CIRAD, Montpellier, France; [Rott, Philippe] Univ Montpellier, Inst Agro, INRAE, CIRAD,BGPI, Montpellier, France; [Beuzelin, Julien M.] Univ Florida, Everglades Res & Educ Ctr, Entomol & Nematol Dept, Belle Glade, FL 33430 USA; [Kanissery, Ramdas] Univ Florida, Southwest Florida Res & Educ Ctr, Hort Sci Dept, Immokalee, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; CIRAD; CIRAD; INRAE; Institut Agro; Universite de Montpellier; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bhadha, JH (corresponding author), Univ Florida, Everglades Res & Educ Ctr, Soil & Water Sci Dept, Belle Glade, FL 33430 USA.	jango@ufl.edu		Bhadha, Jehangir/0000-0002-9436-1725; Kanissery, Ramdas/0000-0003-3161-3865				Abbas T, 2017, PLANTA DANINHA, V35, DOI [10.1590/s0100-83582017350100020, 10.1590/S0100-83582017350100020]; Abraham J, 2014, INT J DRUG DEV RES, V6, P208; Abrahams P, 2017, 2 CAB DFID; [Anonymous], 2008, ADV NAT APPL SCI; Ben-David A, 2014, J MICROBIOL METH, V107, P214, DOI 10.1016/j.mimet.2014.08.023; Berger J, 2004, BIOLOGIA, V59, P9; Bhadha J. H., 2014, Sustainable Agriculture Research, V3, P121; Bhadha JH, 2015, J AQUAT PLANT MANAGE, V53, P44; BRADOW JM, 1985, ACS SYM SER, V268, P285; Bruckner DJ, 2003, CHEMOSPHERE, V51, P515, DOI 10.1016/S0045-6535(02)00790-7; FARRAR RR, 1989, ANN ENTOMOL SOC AM, V82, P593, DOI 10.1093/aesa/82.5.593; Ferguson JJ, 2013, ALLELOPATHY PLANTS S, P944; FISCHER NH, 1985, ACS SYM SER, V268, P133; Galindo JCG, 1999, PHYTOCHEMISTRY, V52, P805, DOI 10.1016/S0031-9422(99)00303-9; Getman-Pickering ZL, 2020, METHODS ECOL EVOL, V11, P215, DOI 10.1111/2041-210X.13340; Ghassan JZ, 2016, INT J SCI TECHNICAL, V1, P1; Gniazdowska A, 2005, ACTA PHYSIOL PLANT, V27, P395, DOI 10.1007/s11738-005-0017-3; Hassan MO, 2014, PHILIPP AGRIC SCI, V97, P368; HOFTE H, 1989, MICROBIOL REV, V53, P242; Jayashree KV, 2018, J APPL SCI COMPUTATI, P1076; Jin NY, 2015, J FAC AGR KYUSHU U, V60, P97; Lenora L., 2016, CHEM SIN, V7, P48; Lenora L.M., 2017, ASIAN J PLANT SCI RE, V7, P1; Li XF, 2011, PLANT SOIL, V341, P383, DOI 10.1007/s11104-010-0652-3; Mallik AU, 2008, ALLELOPATHY IN SUSTAINABLE AGRICULTURE AND FORESTRY, P25, DOI 10.1007/978-0-387-77337-7_2; Mcpherson BF, 1976, PROFESSIONAL PAPERS, V1011, P1; Menon R, 2014, WETLANDS, V34, P1191, DOI 10.1007/s13157-014-0578-2; OKUNADE AL, 1985, J NAT PROD, V48, P472, DOI 10.1021/np50039a020; Parekh Jigna, 2005, Turkish Journal of Biology, V29, P203; RICE E. L., 1984, ALLELOPATHY, P421; SAS Institute Inc, 2017, SASSTAT 143 USERS GU; SAS Institute Inc, 2014, SAS STAT 13 2 US GLM; SCHOONHOVEN LM, 1982, ENTOMOL EXP APPL, V31, P57, DOI 10.1111/j.1570-7458.1982.tb03119.x; Sexton AE, 2017, THESIS; Silva M. S., 2015, Comunicata Scientiae, V6, P359, DOI 10.14295/CS.v6i3.808; Sudirman S, 2017, ORIENTAL J CHEM, V33; Tran TNB, 2012, AQUAT BOT, V103, P30, DOI 10.1016/j.aquabot.2012.05.007; Tripathi P, 2010, Pharmacogn Rev, V4, P153, DOI 10.4103/0973-7847.70909; Yu X, 2007, CHINESE J CHEM, V25, P661	39	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0237258	10.1371/journal.pone.0237258	http://dx.doi.org/10.1371/journal.pone.0237258			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756605	Green Published, gold			2022-12-26	WOS:000560393300058
J	Al-Haqan, A; Boswihi, SS; Pathan, S; Udo, EE				Al-Haqan, Aishah; Boswihi, Samar S.; Pathan, Seema; Udo, Edet E.			Antimicrobial resistance and virulence determinants in coagulase-negative staphylococci isolated mainly from preterm neonates	PLOS ONE			English	Article							CATABOLIC MOBILE ELEMENT; INTENSIVE-CARE-UNIT; MULTIPLEX PCR ASSAY; ANTIBIOTIC-RESISTANCE; BIOFILM FORMATION; RAPID DETECTION; EPIDERMIDIS; SEPSIS; AUREUS; ENTEROTOXIN	Coagulase-negative staphylococci (CoNS) are the most common isolates from blood culture in neonates resulting in high mortality and morbidity. This study investigated CoNS obtained from blood cultures of neonates for antibiotic resistance and virulence factors, and possible association with inflammatory response (C-reactive protein). A total of 93 CoNS isolates were collected from 76 blood cultures of neonates at the Maternity hospital in Kuwait in a six-month period and investigated for susceptibility to antibiotics, carriage of staphylococcal cassette chromosomemec(SCCmec), and virulence-associated genes. The 93 CoNS isolates consisted ofS.epidermidis(76; 81.7%),S.capitis(12; 12.9%),S.hominis(2; 2.1%),S.warneri(2; 2.1%) andS.haemolyticus(1; 1.0%). Eighty-six (92.4%) of the isolates were resistant to cefoxitin (MR-CoNS) while 49 (52.7%) expressed multi-antibiotic resistance. The methicillin-resistant isolates (MR-CoNS) carried SCCmecIII, SCCmecIVa and four combinations of SCCmectypes including SCCmectypes I+IVa (oneS.warneriand 25S.epidermidisisolates), types I+III (oneS.epidermidisisolate), types III+IVa (sixS.epidermidisisolates) and types I+III+IVa (oneS.epidermidisisolate). The most common virulence-related genes wereicaC,seb,arcdetected in 69.7%, 60.5%, 40.8% of the isolates respectively. Two isolates were positive fortst1. No association between C-reactive protein and antibiotic resistance or virulence factors was established. This study revealed thatS.epidermidiscarrying different SCCmecgenetic elements, was the dominant CoNS species isolated from neonatal blood cultures with 90.3% and 36.6% of the isolates positive for genes for biofilm and ACME production respectively.	[Al-Haqan, Aishah; Pathan, Seema] Matern Hosp, Microbiol Lab, Kuwait, Kuwait; [Boswihi, Samar S.; Udo, Edet E.] Kuwait Univ, Dept Microbiol, Fac Med, Kuwait, Kuwait	Kuwait University	Udo, EE (corresponding author), Kuwait Univ, Dept Microbiol, Fac Med, Kuwait, Kuwait.	EDET@hsc.edu.kw	Udo, Edet E/H-7367-2016	Udo, Edet E/0000-0002-7269-7949				Barbier F, 2011, J ANTIMICROB CHEMOTH, V66, P29, DOI 10.1093/jac/dkq410; Bizzarro MJ, 2005, PEDIATRICS, V116, P595, DOI 10.1542/peds.2005-0552; Brito CS, 2014, BRAZ J INFECT DIS, V18, P387, DOI 10.1016/j.bjid.2013.11.010; Cabrera-Contreras R, 2013, ISRN MICROBIOL, V2013, DOI [10.1155/2013/91892123724338, DOI 10.1155/2013/91892123724338]; Clinical and Laboratory Standards Institute, M100S24 CLSI; da Cunha MDRS, 2007, MICROBIOL IMMUNOL, V51, P381, DOI 10.1111/j.1348-0421.2007.tb03925.x; Silva Andre Ricardo Araujo da, 2013, Rev. bras. ter. intensiva, V25, P239, DOI 10.5935/0103-507X.20130041; de Silva GDI, 2002, J CLIN MICROBIOL, V40, P382, DOI 10.1128/JCM.40.02.382-388.2002; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Dong Y, 2018, VIRULENCE, V9, P621, DOI 10.1080/21505594.2017.1419117; Ertugrul S, 2016, IRAN J PEDIATR, V26, DOI 10.5812/ijp.5213; FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872; Granslo HN, 2010, PEDIATR RES, V68, P237, DOI [10.1203/PDR.0b013e3181eb01e0, 10.1203/00006450-201011001-00463]; Hammoud MS, 2017, INT J INFECT DIS, V55, P125, DOI 10.1016/j.ijid.2017.01.006; Hammoud MS, 2012, J PAEDIATR CHILD H, V48, P604, DOI 10.1111/j.1440-1754.2012.02432.x; Hira V, 2010, J CLIN MICROBIOL, V48, P3876, DOI 10.1128/JCM.00967-10; HUEBNER J, 1994, J INFECT DIS, V169, P526, DOI 10.1093/infdis/169.3.526; Klingenberg C, 2005, PEDIATR INFECT DIS J, V24, P817, DOI 10.1097/01.inf.0000176735.20008.cd; Knudtzen FC, 2014, J INFECTION, V68, P149, DOI 10.1016/j.jinf.2013.10.006; Kuzdan C, 2014, J INFECT DEV COUNTR, V8, P1415, DOI 10.3855/jidc.3931; Lai MY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1069-7; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Ma XX, 2011, J MED MICROBIOL, V60, P1661, DOI 10.1099/jmm.0.034066-0; Marchant EA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/586076; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Milisavljevic V, 2005, AM J INFECT CONTROL, V33, P341, DOI 10.1016/j.ajic.2005.02.003; Mularoni A, 2014, PEDIATR INFECT DIS J, V33, pE121, DOI 10.1097/INF.0000000000000175; O'Connor AM, 2018, INFECT GENET EVOL, V61, P60, DOI 10.1016/j.meegid.2018.03.012; Otto M, 2017, FUTURE MICROBIOL, V12, P1031, DOI 10.2217/fmb-2017-0143; da Silva SDP, 2015, FOODBORNE PATHOG DIS, V12, P921, DOI 10.1089/fpd.2015.1941; Pi BR, 2009, J MED MICROBIOL, V58, P731, DOI 10.1099/jmm.0.007351-0; Pinheiro L, 2014, MEM I OSWALDO CRUZ, V109, P871, DOI 10.1590/0074-0276140120; Qazi SA, 2009, PEDIATR INFECT DIS J, V28, pS1, DOI 10.1097/INF.0b013e31819587a9; Qu Y, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-16; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P1896, DOI 10.1128/AAC.01756-10; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; Stach CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143341; Stegger M, 2012, CLIN MICROBIOL INFEC, V18, P395, DOI 10.1111/j.1469-0691.2011.03715.x; Tripathi N, 2012, CLIN PERINATOL, V39, P61, DOI 10.1016/j.clp.2011.12.003; Udo Edet E, 2009, BMC Res Notes, V2, P108, DOI 10.1186/1756-0500-2-108; Udo EE, 2000, INT J ANTIMICROB AG, V15, P19, DOI 10.1016/S0924-8579(00)00119-9; Udo EE, 1999, J MED MICROBIOL, V48, P819, DOI 10.1099/00222615-48-9-819; Udo EE, 1995, MICROB DRUG RESIST, V1, P315, DOI 10.1089/mdr.1995.1.315; Vasconcelos NG, 2011, J APPL MICROBIOL, V111, P749, DOI 10.1111/j.1365-2672.2011.05076.x; Zea-Vera A, 2015, J TROP PEDIATRICS, V61, P1, DOI 10.1093/tropej/fmu079; Zhang KY, 2012, MOL CELL PROBE, V26, P218, DOI 10.1016/j.mcp.2012.04.002; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; Zong ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020191	48	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0236713	10.1371/journal.pone.0236713	http://dx.doi.org/10.1371/journal.pone.0236713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750089	gold, Green Published			2022-12-26	WOS:000560009200010
J	Djague, F; Lunga, PK; Toghueo, KRM; Melogmo, DYK; Fekam, BF				Djague, Fred; Lunga, Paul Keilah; Toghueo, Kouipou Rufin Marie; Melogmo, Dongmo Yanick Kevin; Fekam, Boyom Fabrice			Garcinia kola(Heckel) andAlchornea cordifolia(Schumach. & Thonn.) Mull. Arg. from Cameroon possess potential antisalmonellal and antioxidant properties	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; GLOBAL BURDEN; MECHANISMS; TOXICITY	Drug resistantSalmonellaspecies and shortcomings related to current drugs stress the urgent need to search for new antimicrobial agents to control salmonellosis. This study investigated the antisalmonellal and antioxidant potentials of methanolic and hydro-ethanolic extracts ofGarcinia kolaandAlchornea cordifoliaas potential sources of drugs to controlSalmonellaspecies and to reduce related oxidative stress. The antisalmonellal activity was assessed using the broth microdilution, membrane destabilization and time-kill kinetic assays. While, the DPPH, ABTS and FRAP assays were used for the determination of the antioxidant activities. The minimum inhibitory concentrations ranged from 125 to 1000 mu g/mL, with the methanolic root extract ofG.kolabeing the most active. The time kill kinetic assay revealed a concentration-dependent bacteriostatic activity for promising extracts. Potent extracts fromG.kolashowed the ability to destabilizeS.typhiouter membrane, with the methanolic root extract presenting the highest activity; two-fold higher than those of polymyxin B tested as reference. In addition, this methanolic root extract ofG.kolaalso provoked nucleotide leakage in a concentration-dependent manner. From the antioxidant assays, the hydro-ethanolic extract from the stem bark ofA.cordifoliapresented significant activities comparable to that of Vitamin C. The methanolic root extract ofG.kolaalso presented appreciable antioxidant activities, though less than that ofA.cordifolia. Overall, the phytochemical screening of active extracts revealed the presence of anthocyanins, flavonoids, glycosides, phenols, tannins, triterpenoids and steroids. These results provide evidence of the antibacterial potential ofG.kolaand offer great perspectives in a possible standardisation of an antisalmonellal phytomedicine.	[Djague, Fred; Lunga, Paul Keilah; Toghueo, Kouipou Rufin Marie; Melogmo, Dongmo Yanick Kevin; Fekam, Boyom Fabrice] Univ Yaounde I, Antimicrobial & Biocontrol Agents Unit AmBcAU, Lab Phytobiochem & Med Plants Studies, Fac Sci,Dept Biochem, Yaounde, Cameroon	University of Yaounde I	Lunga, PK (corresponding author), Univ Yaounde I, Antimicrobial & Biocontrol Agents Unit AmBcAU, Lab Phytobiochem & Med Plants Studies, Fac Sci,Dept Biochem, Yaounde, Cameroon.	lungapaul@yahoo.ca	Toghueo, Rufin/ABA-3152-2021; DONGMO, Yanick Kevin MELOGMO/ABB-4321-2020	Toghueo, Rufin/0000-0003-2144-0710; 	Seeding Labs' Instrumental Access Grant [SL2012-2]	Seeding Labs' Instrumental Access Grant	Authors are very grateful to the Seeding Labs' Instrumental Access Grant (SL2012-2) to Prof. Boyom. This work also received materials and equipment support from the Yaounde '-Bielefeld Bilateral Graduate School for Natural Products with Antiparasite and Antibacterial Activity (YaBiNaPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaydha CV, 2019, BIOSENS BIOELECTRON, V129, P224, DOI [10.1016/j.bios.2018.09.078 30318404, DOI 10.1016/J.BIOS.2018.09.078 30318404]; Adeshina G. O., 2012, European Journal of Medicinal Plants, V2, P31; Anantharaman A, 2010, ANTIMICROB AGENTS CH, V54, P1693, DOI 10.1128/AAC.01231-09; Ao TT, 2015, EMERG INFECT DIS, V21, P941, DOI 10.3201/eid2106.140999; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Campos NG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164000; Crum-Cianflone Nancy F, 2008, Curr Gastroenterol Rep, V10, P424, DOI 10.1007/s11894-008-0079-7; Dah-Nouvlessounon D., 2015, Food and Nutrition Sciences, V6, P1395, DOI 10.4236/fns.2015.615145; de Diego-Otero Y, 2009, NEUROPSYCHOPHARMACOL, V34, P1011, DOI 10.1038/npp.2008.152; Esiegwu A. C., 2014, Global Journal of Animal Scientific Research, V2, P170; Ezeokeke E. E., 2017, J ANAL BIOANAL TECH, V8, P353; Farombi EO, 2000, FOOD RES INT, V33, P493, DOI 10.1016/S0963-9969(00)00074-0; Flora O, 2008, AFR J BIOCH RES, V11, P215; Frirdich E, 2005, J ENDOTOXIN RES, V11, P133, DOI 10.1179/096805105X46592; Gal-Mor O, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00391; Gasem MH, 2002, J MED MICROBIOL, V51, P173, DOI 10.1099/0022-1317-51-2-173; Gatsing D, 2008, ETHIOP PHARM J, V26, P83, DOI DOI 10.4314/EPJ.V26I2.43039; Gatsing D, 2010, INT J PHARMACOL, V6, P173, DOI 10.3923/ijp.2010.173.182; Global Burden of Disease Results Tool, 2018, GBD RES TOOL GHDX; Guimaraes DO, 2010, QUIM NOVA, V33, P667, DOI 10.1590/S0100-40422010000300035; Gustafsson MHG, 2002, INT J PLANT SCI, V163, P1045, DOI 10.1086/342521; Hao G, 2009, PEPTIDES, V30, P1421, DOI 10.1016/j.peptides.2009.05.016; Harborne JB, 1976, PHYTOCHEMICAL METHOD, P150; Huckstep RL, 1962, TYPHOID FEVER OTHER; Jay S., 2003, Foodborne microorganisms of public health significance, P207; Kagbo HD, 2010, INTERNET J TOXICOL, V7; Lunga PK, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-302; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mambe FT, 2016, J TAIBAH UNIV MED SC, V11, P121, DOI 10.1016/j.jtumed.2015.12.001; Moukette BM, 2015, TOXICOL REP, V2, P792, DOI 10.1016/j.toxrep.2015.02.007; Naufalin R, 2017, INT FOOD RES J, V24, P379; Naufalin R., 2005, JURNAL TEKNOLOGI DAN, V16, P119; Odeyemi OA, 2011, INT J RES BIOMEDICIN, V1, P5; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972; Pinto NCC, 2017, AN ACAD BRAS CIENC, V89, P2053, DOI 10.1590/0001-3765201720150702; Rastaldo R, 2007, LIFE SCI, V81, P779, DOI 10.1016/j.lfs.2007.07.019; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Saravanan S, 2015, INDIAN J MICROBIOL, V1, DOI [10.1007/s12088-015-0558-026843692, DOI 10.1007/S12088-015-0558-026843692]; Scherer R, 2009, FOOD CHEM, V112, P654, DOI 10.1016/j.foodchem.2008.06.026; Tamokou JDD, 2017, MEDICINAL SPICES AND VEGETABLES FROM AFRICA: THERAPEUTIC POTENTIAL AGAINST METABOLIC, INFLAMMATORY, INFECTIOUS AND SYSTEMIC DISEASES, P207, DOI 10.1016/B978-0-12-809286-6.00008-X; Tang YL, 2008, J PHARMACEUT BIOMED, V48, P1187, DOI 10.1016/j.jpba.2008.09.006; Trombetta D, 2005, ANTIMICROB AGENTS CH, V49, P2474, DOI 10.1128/AAC.49.6.2474-2478.2005; Tsuji BT, 2008, J ANTIMICROB CHEMOTH, V62, P156, DOI 10.1093/jac/dkn133; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; World Health Organization, 2018, SALM NONT; Xing K, 2009, CARBOHYD POLYM, V76, P17, DOI 10.1016/j.carbpol.2008.09.016	47	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0237076	10.1371/journal.pone.0237076	http://dx.doi.org/10.1371/journal.pone.0237076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750082	Green Published, gold			2022-12-26	WOS:000560009200025
J	Frake, AN; Peter, BG; Walker, ED; Messina, JP				Frake, April N.; Peter, Brad G.; Walker, Edward D.; Messina, Joseph P.			Leveraging big data for public health: Mapping malaria vector suitability in Malawi with Google Earth Engine	PLOS ONE			English	Article							MOSQUITO ANOPHELES-GAMBIAE; CLIMATIC FACTORS; LARVAL HABITATS; ABUNDANCE; VILLAGE; AFRICA; BURDEN; MODELS; NDVI; AREA	In an era of big data, the availability of satellite-derived global climate, terrain, and land cover imagery presents an opportunity for modeling the suitability of malaria disease vectors at fine spatial resolutions, across temporal scales, and over vast geographic extents. Leveraging cloud-based geospatial analytical tools, we present an environmental suitability model that considers water resources, flow accumulation areas, precipitation, temperature, vegetation, and land cover. In contrast to predictive models generated using spatially and temporally discontinuous mosquito presence information, this model provides continuous fine-spatial resolution information on the biophysical drivers of suitability. For the purposes of this study the model is parameterized forAnopheles gambiaes.s. in Malawi for the rainy (December-March) and dry seasons (April-November) in 2017; however, the model may be repurposed to accommodate different mosquito species, temporal periods, or geographical boundaries. Final products elucidate the drivers and potential habitat ofAnopheles gambiaes.s. Rainy season results are presented by quartile of precipitation; Quartile four (Q4) identifies areas most likely to become inundated and shows 7.25% of Malawi exhibits suitable water conditions (water only) forAnopheles gambiaes.s., approximately 16% for water plus another factor, and 8.60% is maximally suitable, meeting suitability thresholds for water presence, terrain characteristics, and climatic conditions. Nearly 21% of Malawi is suitable for breeding based on land characteristics alone and 28.24% is suitable according to climate and land characteristics. Only 6.14% of the total land area is suboptimal. Dry season results show 25.07% of the total land area is suboptimal or unsuitable. Approximately 42% of Malawi is suitable based on land characteristics alone during the dry season, and 13.11% is suitable based on land plus another factor. Less than 2% meets suitability criteria for climate, water, and land criteria. Findings illustrate environmental drivers of suitability for malaria vectors, providing an opportunity for a more comprehensive approach to malaria control that includes not only modeled species distributions, but also the underlying drivers of suitability for a more effective approach to environmental management.	[Frake, April N.; Peter, Brad G.] Univ Alabama, Dept Geog, Tuscaloosa, AL 35487 USA; [Walker, Edward D.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Messina, Joseph P.] Univ Alabama, Coll Arts & Sci, Tuscaloosa, AL USA	University of Alabama System; University of Alabama Tuscaloosa; Michigan State University; University of Alabama System; University of Alabama Tuscaloosa	Frake, AN (corresponding author), Univ Alabama, Dept Geog, Tuscaloosa, AL 35487 USA.	afrake@ua.edu	Peter, Brad G./AAT-7678-2021	Peter, Brad G./0000-0002-5724-4482; Frake, April/0000-0002-9875-9140; Messina, Joseph/0000-0002-1978-0778	United States Agency for International Development (USAID) [AID-OAA-L14-00006]; Fogarty International Center/NIH Framework Programs for Global Health Innovation [D43TW009639]; United States Agency for International Development (USAID);  [U19AI089683]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Fogarty International Center/NIH Framework Programs for Global Health Innovation; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); 	This study is made possible in part by the support of the American People provided to the Feed the Future Innovation Lab for Sustainable Intensification through the United States Agency for International Development (USAID). The contents are the sole responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. Program activities are funded by the United States Agency for International Development (USAID) under Cooperative Agreement No. AID-OAA-L14-00006 (PI: Joseph P. Messina). This study was also supported by the Fogarty International Center/NIH Framework Programs for Global Health Innovation D43TW009639 (Intersectoral Fellowships on Irrigated Agriculture and Human Health in Malawi) (PI: Edward D. Walker), and by U19AI089683 (The Intransigence of Malaria in Malawi: Understanding Hidden Reservoirs, Successful Vectors and Prevention Failures). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimi TO, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1033-9; [Anonymous], 2016, LANCET, V388, P2323, DOI 10.1016/S0140-6736(16)32170-5; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-155; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Becking LE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075996, 10.1371/journal.pone.0079276]; Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028; Chavasse Desmond, 2002, Malawi Med J, V14, P7; Chinsinga B, 2012, GREEN BELT INITIATIV; Christiansen-Jucht C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0489-3; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Dambach P, 2012, UTILIZATION COMBINED; Juri MJD, 2015, J VECTOR ECOL, V40, P36, DOI 10.1111/jvec.12130; Debebe Y, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2499-7; Duan SB, 2019, REMOTE SENS ENVIRON, V225, P16, DOI 10.1016/j.rse.2019.02.020; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Foley DH, 2002, MED VET ENTOMOL, V16, P347, DOI 10.1046/j.1365-2915.2002.00382.x; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.50; Gething PW, 2016, NEW ENGL J MED, V375, P2435, DOI 10.1056/NEJMoa1606701; GoM, 2015, NAT IRR MAST PLAN IN; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Haque U, ROLE CLIMATE VARIABI, DOI [10.1371/journal.pone.001434121179555, DOI 10.1371/JOURNAL.PONE.001434121179555]; Hay SI, 1998, T ROY SOC TROP MED H, V92, P12, DOI 10.1016/S0035-9203(98)90936-1; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000209; Huang J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-87; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jayanthi H, 2013, INT J DISAST RISK RE, V4, P71, DOI 10.1016/j.ijdrr.2013.02.001; Jensen H, 2005, TLS-TIMES LIT SUPPL, P3; Kazembe Lawrence N, 2006, Int J Health Geogr, V5, P41, DOI 10.1186/1476-072X-5-41; Kazembe LN, 2006, SPATIAL ANAL MAPPING; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-268; Lehner B., 2008, EOS T AM GEOPHYS UN, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Li X, 2017, CLIM DYNAM, V49, P4047, DOI 10.1007/s00382-017-3563-7; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Lourenco PM, 2011, J VECTOR ECOL, V36, P279, DOI 10.1111/j.1948-7134.2011.00168.x; LUNETTA RS, 1991, PHOTOGRAMM ENG REM S, V57, P677; Lyons CL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-104; Mathanga DP, 2012, ACTA TROP, V121, P212, DOI 10.1016/j.actatropica.2011.06.017; May JM, STUD DIS ECOL; McCann RS, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-17; Mccann RS, 2014, MODELING LARVAL MALA; Meadows M. E., 1985, Z GEOMORPHOLOGIE S, V52, P147; Messina JP, 2012, ANN ASSOC AM GEOGR, V102, P1038, DOI 10.1080/00045608.2012.671134; Metzger ME, MANAGING MOSQUITOES; Miller JR, 2007, NATURWISSENSCHAFTEN, V94, P195, DOI 10.1007/s00114-006-0178-y; Minakawa N, 2002, J MED ENTOMOL, V39, P833, DOI 10.1603/0022-2585-39.6.833; Munga S, 2009, AM J TROP MED HYG, V81, P1079, DOI 10.4269/ajtmh.2009.09-0156; Mutuku FM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-19; Mutuku FM, 2006, AM J TROP MED HYG, V74, P54, DOI 10.4269/ajtmh.2006.74.54; Mutuku FM, 2006, AM J TROP MED HYG, V74, P44, DOI 10.4269/ajtmh.2006.74.44; Mzilahowa T, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1610-1; (NSO) NSO of M. Malawi Integrated Household Survey (2010-2011) (IHS3), 2012, REP HOUS SOC CHAR RE; Olson JM, GLOB CENT FOOD SYST; Openshaw S., 1984, MODIFIABLE AREAL UNI; Organization WH, LARV SOURC MAN SUPPL; Packard, 2016, HIST GLOBAL HLTH INT; Pekel JF, 2016, NATURE, V540, P418, DOI 10.1038/nature20584; Peter BG, 2018, ANN AM ASSOC GEOGR, V108, P989, DOI 10.1080/24694452.2017.1403877; Pombi M, 2017, EVOL APPL, V10, P1102, DOI 10.1111/eva.12517; Raicu I, 2009, HPDC'09: 18TH ACM INTERNATIONAL SYMPOSIUM ON HIGH PERFORMANCE DISTRIBUTED COMPUTING, P207; Rushton SP, 2004, J APPL ECOL, V41, P193, DOI 10.1111/j.0021-8901.2004.00903.x; Service Mike W., 2002, P59; Sewe MO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154204; Shapiro LLM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003489; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-117; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; Sinka ME, 2010, EUROPE MIDDLE E OCCU; Soberon J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175138; Spiers A A, 2002, Malawi Med J, V14, P4; SURTEES G, 1970, INT J ENVIRON STUD, V1, P35, DOI 10.1080/00207237008709393; Teklehaimanot A, 2008, ANN NY ACAD SCI, V1136, P32, DOI 10.1196/annals.1425.037; Tizifa TA, 2018, CURR TROP MED REP, V5, P41, DOI 10.1007/s40475-018-0133-y; Tote C, 2015, REMOTE SENS-BASEL, V7, P1758, DOI 10.3390/rs70201758; Vizy EK, 2015, CLIM DYNAM, V45, P1673, DOI 10.1007/s00382-014-2424-x; von der Heyden CJ, 2004, PROG PHYS GEOG, V28, P544, DOI 10.1191/0309133304pp424oa; Walker PGT, 2016, LANCET GLOB HEALTH, V4, pE474, DOI 10.1016/S2214-109X(16)30073-0; Wan Z., 2015, MOD11A2 MODIS TERRA, DOI [10.5067/MODIS/MOD11A2.006, DOI 10.5067/MODIS/MOD11A2.006]; WHO, 2018, WORLD MAL REP 2018; Wiebe A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1734-y; Williams B, 1994, Model vector-borne other Parasit Dis, P267	83	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0235697	10.1371/journal.pone.0235697	http://dx.doi.org/10.1371/journal.pone.0235697			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750051	Green Published, gold			2022-12-26	WOS:000560009200043
J	Li, H; Jiang, W; Liu, XN; Yuan, LY; Li, TJ; Li, S; Xu, SS; Zhang, WH; Gao, HL; Han, X; Wang, WQ; Wu, CT; Yu, XJ; Xu, HX; Liu, L				Li, Hao; Jiang, Wang; Liu, Xue-Ni; Yuan, Li-Yun; Li, Tian-Jiao; Li, Shuo; Xu, Shuai-Shuai; Zhang, Wu-Hu; Gao, He-Li; Han, Xuan; Wang, Wen-Quan; Wu, Chun-Tao; Yu, Xian-Jun; Xu, Hua-Xiang; Liu, Liang			TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the Hedgehog signaling pathway	ONCOGENE			English	Article							GEMCITABINE; METASTASIS; PROMOTER; METHYLATION; GROWTH	Chemoresistance is a major obstacle to prolonging pancreatic ductal adenocarcinoma (PDAC) patient survival. TET1 is identified as the most important epigenetic modification enzyme that facilitates chemoresistance in cancers. However, the chemoresistance mechanism of TET1 in PDAC is unknown. This study aimed to determine the role of TET1 in the chemoresistance of PDAC. TET1-associated chemoresistance in PDAC was investigated in vitro and in vivo. The clinical significance of TET1 was analyzed in 228 PDAC patients by tissue microarray profiling. We identified that TET1 downregulation is caused by its promoter hypermethylation and correlates with poor survival in PDAC patients. In vitro and in vivo functional studies performed by silencing or overexpressing TET1 suggested that TET1 is able to suppress epithelial-mesenchymal transition (EMT) and sensitize PDAC cells to 5FU and gemcitabine. Then RNA-seq, whole genome bisulfite sequencing (WGBS) and ChIP-seq were used to explore the TET1-associated pathway, and showed that TET1 promotes the transcription of CHL1 by binding and demethylating the CHL1 promoter, which consequently inhibits the Hedgehog pathway. Additionally, inhibiting Hedgehog signaling by CHL1 overexpression or the Hedgehog pathway inhibitor, GDC-0449, reversed the chemoresistance induced by TET1 silencing. Regarding clinical significance, we found that high TET1 and high CHL1 expression predicted a better prognosis in resectable PDAC patients. In summary, we demonstrated that TET1 reverses chemoresistance in PDAC by downregulating the CHL1-associated Hedgehog signaling pathway. PDAC patients with a high expression levels of TET1 and CHL1 have a better prognosis.	[Li, Hao; Jiang, Wang; Li, Tian-Jiao; Li, Shuo; Xu, Shuai-Shuai; Zhang, Wu-Hu; Gao, He-Li; Han, Xuan; Wang, Wen-Quan; Wu, Chun-Tao; Yu, Xian-Jun; Xu, Hua-Xiang; Liu, Liang] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat Surg, Shanghai, Peoples R China; [Li, Hao; Jiang, Wang; Li, Tian-Jiao; Li, Shuo; Xu, Shuai-Shuai; Zhang, Wu-Hu; Gao, He-Li; Han, Xuan; Wang, Wen-Quan; Wu, Chun-Tao; Yu, Xian-Jun; Xu, Hua-Xiang; Liu, Liang] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [Li, Hao; Jiang, Wang; Li, Tian-Jiao; Li, Shuo; Xu, Shuai-Shuai; Zhang, Wu-Hu; Gao, He-Li; Han, Xuan; Wang, Wen-Quan; Wu, Chun-Tao; Yu, Xian-Jun; Xu, Hua-Xiang; Liu, Liang] Shanghai Pancreat Canc Inst, Shanghai, Peoples R China; [Li, Hao; Jiang, Wang; Li, Tian-Jiao; Li, Shuo; Xu, Shuai-Shuai; Zhang, Wu-Hu; Gao, He-Li; Han, Xuan; Wang, Wen-Quan; Wu, Chun-Tao; Yu, Xian-Jun; Xu, Hua-Xiang; Liu, Liang] Fudan Univ, Pancreat Canc Inst, Shanghai, Peoples R China; [Liu, Xue-Ni] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Gen Surg, Sch Med, Shanghai, Peoples R China; [Yuan, Li-Yun] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Biomed Big Data Ctr, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Yu, XJ; Xu, HX; Liu, L (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Pancreat Surg, Shanghai, Peoples R China.; Yu, XJ; Xu, HX; Liu, L (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.; Yu, XJ; Xu, HX; Liu, L (corresponding author), Shanghai Pancreat Canc Inst, Shanghai, Peoples R China.; Yu, XJ; Xu, HX; Liu, L (corresponding author), Fudan Univ, Pancreat Canc Inst, Shanghai, Peoples R China.	yuxianjun@fudanpci.org; xuhuaxiang@fudanpci.org; liuliang@fudanpci.org	Li, Shuo/GXV-6545-2022	Jiang, Wang/0000-0003-4546-3466; wuhu, Zhang/0000-0002-5182-9850; Liu, Liang/0000-0002-7826-3877	National Science Foundation for Distinguished Young Scholars of China [81625016]; National Natural Science Foundation of China [81871941, 81872366, 81827807, 81802675, 81702341, 81802380]; Outstanding Academic Leader Program of the "Technological Innovation Action Plan" in Shanghai Science and Technology Commission [18XD1401200]; Scientific Innovation Project of Shanghai Education Committee [2019-01-07-00-07-E00057]; Young Talented Specialist Training Program of Shanghai	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Academic Leader Program of the "Technological Innovation Action Plan" in Shanghai Science and Technology Commission; Scientific Innovation Project of Shanghai Education Committee; Young Talented Specialist Training Program of Shanghai	This work was supported by grants from the National Science Foundation for Distinguished Young Scholars of China [81625016]; the National Natural Science Foundation of China [81871941, 81872366, 81827807, 81802675, 81702341, and 81802380]; the Outstanding Academic Leader Program of the "Technological Innovation Action Plan" in Shanghai Science and Technology Commission [18XD1401200]; Scientific Innovation Project of Shanghai Education Committee (2019-01-07-00-07-E00057) and the Young Talented Specialist Training Program of Shanghai. The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071338; Baharudin R, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00047; Bhateja P, 2019, CANCERS, V11, DOI 10.3390/cancers11081126; Chen J, 2019, INT J BIOL SCI, V15, P1802, DOI 10.7150/ijbs.34785; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; De Jesus-Acosta A, 2020, BRIT J CANCER, V122, P498, DOI 10.1038/s41416-019-0683-3; Eto K, 2013, BRIT J CANCER, V108, P1488, DOI 10.1038/bjc.2013.108; Feng JH, 2015, INT J CLIN EXP MED, V8, P203; Fu HL, 2014, J BIOMED NANOTECHNOL, V10, P1217, DOI 10.1166/jbn.2014.1861; Gaianigo N, 2017, CANCERS, V9, DOI 10.3390/cancers9090122; Han X, 2017, CELL BIOL INT, V41, P405, DOI 10.1002/cbin.10734; Hsu CH, 2012, CELL REP, V2, P568, DOI 10.1016/j.celrep.2012.08.030; Infante P, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.195; Kang KA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.149; Kumar V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01942-7; Lei JJ, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-66; Li H, 2017, HEPATOLOGY, V66, P136, DOI 10.1002/hep.29116; Martin-Sanchez E, 2017, ONCOTARGET, V8, P15789, DOI 10.18632/oncotarget.15004; Ognibene Marzia, 2018, Oncotarget, V9, P25903, DOI 10.18632/oncotarget.25403; Pei YF, 2016, ONCOTARGET, V7, P31322, DOI 10.18632/oncotarget.8900; Sun M, 2013, P NATL ACAD SCI USA, V110, P9920, DOI 10.1073/pnas.1305172110; Tang H, 2019, ONCOGENE, V38, P3119, DOI 10.1038/s41388-018-0648-7; Thomson JP, 2016, CANCER RES, V76, P3097, DOI 10.1158/0008-5472.CAN-15-1910; Voutsadakis IA, 2011, WORLD J GASTRO ONCOL, V3, P153, DOI 10.4251/wjgo.v3.i11.153; Wajed SA, 2001, ANN SURG, V234, P10, DOI 10.1097/00000658-200107000-00003; Wang CX, 2019, CANCER MED-US, V8, P990, DOI 10.1002/cam4.1983; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wu J, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1334-5; Zhang JF, 2018, CELL PHYSIOL BIOCHEM, V45, P692, DOI 10.1159/000487162; Zhang SR, 2019, EJSO-EUR J SURG ONC, V45, P769, DOI 10.1016/j.ejso.2018.10.539; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhou PT, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0624-9	32	8	9	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 3	2020	39	36					5825	5838		10.1038/s41388-020-01407-8	http://dx.doi.org/10.1038/s41388-020-01407-8		AUG 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NJ1HO	32753651				2022-12-26	WOS:000555747100003
J	Ramos-Martinez, A; Pericas, JM; Fernandez-Cruz, A; Munoz, P; Valerio, M; Kestler, M; Montejo, M; Farinas, MC; Sousa, D; Dominguez, F; Ojeda-Burgos, G; Plata, A; Vidal, L; Miro, JM				Ramos-Martinez, Antonio; Pericas, Juan Manuel; Fernandez-Cruz, Ana; Munoz, Patricia; Valerio, Maricela; Kestler, Martha; Montejo, Miguel; Farinas, M. Carmen; Sousa, Dolores; Dominguez, Fernando; Ojeda-Burgos, Guillermo; Plata, Antonio; Vidal, Laura; Miro, Jose Maria		Grp Apoyo Manejo Endocarditis	Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study	PLOS ONE			English	Article							INFECTIVE ENDOCARDITIS; ANTIBIOTIC-TREATMENT; DIAGNOSIS; THERAPY; ASSOCIATION; GENTAMICIN; MORBIDITY; SURGERY; ADULTS	Enterococcus faecalisinfective endocarditis (EFIE) is a severe disease of increasing incidence. The objective was to analyze whether the outcome of patients with native valve EFIE (NVEFIE) treated with a short course of ampicillin plus ceftriaxone (4wAC) was similar to patients treated according to international guidelines (6wAC). Between January 2008 and June 2018, 1,978 consecutive patients with definite native valve IE were prospectively included in a national registry. Outcomes of patients with NVEFIE treated with 4wAC were compared to those of patients who received 6wAC. Three hundred and twenty-two patients (16.3%) had NVEFIE. One hundred and eighty-three (56.8%) received AC. Thirty-nine patients (21.3%) were treated with 4wAC for four weeks and 70 patients (38.3%) with 6wAC. There were no differences in age or comorbidity. Patients treated 6wAC presented a longer duration of symptoms before diagnosis (21 days, IQR 7-60 days vs. 7 days, IQR 1-22 days; p = 0.002). Six patients presented perivalvular abscess and all of these received 6wAC. Surgery was performed on 14 patients (35.9%) 4wAC and 34 patients (48.6%) 6wAC (p = 0.201). In-hospital mortality, one-year mortality and relapses among 4wAC and 6wAC patients were 10.3% vs. 11.4% (p = 0.851); 17.9% vs. 21.4% (p = 0.682) and 5.1% vs. 4.3% (p = 0.833), respectively. In conclusion, a four-week course of AC may be considered as an alternative regimen in NVEFIE, notably in patients with shorter duration of symptoms and those without perivalvular abscess. These results support the performance of a randomized clinical trial to evaluate the efficacy of this short regimen.	[Ramos-Martinez, Antonio; Fernandez-Cruz, Ana] Hosp Univ Puerta Hierro Majadahonda, Unidad Enfermedades Infecciosas, Serv Med Interna, Majadahonda, Spain; [Ramos-Martinez, Antonio] Inst Invest Sanitaria Puerta Hierro Segovia Arana, Madrid, Spain; [Pericas, Juan Manuel] Inst Recerca Biomed Lleida Fundacio Dr Pifarre, Direcc Clin Terr Enfermedades Infecciosas, Lleida, Spain; [Munoz, Patricia; Valerio, Maricela; Kestler, Martha] Hosp Gen Univ Gregorio Maranon, Serv Microbiol Clin & Enfermedades Infecciosas, Madrid, Spain; [Munoz, Patricia] Univ Complutense Madrid, Inst Invest Sanitaria Gregorio Maranon, Fac Med, CIBER Enfermedades Resp CIBERES CB06 06 0058, Madrid, Spain; [Montejo, Miguel] Hosp Univ Cruces, Unidad Enfermedades Infecciosas, Bilbao, Spain; [Farinas, M. Carmen] Univ Cantabria, Hosp Univ Marques Valdecilla, Dis Unit, Santander, Spain; [Sousa, Dolores] Complejo Hosp A Coruna, Serv Enfermedades Infecciosas, La Coruna, Spain; [Dominguez, Fernando] Hosp Univ Puerta Hierro Majadahonda, Serv Cardiol, Madrid, Spain; [Ojeda-Burgos, Guillermo] Hosp Univ Virgen Victoria, Unidad Gest Clin Enfermedades Infecciosas, Malaga, Spain; [Plata, Antonio] Hosp Reg Malaga, Serv Enfermedades Infecciosas, Malaga, Spain; [Vidal, Laura] Hosp Univ Son Espases, Serv Cardiol, Palma De Mallorca, Spain; [Miro, Jose Maria] Univ Barcelona, Hosp Clin IDIBAPS, Infect Dis Serv, Barcelona, Spain	Hospital Puerta de Hierro-Majadahonda; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Complutense University of Madrid; Hospital Universitario Cruces; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Complejo Hospitalario Universitario A Coruna; Hospital Puerta de Hierro-Majadahonda; Hospital Virgen de la Victoria; Hospital Universitari Son Espases; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Ramos-Martinez, A (corresponding author), Hosp Univ Puerta Hierro Majadahonda, Unidad Enfermedades Infecciosas, Serv Med Interna, Majadahonda, Spain.; Ramos-Martinez, A (corresponding author), Inst Invest Sanitaria Puerta Hierro Segovia Arana, Madrid, Spain.; Miro, JM (corresponding author), Univ Barcelona, Hosp Clin IDIBAPS, Infect Dis Serv, Barcelona, Spain.	aramos220@gmail.com; jmmiro@ub.edu	Cruz, Ana Fernández/L-2429-2019; Ramos-Martinez, Antonio/G-5535-2016	Cruz, Ana Fernández/0000-0003-1189-1120; Sousa, Dolores/0000-0003-2594-5169; Ramos-Martinez, Antonio/0000-0002-4840-9425; Dominguez, Fernando/0000-0001-8408-363X; Ojeda Burgos, Guillermo/0000-0003-0544-4690; Sanchez-Porto, Antonio/0000-0001-6906-7017; Gonzalez-Rico, Claudia/0000-0003-4343-0118	"Fondo de Investigaciones Sanitarias" (FIS) grant from the "Instituto de Salud Carlos III", Madrid, Spain [17/01251]; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain	"Fondo de Investigaciones Sanitarias" (FIS) grant from the "Instituto de Salud Carlos III", Madrid, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain	This work was supported in part by the "Fondo de Investigaciones Sanitarias" (FIS) grant 17/01251 from the "Instituto de Salud Carlos III", Madrid, Spain awarded to JMM. JMM received a personal 80:20 research grant from the Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, during 2017-19. JMP was member of the Endocarditis Team of the Hospital Clinic of Barcelona, Spain when this project was approved by the GAMES Steering Committee.'The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296; Beganovic M, 2018, CLIN INFECT DIS, V67, P303, DOI 10.1093/cid/ciy064; Ben-Ami R, 2004, CLIN INFECT DIS, V38, P843, DOI 10.1086/381971; Cecchi E, 2015, INT J CARDIOL, V190, P151, DOI 10.1016/j.ijcard.2015.04.123; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chirouze C, 2013, CLIN MICROBIOL INFEC, V19, P1140, DOI 10.1111/1469-0691.12166; Christou L, 2007, AM J GASTROENTEROL, V102, P1510, DOI 10.1111/j.1572-0241.2007.01286.x; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; El Rafei A, 2018, J INFECTION, V77, P398, DOI 10.1016/j.jinf.2018.06.013; Fernandez-Hidalgo N, 2013, CLIN INFECT DIS, V56, P1261, DOI 10.1093/cid/cit052; Ferrera C, 2016, INT J CARDIOL, V221, P1022, DOI 10.1016/j.ijcard.2016.07.143; Gavalda Joan, 2007, Ann Intern Med, V146, P574; Habib G, 2009, TURK KARDIYOL DERN A, V37, P89, DOI 10.1093/eurheartj/ehp285; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; KUNIS RL, 1986, J AM COLL CARDIOL, V7, P953, DOI 10.1016/S0735-1097(86)80364-3; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; MAINARDI JL, 1995, ANTIMICROB AGENTS CH, V39, P1984, DOI 10.1128/AAC.39.9.1984; Martinez-Selles M, 2014, INT J CARDIOL, V175, P133, DOI 10.1016/j.ijcard.2014.04.266; McKinnell JA, 2012, INFECT CONT HOSP EP, V33, P718, DOI 10.1086/666331; Munoz P, 2012, CLIN MICROBIOL INFEC, V18, P293, DOI 10.1111/j.1469-0691.2011.03594.x; Munoz P, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001816; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Owens RC, 2008, CLIN INFECT DIS, V46, pS19, DOI 10.1086/521859; Pericas JM, 2015, FUTURE MICROBIOL, V10, P1215, DOI 10.2217/fmb.15.46; Pericas JM, 2014, CLIN MICROBIOL INFEC, V20, pO1075, DOI 10.1111/1469-0691.12756; Pericas JM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192387; Rice LB, 2004, J INFECT DIS, V189, P1113, DOI 10.1086/382086; SERRA P, 1977, ARCH INTERN MED, V137, P1562, DOI 10.1001/archinte.137.11.1562; WILSON WR, 1984, ANN INTERN MED, V100, P816, DOI 10.7326/0003-4819-100-6-816; WILSON WR, 1995, JAMA-J AM MED ASSOC, V274, P1706, DOI 10.1001/jama.274.21.1706	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0237011	10.1371/journal.pone.0237011	http://dx.doi.org/10.1371/journal.pone.0237011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745091	Green Published, gold			2022-12-26	WOS:000560006800054
J	Zannit, HM; Brodt, MD; Silva, MJ				Zannit, Heather M.; Brodt, Michael D.; Silva, Matthew J.			Proliferating osteoblasts are necessary for maximal bone anabolic response to loading in mice	FASEB JOURNAL			English	Article						bone formation; periosteal; thymidine kinase; tibial loading; 3; 6Col1a1	CORTICAL BONE; LINING CELLS; EXPRESSION; LAMELLAR; WOVEN; ADULT	Following mechanical loading, osteoblasts may arise via activation, differentiation, or proliferation to form bone. Our objective was to ablate proliferating osteoblast lineage cells in order to investigate the importance of these cells as a source for loading-induced bone formation. We utilized 3.6Col1a1-tk mice in which replicating osteoblast lineage cells can be ablated in an inducible manner using ganciclovir (GCV). Male and female mice were aged to 5- and 12-months and subjected to 5 days of tibial compression. "Experimental" mice were tk-positive, treated with GCV; "control" mice were either tk-negative treated with GCV, or tk-positive treated with PBS. We confirmed that experimental mice had a decrease in tk-positive cells that arose from proliferation. Next, we assessed bone formation after loading to low (7N) and high (11N) forces and observed that periosteal bone formation rate in experimental mice was reduced by approximately 70% for both forces. Remarkably, woven bone formation induced by high-force loading was blocked in experimental mice. Loading-induced lamellar bone formation was diminished but not prevented in experimental mice. We conclude that osteoblast proliferation induced by mechanical loading is a critical source of bone forming osteoblasts for maximal lamellar formation and is essential for woven bone formation.	[Zannit, Heather M.; Brodt, Michael D.; Silva, Matthew J.] Washington Univ, Musculoskeletal Res Ctr, Dept Biomed Engn, Orthopaed Surg, BJCIH 11th Floor,RM 11617,Campus Box 8233, St Louis, MO 63110 USA	Washington University (WUSTL)	Silva, MJ (corresponding author), Washington Univ, Musculoskeletal Res Ctr, Dept Biomed Engn, Orthopaed Surg, BJCIH 11th Floor,RM 11617,Campus Box 8233, St Louis, MO 63110 USA.	silvam@wustl.edu			HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR047867, AR057235, AR074992, AR060719]; University of Arkansas; Yale University	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); University of Arkansas; Yale University	HHS broken vertical bar NIH broken vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR047867, AR057235, AR074992 and AR060719; University of Arkansas; Yale University	Beck C, 1995, HUM GENE THER, V6, P1525, DOI 10.1089/hum.1995.6.12-1525; Boppart MD, 1998, BONE, V23, P409, DOI 10.1016/S8756-3282(98)00119-7; BORRELLI E, 1988, P NATL ACAD SCI USA, V85, P7572, DOI 10.1073/pnas.85.20.7572; Chermside-Scabbo CJ, 2020, J BONE MINER RES, V35, P1751, DOI 10.1002/jbmr.4031; Chow JWM, 1998, J BONE MINER RES, V13, P1760, DOI 10.1359/jbmr.1998.13.11.1760; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; HEYMAN RA, 1989, P NATL ACAD SCI USA, V86, P2698, DOI 10.1073/pnas.86.8.2698; Jilka RL, 2009, BONE, V44, P275, DOI 10.1016/j.bone.2008.10.037; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kim CH, 2003, J BONE MINER RES, V18, P2116, DOI 10.1359/jbmr.2003.18.12.2116; Kim SW, 2012, J BONE MINER RES, V27, P2075, DOI 10.1002/jbmr.1665; McKenzie JA, 2011, BONE, V48, P250, DOI 10.1016/j.bone.2010.09.005; Meakin LB, 2014, J BONE MINER RES, V29, P1859, DOI 10.1002/jbmr.2222; Moore ER, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0930-1; Patel TK, 2014, J BIOMECH, V47, P451, DOI 10.1016/j.jbiomech.2013.10.052; PEAD MJ, 1988, J BONE MINER RES, V3, P647; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; Sun D, 2018, J ORTHOP RES, V36, P682, DOI 10.1002/jor.23727; TURNER CH, 1994, J BONE MINER RES, V9, P87; Turner CH, 1998, BONE, V22, P463, DOI 10.1016/S8756-3282(98)00041-6; Wang FS, 2003, BONE, V32, P387, DOI 10.1016/S8756-3282(03)00029-2; Wohl GR, 2009, BONE, V44, P320, DOI 10.1016/j.bone.2008.09.010; Zannit HM, 2019, JBMR PLUS, V3, DOI 10.1002/jbm4.10227	24	6	6	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12739	12750		10.1096/fj.202000614R	http://dx.doi.org/10.1096/fj.202000614R		AUG 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32744762	Green Accepted			2022-12-26	WOS:000557255500001
J	Xia, Q; Zhang, HW; Zhang, P; Li, Y; Xu, MC; Li, XB; Li, XJ; Dong, L				Xia, Qin; Zhang, Hanwen; Zhang, Pei; Li, Yang; Xu, Mengchuan; Li, Xiaobo; Li, Xuejun; Dong, Lei			Oncogenic Smurf1 promotes PTEN wild-type glioblastoma growth by mediating PTEN ubiquitylation	ONCOGENE			English	Article							MAMMALIAN TARGET; UBIQUITIN LIGASE; STEM-CELLS; RESISTANCE; RAPAMYCIN; GLIOMA; RECEPTOR; COMPLEX; SMAD7	PI3K/Akt/mTOR signaling pathway activity is highly elevated in glioblastoma (GBM). Although rapamycin is known to inhibit this pathway, GBM patients are resistant to rapamycin monotherapy. This may be related to mutations of tumor suppressor phosphatase and tensin homolog (PTEN). Here, we show that higher expression of E3 ligase Smad ubiquitylation regulatory factor 1 (Smurf1) in GBM is correlated with poor prognosis. Smurf1 promotes cell growth and colony formation by accelerating cell cycle and aberrant signaling pathways. In addition, we show that Smurf1 ubiquitylates and degrades PTEN. We further demonstrate that the oncogenic role of Smurf1 is dependent on PTEN. Upregulated Smurf1 impairs PTEN activity, leading to consistent activation of PI3K/Akt/mTOR signaling pathway; and depletion of Smurf1 dramatically inhibits cell proliferation and tumor growth. Moreover, loss of Smurf1 abolishes the aberrant regulation of PTEN, causing negative feedback on PI3K/Akt/mTOR signaling pathway, and thus leading to rescue of tumor sensitivity to rapamycin in an orthotopic GBM model. Taken together, we show that Smurf1 promotes tumor progression via PTEN, and combined treatment of Smurf1 knockdown with mammalian target of rapamycin (mTOR) inhibition reduces tumor progression. These results identify a unique role of Smurf1 in mTOR inhibitor resistance and provide a strong rationale for combined therapy targeting GBM.	[Xia, Qin; Zhang, Hanwen; Zhang, Pei; Li, Yang; Xu, Mengchuan; Dong, Lei] Beijing Inst Technol, Sch Life Sci, Beijing, Peoples R China; [Li, Xiaobo] Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp, Collaborat Innovat Ctr Tianjin Med Epigenet, Tianjin Key Lab Med Epigenet,Dept Immunol, Tianjin, Peoples R China; [Li, Xuejun] Cent South Univ, Xiangya Hosp, Dept Neurosurg, Changsha, Hunan, Peoples R China	Beijing Institute of Technology; Tianjin Medical University; Central South University	Dong, L (corresponding author), Beijing Inst Technol, Sch Life Sci, Beijing, Peoples R China.	ldong@bit.edu.cn	Zhang, Hanwen/AAG-1299-2022; Zhang, Hanwen/AFK-2928-2022; dong, lei/O-9654-2016	Zhang, Hanwen/0000-0001-8955-7494; Zhang, Hanwen/0000-0001-8955-7494; dong, lei/0000-0001-7530-7427	Beijing Natural Science Foundation [Z190018]; Natural Science Foundation of China [81870123]; China Postdoctoral Science Foundation [2018M641206]; National Science Foundation for Young Scientists of China [81902545]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science Foundation for Young Scientists of China	This work was supported by grants from Beijing Natural Science Foundation (Z190018), The Natural Science Foundation of China (81870123), China Postdoctoral Science Foundation Grant (2018M641206), and the National Science Foundation for Young Scientists of China (81902545).	Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; Chang H, 2018, CELL MOL NEUROBIOL, V38, P421, DOI 10.1007/s10571-017-0485-1; Chen A, 2009, MOL CELL BIOL, V29, P5348, DOI 10.1128/MCB.00407-09; Cheng PL, 2011, NEURON, V69, P231, DOI 10.1016/j.neuron.2010.12.021; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Edinger AL, 2003, CANCER RES, V63, P8451; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Grunwald V, 2002, CANCER RES, V62, P6141; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Holmes B, 2019, J NEURO-ONCOL, V145, P11, DOI 10.1007/s11060-019-03274-0; Iwamaru A, 2007, ONCOGENE, V26, P1840, DOI 10.1038/sj.onc.1209992; Iwanami A, 2013, P NATL ACAD SCI USA, V110, P4339, DOI 10.1073/pnas.1217602110; Juric D, 2015, NATURE, V518, P240, DOI 10.1038/nature13948; Khammanivong A, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-260; Knobbe CB, 2002, NEURO-ONCOLOGY, V4, P196; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Lee JJ, 2011, CELL DEATH DIFFER, V18, P666, DOI 10.1038/cdd.2010.139; Lee MG, 2016, CANCER RES, V76, P1847, DOI 10.1158/0008-5472.CAN-15-1752; Lee YR, 2019, SCIENCE, V364, P651, DOI 10.1126/science.aau0159; Lee YR, 2018, NAT REV MOL CELL BIO, V19, P547, DOI 10.1038/s41580-018-0015-0; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li H, 2017, ONCOGENE, V36, P5668, DOI 10.1038/onc.2017.166; Lin F, 2014, CLIN CANCER RES, V20, P2703, DOI 10.1158/1078-0432.CCR-14-0084; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mondal S, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0126-6; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Podsypanina K, 2001, P NATL ACAD SCI USA, V98, P10320, DOI 10.1073/pnas.171060098; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Stichel D, 2018, ACTA NEUROPATHOL, V136, P793, DOI 10.1007/s00401-018-1905-0; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Wang J, 2019, NAT NEUROSCI, V22, P91, DOI 10.1038/s41593-018-0285-z; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; Xie P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4733; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yu L, 2015, CANCER RES, V75, P1275, DOI 10.1158/0008-5472.CAN-14-2387; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	48	22	22	4	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 3	2020	39	36					5902	5915		10.1038/s41388-020-01400-1	http://dx.doi.org/10.1038/s41388-020-01400-1		JUL 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NJ1HO	32737433				2022-12-26	WOS:000554333300001
J	Gu, JL; Xu, W; Jin, NN; Li, LF; Zhou, Y; Chu, DD; Gong, CX; Iqbal, K; Liu, F				Gu, Jianlan; Xu, Wen; Jin, Nana; Li, Longfei; Zhou, Yan; Chu, Dandan; Gong, Cheng-Xin; Iqbal, Khalid; Liu, Fei			Truncation of Tau selectively facilitates its pathological activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer's disease; Tau protein (Tau); truncation; phosphorylation; aggregation; prion-like activity; protein aggregation; pathogenesis	PAIRED HELICAL FILAMENTS; AMYLOID PRECURSOR PROTEIN; ALPHA-SECRETASE ADAM10; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; IN-VITRO; ABNORMAL PHOSPHORYLATION; HYPERPHOSPHORYLATED TAU; CASPASE-CLEAVAGE; BRAIN	Neurofibrillary tangles of abnormally hyperphosphorylated Tau are a hallmark of Alzheimer's disease (AD) and related tauopathies. Tau is truncated at multiple sites by various proteases in AD brain. Although many studies have reported the effect of truncation on the aggregation of Tau, these studies mostly employed highly artificial conditions, using heparin sulfate or arachidonic acid to induce aggregation. Here, we report for the first time the pathological activities of various truncations of Tau, including site-specific phosphorylation, self-aggregation, binding to hyperphosphorylated and oligomeric Tau isolated from AD brain tissue (AD O-Tau), and aggregation seeded by AD O-Tau. We found that deletion of the first 150 or 230 amino acids (aa) enhanced Tau's site-specific phosphorylation, self-aggregation, and binding to AD O-Tau and aggregation seeded by AD O-Tau, but deletion of the first 50 aa did not produce a significant effect. Deletion of the last 50 aa was found to modulate Tau's site-specific phosphorylation, promote its self-aggregation, and cause it to be captured by and aggregation seeded by AD O-Tau, whereas deletion of the last 20 aa had no such effects. Among the truncated Taus, Tau(151-391)showed the highest pathological activities. AD O-Tau induced aggregation of Tau(151-391)in vitroand in cultured cells. These findings suggest that the first 150 aa and the last 50 aa protect Tau from pathological characteristics and that their deletions facilitate pathological activities. Thus, inhibition of Tau truncation may represent a potential therapeutic approach to suppress Tau pathology in AD and related tauopathies.	[Gu, Jianlan; Xu, Wen; Li, Longfei; Zhou, Yan; Gong, Cheng-Xin; Iqbal, Khalid; Liu, Fei] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Inge Grundke Iqbal Res Floor, Staten Isl, NY 10314 USA; [Gu, Jianlan; Xu, Wen; Jin, Nana; Li, Longfei; Zhou, Yan; Chu, Dandan] Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nantong, Jiangsu, Peoples R China; [Gu, Jianlan; Xu, Wen; Jin, Nana; Li, Longfei; Zhou, Yan; Chu, Dandan] Nantong Univ, Minist Educ China, Nantong, Jiangsu, Peoples R China	Institute for Basic Research in Developmental Disabilities; Nantong University; Ministry of Education, China; Nantong University	Liu, F (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, Inge Grundke Iqbal Res Floor, Staten Isl, NY 10314 USA.	Fei.liu@opwdd.ny.gov			New York State Office for People with Developmental Disabilities and Nantong University; U.S. Alzheimer's Association [DSAD-15-363172]	New York State Office for People with Developmental Disabilities and Nantong University; U.S. Alzheimer's Association(Alzheimer's Association)	This work was supported in part by funds from New York State Office for People with Developmental Disabilities and Nantong University and by U.S. Alzheimer's Association Grant DSAD-15-363172.	Abraha A, 2000, J CELL SCI, V113, P3737; Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; ALAFUZOFF I, 1987, ACTA NEUROPATHOL, V73, P160, DOI 10.1007/BF00693782; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Alonso AD, 2001, J BIOL CHEM, V276, P37967; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Amadoro G, 2004, CELL DEATH DIFFER, V11, P217, DOI 10.1038/sj.cdd.4401314; Arai T, 2006, J NEUROPATH EXP NEUR, V65, P19, DOI 10.1097/01.jnen.0000196133.74087.cb; Arai T, 2005, J BIOL CHEM, V280, P5145, DOI 10.1074/jbc.M409234200; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Basurto-Islas G, 2008, J NEUROPATH EXP NEUR, V67, P470, DOI 10.1097/NEN.0b013e31817275c7; Boluda S, 2015, ACTA NEUROPATHOL, V129, P221, DOI 10.1007/s00401-014-1373-0; BRAAK H, 1986, NEUROSCI LETT, V65, P351, DOI 10.1016/0304-3940(86)90288-0; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chu DD, 2019, ACS CHEM NEUROSCI, V10, P931, DOI 10.1021/acschemneuro.8b00457; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Corsetti V, 2008, MOL CELL NEUROSCI, V38, P381, DOI 10.1016/j.mcn.2008.03.011; Dai CL, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0341-7; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Derisbourg M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09659; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Flores-Rodriguez P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00033; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P14203, DOI 10.1021/bi001876l; Gatta LB, 2002, NEUROREPORT, V13, P2031, DOI 10.1097/00001756-200211150-00008; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; Henriksen K, 2015, J ALZHEIMERS DIS, V43, P1331, DOI 10.3233/JAD-140984; Henriksen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064990; Hu W, 2016, ALZHEIMERS DEMENT, V12, P1066, DOI 10.1016/j.jalz.2016.01.014; Inekci D, 2015, CURR ALZHEIMER RES, V12, P829, DOI 10.2174/1567205012666150710111211; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Kovacech B, 2010, CURR ALZHEIMER RES, V7, P708, DOI 10.2174/156720510793611556; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Li LF, 2019, MOL NEUROBIOL, V56, P6168, DOI 10.1007/s12035-019-1507-4; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; Lyu X J, 2017, Zhonghua Liu Xing Bing Xue Za Zhi, V38, P309, DOI 10.3760/cma.j.issn.0254-6450.2017.03.007; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; Marcinkiewicz M, 2000, J NEUROCHEM, V75, P2133, DOI 10.1046/j.1471-4159.2000.0752133.x; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Miao J, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00034; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Neergaard JS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194802; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; Padmanabhan P, 2019, ELIFE, V8, DOI 10.7554/eLife.45040; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Quinn JP, 2018, J ALZHEIMERS DIS, V63, P13, DOI 10.3233/JAD-170959; Ramcharitar J, 2013, J NEUROPATH EXP NEUR, V72, P824, DOI 10.1097/NEN.0b013e3182a0a39f; Riley KP, 2002, ANN NEUROL, V51, P567, DOI 10.1002/ana.10161; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Saftig P, 2015, PROG NEUROBIOL, V135, P1, DOI 10.1016/j.pneurobio.2015.10.003; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Takeda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9490; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wang YP, 2010, BIOCHEM SOC T, V38, P955, DOI 10.1042/BST0380955; Wilson DM, 1997, AM J PATHOL, V150, P2181; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Xia D, 2015, BBA-MOL BASIS DIS, V1852, P913, DOI 10.1016/j.bbadis.2014.12.017; YANG LS, 1995, EUR J BIOCHEM, V233, P9, DOI 10.1111/j.1432-1033.1995.009_1.x; Yuan XZ, 2017, J ALZHEIMERS DIS, V58, P303, DOI 10.3233/JAD-170061; Zhang WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.43584; Zhang ZT, 2014, NAT MED, V20, P1254, DOI 10.1038/nm.3700; Zhao XH, 2016, NAT MED, V22, P1268, DOI 10.1038/nm.4199; Zhou Y, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00027; Zilka N, 2006, FEBS LETT, V580, P3582, DOI 10.1016/j.febslet.2006.05.029	84	25	25	3	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2020	295	40					13812	13828		10.1074/jbc.RA120.012587	http://dx.doi.org/10.1074/jbc.RA120.012587			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OB4MB	32737201	Green Published, hybrid			2022-12-26	WOS:000578444100009
J	Willing, S; Dyer, E; Schneewind, O; Missiakas, D				Willing, Stephanie; Dyer, Emma; Schneewind, Olaf; Missiakas, Dominique			FmhA and FmhC ofStaphylococcus aureusincorporate serine residues into peptidoglycan cross-bridges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peptidoglycan; biosynthesis; cell division; antibiotic resistance; bacteriocin; Staphylococcus aureus(S; aureus)	LYSOSTAPHIN ENDOPEPTIDASE RESISTANCE; STAPHYLOCOCCUS-EPIDERMIDIS TEXAS-26; CELL-WALL PEPTIDOGLYCANS; METHICILLIN RESISTANCE; INTERPEPTIDE BRIDGE; SURFACE-PROTEINS; MOLECULAR CHARACTERIZATION; AUREUS COPENHAGEN; STRAIN COPENHAGEN; ANCHOR STRUCTURE	Staphylococcal peptidoglycan is characterized by pentaglycine cross-bridges that are cross-linked between adjacent wall peptides by penicillin-binding proteins to confer robustness and flexibility. InStaphylococcus aureus, pentaglycine cross-bridges are synthesized by three proteins: FemX adds the first glycine, and the homodimers FemA and FemB sequentially add two Gly-Gly dipeptides. Occasionally, serine residues are also incorporated into the cross-bridges by enzymes that have heretofore not been identified. Here, we show that the FemA/FemB homologues FmhA and FmhC pair with FemA and FemB to incorporate Gly-Ser dipeptides into cross-bridges and to confer resistance to lysostaphin, a secreted bacteriocin that cleaves the pentaglycine cross-bridge. FmhA incorporates serine residues at positions 3 and 5 of the cross-bridge. In contrast, FmhC incorporates a single serine at position 5. Serine incorporation also lowers resistance toward oxacillin, an antibiotic that targets penicillin-binding proteins, in both methicillin-sensitive and methicillin-resistant strains ofS. aureus. FmhC is encoded by a gene immediately adjacent to lytN, which specifies a hydrolase that cleaves the bond between the fifth glycine of cross-bridges and the alanine of the adjacent stem peptide. In this manner, LytN facilitates the separation of daughter cells. Cell wall damage induced upon lytN overexpression can be alleviated by overexpression of fmhC. Together, these observations suggest that FmhA and FmhC generate peptidoglycan cross-bridges with unique serine patterns that provide protection from endogenous murein hydrolases governing cell division and from bacteriocins produced by microbial competitors.	[Willing, Stephanie; Dyer, Emma; Schneewind, Olaf; Missiakas, Dominique] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Missiakas, Dominique] Argonne Natl Lab, Howard Taylor Ricketts Lab, Lemont, IL 60439 USA; [Willing, Stephanie] LifeArc, London, England	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Missiakas, D (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.; Missiakas, D (corresponding author), Argonne Natl Lab, Howard Taylor Ricketts Lab, Lemont, IL 60439 USA.	dmissiak@bsd.uchicago.edu		Dyer, Emma/0000-0002-5818-3589	National Institute of Allergy and Infectious Diseases, Infectious Disease Branch Grant [AI038897]	National Institute of Allergy and Infectious Diseases, Infectious Disease Branch Grant	This research was supported by the National Institute of Allergy and Infectious Diseases, Infectious Disease Branch Grant AI038897 (to O. S. and D. M.). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Berger-Bachi Brigitte, 1994, Trends in Microbiology, V2, P389, DOI 10.1016/0966-842X(94)90617-3; BERGERBACHI B, 1983, J BACTERIOL, V154, P479; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BROWDER HP, 1965, BIOCHEM BIOPH RES CO, V19, P383, DOI 10.1016/0006-291X(65)90473-0; BROWDER HP, 1968, J BACTERIOL, V96, P1452, DOI 10.1128/JB.96.4.1452-1453.1968; Burts ML, 2008, MOL MICROBIOL, V69, P736, DOI 10.1111/j.1365-2958.2008.06324.x; CHATTERJEE AN, 1964, P NATL ACAD SCI USA, V51, P9, DOI 10.1073/pnas.51.1.9; DeDent A, 2008, EMBO J, V27, P2656, DOI 10.1038/emboj.2008.185; DEHART HP, 1995, APPL ENVIRON MICROB, V61, P1475, DOI 10.1128/AEM.61.4.1475-1479.1995; DEJONGE BLM, 1993, J BACTERIOL, V175, P2779, DOI 10.1128/JB.175.9.2779-2782.1993; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Ehlert K, 1997, J BACTERIOL, V179, P7573, DOI 10.1128/jb.179.23.7573-7576.1997; Ehlert K, 2000, J BACTERIOL, V182, P2635, DOI 10.1128/JB.182.9.2635-2638.2000; Frankel MB, 2011, J BIOL CHEM, V286, P32593, DOI 10.1074/jbc.M111.258863; Frankel MB, 2010, MOL MICROBIOL, V78, P238, DOI 10.1111/j.1365-2958.2010.07334.x; GHUYSEN J. M., 1965, BIOCHEMISTRY, V4, P2245, DOI 10.1021/bi00886a043; GHUYSEN JM, 1963, BIOCHEMISTRY-US, V2, P1119, DOI 10.1021/bi00905a036; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; GREEN CJ, 1993, J BACTERIOL, V175, P5091, DOI 10.1128/JB.175.16.5091-5096.1993; Grundling A, 2007, J BACTERIOL, V189, P2521, DOI 10.1128/JB.01683-06; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; HEATH HE, 1989, BIOCHEM BIOPH RES CO, V160, P1106, DOI 10.1016/S0006-291X(89)80117-2; HENZE U, 1993, J BACTERIOL, V175, P1612, DOI 10.1128/JB.175.6.1612-1620.1993; HIGASHI Y, 1970, J BIOL CHEM, V245, P3697; HIGASHI Y, 1967, P NATL ACAD SCI USA, V57, P1878, DOI 10.1073/pnas.57.6.1878; KAMIRYO T, 1972, J BIOL CHEM, V247, P6306; KATZ W, 1967, J BIOL CHEM, V242, P3207; Kern J, 2010, J MOL BIOL, V401, P757, DOI 10.1016/j.jmb.2010.06.059; Kolar SL, 2011, MICROBIOL-SGM, V157, P2206, DOI 10.1099/mic.0.049692-0; Kopp U, 1996, MICROB DRUG RESIST, V2, P29, DOI 10.1089/mdr.1996.2.29; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; MAIDHOF H, 1991, J BACTERIOL, V173, P3507, DOI 10.1128/jb.173.11.3507-3513.1991; MATSUHASHI M, 1965, P NATL ACAD SCI USA, V54, P587, DOI 10.1073/pnas.54.2.587; MATSUHASHI M, 1986, J BACTERIOL, V167, P975, DOI 10.1128/jb.167.3.975-980.1986; Monteiro JM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41461-1; Pinho MG, 2003, MOL MICROBIOL, V50, P871, DOI 10.1046/j.1365-2958.2003.03719.x; ROBINSON JM, 1979, J BACTERIOL, V137, P1158, DOI 10.1128/JB.137.3.1158-1164.1979; Rohrer S, 1999, P NATL ACAD SCI USA, V96, P9351, DOI 10.1073/pnas.96.16.9351; Rohrer S, 2003, MICROBIOL-SGM, V149, P2733, DOI 10.1099/mic.0.26315-0; Roos M, 1998, J CHROMATOGR B, V705, P183, DOI 10.1016/S0378-4347(97)00506-9; SALTON MRJ, 1952, NATURE, V170, P746, DOI 10.1038/170746a0; SALTON MRJ, 1960, BIOCHIM BIOPHYS ACTA, V39, P398, DOI 10.1016/0006-3002(60)90191-8; Scherr TD, 2013, INFECT IMMUN, V81, P4363, DOI 10.1128/IAI.00819-13; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Stranden AM, 1997, J BACTERIOL, V179, P9, DOI 10.1128/jb.179.1.9-16.1997; STROMINGER JL, 1967, FED PROC, V26, P9; Sugai M, 1997, J BACTERIOL, V179, P1193, DOI 10.1128/jb.179.4.1193-1202.1997; Sugai M, 1997, J BACTERIOL, V179, P4311, DOI 10.1128/jb.179.13.4311-4318.1997; Sugai M, 1998, GENE, V224, P67, DOI 10.1016/S0378-1119(98)00508-3; Thumm G, 1997, MOL MICROBIOL, V23, P1251, DOI 10.1046/j.1365-2958.1997.2911657.x; TIPPER DJ, 1969, BIOCHEMISTRY-US, V8, P2183, DOI 10.1021/bi00833a060; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; TIPPER DJ, 1965, BIOCHEMISTRY-US, V4, P468, DOI 10.1021/bi00879a015; TIPPER DJ, 1968, BIOCHEMISTRY-US, V7, P1441, DOI 10.1021/bi00844a029; TIPPER DJ, 1969, BIOCHEMISTRY-US, V8, P2192, DOI 10.1021/bi00833a061; Ton-That H, 1998, J BIOL CHEM, V273, P29143, DOI 10.1074/jbc.273.44.29143; TonThat H, 1997, J BIOL CHEM, V272, P22285, DOI 10.1074/jbc.272.35.22285; Tschierske M, 1999, FEMS MICROBIOL LETT, V171, P97, DOI 10.1016/S0378-1097(98)00586-2; Tschierske M, 1997, FEMS MICROBIOL LETT, V153, P261, DOI 10.1016/S0378-1097(97)00234-6; WEIDEL W, 1960, J GEN MICROBIOL, V22, P158, DOI 10.1099/00221287-22-1-158; YOCUM RR, 1979, P NATL ACAD SCI USA, V76, P2730, DOI 10.1073/pnas.76.6.2730	66	8	8	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2020	295	39					13664	13676		10.1074/jbc.RA120.014371	http://dx.doi.org/10.1074/jbc.RA120.014371			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NY3VI	32759309	Green Published, hybrid			2022-12-26	WOS:000576321100019
J	Garshelis, DL; Noyce, KV; St-Louis, V				Garshelis, David L.; Noyce, Karen, V; St-Louis, Veronique			Population reduction by hunting helps control human-wildlife conflicts for a species that is a conservation success story	PLOS ONE			English	Article							BEARS URSUS-AMERICANUS; BLACK BEARS; FOOD AVAILABILITY; MANAGEMENT; LANDSCAPE; TRENDS; CARNIVORES; COMPLAINTS; ATTITUDES; SELECTION	Among the world's large Carnivores, American black bears (Ursus americanus) are the foremost conservation success story. Populations have been expanding across North America because the species is adaptable and tolerant of living near people, and because management agencies in the U.S. and Canada controlled hunting and other human-sources of mortality. As a result, human-black bear conflicts (damage to property, general nuisance, threat to human safety) have dramatically increased in some areas, making it urgently important to develop and deploy a variety of mitigation tools. Previous studies claimed that legal hunting did not directly reduce conflicts, but they did not evaluate whether hunting controlled conflicts via management of population size. Here, we compared temporal patterns of phoned-in complaints about black bears (total similar to 63,500) in Minnesota, USA, over 4 decades to corresponding bear population estimates: both doubled during the first decade. We also quantified natural bear foods, and found that large year-to-year fluctuations affected numbers of complaints; however, since this variation is due largely to weather, this factor cannot be managed. Complaints fell sharply when the management agency (1) shifted more responsibility for preventing and mitigating conflicts to the public; and (2) increased hunting pressure to reduce the bear population. This population reduction was more extreme than intended, however, and after hunting pressure was curtailed, population regrowth was slower than anticipated; consequently both population size and complaints remained at relatively low levels statewide for 2 decades (although with local hotspots). These long-term data indicated that conflicts can be kept in tolerable bounds by managing population size through hunting; but due to the bluntness of this instrument and deficiencies and uncertainties in monitoring and manipulating populations, it is wiser to maintain a population at a level where conflicts are socially-acceptable than try to reduce it once it is well beyond that point.	[Garshelis, David L.; Noyce, Karen, V] Minnesota Dept Nat Resources, Grand Rapids, MN 55744 USA; [St-Louis, Veronique] Minnesota Dept Nat Resources, Forest Lake, MN USA		Garshelis, DL (corresponding author), Minnesota Dept Nat Resources, Grand Rapids, MN 55744 USA.	dave.garshelis@state.mn.us			Minnesota Department of Natural Resources	Minnesota Department of Natural Resources	Funded in full by the Minnesota Department of Natural Resources to DLG. The MDNR aided in data collection.	Allen ML, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30988-4; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], **NON-TRADITIONAL**; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Artelle KA, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao0167; Artelle KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25936; Barto K., 2017, **DATA OBJECT**; Baruch-Mordo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085122; Baruch-Mordo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015681; Bautista C, 2019, BIOL CONSERV, V235, P308, DOI 10.1016/j.biocon.2019.04.019; Beckmann JP, 2018, HUM-WILDL INTERACT, V12, P396; Beckmann Jon P., 2008, Human-Wildlife Conflicts, V2, P168; BELANT JL, 2011, HUM WILDLIFE CONFLIC, V0001, P00001; Bergstrom BJ, 2017, J MAMMAL, V98, P1, DOI 10.1093/jmammal/gyw185; Bischof R, 2012, J APPL ECOL, V49, P824, DOI 10.1111/j.1365-2664.2012.02167.x; Campbell MO, 2013, SOC ANIM, V21, P341, DOI 10.1163/15685306-12341260; Can OE, 2014, CONSERV LETT, V7, P501, DOI 10.1111/conl.12117; Davis ML, 2007, J WILDLIFE MANAGE, V71, P2297, DOI 10.2193/2006-427; Dietsch AM, 2018, ECOL MODEL, V367, P10, DOI 10.1016/j.ecolmodel.2017.11.005; Ditmer MA, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00199.1; Ditmer MA, 2018, ECOL MODEL, V387, P205, DOI 10.1016/j.ecolmodel.2018.08.018; Ditmer MA, 2016, J MAMMAL, V97, P54, DOI 10.1093/jmammal/gyv153; Dolson S., 2015, RESPONDING HUMAN BLA; Downing R., 1980, WILDLIFE MANAGEMENT, P247; Dubois S, 2017, CONSERV BIOL, V31, P753, DOI 10.1111/cobi.12896; Evans MJ, 2017, LANDSCAPE URBAN PLAN, V162, P13, DOI 10.1016/j.landurbplan.2017.01.009; Evans MJ, 2014, J WILDLIFE MANAGE, V78, P1477, DOI 10.1002/jwmg.796; Fieberg JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012114; Florida Fish and Wildlife Conservation Commission, 2019, FLOR BLACK BEAR MAN; Garshelis D.L., 2016, IUCN RED LIST THREAT, DOI [DOI 10.2305/IUCN.UK.2016-3.RLTS.T41687A45034604.EN, 10.2305/IUCN.UK.2016-3.RLTS.T41687A45034604]; Garshelis DL, 2006, J WILDLIFE MANAGE, V70, P1634, DOI 10.2193/0022-541X(2006)70[1634:DBIALS]2.0.CO;2; Garshelis David L., 1999, Ursus, V11, P219; Garshelis DL, 2017, URSUS, V28, P31, DOI 10.2192/URSU-D-16-00019.1; Garshelis David L., 2012, Minnesota Department of Natural Resources Summaries of Wildlife Research Findings, P27; Garshelis DL, 2006, URSUS, V17, P1, DOI 10.2192/1537-6176(2006)17[1:SAPEOA]2.0.CO;2; Garshelis DL, 2002, URSUS, V13, P321; Garshelis DL, 2008, FRONTIERS WILDLIFE S, P139; Garshelis DL, 1991, WILDLIFE 2001 POPULA, P1098; Garshelis DL, 2021, BEARS WORLD ECOLOGY, P53; Garshelis DL, 1989, BEAR PEOPLE CONFLICT, P169; Gondek N, 2016, GENETIC BASED ESTIMA; Gore ML, 2008, CONSERV LETT, V1, P136, DOI 10.1111/j.1755-263X.2008.00017.x; Hamr J, 2015, ANIM BIOL, V65, P151, DOI 10.1163/15707563-00002467; Heffelfinger James R., 2013, International Journal of Environmental Studies, V70, P399, DOI 10.1080/00207233.2013.800383; Herfindal I, 2005, J WILDLIFE MANAGE, V69, P1034, DOI 10.2193/0022-541X(2005)069[1034:DRHOLR]2.0.CO;2; Hopkins JB, 2013, J MAMMAL, V94, P1214, DOI 10.1644/13-MAMM-A-009.1; Howe EJ, 2010, URSUS, V21, P131, DOI 10.2192/09GR013.1; Hristienko H, 2007, URSUS, V18, P72, DOI 10.2192/1537-6176(2007)18[72:GITSCA]2.0.CO;2; Johnson HE, 2015, BIOL CONSERV, V187, P164, DOI 10.1016/j.biocon.2015.04.014; Johnson HE, 2018, J WILDLIFE MANAGE, V82, P1102, DOI 10.1002/jwmg.21472; Lennox RJ, 2018, BIOL CONSERV, V224, P277, DOI 10.1016/j.biocon.2018.05.003; Leroux SJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0206711; Mahoney Shane P., 2013, International Journal of Environmental Studies, V70, P448, DOI 10.1080/00207233.2013.801178; Masterson L., 2015, LIVING BEARS HDB, V2nd; Merkle JA, 2013, J MAMMAL, V94, P378, DOI 10.1644/12-MAMM-A-002.1; MILLER S.D., 1990, INT C BEAR RES MANAG, V8, P357; Miller Sterling D., 2013, International Journal of Environmental Studies, V70, P383, DOI 10.1080/00207233.2013.801628; Morehouse AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165425; Moreira-Arce D, 2018, RANGELAND ECOL MANAG, V71, P389, DOI 10.1016/j.rama.2018.02.005; New Jersey Department of Environmental Protection Division of Fish and Wildlife, 2018, STAT REP IMPL 2015 C; Newsome TM, 2015, GLOBAL ECOL BIOGEOGR, V24, P1, DOI 10.1111/geb.12236; Noyce KV, 2001, URSUS-SERIES, V12, P211; NOYCE KV, 1990, INT C BEAR, V8, P169; Noyce KV, 1997, J WILDLIFE MANAGE, V61, P1067, DOI 10.2307/3802103; Obbard ME, 2014, URSUS, V25, P98, DOI 10.2192/URSUS-D-13-00018.1; Penteriani V, 2016, SCI REP-UK, V6, DOI 10.1038/srep20552; Popescu VD, 2016, J APPL ECOL, V53, P1248, DOI 10.1111/1365-2664.12660; Proctor MF, 2018, HUM-WILDL INTERACT, V12, P348; Raithel JD, 2017, J APPL ECOL, V54, P1552, DOI 10.1111/1365-2664.12830; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ryan CW, 2007, URSUS, V18, P46, DOI 10.2192/1537-6176(2007)18[46:IOMPOB]2.0.CO;2; Scheick BK, 2014, URSUS, V25, P24, DOI 10.2192/URSUS-D-12-00020.1; Spencer RD, 2007, URSUS, V18, P217, DOI 10.2192/1537-6176(2007)18[217:HARTHB]2.0.CO;2; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves A, 2010, URSUS, V21, P30, DOI 10.2192/09GR012.1; van Eeden LM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005577; Voyles Z, 2015, URSUS, V26, P11, DOI 10.2192/URSUS-D-14-00038.1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilbur RC, 2018, WILDLIFE SOC B, V42, P22, DOI 10.1002/wsb.854	79	7	7	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237274	10.1371/journal.pone.0237274	http://dx.doi.org/10.1371/journal.pone.0237274			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780755	gold, Green Published			2022-12-26	WOS:000562664700026
J	Herzig, N; He, L; Maiolino, P; Abad, SA; Nanayakkara, T				Herzig, Nicolas; He, Liang; Maiolino, Perla; Abad, Sara-Adela; Nanayakkara, Thrishantha			Conditioned haptic perception for 3D localization of nodules in soft tissue palpation with a variable stiffness probe	PLOS ONE			English	Article							ROBOTIC PALPATION; DESIGN; MOTION; CONTROLLER; ACTUATORS; POSITION; SYSTEM	This paper provides a solution for fast haptic information gain during soft tissue palpation using a Variable Lever Mechanism (VLM) probe. More specifically, we investigate the impact of stiffness variation of the probe to condition likelihood functions of the kinesthetic force and tactile sensors measurements during a palpation task for two sweeping directions. Using knowledge obtained from past probing trials or Finite Element (FE) simulations, we implemented this likelihood conditioning in an autonomous palpation control strategy. Based on a recursive Bayesian inferencing framework, this new control strategy adapts the sweeping direction and the stiffness of the probe to detect abnormal stiff inclusions in soft tissues. This original control strategy for compliant palpation probes shows a sub-millimeter accuracy for the 3D localization of the nodules in a soft tissue phantom as well as a 100% reliability detecting the existence of nodules in a soft phantom.	[Herzig, Nicolas] Univ Sheffield, Dept Automat Control & Syst Engn, Sheffield, S Yorkshire, England; [He, Liang; Nanayakkara, Thrishantha] Imperial Coll London, Dyson Sch Design Engn, London, England; [Maiolino, Perla] Univ Oxford, Oxford Robot Inst, Oxford, England; [Abad, Sara-Adela] UCL, Dept Mech Engn, London, England; [Abad, Sara-Adela] Inst Appl Sustainabil Res, Quito, Ecuador	University of Sheffield; Imperial College London; University of Oxford; University of London; University College London	Herzig, N (corresponding author), Univ Sheffield, Dept Automat Control & Syst Engn, Sheffield, S Yorkshire, England.	n.herzig@sheffield.ac.uk	Nanayakkara, Thrishantha/AAM-5964-2020; Herzig, Nicolas/N-5519-2019	Nanayakkara, Thrishantha/0000-0002-1882-1232; Herzig, Nicolas/0000-0002-5845-2697; He, Liang/0000-0002-4493-4660	United Kingdom Engineering and Physical Sciences Research Council (EPSRC) MOTION grant [EP/N03211X/2]; EPSRC RoboPatient grant [EP/T00603X/1]; EPSRC [EP/N03211X/2, EP/T00603X/1] Funding Source: UKRI	United Kingdom Engineering and Physical Sciences Research Council (EPSRC) MOTION grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC RoboPatient grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	NH PM and TN were funded by the United Kingdom Engineering and Physical Sciences Research Council (EPSRC) MOTION grant [EP/N03211X/2]. TN was also funded by the EPSRC RoboPatient grant [EP/T00603X/1]. https://epsrc.ukri.org/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah Ibrahim, 2018, Smart Multimedia. First International Conference, ICSM 2018. Revised Selected Papers: Lecture Notes in Computer Science (LNCS 11010), P79, DOI 10.1007/978-3-030-04375-9_7; Ahn B, 2014, INT J MED ROBOT COMP, V10, P356, DOI 10.1002/rcs.1543; Ahn B, 2012, MED BIOL ENG COMPUT, V50, P961, DOI 10.1007/s11517-012-0936-2; Ahn B, 2011, J ENDOUROL, V25, P851, DOI 10.1089/end.2010.0468; Albu-Schaffer A, 2007, INT J ROBOT RES, V26, P23, DOI 10.1177/0278364907073776; Ayvali E, 2017, IEEE ROBOT AUTOM LET, V2, P864, DOI 10.1109/LRA.2017.2655619; Ba KX, 2018, IEEE ACCESS, V6, P55680, DOI 10.1109/ACCESS.2018.2871244; Back J, 2014, IEEE INT CONF ROBOT, P2736, DOI 10.1109/ICRA.2014.6907251; Benson JR, 2003, LANCET ONCOL, V4, P56, DOI 10.1016/S1470-2045(03)00961-6; Cheng MY, 2007, IEEE T IND ELECTRON, V54, P1686, DOI 10.1109/TIE.2007.894691; Christiansson GAV, 2007, INT J ROBOT RES, V26, P287, DOI 10.1177/0278364906076264; Ciblak N, 2003, J ROBOTIC SYST, V20, P415, DOI 10.1002/rob.10096; Faragasso A, 2015, IEEE INT C INT ROBOT, P2711, DOI 10.1109/IROS.2015.7353748; Garg Animesh, 2016, 2016 IEEE International Conference on Automation Science and Engineering (CASE), P194, DOI 10.1109/COASE.2016.7743380; Grioli G, 2015, INT J ROBOT RES, V34, P727, DOI 10.1177/0278364914566515; Hardy J, 2015, INT J ROBOT RES, V34, P1211, DOI 10.1177/0278364915584007; He Liang, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P2154, DOI 10.1109/EMBC.2018.8512709; Herzig N, 2018, CONTROL ENG PRACT, V73, P26, DOI 10.1016/j.conengprac.2017.12.007; Herzig N, 2018, IEEE ROBOT AUTOM LET, V3, P1168, DOI 10.1109/LRA.2018.2793961; Herzig N, 2014, IEEE ENG MED BIO, P2065, DOI 10.1109/EMBC.2014.6944022; Hoshi Takeharu, 2010, 2010 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2010), P2822, DOI 10.1109/IROS.2010.5650278; HOWE RD, 1995, IEEE ENG MED BIOL, V14, P318, DOI 10.1109/51.391770; Hughes JAE, 2018, SCI ROBOT, V3, DOI 10.1126/scirobotics.aau3098; Jasim IF, 2014, PROC CIRP, V23, P229, DOI 10.1016/j.procir.2014.10.061; Jia M, 2011, SENSORS-BASEL, V11, P1212, DOI 10.3390/s110101212; KAZEROONI H, 1986, IEEE T ROBOTIC AUTOM, V2, P83, DOI 10.1109/JRA.1986.1087045; Konstantinova J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171706; Konstantinova J, 2014, IEEE T BIO-MED ENG, V61, P1651, DOI 10.1109/TBME.2013.2296877; Koseki Y., 2011, 2011 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2011), P2584, DOI 10.1109/IROS.2011.6048745; Kwon JH, 2014, IEEE ASME INT C ADV, P1375, DOI 10.1109/AIM.2014.6878274; Lee KH, 2017, SOFT ROBOT, V4, P324, DOI 10.1089/soro.2016.0065; Lee MH, 2000, INT J ROBOT RES, V19, P636, DOI 10.1177/027836490001900702; Liu HB, 2010, IEEE T BIO-MED ENG, V57, P404, DOI 10.1109/TBME.2009.2032164; Manti M, 2016, IEEE ROBOT AUTOM MAG, V23, P93, DOI 10.1109/MRA.2016.2582718; Nakhaeinia D, 2014, 2014 CANADIAN CONFERENCE ON COMPUTER AND ROBOT VISION (CRV), P48, DOI 10.1109/CRV.2014.15; Nichols KA, 2015, IEEE T ROBOT, V31, P344, DOI 10.1109/TRO.2015.2402531; Nichols KA, 2013, IEEE INT CONF ROBOT, P4384, DOI 10.1109/ICRA.2013.6631198; Pacchierotti C, 2016, IEEE T BIO-MED ENG, V63, P278, DOI 10.1109/TBME.2015.2455932; Park K., 2017, 2017 INT C MAN AUT R, P1; Penzlin B, 2016, 2ND INTERNATIONAL CONFERENCE ON SYSTEMS INFORMATICS, MODELLING AND SIMULATION (SIMS 2016), P59, DOI 10.1109/SIMS.2016.15; Ramani S, 2008, MED TEACH, V30, P851, DOI 10.1080/01421590802206747; Riviere CN, 2006, P IEEE, V94, P1705, DOI 10.1109/JPROC.2006.880722; Sadati S, 2020, IEEE ROBOTICS AUTOMA; Salman H., 2018, P IEEE INT C ROB AUT, P1; Sangpradit K, 2011, IEEE T BIO-MED ENG, V58, P3319, DOI 10.1109/TBME.2011.2106783; Schlegel S, 2012, IEEE T VIS COMPUT GR, V18, P2305, DOI 10.1109/TVCG.2012.249; Shimoga KB, 1996, INT J ROBOT RES, V15, P335, DOI 10.1177/027836499601500403; SINHA PR, 1993, INT J ROBOT RES, V12, P107, DOI 10.1177/027836499301200201; Sornkarn N, 2017, IEEE T HAPTICS, V10, P183, DOI 10.1109/TOH.2016.2615924; Sornkarn N, 2016, IEEE INT CONF ROBOT, P2657, DOI 10.1109/ICRA.2016.7487425; Sornkarn N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156982; Sornkarn N, 2014, IEEE INT CONF ROBOT, P6685, DOI 10.1109/ICRA.2014.6907846; Sparks JL, 2015, ADV SKIN WOUND CARE, V28, P59, DOI 10.1097/01.ASW.0000460127.47415.6e; Stevenson PG, 2013, J CHROMATOGR A, V1284, P107, DOI 10.1016/j.chroma.2013.02.012; Taylor, 2018, IEEE ROBOTICS AUTOMA, V3, P1816, DOI [DOI 10.1109/LRA.2018.2801481, 10.1109/LRA.2018.2801481]; Le THL, 2016, IEEE ROBOT AUTOM MAG, V23, P150, DOI 10.1109/MRA.2016.2548800; Trejos AL, 2009, INT J ROBOT RES, V28, P1118, DOI 10.1177/0278364909101136; Van Ham R, 2009, IEEE ROBOT AUTOM MAG, V16, P81, DOI 10.1109/MRA.2009.933629; Wegiriya H, 2019, IEEE SENS J, P1; Xie H, 2014, IEEE SENS J, V14, P3283, DOI 10.1109/JSEN.2014.2328182	60	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237379	10.1371/journal.pone.0237379	http://dx.doi.org/10.1371/journal.pone.0237379			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780753	Green Published, Green Accepted, gold			2022-12-26	WOS:000562664700036
J	Moller, SP; Laursen, B; Johannesen, CK; Tolstrup, JS; Schramm, S				Moller, Sanne Pagh; Laursen, Bjarne; Johannesen, Caroline Klint; Tolstrup, Janne S.; Schramm, Stine			Patterns of multimorbidity and demographic profile of latent classes in a Danish population-A register-based study	PLOS ONE			English	Article							EDUCATION; MIGRANTS	Background Multimorbidity is an increasing public health concern and is associated with a range of further adverse outcomes. Identification of disease patterns as well as characteristics of populations affected by multimorbidity is important for prevention strategies to identify those at risk. Aim The aim of the study was to identify and describe demographic characteristics of multimorbidity classes in three age groups (16-44 years, 45-64 years, and 65+ years). Methods Based on register information on 47 chronic diseases and conditions, we used latent class analysis to identify multimorbidity classes in a random sample of the Danish population (n = 470,794). Information on sociodemographic characteristics (age, sex, region of origin, educational level, employment status, and marital status) was obtained from registers and linked to the study population. Age- and sex-adjusted multinomial logistic regression models were used to examine associations between multimorbidity classes and sociodemographic characteristics. Results We identified seven classes among individuals in the age groups 45-64 years and 65+ years and five classes in the age group 16-44 years. Overall, the classes were similar in the three age groups, but varied in size, i.e. the class 'No or few diseases' was larger in the younger age group. The class 'Many diseases' (a class with both somatic diseases and mental illnesses) was only seen in individuals aged 45-64 years and 65+ years. There were social inequalities in odds of belonging to the multimorbidity classes compared to the healthier class. These social inequalities varied but were especially strong in the classes named 'Many diseases' and 'Mental illness, epilepsy'. Conclusion The results of the study suggest that there are social inequalities in multimorbidity but that these inequalities are not universal to all types of multimorbidity. This supports that multimorbidity is diverse and should be prevented and treated accordingly.	[Moller, Sanne Pagh; Laursen, Bjarne; Johannesen, Caroline Klint; Tolstrup, Janne S.; Schramm, Stine] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark	University of Southern Denmark	Moller, SP (corresponding author), Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.	sapm@sdu.dk	Møller, Sanne Pagh/AFR-6368-2022; Johannesen, Caroline/AHE-5174-2022	Johannesen, Caroline/0000-0001-6503-5632; Schramm, Stine/0000-0001-8039-8095; Moller, Sanne Pagh/0000-0001-7552-1212				Andersen GS, 2016, DIABETES RES CLIN PR, V122, P9, DOI 10.1016/j.diabres.2016.09.020; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Boyd CM, 2010, PUBLIC HEALTH REV, V32, P451, DOI 10.1007/BF03391611; Byberg S, 2016, EUR J EPIDEMIOL, V31, P667, DOI 10.1007/s10654-015-0024-7; Diaz E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145233; France EF, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636146; Frolich A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214183; Gellert P, 2019, J AGING HEALTH, V31, P580, DOI 10.1177/0898264317737894; Hall M, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002501; Hvidberg MF, 2016, SCAND J PUBLIC HEALT, V44, P462, DOI 10.1177/1403494816641553; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lanza ST, 2015, PROC LCA PROC LTA US; Larsen FB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169426; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; McLean G, 2014, BRIT J GEN PRACT, V64, pE440, DOI 10.3399/bjgp14X680545; Mercer S, 2016, MULTIMORBIDITY TECHN; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Ng SK, 2018, INT J EPIDEMIOL, V47, P1687, DOI 10.1093/ije/dyy134; Olaya B, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0586-1; Park B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216259; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Petersson F, 2011, SCAND J PUBLIC HEALT, V39, P95, DOI 10.1177/1403494811408483; Porcu M, 2017, J EARLY ADOLESCENCE, V37, P129, DOI 10.1177/0272431616648452; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Schiotz ML, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4314-8; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149; Wang LL, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-016-0580-x	31	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237375	10.1371/journal.pone.0237375	http://dx.doi.org/10.1371/journal.pone.0237375			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780781	Green Published, gold			2022-12-26	WOS:000562664700040
J	Ookawara, S; Ito, K; Sasabuchi, Y; Hayasaka, H; Kofuji, M; Uchida, T; Horigome, K; Imai, S; Akikawa, T; Wada, N; Kiryu, S; Made, S; Shindo, M; Miyazawa, H; Hirai, K; Onishi, Y; Shimoyama, H; Watanabe, A; Tabei, K; Morishita, Y				Ookawara, Susumu; Ito, Kiyonori; Sasabuchi, Yusuke; Hayasaka, Hideyuki; Kofuji, Masaya; Uchida, Takayuki; Horigome, Keita; Imai, Sojiro; Akikawa, Toshiko; Wada, Noriko; Kiryu, Satoshi; Made, Satoru; Shindo, Mitsutoshi; Miyazawa, Haruhisa; Hirai, Keiji; Onishi, Yasushi; Shimoyama, Hirofumi; Watanabe, Akihisa; Tabei, Kaoru; Morishita, Yoshiyuki			Associations of cerebral oxygenation with hemoglobin levels evaluated by near-infrared spectroscopy in hemodialysis patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ANEMIA; IMPACT; RESPONSIVENESS; TRANSFUSION; SATURATION; OUTCOMES; BRAIN	Hemoglobin (Hb) is associated with cerebral oxygenation status owing to its important role of carrying oxygen to systemic tissues. However, data concerning the associations between Hb levels and cerebral regional oxygen saturation (rSO(2)) of hemodialysis (HD) patients is limited. We aimed to identify these associations to consider a target Hb level for renal anemia management. This study included 375 HD patients. Cerebral rSO(2)before HD was monitored using the INVOS 5100c oxygen saturation monitor. Multivariable linear regression analysis showed that cerebral rSO(2)was independently associated with natural logarithm (Ln)-HD duration (standardized coefficient: -0.36), mean blood pressure (standardized coefficient: 0.13), pH (standardized coefficient: -0.10), serum albumin (standardized coefficient: 0.14), presence of diabetes mellitus (standardized coefficient: -0.20), and Hb level (standardized coefficient: 0.29). Furthermore, a generalized linear model with restricted cubic spline function was used to investigate the non-linear association between cerebral rSO(2)and Hb levels. In the multivariable analysis for the adjustment with Ln-HD duration, mean blood pressure, pH, serum albumin, and presence of diabetes mellitus, a linear relationship was demonstrated between the two variables (pfor linearity = 0.79). Hb levels revealed the positive and significant association with cerebral rSO(2)in this study. Moreover, the relationship between cerebral rSO(2)and Hb level was proven to be linear. Therefore, the target Hb level in renal anemia management would be considered to be the upper limits for the appropriate management of renal anemia by previous guidelines and position statement from the viewpoint of maintaining cerebral oxygenation in HD patients.	[Ookawara, Susumu; Ito, Kiyonori; Shindo, Mitsutoshi; Miyazawa, Haruhisa; Hirai, Keiji; Morishita, Yoshiyuki] Jichi Med Univ, Saitama Med Ctr, Dept Integrated Med 1, Div Nephrol, Saitama, Japan; [Sasabuchi, Yusuke] Jichi Med Univ, Data Sci Ctr, Shimotsuke, Tochigi, Japan; [Hayasaka, Hideyuki; Kofuji, Masaya; Uchida, Takayuki] Jichi Med Univ, Saitama Med Ctr, Dept Clin Engn, Saitama, Japan; [Horigome, Keita; Akikawa, Toshiko; Made, Satoru] Hakuyukai Med Corp, Div Hemodialysis, Yuai Nakagawa Clin, Saitama, Japan; [Imai, Sojiro; Wada, Noriko; Kiryu, Satoshi] Minami Uonuma City Hosp, Dept Dialysis, Niigata, Japan; [Onishi, Yasushi; Tabei, Kaoru] Minami Uonuma City Hosp, Dept Internal Med, Niigata, Japan; [Shimoyama, Hirofumi] Hakuyukai Med Corp, Div Nephrol, Yuai Nisshin Clin, Saitama, Japan; [Watanabe, Akihisa] Hakuyukai Med Corp, Div Nephrol, Yuai Nakagawa Clin, Saitama, Japan	Jichi Medical University; Jichi Medical University; Jichi Medical University	Ookawara, S (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Integrated Med 1, Div Nephrol, Saitama, Japan.	su-ooka@hp.tp1.jp		Sasabuchi, Yusuke/0000-0001-7828-0549	Japanese Association of Dialysis Physicians (JADP) [2017-9]; Kidney Foundation, Japan [JKFB 18-7]; JSPS KAKENHI [JP20K11534]	Japanese Association of Dialysis Physicians (JADP); Kidney Foundation, Japan(Kidney Foundation, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japanese Association of Dialysis Physicians (JADP Grant 2017-9), The Kidney Foundation, Japan (JKFB 18-7), and JSPS KAKENHI under Grant No. JP20K11534 to SO. Additionally, Hakuyukai Medical Corporation provided support in the form of salaries for authors KH, TA, S. Imada, HS, and AW. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.	Akizawa T, 2014, THER APHER DIAL, V18, P24, DOI 10.1111/1744-9987.12202; Bradbury BD, 2009, NEPHROL DIAL TRANSPL, V24, P919, DOI 10.1093/ndt/gfn543; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; FDA drug safety communication, 2011, FDA DRUG SAF COMM MO; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Gomez JML, 2002, KIDNEY INT, V61, pS39, DOI 10.1046/j.1523-1755.61.s80.8.x; GRIMM G, 1990, KIDNEY INT, V38, P480, DOI 10.1038/ki.1990.229; HONGO K, 1995, NEUROL RES, V17, P89, DOI 10.1080/01616412.1995.11740293; Hoshino T, 2014, NEPHRON CLIN PRACT, V126, P57, DOI 10.1159/000358432; Hyttel-Sorensen S, 2011, BIOMED OPT EXPRESS, V2, P3047, DOI 10.1364/BOE.2.003047; Ito K, 2017, NEPHRON EXTRA, V7, P42, DOI 10.1159/000471812; Ito K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117474; Johansen KL, 2012, NEPHROL DIAL TRANSPL, V27, P2418, DOI 10.1093/ndt/gfr697; Kovarova L, 2018, NEPHRON, V139, P113, DOI 10.1159/000487092; Kurella M, 2006, NEPHROL DIAL TRANSPL, V21, P2543, DOI 10.1093/ndt/gfl275; Lemmers PMA, 2008, PEDIATRICS, V121, P142, DOI 10.1542/peds.2007-0925; Locatelli F, 2013, NEPHROL DIAL TRANSPL, V28, P1346, DOI 10.1093/ndt/gft033; MacEwen C, 2017, J AM SOC NEPHROL, V28, P2511, DOI 10.1681/ASN.2016060704; MARSH JT, 1991, KIDNEY INT, V39, P155, DOI 10.1038/ki.1991.20; Maslehaty Homajoun, 2012, ISRN Neurol, V2012, P907187, DOI 10.5402/2012/907187; Minato S, 2019, J ARTIF ORGANS, V22, P316, DOI 10.1007/s10047-019-01118-2; Miyazawa H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199366; Moist LM, 2013, AM J KIDNEY DIS, V62, P860, DOI 10.1053/j.ajkd.2013.08.001; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Polinder-Bos HA, 2018, J AM SOC NEPHROL, V29, P1317, DOI 10.1681/ASN.2017101088; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; Sandal G, 2014, TRANSFUSION, V54, P1100, DOI 10.1111/trf.12359; Schmitz J, 2014, PHYSIOL MEAS, V35, P1349, DOI 10.1088/0967-3334/35/7/1349; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Tobias JD, 2006, EXPERT REV MED DEVIC, V3, P235, DOI 10.1586/17434440.3.2.235; Wolfgram DF, 2019, J AM SOC NEPHROL, V30, P2052, DOI 10.1681/ASN.2019050461; Yamamoto H., 2017, RENAL REPLACE THER, V3, P36, DOI [10.1186/s41100-017-0114-y, DOI 10.1186/S41100-017-0114-Y]; Yoshitani K, 2007, ANESTHESIOLOGY, V106, P458, DOI 10.1097/00000542-200703000-00009	35	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0236720	10.1371/journal.pone.0236720	http://dx.doi.org/10.1371/journal.pone.0236720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776946	Green Published, gold			2022-12-26	WOS:000561393800052
J	Al-Maliky, MA; Frentzen, M; Meister, J				Al-Maliky, Mohammed Abbood; Frentzen, Matthias; Meister, Joerg			Combined effects of a topical fluoride treatment and 445 nm laser irradiation of enamel against a demineralization challenge: A light and electron microscopicex vivostudy	PLOS ONE			English	Article							LESION FORMATION; CARIES; ARGON; BOVINE; MICROHARDNESS; RESISTANCE; RETENTION; INCREASE; SURFACE; DENTIN	This study investigated the caries-preventive effect of 445 nm laser radiation in combination with fluoride on the prevention of white spot lesions. Previously, several studies have indicated the ability of 488 nm argon ion laser irradiation to reduce early enamel demineralization. A diode laser (445 nm) could be an alternative technology for possible caries-preventive potential. Each sample of a group of seventeen caries-free bovine teeth was treated in four different ways on four different zones of the labial surface: control/no treatment (C), laser irradiation only (L) (0.3 W, 60 s and applied dose of 90 J/cm(2)), amine fluoride application only (10,000 ppm and pH 3.9) (F), and amine fluoride application followed by laser irradiation (FL). After treatment, the teeth were subjected to a demineralization solution (pH 4.3 for 48 h at 37 degrees C) to induce subsurface lesions. After sectioning, the teeth were examined by light microscopy. Three teeth were analyzed by scanning electron microscopy (SEM). The depths of the subsurface lesions in the C, L, F, and FL groups were 103.01 (+/- 13.04), 96.99 (+/- 14.51), 42.59 (+/- 17.13), and 24.35 (+/- 11.38) mu m, respectively. The pairwise group comparison showed the following results: p < 0.001 for FL versus C, FL versus L, F versus C, and F versus L, p = 0.019 for FL versus F and p = 0.930 for L versus C. The SEM micrographs support the light-microscopic examination. The results of the current study have shown that using relatively low irradiation settings of 445 nm laser on fluoridated enamel may be effective for prevention of white spot lesions.	[Al-Maliky, Mohammed Abbood; Frentzen, Matthias] Univ Bonn, Dent Fac, Dept Periodontol Operat & Prevent Dent, Bonn, Germany; [Al-Maliky, Mohammed Abbood; Frentzen, Matthias; Meister, Joerg] Univ Bonn, Ctr Appl Med Laser Res & Biomed Opt AMLaReBO, Bonn, Germany; [Al-Maliky, Mohammed Abbood] Univ Baghdad, Inst Laser Postgrad Studies, Dept Biomed Applicat, Baghdad, Iraq; [Meister, Joerg] Univ Bonn, Ctr Dentomaxillofacial Med, Bonn, Germany	University of Bonn; University of Bonn; University of Baghdad; University of Bonn	Al-Maliky, MA (corresponding author), Univ Bonn, Dent Fac, Dept Periodontol Operat & Prevent Dent, Bonn, Germany.; Al-Maliky, MA (corresponding author), Univ Bonn, Ctr Appl Med Laser Res & Biomed Opt AMLaReBO, Bonn, Germany.; Al-Maliky, MA (corresponding author), Univ Baghdad, Inst Laser Postgrad Studies, Dept Biomed Applicat, Baghdad, Iraq.	s4moalma@uni-bonn.de	Al-Maliky, Mohammed Abbood/G-9320-2015	Al-Maliky, Mohammed Abbood/0000-0003-2149-2852				Al-Maliky Mohammed Abbood, 2019, Biomed Res Int, V2019, P9101642, DOI 10.1155/2019/9101642; Ana PA, 2006, LASER PHYS, V16, P865, DOI 10.1134/S1054660X06050197; Anderson AM, 2002, AM J ORTHOD DENTOFAC, V122, P251, DOI 10.1067/mod.2002.126596; Anderson JR, 2000, J CLIN LASER MED SUR, V18, P33, DOI 10.1089/clm.2000.18.33; Ayoub HM, 2020, J DENT, V96, DOI 10.1016/j.jdent.2020.103328; BREWER H E, 1956, J Dent Res, V35, P59, DOI 10.1177/00220345560350011801; Chersoni S, 2011, CLIN ORAL INVEST, V15, P443, DOI 10.1007/s00784-010-0406-x; Correa-Afonso AM, 2012, ARCH ORAL BIOL, V57, P1153, DOI 10.1016/j.archoralbio.2012.02.004; CRABB HSM, 1966, NATURE, V209, P611, DOI 10.1038/209611a0; CRUZ R, 1992, SCAND J DENT RES, V100, P154; De Sant'anna GR, 2009, PHOTOMED LASER SURG, V27, P499, DOI 10.1089/pho.2008.2331; Duschner H, 1997, EUR J ORAL SCI, V105, P466, DOI 10.1111/j.1600-0722.1997.tb00232.x; Esteves-Oliveira M, 2017, CLIN ORAL INVEST, V21, P1243, DOI 10.1007/s00784-016-1893-1; Field JC, 2017, EUR J PROSTHODONT RE, V25, P93, DOI [10.1922/EJPRD_01660Field08, 10.1922/E1PRD_01660Field08]; Gerth HUV, 2007, DENT MATER, V23, P1521, DOI 10.1016/j.dental.2006.12.007; Gonzalez-Rodriguez A, 2011, LASER MED SCI, V26, P317, DOI 10.1007/s10103-010-0784-y; Hsu CYS, 1998, J DENT RES, V77, P418, DOI 10.1177/00220345980770021101; Ortiz-Ruiz AJ, 2018, ANN ANAT, V218, P7, DOI 10.1016/j.aanat.2017.12.012; Kim JW, 2016, PROC SPIE, V9692, DOI 10.1117/12.2218662; Lee R, 2017, PROC SPIE, V10044, DOI 10.1117/12.2256739; Lippert F, 2014, ARCH ORAL BIOL, V59, P704, DOI 10.1016/j.archoralbio.2014.04.005; Lombardo G, 2019, EUR J PAEDIATR DENT, V20, P295, DOI 10.23804/ejpd.2019.20.04.07; Maung NL, 2007, J DENT, V35, P794, DOI 10.1016/j.jdent.2007.07.012; Nammour S, 2005, LASER SURG MED, V36, P220, DOI 10.1002/lsm.20128; Nammour S, 2003, LASER SURG MED, V33, P260, DOI 10.1002/lsm.10219; Niemz MH, 2007, LASER TISSUE INTERAC; Noel L, 2003, ANGLE ORTHOD, V73, P249; Ogaard B, 2001, CARIES RES, V35, P40, DOI 10.1159/000049109; Parker S, 2011, INT J LASER DENT, V1, P1; Reis JM, 2014, BIOCHEMISTRY-US, V53, P5008, DOI 10.1021/bi500622x; Rolla G, 1990, J Dent Res, V69 Spec No, P780; SOGNNAES R F, 1965, J South Calif State Dent Assoc, V33, P328; Tavares JG, 2012, PHOTOMED LASER SURG, V30, P433, DOI 10.1089/pho.2011.3104; TENCATE JM, 1982, CARIES RES, V16, P201, DOI 10.1159/000260599; TENCATE JM, 1991, CRIT REV ORAL BIOL M, V2, P283, DOI 10.1177/10454411910020030101; Vlacic J, 2007, AUST DENT J, V52, P101, DOI 10.1111/j.1834-7819.2007.tb00472.x; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Westerman GH, 2006, J AM DENT ASSOC, V137, P638, DOI 10.14219/jada.archive.2006.0260; Westerman Gary H, 2003, Pediatr Dent, V25, P497; Westerman GH, 2004, AM J DENT, V17, P241; Westerman GH, 2002, J CLIN LASER MED SUR, V20, P257, DOI 10.1089/10445470260420768; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364	42	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237195	10.1371/journal.pone.0237195	http://dx.doi.org/10.1371/journal.pone.0237195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764819	Green Published, gold			2022-12-26	WOS:000561029000026
J	Hansen, U; Holmes, DF; Bruckner, P; Bishop, PN				Hansen, Uwe; Holmes, David F.; Bruckner, Peter; Bishop, Paul N.			Analysis of opticin binding to collagen fibrils identifies a single binding site in the gap region and a high specificity towards thin heterotypic fibrils containing collagens II, and XI or V/XI	PLOS ONE			English	Article							MACROMOLECULES; FIBROMODULIN; DECORIN; SURFACE; MEMBER; FAMILY	Opticin is a class III member of the extracellular matrix small leucine-rich repeat protein/proteoglycan (SLRP) family found in vitreous humour and cartilage. It was first identified associated with the surface of vitreous collagen fibrils and several other SLRPs are also known to bind collagen fibrils and it some cases alter fibril morphology. The purpose of this study was to investigate the binding of opticin to the collagen II-containing fibrils found in vitreous and cartilage. Electron microscopic studies using gold labelling demonstrated that opticin binds vitreous and thin cartilage collagen fibrils specifically at a single site in the gap region of the collagen D-period corresponding to the e2 stain band; this is the first demonstration of the binding site of a class III SLRP on collagen fibrils. Opticin did not bind thick cartilage collagen fibrils from cartilage or tactoids formedin vitrofrom collagen II, but shows high specificity for thin, heterotypic collagen fibrils containing collagens II, and XI or V/XI. Vitreous collagen fibrils from opticin null and wild-type mice were compared and no difference in fibril morphology or diameter was observed. Similarly,in vitrofibrillogenesis experiments showed that opticin did not affect fibril formation. We propose that when opticin is bound to collagen fibrils, rather than influencing their morphology it instead hinders the binding of other molecules to the fibril surfaces and/or act as an intermediary bridge linking the collagen fibrils to other non-collagenous molecules.	[Hansen, Uwe; Bruckner, Peter] Univ Hosp Munster, Dept Physiol Chem & Pathobiochem, Munster, Germany; [Hansen, Uwe] Univ Hosp Munster, Inst Musculoskeletal Med, Munster, Germany; [Holmes, David F.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Sch Biol Sci, Fac Biol Med & Hlth, Manchester, Lancs, England; [Bishop, Paul N.] Univ Manchester, Div Evolut & Genom Sci, Sch Biol Sci, Fac Biol Med & Hlth, Manchester, Lancs, England; [Bishop, Paul N.] Manchester Acad Hlth Sci Ctr, Manchester Univ NHS Fdn Trust, Manchester Royal Eye Hosp, Manchester, Lancs, England	University of Munster; University of Munster; University of Manchester; University of Manchester; Manchester Royal Eye Hospital; University of Manchester	Hansen, U (corresponding author), Univ Hosp Munster, Dept Physiol Chem & Pathobiochem, Munster, Germany.; Hansen, U (corresponding author), Univ Hosp Munster, Inst Musculoskeletal Med, Munster, Germany.; Bishop, PN (corresponding author), Univ Manchester, Div Evolut & Genom Sci, Sch Biol Sci, Fac Biol Med & Hlth, Manchester, Lancs, England.; Bishop, PN (corresponding author), Manchester Acad Hlth Sci Ctr, Manchester Univ NHS Fdn Trust, Manchester Royal Eye Hosp, Manchester, Lancs, England.	paul.bishop@manchester.ac.uk; uhansen@uni-muenster.de		Bishop, Paul/0000-0001-7937-7932	Deutsche Forschungsgemeinschaft [SFB 492]; UK Medical Research Council (MRC) [MR/M025365/-I]; MRC [MR/M025365/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Deutsche Forschungsgemeinschaft (SFB 492 project A2 to P. B.; hops//wvAvdfg de/en/) and UK Medical Research Council (MRC Reference: MR/M025365/-I to P.N.B.; https//mrc dim org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beecher N, 2005, INVEST OPHTH VIS SCI, V46, P4046, DOI 10.1167/iovs.05-0325; Bishop PN, 2004, INVEST OPHTH VIS SCI, V45, P1041, DOI 10.1167/iovs.03-1017; Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; Bos KJ, 2001, J MOL BIOL, V306, P1011, DOI 10.1006/jmbi.2000.4429; CHAPMAN JA, 1990, ELECTRON MICROSC REV, V3, P143, DOI 10.1016/0892-0354(90)90018-N; Eyre DR, 2002, BIOCHEM SOC T, V30, P894, DOI 10.1042/bst0300894; Farran A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18047-w; Gottardi R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163552; Hagg R, 1998, J CELL BIOL, V142, P285, DOI 10.1083/jcb.142.1.285; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; HEDLUND H, 1994, MATRIX BIOL, V14, P227, DOI 10.1016/0945-053X(94)90186-4; Hindson VJ, 2005, INVEST OPHTH VIS SCI, V46, P4417, DOI 10.1167/iovs.05-0883; Holmes DF, 2006, P NATL ACAD SCI USA, V103, P17249, DOI 10.1073/pnas.0608417103; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kassner A, 2003, MATRIX BIOL, V22, P131, DOI 10.1016/S0945-053X(03)00008-8; Le Goff MM, 2012, J BIOL CHEM, V287, P28027, DOI 10.1074/jbc.M111.331157; Le Goff MM, 2012, INVEST OPHTH VIS SCI, V53, P228, DOI 10.1167/iovs.11-8514; Le Goff MM, 2003, J BIOL CHEM, V278, P45280, DOI 10.1074/jbc.M303117200; MAYNE R, 1993, J BIOL CHEM, V268, P9381; MEEK KM, 1979, J BIOL CHEM, V254, P710; Monfort J, 2008, OSTEOARTHR CARTILAGE, V16, P749, DOI 10.1016/j.joca.2007.11.007; Reardon AJ, 2000, J BIOL CHEM, V275, P2123, DOI 10.1074/jbc.275.3.2123; Skeie JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127567; Von der Mark K., 2006, DYNAMICS BONE CARTIL, P3; Woltersdorf C, 2017, MATRIX BIOL, V63, P91, DOI 10.1016/j.matbio.2017.02.001	27	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0234672	10.1371/journal.pone.0234672	http://dx.doi.org/10.1371/journal.pone.0234672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764753	gold, Green Published, Green Submitted			2022-12-26	WOS:000561029000020
J	Nekaka, R; Nteziyaremye, J; Oboth, P; Iramiot, JS; Wandabwa, J				Nekaka, Rebecca; Nteziyaremye, Julius; Oboth, Paul; Iramiot, Jacob Stanley; Wandabwa, Julius			Malaria preventive practices and delivery outcomes: A cross-sectional study of parturient women in a tertiary hospital in Eastern Uganda	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE; PREGNANT-WOMEN; ANEMIA	Background Uganda ranks third in the number of deaths attributable to malaria and has some of the highest recorded malaria transmission rates in the general population. Malaria in Pregnancy is associated with detrimental effects for the mother and unborn baby and these effects seem to have long term effects and consequences on the life of the baby. Despite the preventive measures put in place by the World Health Organization in antenatal care, the burden of malaria in pregnancy is still high. We determined the use of malaria preventive strategies during pregnancy and the presence of plasmodium infection, anemia, and low birth weight babies at delivery among parturient women at Mbale regional referral hospital in eastern Uganda. Methods A cross-sectional study was conducted among 210 women delivering at MRRH between July 2017 and January 2018. Information on demographics, antenatal care, and prevention practices was collected using an interviewer-administered questionnaire. Maternal venous blood and cord blood samples were screened for Plasmodium infection by both microscopy of Giemsa-stained blood films andPlasmodium falciparumrapid diagnostic test (pf. HPR2 mRDT). Polymerase Chain Reaction (PCR) was done on cord blood. The presence of anemia was determined by the use of an automated hemoglobin analyzer. Data were analyzed using descriptive and analytical statistics. Results Of the 210 women, 3 (1.4%) and 19(9.1%) tested positive for malaria by using Giemsa stained blood smear microscopy and malaria rapid diagnosticMRDT tests respectively. PCR detected 4(%) of Plasmodium in cord blood. Twenty-nine percent of the women had anaemia and 11 (5.2%) had low birth weight babies. Only 23.3% of the women received at least three doses of IPTp-SP and 57.9% reported sleeping under an Insecticide Treated Net the night before the survey. The women who reported sleeping under a mosquito net the previous night (OR 0.67, 95% CI: 0.24-1.86) and those who reported taking fansidar as a directly observed therapy (OR 0.31, 95% CI: 0.04-2.39) appeared to have few chances of getting plasmodium infection though the findings were not statistically significant. Conclusion The effective use of malaria preventive strategies (IPT-SP and Insecticide Treated Nets) was generally low. Most of the women took less than three doses of SP and there was no strict adherence to the recommended directly observed therapy. The prevalence of Plasmodium infection during pregnancy was low though maternal anaemia and low birth weight were relatively high.	[Nekaka, Rebecca; Oboth, Paul] Busitema Univ, Fac Hlth Sci, Dept Community & Publ Hlth, Tororo, Uganda; [Nteziyaremye, Julius; Wandabwa, Julius] Busitema Univ, Dept Obstet & Gynecol, Fac Hlth Sci, Tororo, Uganda; [Iramiot, Jacob Stanley] Busitema Univ, Dept Microbiol & Immunol, Fac Hlth Sci, Tororo, Uganda		Iramiot, JS (corresponding author), Busitema Univ, Dept Microbiol & Immunol, Fac Hlth Sci, Tororo, Uganda.	jiramiot@gmail.com	Nekaka, Rebecca/GYQ-7546-2022; Nteziyaremye, Julius/ABC-1324-2020	Nekaka, Rebecca/0000-0002-9199-7197; Iramiot, Jacob Stanley/0000-0002-9239-6641	Makerere University-Swedish International Development Agency (Mak-SIDA) Research Cooperation Fund with Public Partner Universities in Uganda	Makerere University-Swedish International Development Agency (Mak-SIDA) Research Cooperation Fund with Public Partner Universities in Uganda	This study was supported by the Makerere University-Swedish International Development Agency (Mak-SIDA) Research Cooperation Fund with Public Partner Universities in Uganda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, WHO POL BRIEF IMPL I; Arinaitwe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073073; Azizi SC, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08471-5; Braun V, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0909-7; Cottrell G, 2015, CLIN INFECT DIS, V60, P1481, DOI 10.1093/cid/civ122; De Beaudrap Pierre, 2016, Malar J, V15, P92, DOI 10.1186/s12936-016-1135-7; Fokam EB, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1228-3; Fried M, 2012, EXPERT REV ANTI-INFE, V10, P1177, DOI [10.1586/ERI.12.98, 10.1586/eri.12.98]; Gutman J, 2013, J INFECT DIS, V208, P907, DOI 10.1093/infdis/jit276; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Mace KE, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0576-8; Minja DTR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-211; Mpogoro FJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-455; Muhammad HU, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1363-x; Namusoke Fatuma, 2010, Malar Res Treat, V2010, P913857, DOI 10.4061/2010/913857; Ndeserua R, 2015, AFR HEALTH SCI, V15, P810, DOI 10.4314/ahs.v15i3.15; Olupot-Olupot P, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2327-0; Ononge Sam, 2014, BMC Res Notes, V7, P712, DOI 10.1186/1756-0500-7-712; Orish VN, 2015, AFR HEALTH SCI, V15, P1087, DOI 10.4314/ahs.v15i4.6; Ouedraogo S, 2013, AM J TROP MED HYG, V88, P292, DOI 10.4269/ajtmh.12-0195; Poespoprodjo JR, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0794-0; Roman E, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-3004-7; Schantz-Dunn Julianna, 2009, Rev Obstet Gynecol, V2, P186; Siddiqui MZ, 2017, SAGE OPEN, V7, DOI 10.1177/2158244017725555; Tegegne Yalewayker, 2019, J Parasitol Res, V2019, P8396091, DOI 10.1155/2019/8396091; Uganda Bureau of Statistics Kampala, 2017, UG DEM HLTH SURV 201; WHO, 2019, WORLD MAL REP; WHO, 2022, WHO RECOMMENDATIONS; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2017, MAL PREGN WOM; World Health Organization, 2008, WORLD MAL REP	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237407	10.1371/journal.pone.0237407	http://dx.doi.org/10.1371/journal.pone.0237407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764806	gold, Green Published			2022-12-26	WOS:000561029000055
J	Latsuzbaia, A; Herold, M; Bertemes, JP; Mossong, J				Latsuzbaia, Ardashel; Herold, Malte; Bertemes, Jean-Paul; Mossong, Joel			Evolving social contact patterns during the COVID-19 crisis in Luxembourg	PLOS ONE			English	Article								We conducted an internet survey using Survey Monkey over six weeks to evaluate the impact of the government interventions on social contact patterns in Luxembourg. Participants were recruited via the science.lu website on March 25, April 2, April 16, May 1 during lockdown, and June 12 and June 25 after the lockdown to provide an estimate of their number of contacts within the previous 24 hours. During the lockdown, a total of 5,644 survey participants with a mean age of 44.2 years reported 18,118 contacts (mean = 3.2, IQR 1-4). The average number of contacts per day increased by 24% from 2.9 to 3.6 over the lockdown period. The average number of contacts decreased with age: 4.2 (IQR 2-5) for participants below 25 years and 1.7 (IQR 1-2) for participants above 64 years. Residents of Portuguese nationality reported a higher number of contacts (mean = 4.3, IQR 2-5) than Luxembourgish (mean = 3.5, IQR 2-4) or other foreign residents, respectively. After lockdown, 1,119 participants reported 7,974 contacts with 7.1 (IQR 3-9) contacts per day on average, of which 61.7% (4,917/7,974) occurred without a facemask (mean = 4.9, IQR 2-6). While the number of social contacts was substantially lower during the lockdown by more than 80% compared to the pre-pandemic period, we observed a more recent 121% increase during the post lockdown period showing an increased potential for COVID-19 spread. Monitoring social contacts is an important indicator to estimate the possible impact of government interventions on social contacts and the COVID-19 spread in the coming months.	[Latsuzbaia, Ardashel; Herold, Malte; Mossong, Joel] Lab Natl Sante, Epidemiol & Microbial Genom Unit, Dudelange, Luxembourg; [Bertemes, Jean-Paul] Luxembourg Natl Res Fund, Luxembourg, Luxembourg		Latsuzbaia, A (corresponding author), Lab Natl Sante, Epidemiol & Microbial Genom Unit, Dudelange, Luxembourg.	ardashel.latsuzbaia@lns.etat.lu	Mossong, Joël/D-4998-2009	Mossong, Joël/0000-0003-0717-9835	Luxembourg National Research Fund [PRIDE17/11823097, C17/BM/11684203]	Luxembourg National Research Fund(Luxembourg National Research Fund)	This work was supported by the Luxembourg National Research Fund (PRIDE17/11823097 and C17/BM/11684203).	Abbott S, 2020, WELLCOME OPEN RES, V5, P112, DOI [10.12688/wellcomeopenres.16006.1, DOI 10.12688/WELLCOMEOPENRES.16006.1, 10.12688/wellcomeopenres.16006.2, DOI 10.12688/WELLCOMEOPENRES.16006.2]; Colbourn T, 2020, LANCET PUBLIC HEALTH, V5, pE236, DOI 10.1016/S2468-2667(20)30072-4; Del Fava E, 2020, DIFFERENTIAL IMPACT, V2020; ECDC, 2020, SIT UPD WORLD MAY 7; Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI 10.1016/j.idm.2020.04.001; Jarvis CI, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01597-8; Kucharski AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004206; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Thompson RN, 2019, EPIDEMICS-NETH, V29, DOI 10.1016/j.epidem.2019.100356; Wu Jianmin, 2022, Crit Rev Food Sci Nutr, V62, P783, DOI 10.1080/10408398.2020.1828813; Zhang JJ, 2020, SCIENCE, V368, P1481, DOI 10.1126/science.abb8001	12	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237128	10.1371/journal.pone.0237128	http://dx.doi.org/10.1371/journal.pone.0237128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760114	Green Published, gold			2022-12-26	WOS:000561027200063
J	Long, HL; Bowman, DD; Yoo, H; Burkhardt-Reed, MM; Bene, ER; Oller, DK				Long, Helen L.; Bowman, Dale D.; Yoo, Hyunjoo; Burkhardt-Reed, Megan M.; Bene, Edina R.; Oller, D. Kimbrough			Social and endogenous infant vocalizations	PLOS ONE			English	Article							PARENTAL INTERACTION; VOCAL DEVELOPMENT; EVOLUTION; ATTACHMENT; LANGUAGE; COORDINATION; FEEDBACK; SPEECH; LEARN; TOOLS	Research on infant vocal development has provided notable insights into vocal interaction with caregivers, elucidating growth in foundations for language through parental elicitation and reaction to vocalizations. A role for infant vocalizations produced endogenously, potentially providing raw material for interaction and a basis for growth in the vocal capacity itself, has received less attention. We report that in laboratory recordings of infants and their parents, the bulk of infant speech-like vocalizations, or "protophones", were directed toward no one and instead appeared to be generated endogenously, mostly in exploration of vocal abilities. The tendency to predominantly produce protophones without directing them to others occurred both during periods when parents were instructed to interact with their infantsandduring periods when parents were occupied with an interviewer, with the infants in the room. The results emphasize the infant as an agent in vocal learning, even when not interacting socially and suggest an enhanced perspective on foundations for vocal language.	[Long, Helen L.; Burkhardt-Reed, Megan M.; Bene, Edina R.; Oller, D. Kimbrough] Univ Memphis, Sch Commun Sci & Disorders, Origins Language Lab, Memphis, TN 38152 USA; [Bowman, Dale D.] Univ Memphis, Dept Math, Memphis, TN 38152 USA; [Yoo, Hyunjoo] Univ Alabama, Coll Arts & Sci, Dept Commun Disorders, Tuscaloosa, AL USA; [Oller, D. Kimbrough] Univ Memphis, Inst Intelligent Syst, Memphis, TN 38152 USA; [Oller, D. Kimbrough] Konrad Lorenz Inst Evolut & Cognit Res, Klosterneuburg, Austria	University of Memphis; University of Memphis; University of Alabama System; University of Alabama Tuscaloosa; University of Memphis	Long, HL (corresponding author), Univ Memphis, Sch Commun Sci & Disorders, Origins Language Lab, Memphis, TN 38152 USA.	hlong@memphis.edu	Long, Helen/AAS-2822-2021	Long, Helen/0000-0001-6406-1222	National Institutes of Health [R01 DC006099, DC011027, DC015108]; National Institute on Deafness and Other Communication Disorders; Plough Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Plough Foundation	The research for this manuscript was funded to DKO by the National Institutes of Health grants R01 DC006099, DC011027, and DC015108 from the National Institute on Deafness and Other Communication Disorders (https://www.nidcd.nih.gov/) and by the Plough Foundation (http://plough.org/) which supports DKO's Chair of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney DH, 2017, INFANCY, V22, P514, DOI 10.1111/infa.12165; AINSWORTH MD, 1969, CHILD DEV, V40, P969, DOI 10.1111/j.1467-8624.1969.tb04561.x; Austin John, 1960, DO THINGS WORDS; Bekoff M, 1998, ANIMAL PLAY EVOLUTIO, V36; Bertossa RC, 2011, PHILOS T R SOC B, V366, P2056, DOI 10.1098/rstb.2011.0035; BLOOM K, 1975, J EXP CHILD PSYCHOL, V19, P209, DOI 10.1016/0022-0965(75)90085-5; BLOOM K, 1987, J CHILD LANG, V14, P211, DOI 10.1017/S0305000900012897; Bornstein M., 2000, COMMUNICATION ARENA, P109; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Braten S., 1998, INTERSUBJECTIVE COMM, P15; Buder E, 2010, SPEECH PROS 2010 5 I, P6; CARROLL SB, 2005, ENDLESS FORMS MOST B; Crown CL, 2002, J PSYCHOLINGUIST RES, V31, P1, DOI 10.1023/A:1014301303616; Darcy, 2003, 2003 OFFSHORE TECHNO; Davis KL., 2018, EMOTIONAL FDN PERSON; Delgado R. E., 2010, AACT ACTION ANAL COD; Dominguez S, 2016, INFANT CHILD DEV, V25, P240, DOI 10.1002/icd.1976; Franklin B, 2014, LANG LEARN DEV, V10, P279, DOI 10.1080/15475441.2013.849176; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Goldstein MH, 2008, PSYCHOL SCI, V19, P515, DOI 10.1111/j.1467-9280.2008.02117.x; Goldstein MH, 2009, CHILD DEV, V80, P636, DOI 10.1111/j.1467-8624.2009.01287.x; Golinkoff RM, 2015, CURR DIR PSYCHOL SCI, V24, P339, DOI 10.1177/0963721415595345; Gottlieb G, 2002, PSYCHOL REV, V109, P211, DOI 10.1037//0033-295X.109.2.211; Gratier M, 2015, FRONT PSYCHOL, V6, DOI [10.3389/fpsyg.2015.01167, 10.3389/fpgyg.2015.01167]; Gratier M, 2011, DEV PSYCHOL, V47, P67, DOI 10.1037/a0020722; Gros-Louis J, 2014, INFANCY, V19, P385, DOI 10.1111/infa.12054; Grossberg S, 2010, NEURAL NETWORKS, V23, P940, DOI 10.1016/j.neunet.2010.07.011; Gruss LT, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0063; Harold MP, 2013, INFANT BEHAV DEV, V36, P84, DOI 10.1016/j.infbeh.2012.10.001; Hsu HC, 2003, DEV PSYCHOL, V39, P976, DOI 10.1037/0012-1649.39.6.976; Hsu HC, 2001, INFANCY, V2, P87, DOI 10.1207/S15327078IN0201_6; Iyer SN, 2016, CLIN LINGUIST PHONET, V30, P470, DOI 10.3109/02699206.2016.1147082; Jaffe J, 2001, MONOGR SOC RES CHILD, V66, P1, DOI 10.1111/1540-5834.00137; Jhang Y., 2017, FRONT COMMUN, V2, P10, DOI [10.3389/fcomm.2017, DOI 10.3389/FCOMM.2017]; KIMBROUGHOLLER D, 1976, J CHILD LANG, V3, P1, DOI 10.1017/S0305000900001276; Kirschner MW, 2006, PLAUSIBILITY LIFE RE; LaFreniere P, 2011, AM J PLAY, V3, P464; Lee CC, 2018, INFANT BEHAV DEV, V50, P140, DOI 10.1016/j.infbeh.2017.12.002; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Locke JL, 2006, HUM NATURE-INT BIOS, V17, P155, DOI 10.1007/s12110-006-1015-x; Locke JL, 2006, BEHAV BRAIN SCI, V29, P259, DOI 10.1017/S0140525X0600906X; Locke JL, 2009, LANG SCI, V31, P33, DOI 10.1016/j.langsci.2007.09.008; Long HL, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01340; Long HL, 2016, ANN M AM SPEECH LANG; Milenkovic P., 2001, TF32 COMPUTER SOFTWA; Moulin-Frier C, 2013, INTERSPEECH ISCA; Moulin-Frier C, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01006; Newman SA, 2012, SCIENCE, V338, P217, DOI 10.1126/science.1222003; Oller DK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51352-0; Oller DK, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00729; Oller DK, 2016, TOP COGN SCI, V8, P382, DOI 10.1111/tops.12198; Oller DK, 2013, P NATL ACAD SCI USA, V110, P6318, DOI 10.1073/pnas.1300337110; OLLER DK, 1988, CHILD DEV, V59, P441, DOI 10.1111/j.1467-8624.1988.tb01479.x; Oller DK., 2005, EVOLUTIONARY PERSPEC, P135, DOI [10.4135/9781452233574.n5, DOI 10.4135/9781452233574.N5]; PANKSEPP J, 1982, BEHAV BRAIN SCI, V5, P407, DOI 10.1017/S0140525X00012759; Panksepp J., 2012, ARCHAEOLOGY MIND NEU; Panksepp J, 2011, AM J PRIMATOL, V73, P545, DOI 10.1002/ajp.20929; PEDERSEN FA, 1979, J GENET PSYCHOL, V135, P51, DOI 10.1080/00221325.1979.10533416; Perrault D. C litior I., 2008, INT C COGN SYST, pEl ; Piaget J., 1952, ORIGINS INTELLIGENCE, P47; Piaget J, 1952, PLAY DREAMS IMITATIO; PIPP S, 1987, CHILD DEV, V58, P648, DOI 10.1111/j.1467-8624.1987.tb01407.x; Ramirez-Esparza N, 2014, DEVELOPMENTAL SCI, V17, P880, DOI 10.1111/desc.12172; Roseberry S, 2014, CHILD DEV, V85, P956, DOI 10.1111/cdev.12166; Schore AN, 2001, INFANT MENT HEALTH J, V22, P7, DOI 10.1002/1097-0355(200101/04)22:1<7::AID-IMHJ2>3.0.CO;2-N; Searle J. R., 1969, SPEECH ACTS ESSAY PH, V626; Sheya A, 2013, ENACTION NEW PARADIG, P123; Skinner B. F., 1957, VERBAL BEHAV; Stark RE., 1981, INFANT MENT HEALTH J, V2, P118, DOI [10.1002/1097-0355(198122)2:23.0.CO;2-5, DOI 10.1002/1097-0355(198122)2:2<LESS, DOI 10.1002/1097-0355(198122)2:23.0.CO;2-5]; TREVARTHEN C., 1979, SPEECH BEGINNINGS HU, P321; TRONICK E, 1978, J AM ACAD CHILD PSY, V17, P1, DOI 10.1016/S0002-7138(09)62273-1; VAUCLAIR J, 1983, J HUM EVOL, V12, P631, DOI 10.1016/S0047-2484(83)80003-7; Vincini S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01323; Warlaumont AS, 2010, COGNITION IN FLUX, P121; Warlaumont AS, 2014, PSYCHOL SCI, V25, P1314, DOI 10.1177/0956797614531023; WASHBURN SL, 1960, SCI AM, V203, P63; Watson JB, 1913, PSYCHOL REV, V20, P158, DOI 10.1037/h0074428; Wells JCK, 2012, AM J PHYS ANTHROPOL, V149, P40, DOI 10.1002/ajpa.22160; WINNICOTT DW, 1960, INT J PSYCHOANAL, V41, P585; Yoo H, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01510; Zimmerman FJ, 2009, PEDIATRICS, V124, P342, DOI 10.1542/peds.2008-2267	81	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0224956	10.1371/journal.pone.0224956	http://dx.doi.org/10.1371/journal.pone.0224956			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NB3DK	32756591	gold, Green Submitted, Green Published			2022-12-26	WOS:000560393300045
J	Milner, R; Lewandowska, M; Ganc, M; Nikadon, J; Niedzialek, I; Jedrzejczak, WW; Skarzynski, H				Milner, Rafal; Lewandowska, Monika; Ganc, Malgorzata; Nikadon, Jan; Niedzialek, Iwona; Jedrzejczak, Wieslaw Wiktor; Skarzynski, Henryk			Electrophysiological correlates of focused attention on low- and high-distressed tinnitus	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; TEST-RETEST RELIABILITY; PERCEPTION TINNITUS; EEG BIOFEEDBACK; AUDITORY-CORTEX; DEFAULT MODE; BRAIN; PAIN; MINDFULNESS; OSCILLATIONS	Objectives The study aimed at determining the EEG correlates of concentration on either low or high-distressed tinnitus. Methods Sixty-seven patients (36 women, mean age = 50.34 +/- 12.94 years) with chronic tinnitus were assigned to either a high (HD) or low (LD) tinnitus-related distress group based on THI results. All participants took part in the EEG study comprising two 3-4 min blocks of focusing on either tinnitus (Tinnitus Focus Condition, TFC) or the sensations from one's own body (Body Focus Condition, BFC). The absolute power and current density of 8 frequency bands in 7 clusters were compared between conditions and groups. Results The most pronounced differences were found in the HD patients in the TFC, relative to the BFC, i.e. reduced power of frontally distributed low alpha (8-10 Hz) and posterior high alpha (10-12 Hz) as well as lower current density of 8-10 Hz rhythm over the right frontal/anterior cingulate cortex and higher middle beta (15-18 Hz) density in the precuneus. The HD, relative to LD patients, in both conditions, exhibited increased low beta (12-15 Hz) power over the left middle area and greater higher beta (15-25 Hz) power in the left posterior region. Conclusions The present study contrasted bioelectrical activity, acquired when concentrating on tinnitus with EEG data collected whilst patients focused on their body. Decreased alpha power and current density in the frontal/cingulate cortex when listening to bothersome tinnitus might reflect greater cortical arousal whereas increased beta power and density in the precuneus/posterior cingulate activity in this condition could be indicative for elevated tension or augmented cognitive/emotional processing of tinnitus sound. Enhanced beta rhythm in patients with highversuslow tinnitus distress, observed independently of the study condition, may be due to greater self-focused attention or more active processing of sensations derived from the own body.	[Milner, Rafal; Ganc, Malgorzata; Jedrzejczak, Wieslaw Wiktor] World Hearing Ctr, Inst Physiol & Pathol Hearing, Dept Expt Audiol, Kajetany Warsaw, Poland; [Lewandowska, Monika] Nicolaus Copernicus Univ, Fac Philosophy & Social Sci, Inst Psychol, Torun, Poland; [Nikadon, Jan] Nicolaus Copernicus Univ, Ctr Modern Interdisciplinary Technol, Torun, Poland; [Niedzialek, Iwona] World Hearing Ctr, Inst Physiol & Pathol Hearing, Audiol & Phoniatr Clin, Kajetany Warsaw, Poland; [Skarzynski, Henryk] World Hearing Ctr, Inst Physiol & Pathol Hearing, Oto Rhino Laryngol Surg Clin, Kajetany Warsaw, Poland	Institute of Physiology & Hearing Pathology; Nicolaus Copernicus University; Nicolaus Copernicus University; Institute of Physiology & Hearing Pathology; Institute of Physiology & Hearing Pathology	Milner, R (corresponding author), World Hearing Ctr, Inst Physiol & Pathol Hearing, Dept Expt Audiol, Kajetany Warsaw, Poland.	rafal.milner@gmail.com	Jedrzejczak, W. Wiktor/L-2529-2015	Jedrzejczak, W. Wiktor/0000-0001-8404-0672; Milner, Rafal/0000-0003-3670-8265; Ganc, Malgorzata/0000-0002-4413-8349; Lewandowska, Monika/0000-0002-7354-3693; Skarzynski, Henryk/0000-0001-7141-9851	National Science Centre (UMO) [1015];  [2011/03/D/NZ4/02431]	National Science Centre (UMO); 	This study was supported by a grant from the Polish 1015 National Science Centre (UMO nr 2011/03/D/NZ4/02431). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjamian P, 2012, JARO-J ASSOC RES OTO, V13, P715, DOI 10.1007/s10162-012-0340-5; AHERN GL, 1979, NEUROPSYCHOLOGIA, V17, P693, DOI 10.1016/0028-3932(79)90045-9; Andersson G, 2002, CLIN PSYCHOL REV, V22, P977, DOI 10.1016/S0272-7358(01)00124-6; Argstatter Heike, 2012, Int Tinnitus J, V17, P31; Ashton H, 2007, NEUROSCI LETT, V426, P23, DOI 10.1016/j.neulet.2007.08.034; Balkenhol T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053180; Barcelona J, 2020, INT J PSYCHOPHYSIOL, V155, P9, DOI 10.1016/j.ijpsycho.2020.04.019; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidet-Caulet A, 2007, J NEUROSCI, V27, P9252, DOI 10.1523/JNEUROSCI.1402-07.2007; Bing-Canar H, 2016, PSYCHOPHYSIOLOGY, V53, P1366, DOI 10.1111/psyp.12678; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; British Society of Audiology, 2011, PUR TON AIR COND BON; Burton H, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-3; Carpenter-Thompson JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144419; Carretie L, 2009, INT J PSYCHOPHYSIOL, V71, P57, DOI 10.1016/j.ijpsycho.2008.07.006; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cederroth CR, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00053; Chen YC, 2018, NEUROPSYCH DIS TREAT, V14, P1919, DOI 10.2147/NDT.S164619; Chen YC, 2017, HUM BRAIN MAPP, V38, P2384, DOI 10.1002/hbm.23525; Chiesa A, 2009, J ALTERN COMPLEM MED, V15, P585, DOI 10.1089/acm.2008.0416; Collura TF, 2009, INTRODUCTION TO QUANTITATIVE EEG AND NEUROFEEDBACK: ADVANCED THEORY AND APPLICATIONS, 2ND EDITION, P195, DOI 10.1016/B978-0-12-374534-7.00008-3; De Cesarei A, 2011, PSYCHOPHYSIOLOGY, V48, P1397, DOI 10.1111/j.1469-8986.2011.01204.x; De Ridder D, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00124; De Ridder D, 2014, NEUROSCI BIOBEHAV R, V44, P16, DOI 10.1016/j.neubiorev.2013.03.021; De Ridder D, 2014, NEUROSCI BIOBEHAV R, V44, P4, DOI 10.1016/j.neubiorev.2012.04.001; De Ridder D, 2013, BRAIN STIMUL, V6, P355, DOI 10.1016/j.brs.2012.07.002; De Ridder D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024273; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Pinheiro ESD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149085; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00029; Eggermont JJ, 2015, EUR J NEUROSCI, V41, P665, DOI 10.1111/ejn.12759; Egner T, 2004, CLIN NEUROPHYSIOL, V115, P131, DOI 10.1016/S1388-2457(03)00353-5; Egner T, 2001, NEUROREPORT, V12, P4155, DOI 10.1097/00001756-200112210-00058; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Faber PL, 2015, COGN PROCESS, V16, P87, DOI 10.1007/s10339-014-0637-x; Fassbender C, 2006, J PSYCHOPHYSIOL, V20, P286, DOI 10.1027/0269-8803.20.4.286; Feng Y, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00059; Formaggio E, 2019, IEEE T NEUR SYS REH, V27, P450, DOI 10.1109/TNSRE.2019.2894848; Frossard J., 2019, PERMUCO PERMUTATION; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; GASSER T, 1985, ELECTROEN CLIN NEURO, V60, P312, DOI 10.1016/0013-4694(85)90005-7; Golm D, 2016, BMC EAR NOSE THROAT, V16, DOI 10.1186/s12901-016-0029-1; Golm D, 2013, HEARING RES, V295, P87, DOI 10.1016/j.heares.2012.03.003; Guntensperger D, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00386; Guntekin B, 2014, NEUROPSYCHOLOGIA, V58, P33, DOI 10.1016/j.neuropsychologia.2014.03.014; Harmony T, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00083; Hartmann T, 2012, NEUROIMAGE, V60, P170, DOI 10.1016/j.neuroimage.2011.12.034; Hauck M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00375; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); Henry JA, 2014, J AM ACAD AUDIOL, V25, P5, DOI 10.3766/jaaa.25.1.2; HOWE RC, 1972, ELECTROEN CLIN NEURO, V32, P681, DOI 10.1016/0013-4694(72)90104-6; Ivanovski B, 2007, ACTA NEUROPSYCHIATR, V19, P76, DOI 10.1111/j.1601-5215.2007.00175.x; Jastreboff P J, 2000, J Am Acad Audiol, V11, P162; JASTREBOFF PJ, 1993, BRIT J AUDIOL, V27, P7, DOI 10.3109/03005369309077884; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Joos K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040544; Kaiser D. A., 2000, J NEUROTHERAPY, V4, P85, DOI DOI 10.1300/J184V04N03_06; Kandeepan S, 2019, J NEUROL, V266, P2197, DOI 10.1007/s00415-019-09390-1; Keng SL, 2011, CLIN PSYCHOL REV, V31, P1041, DOI 10.1016/j.cpr.2011.04.006; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kropotov J. D., 2010, QUANTITATIVE EEG EVE; Kropotov JD, 2016, FUNCTIONAL NEUROMARKERS FOR PSYCHIATRY: APPLICATIONS FOR DIAGNOSIS AND TREATMENT, P1; Lagopoulos J, 2009, J ALTERN COMPLEM MED, V15, P1187, DOI 10.1089/acm.2009.0113; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Lenth R., 2020, EMMEANS ESTIMATED MA; Linden M, 1996, BIOFEEDBACK SELF-REG, V21, P35, DOI 10.1007/BF02214148; Liu A, 2018, SOC COGN AFFECT NEUR, V13, P1269, DOI [10.1093/scan/nsy094 30351422, DOI 10.1093/SCAN/NSY094 30351422]; Llinas R, 2005, TRENDS NEUROSCI, V28, P325, DOI 10.1016/j.tins.2005.04.006; LUBAR JO, 1984, BIOFEEDBACK SELF-REG, V9, P1, DOI 10.1007/BF00998842; May ES, 2019, HUM BRAIN MAPP, V40, P293, DOI 10.1002/hbm.24373; McKenna L, 2018, EAR HEARING, V39, P359, DOI 10.1097/AUD.0000000000000491; Melzack R, 2001, J Dent Educ, V65, P1378; Meyer M., 2014, NEURAL PLAST, V2014; Meyer M, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/468546; Mielczarek M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00146; Milner R, 2016, APPL PSYCHOPHYS BIOF, V41, P225, DOI 10.1007/s10484-015-9318-5; Moazami-Goudarzi M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-40; Mohsen S, 2019, BASIC CLIN NEUROSCI, V10, P499, DOI 10.32598/bcn.9.10.215; Moller A R, 2000, J Am Acad Audiol, V11, P115; Morton DL, 2016, J PAIN RES, V9, P613, DOI 10.2147/JPR.S60433; Neff P, 2019, NEUROSCI LETT, V694, P176, DOI 10.1016/j.neulet.2018.11.008; Nemade SV, 2019, TURK ARCH OTORHINOL, V57, P34, DOI 10.5152/tao.2019.3091; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niedzialek I, 2019, COMPLEMENT THER CLIN, V36, P7, DOI 10.1016/j.ctcp.2019.04.003; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; Novembre G, 2019, NEUROIMAGE, V198, P221, DOI 10.1016/j.neuroimage.2019.05.032; Okamoto H, 2010, P NATL ACAD SCI USA, V107, P1207, DOI 10.1073/pnas.0911268107; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Peng WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091052; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rauschecker JP, 2015, TRENDS COGN SCI, V19, P567, DOI 10.1016/j.tics.2015.08.002; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Riha C, 2020, BRAIN TOPOGR, V33, P413, DOI 10.1007/s10548-020-00772-7; Roberts LE, 2018, HNO, V66, P172, DOI 10.1007/s00106-017-0449-2; Roberts LE, 2013, NEUROSCI BIOBEHAV R, V37, P1754, DOI 10.1016/j.neubiorev.2013.07.007; dos Santos RMR, 2012, INT ARCH OTORHINOLAR, V16, P322, DOI 10.7162/S1809-97772012000300004; Roland LT, 2015, OTOLARYNG HEAD NECK, V152, P919, DOI 10.1177/0194599815571556; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); SALINSKY MC, 1991, ELECTROEN CLIN NEURO, V79, P382, DOI 10.1016/0013-4694(91)90203-G; Schlee W, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/436146; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schulz E, 2015, CEREB CORTEX, V25, P4407, DOI 10.1093/cercor/bhv043; Sedley W, 2016, TRENDS NEUROSCI, V39, P799, DOI 10.1016/j.tins.2016.10.004; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; Sheppard A, 2020, INT J AUDIOL, V59, P5, DOI 10.1080/14992027.2019.1660812; Skarzynski PH, 2017, INT J AUDIOL, V56, P711, DOI 10.1080/14992027.2017.1319080; Song J-J., 2012, SCI WORLD J, V2012, P427941, DOI 10.1100/2012/427941; Spielberger C.D., 1983, MANUAL STATE TRAIT A; STERMAN MB, 1974, EPILEPSIA, V15, P395, DOI 10.1111/j.1528-1157.1974.tb04016.x; Stevens C, 2007, INT J AUDIOL, V46, P208, DOI 10.1080/14992020601102329; Su┬rnmo L., 2005, BIOELECTRIC SIGNAL P, V1, P25, DOI [10.1016/B978-012437552-9/50002-7, DOI 10.1016/B978-012437552-9/50002-7]; Thatcher R. W., 2012, HDB QUANTITATIVE ELE; Theodoroff SM, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1807-9; Thompson DM, 2017, EAR HEARING, V38, P149, DOI 10.1097/AUD.0000000000000363; TONNDORF J, 1987, HEARING RES, V28, P271, DOI 10.1016/0378-5955(87)90054-2; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; van de Velde M, 1998, ELECTROEN CLIN NEURO, V107, P149, DOI 10.1016/S0013-4694(98)00052-2; van der Loo E, 2011, AUTON NEUROSCI-BASIC, V165, P191, DOI 10.1016/j.autneu.2011.06.007; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; van Lutterveld Remko, 2011, Front Psychiatry, V2, P28, DOI 10.3389/fpsyt.2011.00028; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vernon D, 2003, INT J PSYCHOPHYSIOL, V47, P75, DOI 10.1016/S0167-8760(02)00091-0; Wagner M, 2004, BRAIN TOPOGR, V16, P277; Wang SY, 2019, J AFFECT DISORDERS, V257, P287, DOI 10.1016/j.jad.2019.07.026; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Wineland AM, 2012, OTOLARYNG HEAD NECK, V147, P900, DOI 10.1177/0194599812451414; Zeman F, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-7; Zenner HP, 2006, OTOL NEUROTOL, V27, P1054, DOI 10.1097/01.mao.0000231604.64079.77; Zhou R, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00750; Zobay O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120123; 2011, TXB TINNITUS, P1	143	3	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236521	10.1371/journal.pone.0236521	http://dx.doi.org/10.1371/journal.pone.0236521			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NB3DK	32756593	Green Published, gold			2022-12-26	WOS:000560393300061
J	Begun, A; MacGregor, AJ; Pchejetski, D; Kulinskaya, E				Begun, Alexander; MacGregor, Alexander J.; Pchejetski, Dmitri; Kulinskaya, Elena			Dynamic early identification of hip replacement implants with high revision rates. Study based on the NJR data from UK during 2004-2012	PLOS ONE			English	Article							OUTCOMES; MODELS; CUSUM; LONG	Background Hip replacement and hip resurfacing are common surgical procedures with an estimated risk of revision of 4% over 10 year period. Approximately 58% of hip replacements will last 25 years. Some implants have higher revision rates and early identification of poorly performing hip replacement implant brands and cup/head brand combinations is vital. Aims Development of a dynamic monitoring method for the revision rates of hip implants. Methods Data on the outcomes following the hip replacement surgery between 2004 and 2012 was obtained from the National Joint Register (NJR) in the UK. A novel dynamic algorithm based on the CUmulative SUM (CUSUM) methodology with adjustment for casemix and random frailty for an operating unit was developed and implemented to monitor the revision rates over time. The Benjamini-Hochberg FDR method was used to adjust for multiple testing of numerous hip replacement implant brands and cup/ head combinations at each time point. Results Three poorly performing cup brands and two cup/ head brand combinations have been detected. Wright Medical UK Ltd Conserve Plus Resurfacing Cup (cup o), DePuy ASR Resurfacing Cup (cup e), and Endo Plus (UK) Limited EP-Fit Plus Polyethylene cup (cup g) showed stable multiple alarms over the period of a year or longer. An addition of a random frailty term did not change the list of underperforming components. The model with added random effect was more conservative, showing less and more delayed alarms. Conclusions Our new algorithm is an efficient method for early detection of poorly performing components in hip replacement surgery. It can also be used for similar tasks of dynamic quality monitoring in healthcare.	[Begun, Alexander; Kulinskaya, Elena] Univ East Anglia, Sch Comp Sci, Norwich, Norfolk, England; [MacGregor, Alexander J.; Pchejetski, Dmitri] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England	University of East Anglia; University of East Anglia	Kulinskaya, E (corresponding author), Univ East Anglia, Sch Comp Sci, Norwich, Norfolk, England.	e.kulinskaya@uea.ac.uk		Kulinskaya, Elena/0000-0002-9843-1663	Economic and Social Research Council, UK [ES/L011859/1]; Gwen Fish Orthopaedics Trust; ESRC [ES/L011859/1] Funding Source: UKRI	Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Gwen Fish Orthopaedics Trust; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The work by A. Begun and E. Kulinskaya was supported by the Economic and Social Research Council, UK [grant number ES/L011859/1]. The work by A. Begun was further supported by a grant from the Gwen Fish Orthopaedics Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminnayeri M., 2016, AUT J MODELING SIMUL, V48, P103; [Anonymous], 2010, ENGL IND DEPR GUID D; Begun A, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0853-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biswas P, 2008, STAT MED, V27, P3382, DOI 10.1002/sim.3216; Evans JT, 2019, LANCET, V393, P647, DOI 10.1016/S0140-6736(18)31665-9; Hardoon SL, 2007, STAT MED, V26, P5081, DOI 10.1002/sim.2900; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Kandala NB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h756; Kovochich M, 2018, CRIT REV TOXICOL, V48, P853, DOI 10.1080/10408444.2018.1563048; Macpherson Gavin J, 2011, J Bone Joint Surg Am, V93 Suppl 3, P81, DOI 10.2106/JBJS.K.01010; Montgomery D.C., 2011, INTRO STAT QUALITY C, V6th; National Joint Register, 2017, 14 ANN REP 2017; National Joint Register, 2013, 10 ANN REP 2013; National Joint Register, 2015, 12 ANN REP 2015; National Joint Register, 2011, 8 ANN REP 2011; NICE National Institute for Health and Care Excellence, TOT HIP REPL RES ART; NJR Centre, 2017, NJR IMPL PERF AN MET; Norton MR, 2002, J BONE JOINT SURG BR, V84B, P631, DOI 10.1302/0301-620X.84B5.12679; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; R. C. Team, 2016, R LANG ENV STAT COMP; Rueten-Budde AJ, 2019, STAT MED, V38, P269, DOI 10.1002/sim.8002; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Zhang X, 2015, STAT MED, V34, P3336, DOI 10.1002/sim.6547	24	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0236701	10.1371/journal.pone.0236701	http://dx.doi.org/10.1371/journal.pone.0236701			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750091	Green Accepted, Green Published, gold			2022-12-26	WOS:000560009200031
J	Lee, SJ; Cho, S; La, TM; Lee, HJ; Lee, JB; Park, SY; Song, CS; Choi, IS; Lee, SW				Lee, Seo-Jin; Cho, Seongwoo; La, Tae-Min; Lee, Hong-Jae; Lee, Joong-Bok; Park, Seung-Yong; Song, Chang-Seon; Choi, In-Soo; Lee, Sang-Won			Comparison of microbiota in the cloaca, colon, and magnum of layer chicken	PLOS ONE			English	Article							DIVERSITY; BACTERIA; COMMUNITY	Anatomically terminal parts of the urinary, reproductive, and digestive systems of birds all connect to the cloaca. As the feces drain through the cloaca in chickens, the cloacal bacteria were previously believed to represent those of the digestive system. To investigate similarities between the cloacal microbiota and the microbiota of the digestive and reproductive systems, microbiota inhabiting the colon, cloaca, and magnum, which is a portion of the chicken oviduct of 34-week-old, specific-pathogen-free hens were analyzed using a 16S rRNA metagenomic approach using the Ion torrent sequencer and the Qiime2 bioinformatics platform. Beta diversity via unweighted and weighted unifrac analyses revealed that the cloacal microbiota was significantly different from those in the colon and the magnum. Unweighted unifrac revealed that the cloacal microbiota was distal from the microbiota in the colon than from the microbiota in the magnum, whereas weighted unifrac revealed that the cloacal microbiota was located further away from the microbiota in the magnum than from the microbiota inhabiting the colon.Pseudomonasspp. were the most abundant in the cloaca, whereasLactobacillusspp. andFlavobacteriumspp. were the most abundant species in the colon and the magnum. The present results indicate that the cloaca contains a mixed population of bacteria, derived from the reproductive, urinary, and digestive systems, particularly in egg-laying hens. Therefore, sampling cloaca to study bacterial populations that inhabit the digestive system of chickens requires caution especially when applied to egg-laying hens. To further understand the physiological role of the microbiota in chicken cloaca, exploratory studies of the chicken's cloacal microbiota should be performed using chickens of different ages and types.	[Lee, Seo-Jin; Cho, Seongwoo; La, Tae-Min; Lee, Hong-Jae; Lee, Joong-Bok; Park, Seung-Yong; Song, Chang-Seon; Choi, In-Soo; Lee, Sang-Won] Konkuk Univ, Coll Vet Med, Seoul, South Korea	Konkuk University	Lee, SW (corresponding author), Konkuk Univ, Coll Vet Med, Seoul, South Korea.	odssey@konkuk.ac.kr			Konkuk University	Konkuk University	This paper was supported by Konkuk University in 2016 to SWL.	Barbosa A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153215; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Brisbin Jennifer T., 2008, Animal Health Research Reviews, V9, P101, DOI 10.1017/S146625230800145X; Check Hayden E., NATURE NEWS; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dunham H. J., 1998, Bioscience and Microflora, V17, P133; Holben WE, 2004, APPL ENVIRON MICROB, V70, P2263, DOI 10.1128/AEM.70.4.2263-2270.2004; Hou QC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37376; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kohl KD, 2012, J COMP PHYSIOL B, V182, P591, DOI 10.1007/s00360-012-0645-z; Lee SI, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37296-x; Lobato E, 2017, SYMBIOSIS, V71, P155, DOI 10.1007/s13199-016-0419-6; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Maccaferri S, 2011, DIGEST DIS, V29, P525, DOI 10.1159/000332966; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Nakphaichit M, 2019, BENEF MICROBES, V10, P43, DOI 10.3920/BM2018.0034; Nearing JT, 2018, PEERJ, V6, DOI 10.7717/peerj.5364; Pandey N, 2013, WORLD J MICROB BIOT, V29, P1977, DOI 10.1007/s11274-013-1368-3; Panpan Tong, 2017, Agri Gene, V5, P1, DOI 10.1016/j.aggene.2017.06.001; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sneath PHA, 1986, BERGEYS MANUAL SYSTE, V2; SPIEGEL CA, 1980, NEW ENGL J MED, V303, P601, DOI 10.1056/NEJM198009113031102; SPIEGEL CA, 1991, CLIN MICROBIOL REV, V4, P485, DOI 10.1128/CMR.4.4.485-502.1991; Stanley D, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0388-6; Tang Y, 2014, APPL ENVIRON MICROB, V80, P478, DOI 10.1128/AEM.02472-13; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Videvall E, 2018, MOL ECOL RESOUR, V18, P424, DOI 10.1111/1755-0998.12744; Vispo Conrad, 1997, P116; Wilkinson TJ, 2017, FRONT MICROBIOL, V8, P1, DOI 10.3389/fmicb.2017.01089; Zang H., 2004, AA, V1, P3; Zhou H, 2007, POULTRY SCI, V86, P2541, DOI 10.3382/ps.2007-00267; Zhu XY, 2002, APPL ENVIRON MICROB, V68, P124, DOI 10.1128/AEM.68.1.124-137.2002	35	9	9	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0237108	10.1371/journal.pone.0237108	http://dx.doi.org/10.1371/journal.pone.0237108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750076	Green Published, gold			2022-12-26	WOS:000560009200013
J	Caverzasi, E; Cordano, C; Zhu, ALH; Zhao, C; Bischof, A; Kirkish, G; Bennett, DJ; Devereux, M; Baker, N; Inman, J; Yiu, HH; Papinutto, N; Gelfand, JM; Cree, BAC; Hauser, SL; Henry, RG; Green, AJ				Caverzasi, Eduardo; Cordano, Christian; Zhu, Alyssa H.; Zhao, Chao; Bischof, Antje; Kirkish, Gina; Bennett, Daniel J.; Devereux, Michael; Baker, Nicholas; Inman, Justin; Yiu, Hao H.; Papinutto, Nico; Gelfand, Jeffrey M.; Cree, Bruce A. C.; Hauser, Stephen L.; Henry, Roland G.; Green, Ari J.			Imaging correlates of visual function in multiple sclerosis	PLOS ONE			English	Article							NEURODEGENERATION; SEGMENTATION; TRIAL	No single neuroimaging technique or sequence is capable of reflecting the functional deficits manifest in MS. Given the interest in imaging biomarkers for short- to medium-term studies, we aimed to assess which imaging metrics might best represent functional impairment for monitoring in clinical trials. Given the complexity of functional impairment in MS, however, it is useful to isolate a particular functionally relevant pathway to understand the relationship between imaging and neurological function. We therefore analyzed existing data, combining multiparametric MRI and OCT to describe MS associated visual impairment. We assessed baseline data from fifty MS patients enrolled in ReBUILD, a prospective trial assessing the effect of a remyelinating drug (clemastine). Subjects underwent 3T MRI imaging, including Neurite Orientation Dispersion and Density Imaging (NODDI), myelin content quantification, and retinal imaging, using OCT. Visual function was assessed, using low-contrast letter acuity. MRI and OCT data were studied to model visual function in MS, using a partial, least-squares, regression analysis. Measures of neurodegeneration along the entire visual pathway, described most of the observed variance in visual disability, measured by low contrast letter acuity. In those patients with an identified history of ON, however, putative myelin measures also showed correlation with visual performance. In the absence of clinically identifiable inflammatory episodes, residual disability correlates with neurodegeneration, whereas after an identifiable exacerbation, putative measures of myelin content are additionally informative.	[Caverzasi, Eduardo; Cordano, Christian; Zhao, Chao; Bischof, Antje; Kirkish, Gina; Bennett, Daniel J.; Devereux, Michael; Baker, Nicholas; Inman, Justin; Yiu, Hao H.; Papinutto, Nico; Gelfand, Jeffrey M.; Cree, Bruce A. C.; Hauser, Stephen L.; Henry, Roland G.; Green, Ari J.] Univ Calif San Francisco, Div Neuroimmunol & Glial Biol UCSF, Weill Inst Neurosci, Dept Neurol, San Francisco, CA 94143 USA; [Zhu, Alyssa H.] Univ Southern Calif, Imaging Genet Ctr, Stevens Neuroimaging & Informat Inst, Los Angeles, CA 90007 USA; [Bischof, Antje] Univ Hosp Basel, Neurol & Immunol Clin, Basel, Switzerland; [Green, Ari J.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Southern California; University of Basel; University of California System; University of California San Francisco	Green, AJ (corresponding author), Univ Calif San Francisco, Div Neuroimmunol & Glial Biol UCSF, Weill Inst Neurosci, Dept Neurol, San Francisco, CA 94143 USA.; Green, AJ (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	agreen@ucsf.edu	Caverzasi, Eduardo/P-1707-2019; Cordano, Christian/ABC-3629-2020	Cordano, Christian/0000-0002-1413-0442; Caverzasi, Eduardo/0000-0002-0350-0460	Training Fellowship FISM (Fondazione Italiana Sclerosi Multipla) [2013/B/4]; Freiwillige Akademische Gesellschaft, Switzerland; Gottfried and Julia Bangerter-Rhyner Stiftung, Switzerland; UCSF from Genentech; National Institute of Neurological Disorders and Stroke [R35NS111644]; Valhalla Foundation; University of California, San Francisco; Rachleff Family	Training Fellowship FISM (Fondazione Italiana Sclerosi Multipla); Freiwillige Akademische Gesellschaft, Switzerland; Gottfried and Julia Bangerter-Rhyner Stiftung, Switzerland; UCSF from Genentech; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Valhalla Foundation; University of California, San Francisco(University of California System); Rachleff Family	Author CC was supported by a Training Fellowship FISM (Fondazione Italiana Sclerosi Multipla) - Cod. 2013/B/4. AB received travel fees from Actelion and speaker fees from Biogen, and has received research support from the Freiwillige Akademische Gesellschaft, Switzerland, and the Gottfried and Julia Bangerter-Rhyner Stiftung, Switzerland. JMG received research support via UCSF from Genentech for a clinical trial and consulting for Biogen and Alexion. In the past 36 months, BACC has received personal compensation for consulting from Akili, Alexion, Atara, Biogen, EMD Serono, Novartis, Sanofi and TG Therapeutics. SLH was supported by funding from the National Institute of Neurological Disorders and Stroke (R35NS111644) and the Valhalla Foundation. AJG was supported by funding from University of California, San Francisco and the Rachleff Family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Afanador NL, 2013, ANAL CHIM ACTA, V768, P49, DOI 10.1016/j.aca.2013.01.004; Ayadi N, 2018, NEUROL-NEUROIMMUNOL, V5, DOI 10.1212/NXI.0000000000000492; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Calabrese M, 2007, ARCH NEUROL-CHICAGO, V64, P1416, DOI 10.1001/archneur.64.10.1416; Cerqueira JJ, 2018, J NEUROL NEUROSUR PS, V89, P844, DOI 10.1136/jnnp-2017-317509; Comi G, 2012, NEW ENGL J MED, V366, P1000, DOI 10.1056/NEJMoa1104318; Cree BAC, 2019, ANN NEUROL, V85, P653, DOI 10.1002/ana.25463; Cruz-Herranz A, 2016, NEUROLOGY, V86, P2303, DOI 10.1212/WNL.0000000000002774; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Filippi M, 2015, J NEUROL, V262, P1, DOI 10.1007/s00415-014-7340-9; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fox RJ, 2018, NEW ENGL J MED, V379, P846, DOI 10.1056/NEJMoa1803583; Garyfallidis E, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00008; Green AJ, 2017, LANCET, V390, P2481, DOI 10.1016/S0140-6736(17)32346-2; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Martinez-Lapiscina EH, 2016, LANCET NEUROL, V15, P574, DOI 10.1016/S1474-4422(16)00068-5; Martinez-Lapiscina Elena H, 2014, BMC Res Notes, V7, P910, DOI 10.1186/1756-0500-7-910; Mori S, 2009, CURR OPIN NEUROL, V22, P362, DOI 10.1097/WCO.0b013e32832d954b; Neeb H, 2018, Z MED PHYS, DOI [10.1016/j.zemedi.2018.10.004 30442457, DOI 10.1016/J.ZEMEDI.2018.10.004 30442457]; Neeb H, 2012, NEUROIMAGE-CLIN, V1, P121, DOI 10.1016/j.nicl.2012.09.013; Petracca M, 2017, MULT SCLER J, V23, P43, DOI 10.1177/1352458516637679; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	24	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0235615	10.1371/journal.pone.0235615	http://dx.doi.org/10.1371/journal.pone.0235615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745132	gold, Green Published			2022-12-26	WOS:000560006800023
J	Esbensen, BA; Stallknecht, SE; Madsen, ME; Hagelund, L; Pilgaard, T				Esbensen, Bente Appel; Stallknecht, Sandra Elkjaer; Madsen, Maria Elmegaard; Hagelund, Lise; Pilgaard, Trine			Correlations of fatigue in Danish patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis	PLOS ONE			English	Article							SLEEP; PAIN; THERAPY; QUALITY; PERSPECTIVES; ASSOCIATION; PREVALENCE; REMISSION; DISEASES; HEALTH	Objective To describe fatigue in relation to disease-specific and socioeconomic factors and to test possible correlations between fatigue and work impairment, quality of life, pain, sleep, depression, and physical functioning in people with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA). Methods A questionnaire-based cross-sectional survey collecting patient characteristics such as disease characteristics, socioeconomic factors and patient-reported outcomes (PROs) from patients with RA, PsA and axSpA in Denmark. PRO scales included the FACIT-Fatigue sub-scale, Work Productivity and Activity Impairment scale (WPAI), EuroQol (EQ-5D), Medical Outcomes Study Sleep Scale (MOS), Major Depression Inventory (MDI), and Health Assessment Questionnaire (HAQ). Respondents were recruited via routine visits to the outpatient rheumatology clinic; information on diagnosis, treatment and disease activity was collected from medical journals by trained nurses. Results 487 patients participated in the study. Fatigue was more present in women, experienced patients, and patients who changed medication in the past 12 months, who were unemployed, who had less education, and who had lower household income. There was no statistically significant difference between mean fatigue in the three diagnostic groups (p = 0.08). Fatigue correlated with all included PROs (Pearson correlation coefficients, p<0.0001). Stratifying for diagnosis and adjusting for socioeconomic factors did not change the conclusion. Conclusion In a stable, representative group of patients with RA, PsA and axSpA, we found significant correlations between fatigue and work impairment, quality of life, pain, sleep, depression and physical functioning. Fatigue cannot be perceived as a single problem, but rather as a symptom that affects broadly.	[Esbensen, Bente Appel] Rigshosp, Copenhagen Ctr Arthrit Res, Ctr Head & Orthopaed, Ctr Rheumatol & Spine Dis, Glostrup, Denmark; [Esbensen, Bente Appel] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Stallknecht, Sandra Elkjaer; Madsen, Maria Elmegaard] Incentive, Holte, Denmark; [Hagelund, Lise; Pilgaard, Trine] Pfizer Denmark AS, Ballerup, Denmark	Rigshospitalet; University of Copenhagen; Pfizer	Madsen, ME (corresponding author), Incentive, Holte, Denmark.	mem@incentive.dk			Pfizer Denmark	Pfizer Denmark(Pfizer)	This nonpharmacological work was funded by Pfizer Denmark, which is a commercial company. TP is an employee of Pfizer Denmark and LH is a former employee of Pfizer Denmark. Incentive was a paid vendor and is also a commercial company. SES and MEM are employees of Incentive. The funder provided support in the form of salaries for authors TP and LH. The funder also provided consultation fees for authors SES and MEM of Incentive during the conduct of the study and consultation fees outside the submitted work. BAE is an employee of Rigshospitalet and University of Copenhagen and reports a research grant for data collection and personal fees for lead investigator consultancy on the protocol development from the funder during the conduct of the study. In addition, BAE has received other research grants and personal consultancy fees from the funder outside the submitted work. The specific roles of all authors are articulated in the 'author contributions' section.	Bruce Bonnie, 2003, Health Qual Life Outcomes, V1, P20, DOI 10.1186/1477-7525-1-20; Burmester GR, 2011, ANN RHEUM DIS, V70, P755, DOI 10.1136/ard.2010.139725; Calixto OJ, 2014, AUTOIMMUN REV, V13, P641, DOI 10.1016/j.autrev.2013.12.002; Chauffier K, 2012, RHEUMATOLOGY, V51, P60, DOI 10.1093/rheumatology/ker162; Cramp F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008322.pub2; Davies H, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-163; Davis MC, 2010, J PAIN, V11, P1338, DOI 10.1016/j.jpain.2010.03.009; Devlin NJ, 2018, HEALTH ECON, V27, P7, DOI 10.1002/hec.3564; Druce KL, 2016, RHEUMATOLOGY, V55, P1786, DOI 10.1093/rheumatology/kew241; Durcan L, 2014, J RHEUMATOL, V41, P1966, DOI 10.3899/jrheum.131282; Dures E, 2012, ARTHRIT CARE RES, V64, P494, DOI 10.1002/acr.21562; Evers AWM, 2002, PAIN, V100, P141, DOI 10.1016/S0304-3959(02)00274-9; Feldthusen C, 2016, ARCH PHYS MED REHAB, V97, P26, DOI 10.1016/j.apmr.2015.09.022; Feldthusen C, 2013, CLIN RHEUMATOL, V32, P557, DOI 10.1007/s10067-012-2133-y; Hewlett S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009061; Hewlett S, 2011, ARTHRIT CARE RES, V63, pS263, DOI 10.1002/acr.20579; Hewlett S, 2011, RHEUMATOLOGY, V50, P1004, DOI 10.1093/rheumatology/keq282; Hewlett S, 2011, ANN RHEUM DIS, V70, P1060, DOI 10.1136/ard.2010.144691; Katz P, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0649-5; Katz P, 2016, ARTHRIT CARE RES, V68, P81, DOI 10.1002/acr.22577; Loppenthin K, 2015, CLIN RHEUMATOL, V34, P2029, DOI 10.1007/s10067-015-2875-4; Loppenthin K, 2015, RHEUMATOL INT, V35, P1655, DOI 10.1007/s00296-015-3274-5; Loppenthin K, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-49; Mackenbach JP, 2003, PERSPECT BIOL MED, V46, P428, DOI 10.1353/pbm.2003.0039; Madsen M, 2015, MUSCULOSKELET CARE, V13, P31, DOI 10.1002/msc.1082; Madsen SG, 2016, SCAND J RHEUMATOL, V45, P255, DOI 10.3109/03009742.2015.1095943; Mahrholdt H, 2007, HEART, V93, P122, DOI 10.1136/hrt.2005.071290; Maska L, 2011, ARTHRIT CARE RES, V63, pS4, DOI 10.1002/acr.20620; Matcham F, 2015, CLIN PSYCHOL REV, V39, P16, DOI 10.1016/j.cpr.2015.03.004; Meeus M, 2007, CLIN RHEUMATOL, V26, P465, DOI 10.1007/s10067-006-0433-9; Metin ZG, 2016, PAIN MANAG NURS, V17, P140, DOI 10.1016/j.pmn.2016.01.004; Nikolaus S, 2013, ARTHRIT CARE RES, V65, P1128, DOI 10.1002/acr.21949; Olsen CL, 2016, ARTHRIT CARE RES, V68, P1043, DOI 10.1002/acr.22787; Overman CL, 2016, CLIN RHEUMATOL, V35, P409, DOI 10.1007/s10067-015-3035-6; Pilgaard T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218831; Pollard LC, 2006, RHEUMATOLOGY, V45, P885, DOI 10.1093/rheumatology/kel021; Primdahl J, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024338; Prioreschi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153470; Radovits BJ, 2010, ARTHRIT CARE RES, V62, P362, DOI 10.1002/acr.20105; Repping-Wuts H, 2008, INT J NURS STUD, V45, P995, DOI 10.1016/j.ijnurstu.2007.06.007; Rupp I, 2004, ARTHRIT RHEUM-ARTHR, V51, P578, DOI 10.1002/art.20539; Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864; Shin A, 2019, RHEUMATOLOGY, V58, P1617, DOI 10.1093/rheumatology/kez081; Strand V, 2017, ARTHRIT CARE RES, V69, P592, DOI 10.1002/acr.23004; Thomsen T, 2019, ARTHRIT CARE RES, DOI [10.1002/acr.2406031507095, DOI 10.1002/ACR.2406031507095]; Thomsen T, 2017, ANN RHEUM DIS, V76, P1603, DOI 10.1136/annrheumdis-2016-210953; van Dartel SAA, 2013, ARTHRIT CARE RES, V65, P862, DOI 10.1002/acr.21932; van Hoogmoed D, 2010, RHEUMATOLOGY, V49, P1294, DOI 10.1093/rheumatology/keq043; Webster Kimberly, 2003, Health Qual Life Outcomes, V1, P79, DOI 10.1186/1477-7525-1-79; Wells GA, 2009, J RHEUMATOL, V36, P2077, DOI 10.3899/jrheum.090362; Wolfe F, 1996, J RHEUMATOL, V23, P1407; Zangi HA, 2012, ANN RHEUM DIS, V71, P911, DOI 10.1136/annrheumdis-2011-200351; Zhang W, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3141	53	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0237117	10.1371/journal.pone.0237117	http://dx.doi.org/10.1371/journal.pone.0237117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA7OS	32745130	Green Published, gold			2022-12-26	WOS:000560006800025
J	Khalil, MI; Salwa, M; Sultana, S; Al Mamun, MA; Barman, N; Haque, MA				Khalil, Mohammad Ibrahim; Salwa, Marium; Sultana, Sarmin; Al Mamun, Mohammad Abdullah; Barman, Nilima; Haque, M. Atiqul			Role of serum uric acid in ischemic stroke: A case-control study in Bangladesh	PLOS ONE			English	Article							RISK-FACTORS; HYPERURICEMIA; HYPERTENSION; EVENTS; WOMEN	Introduction Increased level of serum uric acid (SUA) is often considered a risk factor for ischemic stroke. This study was conducted to examine the association of SUA level with ischemic stroke and assessed gender-based differences, if any. Methods In this case-control study, neuroimaging-confirmed ischemic stroke patients were recruited as cases within three days of an incident from neurology in-patient department, and as controls, patients without stroke history were recruited from neurology out-patient department. Blood was collected from the respondents of both groups to assess SUA level, lipid profile and oral glucose tolerance test. Binary logistic regression was done for estimating the risks of ischemic stroke. Results A total of 338 participants were recruited, where 169 were cases and 169 were controls. Around 60 percent respondents of both case and control groups were male. Mean SUA levels for cases and controls were 6.03 (SD 1.84) mg/dl and 4.04 (SD 1.46) mg/dl, respectively. After adjustment for age, tobacco consumption status, diabetes, hypertension, coronary heart disease and dyslipidemia, elevated SUA level was found to be significantly associated with ischemic stroke only in females (OR = 1.49; 95% CI = 1.01-2.19; p<0.05). Overall, each unit increase in SUA level exhibits 25 percent increment in odds of having ischemic stroke (OR = 1.25; 95% CI = 1.02-1.5372; p<0.05). Conclusion This study concluded that elevated SUA level is significantly associated with the acute phase of an ischemic stroke and gender-specific analysis demonstrates this association only in females.	[Khalil, Mohammad Ibrahim] Shaheed Suhrawardy Med Coll Hosp, Dept Neurol, Dhaka, Bangladesh; [Salwa, Marium; Sultana, Sarmin; Haque, M. Atiqul] Bangabandhu Sheikh Mujib Med Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh; [Al Mamun, Mohammad Abdullah] Natl Heart Fdn Hosp & Res Inst, Dept Epidemiol & Res, Dhaka, Bangladesh; [Barman, Nilima] Bangladesh Inst Res & Rehabil Diabet Endocrine &, Dept Lab Med, Dhaka, Bangladesh	Bangabandhu Sheikh Mujib Medical University (BSMMU)	Salwa, M (corresponding author), Bangabandhu Sheikh Mujib Med Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh.	mariumsalwa@gmail.com	Barman, Nilima/AAZ-4010-2020; Haque, Atiqul/ACD-5508-2022	Barman, Nilima/0000-0001-9664-5636; Haque, Atiqul/0000-0002-7598-2550; Khalil, Mohammad Ibrahim/0000-0003-4465-1502; Salwa, Marium/0000-0001-7869-3343				BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Bhole V, 2010, AM J MED, V123, P957, DOI 10.1016/j.amjmed.2010.03.027; Boehme AK, 2017, CIRC RES, V120, P472, DOI 10.1161/CIRCRESAHA.116.308398; Chamorro A, 2004, MED HYPOTHESES, V62, P173, DOI 10.1016/S0306-9877(03)00324-4; Chien KL, 2005, ATHEROSCLEROSIS, V183, P147, DOI 10.1016/j.atherosclerosis.2005.01.018; Choi BG, 2018, CLIN EXP PHARMACOL P, V45, P499, DOI 10.1111/1440-1681.12911; Holme I, 2009, J INTERN MED, V266, P558, DOI 10.1111/j.1365-2796.2009.02133.x; Hong JM, 2010, CEREBROVASC DIS, V29, P431, DOI 10.1159/000289346; Hozawa A, 2006, ATHEROSCLEROSIS, V187, P401, DOI 10.1016/j.atherosclerosis.2005.09.020; Iranmanesh F, 2012, IRAN J NEUROL, V11, P1; Jimenez MC, 2016, EUR J NEUROL, V23, P1158, DOI 10.1111/ene.12998; Johnson RJ, 2005, HYPERTENSION, V45, P18, DOI 10.1161/01.HYP.0000150785.39055.e8; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Koton S, 2008, CEREBROVASC DIS, V26, P517, DOI 10.1159/000155990; Kramer CK, 2009, DIABETES CARE, V32, P1272, DOI 10.2337/dc09-0275; Krishnan E, 2007, HYPERTENSION, V49, P298, DOI 10.1161/01.HYP.0000254480.64564.b6; Li CG, 2013, CURR OPIN RHEUMATOL, V25, P210, DOI 10.1097/BOR.0b013e32835d951e; Maloberti A, 2019, J CLIN HYPERTENS, V21, P975, DOI 10.1111/jch.13603; Manini Todd, 2011, Curr Aging Sci, V4, P184; Milionis HJ, 2005, J INTERN MED, V258, P435, DOI 10.1111/j.1365-2796.2005.01565.x; Numata Takeyuki, 2008, Diabetes Res Clin Pract, V80, pe1, DOI 10.1016/j.diabres.2007.10.031; Peng T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/735056; Raina S., 2015, J OBES METAB RES, V2, P228, DOI DOI 10.4103/2347-9906.170903; Rebora P, 2020, BLOOD PRESSURE, V29, P220, DOI 10.1080/08037051.2020.1735929; Romanos E, 2007, J CEREBR BLOOD F MET, V27, P14, DOI 10.1038/sj.jcbfm.9600312; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Ryu WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055210; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; Saha UK, 2018, PUBLIC HEALTH, V160, P26, DOI 10.1016/j.puhe.2018.03.024; SRIDHARAN R, 1992, NEUROEPIDEMIOLOGY, V11, P24, DOI 10.1159/000110903; Strasak AM, 2008, INT J CARDIOL, V125, P232, DOI 10.1016/j.ijcard.2007.11.094; Teramoto T, 2007, J ATHEROSCLER THROMB, V14, P155, DOI 10.5551/jat.E537; Wang ZX, 2016, MOL NEUROBIOL, V53, P1905, DOI 10.1007/s12035-015-9143-0; Waring WS, 2002, QJM-INT J MED, V95, P691, DOI 10.1093/qjmed/95.10.691; World Health Organization, 2017, GLOB AD TOB SURV COM, V2009; Yang XL, 2016, J NEUROL SCI, V370, P57, DOI 10.1016/j.jns.2016.09.019	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236747	10.1371/journal.pone.0236747	http://dx.doi.org/10.1371/journal.pone.0236747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745144	gold, Green Published			2022-12-26	WOS:000560006800016
J	Liu, SZ; Wu, D; Sun, X; Fan, Y; Zha, RR; Jalali, A; Teli, M; Sano, T; Siegel, A; Sudo, A; Agarwal, M; Robling, A; Li, BY; Yokota, H				Liu, Shengzhi; Wu, Di; Sun, Xun; Fan, Yao; Zha, Rongrong; Jalali, Aydin; Teli, Meghana; Sano, Tomohiko; Siegel, Amanda; Sudo, Akihiro; Agarwal, Mangilal; Robling, Alexander; Li, Bai-Yan; Yokota, Hiroki			Mechanical stimulations can inhibit local and remote tumor progression by downregulating WISP1	FASEB JOURNAL			English	Article						bone metastasis; breast cancer; cholesterol; urine; TGF beta calcitriol; vitamin D-3; WISP1	BONE-FORMATION; CANCER; EXERCISE; PATHWAYS	Mechanical stimulations can prevent bone loss, but their effects on the tumor-invaded bone or solid tumors are elusive. Here, we evaluated the effect of knee loading, dynamic loads applied to the knee, on metastasized bone and mammary tumors. In a mouse model, tumor cells were inoculated to the mammary fat pad or the proximal tibia. Daily knee loading was then applied and metabolic changes were monitored mainly through urine. Urine samples were also collected from human subjects before and after step aerobics. The result showed that knee loading inhibited tumor progression in the loaded tibia. Notably, it also reduced remotely the growth of mammary tumors. In the urine, an altered level of cholesterol was observed with an increase in calcitriol, which is synthesized from a cholesterol derivative. In urinary proteins, knee loading in mice and step aerobics in humans markedly reduced WNT1-inducible signaling pathway protein 1, WISP1, which leads to poor survival among patients with breast cancer. In the ex vivo breast cancer tissue assay, WISP1 promoted the growth of cancer fragments and upregulated tumor-promoting genes, such as Runx2, MMP9, and Snail. Collectively, the present preclinical and human study demonstrated that mechanical stimulations, such as knee loading and step aerobics, altered urinary metabolism and downregulated WISP1. The study supports the benefit of mechanical stimulations for locally and remotely suppressing tumor progression. It also indicated the role of WISP1 downregulation as a potential mechanism of loading-driven tumor suppression.	[Liu, Shengzhi; Wu, Di; Sun, Xun; Fan, Yao; Zha, Rongrong; Jalali, Aydin; Teli, Meghana; Sano, Tomohiko; Yokota, Hiroki] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Wu, Di; Sun, Xun; Fan, Yao; Zha, Rongrong; Li, Bai-Yan; Yokota, Hiroki] Harbin Med Univ, Sch Pharm, Dept Pharmacol, Harbin, Peoples R China; [Sano, Tomohiko; Sudo, Akihiro] Mie Univ, Dept Orthoped Surg, Tsu, Mie, Japan; [Siegel, Amanda; Agarwal, Mangilal; Yokota, Hiroki] Indiana Univ Purdue Univ, Integrated Nanosyst Dev Inst, Indianapolis, IN 46202 USA; [Siegel, Amanda] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA; [Agarwal, Mangilal; Yokota, Hiroki] Indiana Univ Purdue Univ, Dept Mech Engn, Indianapolis, IN 46202 USA; [Robling, Alexander; Yokota, Hiroki] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Robling, Alexander; Yokota, Hiroki] Indiana Univ Sch Med, Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN 46202 USA; [Yokota, Hiroki] Indiana Univ Sch Med, Simon Canc Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Harbin Medical University; Mie University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Yokota, H (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	hyokota@iupui.edu			HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR52144, R01AR053237]; HHS | NIH | National Cancer Institute (NCI) [R03CA238555]	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); HHS | NIH | National Cancer Institute (NCI)	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01AR52144 and R01AR053237; HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: R03CA238555	Al-Hendy A, 2016, J CLIN ENDOCR METAB, V101, P1542, DOI 10.1210/jc.2015-3555; Bikle Daniel D, 2014, Adv Exp Med Biol, V810, P282; Coughlin Steven S, 2019, Curr Cancer Rep, V1, P6, DOI 10.25082/CCR.2019.01.002; Coughlin TR, 2017, CURR DRUG TARGETS, V18, P1281, DOI 10.2174/1389450117666161226121650; da Silva PM, 2011, AM J CARDIOVASC DRUG, V11, P93, DOI 10.2165/11591190-000000000-00000; de Boer MC, 2017, CLIN BREAST CANCER, V17, P272, DOI 10.1016/j.clbc.2017.01.006; De Craene B, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1521; Deng WT, 2019, J BIOL CHEM, V294, P5261, DOI 10.1074/jbc.RA118.006122; Ewens A, 2005, ANTICANCER RES, V25, P3905; Ferrari N, 2013, J CELL PHYSIOL, V228, P1137, DOI 10.1002/jcp.24285; Friedenreich CM, 2017, J MOL MED, V95, P1029, DOI 10.1007/s00109-017-1558-9; Guo SS, 2020, J SPORT HEALTH SCI, V9, P53, DOI 10.1016/j.jshs.2019.07.004; Holm NJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030310; Kopecka J, 2020, DRUG RESIST UPDATE, V49, DOI 10.1016/j.drup.2019.100670; Liu SZ, 2018, CANCER RES, V78, P3865, DOI 10.1158/0008-5472.CAN-18-0056; McNeely ML, 2006, CAN MED ASSOC J, V175, P34, DOI 10.1503/cmaj.051073; Minami K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45686; Pauli C, 2017, CANCER DISCOV, V7, P462, DOI 10.1158/2159-8290.CD-16-1154; Prabhu AV, 2016, PROG LIPID RES, V64, P138, DOI 10.1016/j.plipres.2016.09.003; Salvador F, 2019, J PATHOL, V249, P6, DOI 10.1002/path.5292; Shim JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085095; Sun HB, 2012, CONNECT TISSUE RES, V53, P180, DOI 10.3109/03008207.2011.628765; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Venkatesan B, 2010, CELL SIGNAL, V22, P809, DOI 10.1016/j.cellsig.2010.01.005; Wang LQ, 2019, FASEB J, V33, P13710, DOI 10.1096/fj.201901388R; Wang TJ, 2015, RES NURS HEALTH, V38, P39, DOI 10.1002/nur.21633; Woollam M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38920-0; Wu D, 2020, FASEB J, V34, P7578, DOI 10.1096/fj.202000096R; Xu WX, 2015, CELL SIGNAL, V27, P2332, DOI 10.1016/j.cellsig.2015.08.014; Yang S, 2019, FASEB J, V33, P10742, DOI 10.1096/fj.201900306RR; Yousef EM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-609; Zhang P, 2008, BRIT J SPORT MED, V42, P556, DOI 10.1136/bjsm.2007.042556; Zhang P, 2006, J APPL PHYSIOL, V100, P1452, DOI 10.1152/japplphysiol.00997.2005; Zhang P, 2011, BONE, V49, P867, DOI 10.1016/j.bone.2011.06.020	34	4	4	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12847	12859		10.1096/fj.202000713RR	http://dx.doi.org/10.1096/fj.202000713RR		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32744779	Green Accepted, Green Submitted			2022-12-26	WOS:000557254800001
J	Subih, M; AlBarmawi, M; Bashir, DY; Jacoub, SM; Sayyah, NS				Subih, Maha; AlBarmawi, Marwa; Bashir, Dalal Yehia; Jacoub, Shrooq Munir; Sayyah, Najah Sayyah			Correlation between quality of life of cardiac patients and caregiver burden	PLOS ONE			English	Article							HEART-FAILURE PATIENTS; FAMILY CAREGIVERS; CANCER-PATIENTS; STRATEGIES; PREDICTORS; OUTCOMES; NEEDS	Background Caregivers experience high strain related to care giving. There is increasing interest in examining the caregiver burden of cardiac patients and studying the characteristics of caregivers. Purpose To explore the correlation between quality of life cardiac patients and caregiver's burden. Methods A cross-sectional design using a convenience sample of caregivers and patients with cardiac conditions. Sociodemographic sheet, Dutch Objective Burden Inventory (DOBI), and Quality of Life (QLI-Cardiac 4). Linear regression was used to explore the predictors. Results 200 caregivers and 200 patients with cardiac diseases completed the study. The overall mean scores of both DOBI and QLI-4 indicated moderate results 1.51(SD 0.4), 19.8 (SD 4.7) respectively. Predictors of caregiver burden were young, less educated caregivers and high QoL of cardiac patients. Conclusion Caregivers should receive more support and training from healthcare providers to develop their coping and resilience skills in a way that decreases their care burden and improves their quality of care and self-confidence.	[Subih, Maha; AlBarmawi, Marwa; Bashir, Dalal Yehia; Jacoub, Shrooq Munir; Sayyah, Najah Sayyah] Al Zaytoonah Univ Jordan ZUJ, Sch Nursing, Amman, Jordan	Al-Zaytoonah University of Jordan	Subih, M (corresponding author), Al Zaytoonah Univ Jordan ZUJ, Sch Nursing, Amman, Jordan.	maha.subih@zuj.edu.jo		Al Barmawi, Marwa/0000-0002-9135-6314	Al Zaytoonah University of Jordan (ZUJ) [21/172/2018]	Al Zaytoonah University of Jordan (ZUJ)	This work was supported by Al Zaytoonah University of Jordan (ZUJ) (Grant number 21/172/2018) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MS, MA, DY, SJ, NS 750$ to each one Al Zaytoonah University of Jordan: www.zuj.edu.jo	Aasbo G, 2016, SOCIOL HEALTH ILL, V38, P782, DOI 10.1111/1467-9566.12396; Adelman RD, 2014, JAMA-J AM MED ASSOC, V311, P1052, DOI 10.1001/jama.2014.304; Agren S, 2012, J CARD FAIL, V18, P359, DOI 10.1016/j.cardfail.2012.01.014; Agren S, 2010, EUR J CARDIOVASC NUR, V9, P254, DOI 10.1016/j.ejcnurse.2010.03.001; Akbarin M, 2013, EUR J CARDIOVASC NUR, V12, P64, DOI 10.1177/1474515111432996; Bidwell JT, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008080; Bidwell JT, 2017, J CARDIOVASC NURS, V32, P372, DOI 10.1097/JCN.0000000000000350; Chen HM, 2015, PSYCHOGERIATRICS, V15, P20, DOI 10.1111/psyg.12071; Desai AS, 2012, CIRCULATION, V126, P501, DOI 10.1161/CIRCULATIONAHA.112.125435; Ferrans CE, 1985, ADV NURSING SCI; Gren S, 2015, HEART LUNG, V44, P270; Halm MA, 2016, HEART LUNG, V45, P416, DOI 10.1016/j.hrtlng.2016.07.001; Jackson JDS, 2018, DRUG DES DEV THER, V12, P1669, DOI 10.2147/DDDT.S148970; Jenkinson C, 2012, QUALITY LIFE MEASURE; Lee CS, 2017, EUR J CARDIOVASC NUR, V16, P595, DOI 10.1177/1474515117700760; Lukhmana S, 2015, INDIAN J CANCER, V52, P146, DOI 10.4103/0019-509X.175584; Lum HD, 2014, HEART LUNG, V43, P306, DOI 10.1016/j.hrtlng.2014.05.002; Luttik ML, 2007, EUR J HEART FAIL, V9, P695, DOI 10.1016/j.ejheart.2007.01.006; Machado BM, 2018, CAD BRAS TER OCUP, V26, P299, DOI [10.4322/2526-8910.ctoAO1188, 10.4322/2526-8910.ctoao1188]; Makdessi A, 2011, EUR J CARDIOVASC NUR, V10, P234, DOI 10.1016/j.ejcnurse.2010.08.006; Mollaoglu, 2011, DOKUZ EYLUL U J NURS, V4, P125; Peters MEWJ, 2015, ACTA ONCOL, V54, P500, DOI 10.3109/0284186X.2014.953254; Pressler SJ, 2013, J CARDIOVASC NURS, V28, P417, DOI 10.1097/JCN.0b013e3182563877; Punchik B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182148; Terada Tomoko, 2018, J Rural Med, V13, P40, DOI 10.2185/jrm.2955; Van Horn ER, 2007, DIMENS CRIT CARE NUR, V26, P101, DOI 10.1097/01.DCC.0000267803.64734.c1; Van Pelt DC, 2010, CHEST, V137, P88, DOI 10.1378/chest.09-0795; Viana MC, 2013, REV BRAS PSIQUIATR, V35, P115, DOI 10.1590/1516-4446-2012-0919; Vitaliano PP, 2014, ANN BEHAV MED, V47, P198, DOI 10.1007/s12160-013-9538-y; Whittingham K, 2013, PALLIATIVE MED, V27, P596, DOI 10.1177/0269216313477179; Wingham J, 2015, CHRONIC ILLN, V11, P304, DOI 10.1177/1742395315574765; World Health Organisation, 2017, CARD DIS CVDS FACT S; World Health Organization, 2018, NONC DIS NCD COUNTR; World Health Organization, 2020, HLTH STAT INF SYST Q; Yigitalp G, 2017, INT J CARING SCI, V10, P1168; ZINCIR SB, 2014, SCI WORLD J, V2014, DOI DOI 10.1155/2014/896183	36	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0237099	10.1371/journal.pone.0237099	http://dx.doi.org/10.1371/journal.pone.0237099			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA7OS	32745147	Green Published, gold			2022-12-26	WOS:000560006800055
J	Carvalho, AAS; Christofolini, DM; Perez, MM; Alves, BCA; Rodart, I; Figueiredo, FWS; Turke, KC; Feder, D; Junior, MCF; Nucci, AM; Fonseca, FLA				Carvalho, Alzira A. S.; Christofolini, Denise M.; Perez, Matheus M.; Alves, Beatriz C. A.; Rodart, Itatiana; Figueiredo, Francisco W. S.; Turke, Karine C.; Feder, David; Junior, Marcondes C. F.; Nucci, Ana M.; Fonseca, Fernando L. A.			PYGM mRNA expression in McArdle disease: Demographic, clinical, morphological and genetic features	PLOS ONE			English	Article							MYOPHOSPHORYLASE GENE; MUTATIONS	Introduction McArdle disease presents clinical and genetic heterogeneity. There is no obvious association between genotype and phenotype. PYGM (muscle glycogen phosphorylase gene) mRNA expression and its association with clinical, morphological, and genetic aspects of the disease as a set have not been studied previously. Methods We investigated genetic variation in PYGM considering the number of PTCs (premature termination codon) per sample and compared mRNA expression in skeletal muscle samples from 15 patients with McArdle disease and 16 controls to PTCs number and different aspects of the disease. Results The main variant found was c.148C> T (PTC-premature termination codon). Patients with two PTCs showed 42% mRNA expression compared to the control group. Most cases showed an inversely proportional relation among PTCs and mRNA expression. Association between mRNA expression and other aspects of the disease showed no statistically significant difference (p > 0.05). Discussion mRNA expression is not useful as a predictor factor for the prognosis and severity of the disease. Different mechanisms as post-transcriptional events, epigenetics factors or protein function may be involved.	[Carvalho, Alzira A. S.] Ctr Univ Saude ABC, Dept Neurociencias, Lab Doencas Neuromusculares, Santo Andre, SP, Brazil; [Christofolini, Denise M.; Rodart, Itatiana] Ctr Univ Saude ABC, Inst Ideia Fertil Saude Reprod, Santo Andre, SP, Brazil; [Christofolini, Denise M.] Ctr Univ Saude ABC, Dept Genet, Santo Andre, SP, Brazil; [Perez, Matheus M.; Alves, Beatriz C. A.; Fonseca, Fernando L. A.] Ctr Univ Saude ABC, Lab Anal Clin, Santo Andre, SP, Brazil; [Figueiredo, Francisco W. S.] Ctr Univ Saude ABC, Dept Estat, Santo Andre, SP, Brazil; [Turke, Karine C.] Ctr Univ Saude ABC, Santo Andre, SP, Brazil; [Feder, David] Ctr Univ Saude ABC, Dept Farmacol, Santo Andre, SP, Brazil; [Junior, Marcondes C. F.; Nucci, Ana M.] Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil	Universidade Estadual de Campinas	Carvalho, AAS (corresponding author), Ctr Univ Saude ABC, Dept Neurociencias, Lab Doencas Neuromusculares, Santo Andre, SP, Brazil.	alzirasiqueiracarvalho@gmail.com	CHRISTOFOLINI, DENISE MARIA/AAS-5648-2021	Alves de Siqueira Carvalho, Alzira/0000-0002-5485-7937; Alves, Beatriz/0000-0001-9930-7747				Kohn TA, 2014, BIOL OPEN, V3, P1224, DOI 10.1242/bio.20149548; DiMauro S., 2002, Current Molecular Medicine (Hilversum), V2, P189, DOI 10.2174/1566524024605770; Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V4th, P16; Felice KJ, 1996, NEUROLOGY, V47, P581, DOI 10.1212/WNL.47.2.581; Fernandez-Cadenas I, 2003, NEUROLOGY, V61, P1432, DOI 10.1212/WNL.61.10.1432; Garcia-Consuegra I, 2018, HUM MUTAT, V39, P1338, DOI 10.1002/humu.23591; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Gurgel-Giannetti J, 2013, NEUROMOL MED, V15, P470, DOI 10.1007/s12017-013-8233-2; Inal-Gultekin G, 2017, NEUROMUSCULAR DISORD, V27, P997, DOI 10.1016/j.nmd.2017.06.004; Kitaoka Yu, 2014, Biology (Basel), V3, P157, DOI 10.3390/biology3010157; Kubisch C, 1998, HUM MUTAT, V12, P27, DOI 10.1002/(SICI)1098-1004(1998)12:1<27::AID-HUMU4>3.0.CO;2-#; Lucia A, 2008, NAT CLIN PRACT NEURO, V4, P568, DOI 10.1038/ncpneuro0913; Martinuzzi A, 2003, ANN NEUROL, V53, P497, DOI 10.1002/ana.10499; Nogales-Gadea G, 2008, HUM MUTAT, V29, P277, DOI 10.1002/humu.20649; Nogales-Gadea G, 2015, HUM MUTAT, V36, P669, DOI 10.1002/humu.22806; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quinlivan R, 2010, J NEUROL NEUROSUR PS, V81, P1182, DOI 10.1136/jnnp.2009.195040; Tarnopolsky M, 2003, MUSCLE NERVE, V27, P359, DOI 10.1002/mus.10330; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	20	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236597	10.1371/journal.pone.0236597	http://dx.doi.org/10.1371/journal.pone.0236597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735634	Green Published, gold			2022-12-26	WOS:000569367100031
J	Ma, ZH; Jiang, HQ; Meng, C; Cui, SL; Peng, JT; Wang, JW				Ma, Zhonghua; Jiang, Hanqiu; Meng, Chao; Cui, Shilei; Peng, Jingting; Wang, Jiawei			Idiopathic intracranial hypertension in patients with anemia: A retrospective observational study	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; BENIGN; PAPILLEDEMA; POPULATION; DIAGNOSIS; IOWA	Idiopathic intracranial hypertension (IIH) mostly affects obese women in childbearing age, leading to frustrating headache and permanent visual impairment. The exact etiology of this condition is poorly understood, and the population at risk and clinical presentation seems to be homogeneous. However, little attention has been paid to the clinical features of IIH patients with anemia. We herein performed a retrospective observational study by using the data of patients with presumed IIH who were referred to the neurology department of Beijing Tongren Hospital from January 2014 to August 2019 to describe the clinical features and radiological findings in patients with IIH and anemia, and compared these with those without anemia. The patients were divided into two groups based on the presence of anemic diseases. Clinical data including demographic characteristics, clinical features, past medical history, laboratory and neuroradiological findings, diagnoses, treatments and prognosis of these patients were reviewed and compared in both the groups. A total of 153 patients with IIH were enrolled, which included 22 cases with anemia (mean age, 33.23 +/- 9.68 years; 19 [86.36%] female) and 131 cases without anemia (mean age 37.11 +/- 11.56 years; 97 [74.05%] female). In the anemia group, 19/22 cases had iron deficiency anemia and 3/22 had renal anemia. Compared with patients in the non-anemia group, IIH patients with anemia had a shorter disease course, and tended to present pulsatile tinnitus and transverse sinus stenosis (TSS), faster and better prognosis after treatments for correcting anemia and reducing intracranial pressure. Our findings highlighted the importance of obtaining full blood counts in IIH patients with subacute onset, and provided appropriate and prompt treatments if proven anemic in order to bring better outcomes.	[Ma, Zhonghua; Jiang, Hanqiu; Meng, Chao; Cui, Shilei; Peng, Jingting; Wang, Jiawei] Capital Med Univ, Beijing Tongren Hosp, Dept Neurol, Beijing, Peoples R China; [Ma, Zhonghua; Jiang, Hanqiu; Meng, Chao; Cui, Shilei; Peng, Jingting; Wang, Jiawei] Beijing Tongren Hosp, Dept Neurol, Beijing, Peoples R China	Capital Medical University	Wang, JW (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Neurol, Beijing, Peoples R China.; Wang, JW (corresponding author), Beijing Tongren Hosp, Dept Neurol, Beijing, Peoples R China.	wangjwcq@163.com			Beijing Tongren Hospital, Capital Medical University, Key Medical Development Plan [TRYY-KYJJ-2017-054]	Beijing Tongren Hospital, Capital Medical University, Key Medical Development Plan	Funded by "Beijing Tongren Hospital, Capital Medical University, Key Medical Development Plan, TRYY-KYJJ-2017-054". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardissino M, 2019, ACTA NEUROCHIR, V161, P239, DOI 10.1007/s00701-018-3772-9; Auinger P, 2014, INVEST OPHTH VIS SCI, V55, P8173, DOI 10.1167/iovs.14-14961; Balci K, 2007, J CLIN NEUROSCI, V14, P181, DOI 10.1016/j.jocn.2005.09.020; Beguin Y, 1999, HAEMATOLOGICA, V84, P541; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Biousse V, 2003, AM J OPHTHALMOL, V135, P437, DOI 10.1016/S0002-9394(02)02062-7; Chiarella G, 2012, ACTA OTORHINOLARYNGO, V32, P238; Daniels AB, 2007, AM J OPHTHALMOL, V143, P635, DOI 10.1016/j.ajo.2006.12.040; DURCAN FJ, 1988, ARCH NEUROL-CHICAGO, V45, P875; FOLEY J, 1955, BRAIN, V78, P1, DOI 10.1093/brain/78.1.1; FRISEN L, 1982, J NEUROL NEUROSUR PS, V45, P13, DOI 10.1136/jnnp.45.1.13; Gupta MK., 2001, HOSP PHYS, V37, P49; Hartfield DS, 1997, PEDIATR NEUROL, V16, P50, DOI 10.1016/S0887-8994(96)00290-1; Hatem Christina F., 2018, ACTA OPHTHALMOL, V96, P719, DOI [10.1111/aos.13664, DOI 10.1111/AOS.13664]; Jindal M, 2009, EUR ARCH OTO-RHINO-L, V266, P803, DOI 10.1007/s00405-009-0973-0; Kinoshita Y, 2006, NEUROL MED-CHIR, V46, P589, DOI 10.2176/nmc.46.589; Lavie P, 2000, BRIT MED J, V320, P479, DOI 10.1136/bmj.320.7233.479; LILLEY ER, 1990, ARCH OPHTHALMOL-CHIC, V108, P1674, DOI 10.1001/archopht.1990.01070140028014; Mollan SP, 2009, EUR NEUROL, V62, P105, DOI 10.1159/000222781; Mollan SP, 2018, J NEUROL NEUROSUR PS, V89, P1088, DOI 10.1136/jnnp-2017-317440; Mollan Susan P, 2018, Pract Neurol, V18, P485, DOI 10.1136/practneurol-2018-002009; Ogata Toshiyasu, 2008, J Stroke Cerebrovasc Dis, V17, P426, DOI 10.1016/j.jstrokecerebrovasdis.2008.04.008; Scott CJ, 2010, ARCH OPHTHALMOL-CHIC, V128, P705, DOI 10.1001/archophthalmol.2010.94; Shah VA, 2008, NEUROLOGY, V70, P634, DOI 10.1212/01.wnl.0000299893.43918.a8; SISMANIS A, 1987, LARYNGOSCOPE, V97, P1, DOI 10.1288/00005537-198708001-00001; TUGAL O, 1994, AM J PEDIAT HEMATOL, V16, P266; WALL M, 1991, BRAIN, V114, P155; Wall M, 2014, JAMA NEUROL, V71, P693, DOI 10.1001/jamaneurol.2014.133; Wall M, 2010, NEUROL CLIN, V28, P593, DOI 10.1016/j.ncl.2010.03.003; Yri HM, 2012, J NEUROL, V259, P886, DOI 10.1007/s00415-011-6273-9; Yuh WTC, 2000, J MAGN RESON IMAGING, V12, P808, DOI 10.1002/1522-2586(200012)12:6<808::AID-JMRI3>3.0.CO;2-N	31	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236828	10.1371/journal.pone.0236828	http://dx.doi.org/10.1371/journal.pone.0236828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735573	gold, Green Published			2022-12-26	WOS:000569367100050
J	Neo, T; Gozawa, M; Takamura, Y; Inatani, M; Oki, M				Neo, Takuma; Gozawa, Makoto; Takamura, Yoshihiro; Inatani, Masaru; Oki, Masaya			Gene expression profile analysis of the rabbit retinal vein occlusion model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR EDEMA SECONDARY; DIABETIC-RETINOPATHY; DECORIN; BEVACIZUMAB; INFLAMMATION; LASER; VEGF; NEOVASCULARIZATION; PHOTOCOAGULATION	The rabbit retinal vein occlusion (RVO) model is an experimental system that mimics retinal ischemic diseases in humans. The rabbit RVO model is widely used to assess the therapeutic efficacy of various experimental surgical procedures. In the present study, we measured temporal retinal expression of Vegfa, which is known as an ischemic response gene, in rabbit RVO. This analysis revealed that the retinal Vegfa transcriptional response began 7 days after generation of RVO, rather than immediately after induction of ischemia. Next, in order to analyze ischemia-induced changes in gene expression profiles, we performed microarray analysis of day 7 RVO retina versus control retina. The angiogenic regulators Dcn and Mmp1 and pro-inflammatory factors Mmp12 and Cxcl13 were significantly upregulated in RVO retinas. Further, we suggest that epigenetic regulation via the REST/cofactor-complex could contribute to RVO pathology. Among human homologous genes in rabbits, genes associated with hypoxia, angiogenesis, and inflammation were significantly upregulated in RVO retinas. Components of the Tumor necrosis factor-alpha (TNF alpha) and Nuclear factor-kappa B (NF-kappa B) pathways, which play regulatory roles in angiogenesis and inflammation, were significantly upregulated in RVO, and the expression levels of downstream factors, such as the transcription factor AP-1 and chemokines, were increased. Further, connectivity map analyses suggested that inhibitors of the NF-kappa B pathway are potential therapeutic agents for retinal ischemic disease. The present study revealed new insights into the pathology of retinal ischemia using the rabbit RVO model, which accurately recapitulates human disease.	[Neo, Takuma; Oki, Masaya] Univ Fukui, Grad Sch Engn, Dept Appl Chem & Biotechnol, Fukui, Japan; [Gozawa, Makoto; Takamura, Yoshihiro; Inatani, Masaru] Univ Fukui, Fac Med Sci, Dept Ophthalmol, Fukui, Japan; [Oki, Masaya] Univ Fukui, Life Sci Innovat Ctr, Fukui, Japan	University of Fukui; University of Fukui; University of Fukui	Oki, M (corresponding author), Univ Fukui, Grad Sch Engn, Dept Appl Chem & Biotechnol, Fukui, Japan.; Oki, M (corresponding author), Univ Fukui, Life Sci Innovat Ctr, Fukui, Japan.	ma4sa6ya@u-fukui.ac.jp		Oki, Masaya/0000-0002-5563-0443				Ameri H, 2008, GRAEF ARCH CLIN EXP, V246, P1429, DOI 10.1007/s00417-008-0878-4; Avery RL, 2017, RETINA-J RET VIT DIS, V37, P1847, DOI 10.1097/IAE.0000000000001493; Bhisitkul RB, 2006, BRIT J OPHTHALMOL, V90, P1542, DOI 10.1136/bjo.2006.098426; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Boulton M, 1998, BRIT J OPHTHALMOL, V82, P561, DOI 10.1136/bjo.82.5.561; Cehofski LJ, 2015, EXP EYE RES, V138, P87, DOI 10.1016/j.exer.2015.06.011; Cheng SC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20122957; Chui A, 2014, PLACENTA, V35, P596, DOI 10.1016/j.placenta.2014.05.009; Cui JZ, 2009, LASER MED SCI, V24, P653, DOI 10.1007/s10103-008-0577-8; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; Dioum EM, 2008, INVEST OPHTH VIS SCI, V49, P2714, DOI 10.1167/iovs.07-1469; Duh EJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93751; Ehlken C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126859; Feng SF, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/8546423; Gozawa M, 2017, INVEST OPHTH VIS SCI, V58, P5941, DOI 10.1167/iovs.17-22739; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Higashiyama T, 2013, ACTA OPHTHALMOL, V91, P318, DOI 10.1111/j.1755-3768.2011.02298.x; Huttenlocher A, 1996, MATRIX BIOL, V15, P239, DOI 10.1016/S0945-053X(96)90115-8; Jarvelainen H, 2015, MATRIX BIOL, V43, P15, DOI 10.1016/j.matbio.2015.01.023; Jiang J, 2009, J CELL PHYSIOL, V218, P66, DOI 10.1002/jcp.21566; Kakimoto H, 2018, J OCUL PHARMACOL TH, V34, P410, DOI 10.1089/jop.2017.0109; Kanada F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56414-x; Khayat M, 2017, INVEST OPHTH VIS SCI, V58, P6175, DOI 10.1167/iovs.17-22788; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Koch JC, 2011, FEBS J, V278, P3472, DOI 10.1111/j.1742-4658.2011.08269.x; Kreutzer TC, 2008, BRIT J OPHTHALMOL, V92, P351, DOI 10.1136/bjo.2007.123513; Kriechbaum K, 2008, BRIT J OPHTHALMOL, V92, P518, DOI 10.1136/bjo.2007.127282; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lai CY, 2015, J IMMUNOL, V195, P3912, DOI 10.4049/jimmunol.1500194; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Larsson J, 1998, BRIT J OPHTHALMOL, V82, P1438, DOI 10.1136/bjo.82.12.1438; LI JLL, 2012, NANOSCALE RES LETT, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE.0052699; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Lopez-Colome AM, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0418-y; Martin G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191338; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Noh KM, 2012, P NATL ACAD SCI USA, V109, pE962, DOI 10.1073/pnas.1121568109; Rowley SA, 2004, BRIT J OPHTHALMOL, V88, P573, DOI 10.1136/bjo.2003.027466; Saif MW, 2006, EXPERT OPIN DRUG SAF, V5, P553, DOI 10.1517/14740338.5.4.553; Schonherr E, 2004, J VASC RES, V41, P499, DOI 10.1159/000081806; Schonherr E, 2001, J CELL PHYSIOL, V187, P37, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1048>3.0.CO;2-W; Shah Parag K, 2016, World J Clin Pediatr, V5, P35, DOI 10.5409/wjcp.v5.i1.35; Spaide RF, 2012, RETINA-J RET VIT DIS, V32, P1719, DOI 10.1097/IAE.0b013e3182671191; Spranger J, 2000, DIABETOLOGIA, V43, P1404, DOI 10.1007/s001250051546; Stahl A, 2019, LANCET, V394, P1551, DOI 10.1016/S0140-6736(19)31344-3; Stefansson E, 2001, ACTA OPHTHALMOL SCAN, V79, P435, DOI 10.1034/j.1600-0420.2001.790502.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Valle ML, 2019, EXP EYE RES, V178, P27, DOI 10.1016/j.exer.2018.09.009; Nguyen V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47062-2; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Wong MS, 2015, MOL NEUROBIOL, V52, P1364, DOI 10.1007/s12035-014-8945-9; Wu WC, 2015, JAMA OPHTHALMOL, V133, P391, DOI 10.1001/jamaophthalmol.2014.5373; Yang XM, 2009, INVEST OPHTH VIS SCI, V50, P1873, DOI 10.1167/iovs.08-2591; Zeng YK, 2019, MOL VIS, V25, P756; Zhang LL, 2015, J BIOL CHEM, V290, P15018, DOI 10.1074/jbc.M115.641407; 2015, ULLA POSTGRAD PHARM, P1	58	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236928	10.1371/journal.pone.0236928	http://dx.doi.org/10.1371/journal.pone.0236928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735610	Green Published, gold			2022-12-26	WOS:000569367100061
J	Ormsby, AR; Cox, D; Daly, J; Priest, D; Hinde, E; Hatters, DM				Ormsby, Angelique R.; Cox, Dezerae; Daly, James; Priest, David; Hinde, Elizabeth; Hatters, Danny M.			Nascent mutant Huntingtin exon 1 chains do not stall on ribosomes during translation but aggregates do recruit machinery involved in ribosome quality control and RNA	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; IN-VITRO; DISEASE; CELLS; MODEL	Mutations that cause Huntington's Disease involve a polyglutamine (polyQ) sequence expansion beyond 35 repeats in exon 1 of Huntingtin. Intracellular inclusion bodies of mutant Huntingtin protein are a key feature of Huntington's disease brain pathology. We previously showed that in cell culture the formation of inclusions involved the assembly of disordered structures of mHtt exon 1 fragments (Httex1) and they were enriched with translational machinery when first formed. We hypothesized that nascent mutant Httex1 chains co-aggregate during translation by phase separation into liquid-like disordered aggregates and then convert to more rigid, amyloid structures. Here we further examined the mechanisms of inclusion assembly in a human epithelial kidney (AD293) cell culture model. We found mHttex1 did not appear to stall translation of its own nascent chain, or at best was marginal. We also found the inclusions appeared to recruit low levels of RNA but there was no difference in enrichment between early formed and mature inclusions. Proteins involved in translation or ribosome quality control were co-recruited to the inclusions (Ltn1 Rack1) compared to a protein not anticipated to be involved (NACAD), but there was no major specificity of enrichment in the early formed inclusions compared to mature inclusions. Furthermore, we observed co-aggregation with other proteins previously identified in inclusions, including Upf1 and chaperone-like proteins Sgta and Hspb1, which also suppressed aggregation at high co-expression levels. The newly formed inclusions also contained immobile mHttex1 molecules which points to the disordered aggregates being mechanically rigid prior to amyloid formation. Collectively our findings show little evidence that inclusion assembly arises by a discrete clustering of stalled nascent chains and associated quality control machinery. Instead, the machinery appear to be recruited continuously, or secondarily, to the nucleation of inclusion formation.	[Ormsby, Angelique R.; Cox, Dezerae; Daly, James; Priest, David; Hinde, Elizabeth; Hatters, Danny M.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Ormsby, Angelique R.; Cox, Dezerae; Daly, James; Priest, David; Hinde, Elizabeth; Hatters, Danny M.] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne	Hatters, DM (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia.	dhatters@unimelb.edu.au	Cox, Dezerae/I-7265-2019	Cox, Dezerae/0000-0002-5345-8360; Hatters, Danny/0000-0002-9965-2847; Hinde, Elizabeth/0000-0001-8317-1152; , Angelique/0000-0002-2780-9550	National Health and Medical Research Council [APP1184166, APP1161803, APP1102059, APP1154352]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by grants and fellowships from the National Health and Medical Research Council Project to D.M.H. (APP1184166, APP1161803, APP1102059, APP1154352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktar F, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900489; Arthur LL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500154; Brandman O, 2016, NAT STRUCT MOL BIOL, V23, P7, DOI 10.1038/nsmb.3147; Chandrasekaran V, 2019, NAT STRUCT MOL BIOL, V26, P1132, DOI 10.1038/s41594-019-0331-x; Culver BP, 2012, J BIOL CHEM, V287, P21599, DOI 10.1074/jbc.M112.359307; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Gandin V, 2013, MOL CELL BIOL, V33, P2510, DOI 10.1128/MCB.01362-12; Hatters DM, 2012, CURR TOP MED CHEM, V12, P2611; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Joazeiro CAP, 2017, ANNU REV CELL DEV BI, V33, P343, DOI 10.1146/annurev-cellbio-111315-125249; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Liu ZY, 2020, NAT STRUCT MOL BIOL, V27, P363, DOI 10.1038/s41594-020-0399-3; Liu ZQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02460-2; Lykke-Andersen J, 2014, J CELL BIOL, V204, P467, DOI 10.1083/jcb.201311103; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marti E, 2016, BRAIN PATHOL, V26, P779, DOI 10.1111/bpa.12427; Morelli FF, 2017, CELL REP, V20, P2100, DOI 10.1016/j.celrep.2017.08.018; Nucifora LG, 2012, J BIOL CHEM, V287, P16017, DOI 10.1074/jbc.M111.252577; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Peskett TR, 2018, MOL CELL, V70, P588, DOI 10.1016/j.molcel.2018.04.007; Radwan M, 2020, MOL CELL PROTEOMICS, V19, P640, DOI 10.1074/mcp.RA119.001888; Ramdzan YM, 2017, CELL REP, V19, P919, DOI 10.1016/j.celrep.2017.04.029; Ramdzan YM, 2012, NAT METHODS, V9, P467, DOI [10.1038/NMETH.1930, 10.1038/nmeth.1930]; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Subramaniam S., 2019, BIORXIV, DOI [10.1101/629667, DOI 10.1101/629667]; Sundaramoorthy E, 2017, MOL CELL, V65, P751, DOI 10.1016/j.molcel.2016.12.026; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Thibodeau V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025185; Tsvetkov AS, 2013, NAT CHEM BIOL, V9, P586, DOI [10.1038/NCHEMBIO.1308, 10.1038/nchembio.1308]; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; von Horsten S, 2003, HUM MOL GENET, V12, P617, DOI 10.1093/hmg/ddg075; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975	38	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0233583	10.1371/journal.pone.0233583	http://dx.doi.org/10.1371/journal.pone.0233583			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735619	Green Published, Green Submitted, gold			2022-12-26	WOS:000569367100004
J	Santana, ML				Santana Jr, Mario L.			Quantitative genetic analyses provide parameters for selection and conservation of captive Great-billed Seed-finches (Sporophila maximiliani)	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; INBREEDING DEPRESSION; ZEBRA FINCH; MANAGEMENT; PEDIGREE; VARIABILITY; SONG; COANCESTRY; DIVERSITY; CHOICE	The Great-billed Seed-finch (Sporophila maximiliani) is an endangered South American bird that has suffered from trafficking and the destruction of its natural habitat. In contrast, there are over 180,000 Great-billed Seed-finches legally raised in captivity in Brazil. The interest as a pet for Great-billed Seed-finches is due to their exceptional ability to sing. In the present research, the unknown genetic structure of the Great-billed Seed-finch captive population was investigated by quantitative analysis of 6,226 pedigree records. Additionally, 7,671 phenotypic records were available to estimate genetic parameters such as heritability and evolvability of a song-related trait of these birds for competitions. The captive Great-billed Seed-Finch population faces many of the problems commonly encountered in domestic animal populations such as a high level of inbreeding (average of 8.26%, 70.47% of birds were inbred), pedigree bottlenecks, unbalanced contribution of breeding animals and structuring (equivalent number of subpopulations of 2.91). Despite this, most genetic diversity remains preserved within aviaries. The high generation interval (5.74 years) found for this population should help to prevent a rapid increase in inbreeding and genetic drift. These results should serve as strong motivation and support for urgent actions to manage the genetic diversity of captive Great-billed Seed-Finches. From the viewpoint of genetic improvement for singing time in tournaments (STT), this trait presents sufficient variability to allow response to artificial selection given the heritability of 18.7% and evolvability of 2,447%. In contrast, inbreeding and high generation interval appear to be the most considerable barriers that may limit the genetic gain for STT. Widespread adoption of techniques such as optimal genetic contribution selection and implementation of routine genetic diversity monitoring via pedigree analysis and molecular tools can be crucial both in terms of breeding and conservation of genetic diversity of captive Great-billed Seed-Finches.	[Santana Jr, Mario L.] Univ Fed Rondonopolis, Inst Ciencias Agr & Tecnol, Grp Melhoramento Anim Mato Grosso GMAT, Rondonopolis, MG, Brazil		Santana, ML (corresponding author), Univ Fed Rondonopolis, Inst Ciencias Agr & Tecnol, Grp Melhoramento Anim Mato Grosso GMAT, Rondonopolis, MG, Brazil.	santana@ufr.edu.br	Santana, Mário/W-3129-2019	Santana, Mário/0000-0001-8392-1304	extension project "GEMAXI-Avaliacao genetica de passeriformes nativos para caracteristicas de interesse economico" [260220181145431760]	extension project "GEMAXI-Avaliacao genetica de passeriformes nativos para caracteristicas de interesse economico"	I thank the Federal University of Mato Grosso (UFMT), Federal University of Rondonopolis (UFR), CAMEX/CUR, PROCEV and UNISELVA for their support in the formalization and implementation of the extension project "GEMAXI-Avaliacao genetica de passeriformes nativos para caracteristicas de interesse economico", registration number 260220181145431760. I thank Dr. Annaiza Braga Bignardi for her critical review of this manuscript, as well as UFR undergraduate students Joel Alves da Silva and Alcione Farias for their valuable help in creating the database. I also thank all Great-billed Seed-Finch breeders in Brazil.	[Anonymous], 2017, CLUSTER CLUSTER ANAL; BASTOS LF, 2010, REV BIOL NEOTROPICAL, V5, P51; BirdLife International, 2019, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2018-2.RLTS.T22696792A155523636.en; Boichard D., 2002, Proceedings of the 7th World Congress on Genetics Applied to Livestock Production, Montpellier, France, August, 2002. Session 28, P1; Boichard D, 1997, GENET SEL EVOL, V29, P5, DOI 10.1051/gse:19970101; Bolund E, 2010, ANIM BEHAV, V79, P947, DOI 10.1016/j.anbehav.2010.01.014; Brekke P, 2010, P ROY SOC B-BIOL SCI, V277, P3677, DOI 10.1098/rspb.2010.1144; Caballero A, 2000, GENET RES, V75, P331, DOI 10.1017/S0016672399004449; Cava JA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210472; Cecchi F, 2014, ANIM SCI J, V85, P868, DOI 10.1111/asj.12239; Cervantes I, 2008, ITEA-INF TEC ECON AG, V104, P303; Cervantes I, 2011, J ANIM BREED GENET, V128, P56, DOI 10.1111/j.1439-0388.2010.00881.x; de Boer RA, 2016, P R SOC B, P283; deFreitas P, 2015, DIAGNOSTICO ANIMAIS; Destro GFG, 2012, ESFORCOS COMBATE AO, P17; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fernandez J, 2008, GENETICS, V179, P683, DOI 10.1534/genetics.107.083816; Fernandez J, 2011, ANIMAL, V5, P1684, DOI 10.1017/S1751731111000930; Food and Agriculture Organization, 2007, SUB REG REP AN GEN R; Forstmeier W, 2009, EVOLUTION, V63, P2114, DOI 10.1111/j.1558-5646.2009.00688.x; Gonzalez-Recio O, 2007, J DAIRY SCI, V90, P5744, DOI 10.3168/jds.2007-0203; Grueber CE, 2008, CONSERV GENET, V9, P645, DOI 10.1007/s10592-007-9390-3; Grundy B, 2000, ANIM SCI, V70, P373, DOI 10.1017/S1357729800051717; Gutierrez JP, 2009, J ANIM BREED GENET, V126, P327, DOI 10.1111/j.1439-0388.2009.00810.x; Hammerly SC, 2013, MOL ECOL, V22, P5313, DOI 10.1111/mec.12482; Hansen TF, 2011, EVOL BIOL, V38, P258, DOI 10.1007/s11692-011-9127-6; Hemmings NL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1870; HOULE D, 1992, GENETICS, V130, P195; JAMES JW, 1972, THEOR APPL GENET, V42, P272, DOI 10.1007/BF00277555; Jamieson IG, 2011, CONSERV BIOL, V25, P115, DOI 10.1111/j.1523-1739.2010.01574.x; Jensen H, 2007, MOL ECOL, V16, P4066, DOI 10.1111/j.1365-294X.2007.03452.x; Jones KL, 2002, CONSERV BIOL, V16, P789, DOI 10.1046/j.1523-1739.2002.00001.x; Knief U, 2015, HEREDITY, V114, P397, DOI 10.1038/hdy.2014.116; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; LACY RC, 1989, ZOO BIOL, V8, P111, DOI 10.1002/zoo.1430080203; Lacy RC, 1995, ZOO BIOL, V14, P565, DOI 10.1002/zoo.1430140609; Leroy G, 2014, ANIM GENET, V45, P618, DOI 10.1111/age.12178; Leroy G, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-1; Lynch M, GENETICS ANAL QUANTI; Machado RB, 2019, BIODIVERS CONSERV, DOI [10.1007/s10531-019-01722-x, DOI 10.1007/S10531-019-01722-X]; Maignel L., 1996, INTERBULL B, V14, P49; Mattey SN, 2018, AM NAT, V191, P716, DOI 10.1086/697236; Medolago CAB, 2016, WILSON J ORNITHOL, V128, P638, DOI 10.1676/1559-4491-128.3.638; Misztal I., 2002, P 7 WORLD C GEN APPL, V28, P7; Nei M., 1987, MOL EVOLUTIONARY GEN; Nietlisbach P, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2763; Opatova P, 2016, ECOL EVOL, V6, P295, DOI 10.1002/ece3.1868; Pirault P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061544; Pooley EL, 2014, ANIM BEHAV, V97, P153, DOI 10.1016/j.anbehav.2014.09.012; Reid JM, 2007, P ROY SOC B-BIOL SCI, V274, P697, DOI 10.1098/rspb.2006.0092; Ritschard M, 2011, ANIM BEHAV, V82, P1415, DOI 10.1016/j.anbehav.2011.09.026; Santure AW, 2010, MOL ECOL, V19, P1439, DOI 10.1111/j.1365-294X.2010.04554.x; Sick H., 2001, ORNITOLOGIA BRASILEI, V3; Sorensen MK, 2008, LIVEST SCI, V118, P212, DOI 10.1016/j.livsci.2008.01.027; Souza T.O., 2014, ORNITHOLOGIA, V7, P1; Spencer KA, 2005, BEHAV ECOL SOCIOBIOL, V58, P423, DOI 10.1007/s00265-005-0927-5; Stranden I., 2006, Proceedings of the 8th World Congress on Genetics Applied to Livestock Production, Belo Horizonte, Minas Gerais, Brazil, 13-18 August, 2006, P27; Trosch M, 2017, ANIM BEHAV, V126, P261, DOI 10.1016/j.anbehav.2017.02.006; Ubaid FK, 2018, ZOOTAXA, V4442, P551, DOI 10.11646/zootaxa.4442.4.4; Williams H, 2004, ANN NY ACAD SCI, V1016, P1, DOI 10.1196/annals.1298.029; WRIGHT S, 1951, ANN EUGENIC, V15, P323	61	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236647	10.1371/journal.pone.0236647	http://dx.doi.org/10.1371/journal.pone.0236647			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730350	gold, Green Published			2022-12-26	WOS:000556884700093
J	Boesgaard, MW; Harpsoe, K; Malmberg, M; Underwood, CR; Inoue, A; Mathiesen, JM; Konig, GM; Kostenis, E; Gloriam, DE; Brauner-Osborne, H				Boesgaard, Michael W.; Harpsoe, Kasper; Malmberg, Michelle; Underwood, Christina R.; Inoue, Asuka; Mathiesen, Jesper M.; Koenig, Gabriele M.; Kostenis, Evi; Gloriam, David E.; Braeuner-Osborne, Hans			Delineation of molecular determinants for FR900359 inhibition of G(q/11)unlocks inhibition of G alpha(s)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						FR900359; YM-254890; G protein inhibitor; Gs; Gq; G protein; inhibitor; G protein-coupled receptor (GPCR); site-directed mutagenesis; molecular pharmacology	G-PROTEIN ACTIVATION; BETA-GAMMA-SUBUNITS; G-ALPHA; MECHANISM	Heterotrimeric G proteins are essential mediators of intracellular signaling of G protein-coupled receptors. The G(q/11)subfamily consists of G(q), G(11), G(14), and G(16)proteins, of which all but G(16)are inhibited by the structurally related natural products YM-254890 and FR900359. These inhibitors act by preventing the GDP/GTP exchange, which is necessary for activation of all G proteins. A homologous putative binding site for YM-254890/FR900359 can also be found in members of the other three G protein families, G(s), G(i/o), and G(12/13), but none of the published analogs of YM-254890/FR900359 have shown any inhibitory activity for any of these. To explain why the YM-254890/FR900359 scaffold only inhibits G(q/11/14), the present study delineated the molecular selectivity determinants by exchanging amino acid residues in the YM-254890/FR900359-binding site in G(q)and G(s). We found that the activity of a G(s)mutant with a G(q)-like binding site for YM-254890/FR900359 can be inhibited by FR900359, and a minimum of three mutations are necessary to introduce inhibition in G(s). In all, this suggests that although the YM-254890/FR900359 scaffold has proven unsuccessful to derive G(s), G(i/o), and G(12/13)inhibitors, the mechanism of inhibition between families of G proteins is conserved, opening up the possibility of targeting by other, novel inhibitor scaffolds. In lack of a selective G alpha(s)inhibitor, FR900359-sensitive G alpha(s)mutants may prove useful in studies where delicate control over G alpha(s)signaling would be of the essence.	[Boesgaard, Michael W.; Harpsoe, Kasper; Malmberg, Michelle; Underwood, Christina R.; Mathiesen, Jesper M.; Gloriam, David E.; Braeuner-Osborne, Hans] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Biochem, Sendai, Miyagi, Japan; [Koenig, Gabriele M.] Univ Bonn, Inst Pharmaceut Biol, Bonn, Germany; [Kostenis, Evi] Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, Bonn, Germany; [Malmberg, Michelle] TFS, Lund, Sweden; [Underwood, Christina R.] AstraZeneca, Cambridge, England	University of Copenhagen; Tohoku University; University of Bonn; University of Bonn	Gloriam, DE; Brauner-Osborne, H (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark.	david.gloriam@sund.ku.dk; hbo@sund.ku.dk	Harpsøe, Kasper/V-6870-2018; Gloriam, David E./A-1904-2011; Brauner-Osborne, Hans/D-7260-2011	Harpsøe, Kasper/0000-0002-9326-9644; Gloriam, David E./0000-0002-4299-7561; Mathiesen, Jesper Mosolff/0000-0003-4251-4416; Malmberg, Michelle/0000-0001-7575-5895; Underwood, Christina Rye/0000-0002-2333-2177; Brauner-Osborne, Hans/0000-0001-9495-7388	Independent Research Fund Denmark | Medical Sciences [802000280B]; Lundbeck Foundation [R163-201316327, R178-2014-2060, R171-2014-505]; Novo Nordisk Foundation [NNF18OC0031226]; German Research Foundation (DFG) [KO 1582/10-1, KO 1582/10-2, FOR2372, KO 902/17-1, KO 902/17-2]; Japan Society for the Promotion of Science (JSPS) KAKENHI [17K08264]; Japan Agency for Medical Research and Development (AMED) [JP17gm5910013, JP17gm0010004]	Independent Research Fund Denmark | Medical Sciences; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); German Research Foundation (DFG)(German Research Foundation (DFG)); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Independent Research Fund Denmark | Medical Sciences 802000280B (to D. E. G.); Lundbeck Foundation Grants R163-201316327 (to D. E. G.), R178-2014-2060 (to H. B.-O. and D. E. G.), and R171-2014-505 (to C. R. U); Novo Nordisk Foundation Grant NNF18OC0031226; German Research Foundation (DFG) Grants KO 1582/10-1 and KO 1582/10-2 within FOR2372 (to E. K.) as well as KO 902/17-1 and KO 902/17-2 (to G. M. K.); Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 17K08264 (to A. I.); and Japan Agency for Medical Research and Development (AMED) Grants PRIME JP17gm5910013 and LEAP JP17gm0010004 (to A. I.).	Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5744, DOI 10.1111/bph.13348; Annala S, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau5948; Ayoub MA, 2009, J BIOL CHEM, V284, P29136, DOI 10.1074/jbc.M109.042333; Betke KM, 2012, PROG NEUROBIOL, V96, P304, DOI 10.1016/j.pneurobio.2012.01.009; Brea J, 2009, MOL PHARMACOL, V75, P1380, DOI 10.1124/mol.108.054395; Busnelli M, 2016, J MED CHEM, V59, P7152, DOI 10.1021/acs.jmedchem.6b00564; Capote LA, 2015, EUR J PHARMACOL, V763, P143, DOI 10.1016/j.ejphar.2015.05.019; CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669; Christensen HB, 2017, J PHARMACOL TOX MET, V88, P72, DOI 10.1016/j.vascn.2017.07.003; Civciristov S, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan1188; Crusemann M, 2018, ANGEW CHEM INT EDIT, V57, P836, DOI 10.1002/anie.201707996; Ferre S, 2015, TRENDS PHARMACOL SCI, V36, P145, DOI 10.1016/j.tips.2015.01.002; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; Freissmuth M, 1996, MOL PHARMACOL, V49, P602; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Husted AS, 2017, CELL METAB, V25, P777, DOI 10.1016/j.cmet.2017.03.008; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; Kaya AI, 2016, J BIOL CHEM, V291, P19674, DOI 10.1074/jbc.M116.745513; Kaya AI, 2014, J BIOL CHEM, V289, P24475, DOI 10.1074/jbc.M114.572875; Kostenis E, 2020, J BIOL CHEM, V295, P5206, DOI 10.1074/jbc.REV119.007061; Li ZC, 2012, AMINO ACIDS, V43, P793, DOI 10.1007/s00726-011-1133-6; Liu XY, 2019, CELL, V177, P1243, DOI 10.1016/j.cell.2019.04.021; Lyon AM, 2014, STRUCTURE, V22, P1844, DOI 10.1016/j.str.2014.10.008; Malfacini D, 2019, J BIOL CHEM, V294, P5747, DOI 10.1074/jbc.RA118.007250; Navarro G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03522-3; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Onken MD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6852; Prevost GP, 2006, CANCER RES, V66, P9227, DOI 10.1158/0008-5472.CAN-05-4205; Reher R, 2018, CHEMMEDCHEM, V13, P1634, DOI 10.1002/cmdc.201800304; Ross E. M., 2014, CELL LOGIST, V4; Schmitz AL, 2014, CHEM BIOL, V21, P890, DOI 10.1016/j.chembiol.2014.06.003; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Smrcka AV, 2013, TRENDS PHARMACOL SCI, V34, P290, DOI 10.1016/j.tips.2013.02.006; Stallaert W, 2017, MOL PHARMACOL, V91, P533, DOI 10.1124/mol.116.106419; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Syrovatkina V, 2016, J MOL BIOL, V428, P3850, DOI 10.1016/j.jmb.2016.08.002; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Taniguchi M, 2003, J ANTIBIOT, V56, P358, DOI 10.7164/antibiotics.56.358; Taylor VG, 2016, J BIOL CHEM, V291, P5138, DOI 10.1074/jbc.M115.712075; Ushio-Fukai M, 2009, CURR OPIN NEPHROL HY, V18, P153, DOI 10.1097/MNH.0b013e3283252efe; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xiong XF, 2019, CHEMMEDCHEM, V14, P865, DOI 10.1002/cmdc.201900018; Xiong XF, 2016, NAT CHEM, V8, P1035, DOI [10.1038/NCHEM.2577, 10.1038/nchem.2577]; Zhang H, 2018, EUR J MED CHEM, V156, P847, DOI 10.1016/j.ejmech.2018.07.023; Zhang H, 2017, CHEMMEDCHEM, V12, P830, DOI 10.1002/cmdc.201700155	51	5	5	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2020	295	40					13850	13861		10.1074/jbc.RA120.013002	http://dx.doi.org/10.1074/jbc.RA120.013002			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OB4MB	32753482	Green Published, hybrid			2022-12-26	WOS:000578444100012
J	Nagareddy, B; Khan, A; Kim, H				Nagareddy, Bhavika; Khan, Arafat; Kim, Hyungjin			Acetylation modulates the Fanconi anemia pathway by protecting FAAP20 from ubiquitin-mediated proteasomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fanconi anemia; genome stability; the FA core complex; proteolysis; lysine acetylation; DNA repair; protein stability; acetylation; ubiquitylation (ubiquitination); post-translational modification (PTM); acetyltransferase	ATR-DEPENDENT PHOSPHORYLATION; CROSS-LINK REPAIR; DNA-DAMAGE; COMPLEX; CORE; STABILITY; CBP/P300; LYSINES; FANCD2; GENE	Fanconi anemia (FA) is a chromosome instability syndrome of children caused by inherited mutations in one of FA genes, which together constitute a DNA interstrand cross-link (ICL) repair, or the FA pathway. Monoubiquitination of Fanconi anemia group D2 protein (FANCD2) by the multisubunit ubiquitin E3 ligase, the FA core complex, is an obligate step in activation of the FA pathway, and its activity needs to be tightly regulated. FAAP20 is a key structural component of the FA core complex, and regulated proteolysis of FAAP20 mediated by prolylcis-transisomerization and phosphorylation at a consensus phosphodegron motif is essential for preserving the integrity of the FA core complex, and thus FANCD2 monoubiquitination. However, how ubiquitin-dependent FAAP20 degradation is modulated to fine-tune FA pathway activation remains largely un-known. Here, we present evidence that FAAP20 is acetylated by the acetyltransferase p300/CBP on lysine 152, the key residue that when polyubiquitinated results in the degradation of FAAP20. Acetylation or mutation of the lysine residue stabilizes FAAP20 by preventing its ubiquitination, thereby protecting it from proteasome-dependent FAAP20 degradation. Consequently, disruption of the FAAP20 acetylation pathway impairs FANCD2 activation. Together, our study reveals a competition mechanism between ubiquitination and acetylation of a common lysine residue that controls FAAP20 stability and highlights a complex balancing between different posttranslational modifications as a way to refine the FA pathway signaling required for DNA ICL repair and genome stability.	[Nagareddy, Bhavika; Khan, Arafat; Kim, Hyungjin] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Kim, Hyungjin] SUNY Stony Brook, Renaissance Sch Med, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Kim, H (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.; Kim, H (corresponding author), SUNY Stony Brook, Renaissance Sch Med, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA.	hyungjin.kim@stonybrook.edu			National Institutes of Health [CA218132]; American Cancer Society [RSG-18-037-01-DMC]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society)	This work was supported by the National Institutes of Health Grant CA218132 and American Cancer Society Grant RSG-18-037-01-DMC (to H. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali AM, 2012, BLOOD, V119, P3285, DOI 10.1182/blood-2011-10-385963; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Balakrishnan L, 2010, J BIOL CHEM, V285, P4398, DOI 10.1074/jbc.M109.086397; Budzowska M, 2015, EMBO J, V34, P1971, DOI 10.15252/embj.201490878; Cazzalini O, 2014, NUCLEIC ACIDS RES, V42, P8433, DOI 10.1093/nar/gku533; Ceccaldi R, 2016, NAT REV MOL CELL BIO, V17, P337, DOI 10.1038/nrm.2016.48; Chen CS, 2007, CANCER RES, V67, P5318, DOI 10.1158/0008-5472.CAN-06-3996; Chen YH, 2015, MOL CELL, V58, P323, DOI 10.1016/j.molcel.2015.02.031; Clauson C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012732; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Collins NB, 2009, BLOOD, V113, P2181, DOI 10.1182/blood-2008-05-154294; Delvecchio M, 2013, NAT STRUCT MOL BIOL, V20, P1040, DOI 10.1038/nsmb.2642; Dietschy T, 2009, J CELL SCI, V122, P1258, DOI 10.1242/jcs.037747; Douwel DK, 2014, MOL CELL, V54, P460, DOI 10.1016/j.molcel.2014.03.015; Drazic A, 2016, BBA-PROTEINS PROTEOM, V1864, P1372, DOI 10.1016/j.bbapap.2016.06.007; Dutta R, 2016, MOL GENET METAB, V119, P37, DOI 10.1016/j.ymgme.2016.06.013; Dutto I, 2018, CELL MOL LIFE SCI, V75, P1325, DOI 10.1007/s00018-017-2717-4; Elia AEH, 2015, MOL CELL, V59, P867, DOI 10.1016/j.molcel.2015.05.006; Fauquier L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31102-4; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gibbs-Seymour I, 2015, MOL CELL, V57, P150, DOI 10.1016/j.molcel.2014.12.001; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Ho GPH, 2006, MOL CELL BIOL, V26, P7005, DOI 10.1128/MCB.02018-05; Huang M, 2010, MOL CELL, V39, P259, DOI 10.1016/j.molcel.2010.07.005; Huang YL, 2014, CELL REP, V7, P1849, DOI 10.1016/j.celrep.2014.04.029; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jang ER, 2011, FEBS LETT, V585, P47, DOI 10.1016/j.febslet.2010.11.034; Jo U, 2015, MOL CELLS, V38, P669, DOI 10.14348/molcells.2015.0175; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Kee Y, 2009, GENE DEV, V23, P555, DOI 10.1101/gad.1761309; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kim H, 2012, NAT STRUCT MOL BIOL, V19, P164, DOI 10.1038/nsmb.2222; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Leung JWC, 2012, P NATL ACAD SCI USA, V109, P4491, DOI 10.1073/pnas.1118720109; Levran O, 2005, HUM MUTAT, V25, P142, DOI 10.1002/humu.20125; Li A, 2006, BIOCHEM BIOPH RES CO, V350, P818, DOI 10.1016/j.bbrc.2006.08.199; Liszczak G, 2018, NAT CHEM BIOL, V14, P837, DOI 10.1038/s41589-018-0097-1; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Niraj J, 2019, ANNU REV CANC BIOL, V3, P457, DOI 10.1146/annurev-cancerbio-030617-050422; Piekna-Przybylska D, 2016, CELL CYCLE, V15, P1506, DOI 10.1080/15384101.2016.1176815; Rajendra E, 2014, MOL CELL, V54, P858, DOI 10.1016/j.molcel.2014.05.001; Shakeel S, 2019, NATURE, V575, P234, DOI 10.1038/s41586-019-1703-4; Singh TR, 2013, CANCER RES, V73, P4300, DOI 10.1158/0008-5472.CAN-12-3976; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Stauffer D, 2007, J BIOL CHEM, V282, P9678, DOI 10.1074/jbc.M609261200; Swuec P, 2017, CELL REP, V18, P611, DOI 10.1016/j.celrep.2016.11.013; Walden H, 2014, ANNU REV BIOPHYS, V43, P257, DOI 10.1146/annurev-biophys-051013-022737; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4; Wang JM, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007983; Wang JM, 2016, ONCOTARGET, V7, P35724, DOI 10.18632/oncotarget.9595; Wang XZ, 2007, MOL CELL BIOL, V27, P3098, DOI 10.1128/MCB.02357-06; Wojtaszek JL, 2014, NUCLEIC ACIDS RES, V42, P13997, DOI 10.1093/nar/gku1153; Xie J, 2015, J CLIN INVEST, V125, P1523, DOI 10.1172/JCI79325; Xie J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002786; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	62	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2020	295	40					13887	13901		10.1074/jbc.RA120.015288	http://dx.doi.org/10.1074/jbc.RA120.015288			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OB4MB	32763975	Green Published, hybrid			2022-12-26	WOS:000578444100015
J	Umutesi, HG; Hoang, HM; Johnson, HE; Nam, K; Heo, J				Umutesi, Hope Gloria; Hoang, Hanh My; Johnson, Hope Elizabeth; Nam, Kwangho; Heo, Jongyun			Development of Noonan syndrome by deregulation of allosteric SOS autoactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ras; SOS; Noonan syndrome; allostery; autoactivation; guanine nucleotide exchange factor (GEF); Ras protein; allosteric regulation; enzyme kinetics; catalysis; autoinhibition; Son of Sevenless	MUTATIONS CAUSE; RAS ACTIVATION; DISORDERS; GAPS; GEFS	Ras family proteins play an essential role in several cellular functions, including growth, differentiation, and survival. The mechanism of action of Ras mutants in Costello syndrome and cancers has been identified, but the contribution of Ras mutants to Noonan syndrome, a genetic disorder that prevents normal development in various parts of the body, is unknown. Son of Sevenless (SOS) is a Ras guanine nucleotide exchange factor. In response to Ras-activating cell signaling, SOS autoinhibition is released and is followed by accelerative allosteric feedback autoactivation. Here, using mutagenesis-based kinetic and pulldown analyses, we show that Noonan syndrome Ras mutants I24N, T50I, V152G, and D153V deregulate the autoactivation of SOS to populate their active form. This previously unknown process has been linked so far only to the development of Noonan syndrome. In contrast, other Noonan syndrome Ras mutants-V14I, T58I, and G60E-populate their active form by deregulation of the previously documented Ras GTPase activities. We propose a novel mechanism responsible for the deregulation of SOS autoactivation, where I24N, T50I, V152G, and D153V Ras mutants evade SOS autoinhibition. Consequently, they are capable of forming a complex with the SOS allosteric site, thus aberrantly promoting SOS autoactivation, resulting in the population of active Ras mutants in cells. The results of this study elucidate the molecular mechanism of the Ras mutant-mediated development of Noonan syndrome.	[Umutesi, Hope Gloria; Hoang, Hanh My; Johnson, Hope Elizabeth; Nam, Kwangho; Heo, Jongyun] Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington	Heo, J (corresponding author), Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA.	jheo@uta.edu			National Institutes of Health [1R15AI096146-01A1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant 1R15AI096146-01A1 (to J. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOS JL, 1989, CANCER RES, V49, P4682; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Carta C, 2006, AM J HUM GENET, V79, P129, DOI 10.1086/504394; Chen PC, 2010, J CLIN INVEST, V120, P4353, DOI 10.1172/JCI43910; Cirstea IC, 2010, NAT GENET, V42, P27, DOI 10.1038/ng.497; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Cordeddu V, 2015, HUM MUTAT, V36, P1080, DOI 10.1002/humu.22834; Frost A. A., 1953, KINETICS MECH; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Gelb BD, 2015, PROG PEDIATR CARDIOL, V39, P13, DOI 10.1016/j.ppedcard.2015.01.002; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Grewal Thomas, 2011, Genes Cancer, V2, P288, DOI 10.1177/1947601911407330; Gureasko J., 2010, PROTOCOL EXCHANGE, DOI [10.1038/nprot.2010.155, DOI 10.1038/NPROT.2010.155]; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Heo J, 2001, P NATL ACAD SCI USA, V98, P7690, DOI 10.1073/pnas.141230698; Hoang Hanh My, 2021, Small GTPases, V12, P44, DOI 10.1080/21541248.2019.1601954; Jun JE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00239; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Lepri F, 2011, HUM MUTAT, V32, P760, DOI 10.1002/humu.21492; Myers A, 2014, AM J MED GENET A, V164, P2814, DOI 10.1002/ajmg.a.36737; Nakamura Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14190-6; Prendiville TW, 2014, ARCH DIS CHILD, V99, P629, DOI 10.1136/archdischild-2013-305047; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Roberts AE, 2013, LANCET, V381, P333, DOI 10.1016/S0140-6736(12)61023-X; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Runtuwene V, 2011, DIS MODEL MECH, V4, P393, DOI 10.1242/dmm.007112; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Segel I.H, 1993, ENZYME KINETICS; Shin JY, 2016, J BIOL CHEM, V291, P13699, DOI 10.1074/jbc.M115.694422; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Wey M, 2016, BIOCHEMISTRY-US, V55, P543, DOI 10.1021/acs.biochem.5b00902; Wey M, 2013, BIOCHEMISTRY-US, V52, P8465, DOI 10.1021/bi400679q; Yadav KK, 2010, P NATL ACAD SCI USA, V107, P3436, DOI 10.1073/pnas.0914315107	36	5	5	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2020	295	39					13651	13663		10.1074/jbc.RA120.013275	http://dx.doi.org/10.1074/jbc.RA120.013275			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NY3VI	32753483	Green Published, hybrid			2022-12-26	WOS:000576321100018
J	Hammoudi, N; Verdot, R; Delorme, J; Bouam, A; Drancourt, M				Hammoudi, Nassim; Verdot, Romain; Delorme, Jean; Bouam, Amar; Drancourt, Michel			Screening anti-infectious molecules against Mycobacterium ulcerans: A step towards decontaminating environmental specimens	PLOS ONE			English	Article							BURULI DISEASE; GENOME	Mycobacterium ulcerans, a non-tuberculous mycobacterium responsible for Buruli ulcer, resides in poorly defined environmental niches in the vicinity of stagnant water. Very few isolates have been confirmed. With a view to culturingM.ulceransfrom such contaminated environmental specimens, we tested thein vitrosusceptibility of theM.ulceransCU001 strain co-cultivated with XTC cells to anti-infectious molecules registered in the French pharmacopoeia. We used a standardised concentration to identify molecules that were inactive againstM.ulceransand which could be incorporated into a decontaminating solution. Of 116 tested molecules, 64 (55.1%) molecules were ineffective against M. ulcerans CU001. These included 34 (29.3%) antibiotics, 14 (12%) antivirals, eight (6.8%) antiparasitics, and eight (6.8%) antifungals. This left 52 molecules which were active againstM.ulceransCU001. Three of the inactive antimicrobial molecules (oxytetracycline, polymyxin E and voriconazole) were then selected to prepare a decontamination solution which was shown to respectM.ulceransCU001 viability. These three antimicrobials could be incorporated into a decontamination solution to potentially isolate and cultureM.ulceransfrom environmental samples.	[Hammoudi, Nassim; Verdot, Romain; Drancourt, Michel] IHU Mediterranee Infect, Marseille, France; [Hammoudi, Nassim; Bouam, Amar; Drancourt, Michel] Aix Marseille Univ, IHU Mediterranee Infect, MEPHI, IRD, Marseille, France; [Delorme, Jean] AP HM, Pharm Cent, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Drancourt, M (corresponding author), IHU Mediterranee Infect, Marseille, France.; Drancourt, M (corresponding author), Aix Marseille Univ, IHU Mediterranee Infect, MEPHI, IRD, Marseille, France.	michel.drancourt@univ-amu.fr			Fondation Mediterrane e Infection, Marseille, France; Agence Nationale de la Recherche [ANR-17-CE35-0006-01 PRIME]; French Government under the " Investissements d'Avenir " (Investments for the Future) program [10IAHU-03]; Region Provence Alpes Cote d'Azur; European funding FEDER IHUBIOTK	Fondation Mediterrane e Infection, Marseille, France; Agence Nationale de la Recherche(French National Research Agency (ANR)); French Government under the " Investissements d'Avenir " (Investments for the Future) program(French National Research Agency (ANR)); Region Provence Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur); European funding FEDER IHUBIOTK	NH obtained a PhD grant from the Fondation Mediterrane e Infection, Marseille, France. https://www.mediterranee-infection.com/linstitut/infectiopole-sud/This work was supported by Agence Nationale de la Recherche (ANR-17-CE35-0006-01 PRIME, http://www.agencenationale-recherche.fr/) and by the French Government under the " Investissements d'Avenir " (Investments for the Future) program managed by the ANR (reference: Mediterranee Infection 10IAHU-03), as well as the Agence Nationale de la Recherche (ANR-17-CE35-0006-01 PRIME, http://www.agencenationale-recherche.fr/).This work was supported by Region Provence Alpes Cote d'Azur and European funding FEDER IHUBIOTK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiedu K, 2000, WHOCDSCPEGBUI20001; Asmar S, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0479-4; BARKER DJP, 1971, J TROP MED HYG, V74, P260; BARKER DJP, 1972, T ROY SOC TROP MED H, V66, P867, DOI 10.1016/0035-9203(72)90121-6; Bratschi MW, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0636-7; Chauty A, 2007, ANTIMICROB AGENTS CH, V51, P4029, DOI 10.1128/AAC.00175-07; Dorothy YM., 2004, J CLIN MICROBIOLOGY, V42, P5875, DOI [10.1128/JCM.42.12.5875-5876.200415583329, DOI 10.1128/JCM.42.12.5875-5876.200415583329]; FRANZBLAU SG, 1989, ANTIMICROB AGENTS CH, V33, P2115, DOI 10.1128/AAC.33.12.2115; Garchitorena A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002879; Gupta SK, 2017, AM J TROP MED HYG, V97, P810, DOI 10.4269/ajtmh.16-0478; Kaser M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-177; MACCALLUM P, 1948, J PATHOL BACTERIOL, V60, P93, DOI 10.1002/path.1700600111; Marie TR., 2012, J ANTIMICROBIAL CHEM, V56, P687; Mary P., 1973, EXPERIENTIA, V29, P466, DOI [10.1007/BF019267854708349, DOI 10.1007/BF019267854708349]; Moerman R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168462; Palomino JC, 1998, J CLIN MICROBIOL, V36, P402, DOI 10.1128/JCM.36.2.402-408.1998; PORTAELS F, 1988, J GEN MICROBIOL, V134, P849; Portaels F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000178; Roltgen K, 2015, CURR CLIN MICROBIOL, V2, P35, DOI 10.1007/s40588-015-0013-3; Ross BC, 1997, APPL ENVIRON MICROB, V63, P4135, DOI 10.1128/AEM.63.10.4135-4138.1997; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; World Health Organization, WHOCDSCPEGBUI200410; ZINGUE D, 2018, SCI REP UK, V0008; Zingue D, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00045-17	24	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0231685	10.1371/journal.pone.0231685	http://dx.doi.org/10.1371/journal.pone.0231685			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760069	Green Submitted, Green Published, gold			2022-12-26	WOS:000561027200006
J	Steffener, J; Barulli, D; Hill, B				Steffener, Jason; Barulli, Daniel; Hill, Brianna			Neural capacity limits on the responses to memory interference during working memory in young and old adults	PLOS ONE			English	Article							AGE-RELATED-CHANGES; DUAL-TASK PERFORMANCE; BRAIN ACTIVATION; RETRIEVAL; SPAN; REACTIVATION; MECHANISMS; ATTENTION; TRIAL	Advancing age affects the recruitment of task related neural resources thereby changing the efficiency, capacity and use of compensatory processes. With advancing age, brain activity may therefore increase within a region or be reorganized to utilize different brain regions. The different brain regions may be exclusive to old adults or accessible to young and old alike, but non-optimal. Interference during verbal working memory information retention recruits parahippocampal brain regions in young adults similar to brain activity recruited by old adults in the absence of external interference. The current work tests the hypothesis that old adults recruit neural resources to combat increases in age-related intrinsic noise that young adults recruit during high levels of interference during information retention. This experiment administered a verbal delayed item recognition task with low and high levels of an interfering addition task during information maintenance. Despite strong age-related behavioral effects, brain imaging results demonstrated no significant interaction effects between age group and the interference or memory tasks. Significant effects were only found for the interaction between interference level and memory load within the inferior frontal cortex, supplementary motor cortex and posterior supramarginal regions. Results demonstrate that neural resources were shared when facing increasing memory load and interference. The combined cognitive demands resulted in brain activity reaching a neural capacity limit which was similar for both age groups and which brain activation did not increase above. Despite significant behavioral differences the neural capacity limited the detection of age group differences in brain activity.	[Steffener, Jason] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada; [Barulli, Daniel; Hill, Brianna] Columbia Univ Coll Phys & Surg, Dept Neurol, Cognit Neurosci Div, 630 W 168th St, New York, NY 10032 USA; [Barulli, Daniel; Hill, Brianna] Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, 630 W 168th St, New York, NY 10032 USA	University of Ottawa; Columbia University; Columbia University	Steffener, J (corresponding author), Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada.	jason.steffener@uottawa.ca		Steffener, Jason/0000-0001-7341-7526	National Institute on Aging [K01AG035061]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	JS: #K01AG035061; National Institute on Aging; https://www.nia.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Bennett IJ, 2013, NEUROIMAGE, V72, P20, DOI 10.1016/j.neuroimage.2013.01.030; Bopp KL, 2005, J GERONTOL B-PSYCHOL, V60, pP223, DOI 10.1093/geronb/60.5.P223; Cabeza R, 2018, NAT REV NEUROSCI, V19, P701, DOI 10.1038/s41583-018-0068-2; Chadick JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5223; COWAN N, 1988, PSYCHOL BULL, V104, P163, DOI 10.1037/0033-2909.104.2.163; Cox Robert W, 2017, Proc Natl Acad Sci U S A, V114, pE3370, DOI 10.1073/pnas.1614961114; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Doherty JM, 2019, J EXP PSYCHOL LEARN, V45, P1529, DOI 10.1037/xlm0000668; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fabiani M, 2012, PSYCHOPHYSIOLOGY, V49, P283, DOI 10.1111/j.1469-8986.2011.01331.x; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Grinband J, 2008, NEUROIMAGE, V43, P509, DOI 10.1016/j.neuroimage.2008.07.065; Hartley AA, 2011, BRAIN COGNITION, V75, P281, DOI 10.1016/j.bandc.2011.01.004; Holler-Wallscheid MS, 2017, P NATL ACAD SCI USA, V114, pE830, DOI 10.1073/pnas.1601983114; Hughes MM, 2014, BEHAV RES METHODS, V46, P702, DOI 10.3758/s13428-013-0411-5; Jamovi team, 2019, GAMLJ GEN AN LIN MOD; Jonathon Love DDRD, 2019, JAM PROJ 2019; Kahneman D., 1973, ATTENTION EFFORT; Kennedy KM, 2017, NEUROBIOL AGING, V60, P153, DOI 10.1016/j.neurobiolaging.2017.08.027; Logie RH, 2007, CORTEX, V43, P159, DOI 10.1016/S0010-9452(08)70453-2; Ma WJ, 2014, NAT NEUROSCI, V17, P347, DOI 10.1038/nn.3655; Mattis S., 1988, DEMENTIA RATING SCAL; Ollinger JM, 2001, NEUROIMAGE, V13, P210, DOI 10.1006/nimg.2000.0710; Pek J, 2018, PSYCHOL METHODS, V23, P208, DOI 10.1037/met0000126; R Core Team, 2018, R LANG ENV STAT COMP; Raichlen DA, 2017, TRENDS NEUROSCI, V40, P408, DOI 10.1016/j.tins.2017.05.001; Rights JD, 2020, MULTIVAR BEHAV RES, V55, P568, DOI 10.1080/00273171.2019.1660605; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Sakai K, 2004, CEREB CORTEX, V14, P914, DOI 10.1093/cercor/bhh050; Sakai K, 2002, J NEUROSCI, V22, P6315; SALTHOUSE TA, 1984, MEM COGNITION, V12, P613, DOI 10.3758/BF03213350; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schneider-Garces NJ, 2010, J COGNITIVE NEUROSCI, V22, P655, DOI 10.1162/jocn.2009.21230; Smith S, 2007, NEUROIMAGE, V34, P127, DOI 10.1016/j.neuroimage.2006.09.019; Steffener J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00046; Steffener J, 2009, BRAIN IMAGING BEHAV, V3, P142, DOI 10.1007/s11682-008-9056-x; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; Van Impe A, 2011, NEUROPSYCHOLOGIA, V49, P2400, DOI 10.1016/j.neuropsychologia.2011.04.016; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Watanabe K, 2014, NAT NEUROSCI, V17, P601, DOI 10.1038/nn.3667; Wong CN, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00154; Zarahn E, 2007, NEUROBIOL AGING, V28, P784, DOI 10.1016/j.neurobiolaging.2006.03.002	44	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236897	10.1371/journal.pone.0236897	http://dx.doi.org/10.1371/journal.pone.0236897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2EP	32760113	gold, Green Published			2022-12-26	WOS:000561027200018
J	Zhu, QQ; Wu, Q; Wang, AM; Bao, FJ; Zhang, YZ; Liu, J; Yan, JW; Fang, XH; Li, L; Zhang, ZK; Wang, R; Bao, XD; Yao, S; Pan, HF				Zhu, Qing-Qing; Wu, Qian; Wang, Ai-Min; Bao, Fang-Jin; Zhang, Yong-Zhong; Liu, Jie; Yan, Jun-Wei; Fang, Xue-Hui; Li, Ling; Zhang, Ze-Kun; Wang, Rong; Bao, Xun-Di; Yao, Song; Pan, Hai-Feng			Epidemiological characteristics of pulmonary tuberculosis in Anhui Province, Eastern China from 2013 to 2018	PLOS ONE			English	Article							ACTIVE TUBERCULOSIS; SEASONALITY; SUSCEPTIBILITY; IMMUNITY	Objective Pulmonary tuberculosis (TB) is a severe infectious respiratory disease, the burden of which remains high in China. To provide scientific evidence for developing more targeted prevention and control strategies, this study aimed to determine the incidence trends and explore the epidemiological characteristics of pulmonary TB in Anhui Province, Eastern China between 2013 and 2018. Methods The retrospective study analyzed information regarding pulmonary TB cases reported by the National Infectious Disease Reporting System and census data collected from the Anhui Provincial Bureau of Statistics. Results Overall, 211,892 cases of TB patients were reported in Anhui Province, China between 2013 and 2018, with an average annual reported incidence rate of 57.7 per 100,000 persons. A significant decrease in the incidence rate of pulmonary TB (p <0.001) was observed during the study period. Men had a higher incidence rate of pulmonary TB than women (p< 0.001). The highest annual average reported incidence rate was 204.2 per 100,000 persons in those aged 70-74 years. The number of farmers with pulmonary TB, i.e., 155,415, accounted for 73.4% of all cases. Moreover, the peak period of reported cases was from January to March. Four cities along the Yangtze River-Anqing, Tongling, Chizhou, and Wuhu-reported significantly higher incidence rates of pulmonary TB than other cities (p< 0.001). Conclusions From 2013 to 2018, there was a significant decline in the incidence rate of pulmonary TB in Anhui Province, with peaks occurring from January to March. Prevention and control strategies targeting men, people aged 70-74 years, farmers, and the four cities along the Yangtze River should be strengthened.	[Zhu, Qing-Qing; Wang, Ai-Min; Bao, Fang-Jin; Zhang, Yong-Zhong; Liu, Jie; Yan, Jun-Wei; Fang, Xue-Hui; Li, Ling; Zhang, Ze-Kun; Wang, Rong; Bao, Xun-Di; Yao, Song] Anhui Prov TB Inst, Hefei, Anhui, Peoples R China; [Wu, Qian; Pan, Hai-Feng] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China	Anhui Medical University	Yao, S (corresponding author), Anhui Prov TB Inst, Hefei, Anhui, Peoples R China.; Pan, HF (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China.	503562210@qq.com; panhaifeng@ahmu.edu.cn						Akhtar S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-3; Altes HK, 2012, INT J TUBERC LUNG D, V16, P639, DOI 10.5588/ijtld.11.0680; Amoakwa K, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofu120; [Anonymous], 2016, TOP 10 CAUSE DEATH G; Chen C, 2017, INT J TUBERC LUNG D, V21, P1134, DOI 10.5588/ijtld.17.0123; Chen CH, 2016, J FORMOS MED ASSOC, V115, P825, DOI 10.1016/j.jfma.2016.07.001; Dye C, 2003, TUBERCULOSIS, V83, P35, DOI 10.1016/S1472-9792(02)00056-2; Edem VF, 2015, ANN GLOB HEALTH, V81, P669, DOI 10.1016/j.aogh.2015.08.012; Erol A, 2015, DRUG ALCOHOL DEPEN, V156, P1, DOI 10.1016/j.drugalcdep.2015.08.023; Fares A, 2011, J GLOB INFECT DIS, V3, P46, DOI 10.4103/0974-777X.77296; Guo ZY, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6544-4; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Harries AD, 2018, DIAGNOSTICS, V8, DOI 10.3390/diagnostics8040078; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Huynh GH, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0341-4; Lam A, 2017, AM J PHYSIOL-LUNG C, V313, pL218, DOI 10.1152/ajplung.00162.2017; Li XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068102; Li YA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1441-2; Li Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-156; Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC; Luba TR, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3688-x; Mao Q, 2019, INT J INFECT DIS, V80, pS36, DOI 10.1016/j.ijid.2019.02.038; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Naranbat N, 2009, EUR RESPIR J, V34, P921, DOI 10.1183/09031936.00035309; ORME IM, 1987, J IMMUNOL, V138, P4414; Parrinello CM, 2012, INT J TUBERC LUNG D, V16, P32, DOI 10.5588/ijtld.11.0145; Qi Z, 2017, INT J MYCOBACT, V6, P264, DOI 10.4103/ijmy.ijmy_104_17; Rios M, 2000, EUR J EPIDEMIOL, V16, P483, DOI 10.1023/A:1007653329972; Sun YN, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2327-8; WHO, 2016, GLOB TUB REP; WHO, 2017, GLOB TUB REP; Williams CML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104921; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2018, GLOB TUB REP 2018; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, 2014, GLOB TUB REP; Wu SH, 2018, J INFECT PUBLIC HEAL, V11, P300, DOI 10.1016/j.jiph.2017.07.014; Yang XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108369; Zhang TH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-19; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	40	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237311	10.1371/journal.pone.0237311	http://dx.doi.org/10.1371/journal.pone.0237311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760160	Green Published, gold			2022-12-26	WOS:000561027200047
J	Izes, AM; Kimble, B; Norris, JM; Govendir, M				Izes, Aaron M.; Kimble, Benjamin; Norris, Jacqueline M.; Govendir, Merran			Assay validation and determination of in vitro binding of mefloquine to plasma proteins from clinically normal and FIP-affected cats	PLOS ONE			English	Article							FELINE INFECTIOUS PERITONITIS; DRUGS; PHARMACOKINETICS; ANTIMALARIAL; ANALOG; VIRUS	The antimalarial agent mefloquine is currently being investigated for its potential to inhibit feline coronavirus and feline calicivirus infections. A simple, high pressure liquid chromatography assay was developed to detect mefloquine plasma concentrations in feline plasma. The assay's lower limit of quantification was 250 ng/mL. The mean +/- standard deviation intra- and inter-day precision expressed as coefficients of variation were 6.83 +/- 1.75 and 5.33 +/- 1.37%, respectively, whereas intra- and inter-day accuracy expressed as a percentage of the bias were 11.40 +/- 3.73 and 10.59 +/- 3.88%, respectively. Accordingly, this validated assay should prove valuable for future in vivo clinical trials of mefloquine as an antiviral agent against feline coronavirus and feline calicivirus. However, the proportion of mefloquine binding to feline plasma proteins has not been reported. The proportion of drug bound to plasma protein binding is an important concept when developing drug dosing regimens. As cats with feline infectious peritonitis (FIP) demonstrate altered concentrations of plasma proteins, the proportion of mefloquine binding to plasma proteins in both clinically normal cats and FIP-affected cats was also investigated. An in vitro method using rapid equilibrium dialysis demonstrated that mefloquine was highly plasma protein bound in both populations (on average > 99%).	[Izes, Aaron M.; Kimble, Benjamin; Norris, Jacqueline M.; Govendir, Merran] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia	University of Sydney	Govendir, M (corresponding author), Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia.	merran.govendir@sydney.edu.au		Izes, Aaron/0000-0001-8940-384X	Winn Feline Foundation [16-023]; Feline Health Research Foundation - The University of Sydney [183456]; Australian Companion Animal Health Foundation [005/2016]	Winn Feline Foundation; Feline Health Research Foundation - The University of Sydney; Australian Companion Animal Health Foundation	M.G. and J.M.N. received the following awards from the following funders to undertake this research: Winn Feline Foundation 16-023 Australian Companion Animal Health Foundation 005/2016 Feline Health Research Foundation - The University of Sydney IRMA number 183456.	Beer J, 2009, AAPS J, V11, P1, DOI 10.1208/s12248-008-9072-1; Colclough N, 2014, MEDCHEMCOMM, V5, P963, DOI 10.1039/c4md00148f; Cornell University Animal Health Diagnostic Center, CHEM COB REF INT; Vieira JLF, 2016, BRAZ J INFECT DIS, V20, P482, DOI 10.1016/j.bjid.2016.07.005; Gbotosho GO, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-59; Gharibi S, 2019, AUST VET J, V97, P75, DOI 10.1111/avj.12785; Gonzalez R, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011444.pub2; GRANINGER W, 1992, ACTA TROP, V52, P121, DOI 10.1016/0001-706X(92)90027-U; Hendriks G, 2008, J PHARMACEUT BIOMED, V47, P126, DOI 10.1016/j.jpba.2007.12.002; HUANG J, 1983, J PHARM SCI, V72, P1368, DOI 10.1002/jps.2600721137; International Conference on Harmonisation, 2005, INT C HARM TECHN REQ; Izes AM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230975; Jeffery U, 2012, J FELINE MED SURG, V14, P903, DOI 10.1177/1098612X12454862; KARBWANG J, 1994, FUND CLIN PHARMACOL, V8, P491, DOI 10.1111/j.1472-8206.1994.tb00830.x; KARBWANG J, 1990, CLIN PHARMACOKINET, V19, P264, DOI 10.2165/00003088-199019040-00002; Kim Y, 2016, PLOS PATHOG, V12, DOI [10.1371/journal.ppat.1005531, 10.1371/journal.ppat.1005650]; Kratochwil NA, 2002, BIOCHEM PHARMACOL, V64, P1355, DOI 10.1016/S0006-2952(02)01074-2; LAWSON GM, 1994, CLIN CHEM, V40, P1218; Li P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14866; LINDUP WE, 1981, BRIT MED J, V282, P212, DOI 10.1136/bmj.282.6259.212; McDonagh P, 2015, VET MICROBIOL, V176, P370, DOI 10.1016/j.vetmic.2015.02.007; McDonagh P, 2014, VET MICROBIOL, V174, P438, DOI 10.1016/j.vetmic.2014.10.030; Milner E, 2011, EUR J DRUG METAB PH, V36, P151, DOI 10.1007/s13318-011-0047-8; MU JY, 1975, DRUG METAB DISPOS, V3, P198; Murphy BG, 2018, VET MICROBIOL, V219, P226, DOI 10.1016/j.vetmic.2018.04.026; Norris JM, 2007, J FELINE MED SURG, V9, P300, DOI 10.1016/j.jfms.2007.01.007; Pedersen NC, 2019, J FELINE MED SURG, V21, P269, DOI 10.1177/1098612X19835065; Pedersen NC, 2019, J FELINE MED SURG, V21, P271, DOI 10.1177/1098612X19825701; Pedersen NC, 2014, VET J, V201, P133, DOI 10.1016/j.tvjl.2014.04.016; Pedersen NC, 2009, J FELINE MED SURG, V11, P225, DOI 10.1016/j.jfms.2008.09.008; Pellegatti M, 2011, EXPERT OPIN DRUG MET, V7, P1009, DOI 10.1517/17425255.2011.586336; SANSOM LN, 1995, DRUG SAFETY, V12, P227, DOI 10.2165/00002018-199512040-00001; Saverio P., 2007, Journal of Veterinary Diagnostic Investigation, V19, P266; Schlagenhauf P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-357; Vuignier K, 2010, ANAL BIOANAL CHEM, V398, P53, DOI 10.1007/s00216-010-3737-1; Worthing KA, 2012, J FELINE MED SURG, V14, P405, DOI 10.1177/1098612X12441875; Zsila F, 2008, BIOORGAN MED CHEM, V16, P3759, DOI 10.1016/j.bmc.2008.01.053	37	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236754	10.1371/journal.pone.0236754	http://dx.doi.org/10.1371/journal.pone.0236754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756590	Green Published, gold			2022-12-26	WOS:000560393300035
J	Meier, K; Glatz, T; Guijt, MC; Piccininni, M; van der Meulen, M; Atmar, K; Jolink, ATC; Kurth, T; Rohmann, JL; Najafabadi, AHZ				Meier, Karien; Glatz, Toivo; Guijt, Mathijs C.; Piccininni, Marco; van der Meulen, Merel; Atmar, Khaled; Jolink, Anne-Tess C.; Kurth, Tobias; Rohmann, Jessica L.; Najafabadi, Amir H. Zamanipoor		COVID 19 Survey Study Grp	Public perspectives on protective measures during the COVID-19 pandemic in the Netherlands, Germany and Italy: A survey study	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; HEALTH BEHAVIORS; HONG-KONG; OUTBREAK; KNOWLEDGE; IMPACT; SARS	Background The extent to which people implement government-issued protective measures is critical in preventing further spread of coronavirus disease 2019 (COVID-19) caused by coronavirus SARS-CoV-2. Our study aimed to describe the public belief in the effectiveness of protective measures, the reported implementation of these measures, and to identify communication channels used to acquire information on COVID-19 in European countries during the early stage of the pandemic. Methods and findings An online survey available in multiple languages was disseminated starting on March 19th, 2020. After five days, we computed descriptive statistics for countries with more than 500 respondents. Each day, we assessed enacted community containment measures by stage of stringency (I-IV). In total, 9,796 adults responded, of whom 8,611 resided in the Netherlands (stage III), 604 in Germany (stage III), and 581 in Italy (stage IV). To explore possible dynamics as containment strategies intensified, we also included 1,365 responses submitted during the following week. Participants indicated support for governmental measures related to avoiding social gatherings, selective closure of public places, and hand hygiene and respiratory measures (range for all measures: 95.0%-99.7%). Respondents from the Netherlands less frequently considered a complete social lockdown effective (59.2%), compared to respondents in Germany (76.6%) or Italy (87.2%). Italian residents applied enforced social distancing measures more frequently (range: 90.2%-99.3%, German and Dutch residents: 67.5%-97.0%) and self-initiated hygienic and social distancing behaviors (range: 36.3%-96.6%, German and Dutch residents: 28.3%-95.7%). Respondents reported being sufficiently informed about the outbreak and behaviors to avoid infection (range: 90.2%-91.1%). Information channels most commonly reported included television newspapers, official health websites, and social media. One week later, we observed no major differences in submitted responses. Conclusions During the early stage of the COVID-19 pandemic, belief in the effectiveness of protective measures among survey respondents from three European countries was high and participants reported feeling sufficiently informed. In March 2020, implementation of measures differed between countries and were highest among respondents from Italy, who were subjected to the most stringent lockdown measures and greatest COVID-19 burden in Europe during this period.	[Meier, Karien; Guijt, Mathijs C.; van der Meulen, Merel; Atmar, Khaled; Jolink, Anne-Tess C.; Najafabadi, Amir H. Zamanipoor] Leiden Univ, Med Sch, Leiden, Netherlands; [Glatz, Toivo; Piccininni, Marco; Kurth, Tobias; Rohmann, Jessica L.] Charite Univ Med Berlin, Inst Publ Hlth, Berlin, Germany	Leiden University; Leiden University - Excl LUMC; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Najafabadi, AHZ (corresponding author), Leiden Univ, Med Sch, Leiden, Netherlands.; Rohmann, JL (corresponding author), Charite Univ Med Berlin, Inst Publ Hlth, Berlin, Germany.	jessica.rohmann@charite.de; amir@lumc.nl	; Kurth, Tobias/A-9243-2012	Guijt, Mathijs/0000-0002-9958-8590; Kurth, Tobias/0000-0001-7169-2620; van der Meulen, Merel/0000-0002-0001-4408; Piccininni, Marco/0000-0002-1397-0060; Glatz, Toivo/0000-0002-8994-7860; Rohmann, Jessica L./0000-0003-2420-5716; Jolink, Anna/0000-0002-0290-1705				Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], COVID 19 PAND; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bayham J, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0814; Beutels P, 2009, TROP MED INT HEALTH, V14, P85, DOI 10.1111/j.1365-3156.2008.02210.x; Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283; Center for Disease Control and Prevention, 2004, PUBL HLTH GUID COMM; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; de Bruin WB, 2020, AM J PREV MED, V59, P157, DOI 10.1016/j.amepre.2020.05.001; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Durham DP, 2012, J R SOC INTERFACE, V9, P562, DOI 10.1098/rsif.2011.0325; Ebrahim SH, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1066; Fenichel EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058249; Geldsetzer P, 2020, ANN INTERN MED, V173, P157, DOI 10.7326/M20-0912; He F, 2020, J MED VIROL, V92, P719, DOI 10.1002/jmv.25766; Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3; Hollingsworth TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001076; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Kwok KO, 2020, EMERG INFECT DIS, V26, P1575, DOI 10.3201/eid2607.200500; Leung GM, 2004, INFECT CONT HOSP EP, V25, P1033, DOI 10.1086/502340; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Malik AA, 2020, COVID 19 RELATED SOC, DOI [10.1101/2020.03.30.20048090, DOI 10.1101/2020.03.30.20048090]; McFadden SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231808; Pandey Ambarish, 2010, Am J Prev Med, V38, pe1, DOI 10.1016/j.amepre.2009.11.007; R Core Team, 2021, R LANGUAGE ENV STAT; RStudio Team, 2020, RSTUDIO INTEGRATED D; Rubin G.J., 2014, HLTH SERV DELIV RES, V2, P1, DOI [10.3310/hsdr02410, DOI 10.3310/HSDR02410]; Saglietto A, 2020, LANCET, V395, P1110, DOI 10.1016/S0140-6736(20)30690-5; Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022; Tang CSK, 2003, AM J PUBLIC HEALTH, V93, P1887, DOI 10.2105/AJPH.93.11.1887; Vartti AM, 2009, INT J BEHAV MED, V16, P41, DOI 10.1007/s12529-008-9004-6; Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239; Wong CY, 2005, J ADOLESCENT HEALTH, V36, P193, DOI 10.1016/j.jadohealth.2004.02.024; World Health Organization, 2018, COMM RISK PUBL HLTH; World Health Organization, 2019, WHOWHEIHMGIP20191; Yan Y, 2020, MEASURING VOLUNTARY, DOI [10.1101/2020.05.01.20087874, DOI 10.1101/2020.05.01.20087874]; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	37	49	51	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236917	10.1371/journal.pone.0236917	http://dx.doi.org/10.1371/journal.pone.0236917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NB3DK	32756573	gold, Green Published, Green Submitted			2022-12-26	WOS:000560393300049
J	Opara, CN; Akintorin, M; Byrd, A; Cirignani, N; Akintorin, S; Soyemi, K				Opara, Chibuzor Nonye; Akintorin, Mopelola; Byrd, Allison; Cirignani, Natascha; Akintorin, Similolu; Soyemi, Kenneth			Maternal diabetes mellitus as an independent risk factor for clinically significant retinopathy of prematurity severity in neonates less than 1500g	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; PRETERM INFANTS; HYPERGLYCEMIA; POPULATION; INSULIN	Background Retinopathy of prematurity (ROP) is a significant morbidity in preterm babies. Multiple risk factors for severe ROP have been extensively studied, however, only a few studies have included maternal diabetes mellitus (MDM) in their assessment. ROP and diabetic retinopathy are both retinal vascular diseases in which there is leakage and/or neovascularization from damaged retinal vessels. Diabetes may affect ROP development; however, there are conflicting results on the association between MDM and ROP. Objective To determine if MDM is an independent risk factor for clinically significant ROP (ROP > Stage II) in neonates weighing less than 1500g. Design/Method We conducted a retrospective cohort study of neonates weighing Results We extracted 883 paired maternal-neonatal data. The mean (standard deviation) gestational age and birthweight were 28.5 (2.9) weeks and 1052.7 (300.9) grams, respectively. Of the 883 mothers, 72 (8.2%) had DM. The incidence of ROP and severe ROP was 42.4% (374/883) and 6.5% (57/883) respectively. The odds ratio comparing MDM and severe ROP was 3.47 [95% CI: 1.51-7.96]; p<0.01). Compared to Stage I, the risk of MDM in infants with ROP increased from 1.49 in Stage II ROP to 2.59 in Stages III&IV. Severe ROP was associated with infant steroid use (OR: 5.92 [95% CI: 2.83-12.38]; p <0.01), sepsis (OR: 2.13 [95% CI: 1.09-4.14]; p = 0.03) chorioamnionitis (OR: 1.90 [95% CI: 1.03-3.50]; p = 0.04), and maternal steroid use (OR: 0.51 [95% CI: 0.32-0.79]; p<0.01). Conclusion Maternal diabetes is associated with ROP and the strength of association increased with increasing severity of ROP.	[Opara, Chibuzor Nonye; Akintorin, Mopelola; Byrd, Allison; Soyemi, Kenneth] John H Stroger Hosp Cook Cty, Dept Pediat, Chicago, IL 60612 USA; [Cirignani, Natascha] AT Still Univ, Sch Osteopath Med, Mesa, AZ USA; [Akintorin, Similolu] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA	John H Stroger Junior Hospital Cook County; A.T. Still University of Health Sciences; University of Southern California	Opara, CN (corresponding author), John H Stroger Hosp Cook Cty, Dept Pediat, Chicago, IL 60612 USA.	nonyell@yahoo.com		Opara, Chibuzor/0000-0002-1774-2364				Akkoyun I, 2006, J AAPOS, V10, P449, DOI 10.1016/j.jaapos.2006.05.007; Bas AY, 2018, BRIT J OPHTHALMOL, V102, P1711, DOI 10.1136/bjophthalmol-2017-311789; Bental Y, 2011, PEDIATRICS, V128, pE848, DOI 10.1542/peds.2010-3443; Blanco CL, 2006, J PERINATOL, V26, P737, DOI 10.1038/sj.jp.7211594; Blencowe H, 2013, PEDIATR RES, V74, P35, DOI 10.1038/pr.2013.205; Celebi ARC, 2014, MED SCI MONITOR, V20, P1647, DOI 10.12659/MSM.892262; Console V, 1997, Acta Biomed Ateneo Parmense, V68 Suppl 1, P75; Darlow BA, 2005, PEDIATRICS, V115, P990, DOI 10.1542/peds.2004-1309; Fierson WM, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3061; Garg Ruchira, 2003, J Perinatol, V23, P186, DOI 10.1038/sj.jp.7210879; Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Holmstrom G, 1996, ACTA OBSTET GYN SCAN, V75, P628, DOI 10.3109/00016349609054687; Kaempf JW, 2011, J PERINATOL, V31, P251, DOI 10.1038/jp.2010.152; Karna Padmani, 2005, BMC Pediatr, V5, P18, DOI 10.1186/1471-2431-5-18; Kim SJ, 2018, SURV OPHTHALMOL, V63, P618, DOI 10.1016/j.survophthal.2018.04.002; Kumar P, 2011, INDIAN J PEDIATR, V78, P812, DOI 10.1007/s12098-011-0363-7; Lee JH, 2016, AM J PERINAT, V33, P393, DOI 10.1055/s-0035-1565999; Mitra S, 2014, NEONATOLOGY, V105, P189, DOI 10.1159/000357556; Movsas TZ, 2016, J AAPOS, V20, P348, DOI 10.1016/j.jaapos.2016.05.008; Mutlu FM, 2008, J PEDIAT OPHTH STRAB, V45, P291, DOI 10.3928/01913913-20080901-12; PALMER EA, 1991, OPHTHALMOLOGY, V98, P1628; Persson M, 2018, JAMA PEDIATR, V172, P867, DOI 10.1001/jamapediatrics.2018.1811; PUROHIT DM, 1985, PEDIATRICS, V76, P339; Quinn GE, 2018, JAMA OPHTHALMOL, V136, P1383, DOI 10.1001/jamaophthalmol.2018.4290; Rehan VK, 2002, CLIN PEDIATR, V41, P481, DOI 10.1177/000992280204100705; Terry T L, 1944, Trans Am Ophthalmol Soc, V42, P383; Tunay ZO, 2016, AM J OPHTHALMOL, V168, P201, DOI 10.1016/j.ajo.2016.05.022; Wei JN, 2003, DIABETES CARE, V26, P343, DOI 10.2337/diacare.26.2.343; Yau G, 2014, MEDICINE, V93, P314; [No title captured]	32	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236639	10.1371/journal.pone.0236639	http://dx.doi.org/10.1371/journal.pone.0236639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745146	Green Published, gold			2022-12-26	WOS:000560006800035
J	Rejman, M; Siemontowski, P; Siemienski, A				Rejman, Marek; Siemontowski, Piotr; Siemienski, Adam			Comparison of performance of various leg-kicking techniques in fin swimming in terms of achieving the different goals of underwater activities	PLOS ONE			English	Article							ENERGY-EXPENDITURE; STROKE; EFFICIENCY; VELOCITY; PERSPECTIVE; PARAMETERS; DISTANCE; ECONOMY; LEVEL; COST	The aim of this study was to compare underwater fin swimming performance using dolphin, flutter and breaststroke kicks with and without diving gear. Performance was evaluated in terms of average swimming velocity. The parameters of spatiotemporal structure of the stroke reflecting to the swimming economy were employed. Conscious modifications in propulsion technique were considered here with the aim of controlling swimming performance. A total of ten professional scuba divers swam at maximal speed underwater for 50m using each of three techniques: dolphin, flutter, or breaststroke kicks. Swimmers' performance was compared between holding their breath and using breathing apparatus. Two cameras recorded their movements in sagittal and transverse planes. The average swimming velocity (v(av)), stroke length (SL), stroke rate (SR), index of variation of intracycle velocity (VIVIndex) and stroke index (SI) were estimated. Relative to the other techniques, the dolphin kick without a diving gear demonstrated the highest v(av)and low SI and VIV(Index)values, which reflects the most advantageous economy of propulsion at given velocity. Given the lack of statistical differences, using the breaststroke kick and flutter kick when swimming with a diving gear seems to be comparable to dolphin-kick in terms of average velocity and parameters reflecting the economy of propulsion. Thus, a search for fin swimming techniques with the aim of achieving specific goals seemed reasonable. The results suggest, that performance achieved while using various fin swimming techniques was probably controlled by different strategies of leg movements. These strategies revealed differences in a spatiotemporal (SR-SL) structure of the stroke and they were closely associated in terms of the velocity variation decrease.	[Rejman, Marek] Univ Sch Phys Educ Wroclaw, Dept Swimming, Wroclaw, Poland; [Siemontowski, Piotr] Polish Naval Acad, Dept Technol Underwater Activ, Gdynia, Poland; [Siemienski, Adam] Univ Sch Phys Educ Wroclaw, Dept Biomech, Wroclaw, Poland		Rejman, M (corresponding author), Univ Sch Phys Educ Wroclaw, Dept Swimming, Wroclaw, Poland.	marek.rejman@awf.wroc.pl	Rejman, Marek/ABG-5576-2021	Rejman, Marek/0000-0003-3857-6999; Siemienski, Adam/0000-0003-1637-4122				Alves F, 1996, BIOMECHANICS MED SWI, VVII, P185; Barbosa TM, 2006, INT J SPORTS MED, V27, P894, DOI 10.1055/s-2006-923776; Barbosa TM, 2008, EUR J APPL PHYSIOL, V103, P139, DOI 10.1007/s00421-008-0676-z; Barbosa TM, 2008, J SPORT SCI MED, V7, P201; Barbosa TM, 2010, J SCI MED SPORT, V13, P262, DOI 10.1016/j.jsams.2009.01.003; Barbosa TM, 2005, INT J SPORTS MED, V26, P841, DOI 10.1055/s-2005-837450; Colman V., 1999, P 8 INT S BIOMECHANI, P89; Connaboy C, 2009, SPORT BIOMECH, V8, P360, DOI 10.1080/14763140903464321; COSTILL DL, 1985, INT J SPORTS MED, V6, P266, DOI 10.1055/s-2008-1025849; CRAIG AB, 1985, MED SCI SPORT EXER, V17, P625, DOI 10.1249/00005768-198512000-00001; DONALD KW, 1954, J APPL PHYSIOL, V7, P31, DOI 10.1152/jappl.1954.7.1.31; Duda H, 2018, BALT J HEALTH PHYS A, V10, P49, DOI 10.29359/BJHPA.10.4.04; Figueiredo P, 2012, EUR J APPL PHYSIOL, V112, P3319, DOI 10.1007/s00421-011-2284-6; Fish FE, 2013, MAR TECHNOL SOC J, V47, P37; Guillaume N, 2007, HUM MOVEMENT SCI, V26, P426, DOI 10.1016/j.humov.2007.03.002; HOLMER I, 1974, EUR J APPL PHYSIOL O, V33, P105, DOI 10.1007/BF00449512; Kotarbinski T., 1965, PRAXIOLOGY; Lyttle AD, 2000, J SPORT SCI, V18, P801, DOI 10.1080/026404100419856; McArdle WD., 2001, EXERCISE PHYSL ENERG; Nicolas G, 2009, HUM MOVEMENT SCI, V28, P480, DOI 10.1016/j.humov.2009.02.004; Pendergast DR, 1996, MED SCI SPORT EXER, V28, P573, DOI 10.1097/00005768-199605000-00006; Pendergast DR, 2003, UNDERSEA HYPERBAR M, V30, P57; Pendergast DR, 2003, UNDERSEA HYPERBAR M, V30, P75; Prins JH, 2010, 11 INT S BIOM MED SW, P154; Rejman M., 2003, HUMAN MOVEMENTS, V2, P54; Rejman M, 2008, J SPORT SCI MED, V7, P67; Rejman M, 2018, ACTA BIOENG BIOMECH, V20, P151, DOI 10.5277/ABB-01254-2018-03; Rejman M, 2013, J SPORT SCI MED, V12, P171; Rejman M, 2012, J SPORT SCI MED, V11, P682; Rejman M, 2009, J APPL BIOMECH, V25, P340, DOI 10.1123/jab.25.4.340; Robinson G., 2017, DOING RES PROJECT SP; Sanchez J., 2002, PROC 20 INT S BIOMEC, V20, P56; Sanders RH, 2002, P 20 ISBS SWIMM APPL, P1; Vilas-Boas J P, 1996, BIOMECHANICS MED SWI, P167; Vilas-Boas JP, 2010, WORLD BOOK SWIMMING, P120; Wakayoshi K, 1996, BIOMECHANICS MED SWI, V7th, P285; Zamparo P, 2006, EUR J APPL PHYSIOL, V96, P459, DOI 10.1007/s00421-005-0075-7; Zamparo P, 2002, J EXP BIOL, V205, P2665; Zaton K., 2012, HUMAN MOVEMENT, V13, P225, DOI DOI 10.2478/V10038-012-0026-1	39	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236504	10.1371/journal.pone.0236504	http://dx.doi.org/10.1371/journal.pone.0236504			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745109	Green Published, gold			2022-12-26	WOS:000560006800017
J	Sun, JJ; Wang, X; Liu, WF; Ji, P; Shang, AQ; Wu, JL; Zhou, H; Quan, WQ; Yao, YW; Yang, YB; Gu, CZ; Sun, ZJ; Goel, A; Weng, WH; Li, D				Sun, Junjun; Wang, Xuan; Liu, Wenfang; Ji, Ping; Shang, Anquan; Wu, Junlu; Zhou, Hao; Quan, Wenqiang; Yao, Yiwen; Yang, Yibao; Gu, ChenZheng; Sun, Zujun; Goel, Ajay; Weng, Wenhao; Li, Dong			Novel evidence for retinoic acid-induced G (Rig-G) as a tumor suppressor by activating p53 signaling pathway in lung cancer	FASEB JOURNAL			English	Article						epithelial-mesenchymal transition; lung adenocarcinoma; metastasis; p53; prognosis; Rig-G; therapy	EXPRESSION; FAMILY; MEMBER; CELLS	Lung cancer is one of most common malignancies worldwide. We have previously identified retinoic acid-induced gene G (Rig-G) as a tumor suppressor in not only acute promyelocytic leukemia, but also in other solid tumors. However, the clinical significance of Rig-G and the underlying mechanism(s) for its biological function in lung cancer remain largely unexplored. Herein, we first compared the expression of Rig-G between lung cancer (n = 138) and normal tissues (n = 23), from public-available data sets and our patient cohort. We further analyzed the correlation of Rig-G expression with key clinico-pathological features and survival outcomes in a multi-site clinical cohort of 300 lung cancer patients. Functional studies for Rig-G were performed in cell lines, and an animal model to support clinical findings. We found that Rig-G was frequently downregulated in lung cancer tissues and cell lines, and correlated with poor prognosis in lung cancer patients. Overexpression of Rig-G led to significantly reduced cell growth and suppressed migration in A549 and NCI-H1944 cells, accompanied by reduced epithelial-mesenchymal transition. Likewise, restoration of Rig-G in Lewis lung carcinoma cells permitted development of fewer cancer metastases versus controls in an animal model. Gene expression profiling results identified p53 pathway as a key downstream target of Rig-G, and p53 inhibition by pifithrin-alpha caused abrogation of tumor-suppressive effects of Rig-G in lung cancer. In conclusion, we, for the first time, have identified Rig-G as a novel and important tumor suppressor, which may serve as a potential therapeutic target for restoring p53 expression in lung cancer patients.	[Sun, Junjun; Ji, Ping; Shang, Anquan; Wu, Junlu; Quan, Wenqiang; Yao, Yiwen; Yang, Yibao; Gu, ChenZheng; Sun, Zujun; Li, Dong] Tongji Univ, Shanghai Tongji Hosp, Dept Clin Lab, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China; [Wang, Xuan] Putuo Peoples Hosp, Dept Pharm, Shanghai, Peoples R China; [Liu, Wenfang; Zhou, Hao] Tongji Univ, Shanghai Tongji Hosp, Dept Gen Surg, Sch Med, Shanghai, Peoples R China; [Goel, Ajay] City Hope Natl Med Ctr, Dept Mol Diagnost & Expt Therapeut, Beckman Res Inst, Comprehens Canc Ctr, Duarte, CA USA; [Weng, Wenhao] Tongji Univ, Yangpu Hosp, Dept Clin Lab, Sch Med, 450 Tenyue Rd, Shanghai 200090, Peoples R China; [Weng, Wenhao] Tongji Univ, Yangpu Hosp, Inst Gastrointestinal Surg & Translat Med, Sch Med, Shanghai, Peoples R China	Tongji University; Tongji University; City of Hope; Beckman Research Institute of City of Hope; Tongji University; Tongji University	Li, D (corresponding author), Tongji Univ, Shanghai Tongji Hosp, Dept Clin Lab, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China.; Weng, WH (corresponding author), Tongji Univ, Yangpu Hosp, Dept Clin Lab, Sch Med, 450 Tenyue Rd, Shanghai 200090, Peoples R China.; Goel, A (corresponding author), City Hope Natl Med Ctr, Dept Mol Diagnost & Expt Therapeut, Beckman Res Inst, Comprehens Ctr,Biomed Res Ctr, 1218 S Fifth Ave,Suite 2226, Monrovia, CA 91016 USA.	ajgoel@coh.org; wengwenhao2010@hotmail.com; lidong@tongji.edu.cn	Shang, Anquan/K-7456-2015	Shang, Anquan/0000-0003-2820-1982	National Cancer Institute, National Institutes of Health [R01 CA72851, CA181572, CA184792, CA202797, U01 CA187956]; Baylor Sammons Cancer Center and Foundation; Baylor Scott & White Research Institute; Beckman Research Institute of City of Hope; National Natural Science Foundation of China [81272603, 81472179, 81873975, 81672826, 81874179]; Excellent Academic Leader Training Program of Shanghai Health System [2018BR31]; Clinical Research and Cultivation Project of Shanghai Tongji Hospital [ITJ (ZD) 1803]; Municipal Human Resources Development Program for Outstanding Young Talents in Medical and Health Sciences in Shanghai [2017YQ044]; Shanghai Pujiang Talent Plan [18PJD047]	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Sammons Cancer Center and Foundation; Baylor Scott & White Research Institute; Beckman Research Institute of City of Hope; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Academic Leader Training Program of Shanghai Health System; Clinical Research and Cultivation Project of Shanghai Tongji Hospital; Municipal Human Resources Development Program for Outstanding Young Talents in Medical and Health Sciences in Shanghai; Shanghai Pujiang Talent Plan	The present work was supported by the grants R01 CA72851, CA181572, CA184792, CA202797, and U01 CA187956 from the National Cancer Institute, National Institutes of Health, pilot grants from the Baylor Sammons Cancer Center and Foundation, funds from the Baylor Scott & White Research Institute and financial support from the Beckman Research Institute of City of Hope, to Ajay Goel. This work was also supported by grants 81272603, 81472179, and 81873975 from National Natural Science Foundation of China, grant 2018BR31 from Excellent Academic Leader Training Program of Shanghai Health System, and grant ITJ (ZD) 1803 from Clinical Research and Cultivation Project of Shanghai Tongji Hospital to Dong Li. In addition, this work was supported by grants 81672826 and 81874179 from the National Natural Science Foundation of China, grant 2017YQ044 from Municipal Human Resources Development Program for Outstanding Young Talents in Medical and Health Sciences in Shanghai, and grant 18PJD047 from Shanghai Pujiang Talent Plan to Wenhao Weng.	Agustoni F, 2019, CANCER TREAT REV, V72, P15, DOI 10.1016/j.ctrv.2018.08.002; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cao MM, 2019, THORAC CANCER, V10, P3, DOI 10.1111/1759-7714.12916; de Veer MJ, 1998, GENOMICS, V54, P267, DOI 10.1006/geno.1998.5555; Gibbons DL, 2014, MOL CANCER RES, V12, P3, DOI 10.1158/1541-7786.MCR-13-0539; Giroux DJ, 2009, J THORAC ONCOL, V4, P679, DOI 10.1097/JTO.0b013e3181a52370; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Ka WH, 2018, BREAST CANCER-TOKYO, V25, P529, DOI 10.1007/s12282-018-0849-5; Kellar A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/621324; Kim DW, 2018, TRANSL LUNG CANCER R, V7, P4, DOI 10.21037/tlcr.2017.10.07; Kim HJ, 2004, CANCER RES, V64, P2439, DOI 10.1158/0008-5472.CAN-03-2643; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; Li D, 2016, ONCOTARGET, V7, P66032, DOI 10.18632/oncotarget.11797; Lou YJ, 2009, CANCER RES, V69, P3673, DOI 10.1158/0008-5472.CAN-08-4922; Merkel O, 2017, MUTAT RES-REV MUTAT, V773, P1, DOI 10.1016/j.mrrev.2017.02.003; Powell E, 2014, CANCER DISCOV, V4, P405, DOI 10.1158/2159-8290.CD-13-0136; Shen JJ, 2018, CANCER RES, V78, P359, DOI 10.1158/0008-5472.CAN-17-1805; Shiota M, 2008, ONCOGENE, V27, P5543, DOI 10.1038/onc.2008.176; Smith BN, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020017; Wu SG, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0777-1; Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103; Xu GP, 2013, BIOCHEM BIOPH RES CO, V432, P425, DOI 10.1016/j.bbrc.2013.01.132; Yu M, 1997, P NATL ACAD SCI USA, V94, P7406, DOI 10.1073/pnas.94.14.7406; Zhao KL, 2018, EMBO REP, V19, P305, DOI 10.15252/embr.201744465	25	5	5	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11900	11912		10.1096/fj.201903220R	http://dx.doi.org/10.1096/fj.201903220R		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32741018	Green Accepted			2022-12-26	WOS:000558168000001
J	Tu, JY; Liu, XL; Jia, HB; Reilly, J; Yu, SS; Cai, C; Liu, F; Lv, YX; Huang, YW; Lu, ZJ; Han, SS; Jiang, T; Shu, XH; Wu, XY; Tang, ZH; Lu, QW; Liu, MG				Tu, Jiayi; Liu, Xiliang; Jia, Haibo; Reilly, James; Yu, Shanshan; Cai, Chen; Liu, Fei; Lv, Yuexia; Huang, Yuwen; Lu, Zhaojing; Han, Shanshan; Jiang, Tao; Shu, Xinhua; Wu, Xiaoyan; Tang, Zhaohui; Lu, Qunwei; Liu, Mugen			The chromatin remodeler Brg1 is required for formation and maintenance of hematopoietic stem cells	FASEB JOURNAL			English	Article						Brg1; chromatin remodeling; epigenetics; hematopoietic stem cells; Klf2a-NO signaling	ATPASE SUBUNIT; SELF-RENEWAL; NITRIC-OXIDE; BONE-MARROW; BLOOD-FLOW; ZEBRAFISH; DIFFERENTIATION; COMPLEXES; MICROENVIRONMENT; INDUCTION	Hematopoietic stem and progenitor cells (HSPCs) have the ability to self-renew and differentiate into various blood cells, thus playing an important role in maintenance of lifelong hematopoiesis. Brahma-related gene 1 (BRG1), which acts as the ATP subunit of mammalian SWI-SNF-related chromatin remodeling complexes, is involved in human acute myeloid leukemia and highly expresses in short-term HSPCs. But its role and regulatory mechanism for HSPC development have not yet been well established. Here, we generated abrg1knockout zebrafish model using TALEN technology. We found that inbrg1(-/-)embryo, the primitive hematopoiesis remained well, while definitive hematopoiesis formation was significantly impaired. The number of hemogenic endothelial cells was decreased, further affecting definitive hematopoiesis with reduced myeloid and lymphoid cells. During embryogenesis, the nitric oxide (NO) microenvironment inbrg1(-/-)embryo was seriously damaged and the reduction of HSPCs could be partially rescued by a NO donor. Chromatin immunoprecipitation (ChIP) assays showed that BRG1 could bind to the promoter ofKLF2and trigger its transcriptional activity of NO synthase. Our findings show that Brg1 promotesklf2aexpression in hemogenic endothelium and highlight a novel mechanism for HSPC formation and maintenance.	[Tu, Jiayi; Liu, Xiliang; Jia, Haibo; Yu, Shanshan; Cai, Chen; Liu, Fei; Lv, Yuexia; Huang, Yuwen; Lu, Zhaojing; Jiang, Tao; Tang, Zhaohui; Lu, Qunwei; Liu, Mugen] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China; [Reilly, James; Shu, Xinhua] Glasgow Caledonian Univ, Dept Biol & Biomed Sci, Glasgow, Lanark, Scotland; [Han, Shanshan] China Three Gorges Univ, Med Coll, Yichang, Peoples R China; [Wu, Xiaoyan] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat, Wuhan, Peoples R China	Huazhong University of Science & Technology; Glasgow Caledonian University; China Three Gorges University; Huazhong University of Science & Technology	Lu, QW; Liu, MG (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.	luqw@mail.hust.edu.cn; lium@hust.edu.cn	jiang, tao/GWC-7108-2022; Liu, Fei/AAR-6464-2021	Liu, Fei/0000-0002-0310-1072	National Natural Science Foundation of China [81670099, 81870691, 31871260, 81770102, 81670890]; China postdoctoral Science Foundation [2019T120647]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China postdoctoral Science Foundation(China Postdoctoral Science Foundation)	National Natural Science Foundation of China, Grant/Award Number: 81670099, 81870691, 31871260, 81770102 and 81670890; The China postdoctoral Science Foundation, Grant/Award Number: 2019T120647	Abraham BJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-193; Aguilo F, 2011, BLOOD, V117, P5057, DOI 10.1182/blood-2010-08-300145; Asada N, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00119; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bossen C, 2015, NAT IMMUNOL, V16, P775, DOI 10.1038/ni.3170; Buscarlet M, 2014, BLOOD, V123, P1720, DOI 10.1182/blood-2013-02-483495; Choudhuri A, 2017, STEM CELL REP, V8, P1465, DOI 10.1016/j.stemcr.2017.05.018; Choudry FA, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5797521; CIFANI P, 2015, BLOOD, V126; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Carrara RDV, 2018, CLIN TRANSL ONCOL, V20, P542, DOI 10.1007/s12094-017-1751-x; de Jong JLO, 2005, ANNU REV GENET, V39, P481, DOI 10.1146/annurev.genet.39.073003.095931; Eroglu B, 2006, DEV DYNAM, V235, P2722, DOI 10.1002/dvdy.20911; Fatrai S, 2011, BLOOD, V117, P3320, DOI 10.1182/blood-2010-08-303669; Gebuhr TC, 2003, J EXP MED, V198, P1937, DOI 10.1084/jem.20030714; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; Gu QL, 2019, SCIENCE, V363, P1085, DOI 10.1126/science.aav1749; Haladyna JN, 2015, EPIGENOMICS-UK, V7, P301, DOI [10.2217/EPI.14.88, 10.2217/epi.14.88]; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Hu XB, 2019, AUTOPHAGY, V15, P453, DOI 10.1080/15548627.2018.1520548; Huang HT, 2013, NAT CELL BIOL, V15, P1516, DOI 10.1038/ncb2870; Jalnapurkar S, 2019, STEM CELLS, V37, P128, DOI 10.1002/stem.2912; Jin H, 2007, BLOOD, V109, P5208, DOI 10.1182/blood-2007-01-069005; Kanz D, 2016, ANN NY ACAD SCI, V1370, P97, DOI 10.1111/nyas.13030; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Ko M, 2008, MUTAT RES-FUND MOL M, V647, P59, DOI 10.1016/j.mrfmmm.2008.08.004; Koide S, 2015, EXP HEMATOL, V43, pS73, DOI 10.1016/j.exphem.2015.06.164; Konantz M, 2016, EMBO J, V35, P2315, DOI 10.15252/embj.201593454; Lim SE, 2017, EXP HEMATOL, V46, P83, DOI 10.1016/j.exphem.2016.10.002; Liu F, 2017, J BIOL CHEM, V292, P6225, DOI 10.1074/jbc.M116.760314; Liu LL, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0567-7; Lizama CO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8739; Lu ZJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46098; Lucas D, 2017, ADV EXP MED BIOL, V1041, P5, DOI 10.1007/978-3-319-69194-7_2; Michurina T, 2004, MOL THER, V10, P241, DOI 10.1016/j.ymthe.2004.05.030; Moore FE, 2016, J EXP MED, V213, P979, DOI 10.1084/jem.20152013; North TE, 2008, BLOOD, V112, P270; O'Donnell RK, 2016, CANCER RES, V76, P517, DOI 10.1158/0008-5472.CAN-14-3023; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Ruzicka L, 2015, GENESIS, V53, P498, DOI 10.1002/dvg.22868; Sarkaria SM, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700190; Sawamiphak S, 2014, DEV CELL, V31, P640, DOI 10.1016/j.devcel.2014.11.007; Sena JA, 2013, MOL CELL BIOL, V33, P3849, DOI 10.1128/MCB.00731-13; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Theodore LN, 2017, STEM CELL REP, V8, P1226, DOI 10.1016/j.stemcr.2017.03.016; Tiwari A, 2016, STEM CELLS DEV, V25, P1604, DOI 10.1089/scd.2016.0153; Van de Walle I, 2011, BLOOD, V117, P4449, DOI 10.1182/blood-2010-06-290049; Vradii D, 2006, J CELL PHYSIOL, V206, P112, DOI 10.1002/jcp.20432; Wang L, 2011, BLOOD, V118, P4102, DOI 10.1182/blood-2011-05-353235; Wei YL, 2014, BLOOD, V124, P1578, DOI 10.1182/blood-2013-11-541391; Witzel M, 2017, NAT GENET, V49, P742, DOI 10.1038/ng.3833; Wolfe RP, 2013, BIOTECHNOL BIOENG, V110, P1231, DOI 10.1002/bit.24782; Wu Q, 2017, EPIGENOMICS-UK, V9, P919, DOI 10.2217/epi-2017-0034; Xue YY, 2017, DEV CELL, V42, P349, DOI 10.1016/j.devcel.2017.07.012; Yu SS, 2019, BLOOD, V133, P805, DOI 10.1182/blood-2018-09-876599; Yu SS, 2017, HUM MOL GENET, V26, P2335, DOI 10.1093/hmg/ddx137; Zhang CX, 2013, BBA-GEN SUBJECTS, V1830, P2370, DOI 10.1016/j.bbagen.2012.06.008; Zhang JY, 2006, MOL CELL BIOL, V26, P7942, DOI 10.1128/MCB.00700-06; Zhang YF, 2018, TRENDS CELL BIOL, V28, P976, DOI 10.1016/j.tcb.2018.06.001	59	4	4	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11997	12008		10.1096/fj.201903168RR	http://dx.doi.org/10.1096/fj.201903168RR		AUG 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32738093				2022-12-26	WOS:000560233000001
J	Liu, Q; Mo, L; Huang, XQ; Yu, L; LiU, Y				Liu, Qian; Mo, Lin; Huang, Xianqiao; Yu, Lu; LiU, Yang			The effects of self-efficacy and social support on behavior problems in 8 similar to 18 years old children with malignant tumors	PLOS ONE			English	Article								Objective To explore the influence factors of behavior problems of 8 similar to 18 years old children with malignant tumors in the treatment period, as well as the mediating effects of social support self-efficacy and post-traumatic growth. Methods From May 2019 to October 2019, 160 children with malignant tumors during the treatment were selected through convenience sampling method, and were investigated via the General Self-Efficacy Scale, Social Support Questionnaire, Post-Traumatic Growth Scale and Conners' Parent Symptom Questionnaire. Structural equation model was established on the basis of survey results. Results The total detection rate of behavior problems in 8 similar to 18 years old children with malignant tumors was 10.6%. The structural equation models indicated that boys had more behavior problems than girls, self-efficacy, social support and post-traumatic growth can directly affect the behavior problems of 8 similar to 18 years old children with malignant tumors in the treatment period, and the standardized total effect of self-efficacy in both of the first model and the second model was the largest. Self-efficacy is also able to indirectly and negatively predict the behavior problems based on social support or post-traumatic growth. Social support can directly affect behavior problems or indirectly predict behavior problems through self-efficacy and post-traumatic growth. After 2000 bootstrap tests, the mediating effects of social support self-efficacy and post-traumatic growth were confirmed. Conclusion Reduced total detection rate of behavior problems suggests that targeted interventions in recent years may be effective. Interventions focused on improving self-efficacy, social support and post-traumatic growth may lessen behavior problems of children with malignant tumors in the treatment period.	[Liu, Qian; Huang, Xianqiao] Chongqing Med Univ, Acad Pediat, Chongqing, Peoples R China; [Liu, Qian; Mo, Lin; Huang, Xianqiao; Yu, Lu; LiU, Yang] Chongqing Med Univ, Childrens Hosp, Chongqing, Peoples R China; [Liu, Qian; Mo, Lin; Huang, Xianqiao; Yu, Lu; LiU, Yang] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Liu, Qian; Mo, Lin; Huang, Xianqiao; Yu, Lu; LiU, Yang] Natl Clin Res Ctr Child Hlth & Disorders, Chongqing, Peoples R China; [Liu, Qian; Mo, Lin; Huang, Xianqiao; Yu, Lu; LiU, Yang] China Int Sci & Technol Cooperat Base Child Dev &, Chongqing, Peoples R China; [Liu, Qian; Mo, Lin; Huang, Xianqiao; Yu, Lu; LiU, Yang] Chongqing Key Lab Pediat, Chongqing, Peoples R China; [Yu, Lu] Chongqing Med Univ, Dept VIP Outpatient, Affiliated Childrens Hosp, Chongqing, Peoples R China; [LiU, Yang] Chongqing Med Univ, Dept Hematol, Affiliated Childrens Hosp, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Mo, L (corresponding author), Chongqing Med Univ, Childrens Hosp, Chongqing, Peoples R China.; Mo, L (corresponding author), Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China.; Mo, L (corresponding author), Natl Clin Res Ctr Child Hlth & Disorders, Chongqing, Peoples R China.; Mo, L (corresponding author), China Int Sci & Technol Cooperat Base Child Dev &, Chongqing, Peoples R China.; Mo, L (corresponding author), Chongqing Key Lab Pediat, Chongqing, Peoples R China.	molin999@126.com			Chongqing Science and Technology Bureau, China [cstc2018jscx-msybX0110]	Chongqing Science and Technology Bureau, China	This work was supported by the Chongqing Science and Technology Bureau, China (grant number: cstc2018jscx-msybX0110). I am in charge of this project	Allen MR, 2007, THESIS; An YY, 2015, J BEIJING NORMAL U S, V60, P107; Becker H, 2017, ONCOL NURS FORUM, V44, P255, DOI [10.1188/17.ONF.255-264, 10.1168/17.ONF.255-264]; Daruwala SE, 2018, PSYCHIAT RES, V270, P1131, DOI 10.1016/j.psychres.2018.10.023; Duan H., 2017, THESIS; Fan J., 2005, HEBEIMEDJ, V17, P321, DOI DOI 10.3969/J.ISSN.1002-7386.2019.06.010; Geng ZH, 2018, CANCER NURS, V41, pE1, DOI 10.1097/NCC.0000000000000571; Greup SR, 2018, J ADOLESC YOUNG ADUL, V7, P1, DOI 10.1089/jayao.2017.0040; Habersaat S, 2018, CRIM JUSTICE BEHAV, V45, P1852, DOI 10.1177/0093854818800364; Hepburn Millie, 2016, THESIS; Hinz A, 2019, EUR J CANCER CARE, V28, DOI 10.1111/ecc.12952; Holtmaat K, 2019, SUPPORT CARE CANCER, V27, P443, DOI 10.1007/s00520-018-4325-8; Huang IC, 2018, PSYCHO-ONCOLOGY, V27, P2031, DOI 10.1002/pon.4769; Jia XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121480; Jiang TT, 2016, WORLD CHINESE J DIGE, V24, P4058, DOI [10.11569/wcjd.v24.i29.4058, DOI 10.11569/WCJD.V24.I29.4058]; Joseph S, 2010, CLIN PSYCHOL REV, V30, P830, DOI 10.1016/j.cpr.2010.01.002; Kirk Mairi, 2016, THESIS; Li Q., 1998, TIANJIN SOCIAL SCI, V1, P66, DOI [10.16240/j.cnki.1002-3976.1998.01.013, DOI 10.16240/J.CNKI.1002-3976.1998.01.013]; Lim JW, 2019, SUPPORT CARE CANCER, V27, P829, DOI 10.1007/s00520-018-4359-y; Lin CD, 2003, COMPREHENSIVE DICT P; [刘洋 Liu Yang], 2016, [中华护理杂志, Chinese Journal of Nursing], V51, P395; Mamaril NA, 2016, J ENG EDUC, V105, P366, DOI 10.1002/jee.20121; Marusak HA, 2018, NEUROPSYCHOL REV, V28, P123, DOI 10.1007/s11065-017-9365-1; Mee Susan, 2014, Pediatr Nurs, V40, P9; [莫霖 Mo Lin], 2013, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V38, P105; Park M, 2018, PSYCHO-ONCOLOGY, V27, P2257, DOI 10.1002/pon.4819; Rietman AB, 2018, AM J MED GENET B, V177, P319, DOI 10.1002/ajmg.b.32612; Serrano-Villar M, 2017, CHILD PSYCHIAT HUM D, V48, P597, DOI 10.1007/s10578-016-0685-9; Sheline KT, 2017, J COLL STUDENT DEV, V58, P402, DOI 10.1353/csd.2017.0030; Shin H, 2017, DEV PSYCHOL, V53, P114, DOI 10.1037/dev0000250; Su L., 2001, CHIN J CLIN PSYCHOL, V9, P241, DOI [DOI 10.3969/J.ISSN.1005-3611.2001.04.001, 10.3969/j.issn.1005-3611.2001.04.001, DOI 10.16128/J.CNKI.1005-3611.2001.04.001]; [孙玉倩 Sun Yuqian], 2013, [中华行为医学与脑科学杂志, Chinese Journal of Behavioral Medicine and Brain Science], V22, P526; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Tomita M, 2017, PSYCHO-ONCOLOGY, V26, P1198, DOI 10.1002/pon.4298; Trull R, 2014, THESIS; Wang C.K., 2001, CHINESE J APPL PSYCH, V7, P37, DOI [DOI 10.3969/J.ISSN.1006-6020.2001.01.007, 10.3969/j.issn.1006-6020.2001.01.007]; Wang W., 2018, PSYCHOL DEV ED, V34, P112; Weitzman C, 2015, PEDIATRICS, V135, P384, DOI 10.1542/peds.2014-3716; Wondimagegnehu A, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6007-4; Zablotsky B, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0811; Zhang D.J., 2019, J SW U SOC SCI ED, V45, P99, DOI [10.13718/j.cnki.xdsk.2019.01.012, DOI 10.13718/J.CNKI.XDSK.2019.01.012, DOI 10.13718/J.CNKI]; Zhang P, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016319; Zheng DJ, 2018, CANCER-AM CANCER SOC, V124, P3220, DOI 10.1002/cncr.31379; Zuo ZW, 2005, CHINESE MENTAL HLTH, P15, DOI DOI 10.3321/J.ISSN:1000-6729	44	6	7	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236648	10.1371/journal.pone.0236648	http://dx.doi.org/10.1371/journal.pone.0236648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NO3EK	32735627	gold, Green Published			2022-12-26	WOS:000569367100036
J	Lin, S; Su, SW; Jin, LB; Peng, RY; Sun, D; Ji, H; Yu, YJ; Xu, J				Lin, Sue; Su, Shiwen; Jin, Libo; Peng, Renyi; Sun, Da; Ji, Hao; Yu, Youjian; Xu, Jian			Identification of microRNAs and their targets in inflorescences of an Ogura-type cytoplasmic male-sterile line and its maintainer fertile line of turnip (Brassica rapassp. rapifera) via high-throughput sequencing and degradome analysis	PLOS ONE			English	Article							RAPHANUS-SATIVUS; POLLEN ABORTION; NONCODING RNAS; EXPRESSION; MITOCHONDRIAL; MIRNAS; GENE; CMS; MICROSPOROGENESIS; TOLERANCE	Cytoplasmic male sterility (CMS) is a widely used trait in angiosperms caused by perturbations in nucleus-mitochondrion interactions that suppress the production of functional pollen. MicroRNAs (miRNAs) are small non-coding RNAs that act as regulatory molecules of transcriptional or post-transcriptional gene silencing in plants. The discovery of miRNAs and their possible implications in CMS induction provides clues for the intricacies and complexity of this phenomenon. Previously, we characterized an Ogura-CMS line of turnip (Brassica rapassp.rapifera) that displays distinct impaired anther development with defective microspore production and premature tapetum degeneration. In the present study, high-throughput sequencing was employed for a genome-wide investigation of miRNAs. Six small RNA libraries of inflorescences collected from the Ogura-CMS line and its maintainer fertile (MF) line of turnip were constructed. A total of 120 pre-miRNAs corresponding to 89 mature miRNAs were identified, including 87 conversed miRNAs and 33 novel miRNAs. Among these miRNAs, the expression of 10 differentially expressed mature miRNAs originating from 12 pre-miRNAs was shown to have changed by more than two-fold between inflorescences of the Ogura-CMS line and inflorescences of the MF line, including 8 down- and 2 up-regulated miRNAs. The expression profiles of the differentially expressed miRNAs were confirmed by stem-loop quantitative real-time PCR. In addition, to identify the targets of the identified miRNAs, a degradome analysis was performed. A total of 22 targets of 25 miRNAs and 17 targets of 28 miRNAs were identified as being involved in the reproductive development for Ogura-CMS and MF lines of turnip, respectively. Negative correlations of expression patterns between partial miRNAs and their targets were detected. Some of these identified targets, such as squamosa promoter-binding-like transcription factor family proteins, auxin response factors and pentatricopeptide repeat-containing proteins, were previously reported to be involved in reproductive development in plants. Taken together, our results can help improve the understanding of miRNA-mediated regulatory pathways that might be involved in CMS occurrence in turnip.	[Lin, Sue; Jin, Libo; Peng, Renyi] Wenzhou Univ, Coll Life & Environm Sci, Inst Life Sci, Wenzhou, Peoples R China; [Su, Shiwen; Sun, Da; Ji, Hao; Xu, Jian] Wenzhou Vocat Coll Sci & Technol, Wenzhou, Peoples R China; [Yu, Youjian] Zhejiang A&F Univ, Coll Agr & Food Sci, Linan, Peoples R China	Wenzhou University; Zhejiang A&F University	Lin, S (corresponding author), Wenzhou Univ, Coll Life & Environm Sci, Inst Life Sci, Wenzhou, Peoples R China.; Xu, J (corresponding author), Wenzhou Vocat Coll Sci & Technol, Wenzhou, Peoples R China.	iamkari@163.com; zwxuj@qq.com	Sun, Da/I-8414-2015	Sun, Da/0000-0001-7747-9951; Lin, Sue/0000-0003-2539-3157	Special Project on Science and Technology Innovation of Seed and Seedling of Wenzhou [Z20160008]; National Natural Science Foundation of China [31972418]	Special Project on Science and Technology Innovation of Seed and Seedling of Wenzhou; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was jointly supported by funds from the Special Project on Science and Technology Innovation of Seed and Seedling of Wenzhou[Z20160008] (SL), and the National Natural Science Foundation of China [31972418] (SL).	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Banerjee A, 2016, PLANT BIOTECHNOL REP, V10, P185, DOI 10.1007/s11816-016-0401-z; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Chambers C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-87; Chen LiMing, 2009, Molecular Plant Breeding, V7, P757; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen ZW, 2017, CRIT REV PLANT SCI, V36, P55, DOI 10.1080/07352689.2017.1327762; COLHOUN CW, 1981, ANN BOT-LONDON, V48, P417, DOI 10.1093/oxfordjournals.aob.a086145; D'Ario M, 2017, TRENDS PLANT SCI, V22, P1056, DOI 10.1016/j.tplants.2017.09.009; Dahan J, 2013, RNA BIOL, V10, P1469, DOI 10.4161/rna.25568; Ding XL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2352-0; Ding YF, 2020, J AGR FOOD CHEM, V68, P1958, DOI 10.1021/acs.jafc.9b07468; Dong X, 2013, PLANT SCI, V199, P7, DOI 10.1016/j.plantsci.2012.11.001; Fang YN, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2882-0; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; FU TD, 1990, PLANT BREEDING, V104, P115, DOI 10.1111/j.1439-0523.1990.tb00412.x; Gaborieau L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01816; GOTTSCHALK W, 1974, NUCLEUS CALCUTTA, V17, P133; Grant-Downton R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-643; Grant-Downton R, 2009, MOL PLANT, V2, P500, DOI 10.1093/mp/ssp003; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; He H, 2015, SCI CHINA LIFE SCI, V58, P246, DOI 10.1007/s11427-015-4800-0; Horn R, 2014, MITOCHONDRION, V19, P198, DOI 10.1016/j.mito.2014.04.004; Hu J, 2014, MITOCHONDRION, V19, P282, DOI 10.1016/j.mito.2014.02.008; Iwabuchi M, 1999, PLANT MOL BIOL, V39, P183, DOI 10.1023/A:1006198611371; Jiang JX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-146; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kubo T, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9030361; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LASER KD, 1972, BOT REV, V38, P425, DOI 10.1007/BF02860010; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; Lee YP, 2008, THEOR APPL GENET, V117, P905, DOI 10.1007/s00122-008-0830-3; Li C, 2016, J CELL PHYSIOL, V231, P303, DOI 10.1002/jcp.25125; Lin S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218029; Liu Z, 2017, J EXP BOT, V68, P4115, DOI 10.1093/jxb/erx239; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Ma ZM, 2017, PLANT MOL BIOL, V93, P313, DOI 10.1007/s11103-016-0563-7; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Mishra A, 2018, PLANT CELL REP, V37, P177, DOI 10.1007/s00299-018-2248-y; Nahm SH, 2005, THEOR APPL GENET, V111, P1191, DOI 10.1007/s00122-005-0052-x; OGURA H., 1968, Memoirs of the Faculty of Agriculture, Kagoshima University, V6, P39; Omidvar V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2077-0; Peng H, 2012, PLANT MOL BIOL, V80, P85, DOI 10.1007/s11103-012-9898-x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rizzolatti C, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-2056-4; Ru P, 2006, CELL RES, V16, P457, DOI 10.1038/sj.cr.7310057; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Singh A, 2018, PLANTA, V248, P545, DOI 10.1007/s00425-018-2927-5; Singh S, 2019, PLANT REPROD, V32, P231, DOI 10.1007/s00497-019-00371-y; Slatko Barton E, 2018, Curr Protoc Mol Biol, V122, pe59, DOI 10.1002/cpmb.59; Storchova H, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112429; Teotia S, 2015, MOL PLANT, V8, P359, DOI 10.1016/j.molp.2014.12.018; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Wang C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00811; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wei XC, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00894; Willmann MR, 2014, METHODS, V67, P64, DOI 10.1016/j.ymeth.2013.07.003; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Xu J, 2019, SCI TOTAL ENVIRON, V653, P91, DOI 10.1016/j.scitotenv.2018.10.340; Yamagishi H, 2001, THEOR APPL GENET, V103, P725, DOI 10.1007/s001220100614; Yamagishi H, 2014, BREEDING SCI, V64, P38, DOI 10.1270/jsbbs.64.38; Yan JJ, 2015, PLANTA, V241, P109, DOI 10.1007/s00425-014-2167-2; Yang JH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-9; Zhang H, 2008, J PLANT NUTR SOIL SC, V171, P255, DOI 10.1002/jpln.200700079; Zhang Z, 2015, BIOINFORMATICS, V31, P290, DOI 10.1093/bioinformatics/btu633; Zhou XR, 2020, ACTA PHYSIOL PLANT, V42, DOI 10.1007/s11738-020-3013-8	79	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236829	10.1371/journal.pone.0236829	http://dx.doi.org/10.1371/journal.pone.0236829			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730367	gold, Green Published			2022-12-26	WOS:000556884700035
J	Stuart, F; Riley, A; Pourreza, H				Stuart, Forrest; Riley, Alicia; Pourreza, Hossein			A human-machine partnered approach for identifying social media signals of elevated traumatic grief in Chicago gang territories	PLOS ONE			English	Article							COMMUNITY VIOLENCE; SYSTEM AVOIDANCE; CONSEQUENCES; SURVEILLANCE; NETWORKS	There is a critical need to improve trauma-informed services in structurally marginalized communities impacted by violence and its associated traumatic grief. For community residents, particularly gang-associated youth, repeated exposure to traumatic grief causes serious adverse effects that may include negative health outcomes, delinquency, and future violent offenses. The recent proliferation of digital social media platforms, such as Twitter, provide a novel and largely underutilized resource for responding to these issues, particularly among these difficult-to-reach communities. In this paper, we explore the potential for using a human-machine partnered approach, wherein qualitative fieldwork and domain expertise is combined with a computational linguistic analysis of Twitter content among 18 gang territories/neighborhoods on Chicago's South Side. We first employ in-depth interviews and observations to identify common patterns by which residents in gang territories/neighborhoods express traumatic grief on social media. We leverage these qualitative findings, supplemented by domain expertise and computational techniques, to gather both traumatic grief- and gang-related tweets from Twitter. We next utilize supervised machine learning to construct a binary classification algorithm to eliminate irrelevant tweets that may have been gathered by our automated query and extraction techniques. Last, we confirm the validity, or ground truth, of our computational findings by enlisting additional domain expertise and further qualitative analyses of the specific traumatic events discussed in our sample of Twitter content. Using this approach, we find that social media provides useful signals for identifying moments of increased collective traumatic grief among residents in gang territories/neighborhoods. This is the first study to leverage Twitter to systematically ground the collective online articulations of traumatic grief in traumatic offline events occurring in violence-impacted communities. The results of this study will be useful for developing more effective tools-including trauma-informed intervention applications-for community organizations, violence prevention initiatives, and other public health efforts.	[Stuart, Forrest] Stanford Univ, Dept Sociol, Stanford, CA 94305 USA; [Riley, Alicia] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Pourreza, Hossein] Univ Chicago, Res Comp Ctr, Chicago, IL 60637 USA	Stanford University; University of California System; University of California San Francisco; University of Chicago	Stuart, F (corresponding author), Stanford Univ, Dept Sociol, Stanford, CA 94305 USA.	fstuart@stanford.edu	Riley, Alicia R/ABC-5258-2021	Riley, Alicia R/0000-0002-3341-6892	University of Chicago Women's Board; University of Chicago Urban Health Initiative	University of Chicago Women's Board; University of Chicago Urban Health Initiative	FS received seed funding from the University of Chicago Women's Board (https://womensboard.uchicago.edu/) and the University of Chicago Urban Health Initiative (https://www.uchicagomedicine.org/about-us/community/urbanhealth-initiative).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu A., 2013, ICONFERENCE 2013 P F, P549; Anderson E., 2000, CODE STREET DECENCY; [Anonymous], 2011, CBS CHICAGO; Arseniev-Koehler A, 2016, J ADOLESCENT HEALTH, V58, P659, DOI 10.1016/j.jadohealth.2016.02.012; Aslam S., 2018, TWITTER NUMBERS STAT; Bell C C, 1991, J Health Care Poor Underserved, V2, P175; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Boyd D, 2012, INFORM COMMUN SOC, V15, P662, DOI 10.1080/1369118X.2012.678878; Brantingham PJ, 2012, CRIMINOLOGY, V50, P851, DOI 10.1111/j.1745-9125.2012.00281.x; Brayne S., PREDICT SURVEIL DATA; Brayne S, 2017, AM SOCIOL REV, V82, P977, DOI 10.1177/0003122417725865; Brayne S, 2014, AM SOCIOL REV, V79, P367, DOI 10.1177/0003122414530398; Chancellor S, 2019, FAT*'19: PROCEEDINGS OF THE 2019 CONFERENCE ON FAIRNESS, ACCOUNTABILITY, AND TRANSPARENCY, P79, DOI 10.1145/3287560.3287587; Chicago Crime Commission, 2018, GANG BOOK DET OV STR; Cohen C, 2018, MILLENNIALS TECHNOLO; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Daipha Phaedra, 2015, MASTERS UNCERTAINTY; De Choudhury M., 2013, P 7 INT AAAI C WEBLO, V2, P128, DOI [DOI 10.1109/IRI.2012.6302998, 10.1109/IRI.2012.6302998]; Decker SH, 2010, HOMICIDE STUD, V14, P359, DOI 10.1177/1088767910385400; Edwards F, 2016, AM SOCIOL REV, V81, P575, DOI 10.1177/0003122416638652; Fine GA, 2006, J CONTEMP ETHNOGR, V35, P3, DOI 10.1177/0891241605282241; Florini S, 2014, TELEV NEW MEDIA, V15, P223, DOI 10.1177/1527476413480247; Glesmann C., 2009, YOUTH GANGS WHO IS R; Goddard K, 2012, J AM MED INFORM ASSN, V19, P121, DOI 10.1136/amiajnl-2011-000089; Gorman-Smith D, 1998, DEV PSYCHOPATHOL, V10, P101, DOI 10.1017/S0954579498001539; Green BL, 2000, J PERS INTERPERS LOS, V5, P1, DOI 10.1080/10811440008407845; Harding DJ, 2009, SOC FORCES, V88, P757, DOI 10.1353/sof.0.0281; Haskinsa AR, 2017, AM SOCIOL REV, V82, P657, DOI 10.1177/0003122417709294; Headworth S, 2019, AM SOCIOL REV, V84, P171, DOI 10.1177/0003122418818198; James J.P., 2019, J CULT MARKET STRAT, V4, P13; Karamshuk Dmytro, 2017, Online Social Networks and Media, V1, P33, DOI 10.1016/j.osnem.2017.01.002; Lane Jeffrey., 2018, THE DIGITAL STREET; Macmillan R, 2001, ANNU REV SOCIOL, V27, P1, DOI 10.1146/annurev.soc.27.1.1; Neria Y, 2004, J LOSS TRAUMA, V9, P73, DOI 10.1080/15325020490255322; Papachristos AV, 2013, AM SOCIOL REV, V78, P417, DOI 10.1177/0003122413486800; Papachristos AV, 2012, J URBAN HEALTH, V89, P992, DOI 10.1007/s11524-012-9703-9; Pattillo M., 2013, BLACK PICKET FENCES; Patton D, 2016, CHICAGO GANG SOCIAL; Patton D. U., 2016, ARXIV160908779; Patton DU, 2017, NEW MEDIA SOC, V19, P1000, DOI 10.1177/1461444815625949; Patton DU, 2017, SOC SCI COMPUT REV, V35, P226, DOI 10.1177/0894439315613319; Patton DU, 2017, SOC MEDIA SOC, V3, DOI 10.1177/2056305117733344; Patton DU, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0020-x; Patton DU, 2018, BIOMED INFORM INSIGH, V10, DOI 10.1177/1178222618763155; Rich J.A., 2009, WRONG PLACE WRONG TI; S?nchez-Jankowski Martin, 1991, ISLANDS STREET GANGS; Sauro MD, 2003, STRESS, V6, P235, DOI 10.1080/10253890310001616482; Sered Danielle., 2019, WE RECKON VIOLENCE M; Sharkey P, 2010, P NATL ACAD SCI USA, V107, P11733, DOI 10.1073/pnas.1000690107; Skogan W, 2012, EVALUATION CEASE FIR; Sloan L, 2013, SOCIOL RES ONLINE, V18, DOI 10.5153/sro.3001; Slutkin G., 2015, ENVISIONING CRIMINOL, P43, DOI DOI 10.1007/978-3-319-15868-6_5; Smith A., 2014, AFRICAN AM TECHNOLOG; Stuart F, 2020, BALLAD OF THE BULLET: GANGS, DRILL MUSIC, AND THE POWER OF ONLINE INFAMY, P1; Stuart Forest., 2016, OUT ARREST; Stuart F, 2020, SOC PROBL, V67, P191, DOI 10.1093/socpro/spz010; Thrasher F. M., 1927, GANG STUDY 1313 GANG; Twitter Inc, 2019, Q4 FISC YEAR 2018 LE; Zinzow HM, 2009, J CHILD PSYCHOL PSYC, V50, P441, DOI 10.1111/j.1469-7610.2008.02004.x	60	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236625	10.1371/journal.pone.0236625	http://dx.doi.org/10.1371/journal.pone.0236625			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MW2PD	32730354	Green Published, gold			2022-12-26	WOS:000556884700017
J	Mohasses, FC; Solouki, M; Ghareyazie, B; Fahmideh, L; Mohsenpour, M				Mohasses, Fatemeh Chamani; Solouki, Mahmood; Ghareyazie, Behzad; Fahmideh, Leila; Mohsenpour, Motahhareh			Correlation between gene expression levels under drought stress and synonymous codon usage in rice plant by in-silico study	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; TRANSFER-RNA MODIFICATION; AMINO-ACID USAGE; CELLULAR STRESS; SALT TOLERANCE; SEQUENCE EVOLUTION; TRANSGENIC RICE; BIASED CODON; PATTERNS; RESISTANCE	We studied the correlation of synonymous codon usage (SCU) on gene expression levels under drought stress in rice. Sixty genes related to drought stress (with high, intermediate and low expression) were selected from rice meta-analysis data and various codon usage indices such as the effective number of codon usage (ENC), codon adaptation index (CAI) and relative synonymous codon usage (RSCU) were calculated. We found that in genes highly expressing under drought 1) GC content was higher, 2) ENC value was lower, 3) the preferred codons of some amino acids changed and 4) the RSCU ratio of GC-end codons relative to AT-end codons for 18 amino acids increased significantly compared with those in other genes. We introduce ARSCU as theAverage ratio ofRSCUs of GC-end codons to AT-end codons in each gene that could significantly separate high-expression genes under drought from low-expression genes. ARSCU is calculated using the program ARSCU-Calculator developed by our group to help predicting expression level of rice genes under drought. An index above ARSCU threshold is expected to indicate that the gene under study may belong to the "high expression group under drought". This information may be applied for codon optimization of genes for rice genetic engineering. To validate these findings, we further used 60 other genes (randomly selected subset of 43233 genes studied for their response to drought stress). ARSCU value was able to predict the level of expression at 88.33% of the cases. Using third set of 60 genes selected amongst high expressing genes not related to drought, only 31.65% of the genes showed ARSCU value of higher than the set threshold. This indicates that the phenomenon we described in this report may be unique for drought related genes. To justify the observed correlation between CUB and high expressing genes under drought, possible role of tRNA post transcriptional modification and tRFs was hypothesized as possible underlying biological mechanism.	[Mohasses, Fatemeh Chamani; Solouki, Mahmood; Fahmideh, Leila] Univ Zabol, Fac Agr, Dept Plant Breeding & Biotechnol PBB, Zabol, Iran; [Ghareyazie, Behzad; Mohsenpour, Motahhareh] Agr Res Educ & Extens Org AREEO, Agr Biotechnol Res Inst Iran ABRII, Karaj, Iran		Ghareyazie, B; Mohsenpour, M (corresponding author), Agr Res Educ & Extens Org AREEO, Agr Biotechnol Res Inst Iran ABRII, Karaj, Iran.	ghareyazie@yahoo.com; mthrhm@yahoo.com	Mohsenpour, Motahhareh/S-3287-2016; Ghareyazie, Behzad/P-3643-2018	Mohsenpour, Motahhareh/0000-0002-6247-8806; Ghareyazie, Behzad/0000-0001-8804-2931				Acquaah G., 2009, PRINCIPLES PLANT GEN; Ahanger MA, 2017, AOB PLANTS, V9, DOI 10.1093/aobpla/plx025; Ahmad P, 2012, BIOTECHNOL ADV, V30, P524, DOI 10.1016/j.biotechadv.2011.09.006; Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Bashir K, 2019, RECENT ADV CHARACTER, V8, DOI [10.12688/f1000research.17047.1, DOI 10.12688/F1000RESEARCH.17047.1]; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Bennett J, 1997, ADV INSECT CONTROL R, P75; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; Bjork GR, 1999, FEBS LETT, V452, P47, DOI 10.1016/S0014-5793(99)00528-1; BJORK GR, 1987, ANNU REV BIOCHEM, V56, P263, DOI 10.1146/annurev.bi.56.070187.001403; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Chiapello H, 1998, GENE, V209, pGC1, DOI 10.1016/S0378-1119(97)00671-9; Chionh YH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13302; Coghlan A, 2000, YEAST, V16, P1131, DOI 10.1002/1097-0061(20000915)16:12<1131::AID-YEA609>3.0.CO;2-F; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; Cutter AD, 2006, MOL BIOL EVOL, V23, P2303, DOI 10.1093/molbev/msl097; De La Torre AR, 2015, GENOME BIOL EVOL, V7, P1002, DOI 10.1093/gbe/evv044; Dedon PC, 2014, CHEM RES TOXICOL, V27, P330, DOI 10.1021/tx400438d; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Duan JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045117; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Eggers B, 2000, J INT ECON LAW, V3, P525, DOI 10.1093/jiel/3.3.525; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Endres L, 2015, RNA BIOL, V12, P603, DOI 10.1080/15476286.2015.1031947; Fartyal D, 2018, SCI REP-UK, V8, P1; Frei M, 2010, FUNCT PLANT BIOL, V37, P74, DOI 10.1071/FP09079; Gao F, 2010, PLANT CELL TISS ORG, V100, P255, DOI 10.1007/s11240-009-9640-9; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghareyazie B, 1997, MOL BREEDING, V3, P401, DOI 10.1023/A:1009695324100; Goodarzi H, 2008, GENE, V407, P30, DOI 10.1016/j.gene.2007.09.020; Goto S, 2015, PLANT BIOTECHNOL J, V13, P753, DOI 10.1111/pbi.12303; Gout JF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000944; Guo XY, 2007, FEBS LETT, V581, P1015, DOI 10.1016/j.febslet.2007.01.088; Gupta N, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay063; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91; HASTINGS KEM, 1983, J MOL EVOL, V19, P214, DOI 10.1007/BF02099968; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Huang J, 2012, PLANT MOL BIOL, V80, P337, DOI 10.1007/s11103-012-9955-5; Huang LY, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00094; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ingvarsson PK, 2007, MOL BIOL EVOL, V24, P836, DOI 10.1093/molbev/msl212; Ingvarsson PK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-307; James C, 2017, 53 ISAAA; Jan A, 2013, PLANT PHYSIOL, V161, P1202, DOI 10.1104/pp.112.205385; Jung KH, 2015, MOL PLANT, V8, P276, DOI 10.1016/j.molp.2014.10.013; Kumar P, 2016, TRENDS BIOCHEM SCI, V41, P679, DOI 10.1016/j.tibs.2016.05.004; Liu QP, 2005, BIOSYSTEMS, V80, P123, DOI 10.1016/j.biosystems.2004.10.008; Mazumdar P, 2017, ANN BOT-LONDON, V120, P893, DOI 10.1093/aob/mcx112; Mollasadeghi V., 2011, World Applied Sciences Journal, V13, P545; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Nachimuthu VV., 2017, ABIOTIC STRESS MANAG, P339; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Neto JB, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01260; Park EJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020518; Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Redillas MCFR, 2012, PLANT BIOTECHNOL J, V10, P792, DOI 10.1111/j.1467-7652.2012.00697.x; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Shaik R, 2014, PLANT PHYSIOL, V164, P481, DOI 10.1104/pp.113.225862; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; Umashankar V, 2007, BIOINFORMATION, V2, P62; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Verulkar SB, 2014, AGR RES, V3, P32, DOI 10.1007/s40003-014-0094-x; Wang HC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S6; Wang YM, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1206-0; Wani SH, 2014, J RICE RES, V2, pe105; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10; Whittle CA, 2016, GENOME BIOL EVOL, V8, P2722, DOI 10.1093/gbe/evw068; Whittle CA, 2015, G3-GENES GENOM GENET, V5, P2307, DOI 10.1534/g3.115.021402; Williford A, 2012, MOL BIOL EVOL, V29, P3755, DOI 10.1093/molbev/mss184; Wu YQ, 2015, GENES-BASEL, V6, P1125, DOI 10.3390/genes6041125; Xiao BZ, 2007, THEOR APPL GENET, V115, P35, DOI 10.1007/s00122-007-0538-9; Xu DQ, 2008, FEBS LETT, V582, P1037, DOI 10.1016/j.febslet.2008.02.052; Xu H, 2012, PLOONE PUBLIC LIB, V7; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Ye RJ, 2009, PEST MANAG SCI, V65, P1015, DOI 10.1002/ps.1788; Yi SK, 2018, GENOMICS, V110, P134, DOI 10.1016/j.ygeno.2017.09.004	83	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237334	10.1371/journal.pone.0237334	http://dx.doi.org/10.1371/journal.pone.0237334			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776991	Green Published, gold			2022-12-26	WOS:000561393800050
J	Simon, M; Lazzouni, L; Campbell, E; Delcenserie, A; Muise-Hennessey, A; Newman, AJ; Champoux, F; Lepore, F				Simon, Marie; Lazzouni, Latifa; Campbell, Emma; Delcenserie, Audrey; Muise-Hennessey, Alexandria; Newman, Aaron J.; Champoux, Francois; Lepore, Franco			Enhancement of visual biological motion recognition in early-deaf adults: Functional and behavioral correlates	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; SIGN-LANGUAGE; AUDITORY DEPRIVATION; HEARING; BRAIN; COMMUNICATION; INDIVIDUALS; PERCEPTION; ACTIVATION; CORTICES	Deafness leads to brain modifications that are generally associated with a cross-modal activity of the auditory cortex, particularly for visual stimulations. In the present study, we explore the cortical processing of biological motion that conveyed either non-communicative (pantomimes) or communicative (emblems) information, in early-deaf and hearing individuals, using fMRI analyses. Behaviorally, deaf individuals showed an advantage in detecting communicative gestures relative to hearing individuals. Deaf individuals also showed significantly greater activation in the superior temporal cortex (including the planum temporale and primary auditory cortex) than hearing individuals. The activation levels in this region were correlated with deaf individuals' response times. This study provides neural and behavioral evidence that cross-modal plasticity leads to functional advantages in the processing of biological motion following lifelong auditory deprivation.	[Simon, Marie; Lazzouni, Latifa; Campbell, Emma; Delcenserie, Audrey; Lepore, Franco] Univ Montreal, Ctr Rech Neuropsychol & Cognit, Dept Psychol, Montreal, PQ, Canada; [Delcenserie, Audrey; Champoux, Francois] Univ Montreal, Ecole Orthophonie & Audiol, Montreal, PQ, Canada; [Muise-Hennessey, Alexandria; Newman, Aaron J.] Dalhousie Univ, Dept Psychol & Neurosci, NeuroCognit Imaging Lab, Halifax, NS, Canada; [Champoux, Francois] Ctr Rech Inst Univ Geriatrie Montreal, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Dalhousie University; Universite de Montreal	Simon, M (corresponding author), Univ Montreal, Ctr Rech Neuropsychol & Cognit, Dept Psychol, Montreal, PQ, Canada.	marie.simon@umontreal.ca			Canada Research Chair Program [RGPIN-8245-2014]; Canadian Institutes of Health Research [166197]; Med-EL Elektromed; Quebec Bio-Imaging Network	Canada Research Chair Program(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Med-EL Elektromed; Quebec Bio-Imaging Network	This research was supported by the Canada Research Chair Program (#RGPIN-8245-2014, F.L.), the Canadian Institutes of Health Research (#166197, F.L.), and a grant from Med-EL Elektromed (A.J.N., F.L., and F.C.) and from Quebec Bio-Imaging Network (M.S)." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar CDC, 2019, J COGNITIVE NEUROSCI, V31, P1091, DOI 10.1162/jocn_a_01425; Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Auer ET, 2007, J SPEECH LANG HEAR R, V50, P1157, DOI 10.1044/1092-4388(2007/080); Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Bavelier D, 2010, NAT NEUROSCI, V13, P1309, DOI 10.1038/nn1110-1309; Bottari D, 2014, NEUROIMAGE, V94, P172, DOI 10.1016/j.neuroimage.2014.02.031; BROTHERS L, 1990, MOTIV EMOTION, V14, P81, DOI 10.1007/BF00991637; Capek CM, 2010, BRAIN LANG, V112, P129, DOI 10.1016/j.bandl.2009.10.004; Cardin V, 2016, J COGNITIVE NEUROSCI, V28, P20, DOI 10.1162/jocn_a_00872; Cardin V, 2016, NEUROIMAGE, V124, P96, DOI 10.1016/j.neuroimage.2015.08.073; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Corina D, 2007, BRAIN RES, V1152, P111, DOI 10.1016/j.brainres.2007.03.054; Dick AS, 2014, NEUROSCIENTIST, V20, P453, DOI 10.1177/1073858413513502; Emmorey K, 2010, NEUROIMAGE, V49, P994, DOI 10.1016/j.neuroimage.2009.08.001; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; Fang YX, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00094; Fine I, 2005, J COGNITIVE NEUROSCI, V17, P1621, DOI 10.1162/089892905774597173; Friederici AD, 2013, CURR OPIN NEUROBIOL, V23, P250, DOI 10.1016/j.conb.2012.10.002; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Gesture Ozyurek A., 2012, SIGN LANGUAGE INT HD, P626; Goldin-Meadow S, 1999, TRENDS COGN SCI, V3, P419, DOI 10.1016/S1364-6613(99)01397-2; Heimler B, 2014, NEUROSCIENCE, V283, P44, DOI 10.1016/j.neuroscience.2014.08.003; Husain FT, 2009, BRAIN RES, V1276, P140, DOI 10.1016/j.brainres.2009.04.034; Husain FT, 2012, BRAIN RES; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Karns CM, 2012, J NEUROSCI, V32, P9626, DOI 10.1523/JNEUROSCI.6488-11.2012; Lambertz N, 2005, COGNITIVE BRAIN RES, V25, P884, DOI 10.1016/j.cogbrainres.2005.09.010; Levanen S, 1998, CURR BIOL, V8, P869, DOI 10.1016/S0960-9822(07)00348-X; Levanen S, 2001, NEUROSCI LETT, V301, P75, DOI 10.1016/S0304-3940(01)01597-X; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; MacSweeney M, 2004, NEUROIMAGE, V22, P1605, DOI 10.1016/j.neuroimage.2004.03.015; MacSweeney M, 2008, TRENDS COGN SCI, V12, P432, DOI 10.1016/j.tics.2008.07.010; Merabet LB, 2009, NAT REV NEUROSCI, V11; Mitchell RE, 2006, SIGN LANG STUD, V6, P306, DOI 10.1353/sls.2006.0019; Molnar-Szakacs I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000626; Newman AJ, 2015, P NATL ACAD SCI USA, V112, P11684, DOI 10.1073/pnas.1510527112; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pavani F., 2012, NEURAL BASES MULTISE, V22, DOI 10.1201/b11092-28; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; Peuskens H, 2005, EUR J NEUROSCI, V21, P2864, DOI 10.1111/j.1460-9568.2005.04106.x; Purves D, 2012, NEUROSCIENCE; Rizzolatti G, 2016, NAT REV NEUROSCI, V17, P757, DOI 10.1038/nrn.2016.135; Sadato N, 2005, CEREB CORTEX, V15, P1113, DOI 10.1093/cercor/bhh210; Sandler W, 1999, SIGN LANGUAGE LINGUI; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Shiell MM, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/7217630; Shiell MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090498; Simon M, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00206; Strauss E, 2006, COMPENDIUM NEUROPSYC; Strelnikov K, 2009, NEUROPSYCHOLOGIA, V47, P972, DOI 10.1016/j.neuropsychologia.2008.10.017; Trettenbrein PC, 2019, FUNCTIONAL NEUROANAT; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Zaini H, 2013, COMMUNICATIVE NONCOM, P319	55	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0236800	10.1371/journal.pone.0236800	http://dx.doi.org/10.1371/journal.pone.0236800			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC7KJ	32776962	gold, Green Published			2022-12-26	WOS:000561393800043
J	Yu, QQ; Yang, X; Zhang, C; Zhang, XT; Wang, CY; Chen, L; Liu, XL; Gu, YF; He, XM; Hu, L; Liu, WT; Li, Y				Yu, Qingqing; Yang, Xing; Zhang, Chen; Zhang, Xiaotao; Wang, Chaoyu; Chen, Lu; Liu, Xiaolin; Gu, Yufeng; He, Xueming; Hu, Liang; Liu, Wen-Tao; Li, Yan			AMPK activation by ozone therapy inhibits tissue factor-triggered intestinal ischemia and ameliorates chemotherapeutic enteritis	FASEB JOURNAL			English	Article						AMPK; chemotherapeutic enteritis; ozone; thrombosis; TF	FACTOR PATHWAY INHIBITOR; PACLITAXEL; COLITIS; CELLS; HIF-1-ALPHA; EXPRESSION; MUCOSITIS; PROMOTE; DISEASE; CPT-11	Chemotherapeutic enteritis is a major dose-limiting adverse reaction to chemotherapy, with few effective drugs in clinic. Intestinal ischemic injury plays prominent role in chemotherapeutic enteritis clinically. However, mechanism is not clear. In this article, irinotecan (CPT-11) was used to establish chemotherapeutic enteritis mice model. Western blotting, gelatin zymography, immunohistochemistry (IHC), Laser Doppler flowmetry (LDF) were used to detect the pathogenesis of ischemia-hypoxia injury. CPT-11 increased levels of tissue factor (TF) both in the blood and in intestines, and decreased the intestinal blood flow in mice. Interestingly, the elevation of TF in the blood displayed "double-peak," which was consistent with the intestinal mucosal "double-strike" injury trend. Intestinal microthrombus and mixed thrombus formation were detectable in chemotherapeutic enteritis. Furthermore, ozone therapy relieved chemotherapeutic enteritis in mice. Ozone inhibited TF expression induced by CPT-11 via activating AMPK/SOCS3, and effectively ameliorated the intestinal mucosal injury in mice. Moreover, ozone autotransfusion therapy effectively attenuated chemotherapeutic enteritis and the blood hypercoagulability in patients. For the first time, we proposed that TF-induced thrombotic intestinal ischemic injury is a core trigger pathological mechanism of chemotherapeutic enteritis, and provided a new treatment strategy, ozone therapy, to suppress TF expression and treat chemotherapeutic enteritis.	[Yu, Qingqing; Zhang, Xiaotao; Li, Yan] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Oncol, Jingshi Rd 16766, Jinan 250014, Shandong, Peoples R China; [Yu, Qingqing] Jining 1 Peoples Hosp, Dept Oncol, Jining, Peoples R China; [Yang, Xing; Zhang, Chen; Wang, Chaoyu; Chen, Lu; Gu, Yufeng; Hu, Liang; Liu, Wen-Tao] Nanjing Med Univ, Dept Pharmacol, Jiangsu Key Lab Neurodegenerat, 101 Longmian Ave, Nanjing 211166, Peoples R China; [Zhang, Xiaotao] Qingdao Cent Hosp, Dept Radiat Oncol, Qingdao, Peoples R China; [Liu, Xiaolin; Li, Yan] Shandong First Med Univ, Shandong Prov Qianfoshan Hosp, Dept Oncol, Hosp 1, Jinan, Peoples R China; [He, Xueming] Nanjing Med Univ, Ctr Clin Res & Translat Med, Affiliated Lianyungang Oriental Hosp, Kangda Coll, Lianyungang, Peoples R China; [Liu, Wen-Tao] Nanjing Med Univ, Inst Translat Med, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Nanjing Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Nanjing Medical University; Nanjing Medical University	Li, Y (corresponding author), Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Oncol, Jingshi Rd 16766, Jinan 250014, Shandong, Peoples R China.; Hu, L (corresponding author), Nanjing Med Univ, Dept Pharmacol, Jiangsu Key Lab Neurodegenerat, 101 Longmian Ave, Nanjing 211166, Peoples R China.; Liu, WT (corresponding author), Nanjing Med Univ, Inst Translat Med, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China.	lianghu@njmu.edu.cn; painresearch@njmu.edu.cn; liyan16766@163.com	Hu, Liang/GLQ-9734-2022; gu, yu/GSD-4507-2022; zhang, xiaotao/AAV-7730-2021; Yu, Qing-Qing/CAG-9050-2022; Liu, Wentao/AAX-7308-2021	zhang, xiaotao/0000-0001-7213-4970; Yu, Qing-Qing/0000-0001-5695-6747; Hu, Liang/0000-0002-0013-7440; Wang, Chaoyu/0000-0001-9224-5061	Major Science and Technology Innovation Project of Shandong Province [2018CXGC1220]; Major Project of "Science and Technology Innovation Fund" of Nanjing Medical University [2017NJMUCX004]; Natural Science Foundation for Young Scientists of Jiangsu province [BK20161033]; Lianyungang 2020 covid-19 emergency science and technology special fund [SF2016]	Major Science and Technology Innovation Project of Shandong Province; Major Project of "Science and Technology Innovation Fund" of Nanjing Medical University; Natural Science Foundation for Young Scientists of Jiangsu province; Lianyungang 2020 covid-19 emergency science and technology special fund	Major Science and Technology Innovation Project of Shandong Province, Grant/Award Number: 2018CXGC1220; Major Project of "Science and Technology Innovation Fund" of Nanjing Medical University, Grant/Award Number: 2017NJMUCX004; Natural Science Foundation for Young Scientists of Jiangsu province, Grant/Award Number: BK20161033; Lianyungang 2020 covid-19 emergency science and technology special fund, Grant/Award Number: SF2016	Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; Belaaouaj AA, 2000, J BIOL CHEM, V275, P27123; Bocci V, 2015, DRUG DES DEV THER, V9, P2677, DOI 10.2147/DDDT.S74518; Chang YC, 2017, CANCER LETT, V403, P28, DOI 10.1016/j.canlet.2017.06.001; Chen L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01757; Cunningham AC, 2002, BIOCHEM J, V367, P451, DOI 10.1042/BJ20020696; Dai Y, 2007, J MOL CELL CARDIOL, V42, P1036, DOI 10.1016/j.yjmcc.2007.04.001; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Egorina EM, 2011, BLOOD COAGUL FIBRIN, V22, P451, DOI 10.1097/MBC.0b013e328346ef3f; Eliakim R, 2001, DIGEST DIS SCI, V46, P2515, DOI 10.1023/A:1012348525208; Elsayed AG, 2017, CASE REP ONCOL, V10, P689, DOI 10.1159/000479226; Goswami SK, 2010, CURR CARDIOL REV, V6, P265, DOI 10.2174/157340310793566136; Haddad TC, 2006, THROMB RES, V118, P555, DOI 10.1016/j.thromres.2005.10.015; Holz O, 2005, J CLIN PHARMACOL, V45, P498, DOI 10.1177/0091270004273527; Hubner J, 2006, ONKOLOGE, V12, P565; Kunimoto T, 1987, CAN RES, V47, P4; Lalla RV, 2014, CANCER-AM CANCER SOC, V120, P1453, DOI 10.1002/cncr.28592; Lechner D, 2010, ONKOLOGISCHE WELT, V01, P129; Li Q, 2015, TOXICOL APPL PHARM, V289, P133, DOI 10.1016/j.taap.2015.09.025; Li Y, 2015, BRAIN BEHAV IMMUN, V49, P255, DOI 10.1016/j.bbi.2015.06.003; de Jesus CCL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179185; Lu LJ, 2017, J MOL CELL BIOL, V9, P132, DOI 10.1093/jmcb/mjw043; Maggo G, 2014, PATHOL RES PRACT, V210, P606, DOI 10.1016/j.prp.2014.05.005; Mahony R, 2016, CELL MOL LIFE SCI, V73, P3323, DOI 10.1007/s00018-016-2234-x; MARMUR JD, 1993, J CLIN INVEST, V91, P2253, DOI 10.1172/JCI116452; Maroun J A, 2007, Curr Oncol, V14, P13, DOI 10.3747/co.2007.96; McKenna DF, 2013, INT J ORAL MAX IMPL, V28, P1483, DOI 10.11607/jomi.3168; Oe Y, 2016, ARTERIOSCL THROM VAS, V36, P1525, DOI 10.1161/ATVBAHA.116.307883; Paolini A, 2011, ANTICANCER RES, V31, P3727; Paran H, 2007, ISR MED ASSOC J, V9, P488; Peterson DE, 2015, ANN ONCOL, V26, pV139, DOI 10.1093/annonc/mdv202; Silosi I, 2014, ROM J MORPHOL EMBRYO, V55, P1317; Smith NL, 2017, MED GAS RES, V7, P212, DOI 10.4103/2045-9912.215752; Song MS, 2018, MOL MED REP, V17, P2449, DOI 10.3892/mmr.2017.8148; Tashiro M, 2003, AM J GASTROENTEROL, V98, P231; Ucar F, 2013, RENAL FAILURE, V35, P640, DOI 10.3109/0886022X.2013.780530; Van Sebille YZA, 2015, CURR ONCOL REP, V17, DOI 10.1007/s11912-015-0474-9; Vempati P, 2014, CYTOKINE GROWTH F R, V25, P1, DOI 10.1016/j.cytogfr.2013.11.002; Wang L, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/8721257; Xiong AJ, 2018, TRANSL MED J, V7, P326; Yang Y, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5347804; Yokoyama T, 1997, JPN J CLIN ONCOL, V27, P111, DOI 10.1093/jjco/27.2.111; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu Z, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/7083528; ZANKER KS, 1990, CHEMOTHERAPY, V36, P147, DOI 10.1159/000238761; Zhang Y, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0983-6; Zhe Y, 2016, TUMOR BIOL, V37, P13951, DOI 10.1007/s13277-016-5189-5	47	9	9	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					13005	13021		10.1096/fj.201902717RR	http://dx.doi.org/10.1096/fj.201902717RR		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32776374	hybrid			2022-12-26	WOS:000558227500001
J	Byeon, HJ; Kim, JY; Ko, J; Lee, EJ; Don, K; Yoon, JS				Byeon, Hyeong Ju; Kim, Ji-Young; Ko, JaeSang; Lee, Eun Jig; Don, Kikkawa; Yoon, Jin Sook			Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in anin vitromodel	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; LIVER-SPECIFIC DELETION; INSULIN SENSITIVITY; ORBITAL FIBROBLASTS; HEART-FAILURE; PTP1B; INFLAMMATION; DEFICIENCY; ADIPOGENESIS; MECHANISMS	Graves' orbitopathy (GO) is characterised in early stages by orbital fibroblast inflammation, which can be aggravated by oxidative stress and often leads to fibrosis. Protein tyrosine protein 1B (PTP1B) is a regulator of inflammation and a therapeutic target in diabetes. We investigated the role of PTP1B in the GO mechanism using orbital fibroblasts from GO and healthy non-GO subjects. After 24 hours of transfection withPTPN1siRNA, the fibroblasts were exposed to interleukin (IL)-1 beta, cigarette smoke extract (CSE), H2O2, and transforming growth factor (TGF)-beta stimulations. Inflammatory cytokines and fibrosis-related proteins were analysed using western blotting and/or enzyme-linked immunosorbent assay (ELISA). Reactive oxygen species (ROS) release was detected using an oxidant-sensitive fluorescent probe. IL-1 beta, tumor necrosis factor (TNF)-alpha, bovine thyroid stimulating hormone (bTSH), high-affinity human stimulatory monoclonal antibody of TSH receptor (M22), and insulin-like growth factor-1 (IGF-1) significantly increased PTP1B protein production in GO and non-GO fibroblasts.PTPN1silencing significantly blocked IL-1 beta-induced inflammatory cytokine production, CSE- and H2O2-induced ROS synthesis, and TGF-beta-induced expression of collagen I alpha, alpha-smooth muscle actin (SMA), and fibronectin in GO fibroblasts. SilencingPTPN1also decreased phosphorylation levels of Akt, p38, and c-Jun N-terminal kinase (JNK) and endoplasmic reticulum (ER)-stress response proteins in GO cells. PTP1B may be a potential therapeutic target of anti-inflammatory, anti-oxidant and anti-fibrotic treatment of GO.	[Byeon, Hyeong Ju; Kim, Ji-Young; Ko, JaeSang; Yoon, Jin Sook] Yonsei Univ, Inst Vis Res, Coll Med, Dept Ophthalmol,Severance Hosp, Seoul, South Korea; [Lee, Eun Jig] Yonsei Univ, Inst Endocrine Res, Coll Med, Dept Internal Med,Severance Hosp, Seoul, South Korea; [Don, Kikkawa] Univ Calif San Diego, Div Oculofacial Plast & Reconstruct Surg, La Jolla, CA 92093 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of California System; University of California San Diego	Yoon, JS (corresponding author), Yonsei Univ, Inst Vis Res, Coll Med, Dept Ophthalmol,Severance Hosp, Seoul, South Korea.	yoonjs@yuhs.ac	Ko, JaeSang/AAS-6259-2021	Lee, Eun Jig/0000-0002-9876-8370; Yoon, Jin Sook/0000-0002-8751-9467; Ko, JaeSang/0000-0002-3011-7213	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science and ICT [NRF2016M3A9E9941746]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science and ICT(Ministry of Science, ICT & Future Planning, Republic of Korea)	Research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) and funded by the Ministry of Science and ICT (NRF2016M3A9E9941746). JSY received the grant (www.nrf.re.kr).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI M, 1992, CANCER RES, V52, P737; Agouni A, 2011, BIOCHEM J, V438, P369, DOI 10.1042/BJ20110373; Aoki N, 2000, J BIOL CHEM, V275, P39718, DOI 10.1074/jbc.M005615200; Arroba AI, 2015, INVEST OPHTH VIS SCI, V56, P8031, DOI 10.1167/iovs.15-17234; Bahn RS, 2010, NEW ENGL J MED, V362, P726, DOI 10.1056/NEJMra0905750; Berdnikovs S, 2012, J IMMUNOL, V188, P874, DOI 10.4049/jimmunol.1004108; Bettaieb A, 2016, AM J PATHOL, V186, P2043, DOI 10.1016/j.ajpath.2016.04.012; Buckley DA, 2002, MOL CELL BIOL, V22, P1998, DOI 10.1128/MCB.22.7.1998-2010.2002; Burch HB, 1997, EXP EYE RES, V65, P311, DOI 10.1006/exer.1997.0353; Chen BL, 2005, J IMMUNOL, V175, P1310, DOI 10.4049/jimmunol.175.2.1310; Chen PJ, 2016, TOXICOL APPL PHARM, V292, P8, DOI 10.1016/j.taap.2015.12.021; Cho H, 2013, VITAM HORM, V91, P405, DOI 10.1016/B978-0-12-407766-9.00017-1; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Drexler SK, 2010, INT J BIOCHEM CELL B, V42, P506, DOI 10.1016/j.biocel.2009.10.009; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Garcia-Ruiz I, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101263; Garrity JA, 2006, AM J OPHTHALMOL, V142, P147, DOI 10.1016/j.ajo.2006.02.047; Gogiraju R, 2016, CARDIOVASC RES, V111, P204, DOI 10.1093/cvr/cvw101; Gomez E, 2012, J MOL CELL CARDIOL, V52, P1257, DOI 10.1016/j.yjmcc.2012.03.003; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Gu F, 2004, J BIOL CHEM, V279, P49689, DOI 10.1074/jbc.C400261200; Hiromatsu Y, 2014, INTERNAL MED, V53, P353, DOI 10.2169/internalmedicine.53.1518; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Ko J, 2018, INVEST OPHTH VIS SCI, V59, P4477, DOI 10.1167/iovs.18-24509; Kumar S, 2004, J CLIN ENDOCR METAB, V89, P930, DOI 10.1210/jc.2003-031427; Kumar S, 2003, J CLIN ENDOCR METAB, V88, P4246, DOI 10.1210/jc.2003-030380; Kumar S, 2011, J MOL ENDOCRINOL, V46, P155, DOI 10.1530/JME-11-0006; Lacheta D, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/7453260; Liu Q, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2019.11.016; Ludgate M, 2002, CLIN EXP IMMUNOL, V127, P193, DOI 10.1046/j.1365-2249.2002.01792.x; Marcocci C, 2012, EUR THYROID J, V1, P80, DOI 10.1159/000337976; Martin-Granados C, 2015, J MOL CELL BIOL, V7, P517, DOI 10.1093/jmcb/mjv032; Mobasher MA, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.150; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Novaes Priscila, 2016, Clin Diabetes Endocrinol, V2, P19, DOI 10.1186/s40842-016-0037-5; Ortiz C, 2012, J BIOL CHEM, V287, P15263, DOI 10.1074/jbc.M111.303958; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Panzhinskiy E, 2013, DIABETOLOGIA, V56, P598, DOI 10.1007/s00125-012-2782-z; Samantha LS, 2015, INFLAM CELL SIGNAL, V2, pe965; Smith TJ, 2004, J ENDOCRINOL INVEST, V27, P246, DOI 10.1007/BF03345273; Song GJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0545-3; Song Y, 2007, J CLIN ENDOCR METAB, V92, P3764, DOI 10.1210/jc.2007-0660; Taheripak G, 2013, FREE RADICAL BIO MED, V65, P1435, DOI 10.1016/j.freeradbiomed.2013.09.019; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Tsunekawa T, 2017, EBIOMEDICINE, V16, P172, DOI 10.1016/j.ebiom.2017.01.007; Venditti P, 2006, CELL MOL LIFE SCI, V63, P414, DOI 10.1007/s00018-005-5457-9; YI TL, 1991, BLOOD, V78, P2222; Yoon JS, 2013, J ENDOCRINOL, V216, P145, DOI 10.1530/JOE-12-0257; Yoon JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026261; Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200; Zhang JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058115, 10.1371/journal.pone.0076378]; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	55	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237015	10.1371/journal.pone.0237015	http://dx.doi.org/10.1371/journal.pone.0237015			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760098	Green Published, gold			2022-12-26	WOS:000561027200075
J	Ali, J; Awan, MOU; Akca, G; Zeb, I; Amin, BAZ; Ahmad, R; Shah, MM; Nazir, R				Ali, Jawad; Awan, Malik Owais Ullah; Akca, Gulcin; Zeb, Iftikhar; Amin, Bilal A. Z.; Ahmad, Rafiq; Shah, Muhammad Maroof; Nazir, Rashid			Prevalence of diversified antibiotic resistant bacteria within sanitation related facilities of human populated workplaces in Abbottabad	PLOS ONE			English	Article							WASTE-WATER; MOLECULAR CHARACTERIZATION; ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; INFECTIONS; GENES; BREVUNDIMONAS; MECHANISMS; PLASMIDS; STRAIN	Antibiotics discovery was a significant breakthrough in the field of therapeutic medicines, but the over (mis)use of such antibiotics (in parallel) caused the increasing number of resistant bacterial species at an ever-higher rate. This study was thus devised to assess the multi-drug resistant bacteria present in sanitation-related facilities in human workplaces. In this regard, samples were collected from different gender, location, and source-based facilities, and subsequent antibiotic sensitivity testing was performed on isolated bacterial strains. Four classes of the most commonly used antibiotics i.e., beta-lactam, Aminoglycosides, Macrolides, and Sulphonamides, were evaluated against the isolated bacteria. The antibiotic resistance profile of different (70) bacterial strains showed that the antibiotic resistance-based clusters also followed the grouping based on their isolation sources, mainly the gender. Twenty-three bacterial strains were further selected for their 16s rRNA gene based molecular identification and for phylogenetic analysis to evaluate the taxonomic evolution of antibiotic resistant bacteria (ARB). Moreover, the bacterial resistance to Sulphonamides and beta lactam was observed to be the most and to Aminoglycosides and macrolides as the least. Plasmid curing was also performed for multidrug resistant (MDR) bacterial strains, which significantly abolished the resistance potential of bacterial strains for different antibiotics. These curing results suggested that the antibiotic resistance determinants in these purified bacterial strains are present on respective plasmids. Altogether, the data suggested that the human workplaces are the hotspot for the prevalence of MDR bacteria and thus may serve as the source of horizontal gene transfer and further transmission to other environments.	[Ali, Jawad; Zeb, Iftikhar; Ahmad, Rafiq; Shah, Muhammad Maroof] COMSATS Univ Islamabad CUI, Dept Biotechnol, Abbottabad Campus, Tobe Camp, Kpk, Pakistan; [Awan, Malik Owais Ullah; Amin, Bilal A. Z.; Nazir, Rashid] COMSATS Univ Islamabad CUI, Dept Environm Sci, Abbottabad Campus, Tobe Camp, Kpk, Pakistan; [Akca, Gulcin] Gazi Univ, Fac Dent, Dept Med Microbiol, Ankara, Turkey	COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI); Gazi University	Nazir, R (corresponding author), COMSATS Univ Islamabad CUI, Dept Environm Sci, Abbottabad Campus, Tobe Camp, Kpk, Pakistan.	rashidnazir@cuiatd.edu.pk	Nazir, Rashid/D-4366-2016; Zeb, Iftikhar/AAX-3338-2020; Akca, Gülçin/CAA-2023-2022	Zeb, Iftikhar/0000-0002-6374-8791; Nazir, Rashid/0000-0002-1948-969X; Ali, Jawad/0000-0001-6546-3311	Higher Education Commission (HEC) of Pakistan [NRPU20-3657/RD/HEC/14/704]; TWAS-COMSTECH [18-363 RG/REN/AS_C-FR3240305796]	Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan); TWAS-COMSTECH	This scientific compilation was financially supported (to Rashid Nazir) by research grants from Higher Education Commission (HEC) of Pakistan (NRPU20-3657/R&D/HEC/14/704) and TWAS-COMSTECH (18-363 RG/REN/AS_C-FR3240305796). The funders, though, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Andersson DI, 2003, CURR OPIN MICROBIOL, V6, P452, DOI 10.1016/j.mib.2003.09.001; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Berdy J, 1974, Adv Appl Microbiol, V18, P309, DOI 10.1016/S0065-2164(08)70573-2; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Bouki C, 2013, ECOTOX ENVIRON SAFE, V91, P1, DOI 10.1016/j.ecoenv.2013.01.016; Brantley SJ, 2014, DRUG METAB DISPOS, V42, P301, DOI 10.1124/dmd.113.055236; Brook I, 2001, INT J ANTIMICROB AG, V18, P559, DOI 10.1016/S0924-8579(01)00464-2; Chang YT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00893; Chon JW, 2012, FOOD MICROBIOL, V32, P217, DOI 10.1016/j.fm.2012.06.003; Cole MJ, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2707-z; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dutkiewicz J, 2011, ANN AGR ENV MED, V18, P286; Escudeiro P, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00135-19; Ghosh S, 2000, FEMS MICROBIOL LETT, V183, P271, DOI 10.1111/j.1574-6968.2000.tb08970.x; Han XY, 2005, J ANTIMICROB CHEMOTH, V55, P853, DOI 10.1093/jac/dki139; Hu RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051053; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Linhares I, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-19; Lopatkin AJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01532-1; Lu XM, 2017, ENVIRON POLLUT, V229, P102, DOI 10.1016/j.envpol.2017.05.080; McGregor JC, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-25; Mellata M, 2013, FOODBORNE PATHOG DIS, V10, P916, DOI 10.1089/fpd.2013.1533; Mora M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01573; Mukherjee A, 2016, AQUAC RES, V47, P2243, DOI 10.1111/are.12676; Nazir R., 2017, SCI REP, V7, P1, DOI DOI 10.1038/S41598-016-0028-X; Nazir R, 2013, MICROB ECOL, V65, P245, DOI 10.1007/s00248-012-0100-4; Omer AE, 2016, UKSIM INT CONF COMP, P305, DOI 10.1109/UKSim.2016.69; Pitout JDD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00009; Prestinaci F, 2015, PATHOG GLOB HEALTH, V109, P309, DOI 10.1179/2047773215Y.0000000030; Price LB, 2007, ENVIRON HEALTH PERSP, V115, P1738, DOI 10.1289/ehp.10191; Rosander A, 2008, APPL ENVIRON MICROB, V74, P6032, DOI 10.1128/AEM.00991-08; ROSS AA, 2015, MICROBIOME, V0003, DOI DOI 10.1186/S40168-014-0066-1; Ryan MP, 2018, VIRULENCE, V9, P480, DOI 10.1080/21505594.2017.1419116; San Milian A, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0010; Sanchez MB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00658; Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x; Seleiman MF, 2020, CHEMOSPHERE, V250, DOI 10.1016/j.chemosphere.2020.126239; Sommer MOA, 2017, NAT REV MICROBIOL, V15, P688, DOI 10.1038/nrmicro.2017.75; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Struelens MJ, 1998, BRIT MED J, V317, P652, DOI 10.1136/bmj.317.7159.652; Su CP, 2019, EMERG INFECT DIS, V25, P397, DOI 10.3201/eid2503.180708; Szczepanowski R, 2009, MICROBIOL-SGM, V155, P2306, DOI 10.1099/mic.0.028233-0; Tennstedt T, 2003, FEMS MICROBIOL ECOL, V45, P239, DOI 10.1016/S0168-6496(03)00164-8; van Hoek AHAM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00203; Versluis D, 2015, SCI REP-UK, V5, DOI 10.1038/srep11981; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Wright GD, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-123; Yang QX, 2017, ENVIRON POLLUT, V229, P188, DOI 10.1016/j.envpol.2017.05.073; Yoshino Y, 2011, J INFECT CHEMOTHER, V17, P278, DOI 10.1007/s10156-010-0114-0	51	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0233325	10.1371/journal.pone.0233325	http://dx.doi.org/10.1371/journal.pone.0233325			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756562	Green Published, gold, Green Submitted			2022-12-26	WOS:000560393300023
J	Bajaj, R; Kundu, ST; Grzeskowiak, CL; Fradette, JJ; Scott, KL; Creighton, CJ; Gibbons, DL				Bajaj, Rakhee; Kundu, Samrat T.; Grzeskowiak, Caitlin L.; Fradette, Jared J.; Scott, Kenneth L.; Creighton, Chad J.; Gibbons, Don L.			IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion	ONCOGENE			English	Article							LIGASE CBL-B; MIR-200 FAMILY; ORGANIZATION; TRAFFICKING; PATHWAY; TARGET; BREAST	Non-small cell lung cancer (NSCLC) is the deadliest form of cancer worldwide, due in part to its proclivity to metastasize. Identifying novel drivers of invasion and metastasis holds therapeutic potential for the disease. We conducted a gain-of-function invasion screen, which identified two separate hits, IMPAD1 and KDELR2, as robust, independent drivers of lung cancer invasion and metastasis. Given that IMPAD1 and KDELR2 are known to be localized to the ER-Golgi pathway, we studied their common mechanism of driving in vitro invasion and in vivo metastasis and demonstrated that they enhance Golgi-mediated function and secretion. Therapeutically inhibiting matrix metalloproteases (MMPs) suppressed both IMPAD1- and KDELR2-mediated invasion. The hits from this unbiased screen and the mechanistic validation highlight Golgi function as one of the key cellular features altered during invasion and metastasis.	[Bajaj, Rakhee; Kundu, Samrat T.; Fradette, Jared J.; Gibbons, Don L.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Grzeskowiak, Caitlin L.] Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; [Grzeskowiak, Caitlin L.; Scott, Kenneth L.; Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Med, Houston, TX 77030 USA; [Gibbons, Don L.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Kundu, ST; Gibbons, DL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.; Gibbons, DL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	skundu@mdanderson.org; dlgibbon@mdanderson.org		Fradette, Jared/0000-0001-6712-2860; Kundu, Samrat/0000-0002-0117-6986; Bajaj, Rakhee/0000-0002-9990-1655	DoD CDMRP Lung cancer [W81XWH-12-16294]; NIH/NCI [K08 CA151651]; NIH [R37CA214609]; MD Anderson Physician-Scientist Program; Rexanna's Foundation for Fighting Lung Cancer; Jeane F. Shelby Scholarship Fund; generous philanthropic contributions to The University of Texas MD Anderson Lung Cancer Moon Shots Program	DoD CDMRP Lung cancer; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Physician-Scientist Program; Rexanna's Foundation for Fighting Lung Cancer; Jeane F. Shelby Scholarship Fund; generous philanthropic contributions to The University of Texas MD Anderson Lung Cancer Moon Shots Program	This work was supported by the DoD CDMRP Lung cancer research award W81XWH-12-16294 (DLG and KLS), NIH/NCI K08 CA151651, NIH R37CA214609, the MD Anderson Physician-Scientist Program and Rexanna's Foundation for Fighting Lung Cancer (DLG). DLG is an R. Lee Clark Fellow of the University of Texas MD Anderson Cancer Center, supported by the Jeane F. Shelby Scholarship Fund. The work was also supported by the generous philanthropic contributions to The University of Texas MD Anderson Lung Cancer Moon Shots Program. We would like to thank the UTMDACC Department of Veterinary Medicine Facility.	Ahn YH, 2012, J CLIN INVEST, V122, P3170, DOI 10.1172/JCI63608; BERSHADSKY AD, 1994, P NATL ACAD SCI USA, V91, P5686, DOI 10.1073/pnas.91.12.5686; Bogdanov Alexey, 2017, F1000Res, V6, P10, DOI 10.12688/f1000research.10481.1; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Cancino J, 2013, HISTOCHEM CELL BIOL, V140, P395, DOI 10.1007/s00418-013-1130-9; Capitani M, 2009, FEBS LETT, V583, P3863, DOI 10.1016/j.febslet.2009.10.053; Feizi A, 2017, NPJ SYST BIOL APPL, V3, DOI 10.1038/s41540-017-0021-4; Frederick JP, 2008, P NATL ACAD SCI USA, V105, P11605, DOI 10.1073/pnas.0801182105; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gibbons DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005401; Grzeskowiak CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04572-3; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Halberg N, 2016, CANCER CELL, V29, P339, DOI 10.1016/j.ccell.2016.02.013; HANDLER JS, 1989, ANNU REV PHYSIOL, V51, P729, DOI 10.1146/annurev.ph.51.030189.003501; Justus CR, 2014, JOVE-J VIS EXP, DOI 10.3791/51046; Khajah MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193779; Kundu ST, 2016, ONCOGENE, V35, P173, DOI 10.1038/onc.2015.71; Kundu ST, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05013-x; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Martinotti S, 2020, METHODS MOL BIOL, V2109, P225, DOI 10.1007/7651_2019_259; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Ochieng JK, 2020, ONCOGENE; Pangon L, 2016, ONCOGENE, V35, P2834, DOI 10.1038/onc.2015.347; Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998; Parris TZ, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.8; Plasterer C, 2019, G3-GENES GENOM GENET, V9, P1739, DOI 10.1534/g3.118.200873; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Ruggiero Carmen, 2018, Oncotarget, V9, P10228, DOI 10.18632/oncotarget.23421; Ruggiero C, 2015, ONCOTARGET, V6, P3375, DOI 10.18632/oncotarget.3270; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Sohaskey ML, 2008, DEVELOPMENT, V135, P2215, DOI 10.1242/dev.019950; Steeg PS, 2008, NAT CLIN PRACT ONCOL, V5, P206, DOI 10.1038/ncponc1066; Tan XC, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax3772; Tan XC, 2017, J CLIN INVEST, V127, P117, DOI 10.1172/JCI88736; Tang CH, 2009, PROSTATE, V69, P1781, DOI 10.1002/pros.21029; Taylor A, 2016, J VIROL, V90, P4150, DOI 10.1128/JVI.03192-15; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Viotti C, 2016, METHODS MOL BIOL, V1459, P3, DOI 10.1007/978-1-4939-3804-9_1; Vissers LELM, 2011, AM J HUM GENET, V88, P608, DOI 10.1016/j.ajhg.2011.04.002; Wiersma VR, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00007; Wu XM, 2012, ONCOL REP, V27, P1488, DOI 10.3892/or.2012.1670; Xu L, 2017, NEOPLASIA, V19, P374, DOI 10.1016/j.neo.2017.01.011	45	13	13	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2020	39	37					5979	5994		10.1038/s41388-020-01410-z	http://dx.doi.org/10.1038/s41388-020-01410-z		AUG 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NM2OY	32753652	Green Accepted			2022-12-26	WOS:000555747100001
J	Rivas-Garcia, L; Carballo-Amador, MA; Flores-Lopez, CA				Rivas-Garcia, Lynneth; Carballo-Amador, Manuel Alejandro; Flores-Lopez, Carlos Alberto			Design of a AFLP-PCR and PCR-RFLP test that identify the majority of discrete typing units of Trypanosoma cruzi	PLOS ONE			English	Article							CLONAL EVOLUTION; DIVERSITY; PARASITE; IMPACT	Background Chagas disease, caused by the intracellular parasiteTrypanosoma cruzi, is one of the most important parasitological infections in the Americas. It is estimated to infect approximately 6 million people from mostly low income countries in Latin America, although recent infections have been reported in southern US states. Several studies have described an extensive genetic diversity amongT.cruziisolates throughout its geographic distribution in the American continent. This diversity has been correlated with the pathology developed during an infection. However, due to a lack of a single reliable test, current diagnosis practices of the disease are not straightforward since several different tests are applied. The use of current genomic sequence data allows for the selection of molecular markers (MM) that have the ability to identify the Discrete Typing Unit (DTU) ofT.cruziin a given infection, without the need of any sequencing reaction. Methodology/principal findings Applying three criteria on the genomic sequencing data of four different phylogenetic lineages ofT.cruzi, we designed several molecular tests that can be used for the molecular typing of the parasite. The criteria used were: (1) single-copy orthologs ofT.cruzi, (2)T.cruziunique loci, and (3)T.cruzipolymorphic loci. All criteria combined allowed for the selection of 15 MM, 12 of which were confirmed to be functional and replicable in the laboratory with sylvatic samples. Furthermore, one MM produced distinct polymerase chain reaction (PCR) amplicon sizes among distinctT.cruziDTUs, allowing the use of a AFLP-PCR test to distinguish DTUs I, II/IV, V and VI. Whereas two MM can differentiate DTUs I, II, IV and V/VI out of the six current DTUs with a PCR-RFLP test. Conclusions/significance The designed molecular tests provide a practical and inexpensive molecular typing test for the majority of DTUs ofT.cruzi, excluding the need to perform any sequencing reaction. This provides the scientific community with an additional specific, quick and inexpensive test that can enhance the understanding of the correlation between the DTU ofT.cruziand the pathology developed during the infection.	[Rivas-Garcia, Lynneth; Carballo-Amador, Manuel Alejandro; Flores-Lopez, Carlos Alberto] Univ Autonoma Baja California, Fac Ciencias, Ensenada, Baja California, Mexico	Universidad Autonoma de Baja California	Flores-Lopez, CA (corresponding author), Univ Autonoma Baja California, Fac Ciencias, Ensenada, Baja California, Mexico.	cflores2@uabc.edu.mx		Flores-Lopez, Carlos/0000-0003-2694-634X	CONACYT, Mexico [2015-01-547]; Consejo Nacional de Ciencia y Tecnologia	CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	CAFL: received a grant of Problemas Nacionales, CONACYT, Mexico. Grant number: 2015-01-547. Funder full name: Consejo Nacional de Ciencia y Tecnologia URL: https://www.conacyt.gob.mx/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrade LO, 2002, EXP PARASITOL, V100, P269, DOI 10.1016/S0014-4894(02)00024-3; ANDRADE S. G., 1974, Revista de Patologia Tropical, V3, P65; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Baptista RP, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000156; CDC, 2019, PAR AM TRYP; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Cosentino RO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001777; Cura CI, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003765; DARIO MA, 2018, PARASITE, V25, DOI DOI 10.1051/PARASITE/2018002; de Freitas JM, 2006, PLOS PATHOG, V2, P226, DOI 10.1371/journal.ppat.0020024; de Lana M, 1998, EXP PARASITOL, V90, P20, DOI 10.1006/expr.1998.4304; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Flores-Lopez CA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001272; Franzen O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000984; Garcia MN, 2015, AM J TROP MED HYG, V92, P325, DOI 10.4269/ajtmh.14-0238; Grisard EC, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01114-13; Kato H, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007403; Laurent JP, 1997, PARASITOLOGY, V114, P213, DOI 10.1017/S0031182096008414; Lewis MD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001363; Lima L, 2015, ACTA TROP, V151, P166, DOI 10.1016/j.actatropica.2015.07.015; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Martin CMS, 2017, INFECT GENET EVOL, V49, P300, DOI 10.1016/j.meegid.2017.02.006; Nolan MS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006899; Pan American Health Organization, GEN INF CHAG DIS; Pereira Gilberto de Araujo, 2012, Rev. Bras. Hematol. Hemoter., V34, P292, DOI 10.5581/1516-8484.20120074; Pinto CM, 2012, INFECT GENET EVOL, V12, P1328, DOI 10.1016/j.meegid.2012.04.013; POSTAN M, 1987, T ROY SOC TROP MED H, V81, P415, DOI 10.1016/0035-9203(87)90155-6; Revollo S, 1998, EXP PARASITOL, V89, P30, DOI 10.1006/expr.1998.4216; Shender LA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004291; Tanowitz HB, 2017, J CLIN MICROBIOL, V55, P690, DOI 10.1128/JCM.02353-16; Telleria J, 2010, P NATL ACAD SCI USA, V107, P20411, DOI 10.1073/pnas.1015496107; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; World Health Organization, 2015, CHAG DIS AM TRYP; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0237180	10.1371/journal.pone.0237180	http://dx.doi.org/10.1371/journal.pone.0237180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750094	Green Published, gold			2022-12-26	WOS:000560009200004
J	Krug, C; Cavallaro, FL; Wong, KLM; Gasparrini, A; Faye, A; Lynch, CA				Krug, Catarina; Cavallaro, Francesca L.; Wong, Kerry L. M.; Gasparrini, Antonio; Faye, Adama; Lynch, Caroline A.			Evaluation of Senegal supply chain intervention on contraceptive stockouts using routine stock data	PLOS ONE			English	Article								Background Until 2011, stockouts of family planning commodities were common in Senegalese public health facilities. Recognizing the importance of addressing this problem, the Government of Senegal implemented the Informed Push Model (IPM) supply system, which involves logisticians to collect facility-level stock turnover data once a month and provide contraceptive supplies accordingly. The aims of this paper were to evaluate the impact of IPM on contraceptive availability and on stockout duration. Methods and findings To estimate the impact of the IPM on contraceptive availability, stock card data were obtained from health facilities selected through multistage sampling. A total number of 103 health facilities pertaining to 27 districts and nine regions across the country participated in this project. We compared the odds of contraceptive stockouts within the health facilities on the 23 months after the intervention with the 18 months before. The analysis was performed with a logistic model of the monthly time-series. The odds of stockout for any of the five contraceptive products decreased during the 23 months post-intervention compared to the 18 months pre-intervention (odds ratio, 95%CI: 0.34, 0.22-0.51). To evaluate the impact of the IPM on duration of stockouts, a mixed negative binomial zero-truncated regression analysis was performed. The IPM was not effective in reducing the duration of contraceptive stockouts (incidence rate ratio, 95%CI: 0.81, 0.24-2.7), except for the two long-acting contraceptives (intrauterine devices and implants). Our model predicted a decrease in stockout median duration from 23 pre- to 4 days post-intervention for intrauterine devices; and from 19 to 14 days for implants. Conclusions We conclude that the IPM has resulted in greater efficiency in contraceptive stock management, increasing the availability of contraceptive methods in health facilities in Senegal. The IPM also resulted in decreased duration of stockouts for intrauterine devices and implants, but not for any of the short-acting contraception (pills and injectables).	[Krug, Catarina; Cavallaro, Francesca L.; Wong, Kerry L. M.; Lynch, Caroline A.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Cavallaro, Francesca L.] UCL, Inst Child Hlth, London, England; [Gasparrini, Antonio] London Sch Hyg & Trop Med, Dept Publ Hlth Environm & Soc, London, England; [Gasparrini, Antonio] London Sch Hyg & Trop Med, Ctr Stat Methodol, London, England; [Gasparrini, Antonio] London Sch Hyg & Trop Med, Ctr Climate Change & Planetary Hlth, London, England; [Faye, Adama] Univ Cheikh Anta Diop, Inst Sante Dev, Dakar, Senegal	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University Cheikh Anta Diop Dakar	Krug, C (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.	Catarina.Krug@lshtm.ac.uk	Gasparrini, Antonio/F-7627-2012	Gasparrini, Antonio/0000-0002-2271-3568; Lynch, Caroline Anita/0000-0003-0072-0473; Krug, Catarina/0000-0001-7629-3389	MSD through its MSD for mothers program, an initiative of Merck & Co., Inc., Kenilworth, New Jersey, USA; Medical Research Council-UK [MR/M022625/1]; Ministry of Health; MRC [MR/R013349/1, MR/M022625/1] Funding Source: UKRI	MSD through its MSD for mothers program, an initiative of Merck & Co., Inc., Kenilworth, New Jersey, USA; Medical Research Council-UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by MSD, through its MSD for mothers program, an initiative of Merck & Co., Inc., Kenilworth, New Jersey, USA. MSD had no role in the design, collection, analysis and interpretation of data; nor in manuscript writing or in the decision to submit it for publication. The content of this article is solely the responsibility of the authors. AG was supported by the Medical Research Council-UK (Grant ID: MR/M022625/1).; We would like to acknowledge the role of IntraHealth in implementing the IPM-3PL model in Senegal and the Ministry of Health for their support, and the support of healthworkers who patiently allowed our study teams to scan data from their facilities. Finally, we would like to acknowledge the data collectors from Institut Sante et Developpement (Universite Cheikh Anta Diop, Dakar, Senegal).	Agence Nationale de la Statistique et de la Demographie (ANSD) [Senegal] ICF International, 2018, ENQ DEM SANT IND MUL; Agence Nationale de la Statistique et de la Demographie (ANSD) [Senegal] ICF International, 2012, ENQ DEM SANT IND MUL; [Anonymous], 2014, PROM PRACT DISTR; Benson A, 2018, CONTRACEPTION, V97, P439, DOI 10.1016/j.contraception.2018.01.003; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Cavallaro FL, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0163-7; Centre for Multilevel Modelling, 2011, WEIGHT MLWIN; Daff BM, 2014, GLOB HEALTH-SCI PRAC, V2, P245, DOI 10.9745/GHSP-D-13-00171; Devlin Kristen, 2019, SENEGALS COMMUNITY B; Dicko M, 2017, VACCINE, V35, P2209, DOI 10.1016/j.vaccine.2016.11.106; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Fowler S, 2007, J ANTIMICROB CHEMOTH, V59, P990, DOI 10.1093/jac/dkm014; Guo B, 2012, IEEE ENER CONV, P26, DOI 10.1109/ECCE.2012.6342416; Hannoun BJ, 2017, PROVIDING RELIABLE L; Hasselback L, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2316-y; London Summit on Family Planning Metrics Group, 2012, SEN FP2020 REV COMM; Lu Y, 2011, WORLD MEDICINES SITU; McAllister DA, 2019, LANCET GLOB HEALTH, V7, pE47, DOI 10.1016/S2214-109X(18)30408-X; Measurement Learning & Evaluation [MLE] Initiative Senegalaise de Sante Urbaine [ISSU], 2012, 2011 BAS SURV SEN UR; Ministere de la Sante et de l'Action Sociale, 2012, PLAN ACT NAT PLAN FA; Ministere de la Sante et de la Prevention, 2009, POP REG SECT LOC SEX, P56; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Rasbash J, 2015, USERS GUIDE MLWIN; Ross J, 2013, GLOB HEALTH-SCI PRAC, V1, P203, DOI 10.9745/GHSP-D-13-00010; Schocken C., 2004, OVERVIEW GLOBAL FUND; UNICEF Supply Division, 2018, MIDDL E RESP SYNDR H; USAID &VERBAR; DELIVER PROJECT, 2014, TASK ORD 4 7; USAID &VERBAR; DELIVER PROJECT, 2008, 1 USAID VERBAR; USAID &VERBAR; DELIVER PROJECT, 2010, ZIMB INN DISTR SYST; Vledder M, 2015, OPTIMAL SUPPLY CHAIN; World Bank IBRD-IDA, 2018, SENEGAL	31	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236659	10.1371/journal.pone.0236659	http://dx.doi.org/10.1371/journal.pone.0236659			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745110	Green Published, Green Accepted, gold			2022-12-26	WOS:000560006800003
J	Palmer, CK; Gooberman-Hill, R; Blom, AW; Whitehouse, MR; Moore, AJ				Palmer, Cecily K.; Gooberman-Hill, Rachael; Blom, Ashley W.; Whitehouse, Michael R.; Moore, Andrew J.			Post-surgery and recovery experiences following one- and two-stage revision for prosthetic joint infection-A qualitative study of patients' experiences	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY	Deep prosthetic hip infection is a devastating complication of hip replacement surgery, and treatment often involves multiple revision surgeries with antibiotic chemotherapy to control the infection. The aim of this study was to explore patients' experiences of early and longer-term recovery after one-stage or two-stage revision with an excised hip, a temporary cement spacer or a custom-made articulating spacer. We interviewed 32 participants taking part in a surgical trial at two time points (2-4 months and 18 months) following one- or two-stage revision surgery. The analytic approach was inductive using the constant comparative method to generate themes from the data. Participants' early recovery after revision was characterised by a long hospital stay with burdensome antibiotics and limited physiotherapy provision. Participants undergoing two-stage revision with an excised hip or a cement spacer described severe mobility restrictions which affected all aspects of their lives, while those undergoing one-stage revision, or two-stage revision with an articulating spacer were more mobile and independent, with some limitations. Participants with a cement spacer also reported more pain than other treatment groups, while those with an articulating spacer appeared to perceive that their recovery was slow. At 18 months, participants in all groups described both improvements and losses in mobility and functional ability. Participants in all treatment groups expressed considerable emotional resilience during recovery from revision, which may be linked to opportunities to talk with the trial personnel. Participants identified the need for better information and psychological and physical support. Experience of recovery differs after one- and two-stage revision, and further in relation to the use of spacers. Mobility, function, independence and pain are important aspects of recovery which affect all aspects of day-to-day life. Increased information and more opportunities to talk and share experiences may provide psychological support during recovery.	[Palmer, Cecily K.] Univ Hosp Bristol NHS Fdn Trust, Natl Inst Hlth Res, Appl Res Collaborat West NIHR ARC West, Bristol, Avon, England; [Palmer, Cecily K.; Gooberman-Hill, Rachael; Blom, Ashley W.; Whitehouse, Michael R.] Univ Bristol, Bristol, Avon, England; [Palmer, Cecily K.] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Gooberman-Hill, Rachael; Blom, Ashley W.; Whitehouse, Michael R.; Moore, Andrew J.] Univ Bristol, Bristol Med Sch, Translat Hlth Sci, Musculoskeletal Res Unit, Bristol, Avon, England; [Gooberman-Hill, Rachael; Blom, Ashley W.; Whitehouse, Michael R.] Univ Hosp Bristol NHS Fdn Trust, Bristol Biomed Res Ctr, Natl Inst Hlth Res, Bristol, Avon, England	University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of Bristol	Moore, AJ (corresponding author), Univ Bristol, Bristol Med Sch, Translat Hlth Sci, Musculoskeletal Res Unit, Bristol, Avon, England.	a.j.moore@bristol.ac.uk	Moore, Andrew/ABA-8956-2021	Moore, Andrew/0000-0003-3185-1599; Palmer, Cecily/0000-0002-2096-008X; Whitehouse, Michael/0000-0003-2436-9024; Gooberman-Hill, Rachael/0000-0003-3353-2882; Blom, Ashley/0000-0002-9940-1095	National Institute for Health Research Programme Grants for Applied Research (NIHR PGfAR) programme [RP-PG-1210-12005]; NIHR Comprehensive Clinical Research Network (CRN); NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol; National Institute for Health Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol NHS Foundation Trust	National Institute for Health Research Programme Grants for Applied Research (NIHR PGfAR) programme(National Institute for Health Research (NIHR)); NIHR Comprehensive Clinical Research Network (CRN); NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol; National Institute for Health Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol NHS Foundation Trust	This paper presents independent research funded by the National Institute for Health Research Programme Grants for Applied Research (NIHR PGfAR) programme (grant number: RP-PG-1210-12005) and supported by the NIHR Comprehensive Clinical Research Network (CRN). This study was supported by the NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care. Cecily K Palmer's time is supported by the National Institute for Health Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol NHS Foundation Trust. The funders provided support in the form of salaries for [CKP, RGH, AWB, & AJM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Andersson AE, 2010, AM J INFECT CONTROL, V38, P711, DOI 10.1016/j.ajic.2010.03.017; [Anonymous], 2019, NJRS 16 ANN REPORT; Chapple A, 2015, J WOUND OSTOMY CONT, V42, P170, DOI 10.1097/WON.0000000000000096; Faschingbauer M, 2015, INT ORTHOP, V39, P989, DOI 10.1007/s00264-014-2636-z; Gooberman-Hill R, 2013, MUSCULOSKELET CARE, V11, P187, DOI 10.1002/msc.1060; Helwig P, 2014, INT ORTHOP, V38, P1077, DOI 10.1007/s00264-013-2265-y; Knebel C, 2020, SURG INFECT, V21, P877, DOI 10.1089/sur.2019.368; Kunutsor SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169068; Kunutsor SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139166; Lenguerrand E, 2017, BONE JOINT RES, V6, P391, DOI 10.1302/2046-3758.66.BJR-2017-0003.R1; Leonard HAC, 2014, CLIN ORTHOP RELAT R, V472, P1036, DOI 10.1007/s11999-013-3294-y; Matthews PC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1773; Moore AJ, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1499-z; Moore AJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009495; Phillips JE, 2006, J BONE JOINT SURG BR, V88B, P943, DOI 10.1302/0301-620X.88B7.17150; Pope C, 2006, QUALITATIVE RES HLTH; Postler AE, 2017, HIP INT, V27, P180, DOI 10.5301/hipint.5000436; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Snell DL, 2018, DISABIL REHABIL, V40, P1718, DOI 10.1080/09638288.2017.1300947; Strange S, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1213-8; Tande AJ, 2014, CLIN MICROBIOL REV, V27, P302, DOI 10.1128/CMR.00111-13; Tsung JD, 2014, J ARTHROPLASTY, V29, P1813, DOI 10.1016/j.arth.2014.04.013	22	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0237047	10.1371/journal.pone.0237047	http://dx.doi.org/10.1371/journal.pone.0237047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745086	gold, Green Published			2022-12-26	WOS:000560006800042
J	Kiseleva, RY; Glassman, PG; LeForte, KM; Walsh, LR; Villa, CH; Shuvaev, VV; Myerson, JW; Aprelev, PA; Marcos-Contreras, OA; Muzykantov, VR; Greineder, CF				Kiseleva, R. Yu.; Glassman, P. G.; LeForte, K. M.; Walsh, L. R.; Villa, C. H.; Shuvaev, V. V.; Myerson, J. W.; Aprelev, P. A.; Marcos-Contreras, O. A.; Muzykantov, V. R.; Greineder, C. F.			Bivalent engagement of endothelial surface antigens is critical to prolonged surface targeting and protein delivery in vivo	FASEB JOURNAL			English	Article						cell surface; endothelium; ICAM-1; PECAM-1; targeted drug delivery; thrombomodulin	CELL-ADHESION MOLECULE-1; MONOCLONAL-ANTIBODY; TISSUE DISPOSITION; THROMBOMODULIN; ICAM-1; PHARMACOKINETICS; THERAPEUTICS; MODEL; PECAM; LUNG	Targeted drug delivery to the endothelium has the potential to generate localized therapeutic effects at the blood-tissue interface. For some therapeutic cargoes, it is essential to maintain contact with the bloodstream to exert protective effects. The pharmacokinetics (PK) of endothelial surface-targeted affinity ligands and biotherapeutic cargo remain a largely unexplored area, despite obvious translational implications for this strategy. To bridge this gap, we site-specifically radiolabeled mono- (scFv) and bivalent (mAb) affinity ligands specific for the endothelial cell adhesion molecules, PECAM-1 (CD31) and ICAM-1 (CD54). Radiotracing revealed similar lung biodistribution at 30 minutes post-injection (79.3% +/- 4.2% vs 80.4% +/- 10.6% ID/g for alpha ICAM and 58.9% +/- 3.6% ID/g vs. 47.7% +/- 5.8% ID/g for alpha PECAM mAb vs. scFv), but marked differences in organ residence time, with antibodies demonstrating an order of magnitude greater area under the lung concentration vs. time curve (AUC(inf)1698 +/- 352 vs. 53.3 +/- 7.9 ID/g*hrs for alpha ICAM and 1023 +/- 507 vs. 114 +/- 37 ID/g*hrs for alpha PECAM mAb vs scFv). A physiologically based pharmacokinetic model, fit to and validated using these data, indicated contributions from both superior binding characteristics and prolonged circulation time supporting multiple binding-detachment cycles. We tested the ability of each affinity ligand to deliver a prototypical surface cargo, thrombomodulin (TM), using one-to-one protein conjugates. Bivalent mAb-TM was superior to monovalent scFv-TM in both pulmonary targeting and lung residence time (AUC(inf)141 +/- 3.2 vs 12.4 +/- 4.2 ID/g*hrs for ICAM and 188 +/- 90 vs 34.7 +/- 19.9 ID/g*hrs for PECAM), despite having similar blood PK, indicating that binding strength is more important parameter than the kinetics of binding. To maximize bivalent target engagement, we synthesized an oriented, end-to-end anti-ICAM mAb-TM conjugate and found that this therapeutic had the best lung residence time (AUC(inf)253 +/- 18 ID/g*hrs) of all TM modalities. These observations have implications not only for the delivery of TM, but also potentially all therapeutics targeted to the endothelial surface.	[Kiseleva, R. Yu.; Glassman, P. G.; LeForte, K. M.; Walsh, L. R.; Villa, C. H.; Shuvaev, V. V.; Myerson, J. W.; Aprelev, P. A.; Marcos-Contreras, O. A.; Muzykantov, V. R.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Greineder, C. F.] Univ Michigan, Dept Emergency Med & Pharmacol, North Campus Res Complex,B10-154A, Ann Arbor, MI 48109 USA	University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan	Greineder, CF (corresponding author), Univ Michigan, Dept Emergency Med & Pharmacol, North Campus Res Complex,B10-154A, Ann Arbor, MI 48109 USA.	coling@med.umich.edu		Kiseleva, Raisa/0000-0001-8065-3551	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [K08-HL130430, RO1 HL125462, RO1 HL128398]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: K08-HL130430, RO1 HL125462 and RO1 HL128398	Agarwal P, 2015, BIOCONJUGATE CHEM, V26, P176, DOI 10.1021/bc5004982; Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Betts A, 2019, AAPS J, V21, DOI 10.1208/s12248-019-0332-z; Brenner JS, 2018, PULM CIRC, V8, DOI 10.1177/2045893217752329; Brenner Jacob S, 2017, Nanomedicine, V13, P1495, DOI 10.1016/j.nano.2016.12.019; Campagne O, 2018, CLIN CANCER RES, V24, P2631, DOI 10.1158/1078-0432.CCR-17-2265; Chittasupho C, 2009, EUR J PHARM SCI, V37, P141, DOI 10.1016/j.ejps.2009.02.008; Christofidou-Solomidou M, 2003, AM J PHYSIOL-LUNG C, V285, pL283, DOI 10.1152/ajplung.00021.2003; Cilliers C, 2016, AAPS J, V18, P1117, DOI 10.1208/s12248-016-9940-z; DANILOV SM, 1991, LAB INVEST, V64, P118; Datta-Mannan A, 2007, J BIOL CHEM, V282, P1709, DOI 10.1074/jbc.M607161200; Ding BS, 2009, AM J RESP CRIT CARE, V180, P247, DOI 10.1164/rccm.200809-1433OC; Ding BS, 2005, BLOOD, V106, P4191, DOI 10.1182/blood-2005-05-2002; Drachman JG, 2013, HEMATOL-AM SOC HEMAT, P306, DOI 10.1182/asheducation-2013.1.306; Ferrer MCC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102329; Fuentes RE, 2016, J CLIN INVEST, V126, P483, DOI 10.1172/JCI81470; Gadkar K, 2016, EUR J PHARM BIOPHARM, V101, P53, DOI 10.1016/j.ejpb.2016.01.009; Ghaffarian R, 2016, J CONTROL RELEASE, V238, P221, DOI 10.1016/j.jconrel.2016.07.042; Ghaffarian R, 2014, MOL PHARMACEUT, V11, P4350, DOI 10.1021/mp500409y; Greineder CF, 2018, BIOCONJUGATE CHEM, V29, P56, DOI 10.1021/acs.bioconjchem.7b00592; Greineder CF, 2017, BLOOD ADV, V1, P1452, DOI 10.1182/bloodadvances.2017007229; Greineder CF, 2015, FASEB J, V29, P3483, DOI 10.1096/fj.15-271213; Greineder CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080110; Greineder CF, 2013, BLOOD, V122, P1565, DOI 10.1182/blood-2013-03-453498; Hayakawa M, 2017, THROMB HAEMOSTASIS, V117, P851, DOI 10.1160/TH16-07-0547; JACOBSON BS, 1992, EUR J CELL BIOL, V58, P296; Khoshnejad M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19784-2; Khot A, 2017, AAPS J, V19, P1715, DOI 10.1208/s12248-017-0131-3; Kiseleva R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169537; Kiseleva R, 2018, DRUG DELIV TRANSL RE, V8, P883, DOI 10.1007/s13346-017-0464-6; Kiseleva RY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20027-7; Lamberti G, 2012, 2012 38 ANN NE BIOEN; Leipold D, 2019, CTS-CLIN TRANSL SCI, V12, P130, DOI 10.1111/cts.12597; Lertkiatmongkol P, 2016, CURR OPIN HEMATOL, V23, P253, DOI 10.1097/MOH.0000000000000239; Marcos-Contreras OA, 2019, J CONTROL RELEASE, V301, P54, DOI 10.1016/j.jconrel.2019.03.008; Murciano JC, 2003, NAT BIOTECHNOL, V21, P891, DOI 10.1038/nbt846; Murciano JC, 2003, BLOOD, V101, P3977, DOI 10.1182/blood-2002-09-2853; Muro S, 2006, MOL THER, V13, P135, DOI 10.1016/j.ymthe.2005.07.687; Muro S, 2005, CURR PHARM DESIGN, V11, P2383, DOI 10.2174/1381612054367274; Muro S, 2005, BLOOD, V105, P650, DOI 10.1182/blood-2004-05-1714; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; Muzykantov VR, 1999, P NATL ACAD SCI USA, V96, P2379, DOI 10.1073/pnas.96.5.2379; Muzykantov VR., 2013, ISRN VASC MED, V2013, P1, DOI [10.1155/2013/916254, DOI 10.1155/2013/916254]; Myerson JW, 2018, ADV MATER, V30, DOI 10.1002/adma.201802373; NEWMAN PJ, 1994, ANN NY ACAD SCI, V714, P165, DOI 10.1111/j.1749-6632.1994.tb12041.x; Parhiz H, 2018, J CONTROL RELEASE, V291, P106, DOI 10.1016/j.jconrel.2018.10.015; Roki N, 2019, J CONTROL RELEASE, V305, P41, DOI 10.1016/j.jconrel.2019.05.021; Scherpereel A, 2002, J PHARMACOL EXP THER, V300, P777, DOI 10.1124/jpet.300.3.777; Schmitt C, 2015, J CARDIOVASC PHARM, V65, P611, DOI 10.1097/FJC.0000000000000233; Schneider D, 1998, EUR NEUROL, V40, P78, DOI 10.1159/000007962; Shah DK, 2014, J PHARMACOKINET PHAR, V41, P55, DOI 10.1007/s10928-013-9346-9; Shah DK, 2012, J PHARMACOKINET PHAR, V39, P67, DOI 10.1007/s10928-011-9232-2; Shuvaev VV, 2007, J CONTROL RELEASE, V118, P235, DOI 10.1016/j.jconrel.2006.12.025; Shuvaev VV, 2018, J CONTROL RELEASE, V272, P1, DOI 10.1016/j.jconrel.2017.12.025; Shuvaev VV, 2016, J CONTROL RELEASE, V234, P115, DOI 10.1016/j.jconrel.2016.05.040; Shuvaev VV, 2015, J CONTROL RELEASE, V219, P576, DOI 10.1016/j.jconrel.2015.09.055; Shuvaev VV, 2011, FASEB J, V25, P348, DOI 10.1096/fj.10-169789; Villa CH, 2016, ADV DRUG DELIVER REV, V106, P88, DOI 10.1016/j.addr.2016.02.007; Wagner NM, 2013, ARTERIOSCL THROM VAS, V33, P1943, DOI 10.1161/ATVBAHA.113.301783; Wang-Lin SX, 2018, MABS-AUSTIN, V10, P1131, DOI 10.1080/19420862.2018.1494478; Zaitsev S, 2012, BLOOD, V119, P4779, DOI 10.1182/blood-2011-12-398149	62	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11577	11593		10.1096/fj.201902515RR	http://dx.doi.org/10.1096/fj.201902515RR		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32738178	Green Accepted, Green Published			2022-12-26	WOS:000558181900001
J	McDonough, W; Aragon, IV; Rich, J; Murphy, JM; Abou Saleh, L; Boyd, A; Koloteva, A; Richter, W				McDonough, Will; Aragon, Ileana V.; Rich, Justin; Murphy, James M.; Abou Saleh, Lina; Boyd, Abigail; Koloteva, Anna; Richter, Wito			PAN-selective inhibition of cAMP-phosphodiesterase 4 (PDE4) induces gastroparesis in mice	FASEB JOURNAL			English	Article						emesis; gastric retention; nausea; PDE4D; xylazine; ketamine anesthesia	CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; AMP-SPECIFIC PHOSPHODIESTERASE; EMETIC ACTION; SPLICE VARIANT; HIGHLY POTENT; MAP KINASE; CROSS-TALK; RAT-BRAIN; ROLIPRAM; IDENTIFICATION	Inhibitors of cAMP-phosphodiesterase 4 (PDE4) exert a number of promising therapeutic benefits, but adverse effects, in particular emesis and nausea, have curbed their clinical utility. Here, we show that PAN-selective inhibition of PDE4, but not inhibition of PDE3, causes a time- and dose-dependent accumulation of chow in the stomachs of mice fed ad libitum without changing the animals' food intake or the weight of their intestines, suggesting that PDE4 inhibition impairs gastric emptying. Indeed, PDE4 inhibition induced gastric retention in an acute model of gastric motility that traces the passage of a food bolus through the stomach over a 30 minutes time period. In humans, abnormal gastric retention of food is known as gastroparesis, a syndrome predominated by nausea (>90% of cases) and vomiting (>80% of cases). We thus explored the abnormal gastric retention induced by PDE4 inhibition in mice under the premise that it may represent a useful correlate of emesis and nausea. Delayed gastric emptying was produced by structurally distinct PAN-PDE4 inhibitors including Rolipram, Piclamilast, Roflumilast, and RS25344, suggesting that it is a class effect. PDE4 inhibitors induced gastric retention at similar or below doses commonly used to induce therapeutic benefits (e.g., 0.04 mg/kg Rolipram), thus mirroring the narrow therapeutic window of PDE4 inhibitors in humans. YM976, a PAN-PDE4 inhibitor that does not efficiently cross the blood-brain barrier, induced gastroparesis only at significantly higher doses (>= 1 mg/kg). This suggests that PDE4 inhibition may act in part through effects on the autonomic nervous system regulation of gastric emptying and that PDE4 inhibitors that are not brain-penetrant may have an improved safety profile. The PDE4 family comprises four subtypes, PDE4A, B, C, and D. Selective ablation of any of these subtypes in mice did not induce gastroparesisper se, nor did it protect from PAN-PDE4 inhibitor-induced gastroparesis, indicating that gastric retention may result from the concurrent inhibition of multiple PDE4s. Thus, potentially, any of the four PDE4 subtypes may be targeted individually for therapeutic benefits without inducing nausea or emesis. Acute gastric retention induced by PDE4 inhibition is alleviated by treatment with the widely used prokinetic Metoclopramide, suggesting a potential of this drug to alleviate the side effects of PDE4 inhibitors. Finally, given that the cause of gastroparesis remains largely idiopathic, our findings open the possibility that a physiologic or pathophysiologic downregulation of PDE4 activity/expression may be causative in a subset of patients.	[McDonough, Will; Aragon, Ileana V.; Rich, Justin; Murphy, James M.; Abou Saleh, Lina; Boyd, Abigail; Koloteva, Anna; Richter, Wito] Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Biochem & Mol Biol, 5851 USA Dr North,MSB2310, Mobile, AL 36688 USA	University of South Alabama	Richter, W (corresponding author), Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Biochem & Mol Biol, 5851 USA Dr North,MSB2310, Mobile, AL 36688 USA.	richter@southalabama.edu		Richter, Wito/0000-0001-5588-9060	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HL141473, HL076125, HL066299]; Cystic Fibrosis Foundation (CF Foundation) [RICHTE16GO]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); Cystic Fibrosis Foundation (CF Foundation)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL141473, HL076125 and HL066299; Cystic Fibrosis Foundation (CF Foundation), Grant/Award Number: RICHTE16GO	Abi-Gerges A, 2009, CIRC RES, V105, P784, DOI 10.1161/CIRCRESAHA.109.197947; Aoki M, 2001, J PHARMACOL EXP THER, V298, P1142; Ariga M, 2004, J IMMUNOL, V173, P7531, DOI 10.4049/jimmunol.173.12.7531; Aspiotis R, 2010, BIOORG MED CHEM LETT, V20, P5502, DOI 10.1016/j.bmcl.2010.07.076; Azam Mohammed Afzal, 2014, Sci Pharm, V82, P453, DOI 10.3797/scipharm.1404-08; Baillie GS, 2019, NAT REV DRUG DISCOV, V18, P770, DOI 10.1038/s41573-019-0033-4; Baillie GS, 2000, BRIT J PHARMACOL, V131, P811, DOI 10.1038/sj.bjp.0703636; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Blanchard E, 2014, FASEB J, V28, P791, DOI 10.1096/fj.13-240861; Blokland A, 2006, CURR PHARM DESIGN, V12, P2511, DOI 10.2174/138161206777698855; Bolger G.B., 2007, CYCLIC NUCLEOTIDE PH, P99; Bolger GB, 1996, J BIOL CHEM, V271, P1065, DOI 10.1074/jbc.271.2.1065; Bruno O, 2011, BRIT J PHARMACOL, V164, P2054, DOI 10.1111/j.1476-5381.2011.01524.x; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Conti M, 2014, J GEN PHYSIOL, V143, P29, DOI 10.1085/jgp.201311083; Cooney JD, 2016, BLOOD, V128, P2886, DOI 10.1182/blood-2016-09-737676; Donnell AF, 2010, BIOORG MED CHEM LETT, V20, P2163, DOI 10.1016/j.bmcl.2010.02.044; Fujita M, 2012, BIOL PSYCHIAT, V72, P548, DOI 10.1016/j.biopsych.2012.04.030; Ghavami Afshin, 2006, Drugs R D, V7, P63, DOI 10.2165/00126839-200607020-00001; Giembycz MA, 2010, DRUG DES DEV THER, V4, P147; Goto T, 2014, BIOORG MED CHEM LETT, V24, P893, DOI 10.1016/j.bmcl.2013.12.076; Grover M, 2019, GUT, V68, P2238, DOI 10.1136/gutjnl-2019-318712; Hagen TJ, 2014, BIOORG MED CHEM LETT, V24, P4031, DOI 10.1016/j.bmcl.2014.06.002; Hansen RT, 2014, PSYCHOPHARMACOLOGY, V231, P2941, DOI 10.1007/s00213-014-3480-y; Hasler WL, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12091; Hasler WL, 2019, CLIN GASTROENTEROL H, V17, P1285, DOI 10.1016/j.cgh.2018.10.013; Hatzelmann A, 2010, PULM PHARMACOL THER, V23, P235, DOI 10.1016/j.pupt.2010.03.011; HEASLIP RJ, 1995, EUR J PHARMACOL, V286, P281, DOI 10.1016/0014-2999(95)00457-2; Henderson DJP, 2014, BRIT J CANCER, V110, P1278, DOI 10.1038/bjc.2014.22; HIKASA Y, 1986, EUR J PHARMACOL, V130, P229, DOI 10.1016/0014-2999(86)90272-4; HIKASA Y, 1992, EUR J PHARMACOL, V229, P241; HIKASA Y, 1989, AM J VET RES, V50, P1348; HIKASA Y, 1992, J PHARMACOL EXP THER, V261, P746; Hirose R, 2007, EUR J PHARMACOL, V573, P93, DOI 10.1016/j.ejphar.2007.06.045; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Houslay MD, 2003, BIOCHEM SOC T, V31, P1186; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Huang Z, 2001, CURR OPIN CHEM BIOL, V5, P432, DOI 10.1016/S1367-5931(00)00224-6; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; Iona S, 1998, MOL PHARMACOL, V53, P23, DOI 10.1124/mol.53.1.23; JapundzicZigon N, 1997, PHARMACOL RES, V35, P287, DOI 10.1006/phrs.1997.0133; Jin S.L.C., 2006, CYCLIC NUCLEOTIDE PH, P323; Jin S-L Catherine, 2012, Chang Gung Med J, V35, P197; Jin SLC, 1999, P NATL ACAD SCI USA, V96, P11998, DOI 10.1073/pnas.96.21.11998; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Kato A, 2009, CELL MOL LIFE SCI, V66, P3743, DOI 10.1007/s00018-009-0111-6; Kranz M, 2009, BIOORGAN MED CHEM, V17, P5336, DOI 10.1016/j.bmc.2009.03.061; Krishnasamy S, 2018, DIABETES THER, V9, pS1, DOI 10.1007/s13300-018-0454-9; Lamontagne S, 2001, BRAIN RES, V920, P84, DOI 10.1016/S0006-8993(01)03023-2; Lefebvre RA, 2016, EUR J PHARMACOL, V781, P76, DOI 10.1016/j.ejphar.2016.04.003; Lehnart SE, 2005, CELL, V123, P25, DOI 10.1016/j.cell.2005.07.030; Li H, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01048; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Maurice DH, 2011, CURR OPIN PHARMACOL, V11, P656, DOI 10.1016/j.coph.2011.10.009; MCPHEE I, 1995, BIOCHEM J, V310, P965, DOI 10.1042/bj3100965; Mehats C, 2003, FASEB J, V17, P1831, DOI 10.1096/fj.03-0274com; Miro X, 2002, SYNAPSE, V45, P259, DOI 10.1002/syn.10100; Molina CE, 2012, J AM COLL CARDIOL, V59, P2182, DOI 10.1016/j.jacc.2012.01.060; Moretto N, 2015, J PHARMACOL EXP THER, V352, P559, DOI 10.1124/jpet.114.220541; Mori F, 2010, J CHEM NEUROANAT, V40, P36, DOI 10.1016/j.jchemneu.2010.03.004; Naganuma K, 2009, BIOORG MED CHEM LETT, V19, P3174, DOI 10.1016/j.bmcl.2009.04.121; Nelissen E, 2019, NEUROSCI LETT, V699, P41, DOI 10.1016/j.neulet.2019.01.026; Nio Y, 2017, FASEB J, V31, P5307, DOI 10.1096/fj.201700249R; Omar F, 2019, P NATL ACAD SCI USA, V116, P13320, DOI 10.1073/pnas.1822113116; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Page CP, 2011, HANDB EXP PHARMACOL, V204, P391, DOI 10.1007/978-3-642-17969-3_17; Parkman HP, 2016, NEUROGASTROENT MOTIL, V28, P1902, DOI 10.1111/nmo.12893; Parkman HP, 2015, GASTROENTEROL CLIN N, V44, P59, DOI 10.1016/j.gtc.2014.11.015; Pasricha PJ, 2015, GASTROENTEROL CLIN N, V44, P1, DOI 10.1016/j.gtc.2014.11.001; Peng T, 2018, EUR J MED CHEM, V150, P742, DOI 10.1016/j.ejmech.2018.03.046; Polesskaya OO, 2007, BIOL PSYCHIAT, V61, P56, DOI 10.1016/j.biopsych.2006.03.038; Priem E, 2012, NEUROPHARMACOLOGY, V62, P2126, DOI 10.1016/j.neuropharm.2011.12.020; RAEBURN D, 1994, BRIT J PHARMACOL, V113, P1423, DOI 10.1111/j.1476-5381.1994.tb17156.x; Reneerkens OAH, 2009, PSYCHOPHARMACOLOGY, V202, P419, DOI 10.1007/s00213-008-1273-x; Richter W, 2013, EXPERT OPIN THER TAR, V17, P1011, DOI 10.1517/14728222.2013.818656; Richter W, 2011, BASIC RES CARDIOL, V106, P249, DOI 10.1007/s00395-010-0138-8; Robichaud A, 2002, J CLIN INVEST, V110, P1045, DOI 10.1172/JCI200215506; Robichaud A, 2002, BRIT J PHARMACOL, V135, P113, DOI 10.1038/sj.bjp.0704457; Robichaud A, 1999, NEUROPHARMACOLOGY, V38, P289, DOI 10.1016/S0028-3908(98)00190-7; Robichaud A, 2001, NEUROPHARMACOLOGY, V40, P262, DOI 10.1016/S0028-3908(00)00142-8; Ryan S, 2018, BRAIN STRUCT FUNCT, V223, P1731, DOI 10.1007/s00429-017-1575-z; Saldou N, 1998, CELL SIGNAL, V10, P427, DOI 10.1016/S0898-6568(97)00169-1; Sassone-Corsi P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011148; Schaefer TL, 2012, GENES BRAIN BEHAV, V11, P614, DOI 10.1111/j.1601-183X.2012.00796.x; Schmitz T, 2007, J IMMUNOL, V178, P1115, DOI 10.4049/jimmunol.178.2.1115; Seimetz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129327; Seuwen K, 2006, J RECEPT SIG TRANSD, V26, P599, DOI 10.1080/10799890600932220; Sisson TH, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13753; Souness JE, 1997, CELL SIGNAL, V9, P227, DOI 10.1016/S0898-6568(96)00173-8; SOUNESS JE, 1995, BRIT J PHARMACOL, V115, P39; Soykan I, 1998, DIGEST DIS SCI, V43, P2398, DOI 10.1023/A:1026665728213; Srivani P, 2008, CURR PHARM DESIGN, V14, P3854, DOI 10.2174/138161208786898653; Sun JG, 2006, LIFE SCI, V79, P2077, DOI 10.1016/j.lfs.2006.07.001; Suzuki O, 2013, J PHARMACOL SCI, V123, P219, DOI 10.1254/jphs.13103FP; THOMPSON WJ, 1991, PHARMACOL THERAPEUT, V51, P13, DOI 10.1016/0163-7258(91)90039-O; Tiwari S, 2005, BIOCHEM PHARMACOL, V69, P473, DOI 10.1016/j.bcp.2004.10.009; Ukita T, 1999, J MED CHEM, V42, P1088, DOI 10.1021/jm980314l; Wu C, 2016, OBES REV, V17, P429, DOI 10.1111/obr.12385; Yasmeen S, 2019, CELL SIGNAL, V61, P108, DOI 10.1016/j.cellsig.2019.05.011; Zhang HT, 2006, PSYCHOPHARMACOLOGY, V186, P209, DOI 10.1007/s00213-006-0369-4; Zhang KYJ, 2005, EXPERT OPIN THER TAR, V9, P1283, DOI 10.1517/14728222.9.6.1283; Zhao Y, 2003, J PHARMACOL EXP THER, V307, P246, DOI 10.1124/jpet.103.053215; Zhao Y, 2003, J PHARMACOL EXP THER, V305, P565, DOI 10.1124/jpet.102.47407	110	11	11	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12533	12548		10.1096/fj.202001016RR	http://dx.doi.org/10.1096/fj.202001016RR		AUG 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32738081	Green Accepted			2022-12-26	WOS:000558166500001
J	Ameh, S; D'Ambruoso, L; Gomez-Olive, FX; Kahn, K; Tollman, SM; Klipstein-Grobusch, K				Ameh, Soter; D'Ambruoso, Lucia; Gomez-Olive, Francesc Xavier; Kahn, Kathleen; Tollman, Stephen M.; Klipstein-Grobusch, Kerstin			Paradox of HIV stigma in an integrated chronic disease care in rural South Africa: Viewpoints of service users and providers	PLOS ONE			English	Article							HEALTH-CARE; PEOPLE; SYMPTOMS; INSIGHTS	Background An integrated chronic disease management (ICDM) model was introduced by the National Department of Health in South Africa to tackle the dual burden of HIV/AIDS and non-communicable diseases. One of the aims of the ICDM model is to reduce HIV-related stigma. This paper describes the viewpoints of service users and providers on HIV stigma in an ICDM model in rural South Africa. Materials and methods A content analysis of HIV stigmatisation in seven primary health care (PHC) facilities and their catchment communities was conducted in 2013 in the rural Agincourt sub-district, South Africa. Eight Focus Group Discussions were used to obtain data from 61 purposively selected participants who were 18 years and above. Seven In-Depth Interviews were conducted with the nurses-in-charge of the facilities. The transcripts were inductively analysed using MAXQDA 2018 qualitative software. Results The emerging themes were HIV stigma, HIV testing and reproductive health-related concerns. Both service providers and users perceived implementation of the ICDM model may have led to reduced HIV stigma in the facilities. On the other hand, service users and providers thought HIV stigma increased in the communities because community members thought that home-based carers visited the homes of People living with HIV. Service users thought that routine HIV testing, intended for pregnant women, was linked with unwanted pregnancies among adolescents who wanted to use contraceptives but refused to take an HIV test as a precondition for receiving contraceptives. Conclusions Although the ICDM model was perceived to have contributed to reducing HIV stigma in the health facilities, it was linked with stigma in the communities. This has implications for practice in the community component of the ICDM model in the study setting and elsewhere in South Africa.	[Ameh, Soter] Univ Calabar, Fac Med, Dept Community Med, Calabar, Cross River Sta, Nigeria; [Ameh, Soter; Gomez-Olive, Francesc Xavier; Kahn, Kathleen; Tollman, Stephen M.] Univ Witwatersrand, Med Res Council Wits Univ Rural Publ Hlth & Hlth, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Ameh, Soter] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [D'Ambruoso, Lucia] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [D'Ambruoso, Lucia] Univ Aberdeen, Ctr Sustainable Int Dev, Aberdeen, Scotland; [Gomez-Olive, Francesc Xavier; Kahn, Kathleen; Tollman, Stephen M.] Int Network Demog Evaluat Populat & Their Hlth De, Accra, Ghana; [Kahn, Kathleen; Tollman, Stephen M.] Umea Univ, Umea Ctr Global Hlth Res Epidemiol & Global Hlth, Umea, Sweden; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa; [Klipstein-Grobusch, Kerstin] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands	University of Calabar; University of Witwatersrand; Harvard University; Harvard T.H. Chan School of Public Health; University of Aberdeen; University of Aberdeen; Umea University; University of Witwatersrand; Utrecht University; Utrecht University Medical Center	Ameh, S (corresponding author), Univ Calabar, Fac Med, Dept Community Med, Calabar, Cross River Sta, Nigeria.; Ameh, S (corresponding author), Univ Witwatersrand, Med Res Council Wits Univ Rural Publ Hlth & Hlth, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.; Ameh, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	sote_ameh@yahoo.com	Klipstein-Grobusch, Kerstin/F-5555-2016; Gómez-Olivé, Francesc Xavier/AAP-7673-2021; D'Ambruoso, Lucia/X-6795-2019	Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Gómez-Olivé, Francesc Xavier/0000-0002-4876-0848; D'Ambruoso, Lucia/0000-0002-8505-3368; Ameh, Soter/0000-0002-8449-6423; Kahn, Kathleen/0000-0003-3339-3931; Tollman, Stephen/0000-0003-0744-7588	Agincourt Health and Socio-Demographic Surveillance System, a node of the South African Population Research Infrastructure Network (SAPRIN); Medical Research Council; University of the Witwatersrand, South Africa; Wellcome Trust, UK [058893/Z/99/A, 069683/Z/02/Z, 085477/Z/08/Z, 085477/B/08/Z]; Fogarty International Centre of the National Institutes of Health [D43 TW008330]; African Doctoral Dissertation Research Fellowship Programme; Lown Scholars Program, Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; National Department of Science and Innovation	Agincourt Health and Socio-Demographic Surveillance System, a node of the South African Population Research Infrastructure Network (SAPRIN); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of the Witwatersrand, South Africa; Wellcome Trust, UK(Wellcome Trust); Fogarty International Centre of the National Institutes of Health; African Doctoral Dissertation Research Fellowship Programme; Lown Scholars Program, Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; National Department of Science and Innovation	This research conducted by SA was funded by the following: 1) The Agincourt Health and Socio-Demographic Surveillance System, a node of the South African Population Research Infrastructure Network (SAPRIN) and is supported by the National Department of Science and Innovation, the Medical Research Council and the University of the Witwatersrand, South Africa, and the Wellcome Trust, UK (grants 058893/Z/99/A; 069683/Z/02/Z; 085477/Z/08/Z; 085477/B/08/Z); 2) Fogarty International Centre of the National Institutes of Health under the award number D43 TW008330; and 3) an African Doctoral Dissertation Research Fellowship Programme award to the corresponding author. The funding for the publication of this article was provided by the Lown Scholars Program, Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh S, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24771; Ameh S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2177-4; Ameh S, 2017, HEALTH POLICY PLANN, V32, P257, DOI 10.1093/heapol/czw118; Bogart LM, 2013, AIDS CARE, V25, P843, DOI 10.1080/09540121.2012.729808; Breet E, 2014, AIDS CARE, V26, P947, DOI 10.1080/09540121.2014.901486; Clark SJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1467-1; Cluver Lucie D, 2015, AIDS, V29 Suppl 1, pS57, DOI 10.1097/QAD.0000000000000695; Department of Health Republic of South Africa, 2012, NAT CONTR FERT PLANN; Deribew A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-201; Dow DE, 2016, AIDS CARE, V28, P825, DOI 10.1080/09540121.2016.1139043; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Ehiri JE, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026322; Endeshaw M, 2014, AIDS CARE, V26, P935, DOI 10.1080/09540121.2013.869537; Hall KS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195163; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Joint United Nations Programme on HIV and AIDS (New York), CHRON CAR HIV NONC D; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Kalomo EN, 2018, AGING MENT HEALTH, V22, P1570, DOI 10.1080/13607863.2017.1387763; Kingori C, 2013, AIDS PATIENT CARE ST, V27, P481, DOI 10.1089/apc.2012.0403; Kwarisiima D, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6838-6; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu Yan, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P658, DOI 10.11817/j.issn.1672-7347.2014.07.002; Mahomed O. H., 2016, African Journal of Primary Health Care and Family Medicine, V8, P1248; Mahomed OH, 2015, INT J INTEGR CARE, V15; Mahomed OH, 2014, J HEALTH CARE POOR U, V25, P1723, DOI 10.1353/hpu.2014.0176; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; McHenry Megan Song, 2017, J Int Assoc Provid AIDS Care, V16, P215, DOI 10.1177/2325957416668995; Moser A, 2017, EUR J GEN PRACT, V24, DOI [10.1080/13814788.2017.1375091, 10.1080/13814788.2017.1375092]; Mumah JN, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25579; Patel P, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002523; Prinsloo CD, 2017, AJAR-AFR J AIDS RES, V16, P203, DOI 10.2989/16085906.2017.1349683; Rintamaki L, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16245003; Sekoni O O, 2013, Afr J Med Med Sci, V42, P47; Smart T., 2011, HIV NONC DIS NCDS; Sorsdahl KR, 2011, AIDS CARE, V23, P680, DOI 10.1080/09540121.2010.525621; Statistics South Africa, 2018, MID POP EST; Tesfaw G, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1037-9; The Joint United Nations Programme on HIV/AIDS /World Health Organization, 2004, UNAIDS WHO POL STAT; Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9; Treves-Kagan S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2753-2; Turan JM, 2018, AIDS PATIENT CARE ST, V32, P92, DOI 10.1089/apc.2017.0285; United Nations (New York), SUST DEV GOALS; Valenzuela C, 2015, AIDS BEHAV, V19, P235, DOI 10.1007/s10461-014-0908-7; Venables E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164634; Ware JE, 1976, DEV VALIDATION SCALE; Ware LJ, 2019, J HUM HYPERTENS, V33, P157, DOI 10.1038/s41371-018-0125-3; WHO, 2013, HIV AD GUID HIV TEST; World Health Organization, 2014, NONC DIS COUNTR PROF; Yi SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121461; Zuma K, 2016, AJAR-AFR J AIDS RES, V15, P67, DOI 10.2989/16085906.2016.1153491	51	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236270	10.1371/journal.pone.0236270	http://dx.doi.org/10.1371/journal.pone.0236270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NO3EK	32735616	Green Published, Green Submitted, gold			2022-12-26	WOS:000569367100014
J	Lee, SY; Han, JH; Lee, EK; Kim, YK; Hwang, SA; Lee, SH; Kim, M; Cho, GY; Hwang, JH; Kim, SJ; Yoo, JG; Cho, SK; Lee, KJ; Cho, WK				Lee, So-Young; Han, Joo-Hee; Lee, Eun-Kyeong; Kim, Young Kyu; Hwang, Seo-Ah; Lee, Sung-Hyun; Kim, Maria; Cho, Gye Yoon; Hwang, Jae-Ha; Kim, Su-Jin; Yoo, Jae-Gyu; Cho, Seong-Keun; Lee, Kyung-Ju; Cho, Weon-Ki			Structural and functional characterization of recombinant human growth hormone isolated from transgenic pig milk	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; PORCINE OOCYTES; IN-VITRO; PROTEIN; PURIFICATION; DIMERIZATION; SECRETION; COLOSTRUM; CASEINS	This study aimed to establish and reproduce transgenic pigs expressing human growth hormone (hGH) in their milk. We also aimed to purify hGH from the milk, to characterize the purified protein, and to assess the potential of our model for mass production of therapeutic proteins using transgenic techniques. Using similar to 15.5 L transgenic pig milk, we obtained proteins with >= 99% purity after three pre-treatments and five column chromatography steps. To confirm the biosimilarity of our milk-derived purified recombinant hGH (CGH942) with commercially available somatropin (Genotropin), we performed spectroscopy, structural, and biological analyses. We observed no difference between the purified protein and Genotropin samples. Furthermore, rat models were used to assess growth promotion potential. Our results indicate that CGH942 promotes growth, by increasing bone development and body weight. Toxicity assessments revealed no abnormal findings after 4 weeks of continuous administration and 2 weeks of recovery. The no-observed-adverse-effect level for both males and females was determined to be 0.6 mg/kg/day. Thus, no toxicological differences were observed between commercially available somatropin and CGH942 obtained from transgenic pig milk. In conclusion, we describe a transgenic technique using pigs, providing a new platform to produce human therapeutic proteins.	[Lee, So-Young; Han, Joo-Hee; Lee, Eun-Kyeong; Kim, Young Kyu; Hwang, Seo-Ah; Lee, Sung-Hyun; Kim, Maria; Cho, Gye Yoon; Hwang, Jae-Ha; Kim, Su-Jin; Lee, Kyung-Ju; Cho, Weon-Ki] CHO A Pharmaceut Co, CHO A Biotechnol Res Inst, Yeoju Si, Gyeonggi Do, South Korea; [Han, Joo-Hee; Cho, Seong-Keun] Pusan Natl Univ, Coll Nat Resources & Life Sci, Miryang Si, Gyeongsangnam D, South Korea; [Yoo, Jae-Gyu] Rural Dev Adm, Natl Inst Anim Sci, Anim Dis & Biosecur Team, Wanju Gun, Jeollabuk Do, South Korea	Pusan National University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Lee, SY (corresponding author), CHO A Pharmaceut Co, CHO A Biotechnol Res Inst, Yeoju Si, Gyeonggi Do, South Korea.	isso97@choa.co.kr	Yoo, Jae Gyu/AAN-7908-2021; Yoo, Jae Gyu/N-5129-2018	Lee, So-Young/0000-0003-4210-5938; Yoo, Jae Gyu/0000-0002-8542-9193				Ascacio-Martinez JA, 2004, GENE, V340, P261, DOI 10.1016/j.gene.2004.06.058; Bosze Z, 2008, ADV EXP MED BIOL, V606, P357; Catzel D, 2003, PROTEIN EXPRES PURIF, V32, P126, DOI 10.1016/j.pep.2003.07.002; CHANG CN, 1987, GENE, V55, P189, DOI 10.1016/0378-1119(87)90279-4; CUNNINGHAM BC, 1991, SCIENCE, V253, P545, DOI 10.1126/science.1907025; Dalal, 2016, SCI REP-UK, V6, P1, DOI DOI 10.1038/S41598-016-0001-8; Dienys G, 2000, BIOCONJUGATE CHEM, V11, P646, DOI 10.1021/bc990112j; Echelard Y, 2009, TRANSGENIC RES, V18, P361, DOI 10.1007/s11248-008-9229-9; Elfstrand L, 2002, INT DAIRY J, V12, P879, DOI 10.1016/S0958-6946(02)00089-4; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; FRANCHI E, 1991, J BIOTECHNOL, V18, P41, DOI 10.1016/0168-1656(91)90234-M; Geng Zhao-Hui, 2002, Sheng Wu Gong Cheng Xue Bao, V18, P505; GOEDDEL DV, 1979, NATURE, V281, P544, DOI 10.1038/281544a0; HAMMER RE, 1985, NATURE, V315, P413, DOI 10.1038/315413a0; Holtz W, 1999, ANIM REPROD SCI, V57, P177, DOI 10.1016/S0378-4320(99)00054-8; IKEHARA M, 1984, P NATL ACAD SCI-BIOL, V81, P5956, DOI 10.1073/pnas.81.19.5956; Kim JH, 2013, Patent No. [US8420388B2, 8420388]; Komatsu N, 2007, CLIN CHIM ACTA, V377, P228, DOI 10.1016/j.cca.2006.10.009; Korhonen VP, 1997, EUR J BIOCHEM, V245, P482, DOI 10.1111/j.1432-1033.1997.00482.x; Kwon DN, 2006, TRANSGENIC RES, V15, P37, DOI 10.1007/s11248-005-3519-2; Lee Chul-Sang, 2006, Reproductive & Developmental biology, V30, P293; Lee HG, 2009, J REPROD DEVELOP, V55, P484, DOI 10.1262/jrd.20212; Lee Jung-Min, 2012, Lab Anim Res, V28, P115, DOI 10.5625/lar.2012.28.2.115; Lee MH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/315375; LEWIS UJ, 1977, J BIOL CHEM, V252, P3697; LEWIS UJ, 1980, BIOCHEM BIOPH RES CO, V92, P511, DOI 10.1016/0006-291X(80)90363-0; Lipinski D, 2012, J APPL GENET, V53, P435, DOI 10.1007/s13353-012-0110-4; Lu D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123551; Maksimenko OG, 2013, ACTA NATURAE, V5, P33, DOI 10.32607/20758251-2013-5-1-33-46; McGrath BA, 2016, DAIRY SCI TECHNOL, V96, P133, DOI 10.1007/s13594-015-0258-x; Mohanty DP, 2016, SAUDI J BIOL SCI, V23, P577, DOI 10.1016/j.sjbs.2015.06.005; Morcol T, 2001, BIOTECHNOL PROGR, V17, P577, DOI 10.1021/bp010023x; MUKHIJA R, 1995, GENE, V165, P303, DOI 10.1016/0378-1119(95)00525-B; Oliveira JE, 1999, J CHROMATOGR A, V852, P441, DOI 10.1016/S0021-9673(99)00613-5; Pan K, 2013, J AGR FOOD CHEM, V61, P9260, DOI 10.1021/jf402870y; Park JK, 2006, J BIOTECHNOL, V122, P362, DOI 10.1016/j.jbiotec.2005.11.021; Park KW, 2001, ANIM BIOTECHNOL, V12, P173, DOI 10.1081/ABIO-100108344; Park KW, 2001, BIOL REPROD, V65, P1681, DOI 10.1095/biolreprod65.6.1681; PARRISH DB, 1950, J DAIRY SCI, V33, P457, DOI 10.3168/jds.S0022-0302(50)91921-7; Patra AK, 2000, PROTEIN EXPRES PURIF, V18, P182, DOI 10.1006/prep.1999.1179; POTTER H, 1984, P NATL ACAD SCI-BIOL, V81, P7161, DOI 10.1073/pnas.81.22.7161; Quilter CR, 2002, MAMM GENOME, V13, P588, DOI 10.1007/s00335-002-3026-1; Salamone D, 2006, J BIOTECHNOL, V124, P469, DOI 10.1016/j.jbiotec.2006.01.005; Van Cott KE, 1999, GENET ANAL-BIOMOL E, V15, P155, DOI 10.1016/S1050-3862(99)00020-0; VELANDER WH, 1992, P NATL ACAD SCI USA, V89, P12003, DOI 10.1073/pnas.89.24.12003; Wang WH, 1998, MOL REPROD DEV, V51, P346, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;346::AID-MRD15&gt;3.0.CO;2-0; Wang WH, 1997, J REPROD FERTIL, V111, P101, DOI 10.1530/jrf.0.1110101; Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Witkowska E, 2001, J PEPT SCI, V7, P166, DOI 10.1002/psc.316; WROBLEWSKI VJ, 1991, ENDOCRINOLOGY, V129, P465, DOI 10.1210/endo-129-1-465; Yen CH, 2015, PREP BIOCHEM BIOTECH, V45, P18, DOI 10.1080/10826068.2013.877030; Yin XJ, 2003, ZYGOTE, V11, P167, DOI 10.1017/S096719940300220X	53	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236788	10.1371/journal.pone.0236788	http://dx.doi.org/10.1371/journal.pone.0236788			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735629	gold, Green Published			2022-12-26	WOS:000569367100045
J	Meloni, ST; Agaba, P; Chang, CA; Yiltok, E; Oguche, S; Ejeliogu, E; Agbaji, O; Okonkwo, P; Kanki, PJ				Meloni, Seema T.; Agaba, Patricia; Chang, Charlotte A.; Yiltok, Esther; Oguche, Stephen; Ejeliogu, Emeka; Agbaji, Oche; Okonkwo, Prosper; Kanki, Phyllis J.			Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria	PLOS ONE			English	Article							PERINATALLY ACQUIRED HIV; HUMAN-IMMUNODEFICIENCY-VIRUS; HEALTH-CARE TRANSITION; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; YOUNG-PEOPLE; INFECTED ADOLESCENTS; ADULT CARE; FOLLOW-UP; SERVICES	Introduction Adherence to antiretroviral therapy (ART) and retention in treatment programs are required for successful virologic suppression and treatment outcomes. As the number of adolescents living with HIV continues to increase globally, more information about adherence and retention patterns during and through transition from child- to adult-centered care is needed to ensure provision of a high level of care and inform development of targeted interventions to improve patient outcomes in this vulnerable population. In this analysis, we sought to describe long-term trends in adherence, retention, and virologic suppression in adolescents receiving ART at a pediatric HIV clinic in Nigeria through transition to the adult clinic. Setting The Jos University Teaching Hospital, United States President's Emergency Plan for AIDS Relief (PEPFAR)-funded HIV clinic in Jos, Plateau State, Nigeria. Methods We conducted a retrospective observational longitudinal evaluation of data that had been collected during the course of care in a large pediatric ART program in Nigeria. We used descriptive statistics to define our patient population and quantify retention from ART initiation through adolescence and transition to adult-centered care. Logistic regression was used to evaluate predictors of loss to follow-up. We used medication possession ratio (MPR) to quantify adherence for each year a patient was on ART. To evaluate adherence and virologic suppression, we measured the proportion of patients with >= 95% MPR and the proportion with virologic suppression (viral load <= 400 copies/mL) within each age cohort, and used bivariate analyses to examine any association between MPR and VL suppression for all person-years observed. Results A total of 476 patients received at least one dose of ART as an adolescent (ages 10-19 years). The proportions of patients lost to follow-up were: 11.9% (71/597) prior to adolescence, 19.1% (31/162) during adolescence, and 13.7% (10/73) during transition to adult-centered care. While over 80% of patients had >= 95% medication adherence in all age groups, their viral load suppression rates through adolescence and post-transition were only 55.6%-64.0%. For patients that successfully transitioned to adult-centered care, we observed 87.7% (50/57) retention at month 12 post-transition, but only 34.6% (9/26) viral load suppression. Conclusions Our evaluation found considerable proportions of adolescents lost to follow-up throughout the ART program cascade. We also found discrepancies between the proportions of patients with >= 95% MPR and the proportions with VL suppression, suggesting that true medication adherence in this population may be poor. Significant attention and targeted interventions to improve retention and adherence focused on adolescents are needed in order for global programs to achieve 90-90-90 goals.	[Meloni, Seema T.; Chang, Charlotte A.; Kanki, Phyllis J.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Agaba, Patricia] Univ Jos, Dept Family Med, Jos, Nigeria; [Agaba, Patricia; Yiltok, Esther; Oguche, Stephen; Ejeliogu, Emeka; Agbaji, Oche] Jos Univ Teaching Hosp, Jos, Nigeria; [Yiltok, Esther; Oguche, Stephen; Ejeliogu, Emeka] Univ Jos, Dept Pediat, Jos, Nigeria; [Agbaji, Oche] Univ Jos, Dept Med, Jos, Nigeria; [Okonkwo, Prosper] APIN Publ Hlth Initiat Ltd Gte, Abuja, Nigeria	Harvard University; Harvard T.H. Chan School of Public Health; University of Jos; University of Jos; University of Jos	Kanki, PJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	pkanki@hsph.harvard.edu	Agaba, Patricia/AAD-5264-2022	Yiltok, ESther/0000-0002-6133-2899; Kanki, Phyllis/0000-0003-4739-4572	U.S. Department of Health and Human Services, Health Resources and Services Administration [U51HA02522]; U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) [PS001058]	U.S. Department of Health and Human Services, Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded, in part, by the U.S. Department of Health and Human Services, Health Resources and Services Administration (https://www.hrsa.gov) through award number U51HA02522 (PJK) and the Centers for Disease Control and Prevention (CDC, https://www.cdc.gov) through cooperative agreement PS001058 (PJK). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the respective funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwu AL, 2015, J ADOLESCENT HEALTH, V56, P345, DOI 10.1016/j.jadohealth.2014.11.009; Andiman WA, 2011, J PEDIATR-US, V159, P714, DOI 10.1016/j.jpeds.2011.06.040; [Anonymous], 2016, EV CHILD END AIDS 7; Badejo OA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198802; Bain-Brickley D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009513; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2004, ADHERENCE ANTIRETROV, P20; Bundock H, 2011, AIDS PATIENT CARE ST, V25, P465, DOI 10.1089/apc.2010.0279; Cervia JS, 2013, AIDS PATIENT CARE ST, V27, P692, DOI 10.1089/apc.2013.0253; Chaplin B, 2015, INT J MED INFORM, V84, P58, DOI 10.1016/j.ijmedinf.2014.09.006; Crowley R, 2011, ARCH DIS CHILD, V96, P548, DOI 10.1136/adc.2010.202473; Dahourou DL, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.4.21528; Dowshen N, 2011, PEDIATRICS, V128, P762, DOI 10.1542/peds.2011-0068; Evans D, 2013, AIDS RES HUM RETROV, V29, P892, DOI [10.1089/aid.2012.0215, 10.1089/AID.2012.0215]; Goldman JD, 2008, AIDS RES HUM RETROV, V24, P1031, DOI 10.1089/aid.2008.0035; Hazra R, 2010, ANNU REV MED, V61, P169, DOI 10.1146/annurev.med.050108.151127; Hussen SA, 2014, FUTURE VIROL, V9, P921, DOI 10.2217/FVL.14.73; Idele P, 2014, JAIDS-J ACQ IMM DEF, V66, pS144, DOI 10.1097/QAI.0000000000000176; Jones C, 2019, AIDS BEHAV, V23, P2498, DOI 10.1007/s10461-019-02621-6; Judd A, 2018, CURR OPIN HIV AIDS, V13, P236, DOI [10.1097/COH.0000000000000448, 10.1097/coh.0000000000000448]; Lee S, 2015, J INT AIDS SOC, V18, P68, DOI 10.7448/IAS.18.7.20257; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P360; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Lugasi T, 2011, J ADOLESCENT HEALTH, V48, P429, DOI 10.1016/j.jadohealth.2010.10.016; MacDonell K, 2013, AIDS BEHAV, V17, P86, DOI 10.1007/s10461-012-0364-1; Madiba S, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9623159; Martinez J, 2014, PEDIATRICS, V133, P558, DOI 10.1542/peds.2013-4061; Mellins CA, 2011, AIDS PATIENT CARE ST, V25, P413, DOI 10.1089/apc.2011.0025; Meloni ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164030; Meloni ST, 2015, CURR HIV RES, V13, P210, DOI 10.2174/1570162X1303150506183921; Merzel C, 2008, AIDS PATIENT CARE ST, V22, P977, DOI 10.1089/apc.2008.0048; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mofenson LM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18650; Murphy DA, 2005, ARCH PEDIAT ADOL MED, V159, P764, DOI 10.1001/archpedi.159.8.764; Mutwa PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060073; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Newman C, 2014, AIDS PATIENT CARE ST, V28, P381, DOI 10.1089/apc.2013.0346; Nigeria FMoH, 2010, NAT GUID HIV AIDS TR; Nigeria FMoH, 2007, NAT GUID HIV AIDS TR; Njuguna I, 2019, B WORLD HEALTH ORGAN, V97, P837, DOI 10.2471/BLT.19.232702; Okatch H, 2016, JAIDS-J ACQ IMM DEF, V72, P542, DOI 10.1097/QAI.0000000000000994; Petersen I, 2010, AIDS CARE, V22, P970, DOI 10.1080/09540121003623693; Pettitt Edward D, 2013, Afr J Reprod Health, V17, P17; Phelps BR, 2013, AIDS, V27, pS207, DOI 10.1097/QAD.0000000000000095; Reisner Sari L, 2009, Top HIV Med, V17, P14; Sam-Agudu NA, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2347-z; Straub DM, 2018, LANCET CHILD ADOLESC, V2, P214, DOI 10.1016/S2352-4642(18)30005-1; Tulloch O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099061; UNAIDS, AIDSINFO IND PEOPL L; UNICEF, 2016, ALL END AD AIDS PROG; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; WHO, 2014, HLTH WORLDS AD 2 CHA; Wiener L, 2007, SOC WORK HEALTH CARE, V46, P1, DOI 10.1300/J010v46n01_01	53	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236801	10.1371/journal.pone.0236801	http://dx.doi.org/10.1371/journal.pone.0236801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NO3EK	32735566	gold, Green Published			2022-12-26	WOS:000569367100048
J	Pereira, CER; Resende, TP; Armien, AG; Laub, RP; Vannucci, FA; Santos, RL; Gebhart, CJ; Guedes, RMC				Real Pereira, Carlos Eduardo; Resende, Talita Pilar; Armien, Anibal G.; Laub, Ricardo Pereira; Vannucci, Fabio Augusto; Santos, Renato Lima; Gebhart, Connie Jane; Carvalho Guedes, Roberto Mauricio			Survival of Lawsonia intracellularis in porcine peripheral blood monocyte-derived macrophages	PLOS ONE			English	Article							TRANSMISSIBLE ILEAL HYPERPLASIA; PROLIFERATIVE ENTERITIS; SYMBIONT INTRACELLULARIS; COXIELLA-BURNETII; INFECTION; HAMSTERS; ENTEROCYTES; CULTIVATION; BACTERIUM; PIGS	Lawsonia intracellularis, an obligately intracellular enteric bacterium, infects intestinal epithelial cells, but may also be found within macrophages in the intestinal lamina propria of affected pigs. Macrophages play an important role in host defense against infectious agents, but the role of this cell in L. intracellularis infection is not well understood. The aim of this study was to evaluate the permissibility of macrophages to L. intracellularis infection in vitro. Pure culture of L. intracellularis was added to swine peripheral blood monocyte-derived macrophages. Viability of intracytoplasmic L. intracellularis was evaluated at different time points by transmission electron microscopy (TEM). Potential replication of L. intracellularis in macrophages was also evaluated by qPCR. By TEM, phagocytosis L. intracellularis within of phagolysosomes were observed 1-hour post-infection (hpi) and bacterial structures in binary fission at 48 hpi. The number of intracellular bacteria was determined at 1, 4, 24, 48, and 72 hpi by qPCR in infected macrophages and compared to the number of intracellular bacteria from culture in McCoy cells. In both cell lines, the amount of L. intracellularis was decreased at 4 hpiand increased at 24 hpi. The number of intracellular bacteria continued to increase in McCoy cells over time. This is the first study showing interaction, survival and propagation of L. intracellularis in macrophages. These findings are critical to establish an experimental model for future studies of the pathogenesis of porcine proliferative enteropathy and the potential persistence of L. intracellularis in macrophages during chronic infections.	[Real Pereira, Carlos Eduardo; Laub, Ricardo Pereira; Santos, Renato Lima; Carvalho Guedes, Roberto Mauricio] Univ Fed Minas Gerais, Vet Sch, Dept Vet Clin & Surg, Belo Horizonte, MG, Brazil; [Real Pereira, Carlos Eduardo; Resende, Talita Pilar; Gebhart, Connie Jane] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Armien, Anibal G.; Vannucci, Fabio Augusto; Gebhart, Connie Jane] Univ Minnesota, Coll Vet Med, Dept Populat Med, St Paul, MN 55108 USA; [Armien, Anibal G.] Univ Minnesota, Coll Vet Med, Ultrastruct Pathol Unit, Vet Diagnost Lab, St Paul, MN 55108 USA	Universidade Federal de Minas Gerais; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Guedes, RMC (corresponding author), Univ Fed Minas Gerais, Vet Sch, Dept Vet Clin & Surg, Belo Horizonte, MG, Brazil.	guedes@vet.ufmg.br	Resende, Talita Pilar/AGZ-6654-2022; de Lima Santos, Renato/A-1134-2008; Guedes, Roberto/A-2665-2008	Resende, Talita Pilar/0000-0002-7705-714X; de Lima Santos, Renato/0000-0002-4830-0470; Guedes, Roberto/0000-0002-6464-1566	FAPEMIG [APQ-02189-13]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Capes Foundation, Ministry of Education of Brazil	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Capes Foundation, Ministry of Education of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the FAPEMIG (grant numbers: APQ-02189-13). RMCG and RLS are recipients of fellowships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil). TPR had a PhD scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). CERP was supported by the Capes Foundation, Ministry of Education of Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Beron W, 2002, INFECT IMMUN, V70, P5816, DOI 10.1128/IAI.70.10.5816-5821.2002; Bliska JB, 2009, NAT REV MICROBIOL, V7, P165, DOI 10.1038/nrmicro2049; Boutrup TS, 2010, J COMP PATHOL, V143, P101, DOI 10.1016/j.jcpa.2010.01.006; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Danelishvili L, 2015, MICROBES INFECT, V17, P628, DOI 10.1016/j.micinf.2015.05.005; de Bagues MPJ, 2005, CLIN IMMUNOL, V114, P227, DOI 10.1016/j.clim.2004.07.010; Gebhart CJ, 2010, PATHOGENESIS BACTERI, P503; Guedes RMC, 2003, VET MICROBIOL, V91, P135, DOI 10.1016/S0378-1135(02)00301-2; JACOBY RO, 1978, AM J PATHOL, V91, P433; JASNI S, 1994, VET MICROBIOL, V41, P1, DOI 10.1016/0378-1135(94)90130-9; JOHNSON EA, 1978, AM J PATHOL, V91, P451; Klein EC, 1999, J MED PRIMATOL, V28, P11, DOI 10.1111/j.1600-0684.1999.tb00084.x; Lafortune M, 2004, J ZOO WILDLIFE MED, V35, P549, DOI 10.1638/03-080; LAWSON GHK, 1993, J CLIN MICROBIOL, V31, P1136, DOI 10.1128/JCM.31.5.1136-1142.1993; LAWSON GHK, 1993, J COMP PATHOL, V108, P41, DOI 10.1016/S0021-9975(08)80225-3; LAWSON GHK, 1995, VET MICROBIOL, V45, P339, DOI 10.1016/0378-1135(94)00142-J; Lawson GHK, 2000, J COMP PATHOL, V122, P77, DOI 10.1053/jcpa.1999.0347; McGurrin MKJ, 2007, CAN VET J, V48, P927; MCORIST S, 1995, INT J SYST BACTERIOL, V45, P820, DOI 10.1099/00207713-45-4-820; MCORIST S, 1995, RES VET SCI, V59, P255, DOI 10.1016/0034-5288(95)90013-6; Meng S, 2017, CLCWEB-COMP LIT CULT, V19, DOI 10.7771/1481-4374.3117; Mitchell G, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0012-2015; Pereira CER, 2019, BRAZ J MICROBIOL, V50, P539, DOI 10.1007/s42770-019-00042-0; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Segales J, 2001, VET PATHOL, V38, P343, DOI 10.1354/vp.38-3-343; Sica A, 2015, CELL MOL LIFE SCI, V72, P4111, DOI 10.1007/s00018-015-1995-y; Smith DGE, 2001, VET MICROBIOL, V82, P331, DOI 10.1016/S0378-1135(01)00397-2; Stege H, 2004, VET MICROBIOL, V104, P197, DOI 10.1016/j.vetmic.2004.09.015; Sui ZH, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00400; Toyooka K, 2005, J MED MICROBIOL, V54, P1007, DOI 10.1099/jmm.0.46086-0; UMEMURA T, 1982, VET PATHOL, V19, P326, DOI 10.1177/030098588201900313; Vannucci FA, 2012, J CLIN MICROBIOL, V50, P1070, DOI 10.1128/JCM.05976-11; Wattanaphansak S, 2010, J VET DIAGN INVEST, V22, P598, DOI 10.1177/104063871002200416	34	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236887	10.1371/journal.pone.0236887	http://dx.doi.org/10.1371/journal.pone.0236887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735621	gold, Green Published			2022-12-26	WOS:000569367100056
J	Abdelazeem, RM; Youssef, D; El-Azab, J; Hassab-Elnaby, S; Agour, M				Abdelazeem, Rania M.; Youssef, Doaa; El-Azab, Jala; Hassab-Elnaby, Salah; Agour, Mostafa			Three-dimensional visualization of brain tumor progression based accurate segmentation via comparative holographic projection	PLOS ONE			English	Article							ANGULAR SPECTRUM METHOD; DIGITAL HOLOGRAPHY; DISPLAY; PHASE; PROPAGATION; ALGORITHM	We propose a new optical method based on comparative holographic projection for visual comparison between two abnormal follow-up magnetic resonance (MR) exams of glioblastoma patients to effectively visualize and assess tumor progression. First, the brain tissue and tumor areas are segmented from the MR exams using the fast marching method (FMM). The FMM approach is implemented on a computed pixel weight matrix based on an automated selection of a set of initialized target points. Thereafter, the associated phase holograms are calculated for the segmented structures based on an adaptive iterative Fourier transform algorithm (AIFTA). Within this approach, a spatial multiplexing is applied to reduce the speckle noise. Furthermore, hologram modulation is performed to represent two different reconstruction schemes. In both schemes, all calculated holograms are superimposed into a single two-dimensional (2D) hologram which is then displayed on a reflective phase-only spatial light modulator (SLM) for optical reconstruction. The optical reconstruction of the first scheme displays a 3D map of the tumor allowing to visualize the volume of the tumor after treatment and at the progression. Whereas, the second scheme displays the follow-up exams in a side-by-side mode highlighting tumor areas, so the assessment of each case can be fast achieved. The proposed system can be used as a valuable tool for interpretation and assessment of the tumor progression with respect to the treatment method providing an improvement in diagnosis and treatment planning.	[Abdelazeem, Rania M.; Youssef, Doaa; El-Azab, Jala; Hassab-Elnaby, Salah] Cairo Univ, Natl Inst Laser Enhanced Sci NILES, Engn Applicat Laser Dept, Giza, Egypt; [Agour, Mostafa] Aswan Univ, Fac Sci, Phys Dept, Aswan, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Aswan University	Abdelazeem, RM (corresponding author), Cairo Univ, Natl Inst Laser Enhanced Sci NILES, Engn Applicat Laser Dept, Giza, Egypt.	rabdelazeem@niles.edu.eg	Agour, Mostafa/G-4865-2019	Agour, Mostafa/0000-0003-1618-824X; , Rania/0000-0003-4817-3181; Youssef, Doaa/0000-0001-8269-6694				Abdelazeem MR, 2020, J PHYS C SERIES, V1472, P1; Abdelazeem RM, 2020, OPTICAL COHERENCE TO; Agour M, 2013, 2013 3DTV VISION DEP, P1; Agour M, 2016, OPT EXPRESS, V24, P14393, DOI 10.1364/OE.24.014393; Agour M, 2010, J OPT-UK, V12, DOI 10.1088/2040-8978/12/5/055401; Agour M, 2009, J OPT A-PURE APPL OP, V11, DOI 10.1088/1464-4258/11/10/105405; Ahmed I., 2016, P WORLD C ENG, V1, P25; Andrew A. M., 2000, ROBOTICA, V18, P89; [Anonymous], 1948, BIOL SKRIFTER; Arevalo OD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00460; Aslam A, 2015, PROCEDIA COMPUT SCI, V58, P430, DOI 10.1016/j.procs.2015.08.057; Baumbach T, 2006, APPL OPTICS, V45, P925, DOI 10.1364/AO.45.000925; Baumbach T, 2004, P SOC PHOTO-OPT INS, V5457, P598, DOI 10.1117/12.554757; Bruckheimer E, 2016, EUR HEART J-CARD IMG, V17, P845, DOI 10.1093/ehjci/jew087; Bruns H., 1895, EIKONAL, V35; BUCKLEW J, 1979, APPL OPTICS, V18, P2861, DOI 10.1364/AO.18.002861; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chen C, 2019, OPT EXPRESS, V27, P29400, DOI 10.1364/OE.27.029401; Clark K, 2013, J DIGIT IMAGING, V26, P1045, DOI 10.1007/s10278-013-9622-7; Csurka G, 2013, BMVC, V27, P2013; Diaz I, 2013, IEEE ENG MED BIO, P3339, DOI 10.1109/EMBC.2013.6610256; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Erickson BJ, 2011, AM J NEURORADIOL, V32, P1652, DOI 10.3174/ajnr.A2596; Fuzessy Z, 1996, OPT COMMUN, V132, P29, DOI 10.1016/0030-4018(96)00294-5; Gonzalez R.C, 2007, DIGITAL IMAGE PROCES, V3rd; Gonzalez RC, 1977, DIGITAL IMAGE PROCES, P451, DOI DOI 10.1109/CVPR.2014.81; Goodman J. W., 2005, INTRO FOURIER OPTICS; Jia J, 2018, OPT EXPRESS, V26, P17487, DOI 10.1364/OE.26.017487; Kaur A, 2016, 2016 SECOND INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE & COMMUNICATION TECHNOLOGY (CICT), P187, DOI 10.1109/CICT.2016.45; Kaur H, 2016, 2016 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P693, DOI 10.1109/ICACCI.2016.7732127; Kazempourradi S, 2017, PROC SPIE, V10127, DOI 10.1117/12.2252374; Khan MN, 2016, CURR ONCOL, V23, pE383, DOI 10.3747/co.23.3082; Kreis T., 2009, P 3DTV CON, P1; Li X, 2013, OPT EXPRESS, V21, P20577, DOI 10.1364/OE.21.020577; Liang JY, 2012, APPL OPTICS, V51, P3294, DOI 10.1364/AO.51.003294; Liu JP, 2012, J OPT SOC AM A, V29, P1956, DOI 10.1364/JOSAA.29.001956; Makowski M., 2019, HOLOGRAPHIC MAT OPTI; Makowski M, 2013, OPT EXPRESS, V21, P29205, DOI 10.1364/OE.21.029205; Makowski M, 2012, OPT EXPRESS, V20, P25130, DOI 10.1364/OE.20.025130; Matsushima K, 2009, OPT EXPRESS, V17, P19662, DOI 10.1364/OE.17.019662; Murthy GR, 2014, PROCEEDINGS OF 2014 2ND INTERNATIONAL SYMPOSIUM ON COMPUTATIONAL AND BUSINESS INTELLIGENCE (ISCBI), P1, DOI 10.1109/ISCBI.2014.8; NEUMANN DB, 1985, OPT ENG, V24, P625, DOI 10.1117/12.7973540; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Osten W, 2002, OPT LETT, V27, P1764, DOI 10.1364/OL.27.001764; Park JH, 2017, J INFORM DISPLAY, V18, P1, DOI 10.1080/15980316.2016.1255672; Paturzo M, 2010, 3D RES, V1, P31, DOI 10.1007/3DRes.02(2010)06; Poon T-C, 2014, INTRO MODERN DIGITAL; Schmainda KM, 2018, DATA BRAIN TUMOR PRO; Sehgal A, 2016, 2016 CONFERENCE ON ADVANCES IN SIGNAL PROCESSING (CASP), P104; Sethian JA, 1999, GEOPHYSICS, V64, P516, DOI 10.1190/1.1444558; Shaked NT, 2009, APPL OPTICS, V48, pH120, DOI 10.1364/AO.48.00H120; Tran Diem Kieu Thi, 2013, Surg Neurol Int, V4, pS129, DOI 10.4103/2152-7806.110661; Wakunami K, 2010, PROC SPIE, V7619, DOI 10.1117/12.843149; White ML, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213905; Xu LY, 2017, OPT COMMUN, V402, P211, DOI 10.1016/j.optcom.2017.05.076; Xue GL, 2014, OPT EXPRESS, V22, P18473, DOI 10.1364/OE.22.018473; Yaras F, 2008, 2008 3DTV C TRUE VIS, pPD; Yoshikawa H., 2016, SPIE NEWSROOM, V10, P6331; Yu X, 2012, OPT LETT, V37, P4943, DOI 10.1364/OL.37.004943	60	10	10	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236835	10.1371/journal.pone.0236835	http://dx.doi.org/10.1371/journal.pone.0236835			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730365	gold, Green Published			2022-12-26	WOS:000556884700036
J	Droit-Volet, S; Martinelli, SN; Andant, N; Clinchamps, M; Parreira, L; Rouffiac, K; Dambrun, M; Huguet, P; Dubuis, B; Pereira, B; Bouillon, JB; Dutheil, F				Droit-Volet, Sylvie; Martinelli, Sandrine Natalia; Andant, Nicolas; Clinchamps, Maelys; Parreira, Lenise; Rouffiac, Karine; Dambrun, Michael; Huguet, Pascal; Dubuis, Benoit; Pereira, Bruno; Bouillon, Jean-Baptiste; Dutheil, Frederic		COVISTRESS Network	Time and Covid-19 stress in the lockdown situation: Time free, << Dying >> of boredom and sadness	PLOS ONE			English	Article							PERCEPTION; PASSAGE; EMOTION; WORKING; LIFE	A lockdown of people has been used as an efficient public health measure to fight against the exponential spread of the coronavirus disease (Covid-19) and allows the health system to manage the number of patients. The aim of this study (clinicaltrials.gov NCT 0430818) was to evaluate the impact of both perceived stress aroused by Covid-19 and of emotions triggered by the lockdown situation on the individual experience of time. A large sample of the French population responded to a survey on their experience of the passage of time during the lockdown compared to before the lockdown. The perceived stress resulting from Covid-19 and stress at work and home were also assessed, as were the emotions felt. The results showed that people have experienced a slowing down of time during the lockdown. This time experience was not explained by the levels of perceived stress or anxiety, although these were considerable, but rather by the increase in boredom and sadness felt in the lockdown situation. The increased anger and fear of death only explained a small part of variance in the time judgment. The conscious experience of time therefore reflected the psychological difficulties experienced during lockdown and was not related to their perceived level of stress or anxiety.	[Droit-Volet, Sylvie; Andant, Nicolas; Dambrun, Michael; Huguet, Pascal] Univ Clermont Auvergne, LAPSCO, CNRS, Clermont Ferrand, France; [Martinelli, Sandrine Natalia] Univ Poitiers, CNRS, UMR 7295, Poitiers, France; [Clinchamps, Maelys; Pereira, Bruno] CHU Clermont Ferrand, Clin Res & Innovat Direct Biostat, Univ Hosp Clermont Ferrand, Clermont Ferrand, France; [Parreira, Lenise; Rouffiac, Karine] CHU Clermont Ferrand, Occupat & Environm Med, Univ Hosp Clermont Ferrand, Clermont Ferrand, France; [Dubuis, Benoit] Univ Geneva, Fdn INARTIS, UNIGE, Geneva, Switzerland; [Bouillon, Jean-Baptiste] Univ Clermont Auvergne, Univ Hosp Clermont Ferrand, Emergency Med, Clermont Ferrand, France; [Dutheil, Frederic] Univ Clermont Auvergne, Physiol & Psychosocial Stress, Univ Hosp Clermont Ferrand,WittyFit, CNRS,LAPSCO,CHU Clermont Ferrand,Occupat & Enviro, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Poitiers; CHU Clermont Ferrand; CHU Clermont Ferrand; University of Geneva; CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand	Droit-Volet, S (corresponding author), Univ Clermont Auvergne, LAPSCO, CNRS, Clermont Ferrand, France.	sylvie.droit-volet@uca.fr	Parreira, Lenise Marie Santos/L-3263-2018; Saâdaoui, Foued/J-9710-2019	Parreira, Lenise Marie Santos/0000-0002-5466-4182; Saâdaoui, Foued/0000-0002-0574-2922; Droit-Volet, Sylvie/0000-0002-1523-952X; DAMBRUN, Michael/0000-0003-1418-7294; Huguet, Pascal/0000-0002-0707-7655	French national research agency (ANR); CNRS Foundation	French national research agency (ANR)(French National Research Agency (ANR)); CNRS Foundation	The French national research agency (ANR) financially supported this project within the framework of the ANR flash COVID-19. The CNRS Foundation has provided additional financial support.	Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Bar-Haim Y, 2010, COGNITION EMOTION, V24, P255, DOI 10.1080/02699930903387603; Brooks SK, 2020, LANCET; Cocenas-Silva R, 2019, TIMING TIME PERCEPT, V7, P108, DOI 10.1163/22134468-20191138; Danckert JA, 2005, BRAIN COGN, V59, P336; Dhabhar FS, 2014, IMMUNOL RES, V58, P193, DOI 10.1007/s12026-014-8517-0; Droit-Volet S., 2019, TIME SOC, P1; Droit-Volet S, 2019, ILLUSIONS OF TIME: PHILOSOPHICAL AND PSYCHOLOGICAL ESSAYS ON TIMING AND TIME PERCEPTION, P103, DOI 10.1007/978-3-030-22048-8_7; Droit-Volet S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223567; Droit-Volet S, 2019, PSYCH J, V8, P51, DOI 10.1002/pchj.270; Droit-Volet S, 2018, CURR DIR PSYCHOL SCI, V27, P422, DOI 10.1177/0963721418779978; Droit-Volet S, 2017, ACTA PSYCHOL, V173, P116, DOI 10.1016/j.actpsy.2016.12.010; Droit-Volet S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00176; Droit-Volet S, 2015, ACTA PSYCHOL, V156, P77, DOI 10.1016/j.actpsy.2015.01.006; Droit-Volet S, 2010, EMOTION, V10, P908, DOI 10.1037/a0020258; Dutheil F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071658; Dutheil F, 2012, INT J CARDIOL, V158, P322, DOI 10.1016/j.ijcard.2012.04.141; Eastwood JD, 2012, PERSPECT PSYCHOL SCI, V7, P482, DOI 10.1177/1745691612456044; Elhai JD, 2018, SOC SCI COMPUT REV, V36, P707, DOI 10.1177/0894439317741087; Fayolle S, 2015, BEHAV PROCESS, V120, P135, DOI 10.1016/j.beproc.2015.09.014; Grommet EK, 2011, BEHAV PROCESS, V86, P88, DOI 10.1016/j.beproc.2010.10.003; HAMILTON JA, 1984, PERS INDIV DIFFER, V5, P183, DOI 10.1016/0191-8869(84)90050-3; Holmes E. A., 2020, LANCET PSYCHIAT; Jahanshahi AA, 2020, DISTRESS IRANIAN ADU; Jokic T., 2018, TIMING TIME PERCEPT, V6, P71, DOI [10.1163/22134468-00002101, DOI 10.1163/22134468-00002101]; Jonas KJ, 2008, PERS SOC PSYCHOL B, V34, P353, DOI 10.1177/0146167207311202; Lake JI, 2016, NEUROSCI BIOBEHAV R, V64, P403, DOI 10.1016/j.neubiorev.2016.03.003; LePera N., 2011, NEW SCH PSYCHOL B, V8, P15, DOI DOI 10.1037/E741452011-003; Lesage FX, 2011, OCCUP MED-OXFORD, V61, P434, DOI 10.1093/occmed/kqr037; Lesage FX, 2012, OCCUP MED-OXFORD, V62, P600, DOI 10.1093/occmed/kqs140; Martarelli C., 2020, HIGH BOREDOM PRONENE, DOI [10.31234/osf.io/jcf95, DOI 10.31234/OSF.IO/JCF95]; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sarigiannidis I, 2020, COGNITION, V197, DOI 10.1016/j.cognition.2019.104116; Thones S, 2015, J AFFECT DISORDERS, V175, P359, DOI 10.1016/j.jad.2014.12.057; Thompson CG, 2017, BASIC APPL SOC PSYCH, V39, P81, DOI 10.1080/01973533.2016.1277529; Tipples J, 2008, EMOTION, V8, P127, DOI 10.1037/1528-3542.8.1.127; Vodanovich SJ, 2003, J PSYCHOL, V137, P569, DOI 10.1080/00223980309600636; Wearden JH, 2015, CONSCIOUS COGN, V38, P165, DOI 10.1016/j.concog.2015.06.005; Witowska J, 2020, ACTA PSYCHOL, V205, DOI 10.1016/j.actpsy.2020.103061; Yoo JY, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01208; Zhang SX, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112958	43	84	87	9	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0236465	10.1371/journal.pone.0236465	http://dx.doi.org/10.1371/journal.pone.0236465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC7KJ	32776990	Green Published, gold			2022-12-26	WOS:000561393800023
J	Rosen, S; Brisson, BK; Durham, AC; Munroe, CM; McNeill, CJ; Stefanovski, D; Sorenmo, KU; Volk, SW				Rosen, Suzanne; Brisson, Becky K.; Durham, Amy C.; Munroe, Clare M.; McNeill, Conor J.; Stefanovski, Darko; Sorenmo, Karin U.; Volk, Susan W.			Intratumoral collagen signatures predict clinical outcomes in feline mammary carcinoma	PLOS ONE			English	Article							POSTSURGICAL PROGNOSIS; IN-SITU; CANCER; TUMOR; SURVIVAL; ADENOCARCINOMA; MODEL; MICROENVIRONMENT; ASSOCIATION; EXPRESSION	Breast cancer is the most common cause of cancer-related deaths in women worldwide. Identification of reliable prognostic indicators and therapeutic targets is critical for improving patient outcome. Cancer in companion animals often strongly resembles human cancers and a comparative approach to identify prognostic markers can improve clinical care across species. Feline mammary tumors (FMT) serve as models for extremely aggressive triple negative breast cancer (TNBC) in humans, with high rates of local and distant recurrence after resection. Despite the aggressive clinical behavior of most FMT, current prognostic indicators are insufficient for accurately predicting outcome, similar to human patients. Given significant heterogeneity of mammary tumors, there has been a recent focus on identification of universal tumor-permissive stromal features that can predict biologic behavior and provide therapeutic targets to improve outcome. As in human and canine patients, collagen signatures appear to play a key role in directing mammary tumor behavior in feline patients. We find that patients bearing FMTs with denser collagen, as well as longer, thicker and straighter fibers and less identifiable tumor-stromal boundaries had poorer outcomes, independent of the clinical variables grade and surgical margins. Most importantly, including the collagen parameters increased the predictive power of the clinical model. Thus, our data suggest that similarities with respect to the stromal microenvironment between species may allow this model to predict outcome and develop novel therapeutic targets within the tumor stroma that would benefit both veterinary and human patients with aggressive mammary tumors.	[Rosen, Suzanne; Brisson, Becky K.; Munroe, Clare M.; Volk, Susan W.] Univ Penn, Sch Vet Med, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA; [Durham, Amy C.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [McNeill, Conor J.] Hope Adv Vet Ctr, Vienna, VA USA; [Stefanovski, Darko] Univ Penn, New Bolton Ctr, Sch Vet Med, Dept Clin Studies, Kennett Sq, PA 19348 USA; [Sorenmo, Karin U.; Volk, Susan W.] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Volk, SW (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA.; Volk, SW (corresponding author), Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA.	swvolk@vet.upenn.edu		Volk, Susan/0000-0003-3993-4145	Nine Lives Fund; Sugar Rub Fund; National Institutes of Health [R21CA216552, S10RR027128, 1S10OD021633]	Nine Lives Fund; Sugar Rub Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funding from The Nine Lives Fund and The Sugar Rub Fund (sugarrub.org) to SWV, as well as funding from the National Institutes of Health: R21CA216552 (to SWV); S10RR027128 and 1S10OD021633 (to Bruce D. Freedman for acquisition of instrumentation utilized in the Penn Vet Imaging Core facility). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi I, 2015, INTEGR BIOL-UK, V7, P1120, DOI 10.1039/c5ib00040h; ADZICK NS, 1994, ANN SURG, V220, P10, DOI 10.1097/00000658-199407000-00003; Barcus CE, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0801-1; Best SL, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5708-z; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; Boyd NF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2942; Brabrand A, 2015, APMIS, V123, P1, DOI 10.1111/apm.12298; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bredfeldt Jeremy S, 2014, J Pathol Inform, V5, P28, DOI 10.4103/2153-3539.139707; Bredfeldt JS, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016007; Case A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180448; Castagnaro M, 1998, RES VET SCI, V64, P97, DOI 10.1016/S0034-5288(98)90002-9; Castagnaro M, 1998, RES VET SCI, V65, P223, DOI 10.1016/S0034-5288(98)90147-3; Castagnaro M, 1998, J COMP PATHOL, V119, P263, DOI 10.1016/S0021-9975(98)80049-2; Chang YC, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1883-z; Conklin MW, 2012, CELL ADHES MIGR, V6, P249, DOI 10.4161/cam.20567; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Dagher E, 2019, VET PATHOL, V56, P660, DOI 10.1177/0300985819846870; Dagher E, 2019, BMC VET RES, V15, DOI 10.1186/s12917-018-1772-x; Castor MDDC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62346-8; De Maria R, 2005, CANCER RES, V65, P907; Drifka CR, 2016, J HISTOCHEM CYTOCHEM, V64, P519, DOI 10.1369/0022155416659249; Drifka CR, 2015, MODERN PATHOL, V28, P1470, DOI 10.1038/modpathol.2015.97; Garden OA, 2018, VET J, V240, P6, DOI 10.1016/j.tvjl.2018.08.008; Gimenez F, 2010, J FELINE MED SURG, V12, P214, DOI 10.1016/j.jfms.2010.01.004; Golaraei A, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201800241; Gong XY, 2020, ACTA BIOMATER, V108, P128, DOI 10.1016/j.actbio.2020.03.019; Hallmann R, 2015, CURR OPIN CELL BIOL, V36, P54, DOI 10.1016/j.ceb.2015.06.006; Hanley CJ, 2016, ONCOTARGET, V7, P6159, DOI 10.18632/oncotarget.6740; HAYES HM, 1981, VET REC, V108, P476, DOI 10.1136/vr.108.22.476; Ito T, 1996, J VET MED SCI, V58, P723, DOI 10.1292/jvms.58.723; Kakkad SM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116017; Keikhosravi A, 2014, METHOD CELL BIOL, V123, P531, DOI [10.1016/11978-0-12.420138-5.00028-8, 10.1016/B978-0-12-420138-5.00028-8]; Lee BS, 2017, BIOCHEM BIOPH RES CO, V491, P493, DOI 10.1016/j.bbrc.2017.07.007; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li T, 2005, CANCER EPIDEM BIOMAR, V14, P343, DOI 10.1158/1055-9965.EPI-04-0490; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; Lyons TR, 2011, NAT MED, V17, P1109, DOI 10.1038/nm.2416; Malik R, 2015, TRENDS BIOTECHNOL, V33, P230, DOI 10.1016/j.tibtech.2015.01.004; Maller O, 2013, J CELL SCI; Marques CS, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4650-9; Marques CS, 2017, ONCOTARGET, V8, P105775, DOI 10.18632/oncotarget.22398; Maskarinec G, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3378; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; McLane JS, 2014, ACTA BIOMATER, V10, P4811, DOI 10.1016/j.actbio.2014.07.016; Millanta F, 2005, VET PATHOL, V42, P30, DOI 10.1354/vp.42-1-30; Millanta F, 2002, VET PATHOL, V39, P690, DOI 10.1354/vp.39-6-690; Mills SW, 2015, VET PATHOL, V52, P238, DOI 10.1177/0300985814543198; Misdorp W., 2002, Tumors in domestic animals, P575, DOI 10.1002/9780470376928.ch12; MISDORP W, 1980, AM J PATHOL, V98, P573; Munson Linda, 2007, Breast Dis, V28, P7; Murakami S, 2017, ONCOGENE, V36, P1232, DOI 10.1038/onc.2016.288; Natal Rodrigo A, 2018, Tumour Biol, V40, p1010428318770953, DOI 10.1177/1010428318770953; Natal RD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44156-9; Novosad CA, 2006, J AM ANIM HOSP ASSOC, V42, P110, DOI 10.5326/0420110; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Sahai E, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-14; Santos M, 2015, ANTICANCER RES, V35, P4219; Santos M, 2014, VET J, V200, P426, DOI 10.1016/j.tvjl.2014.03.019; Sarkar S, 2017, GENE DEV, V31, P1109, DOI 10.1101/gad.296640.117; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Seixas F, 2011, VET J, V187, P65, DOI 10.1016/j.tvjl.2009.10.030; Seo BR, 2020, P NATL ACAD SCI USA, V117, P11387, DOI 10.1073/pnas.1919394117; Sorenmo KU, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224504; Sorenmo KU, 2019, VET COMP ONCOL, V17, P479, DOI 10.1111/vco.12509; Sridharan R, 2019, ACTA BIOMATER, V89, P47, DOI 10.1016/j.actbio.2019.02.048; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tokarz D, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00272; van Rensburg HJJ, 2018, CANCER RES, V78, P1457, DOI 10.1158/0008-5472.CAN-17-3139; Viste JR, 2002, CAN VET J, V43, P33; Wang GC, 2016, CANCER DISCOV, V6, P80, DOI 10.1158/2159-8290.CD-15-0224; WEIJER K, 1972, J NATL CANCER I, V49, P1697, DOI 10.1093/jnci/49.6.1697; Zappulli V, 2015, VET PATHOL, V52, P46, DOI 10.1177/0300985814528221; Zeltz C, 2020, SEMIN CANCER BIOL, V62, P166, DOI 10.1016/j.semcancer.2019.08.004; Zhou ZH, 2017, J CANCER, V8, P1466, DOI 10.7150/jca.18466	79	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0236516	10.1371/journal.pone.0236516	http://dx.doi.org/10.1371/journal.pone.0236516			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776970	Green Published, gold			2022-12-26	WOS:000561393800027
J	Okamura, H; Ishikawa, K; Kudo, Y; Matsuoka, A; Maruyama, H; Emori, H; Yamamura, R; Hayakawa, C; Tani, S; Tsuchiya, K; Shirahata, T; Toyone, T; Nagai, T; Inagaki, K				Okamura, Hiroki; Ishikawa, Koji; Kudo, Yoshifumi; Matsuoka, Akira; Maruyama, Hiroshi; Emori, Haruka; Yamamura, Ryo; Hayakawa, Chikara; Tani, Soji; Tsuchiya, Koki; Shirahata, Toshiyuki; Toyone, Tomoaki; Nagai, Takashi; Inagaki, Katsunori			Risk factors predicting osteosarcopenia in postmenopausal women with osteoporosis: A retrospective study	PLOS ONE			English	Article							BODY-MASS INDEX; VITAMIN-D; SARCOPENIA; MUSCLE; BONE; OBESITY; DETERMINANTS; ASSOCIATION; FRAILTY; HEALTH	There is growing interest in "osteosarcopenia" as the coexistence of osteoporosis and sarcopenia exacerbates negative outcomes. However, limited information is available regarding the risk factors of osteosarcopenia development in patients with osteoporosis. Therefore, we retrospectively reviewed 276 consecutive patients with postmenopausal osteoporosis who regularly visited Showa University Hospital. Patients were eligible for the study if they were >= 65 years of age and underwent dual-energy X-ray absorptiometry, blood sampling, and physical performance assessment. Patients were divided into the osteosarcopenia and osteoporosis alone groups according to the diagnostic criteria of the Asian Working Group for Sarcopenia. Of the 276 patients with osteoporosis, 54 patients (19.6%) had osteosarcopenia. Patients in the osteosarcopenia group had a greater risk of frailty than did those in the osteoporosis alone group (odds ratio 2.33; 95% confidence interval, 1.13-4.80, P = 0.028). Low body mass index seemed to be the strongest factor related to the development of osteosarcopenia, and none of the patients in the osteosarcopenia group were obese (BMI >= 27.5 kg/m(2)). Multiple logistic analyses revealed that patients aged 65-74 years who had comorbidities such as kidney dysfunction and high levels of HbA1c were at risk of developing osteosarcopenia. Thus, we strongly recommend the assessment of the key components of the diagnosis of osteosarcopenia in an osteoporosis clinic for patients with low body mass index. Furthermore, appropriate assessments, including comorbidities, will help in identifying patients at greater risk of developing osteosarcopenia.	[Okamura, Hiroki; Ishikawa, Koji; Kudo, Yoshifumi; Matsuoka, Akira; Maruyama, Hiroshi; Emori, Haruka; Yamamura, Ryo; Hayakawa, Chikara; Tani, Soji; Tsuchiya, Koki; Shirahata, Toshiyuki; Toyone, Tomoaki; Nagai, Takashi; Inagaki, Katsunori] Showa Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan	Showa University	Ishikawa, K (corresponding author), Showa Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan.	koji.ishikawa@med.showa-u.ac.jp	Ishikawa, Koji/ABC-4850-2020; Okamura, Hiroki/GYU-1536-2022	Ishikawa, Koji/0000-0003-3689-5662; Nagai, Takashi/0000-0002-8815-1182; Okamura, Hiroki/0000-0002-7702-0320	KAKENHI [17K18114, 19K18544]; Japan Orthopaedics and Traumatology Research Foundation [399]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Orthopaedics and Traumatology Research Foundation	This work was supported by grants awarded to K.I by KAKENHI (17K18114 and 19K18544) (KI) and Grant of Japan Orthopaedics and Traumatology Research Foundation (Grant No.399) (KI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy Meliha Kasapoglu, 2019, Folia Med (Plovdiv), V61, P397, DOI 10.3897/folmed.61.e39346; Arai H, 2018, GERIATR GERONTOL INT, V18, P5, DOI 10.1111/ggi.13310; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Beaudart C, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0349-4; Binkley N, 2009, J CLIN DENSITOM, V12, P413, DOI 10.1016/j.jocd.2009.06.004; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Crepaldi G, 2005, J Endocrinol Invest, V28, P66; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Curtis E, 2015, J CELL PHYSIOL, V230, P2618, DOI 10.1002/jcp.25001; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Galvao DA, 2007, PROSTATE CANCER P D, V10, P340, DOI 10.1038/sj.pcan.4500975; Hamad B, 2020, AGING CLIN EXP RES, V32, P1923, DOI 10.1007/s40520-019-01399-w; Hassan EB, 2017, AUST FAM PHYSICIAN, V46, P849; Hirschfeld HP, 2017, OSTEOPOROSIS INT, V28, P2781, DOI 10.1007/s00198-017-4151-8; Huo YR, 2015, J AM MED DIR ASSOC, V16, P290, DOI 10.1016/j.jamda.2014.10.018; Ishikawa K, 2018, CLIN INTERV AGING, V13, P1929, DOI 10.2147/CIA.S180614; Ishikawa K, 2018, CLIN SPINE SURG, V31, pE473, DOI 10.1097/BSD.0000000000000703; Johansson H, 2014, J BONE MINER RES, V29, P223, DOI 10.1002/jbmr.2017; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kawao N, 2015, J CELL BIOCHEM, V116, P687, DOI 10.1002/jcb.25040; Kim MK, 2011, J CLIN ENDOCR METAB, V96, P3250, DOI 10.1210/jc.2011-1602; Kohara K, 2014, ENDOCRINE, V45, P15, DOI 10.1007/s12020-013-9992-0; Nuti R, 2019, INTERN EMERG MED, V14, P85, DOI 10.1007/s11739-018-1874-2; Okochi J., 2006, Geriatrics and Gerontology International, V6, P223, DOI 10.1111/j.1447-0594.2006.00352.x; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Soen S, 2013, J BONE MINER METAB, V31, P247, DOI [CliCa1403323329, 10.1007/s00774-013-0447-8]; Tagliaferri C, 2015, AGEING RES REV, V21, P55, DOI 10.1016/j.arr.2015.03.002; Tanaka K, 2014, BIOCHEM BIOPH RES CO, V450, P482, DOI 10.1016/j.bbrc.2014.05.145; Trajanoska K, 2019, CURR OSTEOPOROS REP, V17, P86, DOI 10.1007/s11914-019-00505-1; Vincent HK, 2012, AGEING RES REV, V11, P361, DOI 10.1016/j.arr.2012.03.002; Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604; Wang YJ, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/482940; Wannamethee SG, 2015, P NUTR SOC, V74, P405, DOI 10.1017/S002966511500169X; Yoshimura N, 2018, OSTEOPOROSIS INT, V29, P2181, DOI 10.1007/s00198-018-4596-4; Yoshimura N, 2017, OSTEOPOROSIS INT, V28, P189, DOI 10.1007/s00198-016-3823-0; Yoshimura N, 2004, OSTEOPOROSIS INT, V15, P139, DOI 10.1007/s00198-003-1518-9; Yoshimura Y, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.03.019	40	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237454	10.1371/journal.pone.0237454	http://dx.doi.org/10.1371/journal.pone.0237454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764814	gold, Green Published			2022-12-26	WOS:000561029000076
J	Albonico, F; Barelli, C; Albanese, D; Manica, M; Partel, E; Rosso, F; Ripellino, S; Pindo, M; Donati, C; Zecconi, A; Mortarino, M; Hauffe, HC				Albonico, Francesca; Barelli, Claudia; Albanese, Davide; Manica, Mattia; Partel, Erika; Rosso, Fausta; Ripellino, Silvia; Pindo, Massimo; Donati, Claudio; Zecconi, Alfonso; Mortarino, Michele; Hauffe, Heidi C.			Raw milk and fecal microbiota of commercial Alpine dairy cows varies with herd, fat content and diet	PLOS ONE			English	Article							BACTERIAL DIVERSITY; GUT MICROBIOTA; LACTATING DAIRY; CYSTIC-FIBROSIS; CATTLE; BUTYRATE; ORIGIN; HEALTH; BACTEROIDES; RESILIENCE	The factors that influence the diversity and composition of raw milk and fecal microbiota in healthy commercial dairy herds are not fully understood, partially because the majority of metataxonomic studies involve experimental farms and/or single factors. We analyzed the raw milk and fecal microbiota of 100 healthy cows from 10 commercial alpine farms from the Province of Trento, Italy, using metataxonomics and applied statistical modelling to investigate which extrinsic and intrinsic parameters (e.g. herd, diet and milk characteristics) correlated with microbiota richness and composition in these relatively small traditional farms. We confirmed that Firmicutes,RuminococcaceaeandLachnospiraceaefamilies dominated the fecal and milk samples of these dairy cows, but in addition, we found an association between the number of observed OTUs and Shannon entropy on each farm that indicates higher microbiota richness is associated with increased microbiota stability. Modelling showed that herd was the most significant factor affecting the variation in both milk and fecal microbiota composition. Furthermore, the most important predictors explaining the variation of microbiota richness were milk characteristics (i.e. percentage fat) and diet for milk and fecal samples, respectively. We discuss how high intra-herd variation could affect the development of treatments based on microbiota manipulation.	[Albonico, Francesca; Barelli, Claudia; Manica, Mattia; Rosso, Fausta; Ripellino, Silvia; Hauffe, Heidi C.] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, Trento, Italy; [Albonico, Francesca; Mortarino, Michele] Univ Milan, Dept Vet Med, Milan, Italy; [Barelli, Claudia] Univ Florence, Dept Biol, Florence, Italy; [Albanese, Davide; Donati, Claudio] Fdn Edmund Mach, Res & Innovat Ctr, Unit Computat Biol, Trento, Italy; [Partel, Erika] Fdn Edmund Mach, Technol Transfer Ctr, Trento, Italy; [Pindo, Massimo] Fdn Edmund Mach, Res & Innovat Ctr, Dept Genom & Biol Fruit Crops, Trento, Italy; [Zecconi, Alfonso] Univ Milan, Dept Biomed Surg & Dent Sci, Milan, Italy; [Albonico, Francesca] Stellenbosch Univ, Inst Wine Biotechnol, Dept Viticulture & Oenol, Matieland, South Africa	Fondazione Edmund Mach; University of Milan; University of Florence; Fondazione Edmund Mach; Fondazione Edmund Mach; Fondazione Edmund Mach; University of Milan; Stellenbosch University	Barelli, C; Hauffe, HC (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, Trento, Italy.; Barelli, C (corresponding author), Univ Florence, Dept Biol, Florence, Italy.	barelli.cla@gmail.com; heidi.hauffe@fmach.it	Hauffe, Heidi Christine/AAU-1684-2021; Albanese, Davide/AAA-7295-2021; Donati, Claudio/J-5180-2012; Zecconi, Alfonso/C-7148-2009	Hauffe, Heidi Christine/0000-0003-3098-8964; Albanese, Davide/0000-0002-9493-3850; Pindo, Massimo/0000-0002-8516-9010; Donati, Claudio/0000-0001-8688-1651; Zecconi, Alfonso/0000-0002-3127-8385; Barelli, Claudia/0000-0002-5979-3442; MANICA, MATTIA/0000-0003-3709-1199	Italian Fondazione Cassa di Risparmio di Trento e Rovereto (CARITRO)	Italian Fondazione Cassa di Risparmio di Trento e Rovereto (CARITRO)	The Italian Fondazione Cassa di Risparmio di Trento e Rovereto (CARITRO) financially supported this study by a grant to the Project MASTIRISK to FA and HCH.	Addis MF, 2016, MOL BIOSYST, V12, P2359, DOI 10.1039/c6mb00217j; Albanese D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09743; Atherly T, 2014, MICROBIOLOGYOPEN, V3, P225, DOI 10.1002/mbo3.159; Bandelj P, 2016, VET RES, V47, DOI 10.1186/s13567-016-0326-0; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bendiks M, 2013, CURR ALLERGY ASTHM R, V13, P487, DOI 10.1007/s11882-013-0382-8; Bonizzi I, 2009, J APPL MICROBIOL, V107, P1319, DOI 10.1111/j.1365-2672.2009.04311.x; Braem G, 2013, J DAIRY SCI, V96, P1499, DOI 10.3168/jds.2012-5493; Breen JE, 2009, J DAIRY SCI, V92, P3106, DOI 10.3168/jds.2008-1562; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Cheng YY, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0143-0; Clayton JB, 2018, AM J PRIMATOL, V80, DOI 10.1002/ajp.22867; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Davis MY, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0198-6; Decaestecker E, 2013, ECOL LETT, V16, P1455, DOI 10.1111/ele.12186; Derakhshani H, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02143; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Deusch S, 2015, COMPUT STRUCT BIOTEC, V13, P55, DOI 10.1016/j.csbj.2014.12.005; DEVEREUX R, 1990, J BACTERIOL, V172, P3609, DOI 10.1128/jb.172.7.3609-3619.1990; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Downing AL, 2014, ECOLOGY, V95, P173, DOI 10.1890/12-1406.1; Doyle CJ, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.02694-16, 10.1128/aem.02694-16]; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Duytschaever G, 2013, J CYST FIBROS, V12, P206, DOI 10.1016/j.jcf.2012.10.003; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Falentin H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00480; Fernandez L, 2013, PHARMACOL RES, V69, P1, DOI 10.1016/j.phrs.2012.09.001; Ganda EK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0291-5; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Gill JJ, 2006, FEMS MICROBIOL ECOL, V56, P471, DOI 10.1111/j.1574-6941.2006.00091.x; Greenhalgh K, 2016, ENVIRON MICROBIOL, V18, P2103, DOI 10.1111/1462-2920.13318; Guan Y, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0517-8; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hauffe HC, 2019, CONSERV GENET, V20, P19, DOI 10.1007/s10592-019-01150-y; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Hollister EB, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0101-x; Honneffer JB, 2014, WORLD J GASTROENTERO, V20, P16489, DOI 10.3748/wjg.v20.i44.16489; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hu XL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01674; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Illumina, 16S MET SEQ LIB PREP; Indugu N, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1098-z; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787; Karkman A, 2017, ANN NY ACAD SCI, V1399, P78, DOI 10.1111/nyas.13326; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Kim M, 2014, J ANIM SCI, V92, P683, DOI 10.2527/jas.2013-6841; Klein-Jobstl D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00622; Kreisinger J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0295; Kuehn JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061959; La-ongkham O, 2015, ARCH MICROBIOL, V197, P561, DOI 10.1007/s00203-015-1089-0; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li L, 2014, CLIN NUTR, V33, P571, DOI 10.1016/j.clnu.2014.04.004; Mahmoud KK, 2007, APPL ENVIRON MICROB, V73, P7488, DOI 10.1128/AEM.01112-07; Mao SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16116; Mao SY, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-237; McIlroy J, 2018, ALIMENT PHARM THER, V47, P26, DOI 10.1111/apt.14384; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Tang MT, 2017, APPL MICROBIOL BIOT, V101, P6355, DOI 10.1007/s00253-017-8348-8; Oikonomou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085904; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Onishi JC, 2017, MICROBIOL-SGM, V163, P1189, DOI 10.1099/mic.0.000496; Pascoe EL, 2017, ISME J, V11, P2644, DOI 10.1038/ismej.2017.133; Piccinini R, 2005, VET RES, V36, P747, DOI 10.1051/vetres:2005030; Piccinini R, 2004, VET RES, V35, P539, DOI 10.1051/vetres:2004030; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030; R Core Team, 2020, R LANG ENV STAT COMP; Raats D, 2011, FOOD MICROBIOL, V28, P465, DOI 10.1016/j.fm.2010.10.009; RAHMAN H, 1985, ZBL VET MED B, V32, P71; Rice WC, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-25; Rodriguez JM, 2014, ADV NUTR, V5, P779, DOI 10.3945/an.114.007229; Rudi K, 2012, VET MICROBIOL, V160, P369, DOI 10.1016/j.vetmic.2012.06.003; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Shah HN, 2009, ANAEROBE, V15, P179, DOI 10.1016/j.anaerobe.2009.08.003; Shanks OC, 2011, APPL ENVIRON MICROB, V77, P2992, DOI 10.1128/AEM.02988-10; Siqueira JF, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.21077; Sloss MW, 1982, PARASSITI MED VET ME; Soulsby EJL, 1986, HELMINTHS ARTHROPODS, V7; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Sun JJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41403; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Tolle A., 1980, B INT DAIRY FED, V120, P4; Van Immerseel F, 2010, J MED MICROBIOL, V59, P141, DOI 10.1099/jmm.0.017541-0; VANCE HN, 1967, CAN J COMPARAT MED, V31, P248; Warinner C, 2014, SCI REP-UK, V4, DOI 10.1038/srep07104; Weese JS, 2017, J VET INTERN MED, V31, P176, DOI 10.1111/jvim.14611; Weese JS, 2015, EQUINE VET J, V47, P641, DOI 10.1111/evj.12361; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Xu HY, 2017, SCI BULL, V62, P767, DOI 10.1016/j.scib.2017.04.019; Yang SZ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01717; Young W, 2015, PEERJ, V3, DOI 10.7717/peerj.888; Zecconi A, 2018, J DAIRY RES, V85, P167, DOI [10.1017/S0022029918000316, 10.1017/s0022029918000316]; Zhang RY, 2015, J SCI FOOD AGR, V95, P1072, DOI 10.1002/jsfa.6800	100	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237262	10.1371/journal.pone.0237262	http://dx.doi.org/10.1371/journal.pone.0237262			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760129	Green Published, gold			2022-12-26	WOS:000561027200003
J	Aoki, S; Hosomi, N; Nishi, H; Nakamori, M; Nezu, T; Shiga, Y; Kinoshita, N; Ueno, H; Ishikawa, K; Imamura, E; Shintani, T; Ohge, H; Kawaguchi, H; Kurihara, H; Maruyama, H				Aoki, Shiro; Hosomi, Naohisa; Nishi, Hiromi; Nakamori, Masahiro; Nezu, Tomohisa; Shiga, Yuji; Kinoshita, Naoto; Ueno, Hiroki; Ishikawa, Kenichi; Imamura, Eiji; Shintani, Tomoaki; Ohge, Hiroki; Kawaguchi, Hiroyuki; Kurihara, Hidemi; Maruyama, Hirofumi			Serum IgG titers to periodontal pathogens predict 3-month outcome in ischemic stroke patients	PLOS ONE			English	Article							FUSOBACTERIUM-NUCLEATUM; PORPHYROMONAS-GINGIVALIS; ANTIBODY-LEVELS; DISEASE; ASSOCIATION; BACTERIA; BRAIN; ACTINOMYCETEMCOMITANS; INFECTIONS; MARKERS	Several cohort studies have shown that periodontal disease is associated with an increased risk for stroke. However, it remains unclear whether serum antibody titers for a specific periodontal pathogen are associated with outcome after ischemic stroke, and which kinds of pathogens are associated with ischemic stroke. We examined the relationship between serum IgG titers to periodontal pathogens and outcome in ischemic stroke patients. A total of 445 patients with acute ischemic stroke (194 female [44.0%], mean age 71.9 +/- 12.3 years) were registered in this study. Serum IgG titers to 9 periodontal pathogens (Porphyromonas gingivalis,Aggregatibacter actinomycetemcomitans,Prevotella intermedia,Prevotella nigrescens,Fusobacterium nucleatum,Treponema denticola,Tannerella forsythensis,Campylobacter rectus,Eikenella corrodens) were evaluated using the enzyme-linked immunosorbent assay (ELISA) method. An unfavorable outcome was defined as a 3 or higher on the modified Rankin Scale. The proportion of patients with unfavorable outcome was 25.4% (113 patients). Based on multivariate logistic regression analysis, numbers of IgG antibodies positive for periodontal pathogens (odds ratio 1.20, 95% CI 1.02-1.41, p = 0.03) were independent predictors of unfavorable outcome in ischemic stroke patients.	[Aoki, Shiro; Nezu, Tomohisa; Shiga, Yuji; Kinoshita, Naoto; Ueno, Hiroki; Ishikawa, Kenichi; Maruyama, Hirofumi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan; [Hosomi, Naohisa] Chikamori Hosp, Dept Neurol, Kochi, Japan; [Hosomi, Naohisa] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Hiroshima, Japan; [Nishi, Hiromi; Kawaguchi, Hiroyuki] Hiroshima Univ Hosp, Dept Gen Dent, Hiroshima, Japan; [Nakamori, Masahiro; Ishikawa, Kenichi; Imamura, Eiji] Suiseikai Kajikawa Hosp, Dept Neurol, Hiroshima, Japan; [Shintani, Tomoaki; Kurihara, Hidemi] Hiroshima Univ Hosp, Ctr Oral Examinat, Hiroshima, Japan; [Ohge, Hiroki] Hiroshima Univ Hosp, Dept Infect Dis, Hiroshima, Japan; [Kurihara, Hidemi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Periodontal Med, Div Appl Life Sci, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University	Hosomi, N (corresponding author), Chikamori Hosp, Dept Neurol, Kochi, Japan.; Hosomi, N (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Hiroshima, Japan.	nhosomi@hiroshima-u.ac.jp	Maruyama, Hirofumi/B-9333-2011	Maruyama, Hirofumi/0000-0001-7613-8717; Aoki, Shiro/0000-0001-5348-5783	JSPS KAKENHI [17K17350, 17K17907, 18K10746]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by research grants from JSPS KAKENHI Grant Number (17K17350, 17K17907, and 18K10746). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Beck JD, 2005, CIRCULATION, V112, P19, DOI 10.1161/CIRCULATIONAHA.104.511998; Chen ZY, 2012, AM J MED, V125, P568, DOI 10.1016/j.amjmed.2011.10.034; Colhoun HM, 2008, J PERIODONTAL RES, V43, P103, DOI 10.1111/j.1600-0765.2007.01001.x; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Dye BA, 2009, J PERIODONTOL, V80, P634, DOI 10.1902/jop.2009.080474; Feuille F, 1996, INFECT IMMUN, V64, P2095, DOI 10.1128/IAI.64.6.2094-2100.1996; Field CA, 2012, J PERIODONTAL RES, V47, P470, DOI 10.1111/j.1600-0765.2011.01455.x; Haheim LL, 2008, J CLIN PERIODONTOL, V35, P473, DOI 10.1111/j.1600-051X.2008.01229.x; Han YPW, 2015, CURR OPIN MICROBIOL, V23, P141, DOI 10.1016/j.mib.2014.11.013; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Heckmann JG, 2003, CAN J NEUROL SCI, V30, P266, DOI 10.1017/S0317167100002717; Hosomi N, 2012, CEREBROVASC DIS, V34, P385, DOI 10.1159/000343659; Kai A, 2008, J MED MICROBIOL, V57, P668, DOI 10.1099/jmm.0.47710-0; Kudo C, 2012, J DENT RES, V91, P1190, DOI 10.1177/0022034512461796; Lafon A, 2014, EUR J NEUROL, V21, P1155, DOI 10.1111/ene.12415; Lee YL, 2013, STROKE, V44, P1026, DOI 10.1161/STROKEAHA.111.000076; Loesche W J, 1998, Ann Periodontol, V3, P161, DOI 10.1902/annals.1998.3.1.161; Loozen G, 2014, J CLIN PERIODONTOL, V41, P1, DOI 10.1111/jcpe.12167; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McColl BW, 2008, J NEUROSCI, V28, P9451, DOI 10.1523/JNEUROSCI.2674-08.2008; McColl BW, 2007, J NEUROSCI, V27, P4403, DOI 10.1523/JNEUROSCI.5376-06.2007; Nakahara T, 2018, J GASTROENTEROL, V53, P269, DOI 10.1007/s00535-017-1368-4; Nishi H, 2020, CLIN EXP IMMUNOL, V200, P302, DOI 10.1111/cei.13430; O'Boyle C, 2020, INT J STROKE, V15, P175, DOI 10.1177/1747493019834191; Park SR, 2014, INFECT IMMUN, V82, P1914, DOI 10.1128/IAI.01226-13; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pussinen PJ, 2004, STROKE, V35, P2020, DOI 10.1161/01.STR.0000136148.29490.fe; Pussinen PJ, 2002, J CLIN MICROBIOL, V40, P512, DOI 10.1128/JCM.40.2.512-518.2002; Pyysalo MJ, 2013, J NEUROL NEUROSUR PS, V84, P1214, DOI 10.1136/jnnp-2012-304635; Rams TE, 2006, J PERIODONTAL RES, V41, P228, DOI 10.1111/j.1600-0765.2005.00860.x; Riviere GR, 2002, ORAL MICROBIOL IMMUN, V17, P113, DOI 10.1046/j.0902-0055.2001.00100.x; Scannapieco Frank A, 2003, Ann Periodontol, V8, P38, DOI 10.1902/annals.2003.8.1.38; Sen S, 2018, STROKE, V49, P355, DOI 10.1161/STROKEAHA.117.018990; Singhrao SK, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2016.1270602; Stein PS, 2012, ALZHEIMERS DEMENT, V8, P196, DOI 10.1016/j.jalz.2011.04.006; SYRJANEN J, 1989, J INTERN MED, V225, P179, DOI 10.1111/j.1365-2796.1989.tb00060.x; Takeuchi Y, 2006, ORAL MICROBIOL IMMUN, V21, P314, DOI 10.1111/j.1399-302X.2006.00296.x; Wu TJ, 2000, ARCH INTERN MED, V160, P2749, DOI 10.1001/archinte.160.18.2749; Yamazaki K, 2007, CLIN EXP IMMUNOL, V149, P445, DOI 10.1111/j.1365-2249.2007.03450.x	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237185	10.1371/journal.pone.0237185	http://dx.doi.org/10.1371/journal.pone.0237185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760103	gold, Green Published			2022-12-26	WOS:000561027200002
J	Chen, YH; Jiang, YN; Chen, Y; Feng, WX; Liu, GY; Yu, CM; Lian, BL; Zhong, F; Zhang, J				Chen, Yanhong; Jiang, Yuna; Chen, Yu; Feng, Wenxiang; Liu, Guoyuan; Yu, Chunmei; Lian, Bolin; Zhong, Fei; Zhang, Jian			Uncovering candidate genes responsive to salt stress in Salix matsudana (Koidz) by transcriptomic analysis	PLOS ONE			English	Article							ARABIDOPSIS; TOLERANCE; IDENTIFICATION; EXPRESSION; GROWTH; OVEREXPRESSION; PROTEIN	Salix matsudana, a member ofSalicaceae, is an important ornamental tree in China. Because of its capability to tolerate high salt conditions,S.matsudanaalso plays an important ecological role when grown along Chinese coastal beaches, where the salinity content is high. Here, we aimed to elucidate the mechanism of higher salt tolerance inS.matsudanavariety '9901' by identifying the associated genes through RNA sequencing and comparing differential gene expression between theS.matsudanasalt-tolerant and salt-sensitive samples treated with 150 mM NaCl. Transcriptomic comparison of the roots of the two samples revealed 2174 and 3159 genes responsive to salt stress in salt-sensitive and salt-tolerant sample, respectively. Real-time polymerase chain reaction analysis of 9 of the responsive genes revealed a strong, positive correlation with RNA sequencing data. The genes were enriched in several pathways, including carbon metabolism pathway, plant-pathogen interaction pathway, and plant hormone signal transduction pathway. Differentially expressed genes (DEGs) encoding transcription factors associated with abiotic stress responses and salt stress response network were identified; their expression levels differed between the two samples in response to salt stress. Hub genes were also revealed by weighted gene co-expression network (WGCNA) analysis. For functional analysis of the DEG encoding sedoheptulose-1,7-bisphosphatase (SBPase), the gene was overexpressed in transgenicArabidopsis, resulting in increased photosynthetic rates, sucrose and starch accumulation, and enhanced salt tolerance. Further functional characterization of other hub DEGs will reveal the molecular mechanism of salt tolerance inS.matsudanaand allow the application ofS.matsudanain coastal afforestation.	[Chen, Yanhong; Jiang, Yuna; Feng, Wenxiang; Liu, Guoyuan; Yu, Chunmei; Lian, Bolin; Zhong, Fei; Zhang, Jian] Nantong Univ, Sch Life Sci, Lab Landscape Plant Genet & Breeding, Nantong, Peoples R China; [Chen, Yu] Nanjing Agr Univ, Coll Hort, Nanjing, Peoples R China	Nantong University; Nanjing Agricultural University	Zhang, J (corresponding author), Nantong Univ, Sch Life Sci, Lab Landscape Plant Genet & Breeding, Nantong, Peoples R China.	ntdxylzw@163.com	jiang, Yuna/GSN-6446-2022	Zhang, Jian/0000-0002-6662-4911	National Natural Science Foundation of China [31971681]; Jiangsu Province Forestry Science and Technology Innovation and Promotion Project [LYKJ [2018]36]; Nantong University Scientific Research Start-up project for Introducing Talents [18R08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Forestry Science and Technology Innovation and Promotion Project; Nantong University Scientific Research Start-up project for Introducing Talents	Jiang Zhang received the following three funds: National Natural Science Foundation of China (31971681,http://www.nsfc.gov.cn/), Jiangsu Province Forestry Science and Technology Innovation and Promotion Project (LYKJ [2018]36, http://jsf.jiangsu.gov.cn/) and Nantong University Scientific Research Start-up project for Introducing Talents (18R08,http://www.ntu.edu.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amirbakhtiar N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213305; Argus G. W., 1997, SYST BOT MONOGR, V52, P1, DOI DOI 10.2307/25096638; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; Chen CJ, 2020, MOL PLANT, V13, P1194, DOI 10.1016/j.molp.2020.06.009; Chen MS, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-2069-3; Chen YH, 2018, BIOL PLANTARUM, V62, P222, DOI 10.1007/s10535-017-0756-1; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Coolen S, 2016, PLANT J, V86, P249, DOI 10.1111/tpj.13167; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Feng LL, 2007, FUNCT PLANT BIOL, V34, P822, DOI 10.1071/FP07074; Goyal E, 2016, SCI REP-UK, V6, DOI 10.1038/srep27752; Jia HX, 2019, PLANT PHYSIOL BIOCH, V144, P222, DOI 10.1016/j.plaphy.2019.09.042; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li H, 2019, SCI TOTAL ENVIRON, V669, P258, DOI 10.1016/j.scitotenv.2019.03.104; Li JB, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103246; Li QT, 2013, INT J MOL SCI, V14, P21053, DOI 10.3390/ijms141021053; Li Y, 2017, PLANTA, V246, P91, DOI 10.1007/s00425-017-2688-6; Liu MY, 2014, MOL BIOL REP, V41, P6555, DOI 10.1007/s11033-014-3539-1; Liu XL, 2012, MOL PLANT, V5, P1082, DOI 10.1093/mp/sss012; Luo SS, 2018, LAND DEGRAD DEV, V29, P1107, DOI 10.1002/ldr.2895; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Meng LS, 2015, J CELL SCI, V128, P2919, DOI 10.1242/jcs.172072; Meraj TA, 2020, GENES-BASEL, V11, DOI 10.3390/genes11040346; Petropoulos SA, 2017, FOOD CHEM, V214, P129, DOI 10.1016/j.foodchem.2016.07.080; Song XX, 2016, GENE, V576, P520, DOI 10.1016/j.gene.2015.10.069; Tian XM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200938; van Dijk EL, 2018, TRENDS GENET, V34, P666, DOI 10.1016/j.tig.2018.05.008; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wu B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171451; Xie RJ, 2018, FUNCT INTEGR GENOMIC, V18, P155, DOI 10.1007/s10142-017-0582-8; Xing DH, 2015, PLANT CELL, V27, P3294, DOI 10.1105/tpc.15.00641; Yang YQ, 2018, J INTEGR PLANT BIOL, V60, P796, DOI 10.1111/jipb.12689; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang F, 2016, SCI REP-UK, V6, DOI 10.1038/srep20582; Zhang J, 2017, HORTIC RES-ENGLAND, V4, DOI 10.1038/hortres.2017.24; Zhang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157777; Zhang J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00748; Zhou Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146242	40	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236129	10.1371/journal.pone.0236129	http://dx.doi.org/10.1371/journal.pone.0236129			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760076	gold, Green Published			2022-12-26	WOS:000561027200072
J	Piccolomini, EL; Zama, F				Loli Piccolomini, Elena; Zama, Fabiana			Monitoring Italian COVID-19 spread by a forced SEIRD model	PLOS ONE			English	Article								Due to the recent evolution of the COVID-19 outbreak, the scientific community is making efforts to analyse models for understanding the present situation and for predicting future scenarios. In this paper, we propose a forced Susceptible-Exposed-Infected-Recovered-Dead (fSEIRD) differential model for the analysis and forecast of the COVID-19 spread in Italian regions, using the data from the Italian Protezione Civile (Italian Civil Protection Department) from 24/02/2020. In this study, we investigate an adaptation of fSEIRD by proposing two different piecewise time-dependent infection rate functions to fit the current epidemic data affected by progressive movement restriction policies put in place by the Italian government. The proposed models are flexible and can be quickly adapted to monitor various epidemic scenarios. Results on the regions of Lombardia and Emilia-Romagna confirm that the proposed models fit the data very accurately and make reliable predictions.	[Loli Piccolomini, Elena] Univ Bologna, Dept Comp Sci & Engn, Bologna, Italy; [Zama, Fabiana] Univ Bologna, Dept Math, Bologna, Italy	University of Bologna; University of Bologna	Zama, F (corresponding author), Univ Bologna, Dept Math, Bologna, Italy.	fabiana.zama@unibo.it	Zama, Fabiana/Q-7798-2018; loli piccolomini, elena/A-1737-2017	Zama, Fabiana/0000-0003-3961-4037; loli piccolomini, elena/0000-0002-9951-3564				Allen Linda J S, 2017, Infect Dis Model, V2, P128, DOI 10.1016/j.idm.2017.03.001; Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; Brauer Fred, 2017, Infect Dis Model, V2, P113, DOI 10.1016/j.idm.2017.02.001; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Keeling M.J., 2011, MODELING INFECT DIS, DOI 10.1111/j.1541-0420.2008.01082-_}7.x; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kounchev O., 2020, ARXIV200411338; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Lopez L., 2020, MODIFIED SEIR MODEL, DOI DOI 10.2139/SSRN.3576802; Morettini M, 2020, DATA BRIEF, V30, DOI 10.1016/j.dib.2020.105526; Piccolomini E. L., 2020, ARXIV200309909; Russo L, 2020, TRACING DAY ZERO FOR, DOI 10.1101/2020.03.17.20037689; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Weitz JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08751; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Zama F., 2016, IFIP ADV INFORM COMM, P517; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	19	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237417	10.1371/journal.pone.0237417	http://dx.doi.org/10.1371/journal.pone.0237417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760133	Green Published, gold			2022-12-26	WOS:000561027200074
J	Shi, PY; Yan, J; Keskinocak, P; Shane, AL; Swann, JL				Shi, Pengyi; Yan, Jia; Keskinocak, Pinar; Shane, Andi L.; Swann, Julie L.			The impact of opening dedicated clinics on disease transmission during an influenza pandemic	PLOS ONE			English	Article							AGENT-BASED SIMULATION; STRATEGIES; SPREAD; MODEL	Dedicated clinics can be established in an influenza pandemic to isolate people and potentially reduce opportunities for influenza transmission. However, their operation requires resources and their existence may attract the worried-well. In this study, we quantify the impact of opening dedicated influenza clinics during a pandemic based on an agent-based simulation model across a time-varying social network of households, workplaces, schools, community locations, and health facilities in the state of Georgia. We calculate performance measures, including peak prevalence and total attack rate, while accounting for clinic operations, including timing and location. We find that opening clinics can reduce disease spread and hospitalizations even when visited by the worried-well, open for limited weeks, or open in limited locations, and especially when the clinics are in operation during times of highest prevalence. Specifically, peak prevalence, total attack rate, and hospitalization reduced 0.07-0.32%, 0.40-1.51%, 0.02-0.09%, respectively, by operating clinics for the pandemic duration.	[Shi, Pengyi] Purdue Univ, Krannert Sch Management, W Lafayette, IN 47907 USA; [Yan, Jia; Keskinocak, Pinar] Georgia Inst Technol, Sch Ind & Syst Engn, Atlanta, GA 30332 USA; [Shane, Andi L.] Emory Univ, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA; [Shane, Andi L.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Swann, Julie L.] North Carolina State Univ, Dept Ind & Syst Engn, Raleigh, NC 27695 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University System of Georgia; Georgia Institute of Technology; Emory University; Children's Healthcare of Atlanta (CHOA); University of North Carolina; North Carolina State University	Swann, JL (corresponding author), North Carolina State Univ, Dept Ind & Syst Engn, Raleigh, NC 27695 USA.	jlswann@ncsu.edu		Swann, Julie/0000-0003-2151-4396	Georgia Tech; Edward P. Fitts and the A. Doug Allison Distinguished Professorship	Georgia Tech; Edward P. Fitts and the A. Doug Allison Distinguished Professorship	This research has been supported in part by a seed grant from Georgia Tech and by the following Georgia Tech benefactors: William W. George, Andrea Laliberte, Claudia L. and J. Paul Raines, and Richard E. "Rick" and Charlene Zalesky. This research has also been supported by Edward P. Fitts and the A. Doug Allison Distinguished Professorship. Any opinions, findings, conclusions, or recommendations are those of the authors and do not necessarily reflect the views of the funding organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aleman DM, 2011, INTERFACES, V41, P301, DOI 10.1287/inte.1100.0550; [Anonymous], 2009, NEW YORK TIMES; Arino J, 2008, J THEOR BIOL, V253, P118, DOI 10.1016/j.jtbi.2008.02.026; Atlanta Regional Commission, 2013, ATL REG; Carrasco LR, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-3; Carrat F, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-26; Centers for Disease Control and Prevention, 2016, INFL FLU; Centers for Disease Control and Prevention, 2013, PEOPL HIGH RISK DEV; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; Ekici A, 2014, M&SOM-MANUF SERV OP, V16, P11, DOI 10.1287/msom.2013.0460; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FitzGerald G, 2012, EMERG MED AUSTRALAS, V24, P159, DOI 10.1111/j.1742-6723.2011.01519.x; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Halder N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-168; Hutton D. W, 2013, OPERATIONS RES HLTH, P225; Li Z., PLOS ONE, V13, DOI [10.1371/journal.pone.020629330359445, DOI 10.1371/JOURNAL.PONE.020629330359445]; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; MediSys Health Network, 2009, PAND INFL PLANN QUEE; Mniszewski SM, 2014, INTEL SYST REF LIBR, V52, P97, DOI 10.1007/978-3-642-39149-1_8; National Center for Health Statistics, 2009, HLTH US 2008 SPEC FE; Prieto DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-251; Roell J, CCHMC PATIENT SURGE; Shi P, 2010, EPIDEMIOL INFECT, V138, P1472, DOI 10.1017/S0950268810000300; Shi PY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-778; Shih HI, 2012, AM J INFECT CONTROL, V40, P165, DOI 10.1016/j.ajic.2011.03.006; Soto-Ferrari M, 2013, PROCEDIA COMPUT SCI, V18, P2187, DOI 10.1016/j.procs.2013.05.389; Tracht SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009018; United States Census Bureau Department of Commence, 2000, CENS; University of Minnesota Center for Infectious Disease Research and Policy, 2009, WORR WELL OV GIV TAS; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361	33	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236455	10.1371/journal.pone.0236455	http://dx.doi.org/10.1371/journal.pone.0236455			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760086	Green Published, Green Submitted, gold			2022-12-26	WOS:000561027200025
J	Boscaro, C; Carotti, M; Albiero, M; Trenti, A; Fadini, GP; Trevisi, L; Sandona, D; Cignarella, A; Bolego, C				Boscaro, Carlotta; Carotti, Marcello; Albiero, Mattia; Trenti, Annalisa; Fadini, Gian Paolo; Trevisi, Lucia; Sandona, Dorianna; Cignarella, Andrea; Bolego, Chiara			Non-genomic mechanisms in the estrogen regulation of glycolytic protein levels in endothelial cells	FASEB JOURNAL			English	Article						endothelium; estrogen; GPER; PFKFB3; USP19	BREAST-CANCER-CELLS; GLUCOSE-TRANSPORTER; RECEPTOR GPER; 6-PHOSPHOFRUCTO-2-KINASE; EXPRESSION; ENZYME; PFKFB3; DEGRADATION; METABOLISM; INHIBITOR	Few studies have explored the mechanisms coupling estrogen signals to metabolic demand in endothelial cells. We recently showed that 17 beta-estradiol (E2) triggers angiogenesis via the membrane G-protein coupled estrogen receptor (GPER) and the key glycolytic protein PFKFB3 as a downstream effector. We herein investigated whether estrogenic agents regulate the stability and/or degradation of glycolytic proteins in human umbilical vein endothelial cells (HUVECs). Similarly to E2, the GPER selective agonist G1 rapidly increased PFKFB3 protein amounts, without affecting mRNA levels. In the presence of cycloheximide, E2 and G1 treatment counteracted PFKFB3 degradation over time, whereas E2-induced PFKFB3 stabilization was abolished by the GPER antagonist G15. Inhibitors of selective SCF E3 ubiquitin ligase (SMER-3) and proteasome (MG132) rapidly increased PFKFB3 protein levels. Accordingly, ubiquitin-bound PFKFB3 was lower in E2- or G1-treated HUVECs. Both agents increased deubiquitinase USP19 levels through GPER signaling. Notably, USP 19 siRNA decreased PFKFB3 levels and abolished E2- and G1-mediated HUVEC tubularization. Finally, E2 and G1 treatments rapidly enhanced glucose transporter GLUT1 levels via GPER independent of transcriptional activation. These findings provide new evidence on mechanisms coupling estrogen signals with the glycolytic program in endothelium and unravel the role of USP19 as a target of the pro-angiogenic effect of estrogenic agents.	[Boscaro, Carlotta; Trenti, Annalisa; Trevisi, Lucia; Bolego, Chiara] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Largo Meneghetti 2, I-35131 Padua, Italy; [Carotti, Marcello; Sandona, Dorianna] Univ Padua, Dept Biomed Sci, Padua, Italy; [Albiero, Mattia; Fadini, Gian Paolo; Cignarella, Andrea] Univ Padua, Dept Med, Padua, Italy; [Albiero, Mattia; Fadini, Gian Paolo] Venetian Inst Mol Med, Padua, Italy	University of Padua; University of Padua; University of Padua; Veneto Institute Molecular Medicine	Bolego, C (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Largo Meneghetti 2, I-35131 Padua, Italy.	chiara.bolego@unipd.it	Albiero, Mattia/AAG-4257-2019	Albiero, Mattia/0000-0003-4142-9738	Universita degli Studi di Padova (University of Padova) [PRID 2018]; Muscular Dystrophy Association (MDA) [577888]	Universita degli Studi di Padova (University of Padova); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association)	Universita degli Studi di Padova (University of Padova), Grant/Award Number: PRID 2018; Muscular Dystrophy Association (MDA), Grant/Award Number: 577888	Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Arao Y, 2018, MOL METAB, V18, P68, DOI 10.1016/j.molmet.2018.09.006; Arnal JF, 2010, ARTERIOSCL THROM VAS, V30, P1506, DOI 10.1161/ATVBAHA.109.191221; Atsumi T, 2002, CANCER RES, V62, P5881; Auslander D, 2018, NAT METHODS, V15, P57, DOI [10.1038/NMETH.4505, 10.1038/nmeth.4505]; Bando H, 2005, CLIN CANCER RES, V11, P5784, DOI 10.1158/1078-0432.CCR-05-0149; Barton M, 2018, J STEROID BIOCHEM, V176, P4, DOI 10.1016/j.jsbmb.2017.03.021; Bolego C, 2006, BIOCHEM BIOPH RES CO, V339, P188, DOI 10.1016/j.bbrc.2005.11.017; Bolego C, 2006, ARTERIOSCL THROM VAS, V26, P2192, DOI 10.1161/01.ATV.0000242186.93243.25; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Carpentier G, 2012, 4 IMAGEJ US DEV C P, P198; Cheng CM, 2001, FASEB J, V15, P907, DOI 10.1096/fj.00-0398com; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Cignarella A, 2010, TRENDS PHARMACOL SCI, V31, P183, DOI 10.1016/j.tips.2010.01.001; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; De Francesco EM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122713; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Doddaballapur A, 2015, ARTERIOSCL THROM VAS, V35, P137, DOI 10.1161/ATVBAHA.114.304277; DONOHUE TM, 1983, BIOCHIM BIOPHYS ACTA, V739, P148, DOI 10.1016/0167-4781(83)90024-6; Eelen G, 2015, CIRC RES, V116, P1231, DOI 10.1161/CIRCRESAHA.116.302855; Feldman RD, 2017, ANNU REV PHARMACOL, V57, P567, DOI 10.1146/annurev-pharmtox-010716-104651; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Ge X, 2015, BIOCHEM BIOPH RES CO, V463, P1115, DOI 10.1016/j.bbrc.2015.06.068; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Guidolin D, 2004, MICROVASC RES, V67, P117, DOI 10.1016/j.mvr.2003.11.002; Heilig C, 2003, AM J PATHOL, V163, P1873, DOI 10.1016/S0002-9440(10)63546-8; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; HORWITZ KB, 1980, J BIOL CHEM, V255, P9699; Huang Y, 2012, P NATL ACAD SCI USA, V109, P17478, DOI 10.1073/pnas.1209281109; Imbert-Fernandez Y, 2014, J BIOL CHEM, V289, P9440, DOI 10.1074/jbc.M113.529990; Koo KH, 2015, ONCOTARGET, V6, P21328, DOI 10.18632/oncotarget.4049; LUDBROOK J, 1994, CLIN EXP PHARMACOL P, V21, P673, DOI 10.1111/j.1440-1681.1994.tb02570.x; Mann GE, 2003, PHYSIOL REV, V83, P183, DOI 10.1152/physrev.00022.2002; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; NEEMAN M, 1989, P NATL ACAD SCI USA, V86, P5585, DOI 10.1073/pnas.86.14.5585; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Ogawa M, 2011, J BIOL CHEM, V286, P41455, DOI 10.1074/jbc.M111.276824; Ohno H, 2011, AM J PHYSIOL-CELL PH, V300, pC1047, DOI 10.1152/ajpcell.00416.2010; Pavlides SC, 2013, ENDOCRINOLOGY, V154, P4030, DOI 10.1210/en.2013-1757; Prossnitz ER, 2015, PHARMACOL REV, V67, P505, DOI 10.1124/pr.114.009712; Qi C, 1999, BIOCHEM BIOPH RES CO, V263, P265, DOI 10.1006/bbrc.1999.1328; Riera L, 2003, FEBS LETT, V550, P23, DOI 10.1016/S0014-5793(03)00808-1; Seidner G, 1998, NAT GENET, V18, P188, DOI 10.1038/ng0298-188; Sharma G, 2018, J STEROID BIOCHEM, V176, P31, DOI 10.1016/j.jsbmb.2017.02.012; Shi J, 1997, AM J PHYSIOL-ENDOC M, V272, pE1016, DOI 10.1152/ajpendo.1997.272.6.E1016; Stangl K, 2010, CARDIOVASC RES, V85, P281, DOI 10.1093/cvr/cvp315; Sudhagar S, 2011, BRIT J CANCER, V105, P953, DOI 10.1038/bjc.2011.349; Tan S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3644; Tang MX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14152; Trenti A, 2017, J PHARMACOL EXP THER, V361, P398, DOI 10.1124/jpet.116.238212; Tschugguel W, 2003, J CLIN ENDOCR METAB, V88, P2281, DOI 10.1210/jc.2002-021165; Tudzarova S, 2011, P NATL ACAD SCI USA, V108, P5278, DOI 10.1073/pnas.1102247108; Veschini L, 2007, BLOOD, V109, P2565, DOI 10.1182/blood-2006-06-032664; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Xu BB, 2018, CELL REP, V24, P181, DOI 10.1016/j.celrep.2018.06.019; Zeng X, 2012, NAT CHEM BIOL, V8, P383, DOI [10.1038/nchembio.801, 10.1038/NCHEMBIO.801]; Zhang L, 2017, FERTIL STERIL, V107, P439, DOI 10.1016/j.fertnstert.2016.11.008	58	9	9	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12768	12784		10.1096/fj.202001130R	http://dx.doi.org/10.1096/fj.202001130R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32757462				2022-12-26	WOS:000558305600001
J	Wang, QQ; Gao, HW; Yuan, RYK; Han, S; Li, XX; Tang, MW; Dong, BQ; Li, JX; Zhao, LC; Feng, JF; Yang, SL				Wang, Qin-Qin; Gao, Hongwei; Yuan, Renyikun; Han, Shan; Li, Xin-Xing; Tang, Meiwen; Dong, Baiqing; Li, Jun-Xiu; Zhao, Li-Chun; Feng, Jianfang; Yang, Shilin			Procyanidin A2, a polyphenolic compound, exerts anti-inflammatory and anti-oxidative activity in lipopolysaccharide-stimulated RAW264.7 cells	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; SIGNALING PATHWAY; NRF2; INFLAMMATION; MECHANISMS; ROLES	Procyandin A2 (PCA2) is a polyphenolic compound which is isolated from grape seeds. It has been reported that PCA2 exhibits antioxidative and anti-inflammatory effects, but its molecular mechanism is still poorly understood. This study tests the hypothesis that PCA2 suppresses lipopolysaccharide (LPS)-induced inflammation and oxidative stress through targeting the nuclear factor-kappa B (NF-kappa B), mitogen-activated protein kinase (MAPK), and NF-E2-related factor 2 (Nrf2) pathways in RAW264.7 cells. PCA2 (20, 40, 80 mu M) exhibited no significant cytotoxicity in RAW264.7 cells and showed an inhibitory effect on an LPS-induced nitrite level. Pro-inflammatory cytokines like tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), prostaglandin E2 (PGE2), nitric oxide (NO), and reactive oxygen species (ROS) were suppressed by PCA2 with a concentration range of 0-80 mu M. The mRNA levels of TNF-alpha and IL-6 were inhibited by PCA2 (80 mu M). The hallmark-protein expression of the NF-kappa B (p-IKK alpha/beta, p-I kappa B alpha, and p-p65) and MAPK (p-p38, p-JNK, and p-ERK) pathways were decreased by PCA2 in LPS-stimulated RAW264.7 cells. In addition, immunofluorescence results indicated that PCA2 (80 mu M) promoted the translocation of NF-kappa B/p65 from the cytoplasm into the nucleus. PCA2 upregulated the expressions of Nrf2 and HO-1 and downregulated the expression of Keap-1. Simultaneously, PCA2 (80 mu M) reversed LPS-induced Nrf2 translocation from the nucleus into the cytoplasm. Collectively, PCA2 protect cells against the damage from inflammation and oxidative injury, which suggest a potential therapeutic strategy for inflammatory and oxidative stress through targeting NF-kappa B, MAPK, and Nrf2 pathways in RAW264.7 cells.	[Wang, Qin-Qin; Gao, Hongwei; Yuan, Renyikun; Han, Shan; Li, Xin-Xing; Tang, Meiwen; Li, Jun-Xiu; Zhao, Li-Chun; Feng, Jianfang; Yang, Shilin] Guangxi Univ Chinese Med, Coll Pharm, Nanning, Peoples R China; [Wang, Qin-Qin; Gao, Hongwei; Han, Shan; Li, Xin-Xing; Li, Jun-Xiu; Zhao, Li-Chun; Feng, Jianfang; Yang, Shilin] Guangxi Engn Technol Res Ctr Advantage Chinese Pa, Nanning, Peoples R China; [Dong, Baiqing] Guangxi Univ Chinese Med, Coll Publ Hlth & Management, Nanning, Peoples R China	Guangxi University of Chinese Medicine; Guangxi University of Chinese Medicine	Zhao, LC; Feng, JF (corresponding author), Guangxi Univ Chinese Med, Coll Pharm, Nanning, Peoples R China.; Zhao, LC; Feng, JF (corresponding author), Guangxi Engn Technol Res Ctr Advantage Chinese Pa, Nanning, Peoples R China.	hyzlc@126.com; fengjianfang@vip.163.com						Afonina IS, 2017, NAT IMMUNOL, V18, P861, DOI 10.1038/ni.3772; Ahmed SMU, 2017, BBA-MOL BASIS DIS, V1863, P585, DOI 10.1016/j.bbadis.2016.11.005; Bognar E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065355; Chen C-C, 2016, MACROPHAGES, V11; Chen Si-Xiang, 2018, Zhonghua Nan Ke Xue, V24, P442; Chen ZJ, 2018, FOOD CHEM TOXICOL, V119, P309, DOI 10.1016/j.fct.2018.02.050; Coleman SL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111888; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Gao HW, 2017, BRIT J PHARMACOL, V174, P2880, DOI 10.1111/bph.13912; Han S, 2019, CELLS, V9, P1; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jiang S, 2017, MOL NEUROBIOL, V54, P1440, DOI 10.1007/s12035-016-9707-7; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Ki YW, 2013, TOXICOL LETT, V218, P235, DOI 10.1016/j.toxlet.2013.02.003; Kim DH, 2013, MOL STUDY DIETARY HE, V8; Lee CC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071363; Li S, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.013945526426531, DOI 10.1371/JOURNAL.PONE.013945526426531]; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513; Lin LL, 2019, CHIN MED-UK, V14, DOI 10.1186/s13020-019-0229-x; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; Ma B, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00378; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Peng XX, 2015, CHIN MED-UK, V10, DOI 10.1186/s13020-015-0045-x; Pereira AM, 2014, PLASTICITY MAPK SIGN, V9; Peterson JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05910-1; Pociennikowska A, 2015, CELL MOL LIFE SCI, V72, P557, DOI DOI 10.1007/s00018-014-1762-5; Prasad S., 2019, NEUROSCIENCE NICOTIN, P355; Rauf A, 2019, BIOMED PHARMACOTHER, V116, DOI 10.1016/j.biopha.2019.108999; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Romero-Garcia S, 2019, INT J ONCOL, V54, P1155, DOI 10.3892/ijo.2019.4696; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Sintara M, 2020, PHYTOCHEM ANALYSIS, V31, P874, DOI 10.1002/pca.2952; Skelly DT, 2019, MOL PSYCHIATR, V24, P1533, DOI 10.1038/s41380-018-0075-8; Sun SC, 2017, NAT REV IMMUNOL, V17, P545, DOI 10.1038/nri.2017.52; Sun Y, 2015, J RECEPT SIG TRANSD, V35, P600, DOI 10.3109/10799893.2015.1030412; Tang Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072109; wieboda P, 2013, PAIN, V2, P7; Wojdasiewicz P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/561459; Xu HY, 2019, J FUNCT FOODS, V62, DOI 10.1016/j.jff.2019.103562; Yan BD, 2017, MOL MED REP, V15, P4005, DOI 10.3892/mmr.2017.6546; Yang HX, 2014, BIOCHEM PHARMACOL, V92, P599, DOI 10.1016/j.bcp.2014.10.001; Yuan RYK, 2019, PHARMACOL RES, V142, P102, DOI 10.1016/j.phrs.2019.02.017; Zhao J, 2014, INT J MOL MED, V33, P1348, DOI 10.3892/ijmm.2014.1696; ZHOU YY, 2019, CHIN MED UK, V0014; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013; [No title captured]; [No title captured]; [No title captured]	51	18	19	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0237017	10.1371/journal.pone.0237017	http://dx.doi.org/10.1371/journal.pone.0237017			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756588	gold, Green Published			2022-12-26	WOS:000560393300059
J	Tolpinrud, A; Firestone, SM; Diaz-Mendez, A; Wicker, L; Lynch, SE; Dunowska, M; Devlin, JM				Tolpinrud, Anita; Firestone, Simon M.; Diaz-Mendez, Andres; Wicker, Leanne; Lynch, Stacey E.; Dunowska, Magdalena; Devlin, Joanne M.			Serological evidence for the presence of wobbly possum disease virus in Australia	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; BRUSHTAIL POSSUM; NEUROLOGICAL DISEASE; TRANSMISSION; IDENTIFICATION; ANTIBODIES; PROTEIN; ELISA; ASSAY	Wobbly possum disease virus (WPDV) is an arterivirus that was originally identified in common brushtail possums (Trichosurus vulpecula) in New Zealand, where it causes severe neurological disease. In this study, serum samples (n = 188) from Australian common brushtail, mountain brushtail (Trichosurus cunninghami) and common ringtail (Pseudocheirus peregrinus) possums were tested for antibodies to WPDV using ELISA. Antibodies to WPDV were detected in possums from all three species that were sampled in the states of Victoria and South Australia. Overall, 16% (30/188; 95% CI 11.0-22.0) of possums were seropositive for WPDV and 11.7% (22/188; 95% CI 7.5-17.2) were equivocal. The frequency of WPDV antibody detection was the highest in possums from the two brushtail species. This is the first reported serological evidence of infection with WPDV, or an antigenically similar virus, in Australian possums, and the first study to find antibodies in species other than common brushtail possums. Attempts to detect viral RNA in spleens by PCR were unsuccessful. Further research is needed to characterise the virus in Australian possums and to determine its impact on the ecology of Australian marsupials.	[Tolpinrud, Anita; Firestone, Simon M.; Diaz-Mendez, Andres; Devlin, Joanne M.] Univ Melbourne, Melbourne Vet Sch, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia; [Tolpinrud, Anita; Wicker, Leanne] Zoos Victoria, Healesville Sanctuary, Australian Wildlife Hlth Ctr, Badger Creek, Vic, Australia; [Lynch, Stacey E.] AgriBio Ctr AgriBiosci, Agr Victoria Res, Bundoora, Vic, Australia; [Dunowska, Magdalena] Massey Univ, Sch Vet Sci, Palmerston North, New Zealand	University of Melbourne; Massey University	Tolpinrud, A (corresponding author), Univ Melbourne, Melbourne Vet Sch, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia.; Tolpinrud, A (corresponding author), Zoos Victoria, Healesville Sanctuary, Australian Wildlife Hlth Ctr, Badger Creek, Vic, Australia.	anita.tolpinrud@unimelb.edu.au		Firestone, Simon/0000-0002-3239-1419; Dunowska, Magdalena/0000-0003-3874-0154; Tolpinrud, Anita/0000-0002-5938-3013; Diaz-Mendez, Andres/0000-0003-3004-8518	Massey University Research Fund [20774]; Zoos Victoria	Massey University Research Fund; Zoos Victoria	This work was supported by the Massey University Research Fund (grant number 20774) and Zoos Victoria (research scholarship; no specific grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, VIR TAX CLASS NOM VI; Bailey AL, 2016, J VIROL, V90, P630, DOI 10.1128/JVI.01433-15; Balasuriya UBR, 2013, VET MICROBIOL, V167, P93, DOI 10.1016/j.vetmic.2013.06.015; Boadella Mariana, 2011, BMC Res Notes, V4, P498, DOI 10.1186/1756-0500-4-498; Carn VM, 1996, BRIT VET J, V152, P377, DOI 10.1016/S0007-1935(96)80033-9; Chang WS, 2019, ONE HEALTH OUTLOOK, V1, DOI 10.1186/s42522-019-0006-x; Chen J, 2015, VIRAL IMMUNOL, V28, P391, DOI 10.1089/vim.2015.0018; Cong YL, 2013, VIROLOGY, V444, P310, DOI 10.1016/j.virol.2013.06.027; Cowan P.E., 2005, HDB NZ MAMMALS; Dea S, 2000, J VIROL METHODS, V87, P109, DOI 10.1016/S0166-0934(00)00158-0; Dunowska M, 2013, NEW ZEAL VET J, V61, P286, DOI 10.1080/00480169.2013.780279; Dunowska M, 2012, VET MICROBIOL, V156, P418, DOI 10.1016/j.vetmic.2011.11.013; Giles JC, 2018, NEW ZEAL VET J, V66, P186, DOI 10.1080/00480169.2018.1465483; Giles J, 2018, VIROLOGY, V522, P73, DOI 10.1016/j.virol.2018.07.003; Giles J, 2016, VIROLOGY, V491, P20, DOI 10.1016/j.virol.2016.01.005; Goldingay R.L., 2004, BIOL AUSTR POSSUMS G; Gulyaeva A, 2017, J VIROL, V91, DOI [10.1128/JVI.02096-16, 10.1128/jvi.02096-16]; Hufschmid J, 2013, AUST J ZOOL, V61, P430, DOI 10.1071/ZO12097; Hufschmid J, 2010, AUST J ZOOL, V58, P250, DOI 10.1071/ZO10030; Innes J., 1990, HDB NZ MAMMALS; MACKINTOSH CG, 1995, NEW ZEAL VET J, V43, P126, DOI 10.1080/00480169.1995.35869; Neumann EJ, 2009, VET J, V180, P325, DOI 10.1016/j.tvjl.2008.07.020; Paterson BM, 1995, NEW ZEAL VET J, V43, P281, DOI 10.1080/00480169./1995.35907; Perrott MRF, 2000, NEW ZEAL VET J, V48, P9, DOI 10.1080/00480169.2000.36150; Perrott MRF, 2000, NEW ZEAL VET J, V48, P3, DOI 10.1080/00480169.2000.36149; Pileri E, 2016, VET RES, V47, DOI 10.1186/s13567-016-0391-4; Pinsky NA, 2003, CLIN DIAGN LAB IMMUN, V10, P19, DOI 10.1128/CDLI.10.1.19-21.2003; Pitkin A, 2009, CAN J VET RES, V73, P91; Sergeant ESG, 2019, EPITOOLS EPIDEMIOLOG; Snijder EJ, 2011, SPRINGER INDEX VIRUS, P65, DOI [10.1007/978-0-387-95919-1_7, DOI 10.1007/978-0-387-95919-1_7]; Warburton B., 2009, LC0910060 LANDC RES	31	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0237091	10.1371/journal.pone.0237091	http://dx.doi.org/10.1371/journal.pone.0237091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750064	Green Published, gold			2022-12-26	WOS:000560009200026
J	Banadakoppa, M; Pennington, K; Balakrishnan, M; Yallampalli, C				Banadakoppa, Manu; Pennington, Kathleen; Balakrishnan, Meena; Yallampalli, Chandra			Complement inhibitor Crry expression in mouse placenta is essential for maintaining normal blood pressure and fetal growth	PLOS ONE			English	Article							NORMAL-PREGNANCY; MURINE HOMOLOG; ACTIVATION; RECEPTOR; SYSTEM; PREECLAMPSIA; MANIPULATION; C5A; C3A	Many circumstantial evidences from human and animal studies suggest that complement cascade dysregulation may play an important role in pregnancy associated complications including preeclampsia. Deletion of rodent specific complement inhibitor gene, Complement Receptor 1-related Gene/Protein y (Crry) produces embryonic lethal phenotype due to complement activation. It is not clear if decreased expression of Crry during pregnancy produces hypertensive phenotype. We downregulated Crry in placenta by injecting inducible lentivialshRNA vectors into uterine horn of pregnant C57BL/6 mice at the time of blastocyst hatching. Placenta specific downregulation of Crry without significant loss of embryos was achieved upon induction of shRNA using an optimal doxycycline dose at mid gestation. Crry downregulation resulted in placental complement deposition. Late-gestation measurements showed that fetal weights were reduced and blood pressure increased in pregnant mice upon downregulation of Crry suggesting a critical role for Crry in fetal growth and blood pressure regulation.	[Banadakoppa, Manu; Pennington, Kathleen; Balakrishnan, Meena; Yallampalli, Chandra] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA	Baylor College of Medicine	Banadakoppa, M; Yallampalli, C (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	banadako@bcm.edu; cyallamp@bcm.edu	Yallampalli, Chandra/B-7655-2014	Banadakoppa, Manu/0000-0003-1401-6065	NIH [HL58144, DK114689]; Preeclampsia Foundation of USA	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Preeclampsia Foundation of USA	CY received funding from NIH grants HL58144 and DK114689. M. Banadakoppa received funding from Preeclampsia Foundation of USA, "Vision Grant" 2017.	Agostinis C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/484321; Albieri A, 1999, AM J REPROD IMMUNOL, V41, P343; Banadakoppa M, 2014, CLIN EXP IMMUNOL, V177, P743, DOI 10.1111/cei.12371; Banadakoppa M, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.13033; Banadakoppa M, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/263109; Bulla R, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00055; Burwick RM, 2018, OBSTET GYNECOL, V132, P1477, DOI 10.1097/AOG.0000000000002980; Denny KJ, 2013, J REPROD IMMUNOL, V97, P211, DOI 10.1016/j.jri.2012.11.006; Derzsy Z, 2010, MOL IMMUNOL, V47, P1500, DOI 10.1016/j.molimm.2010.01.021; Espinoza J, 2019, OBSTET GYNECOL, V133, pE1, DOI 10.1097/AOG.0000000000003018; Fan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016348; Gelber SE, 2015, J IMMUNOL, V195, P1129, DOI 10.4049/jimmunol.1402220; Georgiades P, 2007, BIOTECHNIQUES, V42, P317, DOI 10.2144/000112341; Hagmann M, 2000, SCIENCE, V287, P408, DOI 10.1126/science.287.5452.408; KURTZ CB, 1989, J IMMUNOL, V143, P2058; Lee DS, 2009, GENESIS, V47, P433, DOI 10.1002/dvg.20518; LOKKI AI, 2017, FRONT IMMUNOL; Lokki AI, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00312; Lynch AM, 2010, BJOG-INT J OBSTET GY, V117, P456, DOI 10.1111/j.1471-0528.2009.02473.x; Lynch AM, 2011, OBSTET GYNECOL, V117, P75, DOI 10.1097/AOG.0b013e3181fc3afa; Mao DL, 2003, IMMUNITY, V19, P813, DOI 10.1016/S1074-7613(03)00321-2; MOLINA H, 1992, J EXP MED, V175, P121, DOI 10.1084/jem.175.1.121; Morgan BPHCL, COMPLEMENT REGULATOR; Morioka Y, 2009, GENESIS, V47, P793, DOI 10.1002/dvg.20563; Noris M, 2013, SEMIN NEPHROL, V33, P479, DOI 10.1016/j.semnephrol.2013.08.001; Odegard RA, 2000, OBSTET GYNECOL, V96, P950, DOI 10.1016/S0029-7844(00)01040-1; Qing XP, 2011, KIDNEY INT, V79, P331, DOI 10.1038/ki.2010.393; Redelsperger IM, 2016, J AM ASSOC LAB ANIM, V55, P467; Regal JF, 2015, MOL IMMUNOL, V67, P56, DOI 10.1016/j.molimm.2015.02.030; Richani K, 2005, J MATERN-FETAL NEO M, V17, P239, DOI 10.1080/14767050500072722; Ricklin D, 2016, NAT REV NEPHROL, V12, P383, DOI 10.1038/nrneph.2016.70; Salmon JE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001013; Suny XJ, 1999, P NATL ACAD SCI USA, V96, P628, DOI 10.1073/pnas.96.2.628; TATTON WG, 1979, EXP BRAIN RES, V37, P439; Tsujimura A, 1998, BIOCHEM J, V330, P163, DOI 10.1042/bj3300163; Wang W, 2012, HYPERTENSION, V60, P712, DOI 10.1161/HYPERTENSIONAHA.112.191817; Wu XB, 2008, J IMMUNOL, V181, P2732, DOI 10.4049/jimmunol.181.4.2732; [No title captured]; [No title captured]	39	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236968	10.1371/journal.pone.0236968	http://dx.doi.org/10.1371/journal.pone.0236968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745140	Green Published, gold			2022-12-26	WOS:000560006800048
J	Mayne, B; Tucker, AD; Berry, O; Jarman, S				Mayne, Benjamin; Tucker, Anton D.; Berry, Oliver; Jarman, Simon			Lifespan estimation in marine turtles using genomic promoter CpG density	PLOS ONE			English	Article							CARETTA-CARETTA; AGE; LONGEVITY; EVOLUTION; SURVIVAL; DATABASE	Maximum lifespan for most animal species is difficult to define. This is challenging for wildlife management as it is critical for estimating important aspects of population biology such as mortality rate, population viability, and period of reproductive potential. Recently, it has been shown cytosine-phosphate-guanine (CpG) density is predictive of maximum lifespan in vertebrates. This has made it possible to predict lifespan in long-lived species, which are generally the most intractable. In this study, we use gene promoter CpG density to predict the lifespan of five marine turtle species. Marine turtles are a particularly difficult group for lifespan estimation because of their migratory behaviour, longevity and high juvenile mortality rates, which all restrict individual tracking over their lifespan. Sanger sequencing was used to determine the CpG density in selected promoters. We predicted the lifespans for marine turtle species ranged from 50.4 years (flatback turtle, Natator depressus) to 90.4 years (leatherback turtle, Dermochelys coriacea). These lifespan predictions have broad applications in marine turtle research such as better understanding life cycles and determining population viability.	[Mayne, Benjamin; Berry, Oliver] CSIRO, Environ Future Sci Platform, Indian Oceans Marine Res Ctr, Crawley, WA, Australia; [Tucker, Anton D.] Dept Biodivers Conservat & Attract, Marine Sci Program, Kensington, WA, Australia; [Jarman, Simon] Univ Western Australia, Sch Biol Sci, Perth, WA, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia	Mayne, B (corresponding author), CSIRO, Environ Future Sci Platform, Indian Oceans Marine Res Ctr, Crawley, WA, Australia.	benjamin.mayne@csiro.au	Berry, Oliver/F-3372-2013	Berry, Oliver/0000-0001-7545-5083	North West Shelf Flatback Turtle Conservation Program; CSIRO Environomics Future Science Platform	North West Shelf Flatback Turtle Conservation Program; CSIRO Environomics Future Science Platform	This project is supported by the North West Shelf Flatback Turtle Conservation Program and the CSIRO Environomics Future Science Platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, ANIMAL DIVERSITY WEB; Avens L, 2019, MAR BIOL, V167, DOI 10.1007/s00227-019-3617-y; Avens L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173999; Avens L, 2013, CRC MAR BIOL SER, P97; BEHLER JL, 1979, AUDUBON SOC FIELD GU; Blagosklonny MV, 2013, AGING-US, V5, P227, DOI 10.18632/aging.100551; Blomquist GE, 2009, BIOL LETTERS, V5, P339, DOI 10.1098/rsbl.2009.0009; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Casale P, 2007, SURVIVAL PROBABILITI; Conant R., 1991, FIELD GUIDE REPTILES; CROWDER LB, 1994, ECOL APPL, V4, P437, DOI 10.2307/1941948; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; DEMASTER DP, 1978, J FISH RES BOARD CAN, V35, P912, DOI 10.1139/f78-148; Dodd CK, 1988, BIOL REP US FISH WIL, V88; Dreos R, 2017, NUCLEIC ACIDS RES, V45, pD51, DOI 10.1093/nar/gkw1069; Fitzpatrick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051927; FRAZER NB, 1983, COPEIA, P516, DOI 10.2307/1444398; Guarino FM, 2004, ITAL J ZOOL, V71, P175, DOI 10.1080/11250000409356630; Heppell SS, 1996, ECOL APPL, V6, P556, DOI 10.2307/2269391; Hewavisenthi S, 2001, COPEIA, P668, DOI 10.1643/0045-8511(2001)001[0668:IOIEOT]2.0.CO;2; Hoenig J., 1983, EMPIRICAL USE LONGEV; Hoffman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061082; Lenz AJ, 2016, AUSTRAL ECOL, V41, P580, DOI 10.1111/aec.12347; Mast R., 2005, MARINE TURTLE NEWSLE, V110, P13; Maxwell SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019905; Mayne B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54447-w; McLain AT, 2018, AGING-US, V10, P561, DOI 10.18632/aging.101413; Musick John A., 1997, P137; Oli MK, 1999, OIKOS, V86, P557, DOI 10.2307/3546660; RCore Team, 2020, R LANG ENV STAT COMP; Ripple J., 1996, SEA TURTLES; Robinson JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141460; Snover, 2002, GROWTH ONTOGENY SEA; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Spotila JR, 2004, SEA TURTLES COMPLETE; Tacutu R, 2018, NUCLEIC ACIDS RES, V46, pD1083, DOI 10.1093/nar/gkx1042; Tidiere M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36361; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang Z, 2013, NAT GENET, V45, P701, DOI 10.1038/ng.2615	40	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236888	10.1371/journal.pone.0236888	http://dx.doi.org/10.1371/journal.pone.0236888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735637	gold, Green Published			2022-12-26	WOS:000569367100057
J	Kelly, UL; Grigsby, D; Cady, MA; Landowski, M; Skiba, NP; Liu, J; Remaley, AT; Klingeborn, M; Rickman, CB				Kelly, Una L.; Grigsby, Daniel; Cady, Martha A.; Landowski, Michael; Skiba, Nikolai P.; Liu, Jian; Remaley, Alan T.; Klingeborn, Mikael; Bowes Rickman, Catherine			High-density lipoproteins are a potential therapeutic target for age-related macular degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipoprotein; heparan sulfate; complement; retinal degeneration; aging; high-density lipoprotein (HDL); apolipoprotein; glycosaminoglycan; oligosaccharide; age-related macular degeneration; complement factor H; heparan sulfate proteoglycans; retinal pigmented epithelium	COMPLEMENT FACTOR-H; APOLIPOPROTEIN MIMETIC PEPTIDE; CHOLESTEROL EFFLUX; HEPARAN-SULFATE; BRUCHS MEMBRANE; ALTERNATIVE PATHWAY; BINDING; HDL; POLYMORPHISM; RISK	Strong evidence suggests that dysregulated lipid metabolism involving dysfunction of the retinal pigmented epithelium (RPE) underlies the pathogenesis of age-related macular degeneration (AMD), the leading cause of irreversible blindness in the elderly. A hallmark of AMD is the overproduction of lipid- and protein-rich extracellular deposits that accumulate in the extracellular matrix (Bruch's membrane (BrM)) adjacent to the RPE. We analyzed apolipoprotein A-1 (ApoA-1)-containing lipoproteins isolated from BrM of elderly human donor eyes and found a unique proteome, distinct from high-density lipoprotein (HDL) isolated from donor plasma of the same individuals. The most striking difference is higher concentrations of ApoB and ApoE, which bind to glycosaminoglycans. We hypothesize that this interaction promotes lipoprotein deposition onto BrM glycosaminoglycans, initiating downstream effects that contribute to RPE dysfunction/death. We tested this hypothesis using two potential therapeutic strategies to alter the lipoprotein/protein profile of these extracellular deposits. First, we used short heparan sulfate oligosaccharides to remove lipoproteins already deposited in both the extracellular matrix of RPE cells and aged donor BrM tissue. Second, an ApoA-1 mimetic, 5A peptide, was demonstrated to modulate the composition and concentration of apolipoproteins secreted from primary porcine RPE cells. Significantly, in a mouse model of AMD, this 5A peptide altered the proteomic profile of circulating HDL and ameliorated some of the potentially harmful changes to the protein composition resulting from the high-fat, high-cholesterol diet in this model. Together, these results suggest that targeting HDL interactions with BrM represents a new strategy to slow AMD progression in humans.	[Kelly, Una L.; Grigsby, Daniel; Cady, Martha A.; Landowski, Michael; Skiba, Nikolai P.; Klingeborn, Mikael; Bowes Rickman, Catherine] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Bowes Rickman, Catherine] Duke Univ, Med Ctr, Cell Biol, Durham, NC USA; [Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27515 USA; [Remaley, Alan T.] NHLBI, Lipoprot Metab Sect, Pulm & Vasc Med Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Landowski, Michael] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Wisconsin System; University of Wisconsin Madison	Klingeborn, M; Rickman, CB (corresponding author), Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA.; Rickman, CB (corresponding author), Duke Univ, Med Ctr, Cell Biol, Durham, NC USA.	mikael.klingeborn@duke.edu; bowes007@duke.edu		Landowski, Michael/0000-0003-0151-0689; Klingeborn, Mikael/0000-0003-2907-0371; Bowes Rickman, Catherine/0000-0002-8555-9596	NEI, National Institutes of Health [R01 EY026161, P30 EY005722]; Edward N. and Della L. Thome Memorial Foundation Award in Age-Related Macular Degeneration Research; Research to Prevent Blindness/International Retinal Research Foundation Catalyst award for Innovative Research Approaches for AMD; Research to Prevent Blindness; National Institutes of Health [1R01HL094463, R01 HL144970]	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Edward N. and Della L. Thome Memorial Foundation Award in Age-Related Macular Degeneration Research; Research to Prevent Blindness/International Retinal Research Foundation Catalyst award for Innovative Research Approaches for AMD; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NEI, National Institutes of Health, Grants R01 EY026161 (to C. B. R.) and P30 EY005722 (to Duke Eye Center); an Edward N. and Della L. Thome Memorial Foundation Award in Age-Related Macular Degeneration Research (to C. B. R.); a Research to Prevent Blindness/International Retinal Research Foundation Catalyst award for Innovative Research Approaches for AMD (to C. B. R.); and an unrestricted grant from Research to Prevent Blindness (to the Duke Eye Center). A. R. is supported by intramural NHBLI-DIR funds from the National Institutes of Health. J. L. is supported by National Institutes of Health Grants 1R01HL094463 and R01 HL144970. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amar MJA, 2010, J PHARMACOL EXP THER, V334, P634, DOI 10.1124/jpet.110.167890; AVIRAM M, 1983, BIOCHEM MED METAB B, V30, P111, DOI 10.1016/0006-2944(83)90013-3; Beebe DC, 2013, INVEST OPHTH VIS SCI, V54, P5720, DOI 10.1167/iovs.13-12873; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Boren J, 2016, CURR OPIN LIPIDOL, V27, P473, DOI 10.1097/MOL.0000000000000330; Bourdi M, 2018, REGUL TOXICOL PHARM, V100, P59, DOI 10.1016/j.yrtph.2018.10.009; Burgess S, 2017, OPHTHALMOLOGY, V124, P1165, DOI 10.1016/j.ophtha.2017.03.042; Calabresi L, 2002, ARTERIOSCL THROM VAS, V22, P656, DOI 10.1161/hq0402.105901; Cheung CMG, 2017, J LIPID RES, V58, P1785, DOI 10.1194/jlr.M073684; Clark SJ, 2010, J BIOL CHEM, V285, P30192, DOI 10.1074/jbc.M110.103986; Colijn JM, 2019, OPHTHALMOLOGY, V126, P393, DOI 10.1016/j.ophtha.2018.09.045; Cougnard-Gregoire A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090973; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Ding JD, 2015, AM J PATHOL, V185, P29, DOI 10.1016/j.ajpath.2014.08.026; DISCIPIO RG, 1992, J IMMUNOL, V149, P2592; Duncan KG, 2009, BRIT J OPHTHALMOL, V93, P1116, DOI 10.1136/bjo.2008.144006; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fan Q, 2017, INT J EPIDEMIOL, V46, P1891, DOI 10.1093/ije/dyx189; FEARON DT, 1978, P NATL ACAD SCI USA, V75, P1971, DOI 10.1073/pnas.75.4.1971; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Flood C, 2004, ARTERIOSCL THROM VAS, V24, P564, DOI 10.1161/01.ATV.0000117174.19078.85; Fogelstrand P, 2012, NUTR METAB CARDIOVAS, V22, P1, DOI 10.1016/j.numecd.2011.09.007; Foley EM, 2013, ARTERIOSCL THROM VAS, V33, P2065, DOI 10.1161/ATVBAHA.113.301637; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Heinecke JW, 2009, J LIPID RES, V50, pS167, DOI 10.1194/jlr.R800097-JLR200; Holzer M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38533; Holzer M, 2013, BBA-MOL CELL BIOL L, V1831, P1442, DOI 10.1016/j.bbalip.2013.06.004; Holzer M, 2012, J LIPID RES, V53, P1618, DOI 10.1194/jlr.M027367; Hoofnagle AN, 2012, CLIN CHEM, V58, P777, DOI 10.1373/clinchem.2011.173856; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Islam RM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20965-2; Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11; Keenan TDL, 2014, INVEST OPHTH VIS SCI, V55, P5370, DOI 10.1167/iovs.14-14126; Kelly U, 2010, J IMMUNOL, V185, P5486, DOI 10.4049/jimmunol.0903596; Kelly U, 2009, INVEST OPHTH VIS SCI, V50, P1540, DOI 10.1167/iovs.08-2782; Kersten E, 2018, SURV OPHTHALMOL, V63, P9, DOI 10.1016/j.survophthal.2017.05.003; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klingeborn M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05102-9; Kontush A, 2015, HANDB EXP PHARMACOL, V224, P3, DOI 10.1007/978-3-319-09665-0_1; Landowski M, 2019, P NATL ACAD SCI USA, V116, P3703, DOI 10.1073/pnas.1814014116; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Mahoney DJ, 2004, ANAL BIOCHEM, V330, P123, DOI 10.1016/j.ab.2004.03.055; Marson A, 2009, GLYCOBIOLOGY, V19, P1537, DOI 10.1093/glycob/cwp132; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McHarg S, 2015, JOVE-J VIS EXP, DOI 10.3791/53382; MOLD C, 1984, J IMMUNOL, V133, P882; Molins B, 2016, SCI REP-UK, V6, DOI 10.1038/srep22889; Murphy A.J., 2013, INT SCH RES NETW PHY, P1, DOI DOI 10.1155/2013/186365; Nagata KO, 2013, P NATL ACAD SCI USA, V110, P5034, DOI 10.1073/pnas.1220703110; Navab M, 2000, J LIPID RES, V41, P1495; Ormsby RJ, 2008, INVEST OPHTH VIS SCI, V49, P1763, DOI 10.1167/iovs.07-1297; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; PARTHASARATHY S, 1990, BIOCHIM BIOPHYS ACTA, V1044, P275, DOI 10.1016/0005-2760(90)90314-N; Pennington KL, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0063-5; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pertl L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157210; Phillips MC, 2018, J LIPID RES, V59, P749, DOI 10.1194/jlr.R082313; Pikuleva IA, 2014, PROG RETIN EYE RES, V41, P64, DOI 10.1016/j.preteyeres.2014.03.002; Rickman CB, 2013, INVEST OPHTH VIS SCI, V54, pORSF68, DOI 10.1167/iovs.13-12757; Rizzolo LJ, 2014, EXP EYE RES, V126, P16, DOI 10.1016/j.exer.2013.12.018; Rudolf M, 2018, CURR EYE RES, V43, P135, DOI 10.1080/02713683.2017.1370118; Schultz R, 2018, INVEST OPHTH VIS SCI, V59; Sethi AA, 2008, J BIOL CHEM, V283, P32273, DOI 10.1074/jbc.M804461200; Shah AS, 2013, J LIPID RES, V54, P2575, DOI 10.1194/jlr.R035725; Sharma AK, 1996, P NATL ACAD SCI USA, V93, P10996, DOI 10.1073/pnas.93.20.10996; Shaw PX, 2012, P NATL ACAD SCI USA, V109, P13757, DOI 10.1073/pnas.1121309109; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Skerka C, 2007, MOL IMMUNOL, V44, P3398, DOI 10.1016/j.molimm.2007.02.012; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Storti F, 2017, EXP EYE RES, V165, P65, DOI 10.1016/j.exer.2017.09.008; Sviridov DO, 2013, J PHARMACOL EXP THER, V344, P50, DOI 10.1124/jpet.112.198143; Tabet F, 2010, ARTERIOSCL THROM VAS, V30, P246, DOI 10.1161/ATVBAHA.109.200196; Toomey CB, 2015, P NATL ACAD SCI USA, V112, pE3040, DOI 10.1073/pnas.1424391112; Vaisar T, 2010, CLIN CHIM ACTA, V411, P972, DOI 10.1016/j.cca.2010.03.023; van Leeuwen EM, 2018, PROG RETIN EYE RES, V67, P56, DOI 10.1016/j.preteyeres.2018.04.006; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Vives-Bauza C, 2008, J BIOL CHEM, V283, P24770, DOI 10.1074/jbc.M800706200; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; Wang YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15711; Weichhart T, 2012, J AM SOC NEPHROL, V23, P934, DOI 10.1681/ASN.2011070668; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Yu JM, 2007, BIOCHEMISTRY-US, V46, P8451, DOI 10.1021/bi700459a; Zaferani A, 2012, J BIOL CHEM, V287, P31471, DOI 10.1074/jbc.M112.380386; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	90	10	10	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2020	295	39					13601	13616		10.1074/jbc.RA119.012305	http://dx.doi.org/10.1074/jbc.RA119.012305			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NY3VI	32737203	hybrid, Green Published			2022-12-26	WOS:000576321100014
J	Oliveira, TG; Ifrah, C; Fleysher, R; Stockman, M; Lipton, ML				Oliveira, Tiago Gil; Ifrah, Chloe; Fleysher, Roman; Stockman, Michael; Lipton, Michael L.			Soccer heading and concussion are not associated with reduced brain volume or cortical thickness	PLOS ONE			English	Article							MATTER; VALIDATION; FOOTBALL; NEUROPLASTICITY; EXPOSURE; PLAYERS	Soccer is the most popular sport in the world and, since it is a contact sport, players are at risk for head injury, including concussion. Here, we proposed to investigate the association of heading and concussion with macroscopic brain structure among adult amateur soccer players. For this study, 375 amateur soccer players (median age 23 years) completed HeadCount-12m to estimate heading over the 12 months prior to MRI and lifetime concussion. T1-weighted 3D magnetization prepared rapid acquisition gradient echo (MP-RAGE) MRI was performed at 3 Tesla. Parcellation was performed using Freesurfer to extract regional gray and white matter volumes as well as regional cortical thickness and total intracranial volume. Regional cortical brain volumes were normalized by total intracranial volume. We categorized heading into quartiles and concussion as 0, 1 or 2 or more. Generalized linear regressions were used to test the association of heading or concussion with each brain morphometry metric, including age and sex, as covariates. Neither heading nor concussion were associated with reduced brain volume or cortical thickness. We observed that greater heading was associated with greater gray matter volume in the left inferior parietal area, which may reflect effects related to training.	[Oliveira, Tiago Gil] Univ Minho, Sch Med, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Oliveira, Tiago Gil] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Ifrah, Chloe; Fleysher, Roman; Stockman, Michael; Lipton, Michael L.] Albert Einstein Coll Med, Gruss Magnet Resonance Imaging Ctr, Bronx, NY 10467 USA; [Ifrah, Chloe; Fleysher, Roman; Stockman, Michael; Lipton, Michael L.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Fleysher, Roman; Lipton, Michael L.] Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Universidade do Minho; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Lipton, ML (corresponding author), Albert Einstein Coll Med, Gruss Magnet Resonance Imaging Ctr, Bronx, NY 10467 USA.; Lipton, ML (corresponding author), Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA.; Lipton, ML (corresponding author), Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA.; Lipton, ML (corresponding author), Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA.; Lipton, ML (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	michael.lipton@einstein.yu.edu	Oliveira, Tiago Gil/AAL-2147-2021	Oliveira, Tiago Gil/0000-0003-0509-0562; Lipton, Michael/0000-0001-5421-8441	National Institutes of Health, National Institute of Neurologic Disorders and Stroke [R01 NS082432]; Dana Foundation David Mahoney Neuroimaging Program (MLL)	National Institutes of Health, National Institute of Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Dana Foundation David Mahoney Neuroimaging Program (MLL)	Supported by the National Institutes of Health, National Institute of Neurologic Disorders and Stroke (R01 NS082432) (MLL) (www.nih.gov) and The Dana Foundation David Mahoney Neuroimaging Program (MLL) (www.dana.org).	Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Catenaccio E, 2016, RES SPORTS MED, V24, P416, DOI 10.1080/15438627.2016.1234472; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Erickson KI, 2014, NEUROBIOL AGING, V35, pS20, DOI 10.1016/j.neurobiolaging.2014.03.034; Hales C, 2014, NEUROLOGY, V83, P2307, DOI 10.1212/WNL.0000000000001081; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kunz M., 2007, FIFA MAGAZINE, V7, P10, DOI DOI 10.1080/13673882.2007.9680857; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Lipton ML, 2018, J SCI MED SPORT, V21, P363, DOI 10.1016/j.jsams.2017.08.008; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Rubin TG, 2018, RADIOLOGY, V289, P478, DOI 10.1148/radiol.2018180217; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Valkanova V, 2014, INT PSYCHOGERIATR, V26, P891, DOI 10.1017/S1041610213002482; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910	23	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0235609	10.1371/journal.pone.0235609	http://dx.doi.org/10.1371/journal.pone.0235609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776940	gold, Green Published			2022-12-26	WOS:000561393800013
J	Reed, CA; Chaudhari, AMW; Worthen-Chaudhari, LC; Bigelow, KE; Monfort, SM				Reed, Cody A.; Chaudhari, Ajit M. W.; Worthen-Chaudhari, Lise C.; Bigelow, Kimberly E.; Monfort, Scott M.			A new perspective on transient characteristics of quiet stance postural control	PLOS ONE			English	Article							SENSORY REWEIGHTING DYNAMICS; PRESSURE MEASURES; OLDER-PEOPLE; BALANCE; RISK; VARIABILITY; PREDICTORS; STEADINESS; STABILITY; FALLERS	Postural control provides insight into health concerns such as fall risk but remains relatively untapped as a vital sign of health. One understudied aspect of postural control involves transient responses within center of pressure (CoP) data to events such as vision occlusion. Such responses are masked by common whole-trial analyses. We hypothesized that the transient behavior of postural control would yield unique and clinically-relevant information for quiet stance compared to traditionally calculated whole-trial CoP estimates. Three experiments were conducted to test different aspects of this central hypothesis. To test whether transient, epoch-based characteristics of CoP estimates provide different information than traditional whole-trial estimates, we investigated correlations between these estimates for a population of young adults performing three 60-second trials of quiet stance with eyes closed. Next, to test if transient behavior is a result of sensory reweighting after eye closure, we compared transient characteristics between eyes closed and eyes open conditions. Finally, to test if there was an effect of age on transient behavior, we compared transient characteristics during eyes closed stance between populations of young and older adults. Negligible correlations were found between transient characteristics and whole-trial estimates (p>0.08), demonstrating limited overlap in information between them. Additionally, transient behavior was exaggerated during eyes closed stance relative to eyes open (p<0.044). Lastly, we found that transient characteristics were able to distinguish between younger and older adults, supporting their clinical relevance (p<0.029). An epoch-based approach captured unique and potentially clinically-relevant postural control information compared to whole-trial estimates. While longer trials may improve the reliability of whole-trial estimates, including a complementary assessment of the initial transient characteristics may provide a more comprehensive characterization of postural control.	[Reed, Cody A.; Monfort, Scott M.] Montana State Univ, Dept Mech & Ind Engn, Bozeman, MT 59717 USA; [Chaudhari, Ajit M. W.] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Worthen-Chaudhari, Lise C.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Bigelow, Kimberly E.] Univ Dayton, Dept Mech & Aerosp Engn, Dayton, OH 45469 USA	Montana State University System; Montana State University Bozeman; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Dayton	Monfort, SM (corresponding author), Montana State Univ, Dept Mech & Ind Engn, Bozeman, MT 59717 USA.	scott.monfort@montana.edu	Worthen-Chaudhari, Lise C./B-5618-2012	Worthen-Chaudhari, Lise C./0000-0003-1826-0380; Reed, Cody/0000-0001-6897-8150; Chaudhari, Ajit/0000-0001-5071-7147	Montana State University Norm Asbjornson College of Engineering; Montana State University Library	Montana State University Norm Asbjornson College of Engineering; Montana State University Library	We thank the Organizing Committee of the 2017 annual meeting of the American Society of Biomechanics (ASB), ASB 2017 attendees who participated, and the Ohio State University and University of Dayton volunteers for their support of the ASB Quick Study data collections. We would also like to thank the Montana State University Library for both the support of the Library Author Fund for open access charges associated with this publication and for the data publication in the Dryad repository. Finally, we would like to acknowledge the Montana State University Norm Asbjornson College of Engineering for their sponsoring the Benjamin Fellowship that supported Cody Reed during this work.	Asslander L, 2016, J NEUROPHYSIOL, V116, P272, DOI 10.1152/jn.01145.2015; Asslander L, 2014, J NEUROPHYSIOL, V111, P1852, DOI 10.1152/jn.00669.2013; Bigelow KE, 2011, J GERONTOL A-BIOL, V66, P228, DOI 10.1093/gerona/glq202; BOUCHER P, 1995, DIABETES CARE, V18, P638, DOI 10.2337/diacare.18.5.638; Brown LA, 2006, PARKINSONISM RELAT D, V12, P376, DOI 10.1016/j.parkreldis.2006.03.004; Carpenter MG, 2001, GAIT POSTURE, V13, P35, DOI 10.1016/S0966-6362(00)00093-X; CARROLL JP, 1993, J BIOMECH, V26, P409, DOI 10.1016/0021-9290(93)90004-X; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Doyle RJ, 2007, GAIT POSTURE, V25, P166, DOI 10.1016/j.gaitpost.2006.03.004; Hay L, 1996, EXP BRAIN RES, V108, P129; Honeine JL, 2017, J NEUROPHYSIOL, V117, P777, DOI 10.1152/jn.00725.2016; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; Lafond D, 2004, ARCH PHYS MED REHAB, V85, P896, DOI 10.1016/j.apmr.2003.08.089; Mahoney JR, 2019, J GERONTOL A-BIOL, V74, P1429, DOI 10.1093/gerona/gly245; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Monfort SM, 2016, GAIT POSTURE, V48, P237, DOI 10.1016/j.gaitpost.2016.06.011; Mukaka MM, 2012, MALAWI MED J, V24, P69; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Piirtola M, 2006, GERONTOLOGY, V52, P1, DOI 10.1159/000089820; Pizzigalli L, 2016, J BODYW MOV THER, V20, P409, DOI 10.1016/j.jbmt.2015.12.008; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Quatman-Yates CC, 2015, PEDIATR PHYS THER, V27, P316, DOI 10.1097/PEP.0000000000000193; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; SAFTARI LN, 2018, J PHYSIOL ANTHR APPL, V37, DOI DOI 10.1186/S40101-017-0162-6; Thapa PB, 1996, J GERONTOL A-BIOL, V51, pM239, DOI 10.1093/gerona/51A.5.M239; van der Kooij H, 2011, GAIT POSTURE, V34, P19, DOI 10.1016/j.gaitpost.2011.02.025; VIENNEJUMEAU A, 2019, SYST REV, V8, DOI DOI 10.1186/S13643-018-0916-1; Winter D.A., 2009, DEPRESS ANXIETY, VFourth, DOI [10.1002/9780470549148, DOI 10.1002/DA.22895]; Worthen-Chaudhari LC, 2018, GAIT POSTURE, V64, P141, DOI 10.1016/j.gaitpost.2018.05.031	31	13	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237246	10.1371/journal.pone.0237246	http://dx.doi.org/10.1371/journal.pone.0237246			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776952	Green Published, gold			2022-12-26	WOS:000561393800035
J	Allison, TS; Moritz, J; Turk, P; Stone-Roy, LM				Allison, Tyler S.; Moritz, Joel, Jr.; Turk, Philip; Stone-Roy, Leslie M.			Lingual electrotactile discrimination ability is associated with the presence of specific connective tissue structures (papillae) on the tongue surface	PLOS ONE			English	Article							SENSORY-SUBSTITUTION DEVICES; FUNGIFORM PAPILLAE; 2-POINT DISCRIMINATION; NERVE-ENDINGS; MECHANORECEPTIVE AFFERENTS; VISION SUBSTITUTION; SPEECH-PERCEPTION; ORAL SENSATION; STIMULUS ARRAY; TASTE	Electrical stimulation of nerve endings in the tongue can be used to communicate information to users and has been shown to be highly effective in sensory substitution applications. The anterior tip of the tongue has very small somatosensory receptive fields, comparable to those of the finger tips, allowing for precise two-point discrimination and high tactile sensitivity. However, perception of electrotactile stimuli varies significantly between users, and across the tongue surface. Despite this, previous studies all used uniform electrode grids to stimulate a region of the dorsal-medial tongue surface. In an effort to customize electrode layouts for individual users, and thus improve efficacy for sensory substitution applications, we investigated whether specific neuroanatomical and physiological features of the tongue are associated with enhanced ability to perceive active electrodes. Specifically, the study described here was designed to test whether fungiform papillae density and/or propylthiouracil sensitivity are positively or negatively associated with perceived intensity and/or discrimination ability for lingual electrotactile stimuli. Fungiform papillae number and distribution were determined for 15 participants and they were exposed to patterns of electrotactile stimulation (ETS) and asked to report perceived intensity and perceived number of stimuli. Fungiform papillae number and distribution were then compared to ETS characteristics using comprehensive and rigorous statistical analyses. Our results indicate that fungiform papillae density is correlated with enhanced discrimination ability for electrical stimuli. In contrast, papillae density, on average, is not correlated with perceived intensity of active electrodes. However, results for at least one participant suggest that further research is warranted. Our data indicate that propylthiouracil taster status is not related to ETS perceived intensity or discrimination ability. These data indicate that individuals with higher fungiform papillae number and density in the anterior medial tongue region may be better able to use lingual ETS for sensory substitution.	[Allison, Tyler S.; Stone-Roy, Leslie M.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Moritz, Joel, Jr.] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA; [Moritz, Joel, Jr.] Sapien LLC, Ft Collins, CO USA; [Turk, Philip] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA; [Turk, Philip] Atrium Hlth, Charlotte, NC USA	Colorado State University; Colorado State University; Colorado State University	Stone-Roy, LM (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	Leslie.Stone-Roy@Colostate.edu		Stone-Roy, Leslie/0000-0002-9569-1072	College Research Council Award; Experiential Learning Grant (LSR) from College of Veterinary Medicine and Biomedical Sciences at CSU; Colorado Office of Economic Development and International Trade (OEDIT) [APP-152692]; City of Fort Collins; Colorado State University Libraries Open Access Research and Scholarship Fund	College Research Council Award; Experiential Learning Grant (LSR) from College of Veterinary Medicine and Biomedical Sciences at CSU; Colorado Office of Economic Development and International Trade (OEDIT); City of Fort Collins; Colorado State University Libraries Open Access Research and Scholarship Fund	This research was funded in part by the College Research Council Award and Experiential Learning Grant (LSR) from College of Veterinary Medicine and Biomedical Sciences at CSU. Additionally, this research was funded by the Colorado Office of Economic Development and International Trade (OEDIT, APP-152692), https://choosecolorado.com/(LSR), as well as the City of Fort Collins which provided a match for the OEDIT funding. Publishing costs were supported by The Colorado State University Libraries Open Access Research and Scholarship Fund. The aforementioned funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Finally, Sapien LLC additionally matched the OEDIT funding and provided materials used in the study. Sapien LLC had a role in review of the manuscript and decision to publish.	Arnold G, 2017, MULTISENS RES, V30, P579, DOI 10.1163/22134808-00002561; ASTBACK J, 1995, REGUL PEPTIDES, V59, P389, DOI 10.1016/0167-0115(95)00107-M; Auer ET, 2007, NEUROREPORT, V18, P645, DOI 10.1097/WNR.0b013e3280d943b9; BACH P, 1969, NATURE, V221, P963, DOI 10.1038/221963a0; Bach-y-Rita P, 1998, J REHABIL RES DEV, V35, P427; Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; Bach-y-Rita P., 2005, INTELLECTICA, V40, P115, DOI DOI 10.3406/INTEL.2005.1362; BACHYRITA P, 1967, ACTA NEUROL SCAND, V43, P417, DOI 10.1111/j.1600-0404.1967.tb05747.x; Bangcuyo RG, 2017, EXP BRAIN RES, V235, P2679, DOI 10.1007/s00221-017-5003-7; BARTOSHUK LM, 1994, PHYSIOL BEHAV, V56, P1165, DOI 10.1016/0031-9384(94)90361-1; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Bubic A, 2010, LARGE SCALE BRAIN PL; Caltenco HA, 2013, DISABIL REHABIL-ASSI, V8, P330, DOI 10.3109/17483107.2012.699991; Barros CGC, 2010, NEUROSCI LETT, V476, P123, DOI 10.1016/j.neulet.2010.04.012; Catanzaro D, 2013, APPETITE, V68, P124, DOI 10.1016/j.appet.2013.04.025; Chebat DR, 2007, NEUROREPORT, V18, P1901, DOI 10.1097/WNR.0b013e3282f2a63; Cheung SH, 2009, CURR BIOL, V19, P596, DOI 10.1016/j.cub.2009.02.063; Cholewiak R W, 1986, J Rehabil Res Dev, V23, P20; Danilov Yuri, 2005, Journal of Integrative Neuroscience, V4, P537, DOI 10.1142/S0219635205000914; De Volder AG, 2001, NEUROIMAGE, V14, P129, DOI 10.1006/nimg.2001.0782; Dehmel S, 2008, AM J AUDIOL, V17, pS193, DOI 10.1044/1059-0889(2008/07-0045); Dinehart ME, 2006, PHYSIOL BEHAV, V87, P304, DOI 10.1016/j.physbeh.2005.10.018; Diot B, 2014, MULTISENS RES, V27, P313, DOI 10.1163/22134808-00002458; Duffy VB, 2010, CHEMOSENS PERCEPT, V3, P137, DOI 10.1007/s12078-010-9079-8; Duffy VB, 2004, PHYSIOL BEHAV, V82, P435, DOI 10.1016/j.physbeh.2004.04.060; Essick GK, 2003, PHYSIOL BEHAV, V80, P289, DOI 10.1016/j.physbeh.2003.08.007; FARBMAN AI, 1991, J COMP NEUROL, V304, P172, DOI 10.1002/cne.903040203; Fu KMG, 2003, J NEUROSCI, V23, P7510; Galvin K L, 1991, J Am Acad Audiol, V2, P214; Glick H, 2017, HEARING RES, V343, P191, DOI 10.1016/j.heares.2016.08.012; GREEN BG, 1993, CHEM SENSES, V18, P683, DOI 10.1093/chemse/18.6.683; Haggard P, 2014, NEUROSCI BIOBEHAV R, V47, P469, DOI 10.1016/j.neubiorev.2014.09.015; Hagura N, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1680; HALL MJ, 1975, NATURE, V253, P442, DOI 10.1038/253442a0; Kaczmarek KA, 2011, SCI IRAN, V18, P1476, DOI 10.1016/j.scient.2011.08.020; Karns CM, 2017, HEARING RES, V343, P72, DOI 10.1016/j.heares.2016.07.008; KARRER T, 1991, PHYSIOL BEHAV, V49, P757, DOI 10.1016/0031-9384(91)90315-F; Kim G, 2004, P ANN INT IEEE EMBS, V26, P4948; Kim Y, 2015, IEEE T HAPTICS, V8, P298, DOI 10.1109/TOH.2015.2415213; Kristjansson A, 2016, RESTOR NEUROL NEUROS, V34, P769, DOI 10.3233/RNN-160647; Kupers R, 2014, NEUROSCI BIOBEHAV R, V41, P36, DOI 10.1016/j.neubiorev.2013.08.001; LASS NJ, 1972, PERCEPT MOTOR SKILL, V35, P59, DOI 10.2466/pms.1972.35.1.59; Lynch M P, 1988, J Rehabil Res Dev, V25, P41; LYNCH MP, 1989, J SPEECH HEAR RES, V32, P331, DOI 10.1044/jshr.3202.331; LYNCH MP, 1989, J SPEECH HEAR DISORD, V54, P57, DOI 10.1044/jshd.5401.57; MAEYAMA T, 1989, AM J OTOLARYNG, V10, P342, DOI 10.1016/0196-0709(89)90110-5; Maidenbaum S, 2014, RESTOR NEUROL NEUROS, V32, P813, DOI 10.3233/RNN-130351; MILLER IJ, 1986, ANAT REC, V216, P474, DOI 10.1002/ar.1092160404; MILLER IJ, 1990, PHYSIOL BEHAV, V47, P1213, DOI 10.1016/0031-9384(90)90374-D; Miller Shawn L, 2002, Penn Dent J (Phila), V102, P6; Mistretta CM, 2006, ARCH HISTOL CYTOL, V69, P199, DOI 10.1679/aohc.69.199; Mistretta CM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061341; Mistretta CM, 2017, ANNU REV PHYSIOL, V79, P335, DOI 10.1146/annurev-physiol-022516-034202; Moayedi Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28195-2; Moritz JA, 2017, EVALUATION ELECT TON; Moritz J, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00186; Nau AC, 2015, NEURAL REGEN RES, V10, P1717, DOI 10.4103/1673-5374.169612; Novich SD, 2015, EXP BRAIN RES, V233, P2777, DOI 10.1007/s00221-015-4346-1; Nuessle TM, 2015, JOVE-J VIS EXP, DOI 10.3791/52860; OLLER DK, 1980, J SPEECH HEAR RES, V23, P769, DOI 10.1044/jshr.2304.769; Pagella P, 2014, CELL MOL LIFE SCI, V71, P2241, DOI 10.1007/s00018-013-1549-0; Prescott J, 2000, CHEM SENSES, V25, P239, DOI 10.1093/chemse/25.3.239; Reislev NL, 2016, BRAIN STRUCT FUNCT, V221, P2891, DOI 10.1007/s00429-015-1078-8; Robineau F, 2007, IEEE T BIO-MED ENG, V54, P711, DOI 10.1109/TBME.2006.889180; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Roux FE, 2018, J PHYSIOL-LONDON, V596, P941, DOI 10.1113/JP275243; Sadato N, 2005, NEUROSCIENTIST, V11, P577, DOI 10.1177/1073858405277314; Sakamoto KW, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00136; Sakamoto K, 2010, NEUROSCI RES, V66, P173, DOI 10.1016/j.neures.2009.10.013; Shore SE, 2005, EUR J NEUROSCI, V21, P3334, DOI 10.1111/j.1460-9568.2005.04142.x; SUEMUNE S, 1992, BRAIN RES, V586, P162, DOI 10.1016/0006-8993(92)91389-V; Trulsson M, 2010, J NEUROPHYSIOL, V103, P1741, DOI 10.1152/jn.01146.2009; Trulsson M, 1997, J NEUROPHYSIOL, V77, P737, DOI 10.1152/jn.1997.77.2.737; Tyler Mitchell, 2003, J Integr Neurosci, V2, P159, DOI 10.1142/S0219635203000263; Tyler ME, 2009, IEEE ENG MED BIO, P559, DOI 10.1109/IEMBS.2009.5334556; Vuillerme N, 2011, IEEE ENG MED BIO, P1323, DOI 10.1109/IEMBS.2011.6090311; Vuillerme N, 2007, EXP BRAIN RES, V179, P409, DOI 10.1007/s00221-006-0800-4; Vuillerme N, 2009, GAIT POSTURE, V30, P556, DOI 10.1016/j.gaitpost.2009.07.124; Vuillerme N, 2009, PERVASIVE MOB COMPUT, V5, P268, DOI 10.1016/j.pmcj.2008.04.001; Watanabe IS, 2013, MICROSCOPY-JPN, V62, P259, DOI 10.1093/jmicro/dfs068; WHITEHEAD MC, 1985, AM J ANAT, V173, P185, DOI 10.1002/aja.1001730304; Wildenberg JC, 2013, BRAIN CONNECT, V3, P87, DOI 10.1089/brain.2012.0123; Wilson JA, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045007; Won SY, 2017, J APPL ORAL SCI, V25, P427, DOI 10.1590/1678-7757-2016-0462; Wu C, 2015, CELL TISSUE RES, V361, P233, DOI 10.1007/s00441-014-2074-7; Yamanaka T, 2016, NEUROREPORT, V27, P744, DOI 10.1097/WNR.0000000000000606	86	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237142	10.1371/journal.pone.0237142	http://dx.doi.org/10.1371/journal.pone.0237142			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2FE	32764778	gold, Green Published			2022-12-26	WOS:000561029000004
J	Wahlqvist, F; Bryngelsson, IL; Westberg, H; Vihlborg, P; Andersson, L				Wahlqvist, Fredrik; Bryngelsson, Ing-Liss; Westberg, Hakan; Vihlborg, Per; Andersson, Lena			Dermal and inhalable cobalt exposure-Uptake of cobalt for workers at Swedish hard metal plants	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; URINARY COBALT; NICKEL; CHROMIUM; HEALTH; COSMETICS; CONTACT; RELEASE; RISKS	Purpose Cobalt exposure is known to cause adverse effects on health. A major use of cobalt is in the manufacture of hard metal. Exposure can lead to asthma, hard metal lung disease, contact allergy and increased risk of cancer. Cobalt is mainly absorbed from the pulmonary tract, however penetration through skin may occur. The relationships between exposure to inhalable cobalt in air and on skin and the uptake in blood and urine will be investigated, as well as the association between dermal symptoms and dermal exposure. Methods Cobalt exposure in 71 workers in hard metal production facilities was measured as inhalable cobalt in the breathing zone and cobalt found on skin with acid wash. Uptake of cobalt was determined with concentrations in blood and urine. Correlations between exposure and uptake were analysed. Results Inhalable cobalt in air and cobalt in blood and urine showed rank correlations with coefficients 0.40 and 0.25. Cobalt on skin and uptake in blood and urine presented correlation coefficients of 0.36 and 0.17. Multiple linear regression of cobalt in air and on skin with cobalt in blood showed regression coefficients with cobalt in blood (beta = 203 p < 0.0010, and beta = 0.010, p = 0.0040) and with cobalt in urine (beta = 5779, p = 0.0010, and beta = 0.10, p = 0.60). Conclusions Our data presents statistically significant correlations between exposure to cobalt in air with uptake of cobalt in blood and urine. Cobalt on skin was statistically significant with cobalt in blood but not with urine.	[Wahlqvist, Fredrik; Bryngelsson, Ing-Liss; Westberg, Hakan; Vihlborg, Per; Andersson, Lena] Orebro Univ, Fac Med & Hlth, Dept Occupat & Environm Med, Orebro, Sweden; [Westberg, Hakan; Andersson, Lena] Orebro Univ, Fac Med & Hlth, Sch Med Sci, Orebro, Sweden; [Westberg, Hakan; Andersson, Lena] Orebro Univ, Fac Med & Hlth, Inflammatory Response & Infect Susceptibil Ctr iR, Orebro, Sweden	Orebro University; Orebro University; Orebro University	Andersson, L (corresponding author), Orebro Univ, Fac Med & Hlth, Dept Occupat & Environm Med, Orebro, Sweden.; Andersson, L (corresponding author), Orebro Univ, Fac Med & Hlth, Sch Med Sci, Orebro, Sweden.; Andersson, L (corresponding author), Orebro Univ, Fac Med & Hlth, Inflammatory Response & Infect Susceptibil Ctr iR, Orebro, Sweden.	lena.andersson4@regionorebrolan.se		Andersson, Lena/0000-0001-8166-7955	Knowledge Foundation [20160044]	Knowledge Foundation	This study was supported by the Knowledge Foundation (Ref no. 20160044).	ACGIH, 2019, THRESH LIM VAL CHEM; Alexandersson R., 1979, WORK HLTH, V8, P2; ANGERER J, 1989, INT J ENVIRON AN CH, V35, P81, DOI 10.1080/03067318908028381; [Anonymous], BIOM CHEM BIOL DUST; BALMES JR, 1987, OCCUP MED, V2, P327; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P201, DOI 10.1081/CLT-100102420; Bocca B, 2014, REGUL TOXICOL PHARM, V68, P447, DOI 10.1016/j.yrtph.2014.02.003; Borowska S, 2015, J APPL TOXICOL, V35, P551, DOI 10.1002/jat.3129; CHRISTENSEN JM, 1993, INT ARCH OCC ENV HEA, V65, P233, DOI 10.1007/BF00381196; CUGELL DW, 1990, ARCH INTERN MED, V150, P177, DOI 10.1001/archinte.150.1.177; DOOMSGOOSSENS AE, 1986, J AM ACAD DERMATOL, V15, P1, DOI 10.1016/S0190-9622(86)70135-7; Edling C., OCCUPATIONAL ENV MED; Ferioli A., 1987, 11135 EUR EN COMM EU, P48; Health and Safety Executive (HSE 2000), 2000, 143 HSE; Hogstedt C., 1990, ARBETE HALSA, V21, P1; Hutter HP, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090931; *IARC, 2006, IARC MON EV CARC RIS, V86; IARC, 1991, IARC MONOGRAPHS EVAL, V52; ICHIKAWA Y, 1985, INT ARCH OCC ENV HEA, V55, P269, DOI 10.1007/BF00377685; Jelsma J, 2019, HIP INT, V29, P638, DOI 10.1177/1120700018814225; Julander A, 2010, ANN OCCUP HYG, V54, P340, DOI 10.1093/annhyg/meq002; Julander A, 2009, CONTACT DERMATITIS, V60, P165, DOI 10.1111/j.1600-0536.2008.01497.x; Klasson M, 2017, CONTACT DERMATITIS, V77, P201, DOI 10.1111/cod.12790; Klasson M, 2016, ANN OCCUP HYG, V60, P684, DOI 10.1093/annhyg/mew023; KUSAKA Y, 1989, IND HEALTH, V27, P155, DOI 10.2486/indhealth.27.155; Kusaka Y., 1986, BRIT J IND MED; LASFARGUES G, 1994, AM J IND MED, V26, P585, DOI 10.1002/ajim.4700260502; LAUWERYS R, 1994, SCI TOTAL ENVIRON, V150, P1, DOI 10.1016/0048-9697(94)90125-2; Leyssens L, 2017, TOXICOLOGY, V387, P43, DOI 10.1016/j.tox.2017.05.015; Liden C, 2006, CONTACT DERMATITIS, V54, P233, DOI 10.1111/j.0105-1873.2006.00736.x; Linna A, 2003, AM J IND MED, V44, P124, DOI 10.1002/ajim.10258; Linnainmaa M, 1997, INT ARCH OCC ENV HEA, V69, P193, DOI 10.1007/s004200050136; Midander K, 2014, CONTACT DERMATITIS, V70, P361, DOI 10.1111/cod.12198; Mistretta V, 2016, M S-MED SCI, V32, P732, DOI 10.1051/medsci/20163208021; MORIN Y, 1967, CAN MED ASSOC J, V97, P926; Moulin JJ, 1998, AM J EPIDEMIOL, V148, P241; National Institute of Occupational Health (NIOSH), 2014, DHHS NIOSH PUB, V94-113; NORDBERG G, 1994, SCI TOTAL ENVIRON, V150, P201, DOI 10.1016/0048-9697(94)90151-1; Occupational and Environmental Medicine orebro University Hospital, 2012, 1204 YM OR U HOSP OC; OSHA Annotated PELs, OCC SAF HLTH ADM; Rehfisch P, 2012, J OCCUP ENVIRON MED, V54, P409, DOI 10.1097/JOM.0b013e31824d2d7e; SCANSETTI G, 1994, SCI TOTAL ENVIRON, V150, P141, DOI 10.1016/0048-9697(94)90141-4; SCANSETTI G, 1985, INT ARCH OCC ENV HEA, V57, P19, DOI 10.1007/BF00383542; SHIRAKAWA T, 1989, CHEST, V95, P29, DOI 10.1378/chest.95.1.29; Simonsen LO, 2012, SCI TOTAL ENVIRON, V432, P210, DOI 10.1016/j.scitotenv.2012.06.009; SUNDERMAN FW, 1989, J ORTHOPAED RES, V7, P307, DOI 10.1002/jor.1100070302; Swedish Work Environment Authority, 2018, OCC EXP LIM, P1; Swedish Work Environment Authority, 2011, OCC EXP LIM, V2011, P18; SWENNEN B, 1993, BRIT J IND MED, V50, P835; Thyssen JP, 2010, CONTACT DERMATITIS, V63, P70, DOI 10.1111/j.1600-0536.2010.01752.x; Toxicological Profile for Cobalt. U.S. Department of Health and Human Services, 2004, TOX PROF COB; Westberg H, 2019, INT ARCH OCC ENV HEA, V92, P1087, DOI 10.1007/s00420-019-01446-z; Witzleb WC, 2006, ACTA ORTHOP, V77, P697, DOI 10.1080/17453670610012863	53	6	7	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237100	10.1371/journal.pone.0237100	http://dx.doi.org/10.1371/journal.pone.0237100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760159	Green Published, gold			2022-12-26	WOS:000561027200020
J	Kandanaarachchi, S; Hyndman, RJ; Smith-Miles, K				Kandanaarachchi, Sevvandi; Hyndman, Rob J.; Smith-Miles, Kate			Early classification of spatio-temporal events using partial information	PLOS ONE			English	Article							LINEAR-MODELS; SCAN; CHANGEPOINT	This paper investigates event extraction and early event classification in contiguous spatio-temporal data streams, where events need to be classified using partial information, i.e. while the event is ongoing. The framework incorporates an event extraction algorithm and an early event classification algorithm. We apply this framework to synthetic and real problems and demonstrate its reliability and broad applicability. The algorithms and data are available in the R packageeventstream, and other code in the supplementary material.	[Kandanaarachchi, Sevvandi] RMIT Univ, Sch Sci, Math Sci, Melbourne, Vic, Australia; [Hyndman, Rob J.] Monash Univ, Dept Econometr & Business Stat, Clayton, Vic, Australia; [Smith-Miles, Kate] Univ Melbourne, Sch Math & Stat, Parkville, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Monash University; University of Melbourne	Kandanaarachchi, S (corresponding author), RMIT Univ, Sch Sci, Math Sci, Melbourne, Vic, Australia.	sevvandi.kandanaarachchi@rmit.edu.au		Kandanaarachchi, Sevvandi/0000-0002-0337-0395	Australian Research Council [LP160101885]	Australian Research Council(Australian Research Council)	Funding was provided by the Australian Research Council through the Linkage Project LP160101885. Initials of authors who received the award: KSM, RJH https://www.arc.gov.au/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided by the Australian Research Council through the Linkage Project LP160101885.	Aminikhanghahi S, 2017, KNOWL INF SYST, V51, P339, DOI 10.1007/s10115-016-0987-z; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; [Anonymous], 2019, WHO AIR POLLUTION; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; Atefeh F, 2015, COMPUT INTELL-US, V31, P132, DOI 10.1111/coin.12017; AUGER IE, 1989, B MATH BIOL, V51, P39, DOI 10.1007/BF02458835; Bai JS, 1998, ECONOMETRICA, V66, P47, DOI 10.2307/2998540; Bardwell L, 2019, TECHNOMETRICS, V61, P88, DOI 10.1080/00401706.2018.1438926; Dietterich T., 2019, ICLR; Ditzler G, 2015, IEEE COMPUT INTELL M, V10, P12, DOI 10.1109/MCI.2015.2471196; Earle PS, 2011, ANN GEOPHYS-ITALY, V54, P708, DOI 10.4401/ag-5364; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Geddes JA, 2016, ENVIRON HEALTH PERSP, V124, P281, DOI 10.1289/ehp.1409567; Griffiths B, 1995, 29TH ANNUAL 1995 INTERNATIONAL CARNAHAN CONFERENCE ON SECURITY TECHNOLOGY, PROCEEDINGS, P325, DOI 10.1109/CCST.1995.524931; Guralnik V., 1999, P 5 ACM SIGKDD INT C, P33, DOI DOI 10.1145/312129.312190; Hamunyela E, 2016, REMOTE SENS ENVIRON, V172, P126, DOI 10.1016/j.rse.2015.11.006; HASTIE T, 1993, J ROY STAT SOC B MET, V55, P757; HIJMANS RJ, 2018, RASTER GEOGRAPHIC DA, V2, P8; Hulten G., 2001, KDD-2001. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P97, DOI 10.1145/502512.502529; Jiang Q, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON AUTOMATION AND LOGISTICS ( ICAL 2009), VOLS 1-3, P1154, DOI 10.1109/ICAL.2009.5262595; Jo J., 2017, ARXIV; Johnstone I. M., 2004, SPARSE PRINCIP UNPUB, V7, P151; Ke Y, 2007, IEEE I CONF COMP VIS, P1424; Killick R, 2012, J AM STAT ASSOC, V107, P1590, DOI 10.1080/01621459.2012.737745; Killick R, 2014, J STAT SOFTW, V58, P1; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Leigh C., 2019, PLOS ONE, DOI [10.1101/599712v1, DOI 10.1101/599712V1]; Levelt PF, 2006, IEEE T GEOSCI REMOTE, V44, P1093, DOI 10.1109/TGRS.2006.872333; Li HN, 2004, ENG STRUCT, V26, P1647, DOI 10.1016/j.engstruct.2004.05.018; Li R, 2012, PROC INT CONF DATA, P1273, DOI 10.1109/ICDE.2012.125; Medioni G, 2001, IEEE T PATTERN ANAL, V23, P873, DOI 10.1109/34.946990; Neill DB, 2012, J R STAT SOC B, V74, P337, DOI 10.1111/j.1467-9868.2011.01014.x; Nikles M, 2004, P SOC PHOTO-OPT INS, V5384, P18, DOI 10.1117/12.540270; Papernot N, 2016, 1ST IEEE EUROPEAN SYMPOSIUM ON SECURITY AND PRIVACY, P372, DOI 10.1109/EuroSP.2016.36; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Ruocco M, 2014, MULTIMED TOOLS APPL, V70, P55, DOI 10.1007/s11042-012-1087-z; Sadia F., 2019, WORKING PAPER; SCOTT AJ, 1974, BIOMETRICS, V30, P507, DOI 10.2307/2529204; SEN A, 1975, ANN STAT, V3, P98, DOI 10.1214/aos/1176343001; Suthaharan Shan, 2014, ACM SIGMETRICS Performance Evaluation Review, V41, P70; Tan PN., 2016, INTRO DATA MINING; Venables WN., 2002, MODERN APPL STAT S 4; Verbesselt J, 2012, REMOTE SENS ENVIRON, V123, P98, DOI 10.1016/j.rse.2012.02.022; Verbesselt J, 2010, REMOTE SENS ENVIRON, V114, P2970, DOI 10.1016/j.rse.2010.08.003; Verbesselt J, 2010, REMOTE SENS ENVIRON, V114, P106, DOI 10.1016/j.rse.2009.08.014; Weng J., 2011, P INT AAAI C WEB SOC; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zeng Q, 2019, TRANSPORTMETRICA A, V15, P1867, DOI 10.1080/23249935.2019.1652867; Zhu Z, 2014, REMOTE SENS ENVIRON, V144, P152, DOI 10.1016/j.rse.2014.01.011	57	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236331	10.1371/journal.pone.0236331	http://dx.doi.org/10.1371/journal.pone.0236331			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756613	gold, Green Published			2022-12-26	WOS:000560393300005
J	Jeong, E; Kim, J; Go, M; Lee, SY				Jeong, Eutteum; Kim, Jihee; Go, Miyeon; Lee, Soo Young			Early estrogen-induced gene 1 facilitates osteoclast formation through the inhibition of interferon regulatory factor 8 expression	FASEB JOURNAL			English	Article						bone; bone loss; osteoclast formation; osteoclastogenesis; osteoclasts	TERMINAL DIFFERENTIATION; BONE-RESORPTION; PROTEINS; RECEPTOR; IMMUNE; RANK; OSTEOIMMUNOLOGY; PERIODONTITIS; PLC-GAMMA-2; MECHANISMS	Osteoclast-mediated inflammatory bone resorption is a major cause of many inflammatory bone disorders, including rheumatoid arthritis and periodontitis. However, the mechanisms regulating osteoclast differentiation in inflammatory settings are not well understood. We demonstrate here that early estrogen-induced gene 1 (EEIG1)-deficient mice are protected from inflammatory bone loss as determined with the use of models of lipopolysaccharide (LPS)-induced bone destruction.EEIG1-deficient macrophages markedly decreased RANKL- and TNF alpha-mediated osteoclastogenesis due to the downregulation of the nuclear factor of activated T cells, cytoplasmic 1 (NFATc1), which is an essential transcription factor for osteoclast formation. In contrast, expression of interferon regulatory factor 8 (IRF8), a transcriptional repressor that blocks osteoclast differentiation, is elevated inEEIG1-deficient macrophages relative to wild-type cells. We found that reduced expression of B lymphocyte-induced maturation protein-1 (Blimp1) by siRNA downregulated RANKL-induced EEIG1 levels, whereas overexpression of Blimp1 potentiated EEIG1 levels. Mechanistic studies revealed that EEIG1 forms a complex with Blimp1 to negatively regulate the expression of the anti-osteoclastogenic gene,Irf8. We elucidated a novel mechanism by which EEIG1 restricts IRF8 expression and function, thereby enhancing the osteoclast formation by contributing to Blimp1-mediated IRF8 regulation. Together, these findings identify EEIG1 as a key regulator of osteoclastogenesis and a possible therapeutic target for pathological bone destruction.	[Jeong, Eutteum; Kim, Jihee; Go, Miyeon; Lee, Soo Young] Ewha Womans Univ, Dept Life Sci, C-419,Sci Complex Bldg,52 Ewhayeodae Gil, Seoul 03760, South Korea; [Jeong, Eutteum; Kim, Jihee; Lee, Soo Young] Ewha Womans Univ, Res Ctr Cellular Homeostasis, C-419,Sci Complex Bldg,52 Ewhayeodae Gil, Seoul 03760, South Korea	Ewha Womans University; Ewha Womans University	Lee, SY (corresponding author), Ewha Womans Univ, Dept Life Sci, C-419,Sci Complex Bldg,52 Ewhayeodae Gil, Seoul 03760, South Korea.; Lee, SY (corresponding author), Ewha Womans Univ, Res Ctr Cellular Homeostasis, C-419,Sci Complex Bldg,52 Ewhayeodae Gil, Seoul 03760, South Korea.	leesy@ewha.ac.kr		Kim, Jihee/0000-0002-4755-3169	National Research Foundation of Korea [2019R1A5A6099645]; Korea Basic Science Institute National Research Facilities & Equipment Center [2019R1A6C1010020]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Basic Science Institute National Research Facilities & Equipment Center	This work was supported by grants from the National Research Foundation of Korea (2019R1A5A6099645) and the Korea Basic Science Institute National Research Facilities & Equipment Center (2019R1A6C1010020). We thank T. Kim and W. Jeong for data analysis and interpretation.	Adamopoulos IE, 2015, NAT REV RHEUMATOL, V11, P189, DOI 10.1038/nrrheum.2014.198; Algate K, 2016, J PERIODONTAL RES, V51, P549, DOI 10.1111/jre.12339; Axmann R, 2009, ARTHRITIS RHEUM-US, V60, P2747, DOI 10.1002/art.24781; Boyce BF, 2006, CURR OPIN RHEUMATOL, V18, P427, DOI 10.1097/01.bor.0000231913.32364.32; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Carotta S, 2014, J EXP MED, V211, P2169, DOI 10.1084/jem.20140425; Chen ZH, 2015, J BIOL CHEM, V290, P30163, DOI 10.1074/jbc.M115.663518; Choi HK, 2013, CELL RES, V23, P524, DOI 10.1038/cr.2013.33; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Kim JH, 2014, CELL DEATH DIFFER, V21, P1613, DOI 10.1038/cdd.2014.71; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; Luchin A, 2000, J BONE MINER RES, V15, P451, DOI 10.1359/jbmr.2000.15.3.451; Luo G, 2018, MOL MED REP, V17, P6605, DOI 10.3892/mmr.2018.8698; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Miyauchi Y, 2010, J EXP MED, V207, P751, DOI 10.1084/jem.20091957; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Osta B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00048; Potempa J, 2017, NAT REV RHEUMATOL, V13, P606, DOI 10.1038/nrrheum.2017.132; Schett G, 2011, EUR J CLIN INVEST, V41, P1361, DOI 10.1111/j.1365-2362.2011.02545.x; Shin B, 2014, J BIOL CHEM, V289, P35868, DOI 10.1074/jbc.M114.589614; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tanaka Yoshiya, 2005, Current Drug Targets - Inflammation and Allergy, V4, P325, DOI 10.2174/1568010054022015; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wang DY, 2004, MOL ENDOCRINOL, V18, P402, DOI 10.1210/me.2003-0202; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhao BH, 2012, J EXP MED, V209, P319, DOI 10.1084/jem.20111566; Zhao BH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3379; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	44	1	1	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12894	12906		10.1096/fj.202001197R	http://dx.doi.org/10.1096/fj.202001197R		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32741026	hybrid			2022-12-26	WOS:000558170100001
J	Yang, Y; Xu, PP; He, P; Shi, FS; Tang, YR; Guan, CY; Zeng, H; Zhou, YS; Song, QJ; Zhou, B; Jiang, S; Shao, CY; Sun, J; Yang, YC; Wang, XD; Song, HH				Yang, Yang; Xu, Pianpian; He, Ping; Shi, Fushan; Tang, Yiran; Guan, Chiyu; Zeng, Huan; Zhou, Yingshan; Song, Quanjiang; Zhou, Bin; Jiang, Sheng; Shao, Chunyan; Sun, Jing; Yang, Yongchun; Wang, Xiaodu; Song, Houhui			Mycobacterial PPE13 activates inflammasome by interacting with the NATCH and LRR domains of NLRP3	FASEB JOURNAL			English	Article						IL-1 beta; mycobacteria; NLRP3 inflammasome; PPE13	POLYMORPHIC TANDEM REPEAT; IL-1-BETA PRODUCTION; AIM2 INFLAMMASOME; SECRETION SYSTEM; TUBERCULOSIS; PROTEIN; INTERLEUKIN-1; INFECTION; INNATE; ESX-5	Pathogenic mycobacteria, such asMycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium marinum,can trigger NLRP3 inflammasome activation leading to maturation and secretion of interleukin 1 beta (IL-1 beta). However, the mycobacterial factors involved in the activation of NLRP3 inflammasome are not fully understood. Here, we identified that the PPE family protein PPE13 was responsible for the induction of IL-1 beta secretion in a NLRP3 inflammasome-dependent manner. We found that the recombinantMycobacterium smegmatisexpressing PPE13 activates NLRP3 inflammasome, thereby inducing caspase-1 cleavage and IL-1 beta secretion in J774A.1, BMDMs, and THP-1 macrophages. To examine whether this inflammasome activation was triggered by PPE13 rather than components ofM. smegmatis, PPE13 was introduced into the aforementioned macrophages by lentivirus as a delivery vector. Similarly, this led to the activation of NLRP3 inflammasome, indicating that PPE13 is a direct activator of NLRP3 cascade. We further demonstrated that the NLRP3 complex activated the inflammasome cascade, and the assembly of this complex was facilitated by PPE13 through interacting with the LRR and NATCH domains of NLRP3. Finally, we found that all PPE13 proteins isolated fromM. tuberculosis,M. bovis,andM. marinumcan activate NLRP3 inflammasome through binding to NLRP3, which requires C-terminal repetitive MPTR domain of PPE13. Thus, we, for the first time, revealed that PPE13 triggers the inflammasome-response by interacting with the MPTR domain of PPE13 and the LRR and NATCH domains of NLRP3. These findings provide a novel perspective on the function of PPE proteins in the immune system during mycobacteria invasion.	[Yang, Yang; Xu, Pianpian; Tang, Yiran; Guan, Chiyu; Zeng, Huan; Zhou, Yingshan; Song, Quanjiang; Zhou, Bin; Jiang, Sheng; Shao, Chunyan; Sun, Jing; Yang, Yongchun; Wang, Xiaodu; Song, Houhui] Zhejiang A&F Univ, Coll Anim Sci & Technol, Coll Vet Med,Zhejiang Prov Engn Lab Anim Hlth Ins, Key Lab Appl Technol Green Ecohlth Anim Husb Zhej, Hangzhou 311300, Zhejiang, Peoples R China; [He, Ping] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China; [Shi, Fushan] Zhejiang Univ, Coll Anim Sci, Dept Vet Med, Hangzhou, Peoples R China	Zhejiang A&F University; Chinese Center for Disease Control & Prevention; Zhejiang University	Song, HH (corresponding author), Zhejiang A&F Univ, Coll Anim Sci & Technol, Coll Vet Med,Zhejiang Prov Engn Lab Anim Hlth Ins, Key Lab Appl Technol Green Ecohlth Anim Husb Zhej, Hangzhou 311300, Zhejiang, Peoples R China.	songhh@zafu.edu.cn		Sun, Jing/0000-0002-3400-1920	National Natural Science Foundation of China [31502034, 31502127, 31602119, 31602062, 31770040, 31802258 31902249, 31972648]; Natural Science Foundation of Zhejiang Province [LQ15C180002, LQ19C180003, LQ20C180002, LZ19C180001]; key Research and Development Program of Zhejiang Province [2019C02043]; ZAFU talents starting program [2014FR069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); key Research and Development Program of Zhejiang Province; ZAFU talents starting program	We thank Prof. Michael Niederweis from University of Alabama at Birmingham for providing the vector pMS2 used in this study. The work was funded by the National Natural Science Foundation of China (Grant Nos. 31502034, 31502127, 31602119, 31602062, 31770040, 31802258 31902249, and 31972648), Natural Science Foundation of Zhejiang Province (Grant Nos. LQ15C180002, LQ19C180003, LQ20C180002, and LZ19C180001), the key Research and Development Program of Zhejiang Province (Grant No. 2019C02043) and ZAFU talents starting program (Grant Nos. 2014FR069).	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Abdallah AM, 2011, J IMMUNOL, V187, P4744, DOI 10.4049/jimmunol.1101457; Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; Ahmed A, 2015, IUBMB LIFE, V67, P414, DOI 10.1002/iub.1387; Cadieux N, 2011, MICROBIOL-SGM, V157, P793, DOI 10.1099/mic.0.041996-0; Carlsson F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000895; Chakhaiyar P, 2004, J INFECT DIS, V190, P1237, DOI 10.1086/423938; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; Cubillos-Ruiz Andres, 2008, BMC Res Notes, V1, P110, DOI 10.1186/1756-0500-1-110; Demangel C, 2004, INFECT IMMUN, V72, P2170, DOI 10.1128/IAI.72.4.2170-2176.2004; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Feng ZH, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00116; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; GEYVANPITTIUS NC, 2006, BMC EVOL BIOL, V6; Grover S, 2018, MBIO, V9, DOI 10.1128/mBio.01017-18; HERMANS PWM, 1992, J BACTERIOL, V174, P4157, DOI 10.1128/jb.174.12.4157-4165.1992; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kurenuma T, 2009, INFECT IMMUN, V77, P3992, DOI 10.1128/IAI.00015-09; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mi YJ, 2017, RES MICROBIOL, V168, P234, DOI 10.1016/j.resmic.2016.06.004; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Saiga H, 2012, INT IMMUNOL, V24, P637, DOI 10.1093/intimm/dxs062; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; Sayes F, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005770; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shah S, 2015, INFECT IMMUN, V83, P4349, DOI 10.1128/IAI.00827-15; Shah S, 2013, J IMMUNOL, V191, P3514, DOI 10.4049/jimmunol.1301331; Shi H., 2015, NUTR CANC, V1, P10, DOI DOI 10.1038/NI.3333; Soldini S, 2011, TUBERCULOSIS, V91, P563, DOI 10.1016/j.tube.2011.08.002; Spalinger MR, 2016, J CLIN INVEST, V126, P1783, DOI 10.1172/JCI83669; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; Su HB, 2018, J BIOL CHEM, V293, P10287, DOI 10.1074/jbc.RA118.001696; Sugawara I, 2001, MICROBIOL IMMUNOL, V45, P743, DOI 10.1111/j.1348-0421.2001.tb01310.x; Thi EP, 2013, CELL MICROBIOL, V15, P795, DOI 10.1111/cmi.12073; VANOOSTRUM J, 1991, J STRUCT BIOL, V107, P189; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Wassermann R, 2015, CELL HOST MICROBE, V17, P799, DOI 10.1016/j.chom.2015.05.003; World Health Organization, 2018, GLOB TUB REP 2018; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079; Yang Y, 2013, J INFECT DIS, V208, P1849, DOI 10.1093/infdis/jit347; Zhou ZW, 2020, SCIENCE, V368, P965, DOI 10.1126/science.aaz7548	54	5	5	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12820	12833		10.1096/fj.202000200RR	http://dx.doi.org/10.1096/fj.202000200RR		AUG 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32738179				2022-12-26	WOS:000558180500001
J	Chen, CY; Wang, SQ; Hu, Y; Zhang, M; He, XD; You, CH; Wen, XB; Monroig, O; Tocher, DR; Li, YY				Chen, Cuiying; Wang, Shuqi; Hu, Yu; Zhang, Mei; He, Xianda; You, Cuihong; Wen, Xiaobo; Monroig, Oscar; Tocher, Douglas R.; Li, Yuanyou			miR-26a mediates LC-PUFA biosynthesis by targeting the Lxr alpha-Srebp1 pathway in the marine teleost Siganus canaliculatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						miR-26a; Lxr alpha; Srebp1; LC-PUFA; biosynthesis; Siganus canaliculatus; microRNA (miRNA); fatty acid; gene regulation; fatty acid metabolism	FATTY ACYL DESATURASE; FISH-OIL REPLACEMENT; X-RECEPTOR; ACID BIOSYNTHESIS; LIPID-METABOLISM; LIVER; EXPRESSION; MICRORNAS; GENE; BINDING	MicroRNAs have been recently shown to be important regulators of lipid metabolism. However, the mechanisms of microRNA-mediated regulation of long-chain polyunsaturated fatty acid (LC-PUFA) biosynthesis in vertebrates remain largely unknown. Herein, we for the first time addressed the role of miR-26a in LC-PUFA biosynthesis in the marine rabbitfishSiganus canaliculatus. The results showed that miR-26a was significantly down-regulated in liver of rabbitfish reared in brackish water and inS. canaliculatushepatocyte line (SCHL) incubated with the LC-PUFA precursor alpha-linolenic acid, suggesting that miR-26a may be involved in LC-PUFA biosynthesis because of its abundance being regulated by factors affecting LC-PUFA biosynthesis. Opposite patterns were observed in the expression of liver X receptor alpha (lxr alpha) and sterol regulatory element-binding protein-1 (srebp1), as well as the LC-PUFA biosynthesis-related genes (Delta 4fads2, Delta 6 Delta 5fads2, andelovl5) in SCHL cells incubated with alpha-linolenic acid. Luciferase reporter assays revealed rabbitfishlxr alpha as a target of miR-26a, and overexpression of miR-26a in SCHL cells markedly reduced protein levels of Lxr alpha, Srebp1, and Delta 6 Delta 5 Fads2 induced by the agonist T0901317. Moreover, increasing endogenous Lxr alpha by knockdown of miR-26a facilitated Srebp1 activation and concomitant increased expression of genes involved in LC-PUFA biosynthesis and consequently promoted LC-PUFA biosynthesis bothin vitroandin vivo. These results indicate a critical role of miR-26a in regulating LC-PUFA biosynthesis through targeting the Lxr alpha-Srebp1 pathway and provide new insights into the regulatory network controlling LC-PUFA biosynthesis and accumulation in vertebrates.	[Chen, Cuiying; Wang, Shuqi; Hu, Yu; Zhang, Mei; He, Xianda; You, Cuihong] Shantou Univ, Guangdong Prov Key Lab Marine Biotechnol, Shantou, Peoples R China; [Chen, Cuiying; Wang, Shuqi; Hu, Yu; Zhang, Mei; He, Xianda; You, Cuihong] Shantou Univ, Res Ctr Nutr Feed & Hlth Breeding Aquat Anim Guan, Shantou, Peoples R China; [Wen, Xiaobo; Li, Yuanyou] South China Agr Univ, Coll Marine Sci, Guangzhou, Peoples R China; [Wen, Xiaobo; Li, Yuanyou] Guangdong Lab Lingnan Modern Agr, Guangzhou, Peoples R China; [Monroig, Oscar] CSIC, Inst Acuicultura Torre de la Sal, Castellon de La Plana, Spain; [Tocher, Douglas R.] Univ Stirling, Fac Nat Sci, Inst Aquaculture, Stirling, Scotland	Shantou University; Shantou University; South China Agricultural University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); University of Stirling	Li, YY (corresponding author), South China Agr Univ, Coll Marine Sci, Guangzhou, Peoples R China.; Li, YY (corresponding author), Guangdong Lab Lingnan Modern Agr, Guangzhou, Peoples R China.	yyli16@scau.edu.cn	Monroig, Oscar/K-9117-2014	Monroig, Oscar/0000-0001-8712-0440	National Natural Science Foundation of China [31873040, 31702357]; National Key R&D Program of China [2018YFD0900400]; Guangdong Provincial Key Laboratory of Agro-Animal Genomics and Molecular Breeding Grant [2017B030314058]; Shantou University (STU) Scientific Research Foundation for Talents [NTF19019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Guangdong Provincial Key Laboratory of Agro-Animal Genomics and Molecular Breeding Grant; Shantou University (STU) Scientific Research Foundation for Talents	This work was financially supported by National Natural Science Foundation of China Grants 31873040 and 31702357, National Key R&D Program of China Grant 2018YFD0900400, Guangdong Provincial Key Laboratory of Agro-Animal Genomics and Molecular Breeding Grant 2017B030314058, and The Shantou University (STU) Scientific Research Foundation for Talents Grant NTF19019.	Abedi E, 2014, FOOD SCI NUTR, V2, P443, DOI 10.1002/fsn3.121; Barcelo-Coblijn G, 2009, PROG LIPID RES, V48, P355, DOI 10.1016/j.plipres.2009.07.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bell JG, 2001, J NUTR, V131, P1535, DOI 10.1093/jn/131.5.1535; Bell JG, 2003, J NUTR, V133, P2793, DOI 10.1093/jn/133.9.2793; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Burdge GC, 2006, NUTR RES REV, V19, P26, DOI 10.1079/NRR2005113; Carmona-Antonanzas G, 2014, GENE, V534, P1, DOI 10.1016/j.gene.2013.10.040; Castro LFC, 2016, PROG LIPID RES, V62, P25, DOI 10.1016/j.plipres.2016.01.001; Chen CY, 2019, BBA-MOL CELL BIOL L, V1864, P619, DOI 10.1016/j.bbalip.2019.01.010; Chen CY, 2018, GENE, V676, P306, DOI 10.1016/j.gene.2018.08.063; Chen CY, 2018, AQUACULTURE, V495, P513, DOI 10.1016/j.aquaculture.2018.06.023; Castro LFC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031950; Dong YW, 2018, GENE, V647, P174, DOI 10.1016/j.gene.2018.01.031; Dong YW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160361; FAO, 2016, CONTR FOOD SEC NUTR; Geay F, 2012, MAR GENOM, V5, P7, DOI 10.1016/j.margen.2011.08.003; Gormaz JG, 2010, PROG LIPID RES, V49, P407, DOI 10.1016/j.plipres.2010.05.003; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Janssen CIF, 2014, PROG LIPID RES, V53, P1, DOI 10.1016/j.plipres.2013.10.002; Karbiener M, 2014, STEM CELLS, V32, P1578, DOI 10.1002/stem.1603; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Leaver MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-299; Li YY, 2008, COMP BIOCHEM PHYS B, V151, P183, DOI 10.1016/j.cbpb.2008.06.013; Li YY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205066; Li YY, 2019, MAR BIOTECHNOL, V21, P19, DOI 10.1007/s10126-018-9854-0; Li YY, 2010, P NATL ACAD SCI USA, V107, P16840, DOI 10.1073/pnas.1008429107; Liu Y, 2017, J FISH BIOL, V91, P603, DOI 10.1111/jfb.13375; Minghetti M, 2011, BBA-MOL CELL BIOL L, V1811, P194, DOI 10.1016/j.bbalip.2010.12.008; Monroig O, 2018, POLYUNSATURATED FATTY ACID METABOLISM, P31, DOI 10.1016/B978-0-12-811230-4.00003-X; Monroig O, 2012, AQUACULTURE, V350, P63, DOI 10.1016/j.aquaculture.2012.04.017; Nasopoulou C, 2012, LWT-FOOD SCI TECHNOL, V47, P217, DOI 10.1016/j.lwt.2012.01.018; NORDOY A, 1989, J INTERN MED, V225, P1, DOI 10.1111/j.1365-2796.1989.tb01428.x; Olsen Y, 2011, AQUACULT ENV INTERAC, V1, P187, DOI 10.3354/aei00019; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Qin Y, 2009, BBA-MOL CELL BIOL L, V1791, P140, DOI 10.1016/j.bbalip.2008.12.003; Rayner KJ, 2012, THROMB HAEMOSTASIS, V107, P642, DOI 10.1160/TH11-10-0694; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Sprecher H, 1999, LIPIDS, V34, pS153, DOI 10.1007/BF02562271; Sun DS, 2012, FEBS LETT, V586, P1472, DOI 10.1016/j.febslet.2012.03.068; Sun JJ, 2019, MAR BIOTECHNOL, V21, P475, DOI 10.1007/s10126-019-09895-w; Takeuchi Y, 2010, J BIOL CHEM, V285, P11681, DOI 10.1074/jbc.M109.096107; Tocher DR, 2015, AQUACULTURE, V449, P94, DOI 10.1016/j.aquaculture.2015.01.010; Tur JA, 2012, BRIT J NUTR, V107, pS23, DOI 10.1017/S0007114512001456; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Varin A, 2015, ARTERIOSCL THROM VAS, V35, P1357, DOI 10.1161/ATVBAHA.115.305539; Wang B, 2018, NAT REV ENDOCRINOL, V14, P452, DOI 10.1038/s41574-018-0037-x; Wang H, 2016, RNA BIOL, V13, P500, DOI 10.1080/15476286.2016.1164365; Xie D, 2015, AQUACULT NUTR, V21, P541, DOI 10.1111/anu.12178; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhang QH, 2016, LIPIDS, V51, P1051, DOI 10.1007/s11745-016-4176-3; Zhang QH, 2014, BBA-MOL CELL BIOL L, V1841, P934, DOI 10.1016/j.bbalip.2014.03.009; Zheng XZ, 2005, BBA-MOL CELL BIOL L, V1734, P13, DOI 10.1016/j.bbalip.2005.01.006	59	5	5	4	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2020	295	40					13875	13886		10.1074/jbc.RA120.014858	http://dx.doi.org/10.1074/jbc.RA120.014858			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OB4MB	32759307	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-26	WOS:000578444100014
J	Walsh, HL; Sperry, AJ; Blazer, VS				Walsh, Heather L.; Sperry, Adam J.; Blazer, Vicki S.			The effects of tissue fixation on sequencing and transcript abundance of nucleic acids from microdissected liver samples of smallmouth bass (Micropterus dolomieu)	PLOS ONE			English	Article							LASER-CAPTURE MICRODISSECTION; GENE-EXPRESSION; PCR ANALYSIS; FISH; DNA; TIME; EXTRACTION; FRAMEWORK; CELLS; TOOLS	There is an increasing emphasis on effects-based monitoring to document responses associated with exposure to complex mixtures of chemicals, climate change, pathogens, parasites and other environmental stressors in fish populations. For decades aquatic monitoring programs have included the collection of tissues preserved for microscopic pathology. Consequently, formalin-fixed, paraffin-embedded (FFPE) tissue can be an important reservoir of nucleic acids as technologies emerge that utilize molecular endpoints. Despite the cross-linking effects of formalin, its impact on nucleic acid quality and concentration, amplification, and sequencing are not well described. While fresh-frozen tissue is optimal for working with nucleic acids, FFPE samples have been shown to be conducive for molecular studies. Laser capture microdissection (LCM) is one technology which allows for collection of specific regions or cell populations from fresh or preserved specimens with pathological alterations, pathogens, or parasites. In this study, smallmouth bass (Micropterus dolomieu) liver was preserved in three different fixatives, including 10% neutral buffered formalin (NBF), Z-Fix (R) (ZF), and PAXgene (R) (PG) for four time periods (24 hr, 48 hr, seven days, and 14 days). Controls consisted of pieces of liver preserved in RNALater (R) or 95% ethanol. Smallmouth bass were chosen as they are an economically important sportfish and have been utilized as indicators of exposure to endocrine disruptors and other environmental stressors. Small liver sections were cut out with laser microdissection and DNA and RNA were purified and analyzed for nucleic acid concentration and quality. Sanger sequencing and the NanoString nCounter (R) technology were used to assess the suitability of these samples in downstream molecular techniques. The results revealed that of the formalin fixatives, NBF samples fixed for 24 and 48 hr were superior to ZF samples for both Sanger sequencing and the Nanostring nCounter (R). The non-formalin PAXgene (R) samples were equally successful and they showed greater stability in nucleic acid quality and concentration over longer fixation times. This study demonstrated that small quantities of preserved tissue from smallmouth bass can be utilized in downstream molecular techniques; however, future studies will need to optimize the methods presented here for different tissue types, fish species, and pathological conditions.	[Walsh, Heather L.; Sperry, Adam J.; Blazer, Vicki S.] US Geol Survey, Natl Fish Hlth Res Lab, Leetown Sci Ctr, Kearneysville, WV 25430 USA	United States Department of the Interior; United States Geological Survey	Walsh, HL (corresponding author), US Geol Survey, Natl Fish Hlth Res Lab, Leetown Sci Ctr, Kearneysville, WV 25430 USA.	hwalsh@usgs.gov		Walsh, Heather/0000-0001-6392-4604	USGS Environmental Health (Contaminant Biology Program); USGS Ecosystems (Environments and Fisheries Program) Mission Areas	USGS Environmental Health (Contaminant Biology Program); USGS Ecosystems (Environments and Fisheries Program) Mission Areas	This was fully funded internally by the USGS Environmental Health (Contaminant Biology Program) and the USGS Ecosystems (Environments and Fisheries Program) Mission Areas. There are no actual grant numbers.	Aggerholm-Pedersen N, 2014, TRANSL ONCOL, V7, P687, DOI 10.1016/j.tranon.2014.09.012; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], **NON-TRADITIONAL**; Astolfi A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1982-6; Baumer C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25895-7; Bernet D, 1999, J FISH DIS, V22, P25, DOI 10.1046/j.1365-2761.1999.00134.x; Blazer VS, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-018-6943-5; Blazer VS, 2009, J GREAT LAKES RES, V35, P517, DOI 10.1016/j.jglr.2009.08.005; Bradley WH, 2015, BMC CLIN PATHOL, V15, DOI 10.1186/s12907-015-0017-1; Burgemeister R, 2011, METHODS MOL BIOL, V724, P105, DOI 10.1007/978-1-61779-055-3_7; CAI H, 2019, BMC GENOMICS, DOI DOI 10.1186/S12864-019-5502-Y30760197; Callagy G, 2005, METHODS MOL BIOL, V293, P40, DOI [10.1385/1-59259-853-6:040, DOI 10.1385/1-59259-853-6:040]; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Chiang G., 2010, WATER QUAL RES J CAN, V45, P111, DOI [10.2166/wqrj.2010.015, DOI 10.2166/WQRJ.2010.015]; Christensen JN, 2020, MELANOMA RES, V30, P26, DOI 10.1097/CMR.0000000000000644; Chung JY, 2008, J HISTOCHEM CYTOCHEM, V56, P1033, DOI 10.1369/jhc.2008.951863; Colegrove KM, 2011, J PARASITOL, V97, P868, DOI 10.1645/GE-2756.1; Connon RE, 2012, SENSORS-BASEL, V12, P12741, DOI 10.3390/s120912741; Cook L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01061-18; Cotoi CG, 2012, ROM J MORPHOL EMBRYO, V53, P893; Dedhia P, 2007, ASIAN PAC J CANCER P, V8, P55; Diaz-Viloria N, 2005, J PLANKTON RES, V27, P787, DOI 10.1093/plankt/fbi052; Drury S, 2009, DIAGN MOL PATHOL, V18, P103, DOI 10.1097/PDM.0b013e31817c1ae2; Ekman DR, 2013, ENVIRON PRAC, V15, P409, DOI 10.1017/S1466046613000458; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fierro-Castro C, 2015, COMP BIOCHEM PHYS A, V190, P39, DOI 10.1016/j.cbpa.2015.09.002; Furusato B, 2008, PROSTATE CANCER P D, V11, P194, DOI 10.1038/sj.pcan.4501007; Gloghini A, 2004, J MOL DIAGN, V6, P290, DOI 10.1016/S1525-1578(10)60524-7; Gouveia GR, 2016, NUCLEIC ACIDS EXTRAC, DOI [10.5772/61581, DOI 10.5772/61581]; Groelz D, 2013, EXP MOL PATHOL, V94, P188, DOI 10.1016/j.yexmp.2012.07.002; Hahn CM, 2016, COMP BIOCHEM PHYS D, V20, P27, DOI 10.1016/j.cbd.2016.07.001; Hay A, 2020, HISTOL HISTOPATHOL, V35, P57, DOI 10.14670/HH-18-135; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Hewitt SM, 2008, ARCH PATHOL LAB MED, V132, P1929, DOI 10.1043/1543-2165-132.12.1929; Holley T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050586; Kap M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027704; Kroon F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174762; Kulkarni Meghana M, 2011, Curr Protoc Mol Biol, VChapter 25, DOI 10.1002/0471142727.mb25b10s94; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; Ludyga N, 2012, VIRCHOWS ARCH, V460, P131, DOI 10.1007/s00428-011-1184-9; Martyniuk CJ, 2018, ENVIRON TOXICOL PHAR, V59, P87, DOI 10.1016/j.etap.2018.03.005; Matsuda Y, 2011, J HISTOCHEM CYTOCHEM, V59, P68, DOI 10.1369/jhc.2010.957217; MUNRO HN, 1969, COMP BIOCHEM PHYSIOL, V28, P897, DOI 10.1016/0010-406X(69)92123-9; Nowak B, 2013, J FISH BIOL, V83, P1459, DOI 10.1111/jfb.12235; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Parhar IS, 2005, P NATL ACAD SCI USA, V102, P2204, DOI 10.1073/pnas.0409494102; Patrick H, 2005, SEARCH I SER DEV ATT, P271; Paul Weihs, 1996, NUCL ACIDS RES, V24, P5026, DOI [10.1093/nar/24.24.50269016676, DOI 10.1093/NAR/24.24.50269016676]; Peterson TS, 2013, DIS AQUAT ORGAN, V104, P113, DOI 10.3354/dao02585; Rescan PY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-173; Sanchez W, 2009, TRAC-TREND ANAL CHEM, V28, P150, DOI 10.1016/j.trac.2008.10.012; Schmitt CJ, 2005, SCI TOTAL ENVIRON, V350, P161, DOI 10.1016/j.scitotenv.2005.01.038; Seiler C, 2016, BMC CLIN PATHOL, V16, DOI 10.1186/s12907-016-0039-3; Senguven B, 2014, INT J MED SCI, V11, P494, DOI 10.7150/ijms.8842; Shehadul Islam M, 2017, MICROMACHINES, V8, DOI [10.3390/mi8030085, DOI 10.3390/MI8030085]; Simmons DBD, 2015, ENVIRON TOXICOL CHEM, V34, P1693, DOI 10.1002/etc.3002; Small HJ, 2010, DIS AQUAT ORGAN, V88, P127, DOI 10.3354/dao02148; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Team RC, 2018, R LANG ENV STAT COMP, V2018; Technologies N, 2016, NCOUNTER XT ASS US M; Teh SJ, 1997, AQUAT TOXICOL, V37, P51, DOI 10.1016/S0166-445X(96)00808-9; Uneyama C, 2005, J HISTOCHEMISTRY CYT, V50, P1237; Van Aggelen G, 2010, ENVIRON HEALTH PERSP, V118, P1, DOI 10.1289/ehp.0900985; Veldman-Jones MH, 2015, CANCER RES, V75, P2587, DOI 10.1158/0008-5472.CAN-15-0262; Vinas J, 2008, BIOL REPROD, V79, P738, DOI 10.1095/biolreprod.108.069708; Walker SL, 2002, WATER QUAL RES J CAN, V37, P7, DOI 10.2166/wqrj.2002.003; Warner P, 2017, FACTORS AFFECTING SA; Wernersson AS, 2015, ENVIRON SCI EUR, V27, P1, DOI 10.1186/s12302-015-0039-4; Wester K, 2003, LAB INVEST, V83, P889, DOI 10.1097/01.LAB.0000074892.53211.A5; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	70	3	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0236104	10.1371/journal.pone.0236104	http://dx.doi.org/10.1371/journal.pone.0236104			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776939	Green Published, gold			2022-12-26	WOS:000561393800020
J	Chai, XY; Zhan, JQ; Pan, J; He, MX; Li, B; Wang, J; Ma, HY; Wang, YL; Liu, S				Chai, Xiaoying; Zhan, Jingqiong; Pan, Jing; He, Mengxi; Li, Bo; Wang, Jing; Ma, Hongyan; Wang, Yanlin; Liu, Sen			The rational discovery of multipurpose inhibitors of the ornithine decarboxylase	FASEB JOURNAL			English	Article						inhibitor; negative screening; ornithine decarboxylase; protein-protein interaction; stabilizer	PROTEIN; POLYAMINES; INTERFACES; DOCKING; METABOLISM; MECHANISM	Metabolic reprograming is a hallmark of cancer, and the polyamine metabolic network is dysregulated in many cancers. Ornithine decarboxylase (ODC) is a rate-limiting enzyme for polyamine synthesis in the polyamine metabolic network. In many cancer cells, ODC is over-expressed, so this enzyme has been an attracting anti-cancer drug target. In the catalysis axis (pathway), ODC converts ornithine to putrescine. Meanwhile, ODC's activity is regulated by protein-protein interactions (PPIs), including the ODC-OAZ1-AZIN1 PPI axis and its monomer-dimer equilibrium. Previous studies showed that when ODC's activity is inhibited, the PPIs might counteract the inhibition efficiency. Therefore, we proposed that multipurpose inhibitors that can simultaneously inhibit ODC's activity and perturb the PPIs would be very valuable as drug candidates and molecular tools. To discover multipurpose ODC inhibitors, we established a computational pipeline by combining positive screening and negative screening. We used this pipeline for the forward screening of multipurpose ligands that might inhibit ODC's activity, block ODC-OAZ1 interaction and enhance ODC non-functional dimerization. With a combination of different experimental assays, we identified three multipurpose ODC inhibitors. At last, we showed that one of these inhibitors is a promising drug candidate. This work demonstrated that our computational pipeline is useful for discovering multipurpose ODC inhibitors, and multipurpose inhibitors would be very valuable. Similar with ODC, there are a lot of proteins in human proteome that act as both enzymes and PPI components. Therefore, this work is not only presenting new molecular tools for polyamine study, but also providing potential insights and protocols for discovering multipurpose inhibitors to target more important protein targets.	[Chai, Xiaoying; Pan, Jing; Wang, Jing; Ma, Hongyan; Liu, Sen] Hubei Univ Technol, Natl 111 Ctr Cellular Regulat & Mol Pharmaceut, Key Lab Ind Fermentat, Minist Educ, Wuhan, Peoples R China; [Chai, Xiaoying; Zhan, Jingqiong; Pan, Jing; He, Mengxi; Li, Bo; Wang, Jing; Ma, Hongyan; Wang, Yanlin; Liu, Sen] China Three Gorges Univ, Hubei Key Lab Tumor Microenvironm & Immunotherapy, Peoples Hosp, Yichang, Peoples R China; [Chai, Xiaoying; Liu, Sen] Hubei Univ Technol, Inst Biomed & Pharmaceut Sci, Hubei Key Lab Ind Microbiol, Wuhan 430068, Peoples R China; [Zhan, Jingqiong] First Peoples Hosp Yichang, Dept Gynecol & Obstet, Yichang, Peoples R China	Hubei University of Technology; China Three Gorges University; Hubei University of Technology	Liu, S (corresponding author), Hubei Univ Technol, Inst Biomed & Pharmaceut Sci, Hubei Key Lab Ind Microbiol, Wuhan 430068, Peoples R China.	senliu.ctgu@gmail.com	Liu, Sen/AAH-8368-2021	Liu, Sen/0000-0001-5182-7241	National Natural Science Foundation of China [31670768, 31971150]; Hubei Provincial Science and Technology Department [2019CFA069]; Wuhan Science and Technology Bureau of China [2018060401011319]; HBUT National "111" Center for Cellular Regulation and Molecular Pharmaceutics [XBTK-2018008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Provincial Science and Technology Department; Wuhan Science and Technology Bureau of China; HBUT National "111" Center for Cellular Regulation and Molecular Pharmaceutics	S. L. was supported by the grants from National Natural Science Foundation of China (31670768, 31971150), Hubei Provincial Science and Technology Department (2019CFA069), Wuhan Science and Technology Bureau of China (2018060401011319), and the Collaborative Grant-in-Aid of the HBUT National "111" Center for Cellular Regulation and Molecular Pharmaceutics (XBTK-2018008). The authors thank the generous help from the following persons: Prof. Luhua Lai's lab members, especially Prof. Luhua Lai and Dr Jing Chen (Peking University), for providing us the DOCK-PSCORE suit and kind suggestions, Prof. Gideon Schreiber (Weizmann Institute of Science), for providing us the plasmids for expressing YPET-mODC and CyPET-mOAZ1, and Prof. Nei-Li Chan (National Taiwan University), for providing us the plasmid for expressing hOAZ1.	Ai YB, 2016, J CHEM INF MODEL, V56, P1563, DOI 10.1021/acs.jcim.6b00334; Arruabarrena-Aristorena A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2606; Asher G, 2005, MOL CELL, V17, P645, DOI 10.1016/j.molcel.2005.01.020; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Buontempo F, 2018, LEUKEMIA, V32, P1, DOI 10.1038/leu.2017.301; Cervelli M, 2014, BREAST CANCER RES TR, V148, P233, DOI 10.1007/s10549-014-3156-7; Chen Q, 2017, BBA-GEN SUBJECTS, V1861, P2535, DOI 10.1016/j.bbagen.2017.08.012; COLEMAN CS, 1994, J BIOL CHEM, V269, P3155; Damiani E, 2018, METHODS MOL BIOL, V1694, P469, DOI 10.1007/978-1-4939-7398-9_39; Dayton TL, 2016, EMBO REP, V17, P1721, DOI 10.15252/embr.201643300; Dong P, 2016, SCI REP-UK, V6, DOI 10.1038/srep25129; Fahrmann JF, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00276; Gao M, 2012, P NATL ACAD SCI USA, V109, P3784, DOI 10.1073/pnas.1117768109; GRISHIN NV, 1994, PROTEIN SCI, V3, P2455, DOI 10.1002/pro.5560031231; Huang K, 2019, CELL METAB, V30, P1107, DOI 10.1016/j.cmet.2019.09.014; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; Khait R, 2012, PROTEIN ENG DES SEL, V25, P681, DOI 10.1093/protein/gzs067; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Levin VA, 2018, CNS ONCOL, V6, P257; Li JK, 2020, BIOCHEM BIOPH RES CO, V524, P123, DOI 10.1016/j.bbrc.2020.01.072; Li JK, 2019, MOLECULES, V24, DOI 10.3390/molecules24183351; Liao CZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10754; Luqman S., 2013, PROTOC EXCH, V10, P1, DOI [10.1038/ protex.2013.045, DOI 10.1038/PROTEX.2013.045, 10.1038/protex.2013.045]; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; MITCHELL JLA, 1990, BIOCHIM BIOPHYS ACTA, V1037, P115, DOI 10.1016/0167-4838(90)90109-S; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Nero TL, 2014, NAT REV CANCER, V14, P248, DOI 10.1038/nrc3690; Nowotarski SL, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.3; Ostrem JML, 2016, NAT REV DRUG DISCOV, V15, P771, DOI 10.1038/nrd.2016.139; Paz EA, 2011, ADV CLIN CHEM, V54, P45, DOI 10.1016/B978-0-12-387025-4.00002-9; Qu N, 2003, BIOCHEM J, V375, P465, DOI 10.1042/BJ20030382; Romero P, 2005, GENOME BIOL, V6; Schrodinger, 2010, PYMOL MOL GRAPHICS S; SOLANO F, 1985, FEBS LETT, V190, P324, DOI 10.1016/0014-5793(85)81311-9; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wei DG, 2008, J MED CHEM, V51, P7882, DOI 10.1021/jm8010096; Wu DH, 2015, SCI REP-UK, V5, DOI 10.1038/srep14738; Wu HY, 2015, P NATL ACAD SCI USA, V112, P11229, DOI 10.1073/pnas.1508187112; Zhang Y, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00248	41	4	6	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12907	12921		10.1096/fj.202001222R	http://dx.doi.org/10.1096/fj.202001222R		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32767470				2022-12-26	WOS:000558271700001
J	Hal, WA; Straza, MW; Chen, XF; Mickevicius, N; Erickson, B; Schultz, C; Awan, M; Ahunbay, E; Li, XA; Paulson, ES				Hal, William A.; Straza, Michael W.; Chen, Xinfeng; Mickevicius, Nikolai; Erickson, Beth; Schultz, Chris; Awan, Musaddiq; Ahunbay, Ergun; Li, X. Allen; Paulson, Eric S.			Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac	PLOS ONE			English	Article							MAGNETIC-RESONANCE; ADAPTIVE RADIOTHERAPY; GUIDANCE	Purpose/Objectives Recently a 1.5 Tesla MR Linac has been FDA approved and is commercially available. Clinical series describing treatment methods and outcomes for upper abdominal tumors using a 1.5 Tesla MR Linac are lacking. We present the first clinical series of upper abdominal tumors treated using a 1.5 Tesla MR Linac along with the acquisition of intra-treatment quantitative imaging. Materials/Methods 10 patients with abdominal tumors were treated at our institution. Each patient enrolled in an IRB approved advanced imaging protocol. Both daily real-time adaptive and non-adaptive methods were used, and selection criteria are described. Adaptive plans were based on pre-beam motion-averaged or mid-position images derived from respiratory-correlated 4D-MRI. Quantitative intravoxel incoherent motion diffusion-weighted imaging and T2 mapping were acquired during plan adaptation. Real-time motion monitoring using cine MRI was performed during beam-on. Results Median patient age was 68.2, five patients were female. Tumor types included liver metastatic lesions from melanoma and sarcoma, primary liver hepatocellular carcinoma (HCC), and regional abdominal tumors included pancreatic metastatic lesions from renal cell carcinoma (RCC) along with two cases of recurrent pancreatic cancer. Doses included 30 Gy in 6 fractions, 33 Gy in 5 fractions, 50 Gy in 5 fractions, 45 Gy in 3 fractions, and 60 Gy in 3 fractions, depending on the location and clinical circumstances. Treatments were feasible and were successfully completed in all patients without significant acute toxicity, technical complications, or need for back up CT based treatment plans. Conclusions We present a first clinical series of patients treated for pancreatic tumors, primary liver tumors, and secondary liver tumors with a 1.5 Tesla MR Linear accelerator using adapt-to-position and adapt-to-shape strategies. Treatments were well tolerated by all patients. Acquisition of fully quantitative MR imaging was feasible during the course of the treatment delivery workflow without extending overall treatment times.	[Hal, William A.; Straza, Michael W.; Chen, Xinfeng; Mickevicius, Nikolai; Erickson, Beth; Schultz, Chris; Awan, Musaddiq; Ahunbay, Ergun; Li, X. Allen; Paulson, Eric S.] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Hal, WA (corresponding author), Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA.	whall@mcw.edu		Li, X/0000-0003-2260-0245	Elekta AB, Stockholm, Sweden	Elekta AB, Stockholm, Sweden	The authors received no specific funding for this work, MCW does receive institutional research and travel support from Elekta AB, Stockholm, Sweden.	Acharya S, 2016, INT J RADIAT ONCOL, V96, P785, DOI 10.1016/j.ijrobp.2016.08.006; Chen AM, 2017, ADV RADIAT ONCOL, V2, P167, DOI 10.1016/j.adro.2017.02.002; Dregely I, 2018, J MAGN RESON IMAGING, V48, P13, DOI 10.1002/jmri.26058; Fischer-Valuck BW, 2017, ADV RADIAT ONCOL, V2, P485, DOI 10.1016/j.adro.2017.05.006; Hall WA, 2019, EUR J CANCER, V122, P42, DOI 10.1016/j.ejca.2019.07.021; Henke L, 2016, INT J RADIAT ONCOL, V96, P1078, DOI 10.1016/j.ijrobp.2016.08.036; Kerkmeijer LGW, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00215; Kontaxis C, 2015, PHYS MED BIOL, V60, P7485, DOI 10.1088/0031-9155/60/19/7485; Kupelian P, 2014, SEMIN RADIAT ONCOL, V24, P227, DOI 10.1016/j.semradonc.2014.02.013; Lagendijk JJW, 2014, PHYS MED BIOL, V59, pR349, DOI 10.1088/0031-9155/59/21/R349; Lagendijk JJW, 2014, SEMIN RADIAT ONCOL, V24, P207, DOI 10.1016/j.semradonc.2014.02.009; Liney GP, 2014, SEMIN RADIAT ONCOL, V24, P160, DOI 10.1016/j.semradonc.2014.02.014; O'Connor JPB, 2017, NAT REV CLIN ONCOL, V14, P169, DOI 10.1038/nrclinonc.2016.162; Padgett KR, 2018, CUREUS, V10, DOI 10.7759/cureus.2423; Raaymakers BW, 2009, PHYS MED BIOL, V54, pN229, DOI 10.1088/0031-9155/54/12/N01; Sorensen AG, 2006, J CLIN ONCOL, V24, P3274, DOI 10.1200/JCO.2006.06.6597; Thomas DH, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170522; Tijssen RHN, 2019, RADIOTHER ONCOL, V132, P114, DOI 10.1016/j.radonc.2018.12.011; Winkel D, 2019, CLIN TRANSL RAD ONCO, V18, P54, DOI 10.1016/j.ctro.2019.04.001	19	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0236570	10.1371/journal.pone.0236570	http://dx.doi.org/10.1371/journal.pone.0236570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764748	Green Published, gold			2022-12-26	WOS:000561029000006
J	Cherifi, T; Arsenault, J; Pagotto, F; Quessy, S; Cote, JC; Neira, K; Fournaise, S; Bekal, S; Fravalo, P				Cherifi, Tamazight; Arsenault, Julie; Pagotto, Franco; Quessy, Sylvain; Cote, Jean-Charles; Neira, Kersti; Fournaise, Sylvain; Bekal, Sadjia; Fravalo, Philippe			Distribution, diversity and persistence of Listeria monocytogenes in swine slaughterhouses and their association with food and human listeriosis strains	PLOS ONE			English	Article							QUATERNARY AMMONIUM COMPOUND; MEAT; CONTAMINATION; PORK; PREVALENCE; EPIDEMIOLOGY; SURVEILLANCE; DISINFECTANTS; RESISTANCE; TOLERANCE	Listeria monocytogenesis the etiological agent of listeriosis, a major foodborne disease and an important public health concern. Contamination of meat withL.monocytogenesoccurs frequently at the slaughterhouse. Our aims were; 1) to investigate the distribution ofL.monocytogenesin the processing areas of four swine slaughterhouses; 2) to describe the diversity ofL.monocytogenesstrains by pulsed-field gel electrophoresis; 3) to identify persistentL.monocytogenesstrains and describe their distribution; 4) to investigate the associations between persistence of strains and their following characteristics: detection in food isolates, detection in human clinical isolates, and the presence of benzalkonium chloride (BAC) resistance genes. Various operation areas within the four swine slaughterhouses were sampled on four occasions. A total of 2496 samples were analyzed, andL.monocytogeneswas successfully isolated from 243 samples. The proportion of positive samples ranged from 32 to 58% in each slaughterhouse and from 24 to 68% in each operation area. Fifty-eight different pulsotypes were identified and eight pulsotypes, present in samples collected during 4 visits, were considered persistent. The persistent pulsotypes were significantly more likely to be detected in food (P< 0.01, exact chi(2)) and human clinical cases (P< 0.01, exact chi(2)), respectively. Among pulsotypes harboring the BACbcrABCresistance cassette or theemrEmultidrug transporter gene, 42.8% were persistent compared to 4.5% for pulsotypes without these resistance genes (P< 0.01, exact chi(2)). Our study highlights the importance of persistentL.monocytogenesstrains in the environmental contamination of slaughterhouses, which may lead to repeated contamination of meat products. It also shows that the presence of disinfectants resistance genes is an important contributing factor.	[Cherifi, Tamazight; Quessy, Sylvain; Cote, Jean-Charles; Neira, Kersti; Fravalo, Philippe] Univ Montreal, Fac Med Vet, Chaire Rech Salubr Viandes, St Hyacinthe, PQ, Canada; [Cherifi, Tamazight; Arsenault, Julie; Neira, Kersti; Fravalo, Philippe] Univ Montreal, Fac Med Vet, CRIPA, FQRNT, St Hyacinthe, PQ, Canada; [Cherifi, Tamazight; Quessy, Sylvain; Cote, Jean-Charles; Neira, Kersti] Univ Montreal, Fac Med Vet, GRESA, St Hyacinthe, PQ, Canada; [Arsenault, Julie; Fravalo, Philippe] Univ Montreal, Fac Med Vet, Epidemiol Zoonoses & Publ Hlth Res Unit GREZOSP, St Hyacinthe, PQ, Canada; [Pagotto, Franco] Hlth Canada, Microbiol Res Div, Listeriosis Reference Serv, Bur Microbial Hazards,Food Directorate,Hlth Prod, Ottawa, ON, Canada; [Fournaise, Sylvain] Olymel, Boucherville, PQ, Canada; [Bekal, Sadjia] Labe Sante Publ Quebecw, Ste Anne De Bellevue, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Health Canada	Cherifi, T; Fravalo, P (corresponding author), Univ Montreal, Fac Med Vet, Chaire Rech Salubr Viandes, St Hyacinthe, PQ, Canada.; Cherifi, T; Fravalo, P (corresponding author), Univ Montreal, Fac Med Vet, CRIPA, FQRNT, St Hyacinthe, PQ, Canada.; Cherifi, T (corresponding author), Univ Montreal, Fac Med Vet, GRESA, St Hyacinthe, PQ, Canada.; Fravalo, P (corresponding author), Univ Montreal, Fac Med Vet, Epidemiol Zoonoses & Publ Hlth Res Unit GREZOSP, St Hyacinthe, PQ, Canada.	tamazight.cherifi@umontreal.ca; philippe.fravalo@lecnam.net	Arsenault, Julie/D-5077-2015	Arsenault, Julie/0000-0001-8382-7326; Cherifi, Tamazight/0000-0002-0323-1395; Bekal, Sadjia/0000-0001-9840-0114	Natural Sciences and Engineering Research Council of Canada (NSERC) [RDCPJ 520873-17]; Chaire de recherche en salubrite des viandes	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Chaire de recherche en salubrite des viandes	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) grant number RDCPJ 520873-17 and by industrial partners of the Chaire de recherche en salubrite des viandes to Philippe Fravalo -https://www.nserc-crsng.gc.ca/index_eng.asp-olymel.ca/en/?in The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase B, 2000, INT J FOOD MICROBIOL, V62, P57, DOI 10.1016/S0168-1605(00)00357-3; [Anonymous], 2015, M07 A10 METHODS DILU; Autio T, 2000, J FOOD PROTECT, V63, P1438, DOI 10.4315/0362-028X-63.10.1438; Besse NG, 2000, J APPL MICROBIOL, V89, P944, DOI 10.1046/j.1365-2672.2000.01195.x; BRUCE JL, 1995, P NATL ACAD SCI USA, V92, P5229, DOI 10.1073/pnas.92.11.5229; Carpentier B, 2011, INT J FOOD MICROBIOL, V145, P1, DOI 10.1016/j.ijfoodmicro.2011.01.005; Charlier C, 2017, LANCET INFECT DIS, V17, P510, DOI [10.1016/s1473-3099(16)30521-7, 10.1016/S1473-3099(16)30521-7]; Chasseignaux E, 2001, J APPL MICROBIOL, V91, P888, DOI 10.1046/j.1365-2672.2001.01445.x; Cherifi T, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1363-9; De Cesare A, 2017, FOODBORNE PATHOG DIS, V14, P167, DOI 10.1089/fpd.2016.2211; Drevets DA, 2008, FEMS IMMUNOL MED MIC, V53, P151, DOI 10.1111/j.1574-695X.2008.00404.x; Elhanafi D, 2010, APPL ENVIRON MICROB, V76, P8231, DOI 10.1128/AEM.02056-10; Fagerlund A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151117; Ferreira V, 2014, J FOOD PROTECT, V77, P150, DOI 10.4315/0362-028X.JFP-13-150; Fox EM, 2011, APPL ENVIRON MICROB, V77, P6559, DOI 10.1128/AEM.05529-11; Giovannacci I, 1999, INT J FOOD MICROBIOL, V53, P127, DOI 10.1016/S0168-1605(99)00141-5; Graves LM, 2001, INT J FOOD MICROBIOL, V65, P55, DOI 10.1016/S0168-1605(00)00501-8; Hellstrom S, 2010, J FOOD PROTECT, V73, P641, DOI 10.4315/0362-028X-73.4.641; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Kathariou S., 2002, J FOOD PROT, V65; Kerouanton A, 2010, J MICROBIOL METH, V80, P134, DOI 10.1016/j.mimet.2009.11.008; Keto-Timonen R, 2007, J FOOD PROTECT, V70, P1866, DOI 10.4315/0362-028X-70.8.1866; Kim M, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01201-18; Knabel SJ, 2012, J CLIN MICROBIOL; Kovacevic J, 2016, APPL ENVIRON MICROB, V82, P939, DOI 10.1128/AEM.03741-15; Lopez V, 2008, MEAT SCI, V78, P130, DOI 10.1016/j.meatsci.2007.05.002; Lunden JM, 2003, J FOOD PROTECT, V66, P2062, DOI 10.4315/0362-028X-66.11.2062; Luo LJ, 2017, FOOD CONTROL, V76, P66, DOI 10.1016/j.foodcont.2016.12.037; Martinez-Suarez JV, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00638; Maury MM, 2016, NAT GENET, V48, P308, DOI 10.1038/ng.3501; Meier AB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00397; Meloni D, 2013, J FOOD PROTECT, V76, P1863, DOI 10.4315/0362-028X.JFP-12-505; Mina JSA., 2018, ANTON LEEUW INT J G, P1, DOI DOI 10.1007/S10482-018-1082-0; Morales-Partera AM, 2018, FOOD CONTROL, V92, P208, DOI 10.1016/j.foodcont.2018.04.053; Moretro T, 2017, INT J FOOD MICROBIOL, V241, P215, DOI 10.1016/j.ijfoodmicro.2016.10.025; Nesbakken T, 1996, INT J FOOD MICROBIOL, V31, P161, DOI 10.1016/0168-1605(96)00978-6; Nucera D, 2010, INT J FOOD MICROBIOL, V140, P271, DOI 10.1016/j.ijfoodmicro.2010.04.016; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; Ortiz S, 2016, APPL ENVIRON MICROB, V82, P308, DOI 10.1128/AEM.02824-15; Ortiz S, 2010, FOODBORNE PATHOG DIS, V7, P1177, DOI 10.1089/fpd.2010.0535; Pagotto F., 2011, HPB METHODS MICROBIO, V2; Peccio A, 2003, LETT APPL MICROBIOL, V37, P234, DOI 10.1046/j.1472-765X.2003.01384.x; Skaarup T., 1985, SLAUGHTERHOUSE CLEAN; Tamburro M, 2015, COMP IMMUNOL MICROB, V40, P31, DOI 10.1016/j.cimid.2015.03.004; Tezel U, 2015, CURR OPIN BIOTECH, V33, P296, DOI 10.1016/j.copbio.2015.03.018; Thevenot D, 2006, J APPL MICROBIOL, V101, P7, DOI 10.1111/j.1365-2672.2006.02962.x; Thevenot D, 2005, INT J FOOD MICROBIOL, V102, P85, DOI 10.1016/j.ijfoodmicro.2004.12.008; VANDENELZEN AMG, 1993, VET QUART, V15, P143, DOI 10.1080/01652176.1993.9694393; Wulff G, 2006, APPL ENVIRON MICROB, V72, P4313, DOI 10.1128/AEM.02288-05; Ye K, 2017, LETT APPL MICROBIOL, V64, P309, DOI 10.1111/lam.12721	50	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236807	10.1371/journal.pone.0236807	http://dx.doi.org/10.1371/journal.pone.0236807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760141	gold, Green Published			2022-12-26	WOS:000561027200005
J	Feyissa, TR; Harris, ML; Forder, PM; Loxton, D				Feyissa, Tesfaye Regassa; Harris, Melissa L.; Forder, Peta M.; Loxton, Deborah			Contraceptive use among sexually active women living with HIV in western Ethiopia	PLOS ONE			English	Article							HEALTH BELIEF MODEL; UNMET NEED; UNINTENDED PREGNANCY; PREVALENCE; INTENTIONS; COUNTRIES; QUALITY	Introduction Contraception can help to meet family planning goals for women living with HIV (WLHIV) as well as to support the prevention of mother to child transmission of HIV (PMTCT). However, there is little research into the contraceptive practice among sexually active WLHIV in Ethiopia. Therefore, we aimed to examine contraceptive practice among sexually active WLHIV in western Ethiopia and identify the factors that influenced such practice using the Health Belief Model (HBM). Methods A facility-based cross-sectional survey of 360 sexually active WLHIV was conducted from 19(th)March to 22(nd)June 2018 in western Ethiopia. The eligible participants were WLHIV aged between 18 and 49 years who reported being fecund and sexually active within the previous six months but were not pregnant and not wanting to have another child within two years. Modified Poisson regression analyses were conducted to identify factors that influenced contraceptive practice among sexually active WLHIV in western Ethiopia. Results Among sexually active WLHIV (n = 360), 75% used contraception with 25% having unmet needs. Of the contraceptive users, 44.8% used injectables, 37.4% used condoms and 28.5% used implants. Among 152 recorded births in the last five years, 17.8% were reported as mistimed and 25.7% as unwanted. Compared to WLHIV having no child after HIV diagnosis, having two or more children after HIV diagnosis (Adjusted Prevalence Ratio [APR] = 1.31; 95%CI 1.09-1.58) was associated with increased risk of contraceptive practice. However, sexually active unmarried WLHIV (APR = 0.69; 95%CI 0.50-0.95) were less likely to use any contraception compared to their sexually active married counterparts. Importantly, high perceived susceptibility (APR = 1.49; 95%CI 1.20-1.86) and medium perceived susceptibility (APR = 1.55; 95%CI 1.28-1.87) towards unintended pregnancy were associated with higher risk of contraceptive use than WLHIV with low perceived susceptibility. Conclusions Although contraceptive use amongst sexually active WLHIV was found to be high, our findings highlight the need for strengthening family planning services given the high rate of unintended pregnancies, the high rate of unmet needs for contraception, as well as the lower efficacy with some of the methods. Our findings also suggest that the HBM would be a valuable framework for healthcare providers, programme planners and policymakers to develop guidelines and policies for contraceptive counselling and choices.	[Feyissa, Tesfaye Regassa] Wollega Univ, Coll Hlth Sci, Nekemte, Oromia, Ethiopia; [Feyissa, Tesfaye Regassa; Harris, Melissa L.; Forder, Peta M.; Loxton, Deborah] Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Res Ctr Generat Hlth & Ageing, Callaghan, NSW, Australia	University of Newcastle	Feyissa, TR (corresponding author), Wollega Univ, Coll Hlth Sci, Nekemte, Oromia, Ethiopia.; Feyissa, TR (corresponding author), Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Res Ctr Generat Hlth & Ageing, Callaghan, NSW, Australia.	regassatesfaye@gmail.com		Feyissa, Tesfaye Regassa/0000-0002-6883-7312	Hunter Medical Research Institute/Greaves Family Postgraduate Top-Up Scholarship [G1701582]; University of Newcastle International Postgraduate Research Scholarship (UNIPRS); University of Newcastle Research Scholarship Central 50:50 (UNRSC 50:50); Australian Research Council Discovery Early Career Researcher Award (DECRA)	Hunter Medical Research Institute/Greaves Family Postgraduate Top-Up Scholarship; University of Newcastle International Postgraduate Research Scholarship (UNIPRS); University of Newcastle Research Scholarship Central 50:50 (UNRSC 50:50); Australian Research Council Discovery Early Career Researcher Award (DECRA)(Australian Research Council)	This study was partially supported by the Hunter Medical Research Institute/Greaves Family Postgraduate Top-Up Scholarship (Grant number G1701582). Wollega University (first author's employer organization) facilitated the data collection process. TRF is supported by The University of Newcastle International Postgraduate Research Scholarship (UNIPRS) and The University of Newcastle Research Scholarship Central 50:50 (UNRSC 50:50). Dr Melissa Harris is supported by an Australian Research Council Discovery Early Career Researcher Award (DECRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe M, 2012, SCI TECHNOLOGY ARTS, V1, P38; Abubeker FA, 2019, INT J REPROD MED, V2019; Adir T, 2007, DESIRE CHILDREN UNME; Asfaw HM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-566; Ashaba S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176256; Bankole A, 2014, INT PERSPECT SEX R H, V40, DOI 10.1363/4002814; Belda SS, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2115-5; Berhan Yifru, 2008, Ethiop Med J, V46, P335; Berhane Y, 2013, UTILIZATION MODERN C, V2013, DOI [10.1155/2013/31972424224116, DOI 10.1155/2013/31972424224116]; Bradley SarahE.K., 2012, DHS ANAL STUDIES; Brown W, 2011, CONTRACEPTION, V83, P453, DOI 10.1016/j.contraception.2010.09.010; Butame SA, 2019, PUBLIC HEALTH, V168, P128, DOI 10.1016/j.puhe.2018.12.020; Cahill N, 2018, LANCET, V391, P870, DOI 10.1016/S0140-6736(17)33104-5; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; Cooper D, 2009, AIDS BEHAV, V13, pS38, DOI 10.1007/s10461-009-9550-1; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; Dehlendorf C, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.01.173; Dehlendorf C, 2014, CLIN OBSTET GYNECOL, V57, P659, DOI 10.1097/GRF.0000000000000059; EISEN M, 1985, HEALTH EDUC QUART, V12, P185, DOI 10.1177/109019818501200205; FDRE Ministry of Science and Technolgy, 2014, ETH NAT ETH GUID; Federal Ministry of Health, 2016, DEM HLTH SURV HIV RE; Feyissa GT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211298; Feyissa TR, 2019, AIDS BEHAV, V23, P1431, DOI 10.1007/s10461-018-2346-4; Fite Robera Olana, 2018, BMC Res Notes, V11, P671, DOI 10.1186/s13104-018-3778-7; Floyd S, 2012, TROP MED INT HEALTH, V17, pe84, DOI 10.1111/j.1365-3156.2012.03032.x; Getachew M, 2010, ETHIOP J HEALTH DEV, V24, P214; Gruskin S, 2008, AM J PUBLIC HEALTH, V98, P1746, DOI 10.2105/AJPH.2008.137232; Hall KS, 2012, J MIDWIFERY WOM HEAL, V57, P74, DOI 10.1111/j.1542-2011.2011.00110.x; Halperin DT, 2009, AIDS, V23, pS123, DOI 10.1097/01.aids.0000363785.73450.5a; Halpern V, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004317.pub4; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heale Roberta, 2015, Evid Based Nurs, V18, P66, DOI 10.1136/eb-2015-102129; Jhangri GS, 2012, J FAM PLAN REPROD H, V38, P23, DOI 10.1136/jfprhc-2011-0108; Kahsay ZH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197366; Kaida A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013868; Kalichman SC, 2011, SEX TRANSM INFECT, V87, P183, DOI 10.1136/sti.2010.047514; Lim SS, 2016, LANCET, V388, P1813, DOI 10.1016/S0140-6736(16)31467-2; Lopez LM, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010243.pub3; Lutalo T, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0551-y; Mayhew SH, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4514-2; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Mccoy SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105320; Mon MM, 2012, ASIA-PAC J PUBLIC HE, V24, P151, DOI 10.1177/1010539510381918; Munyazesa E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001600; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Reynolds HW, 2006, SEX TRANSM DIS, V33, P350, DOI 10.1097/01.olq.0000194602.01058.e1; Shiferaw S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187311; Simmons KB, 2018, PERSPECT SEX REPRO H, V50, P67, DOI 10.1363/psrh.12056; Spong CY, 2011, OBSTET GYNECOL, V118, P323, DOI 10.1097/AOG.0b013e3182255999; Teshome A, 2017, INT J GYNECOL OBSTET, V137, P174, DOI 10.1002/ijgo.12110; UNAIDS, 2018, MIL GO GLOB AIDS UPD; UNAIDS, 2020, GLOB HIV AIDS STAT F; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2020, UNM NEED FAM PLANN; WHO, 2015, WHO REC ASS HIV TEST; Williamson T, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-14; Worku S., 2006, Ethiopian Journal of Health Development, V20, P79; World Health Organization, 2015, GUID START ANT THER; Yoo H, 2018, AIDS BEHAV, V22, P3971, DOI 10.1007/s10461-018-2232-0	60	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237212	10.1371/journal.pone.0237212	http://dx.doi.org/10.1371/journal.pone.0237212			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2EP	32760140	Green Published, gold			2022-12-26	WOS:000561027200088
J	Palacios, J; Eichholtz, P; Kok, N				Palacios, Juan; Eichholtz, Piet; Kok, Nils			Moving to productivity: The benefits of healthy buildings	PLOS ONE			English	Article							COGNITIVE FUNCTION; GREEN; VENTILATION; EXPOSURE; IMPACT; COST; WELL	Health is a critical factor for the generation of value by workers. Companies bear substantial costs associated with absenteeism and presenteeism among their employees. This study investigates the impact of the environmental conditions in the workplace on the health and job satisfaction of employees, as core factors of productivity. We provide evidence based on a natural experiment, in which 70% of the workforce of a municipality in the Netherlands was relocated to a building with a design focused on sustainability and health and well-being. We construct a longitudinal dataset based on individual surveys of the entire municipality workforce and include measures before and after the move. The estimation results show a significant improvement in the perceived environmental conditions, as well as in the health and well-being of the relocated workers, measured by the drop in incidence of sick building syndrome symptoms. Results are heterogeneous based on age: older groups of employees enjoy larger health impacts. The relocation effects remain persistent in the medium term (two years after the moving date). Importantly, a mediation analysis suggests that the achieved improvements in health and well-being lead to significantly enhanced job satisfaction and a 2% reduction in the prevalence of sick leave.	[Palacios, Juan] MIT, Dept Urban Studies & Planning, Ctr Real Estate, Cambridge, MA 02139 USA; [Palacios, Juan] IZA, Bonn, Germany; [Eichholtz, Piet; Kok, Nils] Maastricht Univ, Sch Business & Econ, Dept Finance, Maastricht, Netherlands	Massachusetts Institute of Technology (MIT); IZA Institute Labor Economics; Maastricht University	Kok, N (corresponding author), Maastricht Univ, Sch Business & Econ, Dept Finance, Maastricht, Netherlands.	n.kok@maastrichtuniversity.nl		Kok, Nils/0000-0003-0764-9649	Nederlandse Organisatie voor Wetenschappelijk Onderzoek; INTERREG Healthy Building Project	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); INTERREG Healthy Building Project	The Nederlandse Organisatie voor Wetenschappelijk Onderzoek provided funding to Nils Kok for this research -VIDI tel:452-13-004. The research project also received financial support from the INTERREG Healthy Building Project. The other authors received no individual, specific funding for this work.; We thank the editor and an anonymous referee for helpful comments. Michel Weijers (municipality of Venlo) provided excellent support in data collection and enabling this research. Authors are responsible for all errors.	Allen JG, 2016, ENVIRON HEALTH PERSP, V124, P805, DOI 10.1289/ehp.1510037; Altomonte S, 2013, BUILD ENVIRON, V68, P66, DOI 10.1016/j.buildenv.2013.06.008; Bialowolski P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230562; Cedeno-Laurent J. G., 2018, ANN REV PUBLIC HLTH, V39; Cuce E, 2017, APPL ENERG, V194, P247, DOI 10.1016/j.apenergy.2016.09.079; Dean J T., 2017, NOISE COGNITIVE FUNC; Edmans A., 2012, LINK JOB SATISFACTIO, P1; Eichholtz P, 2013, REV ECON STAT, V95, P50, DOI 10.1162/REST_a_00291; Eichholtz P, 2010, AM ECON REV, V100, P2492, DOI 10.1257/aer.100.5.2492; Fisk WJ, 2009, INDOOR AIR, V19, P159, DOI 10.1111/j.1600-0668.2008.00575.x; Galiani S, 2018, J EUR ECON ASSOC, V16, P1189, DOI 10.1093/jeea/jvx042; Hemp P., 2004, HARVARD BUSINESS REV; Hicks R, 2011, STATA J, V11, P605, DOI 10.1177/1536867X1101100407; Imai K, 2013, J R STAT SOC A STAT, V176, P5, DOI 10.1111/j.1467-985X.2012.01032.x; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Karjalainen S, 2012, INDOOR AIR, V22, P96, DOI 10.1111/j.1600-0668.2011.00747.x; Kingma B, 2015, NAT CLIM CHANGE, V5, P1054, DOI 10.1038/NCLIMATE2741; Kraaijvanger, 2020, BRIEF SUST; Lan L, 2011, ENERG BUILDINGS, V43, P1057, DOI 10.1016/j.enbuild.2010.09.001; Li TT, 2018, LANCET PUBLIC HEALTH, V3, pE470, DOI 10.1016/S2468-2667(18)30144-0; Loewenstein G, 2008, J PUBLIC ECON, V92, P1795, DOI 10.1016/j.jpubeco.2007.12.011; MacNaughton P, 2017, BUILD ENVIRON, V114, P178, DOI 10.1016/j.buildenv.2016.11.041; MacNaughton P, 2015, INT J ENV RES PUB HE, V12, P14709, DOI 10.3390/ijerph121114709; Perini K, 2013, BUILD ENVIRON, V70, P110, DOI 10.1016/j.buildenv.2013.08.012; Seppanen O., 2006, EFFECT TEMPERATURE T, P11; Singh A, 2010, AM J PUBLIC HEALTH, V100, P1665, DOI 10.2105/AJPH.2009.180687; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; WHO, 1983, EURO REP STUD, V78, P1, DOI [10.1016/j.buildenv.2007.10.021, DOI 10.1016/J.BUILDENV.2007.10.021]; Zagreus L, 2004, INDOOR AIR, V14, P65, DOI 10.1111/j.1600-0668.2004.00301.x	29	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236029	10.1371/journal.pone.0236029	http://dx.doi.org/10.1371/journal.pone.0236029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2EP	32760082	gold, Green Published			2022-12-26	WOS:000561027200037
J	Ramakrishna, C; Mendonca, S; Ruegger, PM; Kim, JH; Borneman, J; Cantin, EM				Ramakrishna, Chandran; Mendonca, Stacee; Ruegger, Paul M.; Kim, Jane Hannah; Borneman, James; Cantin, Edouard M.			Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; DIFFERENTIAL EXPRESSION ANALYSIS; INTESTINAL MICROBIOTA; ESCHERICHIA-COLI; BACTERIAL-INFECTIONS; SYMBIOTIC BACTERIA; ORAL ACYCLOVIR; GRAFT; TRANSPLANTATION; ENCEPHALITIS	Herpes simplex virus 1 (HSV) is a ubiquitous human virus resident in a majority of the global population as a latent infection. Acyclovir (ACV), is the standard of care drug used to treat primary and recurrent infections, supplemented in some patients with intravenous immunoglobulin (IVIG) treatment to suppress infection and deleterious inflammatory responses. As many diverse medications have recently been shown to change composition of the gut microbiome, we used Illumina 16S rRNA gene sequencing to determine the effects of ACV and IVIG on the gut bacterial community. We found that HSV, ACV and IVIG can all independently disrupt the gut bacterial community in a sex biased manner when given to uninfected C57BL/6 mice. Treatment of HSV infected mice with ACV or IVIG alone or together revealed complex interactions between these drugs and infection that caused pronounced sex biased dysbiosis. ACV reducedBacteroideteslevels in male but not female mice, while levels of the Anti-inflammatory Clostridia (AIC) were reduced in female but not male mice, which is significant as these taxa are associated with protection against the development of graft versus host disease (GVHD) in hematopoietic stem cell transplant (HSCT) patients. Gut barrier dysfunction is associated with GVHD in HSCT patients and ACV also decreasedAkkermansia muciniphila, which is important for maintaining gut barrier functionality. Cumulatively, our data suggest that long-term prophylactic ACV treatment of HSCT patients may contribute to GVHD and also potentially impact immune reconstitution. These data have important implications for other clinical settings, including HSV eye disease and genital infections, where ACV is given long-term.	[Ramakrishna, Chandran; Mendonca, Stacee; Cantin, Edouard M.] Beckman Res Inst City Hope, Dept Mol Immunol, Duarte, CA 91010 USA; [Ruegger, Paul M.; Kim, Jane Hannah; Borneman, James] Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA	City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Riverside	Cantin, EM (corresponding author), Beckman Res Inst City Hope, Dept Mol Immunol, Duarte, CA 91010 USA.; Borneman, J (corresponding author), Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.	borneman@ucr.edu; ecantin@coh.org						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armangue T, 2018, LANCET NEUROL, V17, P760, DOI 10.1016/S1474-4422(18)30244-8; AURELIUS E, 1993, J INFECT DIS, V168, P1248, DOI 10.1093/infdis/168.5.1248; Basso L, 2019, EUR J IMMUNOL, V49, P1984, DOI 10.1002/eji.201848027; Baumrin E, 2019, BIOL BLOOD MARROW TR, V25, P1642, DOI 10.1016/j.bbmt.2019.04.015; Bettegowda C, 2005, P NATL ACAD SCI USA, V102, P1145, DOI 10.1073/pnas.0408861102; Biagi E, 2015, BONE MARROW TRANSPL, V50, P992, DOI 10.1038/bmt.2015.16; Biagi E, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-019-0494-7; BLACK ME, 1991, MOL MICROBIOL, V5, P373, DOI 10.1111/j.1365-2958.1991.tb02119.x; Bradshaw MJ, 2016, NEUROTHERAPEUTICS, V13, P493, DOI 10.1007/s13311-016-0433-7; BREWIN N, 1977, J MOL BIOL, V111, P353, DOI 10.1016/S0022-2836(77)80057-0; CANTIN EM, 1995, J VIROL, V69, P4898, DOI 10.1128/JVI.69.8.4898-4905.1995; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Dadwal SS, 2019, INFECT DIS CLIN N AM, V33, P467, DOI 10.1016/j.idc.2019.02.012; Davis SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006297; De Chiara G, 2012, MOL NEUROBIOL, V46, P614, DOI 10.1007/s12035-012-8320-7; Edgar R.C., 2016, BIORXIV, V081257, DOI 10.1101/081257; Edgar RC., 2016, BIORXIV, DOI [10.1101/074161, DOI 10.1101/074161, 10.1101/2020.05.12.088096]; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Flak MB, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125191; Frobert E, 2014, ANTIVIR RES, V111, P36, DOI 10.1016/j.antiviral.2014.08.013; Gesser RM, 1996, J VIROL, V70, P4097, DOI 10.1128/JVI.70.6.4097-4102.1996; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Gnann JW, 2015, CLIN INFECT DIS, V61, P683, DOI 10.1093/cid/civ369; Grander C, 2018, GUT, V67, P892, DOI 10.1136/gutjnl-2016-313432; Holler E, 2014, BIOL BLOOD MARROW TR, V20, P640, DOI 10.1016/j.bbmt.2014.01.030; Hope S, 2015, SCHIZOPHR RES, V165, P188, DOI 10.1016/j.schres.2015.04.004; Iro MA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012356; JEFFREY WH, 1990, APPL ENVIRON MICROB, V56, P1367, DOI 10.1128/AEM.56.5.1367-1372.1990; Jenq RR, 2015, BIOL BLOOD MARROW TR, V21, P1373, DOI 10.1016/j.bbmt.2015.04.016; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Kakiuchi S, 2017, J INFECT DIS, V215, P865, DOI 10.1093/infdis/jix042; Kennedy PGE, 2013, J NEUROVIROL, V19, P346, DOI 10.1007/s13365-013-0178-6; Khanna KM, 2004, CURR OPIN IMMUNOL, V16, P463, DOI 10.1016/j.coi.2004.05.003; Kimberlin DW, 2011, NEW ENGL J MED, V365, P1284, DOI 10.1056/NEJMoa1003509; Konrad A, 2012, GENE, V492, P117, DOI 10.1016/j.gene.2011.10.039; Kuntz T, 2016, ELIFE, V5, DOI 10.7554/eLife.17052; Liu T, 1996, J VIROL, V70, P264, DOI 10.1128/JVI.70.1.264-271.1996; Lokensgard JR, 2002, J INFECT DIS, V186, pS171, DOI 10.1086/344272; LONNQVIST B, 1993, SUPPORT CARE CANCER, V1, P139, DOI 10.1007/BF00366060; Lundberg P, 2008, J VIROL, V82, P7078, DOI 10.1128/JVI.00619-08; Marques CP, 2008, J IMMUNOL, V181, P6417, DOI 10.4049/jimmunol.181.9.6417; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McGrath N, 1997, J NEUROL NEUROSUR PS, V63, P321, DOI 10.1136/jnnp.63.3.321; Melson J, 2007, AM J HEMATOL, V82, P881, DOI 10.1002/ajh.20976; Nakajima M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134234; Negm OH, 2017, CLIN EXP IMMUNOL, V188, P437, DOI 10.1111/cei.12946; Pavlov VA, 2017, NAT NEUROSCI, V20, P156, DOI 10.1038/nn.4477; Peled JU, 2017, J CLIN ONCOL, V35, P1650, DOI 10.1200/JCO.2016.70.3348; Peterson KL, 2013, NUCL MED BIOL, V40, P638, DOI 10.1016/j.nucmedbio.2013.01.005; Piper HG, 2017, JPEN-PARENTER ENTER, V41, P1202, DOI 10.1177/0148607116658762; Ponec RJ, 1999, GASTROINTEST ENDOSC, V49, P612, DOI 10.1016/S0016-5107(99)70390-1; Ramakrishna C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09884-6; Ramakrishna C, 2017, BEHAV NEUROL, V2017, DOI 10.1155/2017/5238402; Ramakrishna C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002071; Raschilas F, 2002, CLIN INFECT DIS, V35, P254, DOI 10.1086/341405; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosshart SP, 2019, SCIENCE, V365, P461, DOI 10.1126/science.aaw4361; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; SALE GE, 1979, AM J SURG PATHOL, V3, P291, DOI 10.1097/00000478-197908000-00001; Salvadores P, 2001, BMC HEALTH SERV RES, V1, DOI 10.1186/1472-6963-1-9; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Shono Y, 2018, NAT REV CANCER, V18, P283, DOI 10.1038/nrc.2018.10; Shono Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2311; Simms-Waldrip TR, 2017, BIOL BLOOD MARROW TR, V23, P820, DOI 10.1016/j.bbmt.2017.02.004; SPENCER GD, 1986, HUM PATHOL, V17, P621, DOI 10.1016/S0046-8177(86)80135-6; Staffas A, 2018, CELL HOST MICROBE, V23, P447, DOI 10.1016/j.chom.2018.03.002; Stingl Cory, 2018, Curr Treatm Opt Rheumatol, V4, P14, DOI 10.1007/s40674-018-0089-z; Taur Y, 2014, BLOOD, V124, P1174, DOI 10.1182/blood-2014-02-554725; Thion MS, 2018, CELL, V172, P500, DOI 10.1016/j.cell.2017.11.042; Uchimura Y, 2018, IMMUNITY, V49, P545, DOI 10.1016/j.immuni.2018.08.004; van der Lugt B, 2019, IMMUN AGEING, V16, DOI 10.1186/s12979-019-0145-z; Viney M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01481; Weber D, 2016, BONE MARROW TRANSPL, V51, P1087, DOI 10.1038/bmt.2016.66; Weber D, 2017, BIOL BLOOD MARROW TR, V23, P845, DOI 10.1016/j.bbmt.2017.02.006; Wekerle H, 2017, TRENDS IMMUNOL, V38, P483, DOI 10.1016/j.it.2017.03.008; WELLSBURY P, 1993, FEMS MICROBIOL ECOL, V12, P87; Wu WR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01804; Ye SL, 2017, J PHARMACEUT BIOMED, V133, P8, DOI 10.1016/j.jpba.2016.10.018; Zeng MY, 2016, IMMUNITY, V44, P647, DOI 10.1016/j.immuni.2016.02.006; [No title captured]	86	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237189	10.1371/journal.pone.0237189	http://dx.doi.org/10.1371/journal.pone.0237189			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760124	Green Submitted, Green Published, gold			2022-12-26	WOS:000561027200024
J	de Lissa, P; Caldara, R; Nicholls, V; Miellet, S				de Lissa, Peter; Caldara, Roberto; Nicholls, Victoria; Miellet, Sebastien			In pursuit of visual attention: SSVEP frequency-tagging moving targets	PLOS ONE			English	Article							SELECTIVE ATTENTION; SPATIAL ATTENTION; PERCEPTUAL LOAD; REACTION-TIMES; CUED SHIFTS; EEG; FACILITATION; SUPPRESSION; PERFORMANCE; DEPLOYMENT	Previous research has shown that visual attention does not always exactly follow gaze direction, leading to the concepts of overt and covert attention. However, it is not yet clear how such covert shifts of visual attention to peripheral regions impact the processing of the targets we directly foveate as they move in our visual field. The current study utilised the co-registration of eye-position and EEG recordings while participants tracked moving targets that were embedded with a 30 Hz frequency tag in a Steady State Visually Evoked Potentials (SSVEP) paradigm. When the task required attention to be divided between the moving target (overt attention) and a peripheral region where a second target might appear (covert attention), the SSVEPs elicited by the tracked target at the 30 Hz frequency band were significantly, but transiently, lower than when participants did not have to covertly monitor for a second target. Our findings suggest that neural responses of overt attention are only briefly reduced when attention is divided between covert and overt areas. This neural evidence is in line with theoretical accounts describing attention as a pool of finite resources, such as the perceptual load theory. Altogether, these results have practical implications for many real-world situations where covert shifts of attention may discretely reduce visual processing of objects even when they are directly being tracked with the eyes.	[de Lissa, Peter; Caldara, Roberto] Univ Fribourg, Dept Psychol Eye & Brain Mapping Lab iBMLab, Fribourg, Switzerland; [Nicholls, Victoria] Univ Bournemouth, Dept Psychol, Poole, Dorset, England; [Miellet, Sebastien] Univ Wollongong, Sch Psychol, Act Vis Lab, Wollongong, NSW, Australia	University of Fribourg; Bournemouth University; University of Wollongong	de Lissa, P (corresponding author), Univ Fribourg, Dept Psychol Eye & Brain Mapping Lab iBMLab, Fribourg, Switzerland.	peter.delissa@unifr.ch	Miellet, Sebastien/AFL-6215-2022	Miellet, Sebastien/0000-0002-3519-033X; Caldara, Roberto/0000-0002-8260-9949; de Lissa, Peter/0000-0003-3596-5075	Swiss National Science Foundation [100019_156541]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported with funding from the Swiss National Science Foundation (100019_156541) to SM & RC. www.snf.ch The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SK, 2010, P NATL ACAD SCI USA, V107, P13878, DOI 10.1073/pnas.1002436107; Beck DM, 2005, J EXP PSYCHOL HUMAN, V31, P592, DOI 10.1037/0096-1523.31.3.592; Biassoni F, 2018, TRANSPORT RES F-TRAF, V56, P227, DOI 10.1016/j.trf.2018.04.009; Bieg HJ, 2015, EXP BRAIN RES, V233, P2527, DOI 10.1007/s00221-015-4323-8; Chen J, 2019, J NEUROPHYSIOL, V122, P251, DOI 10.1152/jn.00712.2018; Chen J, 2017, J NEUROPHYSIOL, V118, P749, DOI 10.1152/jn.00208.2017; Chen J, 2017, NEUROPSYCHOLOGIA, V102, P206, DOI 10.1016/j.neuropsychologia.2017.06.024; de Brouwer S, 2002, J NEUROPHYSIOL, V87, P1646, DOI 10.1152/jn.00432.2001; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Fehd HM, 2010, J VISION, V10, DOI 10.1167/10.4.19; FRIEDMAN BH, 1991, ELECTROEN CLIN NEURO, V79, P358, DOI 10.1016/0013-4694(91)90200-N; Goncharova II, 2003, CLIN NEUROPHYSIOL, V114, P1580, DOI 10.1016/S1388-2457(03)00093-2; Grgic RG, 2016, CORTEX, V74, P31, DOI 10.1016/j.cortex.2015.10.008; Heinen SJ, 2011, J VISION, V11, DOI 10.1167/11.2.9; JASP Team, 2019, JASP VERS 0 11 1; Jin ZL, 2013, J VISION, V13, DOI 10.1167/13.4.7; Kahneman D., 1973, ATTENTION EFFORT; Kim YJ, 2007, NAT NEUROSCI, V10, P117, DOI 10.1038/nn1821; Lappin JS, 2016, ATTEN PERCEPT PSYCHO, V78, P2469, DOI 10.3758/s13414-016-1162-z; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Lavie N, 2010, CURR DIR PSYCHOL SCI, V19, P143, DOI 10.1177/0963721410370295; Ludwig CJH, 2014, P NATL ACAD SCI USA, V111, pE291, DOI 10.1073/pnas.1313553111; Mishra J, 2011, J NEUROSCI, V31, P992, DOI 10.1523/JNEUROSCI.4834-10.2011; Miskovic V, 2015, PSYCHOPHYSIOLOGY, V52, P81, DOI 10.1111/psyp.12287; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Muller MM, 1998, NAT NEUROSCI, V1, P631, DOI 10.1038/2865; Nicholls VI, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39737-7; Norcia AM, 2015, J VISION, V15, DOI 10.1167/15.6.4; Painter DR, 2014, J NEUROSCI, V34, P3390, DOI 10.1523/JNEUROSCI.3630-13.2014; Palomares M, 2012, J VISION, V12, DOI [10.1167/12.10.15, 10.1167/12.10.18]; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Posner MI, 1978, MODES PERCEIVING PRO, P137; Punsawad Y, 2017, MED BIOL ENG COMPUT, V55, P965, DOI 10.1007/s11517-016-1560-3; Renton AI, 2019, CEREB CORTEX, V29, P2366, DOI 10.1093/cercor/bhy105; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Seya Y, 2012, ATTEN PERCEPT PSYCHO, V74, P493, DOI 10.3758/s13414-011-0247-y; Stormer VS, 2013, J NEUROSCI, V33, P5346, DOI 10.1523/JNEUROSCI.4015-12.2013; Sundberg KA, 2009, NEURON, V61, P952, DOI 10.1016/j.neuron.2009.02.023; Toffanin P, 2009, INT J PSYCHOPHYSIOL, V72, P289, DOI 10.1016/j.ijpsycho.2009.01.006; Van Donkelaar P, 2002, PROG BRAIN RES, V140, P267; Vanegas MI, 2015, J NEUROPHYSIOL, V113, P1100, DOI 10.1152/jn.00774.2014; Wagenmakers EJ, 2018, PSYCHON B REV, V25, P58, DOI [10.3758/s13423-017-1323-7, 10.3758/s13423-017-1343-3]; Zhou Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep46556	50	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0236967	10.1371/journal.pone.0236967	http://dx.doi.org/10.1371/journal.pone.0236967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA7PQ	32750065	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000560009200028
J	Cunningham, JL; Bramstang, L; Singh, A; Jayarathna, S; Rasmusson, AJ; Moazzami, A; Muller, B				Cunningham, Janet L.; Bramstang, Ludvig; Singh, Abhijeet; Jayarathna, Shishanthi; Rasmusson, Annica J.; Moazzami, Ali; Mueller, Bettina			Impact of time and temperature on gut microbiota and SCFA composition in stool samples	PLOS ONE			English	Article							FECAL SAMPLES; COLLECTION METHODS; METABOLOMICS; HEALTH; PCR	Gut dysbiosis has been implicated in the pathophysiology of a growing number of non-communicable diseases. High through-put sequencing technologies and short chain fatty acid (SCFA) profiling enables surveying of the composition and function of the gut microbiota and provide key insights into host-microbiome interactions. However, a methodological problem with analyzing stool samples is that samples are treated and stored differently prior to submission for analysis potentially influencing the composition of the microbiota and its metabolites. In the present study, we simulated the sample acquisition of a large-scale study, in which stool samples were stored for up to two days in the fridge or at room temperature before being handed over to the hospital. To assess the influence of time and temperature on the microbial community and on SCFA composition in a controlled experimental setting, the stool samples of 10 individuals were exposed to room and fridge temperatures for 24 and 48 hours, respectively, and analyzed using 16S rRNA gene amplicon sequencing, qPCR and nuclear magnetic resonance spectroscopy. To best of our knowledge, this is the first study to investigate the influence of storage time and temperature on the absolute abundance of methanogens, and ofLactobacillus reuteri. The results indicate that values obtained for methanogens,L.reuteriand total bacteria are still representative even after storage for up to 48 hours at RT (20 degrees C) or 4 degrees C. The overall microbial composition and structure appeared to be influenced more by laboratory errors introduced during sample processing than by the actual effects of temperature and time. Although microbial activity was demonstrated by elevated SCFA at both 4 degrees C and RT, SCFAs ratios were more stable over the different conditions and may be considered as long as samples are come from similar storage conditions.	[Cunningham, Janet L.; Bramstang, Ludvig; Rasmusson, Annica J.] Uppsala Univ, Dept Neurosci, Psychiat, Uppsala, Sweden; [Singh, Abhijeet; Jayarathna, Shishanthi; Moazzami, Ali; Mueller, Bettina] Swedish Univ Agr Sci, BioCentrum, Dept Mol Sci, Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences	Muller, B (corresponding author), Swedish Univ Agr Sci, BioCentrum, Dept Mol Sci, Uppsala, Sweden.	Bettina.Muller@slu.se	Cunningham, Janet/C-4719-2013; Singh, Abhijeet/AAH-7890-2020; Müller, Bettina/H-3276-2018	Cunningham, Janet/0000-0001-7876-7779; Singh, Abhijeet/0000-0002-0807-6080; Müller, Bettina/0000-0002-0030-7710; Rasmusson, Annica/0000-0002-7228-7755	Ekhaga foundation; Swedish Society of Medicine; ALF Funds from Uppsala University Hospital	Ekhaga foundation; Swedish Society of Medicine; ALF Funds from Uppsala University Hospital	Funding for this study was obtained by Janet Cunningham from the Ekhaga foundation (http://www.ekhagastiftelsen.se), The Swedish Society of Medicine (https://www.sls.se); and ALF Funds from Uppsala University Hospital (https://www.akademiska.se).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell Guy C. J., 2006, Microbial Ecology in Health and Disease, V18, P154, DOI 10.1080/08910600601048969; Attaluri A, 2010, AM J GASTROENTEROL, V105, P1407, DOI 10.1038/ajg.2009.655; Bang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099411; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Christophersen C.T., 2007, THESIS; Clarke G, 2014, MOL ENDOCRINOL, V28, P1221, DOI 10.1210/me.2014-1108; Cong J, 2018, EUR J CLIN MICROBIOL, V37, P1595, DOI 10.1007/s10096-018-3263-1; Duar RM, 2017, FEMS MICROBIOL REV, V41, pS27, DOI 10.1093/femsre/fux030; Dwivedi M, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/6985256; Flores R, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0092-7; Gallego SF, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9010007; Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517; Giraffa G, 2010, RES MICROBIOL, V161, P480, DOI 10.1016/j.resmic.2010.03.001; Gratton J, 2016, ANAL CHEM, V88, P4661, DOI 10.1021/acs.analchem.5b04159; Hugerth LW, 2014, APPL ENVIRON MICROB, V80, P5116, DOI 10.1128/AEM.01403-14; JARRELL KF, 1985, BIOSCIENCE, V35, P298, DOI 10.2307/1309929; Kang DW, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0225-7; Kushak RI, 2018, RES AUTISM SPECT DIS, V49, P65, DOI 10.1016/j.rasd.2018.01.009; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Loftfield E, 2016, CANCER EPIDEM BIOMAR, V25, P1483, DOI 10.1158/1055-9965.EPI-16-0409; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Mu QH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00757; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ott SJ, 2004, DIAGN MICR INFEC DIS, V50, P237, DOI 10.1016/j.diagmicrobio.2004.08.012; Penington JS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22491-7; Pimentel M, 2003, DIGEST DIS SCI, V48, P86, DOI 10.1023/A:1021738515885; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rohnisch HE, 2018, ANAL CHEM, V90, P2095, DOI 10.1021/acs.analchem.7b04324; Szablewski L, 2018, J ALZHEIMERS DIS, V62, P549, DOI 10.3233/JAD-170908; Szopinska JW, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1249-x; Thomas V, 2015, FUTURE MICROBIOL, V10, P1485, DOI 10.2217/fmb.15.87; Vogtmann E, 2017, AM J EPIDEMIOL, V185, P115, DOI 10.1093/aje/kww177; Voigt AY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0639-8; Wang Z, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00301; WEAVER GA, 1986, GUT, V27, P698, DOI 10.1136/gut.27.6.698; Wickham H, 2016, J STATISCAL SOFTWARE; Yang YS, 2018, LIFE SCI, V194, P111, DOI 10.1016/j.lfs.2017.12.027; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zheng P, 2016, MOL PSYCHIATR, V21, P786, DOI 10.1038/mp.2016.44	43	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236944	10.1371/journal.pone.0236944	http://dx.doi.org/10.1371/journal.pone.0236944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745090	Green Published, Green Submitted, gold			2022-12-26	WOS:000560006800018
J	Kawai, H; Ejiri, M; Tsuruta, H; Masui, Y; Watanabe, Y; Hirano, H; Fujiwara, Y; Ihara, K; Tanaka, M; Obuchi, S				Kawai, Hisashi; Ejiri, Manami; Tsuruta, Harukazu; Masui, Yukie; Watanabe, Yutaka; Hirano, Hirohiko; Fujiwara, Yoshinori; Ihara, Kazushige; Tanaka, Masashi; Obuchi, Shuichi			Factors associated with follow-up difficulty in longitudinal studies involving community-dwelling older adults	PLOS ONE			English	Article							ATTRITION; SAMPLE	This study aims to clarify the factors associated with the gradual withdrawal from society in older adults. We defined the stages of follow-up difficulty based on four follow-up surveys on non-respondents of longitudinal mail surveys in community-dwelling older adults to examine the main factors associated with the stages of follow-up difficulty. We conducted a follow-up mail survey (FL1) with respondents of a baseline survey, and three more follow-up surveys with the non-respondents of each previous survey: simplified mail (FL2), postcard (FL3), and home visit surveys (FL4). The respondents of each follow-up survey were defined as a stage of follow-up difficulty; their characteristics concerning social participation and interaction at baseline in each stage were analyzed. The number of respondents in the FL1, FL2, FL3, and FL4 stages and non-respondents (NR) were as follows: 2,361; 462; 234; 84; and 101, respectively. Participation in hobby groups in FL2 and FL3, sports groups in FL4, and neighborhood association and social isolation in NR were significantly associated with the stage of follow-up difficulty. Based on these results, we conclude that the following factors are associated with each stage of follow-up difficulty: 1) a decline in instrumental activities of daily living in the FL2 and FL3 stages, 2) dislike for participating in physical activity such as sports in the FL4 stage, and 3) social isolation, not even belonging to a neighborhood association due to low social interaction in the NR group.	[Kawai, Hisashi; Ejiri, Manami; Tsuruta, Harukazu; Masui, Yukie; Watanabe, Yutaka; Hirano, Hirohiko; Fujiwara, Yoshinori; Obuchi, Shuichi] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; [Watanabe, Yutaka] Hokkaido Univ, Fac Med Dent, Dept Oral Hlth Sci, Gerodontol, Sapporo, Hokkaido, Japan; [Ihara, Kazushige] Hirosaki Univ, Fac Med, Hirosaki, Aomori, Japan; [Tanaka, Masashi] Natl Inst Biomed Innovat Hlth & Nutr, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; Hokkaido University; Hirosaki University	Kawai, H (corresponding author), Tokyo Metropolitan Inst Gerontol, Tokyo, Japan.	hkawai@tmig.or.jp		watanabe, yutaka/0000-0002-4983-2399; Kawai, Hisashi/0000-0003-3015-6041	Health and Labor Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan [H23-Choju-Ippan-001, H23-Choju-Ippan-002, H24-Choju-Ippan-002, H25-Choju-Ippan-005]; Promotion Project of Creating Industry Extending Healthy Life Expectancy from the Japanese Ministry of Economy, Trade and Industry	Health and Labor Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan; Promotion Project of Creating Industry Extending Healthy Life Expectancy from the Japanese Ministry of Economy, Trade and Industry	This work was supported by Health and Labor Sciences Research Grants [H23-Choju-Ippan-001 and 002, H24-Choju-Ippan-002, and H25-Choju-Ippan-005] from the Ministry of Health, Labour and Welfare of Japan, and the Promotion Project of Creating Industry Extending Healthy Life Expectancy from the Japanese Ministry of Economy, Trade and Industry.	Chatfield MD, 2005, J CLIN EPIDEMIOL, V58, P13, DOI 10.1016/j.jclinepi.2004.05.006; Cramm JM, 2015, GERIATR GERONTOL INT, V15, P1087, DOI 10.1111/ggi.12404; Ejiri M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222887; Fujiwara Y, 2013, J GERIATR PSYCH NEUR, V26, P209, DOI 10.1177/0891988713497096; GOUDY WJ, 1985, J GERONTOL, V40, P358, DOI 10.1093/geronj/40.3.358; Haring R, 2009, J CLIN EPIDEMIOL, V62, P252, DOI 10.1016/j.jclinepi.2008.06.010; Kanamori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099638; Kempen GIJM, 2002, J CLIN EPIDEMIOL, V55, P224, DOI 10.1016/S0895-4356(01)00474-7; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Mein G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-164; Mihelic AH, 1997, J GERONTOL B-PSYCHOL, V52, pS37, DOI 10.1093/geronb/52B.1.S37; Nemoto Y, 2018, GERIATR GERONTOL INT, V18, P1259, DOI 10.1111/ggi.13457; Saito Masashige, 2015, Nihon Koshu Eisei Zasshi, V62, P95, DOI 10.11236/jph.62.3_95; Shibasaki K, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2015.06.007; Slymen DJ, 1996, INT J EPIDEMIOL, V25, P411, DOI 10.1093/ije/25.2.411; Sugisawa H, 1999, Nihon Koshu Eisei Zasshi, V46, P551; TENNSTEDT SL, 1992, J GERONTOL, V47, pS313, DOI 10.1093/geronj/47.6.S313; Tomioka K, 2018, J GERONTOL B-PSYCHOL, V73, P799, DOI 10.1093/geronb/gbw059; Uemura K, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2015.09.014; WHO, 2001, WHO INT CLASS FUNCT; Yamakita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141638	21	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0237166	10.1371/journal.pone.0237166	http://dx.doi.org/10.1371/journal.pone.0237166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745148	Green Submitted, Green Published, gold			2022-12-26	WOS:000560006800041
J	Le, DT; Zhang, YQ; Xu, Y; Guo, LX; Ruan, ZP; Burgess, KS; Ge, XJ				Duc-Thanh Le; Zhang, Yu-Qu; Xu, Yong; Guo, Li-Xiu; Ruan, Zhi-Ping; Burgess, Kevin S.; Ge, Xue-Jun			The utility of DNA barcodes to confirm the identification of palm collections in botanical gardens	PLOS ONE			English	Article							FOREST DYNAMICS PLOT; PHYLOGENETIC ANALYSIS; MOLECULAR PHYLOGENETICS; PLASTID DNA; TRNH-PSBA; ARECACEAE; RBCL; EVOLUTION; SPACER; NRDNA	The palm family (Arecaceae) is of high ecological and economic value, yet identification in the family remains a challenge for both taxonomists and horticulturalists. The family consists of approximately 2600 species across 181 genera and DNA barcoding may be a useful tool for species identification within the group. However, there have been few systematic evaluations of DNA barcodes for the palm family. In the present study, five DNA barcodes (rbcL, matK, trnH-psbA, ITS, ITS2) were evaluated for species identification ability across 669 samples representing 314 species and 100 genera in the Arecaceae, employing four analytical methods. The ITS gene region was found to not be a suitable barcode for the palm family, due in part, to low recovery rates and paralogous gene copies. Among the four analyses used, species resolution for ITS2 was much higher than that achieved with the plastid barcodes alone (rbcL, matK, trnH-psbA), and the barcode combination ITS2 + matK + rbcL gave the highest resolution among all single barcodes and their combinations, followed by ITS2 + matK. Among 669 palm samples analyzed, 110 samples (16.3%) were found to be misidentified. The 2992 DNA barcode sequences generated in this study greatly enriches the existing identification toolbox available to plant taxonomists that are interested in researching genetic relationships among palm taxa as well as for horticulturalists that need to confirm palm collections for botanical garden curation and horticultural applications. Our results indicate that the use of the ITS2 DNA barcode gene region provides a useful and cost-effective tool to confirm the identity of taxa in the Palm family.	[Duc-Thanh Le; Zhang, Yu-Qu; Xu, Yong; Guo, Li-Xiu; Ge, Xue-Jun] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Peoples R China; [Duc-Thanh Le] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Ruan, Zhi-Ping] Xiamen Bot Garden, Xiamen, Peoples R China; [Burgess, Kevin S.] Columbus State Univ, Univ Syst Georgia, Dept Biol, Columbus, GA USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University System of Georgia; Columbus State University	Ge, XJ (corresponding author), Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Peoples R China.	xjge@scbg.ac.cn		Ge, Xue-Jun/0000-0002-5008-9475	Biological Resources Program of Chinese Academy of Sciences [ZSSD-009]; International Partnership Program of Chinese Academy of Sciences [GJHZ1620]	Biological Resources Program of Chinese Academy of Sciences; International Partnership Program of Chinese Academy of Sciences	Xue-jun Ge received the financial support of the following: the Biological Resources Program of Chinese Academy of Sciences (ZSSD-009) and the International Partnership Program of Chinese Academy of Sciences (www.cas.ac.cn)(No.GJHZ1620).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmussen CB, 2006, BOT J LINN SOC, V151, P15, DOI 10.1111/j.1095-8339.2006.00521.x; Asmussen CB, 2001, AM J BOT, V88, P1103, DOI 10.2307/2657094; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baker WJ, 2016, BOT J LINN SOC, V182, P207, DOI 10.1111/boj.12401; Baker WJ, 2011, ANN BOT-LONDON, V108, P1417, DOI 10.1093/aob/mcr020; Baker WJ, 2000, MOL PHYLOGENET EVOL, V14, P218, DOI 10.1006/mpev.1999.0697; Baker WJ, 2000, MOL PHYLOGENET EVOL, V14, P195, DOI 10.1006/mpev.1999.0696; Barrett CF, 2019, BOT J LINN SOC, V190, P242, DOI 10.1093/botlinnean/boz015; Braukmann TWA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169515; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coissac E, 2016, MOL ECOL, V25, P1423, DOI 10.1111/mec.13549; Comer JR, 2015, THESIS; Domenech B, 2014, BOT J LINN SOC, V175, P469, DOI 10.1111/boj.12179; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dransfield J., 2008, GENERA PALMARUM THE; Duan HY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53752-8; Elliott TL, 2014, MOL ECOL RESOUR, V14, P883, DOI 10.1111/1755-0998.12277; Fahner NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157505; Felsenstein J, 2004, INFERRING PHYLOGENIE; Fu CN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39161-x; GAUT BS, 1992, J MOL EVOL, V35, P292, DOI 10.1007/BF00161167; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Govaerts R, 2018, WORLD CHECKLIST AREC; Guo MY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01945; Hahn WJ, 2002, SYST BIOL, V51, P92, DOI 10.1080/106351502753475899; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heyduk K, 2016, BIOL J LINN SOC, V117, P106, DOI 10.1111/bij.12551; Hollingsworth PM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0338; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Jeanson ML, 2011, ANN BOT-LONDON, V108, P1445, DOI 10.1093/aob/mcr158; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lewis CE, 2002, PLANT SYST EVOL, V236, P1, DOI 10.1007/s00606-002-0205-1; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Liu J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153008; Meerow AW, 2015, CLADISTICS, V31, P509, DOI 10.1111/cla.12100; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Miller M.A., 2010, P GAT COMP ENV WORKS; Moorhouse-Gann RJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26648-2; Mounce R, 2017, NAT PLANTS, V3, P795, DOI 10.1038/s41477-017-0019-3; Naeem A, 2014, GENET MOL RES, V13, P10341, DOI 10.4238/2014.December.4.29; Noblick LR, 2017, PHYTOTAXA, V294, P2, DOI [10.11646/phytotaxa.294.1.1, 10.11646/phytotaxa.294.1]; Pichardo-Marcano FJ, 2019, MOL PHYLOGENET EVOL, V133, P67, DOI 10.1016/j.ympev.2018.12.030; R Core Team, 2021, R LANGUAGE ENV STAT; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400066; Riffle RL, 2003, ENCY CULTIVATED PALM; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tan SL, 2018, ECOL EVOL, V8, P7195, DOI 10.1002/ece3.4254; Tate JA, 2003, SYST BOT, V28, P723; Twyford AD, 2014, MOL ECOL, V23, P4674, DOI 10.1111/mec.12892; Urbatsch LE, 2000, SYST BOT, V25, P539, DOI 10.2307/2666695; Wagele JW, 2003, MOL PHYLOGENET EVOL, V28, P536, DOI 10.1016/S1055-7903(03)00053-8; Wang XY, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2734960; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533; Xu SZ, 2018, MOL ECOL RESOUR, V18, P128, DOI 10.1111/1755-0998.12715; Yan HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122903; Yan LJ, 2015, MOL ECOL RESOUR, V15, P932, DOI 10.1111/1755-0998.12353; Yang HQ, 2012, ANN BOT FENN, V49, P319, DOI 10.5735/085.049.0603; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x	65	5	5	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0235569	10.1371/journal.pone.0235569	http://dx.doi.org/10.1371/journal.pone.0235569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735584	Green Published, gold			2022-12-26	WOS:000569367100010
J	MacNeil, SD; Rotenberg, B; Sowerby, L; Allen, B; Richard, L; Shariff, SZ				MacNeil, S. Danielle; Rotenberg, Brian; Sowerby, Leigh; Allen, Britney; Richard, Lucie; Shariff, Salimah Z.			Medical use of cocaine and perioperative morbidity following sinonasal surgery-A population study	PLOS ONE			English	Article							ADMINISTRATIVE DATA; TOPICAL COCAINE; NASAL SURGERY; ADRENALINE; ABSORPTION; SINUS; EPIDEMIOLOGY; COMBINATION; VALIDATION; LIDOCAINE	Background Topical cocaine is favoured by many surgeons for sinonasal surgery due to its superior vasoconstrictive and anesthetic properties. However, historical reports suggesting cocaine is associated with an increased risk of cardiac events have led many surgeons to turn to alternative topical medications. The objective of this study was to determine whether cocaine use during sinonasal surgery is associated with an increased risk of perioperative cardiac events and death. Methods We conducted a population-based analysis of patients undergoing sinonasal surgery from 2009-2016 using linked administrative health care data sets in Ontario, Canada. We compared patients treated at institutions that primarily use topical cocaine (exposed group) to those treated at institutions that do not use cocaine (unexposed group). Our primary outcome was a composite of major cardiac events or all-cause mortality within 48 hours of surgery. Due to low event rates, the outcome was compared using a Fisher's exact test. Results Of 10,549 patients who were included in the study, 27.4% were treated at an institution that uses topical cocaine. The rate of the composite of perioperative major cardiac event or all-cause mortality within 48 hours of surgery in the exposed and unexposed groups was, <= 0.2% and 0 (p-value>0.05), respectively. Conclusions In this large real-world cohort of patients undergoing sinonasal surgery, there does not appear to be any significant increased risk of morbidity or mortality associated with cocaine use. These findings have important implications for surgeons performing this procedure.	[MacNeil, S. Danielle; Rotenberg, Brian; Sowerby, Leigh] Schulich Sch Med & Dent, Dept Otolaryngol Head & Neck Surg, London, ON, Canada; [Allen, Britney; Richard, Lucie; Shariff, Salimah Z.] ICES Western, London, ON, Canada		MacNeil, SD (corresponding author), Schulich Sch Med & Dent, Dept Otolaryngol Head & Neck Surg, London, ON, Canada.	Danielle.macneil@lhsc.on.ca		Sowerby, Leigh/0000-0002-5825-2759; Richard, Lucie/0000-0001-6577-5067	ICES; Ontario Ministry of Health and Long-Term Care (MOHLTC); Academic Medical Organization of Southwestern Ontario; Schulich School of Medicine and Dentistry, Western University; Lawson Health Research Institute; St. Joseph's Health Care Foundation [012-1718]	ICES; Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario; Schulich School of Medicine and Dentistry, Western University; Lawson Health Research Institute; St. Joseph's Health Care Foundation	This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The study was completed at the ICES Western site, where core funding is provided by the Academic Medical Organization of Southwestern Ontario, the Schulich School of Medicine and Dentistry, Western University, and the Lawson Health Research Institute. This study also received funding from the St. Joseph's Health Care Foundation grant no. 012-1718 to BR. Parts of this material are based on data and information compiled and provided by CIHI. The analyses, conclusions, opinions and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred.	AlHaddad ST, 2013, INDIAN J ANAESTH, V57, P163, DOI 10.4103/0019-5049.111844; [Anonymous], 2009, COMMUN STAT STIMUL C, V38, P1228; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Bhattacharyya N, 2010, LARYNGOSCOPE, V120, P635, DOI 10.1002/lary.20777; Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832; CAMPBELL JP, 1992, OTOLARYNG HEAD NECK, V107, P697, DOI 10.1177/019459989210700511; De R, 2003, J LARYNGOL OTOL, V117, P109, DOI 10.1258/002221503762624530; DELIKAN AE, 1978, ANAESTH INTENS CARE, V6, P328, DOI 10.1177/0310057X7800600406; Dwyer C, 2016, LARYNGOSCOPE, V126, P1721, DOI 10.1002/lary.25836; Greinwald JH, 1996, LARYNGOSCOPE, V106, P1223, DOI 10.1097/00005537-199610000-00009; Guttmann A, 2010, PEDIATR DIABETES, V11, P122, DOI 10.1111/j.1399-5448.2009.00539.x; Higgins TS, 2011, LARYNGOSCOPE, V121, P422, DOI 10.1002/lary.21286; (IOM) IoM, 2006, REB UN HLTH ENV RUR; Iron K, 2008, LIVING DYING ONTARIO; Juurlink D, 2006, CANADIAN I HLTH INFO; Kara CO, 2001, J OTOLARYNGOL, V30, P145, DOI 10.2310/7070.2001.20197; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kubo N, 1995, Nihon Jibiinkoka Gakkai Kaiho, V98, P1263; Liao BS, 1999, LARYNGOSCOPE, V109, P98, DOI 10.1097/00005537-199901000-00019; LIPS FJ, 1987, ANAESTH INTENS CARE, V15, P141, DOI 10.1177/0310057X8701500204; Long H, 2004, LARYNGOSCOPE, V114, P1625, DOI 10.1097/00005537-200409000-00022; PFLEIDERER AG, 1988, CLIN OTOLARYNGOL, V13, P421, DOI 10.1111/j.1365-2273.1988.tb00315.x; Reid JW, 2019, J OTOLARYNGOL-HEAD N, V48, DOI 10.1186/s40463-019-0337-8; Schultz SE, 2013, CHRON DIS INJ CAN, V33, P160; TARVER CP, 1993, OTOLARYNG HEAD NECK, V109, P653, DOI 10.1177/019459989310900404; Tu Karen, 2007, Open Med, V1, pe18; Valdes CJ, 2014, INT FORUM ALLERGY RH, V4, P646, DOI 10.1002/alr.21325; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Weiner JAC, 2009, JOHNS HOPKINS ACG SY; Williams JI, 1996, SUMMARY STUIDES QUAL	30	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236356	10.1371/journal.pone.0236356	http://dx.doi.org/10.1371/journal.pone.0236356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730351	Green Published, gold			2022-12-26	WOS:000556884700087
J	Nguyen, N; Olivas, TJ; Mires, A; Jin, JX; Yu, SL; Luan, L; Nag, S; Kauffman, KJ; Melia, TJ				Nguyen, Nathan; Olivas, Taryn J.; Mires, Antonio; Jin, Jiaxin; Yu, Shenliang; Luan, Lin; Nag, Shanta; Kauffman, Karlina J.; Melia, Thomas J.			The insufficiency of ATG4A in macroautophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; membrane reconstitution; liposome; cell biology; phosphorylation; autophagy-related protein 4A (ATG4); delipidation; GABARAP like-1; LC3-interacting region (LIR); MST4	AUTOPHAGOSOME FORMATION; ATG8-PE DECONJUGATION; PROTEIN; LC3; PHOSPHORYLATION; DELIPIDATION; MODULATION; MECHANISMS; GABARAP; BINDING	During autophagy, LC3 and GABARAP proteins become covalently attached to phosphatidylethanolamine on the growing autophagosome. This attachment is also reversible. Deconjugation (or delipidation) involves the proteolytic cleavage of an isopeptide bond between LC3 or GABARAP and the phosphatidylethanolamine headgroup. This cleavage is carried about by the ATG4 family of proteases (ATG4A, B, C, and D). Many studies have established that ATG4B is the most active of these proteases and is sufficient for autophagy progression in simple cells. Here we examined the second most active protease, ATG4A, to map out key regulatory motifs on the protein and to establish its activity in cells. We utilized fullyin vitroreconstitution systems in which we controlled the attachment of LC3/GABARAP members and discovered a role for a C-terminal LC3-interacting region on ATG4A in regulating its access to LC3/GABARAP. We then used a gene-edited cell line in which all four ATG4 proteases have been knocked out to establish that ATG4A is insufficient to support autophagy and is unable to support GABARAP proteins removal from the membrane. As a result, GABARAP proteins accumulate on membranes other than mature autophagosomes. These results suggest that to support efficient production and consumption of autophagosomes, additional factors are essential including possibly ATG4B itself or one of its proteolytic products in the LC3 family.	[Nguyen, Nathan; Olivas, Taryn J.; Mires, Antonio; Jin, Jiaxin; Yu, Shenliang; Luan, Lin; Nag, Shanta; Kauffman, Karlina J.; Melia, Thomas J.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Mires, Antonio] Natl Agr Univ La Molina, Lima, Peru; [Jin, Jiaxin] Lanzhou Univ, Hosp 2, Lanzhou, Gansu, Peoples R China	Yale University; University Nacional Agraria La Molina; Lanzhou University	Melia, TJ (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	thomas.melia@yale.edu		Yu, Shenliang/0000-0002-2626-2178	National Institutes of Health [GM100930, NS063973]; China Scholarship Council; Chinese Scholarship Council Student Exchange Fellowship [201406180015]; National Institutes of Health Predoctoral Training Grant [T32 GM007223]; National Agrarian University-La Molina (through the Research Experience for Peruvian Undergraduates (REPU) program)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); Chinese Scholarship Council Student Exchange Fellowship; National Institutes of Health Predoctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Agrarian University-La Molina (through the Research Experience for Peruvian Undergraduates (REPU) program)	This work was supported by National Institutes of Health Grants (GM100930 and NS063973 to T. J. M.), a predoctoral training grant from the China Scholarship Council (to S. Y.), Chinese Scholarship Council Student Exchange Fellowship Grant 201406180015 (to J. J.), National Institutes of Health Predoctoral Training Grant T32 GM007223 (to N. N., T. J. O., and K. J. K.), and funding from the National Agrarian University-La Molina (through the Research Experience for Peruvian Undergraduates (REPU) program to A. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrotis A, 2019, AUTOPHAGY, V15, P976, DOI 10.1080/15548627.2019.1569925; Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Bauvy C, 2009, METHOD ENZYMOL, V452, P47, DOI 10.1016/S0076-6879(08)03604-5; Bishop E, 2018, CANCER CHEMOTH PHARM, V82, P913, DOI 10.1007/s00280-018-3669-6; Cann GM, 2008, DEV DYNAM, V237, P187, DOI 10.1002/dvdy.21392; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; DETER RL, 1967, J CELL BIOL, V35, pC11, DOI 10.1083/jcb.35.2.C11; Dupont N, 2017, METHOD ENZYMOL, V588, P31, DOI 10.1016/bs.mie.2016.09.074; Fu YY, 2019, CANCERS, V11, DOI 10.3390/cancers11050649; Huang TZ, 2017, CANCER CELL, V32, P840, DOI 10.1016/j.ccell.2017.11.005; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kauffman KJ, 2018, AUTOPHAGY, V14, P992, DOI 10.1080/15548627.2018.1437341; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kraft C, 2012, CURR OPIN CELL BIOL, V24, P496, DOI 10.1016/j.ceb.2012.05.001; Kuma A, 2017, AUTOPHAGY, V13, P1619, DOI 10.1080/15548627.2017.1343770; Kumanomidou T, 2006, J MOL BIOL, V355, P612, DOI 10.1016/j.jmb.2005.11.018; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li M, 2012, AUTOPHAGY, V8, P401, DOI 10.4161/auto.18777; Li M, 2011, J BIOL CHEM, V286, P7327, DOI 10.1074/jbc.M110.199059; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Lystad AH, 2019, NAT CELL BIOL, V21, P372, DOI 10.1038/s41556-019-0274-9; Ma TH, 2015, NAT CELL BIOL, V17, P1379, DOI 10.1038/ncb3256; Marino G, 2010, J CLIN INVEST, V120, P2331, DOI 10.1172/JCI42601; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; Musiwaro P, 2013, AUTOPHAGY, V9, P1407, DOI 10.4161/auto.25455; Nair U, 2012, AUTOPHAGY, V8, P780, DOI 10.4161/auto.19385; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2012, AUTOPHAGY, V8, P177, DOI 10.4161/auto.8.2.18373; Nath S, 2014, NAT CELL BIOL, V16, P415, DOI 10.1038/ncb2940; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; O'Sullivan GA, 2005, EUR J NEUROSCI, V22, P2644, DOI 10.1111/j.1460-9568.2005.04448.x; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pattingre S, 2004, METHOD ENZYMOL, V390, P17; Pengo N, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00148; Rasmussen MS, 2017, AUTOPHAGY, V13, P834, DOI 10.1080/15548627.2017.1287651; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Sawa-Makarska J, 2014, NAT CELL BIOL, V16, P425, DOI 10.1038/ncb2935; Shibutani ST, 2014, CELL RES, V24, P58, DOI 10.1038/cr.2013.159; Shirakabe A, 2016, CIRCULATION, V133, P1249, DOI 10.1161/CIRCULATIONAHA.115.020502; Stromhaug PE, 1998, BIOCHEM J, V335, P217, DOI 10.1042/bj3350217; Szalai P, 2015, EXP CELL RES, V333, P21, DOI 10.1016/j.yexcr.2015.02.003; Nguyen TN, 2016, J CELL BIOL, V215, P857, DOI 10.1083/jcb.201607039; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Valverde DP, 2019, J CELL BIOL, V218, P1787, DOI 10.1083/jcb.201811139; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yang ZF, 2015, J BIOL CHEM, V290, P26549, DOI 10.1074/jbc.M115.658088; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Yu ZQ, 2012, AUTOPHAGY, V8, P883, DOI 10.4161/auto.19652; Zhang L, 2016, CANCER LETT, V373, P19, DOI 10.1016/j.canlet.2016.01.022	62	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2020	295	39					13584	13600		10.1074/jbc.RA120.013897	http://dx.doi.org/10.1074/jbc.RA120.013897			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NY3VI	32732290	Green Published, hybrid			2022-12-26	WOS:000576321100013
J	Haidir, IA; Macdonald, DW; Wong, WM; Lubis, MI; Linkie, M				Haidir, Iding A.; Macdonald, David W.; Wong, Wai-Ming; Lubis, Muhammad, I; Linkie, Matthew			Population dynamics of threatened felids in response to forest cover change in Sumatra	PLOS ONE			English	Article							PANTHERA-TIGRIS; NATIONAL-PARK; SUN BEARS; HABITAT; LEOPARD; TIGER; CONSERVATION; OCCUPANCY; INDONESIA; RECOVERY	Habitat loss caused by deforestation is a global driver of predator population declines. However, few studies have focussed on these effects for mesopredator populations, particularly the cryptic and elusive species inhabiting tropical rainforests. We conducted camera trapping from 2009-11 and 2014-16, and used occupancy modelling to understand trends of Sumatran mesopredator occupancy in response to forest loss and in the absence of threats from poaching. By comparing the two survey periods we quantify the trend of occupancy for three sympatric felid species in the tropical rainforest landscape of Kerinci Seblat National Park. Between 2000 and 2014, forest loss across four study sites ranged from 2.6% to 8.4%. Of three threatened felid species, overall occupancy by Sunda clouded leopard (Neofelis diardi) and Asiatic golden cat (Catopuma temminckii) remained stable across all four areas between the two survey periods, whilst marbled cat (Pardofelis marmorata) occupancy increased. In general occupancy estimates for the three species were: lower in lowland forest and increased to attain their highest values in hill forest, where they declined thereafter; increased further from the forest edge; positively correlated with distance to river, except for golden cat in the second survey where the relationship was negative; and, increased further from active deforestation, especially for clouded leopard in the second survey, but this was some 10-15km away. Our study offers fresh insights into these little known mesopredators in Sumatra and raises the practically important question of how far-reaching is the shadow of the encroachment and road development that typified this deforestation.	[Haidir, Iding A.] Indonesian Minist Environm & Forestry, Kerinci Seblat Natl Pk, Jambi, Indonesia; [Haidir, Iding A.; Macdonald, David W.] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit WildCRU, Tubney, England; [Wong, Wai-Ming] Panthera Fdn, New York, NY USA; [Wong, Wai-Ming; Linkie, Matthew] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Lubis, Muhammad, I; Linkie, Matthew] Wildlife Conservat Soc Indonesia Programme, Bogor, Indonesia	Ministry of Environment & Forestry; University of Oxford; University of Kent	Haidir, IA (corresponding author), Indonesian Minist Environm & Forestry, Kerinci Seblat Natl Pk, Jambi, Indonesia.; Haidir, IA (corresponding author), Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit WildCRU, Tubney, England.	iding.haidir@zoo.ox.ac.uk		Achmad Haidir, Iding/0000-0002-1568-5650; Lubis, Muhammad/0000-0003-0710-8076	Robertson Foundation; World Animal Protection; Dr Holly Reed Conservation Fund; Panthera Foundation; Rufford Small Grant	Robertson Foundation; World Animal Protection; Dr Holly Reed Conservation Fund; Panthera Foundation; Rufford Small Grant	All of the funding or sources of support received during this specific study (whether external or internal to our organization) had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding was provided by Robertson Foundation, World Animal Protection, Rufford Small Grant, Dr Holly Reed Conservation Fund and Panthera Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, 42 SESS WORLD HER CO; Bahaa-el-Din L, 2016, BIOL CONSERV, V199, P1, DOI 10.1016/j.biocon.2016.04.013; Beaudrot L, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002357; BIVAND R, 2019, BINDINGS GEOSPATIAL; D'Cruze N, 2015, BIODIVERS CONSERV, V24, P3505, DOI 10.1007/s10531-015-1010-9; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Espinosa S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189740; Farris ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136456; Ferretti F, 2014, EUR J WILDLIFE RES, V60, P559, DOI 10.1007/s10344-014-0810-7; Fuller AK, 2016, J WILDLIFE MANAGE, V80, P794, DOI 10.1002/jwmg.21077; Haidir IA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202876; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harihar A, 2018, ORYX, V52, P78, DOI 10.1017/S0030605317001156; Harihar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040105; Heiniger J, 2018, WILDLIFE RES, V45, P8; Hijmans R.J., 2019, SPATIAL DATA ANAL R, P135; Jacobson AP, 2016, PEERJ, V4, DOI 10.7717/peerj.1974; Jedrzejewski W, 2017, BIOL CONSERV, V206, P132, DOI 10.1016/j.biocon.2016.09.027; Karanth KK, 2016, ENVIRON MANAGE, V57, P189, DOI 10.1007/s00267-015-0595-9; Kery M, 2010, CONSERV BIOL, V24, P1388, DOI 10.1111/j.1523-1739.2010.01479.x; Linkie M, 2008, BIOL CONSERV, V141, P2410, DOI 10.1016/j.biocon.2008.07.002; Linkie M, 2007, BIOL CONSERV, V137, P20, DOI 10.1016/j.biocon.2007.01.016; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; Linkie M, 2018, BIOL CONSERV, V219, P105, DOI 10.1016/j.biocon.2018.01.011; Linkie M, 2015, J APPL ECOL, V52, P851, DOI 10.1111/1365-2664.12461; LUSKIN MS, 2017, NAT COMMUN, V8; Macdonald DW, 2018, BIOL CONSERV, V227, P92, DOI 10.1016/j.biocon.2018.08.027; MacKenzie DI, 2006, J WILDLIFE MANAGE, V70, P367, DOI 10.2193/0022-541X(2006)70[367:MTPORU]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Margono BA, 2014, NAT CLIM CHANGE, V4, P730, DOI [10.1038/nclimate2277, 10.1038/NCLIMATE2277]; McCarthy JL, 2015, GLOB ECOL CONSERV, V3, P210, DOI 10.1016/j.gecco.2014.11.009; Meredith M, 2018, QUICK DIRTY ESTIMATE, P81; Niedballa J, 2016, METHODS ECOL EVOL, V7, P1457, DOI 10.1111/2041-210X.12600; Pusparini W, 2018, ORYX, V52, P25, DOI 10.1017/S0030605317001144; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Rayan DM, 2016, BIOL CONSERV, V204, P360, DOI 10.1016/j.biocon.2016.11.009; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roques S, 2016, CONSERV GENET, V17, P125, DOI 10.1007/s10592-015-0766-5; RStudio. RStudio Team, 2015, R DEV COR TEAM; Shannon G, 2014, PEERJ, V2, DOI 10.7717/peerj.532; Sollman R, 2008, CATNEWS; Sollmann R, 2014, ORYX, V48, P536, DOI 10.1017/S003060531400043X; Sunarto S, 2015, J ZOOL, V296, P104, DOI 10.1111/jzo.12218; Sunarto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030859; Tranquilli S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114154; Wearn OR, 2017, BIOL CONSERV, V212, P162, DOI 10.1016/j.biocon.2017.05.007; Wibisono HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025931; Wong WM, 2013, ANIM CONSERV, V16, P216, DOI 10.1111/j.1469-1795.2012.00587.x; Wong WM, 2013, DIVERS DISTRIB, V19, P700, DOI 10.1111/ddi.12020	49	2	2	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2020	15	8							e0236144	10.1371/journal.pone.0236144	http://dx.doi.org/10.1371/journal.pone.0236144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ND3HD	32785217	Green Published, gold			2022-12-26	WOS:000561793900039
J	Shimizu, S; Mimura, J; Hasegawa, T; Shimizu, E; Imoto, S; Tsushima, M; Kasai, S; Yamazaki, H; Ushida, Y; Suganuma, H; Tomita, H; Yamamoto, M; Nakaji, S; Itoh, K				Shimizu, Sunao; Mimura, Junsei; Hasegawa, Takanori; Shimizu, Eigo; Imoto, Seiya; Tsushima, Michiko; Kasai, Shuya; Yamazaki, Hiromi; Ushida, Yusuke; Suganuma, Hiroyuki; Tomita, Hirofumi; Yamamoto, Masayuki; Nakaji, Shigeyuki; Itoh, Ken			Association of single nucleotide polymorphisms in the NRF2 promoter with vascular stiffness with aging	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE ENTERPRISES; TRANSCRIPTION FACTOR NRF2; FUNCTIONAL POLYMORPHISMS; GENETIC POLYMORPHISMS; DIETARY-CHOLESTEROL; ANTIOXIDATIVE GENE; MAJOR SHAREHOLDERS; OXIDATIVE STRESS; BLOOD-PRESSURE; ARTERIAL	Purpose Pulse wave velocity (PWV), an indicator of vascular stiffness, increases with age and is increasingly recognized as an independent risk factor for cardiovascular disease (CVD). Although many mechanical and chemical factors underlie the stiffness of the elastic artery, genetic risk factors related to age-dependent increases in PWV in apparently healthy people are largely unknown. The transcription factor nuclear factor E2 (NF-E2)-related factor 2 (Nrf2), which is activated by unidirectional vascular pulsatile shear stress or oxidative stress, regulates vascular redox homeostasis. Previous reports have shown that a SNP in theNRF2gene regulatory region (-617C>A; hereafter called SNP-617) affectsNRF2gene expression such that the minor A allele confers lower gene expression compared to the C allele, and it is associated with various diseases, including CVD. We aimed to investigate whether SNP-617 affects vascular stiffness with aging in apparently healthy people. Methods Analyzing wide-ranging data obtained from a public health survey performed in Japan, we evaluated whether SNP-617 affected brachial-ankle PWV (baPWV) in never-smoking healthy subjects (n = 642). We also evaluated the effects of SNP-617 on other cardiovascular and blood test measurements. Results We have shown that not only AA carriers (n = 55) but also CA carriers (n = 247) show arterial stiffness compared to CC carriers (n = 340). Furthermore, SNP-617 also affected blood pressure indexes such as systolic blood pressure and mean arterial pressure but not the ankle brachial pressure index, an indicator of atherosclerosis. Multivariate analysis showed that SNP-617 accelerates the incremental ratio of baPWV with age. Conclusions This study is the first to show that SNP-617 affects the age-dependent increase in vascular stiffness. Our results indicate that low NRF2 activity induces premature vascular aging and could be targeted for the prevention of cardiovascular diseases associated with aging.	[Shimizu, Sunao; Mimura, Junsei; Hasegawa, Takanori; Kasai, Shuya; Yamazaki, Hiromi; Itoh, Ken] Hirosaki Univ, Ctr Adv Med Res, Dept Stress Response Sci, Grad Sch Med, Hirosaki, Aomori, Japan; [Shimizu, Sunao; Yamazaki, Hiromi; Ushida, Yusuke; Suganuma, Hiroyuki; Itoh, Ken] Hirosaki Univ, Dept Vegetable Life Sci, Grad Sch Med, Hirosaki, Aomori, Japan; [Shimizu, Sunao] Kagome Co Ltd, Innovat Div, Dept Nat & Wellness Res, Nasushiobara, Tochigi, Japan; [Imoto, Seiya] Univ Tokyo, Hlth Intelligence Ctr, Minato Ku, Tokyo, Japan; [Shimizu, Eigo; Imoto, Seiya] Univ Tokyo, Human Genome Ctr, Inst Med Sci, Minato Ku, Tokyo, Japan; [Tsushima, Michiko; Tomita, Hirofumi] Hirosaki Univ, Dept Cardiol & Nephrol, Grad Sch Med, Hirosaki, Aomori, Japan; [Yamamoto, Masayuki] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Nakaji, Shigeyuki] Hirosaki Univ, Dept Social Med, Grad Sch Med, Hirosaki, Aomori, Japan; [Yamazaki, Hiromi] Fdn Biomed Res & Innovat Kobe, Inst Biomed Res & Innovat, Dept Hematol Oncol, Kobe, Hyogo, Japan	Hirosaki University; Hirosaki University; Kagome Co., Ltd.; University of Tokyo; University of Tokyo; Hirosaki University; Tohoku University; Hirosaki University; Institute for Biomedical Research & Innovation (IBRI)	Itoh, K (corresponding author), Hirosaki Univ, Ctr Adv Med Res, Dept Stress Response Sci, Grad Sch Med, Hirosaki, Aomori, Japan.; Itoh, K (corresponding author), Hirosaki Univ, Dept Vegetable Life Sci, Grad Sch Med, Hirosaki, Aomori, Japan.	itohk@hirosaki-u.ac.jp	Itoh, Ken/B-9506-2013; Yamamoto, Masayuki/A-4873-2010; Tomita, Hirofumi/E-8627-2013; Kasai, Shuya/AAL-2157-2021	Itoh, Ken/0000-0002-5518-0729; Yamamoto, Masayuki/0000-0002-9073-9436; Kasai, Shuya/0000-0001-7171-4885; Ushida, Yusuke/0000-0003-4117-929X	"Center for Innovation Program" of the Japan Science and Technology Agency [JPMJCE1302]; Joint Research Costs for the Department of Vegetable Life Science from Kagome Co., Ltd.	"Center for Innovation Program" of the Japan Science and Technology Agency; Joint Research Costs for the Department of Vegetable Life Science from Kagome Co., Ltd.	This work was supported by "Center for Innovation Program" of the Japan Science and Technology Agency Grant Number JPMJCE1302 (https://projectdb.jst.go.jp/grant/JST-PROJECT-13423993/) and Joint Research Costs for the Department of Vegetable Life Science from Kagome Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Kagome Co., Ltd. provided support in the form of salaries for authors [SS, YU and HS] and the research costs as the Joint Research Costs, but did not have any additional roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. SS: Sunao Shimizu, YU: Yusuke Ushida, HS: Hiroyuki Suganuma.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arefin S, 2020, CLIN CHIM ACTA, V505, P108, DOI 10.1016/j.cca.2020.02.026; Avolio A, 2013, PULSE, V1, P14, DOI 10.1159/000348620; Barona J, 2012, NUTRIENTS, V4, P1015, DOI 10.3390/nu4081015; Bell SP, 2014, PROG CARDIOVASC DIS, V57, P197, DOI 10.1016/j.pcad.2014.08.001; Benetos A, 2002, CIRCULATION, V105, P1202, DOI 10.1161/hc1002.105135; BIX HP, 1978, B CONCERN ASIA SCHOL, V10, P18, DOI 10.1080/14672715.1978.10409079; Cho HY, 2015, FREE RADICAL BIO MED, V88, P362, DOI 10.1016/j.freeradbiomed.2015.06.012; Conti V, 2015, AGING CLIN EXP RES, V27, P547, DOI 10.1007/s40520-015-0357-9; Costantino S, 2016, J PHYSIOL-LONDON, V594, P2061, DOI 10.1113/JP270538; Delanaye P, 2017, NEPHRON, V136, P302, DOI 10.1159/000469669; Di Angelantonio E, 2019, LANCET GLOB HEALTH, V7, pE1332, DOI 10.1016/S2214-109X(19)30318-3; Gounden V., 2020, RENAL FUNCTION TESTS; Gounder SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045697; Harada N, 2012, FREE RADICAL BIO MED, V53, P2256, DOI 10.1016/j.freeradbiomed.2012.10.001; Hartikainen JM, 2012, CANCER RES, V72, P5537, DOI 10.1158/0008-5472.CAN-12-1474; Heiss EH, 2009, J BIOL CHEM, V284, P31579, DOI 10.1074/jbc.M109.009175; Honkura Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19329; Itabashi C, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00651; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kang Dongchon, 2013, Nihon Naika Gakkai Zasshi, V102, P3088; Karan A, 2020, PHARMACOL RES, V153, DOI 10.1016/j.phrs.2019.104601; Kawai Y, 2015, J HUM GENET, V60, P581, DOI 10.1038/jhg.2015.68; Kim S, 2020, FREE RADICAL BIO MED, V150, P161, DOI 10.1016/j.freeradbiomed.2020.02.017; Kloska D, 2019, VASC PHARMACOL, V112, P42, DOI 10.1016/j.vph.2018.08.009; Kubben N, 2016, CELL, V165, P1361, DOI 10.1016/j.cell.2016.05.017; Kunnas T, 2016, INT J MED SCI, V13, P325, DOI 10.7150/ijms.14849; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; Masuko H, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-97; Matsuzaka M, 2008, LUMINESCENCE, V23, P132, DOI 10.1002/bio.1022; McNamara DJ, 2000, BBA-MOL CELL BIOL L, V1529, P310, DOI 10.1016/S1388-1981(00)00156-6; Mimura J, 2015, FREE RADICAL BIO MED, V88, P221, DOI 10.1016/j.freeradbiomed.2015.06.019; Nagasaki M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9018; Niu N, 2019, TRENDS PHARMACOL SCI, V40, P253, DOI 10.1016/j.tips.2019.02.004; O'Mahony DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051104; Okada Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03274-0; Okano Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073794; Papamichael CM, 2000, AM J CARDIOL, V86, P615, DOI 10.1016/S0002-9149(00)01038-9; POOT M, 1991, MUTAT RES, V256, P177, DOI 10.1016/0921-8734(91)90010-9; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Safdar A, 2010, FREE RADICAL BIO MED, V49, P1487, DOI 10.1016/j.freeradbiomed.2010.08.010; Shimoyama Y, 2014, INT J MED SCI, V11, P726, DOI 10.7150/ijms.8590; Shimoyama Y, 2014, NAGOYA J MED SCI, V76, P113; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Suzuki T, 2013, MOL CELL BIOL, V33, P2402, DOI 10.1128/MCB.00065-13; Tadaka S, 2018, NUCLEIC ACIDS RES, V46, pD551, DOI 10.1093/nar/gkx978; Ungvari I, 2012, J COMMUN GENET, V3, P25, DOI 10.1007/s12687-011-0075-8; Ungvari Z, 2019, GEROSCIENCE, V41, P727, DOI 10.1007/s11357-019-00107-w; Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P866, DOI 10.1093/gerona/glr092; Yamamoto T, 2004, BIOCHEM BIOPH RES CO, V321, P72, DOI 10.1016/j.bbrc.2004.06.112	54	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0236834	10.1371/journal.pone.0236834	http://dx.doi.org/10.1371/journal.pone.0236834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780748	gold, Green Published			2022-12-26	WOS:000562664700003
J	Ustinova, M; Ansone, L; Silamikelis, I; Rovite, V; Elbere, I; Silamikele, L; Kalnina, I; Fridmanis, D; Sokolovska, J; Konrade, I; Pirags, V; Klovins, J				Ustinova, Monta; Ansone, Laura; Silamikelis, Ivars; Rovite, Vita; Elbere, Ilze; Silamikele, Laila; Kalnina, Ineta; Fridmanis, Davids; Sokolovska, Jelizaveta; Konrade, Ilze; Pirags, Valdis; Klovins, Janis			Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response	PLOS ONE			English	Article							INSULIN; CANCER; METASTASIS; PLASMA; LIVER; SATB1; DRUG	Metformin, a biguanide agent, is the first-line treatment for type 2 diabetes mellitus due to its glucose-lowering effect. Despite its wide application in the treatment of multiple health conditions, the glycemic response to metformin is highly variable, emphasizing the need for reliable biomarkers. We chose the RNA-Seq-based comparative transcriptomics approach to evaluate the systemic effect of metformin and highlight potential predictive biomarkers of metformin response in drug-naive volunteers with type 2 diabetesin vivo. The longitudinal blood-derived transcriptome analysis revealed metformin-induced differential expression of novel and previously described genes involved in cholesterol homeostasis (SLC46A1andLRP1), cancer development(CYP1B1,STAB1,CCR2,TMEM176B), and immune responses (CD14,CD163) after administration of metformin for three months. We demonstrate for the first time a transcriptome-based molecular discrimination between metformin responders (delta HbA1c >= 1% or 12.6 mmol/mol) and non-responders (delta HbA1c < 1% or 12.6 mmol/mol), that is determined by expression levels of 56 genes, explaining 13.9% of the variance in the therapeutic efficacy of the drug. Moreover, we found a significant upregulation ofIRS2gene (log(2)FC 0.89) in responders compared to non-responders before the use of metformin. Finally, we provide evidence for the mitochondrial respiratory complex I as one of the factors related to the high variability of the therapeutic response to metformin in patients with type 2 diabetes mellitus.	[Ustinova, Monta; Ansone, Laura; Silamikelis, Ivars; Rovite, Vita; Elbere, Ilze; Silamikele, Laila; Kalnina, Ineta; Fridmanis, Davids; Konrade, Ilze; Pirags, Valdis; Klovins, Janis] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Sokolovska, Jelizaveta; Pirags, Valdis] Univ Latvia, Fac Med, Riga, Latvia; [Konrade, Ilze] Riga Stradins Univ, Fac Med, Riga, Latvia	Latvian Biomedical Research & Study Centre; University of Latvia; Riga Stradins University	Klovins, J (corresponding author), Latvian Biomed Res & Study Ctr, Riga, Latvia.	Klovins@biomed.lu.lv	Fridmanis, Davids/I-3292-2017; Kalnina, Ineta/AAY-9281-2020; Klovins, Janis/C-5695-2011	Fridmanis, Davids/0000-0003-0310-0448; Elbere, Ilze/0000-0003-4381-885X; Silamikelis, Ivars/0000-0002-7932-1047; Sokolovska, Jelizaveta/0000-0003-0448-8229; Klovins, Janis/0000-0001-8362-5505	European Regional Development Fund [1.1.1.1/16/A/091]	European Regional Development Fund(European Commission)	The study was supported by the European Regional Development Fund under the project "Investigation of interplay between multiple determinants influencing response to metformin: search for reliable predictors for efficacy of type 2 diabete therapy"(Project No.: 1.1.1.1/16/A/091, https://ec.europa.eu/regional_policy/en/funding/erdf/) to JK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrzejewski S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-12; Asiedu MK, 2018, BASIC CLIN PHARMACOL, V122, P214, DOI 10.1111/bcpt.12898; Athreya AP, 2017, ONCOTARGET, V8, P27199, DOI 10.18632/oncotarget.16109; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Chawla Aastha, 2016, Indian J Endocrinol Metab, V20, P546, DOI 10.4103/2230-8210.183480; Clifford AJ, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-66; Cook MN, 2007, DIABETIC MED, V24, P350, DOI 10.1111/j.1464-5491.2007.02078.x; Cuajungco MP, 2012, ACTA HISTOCHEM, V114, P705, DOI 10.1016/j.acthis.2011.12.006; DeAngelis AM, 2008, DIABETES, V57, P2296, DOI 10.2337/db08-0379; Ding L, 2015, ONCOTARGET, V6, P36441, DOI 10.18632/oncotarget.5541; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Elbere I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204317; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Garber AJ, 1997, AM J MED, V103, P491, DOI 10.1016/S0002-9343(97)00254-4; Geeleher P, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r47; Geerling JJ, 2014, DIABETES, V63, P880, DOI 10.2337/db13-0194; Gillespie ZE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41839-1; Gunton JE, 2003, J CLIN ENDOCR METAB, V88, P1323, DOI 10.1210/jc.2002-021394; Holman N, 2015, DIABETIC MED, V32, P1119, DOI 10.1111/dme.12791; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Hwang SH, 2019, CANCER SCI, V110, P1256, DOI 10.1111/cas.13952; Jung J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18082-7; Kashi Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151543; Kawarabayashi R, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/6549242; Lashen H, 2010, THER ADV ENDOCRINOL, V1, P117, DOI 10.1177/2042018810380215; Laustriat D, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.35; Law Charity W, 2016, F1000Res, V5, DOI 10.12688/f1000research.9005.3; Lee SH, 2013, BMB REP, V46, P181, DOI 10.5483/BMBRep.2013.46.4.033; Luizon MR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006449; Do MT, 2014, TOXICOL APPL PHARM, V280, P138, DOI 10.1016/j.taap.2014.07.021; Mir R, 2012, CURR DRUG TARGETS, V13, P1603, DOI 10.2174/138945012803530008; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Padilla J, 2017, EXP BIOL MED, V242, P617, DOI 10.1177/1535370216689825; Rashid M, 2019, PAK J MED SCI, V35, P71, DOI 10.12669/pjms.35.1.100; Robert F, 2003, DIABETES METAB, V29, P279, DOI 10.1016/S1262-3636(07)70037-X; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Rotermund C, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00400; Rovite V, 2018, J EPIDEMIOL, V28, P353, DOI 10.2188/jea.JE20170079; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Sambol NC, 1996, J CLIN PHARMACOL, V36, P1012, DOI 10.1177/009127009603601105; Segovia M, 2019, CANCER CELL, V35, P767, DOI 10.1016/j.ccell.2019.04.003; Shikata E, 2007, J HUM GENET, V52, P117, DOI 10.1007/s10038-006-0087-0; Tsuei AC, 2012, CELL STRESS CHAPERON, V17, P23, DOI 10.1007/s12192-011-0282-6; Tu W, 2012, LIVER INT, V32, P1064, DOI 10.1111/j.1478-3231.2012.02815.x; Ustinova M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224835; Vallianou NG, 2019, HORM-INT J ENDOCRINO, V18, P141, DOI 10.1007/s42000-019-00093-w; Verbist B, 2015, DRUG DISCOV TODAY, V20, P505, DOI 10.1016/j.drudis.2014.12.014; Wang QY, 2018, INT J GENOMICS, V2018, DOI 10.1155/2018/9469670; Whang A, 2019, EBIOMEDICINE, V39, P591, DOI 10.1016/j.ebiom.2018.11.046; Xu H, 2016, J ENDOCRINOL, V229, P133, DOI 10.1530/JOE-15-0409; Yang X, 2017, BBA-MOL BASIS DIS, V1863, P1984, DOI 10.1016/j.bbadis.2016.09.019; Yu BX, 2020, BIOCHEM BIOPH RES CO, V522, P838, DOI 10.1016/j.bbrc.2019.11.181; Zhou XB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku310; Zi FM, 2018, ONCOL LETT, V15, P683, DOI 10.3892/ol.2017.7412	58	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237400	10.1371/journal.pone.0237400	http://dx.doi.org/10.1371/journal.pone.0237400			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780768	gold, Green Published			2022-12-26	WOS:000562664700011
J	Zhang, AD; Zhu, ZW; Shang, J; Zhang, SM; Shen, HB; Wu, XX; Zha, DS				Zhang, Aidong; Zhu, Zongwen; Shang, Jing; Zhang, Shengmei; Shen, Haibin; Wu, Xuexia; Zha, Dingshi			Transcriptome profiling and gene expression analyses of eggplant (Solanum melongena L.) under heat stress	PLOS ONE			English	Article							RNA-SEQ EXPERIMENTS; SHOCK PROTEINS; CONFERS HEAT; TOLERANCE; ARABIDOPSIS; DROUGHT; PLANTS; CHAPERONES; RESPONSES; SEQUENCE	Global warming induces heat stress in eggplant, seriously affecting its quality and yield. The response to heat stress is a complex regulatory process; however, the exact mechanism in eggplant is unknown. We analyzed the transcriptome of eggplant under different high-temperature treatments using RNA-Seq technology. Three libraries treated at high temperatures were generated and sequenced. There were 40,733,667, 40,833,852, and 40,301,285 clean reads with 83.98%, 79.69%, and 84.42% of sequences mapped to the eggplant reference genome in groups exposed to 28 degrees C (CK), 38 degrees C (T38), and 43 degrees C (T43), respectively. There were 3,067 and 1,456 DEGs in T38 vs CK and T43 vs CK groups, respectively. In these two DEG groups, 315 and 342 genes were up- and down-regulated, respectively, in common. Differential expression patterns of DEGs in antioxidant enzyme systems, detoxication, phytohormones, and transcription factors under heat stress were investigated. We screened heat stress-related genes for further validation by qRT-PCR. Regulation mechanisms may differ under different temperature treatments, in which heat shock proteins and heat stress transcription factors play vital roles. These results provide insight into the molecular mechanisms of the heat stress response in eggplant and may be useful in crop breeding.	[Zhang, Aidong; Zhu, Zongwen; Shen, Haibin; Wu, Xuexia; Zha, Dingshi] Shanghai Acad Agr Sci, Hort Res Inst, Shanghai Key Lab Protected Hort Technol, Shanghai, Peoples R China; [Shang, Jing] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Zhang, Shengmei] Nanjing Agr Univ, Coll Hort, Nanjing, Peoples R China	Shanghai Academy of Agricultural Sciences; Shanghai Ocean University; Nanjing Agricultural University	Wu, XX; Zha, DS (corresponding author), Shanghai Acad Agr Sci, Hort Res Inst, Shanghai Key Lab Protected Hort Technol, Shanghai, Peoples R China.	wuxuexiarose@sohu.com; dingshizha@sohu.com			National Key Technology RD Program [2017YFD0101904]; Agricultural Committee Basic Project [6-2-3]; China Agriculture Research System [CARS-25]; Shanghai Academy of Agricultural Sciences "Excellent" Team Building Plan Project [20170106]	National Key Technology RD Program(National Key Technology R&D Program); Agricultural Committee Basic Project; China Agriculture Research System; Shanghai Academy of Agricultural Sciences "Excellent" Team Building Plan Project	This research was financially supported by grants from National Key Technology R&D Program during the 13th Five-Year Plan Period (2017YFD0101904), Agricultural Committee Basic Project (Shanghai Agricultural word (2015) No 6-2-3), China Agriculture Research System (CARS-25) and Shanghai Academy of Agricultural Sciences "Excellent" Team Building Plan Project (20170106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Whaibi Mohamed H., 2011, Journal of King Saud University Science, V23, P139, DOI 10.1016/j.jksus.2010.06.022; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bharti K, 2004, PLANT CELL, V16, P1521, DOI 10.1105/tpc.019927; Bita CE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-384; Carra S, 2017, CELL STRESS CHAPERON, V22, P601, DOI 10.1007/s12192-017-0787-8; Chandler JW, 2004, J EXP BOT, V55, P1433, DOI 10.1093/jxb/erh131; Chen H, 2010, BIOCHEM BIOPH RES CO, V401, P238, DOI 10.1016/j.bbrc.2010.09.038; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cortina C, 2005, PLANT SCI, V169, P75, DOI 10.1016/j.plantsci.2005.02.026; Dobra J, 2010, J PLANT PHYSIOL, V167, P1360, DOI 10.1016/j.jplph.2010.05.013; Du XP, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1400-8; Fang YJ, 2015, J EXP BOT, V66, P6803, DOI 10.1093/jxb/erv386; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Garcia-Seco D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1198-1; Guo WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135667; Hahn A, 2011, PLANT CELL, V23, P741, DOI 10.1105/tpc.110.076018; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; He B, 2017, S AFR J BOT, V112, P203, DOI 10.1016/j.sajb.2017.05.032; Higashi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10533; Hirakawa H, 2014, DNA RES, V21, P649, DOI 10.1093/dnares/dsu027; Hong SW, 2001, PLANT J, V27, P25, DOI 10.1046/j.1365-313x.2001.01066.x; Hwang JE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28552-1; Ikeda M, 2011, PLANT PHYSIOL, V157, P1243, DOI 10.1104/pp.111.179036; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Li Li, 2015, Acta Ecologica Sinica - International Journal, V35, P196, DOI 10.1016/j.chnaes.2015.09.006; Liu XH, 2020, PLANT BIOTECHNOL J, V18, P1317, DOI 10.1111/pbi.13297; Mishra RC, 2016, CRIT REV BIOTECHNOL, V36, P862, DOI 10.3109/07388551.2015.1051942; Mishra SK, 2002, GENE DEV, V16, P1555, DOI 10.1101/gad.228802; Mittler R, 2012, TRENDS BIOCHEM SCI, V37, P118, DOI 10.1016/j.tibs.2011.11.007; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Peck SC., 1992, ENERG J, V13, P55, DOI [10.5547/ISSN0195-6574-EJ-Vol13-No1-4, DOI 10.5547/ISSN0195-6574-EJ-Vol13-No1-4]; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Qi XH, 2012, GENOMICS, V99, P160, DOI 10.1016/j.ygeno.2011.12.008; Qian YX, 2019, GENE, V692, P68, DOI 10.1016/j.gene.2018.12.062; Rai AN, 2013, MOL BIOL REP, V40, P6429, DOI 10.1007/s11033-013-2757-2; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Rojas A, 2002, PLANT PHYSIOL, V129, P1207, DOI 10.1104/pp.010927; Rong W, 2014, PLANT BIOTECHNOL J, V12, P468, DOI 10.1111/pbi.12153; Saidi Y, 2009, PLANT CELL, V21, P2829, DOI 10.1105/tpc.108.065318; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Schramm F, 2008, PLANT J, V53, P264, DOI 10.1111/j.1365-313X.2007.03334.x; Sedaghatmehr M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12439; Sun LP, 2012, PLANT CELL REP, V31, P1473, DOI 10.1007/s00299-012-1262-8; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tutar O, 2017, MAR ENVIRON RES, V132, P94, DOI 10.1016/j.marenvres.2017.10.011; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wang G, 2012, ACTA PHYSIOL PLANT, V34, P107, DOI 10.1007/s11738-011-0809-6; Wang LB, 2018, COMPUT BIOL CHEM, V77, P413, DOI 10.1016/j.compbiolchem.2018.09.012; Wang M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040883; Waseem M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30468-9; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Xue Y, 2010, BIOL PLANTARUM, V54, P105, DOI 10.1007/s10535-010-0015-1; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshida T, 2011, MOL GENET GENOMICS, V286, P321, DOI 10.1007/s00438-011-0647-7; Zhang AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168367; Zhang SM, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1960-2; Zhang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049652; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	63	7	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0236980	10.1371/journal.pone.0236980	http://dx.doi.org/10.1371/journal.pone.0236980			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780737	Green Published, gold			2022-12-26	WOS:000562664700035
J	Tumuhamye, J; Sommerfelt, H; Bwanga, F; Ndeezi, G; Mukunya, D; Napyo, A; Nankabirwa, V; Tumwine, JK				Tumuhamye, Josephine; Sommerfelt, Halvor; Bwanga, Freddie; Ndeezi, Grace; Mukunya, David; Napyo, Agnes; Nankabirwa, Victoria; Tumwine, James K.			Neonatal sepsis at Mulago national referral hospital in Uganda: Etiology, antimicrobial resistance, associated factors and case fatality risk	PLOS ONE			English	Article							YOUNG INFANTS; ENTEROBACTERIACEAE; INFECTIONS; ANTIBIOTICS; ILLNESS	Background Sepsis is the third most common cause of death among neonates, with about 225,000 newborns dying every year globally. Data concerning the microbial etiology of neonatal sepsis and antimicrobial resistance profiles of its causative agents are necessary to inform targeted and effective treatment and prevention strategies. Objective To determine the proportion of newborns with symptoms and signs of sepsis who had a positive blood culture, its bacterial etiology, the antimicrobial resistance patterns as well as the factors associated with culture-positivity and case fatality at Mulago national referral hospital in Uganda. Methods We conducted a cross-sectional study among 359 neonates with symptoms and signs of sepsis who presented to the pediatric emergency care unit of Mulago national referral hospital from mid-January to end of December 2018. We performed blood culture and antimicrobial susceptibility testing, and conducted polymerase chain reaction to identify methicillin-resistantStaphylococcus aureus(MRSA) isolates. We used multivariable logistic regression to estimate the association between potential risk factors and culture-positive neonatal sepsis. Findings Of the 359 neonates recruited, 46 (12.8%; 95% CI 9.5%, 16.7%) had a positive blood culture. The predominant isolated bacteria wereStaphylococcus aureusin 29 (63.0%),Escherichia coliin seven (15.2%), andKlebsiella pneumoniaein five (10.9%). Of the 46 pathogens, 73.9% were resistant to ampicillin, 23.9% to gentamicin and 8.7% to ceftriaxone. We isolated MRSA from the blood specimens of 19 (5.3%) of the 359 neonates, while 3 (0.8%) grew extended spectrum beta lactamase producers. The case fatality risk among neonates with neonatal sepsis was 9.5% (95% CI: 6.6%, 13.0%). Cesarean section delivery was strongly associated with culture-positive sepsis (adjusted odds ratio 3.45, 95% CI: 1.2, 10.1). Conclusion One in eight neonates with clinical signs of sepsis grew a likely causative bacterial pathogen.S.aureuswas the main pathogen isolated and a third of these isolates were MRSA. A significant proportion of the isolated bacterial pathogens were resistant to the first and second line antibiotics used for the treatment of neonatal sepsis. There is need to revisit the current treatment guidelines for neonatal sepsis.	[Tumuhamye, Josephine; Sommerfelt, Halvor; Mukunya, David; Napyo, Agnes; Nankabirwa, Victoria] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth CISMAC, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Bwanga, Freddie] Makerere Univ, Dept Med Microbiol, Kampala, Uganda; [Ndeezi, Grace; Tumwine, James K.] Makerere Univ, Dept Pediat & Child Hlth, Kampala, Uganda; [Napyo, Agnes] Busitema Univ, Dept Publ Hlth, Mbale, Uganda; [Nankabirwa, Victoria] Makerere Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Kampala, Uganda	University of Bergen; Makerere University; Makerere University; Makerere University	Tumuhamye, J (corresponding author), Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth CISMAC, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	tphynne@gmail.com	Sommerfelt, Halvor/ABD-3552-2020; Mukunya, David/ABD-2958-2020	Sommerfelt, Halvor/0000-0002-5670-9786; Mukunya, David/0000-0002-3892-9777	Norwegian programme for capacity development in higher education and research for development (NORHED) through the Survival Pluss project [UGA-13-0030]; Centre for Intervention Science in Maternal and Child Health (CISMAC) - Research Council of Norway through its Centres of Excellence scheme and the University of Bergen (UiB), Norway [223269]	Norwegian programme for capacity development in higher education and research for development (NORHED) through the Survival Pluss project; Centre for Intervention Science in Maternal and Child Health (CISMAC) - Research Council of Norway through its Centres of Excellence scheme and the University of Bergen (UiB), Norway	This work was funded by the Norwegian programme for capacity development in higher education and research for development (NORHED) through the Survival Pluss project (Project Number; UGA-13-0030). JKT received the grant. URL: https://norad.no/en/front/funding/norhed/projects/norhed-project-in-south-sudan-and-uganda/. The NORHED played no role in design, analysis or interpretation of the study findings. The contribution by VN and HS was supported by the Centre for Intervention Science in Maternal and Child Health (CISMAC; project number 223269), which is funded by the Research Council of Norway through its Centres of Excellence scheme and the University of Bergen (UiB), Norway.	Aswinn W., 2006, KONEMANS COLOR ATLAS, V6 th; Baqui AH, 2018, LANCET GLOB HEALTH, V6, pE1297, DOI 10.1016/S2214-109X(18)30385-1; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Chaurasia S, 2016, LANCET GLOB HEALTH, V4, pE752, DOI 10.1016/S2214-109X(16)30148-6; Clinical and Laboratory Standards Institute, 2022, M100 CLSI S; Cohen D, 2019, CLIN RHEUMATOLOGY; Downie L, 2013, ARCH DIS CHILD, V98, P146, DOI 10.1136/archdischild-2012-302033; Edmond K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000213; Eibach D, 2016, INT J MED MICROBIOL, V306, P249, DOI 10.1016/j.ijmm.2016.05.006; El-Din EMRS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/509484; Flokas ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171216; Garcia C, 2016, AM J TROP MED HYG, V94, P285, DOI 10.4269/ajtmh.15-0373; Geneva; W, 2005, INTEGRATED MANAGEMEN; Geyesus T, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0892-y; Giannoni E, 2018, J PEDIATR-US, V201, P106, DOI 10.1016/j.jpeds.2018.05.048; Giriyapur Ravi S, 2011, J Lab Physicians, V3, P33, DOI 10.4103/0974-2727.78561; John Bua, 2015, BMC Res Notes, V8, P339, DOI 10.1186/s13104-015-1308-4; Kabwe M, 2016, PEDIATR INFECT DIS J, V35, pE191, DOI 10.1097/INF.0000000000001154; Kayange N, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-39; Kayom VO, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1323-4; Khalil N, 2020, ARCH DIS CHILDHOOD; Lever A, 2007, BMJ-BRIT MED J, V335, P879, DOI 10.1136/bmj.39346.495880.AE; Liang L, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00277; M'Zali FH, 2000, J ANTIMICROB CHEMOTH, V45, P881, DOI 10.1093/jac/45.6.881; Marando R, 2018, INT J MED MICROBIOL, V308, P803, DOI 10.1016/j.ijmm.2018.06.012; Masanja PP, 2019, J TROPICAL PEDIAT; McClure JA, 2006, J CLIN MICROBIOL, V44, P1141, DOI 10.1128/JCM.44.3.1141-1144.2006; Mhada TV, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-904; Mo Health, 2016, UG CLIN GUID; Mugalu J, 2006, Afr Health Sci, V6, P120; Mukonzo JK, 2013, J MULTIDISCIP HEALTH, V6, P303, DOI 10.2147/JMDH.S49075; Murthy S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215683; Musoke RN, 2000, J TROP PEDIATRICS, V46, P86, DOI 10.1093/tropej/46.2.86; Nelson Edwin, 2014, BMC Res Notes, V7, P279, DOI 10.1186/1756-0500-7-279; Nwadioha S I, 2011, Niger Postgrad Med J, V18, P130; Okomo U, 2019, LANCET INFECT DIS; Palatnik A, 2019, J PERINATOL, V39, P949, DOI 10.1038/s41372-019-0395-9; Pius Simon, 2016, Niger Postgrad Med J, V23, P146, DOI 10.4103/1117-1936.190340; Ruppe E, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0061-0; Schiller R, 2018, LANCET CHILD ADOLESC, V2, P281, DOI 10.1016/S2352-4642(17)30180-3; Schrag SJ, 2012, PEDIATR INFECT DIS J, V31, P821, DOI 10.1097/INF.0b013e31825c4b5a; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; Stryjewski ME, 2014, CLIN INFECT DIS, V58, pS10, DOI 10.1093/cid/cit613; Talbert AWA, 2010, PEDIATR INFECT DIS J, V29, P945, DOI 10.1097/INF.0b013e3181dfca8c; Uganda Bureau of Statistcs (UBOS) and ICF, 2017, UG DEM HLTH SURV 201; Uzun B, 2014, MIKROBIYOL BUL, V48, P469, DOI 10.5578/mb.7748; Vergnano S, 2005, Arch Dis Child Fetal Neonatal Ed, V90, pF220, DOI 10.1136/adc.2002.022863; Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0; Waters Donald, 2011, J Glob Health, V1, P154; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X; Zaidi AKM, 2009, PEDIATR INFECT DIS J, V28, pS10, DOI 10.1097/INF.0b013e3181958769	51	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237085	10.1371/journal.pone.0237085	http://dx.doi.org/10.1371/journal.pone.0237085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776958	Green Published, gold			2022-12-26	WOS:000561393800024
J	Nardone, AL; Casey, JA; Rudolph, KE; Karasek, D; Mujahid, M; Morello-Frosch, R				Nardone, Anthony L.; Casey, Joan A.; Rudolph, Kara E.; Karasek, Deborah; Mujahid, Mahasin; Morello-Frosch, Rachel			Associations between historical redlining and birth outcomes from 2006 through 2015 in California	PLOS ONE			English	Article							OWNERS LOAN CORPORATION; NEW-YORK-CITY; RESIDENTIAL SECURITY; STRUCTURAL RACISM; PRETERM BIRTH; WEIGHT; HEALTH; RISK; GENTRIFICATION; DISPARITIES	Background Despite being one of the wealthiest nations, disparities in adverse birth outcomes persist across racial and ethnic lines in the United States. We studied the association between historical redlining and preterm birth, low birth weight (LBW), small-for-gestational age (SGA), and perinatal mortality over a ten-year period (2006-2015) in Los Angeles, Oakland, and San Francisco, California. Methods We used birth outcomes data from the California Office of Statewide Health Planning and Development between January 1, 2006 and December 31, 2015. Home Owners' Loan Corporation (HOLC) Security Maps developed in the 1930s assigned neighborhoods one of four grades that pertained to perceived investment risk of borrowers from that neighborhood: green (grade A) were considered "Best", blue (grade B) "Still Desirable", yellow (grade C) "Definitely Declining", and red (grade D, hence the term "redlining") "Hazardous". Geocoded residential addresses at the time of birth were superimposed on HOLC Security Maps to assign each birth a HOLC grade. We adjusted for potential confounders present at the time of Security Map creation by assigning HOLC polygons areal-weighted 1940s Census measures. We then employed propensity score matching methods to estimate the association of historical HOLC grades on current birth outcomes. Because tracts graded A had almost no propensity of receiving grade C or D and because grade B tracts had low propensity of receiving grade D, we examined birth outcomes in the three following comparisons: B vs. A, C vs. B, and D vs. C. Results The prevalence of preterm birth, SGA and mortality tended to be higher in worse HOLC grades, while the prevalence of LBW varied across grades. Overall odds of mortality and preterm birth increased as HOLC grade worsened. Propensity score matching balanced 1940s census measures across contrasting groups. Logistic regression models revealed significantly elevated odds of preterm birth (odds ratio (OR): 1.02, 95% confidence interval (CI): 1.00-1.05), and SGA (OR: 1.03, 95% CI: 1.00-1.05) in the C vs. B comparison and significantly reduced odds of preterm birth (OR: 0.93, 95% CI: 0.91-0.95), LBW (OR: 0.94-95% CI: 0.92-0.97), and SGA (OR: 0.94, 95% CI: 0.92-0.96) in the D vs. C comparison. Results differed by metropolitan area and maternal race. Conclusion Similar to prior studies on redlining, we found that worsening HOLC grade was associated with adverse birth outcomes, although this relationship was less clear after propensity score matching and stratifying by metropolitan area. Higher odds of preterm birth and SGA in grade C versus grade B neighborhoods may be caused by higher-stress environments, racial segregation, and lack of access to resources, while lower odds of preterm birth, SGA, and LBW in grade D versus grade C neighborhoods may due to population shifts in those neighborhoods related to gentrification.	[Nardone, Anthony L.] Univ Calif Berkeley, Univ Calif San Francisco Joint Med Program, Berkeley, CA 94720 USA; [Casey, Joan A.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Rudolph, Kara E.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Karasek, Deborah] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Mujahid, Mahasin; Morello-Frosch, Rachel] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Morello-Frosch, Rachel] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA USA	University of California System; University of California Berkeley; Columbia University; Columbia University; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Nardone, AL (corresponding author), Univ Calif Berkeley, Univ Calif San Francisco Joint Med Program, Berkeley, CA 94720 USA.; Morello-Frosch, R (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA USA.	Anthony.nardone@ucsf.edu; rmf@berkeley.edu		Morello-Frosch, Rachel/0000-0003-1153-7287; Nardone, Anthony/0000-0003-0789-0774	National Institutes of Health Environmental influences on Child Health Outcomes (ECHO) program [UG30D023272, UH30D023272]; UC Berkeley Superfund Research Program [P42ES004705]; Transdisciplinary Postdoctoral Fellowship of the Preterm Birth Initiative at UCSF; National Institutes of Environmental Health Sciences [R00 ES027023, P30 ES009089]	National Institutes of Health Environmental influences on Child Health Outcomes (ECHO) program; UC Berkeley Superfund Research Program; Transdisciplinary Postdoctoral Fellowship of the Preterm Birth Initiative at UCSF; National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	RMF was supported by the National Institutes of Health Environmental influences on Child Health Outcomes (ECHO) program (UG30D023272 and UH30D023272) and the UC Berkeley Superfund Research Program (P42ES004705). DK was supported by the Transdisciplinary Postdoctoral Fellowship of the Preterm Birth Initiative at UCSF. JAC was supported by the National Institutes of Environmental Health Sciences R00 ES027023 and P30 ES009089.	[Anonymous], EFFECTS 1930S REDLIN; Badger Emily, 2019, NEW YORK TIMES; Benmarhnia T, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/EHP490, 10.1289/ehp490]; Bhatia N, 2015, INT J ENV RES PUB HE, V12, P9427, DOI 10.3390/ijerph120809427; Bivand R., 2019, INTERFACE GEOMETRY E; Bond JC, 2019, J EPIDEMIOL COMMUN H, V73, P913, DOI 10.1136/jech-2018-211937; Buka SL, 2003, AM J EPIDEMIOL, V157, P1, DOI 10.1093/aje/kwf170; Burris HH, 2017, SEMIN PERINATOL, V41, P360, DOI 10.1053/j.semperi.2017.07.002; Carmichael SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182862; Casey JA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121546; Chambers BD, 2018, J RACIAL ETHN HEALTH, V5, P966, DOI 10.1007/s40615-017-0444-z; Chambers BD, 2019, J URBAN HEALTH, V96, P159, DOI 10.1007/s11524-018-0272-4; Crossney KB, 2005, URBAN GEOGR, V26, P707, DOI 10.2747/0272-3638.26.8.707; Esenwa C, 2018, STROKE, V49, P465, DOI 10.1161/STROKEAHA.117.020169; Federal Housing Administration, 1936, UND MAN, P226; Flores MES, 2012, WOMEN HEALTH ISS, V22, pE501, DOI 10.1016/j.whi.2012.07.005; Gibbons J, J URBAN HEAL B NEW Y, V93; Gibbons J, 2019, SSM-POPUL HLTH, V7, DOI 10.1016/j.ssmph.2019.100358; Greer J, 2013, J URBAN HIST, V39, P275, DOI 10.1177/0096144212436724; Hiller A., 2003, J PLAN HIST, V2, P3, DOI 10.1177/1538513202239694; Hillier AE, 2003, J URBAN HIST, V29, P394, DOI 10.1177/0096144203029004002; Ho DE, 2011, J STAT SOFTW, V42; Hoffman JS, 2020, CLIMATE, V8, DOI 10.3390/cli8010012; Huggins JC, 2017, CITYSCAPE, V19, P267; Huynh M, 2014, J URBAN HEALTH, V91, P211, DOI 10.1007/s11524-013-9823-x; Izenberg JM, 2018, HEALTH PLACE, V52, P188, DOI 10.1016/j.healthplace.2018.06.002; Jackson Kenneth, 1985, CRABGRASS FRONTIER S; Jacoby SF, 2018, SOC SCI MED, V199, P87, DOI 10.1016/j.socscimed.2017.05.038; Kochhar R., 2014, WEALTH INEQUALITY HA; Kramer MR, 2017, SSM-POPUL HLTH, V3, P609, DOI 10.1016/j.ssmph.2017.07.004; Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668; Krieger N, 2020, AM J EPIDEMIOL; Krieger N, 2020, AM J PUBLIC HEALTH, V110, P1046, DOI 10.2105/AJPH.2020.305656; Krieger N, 2012, AM J PUBLIC HEALTH, V102, P936, DOI 10.2105/AJPH.2011.300544; Kwate NOA, 2013, J URBAN HEALTH, V90, P632, DOI 10.1007/s11524-012-9725-3; Ma XG, 2016, MATERN CHILD HLTH J, V20, P187, DOI 10.1007/s10995-015-1818-7; MacDorman M. F., 2015, NATL VITAL STAT REPO, V64, P1; Malat J, 2017, STRESS, V20, P379, DOI 10.1080/10253890.2017.1341871; Manson S., 2017, IPUMS NATL HIST GEOG; Martin JA, 2019, NATL VITAL STAT REP, V68, P8; Massey D.S., 1993, AM APARTHEID SEGREGA; MASSEY DS, 1988, SOC FORCES, V67, P281, DOI 10.2307/2579183; Matoba N, 2019, MATERN CHILD HLTH J, V23, P1251, DOI 10.1007/s10995-019-02765-w; McClure E, 2019, HEALTH PLACE, V55, P9, DOI 10.1016/j.healthplace.2018.10.004; Mehra R, 2017, SOC SCI MED, V191, P237, DOI 10.1016/j.socscimed.2017.09.018; Mendez DD, 2014, ETHNIC HEALTH, V19, P479, DOI 10.1080/13557858.2013.846300; Michney TM, 2019, J URBAN HIST, P1; Mitchell B., 2018, HOLC REDLINING MAPS; Namin S, 2020, SOC SCI MED, V246, DOI 10.1016/j.socscimed.2019.112758; Nardone A, 2020, LANCET PLANET HEAL, P246; Nardone A, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0782-x; Nelson RK, 2019, AM PANOR; Nkansah-Amankra S, 2010, MATERN CHILD HLTH J, V14, P774, DOI 10.1007/s10995-009-0508-8; Osypuk TL, 2010, SOC SCI MED, V70, P550, DOI 10.1016/j.socscimed.2009.10.034; Pasek J., 2018, WEIGHTING WEIGHTED S; Pearl M, 2018, PAEDIATR PERINAT EP, V32, P412, DOI 10.1111/ppe.12482; Rothstein R., 2017, COLOR LAW FORGOTTEN; Salow AD, 2018, ASS NEIGHBORHOOD LEV, DOI [10.1016/j.ajog.2018.01.022, DOI 10.1016/J.AJOG.2018.01.022]; Sanchez-Vaznaugh EV, 2016, MATERN CHILD HLTH J, V20, P1849, DOI 10.1007/s10995-016-1988-y; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Sealy-Jefferson S, 2015, AM J EPIDEMIOL, V182, P485, DOI 10.1093/aje/kwv106; Strutz KL, 2014, AM J PUBLIC HEALTH, V104, pE125, DOI 10.2105/AJPH.2014.301904; Stuart EA, 2008, DEV PSYCHOL, V44, P395, DOI 10.1037/0012-1649.44.2.395; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Talge NM, 2014, PEDIATRICS, V133, P844, DOI 10.1542/peds.2013-3285; Urban Displacement Project, REDL GENTR; van der Laan MJ, 2007, SUPER LEARNER; World Bank, CURR HLTH EXP PER CA; Zhang P, 2019, ECOL LETT, V22, P200, DOI 10.1111/ele.13181	69	46	46	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237241	10.1371/journal.pone.0237241	http://dx.doi.org/10.1371/journal.pone.0237241			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2FE	32764800	gold, Green Published			2022-12-26	WOS:000561029000046
J	Ross, AK; de Almeida, RC; Ramos, YFM; Li, JH; Meulenbelt, I; Guilak, F				Ross, Alison K.; de Almeida, Rodrigo Coutinho; Ramos, Yolande F. M.; Li, Jiehan; Meulenbelt, Ingrid; Guilak, Farshid			The miRNA-mRNA interactome of murine induced pluripotent stem cell-derived chondrocytes in response to inflammatory cytokines	FASEB JOURNAL			English	Article						induced pluripotent stem cell; inflammation; microRNA; RNA-sequencing; tissue engineering	HUMAN ARTICULAR CHONDROCYTES; TISSUE-ENGINEERED CARTILAGE; KNEE OSTEOARTHRITIS; MAMMALIAN MICRORNAS; EXPRESSION; TARGETS; INTERLEUKIN-1; INDUCTION; REDIFFERENTIATION; CHONDROGENESIS	Osteoarthritis (OA) is a degenerative joint disease, and inflammation within an arthritic joint plays a critical role in disease progression. Pro-inflammatory cytokines, specifically IL-1 and TNF-alpha, induce aberrant expression of catabolic and degradative enzymes and inflammatory cytokines in OA and result in a challenging environment for cartilage repair and regeneration. MicroRNAs (miRNAS) are small noncoding RNAs and are important regulatory molecules that act by binding to target messenger RNAs (mRNAs) to reduce protein synthesis and have been implicated in many diseases, including OA. The goal of this study was to understand the mechanisms of miRNA regulation of the transcriptome of tissue-engineered cartilage in response to IL-1 beta and TNF-alpha using an in vitro murine induced pluripotent stem cell (miPSC) model system. We performed miRNA and mRNA sequencing to determine the temporal and dynamic responses of genes to specific inflammatory cytokines as well as miRNAs that are differentially expressed (DE) in response to both cytokines or exclusively to IL-1 beta or TNF-alpha. Through integration of mRNA and miRNA sequencing data, we created networks of miRNA-mRNA interactions which may be controlling the response to inflammatory cytokines. Within the networks, hub miRNAs, miR-29b-3p, miR-17-5p, and miR-20a-5p, were identified. As validation of these findings, we found that delivery of miR-17-5p and miR-20a-5p mimics significantly decreased degradative enzyme activity levels while also decreasing expression of inflammation-related genes in cytokine-treated cells. This study utilized an integrative approach to determine the miRNA interactome controlling the response to inflammatory cytokines and novel mediators of inflammation-driven degradation in tissue-engineered cartilage.	[Ross, Alison K.; Li, Jiehan; Guilak, Farshid] Washington Univ, Dept Orthopaed Surg, Couch Biomed Res Bldg,Room 3121,Campus Box 8233, St Louis, MO 63110 USA; [Ross, Alison K.; Li, Jiehan; Guilak, Farshid] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA; [Ross, Alison K.; Li, Jiehan; Guilak, Farshid] Shriners Hosp Children, St Louis, MO USA; [Ross, Alison K.; Li, Jiehan; Guilak, Farshid] Washington Univ, Ctr Regenerat Med, St Louis, MO 63110 USA; [de Almeida, Rodrigo Coutinho; Ramos, Yolande F. M.; Meulenbelt, Ingrid] Leiden Univ, Dept Biomed Data Sci, Sect Mol Epidemiol, Med Ctr, Leiden, Netherlands	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Guilak, F (corresponding author), Washington Univ, Dept Orthopaed Surg, Couch Biomed Res Bldg,Room 3121,Campus Box 8233, St Louis, MO 63110 USA.	guilak@wustl.edu	Meulenbelt, Ingrid/F-4756-2011; Ramos, Yolande F. M./C-3774-2018	Meulenbelt, Ingrid/0000-0001-7786-7081; Ross, Alison/0000-0003-2563-220X; Ramos, Yolande F. M./0000-0003-1459-413X; Li, Jiehan/0000-0002-0528-5303	Nancy Taylor Foundation for Chronic Diseases; Arthritis Foundation; NIH [AG46927, AG15768, AR76820, P30 AR74992, P30 AR073752]; Philip and Sima Needleman Fellowship for Regenerative Medicine from the Washington University Center of Regenerative Medicine; NSF Graduate Research Fellowship Program [DGE-1745038]; Bioinformatics Research Core at the Washington University Center of Regenerative Medicine	Nancy Taylor Foundation for Chronic Diseases; Arthritis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip and Sima Needleman Fellowship for Regenerative Medicine from the Washington University Center of Regenerative Medicine; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Bioinformatics Research Core at the Washington University Center of Regenerative Medicine	This study was supported in part by the Nancy Taylor Foundation for Chronic Diseases, the Arthritis Foundation, NIH (AG46927, AG15768, AR76820, P30 AR74992, P30 AR073752), the Philip and Sima Needleman Fellowship for Regenerative Medicine from the Washington University Center of Regenerative Medicine, and the NSF Graduate Research Fellowship Program (DGE-1745038). Funding for this project and technical support was also provided by the Bioinformatics Research Core at the Washington University Center of Regenerative Medicine. We sincerely thank Sara Oswald for editorial assistance and Dr Audrey McAlinden for advice and discussion on this study.	Adkar SS, 2017, TRENDS MOL MED, V23, P917, DOI 10.1016/j.molmed.2017.08.002; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Asahara Hiroshi, 2016, J Bone Metab, V23, P121, DOI 10.11005/jbm.2016.23.3.121; Bai XD, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9450240; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bastiaansen-Jenniskens Y., 2017, CARTILAGE, V2, P81, DOI [10.1007/978-3-319-45803-8_5, DOI 10.1007/978-3-319-45803-8_5]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brunger JM, 2017, STEM CELL REP, V8, P1202, DOI 10.1016/j.stemcr.2017.03.022; Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Cisternas MG, 2016, ARTHRIT CARE RES, V68, P574, DOI 10.1002/acr.22721; Cong L, 2017, OSTEOARTHR CARTILAGE, V25, P1362, DOI 10.1016/j.joca.2017.03.012; Crowe N, 2016, OSTEOARTHR CARTILAGE, V24, P534, DOI 10.1016/j.joca.2015.10.002; de Almeida RC, 2019, ANN RHEUM DIS, V78, P270, DOI 10.1136/annrheumdis-2018-213882; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunn W, 2009, ARTHRITIS RHEUM-US, V60, P2333, DOI 10.1002/art.24678; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fioravanti A, 2009, RHEUMATOL INT, V29, P961, DOI 10.1007/s00296-009-0872-0; Fisch KM, 2018, OSTEOARTHR CARTILAGE, V26, P1531, DOI 10.1016/j.joca.2018.07.012; Furman BD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4591; Glass KA, 2014, BIOMATERIALS, V35, P5921, DOI 10.1016/j.biomaterials.2014.03.073; Goldring MB, 2015, CURR OPIN PHARMACOL, V22, P51, DOI 10.1016/j.coph.2015.03.004; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; Grunke M, 2006, ANN RHEUM DIS, V65, P555, DOI 10.1136/ard.2006.053272; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Haseeb A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15388-4; Hong E, 2013, TISSUE ENG PT A, V19, P1015, DOI [10.1089/ten.tea.2012.0055, 10.1089/ten.TEA.2012.0055]; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Kraus VB, 2012, OSTEOARTHR CARTILAGE, V20, P271, DOI 10.1016/j.joca.2011.12.009; Kriegsmann M, 2016, VIRCHOWS ARCH, V469, P93, DOI 10.1007/s00428-016-1939-4; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Le LTT, 2016, J MOL MED, V94, P583, DOI 10.1007/s00109-015-1374-z; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Loeser RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054633; Lofgren M, 2018, RES VET SCI, V118, P466, DOI 10.1016/j.rvsc.2018.04.013; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matthews GL, 2011, EXPERT OPIN EMERG DR, V16, P479, DOI 10.1517/14728214.2011.576670; McAlinden A, 2018, J ORTHOP RES, V36, P33, DOI 10.1002/jor.23822; McAlinden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075012; Meng S, 2019, FOOD CHEM X, V1, DOI 10.1016/j.fochx.2019.100004; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Moutos FT, 2016, P NATL ACAD SCI USA, V113, pE4513, DOI 10.1073/pnas.1601639113; Nakamura Y, 2011, MOL CELL BIOL, V31, P3019, DOI 10.1128/MCB.05178-11; Ousema PH, 2012, BIOMATERIALS, V33, P8967, DOI 10.1016/j.biomaterials.2012.08.045; Philippe L, 2013, ANN RHEUM DIS, V72, P1071, DOI 10.1136/annrheumdis-2012-201654; Philippe L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00070; Ratneswaran A, 2020, CURR OPIN RHEUMATOL, V32, P80, DOI 10.1097/BOR.0000000000000680; Shen J, 2017, CONNECT TISSUE RES, V58, P49, DOI 10.1080/03008207.2016.1208655; Soul J, 2018, ANN RHEUM DIS, V77, P423, DOI 10.1136/annrheumdis-2017-212603; Soyocak A, 2017, GENE, V627, P207, DOI 10.1016/j.gene.2017.06.027; Steinberg J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09335-6; Svala E, 2015, CONNECT TISSUE RES, V56, P315, DOI 10.3109/03008207.2015.1027340; Swingler TE, 2019, CLIN EXP RHEUMATOL, V37, P40; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thysen S, 2015, DIS MODEL MECH, V8, P17, DOI 10.1242/dmm.016881; van den Berg WB, 1999, CLIN EXP RHEUMATOL, V17, pS105; Vicente R, 2016, NAT REV RHEUMATOL, V12, P211, DOI 10.1038/nrrheum.2015.162; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wehling N, 2009, ARTHRITIS RHEUM-US, V60, P801, DOI 10.1002/art.24352; Willard VP, 2014, ARTHRITIS RHEUMATOL, V66, P3062, DOI 10.1002/art.38780; Wilusz RE, 2008, J ORTHOP RES, V26, P504, DOI 10.1002/jor.20538; Yamasaki K, 2009, ARTHRITIS RHEUM-US, V60, P1035, DOI 10.1002/art.24404; Zhang DW, 2015, SCI REP-UK, V5, DOI 10.1038/srep12775	75	9	9	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11546	11561		10.1096/fj.202000889R	http://dx.doi.org/10.1096/fj.202000889R		AUG 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32767602	Green Accepted, Green Published			2022-12-26	WOS:000558272000001
J	Kodaka, N; Nakano, C; Oshio, T; Watanabe, K; Niitsuma, K; Imaizumi, C; Matsuse, H				Kodaka, Norio; Nakano, Chihiro; Oshio, Takeshi; Watanabe, Kayo; Niitsuma, Kumiko; Imaizumi, Chisato; Matsuse, Hiroto			Predictors of radiological aggravations of pulmonary MAC disease	PLOS ONE			English	Article							MYCOBACTERIUM-AVIUM COMPLEX; NONTUBERCULOUS MYCOBACTERIA; CLINICAL-FEATURES; INTRACELLULARE; EPIDEMIOLOGY; TUBERCULOSIS; INFECTIONS	Background and objectives The number of patients with pulmonaryMycobacterium aviumcomplex (MAC) disease is increasing worldwide, especially among middle-aged women and never-smokers. However, little is known about the factors causing exacerbations of pulmonary MAC disease in untreated patients. The aim of the present study was to identify the predictors of radiological aggravations of pulmonary MAC disease. Methods From April 2011 to December 2018, 238 MAC patients at our institute were newly diagnosed with pulmonary MAC disease according to the 2007 American Thoracic Society/Infectious Disease Society guideline. Their medical records were examined retrospectively for their clinical findings. The radiological findings at the time of the diagnosis and 1 year later were evaluated. To identify the predictors of radiological aggravation, multivariable analysis was performed with the data of 167 treatment-naive patients. Results Female, never-smoker, and nodular/bronchiectatic (NB) type were predominant in patients with pulmonary MAC disease. Univariate analysis of data from treatment-naive subjects showed that no lung diseases other than MAC, extensive radiological findings, and a positive acid-fast bacilli (AFB) smear were significantly associated with radiological aggravations. On multivariate analysis, the radiological factor (larger affected area) and absence of other lung disease were significantly associated with radiological aggravations. In particular, the presence of abnormal shadows in more than 3 lobes was significantly associated with radiological aggravations. Conclusions In this study, the presence of extensive radiological findings and the absence of lung diseases other than MAC were predictors of radiological aggravations of treatment-naive pulmonary MAC disease. In particular, the presence of abnormal shadows in more than 3 lobes was significantly associated with radiological aggravations.	[Kodaka, Norio; Nakano, Chihiro; Oshio, Takeshi; Watanabe, Kayo; Niitsuma, Kumiko; Imaizumi, Chisato; Matsuse, Hiroto] Toho Univ, Ohashi Med Ctr, Dept Internal Med, Div Resp Med, Tokyo, Japan	Toho University	Matsuse, H (corresponding author), Toho Univ, Ohashi Med Ctr, Dept Internal Med, Div Resp Med, Tokyo, Japan.	hiroto.matsuse@med.toho-u.ac.jp		Matsuse, Hiroto/0000-0003-0242-5005				Boyle DP, 2015, AM J RESP CRIT CARE, V191, P1310, DOI 10.1164/rccm.201501-0067OC; Daley CL, 2010, INT J TUBERC LUNG D, V14, P665; Furuuchi K, 2019, RESP MED, V152, P74, DOI 10.1016/j.rmed.2019.05.001; Gochi M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008058; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; HARTZ A, 1986, MED DECIS MAKING, V6, P149, DOI 10.1177/0272989X8600600304; Hoefsloot W, 2013, EUR RESPIR J, V42, P1604, DOI 10.1183/09031936.00149212; Hwang JA, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00537-2016; Kendall BA, 2013, SEMIN RESP CRIT CARE, V34, P87, DOI 10.1055/s-0033-1333567; Kim RD, 2008, AM J RESP CRIT CARE, V178, P1066, DOI 10.1164/rccm.200805-686OC; Kim SJ, 2014, INT J TUBERC LUNG D, V18, P730, DOI 10.5588/ijtld.13.0792; Kitada S, 2012, INT J TUBERC LUNG D, V16, P660, DOI 10.5588/ijtld.11.0534; Koh WJ, 2012, CHEST, V142, P1482, DOI 10.1378/chest.12-0494; Kotilainen H, 2011, SCAND J INFECT DIS, V43, P188, DOI 10.3109/00365548.2010.535558; Kurashima A, 2013, J MYCOBAC DIS, V03, P1, DOI [10.4172/2161-1068.1000127, DOI 10.4172/2161-1068.1000127]; MICHELININORRIS MB, 1992, J INFECT DIS, V165, P702, DOI 10.1093/infdis/165.4.702; Middleton AM, 2000, MOL MICROBIOL, V38, P381, DOI 10.1046/j.1365-2958.2000.02137.x; Morimoto K, 2017, ANN AM THORAC SOC, V14, P49, DOI [10.1513/annalsats.201607-573oc, 10.1513/AnnalsATS.201607-573OC]; Nishiuchi Y, 2007, CLIN INFECT DIS, V45, P347, DOI 10.1086/519383; Pan SW, 2017, CLIN INFECT DIS, V65, P927, DOI 10.1093/cid/cix479; Pfeffer PE, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0579-9; Prevots DR, 2015, CLIN CHEST MED, V36, P13, DOI 10.1016/j.ccm.2014.10.002; PRINCE DS, 1989, NEW ENGL J MED, V321, P863, DOI 10.1056/NEJM198909283211304; Simons S, 2011, EMERG INFECT DIS, V17, P343, DOI 10.3201/eid1703.100604; Song JW, 2008, AM J ROENTGENOL, V191, pW160, DOI 10.2214/AJR.07.3505; Uwamino Y, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4668-x; Yamazaki Y, 2006, CELL MICROBIOL, V8, P806, DOI 10.1111/j.1462-5822.2005.00667.x; Ziedalski TM, 2006, CHEST, V130, P995, DOI 10.1378/chest.130.4.995	30	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237071	10.1371/journal.pone.0237071	http://dx.doi.org/10.1371/journal.pone.0237071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760104	gold, Green Published			2022-12-26	WOS:000561027200031
J	Garcia-Oliveira, AL; Kimata, B; Kasele, S; Kapinga, F; Masumba, E; Mkamilo, G; Sichalwe, C; Bredeson, JV; Lyons, JB; Shah, T; Muranaka, S; Katari, MS; Ferguson, ME				Garcia-Oliveira, Ana Luisa; Kimata, Bernadetha; Kasele, Salum; Kapinga, Fortunus; Masumba, Esther; Mkamilo, Geoffrey; Sichalwe, Caroline; Bredeson, Jessen, V; Lyons, Jessica B.; Shah, Trushar; Muranaka, Satoru; Katari, Manpreet S.; Ferguson, Morag E.			Genetic analysis and QTL mapping for multiple biotic stress resistance in cassava	PLOS ONE			English	Article							MOSAIC DISEASE; DIALLEL ANALYSIS; VIRUS PANDEMICS; VIRAL-INFECTION; EPIDEMIOLOGY; TRAITS; IMPROVEMENT; MANAGEMENT; GERMPLASM; BIOLOGY	In Sub-Saharan Africa cassava (Manihot esculentaCrantz) is one of the most important food crops where more than 40% of the population relies on it as their staple carbohydrate source. Biotic constraints such as viral diseases, mainly Cassava Mosaic Disease (CMD) and Cassava Brown Streak Disease (CBSD), and arthropod pests, particularly Cassava Green Mite (CGM), are major constraints to the realization of cassava's full production potential in Africa. To address these problems, we aimed to map the quantitative trait loci (QTL) associated with resistance to CBSD foliar and root necrosis symptoms, foliar CMD and CGM symptoms in a full-sib mapping population derived from the genotypes AR40-6 and Albert. A high-density linkage map was constructed with 2,125 SNP markers using a genotyping-by-sequencing approach. For phenotyping, clonal evaluation trials were conducted with 120 F(1)individuals for two consecutive field seasons using an alpha-lattice design at Chambezi and Naliendele, Tanzania. Previously identified QTL for resistance to CBSD foliar symptoms were corroborated, and a new putative QTL for CBSD root necrosis identified (qCBSDRNc14AR) from AR40-6. Two QTL were identified within the region of the previously recognizedCMD2locus from this population in which both parents are thought to possess theCMD2locus. Interestingly, a minor but consistent QTL,qCGM18AR, for CGM resistance at 3 months after planting stage was also detected and co-localized with a previously identified SSR marker, NS346, linked with CGM resistance. Markers underlying these QTL may be used to increase efficiencies in cassava breeding programs.	[Garcia-Oliveira, Ana Luisa; Ferguson, Morag E.] Int Inst Trop Agr IITA, Nairobi, Kenya; [Garcia-Oliveira, Ana Luisa; Shah, Trushar] ICRAF, CIMMYT, Excellence Breeding EiB, Nairobi, Kenya; [Kimata, Bernadetha; Kapinga, Fortunus; Mkamilo, Geoffrey] Tanzania Agr Res Inst TARI, Naliendele, Mtwara, Tanzania; [Kasele, Salum; Sichalwe, Caroline] TARI, Ukiriguru, Tanzania; [Masumba, Esther] TARI, Kibaha, Tanzania; [Bredeson, Jessen, V; Lyons, Jessica B.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Muranaka, Satoru] Japan Int Res Ctr Agr Sci JIRCAS, Tsukuba, Ibaraki, Japan; [Katari, Manpreet S.] NYU, Dept Biol, New York, NY 10003 USA	CGIAR; World Agroforestry (ICRAF); University of California System; University of California Berkeley; Japan International Research Center for Agricultural Sciences; New York University	Ferguson, ME (corresponding author), Int Inst Trop Agr IITA, Nairobi, Kenya.	m.ferguson@cgiar.org	Lyons, Jessica/ABB-5014-2020	Lyons, Jessica/0000-0002-3886-2146; Shah, Trushar/0000-0002-0091-7981; Katari, Manpreet/0000-0002-3377-063X; Garcia-Oliveira, Ana Luisa/0000-0001-8561-4172	Bill and Melinda Gates Foundation (BMGF) [OPPGD1016]; BMGF [OPPGD1493]	Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); BMGF	This work was funded by the Bill and Melinda Gates Foundation (BMGF) grant no. OPPGD1016 to MF, IITA. Work by JB and JL was supported by BMGF grant OPPGD1493 to Dr. Steve Rounsley, who at the time was at the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akano AO, 2002, THEOR APPL GENET, V105, P521, DOI 10.1007/s00122-002-0891-7; Alaba OA, 2015, G3-GENES GENOM GENET, V5, P133, DOI 10.1534/g3.114.015008; Alicai T, 2007, PLANT DIS, V91, P24, DOI 10.1094/PD-91-0024; BECKER F, 1993, PLANT J, V3, P875, DOI 10.1111/j.1365-313X.1993.00875.x; Bellotti AC, 1999, ANNU REV ENTOMOL, V44, P343, DOI 10.1146/annurev.ento.44.1.343; Bellotti Anthony C., 2001, P209, DOI 10.1079/9780851995243.0209; Beyene G, 2016, MOL PLANT PATHOL, V17, P1095, DOI 10.1111/mpp.12353; Bigirimana S., 2011, New Disease Reports, V24, P26; Bondar G., 1938, 3 REV ENTOMOLOGIA RI, V9, P441; Bredeson JV, 2016, NAT BIOTECHNOL, V34, P562, DOI 10.1038/nbt.3535; Calvert L. A., 2002, CASSAVA BIOL PRODUCT, P237; Ceballos H., 2020, CROP BREED GENET GEN, V2; Ceballos H, 2010, HANDB PLANT BREED, V7, P53, DOI 10.1007/978-0-387-92765-7_2; Chalwe A, 2015, EUPHYTICA, V205, P103, DOI 10.1007/s10681-015-1404-5; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Cuambe C, 2007, ROOT TUBER CROPS POV; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dieng H, 2011, J PHYTOPATHOL, V159, P707, DOI 10.1111/j.1439-0434.2011.01830.x; Ephraim N., 2015, INT J PLANT PHYSL BI, V7, P12; Ezenwaka L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231008; Ezenwaka L, 2018, CROP SCI, V58, P1907, DOI 10.2135/cropsci2018.01.0024; Food and Agriculture Organization (FAO), 2011, CASS VIR VERG EP E A; Fregene M., 2001, P179, DOI 10.1079/9780851995243.0179; Frei A, 2005, CROP SCI, V45, P379, DOI 10.2135/cropsci2005.0379; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; HAHN SK, 1980, EUPHYTICA, V29, P673, DOI 10.1007/BF00023215; Campo BVH, 2011, FOOD SECUR, V3, P329, DOI 10.1007/s12571-011-0141-4; Hillocks R. J., 1999, African Journal of Root and Tuber Crops, V3, P57; IITA, 2011, COMB THREAT CBSD; IITA, 1990, CASS TROP AFR REF MA, P1; Jaramillo G, 2005, CROP SCI, V45, P1058, DOI 10.2135/cropsci2004.0314; Jennings D. L., 2001, P149, DOI 10.1079/9780851995243.0149; JENNINGS D. L., 1957, EAST AFRICAN AGRIC JOUR, V22, P213; JOHNSON HERBERT W., 1955, AGRON JOUR, V47, P314; Kaweesi T, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0216-x; Kawuki RS, 2016, BREEDING SCI, V66, P560, DOI 10.1270/jsbbs.16005; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kulembeka HP, 2012, EUPHYTICA, V187, P277, DOI 10.1007/s10681-012-0730-0; Kulembeka HPK, 2010, THESIS, P1; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; KUON JE, 2019, BMC BIOL, V17, DOI DOI 10.1186/S12915-018-0614-4; LANDER ES, 1989, GENETICS, V121, P185; Legg JP, 2006, ADV VIRUS RES, V67, P355, DOI 10.1016/S0065-3527(06)67010-3; Legg JP, 2011, VIRUS RES, V159, P161, DOI 10.1016/j.virusres.2011.04.018; Legg J.P., 2003, P C PLANT VIROLOGY S, P517; Legg JP, 2015, ADV VIRUS RES, V91, P85, DOI 10.1016/bs.aivir.2014.10.001; Legg JP, 2014, PEST MANAG SCI, V70, P1446, DOI 10.1002/ps.3793; Legg JP, 1998, INT J PEST MANAGE, V44, P17, DOI 10.1080/096708798228473; Leuschner K., 1982, ROOT CROPS E AFRICA; Lokko Y, 2005, AFR J BIOTECHNOL, V4, P873; Lynam J., 2011, 208 FAO, P1; Choperena EDM, 2012, REV COLOMB ENTOMOL, V38, P70; Machi Andre Ricardo, 2014, Australian Journal of Basic and Applied Sciences, V8, P342; Mahungu N. M., 1994, African Crop Science Journal, V2, P539; Maruthi MN, 2005, J PHYTOPATHOL, V153, P307, DOI 10.1111/j.1439-0434.2005.00974.x; Masumba EA, 2017, THEOR APPL GENET, V130, P2069, DOI 10.1007/s00122-017-2943-z; Mohammed IU, 2012, ADV VIROL, V2012, DOI 10.1155/2012/795697; Mulimbi W., 2012, New Disease Reports, V26, P11, DOI 10.5197/j.2044-0588.2012.026.011; NICHOLS R. F. W., 1950, EAST AFRICAN AGRIC JOUR, V15, P154; Nzuki I, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01168; Okogbenin E, 2007, CROP SCI, V47, P1895, DOI 10.2135/cropsci2006.10.0688; Okogbenin E, 2012, CROP SCI, V52, P2576, DOI 10.2135/cropsci2011.11.0586; Olasanmi B., 2014, J ROOT CROPS, V40, P15; Orkwor G.C, 1998, FOOD YAMS ADV RES; Pati BL, 2015, J GEN VIROL, V96, P956, DOI 10.1099/vir.0.000014; Rabbi I, 2014, CROP SCI, V54, P1384, DOI 10.2135/cropsci2013.07.0482; Rabbi IY, 2014, VIRUS RES, V186, P87, DOI 10.1016/j.virusres.2013.12.028; Rey C, 2017, ANNU REV VIROL, V4, P429, DOI 10.1146/annurev-virology-101416-041913; Roux-Cuvelier M., 2014, New Disease Reports, V30, P28; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheat S, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00567; Shirima RR, 2019, PLANT DIS, V103, P2652, DOI 10.1094/PDIS-05-18-0750-RE; Smith CM, 2012, ANNU REV ENTOMOL, V57, P309, DOI 10.1146/annurev-ento-120710-100642; STOREY H. H., 1936, East African Agricultural Journal, V2, P34; Suzuki N, 2014, NEW PHYTOL, V203, P32, DOI 10.1111/nph.12797; Tomlinson KR, 2018, MOL PLANT PATHOL, V19, P1282, DOI 10.1111/mpp.12613; Van Ooijen J., 2006, SOFTWARE CALCULATION; Wiesner-Hanks T, 2016, ANNU REV PHYTOPATHOL, V54, P229, DOI 10.1146/annurev-phyto-080615-100037; Wolfe MD, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.11.0118; Yang P, 2014, P NATL ACAD SCI USA, V111, P2104, DOI 10.1073/pnas.1320362111; Yaninek Steve, 2003, P61, DOI 10.1079/9780851996394.0061; Yu YongTao, 2006, Journal of Maize Sciences, V14, P88; Zacarias AM, 2008, THESIS; Zhang LY, 2015, J HERED, V106, P741, DOI 10.1093/jhered/esv080; 2005, ENTOMOL BER, V65, P2	86	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236674	10.1371/journal.pone.0236674	http://dx.doi.org/10.1371/journal.pone.0236674			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756600	gold, Green Published			2022-12-26	WOS:000560393300042
J	Ben Saad, R; Ben Romdhane, W; Zouari, N; Ben Hsouna, A; Harbaoui, M; Brini, F; Ghneim-Herrera, T				Ben Saad, Rania; Ben Romdhane, Walid; Zouari, Nabil; Ben Hsouna, Anis; Harbaoui, Marwa; Brini, Faical; Ghneim-Herrera, Thaura			Characterization of a novel LmSAP gene promoter from Lobularia maritima: Tissue specificity and environmental stress responsiveness	PLOS ONE			English	Article							AELUROPUS-LITTORALIS DIRECTS; ARABIDOPSIS-THALIANA; ALSAP GENE; INDUCIBLE EXPRESSION; REGULATORY ELEMENTS; FUNCTIONAL-ANALYSIS; TRANSGENIC TOBACCO; ZINC-FINGER; COLD STRESS; RICE	Halophyte Lobularia maritima LmSAP encodes an A20AN1 zinc-finger stress-associated protein which expression is up-regulated by abiotic stresses and heavy metals in transgenic tobacco. To deepen our understanding of LmSAP function, we isolated a 1,147 bp genomic fragment upstream of LmSAP coding sequence designated as PrLmSAP. In silico analyses of PrLmSAP revealed the presence of consensus CAAT and TATA boxes and cis-regulatory elements required for abiotic stress, phytohormones, pathogen, and wound responses, and also for tissue-specific expression. The PrLmSAP sequence was fused to the beta-glucuronidase (gusA) reporter gene and transferred to rice. Histochemical GUS staining showed a pattern of tissue-specific expression in transgenic rice, with staining observed in roots, coleoptiles, leaves, stems and floral organs but not in seeds or in the root elongation zone. Wounding strongly stimulated GUS accumulation in leaves and stems. Interestingly, we observed a high stimulation of the promoter activity when rice seedlings were exposed to NaCl, PEG, ABA, MeJA, GA, cold, and heavy metals (Al3+, Cd2+, Cu2+ and Zn2+). These results suggest that the LmSAP promoter can be a convenient tool for stress-inducible gene expression and is a potential candidate for crop genetic engineering.	[Ben Saad, Rania; Ben Romdhane, Walid; Zouari, Nabil; Ben Hsouna, Anis; Harbaoui, Marwa; Brini, Faical] Univ Sfax, Ctr Biotechnol Sfax, Biotechnol & Plant Improvement Lab, Sfax, Tunisia; [Ben Romdhane, Walid] King Saud Univ, Coll Food & Agr Sci, Plant Prod Dept, Riyadh, Saudi Arabia; [Ben Hsouna, Anis] Fac Sci Gafsa, Dept Life Sci, Gafsa, Tunisia; [Ghneim-Herrera, Thaura] Univ Icesi, Dept Ciencias Biol, Cali, Colombia	Centre de Biotechnologie de Sfax; Universite de Sfax; King Saud University; Universite de Gafsa; Universidad ICESI	Ben Saad, R (corresponding author), Univ Sfax, Ctr Biotechnol Sfax, Biotechnol & Plant Improvement Lab, Sfax, Tunisia.	raniabensaad@gmail.com	zouari, nabil/D-7724-2019; Ben Romdhane, Walid Ben/ABB-6543-2020	zouari, nabil/0000-0002-9873-7566; Ben Hsouna, Anis/0000-0002-3837-5532; Brini, faical/0000-0002-8435-381X	Ministry of Higher Education and Scientific Research of Tunisia	Ministry of Higher Education and Scientific Research of Tunisia	This study was funded by Ministry of Higher Education and Scientific Research of Tunisia, contrat programme 2019-2022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behnam B., 2006, PLANT BIOTECHNOL-NAR, V23, P169, DOI [10.5511/plantbiotechnology.23.169, DOI 10.5511/PLANTBIOTECHNOLOGY.23.169]; Ben Saad R, 2018, J PLANT PHYSIOL, V231, P234, DOI 10.1016/j.jplph.2018.09.019; Ben Saad R, 2018, FUNCT PLANT BIOL, V45, P378, DOI 10.1071/FP17202; Ben Saad R, 2012, PLANT CELL ENVIRON, V35, P626, DOI 10.1111/j.1365-3040.2011.02441.x; Ben Saad R, 2011, TRANSGENIC RES, V20, P1003, DOI 10.1007/s11248-010-9474-6; Ben-Saad R, 2015, PLANT CELL REP, V34, P1791, DOI 10.1007/s00299-015-1825-6; Bhatnagar-Mathur P, 2007, PLANT CELL REP, V26, P2071, DOI 10.1007/s00299-007-0406-8; Bisht NC, 2007, PLANT CELL REP, V26, P727, DOI 10.1007/s00299-006-0274-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN H, 1994, BIOTECHNIQUES, V16, P664; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Datta K, 2012, PLANT BIOTECHNOL J, V10, P579, DOI 10.1111/j.1467-7652.2012.00688.x; Dixit A, 2018, PLANT CELL ENVIRON, V41, P1171, DOI 10.1111/pce.13103; Dong CJ, 2010, J INTEGR PLANT BIOL, V52, P914, DOI 10.1111/j.1744-7909.2010.00966.x; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Gawel NJ, 1991, MOL BIOL REP, V9, P262, DOI DOI 10.1007/BF02672076; Giri J, 2013, BIOESSAYS, V35, P639, DOI 10.1002/bies.201200181; Giri J, 2011, NEW PHYTOL, V191, P721, DOI 10.1111/j.1469-8137.2011.03740.x; Golldack D, 2003, PLANT MOL BIOL, V51, P71, DOI 10.1023/A:1020763218045; GUBLER F, 1995, PLANT CELL, V7, P1879, DOI 10.1105/tpc.7.11.1879; Guo LL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-18; Guo WJ, 2003, NEW PHYTOL, V159, P369, DOI 10.1046/j.1469-8137.2003.00813.x; Hernandez-Garcia CM, 2014, PLANT SCI, V217, P109, DOI 10.1016/j.plantsci.2013.12.007; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hong B, 2006, SCI CHINA SER C, V49, P436, DOI 10.1007/s11427-006-2014-1; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Huang J, 2008, GENE, V420, P135, DOI 10.1016/j.gene.2008.05.019; Huang RW, 2015, HORTSCIENCE, V50, P636, DOI 10.21273/HORTSCI.50.5.636; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jeong HJ, 2015, J INTEGR PLANT BIOL, V57, P913, DOI 10.1111/jipb.12362; Jiang C, 1996, PLANT MOL BIOL, V30, P679, DOI 10.1007/BF00049344; Jiang PP, 2018, BMC BIOTECHNOL, V18, DOI 10.1186/s12896-018-0470-x; Kang MY, 2011, PLANT MOL BIOL, V75, P451, DOI 10.1007/s11103-011-9748-2; Kanneganti V, 2008, PLANT MOL BIOL, V66, P445, DOI 10.1007/s11103-007-9284-2; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Kathuria H, 2007, CRIT REV PLANT SCI, V26, P65, DOI 10.1080/07352680701252809; Ke JS, 1997, PLANT PHYSIOL, V113, P357, DOI 10.1104/pp.113.2.357; Kothari KS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01057; Lee S, 2002, PLANTA, V215, P689, DOI [10.1007/s00425-002-0821-6, 10.1007/s00425-002-0793-6]; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Liu WS, 2016, CURR OPIN BIOTECH, V37, P36, DOI 10.1016/j.copbio.2015.10.001; Liu YJ, 2011, J PLANT PHYSIOL, V168, P1098, DOI 10.1016/j.jplph.2010.12.013; Long SP, 2015, CELL, V161, P56, DOI 10.1016/j.cell.2015.03.019; MCELROY D, 1990, PLANT CELL, V2, P163, DOI 10.1105/tpc.2.2.163; Michiels A, 2003, PLANT MOL BIOL REP, V21, P295, DOI 10.1007/BF02772805; Mishra A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00829; Nakashima K, 2014, PLANTA, V239, P47, DOI 10.1007/s00425-013-1960-7; Nishiuchi T, 2004, J BIOL CHEM, V279, P55355, DOI 10.1074/jbc.M409674200; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Peremarti A, 2010, PLANT MOL BIOL, V73, P363, DOI 10.1007/s11103-010-9628-1; Polizel AM, 2011, GENET MOL RES, V10, P3641, DOI 10.4238/2011.October.21.4; Popova OV, 2008, GENE, V423, P142, DOI 10.1016/j.gene.2008.07.017; Popova OV, 2007, J PLANT PHYSIOL, V164, P1278, DOI 10.1016/j.jplph.2006.08.011; Quinn JM, 2000, J BIOL CHEM, V275, P6080, DOI 10.1074/jbc.275.9.6080; Quinn JM, 2003, EUKARYOT CELL, V2, P995, DOI 10.1128/EC.2.5.995-1002.2003; QUINN JM, 1995, PLANT CELL, V7, P623, DOI 10.1105/tpc.7.5.623; Ren YJ, 2009, PLANT SCI, V176, P528, DOI 10.1016/j.plantsci.2009.01.010; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; Shi HZ, 2003, PLANT CELL, V15, P19, DOI 10.1105/tpc.007872; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; SKRIVER K, 1991, P NATL ACAD SCI USA, V88, P7266, DOI 10.1073/pnas.88.16.7266; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; Sun QH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-90; Sutoh K, 2003, PLANT J, V34, P635, DOI 10.1046/j.1365-313X.2003.01753.x; Takasaki H, 2010, MOL GENET GENOMICS, V284, P173, DOI 10.1007/s00438-010-0557-0; Tiwari V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148494; Tiwari V, 2014, PLANT CELL PHYSIOL, V55, P201, DOI 10.1093/pcp/pct172; Vij S, 2006, MOL GENET GENOMICS, V276, P565, DOI 10.1007/s00438-006-0165-1; Wu Y., 2008, Sugar Tech, V10, P36, DOI 10.1007/s12355-008-0006-0; Xu RQ, 2006, PLANT MOL BIOL, V61, P799, DOI 10.1007/s11103-006-0051-6; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Zhang M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174987; Zientara K, 2009, J BIOTECHNOL, V139, P258, DOI 10.1016/j.jbiotec.2008.12.001	76	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236943	10.1371/journal.pone.0236943	http://dx.doi.org/10.1371/journal.pone.0236943			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735612	Green Published, gold			2022-12-26	WOS:000569367100063
J	Supo-Escalante , RR; Medico, A; Gushiken, E; Olivos-Ramirez, GE; Quispe, Y; Torres, F; Zamudio, M; Antiparra, R; Amzel, LM; Gilman, RH; Sheen, P; Zimic, M				Supo-Escalante, Rydberg Roman; Medico, Aldhair; Gushiken, Eduardo; Olivos-Ramirez, Gustavo E.; Quispe, Yaneth; Torres, Fiorella; Zamudio, Melissa; Antiparra, Ricardo; Amzel, L. Mario; Gilman, Robert H.; Sheen, Patricia; Zimic, Mirko			Prediction of Mycobacterium tuberculosis pyrazinamidase function based on structural stability, physicochemical and geometrical descriptors	PLOS ONE			English	Article							NORMAL-MODE ANALYSIS; PNCA GENE-MUTATIONS; MOLECULAR-DYNAMICS; PROTEIN FUNCTION; RESISTANCE; CONSTANT; TRENDS	Background Pyrazinamide is an important drug against the latent stage of tuberculosis and is used in both first- and second-line treatment regimens. Pyrazinamide-susceptibility test usually takes a week to have a diagnosis to guide initial therapy, implying a delay in receiving appropriate therapy. The continued increase in multi-drug resistant tuberculosis and the prevalence of pyrazinamide resistance in several countries makes the development of assays for prompt identification of resistance necessary. The main cause of pyrazinamide resistance is the impairment of pyrazinamidase function attributed to mutations in the promoter and/or pncA coding gene. However, not all pncA mutations necessarily affect the pyrazinamidase function. Objective To develop a methodology to predict pyrazinamidase function from detected mutations in the pncA gene. Methods We measured the catalytic constant (k(cat)), K-M, enzymatic efficiency, and enzymatic activity of 35 recombinant mutated pyrazinamidase and the wild type (Protein Data Bank ID = 3pl1). From all the 3D modeled structures, we extracted several predictors based on three categories: structural stability (estimated by normal mode analysis and molecular dynamics), physicochemical, and geometrical characteristics. We used a stepwise Akaike's information criterion forward multiple log-linear regression to model each kinetic parameter with each category of predictors. We also developed weighted models combining the three categories of predictive models for each kinetic parameter. We tested the robustness of the predictive ability of each model by 6-fold cross-validation against random models. Results The stability, physicochemical, and geometrical descriptors explained most of the variability (R-2) of the kinetic parameters. Our models are best suited to predict k(cat), efficiency, and activity based on the root-mean-square error of prediction of the 6-fold cross-validation. Conclusions This study shows a quick approach to predict the pyrazinamidase function only from the pncA sequence when point mutations are present. This can be an important tool to detect pyrazinamide resistance.	[Supo-Escalante, Rydberg Roman; Medico, Aldhair; Gushiken, Eduardo; Olivos-Ramirez, Gustavo E.; Quispe, Yaneth; Torres, Fiorella; Zamudio, Melissa; Antiparra, Ricardo; Sheen, Patricia; Zimic, Mirko] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab Bioinformat Biol Mol & Desarrollos Tecnol, Lima, Peru; [Amzel, L. Mario] Johns Hopkins Univ, Dept Biophys & Biophys Chem, Baltimore, MD USA; [Gilman, Robert H.] Johns Hopkins Sch Publ Hlth, Int Hlth Dept, Baltimore, MD USA	Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zimic, M (corresponding author), Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab Bioinformat Biol Mol & Desarrollos Tecnol, Lima, Peru.	mirko.zimic@upch.pe		Gushiken-Ibanez, Eduardo/0000-0002-2510-9163; Gilman, Robert/0000-0002-9037-0712; Supo, Rydberg/0000-0003-4651-3111; Medico, Aldhair/0000-0003-1855-0855; Olivos Ramirez, Gustavo Enrique/0000-0002-9300-1779	Wellcome Trust Intermediate Fellowship [099805/Z/12/Z]; FONDECyT-Peru [037-2014]; Grand Challenge Canada [0687-0110]	Wellcome Trust Intermediate Fellowship(Wellcome Trust); FONDECyT-Peru; Grand Challenge Canada	This research was funded by the Wellcome Trust Intermediate Fellowship (grant 099805/Z/12/Z) (PS). This study was also partially funded Grand Challenge Canada (grant 0687-0110) (PS), by FONDECyT-Peru (grant 037-2014) (MZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Aggarwal M, 2018, J CELL BIOCHEM, V119, P2567, DOI 10.1002/jcb.26420; Alcantara R, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01165-19; Alcantara R, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01162-18; Allana S, 2017, EMERG INFECT DIS, V23, P491, DOI 10.3201/eid2303.161034; [Anonymous], 1992, J HAZARDOUS MAT, DOI [DOI 10.1016/0304-3894(92)87022-8, 10.1016/0304-3894(92)87022-8]; Aono A, 2018, J MICROBIOL METH, V154, P52, DOI 10.1016/j.mimet.2018.09.018; Aono A, 2014, ANTIMICROB AGENTS CH, V58, P4928, DOI 10.1128/AAC.02394-14; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bauer JA, 2019, MOLECULES, V24, DOI 10.3390/molecules24183293; BERENDSEN HJC, 1991, NATO ADV SCI I E-APP, V205, P139; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Berezovsky IN, 2017, CURR OPIN STRUC BIOL, V42, P67, DOI 10.1016/j.sbi.2016.10.021; Bromberg Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S8; Carter Joshua J, 2019, SSRN ELECT J, V37, DOI [10.1101/518142, DOI 10.2139/SSRN.3391941]; Caviedes L, 2007, Indian J Med Microbiol, V25, P87; Chaidir L, 2019, J GLOB ANTIMICROB RE, V16, P170, DOI 10.1016/j.jgar.2018.08.018; Chen CY, 2009, P NATL ACAD SCI USA, V106, P3764, DOI 10.1073/pnas.0900266106; Cheng SJ, 2000, ANTIMICROB AGENTS CH, V44, P528, DOI 10.1128/AAC.44.3.528-532.2000; Cirillo DM, 2015, INT J MYCOBACTERIOLO, V4, P42, DOI [10.1080/10893950390219083, DOI 10.1080/10893950390219083]; Doustdar F, 2015, PROTEIN J, V34, P181, DOI 10.1007/s10930-015-9610-5; Esmaeeli R, 2019, J CELL BIOCHEM, V120, P2502, DOI 10.1002/jcb.27543; Ewald PP, 1921, ANN PHYS-BERLIN, V64, P253; Madrazo-Moya CF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213046; Gherardini Pier Federico, 2008, Briefings in Functional Genomics & Proteomics, V7, P291, DOI 10.1093/bfgp/eln030; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2; Hunt Martin, 2019, Wellcome Open Res, V4, P191, DOI 10.12688/wellcomeopenres.15603.1; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Hvidsten TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006266; Iwamoto T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212798; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Junaid M, 2019, J CHEM INF MODEL, V59, P498, DOI 10.1021/acs.jcim.8b00525; Karmakar M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58635-x; Karshikoff A, 2015, FEBS J, V282, P3899, DOI 10.1111/febs.13343; Khadem-Maaref M, 2017, J MOL GRAPH MODEL, V73, P24, DOI 10.1016/j.jmgm.2017.01.021; Khan MT, 2018, J CELL BIOCHEM; Khan MJ, 2020, J INTELL FUZZY SYST, V38, P4327, DOI 10.3233/JIFS-190944; Khan MT, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3764-2; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lamont EA, 2019, EBIOMEDICINE, V49, P374, DOI 10.1016/j.ebiom.2019.10.014; Lopez-Blanco J. R., 2014, ELS, DOI [10.1002/9780470015902.a0020204.pub2, DOI 10.1002/9780470015902.A0020204.PUB2]; MALMBERG CG, 1956, J RES NAT BUR STAND, V56, P1, DOI 10.6028/jres.056.001; Maningi NE, 2015, J CLIN MICROBIOL, V53, P3779, DOI 10.1128/JCM.01179-15; Martin A, 2006, J ANTIMICROB CHEMOTH, V58, P327, DOI 10.1093/jac/dkl231; Maslov DA, 2015, TUBERCULOSIS, V95, P608, DOI 10.1016/j.tube.2015.05.013; Masso M, 2011, IEEE ENG MED BIO, P3221, DOI 10.1109/IEMBS.2011.6090876; Masso M, 2011, IEEE ENG MED BIO, P3225, DOI 10.1109/IEMBS.2011.6090877; Mehmood A, 2018, J CHEM INF MODEL, V58, P1836, DOI 10.1021/acs.jcim.8b00370; Mestdagh M, 1999, ANTIMICROB AGENTS CH, V43, P2317, DOI 10.1128/AAC.43.9.2317; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pazhang M, 2018, INT J BIOL MACROMOL, V108, P1339, DOI 10.1016/j.ijbiomac.2017.11.039; Petrella S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015785; Phelan J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0385-x; Quiliano M, 2011, BIOINFORMATION, V6, P335, DOI 10.6026/97320630006335; Lopez-Blanco JR, 2014, NUCLEIC ACIDS RES, V42, pW271, DOI 10.1093/nar/gku339; Rasool N, 2019, COMPUT BIOL CHEM, V83, DOI 10.1016/j.compbiolchem.2019.107108; Ruiz-Pernia JJ, 2012, J CHEM THEORY COMPUT, V8, P1532, DOI 10.1021/ct300064f; Sacquin-Mora S, 2016, METHOD ENZYMOL, V578, P227, DOI 10.1016/bs.mie.2016.05.022; Schleusener V, 2017, SCI REP-UK, V7, DOI 10.1038/srep46327; Scorpio A, 1997, ANTIMICROB AGENTS CH, V41, P540, DOI 10.1128/AAC.41.3.540; Sengstake S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2594-3; Sheen P, 2013, TUBERCULOSIS, V93, P515, DOI 10.1016/j.tube.2013.03.005; Sheen P, 2012, AM J TROP MED HYG, V87, P153, DOI 10.4269/ajtmh.2012.10-0565; Sheen P, 2009, TUBERCULOSIS, V89, P109, DOI 10.1016/j.tube.2009.01.004; Sivanandam M, 2018, J BIOMOL STRUCT DYN, V36, P3246, DOI 10.1080/07391102.2017.1384761; Skjaerven L, 2011, PROTEINS, V79, P232, DOI 10.1002/prot.22875; Skjaerven L, 2009, J MOL STRUC-THEOCHEM, V898, P42, DOI 10.1016/j.theochem.2008.09.024; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P636, DOI 10.1128/AAC.41.3.636; Sun QG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14238-3; Tam KKG, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/JCM.00145-19, 10.1128/jcm.00145-19]; Tama F, 2000, PROTEINS, V41, P1; TIDOR B, 1993, PROTEINS, V15, P71, DOI 10.1002/prot.340150109; Valdebenito-Maturana B, 2017, J COMPUT CHEM, V38, P467, DOI 10.1002/jcc.24712; Vasquez-Campos L, 2004, INT J TUBERC LUNG D, V8, P465; Vats C, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S2-S14; Wabale VR, 2017, BACTERIOL MICOL, V5, P1, DOI [10.15406/jbmoa.2017.05.00123, DOI 10.15406/JBMOA.2017.05.00123]; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Werngren J, 2017, J CLIN MICROBIOL, V55, P1920, DOI 10.1128/JCM.02532-16; Whitfield MG, 2015, J CLIN MICROBIOL, V53, P3633, DOI 10.1128/JCM.01001-15; Whitfield MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133869; World Health Organization, 2019, WORLD HLTH STAT MON; Wu XY, 2019, INFECT GENET EVOL, V72, P147, DOI 10.1016/j.meegid.2018.11.012; Yadon AN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00721-2; Yang TW, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000007482, 10.1097/md.0000000000007482]; Yoon JH, 2014, WORLD J MICROB BIOT, V30, P2821, DOI 10.1007/s11274-014-1706-0; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x; Zhang Y, 2017, MODE ACTION PYRAZINA, V52, P790; Zhang Y, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0023-2013	92	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0235643	10.1371/journal.pone.0235643	http://dx.doi.org/10.1371/journal.pone.0235643			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735615	gold, Green Published			2022-12-26	WOS:000569367100011
J	McGrail, DJ; Dai, JL; McAndrews, KM; Kalluri, R				McGrail, Daniel J.; Dai, Jianli; McAndrews, Kathleen M.; Kalluri, Raghu			Enacting national social distancing policies corresponds with dramatic reduction in COVID19 infection rates	PLOS ONE			English	Article								The outbreak the SARS-CoV-2 (CoV-2) virus has resulted in over 6.5 million cases of COVID19, greatly stressing global healthcare infrastructure. Lacking medical prophylactic measures to combat disease spread, many nations have adopted social distancing policies in order to mitigate transmission of CoV-2. While mathematical models have suggested the efficacy of social distancing to curb the spread of CoV-2, there is a lack of systematic studies to quantify the real-world efficacy of these approaches. Here, we first demonstrate that implementation of social distancing policies in US states corresponded with a reduction in COVID19 spread rates, and that the reduction in spread rate is proportional to the average change in mobility. We validate this observation on a worldwide scale by analyzing COVID19 spread rate in 134 nations with varying social distancing policies. Globally, we find that social distancing policies significantly reduced the COVID19 spread rate, with resulting in an estimated 65% reduction (95% CI = 39-80%) in new COVID19 cases over a two week time period. These data suggest that social distancing policies may be a powerful tool to prevent spread of COVID19 in real-world scenarios.	[McGrail, Daniel J.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Dai, Jianli; McAndrews, Kathleen M.; Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Kalluri, Raghu] Rice Univ, Sch Bioengn, Houston, TX 77005 USA; [Kalluri, Raghu] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Rice University; Baylor College of Medicine	McGrail, DJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.; Kalluri, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77030 USA.; Kalluri, R (corresponding author), Rice Univ, Sch Bioengn, Houston, TX 77005 USA.; Kalluri, R (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	djmcgrail@mdanderson.org; rkalluri@mdanderson.org	Dai, Jianli/AAQ-3309-2021; McGrail, Daniel/F-3967-2014; Kalluri, Raghu/E-2677-2015	McAndrews, Kathleen/0000-0002-4092-4991; McGrail, Daniel/0000-0002-6669-6069; Kalluri, Raghu/0000-0002-2190-547X				Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Eichenbaum M.S., 2020, 26882 NBER, DOI [10.3386/w26882, DOI 10.3386/W26882]; Ferguson N. M., 2020, REPORT 9 IMPACT NONP, V10, DOI [10.25561/77482, DOI 10.1007/S11538-020-00726-X]; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Grad S., 2020, SOCIAL DISTANCING ST, V2020, DOI [10.11392/jsao.49.40, DOI 10.1101/2020.03.22.20041079]; Greenstone M., 2020, DOES SOCIAL DISTANCI, DOI DOI 10.2139/SSRN.3561244; Keating D, 2020, NEW YORK TIMES; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Leung K, 2020, LANCET, DOI [10.1016/S0140-6736(20)30746-7, 10.1016/S0140-6736(20)30746-732277878, DOI 10.1016/S0140-6736(20)30746-7]; Maier BF, 2020, SCIENCE, V368, P742, DOI 10.1126/science.abb4557; Wagner AB, 2020, SOCIAL DISTANCING HA, DOI [10.1101/2020.04.27.20081836, DOI 10.1101/2020.04.27.20081836]; Yong SEF, 2020, LANCET INFECT DIS, V20, P809, DOI 10.1016/S1473-3099(20)30273-5; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	13	62	62	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236619	10.1371/journal.pone.0236619	http://dx.doi.org/10.1371/journal.pone.0236619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730356	Green Published, Green Submitted, gold			2022-12-26	WOS:000556884700002
J	Barbieri, JF; Gaspari, AF; Teodoro, CL; Motta, L; Castano, LAA; Bertuzzi, R; Bernades, CF; Chacon-Mikahil, MPT; de Moraes, AC				Barbieri, Joao Francisco; Gaspari, Arthur Fernandes; Teodoro, Cassia Lopes; Motta, Leonardo; Arcila Castano, Luz Albany; Bertuzzi, Romulo; Bernades, Celene Fernandes; Traina Chacon-Mikahil, Mara Patricia; de Moraes, Antonio Carlos			The effect of an airflow restriction mask (ARM) on metabolic, ventilatory, and electromyographic responses to continuous cycling exercise	PLOS ONE			English	Article								This study analyzed the physiological adjustments caused by the use of the Elevation training mask (R) (2.0), an airflow restriction mask (ARM) during continuous exercise. Eighteen physically active participants (12 men and 6 women) were randomized to two protocols: continuous exercise with mask (CE-ARM) and continuous exercise without mask (CE). Exercise consisted of cycling for 20 minutes at 60% of maximum power. Metabolic variables, lactate, and gas concentration were obtained from arterialized blood samples at pre and post exercise. Continuous expired gases and myoelectric activity of the quadriceps were performed at rest and during the test. We observed no reduction in oxygen saturation in CE-ARM, leading to lower pH, higher carbon dioxide, and greater hematocrit (all p <0.05). The expired gas analysis shows that the CE-ARM condition presented higher oxygen uptake and expired carbon dioxide concentrations (p <0.05). The CE-ARM condition also presented lower ventilatory volume, ventilatory frequency, and expired oxygen pressure (p <0.05). No changes in electromyography activity and lactate concentrations were identified. We conclude that using ARM does not induce hypoxia and represents an additional challenge for the control of acid-base balance, and we suggest the use of ARM as being suitable for respiratory muscle training.	[Barbieri, Joao Francisco; Gaspari, Arthur Fernandes; Teodoro, Cassia Lopes; Motta, Leonardo; Arcila Castano, Luz Albany; Bernades, Celene Fernandes; Traina Chacon-Mikahil, Mara Patricia; de Moraes, Antonio Carlos] Univ Estadual Campinas, Sch Phys Educ, Dept Sport Sci, Campinas, Brazil; [Bertuzzi, Romulo] Univ Sao Paulo, Sch Phys Educ & Sport, Endurance Performance Res GEDAE USP, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo	Barbieri, JF (corresponding author), Univ Estadual Campinas, Sch Phys Educ, Dept Sport Sci, Campinas, Brazil.	joao.francisco.barbien@gmail.com	Bertuzzi, Romulo/E-7048-2012	MORAES, ANTONIO CARLOS/0000-0002-0489-8204; Gaspari, Arthur/0000-0002-6063-1694	Faepex (Fund for Support to Teaching, Research and Outreach Activities) [519.292]	Faepex (Fund for Support to Teaching, Research and Outreach Activities)	A.C.M. received funding from Faepex (Fund for Support to Teaching, Research and Outreach Activities) under Grant 519.292. https://www.prp.unicamp.br/pt-br/faepex The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee P, 2005, J APPL PHYSIOL, V99, P2307, DOI 10.1152/japplphysiol.00891.2004; Calverley PMA, 2003, EUROPEAN RESP J S; Granados J, 2016, J STRENGTH COND RES; Hall JE, 2011, J CHEM INFORM MODELI; Hamlin MJ, 2010, SCAND J MED SCI SPOR; HERMENS H, 2000, J ELECTROMYOGR KINES; Howley ET, 1995, MED SCI SPORTS EXERC; Illi SK, 2012, SPORTS MED; Kurobe K, 2015, CLIN PHYSL FUNCT IMA; Levine BD, 2002, HIGH ALT MED BIOL; Levine BD, 2006, ADV EXPT MED BIOL; Porcari JP, 2016, J SPORT SCI MED; Richardson MX, 2008, EUROPEAN J APPL PHYS; Romero-Arenas S, 2019, J STRENGTH COND RES; Rusko HK, 2004, J SPORTS SCI; Sellers JH, 2016, J STRENGTH COND RES; Smolka L, 2014, J SPORT SCI MED; Warren B, 2017, INT J EXERC SCI; Woorons X, 2007, RESP PHYSL NEUROBIOL	19	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237010	10.1371/journal.pone.0237010	http://dx.doi.org/10.1371/journal.pone.0237010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780739	gold, Green Published			2022-12-26	WOS:000562664700025
J	Huet, S; Gargiulo, F; Pratto, F				Huet, Sylvie; Gargiulo, Floriana; Pratto, Felicia			Can gender inequality be created without inter-group discrimination?	PLOS ONE			English	Article							SOCIAL-DOMINANCE; SELF-ESTEEM; SEX; WOMEN; MEN; STEREOTYPES; GAP; MASCULINITY; COMMUNALITY; PERSPECTIVE	Understanding human societies requires knowing how they develop gender hierarchies, which are ubiquitous. We test whether a simple agent-based dynamic process could create gender inequality. Relying on evidence of gendered status concerns, self-construals, and cognitive habits, our model included a gender difference in how responsive male-like and female-like agents are to others' opinions about the level of esteem for someone. We simulate a population who interact in pairs of randomly selected agents to influence each other about their esteem judgments of self and others. Half the agents are more influenced by their relative status rank during the interaction than the others. Without prejudice, stereotypes, segregation, or categorization, our model produces inter-group inequality of self-esteem and status that is stable, consensual, and exhibits characteristics of glass ceiling effects. Outcomes are not affected by relative group size. We discuss implications for group orientation to dominance and individuals' motivations to exchange.	[Huet, Sylvie] Univ Clermont Auvergne, Ctr Clermont Ferrand, INRAE, UR LISC, F-63178 Aubiere, France; [Huet, Sylvie] LAPSCO, F-63000 Clermont Ferrand, France; [Gargiulo, Floriana] CNRS GEMASS, Paris, France; [Pratto, Felicia] Univ Connecticut, Dept Psychol Sci, Storrs, CT USA	INRAE; Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); University of Connecticut	Huet, S (corresponding author), Univ Clermont Auvergne, Ctr Clermont Ferrand, INRAE, UR LISC, F-63178 Aubiere, France.; Huet, S (corresponding author), LAPSCO, F-63000 Clermont Ferrand, France.	sylvie.huet@inrae.fr	Huet, Sylvie/AAV-5505-2020; Gargiulo, Floriana/GYJ-8061-2022	Huet, Sylvie/0000-0003-2973-7738; 				Abele AE, 2007, J PERS SOC PSYCHOL, V93, P751, DOI 10.1037/0022-3514.93.5.751; Acker J, 2009, SOCIOL TRAV, V51, P199, DOI 10.1016/j.soctra.2009.03.004; Adams RB, 2016, AM ECON REV, V106, P277, DOI 10.1257/aer.p20161034; ALBERT AA, 1988, SOCIOL FORUM, V3, P184, DOI 10.1007/BF01115290; Albrecht J, 2003, J LABOR ECON, V21, P145, DOI 10.1086/344126; Arulampalam W, 2007, IND LABOR RELAT REV, V60, P163, DOI 10.1177/001979390706000201; Axelrod R, 1997, J CONFLICT RESOLUT, V41, P203, DOI 10.1177/0022002797041002001; Bakan D ., 1966, DUALITY HUMAN EXISTE; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Belotti EG, 1991, DALLA PARTE BAMBINE, V45; Bleidorn W, 2016, J PERS SOC PSYCHOL, V111, P396, DOI 10.1037/pspp0000078; Bosson JK, 2013, J PERS SOC PSYCHOL, V105, P425, DOI 10.1037/a0033126; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Byrne D, 1997, J SOC PERS RELAT, V14, P417, DOI 10.1177/0265407597143008; Caporael LinndaR., 1996, J SOC EVOL SYST, V19, P261, DOI [10.1016/S1061-7361(96)90036-3, DOI 10.1016/S1061-7361(96)90036-3]; Carli L., 2013, SAGE HDB GENDER PSYC, P16; Carli LL, 2001, J SOC ISSUES, V57, P725, DOI 10.1111/0022-4537.00238; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Cejka MA, 1999, PERS SOC PSYCHOL B, V25, P413, DOI 10.1177/0146167299025004002; Conway M, 1996, J PERS SOC PSYCHOL, V71, P25, DOI 10.1037/0022-3514.71.1.25; Conway M, 2000, SEX ROLES, V43, P181, DOI 10.1023/A:1007076813819; Cotter DA, 2001, SOC FORCES, V80, P655, DOI 10.1353/sof.2001.0091; Crano WD, 1972, PRELIMINARY INVESTIG; Cuddy AJC, 2015, J PERS SOC PSYCHOL, V109, P622, DOI 10.1037/pspi0000027; Dahl J, 2015, SOC PSYCHOL-GERMANY, V46, P242, DOI 10.1027/1864-9335/a000248; DARLEY WK, 1995, J ADVERTISING, V24, P41, DOI 10.1080/00913367.1995.10673467; Davis L., 1986, International Journal of Educational Development, V6, P61, DOI 10.1016/0738-0593(86)90041-6; DEFFUANT G, 2013, JASSS J ARTIF SOC S, V16; Deffuant G, 2018, ADV COMPLEX SYST, V21, DOI 10.1142/S0219525918500212; DiMuccio SH, 2020, CURR OPIN BEHAV SCI, V34, P25, DOI 10.1016/j.cobeha.2019.11.010; Duripinar F, 2016, 12 ART INT INT DIG E, P7; Durkheim E., 1922, ED SOCIOLOGIE; EAGLY AH, 1984, J PERS SOC PSYCHOL, V46, P735, DOI 10.1037/0022-3514.46.4.735; EAGLY AH, 1978, PSYCHOL BULL, V85, P86, DOI 10.1037/0033-2909.85.1.86; Favaretto R, 2017, SIBGRAPI, P223, DOI 10.1109/SIBGRAPI.2017.36; Favaretto RM, 2016, IEEE IMAGE PROC, P2936, DOI 10.1109/ICIP.2016.7532897; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Flache A, 2017, JASSS-J ARTIF SOC S, V20, DOI 10.18564/jasss.3521; Foels R, 2010, SEX ROLES, V62, P684, DOI 10.1007/s11199-010-9775-5; Folke O, 2016, COMP POLIT STUD, V49, P567, DOI 10.1177/0010414015621073; Friedl E, 1975, WOMEN MEN ANTHR VIEW; Gargiulo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008828; GLICK P, 1988, J PERS SOC PSYCHOL, V55, P178, DOI 10.1037/0022-3514.55.2.178; Glick P, 2000, J PERS SOC PSYCHOL, V79, P763, DOI 10.1037/0022-3514.79.5.763; Gokariksel B, 2019, SIGNS, V44, P561, DOI 10.1086/701154; Gould RV, 2002, AM J SOCIOL, V107, P1143, DOI 10.1086/341744; Guimond S, 2006, J PERS SOC PSYCHOL, V90, P221, DOI 10.1037/0022-3514.90.2.221; Hall JA, 1999, J PERS SOC PSYCHOL, V77, P350, DOI 10.1037/0022-3514.77.2.350; Hargittai I., 2007, ROAD STOCKHOLM NOBEL; Harris Marvin, 1993, SEX GENDER HIERARCHI, P57; Hartmann H., 2004, CHALLENGE, V47, P30; Hedstrom P, 2010, ANNU REV SOCIOL, V36, P49, DOI 10.1146/annurev.soc.012809.102632; Henslin J.M., 1999, EARTH SOCIOLOGY INTR, Vtenth, P142; Heritier Francoise, 1996, MASCULIN FEMININ PEN; Hoyenga K. B., 1993, SOCIAL STRATIFICATIO, V1, P139; Huberman BA, 2004, SOC PSYCHOL QUART, V67, P103, DOI 10.1177/019027250406700109; Huet S., 2017, UNDERSTANDING INTERA, P137; Huet S, 2017, ADV SOCIAL SIMULATIO, V528, P13; Huet S, 2007, JASSS-J ARTIF SOC S, V10; Kalaitzi S, 2017, EQUAL DIVERS INCL, V36, P457, DOI 10.1108/EDI-03-2017-0058; Kempf D, 2006, MARKET LETT, V17, P5, DOI 10.1007/s11002-006-3545-8; Kleinjans KJ, 2017, KYKLOS, V70, P565, DOI 10.1111/kykl.12149; Kuchynka SL, 2018, J SOC ISSUES, V74, P529, DOI 10.1111/josi.12281; LeandroDihl EstevaoTesta,, 2017, IEEE VIRTUAL HUMANS, P1; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037/0022-3514.68.3.518; Leary MR, 2005, EUROPEAN REV SOCIAL, V16, P76; Lee IC, 2011, PSYCHOL BULL, V137, P1029, DOI 10.1037/a0025410; Lee J, 2015, J BUS RES, V68, P1341, DOI 10.1016/j.jbusres.2014.12.004; Lincoln AE, 2012, SOC STUD SCI, V42, P307, DOI 10.1177/0306312711435830; Lynn FB, 2009, AM J SOCIOL, V115, P755, DOI 10.1086/603537; Manzo G, 2015, SOCIOL METHOD RES, V44, P329, DOI 10.1177/0049124114544225; Mark NP, 2003, AM SOCIOL REV, V68, P319, DOI 10.2307/1519727; Markus H.R., 1989, GENDER THOUGHT PSYCH, P100, DOI [10.1007/978-1-4612-3588-0_6, DOI 10.1007/978-1-4612-3588-0_6]; Mason WA, 2007, PERS SOC PSYCHOL REV, V11, P279, DOI 10.1177/1088868307301032; MCGUIRE WJ, 1976, J PERS SOC PSYCHOL, V33, P743, DOI 10.1037/0022-3514.33.6.743; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; MERTON RK, 1988, ISIS, V79, P606, DOI 10.1086/354848; Meyers-Levy J, 2015, J CONSUM PSYCHOL, V25, P129, DOI 10.1016/j.jcps.2014.06.003; MEYERSLEVY J, 1991, J MARKETING RES, V28, P84, DOI 10.2307/3172728; MEYERSLEVY J, 1988, J CONSUM RES, V14, P522, DOI 10.1086/209133; Mize TD, 2019, SOC PROBL, V66, P86, DOI 10.1093/socpro/spx032; Murphy RP, 2014, SOC COMPASS, V61, P594, DOI 10.1177/0037768614547487; Nordman CJ, 2009, J AFR ECON, V18, P592, DOI 10.1093/jae/ejn029; Oluwaniyi Oluwatoyin O., 2012, J PAN AFRICAN STUDIE, V5, P128; Pettigrew TF, 1998, ANNU REV PSYCHOL, V49, P65, DOI 10.1146/annurev.psych.49.1.65; Petty R.E., 1986, COMMUN PERSUATION, P123; Pornpitakpan C, 2004, J APPL SOC PSYCHOL, V34, P243, DOI 10.1111/j.1559-1816.2004.tb02547.x; Pratto F, 1997, J PERS SOC PSYCHOL, V72, P37, DOI 10.1037/0022-3514.72.1.37; Pratto F, 1997, BRIT J SOC PSYCHOL, V36, P49, DOI 10.1111/j.2044-8309.1997.tb01118.x; Pratto F., 2004, PSYCHOL GENDER, P242; Pratto F., 1999, ADV EXPT SOCIAL PSYC, V31, P191, DOI [DOI 10.1016/S0065-2601(08)60274-9, 10.1016/S0065-2601(08)60274-9]; Pratto F, 2013, J SOCIAL POLITICAL P, V1, P2195; Pratto F, 2013, SOC PSYCHOL PERS SCI, V4, P587, DOI 10.1177/1948550612473663; Pratto F, 2012, J SOC ISSUES, V68, P28, DOI 10.1111/j.1540-4560.2011.01734.x; Prentice DA, 2002, PSYCHOL WOMEN QUART, V26, P269, DOI 10.1111/1471-6402.t01-1-00066; Putrevu S., 2001, ACAD MARKETING SCI R, P14; Rasool S, 2016, AGENDA-EMPOWER WOMEN, V30, P39, DOI 10.1080/10130950.2016.1275199; Ridgeway CL., 2004, PSYCHOL GENDER, P217; RIORDAN C, 1983, SOC PSYCHOL QUART, V46, P261, DOI 10.2307/3033797; Rosaldo M, 1974, WOMAN CULTURE SOC; ROSSITER MW, 1993, SOC STUD SCI, V23, P325, DOI 10.1177/030631293023002004; Sacks K., 1974, WOMEN CULTURE SOC, P189; Sanday Peggy Reeves, 1981, FEMALE POWER MALE DO; Schwendinger J, 1983, SAGE LIB SOCIAL RES, V148; SIDANIUS J, 1991, J SOC ISSUES, V47, P131, DOI 10.1111/j.1540-4560.1991.tb01827.x; Sidanius J., 1999, SOCIAL DOMINANCE INT; Smith ER, 2007, PERS SOC PSYCHOL REV, V11, P87, DOI 10.1177/1088868306294789; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Takarinda KC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147828; Tate, 2020, TURN PRIZ; Tormala ZL, 2007, SOC PERSONAL PSYCHOL, V1, P469, DOI 10.1111/j.1751-9004.2007.00025.x; Treas J, 2016, SEX ROLES, V74, P495, DOI 10.1007/s11199-015-0575-9; TURNER JC, 1975, EUR J SOC PSYCHOL, V5, P5, DOI 10.1002/ejsp.2420050102; Uhlmann EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194871; Vandello JA, 2008, J PERS SOC PSYCHOL, V95, P1325, DOI 10.1037/a0012453; Vilela A.M., 2016, J MARKET COMMUN, V22, P18, DOI DOI 10.1080/13527266.2013.841272; Weaver JR, 2010, SEX ROLES, V62, P241, DOI 10.1007/s11199-009-9713-6; West MP, 2018, PSYCHOL CRIME LAW, V24, P761, DOI 10.1080/1068316X.2018.1438432; Williams J. E., 1990, CROSS CULTURAL RES M, V13; Wisman A, 2015, J EXP SOC PSYCHOL, V60, P121, DOI 10.1016/j.jesp.2015.05.006; Wong A, 2018, J HEALTH ORGAN MANAG, V32, P779, DOI 10.1108/JHOM-02-2018-0061; Wood W, 2002, PSYCHOL BULL, V128, P699, DOI 10.1037//0033-2909.128.5.699; WRIGHT EO, 1995, AM SOCIOL REV, V60, P407, DOI 10.2307/2096422; Yamak S, 2016, GENDER WORK ORGAN, V23, P125, DOI 10.1111/gwao.12115; Young HP, 2009, AM ECON REV, V99, P1899, DOI 10.1257/aer.99.5.1899; [No title captured]	126	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0236840	10.1371/journal.pone.0236840	http://dx.doi.org/10.1371/journal.pone.0236840			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NE5TX	32780742	Green Submitted, gold, Green Published			2022-12-26	WOS:000562664700042
J	Robles-Vera, I; de la Visitacion, N; Toral, M; Sanchez, M; Romero, M; Gomez-Guzman, M; Yang, T; Izquierdo-Garcia, JL; Guerra-Hernandez, E; Ruiz-Cabello, J; Raizada, MK; Perez-Vizcaino, F; Jimenez, R; Duarte, J				Robles-Vera, Inaki; de la Visitacion, Nestor; Toral, Marta; Sanchez, Manuel; Romero, Miguel; Gomez-Guzman, Manuel; Yang, Tao; Izquierdo-Garcia, Jose L.; Guerra-Hernandez, Eduardo; Ruiz-Cabello, Jesus; Raizada, Mohan K.; Perez-Vizcaino, Francisco; Jimenez, Rosario; Duarte, Juan			ProbioticBifidobacterium breveprevents DOCA-salt hypertension	FASEB JOURNAL			English	Article						DOCA-salt hypertension; endothelial dysfunction; gut microbiota; immune system; probiotics	CHAIN FATTY-ACIDS; GUT MICROBIOTA; BLOOD-PRESSURE; ENDOTHELIAL DYSFUNCTION; INTESTINAL BARRIER; RECEPTOR 4; BUTYRATE; ACTIVATION; INHIBITION; DYSBIOSIS	Many probiotics that affect gut microbial ecology have been shown to produce beneficial effects on renin-angiotensin-dependent rodent models and human hypertension. We hypothesized thatBifidobacterium breveCECT7263 (BFM) would attenuate hypertension in deoxycorticosterone acetate (DOCA)-salt rats, a renin-independent model of hypertension. Rats were randomly divided into five groups: control, DOCA-salt, treated DOCA-salt-BFM, treated DOCA-salt-butyrate, and treated DOCA-salt-acetate, for 5 weeks. BFM prevented the increase in systolic blood pressure, cardiac weight, and renal damage induced by DOCA-salt. BFM increased acetate-producing bacterial population and gut acetate levels, improved colonic integrity, normalized endotoxemia, plasma trimethylamine (TMA) levels, and restored the Th17 and Treg content in mesenteric lymph nodes and aorta. Furthermore, BFM improved nitric oxide-dependent vasorelaxation induced by acetylcholine in aortic rings and reduced NADPH oxidase activity in DOCA-salt animals. These protective effects were mimicked by acetate, but not by butyrate supplementation. These data demonstrate that BFM induces changes in gut microbiota linked with attenuation of endothelial dysfunction and increase in blood pressure in this low-renin form of hypertension. These beneficial effects seem to be mediated by increased acetate and reduced TMA production by gut microbiota, thus, improving gut integrity and restoring Th17/Tregs polarization and endotoxemia.	[Robles-Vera, Inaki; de la Visitacion, Nestor; Sanchez, Manuel; Romero, Miguel; Gomez-Guzman, Manuel; Jimenez, Rosario; Duarte, Juan] Univ Granada, Dept Pharmacol, Sch Pharm, Granada 18071, Spain; [Robles-Vera, Inaki; de la Visitacion, Nestor; Sanchez, Manuel; Romero, Miguel; Gomez-Guzman, Manuel; Jimenez, Rosario; Duarte, Juan] Univ Granada, Ctr Biomed Res CIBM, Granada, Spain; [Toral, Marta] Ctr Nacl Invest Cardiovasc CHIC, Gene Regulat Cardiovasc Remodeling & Inflammat Gr, Madrid, Spain; [Toral, Marta; Romero, Miguel; Jimenez, Rosario; Duarte, Juan] CIBER Enfermedades Cardiovasc CiberCV, Madrid, Spain; [Sanchez, Manuel; Romero, Miguel; Gomez-Guzman, Manuel; Jimenez, Rosario; Duarte, Juan] Inst Invest Biosanitaria Granada, Granada, Spain; [Yang, Tao] Univ Toledo, Coll Med & Life Sci, Microbiome Consortium, Toledo, OH USA; [Yang, Tao] Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, Ctr Hypertens & Precis Med, Toledo, OH USA; [Izquierdo-Garcia, Jose L.; Ruiz-Cabello, Jesus] CIC BiomaGUNE, Donostia San Sebastian, Spain; [Guerra-Hernandez, Eduardo] Univ Granada, Dept Nutr & Bromatol, Granada, Spain; [Raizada, Mohan K.] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Perez-Vizcaino, Francisco] Univ Complutense Madrid, Fac Med, Dept Farmacol & Toxicol, Madrid, Spain; [Perez-Vizcaino, Francisco] Ciber Enfermedades Resp Ciberes, Madrid, Spain; [Perez-Vizcaino, Francisco] Inst Invest Sanitaria Gregorio Maranon IISGM, Madrid, Spain	University of Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Instituto de Investigacion Biosanitaria IBS Granada; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; CIC biomaGUNE; University of Granada; State University System of Florida; University of Florida; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Sanchez, M; Duarte, J (corresponding author), Univ Granada, Dept Pharmacol, Sch Pharm, Granada 18071, Spain.	manuelsanchersantos@ugr.es; jmduarte@ugr.es	Sanchez, Manuel/C-4401-2008; Duarte, Juan/AAH-1574-2020; Duarte, Juan/K-6472-2014; Romero, Miguel/K-6053-2014; de la Visitación, Néstor/K-5729-2017; JIMENEZ, ROSARIO/K-9701-2014; Toral, Marta/K-6709-2014; Ruiz-Cabello, Jesus/A-9570-2012; Gómez-Guzmán, M/E-3341-2012; Izquierdo-Garcia, Jose/L-3293-2013; perez, miguel/GXF-5077-2022; Robles Vera, Inaki/K-6355-2017; Perez-Vizcaino, Francisco/A-9735-2011	Sanchez, Manuel/0000-0002-3975-3398; Duarte, Juan/0000-0002-9153-5857; Duarte, Juan/0000-0002-9153-5857; Romero, Miguel/0000-0003-0578-1099; de la Visitación, Néstor/0000-0001-7229-9601; JIMENEZ, ROSARIO/0000-0003-3872-2669; Toral, Marta/0000-0001-5324-8569; Ruiz-Cabello, Jesus/0000-0001-8681-5056; Gómez-Guzmán, M/0000-0003-2452-9286; Izquierdo-Garcia, Jose/0000-0002-7907-3776; Robles Vera, Inaki/0000-0001-6002-9241; Perez-Vizcaino, Francisco/0000-0001-6309-7418	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (Ministeri d'Economia, Industria i Competitivitat) [SAF2017-84894-R]; HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL102033]; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia) [CTS164]	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (Ministeri d'Economia, Industria i Competitivitat); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia)	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (Ministeri d'Economia, Industria i Competitivitat), Grant/Award Number: SAF2017-84894-R; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL102033; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia), Grant/Award Number: CTS164	Adnan S, 2017, PHYSIOL GENOMICS, V49, P96, DOI 10.1152/physiolgenomics.00081.2016; Amador CA, 2014, HYPERTENSION, V63, P797, DOI 10.1161/HYPERTENSIONAHA.113.02883; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Bartley A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01593; Bartolomaeus H, 2019, CIRCULATION, V139, P1407, DOI 10.1161/CIRCULATIONAHA.118.036652; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bomfim GF, 2012, CLIN SCI, V122, P535, DOI 10.1042/CS20110523; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; de Montgolfier O, 2019, GEROSCIENCE, V41, P511, DOI 10.1007/s11357-019-00070-6; Eamin EE, 2013, J NUTR, V143, P1872, DOI 10.3945/jn.113.179549; Elinav E, 2013, MUCOSAL IMMUNOL, V6, P4, DOI 10.1038/mi.2012.115; Friques AGF, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0759-7; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; GAVRAS H, 1975, CIRC RES, V36, P300, DOI 10.1161/01.RES.36.2.300; Gomez-Arango LF, 2016, HYPERTENSION, V68, P974, DOI 10.1161/HYPERTENSIONAHA.116.07910; Gomez-Guzman M, 2015, MOL NUTR FOOD RES, V59, P2326, DOI 10.1002/mnfr.201500290; Grangette C, 2012, GUT, V61, P331, DOI 10.1136/gutjnl-2011-301476; Gronlund MM, 2007, CLIN EXP ALLERGY, V37, P1764, DOI 10.1111/j.1365-2222.2007.02849.x; Hamer HM, 2009, CLIN NUTR, V28, P88, DOI 10.1016/j.clnu.2008.11.002; Harrison OJ, 2015, MUCOSAL IMMUNOL, V8, P1226, DOI 10.1038/mi.2015.13; Nguyen H, 2013, CARDIOVASC RES, V97, P696, DOI 10.1093/cvr/cvs422; Huang N, 1997, CYTOKINE, V9, P27, DOI 10.1006/cyto.1996.0132; Izquierdo-Garcia JL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-363; Jaworska K, 2019, CARDIOVASC RES, V115, P1948, DOI 10.1093/cvr/cvz231; Zarzuelo MJ, 2013, CARDIOVASC RES, V99, P622, DOI 10.1093/cvr/cvt152; Juraschek SP, 2015, AM J HYPERTENS, V28, P216, DOI 10.1093/ajh/hpu117; Karbach SH, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003698; Khalesi S, 2014, HYPERTENSION, V64, P897, DOI 10.1161/HYPERTENSIONAHA.114.03469; Kim S, 2018, CLIN SCI, V132, P701, DOI [10.1042/CS20180087, 10.1042/cs20180087]; Lewis-Mikhael AM, 2020, PHARMACOL RES, V153, DOI 10.1016/j.phrs.2020.104663; Li J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0222-x; Li M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00533; Li M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00233; Liang CF, 2013, ARTERIOSCL THROM VAS, V33, P777, DOI 10.1161/ATVBAHA.112.301087; Lim MY, 2019, GEROSCIENCE, V41, P935, DOI 10.1007/s11357-019-00121-y; Mariadason JM, 2008, EPIGENETICS-US, V3, P28, DOI 10.4161/epi.3.1.5736; Marques FZ, 2018, NAT REV CARDIOL, V15, P20, DOI 10.1038/nrcardio.2017.120; Marques FZ, 2017, CIRCULATION, V135, P964, DOI [10.1161/CIRCULATIONAHA.116.024545, 10.1161/circulationaha.116.024545]; Mell B, 2015, PHYSIOL GENOMICS, V47, P187, DOI 10.1152/physiolgenomics.00136.2014; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Rath S, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02966; Robles-Vera I, 2020, BRIT J PHARMACOL, V177, P2006, DOI 10.1111/bph.14965; Robles-Vera I, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.201900616; Robles-Vera I, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800298; Santisteban MM, 2017, CIRC RES, V120, P312, DOI 10.1161/CIRCRESAHA.116.309006; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sharma RK, 2019, CIRC RES, V124, P727, DOI 10.1161/CIRCRESAHA.118.313882; Singh H, 2019, GEROSCIENCE, V41, P907, DOI 10.1007/s11357-019-00098-8; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sun S, 2019, HYPERTENSION, V73, P998, DOI 10.1161/HYPERTENSIONAHA.118.12109; Suzuki T, 2008, BRIT J NUTR, V100, P297, DOI 10.1017/S0007114508888733; Toral M, 2019, ACTA PHYSIOL, V227, DOI 10.1111/apha.13285; Toral M, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00231; Toral M, 2014, CLIN SCI, V127, P33, DOI 10.1042/CS20130339; Van Deun K, 2008, AVIAN PATHOL, V37, P379, DOI 10.1080/03079450802216603; Vinh A, 2010, CIRCULATION, V122, P2529, DOI 10.1161/CIRCULATIONAHA.109.930446; Walejko JM, 2018, INT J CARDIOL, V271, P336, DOI 10.1016/j.ijcard.2018.04.074; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yang T, 2015, HYPERTENSION, V65, P1331, DOI 10.1161/HYPERTENSIONAHA.115.05315; Yap WB, 2016, KOREAN J PHYSIOL PHA, V20, P621, DOI 10.4196/kjpp.2016.20.6.621	65	25	25	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13626	13640		10.1096/fj.202001532R	http://dx.doi.org/10.1096/fj.202001532R		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32780919				2022-12-26	WOS:000558419300001
J	Mu, Q; Wang, H; Tong, L; Fang, QH; Xiang, MQ; Han, LY; Jin, LN; Yang, J; Qian, Z; Ning, G; Zhang, YF; Zhang, ZG				Mu, Qian; Wang, Hui; Tong, Lei; Fang, Qianhua; Xiang, Minqi; Han, Luyu; Jin, Lina; Yang, Jian; Qian, Zhen; Ning, Guang; Zhang, Yifei; Zhang, Zhiguo			Betulinic acid improves nonalcoholic fatty liver disease through YY1/FAS signaling pathway	FASEB JOURNAL			English	Article						betulinic acid; fatty acid synthase; NAFLD; triglyceride; Yin Yang 1	IN-VIVO; SYNTHASE INHIBITORS; X-RECEPTOR; TRANSCRIPTION; YY1; PATHOGENESIS; PROGRESSION; STEATOSIS; LIPOGENESIS; METABOLISM	The increasing prevalence of nonalcoholic fatty liver disease (NAFLD) worldwide indicates the urgent need to develop novel and effective treatment strategies. Betulinic acid (BA), a naturally occurring plant-derived pentacyclic triterpenoid, has an outstanding effect in improving metabolism. However, the pharmacological action and mechanism of BA in NAFLD remain unclear. Here, we show that BA-treated high-fat diet mice and methionine-choline deficient diet-fed mice are resistant to hepatic steatosis when compared with vehicle-treated mice. BA alleviates fatty acid synthesis, fibrosis, and inflammation and promotes fatty acid oxidation. Meanwhile, fatty acid synthase (FAS) expression and activity are markedly inhibited with BA treatment both in vitro and in vivo. Moreover, BA inhibits FAS expression through transcriptional suppression of Yin Yang 1 (YY1), leading to retard hepatocytes triglyceride accumulation. Collectively, BA protects hepatocytes from abnormal lipid deposition in NAFLD through YY1/FAS pathway. Our findings establish a novel role of BA in representing a possible therapeutic strategy to reverse NAFLD.	[Mu, Qian; Wang, Hui; Tong, Lei; Fang, Qianhua; Xiang, Minqi; Jin, Lina; Yang, Jian; Ning, Guang; Zhang, Yifei; Zhang, Zhiguo] Shanghai Jiao Tong Univ, Ruijin Hosp,Natl Hlth Commiss PR China,Key Lab En, Shanghai Natl Clin Res Ctr Metab Dis,Shanghai Ins, Sch Med,Shanghai Natl Ctr Translat Med,Dept Endoc, Shanghai, Peoples R China; [Han, Luyu] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Shanghai, Peoples R China; [Qian, Zhen] Changchun Univ Chinese Med, Sch Pharm, Dept Pharmacol, Changchun, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; University of Chinese Academy of Sciences, CAS; Changchun University of Chinese Medicine	Zhang, YF; Zhang, ZG (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Endocrine & Metab Dis, Sch Med,Dept Endocrinol & Metab, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China.	feifei-a@163.com; zhangzhiguo@outlook.com	Zhang, Yifei/GRO-3001-2022	Yang, Jian/0000-0002-3390-5127	National Key Research and Development Program [2016YFC0901201]; National Natural Science Foundation of China [81570719, 81670797, 81770863]; Shanghai Talent Development Fund [2018091]; Key Laboratory for Endocrine and Metabolic Diseases; Ministry of Science & Technology Innovation Fund [2011YQ030114]; Basic Important Program [10JC141100]; Ministry of Science and Technology [2012ZX09303006-001]; Shanghai Municipal Education Commission; Shanghai Education Development Foundation [14SG17]	National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Talent Development Fund; Key Laboratory for Endocrine and Metabolic Diseases; Ministry of Science & Technology Innovation Fund; Basic Important Program; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation	National Key Research and Development Program, Grant/Award Number: 2016YFC0901201; National Natural Science Foundation of China, Grant/Award Number: 81570719, 81670797 and 81770863; Shanghai Talent Development Fund, Grant/Award Number: 2018091; Key Laboratory for Endocrine and Metabolic Diseases; Ministry of Science & Technology Innovation Fund, Grant/Award Number: 2011YQ030114; Shanghai Talent development fund, Grant/Award Number: 2018091; Basic Important Program, Grant/Award Number: 10JC141100; Ministry of Science and Technology, Grant/Award Number: 2012ZX09303006-001; Shanghai Municipal Education Commission; Shanghai Education Development Foundation, Grant/Award Number: 14SG17	Ajala-Lawal RA, 2020, ARCH PHYSIOL BIOCHEM, V126, P107, DOI 10.1080/13813455.2018.1498901; Angulo P, 2007, NUTR REV, V65, pS57, DOI [10.1111/j.1753-4887.2007.tb00329.x, 10.1301/nr.2007.jun.S57-S63]; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Denechaud PD, 2016, J CLIN INVEST, V126, P137, DOI 10.1172/JCI81542; Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345; Fan HJ, 2016, ONCOL REP, V35, P2651, DOI 10.3892/or.2016.4682; Fulda S, 2009, MOL NUTR FOOD RES, V53, P140, DOI 10.1002/mnfr.200700491; Gao P, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw2050; Gu M, 2019, BRIT J PHARMACOL, V176, P847, DOI 10.1111/bph.14570; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Her GM, 2013, BBA-MOL CELL BIOL L, V1831, P1037, DOI 10.1016/j.bbalip.2013.02.002; Imajo K, 2012, CELL METAB, V16, P44, DOI 10.1016/j.cmet.2012.05.012; Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6; Kapur P, 2005, MODERN PATHOL, V18, P1107, DOI 10.1038/modpathol.3800395; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Kim KD, 2019, NUTR METAB CARDIOVAS, V29, P409, DOI 10.1016/j.numecd.2018.12.001; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kley JT, 2011, BIOORG MED CHEM LETT, V21, P5924, DOI 10.1016/j.bmcl.2011.07.083; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Laavola M, 2016, J NAT PROD, V79, P274, DOI 10.1021/acs.jnatprod.5b00709; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Li YJ, 2019, THERANOSTICS, V9, P7599, DOI 10.7150/thno.34931; Lu Y, 2014, GUT, V63, P170, DOI 10.1136/gutjnl-2012-303150; Rios JL, 2018, PLANTA MED, V84, P8, DOI 10.1055/s-0043-123472; Menendez JA, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.4; Mullen GE, 2015, BIOORG MED CHEM LETT, V25, P4363, DOI 10.1016/j.bmcl.2015.08.087; Musso G, 2013, PROG LIPID RES, V52, P175, DOI 10.1016/j.plipres.2012.11.002; Oslob JD, 2013, ACS MED CHEM LETT, V4, P113, DOI 10.1021/ml300335r; Pandey PR, 2012, RECENT PAT ANTI-CANC, V7, P185; Peverill W, 2014, INT J MOL SCI, V15, P8591, DOI 10.3390/ijms15058591; Ratziu V, 2005, J HEPATOL, V42, P12, DOI 10.1016/j.jhep.2004.11.027; Safayhi H, 1997, PLANTA MED, V63, P487, DOI 10.1055/s-2006-957748; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Syed-Abdul MM, 2020, HEPATOLOGY, V72, P103, DOI 10.1002/hep.31000; Verdeguer F, 2016, MOL CELL BIOL, V36, P184, DOI 10.1128/MCB.00722-15; Wan Y, 2013, INT IMMUNOPHARMACOL, V17, P184, DOI 10.1016/j.intimp.2013.06.012; Wong MCS, 2019, NAT REV GASTRO HEPAT, V16, P57, DOI 10.1038/s41575-018-0055-0; Wu SR, 2018, CANCER RES, V78, P4549, DOI 10.1158/0008-5472.CAN-17-4047; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhang MJ, 2017, SEMIN LIVER DIS, V37, P363, DOI 10.1055/s-0037-1607451; Zhang ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep20848	49	9	9	7	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					13033	13048		10.1096/fj.202000546R	http://dx.doi.org/10.1096/fj.202000546R		AUG 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32777136				2022-12-26	WOS:000558418900001
J	Bobardt, M; Hansson, MJ; Mayo, P; Ure, D; Foster, R; Gallay, P				Bobardt, Michael; Hansson, Magnus Joakim; Mayo, Patrick; Ure, Daren; Foster, Robert; Gallay, Philippe			Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver mice	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GENOTYPE 1 INFECTION; CYCLOPHILIN INHIBITORS; PEGYLATED INTERFERON; ALISPORIVIR PLUS; RIBAVIRIN; COMBINATION; THERAPIES; DRUGS	We previously reported that the non-immunosuppressive cyclophilin inhibitors (CypIs)-cyclosporin A analog CRV431 and sanglifehrin analog NV556-efficiently inhibit HCV replicationin vitro. In this study, we asked whether they can also reduce HCV replicationin vivo. We found that a single oral administration of CRV431 and NV556 to HCV-infected humanized-liver mice drastically reduced HCV blood levels. The antiviral effect was observed when CRV431 or NV556 were each individually administered with HCV, 3, 6 weeks or even 3 months post-infection when viral replication is robust. These results were confirmed in chimeric mice implanted with human hepatocytes isolated from three distinct donors. Remarkably, no viral rebound was observed 5 months after a single dose administration of 50 mg/kg of CRV431 or NV556 four weeks post-HCV infection, indicating the possibility of suppression of an established viral infection. Since we recently demonstrated that both CRV431 and NV556 also inhibit the development of liver fibrosis and hepatocellular carcinoma in nonviral-induced non-alcoholic steatohepatitis mouse models, our present data suggest that the two entirely structurally different CypIs-CRV431 and NV556-derived from unrelated natural products, represent attractive partners to current direct-acting agent (DAA) regimens for the treatment of hepatitis C and liver diseases.	[Bobardt, Michael; Gallay, Philippe] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Hansson, Magnus Joakim] NeuroVive Pharmaceut AB, Lund, Sweden; [Mayo, Patrick; Ure, Daren; Foster, Robert] Hepion Pharmaceut, Edison, NJ USA	Scripps Research Institute	Gallay, P (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.	gallay@scripps.edu		Mayo, Patrick/0000-0001-6350-5258	National Institute of Allergy and Infectious Diseases [R01A1143931, R01A1125365]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Institute of Allergy and Infectious Diseases (grant numbers R01A1143931 and R01A1125365). This funder provided support in the form of salaries for authors MB and PG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. NeuroVive Pharmaceutical AB (Abliva) provided support in the form of salary for author MH. Hepion Pharmaceuticals provided support in the form of salary for authors PM, DU, and RF. These companies provided the drugs and participated in the revision of the manuscript, but did not have any role in the study design, data collection and analysis, or decision to publish the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baumert TF, 2019, GASTROENTEROLOGY, V156, P431, DOI 10.1053/j.gastro.2018.10.024; Buti M, 2015, J VIRAL HEPATITIS, V22, P596, DOI 10.1111/jvh.12360; Chatterji U, 2014, ANTIMICROB AGENTS CH, V58, P3327, DOI 10.1128/AAC.00016-14; Chatterji U, 2010, J HEPATOL, V53, P50, DOI 10.1016/j.jhep.2010.01.041; Coelmont L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013687; de Wilde AH, 2018, VIROLOGY, V522, P46, DOI 10.1016/j.virol.2018.06.011; Fernandes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009815; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Gallay P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217433; Gallay PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134707; Gallay PA, 2013, DRUG DES DEV THER, V7, P105, DOI 10.2147/DDDT.S30946; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Hansson MJ, 2015, CHEM BIOL, V22, P285, DOI 10.1016/j.chembiol.2014.10.023; Heim MH, 2013, NAT REV IMMUNOL, V13, P535, DOI 10.1038/nri3463; HOPKINS S, 2015, BBA-GEN SUBJECTS, V1850, P2103, DOI DOI 10.1016/J.BBAGEN.2014.11.011; Hopkins S, 2012, VIRUSES-BASEL, V4, P2558, DOI 10.3390/v4112558; Kowdley KV, 2005, J CLIN GASTROENTEROL, V39, pS3, DOI 10.1097/01.mcg.0000145494.76305.11; Kuo J, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01129; Kuo J, 2019, J PHARMACOL EXP THER, V371, P231, DOI 10.1124/jpet.119.261099; Lin K, 2013, ANTIVIR RES, V99, P68, DOI 10.1016/j.antiviral.2013.03.020; Liu ZQ, 2020, J VIRAL HEPATITIS, V27, P585, DOI 10.1111/jvh.13270; Manns MP, 2013, NAT REV DRUG DISCOV, V12, P595, DOI 10.1038/nrd4050; Ozaras R, 2013, NEW ENGL J MED, V369, P679, DOI 10.1056/NEJMc1307589; Pawlotsky JM, 2015, HEPATOLOGY, V62, P1013, DOI 10.1002/hep.27960; ROSENWIRTH B, 1994, ANTIMICROB AGENTS CH, V38, P1763, DOI 10.1128/AAC.38.8.1763; Seeff LB, 1997, HEPATOLOGY, V26, pS21, DOI 10.1002/hep.510260704; Serrano SS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111409; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Trepo C, 2014, LIVER INT, V34, P29, DOI 10.1111/liv.12409; Wang Z, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0018-9; Wu T, 2019, DIGEST DIS SCI, V64, P1782, DOI 10.1007/s10620-019-05511-y; Yau AHL, 2014, CAN J GASTROENTEROL, V28, P445, DOI 10.1155/2014/549624; Zajac M, 2019, EUR J MED CHEM, V165, P225, DOI 10.1016/j.ejmech.2019.01.025; Zeuzem S, 2015, ALIMENT PHARM THER, V42, P829, DOI 10.1111/apt.13342	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237236	10.1371/journal.pone.0237236	http://dx.doi.org/10.1371/journal.pone.0237236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764799	gold, Green Published			2022-12-26	WOS:000561029000038
J	Bouget, J; Balusson, F; Viglino, D; Roy, PM; Lacut, K; Pavageau, L; Oger, E				Bouget, Jacques; Balusson, Frederic; Viglino, Damien; Roy, Pierre-Marie; Lacut, Karine; Pavageau, Laure; Oger, Emmanuel			Major bleeding risk and mortality associated with antiplatelet drugs in real-world clinical practice. A prospective cohort study	PLOS ONE			English	Article							ED AMERICAN-COLLEGE; DOSE ACETYLSALICYLIC-ACID; ANTITHROMBOTIC THERAPY; ISCHEMIC-STROKE; CLOPIDOGREL; PREVENTION; ASPIRIN; METAANALYSIS; THROMBOSIS; DISEASE	Background Major bleedings other than gastrointestinal (GI) and intracranial (ICH) and mortality rates associated with antiplatelet drugs in real-world clinical practice are unknown. The objective was to estimate major bleeding risk and mortality among new users of antiplatelet drugs in real-world clinical practice. Methods and findings A population-based prospective cohort using the French national health data system (SNIIRAM), identified 69,911 adults living within five well-defined geographical areas, who were new users of antiplatelet drugs in 2013-2015 and who had not received any antithrombotics in 2012. Among them, 63,600 started a monotherapy and 6,311 a dual regimen. Clinical data for all adults referred for bleeding was collected from all emergency departments within these areas, and medically validated. Databases were linked using common key variables. The main outcome measure was time to major bleeding (GI, ICH and other bleedings). Secondary outcomes were death, and event-free survival (EFS). Hazard ratios (HR) were derived from adjusted Cox proportional hazard models. We used Inverse Propensity of Treatment Weighting as a stratified sensitivity analysis according to the antiplatelet monotherapy indication: primary prevention without cardiovascular (CV) risk factors, with CV risk factors, and secondary prevention. We observed 250 (0.36%) major haemorrhages, 81 ICH, 106 GI and 63 other types of bleeding. Incidences were twice as high in dual therapy as in monotherapy. Compared to low-dose aspirin (<= 100 mg daily), high-dose (> 100 up to 325 mg daily) was associated with an increased risk of ICH (HR = 1.80, 95%CI 1.10 to 2.95). EFS was improved by high-dose compared to low-dose aspirin (1.41, 1.04 to 1.90 and 1.32, 1.03 to 1.68) and clopidogrel (1.30, 0.73 to 2.3 and 1.7, 1.24 to 2.34) respectively in primary prevention with and without CV risk factors. Conclusion The incidence of major bleeding and mortality was low. In monotherapy, low-dose aspirin was the safest therapeutic option whatever the indication.	[Bouget, Jacques; Balusson, Frederic; Oger, Emmanuel] Univ Rennes, EA 7449 Pharmacoepidemiol & Hlth Serv Res REPERES, CHU Rennes, Rennes, France; [Viglino, Damien] Grenoble Alpes Univ Hosp, Emergency Dept, Grenoble, France; [Roy, Pierre-Marie] Univ Angers, Inst MITOVASC, Ctr Hosp Univ, Emergency Dept, Angers, France; [Roy, Pierre-Marie] F CRIN INNOVTE, Paris, France; [Lacut, Karine] Univ Brest, Univ Bretagne Loire, CIC 1412, INSERM,CIC 1412,CHRU Brest, Brest, France; [Pavageau, Laure] Univ Hosp, Emergency Dept, Nantes, France	CHU Rennes; Universite de Rennes; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Nantes Universite; CHU de Nantes	Oger, E (corresponding author), Univ Rennes, EA 7449 Pharmacoepidemiol & Hlth Serv Res REPERES, CHU Rennes, Rennes, France.	emmanuel.oger@univ-rennes1.fr	Roy, Pierre-Marie/AAA-7737-2022	Lacut, Karine/0000-0002-4849-0454; OGER, Emmanuel/0000-0001-9837-2977	National Clinical Research Hospital Program of the French Ministry of Health [PHRC-12-009-0243]	National Clinical Research Hospital Program of the French Ministry of Health	This study was supported by the National Clinical Research Hospital Program of the French Ministry of Health (PHRC-12-009-0243). The funder had no role in the study design, data collection, analysis, or interpretation, in the writing of the article, or in the decision to submit it for publication.	Alonso-Coello P, 2012, CHEST, V141, pE669S, DOI 10.1378/chest.11-2307; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bannay A, 2016, MED CARE, V54, P188, DOI 10.1097/MLR.0000000000000471; Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133; Berger JS, 2011, AM HEART J, V162, P98, DOI 10.1016/j.ahj.2011.04.015; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bouget J, 2019, FUND CLIN PHARMACOL, V33, P443, DOI 10.1111/fcp.12444; Soriano LC, 2017, NEUROLOGY, V89, P2280, DOI 10.1212/WNL.0000000000004694; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Di Minno A, 2015, BLOOD REV, V29, P335, DOI 10.1016/j.blre.2015.03.004; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Ding L, 2018, EUR J NEUROL, V25, P1276, DOI 10.1111/ene.13695; Eikelboom JW, 2012, CHEST, V141, pE89S, DOI 10.1378/chest.11-2293; Rodriguez LAG, 2011, CIRCULATION, V123, P1108, DOI 10.1161/CIRCULATIONAHA.110.973008; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hilkens NA, 2018, NEUROLOGY, V90, pE683, DOI 10.1212/WNL.0000000000004997; Huang WY, 2018, JAMA NEUROL, V75, P1511, DOI 10.1001/jamaneurol.2018.2215; Johnston SC, 2018, NEW ENGL J MED, V379, P215, DOI 10.1056/NEJMoa1800410; Kaatz S, 2015, J THROMB HAEMOST, V13, P2119, DOI 10.1111/jth.13140; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Lanas A, 2015, CLIN GASTROENTEROL H, V13, P906, DOI 10.1016/j.cgh.2014.11.007; Lansberg MG, 2012, CHEST, V141, pE601S, DOI 10.1378/chest.11-2302; Li LX, 2017, LANCET, V390, P490, DOI 10.1016/S0140-6736(17)30770-5; Mahmoud AN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175283; Mauri L, 2016, EUR HEART J, V37, P378, DOI 10.1093/eurheartj/ehv614; McNeil JJ, 2018, NEW ENGL J MED, V379, P1519, DOI 10.1056/NEJMoa1803955; McNeil JJ, 2018, NEW ENGL J MED, V379, P1509, DOI 10.1056/NEJMoa1805819; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; NORRVING B, 1991, LANCET, V338, P1345; Oger E, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0841-6; Pannach S, 2017, J GASTROENTEROL, V52, P1211, DOI 10.1007/s00535-017-1320-7; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Sandercock PAG, 2014, COCHRANE DATABASE SY, V26; Savarese G, 2016, EUR HEART J-CARD PHA, V2, P218, DOI 10.1093/ehjcvp/pvw011; Spoendlin J, 2018, PHARMACOEPIDEM DR S, V27, P1361, DOI 10.1002/pds.4668; Tillman H, 2019, JAMA NEUROL, V76, P774, DOI 10.1001/jamaneurol.2019.0932; Valkhoff VE, 2013, CAN J GASTROENTEROL, V27, P159, DOI 10.1155/2013/596015; Vandvik O, 2012, CHEST, V141, pE637S, DOI 10.1378/chest.11-2306; Vazquez FJ, 2016, THROMB RES, V138, P1, DOI 10.1016/j.thromres.2015.12.013; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Zheng SL, 2019, JAMA-J AM MED ASSOC, V321, P277, DOI 10.1001/jama.2018.20578	44	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237022	10.1371/journal.pone.0237022	http://dx.doi.org/10.1371/journal.pone.0237022			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764775	gold, Green Published			2022-12-26	WOS:000561029000018
J	Lamelas-Lopez, L; Pardavila, X; Borges, PAV; Santos-Reis, M; Amorim, IR; Santos, MJ				Lamelas-Lopez, Lucas; Pardavila, Xose; Borges, Paulo A. V.; Santos-Reis, Margarida; Amorim, Isabel R.; Santos, Maria J.			Modelling the distribution of Mustela nivalis and M. putorius in the Azores archipelago based on native and introduced ranges	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; ISLAND AZORES; SAMPLE-SIZE; BIODIVERSITY; PERFORMANCE; PREDICTION; ECOLOGY; MAMMALS; NICHE; BIAS	The aims of this study were to predict the potential distribution of two introduced Mustelidae,Mustela nivalisandM.putoriusin the Azores archipelago (Portugal), and evaluate the relative contribution of environmental factors from native and introduced ranges to predict species distribution ranges in oceanic islands. We developed two sets of Species Distribution Models using MaxEnt and distribution data from the native and introduced ranges of the species to project their potential distribution in the archipelago. We found differences in the predicted distributions for the models based on introduced and on native occurrences for both species, with different most important variables being selected. Climatic variables were most important for the introduced range models, while other groups of variables (i.e., human-disturbance) were included in the native-based models. Most of the islands of the Azorean archipelago were predicted to have suitable habitat for both species, even when not yet occupied. Our results showed that predicting the invaded range based on introduced range environmental conditions predicted a narrower range. These results highlight the difficulty to transfer models from native to introduced ranges across taxonomically related species, making it difficult to predict future invasions and range expansion.	[Lamelas-Lopez, Lucas; Borges, Paulo A. V.] Univ Azores, CE3c Ctr Ecol Evolut & Environm Changes, Azorean Biodivers Grp, Dept Environm Sci & Engn,Fac Agr & Environm, Azores, Portugal; [Pardavila, Xose] Univ Santiago de Compostela, Dept Cellular Biol & Ecol, Santiago, Spain; [Santos-Reis, Margarida] Univ Lisbon, Fac Sci, CE3c Ctr Ecol Evolut & Environm Changes, Lisbon, Portugal; [Amorim, Isabel R.] Azorean Biodivers Grp, CE3c Ctr Ecol Evolut & Environm Changes, Azores, Portugal; [Amorim, Isabel R.] Univ Azores, Azores, Portugal; [Santos, Maria J.] Univ Zurich, Univ Res Prior Program Global Change & Biodivers, Zurich, Switzerland; [Santos, Maria J.] Univ Zurich, Dept Geog, Zurich, Switzerland	Universidade dos Acores; Universidade de Santiago de Compostela; Universidade de Lisboa; Universidade dos Acores; University of Zurich; University of Zurich	Lamelas-Lopez, L (corresponding author), Univ Azores, CE3c Ctr Ecol Evolut & Environm Changes, Azorean Biodivers Grp, Dept Environm Sci & Engn,Fac Agr & Environm, Azores, Portugal.	lucas.l.lopez@uac.pt	Amorim do Rosario, Isabel/AAW-2610-2020; Borges, Paulo/B-2780-2008; Santos, Maria Joao/M-5034-2013	Amorim do Rosario, Isabel/0000-0001-6847-3320; Santos-Reis, Margarida/0000-0002-0337-963X; Pardavila, Xose/0000-0001-9772-0052; Lamelas Lopez, Lucas/0000-0002-2230-7033; Borges, Paulo/0000-0002-8448-7623; Santos, Maria Joao/0000-0002-6558-7477	Fundacao para a Ciencia e Tecnologia -FCT [SFRH/BD/115022/2016, UID/BIA/00329/2019, SFRH/BPD/102804/2014]; University Research Priority Program in Global Change and Biodiversity from the University of airich	Fundacao para a Ciencia e Tecnologia -FCT(Portuguese Foundation for Science and Technology); University Research Priority Program in Global Change and Biodiversity from the University of airich	LLL (SFRH/BD/115022/2016) and PAVB and MSR (UID/BIA/00329/2019) and IAR (SFRH/BPD/102804/2014) were supported by the Fundacao para a Ciencia e Tecnologia -FCT. MJS was supported by the University Research Priority Program in Global Change and Biodiversity from the University of airich.	Alcover JA, 2015, ZOOTAXA, V4057, P151, DOI 10.11646/zootaxa.4057.2.1; Aparicio BA, 2018, J INSECT CONSERV, P1; Araujo MB, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat4858; Arechavaleta M, 2009, HONGOS PLANTAS ANIMA; Assing V, 2010, LIST TERRESTRIAL MAR; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x; Bellard C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0623; Bencatel J., 2019, ATLAS MAMIFEROS PORT, V2nd; Bicknell TWJ, 2009, BIRD STUDY, V56, P419, DOI 10.1080/00063650903216618; Borges PAV, 2006, J BIOGEOGR, V33, P169, DOI 10.1111/j.1365-2699.2005.01324.x; Bried Joel, 2009, Ecological Restoration, V27, P27, DOI 10.3368/er.27.1.27; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Burnham K P, 2003, MODEL SELECT MULTIMO; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cardoso P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063294; Rando JC, 2013, ZOOTAXA, V3647, P343, DOI 10.11646/zootaxa.3647.2.6; CEBALLOS G, 1995, CONSERV BIOL, V9, P559, DOI 10.1046/j.1523-1739.1995.09030559.x; Clapperton BK, 2001, J ROY SOC NEW ZEAL, V31, P185, DOI 10.1080/03014223.2001.9517647; Clout MN, 2008, WILDLIFE RES, V35, P180, DOI 10.1071/WR07091; Collares-Pereira M, 2000, EUR J EPIDEMIOL, V16, P1151, DOI 10.1023/A:1010916132497; Corbett GB, 1980, MAMMALS BRITAIN EURO; Costa M, 2013, MOL ECOL, V22, P5130, DOI 10.1111/mec.12456; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Cuyckens GAE, 2015, J ARID ENVIRON, V115, P14, DOI 10.1016/j.jaridenv.2014.12.009; de Azevedo EB, 1999, AGR WATER MANAGE, V40, P393, DOI 10.1016/S0378-3774(99)00012-8; Doherty TS, 2016, P NATL ACAD SCI USA, V113, P11261, DOI 10.1073/pnas.1602480113; Dungan JL, 2002, ECOGRAPHY, V25, P626, DOI 10.1034/j.1600-0587.2002.250510.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Fitzpatrick MC, 2005, Invasive Plants: Ecological and Agricultural Aspects, P45, DOI 10.1007/3-7643-7380-6_3; Frutuoso G, 1561, SAUDADES TERRA; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Gaspar Clara, 2008, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, P1; Global Invasive Species Database, 2018, SPEC PROF MUST NIV; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hervias S, 2014, J ZOOL, V292, P39, DOI 10.1111/jzo.12082; Hervias S, 2013, BIOL INVASIONS, V15, P143, DOI 10.1007/s10530-012-0274-1; Hortal J, 2008, OIKOS, V117, P847, DOI 10.1111/j.0030-1299.2008.16434.x; Hortal J, 2010, J NAT CONSERV, V18, P247, DOI 10.1016/j.jnc.2009.11.002; Innes J., 1990, HDB NZ MAMMALS; Kauhala K, 1996, WILDLIFE BIOL, V2, P197, DOI 10.2981/wlb.1996.019; King CM., 2005, HDB NZ MAMMALS; Kuemmerle T, 2010, BIOL CONSERV, V143, P908, DOI 10.1016/j.biocon.2009.12.038; Lever C, 1985, NATURALIZED MAMMALS; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Long JL, 2003, INTRO MAMMALS WORLD; Long RA, 2011, LANDSCAPE ECOL, V26, P327, DOI 10.1007/s10980-010-9547-1; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mathias ML, 1998, MAMMALIA, V62, P397, DOI 10.1515/mamm.1998.62.3.397; McDonald RA, 2019, IUCN RED LIST THREAT; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Monteiro LR, 1996, BIOL CONSERV, V78, P319, DOI 10.1016/S0006-3207(96)00037-7; Neves Veronica C., 2011, Arquipelago-Life and Marine Sciences, P15; Ordenana MA, 2010, J MAMMAL, V91, P1322, DOI 10.1644/09-MAMM-A-312.1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pitta-Groz M, 2002, P WORKSH INV AL SPEC; Proosdij ASJ, 2016, ECOGRAPHY, V39, P542, DOI DOI 10.1111/ECOG.01509; Ragg JR, 1998, NEW ZEAL J ECOL, V22, P113; Rando JC, 2017, ZOOTAXA, V4282, P567, DOI 10.11646/zootaxa.4282.3.9; Rilov G, 2004, BIOL INVASIONS, V6, P347, DOI 10.1023/B:BINV.0000034614.07427.96; Rodrigues M, 2017, BIOL INVASIONS, V19, P399, DOI 10.1007/s10530-016-1287-y; Santos MJ, 2009, MAMM BIOL, V74, P446, DOI 10.1016/j.mambio.2009.08.007; Seebens H., 2018, P NATL ACAD SCI USA; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Sheffield Steven R., 1994, Mammalian Species, V454, P1; Skumatov D., 2016, IUCN RED LIST THREAT, V2016, DOI [10.2305/IUCN.UK.2016-1.RLTS.T41658A45214384.en, DOI 10.2305/IUCN.UK.2016-1.RLTS.T41658A45214384.EN]; SLA (Servicezentrum Landentwicklung und Agrarforderung), 2019, SCHLAEG 2019 HAUPTZ; Smith GP, 1995, NEW ZEAL J ZOOL, V22, P363, DOI 10.1080/03014223.1995.9518054; Terzopoulou S, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0273; Towns DR, 2011, ANIM CONSERV, V14, P466, DOI 10.1111/j.1469-1795.2011.00497.x; Triantis KA, 2010, ECOGRAPHY, V33, P285, DOI 10.1111/j.1600-0587.2010.06203.x; Vaclavik T, 2012, J BIOGEOGR, V39, P42, DOI 10.1111/j.1365-2699.2011.02589.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Welk E, 2002, DIVERS DISTRIB, V8, P219, DOI 10.1046/j.1472-4642.2002.00144.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602	82	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237216	10.1371/journal.pone.0237216	http://dx.doi.org/10.1371/journal.pone.0237216			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764786	Green Accepted, Green Published, gold			2022-12-26	WOS:000561029000071
J	Oya, M; Taniguchi, Y; Fujimura, N; Miyamoto, K; Oya, M				Oya, Miyako; Taniguchi, Yosuke; Fujimura, Naoaki; Miyamoto, Karen; Oya, Masaru			Kinetic analysis of hemoglobin detergency by probability density functional method	PLOS ONE			English	Article							STAINLESS-STEEL SURFACE; ADENOSINE-TRIPHOSPHATE; CLEANING ASSESSMENT; SINGLE-USE; SOIL; VALIDATION; REMOVAL; PROTEIN; BLOOD; EFFICIENCY	In this study, washing tests were performed using samples prepared by contaminating fabrics with hemoglobin, and a kinetic analysis was conducted based the probability density functional method, which expresses the cleaning power using two parameters sigma(rl)(related to the cleaning mechanism) and mu(rl)(related to the level of cleaning power). This method allows for the processing of uncertainties specific to protein washing under the assumption that the soil adhesion and detergency are in accordance with a normal distribution. A certain amount of hemoglobin solution was soaked in a cloth, dried, and steam-treated, and then used as a sample for a cleaning test. Two parameters sigma(rl)and mu(rl)were calculated based on the detergency (%) after 5 min, 10 min, 15 min, and 20 min of washing with respect to different pH and temperature levels, and different sodium dodecyl sulfate (SDS) concentration and temperature levels. Based on the results, the value of sigma(rl)indicated that the hemoglobin was removed by the dissolving action. In addition,mu(rl)increased in accordance with an increase in the pH, SDS concentration, and temperature. With respect to mu(rl), the relationship of Delta X+Delta Y=Delta(X+Y)was observed in several cases, where Delta Xrepresents the effect of the pH or SDS concentration,Delta Yis the temperature effect, and Delta(X+Y)is the combined effect. Therefore, there may be an additive relationship between the pH and temperature effects, and the SDS concentration and temperature effects.	[Oya, Miyako] Kimitsu Chuo Hosp, Surg Dept, Kisarazu, Chiba, Japan; [Taniguchi, Yosuke; Fujimura, Naoaki; Miyamoto, Karen; Oya, Masaru] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa, Japan	Yokohama National University	Oya, M (corresponding author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa, Japan.	moya@ynu.ac.jp		Oya, Masaru/0000-0001-8647-3914	Japan Society for the Promotion of Science (JSPS) [17H01953, 17H00814]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The author (Masaru Oya) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by Grant-in -Aid for Scientific Research (B) (17H01953) and Grantin -Aid for Scientific Research (A) (17H00814) from Japan Society for the Promotion of Science (JSPS).	Alfa MJ, 2006, INFECT CONT HOSP EP, V27, P841, DOI 10.1086/506397; Alfa MJ, 2016, J HOSP INFECT, V93, P83, DOI 10.1016/j.jhin.2016.01.023; Alfa MJ, 2010, J HOSP INFECT, V74, P168, DOI 10.1016/j.jhin.2009.06.030; Alfa MJ, 2006, AM J INFECT CONTROL, V34, P561, DOI 10.1016/j.ajic.2006.01.010; Alfa MJ, 2014, AM J INFECT CONTROL, V42, pE1, DOI 10.1016/j.ajic.2013.08.007; Alfa MJ, 2013, AM J INFECT CONTROL, V41, pS56, DOI 10.1016/j.ajic.2012.12.006; Alfa MJ, 2013, AM J INFECT CONTROL, V41, P245, DOI 10.1016/j.ajic.2012.03.018; Alfa MJ, 2013, AM J INFECT CONTROL, V41, P249, DOI 10.1016/j.ajic.2012.03.015; Alfa MJ, 2012, AM J INFECT CONTROL, V40, P860, DOI 10.1016/j.ajic.2011.10.006; Alfa MJ, 2003, AM J INFECT CONTROL, V31, P193, DOI 10.1067/mic.2003.22; BOURNE MC, 1963, J AM OIL CHEM SOC, V40, P523, DOI 10.1007/BF02822457; BOURNE MC, 1963, J AM OIL CHEM SOC, V40, P517, DOI 10.1007/BF02822456; BOURNE MC, 1965, J AM OIL CHEM SOC, V42, P546, DOI 10.1007/BF02540100; Freudenthal A.M., 1966, J STRUCT DIV, V92, P267; Fujimoto A, 2017, J OLEO SCI, V66, P1109, DOI 10.5650/jos.ess17043; Fushimi R, 2013, AM J INFECT CONTROL, V41, P161, DOI 10.1016/j.ajic.2012.02.030; Gelamo EL, 2002, BBA-PROTEIN STRUCT M, V1594, P84, DOI 10.1016/S0167-4838(01)00287-4; Gold KM, 2013, AM J INFECT CONTROL, V41, P901, DOI 10.1016/j.ajic.2013.01.029; Gonzalez EA, 2017, AM J INFECT CONTROL, V45, P194, DOI 10.1016/j.ajic.2016.07.025; Hamed MMA, 2015, ALEX J MED, V51, P95, DOI 10.1016/j.ajme.2014.05.002; Htwe EE, 2017, COLLOID SURFACE B, V159, P118, DOI 10.1016/j.colsurfb.2017.07.074; Ishikawa Y, 2006, J OLEO SCI, V55, P511, DOI [10.5650/jos.55.511, DOI 10.5650/JOS.55.511]; Ishikawa Yusuke, 2007, J Oleo Sci, V56, P163; Ishikawa Y, 2008, J OLEO SCI, V57, P99, DOI 10.5650/jos.57.99; JACOBS TL, 1992, J ENVIRON ENG-ASCE, V118, P878, DOI 10.1061/(ASCE)0733-9372(1992)118:6(878); JENNINGS WG, 1959, J DAIRY SCI, V42, P1763, DOI 10.3168/jds.S0022-0302(59)90806-9; KISSA E, 1975, TEXT RES J, V45, P736, DOI 10.1177/004051757504501007; Kurono R, 2013, J JPN RES ASS TEXT E, V54, P750, DOI [10.11419/senshoshi.54.8_750, DOI 10.11419/SENSHOSHI.54.8_750]; Kurono R, 2013, J OLEO SCI, V62, P223, DOI 10.5650/jos.62.223; Liu W, 2007, INT J BIOL MACROMOL, V41, P548, DOI 10.1016/j.ijbiomac.2007.07.006; Murray BS, 1998, COLLOID SURFACE B, V10, P227, DOI 10.1016/S0927-7765(97)00066-0; Nagata A, 1995, BIOSCI BIOTECH BIOCH, V59, P2277, DOI 10.1271/bbb.59.2277; Oya M, 2019, TEXT RES J, V89, P2236, DOI 10.1177/0040517518790978; PATRICK RL, 1961, J COLL SCI IMP U TOK, V16, P93, DOI 10.1016/0095-8522(61)90010-1; Penna TCV, 2000, INFECT CONT HOSP EP, V21, P499, DOI 10.1086/501793; Sakiyama T, 1998, J FERMENT BIOENG, V85, P297, DOI 10.1016/S0922-338X(97)85678-4; SCHOTT H, 1975, J AM OIL CHEM SOC, V52, P225, DOI 10.1007/BF02639146; Smith GWG, 2012, AM J INFECT CONTROL, V40, pE255, DOI 10.1016/j.ajic.2012.05.009; Tardioli S, 2010, J COLLOID INTERF SCI, V347, P96, DOI 10.1016/j.jcis.2010.03.017; UTERMOHLEN WP, 1947, TEXT RES J, V17, P670, DOI 10.1177/004051754701701203; Vaughn TH, 1941, IND ENG CHEM, V33, P1011, DOI 10.1021/ie50380a011	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237255	10.1371/journal.pone.0237255	http://dx.doi.org/10.1371/journal.pone.0237255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764804	Green Published, gold			2022-12-26	WOS:000561029000074
J	Kauttonen, J; Hannukainen, J; Tikka, P; Suomala, J				Kauttonen, Janne; Hannukainen, Jenni; Tikka, Pia; Suomala, Jyrki			Predictive modeling for trustworthiness and other subjective text properties in online nutrition and health communication	PLOS ONE			English	Article							INFORMATION-SEEKING; BIASED ASSIMILATION; PREFERENCES; DECEPTION; COHERENCE; CUES; LIE	While the internet has democratized and accelerated content creation and sharing, it has also made people more vulnerable to manipulation and misinformation. Also, the received information can be distorted by psychological biases. This is problematic especially in health-related communications which can greatly affect the quality of life of individuals. We assembled and analyzed 364 texts related to nutrition and health from Finnish online sources, such as news, columns and blogs, and asked non-experts to subjectively evaluate the texts. Texts were rated for their trustworthiness, sentiment, logic, information, clarity, and neutrality properties. We then estimated individual biases and consensus ratings that were used in training regression models. Firstly, we found that trustworthiness was significantly correlated to the information, neutrality and logic of the texts. Secondly, individual ratings for information and logic were significantly biased by the age and diet of the raters. Our best regression models explained up to 70% of the total variance of consensus ratings based on the low-level properties of texts, such as semantic embeddings, presence of key-terms and part-of-speech tags, references, quotes and paragraphs. With a novel combination of crowdsourcing, behavioral analysis, natural language processing and predictive modeling, our study contributes to the automated identification of reliable and high-quality online information. While critical evaluation of truthfulness cannot be surrendered to the machine only, our findings provide new insights into automated evaluation of subjective text properties and analysis of morphologically-rich languages in regards to trustworthiness.	[Kauttonen, Janne] Haaga Helia Univ Appl Sci, Digital Business, Helsinki, Finland; [Kauttonen, Janne; Hannukainen, Jenni; Suomala, Jyrki] Laurea Univ Appl Sci, NeuroLab, Espoo, Finland; [Tikka, Pia] Tallinn Univ, Enact Virtual Lab, Balt Film Media Arts & Commun Sch, Tallinn, Estonia	Haaga-Helia University of Applied Sciences; Laurea University of Applied Sciences; Tallinn University	Kauttonen, J (corresponding author), Haaga Helia Univ Appl Sci, Digital Business, Helsinki, Finland.; Kauttonen, J (corresponding author), Laurea Univ Appl Sci, NeuroLab, Espoo, Finland.	janne.kauttonen@haaga-helia.fi		Tikka, pia/0000-0003-3658-7993; Kauttonen, Janne/0000-0003-2432-5072	Helsingin Sanomat Foundation; Estonian Research Council via grant MOBTT90	Helsingin Sanomat Foundation; Estonian Research Council via grant MOBTT90	This work is part of the "Confidence AI" project funded by Helsingin Sanomat Foundation (https://www.hssaatio.fi) through "The post-truth era" research program (JK,JH,JS). The work was supported by the Estonian Research Council (https://www.etag.ee) via grant MOBTT90 (PT).	AFROZ S, 2012, P IEEE S SECUR PRIV, P00461, DOI DOI 10.1109/SP.2012.34; Amorim E, 2018, NAACL, P229; [Anonymous], 1995, J R STAT SOC B; BROMME R, 2014, EDUC PSYCHOL US, V0049, P00059, DOI DOI 10.1080/00461520.2014.921572; BROUSSARD KM, 2000, TESOL QUART, V0034, P00787; CHANG LJ, 2010, COGNITIVE PSYCHOL, V0061, P00087; Cialdini RB, 2008, INFLUENCE SCI PRACTI, V5th; CIAMPAGLIA GL, 2015, PLOS ONE, V0010; COZMA M, 2018, P 56 ANN M ASS COMP, P00503; Crawford M, 2015, J BIG DATA, P2, DOI [10.1186/s40537-015-0029-9, DOI 10.1186/S40537-015-0029-9]; DEMICHELI V, 2012, COCHRANE DB SYST REV; DRUCKER H, 1997, ADV NEUR IN, V0009, P00155; EASTIN MS, 2006, CYBERPSYCHOL BEHAV, V0009, P00494; ELLETT FS, 1986, SYNTHESE, V0067, P00157, DOI DOI 10.1007/BF00540066; ESCOFFERY C, 2005, J AM COLL HEALTH, V0053, P00183; Feng S, 2012, P 50 ANN M ASS COMP, V2, P171; Gardner RC, 2001, PSYCHOL STAT USING S; GAZIANO C, 1986, JOURNALISM QUART, V0063, P00451, DOI DOI 10.1177/107769908606300301; Ginter F, 2017, LINDAT CLARIN DIGITA; GOLDBERG LR, 2002, PERS INDIV DIFFER, V0032, P00049, DOI DOI 10.1016/S0191-8869(01)00005-8; Gorman SE, 2016, DENYING GRAVE WHY WE; Graves L., 2018, UNDERSTANDING PROMIS; GRAY NJ, 2005, SOC SCI MED, V0060, P01467; HANCOCK JT, 2008, DISCOURSE PROCESS, V0045, P00001, DOI DOI 10.1080/01638530701739181; Hardalov M, 2016, INT C ART INT METH S; HASSAN N, 2017, KDD17 P 23 ACM, P01803, DOI DOI 10.1145/3097983.3098131; HAUCH V, 2015, PERS SOC PSYCHOL REV, V0019, P00307; Hautamaki A., 2020, VIEWPOINT RELATIVISM, DOI [10.1007/978-3-030-34595-2, DOI 10.1007/978-3-030-34595-2]; Joulin A., 2016, ARXIV161203651; KAHAN DM, 2011, J RISK RES, V0014, P00147, DOI DOI 10.1080/13669877.2010.511246; Kakkonen T, 2006, SCIENCE, V80, P500; KIM HK, 2017, NEUROCOMPUTING, V0266, P00336, DOI DOI 10.1016/J.NEUCOM.2017.05.046; KIM S, 2005, J GERONTOL B PSYCHOL, V0060, pP 215; KOREN Y, 2009, COMPUTER, V0042, P00030, DOI DOI 10.1109/MC.2009.263; KOREN Y, 2011, REC SYST HDB, P00145, DOI DOI 10.1007/978-0-387-85820-3_5; Korenius T, 2004, P 13 ACM C INF KNOWL, P625; Kumar V, 2017, J WRIT ANAL, V1, P176; KUNDA Z, 1990, PSYCHOL BULL, V0108, P00480, DOI DOI https://doi.org/10.1037/0033-2909.108.3.480; Lehmann EL, 2006, NONPARAMETRICS STAT; LILLEBERG J, 2015, P 2015 IEEE 14 INT, P00136; LORD CG, 1979, J PERS SOC PSYCHOL, V0037, P02098, DOI DOI 10.1037/0022-3514.37.11.2098; LORD CG, 2009, SOC PERSONAL PSYCHOL, V0003, P00827, DOI DOI 10.1111/J.1751-9004.2009.00203.X; MALKA A, 2009, RISK ANAL, V0029, P00633; Mavragani A, 2018, BDCC, V2, P2, DOI [10.3390/bdcc2010002, DOI 10.3390/BDCC2010002]; McIntyre L., 2018, POST TRUTH; MCNEIL BJ, 1982, NEW ENGL J MED, V0306, P01259; Mikolov T., 2013, P ICLR WORKSH 2013, P1; Mitchell BYA, 2017, PEW RES CENT, P1; Mitra Tanushree, 2014, CSCW C, P49, DOI [10.1145/2531602.2531656, DOI 10.1145/2531602.2531656]; MUNRO GD, 2010, J APPL SOC PSYCHOL, V0040, P00579, DOI DOI 10.1111/J.1559-1816.2010.00588.X; NEWMAN ML, 2003, PERS SOC PSYCHOL B, V0029, P00665; Newman N, 2017, REUTERS I DIGITAL NE; Ott M, 2011, 49 ANN M ASS COMP LI, P309; PAN LY, 2011, J INTERACT MARK, V0025, P00067, DOI DOI 10.1016/J.INTMAR.2011.01.002; Pedregosa F, 2017, J MACHINE LEARNING R; Phandi P, 2015, EMNLP, P431, DOI [10.18653/v1/D15-1049, DOI 10.18653/V1/D15-1049]; Pisarevskaya D, 2017, NATURAL LANGUAGE PRO, P1; QUIJANOSANCHEZ L, 2018, KNOWL BASED SYST, V0149, P00155, DOI DOI 10.1016/J.KNOSYS.2018.03.010; RICCI F, 2011, REC SYST HDB, P00001, DOI DOI 10.1007/978-0-387-85820-3_1; SLATER MD, 1997, JOURNALISM MASS COMM, V0074, P00108, DOI DOI 10.1177/107769909707400109; Sloman S, 2017, KNOWLEDGE ILLUSION W; Snow R, 2008, P C EMP METH NAT LAN, P254; StrOmsO HI, 2017, B SCI TECHNOL SOC, V37, DOI [10.1177/0270467617740495, DOI 10.1177/0270467617740495]; STROMSO HI, 2011, EDUC PSYCHOL UK, V0031, P00177, DOI DOI 10.1080/01443410.2010.538039; THAGARD P, 2011, LOGIC EPISTEMOL UNIT, V0021, P00329, DOI DOI 10.1007/978-90-481-9609-8_14; THAGARD P, 2007, PHILOS SCI, V0074, P00028, DOI DOI 10.1086/520941; THAGARD P, 2012, SOUTHERN J PHILOS, V0050, P00042, DOI DOI 10.1111/J.2041-6962.2011.00091.X; Tikhonov AN, 1978, MATH COMPUT, V32, P491; WU ZH, 2012, PHYSICA A, V0391, P02475, DOI DOI 10.1016/J.PHYSA.2011.12.019; Yamamoto Y, 2008, LECT NOTES COMPUTER, P206, DOI [10.1007/978-3-540-85481-4_17, DOI 10.1007/978-3-540-85481-4_17]; Yang D, 2015, EMPIRICAL METHODS NA, P2367; Zhou Z., 2012, DATA MINING KNOWLEDG; ZOU H, 2005, J R STAT SOC B 2, V0067, P00301, DOI DOI 10.1111/J.1467-9868.2005.00503.X	73	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0237144	10.1371/journal.pone.0237144	http://dx.doi.org/10.1371/journal.pone.0237144			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2EP	32760095	Green Published, gold			2022-12-26	WOS:000561027200021
J	Mbuvha, R; Marwala, T				Mbuvha, Rendani; Marwala, Tshilidzi			Bayesian inference of COVID-19 spreading rates in South Africa	PLOS ONE			English	Article								The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has highlighted the need for performing accurate inference with limited data. Fundamental to the design of rapid state responses is the ability to perform epidemiological model parameter inference for localised trajectory predictions. In this work, we perform Bayesian parameter inference using Markov Chain Monte Carlo (MCMC) methods on the Susceptible-Infected-Recovered (SIR) and Susceptible-Exposed-Infected-Recovered (SEIR) epidemiological models with time-varying spreading rates for South Africa. The results find two change points in the spreading rate of COVID-19 in South Africa as inferred from the confirmed cases. The first change point coincides with state enactment of a travel ban and the resultant containment of imported infections. The second change point coincides with the start of a state-led mass screening and testing programme which has highlighted community-level disease spread that was not well represented in the initial largely traveller based and private laboratory dominated testing data. The results further suggest that due to the likely effect of the national lockdown, community level transmissions are slower than the original imported case driven spread of the disease.	[Mbuvha, Rendani] Univ Witwatersrand, Sch Stat & Actuarial Sci, Johannesburg, South Africa; [Mbuvha, Rendani; Marwala, Tshilidzi] Univ Johannesburg, Inst Intelligent Syst, Johannesburg, South Africa	University of Witwatersrand; University of Johannesburg	Mbuvha, R (corresponding author), Univ Witwatersrand, Sch Stat & Actuarial Sci, Johannesburg, South Africa.; Mbuvha, R (corresponding author), Univ Johannesburg, Inst Intelligent Syst, Johannesburg, South Africa.	rendani.mbuvha@wits.ac.za		Mbuvha, Rendani/0000-0002-7337-9176	Google PhD fellowship Programme	Google PhD fellowship Programme(Google Incorporated)	RM is supported by the Google PhD fellowship Programme. URL:https://research.google/outreach/phd-fellowship/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Blackwood JC., 2018, LETT BIOMATH, V5, P195, DOI [10.30707/LiB5.1Blackwood, DOI 10.30707/LIB5.1BLACKWOOD]; Boulkaibet I., 2012, TOPICS MODEL VALIDAT, V4, P75; Brauer F., 2008, CHAP COMPARTMENTAL M, P19, DOI [10.1007/978-3-540-78911-6_2, DOI 10.1007/978-3-540-78911-6_2, 10.1007/978-3-540-78911-6, DOI 10.1007/978-3-540-78911-6]; Dehning J, 2020, INFERRING COVID 19 S; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Ferguson NM, 2020, REPORT 9 IMPACT NONP; Hellewell J, 2020, FEASIBILITY CONTROLL; Karim SA, 2020, SAS COVID 19 PANDEMI; Lourenco J, 2020, FUNDAMENTAL PRINCIPL, DOI 10.1101/2020.03.24.20042291(2020; Mbuvha R, 2019, AUTOMATIC RELEVANCE; Mbuvha R, 2020, DAT DRIVEN MANAGEMEN; Mbuvha R, 2019, LECT NOTES COMPUT SC, V11731, P420, DOI 10.1007/978-3-030-30493-5_42; Ministry of Health RSA, 2020, UPD COVID 19; Neal Radford M, 2012, BAYESIAN LEARNING NE, V118; Neal Radford M, 2011, HDB MARKOV CHAIN MON, V2, P2, DOI DOI 10.1201/B10905-6; Song PX, 2020, EPIDEMIOLOGICAL FORE; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; WHO-China Joint Mission Members, 2020, REP WHO CHIN JOINT M; Zhou C, 2020, DETECTING SUSPECTED	20	24	24	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0237126	10.1371/journal.pone.0237126	http://dx.doi.org/10.1371/journal.pone.0237126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756608	Green Published, Green Submitted, gold			2022-12-26	WOS:000560393300031
J	Peltonen, R; Gramkow, MH; Dehlendorff, C; Osterlund, PJ; Johansen, JS; Isoniemi, H				Peltonen, Reetta; Gramkow, Mathias H.; Dehlendorff, Christian; Osterlund, Pia J.; Johansen, Julia S.; Isoniemi, Helena			Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases	PLOS ONE			English	Article							HEPATIC RESECTION; LIQUID BIOPSY; PLASMA YKL-40; CANCER; INTERLEUKIN-6; RECURRENCE; SURVIVAL; RECOMMENDATIONS; MANAGEMENT; ANTIBODY	Background The inflammatory biomarkers, YKL-40 and interleukin-6 (IL-6), are elevated in patients with metastatic colorectal cancer. We examined their associations with relapse-free survival and overall survival in combination with serum C-reactive protein (CRP), carcinoembryonic antigen (CEA), and carbohydrate antigen 19-9 (CA19-9) in patients with colorectal liver metastases. Methods Altogether 441 consecutive patients undergoing liver resection at Helsinki University Hospital between 1998 and 2013 were included in the study. Pre- and postoperative YKL-40 and IL-6 were determined from serum samples with commercially available enzyme-linked immunosorbent assay (ELISA) kits, and CRP, CEA, and CA19-9 by routine methods. Associations between these biomarkers and relapse-free and overall survival were examined using Cox regression analysis. Results Patients with 2-5 elevated biomarkers were at an increased risk of relapse compared to those with 0-1 elevated biomarkers, preoperatively (HR 1.37, 95% CI 1.1-1.72) or postoperatively (HR 1.54, 95% CI 1.23-1.92). Patients with 2-5 elevated biomarkers were also at an increased risk of death compared to those with 0-1 elevated biomarkers, preoperatively (HR 1.76, 95% CI 1.39-2.24) or postoperatively (HR 1.83, 95% CI 1.44-2.33). Conclusion The results suggest that a protein panel of the inflammatory biomarkers YKL-40, IL-6, and CRP, and the cancer biomarkers CEA and CA19-9 might identify patients that benefit from more aggressive treatment and surveillance, although the additional value of IL-6 and CRP in this aspect is limited.	[Peltonen, Reetta; Isoniemi, Helena] Univ Helsinki, Abdominal Ctr, Transplantat & Liver Surg, Helsinki, Finland; [Peltonen, Reetta; Isoniemi, Helena] Helsinki Univ Hosp, Helsinki, Finland; [Gramkow, Mathias H.; Johansen, Julia S.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Oncol, Herlev, Denmark; [Dehlendorff, Christian] Danish Canc Soc, Res Ctr, Stat & Pharmacoepidemiol, Copenhagen O, Denmark; [Osterlund, Pia J.] Tampere Univ Hosp, Dept Oncol, Tampere, Finland; [Osterlund, Pia J.] Univ Tampere, Tampere, Finland; [Osterlund, Pia J.] Helsinki Univ Hosp, Dept Oncol, Helsinki, Finland; [Osterlund, Pia J.] Univ Helsinki, Helsinki, Finland; [Johansen, Julia S.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Med, Herlev, Denmark; [Johansen, Julia S.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen K, Denmark	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Copenhagen; Danish Cancer Society; Tampere University; Tampere University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Copenhagen; University of Copenhagen	Peltonen, R (corresponding author), Univ Helsinki, Abdominal Ctr, Transplantat & Liver Surg, Helsinki, Finland.; Peltonen, R (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	reeta.peltonen@hus.fi	Gramkow, Mathias/GQI-2410-2022; Gramkow, Mathias Holsey/ABF-4706-2021	Osterlund, Pia/0000-0002-7124-3515; Gramkow, Mathias Holsey/0000-0002-3827-6489	Competitive State Research Financing of the Expert Responsibility Area of Helsinki University Hospital; Tampere University Hospital; Cancer Foundation Finland; Danish Cancer Society; Suomen Onkologiayhdistys; Finska Lakaresallskapet; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark	Competitive State Research Financing of the Expert Responsibility Area of Helsinki University Hospital; Tampere University Hospital; Cancer Foundation Finland; Danish Cancer Society(Danish Cancer Society); Suomen Onkologiayhdistys; Finska Lakaresallskapet; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark	This study was financially supported by the Competitive State Research Financing of the Expert Responsibility Area of Helsinki University Hospital (RP, PO, HI) and Tampere University Hospital (PO), the Cancer Foundation Finland (RP, PO, HI), Suomen Onkologiayhdistys (RP), the Danish Cancer Society (MG), and Finska Lakaresallskapet (PO). The YKL-40 and IL-6 kits and analysis were funded by the Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benesova L, 2019, WORLD J GASTROENTERO, V25, P6939, DOI 10.3748/wjg.v25.i48.6939; Bojesen SE, 2011, CLIN CHIM ACTA, V412, P709, DOI 10.1016/j.cca.2011.01.022; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bredt LC, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-391; Del Giudice M, 2018, BRAIN BEHAV IMMUN, V70, P61, DOI 10.1016/j.bbi.2018.02.013; Dijkgraaf EM, 2015, ANN ONCOL, V26, P2141, DOI 10.1093/annonc/mdv309; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He YP, 2020, CANCER MANAG RES, V12, P1621, DOI 10.2147/CMAR.S240869; Jayatilaka H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15584; Jefri M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1592-3; Johansen JS, 2009, J CLIN ONCOL, V27, P572, DOI 10.1200/JCO.2008.18.8367; Kanas Gena P, 2012, Clin Epidemiol, V4, P283, DOI 10.2147/CLEP.S34285; Knudsen LS, 2008, BIOMARKERS, V13, P59, DOI 10.1080/13547500701615017; Knupfer H, 2010, INT J COLORECTAL DIS, V25, P135, DOI 10.1007/s00384-009-0818-8; Kostner AH, 2016, J SURG ONCOL, V114, P895, DOI 10.1002/jso.24415; Kumara HMCS, 2016, WORLD J GASTRO ONCOL, V8, P607, DOI 10.4251/wjgo.v8.i8.607; Lee JW, 2019, NATURE, V567, P249, DOI 10.1038/s41586-019-1004-y; Lippitz BE, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1093722; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Margonis GA, 2018, JAMA SURG, V153, DOI 10.1001/jamasurg.2018.0996; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Nagasaki T, 2014, BRIT J CANCER, V110, P469, DOI 10.1038/bjc.2013.748; Nasr R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071867; Nicholson BD, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011134.pub2; Nielsen AR, 2011, CYTOKINE, V55, P152, DOI 10.1016/j.cyto.2011.03.014; Nilsonne G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165799; Normanno N, 2018, CANCER TREAT REV, V70, P1, DOI 10.1016/j.ctrv.2018.07.007; Peltonen R., 2018, TUMOUR BIOL, V40, P1, DOI [10.1177/1010428317752944, DOI 10.1177/1010428317752944]; Porporato PE, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.3; Qiu QC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33239-8; Rossi JF, 2015, CLIN CANCER RES, V21, P1248, DOI 10.1158/1078-0432.CCR-14-2291; Sakamoto Y, 2015, ANTICANCER RES, V35, P2359; Sorbye H, 2007, ANN ONCOL, V18, P1666, DOI 10.1093/annonc/mdm267; Spelt L, 2012, EJSO-EUR J SURG ONC, V38, P16, DOI 10.1016/j.ejso.2011.10.013; Tarpgaard LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087746; Thomsen M, 2018, BRIT J CANCER, V118, P1609, DOI 10.1038/s41416-018-0115-9; Thomsen M, 2016, ONCOTARGET, V7, P75013, DOI 10.18632/oncotarget.12601; Vainer Noomi, 2018, Oncotarget, V9, P29820, DOI 10.18632/oncotarget.25661; Vauthey JN, 2013, ANN SURG, V258, P619, DOI 10.1097/SLA.0b013e3182a5025a; Vigano L, 2014, ANN SURG ONCOL, V21, P1276, DOI 10.1245/s10434-013-3421-8; Wolf J, 2014, CYTOKINE, V70, P11, DOI 10.1016/j.cyto.2014.05.024; Yamada T, 2019, DIGESTION, V99, P39, DOI 10.1159/000494411; Yeh KY, 2010, JPN J CLIN ONCOL, V40, P580, DOI 10.1093/jjco/hyq010; Yeo IJ, 2019, PHARMACOL THERAPEUT, V203, DOI 10.1016/j.pharmthera.2019.107394	46	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236569	10.1371/journal.pone.0236569	http://dx.doi.org/10.1371/journal.pone.0236569			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756596	Green Published, gold			2022-12-26	WOS:000560393300055
J	Qian, CY; Liu, H; Feng, Y; Meng, SL; Wang, D; Nie, M; Xu, MF				Qian, Chengyuan; Liu, Hong; Feng, Yan; Meng, Shenglan; Wang, Dong; Nie, Mao; Xu, Mingfang			Clinical characteristics and risk of second primary lung cancer after cervical cancer: A population-based study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; INTERNATIONAL ASSOCIATION; ADENOCARCINOMA; RADIOTHERAPY; STATISTICS; TRENDS; MEN	Background Lung cancer is increasingly common as a second primary malignancy. However, the clinical characteristics of second primary non-small cell lung cancer after cervical cancer (CC-NSCLC) compared with first primary non-small cell lung cancer (NSCLC1) is unknown. Methods The Surveillance, Epidemiology, and End Results (SEER) cancer registry between 1998 and 2010 was used to conduct a large population-based cohort analysis. The demographic and clinical characteristics, as well as prognostic data, were systematically analyzed. The overall survival (OS) in the two cohorts was further compared. The risk factors of second primary lung cancer in patients with cervical cancer were also analyzed. Results A total of 557 patients (3.52%) developed second primary lung cancer after cervical cancer, and 451 were eligible for inclusion in the final analyses. Compared with NSCLC1, patients with CC-NSCLC had a higher rate of squamous cell carcinoma (SCC) (36.59% vs 19.07%,P< 0.01). The median OS was longer for CC-NSCLC than for NSCLC1 before propensity score matching (PSM) (16 months vs. 13 months) but with no significant difference after PSM (16 months vs. 17 months). The high-risk factors for the development of cervical cancer to CC-NSCLC include age 50-79 years, black race [odds ratio (OR) 1.417; 95% confidence interval (CI) 1.095-1.834;P< 0.05], and history of radiotherapy (OR 1.392; 95% CI 1.053-1.841;P< 0.05). Conclusion Age 50-79 years, black race, and history of radiotherapy were independent risk factors for second primary lung cancer in patients with cervical cancer. Patients with CC-NSCLC had distinctive clinical characteristics and better prognosis compared with patients with NSCLC1.	[Qian, Chengyuan; Liu, Hong; Feng, Yan; Wang, Dong; Xu, Mingfang] Army Med Univ, Daping Hosp, Canc Ctr, Chongqing, Peoples R China; [Meng, Shenglan] Army Med Univ, Daping Hosp, Dept Thorac Surg, Chongqing, Peoples R China; [Nie, Mao] Chongqing Med Univ, Dept Orthopaed Surg, Affiliated Hosp 2, Chongqing, Peoples R China	Army Medical University; Army Medical University; Chongqing Medical University	Xu, MF (corresponding author), Army Med Univ, Daping Hosp, Canc Ctr, Chongqing, Peoples R China.; Nie, M (corresponding author), Chongqing Med Univ, Dept Orthopaed Surg, Affiliated Hosp 2, Chongqing, Peoples R China.	302218@cqmu.edu.cm; xusiyi023@126.com	Nie, Mao/GZM-0399-2022		National Natural Science Foundation of China (NSFC) [81502241]; Kuanren Talents Program of the second affiliated hospital of Chongqing Medical University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Kuanren Talents Program of the second affiliated hospital of Chongqing Medical University	This work was supported by grants from the National Natural Science Foundation of China (NSFC) No. 81502241 to CQ, and Kuanren Talents Program of the second affiliated hospital of Chongqing Medical University to MN.	Aguilar EJ, 2019, ANN ONCOL, V30, P1653, DOI 10.1093/annonc/mdz288; Barta JA, 2019, ANN GLOB HEALTH, V85, DOI 10.5334/aogh.2419; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bright C, 2019, LANCET ONCOL, V20, P531, DOI 10.1016/S1470-2045(18)30903-3; Chaturvedi AK, 2009, J CLIN ONCOL, V27, P967, DOI 10.1200/JCO.2008.18.4549; de Gonzalez AB, 2011, LANCET ONCOL, V12, P353, DOI 10.1016/S1470-2045(11)70061-4; Eraumeni JE, 2006, NEW MALIGNANCIES CAN, P1; Faurschou A, 2007, EXP DERMATOL, V16, P485, DOI 10.1111/j.1600-0625.2007.00551.x; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Jemal A, 2018, NEW ENGL J MED, V378, P1999, DOI [10.1056/NEJMoa1715907, 10.1056/nejmoa1715907]; Jin Jill, 2018, JAMA, V320, P732, DOI 10.1001/jama.2018.11365; Kuo SW, 2014, J THORAC CARDIOV SUR, V148, P1200, DOI 10.1016/j.jtcvs.2014.04.038; Li JJ, 2017, ONCOTARGET, V8, P89236, DOI 10.18632/oncotarget.19183; Lin YZ, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-1126-7; Lindeman NI, 2018, J MOL DIAGN, V20, P129, DOI 10.1016/j.jmoldx.2017.11.004; Liu SZ, 2018, CHINESE J CANCER RES, V30, P580, DOI 10.21147/j.issn.1000-9604.2018.06.02; Lortet-Tieulent J, 2014, LUNG CANCER, V84, P13, DOI 10.1016/j.lungcan.2014.01.009; Mariotto AB, 2007, CANCER EPIDEM BIOMAR, V16, P566, DOI 10.1158/1055-9965.EPI-06-0782; Naik A, 2016, CANCER RADIOTHER, V20, P370, DOI 10.1016/j.canrad.2016.05.011; Pan YJ, 2019, J THORAC ONCOL, V14, P2003, DOI 10.1016/j.jtho.2019.07.022; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Teng CJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001803; Travis William D, 2011, Proc Am Thorac Soc, V8, P381, DOI 10.1513/pats.201107-042ST; Woodard GA, 2016, CANCER TREAT RES, V170, P47, DOI 10.1007/978-3-319-40389-2_3; Zang RC, 2020, ANN THORAC SURG, V109, P389, DOI 10.1016/j.athoracsur.2019.08.017; Zhong YJ, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00404	26	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0231807	10.1371/journal.pone.0231807	http://dx.doi.org/10.1371/journal.pone.0231807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756555	gold, Green Published			2022-12-26	WOS:000560393300014
J	Shrestha, K; Van Strien, J; Singh, N; Inthavong, K				Shrestha, Kendra; Van Strien, James; Singh, Narinder; Inthavong, Kiao			Primary break-up and atomization characteristics of a nasal spray	PLOS ONE			English	Article							DROPLET-SIZE DISTRIBUTION; DEPOSITION; PARAMETERS	The primary objective of this research was to extract the essential information needed for setting atomization break up models, specifically, the Linear Instability Sheet Atomization (LISA) breakup model, and alternative hollow cone models. A secondary objective was to gain visualization and insight into the atomization break up mechanism caused by the effects of viscosity and surface tension on primary break-up, sheet disintegration, ligament and droplet formation. High speed imaging was used to capture the near-nozzle characteristics for water and drug formulations. This demonstrated more rapid atomization for lower viscosities. Image processing was used to analyze the near-nozzle spray characteristics during the primary break-up of the liquid sheet into ligament formation. Edges of the liquid sheet, spray break-up length, break-up radius, cone angle and dispersion angle were obtained. Spray characteristics pertinent for primary breakup modelling were determined from high speed imaging of multiple spray actuations. The results have established input data for computational modelling involving parametrical analysis of nasal drug delivery.	[Shrestha, Kendra; Van Strien, James; Inthavong, Kiao] RMIT Univ, Sch Engn, Mech & Automot Engn, Bundoora, Vic, Australia; [Singh, Narinder] Univ Sydney, Fac Med & Hlth, Sydney Med Sch, Sydney, NSW, Australia; [Singh, Narinder] Westmead Hosp, Dept Otolaryngol Head & Neck Surg, Sydney, NSW, Australia	Royal Melbourne Institute of Technology (RMIT); University of Sydney; University of Sydney	Inthavong, K (corresponding author), RMIT Univ, Sch Engn, Mech & Automot Engn, Bundoora, Vic, Australia.	kiao.inthavong@rmit.edu.au	inthavong, kiao/B-3526-2012	inthavong, kiao/0000-0003-0476-0237; Van Strien, James/0000-0002-5258-8892; Shrestha, Kendra/0000-0002-5919-8985	Garnett Passe and Rodney Williams Memorial Foundation Conjoint Grant 2019	Garnett Passe and Rodney Williams Memorial Foundation Conjoint Grant 2019	We gratefully acknowledge the financial support provided by Garnett Passe and Rodney Williams Memorial Foundation Conjoint Grant 2019 (to KI and NS).	Baumgarten C., 2006, HEAT MASS TRANSFER; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Cheng YS, 2001, J AEROSOL MED, V14, P267, DOI 10.1089/08942680152484199; Chung IP, 1998, 11 ANN C LIQ AT SPRA; Chung KY, 2000, ANN OCCUP HYG, V44, P455, DOI 10.1016/S0003-4878(00)00005-3; Dayal P, 2004, J PHARM SCI-US, V93, P1725, DOI 10.1002/jps.20090; De Villiers E, 2004, SAE TECHNICAL PAPERS; Dong JL, 2018, INT J PHARMACEUT, V543, P83, DOI 10.1016/j.ijpharm.2018.03.046; dos Santos F, 2011, OIL GAS SCI TECHNOLO; Doughty DV, 2010, J AEROSOL MED PULMON; Foo MY, 2007, J AEROSOL MED, V20, P495, DOI 10.1089/jam.2007.0638; Fung M.C., 2012, 9 INT C CFD MINERALS, P1; Fung MC, 2013, J PHARM SCI-US, V102, P1024, DOI 10.1002/jps.23449; Fung MC, 2012, AEROSOL SCI TECH, V46, P1219, DOI 10.1080/02786826.2012.704098; Guo C, 2006, J PHARM SCI-US; Han FW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203875; Huh K. Y., 1991, P INT C MULT FLOWS 9; Inthavong K, 2008, COMPUT BIOL MED, V38, P713, DOI 10.1016/j.compbiomed.2008.03.008; Inthavong K, 2012, AEROSOL SCI TECH, V46, P165, DOI 10.1080/02786826.2011.617793; Inthavong K, 2011, J AEROSOL SCI, V42, P100, DOI 10.1016/j.jaerosci.2010.11.008; Inthavong K, 2016, J VIS, P1; Inthavong K, 2015, J AEROSOL MED PULM D, V28, P59, DOI 10.1089/jamp.2013.1093; Inthavong K, 2014, PHARM RES-DORDR, V31, P1930, DOI 10.1007/s11095-013-1294-y; Jamali S., 2015, P 9 MEDITERRANEAN CO; Kelly JT, 2004, AEROSOL SCI TECH, V38, P1063, DOI 10.1080/027868290883360; Kimbell JS, 2007, J AEROSOL MED, V20, P59, DOI 10.1089/jam.2006.0531; Kirkpatrick MP, 2005, INT J HEAT MASS TRAN, V48, P341, DOI 10.1016/j.ijheatmasstransfer.2004.08.016; Kooij S, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.031019; Kundoor V, 2010, PHARM RES-DORD, V27, P30, DOI 10.1007/s11095-009-0002-4; Lelong N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078659; Liu XF, 2010, INT J PHARMACEUT, V388, P82, DOI 10.1016/j.ijpharm.2009.12.041; Newman S P, 1988, Rhinology, V26, P111; Senecal PK, 1999, INT J MULTIPHAS FLOW, V25, P1073, DOI 10.1016/S0301-9322(99)00057-9; SHAO CX, 2018, AIP ADV, V8, DOI DOI 10.1063/1.5017162; Sosnowski TR, 2019, INT J PHARMACEUT; Suh ES, 1999, SAE TECHNICAL PAPERS; Suman JD, 1999, PHARMACEUT RES, V16, P1648, DOI 10.1023/A:1011933410898; Tong XW, 2016, COMPUT BIOL MED, V77, P40, DOI 10.1016/j.compbiomed.2016.08.002	38	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236063	10.1371/journal.pone.0236063	http://dx.doi.org/10.1371/journal.pone.0236063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756567	gold, Green Published			2022-12-26	WOS:000560393300010
J	Tchounga, BK; Charpentier, C; Coffie, PA; Dabis, F; Descamps, D; Eholie, SP; Ekouevi, DK				Tchounga, Boris K.; Charpentier, Charlotte; Coffie, Patrick A.; Dabis, Francois; Descamps, Diane; Eholie, Serge P.; Ekouevi, Didier K.			Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d'Ivoire West Africa	PLOS ONE			English	Article							VITRO PHENOTYPIC SUSCEPTIBILITY; VIRAL LOAD ASSAY; HIV-2-INFECTED PATIENTS; REVERSE-TRANSCRIPTASE; INHIBITOR RESISTANCE; INTEGRASE INHIBITORS; SENEGAL IMPLICATIONS; CLINICAL-USE; VIRUS; THERAPY	Introduction The long-term prognosis of HIV-2-infected patients receiving antiretroviral therapy (ART) is still challenging, due to the intrinsic resistance to non-nucleoside reverse transcriptase inhibitors (NNRTI) and the suboptimal response to some protease inhibitors (PI). The objective was to describe the 5-years outcomes among HIV-2 patients harboring drug-resistant viruses. Methods A clinic-based cohort of HIV-2-patients experiencing virologic failure, with at least one drug resistance mutation was followed from January 2012 to August 2017 in Cote d'Ivoire. Follow-up data included death, lost to follow-up (LTFU), immuno-virological responses. The Kaplan-Meier curve was used to estimate survival rates. Results A total of 31 HIV-2 patients with virologic failure and with at least one drug resistance mutation were included. Two-third of them were men, 28(90.3%) were on PI-based ART-regimen at enrolment and the median age was 50 years (IQR = 46-54). The median baseline CD4 count and viral load were 456 cells/mm(3)and 3.7 log(10)c/mL respectively, and the participants have been followed-up in median 57 months (IQR = 24-60). During this period, 21 (67.7%) patients switched at least one antiretroviral drug, including two (6.5%) and three (9.7%) who switched to a PI-based and an integrase inhibitor-based regimen respectively. A total of 10(32.3%) patients died and 4(12.9%) were LTFU. The 36 and 60-months survival rates were 68.5% and 64.9%, respectively. Among the 17 patients remaining in care, six(35.3%) had an undetectable viral load (<50 c/mL) and for the 11 others, the viral load ranged from 2.8 to 5.6 log(10)c/mL. Twelve patients were receiving lopinavir at the time of first genotype, five(42%) had a genotypic susceptibility score (GSS) <= 1 and 4(33%) a GSS >2. Conclusions The 36-months survival rate among ART-experienced HIV-2 patients with drug-resistant viruses is below 70%,lower than in HIV-1. There is urgent need to improve access to second-line ART for patients living with HIV-2 in West Africa	[Tchounga, Boris K.] Programme PACCI, Site Rech ANRS Cote dIvoire, Abidjan, Cote Ivoire; [Charpentier, Charlotte; Descamps, Diane] Univ Paris, INSERM, UMR 1137, IAME, Paris, France; [Coffie, Patrick A.; Eholie, Serge P.] Univ Felix Houphouet Boigny, Dept Dermatol & Malad Infect, UFR Sci Med, Abidjan, Cote Ivoire; [Dabis, Francois; Ekouevi, Didier K.] Univ Bordeaux, Ctr Inserm 1219, Bordeaux, France; [Dabis, Francois; Ekouevi, Didier K.] Univ Bordeaux, Inst Sante Publ Epidemiol & Dev, Bordeaux, France; [Tchounga, Boris K.] Elizabeth Glazer Pediat AIDS Fdn Yaounde Off, Yaounde, Cameroon; [Dabis, Francois] Agence Natl Rech SIDA & Hepatites, Paris, France; [Ekouevi, Didier K.] Univ Lome, Fac Sci Sante, Dept Sante Publ, Lome, Togo	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Tchounga, BK (corresponding author), Programme PACCI, Site Rech ANRS Cote dIvoire, Abidjan, Cote Ivoire.; Tchounga, BK (corresponding author), Elizabeth Glazer Pediat AIDS Fdn Yaounde Off, Yaounde, Cameroon.	boris.tchounga@yahoo.fr		Tchounga, Boris Kevin/0000-0002-8747-9610	National Cancer Institute (NCI); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Allergy and Infectious Diseases (NIAID) [5U01AI069919]; EDCTP2 Training and Mobility Action [TMA 2016 CDF 1597 EDIIMark-2]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EDCTP2 Training and Mobility Action	The Main study was conducted under the IeDEA West Africa collaboration grants funded by the National Cancer Institute (NCI); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Allergy and Infectious Diseases (NIAID); Grant number: 5U01AI069919 awarded to Pr Francois Dabis. The specific analyses and results reported in this publication were conducted under the EDCTP2 Training and Mobility Action awarded to Dr Boris Kevin Tchounga as Career Development Fellowship grant. Grant number: TMA 2016 CDF 1597 EDIIMark-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, PAN ANT GUID AD AD G, P288; Avettand-Fenoel V, 2014, J CLIN MICROBIOL; Ba S, 2018, CLIN INFECT DIS, V67, P1588, DOI 10.1093/cid/ciy324; Balestre E, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20044; Benard A, 2011, CLIN INFECT DIS, V52, P1257, DOI 10.1093/cid/cir123; Borrego P, 2013, AIDS REV, V15, P49; Caixas U, 2012, J ANTIMICROB CHEMOTH, V67, P2538, DOI 10.1093/jac/dks240; Campbell-Yesufu OT, 2011, CLIN INFECT DIS, V52, P780, DOI 10.1093/cid/ciq248; Chang M, 2012, J CLIN VIROL, V55, P128, DOI 10.1016/j.jcv.2012.06.024; Charpentier C, 2014, AIDS, V28, P1161, DOI 10.1097/QAD.0000000000000244; Charpentier C, 2011, ANTIVIR THER, V16, P937, DOI 10.3851/IMP1826; Charpentier C, 2010, AIDS, V24, P2753, DOI 10.1097/QAD.0b013e32833f9e36; Damond F, 2004, ANTIVIR THER, V9, P635; Descamps D, 2015, CLIN INFECT DIS, V60, P1521, DOI 10.1093/cid/civ124; Ekouevi DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066135; Faria NR, 2012, J GEN VIROL, V93, P889, DOI 10.1099/vir.0.038638-0; Gilleece Y, 2010, HIV MED, V11, P611, DOI 10.1111/j.1468-1293.2010.00889.x; Gottlieb GS, 2008, AIDS, V22, P2069, DOI 10.1097/QAD.0b013e32830edd44; Gottlieb GS, 2009, CLIN INFECT DIS, V48, P476, DOI 10.1086/596504; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jallow S, 2009, J CLIN MICROBIOL, V47, P2200, DOI 10.1128/JCM.01654-08; Kong R, 2012, J VIROL, V86, P947, DOI 10.1128/JVI.06155-11; Matheron S, 2008, AIDS, V22, P2073, DOI 10.1097/QAD.0b013e32830edd59; Matheron S, 2018, CLIN INFECT DIS, V67, P1161, DOI 10.1093/cid/ciy245; Morlat P., 2016, PRISE CHARGE MED PER, P18; Peterson K, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/463704; PNLS Cote d'Ivoire, 2015, DIR NAT 2015 PRIS CH; Raugi DN, 2013, ANTIMICROB AGENTS CH, V57, P2751, DOI 10.1128/AAC.00405-13; Ren J, 2002, P NATL ACAD SCI USA, V99, P14410, DOI 10.1073/pnas.222366699; Roquebert B, 2008, J ANTIMICROB CHEMOTH, V62, P914, DOI 10.1093/jac/dkn335; Roquebert B, 2008, AIDS, V22, P2045, DOI 10.1097/QAD.0b013e32830f4c7d; Smith RA, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0146-8; Smith RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045372; Styer LM, 2013, J CLIN VIROL, V58, pE127, DOI 10.1016/j.jcv.2013.09.007; Tchounga B, 2016, CURR OPIN HIV AIDS; Visseaux B, 2016, INFECT GENET EVOL J; Visseaux B, 2012, ANTIMICROB AGENTS CH, V56, P137, DOI 10.1128/AAC.05313-11; Waldrop G, 2016, TROP MED INT HEALTH, V21, P1124, DOI 10.1111/tmi.12746; (WHO) WHO, 2019, UPD REC 1 2 LIN ANT, P16; Witvrouw M, 2004, ANTIVIR THER, V9, P57; World Health Organization, 2018, 2016 CONS GUID US S, P82	41	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236642	10.1371/journal.pone.0236642	http://dx.doi.org/10.1371/journal.pone.0236642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756581	Green Published, gold			2022-12-26	WOS:000560393300062
J	Zvizdic, Z; Kovacevic, A; Milisic, E; Jonuzi, A; Vranic, S				Zvizdic, Zlatan; Kovacevic, Aladin; Milisic, Emir; Jonuzi, Asmir; Vranic, Semir			Clinical course and short-term outcome of postsplenectomy reactive thrombocytosis in children without myeloproliferative disorders: A single institutional experience from a developing country	PLOS ONE			English	Article							RISK-FACTORS; SPLENECTOMY; THROMBOSIS; THROMBOEMBOLISM; ETIOLOGY	Objectives To evaluate the clinical outcome and complications in the pediatric population who had splenectomy at our institution, emphasizing the incidence of postplenectomy reactive thrombocytosis (RT) and its clinical significance in children without underlying hematological malignancies. Materials and methods The medical records of pediatric patients undergoing splenectomy were retrospectively reviewed for the period 1999-2018. The following variables were analyzed: Demographic parameters (age, sex), indications for surgery, operative procedures, preoperative and postoperative platelet count (postplenectomy RT), the use of anticoagulant therapy, and postoperative complications. The patients were divided into two groups according to indications for splenectomy: The non-neoplastic hematology group and the non-hematology group (splenectomy for trauma or other spleen non-hematological pathology). Results Fifty-two pediatric (37 male and 15 female) patients who underwent splenectomy at our institution were reviewed. Thirty-four patients (65%) were in the non-hematological group (splenic rupture, cysts, and abscess) and 18 patients (35%) in the non-neoplastic hematological group (hereditary spherocytosis and immune thrombocytopenia). The two groups did not differ significantly in regards to the patients' age, sex, and preoperative platelet count (P>0.05 for all variables). Forty-nine patients (94.2%) developed postplenectomy RT. The percentages of mild, moderate and extreme thrombocytosis were 48.9%, 30.7%, and 20.4%, respectively. The comparisons of RT patients between the non-neoplastic hematology and the non-hematology group revealed no significant differences in regards to the patients' age, sex, preoperative and postoperative platelet counts, preoperative and postoperative leukocyte counts, and the average length of hospital stay (P>0.05 for all variables). None of the patients from the cohort was affected by any thrombotic or hemorrhagic complications. Conclusions We confirm that RT is a very common event following splenectomy, but in this study it was not associated with clinically evident thrombotic or hemorrhagic complications in children undergoing splenectomy for trauma, structural lesions or non-neoplastic hematological disorders.	[Zvizdic, Zlatan; Milisic, Emir; Jonuzi, Asmir] Univ Clin Ctr Sarajevo, Clin Pediat Surg, Sarajevo, Bosnia & Herceg; [Kovacevic, Aladin] Publ Hlth Inst Community Hlth Ctr Jajce, Jajce, Bosnia & Herceg; [Vranic, Semir] Qatar Univ, QU Hlth, Coll Med, Doha, Qatar	University of Sarajevo; Qatar University	Vranic, S (corresponding author), Qatar Univ, QU Hlth, Coll Med, Doha, Qatar.	semir.vranic@gmail.com	Vranic, Semir/I-6823-2019	Vranic, Semir/0000-0001-9743-7265; Milisic, Emir/0000-0002-0927-3369; Zvizdic, Zlatan/0000-0003-1238-880X	Qatar National Library	Qatar National Library(Qatar National Research Fund (QNRF))	The publication of this article was funded by the Qatar National Library. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbui T, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-018-0054-y; BOXER MA, 1978, ARCH SURG-CHICAGO, V113, P808; Chen Hsiu-Lin, 1999, Acta Paediatrica Sinica, V40, P309; Dame C, 2005, BRIT J HAEMATOL, V129, P165, DOI 10.1111/j.1365-2141.2004.05329.x; Das A, 2014, PEDIATR BLOOD CANCER, V61, P29, DOI 10.1002/pbc.24766; Caro-Paton GD, 2014, AN PEDIATR, V81, P318, DOI 10.1016/j.anpedi.2013.10.017; Denton A, 2007, ARCH DIS CHILD, V92, P515, DOI 10.1136/adc.2006.111484; JOHNSON M, 1995, J VASC SURG, V22, P443, DOI 10.1016/S0741-5214(95)70013-7; Kashuk JL, 2010, SURGERY, V148, P667, DOI 10.1016/j.surg.2010.07.013; Khan Palwasha N, 2009, Proc (Bayl Univ Med Cent), V22, P9; Kucine N, 2014, HAEMATOLOGICA, V99, P620, DOI 10.3324/haematol.2013.092684; Kushnir M, 2016, J THROMB THROMBOLYS, V42, P545, DOI 10.1007/s11239-016-1398-4; Lee DH, 2015, INT J SURG, V24, P27, DOI 10.1016/j.ijsu.2015.10.011; Li AJ, 2005, CLIN CANCER RES, V11, P8015, DOI 10.1158/1078-0432.CCR-05-1058; Lucas C, 2010, SURGERY, V148, P674; Matsubara K, 2004, ACTA HAEMATOL-BASEL, V111, P132, DOI 10.1159/000076520; Michiels JJ, 2001, BEST PRACT RES CL HA, V14, P401, DOI 10.1053/beha.2001.0141; Oida T, 2012, HEPATO-GASTROENTEROL, V59, P1033, DOI 10.5754/hge10032; Oliveira JA, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27467; Oomen MWN, 2013, J PEDIATR SURG, V48, P2276, DOI 10.1016/j.jpedsurg.2013.03.078; Park Yae Min, 2009, Blood Research, V44, P298; Rottenstreich A, 2018, WORLD J SURG, V42, P675, DOI 10.1007/s00268-017-4185-2; Schafer AI, 2004, NEW ENGL J MED, V350, P1211, DOI 10.1056/NEJMra035363; Schafer AI, 2001, BLOOD REV, V15, P159, DOI 10.1054/blre.2001.0162; SCHAFER AI, 1984, BLOOD, V64, P1; Stringer MD, 2018, J PAEDIATR CHILD H, V54, P1184, DOI 10.1111/jpc.14227; Troendle SB, 2007, PEDIATR BLOOD CANCER, V49, P781, DOI 10.1002/pbc.21319; YOHANNAN MD, 1994, CLIN PEDIATR, V33, P340, DOI 10.1177/000992289403300605; Zulkafli Zefarina, 2019, Oman Med J, V34, P336, DOI 10.5001/omj.2019.65; Zvizdic Z KK, 2011, MED J, V17, P66	30	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0237016	10.1371/journal.pone.0237016	http://dx.doi.org/10.1371/journal.pone.0237016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756575	Green Published, gold			2022-12-26	WOS:000560393300057
J	Hesselink, L; Spijkerman, R; Hellebrekers, P; van Bourgondien, RJ; Blasse, E; Haitjema, S; Huisman, A; van Solinge, WW; Van Wessem, KJP; Koenderman, L; Leenen, LPH; Hietbrink, F				Hesselink, Lillian; Spijkerman, Roy; Hellebrekers, Pien; van Bourgondien, Robert J.; Blasse, Enja; Haitjema, Saskia; Huisman, Albert; van Solinge, Wouter W.; Van Wessem, Karlijn J. P.; Koenderman, Leo; Leenen, Luke P. H.; Hietbrink, Falco			Fragile neutrophils in surgical patients: A phenomenon associated with critical illness	PLOS ONE			English	Article							FLOW-CYTOMETRY; POLYMORPHONUCLEAR NEUTROPHIL; CIRCULATING NEUTROPHILS; FREE DNA; DYSFUNCTION; CELLS; APOPTOSIS; SEPSIS; GRANULOCYTES; PHAGOCYTOSIS	Leukocyte viability (determined by e.g. propidium iodide [PI] staining) is automatically measured by hematology analyzers to check for delayed bench time. Incidental findings in fresh blood samples revealed the existence of leukocytes with decreased viability in critically ill surgical patients. Not much is known about these cells and their functional and/or clinical implications. Therefore, we investigated the incidence of decreased leukocyte viability, the implications for leukocyte functioning and its relation with clinical outcomes. An automated alarm was set in a routine hematology analyzer (Cell-Dyn Sapphire) for the presence of non-viable leukocytes characterized by increased fluorescence in the PI-channel (FL3:630 +/- 30nm). Patients with non-viable leukocytes were prospectively included and blood samples were drawn to investigate leukocyte viability in detail and to investigate leukocyte functioning (phagocytosis and responsiveness to a bacterial stimulus). Then, a retrospective analysis was conducted to investigate the incidence of fragile neutrophils in the circulation and clinical outcomes of surgical patients with fragile neutrophils hospitalized between 2013-2017. A high FL3 signal was either caused by 1) neutrophil autofluorescence which was considered false positive, or by 2) actual non-viable PI-positive neutrophils in the blood sample. These two causes could be distinguished using automatically generated data from the hematology analyzer. The non-viable (PI-positive) neutrophils proved to be viable (PI-negative) in non-lysed blood samples, and were therefore referred to as 'fragile neutrophils'. Overall leukocyte functioning was not impaired in patients with fragile neutrophils. Of the 11 872 retrospectively included surgical patients, 75 (0.63%) were identified to have fragile neutrophils during hospitalization. Of all patients with fragile neutrophils, 75.7% developed an infection, 70.3% were admitted to the ICU and 31.3% died during hospitalization. In conclusion, fragile neutrophils occur in the circulation of critically ill surgical patients. These cells can be automatically detected during routine blood analyses and are an indicator of critical illness.	[Hesselink, Lillian; Spijkerman, Roy; Hellebrekers, Pien; van Bourgondien, Robert J.; Van Wessem, Karlijn J. P.; Leenen, Luke P. H.; Hietbrink, Falco] Univ Med Ctr Utrecht, Dept Trauma Surg, Utrecht, Netherlands; [Hesselink, Lillian; Spijkerman, Roy; Hellebrekers, Pien; Koenderman, Leo] Wilhelmina Childrens Hosp, Ctr Translat Immunol, Utrecht, Netherlands; [Blasse, Enja; Haitjema, Saskia; Huisman, Albert; van Solinge, Wouter W.] Dept Clin Chem & Hematol, Utrecht, Netherlands; [Koenderman, Leo] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [Koenderman, Leo] Wilhelmina Childrens Hosp, Utrecht, Netherlands; [Hietbrink, Falco] Univ Med Ctr Utrecht, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center	Hesselink, L; Hietbrink, F (corresponding author), Univ Med Ctr Utrecht, Dept Trauma Surg, Utrecht, Netherlands.; Hesselink, L (corresponding author), Wilhelmina Childrens Hosp, Ctr Translat Immunol, Utrecht, Netherlands.; Hietbrink, F (corresponding author), Univ Med Ctr Utrecht, Utrecht, Netherlands.	f.hietbrink@umcutrecht.nl; l.hesselink@umcutrecht.nl		Van Solinge, Wouter/0000-0003-2867-2581; Hesselink, Lillian/0000-0001-8793-6650; van Wessem, Karlijn/0000-0002-1166-0990				[Anonymous], 2011, DETECTION APOPTOSIS; Baj Z, 2018, CENT EUR J IMMUNOL, V43, P168, DOI 10.5114/ceji.2018.77387; Benedek O, 2016, ACTA MED MARISIENSIS, V62, P368, DOI [10.1515/amma-2015-0099, DOI 10.1515/AMMA-2015-0099]; Benedek O, 2015, J CRIT CARE MED, V1, P113, DOI 10.1515/jccm-2015-0019; Bicker H, 2008, CLIN CHEM, V54, P911, DOI 10.1373/clinchem.2007.101337; Bolliger M, 2018, EUR SURG, V50, P256, DOI 10.1007/s10353-018-0551-z; Bruegel M, 2015, CLIN CHEM LAB MED, V53, P1057, DOI 10.1515/cclm-2014-0945; Butt I, 2008, J NEPAL MED ASSOC, V47, P82; Chang Chih-Chun, 2016, Asian Pac J Cancer Prev, V17, P1847; Crowley L.C., 2016, COLD SPRING HARB PRO, V2016, P953; DIAMOND MS, 1993, J CELL BIOL, V120, P545, DOI 10.1083/jcb.120.2.545; Furze RC, 2008, IMMUNOLOGY, V125, P281, DOI 10.1111/j.1365-2567.2008.02950.x; GLASSER L, 1990, AM J CLIN PATHOL, V93, P662, DOI 10.1093/ajcp/93.5.662; Gogenur M, 2017, CRIT CARE, V21, DOI 10.1186/s13054-016-1578-9; Gomes NE, 2010, BRAZ J MED BIOL RES, V43, P853, DOI 10.1590/S0100-879X2010000900007; Groeneveld KM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/509513; Gruver-Yates Amanda L, 2013, Cells, V2, P202, DOI 10.3390/cells2020202; Hampson P, 2017, ANN SURG, V265, P1241, DOI 10.1097/SLA.0000000000001807; Hoffmann JJML, 2009, CLIN CHEM LAB MED, V47, P903, DOI 10.1515/CCLM.2009.224; Huisman Albert, 2004, Lab Hematol, V10, P68, DOI 10.1532/LH96.04017; Ishikawa H, 2016, VIROLOGY, V499, P23, DOI 10.1016/j.virol.2016.08.025; Jiang LZ, 2016, NAT PROTOC, V11, P655, DOI 10.1038/nprot.2016.028; Kabutomuri O, 2000, ARCH INTERN MED, V160, P3326, DOI 10.1001/archinte.160.21.3326-a; Kaufmann I, 2006, SHOCK, V26, P254, DOI 10.1097/01.shk.0000223131.64512.7a; Kim YR, 1998, CLIN LAB HAEMATOL, V20, P21, DOI 10.1046/j.1365-2257.1998.00092.x; Kuijpers TW, 1999, J IMMUNOL METHODS, V232, P211, DOI 10.1016/S0022-1759(99)00178-7; Latger-Cannard V, 2004, CLIN LAB HAEMATOL, V26, P177, DOI 10.1111/j.1365-2257.2004.00599.x; Lee S, 2015, AM J HEMATOL, V90, P679, DOI 10.1002/ajh.23943; Man WH, 2013, EUR NEUROPSYCHOPHARM, V23, P1408, DOI 10.1016/j.euroneuro.2013.08.005; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; MARSH JC, 1967, J CLIN INVEST, V46, P1943, DOI 10.1172/JCI105684; MCCALL CE, 1969, J EXP MED, V129, P267, DOI 10.1084/jem.129.2.267; Meaney MP, 2016, JOVE-J VIS EXP, DOI 10.3791/54264; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; Muller Robert, 2006, Lab Hematol, V12, P15, DOI 10.1532/LH96.05041; Nowakowski GS, 2009, J CLIN ONCOL, V27, P1844, DOI 10.1200/JCO.2008.17.0795; Orlova DY, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2992140; Perfetto Stephen P, 2010, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0934s53; Petriz J, 2018, METHODS, V134, P149, DOI 10.1016/j.ymeth.2017.12.012; Pietkiewicz S, 2015, J IMMUNOL METHODS, V423, P99, DOI 10.1016/j.jim.2015.04.025; Pillay J, 2010, J LEUKOCYTE BIOL, V88, P211, DOI 10.1189/jlb.1209793; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Rodriguez MD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02491; Rudensky B, NEUTROPHIL CD64 EXPR; Schmidt S, 2004, CELL DEATH DIFFER, V11, pS45, DOI 10.1038/sj.cdd.4401456; Shidham VB, 2000, ARCH PATHOL LAB MED, V124, P1291; Stephan F, 2002, CRIT CARE MED, V30, P315, DOI 10.1097/00003246-200202000-00009; Tak T, 2017, BLOOD, V129, P3476, DOI 10.1182/blood-2016-07-727669; Taneja R, 2008, SHOCK, V30, P618, DOI 10.1097/SHK.0b013e318173ef9c; ten Berg MJ, 2007, CLIN CHEM LAB MED, V45, P13, DOI 10.1515/CCLM.2007.009; Verbrugge A, DIFFERENTIAL EXPRESS, DOI [10.1189/jlb.0705370 16461736, DOI 10.1189/JLB.0705370]	51	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0236596	10.1371/journal.pone.0236596	http://dx.doi.org/10.1371/journal.pone.0236596			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750099	gold, Green Published			2022-12-26	WOS:000560009200015
J	Ahmed, M; Seid, A				Ahmed, Mohammed; Seid, Abdu			Factors associated with premarital HIV testing among married women in Ethiopia	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSMISSION; HIV/AIDS; COUPLES; PREVENTION; AFRICA; STIGMA	Background Premarital HIV testing is the key entry point in prevention, care, treatment, and support services, in which people learn their HIV status and its implications to make informed decisions about their health. This study was, therefore, conducted to identify factors associated with premarital HIV testing among married women in Ethiopia. Methods A cross-sectional study design was used, and secondary data analysis was done using 2016 Ethiopian demographic health survey (EDHS). Two-stage stratified cluster sampling technique was used. The data were analyzed by using SPSS version 20. Frequencies and weighted percentage of the variables, and second-order Rao-Scott statistic were computed. Multivariate logistic regression analysis was performed to control confounders and to identify predictors of premarital HIV testing. Adjusted odds ratio with 95% confidence interval was considered to declare statistically significant associations. Result The total sample comprised 9602 married women. In this study, the odds of premarital HIV testing were associated with being urban residents (AOR: 1.81; 95% CI:2.74-5.20), attended primary education (AOR:1.54; 95%:1.27-1.87),secondary education(AOR:2.34; 95% CI:1.70-3.23),higher education(AOR:2.92; 95% CI:1.90-4.50),access to media (AOR: 1.44; 95% CI:1.20-1.76),being rich(AOR: 1.52; 95%CI:1.12-2.07),andrichest(AOR: 1.67;95%CI:1.15-2.44),known the place of HIV testing(AOR: 4.95; 95% CI:3.44-7.11),discriminatory attitude to PLHIV (AOR: 1.47; 95%CI:1.23-1.76),being khat chewer(AOR:1.60;95%CI:1.11-2.31), and alcohol drinker(AOR: 1.55; 95% CI:1.27-1.90). Conclusion It is possible to conclude that being urban resident, attending education (primary, secondary, higher), media access, improved wealth index, knowing the places for HIV testing, chewing khat, drinking alcohol, and having discriminatory attitude towards PLHIV were positively associated with premarital HIV testing. The Ethiopian government needs to step up efforts to expand education for all Women. Advancing access to HIV testing for rural women may also increase premarital HIV testing services uptake. Further qualitative researches need to be done to assess the relationship between discriminatory attitude towards PLHIV and premarital HIV testing.	[Ahmed, Mohammed] Woldia Univ, Dept Publ Hlth, Coll Hlth Sci, Woldia, Ethiopia; [Seid, Abdu] Woldia Univ, Dept Midwifery, Coll Hlth Sci, Woldia, Ethiopia		Ahmed, M (corresponding author), Woldia Univ, Dept Publ Hlth, Coll Hlth Sci, Woldia, Ethiopia.	mohaasrar12@gmail.com		Ahmed, Mohammed/0000-0003-1567-1571				Akoku DA, 2018, PLOS ONE, V13; ALTMAN R, 1992, J ACQ IMMUN DEF SYND, V5, P7; [Anonymous], 2013, GLOBAL INFORM ADVICE; Assefa Seme, 2005, Ethiopian Journal of Health Development, V19, P116; Ayiga N, 2013, AFR HEALTH SCI, V13, P278, DOI 10.4314/ahs.v13i2.12; Barmania S, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0120-8; Bekele YA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228783; Campbell CA, 1999, WOMEN FAMILIES HIV A; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Chen NE, 2011, INFECT DIS REP, V3, P20, DOI 10.4081/idr2011.e6; CLEARY PD, 1987, JAMA-J AM MED ASSOC, V258, P1757, DOI 10.1001/jama.258.13.1757; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; (CSA) CSA, 2016, EM OBST NEWB CAR NEE; Desta WG, 2017, AIDS RES TREAT, V2017, DOI 10.1155/2017/9034282; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Fabiani M, 2007, AIDS CARE, V19, P733, DOI 10.1080/09540120601087731; Fanta W, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-8; Federal Democratic Republic of Ethiopia, 2005, REP PROGR IMPL DECL; Federal Ministry of Health, 2007, GUID HIV COUNS TEST; Godfrey-Faussett P, 2002, B WORLD HEALTH ORGAN, V80, P939; Ibrahim M., 2013, INT J PREVENTION TRE, V2, P23, DOI DOI 10.5923/j.ijpt.20130203.01; Kates J., 2013, REPORT WOMEN HIV AID; Kebede D, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-109; Ketema Lemma, 2005, ETHIOP J HEALTH DEV, V19, P174; Matovu JKB, 2010, CURR HIV RES, V8, P430, DOI 10.2174/157016210793499303; MCKILLIP J, 1991, AM J PUBLIC HEALTH, V81, P650, DOI 10.2105/AJPH.81.5.650; Misiri H, 2004, CROAT MED J, V45, P84; Monjok Emmanuel, 2009, Afr J Reprod Health, V13, P21; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; Oginni A., 2014, AIDS RES HUMAN RETRO, V30; Ogunbodede EO, 2004, INT DENT J, V54, P352; Onsomu Elijah O., 2013, SAGE OPEN, P1, DOI 10.1177/215824401349; Sinku Y, 2016, HIV AIDS-RES PALLIAT, V8, P135, DOI 10.2147/HIV.S110337; Treves-Kagan S, 2017, AIDS BEHAV, V21, P2579, DOI 10.1007/s10461-016-1671-8; Vermund SH, 2013, CURR HIV-AIDS REP, V10, P169, DOI 10.1007/s11904-013-0155-y; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1; World Health Organization, 2012, STAT HIV TEST COUNS	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0235830	10.1371/journal.pone.0235830	http://dx.doi.org/10.1371/journal.pone.0235830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA7OS	32745083	Green Published, gold			2022-12-26	WOS:000560006800051
J	Baye, Y; Demeke, T; Birhan, N; Semahegn, A; Birhanu, S				Baye, Yohannes; Demeke, Tesfaye; Birhan, Nigusie; Semahegn, Agumasie; Birhanu, Simon			Nurses' work-related stress and associated factors in governmental hospitals in Harar, Eastern Ethiopia: A cross-sectional study	PLOS ONE			English	Article							OCCUPATIONAL STRESS; PUBLIC HOSPITALS; HEALTH	Introduction Work-related stress causes poor quality of nursing care and increases the risk of medical errors. Research evidence is so limited to nurses' work-related stress in eastern Ethiopia. Therefore, this study aimed to assess work-related stress and associated factors among nurses working in governmental hospitals in Harar, Eastern Ethiopia. Methods Institution-based quantitative cross-sectional study was conducted among 367 nurses from 15(th)to 30(th)March, 2015. Simple random sampling technique was applied to recruit study participants. Data were collected using structured self-administered questionnaire. Descriptive statistics, bivariate and multivariate logistic regressions were carried out. The statistical association was declared using adjusted odds ratio at 95% confidence interval (CI) and P-value of less than 0.05. Results A total of 398 study participants were involved in the study, and the response rate was 92.2% (367/398). More than half of 202(55%) of the participants were males. One third (33.8%, n = 124) of study participants' age ranged between 26 to 34 years. The prevalence of work-related stress in the current study was 66.2%. Nurses, who reared child (AOR = 2.1, 95% CI: 1.2, 3.7), working in intensive care units (AOR = 4.5, 95% CI: 1.4, 17.7), work on rotation (AOR = 2.5, 95% CI: 1.4, 4.4), and nurses who had a chronic medical illness (AOR = 2.6, 95% CI: 1.2, 5.7) were significantly associated with nurses' work-related stress. Conclusion Two-thirds of nurses who were working at government hospitals had work-related stress. Work-related stress was associated with child-rearing, working units, work on rotation, and chronic medical illness. We suggested the hospital's administration, and other concerned stakeholders should design a strategy to undertake necessary measures such as hiring more nurses to minimize workload and rescheduling work shift to alleviate work-related stress among nurses.	[Baye, Yohannes; Semahegn, Agumasie; Birhanu, Simon] Haramaya Univ, Sch Nursing & Midwifery, Coll Hlth & Med Sci, Harar, Ethiopia; [Demeke, Tesfaye; Birhan, Nigusie] Univ Gondar, Sch Nursing & Midwifery, Coll Med & Hlth Sci, Gondar, Ethiopia	Haramaya University; University of Gondar	Baye, Y (corresponding author), Haramaya Univ, Sch Nursing & Midwifery, Coll Hlth & Med Sci, Harar, Ethiopia.	yohannesbaye21@gmail.com		Baye, Yohannes/0000-0003-0775-3999				Akinboye J.O., 2002, COPING STRESS LIFE W; Alhajjar BI, 2013, THESIS; Aoki M, 2011, INT J DISABIL HUM DE, V9, P19; Beheshtifar M., 2011, EUROPEAN J EC FINANC, V38, P59; Burke Michelle, 2013, Br J Community Nurs, V18, P535; Dollard MF., 2007, INT J STRESS MANAG, V14, P417, DOI [10.1037/1072-5245.14.4.417, DOI 10.1037/1072-5245.14.4.417]; El Dahshan ME, 2014, EGYPTIAN J COMMUNITY, V32; El Dahshan MEA, 2014, EGYPT J COMMUNITY ME, V32; Evans Lorella, 2002, Br J Nurs, V11, P576; French S E, 2000, J Nurs Meas, V8, P161; Hamaideh SH, 2008, INT NURS REV, V55, P40, DOI 10.1111/j.1466-7657.2007.00605.x; Hart P, CHAPITRE HDB IND WOR, V2; Health and Safety Executive (HSE), 2001, TACKL WORK REL STRES; Kane Pratibha P, 2009, Indian J Occup Environ Med, V13, P28, DOI 10.4103/0019-5278.50721; Lexshimi RGR, 2007, MED HEALTH-KUALA LUM, V2, P146; Makie VV, 2006, THESIS; Mark G, 2012, BRIT J HEALTH PSYCH, V17, P505, DOI 10.1111/j.2044-8287.2011.02051.x; McCarthy VJC, 2010, OCCUP MED-OXFORD, V60, P604, DOI 10.1093/occmed/kqq148; Mehrabi T, 2008, IRAN J NURS MIDWIFER, V12; Mohamed F. A., 2011, The Journal of American Science, V7, P304; Mojdeh S, 2008, IRAN J NURS MIDWIFER, V13, P1; Mojoyinolla JK, 2008, STUD ETHNO-MED, V2, P143, DOI 10.1080/09735070.2008.11886326; Moustaka L., 2010, HLTH SCI J, V4, P210; Nakakis K., 2008, HLTH SCI J, V2, P183; Negeliskii C, 2011, REV LAT-AM ENFERM, V19, P606, DOI 10.1590/S0104-11692011000300021; Onasoga OA, 2013, EUR J EXP BIOL, V3, P473; Rosnah I, 2008, J COMMUNITY HLTH, V14, P78; Salilih SZ, 2014, WORKPLACE HEALTH SAF, V62, P326, DOI 10.3928/21650799-20140708-02; Salleh AL., 2008, INT REV BUS RES PAP, V4, P64; Sharifah Zainiyah SY., 2011, MALAYSIAN J PUBLIC H, V11, P78; Shen HC, 2005, J OCCUP HEALTH, V47, P218, DOI 10.1539/joh.47.218; Shirey MR, 2006, NURS ECON, V24, P193; Smeltzer SC, 2008, TXB MED SURG NURSING, V11, P410; Sveinsdottir H, 2006, INT J NURS STUD, V43, P875, DOI 10.1016/j.ijnurstu.2005.11.002; Thian J. H. M., 2013, SINGAPORE NURSING J, V40, P24; Vokic N. P., 2007, EFZG WORKING PAPER S, V5, P1; Woo Oh Jae, 2013, [Journal of Digital Convergence, 디지털융복합연구], V11, P469; Wu H, 2010, J ADV NURS, V66, P627, DOI 10.1111/j.1365-2648.2009.05203.x	38	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236782	10.1371/journal.pone.0236782	http://dx.doi.org/10.1371/journal.pone.0236782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA7OS	32745142	Green Published, gold			2022-12-26	WOS:000560006800024
J	Bosamia, TC; Dodia, SM; Mishra, GP; Ahmad, S; Joshi, B; Thirumalaisamy, PP; Kumar, N; Rathnakumar, AL; Sangh, C; Kumar, A; Thankappan, R				Bosamia, Tejas C.; Dodia, Sneha M.; Mishra, Gyan P.; Ahmad, Suhail; Joshi, Binal; Thirumalaisamy, Polavakkalipalayam P.; Kumar, Narendra; Rathnakumar, Arulthambi L.; Sangh, Chandramohan; Kumar, Abhay; Thankappan, Radhakrishnan			Unraveling the mechanisms of resistance to Sclerotium rolfsii in peanut (Arachis hypogaea L.) using comparative RNA-Seq analysis of resistant and susceptible genotypes	PLOS ONE			English	Article							BRASSICA-NAPUS; GENE-EXPRESSION; TRANSCRIPTION FACTORS; PLANT IMMUNITY; SALICYLIC-ACID; OILSEED RAPE; DEFENSE; IDENTIFICATION; ARABIDOPSIS; CULTIVARS	Stem rot, a devastating fungal disease of peanut, is caused bySclerotium rolfsii. RNA-sequencing approaches have been used to unravel the mechanisms of resistance to stem rot in peanut over the course of fungal infection in resistant (NRCG-CS85) and susceptible (TG37A) genotypes under control conditions and during the course of infection. Out of about 290 million reads, nearly 251 million (92.22%) high-quality reads were obtained and aligned to theArachis duranensisandArachis ipaensisgenomes with the average mapping of 78.91% and 78.61%, respectively. In total, about 48.6% of genes were commonly regulated, while approximately 21.8% and 29.6% of uniquely regulated genes fromA.duranensisandA.ipaensisgenomes, respectively, were identified. Several annotated transcripts, such as receptor-like kinases, jasmonic acid pathway enzymes, and transcription factors (TFs), including WRKY, Zinc finger protein, and C2-H2 zinc finger, showed higher expression in resistant genotypes upon infection. These transcripts have a known role in channelizing the downstream of pathogen perception. The higher expression of WRKY transcripts might have induced the systemic acquired resistance (SAR) by the activation of the jasmonic acid defense signaling pathway. Furthermore, a set of 30 transcripts involved in the defense mechanisms were validated with quantitative real-time PCR. This study suggested PAMP-triggered immunity as a probable mechanism of resistance, while the jasmonic acid signaling pathway was identified as a possible defense mechanism in peanut. The information generated is of immense importance in developing more effective ways to combat the stem rot disease in peanut.	[Bosamia, Tejas C.; Dodia, Sneha M.; Mishra, Gyan P.; Ahmad, Suhail; Joshi, Binal; Thirumalaisamy, Polavakkalipalayam P.; Kumar, Narendra; Rathnakumar, Arulthambi L.; Sangh, Chandramohan; Kumar, Abhay; Thankappan, Radhakrishnan] ICAR Directorate Groundnut Res ICAR DGR, Junagadh, Gujarat, India; [Mishra, Gyan P.] Indian Agr Res Inst IARI, New Delhi, India; [Kumar, Abhay] ICAR Natl Res Ctr Litchi, Muzaffarpur, India	Indian Council of Agricultural Research (ICAR); ICAR - Directorate of Groundnut Research; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre for Litchi	Thankappan, R (corresponding author), ICAR Directorate Groundnut Res ICAR DGR, Junagadh, Gujarat, India.	radhakrishnan.nrcg@gmail.com	KUMAR, ABHAY/H-3073-2019; Mishra, Gyan P./E-5980-2010; bosamia, tejas/P-2264-2019	KUMAR, ABHAY/0000-0002-1104-6771; Mishra, Gyan P./0000-0002-7023-2638; bosamia, tejas/0000-0002-2079-2397	National Agricultural Science Fund (NASF) of Indian Council of Agricultural Research (ICAR), New Delhi, India	National Agricultural Science Fund (NASF) of Indian Council of Agricultural Research (ICAR), New Delhi, India	The consumables and sequencing service were supported by the National Agricultural Science Fund (NASF) of Indian Council of Agricultural Research (ICAR), New Delhi, India.	Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bera S. K., 2014, Electronic Journal of Plant Breeding, V5, P22; Bera SK., 2011, INDIAN J PLANT GENET, V24, P96; Bertioli DJ, 2019, NAT GENET, V51, P877, DOI 10.1038/s41588-019-0405-z; Bertioli DJ, 2016, NAT GENET, V48, P438, DOI 10.1038/ng.3517; Breen S, 2017, TRENDS PLANT SCI, V22, P871, DOI 10.1016/j.tplants.2017.06.013; Cai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053388; Chen XP, 2013, PLANT BIOTECHNOL J, V11, P115, DOI 10.1111/pbi.12018; Chet I, 1975, MICROB ECOL, V2, P194, DOI 10.1007/BF02010439; Cui F, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00217; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dodia S. M., 2016, International Journal of Tropical Agriculture, V34, P1135; Dodia SM, 2019, THEOR APPL GENET, V132, P1001, DOI 10.1007/s00122-018-3255-7; Dzhavakhiya V.G., 2007, COMPREHENSIVE MOL PH, P265, DOI DOI 10.1016/B978-0-444-52132; Girard IJ, 2017, J EXP BOT, V68, P5079, DOI 10.1093/jxb/erx338; GRICHAR W J, 1992, Peanut Science, V19, P55, DOI 10.3146/i0095-3679-19-1-15; Grison R, 1996, NAT BIOTECHNOL, V14, P643, DOI 10.1038/nbt0596-643; Hammond-Kosack KE, 2008, PLANT SIGNAL BEHAV, V3, P993, DOI 10.4161/psb.6292; Hao K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01029-3; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Jogi A, 2016, MICROBIOL RES, V184, P1, DOI 10.1016/j.micres.2015.11.003; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; Kim KH, 2011, DNA RES, V18, P483, DOI 10.1093/dnares/dsr033; Kukurba Kimberly R, 2015, Cold Spring Harb Protoc, V2015, P951, DOI 10.1101/pdb.top084970; Kulkarni KS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00847; Laluk Kristin, 2010, Arabidopsis Book, V8, pe0136, DOI 10.1199/tab.0136; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Presti L, 2015, ANNU REV PLANT BIOL, V66, P513, DOI 10.1146/annurev-arplant-043014-114623; Mengiste T, 2012, ANNU REV PHYTOPATHOL, V50, P267, DOI 10.1146/annurev-phyto-081211-172955; Meyer FE, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00191; Mishra GP, 2015, CROP PROT, V77, P74, DOI 10.1016/j.cropro.2015.07.019; Moretzsohn MC, 2013, ANN BOT-LONDON, V111, P113, DOI 10.1093/aob/mcs237; Naoumkina MA, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-132; Nawade B, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01271; Novakova M, 2014, PLANT PHYSIOL BIOCH, V80, P308, DOI 10.1016/j.plaphy.2014.04.019; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Peng Z, 2017, SCI REP-UK, V7, DOI 10.1038/srep40066; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pusztahelyi T, 2017, FUNGAL METABOLITES R, P1; Rangaswamy G, 1999, DIS CROP PLANTS INDI, P60; Robb J, 2007, PLANTA, V226, P299, DOI 10.1007/s00425-007-0482-6; Rong W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01723; Seijo G, 2007, AM J BOT, V94, P1963, DOI 10.3732/ajb.94.12.1963; Staal J, 2008, PLANT J, V55, P188, DOI 10.1111/j.1365-313X.2008.03503.x; Sui N, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00007; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tan GX, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00428; Tena G, 2011, CURR OPIN PLANT BIOL, V14, P519, DOI 10.1016/j.pbi.2011.05.006; Termorshuizen Aad J., 2007, P643; Thirumalaisamy P. P., 2014, Journal of Mycology and Plant Pathology, V44, P459; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Varadharajan Karthikeyan, 2006, Archives of Phytopathology and Plant Protection, V39, P215, DOI 10.1080/03235400500094225; Varshney RK, 2014, THEOR APPL GENET, V127, P445, DOI 10.1007/s00122-013-2230-6; Verhage A, 2010, PLANT PHYSIOL, V154, P536, DOI 10.1104/pp.110.161570; Wan LY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01900; Wang XL, 2014, VIRULENCE, V5, P722, DOI 10.4161/viru.29798; Wang Z, 2014, MOL PLANT PATHOL, V15, P677, DOI 10.1111/mpp.12123; Wang Z, 2012, PLANT SCI, V184, P75, DOI 10.1016/j.plantsci.2011.12.013; Wu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19007; Xie Fuliang, 2012, Plant Mol Biol; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073767; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Zhang WG, 2013, PLANT CELL, V25, P4227, DOI 10.1105/tpc.113.117010; Zhao JW, 2007, PLANTA, V227, P13, DOI 10.1007/s00425-007-0586-z; Zhao JW, 2009, MOL PLANT PATHOL, V10, P635, DOI [10.1111/J.1364-3703.2009.00558.X, 10.1111/j.1364-3703.2009.00558.x]; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004	67	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236823	10.1371/journal.pone.0236823	http://dx.doi.org/10.1371/journal.pone.0236823			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745143	gold, Green Published			2022-12-26	WOS:000560006800019
J	Soma, DD; Zogo, BM; Some, A; Tchiekoi, BN; Hien, DFD; Pooda, HS; Coulibaly, S; Gnambani, JE; Ouari, A; Mouline, K; Dahounto, A; Ouedraogo, GA; Fournet, F; Koffi, AA; Pennetier, C; Moiroux, N; Dabire, RK				Soma, Dieudonne Diloma; Zogo, Barnabas Mahugnon; Some, Anthony; Tchiekoi, Bertin N'Cho; Hien, Domonbabele Francois de Sales; Pooda, Hermann Sie; Coulibaly, Sanata; Gnambani, Jacques Edounou; Ouari, Ali; Mouline, Karine; Dahounto, Amal; Ouedraogo, Georges Anicet; Fournet, Florence; Koffi, Alphonsine Amanan; Pennetier, Cedric; Moiroux, Nicolas; Dabire, Roch Kounbobr			Anopheles bionomics, insecticide resistance and malaria transmission in southwest Burkina Faso: A pre-intervention study	PLOS ONE			English	Article							FUNESTUS DIPTERA; GAMBIAE; CULICIDAE; KDR; MUTATION; VECTORS; RATES; NETS	Background Twenty-seven villages were selected in southwest Burkina Faso to implement new vector control strategies in addition to long lasting insecticidal nets (LLINs) through a Randomized Controlled Trial (RCT). We conducted entomological surveys in the villages during the dry cold season (January 2017), dry hot season (March 2017) and rainy season (June 2017) to describe malaria vectors bionomics, insecticide resistance and transmission prior to this trial. Methods We carried out hourly catches (from 17:00 to 09:00) inside and outside 4 houses in each village using the Human Landing Catch technique. Mosquitoes were identified using morphological taxonomic keys. Specimens belonging to theAnopheles gambiaecomplex andAnopheles funestus groupwere identified using molecular techniques as well as detection ofPlasmodium falciparuminfection and insecticide resistance target-site mutations. Results EightAnophelesspecies were detected in the area.Anopheles funestus s.swas the main vector during the dry cold season. It was replaced byAnopheles coluzziiduring the dry hot season whereasAn.coluzziiandAn.gambiae s.s. were the dominant species during the rainy season. Species composition of theAnophelespopulation varied significantly among seasons. All insecticide resistance mechanisms (kdr-w,kdr-eandace-1target site mutations) investigated were found in each members of theAn.gambiaecomplex but at different frequencies. We observed early and late biting phenotypes in the main malaria vector species. Entomological inoculation rates were 2.61, 2.67 and 11.25 infected bites per human per month during dry cold season, dry hot season and rainy season, respectively. Conclusion The entomological indicators of malaria transmission were high despite the universal coverage with LLINs. We detected early and late biting phenotypes in the main malaria vector species as well as physiological insecticide resistance mechanisms. These data will be used to evaluate the impact of complementary tools to LLINs in an upcoming RCT.	[Soma, Dieudonne Diloma; Some, Anthony; Hien, Domonbabele Francois de Sales; Pooda, Hermann Sie; Coulibaly, Sanata; Gnambani, Jacques Edounou; Ouari, Ali; Mouline, Karine; Dahounto, Amal; Moiroux, Nicolas; Dabire, Roch Kounbobr] Inst Rech Sci Sante IRSS, Bobo Dioulasso, Burkina Faso; [Soma, Dieudonne Diloma; Ouedraogo, Georges Anicet] Univ Nazi Boni, Bobo Dioulasso, Burkina Faso; [Soma, Dieudonne Diloma; Zogo, Barnabas Mahugnon; Some, Anthony; Tchiekoi, Bertin N'Cho; Mouline, Karine; Dahounto, Amal; Fournet, Florence; Pennetier, Cedric; Moiroux, Nicolas] Univ Montpellier, MIVEGEC, CNRS, IRD, Montpellier, France; [Zogo, Barnabas Mahugnon; Tchiekoi, Bertin N'Cho; Koffi, Alphonsine Amanan; Pennetier, Cedric] Inst Pierre Richet IPR, Bouake, Cote Ivoire; [Zogo, Barnabas Mahugnon] Univ Abomey Calavi, Abomey Calavi, Benin; [Pooda, Hermann Sie] Univ Dedougou, Dedougou, Burkina Faso	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Abomey Calavi	Soma, DD (corresponding author), Inst Rech Sci Sante IRSS, Bobo Dioulasso, Burkina Faso.; Soma, DD (corresponding author), Univ Nazi Boni, Bobo Dioulasso, Burkina Faso.; Soma, DD (corresponding author), Univ Montpellier, MIVEGEC, CNRS, IRD, Montpellier, France.	dieusoma@yahoo.fr	Dabire, Roch Kounbobr/ABF-3525-2020; Moiroux, Nicolas/AFT-2925-2022	Moiroux, Nicolas/0000-0001-6755-6167	French Initiative 5% Expertise France [15SANIN213]	French Initiative 5% Expertise France	This work was part of the REACT project, funded by the French Initiative 5% Expertise France (No 15SANIN213)	Abduselam N, 2016, P 20 AUSTR FLUID MEC, P1; Adja AM, 2011, ANN TROP MED PARASIT, V105, P13, DOI 10.1179/136485910X12851868780388; Afrane YA, 2016, CURRENT TOPICS IN MALARIA, P473, DOI 10.5772/65359; Akono PN, 2018, AFR ENTOMOL, V26, P429, DOI 10.4001/003.026.0429; Alout H, 2017, TRENDS PARASITOL, V33, P610, DOI 10.1016/j.pt.2017.04.006; Alout H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29755; Alout H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063849; [Anonymous], 2009, ANOPHELES BIOL TRANS; [Anonymous], 1968, ANOPHELINAE AFR S SA; Antonio-nkondjio C, 2006, T R SOC TROP MED HYG, P2585; Bates D., 2019, AUTONOMOUS PRUNING M; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Bhatt S, 2015, ELIFE, V4, DOI 10.7554/eLife.09672; Boissiere A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054820; Carrasco D, 2019, CURR OPIN INSECT SCI, V34, P48, DOI 10.1016/j.cois.2019.03.005; Coffinet T, 2009, Med Trop (Mars), V69, P109; Cohuet A, 2002, MOL ECOL NOTES, V2, P498, DOI 10.1046/j.1471-8286.2002.00290.x; Costantini C., 1999, Parassitologia (Rome), V41, P595; Dabire KR, 2008, J VECTOR ECOL, V33, P70, DOI 10.3376/1081-1710(2008)33[70:YTYASV]2.0.CO;2; Dabire KR, 2007, J MED ENTOMOL, V44, P990, DOI 10.1603/0022-2585(2007)44[990:AFDCIA]2.0.CO;2; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; Dabire RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101484; Dao A, 2014, NATURE, V516, P387, DOI 10.1038/nature13987; DAVIDSON G, 1954, NATURE, V174, P792, DOI 10.1038/174792a0; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; Dia I, 2008, ACTA TROP, V105, P145, DOI 10.1016/j.actatropica.2007.10.010; Diabate A, 2004, TROP MED INT HEALTH, V9, P1267, DOI 10.1111/j.1365-3156.2004.01336.x; Diabate A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-5; Dinno A, 2017, R PACKAGE VERSION 13; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Duvallet G, 2017, ENTOMOLOGIE MED VET; Epopa PS, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2747-5; Essandoh J, 2013, MALARIA J, V12, P1; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gillies M, 1987, PUBL S AFRI CAN I ME, V55, P1; GILLIES M. T., 1960, BULL ENT RES, V51, P243, DOI 10.1017/S0007485300057953; GILLIES M. T., 1964, Bulletin of Entomological Research, V55, P1, DOI 10.1017/S0007485300049221; GILLIES MT, 1963, ANN TROP MED PARASIT, V57, P435, DOI 10.1080/00034983.1963.11686197; Gimonneau G, 2012, MED VET ENTOMOL, V26, P9, DOI 10.1111/j.1365-2915.2011.00957.x; Goudet J, 1996, GENETICS, V144, P1933; Guelbeogo W. M, 2009, MALARIA J, V8, P1; HALDANE JBS, 1954, J GENET, V52, P631, DOI 10.1007/BF02985085; Hien AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173098; Hien DF, 2018, 7 MULT IN MAL PAN C, P1; INSD, 2015, TABL BORD EC SOC 201; INSD, 2016, ANN STAT 2015 REG SU; INSD, 2017, ENQ NAT SECT ORP ENS; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; MacDonnald G., 1955, EPIDEMIOLOGICAL BASI, V132, P20; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Mattingly PF, 1973, CONTRIBUTIONS FAUNE, P7; Ministere de la Sante, 2018, ANN STAT 2017; Moiroux N, 2012, J INFECT DIS, V206, P1622, DOI 10.1093/infdis/jis565; Monroe A, 2019, MALARIA J, P1; Ndiath MO, 2014, MALARIA J, V13, P1; Pages F, 2007, MED MALADIES INFECT, V37, P153, DOI 10.1016/j.medmal.2006.10.009; Platt N, 2015, HEREDITY, V115, P243, DOI 10.1038/hdy.2015.33; PNLP, 2014, DIR NAT PRIS CHARG P; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F., 2017, POPULATION GENETIC D, P1; Russell L., 2019, ESTIMATED MARGINAL M, P216; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Silver JB., 2008, SAMPLING ADULTS ANIM, P493, DOI [10.1007/978-1-4020-6666-5_6, DOI 10.1007/978-1-4020-6666-5_6]; Sokhna C, 2013, CLIN MICROBIOL INFEC, V19, P902, DOI 10.1111/1469-0691.12314; Sovi A, 2013, PARASITE VECTOR, V6, P1; Storeng KT, 2019, LANCET, V394, P184, DOI 10.1016/S0140-6736(19)30429-5; Tabue RN, 2017, PARASITE VECTOR, P1; The R Development Core Team, 2008, R LANGUAGE ENV STAT, P1; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; WHO, 2016, WORLD MAL REP 2016; WHO, 2019, WORLD MALARIA REPORT; WHO, 2018, HOUS SURV IND MAL CO; WHO, 2018, WORLD MALARIA REPORT, P238; WHO, 2015, WORLD MAL REP 2015; World Health Organization, 2017, DEPRESSION	80	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236920	10.1371/journal.pone.0236920	http://dx.doi.org/10.1371/journal.pone.0236920			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745085	Green Published, gold, Green Submitted			2022-12-26	WOS:000560006800046
J	Camarena, KR; Claudy, S; Wang, JJ; Wright, AL				Camarena, Kara Ross; Claudy, Sarah; Wang, Jijun; Wright, Austin L.			Political and environmental risks influence migration and human smuggling across the Mediterranean Sea	PLOS ONE			English	Article							ENFORCEMENT	Since 2007 the number of refugees fleeing conflict and violence has doubled to more than 25 million. We leverage high frequency data on migration, sea conditions, and riots to investigate how political and environmental risks influence migration and human smuggling across the Mediterranean Sea. We report results from two observational studies. A high frequency time-series study demonstrates that risks alter migration patterns. An event study design demonstrates the effectiveness of a policy intervention that targeted Libyan militias engaged in human smuggling. The results highlight the important role of environmental and political risks in transit countries and their implications for migration and human smuggling.	[Camarena, Kara Ross; Wang, Jijun; Wright, Austin L.] Univ Chicago, Harris Sch Publ Policy, Chicago, IL 60637 USA; [Claudy, Sarah] US Dept Navy, Washington, DC USA	University of Chicago	Camarena, KR (corresponding author), Univ Chicago, Harris Sch Publ Policy, Chicago, IL 60637 USA.	karaross@uchicago.edu	Camarena, Kara/ABH-7961-2020	/0000-0001-5561-2213	Pearson Institute for the Study and Resolution of Global Conflicts	Pearson Institute for the Study and Resolution of Global Conflicts	Author names appear in alphabetical order. The opinions disclosed in this work are the authors' own and not a reflection of the official position of the Department of the Navy or the Department of Defense. We thank colleagues for feedback on the argument and research design. We also thank Antonio Saccone (Head, Operational Sector, Frontex) for a comprehensive overview of data collection on migration in the Mediterranean. Laura Bergedieck provided excellent research assistance. Support from the Pearson Institute for the Study and Resolution of Global Conflicts is gratefully acknowledged. All errors remain our own.	Adhikari P, 2013, AM J POLIT SCI, V57, P82, DOI 10.1111/j.1540-5907.2012.00598.x; [Anonymous], 2015, EC EXPL EXPL EV YOU; Baker G, 2002, Q J ECON, V117, P39, DOI 10.1162/003355302753399445; Benattia, 2017, MIXED MIGRATION TREN; Campana P, 2018, EUR J CRIMINOL, V15, P481, DOI 10.1177/1477370817749179; Collyer M, 2007, ANTIPODE, V39, P668, DOI 10.1111/j.1467-8330.2007.00546.x; Copernicus Marine Environment Monitoring Service, 2018, MED SEA WAV AN FOR; Dell M, 2014, J ECON LIT, V52, P740, DOI 10.1257/jel.52.3.740; Displacement Tracking Matrix, 2019, YEM AR ASS ROUND 37; Eaton Tim, 2018, LIBYAS WAR EC PREDAT; Elumami A, 2017, ARMED FORCE CLAIMS V; Europol, 2016, MIGR SMUGGL NETW; Gathmann C, 2008, J PUBLIC ECON, V92, P1926, DOI 10.1016/j.jpubeco.2008.04.006; Getmansky A, 2019, Q J POLIT SCI, V14, P329, DOI 10.1561/100.00018094; GROSSMAN SJ, 1986, J POLIT ECON, V94, P691, DOI 10.1086/261404; Hijmans R., 2018, GADM DATABASE GLOBAL; Hsiang SM, 2014, CLIMATIC CHANGE, V123, P39, DOI 10.1007/s10584-013-0868-3; International Organization for Migration, 2018, MIX MIGR FLOWS MED C; International Organization for Migration, 2018, MISS MIGR PROJ; IOM, 2017, FAT JOURN 1, V3; Karasapan O., 2017, TRAGEDY MIGRANTS LIB; Lessem R, 2018, REV ECON STUD, V85, P2353, DOI 10.1093/restud/rdx078; Maher S, 2018, ANN AM ACAD POLIT SS, V676, P36, DOI 10.1177/0002716217743935; Malakooti A., 2016, SMUGGLING DATA RES G, P85; Malakooti Arezo, 2013, MIXED MIGRATION LIBY; Martinez DE, 2016, J ETHN MIGR STUD, V42, P103, DOI 10.1080/1369183X.2015.1076720; Massey DS, 2016, AM J SOCIOL, V121, P1557, DOI 10.1086/684200; Micallef M., 2017, ANTIHUMAN SMUGGLING; Michael M., 2017, BACKED ITALY LIBYA E; Papadopoulou A., 2016, IMPLEMENTATION HOTSP; Raleigh C, 2010, J PEACE RES, V47, P651, DOI 10.1177/0022343310378914; Schapendonk J, 2013, AFR-EUR GROUP INTERD, V8, P9; Schon J, 2019, J PEACE RES, V56, P12, DOI 10.1177/0022343318806044; Thompson SA, 2017, EFFORTS RESCUE MIGRA; Triandafyllidou A, 2018, ANN AM ACAD POLIT SS, V676, P212, DOI 10.1177/0002716217752330; Walsh D, 2017, GOING IT STALLS FLOW; Wintour P., 2017, ITALYS DEAL STEM FLO; Zhang SX, 2018, ANN AM ACAD POLIT SS, V676, P6, DOI 10.1177/0002716217746908	38	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236646	10.1371/journal.pone.0236646	http://dx.doi.org/10.1371/journal.pone.0236646			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NO3EK	32735571	Green Published, gold			2022-12-26	WOS:000569367100035
J	Gedeon, PC; Streicker, MA; Schaller, TH; Archer, GE; Jokinen, MP; Sampson, JH				Gedeon, Patrick C.; Streicker, Michael A.; Schaller, Teilo H.; Archer, Gary E.; Jokinen, Micheal P.; Sampson, John H.			GLP toxicology study of a fully-human T cell redirecting CD3:EGFRvIII binding immunotherapeutic bispecific antibody	PLOS ONE			English	Article							BLINATUMOMAB; RECEPTOR; MICE	We recently reported the development of a fully-human, CD3-binding bispecific antibody for immunotherapy of malignant glioma. To translate this therapeutic (hEGFRvIII-CD3-bi-scFv) to clinical trials and to help further the translation of other similar CD3-binding therapeutics, some of which are associated with neurologic toxicities, we performed a good laboratory practice (GLP) toxicity study to assess for potential behavioral, chemical, hematologic, and pathologic toxicities including evaluation for experimental autoimmune encephalomyelitis (EAE). To perform this study, male and female C57/BL6 mice heterozygous for the human CD3 transgene (20/sex) were allocated to one of four designated groups. All animals were administered one dose level of hEGFRvIII-CD3 bi-scFv or vehicle control. Test groups were monitored for feed consumption, changes in body weight, and behavioral disturbances including signs of EAE. Urinalysis, hematologic, and clinical chemistry analysis were also performed. Vehicle and test chemical-treated groups were humanely euthanized 48 hours or 14 days following dose administration. Complete gross necropsy of all tissues was performed, and selected tissues plus all observed gross lesions were collected and evaluated for microscopic changes. This included hematoxylin-eosin histopathological evaluation and Fe-ECR staining for myelin sheath enumeration. There were no abnormal clinical observations or signs of EAE noted during the study. There were no statistical changes in food consumption, body weight gain, or final body weight among groups exposed to hEGFRvIII-CD3 bi-scFv compared to the control groups for the 2- and 14-day timepoints. There were statistical differences in some clinical chemistry, hematologic and urinalysis endpoints, primarily in the females at the 14-day timepoint (hematocrit, calcium, phosphorous, and total protein). No pathological findings related to hEGFRvIII-CD3 bi-scFv administration were observed. A number of gross and microscopic observations were noted but all were considered to be incidental background findings. The results of this study allow for further translation of this and other important CD3 modulating bispecific antibodies.	[Gedeon, Patrick C.; Schaller, Teilo H.; Archer, Gary E.; Sampson, John H.] Duke Univ, Dept Neurosurg, Duke Brain Tumor Immunotherapy Program, Med Ctr, Durham, NC 27710 USA; [Gedeon, Patrick C.; Sampson, John H.] Duke Univ, Dept Biomed Engn, Durham, NC 27710 USA; [Gedeon, Patrick C.; Schaller, Teilo H.; Archer, Gary E.; Sampson, John H.] Duke Univ, Preston Robert Tisch Brain Tumor Ctr, Dept Neurosurg, Med Ctr, Durham, NC 27710 USA; [Streicker, Michael A.; Jokinen, Micheal P.] Integrated Lab Syst Inc, Res Triangle Pk, NC USA; [Schaller, Teilo H.; Sampson, John H.] Duke Univ, Dept Pathol, Med Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Sampson, JH (corresponding author), Duke Univ, Dept Neurosurg, Duke Brain Tumor Immunotherapy Program, Med Ctr, Durham, NC 27710 USA.; Sampson, JH (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27710 USA.; Sampson, JH (corresponding author), Duke Univ, Preston Robert Tisch Brain Tumor Ctr, Dept Neurosurg, Med Ctr, Durham, NC 27710 USA.; Sampson, JH (corresponding author), Duke Univ, Dept Pathol, Med Ctr, Durham, NC 27710 USA.	john.sampson@duke.edu	Gedeon, Patrick C./G-6563-2013; Schaller, Teilo/D-6920-2013	Gedeon, Patrick C./0000-0002-5387-1833; Schaller, Teilo/0000-0002-5036-5820	National Institutes of Health [F30CA196199, R01NS08541, U01NS090284, R01CA177476, R01NS086943, R01NS099463]; Duke University Division of Laboratory Animal Resources (DLAR); Duke Transgenic Mouse Facility	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University Division of Laboratory Animal Resources (DLAR); Duke Transgenic Mouse Facility	This work was supported by funding from the National Institutes of Health: F30CA196199 (P.C. Gedeon), R01NS08541 (J.H. Sampson), U01NS090284 (J.H. Sampson), R01CA177476 (J.H. Sampson), R01NS086943 (J. H. Sampson), and R01NS099463 (J.H. Sampson). The funders provided support in the form of compensation that was used to contract with Integrated Laboratory Systems, Inc. under a Research Support Services Agreement made between Duke University and Integrated Laboratory Systems, Inc. for assistance in conducting the described study. The funders additionally provided support in the form of salaries for authors P.C. Gedeon, T.H. Schaller, G.E. Archer, and J.H. Sampson and research materials. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the `author contributions' section."; We would like to acknowledge the Duke University Division of Laboratory Animal Resources (DLAR), the Duke Transgenic Mouse Facility, Dr. Roger McLendon, and Traci Reddick for their generous support, advice, and assistance with this research study. A preliminary report of the results described in this manuscript was included in a dissertation [18].	Brudno JN, 2016, BLOOD, V127, P3321, DOI 10.1182/blood-2016-04-703751; Elson G, 2006, ANTICD3 ANTIBODY FOR, Patent No. US20070065437A1; Gedeon PC, 2018, CLIN CANCER RES, V24, P3611, DOI 10.1158/1078-0432.CCR-17-0126; Gedeon PC, 2017, THESIS; Harada K, 1999, LIVER, V19, P318, DOI 10.1111/j.1478-3231.1999.tb00056.x; Jen EY, 2019, CLIN CANCER RES, V25, P473, DOI 10.1158/1078-0432.CCR-18-2337; Klinger M, 2020, CANCER RES, V80, P91, DOI 10.1158/0008-5472.CAN-19-1131; Labrijn AF, 2019, NAT REV DRUG DISCOV, V18, P585, DOI 10.1038/s41573-019-0028-1; Maronpot R, 1999, PATHOLOGY MOUSE; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; Przepiorka D, 2015, CLIN CANCER RES, V21, P4035, DOI 10.1158/1078-0432.CCR-15-0612; Pulte ED, 2018, ONCOLOGIST, V23, P1366, DOI 10.1634/theoncologist.2018-0179; Radovsky AE, 1999, PATHOLOGY MOUSE REFE; Topp MS, 2015, LANCET ONCOL, V16, P57, DOI 10.1016/S1470-2045(14)71170-2; US Department of Health and Human Services Food and Drug Adminoistration, 2006, GUID IND INV REV EXP; WANG BP, 1994, P NATL ACAD SCI USA, V91, P9402, DOI 10.1073/pnas.91.20.9402; Wang NH, 1998, INT IMMUNOL, V10, P1777, DOI 10.1093/intimm/10.12.1777; Ward JM, 1999, LAB INVEST, V79, P3	18	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236374	10.1371/journal.pone.0236374	http://dx.doi.org/10.1371/journal.pone.0236374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735564	Green Published, gold			2022-12-26	WOS:000569367100017
J	Liu, XH; Xie, R; Yu, LL; Chen, SH; Yang, XY; Singh, AK; Li, HZ; Wu, C; Yu, XC				Liu, Xiuhua; Xie, Rong; Yu, Lily L.; Chen, Shih-Hsun; Yang, Xiaoyun; Singh, Anup K.; Li, Hongzhi; Wu, Chen; Yu, Xiaochun			AI26 inhibits the ADP-ribosylhydrolase ARH3 and suppresses DNA damage repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation; dePARylation; DNA damage response; cancer therapy; ARH3; inhibitor; DNA repair	RIBOSYLATION; POLY(ADP-RIBOSE); RIBOSE; PROTEINS; FAMILY; PARG; IDENTIFICATION; REVERSIBILITY; RECRUITMENT; DOMAINS	The ADP-ribosylhydrolase ARH3 plays a key role in DNA damage repair, digesting poly(ADP-ribose) and removing ADP-ribose from serine residues of the substrates. Specific inhibitors that selectively target ARH3 would be a useful tool to examine DNA damage repair, as well as a possible strategy for tumor suppression. However, efforts to date have not identified any suitable compounds. Here, we usedin silicoand biochemistry screening to search for ARH3 inhibitors. We discovered a small molecule compound named ARH3 inhibitor 26 (AI26) as, to our knowledge, the first ARH3 inhibitor. AI26 binds to the catalytic pocket of ARH3 and inhibits the enzymatic activity of ARH3 with an estimated IC(50)of similar to 2.41 mu min vitro. Moreover, hydrolysis of DNA damage-induced ADP-ribosylation was clearly inhibited when cells were pretreated with AI26, leading to defects in DNA damage repair. In addition, tumor cells with DNA damage repair defects were hypersensitive to AI26 treatment, as well as combinations of AI26 and other DNA-damaging agents such as camptothecin and doxorubicin. Collectively, these results reveal not only a chemical probe to study ARH3-mediated DNA damage repair but also a chemotherapeutic strategy for tumor suppression.	[Liu, Xiuhua; Xie, Rong; Yang, Xiaoyun; Wu, Chen] Hebei Univ, Coll Life Sci, Inst Life Sci & Green Dev, Baoding, Hebei, Peoples R China; [Yu, Lily L.] Westridge Sch, Pasadena, CA USA; [Chen, Shih-Hsun] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Singh, Anup K.] City Hope Natl Med Ctr, Dept Canc Genet & Epigenet, Beckman Res Inst, Duarte, CA USA; [Li, Hongzhi] City Hope Natl Med Ctr, Beckman Res Inst, Drug Discovery & Struct Biol Core Facil, Duarte, CA USA; [Yu, Xiaochun] Westlake Univ, Sch Life Sci, Hangzhou, Zhejiang, Peoples R China	Hebei University; National Taiwan University; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Westlake University	Yu, XC (corresponding author), Westlake Univ, Sch Life Sci, Hangzhou, Zhejiang, Peoples R China.	yuxiaochun@westlake.edu.cn			National Natural Science Foundation of China [81874160, 31670812]; Foundation of Hebei Educational Committee [ZD2020183]; Ministry of Education ChunHui Project [5]; Natural Science Foundation of Hebei Province [C2018201171]; Hebei Province Foundation for Returned Overseas Chinese Scholars; Westlake University; National Cancer Institute [P30CA033572, CA233664, CA130899, CA240392]; Tower Cancer Research Foundation; Ovarian Cancer Research Fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Hebei Educational Committee; Ministry of Education ChunHui Project; Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Hebei Province Foundation for Returned Overseas Chinese Scholars; Westlake University; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Tower Cancer Research Foundation; Ovarian Cancer Research Fund	This work was supported by National Natural Science Foundation of China Grants 81874160 and 31670812, Foundation of Hebei Educational Committee Grant ZD2020183, Ministry of Education ChunHui Project Grant 5, Natural Science Foundation of Hebei Province Grant C2018201171, and funds from the Hebei Province Foundation for Returned Overseas Chinese Scholars and from Westlake University. The Drug Discovery & Structural Biology Core facility of City of Hope is supported by National Cancer Institute Grant P30CA033572. A. K. S. was partially supported by the Tower Cancer Research Foundation and by National Cancer Institute Grant CA233664. S.-H. C. was partially supported by National Cancer Institute Grants CA130899 and CA240392 and by the Ovarian Cancer Research Fund. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abplanalp J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02253-1; Aguiar RCT, 2005, J BIOL CHEM, V280, P33756, DOI 10.1074/jbc.M505408200; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Bock FJ, 2015, MOL CELL, V58, P911, DOI 10.1016/j.molcel.2015.06.012; Bonfiglio JJ, 2017, MOL CELL, V65, P932, DOI 10.1016/j.molcel.2017.01.003; Breslin C, 2015, NUCLEIC ACIDS RES, V43, P6934, DOI 10.1093/nar/gkv623; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Chen SH, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4340; Cheruiyot A, 2015, DNA REPAIR, V35, P106, DOI 10.1016/j.dnarep.2015.09.021; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fontana P, 2017, ELIFE, V6, DOI 10.7554/eLife.28533; Gupte R, 2017, GENE DEV, V31, P101, DOI 10.1101/gad.291518.116; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hottiger MO, 2015, ANNU REV BIOCHEM, V84, P227, DOI 10.1146/annurev-biochem-060614-034506; Huth JR, 2005, J AM CHEM SOC, V127, P217, DOI 10.1021/ja0455547; Kassab MA, 2019, DNA REPAIR, V76, P20, DOI 10.1016/j.dnarep.2019.02.002; Kaufmann T, 2017, NUCLEIC ACIDS RES, V45, P9741, DOI 10.1093/nar/gkx604; Lan L, 2014, NUCLEIC ACIDS RES, V42, P2330, DOI 10.1093/nar/gkt1233; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Leidecker O, 2016, NAT CHEM BIOL, V12, P998, DOI 10.1038/nchembio.2180; Leung AKL, 2014, J CELL BIOL, V205, P613, DOI 10.1083/jcb.201402114; Leutert M, 2018, CELL REP, V24, P1916, DOI 10.1016/j.celrep.2018.07.048; Li M, 2013, GENE DEV, V27, P1752, DOI 10.1101/gad.226357.113; Lin KY, 2017, CELL, V169, P183, DOI 10.1016/j.cell.2017.03.034; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Liu C, 2017, NUCLEIC ACIDS RES, V45, P8129, DOI 10.1093/nar/gkx565; Martiniano R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10326; Mashimo M, 2014, DNA REPAIR, V23, P88, DOI 10.1016/j.dnarep.2014.03.005; Min W, 2009, FRONT BIOSCI-LANDMRK, V14, P1619, DOI 10.2741/3329; Mortusewicz O, 2011, NUCLEIC ACIDS RES, V39, P5045, DOI 10.1093/nar/gkr099; MOSS J, 1985, P NATL ACAD SCI USA, V82, P5603, DOI 10.1073/pnas.82.17.5603; Mueller-Dieckmann C, 2006, P NATL ACAD SCI USA, V103, P15026, DOI 10.1073/pnas.0606762103; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Palazzo L, 2018, ELIFE, V7, DOI 10.7554/eLife.34334; Pessetto ZY, 2012, BREAST CANCER RES TR, V134, P511, DOI 10.1007/s10549-012-2079-4; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; Pourfarjam Y, 2018, J BIOL CHEM, V293, P12350, DOI 10.1074/jbc.RA118.003586; Rosenthal F, 2013, NAT STRUCT MOL BIOL, V20, P502, DOI 10.1038/nsmb.2521; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Shirai H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.133; Teloni F, 2016, NUCLEIC ACIDS RES, V44, P993, DOI 10.1093/nar/gkv1383; Vyas S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5426; Vyas S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3240; Wang MX, 2018, J BIOL CHEM, V293, P14470, DOI 10.1074/jbc.RA118.004284; Zhang F, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv939; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603; Zhen YL, 2017, CELL REP, V21, P2326, DOI 10.1016/j.celrep.2017.10.106	48	4	5	6	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2020	295	40					13838	13849		10.1074/jbc.RA120.012801	http://dx.doi.org/10.1074/jbc.RA120.012801			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OB4MB	32753484	hybrid, Green Published			2022-12-26	WOS:000578444100011
J	Shi, YL; Wang, XY; Xu, ZY; He, Y; Guo, CY; He, LJ; Huan, CJ; Cai, CH; Huang, JQ; Zhang, J; Li, YQ; Zeng, CL; Zhang, X; Wang, LR; Ke, YH; Cheng, HQ				Shi, Yueli; Wang, Xinyu; Xu, Zhiyong; He, Ying; Guo, Chunyi; He, Lingjuan; Huan, Caijuan; Cai, Changhong; Huang, Jiaqi; Zhang, Jie; Li, Yiqing; Zeng, Chunlai; Zhang, Xue; Wang, Linrun; Ke, Yuehai; Cheng, Hongqiang			PDLIM5 inhibits STUB1-mediated degradation of SMAD3 and promotes the migration and invasion of lung cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lung cancer; proteasome degradation; ENH; STUB1; E3 ubiquitin ligase; transforming growth factor beta (TGF-B); lung cancer; cell invasion; cell motility; invasion; protein degradation; signal transduction; tumor metastasis; ubiquitin	EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; TUMOR-SUPPRESSOR; PDZ; BREAST; TUMORIGENESIS; ACTIVATION; EXPRESSION; COMPLEX; GENES	Transforming growth factor beta (TGF beta) signaling plays an important role in regulating tumor malignancy, including in non-small cell lung cancer (NSCLC). The major biological responses of TGF beta signaling are determined by the effector proteins SMAD2 and SMAD3. However, the regulators of TGF beta-SMAD signaling are not completely revealed yet. Here, we showed that the scaffolding protein PDLIM5 (PDZ and LIM domain protein 5, ENH) critically promotes TGF beta signaling by maintaining SMAD3 stability in NSCLC. First, PDLIM5 was highly expressed in NSCLC compared with that in adjacent normal tissues, and high PDLIM5 expression was associated with poor outcome. Knockdown of PDLIM5 in NSCLC cells decreased migration and invasionin vitroand lung metastasisin vivo. In addition, TGF beta signaling and TGF beta-induced epithelial-mesenchymal transition was repressed by PDLIM5 knockdown. Mechanistically, PDLIM5 knockdown resulted in a reduction of SMAD3 protein levels. Overexpression of SMAD3 reversed the TGF beta-signaling-repressing and anti-migration effects induced by PDLIM5 knockdown. Notably, PDLIM5 interacted with SMAD3 but not SMAD2 and competitively suppressed the interaction between SMAD3 and its E3 ubiquitin ligase STUB1. Therefore, PDLIM5 protected SMAD3 from STUB1-mediated proteasome degradation. STUB1 knockdown restored SMAD3 protein levels, cell migration, and invasion in PDLIM5-knockdown cells. Collectively, our findings indicate that PDLIM5 is a novel regulator of basal SMAD3 stability, with implications for controlling TGF beta signaling and NSCLC progression.	[Shi, Yueli; Wang, Xinyu; Xu, Zhiyong; Guo, Chunyi; Huang, Jiaqi; Li, Yiqing; Zhang, Xue; Ke, Yuehai; Cheng, Hongqiang] Zhejiang Univ, Dept Pathol & Pathophysiol, Sch Med, Hangzhou, Peoples R China; [He, Ying] Huzhou Univ, Affiliated Hosp 1, Key Lab Translat Med, Huzhou, Peoples R China; [He, Lingjuan; Wang, Linrun] Zhejiang Univ, Affiliated Hosp 1, Dept Pharm, Sch Med, Hangzhou, Peoples R China; [Huan, Caijuan] Zhejiang Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Sch Med, Hangzhou, Peoples R China; [Cai, Changhong; Zeng, Chunlai] Lishui Cent Hosp, Dept Cardiol, Lishui, Peoples R China; [Zhang, Jie] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Urol, Sch Med, Hangzhou, Peoples R China; [Cheng, Hongqiang] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Cardiol, Sch Med, Hangzhou, Peoples R China	Zhejiang University; Huzhou University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Ke, YH; Cheng, HQ (corresponding author), Zhejiang Univ, Dept Pathol & Pathophysiol, Sch Med, Hangzhou, Peoples R China.; Cheng, HQ (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Cardiol, Sch Med, Hangzhou, Peoples R China.	yke@zju.edu.cn; hqcheng11@zju.edu.cn		Xu, Zhiyong/0000-0001-9873-8617	Zhejiang Provincial Natural Science Foundation of China [LZ18H020001]; National Natural Science Foundation of China [81673512, 31871399, 81530001, 81700064]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported Zhejiang Provincial Natural Science Foundation of China Grant LZ18H020001 (to H. C.) and National Natural Science Foundation of China Grants 81673512 (to L. W.), 31871399 (to H. C.), 81530001 (to Y. K.), and 81700064 (to C. H.).	Aggarwal K, 2012, NAT CELL BIOL, V14, P656, DOI 10.1038/ncb2534; Asselin-Paturel C, 1998, INT J CANCER, V77, P7, DOI 10.1002/(SICI)1097-0215(19980703)77:1<7::AID-IJC2>3.0.CO;2-Y; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bowe RA, 2014, MOL BIOL CELL, V25, P184, DOI 10.1091/mbc.E13-06-0306; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen H, 2005, AM J PHYSIOL-LUNG C, V288, pL683, DOI 10.1152/ajplung.00298.2004; Chen HN, 2016, CANCER RES, V76, P1122, DOI 10.1158/0008-5472.CAN-15-1962; Chen NY, 2014, CANCER RES, V74, P5683, DOI 10.1158/0008-5472.CAN-14-1171; Chen TJ, 2015, AM J RESP CRIT CARE, V191, P678, DOI 10.1164/rccm.201405-0941OC; Cheng H, 2016, J BIOMOL SCREEN, V21, P333, DOI 10.1177/1087057115625924; Cheng HQ, 2010, CIRC RES, V107, P348, DOI 10.1161/CIRCRESAHA.110.218735; Elbediwy A, 2018, J CELL SCI, V131, DOI 10.1242/jcs.221788; Fernandez-Cortes M, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00803; Fu CT, 2019, J CLIN INVEST, V129, P4745, DOI 10.1172/JCI128293; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Hamidi H, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2646; Hirsch FR, 2017, LANCET, V389, P299, DOI 10.1016/S0140-6736(16)30958-8; Huang Z, 2020, HEPATOLOGY, V71, P1643, DOI 10.1002/hep.30930; Jiao JT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04936-9; Kales SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087116; Lasorella A, 2006, P NATL ACAD SCI USA, V103, P4976, DOI 10.1073/pnas.0600168103; Li SM, 2014, J BIOL CHEM, V289, P34152, DOI 10.1074/jbc.M113.546077; Lin CS, 2013, J BIOL CHEM, V288, P29403, DOI 10.1074/jbc.M113.470708; Liu X, 2017, ONCOTARGET, V8, P98117, DOI 10.18632/oncotarget.20981; Liu Z, 2015, ONCOGENE, V34, P1300, DOI 10.1038/onc.2014.64; Maeno-Hikichi Y, 2003, NAT NEUROSCI, V6, P468, DOI 10.1038/nn1041; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Miyazono K, 2018, FRONT MED-PRC, V12, P387, DOI 10.1007/s11684-018-0646-8; PEDERSEN H, 1994, CANCER RES, V54, P120; Shui IM, 2014, EUR UROL, V65, P1069, DOI 10.1016/j.eururo.2013.12.058; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Staruschenko A, 2010, J BIOL CHEM, V285, P15167, DOI 10.1074/jbc.M110.106153; Sthanam LK, 2017, BIOMATERIALS, V119, P9, DOI 10.1016/j.biomaterials.2016.12.006; Sun F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13331-x; Sun F, 2015, J BIOL CHEM, V290, P7362, DOI 10.1074/jbc.C115.637918; Sundqvist A, 2018, NUCLEIC ACIDS RES, V46, P1180, DOI 10.1093/nar/gkx1190; Velthuis AJWT, 2007, THESCIENTIFICWORLDJO, V7, P1470, DOI 10.1100/tsw.2007.232; Wang L, 2016, ONCOGENE, V35, P867, DOI 10.1038/onc.2015.141; Wei XD, 2018, BIOCHEM BIOPH RES CO, V499, P338, DOI 10.1016/j.bbrc.2018.03.159; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; Xia T, 2013, J BIOL CHEM, V288, P1785, DOI 10.1074/jbc.M112.439760; Xin H, 2005, J BIOL CHEM, V280, P20842, DOI 10.1074/jbc.M412275200; Xue JF, 2014, J CLIN INVEST, V124, P564, DOI 10.1172/JCI71104; Yan Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7137; Ying Z, 2017, J CLIN INVEST, V127, P1725, DOI 10.1172/JCI90439; Zheng M, 2010, J MOL CELL BIOL, V2, P96, DOI 10.1093/jmcb/mjp038	50	13	14	2	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2020	295	40					13798	13811		10.1074/jbc.RA120.014976	http://dx.doi.org/10.1074/jbc.RA120.014976			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OB4MB	32737199	Green Published, hybrid			2022-12-26	WOS:000578444100008
J	Torgeson, KR; Clarkson, MW; Kumar, GS; Page, R; Peti, W				Torgeson, Kristiane R.; Clarkson, Michael W.; Kumar, Ganesan Senthil; Page, Rebecca; Peti, Wolfgang			Cooperative dynamics across distinct structural elements regulate PTP1B activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-tyrosine phosphatase; PTP1B; enzyme; NMR spectroscopy; C-13 methyl ILV dynamics; ct-CPMG; nuclear magnetic resonance (NMR); protein dynamic; enzyme catalysis; enzyme mechanism	PROTEIN-TYROSINE-PHOSPHATASE; NMR-SPECTROSCOPY; ASSIGNMENTS; INHIBITION; TIMESCALES; STRATEGY; MOTIONS; LOOP	Protein-tyrosine phosphatase 1B (PTP1B) is the canonical enzyme for investigating how distinct structural elements influence enzyme catalytic activity. Although it is recognized that dynamics are essential for PTP1B function, the data collected thus far have not resolved whether distinct elements are dynamically coordinated or, alternatively, whether they fulfill their respective functions independently. To answer this question, we performed a comprehensive(13)C-methyl relaxation study of Ile, Leu, and Val (ILV) residues of PTP1B, which, because of its substantially increased sensitivity, provides a comprehensive understanding of the influence of protein motions on different time scales for enzyme function. We discovered that PTP1B exhibits dynamics at three distinct time scales. First, it undergoes a distinctive slow motion that allows for the dynamic binding and release of its two most N-terminal helices from the catalytic core. Second, we showed that PTP1B(13)C-methyl group side chain fast time-scale dynamics and(15)N backbone fast time-scale dynamics are fully consistent, demonstrating that fast fluctuations are essential for the allosteric control of PTP1B activity. Third, and most importantly, using(13)C ILV constant-time Carr-Purcell-Meiboom-Gill relaxation measurements experiments, we demonstrated that all four catalytically important loops-the WPD, Q, E, and substrate-binding loops-work in dynamic unity throughout the catalytic cycle of PTP1B. Thus, these data show that PTP1B activity is not controlled by a single functional element, but instead all key elements are dynamically coordinated. Together, these data provide the first fully comprehensive picture on how the validated drug target PTP1B functions.	[Torgeson, Kristiane R.; Clarkson, Michael W.; Kumar, Ganesan Senthil; Page, Rebecca; Peti, Wolfgang] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Arizona	Peti, W (corresponding author), Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA.	wolfgangpeti@email.arizona.edu		Clarkson, Michael W/0000-0002-4323-3424	American Diabetes Association Pathway to Stop Diabetes Grant [1-14-ACN-31]; National Institutes of Health [R01GM098482, T32GM008804]	American Diabetes Association Pathway to Stop Diabetes Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the American Diabetes Association Pathway to Stop Diabetes Grant 1-14-ACN-31 (to W. P.) and by National Institutes of Health Grants and R01GM098482 (to R. P.) and T32GM008804 (to K. R. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bhabha G, 2013, NAT STRUCT MOL BIOL, V20, P1243, DOI 10.1038/nsmb.2676; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Choy MS, 2017, MOL CELL, V65, P644, DOI 10.1016/j.molcel.2017.01.014; Critton DA, 2011, J MOL BIOL, V405, P619, DOI 10.1016/j.jmb.2010.11.020; Cui DS, 2019, J AM CHEM SOC, V141, P12634, DOI 10.1021/jacs.9b04470; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Feldhammer M, 2013, CRIT REV BIOCHEM MOL, V48, P430, DOI 10.3109/10409238.2013.819830; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hjortness MK, 2018, BIOCHEMISTRY-US, V57, P6443, DOI 10.1021/acs.biochem.8b00656; Iversen LF, 2000, J BIOL CHEM, V275, P10300, DOI 10.1074/jbc.275.14.10300; Iverson DB, 2020, BIOCHEMISTRY-US, V59, P2698, DOI 10.1021/acs.biochem.0c00485; Keedy DA, 2018, ELIFE, V7, DOI 10.7554/eLife.36307; Krejcirikova A, 2012, J BIOMOL NMR, V54, P135, DOI 10.1007/s10858-012-9667-9; Krishnan N, 2015, J CLIN INVEST, V125, P3163, DOI 10.1172/JCI80323; Krishnan N, 2014, NAT CHEM BIOL, V10, P558, DOI [10.1038/NCHEMBIO.1528, 10.1038/nchembio.1528]; Kumar GS, 2018, P NATL ACAD SCI USA, V115, P4655, DOI 10.1073/pnas.1721441115; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lisi GP, 2016, PROG NUCL MAG RES SP, V92-93, P1, DOI 10.1016/j.pnmrs.2015.11.001; Massi F, 2006, BIOCHEMISTRY-US, V45, P10787, DOI 10.1021/bi060764c; Otten R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03562-9; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024; Peti W, 2016, METHODS MOL BIOL, V1447, P181, DOI 10.1007/978-1-4939-3746-2_11; Rosenzweig R, 2014, ANNU REV BIOCHEM, V83, P291, DOI 10.1146/annurev-biochem-060713-035829; Ruschak AM, 2010, J BIOMOL NMR, V46, P75, DOI 10.1007/s10858-009-9376-1; TONKS NK, 1988, J BIOL CHEM, V263, P6722; Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; Whittier SK, 2013, SCIENCE, V341, P899, DOI 10.1126/science.1241735; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803	34	6	6	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2020	295	40					13829	13837		10.1074/jbc.RA120.014652	http://dx.doi.org/10.1074/jbc.RA120.014652			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OB4MB	32737198	Green Published, hybrid			2022-12-26	WOS:000578444100010
J	Wu, SM; Feng, PH; Chuang, HC; Ho, SC; Chung, KF; Chen, KY; Wu, GS; Chen, TT; Tseng, CH; Liu, WT; Lee, KY				Wu, Sheng-Ming; Feng, Po-Hao; Chuang, Hsiao-Chi; Ho, Shu-Chuan; Chung, Kian Fan; Chen, Kuan-Yuan; Wu, Guang-Sing; Chen, Tzu-Tao; Tseng, Chien-Hua; Liu, Wen-Te; Lee, Kang-Yun			Impaired lnc-IL7R modulatory mechanism of Toll-like receptors is associated with an exacerbator phenotype of chronic obstructive pulmonary disease	FASEB JOURNAL			English	Article						COPD; exacerbation; inflammation; lnc-IL7R; Toll-like receptor	LONG NONCODING RNA; SYSTEMIC INFLAMMATION; CIGARETTE-SMOKE; COPD	Patients with chronic obstructive pulmonary disease (COPD) are susceptible to bacterial infections, which worsen lung inflammation and contribute to lung function decline and acute exacerbation. Long noncoding (lnc) RNAs are emerging regulators of inflammation with unknown clinical relevance. Herein, we report that levels of the Toll-like receptor (TLR)-related lnc interleukin (IL) 7 receptor (IL7R) were significantly reduced in peripheral blood mononuclear cells from patients with COPD compared with those from normal controls, and the levels were correlated with pulmonary function. Moreover lnc-IL7R levels were reduced in lavaged alveolar macrophages and primary human small airway epithelial cells (HSAEpCs) from patients with COPD. Lnc-IL7R knockdown in primary human macrophages, HSAEpCs, and human pulmonary microvascular endothelial cells (HPMECs) significantly augmented the induction of proinflammatory mediators after TLR2/4 activation. By contrast, lnc-IL7R overexpression attenuated inflammation after TLR2/4 activation. Similar results with lnc-IL7R-mediated inflammation were observed in COPD HSAEpCs. Mechanistically, lnc-IL7R mediated a repressive chromatin state of the proinflammatory gene promoter as a result of decreased acetylation (H3K9ac) and increased methylation (H3K9me3 and H3K27me3). Plasma lnc-IL7R levels were reduced in patients with COPD who experienced more acute exacerbation in the previous year. Notably, patients with lower lnc-IL7R levels in the subsequent year had increased exacerbation risk. Low lnc-IL7R expression in COPD may augment TLR2/4-mediated inflammation and be associated with acute exacerbation.	[Wu, Sheng-Ming; Feng, Po-Hao; Chuang, Hsiao-Chi; Ho, Shu-Chuan; Chen, Kuan-Yuan; Wu, Guang-Sing; Chen, Tzu-Tao; Tseng, Chien-Hua; Liu, Wen-Te; Lee, Kang-Yun] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, New Taipei, Taiwan; [Wu, Sheng-Ming; Feng, Po-Hao; Chuang, Hsiao-Chi; Chen, Tzu-Tao; Tseng, Chien-Hua; Liu, Wen-Te; Lee, Kang-Yun] Taipei Med Univ, Coll Med, Sch Med, Div Pulm Med,Dept Internal Med, Taipei, Taiwan; [Chuang, Hsiao-Chi; Ho, Shu-Chuan; Liu, Wen-Te] Taipei Med Univ, Sch Resp Therapy, Coll Med, Taipei, Taiwan; [Chung, Kian Fan] Imperial Coll London, Natl Heart & Lung Inst, Airways Dis, London, England; [Chung, Kian Fan] Royal Brompton & Harefield NHS Trust, London, England; [Chen, Kuan-Yuan; Lee, Kang-Yun] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Tseng, Chien-Hua] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Taipei Medical University; National Taiwan University	Lee, KY (corresponding author), Taipei Med Univ, Sch Med, Dept Internal Med, Div Pulm Med, 250 Wuxing St, Taipei 11031, Taiwan.	lee4949@ms41.hinet.net			Ministry of Science and Technology, Taiwan (MOST) [05-2314-B-038-056-MY3, 107-2314-B-038-114, 108-2314-B-038-111-MY3, 108-2314-B-038-063-MY3]; Ministry of Education of the R.O.C [DP2-108-21121-T04-01, DP2-109-21121-01-T-01]; Taipei Medical University; Shuang Ho Hospital [107F RP-01-3, 108-FRP-04, 109-FRP-03]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); Ministry of Education of the R.O.C; Taipei Medical University; Shuang Ho Hospital	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: 05-2314-B-038-056-MY3, 107-2314-B-038-114, 108-2314-B-038-111-MY3, and 108-2314-B-038-063-MY3; Ministry of Education of the R.O.C, Grant/Award Number: DP2-108-21121-T04-01 and DP2-109-21121-01-T-01; Taipei Medical University and Shuang Ho Hospital, Grant/Award Number: 106TMU-SHH-18 and 107TMU-SHH-09; Shuang Ho Hospital, Grant/Award Number: 107F RP-01-3, 108-FRP-04, and 109-FRP-03	Amsellem V, 2011, AM J RESP CRIT CARE, V184, P1358, DOI 10.1164/rccm.201105-0802OC; Angrisano T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-172; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Barnes PJ, 2016, J ALLERGY CLIN IMMUN, V138, P16, DOI 10.1016/j.jaci.2016.05.011; Barnes PJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.76; Berenson CS, 2014, THORAX, V69, P811, DOI 10.1136/thoraxjnl-2013-203669; Bezemer GFG, 2012, PHARMACOL REV, V64, P337, DOI 10.1124/pr.111.004622; Bradford E., 2017, COPD, V18, P180, DOI DOI 10.1186/S12931-017-0662-2; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Buckley CD, 2011, IMMUNOL LETT, V138, P12, DOI 10.1016/j.imlet.2011.02.010; Chen TT, 2017, SCI REP-UK, V7, DOI 10.1038/srep46667; Chowdhury IH, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3427461; Cui HC, 2014, EUR J IMMUNOL, V44, P2085, DOI 10.1002/eji.201344126; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Ding L, 2017, MOL CANCER THER, V16, P1068, DOI 10.1158/1535-7163.MCT-16-0454; Fan YY, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180483; Freeman CM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-13; Geng H, 2016, GENES DIS, V3, P72, DOI 10.1016/j.gendis.2016.01.004; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hadjicharalambous MR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02906; Han MK, 2017, LANCET RESP MED, V5, P619, DOI 10.1016/S2213-2600(17)30207-2; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jiang DH, 2006, CELL RES, V16, P693, DOI 10.1038/sj.cr.7310085; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Lafferty EI, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-57; Lee KY, 2012, EUR RESPIR J, V40, P863, DOI 10.1183/09031936.00146811; Liu DS, 2018, INFLAMMATION, V41, P654, DOI 10.1007/s10753-017-0720-4; Massone S, 2011, NEUROBIOL DIS, V41, P308, DOI 10.1016/j.nbd.2010.09.019; Nadigel J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-149; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Pons J, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-64; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Qu XY, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/7501851; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Sethi Sanjay, 2004, Proc Am Thorac Soc, V1, P109, DOI 10.1513/pats.2306029; Sinden NJ, 2010, THORAX, V65, P930, DOI 10.1136/thx.2009.130260; Sundar IK, 2013, ANTIOXID REDOX SIGN, V18, P1956, DOI 10.1089/ars.2012.4863; Tang WX, 2016, INT J CHRONIC OBSTR, V11, P2951, DOI 10.2147/COPD.S109570; Thai P, 2013, AM J RESP CELL MOL, V49, P204, DOI 10.1165/rcmb.2013-0159RC; Wan B, 2018, CLIN RESPIR J, V12, P1607, DOI 10.1111/crj.12717; Wedzicha Jadwiga A, 2004, Proc Am Thorac Soc, V1, P115, DOI 10.1513/pats.2306030; Yang SR, 2008, AM J RESP CELL MOL, V38, P689, DOI 10.1165/rcmb.2007-0379OC; Ye Z, 2017, MOL MED REP, V15, P1412, DOI 10.3892/mmr.2017.6150; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	48	4	4	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					13317	13332		10.1096/fj.202000632R	http://dx.doi.org/10.1096/fj.202000632R		AUG 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32780913				2022-12-26	WOS:000558418600001
J	Barth, J; Geed, S; Mitchell, A; Lum, PS; Edwards, DF; Dromerick, AW				Barth, Jessica; Geed, Shashwati; Mitchell, Abigail; Lum, Peter S.; Edwards, Dorothy F.; Dromerick, Alexander W.			Characterizing upper extremity motor behavior in the first week after stroke	PLOS ONE			English	Article							UPPER-LIMB RECOVERY; ARM ACTIVITY; ACCELERATION METRICS; CORTICAL INFARCTS; SUBACUTE STROKE; REHABILITATION; ACCELEROMETRY; COMPENSATION; NONUSE; BRAIN	Background Animal models of brain recovery identify the first days after lesioning as a time of great flux in sensorimotor function and physiology. After rodent motor system lesioning, daily skill training in the less affected forelimb reduces skill acquisition in the more affected forelimb. We asked whether spontaneous human motor behaviors of the less affected upper extremity (UE) early after stroke resemble the animal training model, with the potential to suppress clinical recovery. Methods This prospective observational study used a convenience sample of patients (n = 25, mean 4.5 +/- 1.8) days after stroke with a wide severity range; Controls were hospitalized for non-neurological conditions (n = 12). Outcome measures were Accelerometry, Upper-Extremity Fugl-Meyer (UEFM), Action Research Arm Test (ARAT), Shoulder Abduction/ Finger Extension Test (SAFE), NIH Stroke Scale (NIHSS). Results Accelerometry indicated total paretic UE movement was reduced compared to controls, primarily due to a 44% reduction of bilateral UE use. Unilateral paretic movement was unchanged. Thus, movement shifted early after stroke; bilateral use was reduced and unilateral use of the non-paretic UE was increased by 77%. Low correlations between movement time and motor performance prompted an exploratory factor analysis (EFA) revealing a 2-component solution; motor performance tests load on one component (motor performance) whereas accelerometry-derived variables load on a second orthogonal component (quantity of movement). Conclusions Early after stroke, spontaneous overall UE movement is reduced, and movement shifts to unilateral use of the non-paretic UE. Two mechanisms that could influence motor recovery may already be in place 4.5 +/- 1.8 days post stroke: (1) the overuse of the less affected UE, which could set the stage for learned non-use and (2) skill acquisition in the non-paretic limb that could impede recovery. Accurate UE motor assessment requires two independent constructs: motor performance and quantity of movement. These findings provide opportunities and measurement methods for studies to develop new behaviorally-based stroke recovery treatments that begin early after onset.	[Barth, Jessica; Geed, Shashwati; Mitchell, Abigail; Dromerick, Alexander W.] MedStar Natl Rehabil Network, Washington, DC 20010 USA; [Geed, Shashwati; Dromerick, Alexander W.] Georgetown Univ, Dept Rehabil Med, Washington, DC 20057 USA; [Lum, Peter S.] Catholic Univ Amer, Dept Biomed Engn, Washington, DC 20064 USA; [Edwards, Dorothy F.] Univ Wisconsin, Dept Kinesiol & Occupat Therapy, Madison, WI USA	Georgetown University; Catholic University of America; University of Wisconsin System; University of Wisconsin Madison	Dromerick, AW (corresponding author), MedStar Natl Rehabil Network, Washington, DC 20010 USA.; Dromerick, AW (corresponding author), Georgetown Univ, Dept Rehabil Med, Washington, DC 20057 USA.	Alexander.W.Dromerick@medstar.net	Barth, Jessica/HCH-8661-2022	Barth, Jessica/0000-0001-8051-9539; Geed, Shashwati/0000-0003-0190-6923; Mitchell, Abigail/0000-0003-1951-0660	Center for Brain Plasticity and Recovery; Stroke Central Atlantic Network for Research [NINDS NS086513]; Department of Health and Human Services [NIDILRR 90REGE0004]	Center for Brain Plasticity and Recovery; Stroke Central Atlantic Network for Research; Department of Health and Human Services	The following work was funded by the following: Center for Brain Plasticity and Recovery (JB, SG, AM, PL, DE, AD) Stroke Central Atlantic Network for Research: NINDS NS086513 (JB, SG, DE, AD) Department of Health and Human Services: NIDILRR 90REGE0004 (PL, AWD) Stroke Central Atlantic Network for Research: NINDS NS086513 (JB, SG, DE, AD) Full names of commercial companies that funded the study or authors (N/A).	Allred RP, 2008, EXP NEUROL, V210, P172, DOI 10.1016/j.expneurol.2007.10.010; Allred RP, 2010, BEHAV NEUROSCI, V124, P124, DOI 10.1037/a0018457; ANDREWS K, 1979, RHEUMATOL REHABIL, V18, P43, DOI 10.1093/rheumatology/18.1.43; Bailey RR, 2015, NEUROREHAB NEURAL RE, V29, P969, DOI 10.1177/1545968315583720; Bailey RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103135; Bailey RR, 2013, J REHABIL RES DEV, V50, P1213, DOI 10.1682/JRRD.2012.12.0222; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Carmichael ST, 2017, EXP NEUROL, V287, P384, DOI 10.1016/j.expneurol.2016.02.007; Carmichael ST, 2003, CURR OPIN NEUROL, V16, P699, DOI 10.1097/00019052-200312000-00009; Carter AR, 2010, CURR NEUROL NEUROSCI, V10, P158, DOI 10.1007/s11910-010-0091-9; Cirstea MC, 2000, BRAIN, V123, P940, DOI 10.1093/brain/123.5.940; Cramer SC, 2008, CURR OPIN NEUROL, V21, P76, DOI 10.1097/WCO.0b013e3282f36cb6; Dobkin BH, 2005, NEW ENGL J MED, V352, P1677, DOI 10.1056/NEJMcp043511; Dromerick AW, 2003, J REHABIL RES DEV, V40, P1, DOI 10.1682/JRRD.2003.01.0001; DUNCAN PW, 1983, PHYS THER, V63, P1606, DOI 10.1093/ptj/63.10.1606; Enderby P M, 1987, Int Rehabil Med, V8, P166; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Garra G, 2013, PEDIATR EMERG CARE, V29, P17, DOI 10.1097/PEC.0b013e31827b2299; Gebruers N, 2014, AM J PHYS MED REHAB, V93, P245, DOI 10.1097/PHM.0000000000000045; Gebruers N, 2013, J REHABIL RES DEV, V50, P1099, DOI 10.1682/JRRD.2012.09.0166; Geed S, 2017, J MOTOR BEHAV, V49, P312, DOI 10.1080/00222895.2016.1204265; Geed S, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00007; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Gittler M, 2018, JAMA-J AM MED ASSOC, V319, P820, DOI 10.1001/jama.2017.22036; Han CE, 2013, NEUROREHAB NEURAL RE, V27, P439, DOI 10.1177/1545968312471904; Hubbard IJ, 2009, OCCUP THER INT, V16, P175, DOI 10.1002/oti.275; Iacovelli C, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0603-z; Jones TA, 2017, NAT REV NEUROSCI, V18, P267, DOI 10.1038/nrn.2017.26; JReding M, 1988, STROKE; Jvreskog, 1996, APPL FACTOR ANAL NAT; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Lang Catherine E, 2007, J Neurol Phys Ther, V31, P56; Lang CE, 2006, ARCH PHYS MED REHAB, V87, P1605, DOI 10.1016/j.apmr.2006.09.003; Lang CE, 2013, J HAND THER, V26, P104, DOI 10.1016/j.jht.2012.06.005; Levin MF, 2009, NEUROREHAB NEURAL RE, V23, P313, DOI 10.1177/1545968308328727; Leyton ASF, 1917, Q J EXP PHYSIOL, V11, P135, DOI 10.1113/expphysiol.1917.sp000240; Lum PS, 2009, TOP STROKE REHABIL, V16, P237, DOI 10.1310/tsr1604-237; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; Michielsen ME, 2012, ARCH PHYS MED REHAB, V93, P1975, DOI 10.1016/j.apmr.2012.03.016; National Institutes of Health Stroke Scale (NIHSS), WILEY STATSREF STAT; Nijland RHM, 2010, STROKE, V41, P745, DOI 10.1161/STROKEAHA.109.572065; Pedretti LW, 2001, OCCUPATIONAL THERAPY; Rand D, 2015, J STROKE CEREBROVASC, V24, P274, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.039; Roby-Brami A, 2003, ACTA NEUROL SCAND, V107, P369, DOI 10.1034/j.1600-0404.2003.00021.x; SCANR, 2018, TRIUMPH STROK; Stinear CM, 2017, ANN CLIN TRANSL NEUR, V4, P811, DOI 10.1002/acn3.488; Stinear CM, 2017, STROKE, V48, P1011, DOI 10.1161/STROKEAHA.116.015790; Stinear CM, 2012, BRAIN, V135, P2527, DOI 10.1093/brain/aws146; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; TAUB E, 1994, J EXP ANAL BEHAV, V61, P281, DOI 10.1901/jeab.1994.61-281; Thrane G, 2011, J REHABIL MED, V43, P299, DOI 10.2340/16501977-0676; Urbin MA, 2015, ARCH PHYS MED REHAB, V96, P854, DOI 10.1016/j.apmr.2014.11.018; Urbin MA, 2015, J NEUROL PHYS THER, V39, P111, DOI 10.1097/NPT.0000000000000085; Uswatte G, 2006, NEUROLOGY, V67, P1189, DOI 10.1212/01.wnl.0000238164.90657.c2; Uswatte G, 2005, ARCH PHYS MED REHAB, V86, P1498, DOI 10.1016/j.apmr.2005.01.010; Uswatte G, 2000, STROKE, V31, P662, DOI 10.1161/01.STR.31.3.662; Uswatte G, 2006, ARCH PHYS MED REHAB, V87, P1340, DOI 10.1016/j.apmr.2006.06.006; Uswatte G, 2009, REHABIL PSYCHOL, V54, P398, DOI 10.1037/a0017501; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; van der Pas SC, 2011, ARCH PHYS MED REHAB, V92, P1437, DOI 10.1016/j.apmr.2011.02.021; Veerbeek JM, 2011, STROKE, V42, P1482, DOI 10.1161/STROKEAHA.110.604090; WEINTRAUB S, 1988, J NEUROL NEUROSUR PS, V51, P1481, DOI 10.1136/jnnp.51.12.1481; Wong DL, 2001, PAIN, V89, P295, DOI 10.1016/S0304-3959(00)00375-4; Zeiler SR, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-0927-x; Zeiler SR, 2013, CURR OPIN NEUROL, V26, P609, DOI 10.1097/WCO.0000000000000025	67	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0221668	10.1371/journal.pone.0221668	http://dx.doi.org/10.1371/journal.pone.0221668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC7KJ	32776927	gold, Green Published, Green Submitted			2022-12-26	WOS:000561393800011
J	Coulibali, Z; Cambouris, AN; Parent, SE				Coulibali, Zonlehoua; Cambouris, Athyna Nancy; Parent, Serge-etienne			Site-specific machine learning predictive fertilization models for potato crops in Eastern Canada	PLOS ONE			English	Article							PHOSPHORUS SATURATION INDEX; PRINCE-EDWARD-ISLAND; SOLANUM-TUBEROSUM L.; NITROGEN-FERTILIZATION; YIELD RESPONSE; PRODUCTION SYSTEMS; SUGAR-BEET; NITRATE; MANAGEMENT; CORN	Statistical modeling is commonly used to relate the performance of potato (Solanum tuberosumL.) to fertilizer requirements. Prescribing optimal nutrient doses is challenging because of the involvement of many variables including weather, soils, land management, genotypes, and severity of pests and diseases. Where sufficient data are available, machine learning algorithms can be used to predict crop performance. The objective of this study was to determine an optimal model predicting nitrogen, phosphorus and potassium requirements for high tuber yield and quality (size and specific gravity) as impacted by weather, soils and land management variables. We exploited a data set of 273 field experiments conducted from 1979 to 2017 in Quebec (Canada). We developed, evaluated and compared predictions from a hierarchical Mitscherlich model,k-nearest neighbors, random forest, neural networks and Gaussian processes. Machine learning models returned R(2)values of 0.49-0.59 for tuber marketable yield prediction, which were higher than the Mitscherlich model R-2(0.37). The models were more likely to predict medium-size tubers (R-2= 0.60-0.69) and tuber specific gravity (R-2= 0.58-0.67) than large-size tubers (R-2= 0.55-0.64) and marketable yield. Response surfaces from the Mitscherlich model, neural networks and Gaussian processes returned smooth responses that agreed more with actual evidence than discontinuous curves derived fromk-nearest neighbors and random forest models. When conditioned to obtain optimal dosages from dose-response surfaces given constant weather, soil and land management conditions, some disagreements occurred between models. Due to their built-in ability to develop recommendations within a probabilistic risk-assessment framework, Gaussian processes stood out as the most promising algorithm to support decisions that minimize economic or agronomic risks.	[Coulibali, Zonlehoua; Parent, Serge-etienne] Univ Laval, Dept Soils & Agrifood Engn, Quebec City, PQ, Canada; [Cambouris, Athyna Nancy] Agr & Agri Food Canada, Quebec Res & Dev Ctr, Quebec City, PQ, Canada	Laval University; Agriculture & Agri Food Canada	Parent, SE (corresponding author), Univ Laval, Dept Soils & Agrifood Engn, Quebec City, PQ, Canada.	serge-etienne.parent.1@ulaval.ca		Parent, Essi/0000-0003-1679-2287	Natural Sciences and Engineering Council of Canada [CRDPJ 385199-09, DG -2254]; Quebec Ministry of Agriculture, Fisheries and Food [IA216581]; Centre SEVE; Patate Dolbec Inc.; Groupe Gosselin FG; Agriparmentier Inc.; Ferme Daniel Bolduc Inc.; Patate Laurentienne; Ferme Bergeron-Niquet; Patates Lac-St-Jean	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Quebec Ministry of Agriculture, Fisheries and Food; Centre SEVE; Patate Dolbec Inc.; Groupe Gosselin FG; Agriparmentier Inc.; Ferme Daniel Bolduc Inc.; Patate Laurentienne; Ferme Bergeron-Niquet; Patates Lac-St-Jean	ZC is partly funded by the Natural Sciences and Engineering Council of Canada (CRDPJ 385199-09 and DG -2254 -https://www.nserc-crsng.gc.ca), the Quebec Ministry of Agriculture, Fisheries and Food (IA216581 -https://www.mapaci.gouv.qc.ca), Centre SEVE (hops://pentreseve.recherche.usherbrooke.ca/), Patate Dolbec Inc. (https://patatesdolbeacom/), Groupe Gosselin FG (http://gosselingacom), Agriparmentier Inc., Ferme Daniel Bolduc Inc. (http://termedanielbolduc.corri/), Patate Laurentienne, Ferme Bergeron-Niquet, and Patates Lac-St-Jean (http://plsj.ca/).There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Soboh G, 2002, FACTORS AFFECTING SP; Andrews M, 2013, ANN APPL BIOL, V163, P174, DOI 10.1111/aab.12045; ANGUS JF, 1993, PLANT SOIL, V155, P57, DOI 10.1007/BF00024984; Barber S.A, 1995, SOIL NUTR BIOAVAILAB, V2nd ed.; Belanger G, 2000, AGRON J, V92, P902, DOI 10.2134/agronj2000.925902x; Belanger G, 2002, AM J POTATO RES, V79, P269, DOI 10.1007/BF02986360; BOCK BR, 1990, SOIL SCI SOC AM J, V54, P1784, DOI 10.2136/sssaj1990.03615995005400060047x; Bohl W. H., 2010, COMMERCIAL POTATO PR; Boiteau G, 2014, CAN J SOIL SCI, V94, P463, DOI [10.4141/CJSS2013-095, 10.4141/cjss2013-095]; Bolinder MA, 2015, CAN J SOIL SCI, V95, P87, DOI [10.4141/CJSS-2014-091, 10.4141/cjss-2014-091]; BULLOCK DG, 1994, AGRON J, V86, P191, DOI 10.2134/agronj1994.00021962008600010033x; Bussan AJ, 2007, CROP SCI, V47, P2462, DOI 10.2135/cropsci2007.01.0026; Cambouris AN, 2016, AGRON J, V108, P391, DOI 10.2134/agronj2015.0351; Camire ME, 2009, CRIT REV FOOD SCI, V49, P823, DOI 10.1080/10408390903041996; Centre de Rufurence en Agriculture et Agroalimentaire du Quubec(CRAAQ), 2010, GUID REF FERT; CERRATO ME, 1990, AGRON J, V82, P138, DOI 10.2134/agronj1990.00021962008200010030x; CESCAS MP, 1978, NAT CAN, V105, P259; CFIA, 2015, POT PLANTS CHAR MAT; Chantre GR, 2012, COMPUT ELECTRON AGR, V88, P95, DOI 10.1016/j.compag.2012.07.005; Coulibali Z, 2020, PLOS ONE, V15, P1; Crisci C, 2012, ECOL MODEL, V240, P113, DOI 10.1016/j.ecolmodel.2012.03.001; Dahnke W. C., 1990, SOIL TESTING PLANT A, V3, P45; Dampney P, 2011, R443 POT COUNC AGR H; Daoui K, 2014, PROCEDIA ENGINEER, V83, P344, DOI 10.1016/j.proeng.2014.09.026; Dessureault-Rompre J, 2015, CAN J SOIL SCI, V95, P63, DOI [10.4141/cjss-2014-057, 10.4141/CJSS-2014-057]; Dessureault-Rompre J, 2012, SOIL SCI SOC AM J, V76, P936, DOI 10.2136/sssaj2011.0377; Di Paola A, 2016, J SCI FOOD AGR, V96, P709, DOI 10.1002/jsfa.7359; Diriba SG, 2017, J AGR CROPS ACAD RES, V3, P78; Dodds KG, 1996, FERT RES, V45, P117, DOI 10.1007/BF00790661; DUBETZ S, 1975, AM POTATO J, V52, P399, DOI 10.1007/BF02852794; Egozcue JJ, 2005, MATH GEOL, V37, P795, DOI 10.1007/s11004-005-7381-9; Ellissu┐che D., 1996, POMME TERRE, P71; Feddes RA, 1971, WATER HEAT CROP GROW; Firman D. M., 2007, P719, DOI 10.1016/B978-044451018-1/50075-0; Flis S., 2019, CROPS SOILS, V52, P8; Fortin JG, 2015, COMPUT ELECTRON AGR, V110, P259, DOI 10.1016/j.compag.2014.11.025; Fortin JG, 2008, AGR FOREST METEOROL, V148, P1332, DOI 10.1016/j.agrformet.2008.03.012; Fortin JG, 2010, COMPUT ELECTRON AGR, V73, P126, DOI 10.1016/j.compag.2010.05.011; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Gianquinto G., 2000, MANAGEMENT NITROGEN, P35; Gregory P. J., 1992, The potato crop: the scientific basis for improvement., P214; GREWAL K S, 1991, Journal of Soil Science, V42, P251; Griffin T.S., 1993, SIMULATION MODEL POT; Hatfield JL, 2015, AGRON J, V107, P1215, DOI 10.2134/agronj15.0076; Haverkort AJ, 2015, FIELD CROP RES, V182, P76, DOI 10.1016/j.fcr.2015.06.002; Hawkesford M, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P135, DOI 10.1016/B978-0-12-384905-2.00006-6; Hendershot WH, 1993, SOIL SAMPLING METHOD, V2, P201; Hofman G, 2000, MANAGEMENT NITROGEN, P121; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Hutchinson MF, 2009, J APPL METEOROL CLIM, V48, P725, DOI 10.1175/2008JAMC1979.1; Huwing H., 2012, LAND FORT, V2012, p[12, 36]; Inman D, 2005, AGRON J, V97, P169, DOI 10.2134/agronj2005.0169; ISFAN D, 1995, COMMUN SOIL SCI PLAN, V26, P2531, DOI 10.1080/00103629509369466; Jiang YF, 2011, NUTR CYCL AGROECOSYS, V91, P307, DOI 10.1007/s10705-011-9463-z; Kahle D, 2013, R J, V5, P144; Khiari L, 2000, J ENVIRON QUAL, V29, P1561, DOI 10.2134/jeq2000.00472425002900050024x; Kirkman Michael A., 2007, P27; KLEINKOPF GE, 1981, AGRON J, V73, P799; Kooman PL, 1996, EUR J AGRON, V5, P207, DOI 10.1016/S1161-0301(96)02032-1; Kyveryga PM, 2007, AGRON J, V99, P1048, DOI 10.2134/agronj2006.0339; Laboski CAM, 2007, AM J POTATO RES, V84, P283, DOI 10.1007/BF02986240; Leblanc MA, 2016, PROGR SOIL SCI, P253, DOI 10.1007/978-3-319-28295-4_16; Levy D, 2007, AM J POTATO RES, V84, P487, DOI 10.1007/BF02987885; Li H, 1999, CAN J PLANT SCI, V79, P439, DOI 10.4141/P98-042; Liakos KG, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18082674; MacKerron D. K. L., 2007, P753, DOI 10.1016/B978-044451018-1/50077-4; MAIER NA, 1994, AUST J EXP AGR, V34, P813, DOI 10.1071/EA9940813; Marouani A, 2015, J NEW SCI AGR BIOTEC, V13, P399; Marshall B., 2007, P777, DOI 10.1016/B978-044451018-1/50078-6; Martin-Fernandez JA, 2003, MATH GEOL, V35, P253, DOI 10.1023/A:1023866030544; McKinney W., 2010, 9 PYTHON SCI C, V445, P51; MICHAELSON GJ, 1987, COMMUN SOIL SCI PLAN, V18, P1003, DOI 10.1080/00103628709367877; Mondani F., 2011, Notulae Scientia Biologicae, V3, P42; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Morton JT, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00162-16; Moulin AP, 2012, CAN J PLANT SCI, V92, P771, DOI [10.4141/cjps2011-005, 10.4141/CJPS2011-005]; Mucherino A., 2009, OPER RES-GER, V9, P121, DOI [10.1007/s12351-009-0054-6, DOI 10.1007/S12351-009-0054-6]; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; NEETESON JJ, 1989, NETH J AGR SCI, V37, P129; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Palarea-Albaladejo J, 2015, CHEMOMETR INTELL LAB, V143, P85, DOI 10.1016/j.chemolab.2015.02.019; Parent LE, 2014, CRAAQ C POMM TERR 20; Parent SE, 2017, FRONT ENV SCI-SWITZ, V5, DOI 10.3389/fenvs.2017.00081; Parent SE, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00039, 10.3389/fpls.2013.00449]; Parizeau M., 2006, RESEAUX NEURONES, P27; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pellerin A., 2010, GUIDE REFERENCE FERT, P359; Pellerin A, 2006, CAN J SOIL SCI, V86, P711, DOI 10.4141/S05-070; Pellerin A, 2006, CAN J SOIL SCI, V86, P897, DOI 10.4141/S05-071; Peralta JM, 2002, AGR ECOSYST ENVIRON, V88, P23, DOI 10.1016/S0167-8809(01)00157-8; Petropoulos SA, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10040474; Piikki K, 2015, PRECIS AGRIC, V16, P29, DOI 10.1007/s11119-014-9381-6; Qin ZS, 2018, AGRON J, V110, P2596, DOI 10.2134/agronj2018.03.0222; R Core Team, 2021, R LANGUAGE ENV STAT; Rajsic P, 2008, AGR SYST, V97, P56, DOI 10.1016/j.agsy.2007.12.001; Raman KV, 1992, POTATO CROP SCI BASI; Rangarajan A., 2009, CROP ROTATION ORGANI; Rasmussen C, 2006, GAUSSIAN PROCESSES M, V38, P715; Raymundo R, 2014, FIELD CROP RES, V166, P173, DOI 10.1016/j.fcr.2014.06.017; REX BL, 1991, CAN J PLANT SCI, V71, P289, DOI 10.4141/cjps91-039; Rich AE, 1983, POTATO DIS, Vxiv; SANDS PJ, 1979, FIELD CROP RES, V2, P309, DOI 10.1016/0378-4290(79)90031-5; Sharifi M, 2009, PLANT SOIL, V320, P267, DOI 10.1007/s11104-009-9892-5; Sincik M, 2008, AM J POTATO RES, V85, P150, DOI 10.1007/s12230-008-9011-9; Sinclair TR, 2000, FIELD CROP RES, V68, P165, DOI 10.1016/S0378-4290(00)00105-2; Singh J, 2005, J AM WATER RESOUR AS, V41, P343, DOI 10.1111/j.1752-1688.2005.tb03740.x; Soil Classification Working Group, 1998, CAN SYST SOIL CLASS, P188; Soman T., 2005, WSEAS Transactions on Computers, V4, P548; Stalham MA, 2005, RES REV, P1; Struik Paul C., 2007, P219; Tabi M, 1990, INVENTAIRE PROBLEMES; Templ M, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P341; Torma S, 2018, ACTA AGR SCAND B-S P, V68, P358, DOI 10.1080/09064710.2017.1406134; Tran T.S., 1993, SOIL SAMPL METHODS A, V43, P49; Trehan S. P., 2001, Better Crops International, V15, P18; Tremblay N, 2012, AGRON J, V104, P1658, DOI 10.2134/agronj2012.0184; Valkama E, 2013, AGR ECOSYST ENVIRON, V164, P1, DOI 10.1016/j.agee.2012.09.010; Valkama E, 2009, AGR ECOSYST ENVIRON, V130, P75, DOI 10.1016/j.agee.2008.12.004; van den Boogaart K., 2014, COMPOSITIONS COMPOSI; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Van Rossum G, 1995, R9526 CS CWI; Vanlauwe B, 2011, PLANT SOIL, V339, P35, DOI 10.1007/s11104-010-0462-7; Vischi F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40202-8; White Philip J., 2007, P739; WICKHAM H, 2017, R PACKAGE VERSION, V1, P1, DOI DOI 10.1590/S0100-204X2017000300003; Xu Y, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00083; Yang XL, 2015, SOIL SCI SOC AM J, V79, P1556, DOI 10.2136/sssaj2015.04.0164; YOUNG D. A., 1964, AMER POTATO J, V41, P401, DOI 10.1007/BF02908891; Yuan J, 2010, COMPUT ELECTRON AGR, V70, P33, DOI 10.1016/j.compag.2009.08.009; Zebarth BJ, 2009, AGRON J, V101, P1573, DOI 10.2134/agronj2009.0184; Zebarth BJ, 2015, GROUND WATER MONIT R, V35, P30, DOI 10.1111/gwmr.12088; Zebarth BJ, 2015, GROUND WATER MONIT R, V35, P82, DOI 10.1111/gwmr.12092; Zebarth BJ, 2009, AM J POTATO RES, V86, P209, DOI 10.1007/s12230-009-9074-2; Zebarth BJ, 2004, CAN J PLANT SCI, V84, P855, DOI 10.4141/P03-123; Zebarth BJ, 2007, NITROGEN MANAGEMENT; Zhang D., 2007, ADV MACHINE LEARNING, DOI [10.4018/978-1-59140-941-0, DOI 10.4018/978-1-59140-941-0]	136	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0230888	10.1371/journal.pone.0230888	http://dx.doi.org/10.1371/journal.pone.0230888			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764750	gold, Green Published, Green Submitted			2022-12-26	WOS:000561029000037
J	Wu, MN; Wang, PY; Gao, MJ; Shen, DX; Zhao, QL				Wu, Meina; Wang, Pingyang; Gao, Mengjie; Shen, Dongxu; Zhao, Qiaoling			Transcriptome analysis of the eggs of the silkworm pale red egg (re(p)-1) mutant at 36 hours after oviposition	PLOS ONE			English	Article							SILKMOTH CHORION; BOMBYX-MORI; GENE; SYSTEM; IDENTIFICATION; DEHYDROGENASE; INVOLVEMENT; ANNOTATION; BLAST2GO; MUTATION	The egg stage is one of the most critical periods in the life history of silkworms, during which physiological processes such as sex determination, tissue organ formation and differentiation, diapause and pigmentation occur. In addition, egg color gradually emerges around 36h after oviposition. The red egg mutantre(p)-1, which was recently discovered in the C-1(H) wild-type, C-1(H) exhibits a brown egg color. In this study, the transcriptome of the eggs was analyzed 36h after oviposition. Between there(p)-1 mutant and the C-1(H) wild-type, 800 differentially expressed genes (DEGs) were identified, including 325 up-regulated genes and 475 down-regulated genes. These DEGs were mainly involved in biological processes (metabolic process, cellular process, biological regulation and regulation of biological process and localization), cellular components (membrane, membrane part, cell, cell part and organelle) and molecular functions (binding, catalytic activity, transporter activity, structural molecule activity and molecular transducer activity). The pathway enrichment of these DEGs was performed based on the KEGG database, and the results indicated that these DEGs were mainly involved in pathways in the following categories: metabolic pathways, longevity-regulating pathway-multiple species, protein processing in endoplasmic reticulum, peroxisome, carbon metabolism and purine metabolism. Further analysis showed that a large number of silkworm growth- and development-related genes and ommochrome synthesis- and metabolism-related genes were differentially expressed, most of which were up-regulated in the mutant. Our research findings provide new experimental evidence for research on ommochrome pigmentation and lay the foundation for further research on the mechanism of there(p)-1 mutant.	[Wu, Meina; Wang, Pingyang; Gao, Mengjie; Shen, Dongxu; Zhao, Qiaoling] Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang, Jiangsu, Peoples R China; [Wu, Meina; Wang, Pingyang; Gao, Mengjie; Shen, Dongxu; Zhao, Qiaoling] Chinese Acad Agr Sci, Sericulture Res Inst, Zhenjiang, Jiangsu, Peoples R China; [Wang, Pingyang] Guangxi Zhuang Autonomous Reg Res Acad Sericultur, Nanning, Guangxi, Peoples R China	Jiangsu University of Science & Technology; Chinese Academy of Agricultural Sciences	Zhao, QL (corresponding author), Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang, Jiangsu, Peoples R China.; Zhao, QL (corresponding author), Chinese Acad Agr Sci, Sericulture Res Inst, Zhenjiang, Jiangsu, Peoples R China.	qlzhao302@126.com	Wang, Pingyang/HHC-2182-2022	Wang, Pingyang/0000-0003-3908-6561	National Natural Science Foundation of China [31972616]; Innovation Plan of Jiangsu Province [KYCX19_ 1656]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Plan of Jiangsu Province	This work was supported by grants from the National Natural Science Foundation of China (No. 31972616) (Qiaoling Zhao)and the Innovation Plan of Jiangsu Province (KYCX19_ 1656) (Meina Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Benjamini Y, 2001, ANN STAT, V29, P1165; Busse MS, 2007, EMBO J, V26, P3826, DOI 10.1038/sj.emboj.7601798; BYRNE BM, 1989, PROG BIOPHYS MOL BIO, V53, P33, DOI 10.1016/0079-6107(89)90005-9; Chen JQ, 2008, CELL TISSUE RES, V331, P725, DOI 10.1007/s00441-007-0516-1; Chen ZW, 2015, SCI REP-UK, V5, DOI 10.1038/srep16424; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dacks AM, 2006, INSECT BIOCHEM MOLEC, V36, P741, DOI 10.1016/j.ibmb.2006.07.002; Davis SP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003590; Falchuk KH, 2001, BIOMETALS, V14, P385, DOI 10.1023/A:1012994427351; Futahashi R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/j.ibmb.2008.05.007; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hara Y, 2008, GENES GENET SYST, V83, P433, DOI 10.1266/ggs.83.433; HAYASHI Y, 1961, NATURE, V192, P756, DOI 10.1038/192756b0; [何芬 He Fen], 2017, [蚕业科学, Acta Sericologica Sinica], V43, P913; Insausti TC, 2008, J EXP BIOL, V211, P780, DOI 10.1242/jeb.014043; Iseli C, 1999, P INT C INTELL SYST, V138-148; Kanao T, 2002, EUR J BIOCHEM, V269, P1926, DOI 10.1046/j.1432-1033.2002.02849.x; Komoto N, 2009, INSECT BIOCHEM MOLEC, V39, P152, DOI 10.1016/j.ibmb.2008.10.003; Liang JB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-173; Lin Y, 2013, J BIOL CHEM, V288, P13345, DOI 10.1074/jbc.M113.462556; Linzen B., 1974, ADV INSECT PHYSL, P117, DOI DOI 10.1016/S0065-2806(08)60130-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng Y, 2009, GENES CELLS, V14, P129, DOI 10.1111/j.1365-2443.2008.01257.x; Mohri H, 2012, P JPN ACAD B-PHYS, V88, P397, DOI 10.2183/pjab.88.397; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagamani SCS, 2012, GENET MED, V14, P501, DOI 10.1038/gim.2011.1; Osanai-Futahashi M, 2016, HEREDITY, V116, P135, DOI 10.1038/hdy.2015.74; Osanai-Futahashi M, 2012, J BIOL CHEM, V287, P17706, DOI 10.1074/jbc.M111.321331; [彭晨星 Peng Chenxing], 2016, [蚕业科学, Acta Sericologica Sinica], V42, P373; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Phillips J. P., 1980, GENET BIOL DROSOPHIL, P542; [秦俭 Qin Jian], 2010, [蚕业科学, Acta Sericologica Sinica], V36, P645; Quan GX, 2002, MOL GENET GENOMICS, V267, P1, DOI 10.1007/s00438-001-0629-2; RAPP UR, 1991, ONCOGENE, V6, P495; REGIER JC, 1982, DEV BIOL, V92, P159, DOI 10.1016/0012-1606(82)90160-9; REGIER JC, 1980, DEV BIOL, V76, P286, DOI 10.1016/0012-1606(80)90380-2; Sawada H, 2000, COMP BIOCHEM PHYS B, V125, P421, DOI 10.1016/S0305-0491(99)00179-0; Tatematsu K, 2011, GENES CELLS, V16, P331, DOI 10.1111/j.1365-2443.2011.01490.x; VANLINT J, 1992, J BIOL CHEM, V267, P25916; Wang PY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175994; Wang XL, 2019, INSECT BIOCHEM MOLEC, V104, P58, DOI 10.1016/j.ibmb.2018.12.005; Xiang Z.H., 2005, BIOL SERICULTURE, P1; Zhang HY, 2017, J INSECT PHYSIOL, V101, P142, DOI 10.1016/j.jinsphys.2017.07.013	45	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237242	10.1371/journal.pone.0237242	http://dx.doi.org/10.1371/journal.pone.0237242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764803	gold, Green Published			2022-12-26	WOS:000561029000058
J	Paraschivescu, C; Barbosa, S; Lorivel, T; Glaichenhaus, N; Davidovic, L				Paraschivescu, Cristina; Barbosa, Susana; Lorivel, Thomas; Glaichenhaus, Nicolas; Davidovic, Laetitia			Cytokine changes associated with the maternal immune activation (MIA) model of autism: A penalized regression approach	PLOS ONE			English	Article							FETAL-BRAIN DEVELOPMENT; TNF-ALPHA; MICE; INFECTION; ABNORMALITIES; PREGNANCY; BEHAVIOR	Maternal immune activation (MIA) during pregnancy induces a cytokine storm that alters neurodevelopment and behavior in the progeny. In humans, MIA increases the odds of developing neuropsychiatric disorders such as autism spectrum disorder (ASD). In mice, MIA can be induced by injecting the viral mimic polyinosinic:polycytidylic acid (poly(I:C)) to pregnant dams. Although the murine model of MIA has been extensively studied, it is not clear whether MIA results in cytokine changes in the progeny at early postnatal stages. Further, the murine model of MIA suffers from a lack of reproducibility and high inter-individual variability. Multivariable (MV) statistical analysis is widely used in human studies to control for confounders and covariates such as sex, age and exposure to environmental factors. We therefore reasoned that animal studies in general and studies on the MIA model in particular could benefit from MV analyses to account for complex phenotype interactions and high inter-individual variability. Here, we used MV statistical analysis to identify cytokines associated with MIA after adjustment for covariates. Besides confirming the association between previously described variables and MIA, we identified new cytokines that could play a role in behavioural alterations in the progeny during the early postnatal period.	[Paraschivescu, Cristina; Barbosa, Susana; Lorivel, Thomas; Glaichenhaus, Nicolas; Davidovic, Laetitia] CNRS, Inst Pharmacol Mol & Cellulaire, Valbonne, France; [Paraschivescu, Cristina; Barbosa, Susana; Lorivel, Thomas; Glaichenhaus, Nicolas; Davidovic, Laetitia] Univ Cote Azur, Nice, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Davidovic, L (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, Valbonne, France.; Davidovic, L (corresponding author), Univ Cote Azur, Nice, France.	davidovic@ipmc.cnrs.fr	Davidovic, Laetitia/O-8952-2016	Davidovic, Laetitia/0000-0002-1507-5625	Fondation de France	Fondation de France(Fondation de France)	LD and NG acknowledge the generous support of the Fondation de France under the 2018 Program "Autisme et neurode ' veloppement" and the 2017 Program "Recherche fondamentale et clinique sur les maladies psychiatriques", respectively. CP is greatly indebted to the Labex Signalife PhD program from the Universite Cote d'Azur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault D, 2014, BRAIN BEHAV IMMUN, V38, P77, DOI 10.1016/j.bbi.2013.12.016; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Brown AS, 2018, AM J PSYCHIAT, V175, P1073, DOI 10.1176/appi.ajp.2018.17121311; Bunea F, 2011, NEUROIMAGE, V55, P1519, DOI 10.1016/j.neuroimage.2010.12.028; Camara ML, 2013, PSYCHONEUROENDOCRINO, V38, P3102, DOI 10.1016/j.psyneuen.2013.09.010; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Desboulets LD, 2018, AMSE WORKING PAPERS, V1852; Doerken S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217057; Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194; Estes ML, 2015, NAT REV NEUROSCI, V16, P469, DOI 10.1038/nrn3978; Ferhat AT, 2016, JOVE-J VIS EXP, DOI 10.3791/53871; Filiano AJ, 2015, BRAIN RES, V1617, P18, DOI 10.1016/j.brainres.2014.07.050; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garay PA, 2013, BRAIN BEHAV IMMUN, V31, P54, DOI 10.1016/j.bbi.2012.07.008; Garay Paula A, 2010, Front Synaptic Neurosci, V2, P136, DOI 10.3389/fnsyn.2010.00136; Gilmore JH, 2005, J NEUROIMMUNOL, V159, P106, DOI 10.1016/j.jneuroim.2004.10.008; Goines PE, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-13; Harrell FE, 2001, REGRESSION MODELING; Heinze G, 2018, BIOMETRICAL J, V60, P431, DOI 10.1002/bimj.201700067; Heuer LS, 2019, BIOL PSYCHIAT, V86, P255, DOI 10.1016/j.biopsych.2019.04.037; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huang YS, 2009, BRAIN RES, V1304, P38, DOI 10.1016/j.brainres.2009.09.009; Jiang HY, 2016, BRAIN BEHAV IMMUN, V58, P165, DOI 10.1016/j.bbi.2016.06.005; Jones KL, 2017, MOL PSYCHIATR, V22, P273, DOI 10.1038/mp.2016.77; Jung K, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02215; Kentner AC, 2019, NEUROPSYCHOPHARMACOL, V44, P245, DOI 10.1038/s41386-018-0185-7; Kim S, 2017, NATURE, V549, P528, DOI 10.1038/nature23910; Kodangattil JN, 2012, EUR J INFLAMM, V10, P311, DOI 10.1177/1721727X1201000307; Krakowiak P, 2017, BIOL PSYCHIAT, V81, P442, DOI 10.1016/j.biopsych.2015.08.007; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Mousa A, 2013, INT J MOL SCI, V14, P13931, DOI 10.3390/ijms140713931; Mueller FS, 2019, BRAIN BEHAV IMMUN, V80, P406, DOI 10.1016/j.bbi.2019.04.019; Murray KN, 2019, BRAIN BEHAV IMMUN, V75, P48, DOI 10.1016/j.bbi.2018.09.005; Ouyang SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069356; Pacheco-Lopez G, 2013, SCHIZOPHRENIA BULL, V39, P319, DOI 10.1093/schbul/sbr178; Pan WH, 2013, NEUROSCI BIOBEHAV R, V37, P184, DOI 10.1016/j.neubiorev.2012.11.009; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Saghazadeh A, 2019, J PSYCHIATR RES, V115, P90, DOI 10.1016/j.jpsychires.2019.05.019; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Szumilas M, 2010, J CAN ACAD CHILD ADO, V19, P227; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wu WL, 2017, BRAIN BEHAV IMMUN, V62, P11, DOI 10.1016/j.bbi.2016.11.007	50	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0231609	10.1371/journal.pone.0231609	http://dx.doi.org/10.1371/journal.pone.0231609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2EP	32760152	Green Published, gold			2022-12-26	WOS:000561027200033
J	McNitt, DC; Alonso, RS; Cherry, MJ; Fies, ML; Kelly, MJ				McNitt, David C.; Alonso, Robert S.; Cherry, Michael J.; Fies, Michael L.; Kelly, Marcella J.			Sex-specific effects of reproductive season on bobcat space use, movement, and resource selection in the Appalachian Mountains of Virginia	PLOS ONE			English	Article							HOME-RANGE SIZE; CAUSE-SPECIFIC MORTALITY; LYNX-RUFUS; HABITAT SELECTION; ADULT BOBCATS; DISPERSAL CHARACTERISTICS; ACTIVITY PATTERNS; MICROHABITAT USE; BEAR PREDATION; SURVIVAL	Across taxa, sex-specific demands vary temporally in accordance with reproductive investments. In solitary carnivores, females must provision and protect young independently while meeting increased energetic demands. Males seek to monopolize access to females by maintaining large territories and defending them from other males. For many species, it is poorly understood how these demands relate to broad-scale animal movements. To investigate predictions surrounding the reproductive strategies of solitary carnivores and effects of local conditions on bobcat (Lynx rufus) spatial ecology, we examined the effects of sex and reproductive season on home range size, movement rate, and resource selection of bobcats in the central Appalachian Mountains. Male seasonal home ranges were approximately 3 times larger than those of females (33.9 +/- 2.6 vs. 12.1 +/- 2.4 km(2), x +/- SE), and male movement rates were 1.4 times greater than females (212.6 +/- 3.6 vs. 155 +/- 8.2 m/hr), likely reflecting male efforts to maximize access to females. Both sexes appear to maintain relatively stable seasonal home ranges despite temporally varying reproductive investments, instead adjusting movements within home ranges. Males increased movements during the dispersal period, potentially reflecting increased territoriality prior to breeding. Females increased movements during the kitten-rearing period, when foraging more intensively, and frequently returning to den sites. Both sexes selected home ranges at higher elevations. However, females selected deciduous forest and avoided fields, whereas males selected fields and avoided deciduous forest, perhaps explained by male pressure to access multiple females across several mountain ridges and higher risk tolerance. Seasonal changes in home range selection likely reflect changes in home range shape. Increased female avoidance of fields during kitten rearing may indicate female avoidance of presumably resource rich, yet risky, fields at the time when kittens are most vulnerable. Our results indicate that while reproductive chronology influences the spatial ecology of solitary carnivores, effects may be constrained by territoriality.	[McNitt, David C.; Alonso, Robert S.; Cherry, Michael J.; Kelly, Marcella J.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Fies, Michael L.] Virginia Dept Game & Inland Fisheries, Verona, VA USA; [Cherry, Michael J.] Texas A&M Univ, Caesar Kleberg Wildlife Res Inst, Kingsville, TX USA	Virginia Polytechnic Institute & State University; Texas A&M University System; Texas A&M University Kingsville	McNitt, DC (corresponding author), Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	dmcnitt@vt.edu	Kelly, Marcella/B-4891-2011	Kelly, Marcella/0000-0001-9044-3873	Virginia Department of Game & Inland Fisheries (VDGIF); US Fish & Wildlife Service through the Wildlife and Sport Fish Restoration Program [F13AF00648, WE99R]	Virginia Department of Game & Inland Fisheries (VDGIF); US Fish & Wildlife Service through the Wildlife and Sport Fish Restoration Program	Financial support provided by the Virginia Department of Game & Inland Fisheries (VDGIF) came from the US Fish & Wildlife Service through the Wildlife and Sport Fish Restoration Program Project Grant #F13AF00648 (WE99R). VDGIF furbearer biologist M.L. Fies assisted with preparation of the manuscript.	Abouelezz HG, 2018, LANDSCAPE ECOL, V33, P1301, DOI 10.1007/s10980-018-0654-8; Allen ML, 2015, J ETHOL, V33, P9, DOI 10.1007/s10164-014-0418-0; Althoff DP, 1997, J WILDLIFE MANAGE, V61, P450, DOI 10.2307/3802603; Arguez A, 2010, NOAA's US climate normals (1981-2010), V10, Patent No. 00444128; BAILEY TN, 1974, J WILDLIFE MANAGE, V38, P435, DOI 10.2307/3800874; Balme GA, 2017, J ANIM ECOL, V86, P1224, DOI 10.1111/1365-2656.12713; Balme GA, 2013, MAMMAL REV, V43, P221, DOI 10.1111/j.1365-2907.2012.00219.x; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; BEKOFF M, 1984, ANNU REV ECOL SYST, V15, P191, DOI 10.1146/annurev.es.15.110184.001203; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Bond BT, 2002, J WILDLIFE MANAGE, V66, P1171, DOI 10.2307/3802950; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Brooks JJ, 1999, WILDLIFE SOC B, V27, P1089; Carstensen M, 2009, J WILDLIFE MANAGE, V73, P175, DOI 10.2193/2006-107; Chamberlain M, 2003, AM MIDL NAT, V149, P395, DOI 10.1674/0003-0031(2003)149[0395:SUMAHS]2.0.CO;2; Chamberlain MJ, 1999, J WILDLIFE MANAGE, V63, P613, DOI 10.2307/3802650; Cherry MJ, 2016, WILDLIFE RES, V43, P662, DOI 10.1071/WR16052; Cochrane JC, 2006, SOUTHEAST NAT, V5, P711, DOI 10.1656/1528-7092(2006)5[711:SOOABI]2.0.CO;2; Conner LM, 2001, PROCEEDINGS OF THE FIFTY-FIFTH ANNUAL CONFERENCE OF THE SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P418; Conner LM, 2003, ECOLOGY, V84, P526, DOI 10.1890/0012-9658(2003)084[0526:ACODBA]2.0.CO;2; Donovan TM, 2011, BIOL CONSERV, V144, P2799, DOI 10.1016/j.biocon.2011.06.026; Elizalde-Arellano C, 2012, AM MIDL NAT, V168, P247; Ferguson AW, 2009, CAN J ZOOL, V87, P1052, DOI 10.1139/Z09-095; Fleming CH, 2018, ECOL APPL, V28, P1003, DOI 10.1002/eap.1704; Fleming CH, 2015, ECOLOGY, V96, P1182, DOI 10.1890/14-2010.1; Fleming CH, 2018, CTMM CONTINUOUS TIME; FOX JF, 1982, EVOLUTION, V36, P800, DOI 10.2307/2407893; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; GITTLEMAN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P57, DOI 10.1007/BF00296396; Godbois IA, 2003, PROCEEDINGS OF THE FIFTY-SEVENTH ANNUAL CONFERENCE OF THE SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P228; Godbois IA, 2004, J WILDLIFE MANAGE, V68, P514, DOI 10.2193/0022-541X(2004)068[0514:SPOBRT]2.0.CO;2; Goyal SP, 2014, CURRENT SCI, P1595; HOWARD WALTER E., 1960, AMER MIDLAND NAT, V63, P152, DOI 10.2307/2422936; Hughes AM, 2019, J WILDLIFE MANAGE, V83, P1711, DOI 10.1002/jwmg.21747; JACKSON DL, 1988, J WILDLIFE MANAGE, V52, P515, DOI 10.2307/3801602; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Johnson SA, 2010, J WILDLIFE MANAGE, V74, P379, DOI 10.2193/2008-253; Kamler JF, 2000, SOUTHWEST NAT, V45, P543, DOI 10.2307/3672608; Katnik DD, 2005, J WILDLIFE MANAGE, V69, P20, DOI 10.2193/0022-541X(2005)069&lt;0020:LPVMCS&gt;2.0.CO;2; KITCHINGS JT, 1984, J WILDLIFE MANAGE, V48, P957, DOI 10.2307/3801447; KNICK ST, 1990, WILDLIFE MONOGR, P1; KNOWLES PR, 1985, CAN FIELD NAT, V99, P6; KOEHLER GM, 1989, J WILDLIFE MANAGE, V53, P197, DOI 10.2307/3801331; Kolowski JM, 2002, J WILDLIFE MANAGE, V66, P822, DOI 10.2307/3803146; KUNKEL KE, 1994, CAN J ZOOL, V72, P1557, DOI 10.1139/z94-207; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lancia R.A., 1986, P425; LITVAITIS JA, 1986, J WILDLIFE MANAGE, V50, P110, DOI 10.2307/3801498; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Lopez G., 2010, Wildlife Biology in Practice, V6, P67; Lovallo MJ, 1996, AM MIDL NAT, V135, P241, DOI 10.2307/2426706; Lovallo MJ, 2003, BOBCAT LYNX WILD MAM, P758; Mabry KE, 2008, AM NAT, V172, P625, DOI 10.1086/591682; Manly B.F.J., 2002, RESOURCE SELECTION A; MATHEWS NE, 1988, CAN J ZOOL, V66, P1241, DOI 10.1139/z88-179; MCCORD CM, 1974, J MAMMAL, V55, P428, DOI 10.2307/1379010; McNitt DC, 2020, FOREST ECOL MANAG, V465, DOI 10.1016/j.foreco.2020.118066; McNitt DC, 2019, THESIS; Menzel MA, 1999, FOREST ECOL MANAG, V114, P227, DOI 10.1016/S0378-1127(98)00353-3; Morin DJ, 2018, POPUL ECOL, V60, P197, DOI 10.1007/s10144-018-0606-9; Morin DJ, 2016, WILDLIFE SOC B, V40, P669, DOI 10.1002/wsb.723; Morin DJ, 2016, J WILDLIFE MANAGE, V80, P824, DOI 10.1002/jwmg.21080; Mosby Cory E., 2012, Prairie Naturalist, V44, P47; Nelson MA., 2015, J SEAFWA, V2, P208; Oftedal O.T., 1989, P355; Quinn N.W.S., 1987, P682; R Core Team, R LANG ENV STAT COMP; Roberts NM, 2010, J FISH WILDL MANAG, V1, P169, DOI 10.3996/122009-JFWM-026; Rockhill AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069213; ROLLINGS CT, 1945, J WILDLIFE MANAGE, V9, P131, DOI 10.2307/3795892; RUCKER RA, 1989, SOUTHWEST NAT, V34, P101, DOI 10.2307/3671814; Sandell M., 1989, P164; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; SHORT HL, 1971, J WILDLIFE MANAGE, V35, P435, DOI 10.2307/3799694; Shuman R.M., 2018, J SE ASS FISH WILDLI, V5, P78; Shuman RM, 2017, J WILDLIFE MANAGE, V81, P834, DOI 10.1002/jwmg.21257; SIKES RS, 1993, SOUTHWEST NAT, V38, P336, DOI 10.2307/3671612; Spritzer MD, 2002, AM MIDL NAT, V148, P271, DOI 10.1674/0003-0031(2002)148[0271:DMUASA]2.0.CO;2; Stearns S.C., 1992, pi; Stys Elizabeth D., 1993, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V47, P80; TAYLOR CR, 1972, SCIENCE, V178, P1096, DOI 10.1126/science.178.4065.1096; Tucker SA, 2008, J WILDLIFE MANAGE, V72, P1114, DOI 10.2193/2007-291; WINEGARNER CE, 1982, J MAMMAL, V63, P680, DOI 10.2307/1380281	84	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0225355	10.1371/journal.pone.0225355	http://dx.doi.org/10.1371/journal.pone.0225355			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750055	gold, Green Published			2022-12-26	WOS:000560009200007
J	Tilahun, M; Shimelis, E; Wogayehu, T; Assefa, G; Wondimagegn, G; Mekonnen, A; Hailu, T; Bobosha, K; Aseffa, A				Tilahun, Melaku; Shimelis, Ezra; Wogayehu, Teklu; Assefa, Gebeyehu; Wondimagegn, Getachew; Mekonnen, Alemayehu; Hailu, Tsegaye; Bobosha, Kidist; Aseffa, Abraham			Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RISK-FACTORS	Introduction Multi-drug resistance is a major challenge in the control of tuberculosis. Despite newer modalities for diagnosis and treatment, people are still suffering from this disease. Understanding the common gene mutations conferring rifampicin and isoniazid resistance is crucial for the implementation of effective molecular tools at local and national levels. Hence, this study aimed to evaluate the molecular detection of rifampicin and isoniazid-resistant gene mutations inM.tuberculosisisolates in Addis Ababa, Ethiopia. Method Health Center-based cross-sectional study was conducted between January and September 2017 in Addis Ababa, Ethiopia. The collected sputum samples were processed for mycobacterial isolation and Region of difference 9 based polymerase chain reaction for species identification. To characterize the rifampicin and isoniazid-resistantM.tuberculosisisolates, a molecular genetic assay (GenoType MTBDRplus) was used; the assay is based on DNA-STRIP technology. Result Culture positivity was confirmed in 82.6% (190/230) of smear-positive newly diagnosed pulmonary tuberculosis cases enrolled in the study. From 190 isolates 93.2% were sensitive for both rifampicin and isoniazid, and 6.8% of the isolates were resistant to at least one of the tested anti-TB drugs. Gene mutations were observed in all studied multidrug resistance-associated gene loci (rpoB,katG, andinhA). Two isolates exhibited heteroresistance, a mutated, as well as wild type sequences, were detected in the respective strains. MDR-TB case was observed in 1.1% (2/190) of the cases. All the MDR-TB cases were positive for HIV and found to have a history of prior hospital admission. Conclusion In our finding a relatively high prevalence of any drug resistance was observed and the overall prevalence of multidrug-resistant tuberculosis was 1.1%.The majority of drug-resistant isolates demonstrated common mutations. Heteroresistant strains were detected, signaling the existence of anM.tuberculosispopulation with variable responses to anti-tuberculosis drugs or of mixed infections.	[Tilahun, Melaku; Shimelis, Ezra; Assefa, Gebeyehu; Hailu, Tsegaye; Bobosha, Kidist; Aseffa, Abraham] Armauer Hansen Res Inst AHRI, Addis Ababa, Ethiopia; [Tilahun, Melaku; Wogayehu, Teklu] Arba Minch Univ AMU, Dept Biol, Coll Nat Sci, Arba Minch, Ethiopia; [Shimelis, Ezra] Addis Ababa Univ AAU, Sch Publ Hlth, Black Lion Hosp, Coll Hlth Sci, Addis Ababa, Ethiopia; [Wondimagegn, Getachew] KNCV TB Fdn, Addis Ababa, Ethiopia; [Mekonnen, Alemayehu] Ethiopian Publ Hlth Assoc, Addis Ababa, Ethiopia	KNCV Tuberculosis Foundation	Tilahun, M; Shimelis, E (corresponding author), Armauer Hansen Res Inst AHRI, Addis Ababa, Ethiopia.; Tilahun, M (corresponding author), Arba Minch Univ AMU, Dept Biol, Coll Nat Sci, Arba Minch, Ethiopia.; Shimelis, E (corresponding author), Addis Ababa Univ AAU, Sch Publ Hlth, Black Lion Hosp, Coll Hlth Sci, Addis Ababa, Ethiopia.	mtilahun600@gmail.com; ezrashimelis@yahoo.com	Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150; Mitku, Gebeyehu Assefa/0000-0003-1308-7566; Tilahun, Melaku/0000-0002-3101-3926	AHRI	AHRI	This work is supported by AHRI core budget. AHRI Receives core support from Sida, Norad and the Government of Ethiopia.	Abate D, 2014, INT J TUBERC LUNG D, V18, P946, DOI 10.5588/ijtld.13.0926; Nugussie DA, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6325484; Alelign A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3978-3; [Anonymous], 2012, GENOTYPE MTBDR PLUS; Brhane M, 2017, INFECT DRUG RESIST, V10, P75, DOI 10.2147/IDR.S127903; Central Statistical Agency of Ethiopia, 2014, POP PROJ ETH ALL REG; Damena D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218545; Dean AS, 2014, EUR RESPIR J, V44, P251, DOI 10.1183/09031936.00205413; Desalegn DM, 2019, AFR J LAB MED, V8, DOI 10.4102/ajlm.v8i1.793; Diriba G, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0554-4; Eldholm V, 2016, ELIFE, V5, DOI 10.7554/eLife.16644; Eshetie S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2323-y; Ethiopian Health and Nutrition Research Institute Federal Ministry of Health, 2009, GUID QUAL ASS SMEAR; Geremew D, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4031-2; Hagos AA, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2734-4; Haile B, 2020, NEW MICROB NEW INFEC, V33, DOI 10.1016/j.nmni.2019.100620; Ibrahim E, 2017, EGYPT J CHEST DIS TU, V66, P405, DOI 10.1016/j.ejcdt.2016.11.002; Jerene Degu, 2005, MedGenMed, V7, P66, DOI 10.1186/1758-2652-7-3-66; Ling Daphne I, 2008, Expert Rev Respir Med, V2, P583, DOI 10.1586/17476348.2.5.583; Mehari K, 2019, CAN J INFECT DIS MED, V2019, DOI 10.1155/2019/2923549; Mekonnen D, 2015, INT J INFECT DIS, V39, P34, DOI 10.1016/j.ijid.2015.06.013; Mesfin EA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197737; Ministry of Health (MOH), 2018, GUID MAN TB DR TB LE; Mulu W, 2015, AFR HEALTH SCI, V15, P368, DOI 10.4314/ahs.v15i2.9; Ogari CO, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3911-9; Okethwangu D, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4014-3; Organization WH, 2011, GUID PROGR MAN DRUG; Orikiriza P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118191; Parsons LM, 2002, J CLIN MICROBIOL, V40, P2339, DOI 10.1128/JCM.40.7.2339-2345.2002; Sandhu GK, 2011, J GLOB INFECT DIS, V3, P143, DOI 10.4103/0974-777X.81691; Stagg HR, 2017, INT J TUBERC LUNG D, V21, P129, DOI 10.5588/ijtld.16.0716; Stinson K., 2014, GLOBAL LAB INITIATIV, P147; Tadesse M, 2016, INT J MYCOBACT, V5, P185, DOI 10.1016/j.ijmyco.2016.02.009; Tessema B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-37; Tilahun M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193083; Warren R, 2006, J CLIN MICROBIOL, V44, P254, DOI 10.1128/JCM.44.1.254-256.2006; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Wondale B, 2018, INFECT DRUG RESIST, V11, P1581, DOI 10.2147/IDR.S165088; Workicho A, 2017, INFECT DRUG RESIST, V10, P91, DOI 10.2147/IDR.S126274	39	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0236054	10.1371/journal.pone.0236054	http://dx.doi.org/10.1371/journal.pone.0236054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750053	Green Published, gold			2022-12-26	WOS:000560009200020
J	Werckenthin, A; Huber, J; Arnold, T; Koziarek, S; Plath, MJA; Plath, JA; Stursberg, O; Herzel, H; Stengl, M				Werckenthin, Achim; Huber, Jannik; Arnold, Thordis; Koziarek, Susanne; Plath, Marcus J. A.; Plath, Jenny A.; Stursberg, Olaf; Herzel, Hanspeter; Stengl, Monika			Neither per, nor tim1, norcry2 alone are essential components of the molecular circadian clockwork in the Madeira cockroach	PLOS ONE			English	Article							HORMONE-IMMUNOREACTIVE NEURONS; ACCESSORY MEDULLA; LEUCOPHAEA-MADERAE; RNA INTERFERENCE; LOCOMOTOR RHYTHMS; EFFECTS MODELS; OPTIC LOBE; PACEMAKER; GENE; BRAIN	Circadian clocks control rhythms in physiology and behavior entrained to 24 h light-dark cycles. Despite of conserved general schemes, molecular circadian clockworks differ between insect species. With RNA interference (RNA(i)) we examined an ancient circadian clockwork in a basic insect, the hemimetabolous Madeira cockroach Rhyparobia maderae. With injections of double-stranded RNA (dsRNA) of cockroach period (Rm'per), timeless 1 (Rm'tim1), or cryptochrome 2 (Rm'cry2) we searched for essential components of the clock's core negative feedback loop. Single injections of dsRNA of each clock gene into adult cockroaches successfully and permanently knocked down respective mRNA levels within similar to two weeks deleting daytime-dependent mRNA rhythms for Rm'per and Rm'cry2. Rm'per(RNAi) or Rm'cry2(RNAi) affected total mRNA levels of both genes, while Rm'tim1 transcription was independent of both, also keeping rhythmic expression. Unexpectedly, circadian locomotor activity of most cockroaches remained rhythmic for each clock gene knockdown employed. It expressed weakened rhythms and unchanged periods for Rm'per(RNAi) and shorter periods for Rm'tim1(RNAi) and Rm'cry2(RNAi).As a hypothesis of the cockroach's molecular clockwork, a basic network of switched differential equations was developed to model the oscillatory behavior of clock cells expressing respective clock genes. Data were consistent with two synchronized main groups of coupled oscillator cells, a leading (morning) oscillator, or a lagging (evening) oscillator that couple via mutual inhibition. The morning oscillators express shorter, the evening oscillators longer endogenous periods based on core feedback loops with either PER, TIM1, or CRY2/PER complexes as dominant negative feedback of the clockwork. We hypothesize that dominant morning oscillator cells with shorter periods express PER, but not CRY2, or TIM1 as suppressor of clock gene expression, while two groups of evening oscillator cells with longer periods either comprise TIM1 or CRY2/PER suppressing complexes. Modelling suggests that there is an additional negative feedback next to Rm'PER in cockroach morning oscillator cells.	[Werckenthin, Achim; Arnold, Thordis; Koziarek, Susanne; Plath, Marcus J. A.; Plath, Jenny A.; Stengl, Monika] Univ Kassel, Dept Anim Physiol Neuroethol, Kassel, Germany; [Huber, Jannik; Stursberg, Olaf] Univ Kassel, Dept Control & Syst Theory, Kassel, Germany; [Herzel, Hanspeter] Charite, Dept Theoret Biol, Berlin, Germany	Universitat Kassel; Universitat Kassel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Stengl, M (corresponding author), Univ Kassel, Dept Anim Physiol Neuroethol, Kassel, Germany.	stengl@uni-kassel.de		Plath, Marcus J. A./0000-0003-4871-6537; Stursberg, Olaf/0000-0002-9600-457X; Arnold, Thordis/0000-0003-4413-242X	University of Kassel Graduate School Program (Graduate School Clocks) [P/979]; Deutsche Forschungsgemeinschaft (DFG) [HE2168/11-1, SPP2041, STE531/18-3, STE531/21-1, STE531/25-1, STE531/26-1]	University of Kassel Graduate School Program (Graduate School Clocks); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the University of Kassel Graduate School Program (Graduate School Clocks P/979; https://www.uni-kassel.de/einrichtungen/de/graduiertenakademie/startseite.html) to OS, HH, and MS and by the Deutsche Forschungsgemeinschaft (DFG; https://www.dfg.de/) with grants HE2168/11-1, SPP2041 to HH and STE531/18-3, STE531/21-1, STE531/25-1, STE531/26-1 to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold T, 2020, J COMP NEUROL, V528, P1754, DOI 10.1002/cne.24844; Benna C, 2010, CURR BIOL, V20, P346, DOI 10.1016/j.cub.2009.12.048; Boisgontier MP, 2016, NEUROSCI BIOBEHAV R, V68, P1004, DOI 10.1016/j.neubiorev.2016.05.034; Bortolussi L, 2008, LECT NOTES COMPUT SC, V5016, P424; Danbara Y, 2010, J INSECT PHYSIOL, V56, P1738, DOI 10.1016/j.jinsphys.2010.07.002; Dolezelova E, 2007, INSECT BIOCHEM MOLEC, V37, P318, DOI 10.1016/j.ibmb.2006.12.003; Gestrich J, 2018, J BIOL RHYTHM, V33, P35, DOI 10.1177/0748730417739471; GLASS L, 1978, J MATH BIOL, V6, P207, DOI 10.1007/BF02547797; Goda T, 2016, J NEUROSCI, V36, P11739, DOI 10.1523/JNEUROSCI.0964-16.2016; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hardin PE, 2011, ADV GENET, V74, P141, DOI 10.1016/B978-0-12-387690-4.00005-2; Helfrich-Forster C, 2018, ANNU REV ENTOMOL, V63, P69, DOI 10.1146/annurev-ento-020117-043201; Helfrich-Forster C, 2014, J NEUROGENET, V28, P329, DOI 10.3109/01677063.2014.905556; Helfrich-Forster C, 2009, J BIOL RHYTHM, V24, P259, DOI 10.1177/0748730409339614; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Henzinger TA, 2000, NATO ADV SCI I F-COM, V170, P265; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kamae Y, 2012, J BIOL RHYTHM, V27, P126, DOI 10.1177/0748730411435997; Kistenpfennig C, 2018, J BIOL RHYTHM, V33, P24, DOI 10.1177/0748730417738612; Komin N, 2011, INTERFACE FOCUS, V1, P167, DOI 10.1098/rsfs.2010.0327; Kutaragi Y, 2018, ZOOL LETT, V4, DOI 10.1186/s40851-018-0109-8; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Liang XT, 2019, NEURON, V102, P843, DOI 10.1016/j.neuron.2019.03.028; LINDSTROM MJ, 1988, J AM STAT ASSOC, V83, P1014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michael AK, 2017, PHOTOCHEM PHOTOBIOL, V93, P128, DOI 10.1111/php.12677; Michel S, 2019, EUR J NEUROSCI; Moriyama Y, 2008, J BIOL RHYTHM, V23, P308, DOI 10.1177/0748730408320486; Moriyama Y, 2012, J BIOL RHYTHM, V27, P467, DOI 10.1177/0748730412462207; PAGE TL, 1982, SCIENCE, V216, P73, DOI 10.1126/science.216.4541.73; PAGE TL, 1977, P NATL ACAD SCI USA, V74, P1277, DOI 10.1073/pnas.74.3.1277; PAGE TL, 1985, J INSECT PHYSIOL, V31, P235, DOI 10.1016/0022-1910(85)90125-8; PAGE TL, 1983, J COMP PHYSIOL, V152, P231, DOI 10.1007/BF00611187; PETRI B, 1995, CELL TISSUE RES, V282, P3, DOI 10.1007/BF00319128; Reischig T, 2003, CELL TISSUE RES, V314, P421, DOI 10.1007/s00441-003-0772-7; Reischig T, 2003, J EXP BIOL, V206, P1877, DOI 10.1242/jeb.00373; Reischig T, 2002, J COMP NEUROL, V443, P388, DOI 10.1002/cne.10133; Reischig T, 1996, CELL TISSUE RES, V285, P305, DOI 10.1007/s004410050648; Reischig T, 2004, CELL TISSUE RES, V318, P553, DOI 10.1007/s00441-004-0927-1; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; Schendzielorz T., 2014, THESIS; Schubert FK, 2018, J COMP NEUROL, V526, P1209, DOI 10.1002/cne.24406; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Soehler S, 2011, CELL TISSUE RES, V343, P559, DOI 10.1007/s00441-010-1091-4; STENGL M, 1994, J COMP PHYSIOL A, V175, P203, DOI 10.1007/BF00215116; Stengl M, 2016, CURR OPIN NEUROBIOL, V41, P44, DOI 10.1016/j.conb.2016.07.010; Stengl M, 2015, CURR OPIN INSECT SCI, V12, P38, DOI 10.1016/j.cois.2015.09.007; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Tokuoka A, 2017, ZOOL LETT, V3, DOI 10.1186/s40851-017-0066-7; Tomioka K, 2015, CURR OPIN INSECT SCI, V7, P58, DOI 10.1016/j.cois.2014.12.006; Tomioka K, 2010, CELL MOL LIFE SCI, V67, P1397, DOI 10.1007/s00018-009-0232-y; Tomioka K, 2009, SLEEP BIOL RHYTHMS, V7, P144, DOI 10.1111/j.1479-8425.2009.00407.x; Uryu O, 2013, J INSECT PHYSIOL, V59, P494, DOI 10.1016/j.jinsphys.2013.02.009; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Virtanen P, 2019, COURNAPEAU D SCIPY 1; Werckenthin A, 2012, J BIOL RHYTHM, V27, P453, DOI 10.1177/0748730412462109; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Yao Z, 2014, SCIENCE, V343, P1516, DOI 10.1126/science.1251285; Yoshii T, 2004, J INSECT PHYSIOL, V50, P479, DOI 10.1016/j.jinsphys.2004.02.011; Yoshii Taishi, 2016, Commun Integr Biol, V9, pe1102805, DOI 10.1080/19420889.2015.1102805; Yoshii T, 2012, PROG BRAIN RES, V199, P59, DOI 10.1016/B978-0-444-59427-3.00027-7	66	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2020	15	8							e0235930	10.1371/journal.pone.0235930	http://dx.doi.org/10.1371/journal.pone.0235930			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7PQ	32750054	gold, Green Published			2022-12-26	WOS:000560009200033
J	Bachsais, M; Salti, S; Zaoui, K; Hassan, GS; Aoudjit, F; Mourad, W				Bachsais, Meriem; Salti, Suzanne; Zaoui, Kossay; Hassan, Ghada S.; Aoudjit, Fawzi; Mourad, Walid			CD154 inhibits death of T cells via a Cis interaction with the alpha 5 beta 1 integrin	PLOS ONE			English	Article							SOLUBLE CD40 LIGAND; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; PLASMA-LEVELS; BINDING; ACTIVATION; CD22; RECEPTORS; APOPTOSIS; MASKING	CD154 plays a major role in the pathogenesis of several autoimmune and inflammatory diseases. In addition to CD40, soluble CD154 (sCD154) binds to other receptors namely alpha IIb beta 3, alpha M beta 2, alpha 5 beta 1 and alpha v beta 3 integrins. We have previously reported that binding of sCD154 to alpha 5 beta 1 integrin expressed on several human T cell lines is capable of inhibiting Fas-induced cell death. In the current study, we show that such effect of the sCD154/alpha 5 beta 1 interaction is not restricted to the cell death response induced by Fas but could also be exhibited toward other death signals such as TRAIL and TNF- alpha. We also demonstrate that sCD154 is capable of inhibiting Fas-mediated death of human activated T cells, more importantly of CD4(+)than CD8(+)T ones. Our data also show that membrane-bound CD154 and alpha 5 beta 1 integrin expressed on the surface of distinct cells failed to influence cell death responses. However, when membrane-bound CD154 and alpha 5 beta 1 are expressed on the surface of same cell, their interaction was capable of down regulating cell death. CD154 was shown to co-localize with the alpha 5 beta 1 integrin on the surface of these cells. These data strongly suggest a cis-type of interaction between CD154 and alpha 5 beta 1 when both are expressed on the same cell surface, rather than a trans-interaction which usually implicates the ligand and its receptor each expressed on the surface of a distinct cell. Taken together, these findings add to the list of roles through which CD154 is contributing to the pathogenesis of autoimmune-inflammatory diseases, i.e. by protecting T cells from death and enhancing their survival.	[Bachsais, Meriem; Salti, Suzanne; Zaoui, Kossay; Hassan, Ghada S.; Mourad, Walid] Ctr Rech Ctr Hosp Univ Montreal CR CHUM, Lab Immunol Cellulaire & Mol, Montreal, PQ, Canada; [Aoudjit, Fawzi] Univ Laval, CHU Quebec, Ctr Rech, Quebec City, PQ, Canada	Universite de Montreal; Laval University	Mourad, W (corresponding author), Ctr Rech Ctr Hosp Univ Montreal CR CHUM, Lab Immunol Cellulaire & Mol, Montreal, PQ, Canada.	mw.mourad@umontreal.ca		Aoudjit, Fawzi/0000-0001-9579-2941; Hassan, Ghada S./0000-0002-1391-5248; Mourad, Walid/0000-0002-1859-9387	Heart and Stroke Foundation of Canada [G-16-00012570]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by a grant-inaid from the Heart and Stroke Foundation of Canada (G-16-00012570), awarded to W.M. (principal investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alturaihi H, 2015, EUR J IMMUNOL, V45, P592, DOI 10.1002/eji.201444941; Andersson KE, 2007, EUR J IMMUNOL, V37, P516, DOI 10.1002/eji.200636693; Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Anel A, 2011, RECENT PATENTS INFLA, V5, P184, DOI 10.2174/187221311797264883; [Anonymous], 2007, LIFE BREATH RESP DIS; Bachsais M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158987; Back J, 2007, P NATL ACAD SCI USA, V104, P3978, DOI 10.1073/pnas.0607418104; Benslimane N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043070; Bluestone JA, 2015, J CLIN INVEST, V125, P2250, DOI 10.1172/JCI78089; Brenner B, 1997, FEBS LETT, V417, P301, DOI 10.1016/S0014-5793(97)01306-9; Brinkmann V, 1996, J IMMUNOL, V156, P4100; Brummer J, 2001, AM J PATHOL, V159, P537, DOI 10.1016/S0002-9440(10)61725-7; Bugajska U, 2002, J NATL CANCER I, V94, P1381; Chemin K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00353; Clark J, 2005, ANN RHEUM DIS, V64, P70, DOI 10.1136/ard.2005.042523; Collins BE, 2004, P NATL ACAD SCI USA, V101, P6104, DOI 10.1073/pnas.0400851101; Cope AP, 2007, CLIN EXP RHEUMATOL, V25, pS4; Danese S, 2004, GUT, V53, P1035, DOI 10.1136/gut.2003.026278; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Doucey MA, 2003, J BIOL CHEM, V278, P26983, DOI 10.1074/jbc.M302709200; Eguchi K, 2001, INTERNAL MED, V40, P275, DOI 10.2169/internalmedicine.40.275; El Fakhry Y, 2012, J BIOL CHEM, V287, P18055, DOI 10.1074/jbc.M111.333989; El Fakhry Y, 2010, EUR J IMMUNOL, V40, P770, DOI 10.1002/eji.200939646; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Elia A, 2014, J INTERF CYTOK RES, V34, P769, DOI 10.1089/jir.2013.0061; Ferro D, 2004, ARTHRITIS RHEUM, V50, P1693, DOI 10.1002/art.20177; Ford GS, 1999, J IMMUNOL, V162, P4037; Hassan GS, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4153; Hassan Ghada S., 2009, Current Immunology Reviews, V5, P285; Hassan GS, 2011, IMMUNOBIOLOGY; Held W, 2011, CELL MOL LIFE SCI, V68, P3469, DOI 10.1007/s00018-011-0798-z; Henn V, 2001, BLOOD, V98, P1047, DOI 10.1182/blood.V98.4.1047; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jin L, 2002, J EXP MED, V195, P1199, DOI 10.1084/jem.20011796; Jin Yinzhu, 2001, Journal of Medical and Dental Sciences, V48, P23; Karnell JL, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aar6584; Kaskow BJ, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029025; Kawai M, 2008, ARTHRITIS RHEUM-US, V58, P3562, DOI 10.1002/art.23994; Koppenhoefer U, 1997, FEBS LETT, V414, P444, DOI 10.1016/S0014-5793(97)01035-1; Kowal K, 2006, J THROMB HAEMOST, V4, P2718, DOI 10.1111/j.1538-7836.2006.02206.x; Larson MK, 2006, BLOOD, V108, P1509, DOI 10.1182/blood-2005-11-011957; Lee MW, 2015, BIOCHEM BIOPH RES CO, V463, P894, DOI 10.1016/j.bbrc.2015.05.133; Leveille C, 2007, J BIOL CHEM, V282, P5143, DOI 10.1074/jbc.M608342200; Lin YP, 2009, MOL IMMUNOL, V46, P3328, DOI 10.1016/j.molimm.2009.07.021; Loubaki L, 2010, MOL IMMUNOL, V47, P2112, DOI 10.1016/j.molimm.2010.03.011; Mewar D, 2006, BIOMED PHARMACOTHER, V60, P648, DOI 10.1016/j.biopha.2006.09.002; Moudgil KD, 2011, J INTERF CYTOK RES, V31, P695, DOI 10.1089/jir.2011.0065; Nakayamada S, 2007, ARTHRITIS RHEUM, V56, P1559, DOI 10.1002/art.22581; Nitschke L, 2009, IMMUNOL REV, V230, P128, DOI 10.1111/j.1600-065X.2009.00801.x; Okwor I, 2015, J IMMUNOL, V195, P3218, DOI 10.4049/jimmunol.1500922; Perper SJ, 2019, J IMMUNOL, V203, P58, DOI 10.4049/jimmunol.1900043; Pietravalle F, 1996, J BIOL CHEM, V271, P5965, DOI 10.1074/jbc.271.11.5965; POWIS G, 1994, CANCER RES, V54, P2419; Prasad KSS, 2003, P NATL ACAD SCI USA, V100, P12367, DOI 10.1073/pnas.2032886100; Razi N, 1998, P NATL ACAD SCI USA, V95, P7469, DOI 10.1073/pnas.95.13.7469; Saggu G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07506-1; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Severson C, 2010, RESULTS PROBL CELL D, V51, P75, DOI 10.1007/400_2009_12; Shakibaei M, 2010, ANTIOXID REDOX SIGN, V13, P821, DOI 10.1089/ars.2009.3036; Skapenko A, 2005, ARTHRITIS RES THER, V7, pS4, DOI 10.1186/ar1703; Suarez-Fueyo A, 2016, CURR OPIN IMMUNOL, V43, P32, DOI 10.1016/j.coi.2016.09.001; T Georgopoulos N, 2006, CELL DEATH DIFFER, V13, P1789, DOI 10.1038/sj.cdd.4401859; Takada YK, 2019, J IMMUNOL, V203, P1383, DOI 10.4049/jimmunol.1801630; Tamura N, 2001, J RHEUMATOL, V28, P2583; THELEN M, 1994, P NATL ACAD SCI USA, V91, P4960, DOI 10.1073/pnas.91.11.4960; Vakkalanka RK, 1999, ARTHRITIS RHEUM, V42, P871, DOI 10.1002/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J; Yazdany J, 2004, LUPUS, V13, P377, DOI 10.1191/0961203304lu1030oa; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201	70	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0235753	10.1371/journal.pone.0235753	http://dx.doi.org/10.1371/journal.pone.0235753			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745080	Green Published, gold			2022-12-26	WOS:000560006800050
J	Bizimana, T; Kayumba, PC; Heide, L				Bizimana, Thomas; Kayumba, Pierre Claver; Heide, Lutz			Prices, availability and affordability of medicines in Rwanda	PLOS ONE			English	Article								Background Access to affordable and good quality medicines is a key to meeting Sustainable Development Goal No. 3 by the year 2030. Prices, availability and affordability of essential medicines have been studied in many developing countries, but no such information has been published about Rwanda yet. This study aimed at providing data on prices, availability and affordability of medicines in different health facilities of Rwanda. Methods A survey was carried out on availability, prices and affordability of 18 medicines in Kigali City and five districts of Rwanda. 44 health facilities were surveyed, including public and faith-based hospitals, public and faith-based health centers and private pharmacies. The standardized methodology developed by WHO and Health Action International (HAI) was used to collect and analyze the data. Findings Prices for generic medicines in public and faith-based health facilities were remarkably low, with median price ratios (MPRs) of 1.0 in comparison to the international procurement prices published by Management Sciences for Health. In private pharmacies, prices were twice as high (MPR = 1.99 for generics). Availability of medicines fell short of the of 80% target set by WHO, but was better than reported from many other developing countries. Availability of medicines was highest in the private sector (71.3%) and slightly lower in the faith-based (62.8%) and public (59.6%) sectors. The government procurement agency was found to work efficiently, achieving prices 30% below the international procurement price given in the International Medical Product Price Guide. Affordability of medicines was better in the public and faith-based sectors than in the private sector. Conclusion In Rwanda, medicines are affordable but poorly available in both the public and the faith-based sectors. Further improvements of the availability of medicines in the public and the faith-based health facilities represent the most important key to increase accessibility and affordability of medicines in Rwanda.	[Bizimana, Thomas] Univ Rwanda, Coll Med & Hlth Sci CMHS, Sch Med & Pharm, Dept Pharm, Kigali, Rwanda; [Kayumba, Pierre Claver] Univ Rwanda, East African Community Reg Ctr Excellence Vaccine, Kigali, Rwanda; [Heide, Lutz] Eberhard Karls Univ Tubingen, Pharmaceut Inst, Tubingen, Germany	University of Rwanda; University of Rwanda; Eberhard Karls University of Tubingen	Heide, L (corresponding author), Eberhard Karls Univ Tubingen, Pharmaceut Inst, Tubingen, Germany.	heide@uni-tuebingen.de	Bizimana, Thomas/GLV-3526-2022	Bizimana, Thomas/0000-0003-3110-1018; Heide, Lutz/0000-0001-7809-7453	Baden-WurttembergSTIPENDIUM for University Students -BWS plus, a programme of the Baden-Wu rttemberg Stiftung; Deutsche Forschungsgemeinschaft; University of Tubingen	Baden-WurttembergSTIPENDIUM for University Students -BWS plus, a programme of the Baden-Wu rttemberg Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tubingen	The authors gratefully acknowledge financial support from the Baden-WurttembergSTIPENDIUM for University Students -BWS plus, a programme of the Baden-Wu rttemberg Stiftung. This publication was produced in the BWS plus project "Joint teaching and research on essential medicines in Rwanda". We furthermore acknowledge support for open access publication by the Deutsche Forschungsgemeinschaft and the Open Access Publishing Fund of the University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript".	[Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; Burrone E, 2019, B WORLD HEALTH ORGAN, V97, P575, DOI 10.2471/BLT.18.229179; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Fang Y, 2012, MED PRICES AVAILABIL; Kalisa I, 2015, DEV COMMUNITY BASED; Khuluza F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175399; Management Sciences for Health, 2016, MSH INT MED PROD PRI; Ministry of Health-Rwanda, 2015, NAT LIST ESS MED PAE, V1st; Ministry of Health-Rwanda, 2017, PRIV HLTH FAC RWAND; Ministry of Health-Rwanda, 2015, NAT LIST ESS MED AD, V6th; Ministry of Health-Rwanda, 2012, GYN OBST CLIN PROT T; Ministry of Health-Rwanda, 2017, LIST AUTH MED AUG 20; Nditunze L., 2015, RWANDA J, V2, P85, DOI [10.4314/rjhs.v2i1.12F, DOI 10.4314/RJHS.V2I1.12F]; Nyanwura EM, 2013, INT J SCI TECHNOL RE, V2, P208; Republic of Rwanda-Ministry of Health, 2013, MINISTRY HLTH ANN RE; UN Commission on Life-Saving Commodities for Women and Children, 2012, EV WOM EV CHILD COMM; United Nations Economic and Social Council, 2019, PROGR SUST DEV GOAL; WHO, 2017, UPD WHO REC TRAN ACI; WHO, 2013, FOLL UP POL DECL HIG; Wirtz VJ, 2017, LANCET, V389, P403, DOI 10.1016/S0140-6736(16)31599-9; World Health Organization, 2016, ASS MED PRIC REIMB S; World Health Organization, 2009, WHO MOD FORM 2008; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization, WHO MOD PRESCR INF D; World Health Organization Health Action International, 2016, MEAS MED PRIC AV AFF, V2nd	27	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236411	10.1371/journal.pone.0236411	http://dx.doi.org/10.1371/journal.pone.0236411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745100	gold, Green Published			2022-12-26	WOS:000560006800012
J	Roselli, C; Meli, MA; Fagiolino, I; Desideri, D				Roselli, Carla; Meli, Maria Assunta; Fagiolino, Ivan; Desideri, Donatella			Bioaccessibility assessment of stable elements and Po-210 in food	PLOS ONE			English	Article							VITRO DIGESTION MODEL; TOXIC ELEMENTS; METALS; APPLICABILITY; RETENTION; SHELLFISH; SELENIUM; BERRIES; PB-210; ALGAE	Element bioaccessibility consists of the fraction of the element that is mobilized from food matrices into digestive extractants. The degree of bioaccessibility of a toxic metal is a fundamental consideration in estimating its bioavailability. In addition, gaining a better understanding of the essential elements released into the gastro intestinal fluids allows a more thorough assessment of the health benefits of food matrices in the field of nutrition science. In the present study, anin vitrodigestion model simulating gastro-intestinal digestion (GID) was used to investigate the bioaccessibility of stable elements in mixed leaf salad and(210)Po in various foods (meat, seafood, vegetables). The simulation was carried out over three phases: after a pre-treatment with a saliva solution, raw and cooked seafood samples were subjected to a complete simulated gastrointestinal digestion (gastric digestion followed by bile-pancreas digestion). The(210)Po bioaccessibility was found to range from 16.2 +/- 9.39% to 62.8 +/- 17.7% and from 6.26 +/- 2.15% to 67.5 +/- 13.1% for raw and cooked food respectively. Moreover, bioaccessibility could not be determined for As, Cd, Ce, Co, Cr, Hg, La, Pb, Sb, Sn, Te, Th, Tl, Ti, U. It proved to be poor (1-16%) for Al, Fe and S; fair (40-50%) for Cu, P, and Si; and high (>50%) for Ba, Ca, K, Mg, Mn, Ni, Rb, Sr, Zn. The results show that bioaccessibility varies according to the chemical form of the element in the food as well as the matrix composition.	[Roselli, Carla; Meli, Maria Assunta; Desideri, Donatella] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy; [Fagiolino, Ivan] GRUPPO CSA SpA, Rimini, RN, Italy	University of Urbino	Meli, MA (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy.	maria.meli@uniurb.it		meli, maria assunta/0000-0002-3292-3593				Amiard JC, 2008, FOOD CHEM TOXICOL, V46, P2010, DOI 10.1016/j.fct.2008.01.041; ATSDR, 2007, TOX PROF LEAD DRAFT; Belivermis M, 2016, ICES J MAR SCI, V73, P753, DOI 10.1093/icesjms/fsv236; Lopes ACBD, 2015, J TOXICOL ENV HEAL A, V78, P92, DOI 10.1080/15287394.2014.942125; Brown JE, 2011, J ENVIRON RADIOACTIV, V102, P430, DOI 10.1016/j.jenvrad.2010.06.016; Cabanero AI, 2004, ANAL CHIM ACTA, V526, P51, DOI 10.1016/j.aca.2004.09.039; CHERRY RD, 1982, SCIENCE, V218, P54, DOI 10.1126/science.7123217; Desideri D, 2016, J TOXICOL ENV HEAL A, V79, P112, DOI 10.1080/15287394.2015.1113598; Desideri D, 2018, J ANAL TOXICOL, V42, P417, DOI 10.1093/jat/bky019; Desideri D, 2018, J TOXICOL ENV HEAL A, V81, P212, DOI 10.1080/15287394.2018.1436480; Desideri D, 2017, J TOXICOL ENV HEAL A, V80, P230, DOI 10.1080/15287394.2017.1285733; Fink RM, 1950, BIOL STUDIES POLONIU; Gao S, 2014, ECOTOX ENVIRON SAFE, V110, P261, DOI 10.1016/j.ecoenv.2014.09.013; Hollebeeck S, 2013, FOOD CHEM, V138, P1936, DOI 10.1016/j.foodchem.2012.11.041; Hunt GJ, 2007, J RADIOL PROT, V27, P405, DOI 10.1088/0952-4746/27/4/002; Hunt G. J., 1993, Journal of Radiological Protection, V13, P119, DOI 10.1088/0952-4746/13/2/003; Hur SJ, 2011, FOOD CHEM, V125, P1, DOI 10.1016/j.foodchem.2010.08.036; ICRP, 1993, ANN ICRP, V67, P3; International Commission on Radiological Protection ICRP, 1979, ANN ICRP, V30, P3; Kong F, 2008, J FOOD SCI, V73, pR67, DOI 10.1111/j.1750-3841.2008.00766.x; Kong FB, 2009, FOOD BIOPHYS, V4, P180, DOI 10.1007/s11483-009-9116-9; Laird BD, 2013, FOOD CHEM TOXICOL, V58, P381, DOI 10.1016/j.fct.2013.04.033; Lestienne I, 2005, J AGR FOOD CHEM, V53, P3240, DOI 10.1021/jf0480593; Meli MA, 2018, SCI TOTAL ENVIRON, V613, P1566, DOI 10.1016/j.scitotenv.2017.08.320; Meli MA, 2015, J TOXICOL ENV HEAL A, V78, P617, DOI 10.1080/15287394.2014.1004006; Meli MA, 2019, J RADIOANAL NUCL CH, V321, P647, DOI 10.1007/s10967-019-06604-8; Meli MA, 2018, J TOXICOL ENV HEAL A, V81, P1123, DOI 10.1080/15287394.2018.1520160; Metian M, 2009, ECOTOX ENVIRON SAFE, V72, P1499, DOI 10.1016/j.ecoenv.2008.10.009; Oomen AG, 2003, ARCH ENVIRON CON TOX, V44, P281, DOI 10.1007/s00244-002-1278-0; Persson BRR, 2011, J ENVIRON RADIOACTIV, V102, P420, DOI 10.1016/j.jenvrad.2011.01.005; Reyes LH, 2006, J CHROMATOGR A, V1110, P108, DOI 10.1016/j.chroma.2006.01.088; Rodushkin I, 1999, SCI TOTAL ENVIRON, V231, P53, DOI 10.1016/S0048-9697(99)00080-7; Roselli C, 2017, J RADIOL PROT, V37, P907, DOI 10.1088/1361-6498/aa869b; Thomas PA, 2001, RADIAT PROT DOSIM, V97, P241, DOI 10.1093/oxfordjournals.rpd.a006669; U.S. EPA, 2014, 6010DSW846 US EPA; United Nations Scientific Committee on the Effects of Atomic Radiation, 1988, UNSCEAR 1988 SOURC E; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, SOURC EFF ION RAD; United States Environmental Protection Agency US EPA, 1994, 7470ASW846 US EPA; US EPA, 1996, 3050B USEPA; US EPA, 2014, 6020BSW846 US EPA; Valentin Jack, 2006, Annals of the ICRP, V36, P1, DOI 10.1016/j.icrp.2007.02.001; Versantvoort CHM, 2005, FOOD CHEM TOXICOL, V43, P31, DOI 10.1016/j.fct.2004.08.007	42	2	2	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236871	10.1371/journal.pone.0236871	http://dx.doi.org/10.1371/journal.pone.0236871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745115	Green Published, gold			2022-12-26	WOS:000560006800037
J	Todd, KV; Tripp, RA				Todd, Kyle V.; Tripp, Ralph A.			Exosome-mediated human norovirus infection	PLOS ONE			English	Article							VIRUS; REPLICATION; MECHANISMS; SECRETION; MEMBRANE; PROTEINS; CLUSTERS; RECEPTOR; CULTURE	Human norovirus (HuNoV) is a leading cause of acute gastroenteritis. Outbreaks normally occur via the fecal-oral route. HuNoV infection is thought to occur by viral particle transmission, but increasing evidence suggests a function for exosomes in HuNoV infection. HuNoV is contained within stool-derived exosomes, and exosome-associated HuNoV has been shown to replicate in human intestinal enteroids. In this study, we examine exosome-associated HuNoV infection of Vero cells and show that exosomes containing HuNoV may attach, infect, and be passaged in Vero cells. These findings support earlier findings and have implications for developing HuNoV disease intervention strategies.	[Todd, Kyle V.; Tripp, Ralph A.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Tripp, RA (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	ratripp@uga.edu		Tripp, Ralph/0000-0002-2924-9956	Bill and Melinda Gates Foundation [OPP1117272]; Georgia Research Alliance	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Georgia Research Alliance	R.A.T. received funding from the Bill and Melinda Gates Foundation (OPP1117272) and the Georgia Research Alliance to complete these studies. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Andreu Z, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00442; Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI 10.1586/ERV.09.19; Bartsch SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151219; Bird SW, 2014, P NATL ACAD SCI USA, V111, P13081, DOI 10.1073/pnas.1401437111; Chhabra P, 2019, J GEN VIROLOGY; Costantini V, 2018, EMERG INFECT DIS, V24, P1453, DOI 10.3201/eid2408.180126; Costantini V, 2010, J CLIN MICROBIOL, V48, P2770, DOI 10.1128/JCM.00654-10; Edgar JR, 2014, TRAFFIC, V15, P197, DOI 10.1111/tra.12139; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; Haga K, 2016, P NATL ACAD SCI USA, V113, pE6248, DOI 10.1073/pnas.1605575113; Hosmillo M, 2020, MBIO, V11, DOI 10.1128/mBio.00215-20; Hyde JL, 2009, J VIROL, V83, P9709, DOI 10.1128/JVI.00600-09; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Jones MK, 2015, NAT PROTOC, V10, P1939, DOI 10.1038/nprot.2015.121; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Koga Y, 2011, J GASTROINTEST ONCOL, V2, P215, DOI 10.3978/j.issn.2078-6891.2011.015; Lee HS, 2009, J PROTEOME RES, V8, P2851, DOI 10.1021/pr900009y; Lehrich BM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113538; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Mobius W, 2002, J HISTOCHEM CYTOCHEM, V50, P43; Murakami K, 2020, P NATL ACAD SCI USA, V117, P1700, DOI 10.1073/pnas.1910138117; Nagashima S, 2014, J GEN VIROL, V95, P2166, DOI 10.1099/vir.0.066910-0; Nagashima S, 2014, ARCH VIROL, V159, P979, DOI 10.1007/s00705-013-1912-3; Orchard RC, 2016, SCIENCE, V353, P933, DOI 10.1126/science.aaf1220; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pogan R, 2018, J PHYS-CONDENS MAT, V30, DOI 10.1088/1361-648X/aaa43b; Putz U, 2008, J BIOL CHEM, V283, P32621, DOI 10.1074/jbc.M804120200; Santiana M, 2018, CELL HOST MICROBE, V24, P208, DOI 10.1016/j.chom.2018.07.006; Shoemaker GK, 2010, MOL CELL PROTEOMICS, V9, P1742, DOI 10.1074/mcp.M900620-MCP200; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Todd KV, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040439; Villarroya-Beltri C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13588; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Yin X, 2016, J VIROL, V90, P4232, DOI 10.1128/JVI.02804-15; Zhang J, 2015, J CLIN VIROL, V72, P95, DOI 10.1016/j.jcv.2015.09.009	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0237044	10.1371/journal.pone.0237044	http://dx.doi.org/10.1371/journal.pone.0237044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745122	gold, Green Published			2022-12-26	WOS:000560006800040
J	Jerabkova, K; Liao, YR; Kleiss, C; Fournane, S; Durik, M; Agote-Aran, A; Brino, L; Sedlacek, R; Sumara, I				Jerabkova, Katerina; Liao, Yongrong; Kleiss, Charlotte; Fournane, Sadek; Durik, Matej; Agote-Aran, Arantxa; Brino, Laurent; Sedlacek, Radislav; Sumara, Izabela			Deubiquitylase UCHL3 regulates bi-orientation and segregation of chromosomes during mitosis	FASEB JOURNAL			English	Article						Aurora B; DUBs; chromosome alignment; chromosome segregation; mitosis	SPINDLE-ASSEMBLY CHECKPOINT; AURORA-B; CENTROMERIC MCAK; CENP-E; UBIQUITIN; KINASE; COMPLEX; ANAPHASE; SITES; LOCALIZATION	Equal segregation of chromosomes during mitosis ensures euploidy of daughter cells. Defects in this process may result in an imbalance in the chromosomal composition and cellular transformation. Proteolytic and non-proteolytic ubiquitylation pathways ensure directionality and fidelity of mitotic progression but specific mitotic functions of deubiquitylating enzymes (DUBs) remain less studied. Here we describe the role of the DUB ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCHL3) in the regulation of chromosome bi-orientation and segregation during mitosis. Downregulation or inhibition of UCHL3 leads to chromosome alignment defects during metaphase. Frequent segregation errors during anaphase are also observed upon inactivation of UCHL3. Mechanistically, UCHL3 interacts with and deubiquitylates Aurora B, the catalytic subunit of chromosome passenger complex (CPC), known to be critically involved in the regulation of chromosome alignment and segregation. UCHL3 does not regulate protein levels of Aurora B or the binding of Aurora B to other CPC subunits. Instead, UCHL3 promotes localization of Aurora B to kinetochores, suggesting its role in the error correction mechanism monitoring bi-orientation of chromosomes during metaphase. Thus, UCHL3 contributes to the regulation of faithful genome segregation and maintenance of euploidy in human cells.	[Jerabkova, Katerina; Liao, Yongrong; Kleiss, Charlotte; Fournane, Sadek; Durik, Matej; Agote-Aran, Arantxa; Brino, Laurent; Sumara, Izabela] Inst Genet & Biol Mol & Cellulaire IGBMC, Dept Dev & Stem Cells, Illkirch Graffenstaden, France; [Jerabkova, Katerina; Liao, Yongrong; Kleiss, Charlotte; Fournane, Sadek; Durik, Matej; Agote-Aran, Arantxa; Brino, Laurent; Sumara, Izabela] Ctr Natl Rech Sci UMR 7104, Strasbourg, France; [Jerabkova, Katerina; Liao, Yongrong; Kleiss, Charlotte; Fournane, Sadek; Durik, Matej; Agote-Aran, Arantxa; Brino, Laurent; Sumara, Izabela] Inst Natl Sante & Rech Med U964, Strasbourg, France; [Jerabkova, Katerina; Liao, Yongrong; Kleiss, Charlotte; Fournane, Sadek; Durik, Matej; Agote-Aran, Arantxa; Brino, Laurent; Sumara, Izabela] Univ Strasbourg, Strasbourg, France; [Jerabkova, Katerina; Sedlacek, Radislav] Inst Mol Genet CAS, Lab Transgen Models Dis, Vvi, Vestec, Czech Republic; [Jerabkova, Katerina; Sedlacek, Radislav] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Sedlacek, Radislav] Inst Mol Genet CAS, Czech Ctr Phenogen, Vvi, Vestec, Czech Republic; [Brino, Laurent] Ksilink, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Sedlacek, R (corresponding author), Inst Mol Genet CAS, Lab Transgen Models Dis, Vvi, Vestec, Czech Republic.; Sumara, I (corresponding author), Inst Genet & Biol Mol & Cellulaire IGBMC, Illkirch Graffenstaden, France.	radislav.sedlacek@img.cas.cz; sumara@igbmc.fr	; Jerabkova, Katerina/S-3487-2017	Kleiss, Charlotte/0000-0001-7842-8275; Brino, laurent/0000-0002-9036-1461; Sumara, Izabela/0000-0002-5968-3358; Jerabkova, Katerina/0000-0003-4734-6458; LIAO, Yongrong/0000-0001-9053-4900	Agence Nationale de la Recherche (ANR) [ANR-10-LABX-0030-INRT]; Ligue Contre le Cancer; China Scholarship Council (CSC); Czech Academy of Sciences [RVO68378050]; Ministry of Education, Youth, and Sports of the Czech Republic [LM2015040]; CNRS; Fondation ARC pour la recherche sur le cancer; Institut National du Cancer (INCa); USIAS; Programme Federateur Aviesan; INSERM; Sanofi iAward Europe; IGBMC	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ligue Contre le Cancer(Ligue nationale contre le cancer); China Scholarship Council (CSC)(China Scholarship Council); Czech Academy of Sciences(Czech Academy of Sciences); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation ARC pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); USIAS; Programme Federateur Aviesan; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Sanofi iAward Europe; IGBMC	Agence Nationale de la Recherche (ANR), Grant/Award Number: ANR-10-LABX-0030-INRT; Ligue Contre le Cancer; China Scholarship Council (CSC); Czech Academy of Sciences, Grant/Award Number: RVO68378050; Ministry of Education, Youth, and Sports of the Czech Republic, Grant/Award Number: LM2015040; IGBMC; CNRS; Fondation ARC pour la recherche sur le cancer; Institut National du Cancer (INCa); USIAS; Programme Federateur Aviesan; INSERM; Sanofi iAward Europe	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Artavanis-Tsakonas K, 2010, J BIOL CHEM, V285, P6857, DOI 10.1074/jbc.M109.072405; Ben-David U, 2020, NAT REV GENET, V21, P44, DOI 10.1038/s41576-019-0171-x; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Dennissen FJA, 2011, FEBS LETT, V585, P2568, DOI 10.1016/j.febslet.2011.06.037; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Ems-McClung SC, 2013, CURR BIOL, V23, P2491, DOI 10.1016/j.cub.2013.10.054; Fournane Sadek, 2012, Genes Cancer, V3, P697, DOI 10.1177/1947601912473477; Frickel EM, 2007, CELL MICROBIOL, V9, P1601, DOI 10.1111/j.1462-5822.2007.00896.x; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Jerabkova K, 2019, SEMIN CELL DEV BIOL, V93, P100, DOI 10.1016/j.semcdb.2018.12.007; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Krenn V, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00225; Krupina K, 2018, MOL CELL ONCOL, V5, DOI 10.1080/23723556.2016.1271494; Krupina K, 2016, DEV CELL, V36, P63, DOI 10.1016/j.devcel.2015.12.017; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Maerki S, 2010, CELL CYCLE, V9, P2921, DOI 10.4161/cc.9.15.12740; Maerki S, 2009, J CELL BIOL, V187, P791, DOI 10.1083/jcb.200906117; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Musacchio A, 2011, PHILOS T R SOC B, V366, P3595, DOI 10.1098/rstb.2011.0072; Nishi R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36235-0; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Saurin AT, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00062; Saurin AT, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1319; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Shrestha RL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00209-z; Song ZW, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1628-8; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Sumara I, 2008, TRENDS CELL BIOL, V18, P84, DOI 10.1016/j.tcb.2007.12.001; Sumara I, 2007, CELL CYCLE, V6, P3004, DOI 10.4161/cc.6.24.5068; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Tanaka TU, 2010, EMBO J, V29, P4070, DOI 10.1038/emboj.2010.294; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Vader G, 2007, MOL BIOL CELL, V18, P4553, DOI 10.1091/mbc.E07-04-0328; Wordeman L, 2007, J CELL BIOL, V179, P869, DOI 10.1083/jcb.200707120; Wu M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08043-7; Zhang MH, 2020, ONCOGENE, V39, P322, DOI 10.1038/s41388-019-0987-z; Zhang X, 2007, MOL BIOL CELL, V18, P3264, DOI 10.1091/mbc.E07-01-0086	50	2	2	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12751	12767		10.1096/fj.202000769R	http://dx.doi.org/10.1096/fj.202000769R		AUG 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32738097	Green Published			2022-12-26	WOS:000558165400001
J	Bartolo, S; Mancel, O; Deliege, E; Carpentier, S; Dessein, R; Faure, K; Subtil, D				Bartolo, Stephanie; Mancel, Ophelie; Deliege, Emilie; Carpentier, Sophie; Dessein, Rodrigue; Faure, Karine; Subtil, Damien			Determinants of pregnant women's knowledge about influenza and the influenza vaccine: A large, single-centre cohort study	PLOS ONE			English	Article							SEASONAL INFLUENZA; MATERNAL IMMUNIZATION; PRETERM DELIVERY; SAFETY; INFECTION; ATTITUDES; RISK; ARM	Introduction Although influenza can lead to adverse outcomes during pregnancy, the level of influenza vaccine coverage among pregnant women remains very low. According to the literature, a high level of knowledge about influenza disease and the influenza vaccine is one of the main determinants of vaccination coverage. The objective of the present study was to describe pregnant women's level of knowledge of these topics and to identify any corresponding determinants. Material and methods A prospective, observational, hospital-based study of women having given birth in our university medical centre during the 2014-2015 influenza season. Data were collected through a self-questionnaire or extracted from medical records. Determinants of highest knowledge were identified using logistic regression. Results Of the 2069 women included in the study, 827 (40%) did not know that influenza can lead to severe adverse outcomes for the mother, and 960 (46%) did not know about possible severe adverse outcomes for the baby. Two hundred and one women (9.8%) stated that the vaccine was "contraindicated" or "unnecessary" during pregnancy. Only 205 women (17%) had been vaccinated during a previous pregnancy. Determinants of the highest level of knowledge were age over 24, a high educational level, previous influenza vaccination, nulliparity, and the recommendation of vaccination by a healthcare professional. Conclusions Recommending vaccination during pregnancy appears to increase knowledge about influenza and its vaccine among pregnant women.	[Bartolo, Stephanie; Subtil, Damien] CHU Lille, ULR 2694 METRICS Evaluat Technol Sante & Prat Med, Univ Lille, Lille, France; [Bartolo, Stephanie] Hop Douai, Unite Meres Enfants & Nouveau Nes, Rue Cambrai, Douai, France; [Mancel, Ophelie; Deliege, Emilie; Carpentier, Sophie; Subtil, Damien] Univ Lille, Unite Femmes Mere & Nouveaux Nes, CHU Lille, Lille, France; [Dessein, Rodrigue; Faure, Karine] Lille Univ, Fac Med, Pole Rech, EA7366,Translat Res Host Pathogen Relationships, Lille, France; [Faure, Karine] Lille Univ, Infect Dis Unit, CHU Lille, Rue Michel Polonowski, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Bartolo, S (corresponding author), CHU Lille, ULR 2694 METRICS Evaluat Technol Sante & Prat Med, Univ Lille, Lille, France.; Bartolo, S (corresponding author), Hop Douai, Unite Meres Enfants & Nouveau Nes, Rue Cambrai, Douai, France.	stephanie.bartolo@ch-douai.fr						[Anonymous], 2014, Obstet Gynecol, V124, P648, DOI 10.1097/01.AOG.0000453599.11566.11; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2012, RELEVE EPIDEMIOLOGIQ, DOI [10.1016/J.VACCINE.2016.06.054, DOI 10.1016/J.VACCINE.2016.06.054]; Anselem O, 2013, PRESSE MED, V42, P1453, DOI 10.1016/j.lpm.2013.01.064; Beel ER, 2013, HUM VACC IMMUNOTHER, V9, P1926, DOI 10.4161/hv.25096; Blanchard-Rohner G, 2012, J MATERN-FETAL NEO M, V25, P1800, DOI 10.3109/14767058.2012.663835; Blondel B, 2017, J GYNECOL OBSTET HUM, V46, P701, DOI 10.1016/j.jogoh.2017.09.002; Chamberlain Allison T, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.d37b61bceebae5a7a06d40a301cfa819; Chambers CD, 2016, VACCINE, V34, P4443, DOI 10.1016/j.vaccine.2016.06.054; Ding H, 2017, MMWR-MORBID MORTAL W, V66, P1016, DOI 10.15585/mmwr.mm6638a2; Freund R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020900; Gaudelus J, PREVENTION VACCINALE; Haberg SE, 2013, NEW ENGL J MED, V368, P333, DOI 10.1056/NEJMoa1207210; Ko Hyun Sun, 2015, Obstet Gynecol Sci, V58, P81, DOI 10.5468/ogs.2015.58.2.81; Louik C, 2016, VACCINE, V34, P4450, DOI 10.1016/j.vaccine.2016.06.078; Maurici M, 2015, J MATERN-FETAL NEO M, P1; Mayet AY, 2017, SAUDI PHARM J, V25, P76, DOI 10.1016/j.jsps.2015.12.001; Napolitano F, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2138-2; Nunes MC, 2016, JAMA PEDIATR, V170, P840, DOI 10.1001/jamapediatrics.2016.0921; Tong A, 2008, J OBSTET GYNAECOL CA, V30, P404, DOI 10.1016/S1701-2163(16)32825-0; Vellozzi C, 2009, VACCINE, V27, P2114, DOI 10.1016/j.vaccine.2009.01.125; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018; Yudin MH, 2014, INT J WOMENS HEALTH, V6, P681, DOI 10.2147/IJWH.S47235; Yudin MH, 2009, J OBSTET GYNAECOL CA, V31, P120, DOI 10.1016/S1701-2163(16)34095-6; Yuen CYS, 2014, VACCINE, V32, P4602, DOI 10.1016/j.vaccine.2014.06.067; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	27	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236793	10.1371/journal.pone.0236793	http://dx.doi.org/10.1371/journal.pone.0236793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735607	Green Published, gold			2022-12-26	WOS:000569367100046
J	Lott, C; Eich, A; Unger, B; Makarow, D; Battagliarin, G; Schlegel, K; Lasut, MT; Weber, M				Lott, Christian; Eich, Andreas; Unger, Boris; Makarow, Dorothee; Battagliarin, Glauco; Schlegel, Katharina; Lasut, Markus T.; Weber, Miriam			Field and mesocosm methods to test biodegradable plastic film under marine conditions	PLOS ONE			English	Article							ENVIRONMENTAL DEGRADATION; CARRIER BAGS; POLYHYDROXYALKANOATES; SEA; POLYESTERS; ECOSYSTEM; BLENDS; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE); DETERIORATION; PENETRATION	The pollution of the natural environment, especially the world's oceans, with conventional plastic is of major concern. Biodegradable plastics are an emerging market bringing along potential chances and risks. The fate of these materials in the environment and their possible effects on organisms and ecosystems has rarely been studied systematically and is not well understood. For the marine environment, reliable field test methods and standards for assessing and certifying biodegradation to bridge laboratory respirometric data are lacking. In this work we present newly developed field tests to assess the performance of (biodegradable) plastics under natural marine conditions. These methods were successfully applied and validated in three coastal habitats (eulittoral, benthic and pelagic) and two climate zones (Mediterranean Sea and tropical Southeast Asia). Additionally, a stand-alone mesocosm test system which integrated all three habitats in one technical system at 400-L scale independent from running seawater is presented as a methodological bridge. Films of polyhydroxyalkanoate copolymer (PHA) and low density polyethylene (LD-PE) were used to validate the tests. While LD-PE remained intact, PHA disintegrated to a varying degree depending on the habitat and the climate zone. Together with the existing laboratory standard test methods, the field and mesocosm test systems presented in this work provide a 3-tier testing scheme for the reliable assessment of the biodegradation of (biodegradable) plastic in the marine environment. This toolset of tests can be adapted to other aquatic ecosystems.	[Lott, Christian; Eich, Andreas; Weber, Miriam] HYDRA Marine Sci GmbH, Sinzheim, Germany; [Unger, Boris; Makarow, Dorothee] HYDRA Fieldwork, Sulzburg, Germany; [Battagliarin, Glauco; Schlegel, Katharina] BASF SE, Ludwigshafen, Germany; [Lasut, Markus T.] UNSRAT, Manado, Sulawesi Utara, Indonesia	BASF	Weber, M (corresponding author), HYDRA Marine Sci GmbH, Sinzheim, Germany.	m.weber@hydramarinesciences.com	Lasut, Markus Talintukan/AAC-7127-2021	Lasut, Markus Talintukan/0000-0003-2087-1877; Lott, Christian/0000-0003-4799-6012; Eich, Andreas/0000-0002-9547-6487	Mediterranean Sea from the European Commission within the European Union's FP7 project "Open-Bio" in the Mediterranean Sea [KBBE/FP7EN/613677]; BASF in SE Asia	Mediterranean Sea from the European Commission within the European Union's FP7 project "Open-Bio" in the Mediterranean Sea; BASF in SE Asia(BASF)	The study is funded in part by the Mediterranean Sea from the European Commission under the grant agreement no. KBBE/FP7EN/613677 within the European Union's FP7 project "Open-Bio" in the Mediterranean Sea and by BASF in SE Asia. HYDRA Institut fur Meereswissenschaften AG (until 2018) provided support in the form of salaries for authors CL, AE, MW, BU, and DM, and provided research materials. HYDRA Marine Sciences GmbH (from 2019 on) provided support in the form of salaries for authors CL, AE, and MW, and provided research materials. HYDRA Fieldwork GbR (from 2019 on) provided support in the form of salaries for authors BU and DM, and provided research materials. BASF SE provided support in the form of salaries for authors KS and GB, and provided research materials and additional funding. The funders did not have any additional roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Accinelli C, 2012, CHEMOSPHERE, V89, P136, DOI 10.1016/j.chemosphere.2012.05.028; [Anonymous], 2000, 13432200012 DIN EN, DOI [10.31030/9010637., DOI 10.31030/9010637]; [Anonymous], 196792016 ISO; [Anonymous], 239772 ISOCD; [Anonymous], 153142018 ISO; [Anonymous], 239771 ISOCD; [Anonymous], 2015, D799115 ASTM INT, DOI [10.1520/D7991-15, DOI 10.1520/D7991-15]; [Anonymous], 170882012 ISO; [Anonymous], 2019, D6400 ASTM, DOI [10.1520/D6400-19., DOI 10.1520/D6400-19]; [Anonymous], 188302016 ISO; [Anonymous], 17033201803E DIN EN, DOI [10.31030/2692801, DOI 10.31030/2692801]; [Anonymous], 22766 ISO; [Anonymous], 2017, D669117 ASTM INT, DOI [10.1520/D6691-17, DOI 10.1520/D6691-17]; [Anonymous], 224042019 ISO; [Anonymous], 2012, D747312 ASTM INT, DOI [10.1520/D7473-12, DOI 10.1520/D7473-12]; Balestri E, 2017, SCI TOTAL ENVIRON, V605, P755, DOI 10.1016/j.scitotenv.2017.06.249; Beltran-Sanahuja A, 2020, ENVIRON POLLUT, V259, DOI 10.1016/j.envpol.2019.113836; Bergmann M., 2019, LITTERBASE; Billerbeck M, 2006, MAR ECOL PROG SER, V326, P61, DOI 10.3354/meps326061; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; Brandl H., 1992, BIODEGRADATION, V2, P237; BRESLIN VT, 1993, J APPL POLYM SCI, V48, P2063, DOI 10.1002/app.1993.070481201; Briassoulis D, 2019, SCI TOTAL ENVIRON, V688, P208, DOI 10.1016/j.scitotenv.2019.06.129; Burgstaller M, 2018, GUTACHTEN BEHANDLUNG; Chen X, 2011, POLYM POLYM COMPOSIT, V19; Deroine M, 2015, J POLYM ENVIRON, V23, P493, DOI 10.1007/s10924-015-0736-5; Deroine M, 2014, POLYM DEGRAD STABIL, V105, P237, DOI 10.1016/j.polymdegradstab.2014.04.026; DOI Y, 1992, POLYM DEGRAD STABIL, V36, P173, DOI 10.1016/0141-3910(92)90154-W; Dunne RP, 1996, MAR ECOL PROG SER, V144, P109, DOI 10.3354/meps144109; Eich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137201; European Commission, 2019, EUR GREEN DEAL; FLEISCHMANN EM, 1989, LIMNOL OCEANOGR, V34, P1623, DOI 10.4319/lo.1989.34.8.1623; Green DS, 2016, ENVIRON POLLUT, V208, P426, DOI 10.1016/j.envpol.2015.10.010; Green DS, 2015, ENVIRON SCI TECHNOL, V49, P5380, DOI 10.1021/acs.est.5b00277; Harrison JP, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171792; Heimowska A, 2017, POL J CHEM TECH, V19; Imam SH, 1999, APPL ENVIRON MICROB, V65, P431; IMAM SH, 1992, CURR MICROBIOL, V25, P1, DOI 10.1007/BF01570075; Kalogerakis N, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00084; KAPLAN DL, 1994, POLYM DEGRAD STABIL, V45, P165, DOI 10.1016/0141-3910(94)90133-3; Kershaw PJ, 2016, GESAMP REPORTS STUDI, V93; Kirstein IV, 2018, MAR ENVIRON RES, V142, P147, DOI 10.1016/j.marenvres.2018.09.028; Krasowska K, 2006, POLIMERY-W, V51, P21, DOI 10.14314/polimery.2006.021; Le Duigou A, 2009, POLYM DEGRAD STABIL, V94, P1151, DOI 10.1016/j.polymdegradstab.2009.03.025; Leonhardt I, 2015, MBIO, V6, DOI 10.1128/mBio.00143-15; Lott C, 2016, KBBEFP7EN613677 2; Lott C, 2016, KBBEFP7EN613677; Mayer JM, 1996, ACS SYM SER, V627, P159; MERGAERT J, 1995, CAN J MICROBIOL, V41, P154, DOI 10.1139/m95-182; Napper IE, 2019, ENVIRON SCI TECHNOL, V53, P4775, DOI 10.1021/acs.est.8b06984; Nazareth M, 2019, J HAZARD MATER, V366, P714, DOI 10.1016/j.jhazmat.2018.12.052; O'Brine T, 2010, MAR POLLUT BULL, V60, P2279, DOI 10.1016/j.marpolbul.2010.08.005; Oberbeckmann S, 2014, FEMS MICROBIOL ECOL, V90, P478, DOI 10.1111/1574-6941.12409; Pauli NC, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170549; PEGRAM JE, 1989, POLYM DEGRAD STABIL, V26, P333, DOI 10.1016/0141-3910(89)90112-2; Pelegrini K, 2016, J APPL POLYM SCI, V133, DOI 10.1002/app.43290; Ratto J.A., 2001, ACS SYM SER, V786, P316, DOI [10.1021/bk-2001-0786.ch020, DOI 10.1021/BK-2001-0786.CH020]; Ratto JA, 2011, BIODEGRADATION TOXIC; Rutkowska M, 1998, REACT FUNCT POLYM, V38, P27, DOI 10.1016/S1381-5148(98)00029-7; Rutkowska M, 2003, MACROMOL SYMP, V197, P421, DOI 10.1002/masy.200350736; Rutkowska M, 2002, POL J ENVIRON STUD, V11, P267; Rutkowska M, 2008, J POLYM ENVIRON, V16, P183, DOI 10.1007/s10924-008-0100-0; Salim YS, 2012, APPL BIOCHEM BIOTECH, V167, P314, DOI 10.1007/s12010-012-9688-6; Sangwan P, 2011, DEGRADABLE PLASTICS; Seggiani M, 2017, MATERIALS, V10, pNIL0043, DOI 10.3390/ma10040326; Sekiguchi T, 2011, POLYM DEGRAD STABIL, V96, P1397, DOI 10.1016/j.polymdegradstab.2011.03.004; Sridewi N, 2006, POLYM DEGRAD STABIL, V91, P2931, DOI 10.1016/j.polymdegradstab.2006.08.027; Stuparu D, 2015, TECHNICAL REPORT MAR; Thellen C, 2008, J POLYM ENVIRON, V16, P1, DOI 10.1007/s10924-008-0079-6; Tosin M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00225; Tsuji H, 2002, POLYM DEGRAD STABIL, V75, P357, DOI 10.1016/S0141-3910(01)00239-7; UNEP. Biodegradable Plastics and Marine Litter, 2015, BIOD PLAST MAR LITT, DOI [10.18356/1dc5344e-en, DOI 10.18356/1DC5344E-EN]; Voinova O, 2008, MACROMOL SYMP, V269, P34, DOI 10.1002/masy.200850906; Volova TG, 2007, POLYM DEGRAD STABIL, V92, P580, DOI 10.1016/j.polymdegradstab.2007.01.011; Volova TG, 2006, MICROBIOLOGY+, V75, P593, DOI 10.1134/S0026261706050092; Volova TG, 2010, POLYM DEGRAD STABIL, V95, P2350, DOI 10.1016/j.polymdegradstab.2010.08.023; Wellfair S, 2008, PLYMOUTH STUDENT SCI, V1, P243; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Zheng Y, 2005, CRIT REV BIOTECHNOL, V25, P243, DOI 10.1080/07388550500346359; Zumstein MT, 2019, ENVIRON SCI TECHNOL, V53, P9967, DOI 10.1021/acs.est.9b04513	80	16	16	7	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236579	10.1371/journal.pone.0236579	http://dx.doi.org/10.1371/journal.pone.0236579			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735596	gold, Green Published			2022-12-26	WOS:000569367100028
J	Park, KY; Lee, JJ; Dierker, D; Marple, LM; Hacker, CD; Roland, JL; Marcus, DS; Milchenko, M; Miller-Thomas, MM; Benzinger, TL; Shimony, JS; Snyder, AZ; Leuthardt, EC				Park, Ki Yun; Lee, John J.; Dierker, Donna; Marple, Laura M.; Hacker, Carl D.; Roland, Jarod L.; Marcus, Daniel S.; Milchenko, Mikhail; Miller-Thomas, Michelle M.; Benzinger, Tammie L.; Shimony, Joshua S.; Snyder, Abraham Z.; Leuthardt, Eric C.			Mapping language function with task-based vs. resting-state functional MRI	PLOS ONE			English	Article							BRAIN-TUMORS; CONNECTIVITY; FMRI; NETWORK; IMPLEMENTATION; SYSTEM; MOTOR; ORGANIZATION; ASSOCIATION; ACTIVATION	Background Use of functional MRI (fMRI) in pre-surgical planning is a non-invasive method for pre-operative functional mapping for patients with brain tumors, especially tumors located near eloquent cortex. Currently, this practice predominantly involves task-based fMRI (T-fMRI). Resting state fMRI (RS-fMRI) offers an alternative with several methodological advantages. Here, we compare group-level analyses of RS-fMRI vs. T-fMRI as methods for language localization. Purpose To contrast RS-fMRI vs. T-fMRI as techniques for localization of language function. Methods We analyzed data obtained in 35 patients who had both T-fMRI and RS-fMRI scans during the course of pre-surgical evaluation. The RS-fMRI data were analyzed using a previously trained resting-state network classifier. The T-fMRI data were analyzed using conventional techniques. Group-level results obtained by both methods were evaluated in terms of two outcome measures: (1) inter-subject variability of response magnitude and (2) sensitivity/specificity analysis of response topography, taking as ground truth previously reported maps of the language system based on intraoperative cortical mapping as well as meta-analytic maps of language task fMRI responses. Results Both fMRI methods localized major components of the language system (areas of Broca and Wernicke) although not with equal inter-subject consistency. Word-stem completion T-fMRI strongly activated Broca's area but also several task-general areas not specific to language. RS-fMRI provided a more specific representation of the language system. Conclusion We demonstrate several advantages of classifier-based mapping of language representation in the brain. Language T-fMRI activated task-general (i.e., not language-specific) functional systems in addition to areas of Broca and Wernicke. In contrast, classifier-based analysis of RS-fMRI data generated maps confined to language-specific regions of the brain.	[Park, Ki Yun; Lee, John J.; Dierker, Donna; Marple, Laura M.; Marcus, Daniel S.; Milchenko, Mikhail; Miller-Thomas, Michelle M.; Benzinger, Tammie L.; Shimony, Joshua S.; Snyder, Abraham Z.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA; [Hacker, Carl D.; Leuthardt, Eric C.] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO USA; [Roland, Jarod L.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California San Francisco	Shimony, JS (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA.	shimonyj@wustl.edu	Roland, Jarod L/J-1433-2019; Benzinger, Tammie/L-6104-2013	Roland, Jarod L/0000-0002-1312-8826; Benzinger, Tammie/0000-0002-8114-0552; Miller-Thomas, Michelle/0000-0002-1329-4031; Park, Ki Yun/0000-0003-2413-9421	National Cancer Institute of the National Institute for Health [R01CA203861]	National Cancer Institute of the National Institute for Health	ECL and JSS received funding from the National Cancer Institute of the National Institute for Health for its support via grant R01CA203861 (www.nih.gov) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baciu MV, 2005, NEURORADIOLOGY, V47, P835, DOI 10.1007/s00234-005-1431-3; Baldassarre A, 2014, BRAIN, V137, P3267, DOI 10.1093/brain/awu297; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Benjamin CF, 2017, HUM BRAIN MAPP, V38, P4239, DOI 10.1002/hbm.23661; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Borchers S, 2012, NAT REV NEUROSCI, V13, P63, DOI 10.1038/nrn3140; Branco P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00011; Brennan Nicole Petrovich, 2016, Top Magn Reson Imaging, V25, P1, DOI 10.1097/RMR.0000000000000074; Briganti C, 2012, AM J NEURORADIOL, V33, P1983, DOI 10.3174/ajnr.A3064; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Cohen RA, 1999, J NEUROPSYCH CLIN N, V11, P444, DOI 10.1176/jnp.11.4.444; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dierker D, 2017, NEUROIMAG CLIN N AM, V27, P621, DOI 10.1016/j.nic.2017.06.011; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Duffau H, 2011, WORLD NEUROSURG, V76, P525, DOI 10.1016/j.wneu.2011.07.040; Friederici AD, 2013, CURR OPIN NEUROBIOL, V23, P250, DOI 10.1016/j.conb.2012.10.002; Ghinda DC, 2018, NEUROSCI BIOBEHAV R, V84, P245, DOI 10.1016/j.neubiorev.2017.11.019; Gordon EM, 2017, NEURON, V95, P791, DOI 10.1016/j.neuron.2017.07.011; Haberg A, 2004, NEUROSURGERY, V54, P902, DOI 10.1227/01.NEU.0000114510.05922.F8; Hacker CD, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.9.FOCUS19656; Hacker CD, 2013, NEUROIMAGE, V82, P616, DOI 10.1016/j.neuroimage.2013.05.108; Hamberger MJ, 2014, EPILEPSIA, V55, P933, DOI 10.1111/epi.12644; Hart MG, 2018, NEUROSURGERY; Hugdahl K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00430; Joliot M, 2016, NEUROPSYCHOLOGIA, V93, P437, DOI 10.1016/j.neuropsychologia.2016.03.013; Jones OP, 2017, NEUROIMAGE-CLIN, V13, P378, DOI 10.1016/j.nicl.2016.12.028; Kahn E, 2017, J NEUROSURG, V127, P1461, DOI 10.3171/2017.3.JNS17659; Kamran M, 2014, NEUROIMAG CLIN N AM, V24, P655, DOI 10.1016/j.nic.2014.07.009; Kolling N, 2016, NAT NEUROSCI, V19, P1280, DOI 10.1038/nn.4382; Laumann TO, 2017, CEREB CORTEX, V27, P4719, DOI 10.1093/cercor/bhw265; Laumann TO, 2015, NEURON, V87, P657, DOI 10.1016/j.neuron.2015.06.037; Lee MS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040370, 10.1371/journal.pone.0035710]; Lemee JM, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1362; Leuthardt EC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198349; Lu JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14248-5; Mannfolk P, 2011, J MAGN RESON IMAGING, V34, P511, DOI 10.1002/jmri.22654; McGirt MJ, 2009, NEUROSURGERY, V65, P463, DOI 10.1227/01.NEU.0000349763.42238.E9; Mennes M, 2013, CEREB CORTEX, V23, P223, DOI 10.1093/cercor/bhs010; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Neta M, 2015, J NEUROSCI, V35, P253, DOI 10.1523/JNEUROSCI.1313-14.2015; Ojemann G, 2008, J NEUROSURG, V108, P411, DOI 10.3171/JNS/2008/108/2/0411; Poeppel D, 2012, J NEUROSCI, V32, P14125, DOI 10.1523/JNEUROSCI.3244-12.2012; Poldrack RA, 2016, ANNU REV PSYCHOL, V67, P587, DOI 10.1146/annurev-psych-122414-033729; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Raut RV, 2019, NEUROIMAGE, V194, P211, DOI 10.1016/j.neuroimage.2019.03.020; Roland JL, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101850; Roland JL, 2017, J NEUROSURG-PEDIATR, V20, P583, DOI 10.3171/2017.6.PEDS1711; Rosazza C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098860; Sair HI, 2016, HUM BRAIN MAPP, V37, P913, DOI 10.1002/hbm.23075; Sanai N, 2008, NEW ENGL J MED, V358, P18, DOI 10.1056/NEJMoa067819; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; Schneider FC, 2016, AM J NEURORADIOL, V37, P101, DOI 10.3174/ajnr.A4472; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Silva MA, 2018, NEUROIMAGE-CLIN, V17, P794, DOI 10.1016/j.nicl.2017.12.008; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476; Sun X, 2014, IEEE SIGNAL PROC LET, V21, P1389, DOI 10.1109/LSP.2014.2337313; Szaflarski JP, 2017, NEUROLOGY, V88, P395, DOI 10.1212/WNL.0000000000003532; Tanaka Naoaki, 2016, Top Magn Reson Imaging, V25, P19, DOI 10.1097/RMR.0000000000000073; Tie YM, 2014, HUM BRAIN MAPP, V35, P1018, DOI 10.1002/hbm.22231; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; Wang DH, 2015, NAT NEUROSCI, V18, P1853, DOI 10.1038/nn.4164; Woodworth GF, 2009, NEUROSURGERY, V64, P919, DOI 10.1227/01.NEU.0000341902.44760.10; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yeo BTT, 2015, CEREB CORTEX, V25, P3654, DOI 10.1093/cercor/bhu217	69	14	15	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236423	10.1371/journal.pone.0236423	http://dx.doi.org/10.1371/journal.pone.0236423			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735611	gold, Green Published			2022-12-26	WOS:000569367100023
J	Stears, K; Shrader, AM				Stears, Keenan; Shrader, Adrian M.			Coexistence between wildlife and livestock is contingent on cattle density and season but not differences in body size	PLOS ONE			English	Article							AFRICAN SAVANNAS; COMPETITION; FACILITATION; SELECTION; HABITAT; DEER; HERBIVORES; MANAGEMENT; DIVERSITY; INCREASES	Many studies on the coexistence of wildlife with livestock have focused primarily on similar-sized species. Furthermore, many of these studies have used dietary overlap as a measure of potential competition between interacting species and thus lack the important link between dietary overlap and any negative effects on a particular species-a prerequisite for competition. Consequently, the mechanisms that drive interspecific interactions between wildlife and cattle are frequently overlooked. To address this, we used an experimental setup where we leveraged different cattle stocking rates across two seasons to identify the drivers of interspecific interactions (i.e. competition and facilitation) between smaller-bodied oribi antelope and cattle. Using direct foraging observations, we assessed dietary overlap and grass regrowth, and also calculated oribi nutritional intake rates. Ultimately, we found that cattle compete with, and facilitate, smaller-bodied oribi antelope through bottom-up control. Specifically, cattle facilitated oribi during the wet season, irrespective of cattle stocking density, because cattle foraging produced high-quality grass regrowth. In contrast, during the dry season, cattle and oribi did not co-exist in the same areas (i.e. no direct dietary overlap). Despite this, we found that cattle foraging at high densities during the previous wet season reduced the dry season availability of oribi's preferred grass species. To compensate, oribi expanded their dry season diet breadth and included less palatable grass species, ultimately reducing their nutritional intake rates. Thus, cattle competed with oribi through a delayed, across-season habitat modification. We show that differences in body size alone may not be able to offset competitive interactions between cattle and wildlife. Finally, understanding the mechanisms that drive facilitation and competition are key to promoting coexistence between cattle and wildlife.	[Stears, Keenan] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Stears, Keenan] Kruger Natl Pk, Sci Serv, Ndlovu Node, South African Environm Observat Network, Phalaborwa, South Africa; [Stears, Keenan; Shrader, Adrian M.] Univ KwaZulu Natal, Scottsville, South Africa; [Shrader, Adrian M.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Pretoria, South Africa	University of California System; University of California Santa Barbara; National Research Foundation - South Africa; South African Environmental Observation Network (SAEON); University of Kwazulu Natal; University of Pretoria	Stears, K (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.; Stears, K (corresponding author), Kruger Natl Pk, Sci Serv, Ndlovu Node, South African Environm Observat Network, Phalaborwa, South Africa.; Stears, K (corresponding author), Univ KwaZulu Natal, Scottsville, South Africa.	keenanstears@ucsb.edu	Shrader, Adrian M/E-9472-2010	Shrader, Adrian M/0000-0002-6451-6132; Stears, Keenan/0000-0003-1012-5838	Rufford Small Grants Foundation [11001-1]; Ideal Wild; University of KwaZulu-Natal	Rufford Small Grants Foundation; Ideal Wild; University of KwaZulu-Natal	KS was supported by The Rufford Small Grants Foundation (11001-1), Ideal Wild and a Doctoral Research Grant from the University of KwaZulu-Natal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, R LANG ENV STAT COMP; Arsenault R, 2002, OIKOS, V97, P313, DOI 10.1034/j.1600-0706.2002.970301.x; Arsenault R, 2008, OIKOS, V117, P1711, DOI 10.1111/j.1600-0706.2008.16575.x; Arsenault R, 2011, CAN J ZOOL, V89, P900, DOI [10.1139/Z11-067, 10.1139/z11-067]; Augustine David J., 2011, Smithsonian Contributions to Zoology, P55; Bakker ES, 2009, BASIC APPL ECOL, V10, P141, DOI 10.1016/j.baae.2007.10.009; Bauchinger Ulf, 2012, P193; Beck JL, 2005, RANGELAND ECOL MANAG, V58, P135, DOI 10.2111/03-13.1; Bell R.H.V., 1970, ANIMAL POPULATIONS R, P111; Bhola N, 2012, BIODIVERS CONSERV, V21, P1509, DOI 10.1007/s10531-012-0261-y; Bonnet O, 2011, RANGELAND ECOL MANAG, V64, P366, DOI 10.2111/REM-D-10-00186.1; Breebaart L., 2002, African Journal of Range and Forage Science, V19, P13, DOI 10.2989/10220110209485770; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Butt B, 2012, PASTORALISM, V2, DOI 10.1186/2041-7136-2-9; Clements HS, 2019, J APPL ECOL, V56, P537, DOI 10.1111/1365-2664.13300; Codron D, 2011, EVOL ECOL RES, V13, P217; Coverdale B, 2006, ORIBI ANTELOPE OUREB; DARD, 2016, BEEF CATTL VELD; DeGabriel JL, 2011, J APPL ECOL, V48, P1269, DOI 10.1111/j.1365-2664.2011.02032.x; Derner JD, 2006, FRONT ECOL ENVIRON, V4, P459, DOI 10.1890/1540-9295(2006)4[459:ALWGAB]2.0.CO;2; Du Toit JT, 1999, BIODIVERS CONSERV, V8, P1643, DOI 10.1023/A:1008959721342; du Toit JT, 2017, RANGELAND SYSTEMS; Dunham KM, 2003, BIOL CONSERV, V113, P111, DOI 10.1016/S0006-3207(02)00354-3; DUTOIT JT, 1989, AM NAT, V133, P736, DOI 10.1086/284949; Evans GC., 1972, QUANTITATIVE ANAL PL; Fuhlendorf SD, 2001, BIOSCIENCE, V51, P625, DOI 10.1641/0006-3568(2001)051[0625:RHOREM]2.0.CO;2; Fynn RWS, 2016, J APPL ECOL, V53, P388, DOI 10.1111/1365-2664.12591; Gergs A, 2014, J ANIM ECOL, V83, P758, DOI 10.1111/1365-2656.12195; GORDON IJ, 1988, J APPL ECOL, V25, P1, DOI 10.2307/2403605; Grootenhuis JG, 2000, WILDLIFE CONSERVATIO, P382; Hobbs NT, 1996, ECOL APPL, V6, P200, DOI 10.2307/2269564; ILLIUS AW, 1987, J ANIM ECOL, V56, P989, DOI 10.2307/4961; Kimuyu DM, 2017, ECOL APPL, V27, P786, DOI 10.1002/eap.1482; Kutt AS, 2012, ANIM CONSERV, V15, P416, DOI 10.1111/j.1469-1795.2012.00530.x; Ludecke D., 2020, J OPEN SOURCE SOFTW; MEISSNER HH, 1983, CLASSIFICATION LIVES; Odadi WO, 2017, J APPL ECOL, V54, P935, DOI 10.1111/1365-2664.12785; Odadi WO, 2011, EVOL ECOL RES, V13, P237; Odadi WO, 2011, SCIENCE, V333, P1753, DOI 10.1126/science.1208468; Ottichilo W., 2000, WILDLIFE CONSERVATIO, P203, DOI [10.1007/978-94-011-4012-6, DOI 10.1007/978-94-011-4012-6]; Owen-Smith N., 1985, Transvaal Museum Monograph, P167; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; Owen-Smith RN., 2002, ADAPTIVE HERBIVORE E, VStudent; OWENSMITH N, 1993, 17 INT GRASSL C NZ G, P00691; Prins H.H.T., 1998, P449; Prins Herbert H.T., 2000, Conservation Biology Series (Dordrecht), V12, P51; Ranglack DH, 2015, J APPL ECOL, V52, P467, DOI 10.1111/1365-2664.12386; RUYLE GB, 1985, J ANIM SCI, V61, P349, DOI 10.2527/jas1985.612349x; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; SHENK JS, 1991, CROP SCI, V31, P469, DOI 10.2135/cropsci1991.0011183X003100020049x; Shrader A.M., 2016, RED LIST MAMMALS S A; Stears K, 2015, ANIM BEHAV, V108, P155, DOI 10.1016/j.anbehav.2015.07.012; Stewart KEJ, 2001, J APPL ECOL, V38, P1148, DOI 10.1046/j.1365-2664.2001.00658.x; Treydte AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082831; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; Verweij RJT, 2006, OIKOS, V114, P108, DOI 10.1111/j.2006.0030-1299.14209.x; VESEY-FITZGERALD DESMOND F., 1960, JOUR MAMMAL, V41, P161, DOI 10.2307/1376351; Voeten MM, 1999, OECOLOGIA, V120, P287, DOI 10.1007/s004420050860; WALKER B H, 1976, South African Journal of Wildlife Research, V6, P1; WESTERN D, 1993, AFR J ECOL, V31, P269, DOI 10.1111/j.1365-2028.1993.tb00541.x; Young TP, 2005, BIOL CONSERV, V122, P351, DOI 10.1016/j.biocon.2004.08.007	61	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236895	10.1371/journal.pone.0236895	http://dx.doi.org/10.1371/journal.pone.0236895			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735578	gold, Green Published			2022-12-26	WOS:000569367100059
J	Wang, JX; Shen, P; Liao, S; Duan, L; Zhu, DD; Chen, JL; Chen, LT; Sun, XL; Duan, YN				Wang, Jianxin; Shen, Pei; Liao, Sha; Duan, Lian; Zhu, Dandan; Chen, Jinling; Chen, Liuting; Sun, Xiaolei; Duan, Yinong			Selenoprotein P inhibits cell proliferation and ROX production in HCC cells	PLOS ONE			English	Article							DOWN-REGULATION; EXPRESSION; SELENIUM; ACCUMULATION; ALPHA; SEPP1	Selenoprotein P (SEPP1) is a kind of secretory glycoproteins with an antioxidant effect during the development of some diseases. In this study, we attempted to observe the expression of SEPP1 in livers from the patients with hepatocellular carcinoma (HCC) and explore its effect on HCC cells. All the tissues from patients with HCC were obtained from Affiliated Hospital of Nantong University. Western blot and immunohistochemical results showed that SEPP1 was reduced in HCC liver tissues. Its expression was negatively correlated with Ki67 expression in tissues. The expression of SEPP1 in normal liver cell line was significantly higher than those in the liver cancer cell lines. Serum starvation and release experiment demonstrated that SEPP1 expression was reduced and PCNA expression was increased, when the serum was re-added into cell culture system and the cells were on a proliferation state. After SEPP1 over-expression plasmid was transfected into HepG2 cells, cell proliferation of HepG2 cells and PCNA expression level were all inhibited by SEPP1. Results obtained via 8-isoprostane ELISA further indicated that inhibited ROS level was found in HepG2 cells transfected with SEPP1 over-expression plasmid. In addition, RT-qPCR results demonstrated that GPX1 expression levels increased in HepG2 cells transfected with SEPP1 over-expression plasmid. In conclusion, SEPP1 may inhibit the proliferation of HCC cells, accompanied by the reduction of ROS production and the increasing of GPX1 expression.	[Wang, Jianxin; Shen, Pei; Liao, Sha] Nantong Univ, Affiliated Hosp, Dept Lab Med, Nantong, Jiangsu, Peoples R China; [Duan, Lian] Nantong Univ, Sch Med, Dept Med Informat, Nantong, Jiangsu, Peoples R China; [Zhu, Dandan; Chen, Jinling; Chen, Liuting; Sun, Xiaolei; Duan, Yinong] Nantong Univ, Sch Med, Dept Pathogen Biol, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University; Nantong University	Wang, JX (corresponding author), Nantong Univ, Affiliated Hosp, Dept Lab Med, Nantong, Jiangsu, Peoples R China.; Duan, YN (corresponding author), Nantong Univ, Sch Med, Dept Pathogen Biol, Nantong, Jiangsu, Peoples R China.	wwbft@126.com; yinongduan@aliyun.com	Duan, yinong/GSD-9438-2022; zhu, dd885/GRO-1645-2022	Duan, Yinong/0000-0001-5824-5762	National Natural Science Foundation of China [81871677]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Natural Science Foundation of China (YND, Grant Numbers 81871677) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademowo OS, 2017, FREE RADICAL BIO MED, V108, P77, DOI 10.1016/j.freeradbiomed.2017.03.008; Al-Taie OH, 2004, NUTR CANCER, V48, P6, DOI 10.1207/s15327914nc4801_2; Barrett CW, 2015, J CLIN INVEST, V125, P2646, DOI 10.1172/JCI76099; Barrett CW, 2013, CANCER RES, V73, P1245, DOI 10.1158/0008-5472.CAN-12-3150; Calvo A, 2002, CANCER RES, V62, P5325; Cao Y, 2017, ONCOL LETT, V13, P4109, DOI 10.3892/ol.2017.5999; Czaja MJ, 2002, ANTIOXID REDOX SIGN, V4, P759, DOI 10.1089/152308602760598909; Dreher I, 1997, J BIOL CHEM, V272, P29364, DOI 10.1074/jbc.272.46.29364; Eckers JC, 2013, INT J RADIAT ONCOL, V87, P619, DOI 10.1016/j.ijrobp.2013.06.2063; Gonzalez-Moreno O, 2011, PROSTATE, V71, P824, DOI 10.1002/pros.21298; Gresner P, 2009, LUNG CANCER, V65, P34, DOI 10.1016/j.lungcan.2008.10.023; Hill KE, 2012, J BIOL CHEM, V287, P40414, DOI 10.1074/jbc.M112.421404; Huang W, 2016, PATHOL RES PRACT, V212, P171, DOI 10.1016/j.prp.2015.11.015; Kastl Lena, 2014, Free Radic Biol Med, V75 Suppl 1, pS32, DOI 10.1016/j.freeradbiomed.2014.10.765; Li CL, 2007, WORLD J GASTROENTERO, V13, P2363, DOI 10.3748/wjg.v13.i16.2363; Meplan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073316; Meyer HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046644; Moro T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146592; Rajendran J, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809456; Rohr-Udilova N, 2012, HEPATOLOGY, V55, P1112, DOI 10.1002/hep.24808; Steinbrenner H, 2006, FREE RADICAL RES, V40, P936, DOI 10.1080/10715760600806248; Traulsen H, 2004, FREE RADICAL RES, V38, P123, DOI 10.1080/10715760320001634852; Wu JH, 2015, ONCOL LETT, V10, P2347, DOI 10.3892/ol.2015.3621; Xiao WS, 2013, FREE RADICAL BIO MED, V65, P70, DOI 10.1016/j.freeradbiomed.2013.06.010; Yi YS, 2003, BBA-MOL BASIS DIS, V1638, P249, DOI 10.1016/S0925-4439(03)00090-5; Yin JX, 2018, J MOL RECOGNIT, V31, DOI 10.1002/jmr.2714; Yuan K, 2016, CELL DEATH DIFFER, V23, P616, DOI 10.1038/cdd.2015.129; Zhang YY, 2011, AM J PHYSIOL-ENDOC M, V300, pE77, DOI 10.1152/ajpendo.00380.2010; Zhou XD, 2012, J NUTR BIOCHEM, V23, P532, DOI 10.1016/j.jnutbio.2011.02.008	29	3	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236491	10.1371/journal.pone.0236491	http://dx.doi.org/10.1371/journal.pone.0236491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735635	Green Published, gold			2022-12-26	WOS:000569367100024
J	Laverde, EE; Lai, YH; Leng, FF; Balakrishnan, L; Freudenreich, CH; Liu, Y				Laverde, Eduardo E.; Lai, Yanhao; Leng, Fenfei; Balakrishnan, Lata; Freudenreich, Catherine H.; Liu, Yuan			R-loops promote trinucleotide repeat deletion through DNA base excision repair enzymatic activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						R-loops; trinucleotide repeat instability; base excision repair; DNA base damage; DNA repair; DNA damage; DNA endonuclease; DNA polymerase; DNA structure	RNASE-H; EXPANSION; TRANSCRIPTION; INSTABILITY; MECHANISM; HYBRIDS; ONSET	Trinucleotide repeat (TNR) expansion and deletion are responsible for over 40 neurodegenerative diseases and associated with cancer. TNRs can undergo somatic instability that is mediated by DNA damage and repair and gene transcription. Recent studies have pointed toward a role for R-loops in causing TNR expansion and deletion, and it has been shown that base excision repair (BER) can result in CAG repeat deletion from R-loops in yeast. However, it remains unknown how BER in R-loops can mediate TNR instability. In this study, using biochemical approaches, we examined BER enzymatic activities and their influence on TNR R-loops. We found that AP endonuclease 1 incised an abasic site on the nontemplate strand of a TNR R-loop, creating a double-flap intermediate containing an RNA:DNA hybrid that subsequently inhibited polymerase beta (pol beta) synthesis of TNRs. This stimulated flap endonuclease 1 (FEN1) cleavage of TNRs engaged in an R-loop. Moreover, we showed that FEN1 also efficiently cleaved the RNA strand, facilitating pol beta loop/hairpin bypass synthesis and the resolution of TNR R-loops through BER. Consequently, this resulted in fewer TNRs synthesized by pol beta than those removed by FEN1, thereby leading to repeat deletion. Our results indicate that TNR R-loops preferentially lead to repeat deletion during BER by disrupting the balance between the addition and removal of TNRs. Our discoveries open a new avenue for the treatment and prevention of repeat expansion diseases and cancer.	[Laverde, Eduardo E.; Leng, Fenfei; Liu, Yuan] Florida Int Univ, Biochem PhD Program, Miami, FL 33199 USA; [Lai, Yanhao; Leng, Fenfei; Liu, Yuan] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Leng, Fenfei; Liu, Yuan] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA; [Balakrishnan, Lata] Indiana Purdue Univ Indianapolis, Dept Biol, Indiana, PA USA; [Freudenreich, Catherine H.] Tufts Univ, Dept Biol, Medford, MA USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University; State University System of Florida; Florida International University; Tufts University	Liu, Y (corresponding author), Florida Int Univ, Biochem PhD Program, Miami, FL 33199 USA.; Liu, Y (corresponding author), Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA.; Liu, Y (corresponding author), Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA.	yualiu@fiu.edu		Freudenreich, Catherine/0000-0002-1652-2917	National Institutes of Health [R01ES023569, 1R21AI125973-01A1]; Florida International University; National Science Foundation [MCB1817499, 1929346]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida International University; National Science Foundation(National Science Foundation (NSF))	This study was supported by National Institutes of Health Grant R01ES023569 (to Y. Liu). E. L. was supported by a Florida International UniversityMcNair Graduate Fellowship and Dissertation Year Fellowship. C. H. F. was supported by National Science Foundation Grant MCB1817499. F. L. was supported by National Institutes of Health Grant 1R21AI125973-01A1. L. B. was supported by National Science Foundation Grant 1929346. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Altinoz MA, 2016, CLIN TRANSL ONCOL, V18, P9, DOI 10.1007/s12094-015-1356-1; Beaver JM, 2016, DNA REPAIR, V48, P17, DOI 10.1016/j.dnarep.2016.10.006; Beaver JM, 2015, NUCLEIC ACIDS RES, V43, P5948, DOI 10.1093/nar/gkv530; Becherel OJ, 2015, HUM MOL GENET, V24, P5759, DOI 10.1093/hmg/ddv296; Bettencourt C, 2016, ANN NEUROL, V79, P983, DOI 10.1002/ana.24656; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Garcia-Muse T, 2019, CELL, V179, P604, DOI 10.1016/j.cell.2019.08.055; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004318; Grunseich C, 2018, MOL CELL, V69, P426, DOI 10.1016/j.molcel.2017.12.030; Keijzers G, 2016, CRIT REV BIOCHEM MOL, V51, P440, DOI 10.1080/10409238.2016.1215407; Keum JW, 2016, AM J HUM GENET, V98, P287, DOI 10.1016/j.ajhg.2015.12.018; Khristich AN, 2020, J BIOL CHEM, V295, P4134, DOI 10.1074/jbc.REV119.007678; Lai YH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12465; Lai YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056960; Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003; Lin YF, 2011, CELL CYCLE, V10, P611, DOI 10.4161/cc.10.4.14729; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Liu Y, 2012, TRENDS BIOCHEM SCI, V37, P162, DOI 10.1016/j.tibs.2011.12.002; Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286; Loomis EW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004294; MCMURRAY CT, 1995, CHROMOSOMA, V104, P2; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Neil AJ, 2018, NUCLEIC ACIDS RES, V46, P3487, DOI 10.1093/nar/gky099; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; Reddy K, 2014, NUCLEIC ACIDS RES, V42, P10473, DOI 10.1093/nar/gku658; Reddy K, 2011, NUCLEIC ACIDS RES, V39, P1749, DOI 10.1093/nar/gkq935; Ren Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177299; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Su XFA, 2017, P NATL ACAD SCI USA, V114, pE8392, DOI 10.1073/pnas.1711283114; Tang W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001270; Thion MS, 2018, J HUNTINGTONS DIS, V7, P201, DOI 10.3233/JHD-180290; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; Xu M, 2014, NUCLEIC ACIDS RES, V42, P3675, DOI 10.1093/nar/gkt1372; Xu Meng, 2013, Nucleic Acids Res, V41, P1684, DOI 10.1093/nar/gks1306; Zhan XY, 1997, J BIOL CHEM, V272, P22023, DOI 10.1074/jbc.272.35.22023; Zhao XN, 2018, DNA REPAIR, V69, P1, DOI 10.1016/j.dnarep.2018.07.001; Zhao XN, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007719	39	7	7	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2020	295	40					13902	13913		10.1074/jbc.RA120.014161	http://dx.doi.org/10.1074/jbc.RA120.014161			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OB4MB	32763971	Green Published, hybrid			2022-12-26	WOS:000578444100016
J	Byun, JS; Oh, M; Lee, S; Gil, JE; Mo, Y; Ku, B; Kim, WK; Oh, KJ; Lee, EW; Bae, KH; Lee, SC; Han, BS				Byun, Jeong Su; Oh, Mihee; Lee, Seonha; Gil, Jung-Eun; Mo, Yeajin; Ku, Bonsu; Kim, Won-Kon; Oh, Kyoung-Jin; Lee, Eun-Woo; Bae, Kwang-Hee; Lee, Sang Chul; Han, Baek-Soo			The transcription factor PITX1 drives astrocyte differentiation by regulating the SOX9 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						astrocyte; gliogenesis; human embryonic stem cell; transcription factor; paired-like homeodomain transcription factor 1 (PITX1); sex-determining region Y box 9 (SOX9); glial cell; neural stem cell (NSC); cell differentiation	STEM-CELLS; ASTROGLIAL SUBTYPES; IN-VITRO; EXPRESSION; HINDLIMB; GFAP; SPECIFICATION; INITIATION; DEFINES; EMBRYO	Astrocytes perform multiple essential functions in the developing and mature brain, including regulation of synapse formation, control of neurotransmitter release and uptake, and maintenance of extracellular ion balance. As a result, astrocytes have been implicated in the progression of neurodegenerative disorders such as Alzheimer's disease, Huntington's disease, and Parkinson's disease. Despite these critical functions, the study of human astrocytes can be difficult because standard differentiation protocols are time-consuming and technically challenging, but a differentiation protocol recently developed in our laboratory enables the efficient derivation of astrocytes from human embryonic stem cells. We used this protocol along with microarrays, luciferase assays, electrophoretic mobility shift assays, and ChIP assays to explore the genes involved in astrocyte differentiation. We demonstrate that paired-like homeodomain transcription factor 1 (PITX1) is critical for astrocyte differentiation. PITX1 overexpression induced early differentiation of astrocytes, and its knockdown blocked astrocyte differentiation. PITX1 overexpression also increased and PITX1 knockdown decreased expression of sex-determining region Y box 9 (SOX9), known initiator of gliogenesis, during early astrocyte differentiation. Moreover, we determined that PITX1 activates the SOX9 promoter through a unique binding motif. Taken together, these findings indicate that PITX1 drives astrocyte differentiation by sustaining activation of the SOX9 promoter.	[Byun, Jeong Su; Oh, Mihee; Lee, Seonha; Gil, Jung-Eun; Han, Baek-Soo] Korea Res Inst Biosci & Biotechnol, Biodef Res Ctr, Daejeon, South Korea; [Mo, Yeajin; Ku, Bonsu] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea; [Kim, Won-Kon; Oh, Kyoung-Jin; Lee, Eun-Woo; Bae, Kwang-Hee; Lee, Sang Chul] Korea Res Inst Biosci & Biotechnol, Metab Regulat Res Ctr, Daejeon, South Korea; [Lee, Seonha; Kim, Won-Kon; Oh, Kyoung-Jin; Bae, Kwang-Hee; Lee, Sang Chul; Han, Baek-Soo] Univ Sci & Technol Korea, Dept Funct Genom, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST)	Han, BS (corresponding author), Korea Res Inst Biosci & Biotechnol, Biodef Res Ctr, Daejeon, South Korea.; Han, BS (corresponding author), Univ Sci & Technol Korea, Dept Funct Genom, Daejeon, South Korea.	bshan@kribb.re.kr	Oh, Kyoung-Jin/AAV-1483-2021	Oh, Kyoung-Jin/0000-0002-2224-7202; Ku, Bonsu/0000-0003-1784-8975	Korea Research Institute of Bioscience and Biotechnology Research Initiative Programme [KGM5321911, KGM1121911]; Korea National Research of Foundation [2013M3A9A7046301, 2017R1E1A1A01074745]	Korea Research Institute of Bioscience and Biotechnology Research Initiative Programme; Korea National Research of Foundation	This work was partly supported by Korea Research Institute of Bioscience and Biotechnology Research Initiative Programme Grants KGM5321911 and KGM1121911 and the Korea National Research of Foundation Grants 2013M3A9A7046301 and 2017R1E1A1A01074745.	BARGER SW, 1992, BIOCHIM BIOPHYS ACTA, V1160, P105, DOI 10.1016/0167-4838(92)90043-D; Byun JS, 2020, NEUROSCI LETT, V716, DOI 10.1016/j.neulet.2019.134681; Cai N, 2012, CEREBELLUM, V11, P181, DOI 10.1007/s12311-011-0294-x; Cao Z, 2016, BMB REP, V49, P548, DOI 10.5483/BMBRep.2016.49.10.071; Davies SJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017328; Del Rio JA, 2000, CEREB CORTEX, V10, P784, DOI 10.1093/cercor/10.8.784; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Duboc V, 2011, DEVELOPMENT, V138, P5301, DOI 10.1242/dev.074153; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Farhy-Tselnicker I, 2018, NEURAL DEV, V13, DOI 10.1186/s13064-018-0104-y; Garwood CJ, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.50; Gu XL, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-12; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Infante CR, 2013, DEV BIOL, V374, P234, DOI 10.1016/j.ydbio.2012.11.017; Island ML, 2002, MOL CELL BIOL, V22, P7120, DOI 10.1128/MCB.22.20.7120-7133.2002; Jo A, 2014, GENES DIS, V1, P149, DOI 10.1016/j.gendis.2014.09.004; Kang P, 2012, NEURON, V74, P79, DOI 10.1016/j.neuron.2012.01.024; Khakh BS, 2014, ACS CHEM NEUROSCI, V5, P494, DOI 10.1021/cn500100r; Klum S, 2018, EMBO REP, V19, DOI 10.15252/embr.201846635; Krencik R, 2011, NAT PROTOC, V6, P1710, DOI 10.1038/nprot.2011.405; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Lanctot C, 1997, DEVELOPMENT, V124, P2807; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Mandal A, 2006, DIFFERENTIATION, V74, P81, DOI 10.1111/j.1432-0436.2006.00051.x; Marinaro C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019419; Martini S, 2013, STEM CELLS, V31, P741, DOI 10.1002/stem.1320; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Mertens J, 2016, NAT REV NEUROSCI, V17, P424, DOI 10.1038/nrn.2016.46; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Ohira T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217605; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Phatnani H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020628; Prevostel C, 2017, EUR J CANCER, V86, P150, DOI 10.1016/j.ejca.2017.08.037; Prince KL, 2011, NAT REV ENDOCRINOL, V7, P727, DOI 10.1038/nrendo.2011.119; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; Shaltouki A, 2013, STEM CELLS, V31, P941, DOI 10.1002/stem.1334; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Song I, 2016, BMB REP, V49, P343, DOI 10.5483/BMBRep.2016.49.6.032; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Swistowski A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006233; Szeto DP, 1996, P NATL ACAD SCI USA, V93, P7706, DOI 10.1073/pnas.93.15.7706; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Tabata H, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00114; TREISMAN J, 1989, CELL, V59, P553; Ushita M, 2009, OSTEOARTHR CARTILAGE, V17, P1065, DOI 10.1016/j.joca.2009.02.003; von Bartheld CS, 2016, J COMP NEUROL, V524, P3865, DOI 10.1002/cne.24040; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Zhao XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109171	53	5	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2020	295	39					13677	13690		10.1074/jbc.RA120.013352	http://dx.doi.org/10.1074/jbc.RA120.013352			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NY3VI	32759168	Green Published, hybrid			2022-12-26	WOS:000576321100020
J	Boorgula, GDY; Peterson, AT; Foley, DH; Ganta, RR; Raghavan, RK				Boorgula, Gunavanthi D. Y.; Peterson, A. Townsend; Foley, Desmond H.; Ganta, Roman R.; Raghavan, Ram K.			Assessing the current and future potential geographic distribution of the American dog tick,Dermacentor variabilis(Say) (Acari: Ixodidae) in North America	PLOS ONE			English	Article							DERMACENTOR-VARIABILIS; ANAPLASMA-MARGINALE; BOVINE ANAPLASMOSIS; IXODES-RICINUS; CLIMATE-CHANGE; TICK; PATHOGENS; SAY	The American dog tick,Dermacentor variabilis, is a veterinary- and medically- significant tick species that is known to transmit several diseases to animal and human hosts. The spatial distribution of this species in North America is not well understood, however; and knowledge of likely changes to its future geographic distribution owing to ongoing climate change is needed for proper public health planning and messaging. Two recent studies have evaluated these topics forD.variabilis; however, less-rigorous modeling approaches in those studies may have led to erroneous predictions. We evaluated the present and future distribution of this species using a correlative maximum entropy approach, using publicly available occurrence information. Future potential distributions were predicted under two representative concentration pathway (RCP) scenarios; RCP 4.5 for low-emissions and RCP 8.5 for high-emissions. Our results indicated a broader current distribution of this species in all directions relative to its currently known extent, and dramatic potential for westward and northward expansion of suitable areas under both climate change scenarios. Implications for disease ecology and public health are discussed.	[Boorgula, Gunavanthi D. Y.; Ganta, Roman R.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA; [Peterson, A. Townsend] Univ Kansas, Coll Liberal Arts & Sci, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Foley, Desmond H.] Natl Museum Hist, Walter Reed Biosystemat Unit, Dept Entomol, Washington, DC USA; [Raghavan, Ram K.] Univ Missouri, Coll Vet Med, Ctr Vector Borne & Emerging Infect Dis, Dept Vet Pathobiol, Columbia, SC 29210 USA; [Raghavan, Ram K.] Univ Missouri, Coll Vet Med, Ctr Vector Borne & Emerging Infect Dis, Dept Publ Hlth, Columbia, SC 29210 USA; [Raghavan, Ram K.] Univ Missouri, Sch Hlth Profess, Columbia, SC 29210 USA; [Boorgula, Gunavanthi D. Y.] Univ Texas Tyler, Hlth Sci Ctr, Ctr Biomed Res, Dept Pulm Immunol, Tyler, TX 75799 USA	Kansas State University; University of Kansas; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Raghavan, RK (corresponding author), Univ Missouri, Coll Vet Med, Ctr Vector Borne & Emerging Infect Dis, Dept Vet Pathobiol, Columbia, SC 29210 USA.; Raghavan, RK (corresponding author), Univ Missouri, Coll Vet Med, Ctr Vector Borne & Emerging Infect Dis, Dept Publ Hlth, Columbia, SC 29210 USA.; Raghavan, RK (corresponding author), Univ Missouri, Sch Hlth Profess, Columbia, SC 29210 USA.	RaghavanRK@missouri.edu		Raghavan, Ram/0000-0002-2657-3398	National Institutes of Allergy and Infectious Disease [AI070908]; National Science Foundation [IIA-1920946]	National Institutes of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF))	RG. PHS grant number AI070908. National Institutes of Allergy and Infectious Disease. TP; RR. (IIA-1920946). National Science Foundation.	Alderink Fred J., 1983, B TEXAS AGR EXPT STA; Alkishe AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189092; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; BISHOPP FC, 1945, J PARASITOL, V31, P1, DOI 10.2307/3273061; CAMPBELL A, 1979, ENVIRON ENTOMOL, V8, P734, DOI 10.1093/ee/8.4.734; CDC, 2019, TULAREMIA; CDC, 2019, GEOGR DISTR TICKS BI; Cobos ME, 2019, PEERJ, V7, DOI 10.7717/peerj.6281; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Escobar LE, 2014, GEOSPATIAL HEALTH, V9, P221, DOI 10.4081/gh.2014.19; Estrada-Pena A, 2003, ECOGRAPHY, V26, P661, DOI 10.1034/j.1600-0587.2003.03530.x; Estrada-Pena A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00029; Estrada-Pena A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00064; Estrada-Pena A, 2008, PARASITOL RES, V103, pS87, DOI 10.1007/s00436-008-1056-7; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Furman DP, 1984, B CALIFORNIA INSECT; GOODGER WJ, 1979, J AM VET MED ASSOC, V174, P1333; Gray JS, 2009, INTERDISCIP PERSPECT; Guzman-Cornejo C, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.569.7221; Hall MC, 1917, J AM VET MED ASS, V51; Halos L, 2010, APPL ENVIRON MICROB, V76, P4413, DOI 10.1128/AEM.00610-10; Hanzlicek GA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151924; Holden K, 2003, J MED ENTOMOL, V40, P534, DOI 10.1603/0022-2585-40.4.534; Hooker WA, 1909, J ECON ENTOMOL, V2, P403, DOI 10.1093/jee/2.6.403; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8; James AM, 2015, MED VET ENTOMOL, V29, P178, DOI 10.1111/mve.12099; Jore S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-84; KOCAN KM, 1981, AM J VET RES, V42, P15; Kollars TM, 2000, EXP APPL ACAROL, V24, P631, DOI 10.1023/A:1026566301325; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; MacArthur R.H., 1972, pvii; Matheson R, 1950, MED ENTOMOLOGY; MCENROE W D, 1975, Acarologia (Paris), V17, P208; Medlock JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-1; Minigan JN, 2018, TICKS TICK-BORNE DIS, V9, P354, DOI 10.1016/j.ttbdis.2017.11.012; Ogden NH, 2008, J THEOR BIOL, V254, P621, DOI 10.1016/j.jtbi.2008.06.020; Okafor CC, 2018, VET PARASITOL REG ST, V14, P32, DOI 10.1016/j.vprsr.2018.08.004; Owens HL, 2013, ECOLOGICAL MODELLING; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2017, J MED ENTOMOL, V54, P1103, DOI 10.1093/jme/tjx097; Peterson AT, 2017, J MED ENTOMOL, V54, P1080, DOI 10.1093/jme/tjx095; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2013, ECOLOGY, V94, P1409, DOI 10.1890/12-1520.1; Raghavan RK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209082; Raghavan RK, 2016, VECTOR-BORNE ZOONOT, V16, P569, DOI 10.1089/vbz.2016.1975; Raghavan RK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150180; Raghavan RK, 2013, VECTOR-BORNE ZOONOT, V13, P449, DOI 10.1089/vbz.2012.1234; Schriefer Martin E., 1994, P314; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Suss J, 2008, J TRAVEL MED, V15, P39, DOI 10.1111/j.1708-8305.2007.00176.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; WILKINSON PR, 1967, CAN J ZOOLOG, V45, P517, DOI 10.1139/z67-066; WINER L. H., 1941, JOUR INVEST DERMAT, V4, P249, DOI 10.1038/jid.1941.25; Yunik MEM, 2016, CAN J VET RES, V80, P171	57	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0237191	10.1371/journal.pone.0237191	http://dx.doi.org/10.1371/journal.pone.0237191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32776959	Green Published, gold			2022-12-26	WOS:000561393800010
J	Che, DH; Yang, ZR; Wei, H; Wang, XD; Gao, JY				Che, Dehong; Yang, Zhirong; Wei, Hong; Wang, Xuedong; Gao, Jiayin			The Adler grade by Doppler ultrasound is associated with clinical pathology of cervical cancer: Implication for clinical management	PLOS ONE			English	Article							DIAGNOSIS; PREDICTION; CA19-9; CA125	Objective To analyze the relationship of Adler grade by transvaginal color Doppler flow imaging (TV-CDFI) and the clinical pathological parameters of patients with cervical cancer, and to identify the value of Adler grade in the diagnosis and treatment of cervical cancer. Methods Patients with cervical cancer diagnosed pathologically in our hospital from January 1, 2019 to December 31, 2019 were included, All patients underwent TV-CDFI examination, and the images were divided into 0 to III grades according to the Adler grades, and the correlations between the Adler classification and clinical pathological parameters (clinical stage, mass size, pathological type, squamous cell carcinoma subtype, CA125, CA199) were analyzed. Results A total of 162 patients with cervical cancer were included. With the increase of Adler severity, the clinical stage of cervical cancer increased accordingly. the cancer size differed significantly in patients with different Adler grade (p = 0.004); There were significant differences in the level of CA125, CA199 between the squamous cell carcinoma and adenocarcinoma (all p<0.05). the Adler grade was positively related with the clinical stage, pathological type and squamous cell carcinoma subtypes of cervical cancer (all p<0.05), no correlations were found among the Adler grade and the cancer size, CA125, CA199 (all p>0.05). The area under ROC curve of the cervical squamous cell carcinoma predicted by Adler grade based on FIGO results and pathological results was 0.811and 0.762 respectively (all p<0.05). Conclusions Adler grades are closely associated with the clinical pathology of cervical cancer, which may be a convenient and effective approach for the assisting assessment of cervical cancer.	[Che, Dehong; Gao, Jiayin] Harbin Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 2, Harbin, Peoples R China; [Yang, Zhirong] Harbin Red Cross Ctr Hosp, Dept Ultrasound, Harbin, Peoples R China; [Wei, Hong] Harbin Med Univ, Affiliated Hosp 2, Dept Ultrasound, Harbin, Peoples R China; [Wang, Xuedong] Daqing Gen Hosp, Longnan Hosp, Dept Obstet & Gynecol, Daqing, Peoples R China	Harbin Medical University; Harbin Medical University	Gao, JY (corresponding author), Harbin Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 2, Harbin, Peoples R China.	dsp082901@163.com						ADLER DD, 1990, ULTRASOUND MED BIOL, V16, P553, DOI 10.1016/0301-5629(90)90020-D; Arya S, 2017, J PERINAT MED, V45, P745, DOI 10.1515/jpm-2016-0361; Bhatla N, 2019, INT J GYNECOL OBSTET, V145, P129, DOI 10.1002/ijgo.12749; Charakorn C, 2018, GYNECOL ONCOL, V150, P190, DOI 10.1016/j.ygyno.2018.03.056; Cibula D, 2018, RADIOTHER ONCOL, V127, P404, DOI 10.1016/j.radonc.2018.03.003; Cohen PA, 2019, LANCET, V393, P169, DOI 10.1016/S0140-6736(18)32470-X; COUTLEE F, 1991, MOL CELL PROBE, V5, P241, DOI 10.1016/0890-8508(91)90046-M; Ebina Y, 2019, INT J CLIN ONCOL, V24, P1, DOI 10.1007/s10147-018-1351-y; Exacoustos C, 2017, SEMIN REPROD MED, V35, P5, DOI 10.1055/s-0036-1597127; FUJII S, 1988, CANCER, V62, P541, DOI 10.1002/1097-0142(19880801)62:3<541::AID-CNCR2820620317>3.0.CO;2-4; Grjibovski AM, 2018, INT HEALTH, V10, P92, DOI 10.1093/inthealth/ihx068; Haldorsen IS, 2019, CURR ONCOL REP, V21, DOI 10.1007/s11912-019-0824-0; Hickey GL, 2015, EUR J CARDIO-THORAC, V48, P180, DOI 10.1093/ejcts/ezv168; Hu XL, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0647-3; Huang Z, 2019, EUR J MED CHEM, V181, DOI 10.1016/j.ejmech.2019.07.044; Infante F, 2018, J ULTRAS MED, V37, P1467, DOI 10.1002/jum.14489; Jansen EEL, 2020, EUR J CANCER, V127, P207, DOI 10.1016/j.ejca.2019.12.013; Jurado M, 2008, WORLD J SURG ONCOL, V6, DOI 10.1186/1477-7819-6-126; Kallialay I, 2020, ANN ONCOL, V31, P213, DOI 10.1016/j.annonc.2019.11.004; Kori M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200717; Laengsri V, 2018, LAB MED, V49, P97, DOI 10.1093/labmed/lmx080; Lekskul Navamol, 2015, Asian Pac J Cancer Prev, V16, P4719; Loopik DL, 2020, GYNECOL ONCOL, V157, P195, DOI 10.1016/j.ygyno.2020.01.023; Ma GZ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007600; Mitsuhashi A, 2009, ANN ONCOL, V20, P71, DOI 10.1093/annonc/mdn552; Murfin J, 2020, J CLIN NURS, V29, P393, DOI 10.1111/jocn.15094; Ngan HYS, 2018, INT J GYNECOL OBSTET, V143, P79, DOI 10.1002/ijgo.12615; Palsdottir K, 2015, ULTRASOUND OBST GYN, V45, P470, DOI 10.1002/uog.14643; Patel-Lippmann K, 2017, MAGN RESON IMAGING C, V25, P635, DOI 10.1016/j.mric.2017.03.007; Romosan G, 2014, ARCH GYNECOL OBSTET, V289, P705, DOI 10.1007/s00404-013-3091-6; Ruscito I, 2018, BRIT J CANCER, V119, P330, DOI 10.1038/s41416-018-0157-z; Shrestha Aamod Dhoj, 2018, Asian Pac J Cancer Prev, V19, P319; Tariq M, 2017, J CELL BIOCHEM, V118, P2484, DOI 10.1002/jcb.25895; Wang HR, 2018, J BIOL REG HOMEOS AG, V32, P123; Wang PP, 2018, J BUON, V23, P769; Wang RJ, 2020, CANCER LETT, V471, P88, DOI 10.1016/j.canlet.2019.11.039; Wang S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004361; Wang WG, 2017, CLIN CHIM ACTA, V470, P51, DOI 10.1016/j.cca.2017.04.023; Wright JD, 2019, OBSTET GYNECOL, V134, P49, DOI 10.1097/AOG.0000000000003311; Xiao C, 2018, CHINESE J ULTRASOUND, V34, P23; Xie XZ, 2018, INT J CLIN ONCOL, V23, P522, DOI 10.1007/s10147-017-1225-8; Yang WT, 2002, J ULTRAS MED, V21, P1227, DOI 10.1023/A:1016580715595; Yang YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32427; Yu J, 2019, ONCOL LETT, V18, P2356, DOI 10.3892/ol.2019.10527; Zhou XC, 2017, J GYNECOL ONCOL, V28, DOI 10.3802/jgo.2017.28.e11; 2019, LANCET, V393, P104, DOI DOI 10.1016/S0140-6736(19)30003-030638568	46	4	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0236725	10.1371/journal.pone.0236725	http://dx.doi.org/10.1371/journal.pone.0236725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	32777812	Green Published, gold			2022-12-26	WOS:000561393800041
J	Lin, BY; Li, YX; Wang, TP; Qiu, YM; Chen, ZZ; Zhao, K; Lu, N				Lin, Binyan; Li, Yongxu; Wang, Tiepeng; Qiu, Yangmin; Chen, Zhenzhong; Zhao, Kai; Lu, Na			CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK	ONCOGENE			English	Article							NF-KAPPA-B; METASTASIS; VARIANCE; EMT	Metastatic breast cancer is characterized by high mortality and limited therapeutic target. During tumor metastasis, cytoskeletal reorganization is one of the key steps in the migration and invasion of breast cancer cells. Collapsin response mediator protein 2 (CRMP2) is a cytosolic phosphoprotein that plays an important role in regulating cytoskeletal dynamics. Previous researches have reported that altered CRMP2 expression is associated with breast cancer progression, but the underlying mechanism remains poorly understood. Here, we show that CRMP2 expression is reduced in various subtypes of breast cancers and negatively correlated with lymphatic metastasis. Overexpression of CRMP2 significantly inhibits invasion and stemness in breast cancer cells, while downregulation of CRMP2 promotes cell invasion, which is not required for tubulin polymerization. Mechanistic studies demonstrate that CRMP2 interacts with RECK, prevents RECK degradation, which, in turn, blocks NF-kappa B and Wnt signaling pathways. Furthermore, we find that phosphorylation of CRMP2 at T514 and S522 remarkably abolishes its functions to bind with RECK and to inhibit cell invasion. Pharmacologic rescue of CRMP2 expression suppressed breast cancer metastasis in vitro and in vivo and stimulated a synergetic effect with FN-1501 that induces CRMP2 dephosphorylation. Collectively, this study highlights the potential of CRMP2 as a therapeutic target in breast cancer metastasis and reveals a distinct mechanism of CRMP2.	[Lin, Binyan; Li, Yongxu; Wang, Tiepeng; Qiu, Yangmin; Chen, Zhenzhong; Zhao, Kai; Lu, Na] China Pharmaceut Univ, State Key Lab Nat Med, Jiangsu Key Lab Carcinogenesis & Intervent, Dept Physiol,Sch Basic Med & Clin Pharm, 24 Tongjiaxiang, Nanjing 210009, Peoples R China; [Lin, Binyan] Nanjing Univ Chinese Med, Sch Pharm, Xianlin Ave 138, Nanjing 210023, Peoples R China	China Pharmaceutical University; Nanjing University of Chinese Medicine	Zhao, K; Lu, N (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Jiangsu Key Lab Carcinogenesis & Intervent, Dept Physiol,Sch Basic Med & Clin Pharm, 24 Tongjiaxiang, Nanjing 210009, Peoples R China.	cpuzhaokai@163.com; nalu@cpu.edu.com		Qiu, Yangmin/0000-0001-6039-7909; Wang, Tiepeng/0000-0002-0691-2882; Zhao, Kai/0000-0002-4492-6185	National Natural Science Foundation of China [81872899, 81903625]; National Science & Technology Major Project [2017ZX09101003-005023, 2017ZX09301014, 2018ZX09711001-003-007]; Social Development Project of Jiangsu Provincial Science and Technology Department [BE2018711]; Natural Science Foundation of Jiangsu Province [BK20190563]; "Double First-Class" University project [CPU2018GY17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project; Social Development Project of Jiangsu Provincial Science and Technology Department; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); "Double First-Class" University project	This work was supported by the National Natural Science Foundation of China (Nos. 81872899 and 81903625), the National Science & Technology Major Project (Nos. 2017ZX09101003-005023, 2017ZX09301014, and 2018ZX09711001-003-007), Social Development Project of Jiangsu Provincial Science and Technology Department (BE2018711), Natural Science Foundation of Jiangsu Province (BK20190563), and the "Double First-Class" University project (CPU2018GY17).	Abe H, 2018, SCIENCE, V360, P50, DOI 10.1126/science.aao2300; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Armstrong RA, 2002, OPHTHAL PHYSL OPT, V22, P248, DOI 10.1046/j.1475-1313.2002.00020.x; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Deng J, 2004, MOL CARCINOGEN, V39, P139, DOI 10.1002/mc.10169; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Duciel L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39643-y; Farago M, 2005, CANCER RES, V65, P5792, DOI 10.1158/0008-5472.CAN-05-1021; Fife CM, 2014, BRIT J PHARMACOL, V171, P5507, DOI 10.1111/bph.12704; Geng SQ, 2014, CANCER LETT, V349, P1, DOI 10.1016/j.canlet.2014.03.036; Grant NJ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1691-1; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Ma B, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00378; Matsunuma R, 2018, P NATL ACAD SCI USA, V115, pE11978, DOI 10.1073/pnas.1810598115; Matsuzaki T, 2018, BIOL OPEN, V7, DOI 10.1242/bio.033985; McDonald ES, 2016, J NUCL MED, V57, p9S, DOI 10.2967/jnumed.115.157834; Mishra P, 2019, ANN CARD ANAESTH, V22, P407, DOI 10.4103/aca.ACA_94_19; Moutal A, 2019, MOL NEUROBIOL, V56, P6736, DOI 10.1007/s12035-019-1568-4; Moutal A, 2018, MOL NEUROBIOL, V55, P4403, DOI 10.1007/s12035-017-0653-9; Oliemuller E, 2013, INT J CANCER, V132, P1986, DOI 10.1002/ijc.27881; Pastushenko I, 2019, TRENDS CELL BIOL, V29, P212, DOI 10.1016/j.tcb.2018.12.001; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Quach TT, 2015, MOL PSYCHIATR, V20, P1037, DOI 10.1038/mp.2015.77; Schlenker E, 2016, METHODS MOL BIOL, V1366, P271, DOI 10.1007/978-1-4939-3127-9_21; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Shih YW, 2010, CELL BIOCHEM BIOPHYS, V58, P31, DOI 10.1007/s12013-010-9091-2; Shimada K, 2014, BREAST CANCER-TOKYO, V21, P715, DOI 10.1007/s12282-013-0447-5; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Walsh LA, 2015, ONCOGENE, V34, P2189, DOI 10.1038/onc.2014.175; Wang Y, 2018, J MED CHEM, V61, P1499, DOI 10.1021/acs.jmedchem.7b01261; Wilson SM, 2012, NEUROSCIENCE, V210, P451, DOI 10.1016/j.neuroscience.2012.02.038; Wu YY, 2012, MOL CANCER RES, V10, P1597, DOI 10.1158/1541-7786.MCR-12-0155-T; Yan W, 2018, CELL PHYSIOL BIOCHEM, V47, P489, DOI 10.1159/000489983; Zardavas D, 2013, NAT REV CLIN ONCOL, V10, P191, DOI 10.1038/nrclinonc.2013.29; Zheng YR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04954-7	39	6	6	1	16	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2020	39	37					6024	6040		10.1038/s41388-020-01412-x	http://dx.doi.org/10.1038/s41388-020-01412-x		AUG 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NM2OY	32778769				2022-12-26	WOS:000558201400001
J	Soe, HJ; Manikam, R; Raju, CS; Khan, MA; Sekaran, SD				Soe, Hui Jen; Manikam, Rishya; Raju, Chandramathi Samudi; Khan, Mohammad Asif; Sekaran, Shamala Devi			Correlation of host inflammatory cytokines and immune-related metabolites, but not viral NS1 protein, with disease severity of dengue virus infection	PLOS ONE			English	Article							ENDOTHELIAL BARRIER FUNCTION; FATTY-ACID OXIDATION; LIPID-METABOLISM; INSULIN-RESISTANCE; SERUM-LEVELS; CELLS; HMGB1; ANTIGEN; CONTRIBUTES; ASSOCIATION	Severe dengue can be lethal caused by manifestations such as severe bleeding, fluid accumulation and organ impairment. This study aimed to investigate the role of dengue non-structural 1 (NS1) protein and host factors contributing to severe dengue. Electrical cell-substrate impedance sensing system was used to investigate the changes in barrier function of microvascular endothelial cells treated NS1 protein and serum samples from patients with different disease severity. Cytokines and metabolites profiles were assessed using a multiplex cytokine assay and liquid chromatography mass spectrometry respectively. The findings showed that NS1 was able to induce the loss of barrier function in microvascular endothelium in a dose dependent manner, however, the level of NS1 in serum samples did not correlate with the extent of vascular leakage induced. Further assessment of host factors revealed that cytokines such as CCL2, CCL5, CCL20 and CXCL1, as well as adhesion molecule ICAM-1, that are involved in leukocytes infiltration were expressed higher in dengue patients in comparison to healthy individuals. In addition, metabolomics study revealed the presence of deregulated metabolites involved in the phospholipid metabolism pathway in patients with severe manifestations. In conclusion, disease severity in dengue virus infection did not correlate directly with NS1 level, but instead with host factors that are involved in the regulation of junctional integrity and phospholipid metabolism. However, as the studied population was relatively small in this study, these exploratory findings should be confirmed by expanding the sample size using an independent cohort to further establish the significance of this study.	[Soe, Hui Jen; Raju, Chandramathi Samudi] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Manikam, Rishya] Univ Malaya, Trauma & Emergency Acad, Fac Med, Kuala Lumpur, Malaysia; [Khan, Mohammad Asif] Perdana Univ, Sch Data Sci, Ctr Bioinformat, Serdang, Selangor, Malaysia; [Sekaran, Shamala Devi] MAHSA Univ, Fac Med & Biomed Sci, Jenjarom, Selangor, Malaysia	Universiti Malaya; Universiti Malaya; Perdana University; Mahsa University	Sekaran, SD (corresponding author), MAHSA Univ, Fac Med & Biomed Sci, Jenjarom, Selangor, Malaysia.	shamaladevi@mahsa.edu.my	Khan, M. Asif/ABE-7839-2021; Manikam, Rishya/F-5908-2014; samudi@raju, Chandramathi/AAR-1595-2021; Sekaran, Shamala Devi/B-9735-2010; SOE, HUI JEN/P-6740-2017	Khan, M. Asif/0000-0001-9202-279X; Sekaran, Shamala Devi/0000-0002-0478-0425; SOE, HUI JEN/0000-0002-6118-3408	University of Malaya [RP042C-15HTM]; University Malaya [PG255-2015B]	University of Malaya(Universiti Malaya); University Malaya(Universiti Malaya)	SDS received grant from University of Malaya Research Grant Grant No: RP042C-15HTM https://umresearch.um.edu.my/funding-opportunities-information SHJ received grant from University Malaya Postgraduate Research Grant Grant No: PG255-2015B. https://umresearch.um.edu.my/funding-opporturities-information The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhishek KS, 2017, INDIAN J PATHOL MICR, V60, P66, DOI 10.4103/0377-4929.200027; Adikari TN, 2016, CLIN EXP IMMUNOL, V184, P90, DOI 10.1111/cei.12747; Allonso D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113634; Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Anupriya MG, 2018, PROSTAG OTH LIPID M, V136, P44, DOI 10.1016/j.prostaglandins.2018.05.001; Back Anne Tuiskunen, 2013, Infect Ecol Epidemiol, V3, DOI 10.3402/iee.v3i0.19839; Breslow DK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013326; Calder PC, 2015, JPEN-PARENTER ENTER, V39, p18S, DOI 10.1177/0148607115595980; Cardier JE, 2006, ENDOTHELIUM-J ENDOTH, V13, P335, DOI 10.1080/10623320600972135; Carvalho DM, 2014, J TROP MED, V2014, P9; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; Chen HR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007033; Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142; Chiang John Y L, 2017, Liver Res, V1, P3, DOI 10.1016/j.livres.2017.05.001; Chu X, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1490-y; Clark PR, 2007, J INVEST DERMATOL, V127, P762, DOI 10.1038/sj.jid.5700670; Cogan J.E., 2018, DENG SEV DENG; Conde JN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00213; Cui L, 2017, J VIROL, V91, DOI [10.1128/jvi.00386-17, 10.1128/JVI.00386-17]; Hernandez SID, 2016, MEM I OSWALDO CRUZ, V111, P161, DOI 10.1590/0074-02760150359; Oliveira RAD, 2017, J CLIN VIROL, V89, P39, DOI 10.1016/j.jcv.2017.02.007; Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244; Dustin ML, 2014, CANCER IMMUNOL RES, V2, P1023, DOI 10.1158/2326-6066.CIR-14-0161; Florens N, 2016, TOXINS, V8, DOI 10.3390/toxins8120376; Fukuda EY, 2005, INFECT IMMUN, V73, P4017, DOI 10.1128/IAI.73.7.4017-4024.2005; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gibson MS, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00654; Gimenez MS, 2011, INT J MOL SCI, V12, P2408, DOI 10.3390/ijms12042408; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Gowda GAN, 2009, LIPIDS, V44, P527, DOI 10.1007/s11745-009-3296-4; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hashizume M, 2011, INFLAMM REGEN, V31, P325, DOI DOI 10.2492/inflammregen.31.325; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Huang WC, 2012, INFLAMMATION, V35, P350, DOI 10.1007/s10753-011-9325-5; Ishizaki K, 2005, HEPATOL RES, V33, P174, DOI 10.1016/j.hepres.2005.09.029; Iyngkaran N., 1995, Singapore Medical Journal, V36, P218; Jenkins S, 2013, COMPOUND IDENTIFICAT; Kang YS, 2010, KIDNEY INT, V78, P883, DOI 10.1038/ki.2010.263; Khan RA, 2019, CYTOKINE, V123, DOI 10.1016/j.cyto.2019.154780; Khunchai S, 2012, BIOCHEM BIOPH RES CO, V423, P398, DOI 10.1016/j.bbrc.2012.05.137; KIM BM, 2018, SCI REPORTS, V8, DOI DOI 10.1038/S41598-018-25699-929760499; Klassen P, 2001, AM J CLIN NUTR, V73, P647; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Lee YH, 2016, J GEN VIROL, V97, P3103, DOI 10.1099/jgv.0.000637; Li J, 2015, ASIAN J PHARM SCI, V10, P81, DOI 10.1016/j.ajps.2014.09.004; Lindegaard B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0186755; Lindegaard B, 2013, DIABETES, V62, P3064, DOI 10.2337/db12-1095; Liu Jing-Hua, 2006, Zhonghua Yi Xue Za Zhi, V86, P1191; Luo Y, 2013, BIOCHEM BIOPH RES CO, V438, P732, DOI 10.1016/j.bbrc.2013.07.098; Mangione Julia N A, 2014, Trop Med Health, V42, P137, DOI 10.2149/tmh.2014-09; Modhiran N, 2017, IMMUNOL CELL BIOL, V95, P491, DOI 10.1038/icb.2017.5; Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863; Narayanan S, 2014, J IMMUNOL S, V192, P74; Nemesio H, 2014, J PHYS CHEM B, V118, P10142, DOI 10.1021/jp504911r; Oliveira ERA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16197-5; Olsen ASB, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170069; Ong SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041932; Paranavitane SA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0570-8; Pedersen L, 2012, AM J PHYSIOL-ENDOC M, V302, pE831, DOI 10.1152/ajpendo.00339.2011; Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584; Priyadarshini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008709; Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738; Purnami NMA, 2015, PAEDIATR INDONES, V55, P87; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Ramos TN, 2014, J IMMUNOL, V192, P4469, DOI 10.4049/jimmunol.1400135; Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7; Rivino L, 2018, ADV EXP MED BIOL, V1062, P241, DOI 10.1007/978-981-10-8727-1_17; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Salazar MI, 2014, J PROTEOMICS, V111, P6, DOI 10.1016/j.jprot.2014.06.002; Samanta J, 2015, WORLD J CLIN CASES, V3, P125, DOI 10.12998/wjcc.v3.i2.125; Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277; Sehrawat P, 2018, MEDITERR J HEMATOL I, V10, DOI 10.4084/MJHID.2018.023; Simmons CP, 2015, VACCINE, V33, P7061, DOI 10.1016/j.vaccine.2015.09.103; Singh S, 2018, J GEN VIROLOGY; Soe HJ, 2017, J GEN VIROL, V98, P2993, DOI 10.1099/jgv.0.000981; Soo KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154760; Stolwijk JA, 2015, PFLUG ARCH EUR J PHY, V467, P2193, DOI 10.1007/s00424-014-1674-0; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; van Diepen JA, 2013, ATHEROSCLEROSIS, V228, P306, DOI 10.1016/j.atherosclerosis.2013.02.028; van Gorp ECM, 2002, CLIN INFECT DIS, V34, P1150, DOI 10.1086/339539; Verma R, 2011, ANN INDIAN ACAD NEUR, V14, P272, DOI 10.4103/0972-2327.91946; Vervaeke P, 2015, REV MED VIROL, V25, P50, DOI 10.1002/rmv.1818; Vielma SA, 2014, ADIPOCYTE, V3, P126, DOI 10.4161/adip.28287; Villareal VA, 2015, ANTIVIR RES, V124, P110, DOI 10.1016/j.antiviral.2015.10.013; Villas-Boas CSA, 2009, BRAZ J MED BIOL RES, V42, P1020, DOI 10.1590/S0100-879X2009001100004; Wang F, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-30; Wijeratne DT, 2019, IMMUN INFLAMM DIS, V7, P276, DOI 10.1002/iid3.271; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Wlodarska M, 2017, CELL HOST MICROBE, V22, P25, DOI 10.1016/j.chom.2017.06.007; World Health Organization, 2009, DENGUE GUIDELINES DI; Yang YB, 2018, J BIOL CHEM, V293, P6230, DOI 10.1074/jbc.R117.000582; Yao HW, 2017, FREE RADICAL BIO MED, V112, P179, DOI 10.1016/j.freeradbiomed.2017.10.281; Yaseen M, 2011, ANAESTH PAIN INTENSI, V15; Yong YK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1226-4; Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000; Zhou Kecheng, 2015, Lipid Insights, V8, P11, DOI 10.4137/LPI.S31615	98	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237141	10.1371/journal.pone.0237141	http://dx.doi.org/10.1371/journal.pone.0237141			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764789	gold, Green Published			2022-12-26	WOS:000561029000002
J	Anwar, N; Pervez, S; Chundriger, Q; Awan, S; Moatter, T; Ali, TS				Anwar, Namrah; Pervez, Shahid; Chundriger, Qurratulain; Awan, Sohail; Moatter, Tariq; Ali, Tazeen Saeed			Oral cancer: Clinicopathological features and associated risk factors in a high risk population presenting to a major tertiary care center in Pakistan	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NECK-CANCER; SOCIOECONOMIC-STATUS; CAVITY CANCER; ANATOMICAL SITES; HEAD; EPIDEMIOLOGY; PREVALENCE; PATHOLOGY; EDITION	Oral squamous cell carcinoma (OSCC) has the highest prevalence in head and neck cancers and is the first and second most common cancer in males and females of Pakistan respectively. Major risk factors include peculiar chewing habits like areca nut, betel quid, and tobacco. The majority of OSCC presents at an advanced stage with poor prognosis. On the face of such a high burden of this preventable cancer, there is a relative lack of recent robust data and its association with known risk factors from Pakistan. The aim of this study was to identify the socioeconomic factors and clinicopathological features that may contribute to the development of OSCC. A total of 186 patients diagnosed and treated at a tertiary care hospital, Karachi Pakistan were recruited. Clinicopathological and socioeconomic information was obtained on a structured questionnaire. Descriptive analysis was done for demographics and socioeconomic status (SES) while regression analysis was performed to evaluate the association between SES and chewing habits, tumor site, and tumor stage. The majority of patients were males and the mean age of OSCC patients was 47.62 +/- 12.18 years. Most of the patients belonged to low SES (68.3%) and 77.4% were habitual of chewing. Gender (male) and SES were significantly associated with chewing habits (p<0.05). Odds of developing buccal mucosa tumors in chewers (of any type of substance) and gutka users were 2 and 4 times higher than non-chewers respectively. Middle age, chewing habits, and occupation were significantly associated with late stage presentation of OSCC (p<0.05). In conclusion, male patients belonging to low SES in their forties who had chewing habits for years constituted the bulk of OSCC. Buccal mucosa was the most common site in chewers and the majority presented with late stage tumors.	[Anwar, Namrah; Pervez, Shahid; Chundriger, Qurratulain; Moatter, Tariq] Aga Khan Univ Hosp, Dept Pathol & Lab Med, Karachi, Pakistan; [Awan, Sohail] Aga Khan Univ Hosp, Dept Otolaryngol Head & Neck Surg, Karachi, Pakistan; [Ali, Tazeen Saeed] Aga Khan Univ Hosp, Sch Nursing & Midwifery, Karachi, Pakistan	Aga Khan University; Aga Khan University; Aga Khan University	Ali, TS (corresponding author), Aga Khan Univ Hosp, Sch Nursing & Midwifery, Karachi, Pakistan.	tazeen.ali@aku.edu	Ali, Tazeen Saeed/AAW-5284-2020; S Ali, Tazeen/AAC-8790-2022; Awan, Sohail/ABB-3892-2021	S Ali, Tazeen/0000-0002-8896-8766; Awan, Muhammad Sohail/0000-0001-8323-7350	University Research Council Grant of Aga Khan University Hospital	University Research Council Grant of Aga Khan University Hospital	This study was partially funded by University Research Council Grant of Aga Khan University Hospital awarded to SP. All the funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Akram S, 2013, PAK J MED SCI, V29, P783, DOI 10.12669/pjms.293.3453; Alam AY, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-50; Allen L, 2017, LANCET GLOB HEALTH, V5, pE277, DOI 10.1016/s2214-109x(17)30058-x; [Anonymous], 2017, J AM HEART ASSOC; [Anonymous], 2016, MEDICINE, DOI DOI 10.1097/MD.0000000000002314; Azam MN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156887; Baig MS, 2015, PAK J MED HEALTH SCI, V9, P1269; Bhawna G, 2013, ASIAN PAC J CANCER P, V14, P3323, DOI 10.7314/APJCP.2013.14.5.3323; Bhisey RA, 2012, INDIAN J CANCER, V49, P364, DOI 10.4103/0019-509X.107735; Brandizzi D, 2008, MED ORAL PATOL ORAL, V13, pE544; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cadoni G, 2017, ACTA OTORHINOLARYNGO, V37, P458, DOI 10.14639/0392-100X-1246; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Chu KP, 2011, CANCER-AM CANCER SOC, V117, P1935, DOI 10.1002/cncr.25723; Ernani V, 2015, ONCOLOGY-BASEL, V89, P187, DOI 10.1159/000398801; Fantom N., 2016, WORLD BANKS CLASSIFI; Feller L., 2012, J CANC THER, V3, P263, DOI [10.4236/jct.2012.34037, DOI 10.4236/JCT.2012.34037]; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Flora MS, 2012, WHO S E ASIA J PUBLI, V169; Gadbail AR, 2017, J ORAL PATHOL MED, V46, P448, DOI 10.1111/jop.12553; Garcia-Martin JM, 2019, EPIDEMIOLOGY ORAL CA, P81; Ghani WMN, 2019, CANCER INVEST, V37, P275, DOI 10.1080/07357907.2019.1635614; Ghani WMN, 2019, ORAL DIS, V25, P447, DOI 10.1111/odi.12995; Gupta AK, 2020, REGUL TOXICOL PHARM, V110, DOI 10.1016/j.yrtph.2019.104548; Gupta B, 2016, ONCOLOGY-BASEL, V91, P13, DOI 10.1159/000446117; Hsu W-L, 2017, INT J HEAD NECK SCI, V1, P180; Huque Rumana, 2017, Indian J Public Health, V61, pS18, DOI 10.4103/ijph.IJPH_233_17; Hwang E, 2013, ORAL ONCOL, V49, P1072, DOI 10.1016/j.oraloncology.2013.08.002; IARC, 2004, TOB SMOK INV SMOK; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V89, P1; Javed F, 2010, ORAL SURG ORAL MED O, V109, P857, DOI 10.1016/j.tripleo.2009.12.038; Jiang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137023; John RM, 2018, INDIAN J MED RES, V148, P46, DOI 10.4103/ijmr.IJMR_1822_17; Johnson S, 2012, J OTOLARYNGOL-HEAD N, V41, P102, DOI 10.2310/7070.2011.110077; Kato MG, 2016, OTOLARYNGOLOGY HEAD; Keith H, 2017, J DENT ORAL HLTH, V3, P1; Khan TZ, 2016, RAWAL MED J, V41, P450; Khawaja Muhammad RizwanulHaq, 2006, Asian Pac J Cancer Prev, V7, P95; Krishna A, 2014, ASIAN PAC J CANCER P, V15, P6755, DOI 10.7314/APJCP.2014.15.16.6755; Lee YCA, 2019, HEAD NECK-J SCI SPEC, V41, P92, DOI 10.1002/hed.25383; Leemans CR, 2018, NAT REV CANCER, V18, P269, DOI 10.1038/nrc.2018.11; Li YC, 2019, J CANCER, V10, P4054, DOI 10.7150/jca.29765; Liao CT, 2014, ORAL ONCOL, V50, P721, DOI 10.1016/j.oraloncology.2014.04.010; Lydiatt WM, 2017, CA-CANCER J CLIN, V67, P122, DOI 10.3322/caac.21389; Maasland DHE, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-187; Madani Abdoul Hossain, 2012, Indian J Public Health, V56, P57, DOI 10.4103/0019-557X.96977; Madathil SA, 2016, ORAL ONCOL, V60, P25, DOI 10.1016/j.oraloncology.2016.06.011; Mummudi N, 2019, CLIN ONCOL-UK, V31, P520, DOI 10.1016/j.clon.2019.05.013; Mutti Seema, 2016, Indian J Community Med, V41, P280, DOI 10.4103/0970-0218.193337; Myint SK, 2016, SE ASIAN J TROP MED, V47, P1089; Naghavi AO, 2016, CANCER EPIDEMIOL, V45, P18, DOI 10.1016/j.canep.2016.09.005; Pradhan NA, 2018, J PAK MED ASSOC, V68, P709; Shah G, 2012, INDIAN J MED PAEDIAT, V33, P71, DOI 10.4103/0971-5851.99726; Si BSMS, 2016, J INVESTIG CLIN DENT, V7, P127, DOI 10.1111/jicd.12145; Siddiqi K, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0424-2; Singer S, 2017, SUPPORT CARE CANCER, V25, P1391, DOI 10.1007/s00520-016-3528-0; Su WWY, 2019, HEAD NECK-J SCI SPEC, V41, P1475, DOI 10.1002/hed.25579; Tanaka T, 2011, J ONCOL, V2011, DOI 10.1155/2011/603740; Tsai KY, 2009, COMMUNITY DENT ORAL, V37, P555, DOI 10.1111/j.1600-0528.2009.00504.x; Westra WH, 2017, HEAD NECK PATHOL, V11, P41, DOI 10.1007/s12105-017-0793-2; Zaw KK, 2014, MYANM MED RES C	61	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236359	10.1371/journal.pone.0236359	http://dx.doi.org/10.1371/journal.pone.0236359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760151	Green Published, gold			2022-12-26	WOS:000561027200054
J	Papale, E; Prakash, S; Singh, S; Batibasaga, A; Buscaino, G; Piovano, S				Papale, Elena; Prakash, Shritika; Singh, Shubha; Batibasaga, Aisake; Buscaino, Giuseppa; Piovano, Susanna			Soundscape of green turtle foraging habitats in Fiji, South Pacific	PLOS ONE			English	Article							SNAPPING SHRIMP; SEA-TURTLE; CARETTA-CARETTA; CHELONIA-MYDAS; PRODUCTION PATTERNS; UNDERWATER HEARING; BIOLOGICAL ORIGIN; BITING BEHAVIOR; SITE FIDELITY; SETTLEMENT	The soundscape features of the marine environment provide crucial information about ecosystem health for many species, and they are defined by the local biological, geophysical, and anthropogenic components. In this study, we investigated the soundscape at green turtle neritic foraging habitats in Fiji, South Pacific, with the aims of characterizing the contribution of each component and of comparing the levels of acoustic pressure among sites with different abundances of sea turtles. Four sites were selected at two islands, and one hydrophone was deployed at each site. Generalized additive models highlighted that sound pressure levels (SPLs) at low frequencies (125-250 Hz) were especially affected by wind conditions, while at higher frequencies (>250 Hz) SPLs were mostly influenced by fish and crustacean acoustic activity. Higher abundances of green turtles were found at sites with the highest levels of SPLs and the highest number of acoustic emissions by fishes and crustaceans but were not related to maximum seagrass and macroalgae coverage, or the highest number of fish. The selected coastal habitats have negligible anthropogenic noise, thus this study informs physiological and behavioral studies of the acoustic signatures that sea turtles might target and provides a baseline against which potential impact of soundscape changes on sea turtle spatial abundance and distribution can be evaluated.	[Papale, Elena; Buscaino, Giuseppa] CNR, BioacousticsLab, IAS Capo Granitola, Torretta Granitola, Italy; [Papale, Elena] Univ Torino, Dept Life Sci & Syst Biol, Turin, Italy; [Prakash, Shritika; Singh, Shubha; Piovano, Susanna] Univ South Pacific, Sch Marine Studies, Suva, Fiji; [Batibasaga, Aisake] Minist Fisheries, Suva, Fiji	Consiglio Nazionale delle Ricerche (CNR); University of Turin; University of the South Pacific	Papale, E (corresponding author), CNR, BioacousticsLab, IAS Capo Granitola, Torretta Granitola, Italy.; Papale, E (corresponding author), Univ Torino, Dept Life Sci & Syst Biol, Turin, Italy.; Piovano, S (corresponding author), Univ South Pacific, Sch Marine Studies, Suva, Fiji.	elena.papale@ias.cnr.it; susanna.piovano@usp.ac.fj		Prakash, Shritika/0000-0002-3900-3984; Singh, Shubha/0000-0001-6171-8540; papale, elena/0000-0002-5150-9240	Pacific Islands Regional Office of the United States National Oceanic and Atmospheric Administration [NA17NMF4540081]; Ministry of Fisheries	Pacific Islands Regional Office of the United States National Oceanic and Atmospheric Administration; Ministry of Fisheries	SPi received the award from the Pacific Islands Regional Office of the United States National Oceanic and Atmospheric Administration (grant NA17NMF4540081, https://www.fisheries.noaa.gov/about/pacific-islands-regional-office), which partially funded the field activities at Yadua Island. Field activities at Makogai Island were partially supported by Ministry of Fisheries (www.fisheries.gov.fj). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, which remains entirely on the authors. However, we acknowledge that at time of this research AB was Director of Ministry of Fisheries.	Abrahms B, 2019, P NATL ACAD SCI USA, V116, P5582, DOI 10.1073/pnas.1819031116; Acoustical Society of America, 2004, S1112004 ANSI AC SOC; Ahonen H, 2017, MAR POLLUT BULL, V123, P97, DOI 10.1016/j.marpolbul.2017.09.019; Alvarez-Varas R, 2021, ZOOL J LINN SOC-LOND, V191, P434, DOI 10.1093/zoolinnean/zlaa066; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Au WWL, 1998, J ACOUST SOC AM, V103, P41, DOI 10.1121/1.423234; Bartol SM, 2003, CRC MAR BIOL SER, P79; Bartol SM, 1999, COPEIA, P836, DOI 10.2307/1447625; Bertucci F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135733; Bohnenstiehl DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143691; Brill R, 2006, SEA TURTLE PELAGIC F, P98; Buscaino G, 2016, SCI REP-UK, V6, DOI 10.1038/srep34230; Buscaino G, 2012, J ACOUST SOC AM, V132, P1792, DOI 10.1121/1.4742744; CATO DH, 1980, J ACOUST SOC AM, V68, P1056, DOI 10.1121/1.384989; Ceraulo M, 2018, ECOL INDIC, V85, P1030, DOI 10.1016/j.ecolind.2017.08.066; Cheng J, 2019, CREATE INTERACTIVE W; Coquereau L, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160606; Eckert KL, 2006, MARINE TURTLE TAGGIN, P40; Ehrhart Llewellyn M., 1999, P61; Endres CS, 2009, J EXP BIOL, V212, P3823, DOI 10.1242/jeb.033068; Erbe C, 2015, PROG OCEANOGR, V137, P38, DOI 10.1016/j.pocean.2015.05.015; Farina, 2018, J ECOACOUSTICS, V2, P5, DOI [10.22261/jea.trzd5i, DOI 10.22261/JEA.TRZD5I]; Farina, 2014, SOUNDSCAPE ECOLOGY P, DOI DOI 10.1007/978-94-007-7374-5; Fay R, 2009, INTEGR ZOOL, V4, P26, DOI 10.1111/j.1749-4877.2008.00132.x; Ferrara CR, 2013, J COMP PSYCHOL, V127, P24, DOI 10.1037/a0029656; Ferrara CR, 2014, HERPETOLOGICA, V70, P149, DOI 10.1655/HERPETOLOGICA-D-13-00050R2; Freeman SE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201766; Fuentes MMPB, 2006, WILDLIFE RES, V33, P671, DOI 10.1071/WR05081; Fury CA, 2011, ESTUAR COAST SHELF S, V93, P389, DOI 10.1016/j.ecss.2011.05.003; Giles JC, 2009, J ACOUST SOC AM, V126, P434, DOI 10.1121/1.3148209; Hall RJ, 2018, PEERJ, V6, DOI 10.7717/peerj.5572; Hancock JM, 2018, MAR ECOL PROG SER, V600, P165, DOI 10.3354/meps12633; HANSEN P, 1979, ANIM BEHAV, V27, P1270, DOI 10.1016/0003-3472(79)90073-3; Haver SM, 2017, DEEP-SEA RES PT I, V122, P95, DOI 10.1016/j.dsr.2017.03.002; Herberholz J, 2001, BIOL BULL, V201, P6, DOI 10.2307/1543520; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; JOHNSON MW, 1947, BIOL BULL, V93, P122, DOI 10.2307/1538284; KAISER JF, 1990, INT CONF ACOUST SPEE, P381, DOI 10.1109/ICASSP.1990.115702; Kaplan MB, 2016, SCI REP-UK, V6, DOI 10.1038/srep31862; Kaplan MB, 2015, MAR ECOL PROG SER, V533, P93, DOI 10.3354/meps11382; Kasumyan A.O., 2008, J ICHTHYOL, V48, P981, DOI [10.1134/S0032945208110039, DOI 10.1134/S0032945208110039]; Kennedy EV, 2010, J EXP MAR BIOL ECOL, V395, P85, DOI 10.1016/j.jembe.2010.08.017; Ketten D, 2006, FUNCTIONAL MEASURES; Kingsford MJ, 2002, B MAR SCI, V70, P309; Krause B. L., 1993, SOUNDSCAPE NEWSL, V6, P4; Lavender AL, 2014, J EXP BIOL, V217, P2580, DOI 10.1242/jeb.096651; Lillis A, 2016, J ACOUST SOC AM, V140, P3071, DOI [10.1121/1.4969566, DOI 10.1121/1.4969566]; Lillis A, 2018, CORAL REEFS, V37, P597, DOI 10.1007/s00338-018-1684-z; Lillis A, 2017, J ACOUST SOC AM, V142, P3311, DOI 10.1121/1.5012751; Lillis A, 2016, PEERJ, V4, DOI 10.7717/peerj.2557; Lillis A, 2014, MAR ECOL PROG SER, V509, P57, DOI 10.3354/meps10917; Lillis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079337; Limpus C.J., 2000, MARINE TURTLE NEWSLE, V89, P13; LIMPUS CJ, 1980, HERPETOLOGICA, V36, P162; Lohmann KJ, 2008, J EXP MAR BIOL ECOL, V356, P83, DOI 10.1016/j.jembe.2007.12.017; Lohmann KJ, 2013, CRC MAR BIOL SER, P59; Lucke K, 2016, J ACOUST SOC AM, V139, P3097, DOI 10.1121/1.4952711; Martin KJ, 2012, J EXP BIOL, V215, P3001, DOI 10.1242/jeb.066324; McCauley R.D., 2000, APPEA J, V40, P692, DOI DOI 10.1071/AJ99048; McWilliam JN, 2013, J EXP MAR BIOL ECOL, V446, P166, DOI 10.1016/j.jembe.2013.05.012; Menze S, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160370; Monczak A, 2019, MAR ECOL PROG SER, V609, P49, DOI 10.3354/meps12813; Montgomery JC, 2001, FISH FISH, V2, P261, DOI 10.1046/j.1467-2960.2001.00053.x; Mullet TC, 2017, BIOSEMIOTICS-NETH, V10, P319, DOI 10.1007/s12304-017-9288-5; Murphy HM, 2010, MAR FRESHWATER RES, V61, P236, DOI 10.1071/MF09068; Musick John A., 1997, P137; Nolan BA, 1970, FORMA FUNCT, V2, P289; Parmentier E, 2015, J FISH BIOL, V86, P1507, DOI 10.1111/jfb.12651; Piercy JJB, 2014, MAR ECOL PROG SER, V516, P35, DOI 10.3354/meps10986; Pijanowski BC, 2011, LANDSCAPE ECOL, V26, P1213, DOI 10.1007/s10980-011-9600-8; Pijanowski BC, 2011, BIOSCIENCE, V61, P203, DOI 10.1525/bio.2011.61.3.6; Piniak WED, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159711; Piniak WED, 2012, ADV EXP MED BIOL, V730, P83, DOI 10.1007/978-1-4419-7311-5_18; Piovano S, 2013, ETHOL ECOL EVOL, V25, P12, DOI 10.1080/03949370.2012.711777; Piovano S, 2012, AFR J MAR SCI, V34, P283, DOI 10.2989/1814232X.2012.675126; Piovano S, 2020, MAR ECOL PROG SER, V640, P201, DOI 10.3354/meps13287; Piovano S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39475-w; Piovano S, 2004, ITAL J ZOOL, V71, P213, DOI 10.1080/11250000409356638; Putland RL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06347-0; Radford CA, 2014, MAR ECOL PROG SER, V505, P19, DOI 10.3354/meps10782; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; Radford CA, 2008, OECOLOGIA, V156, P921, DOI 10.1007/s00442-008-1041-y; Ricci SW, 2016, MAR ECOL PROG SER, V550, P25, DOI 10.3354/meps11724; RIDGWAY SH, 1969, P NATL ACAD SCI USA, V64, P884, DOI 10.1073/pnas.64.3.884; Samuel Y, 2005, J ACOUST SOC AM, V117, P1465, DOI 10.1121/1.1847993; SCHEIN H, 1975, Marine Behaviour and Physiology, V3, P83; Senko J, 2010, J EXP MAR BIOL ECOL, V391, P92, DOI 10.1016/j.jembe.2010.06.017; Simpson SD, 2008, ANIM BEHAV, V75, P1861, DOI 10.1016/j.anbehav.2007.11.004; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Staaterman E, 2013, CORAL REEFS, V32, P553, DOI 10.1007/s00338-012-1007-8; Staaterman E, 2014, MAR ECOL PROG SER, V508, P17, DOI 10.3354/meps10911; Stanley JA, 2012, P ROY SOC B-BIOL SCI, V279, P3622, DOI 10.1098/rspb.2012.0697; Stanley JA, 2010, BEHAV ECOL, V21, P113, DOI 10.1093/beheco/arp159; Swimmer Y, 2005, MAR ECOL PROG SER, V295, P273, DOI 10.3354/meps295273; Taquet C, 2006, MAR ECOL PROG SER, V306, P295, DOI 10.3354/meps306295; The GIMP Development Team, 2019, GNU IM MAN PROGR; Thomson JA, 2012, MAR ECOL PROG SER, V453, P213, DOI 10.3354/meps09637; Torri M, 2018, PROG OCEANOGR, V162, P25, DOI 10.1016/j.pocean.2018.02.009; Tricas TC, 2014, MAR ECOL PROG SER, V511, P1, DOI 10.3354/meps10930; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010660; Wildermann NE, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00155; Wood S., 2017, GEN ADDITIVE MODELS, V2nd Edn	103	6	7	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236628	10.1371/journal.pone.0236628	http://dx.doi.org/10.1371/journal.pone.0236628			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756577	Green Accepted, Green Published, gold			2022-12-26	WOS:000560393300019
J	Jung, J; Jeong, S; Jeong, H; Oh, HE; Choi, JW; Lee, ES; Kim, YS; Kwak, Y; Kim, WH; Lee, JH				Jung, Jiyoon; Jeong, Sanghoon; Jeong, Hoiseon; Oh, Hwa Eun; Choi, Jung-Woo; Lee, Eung Seok; Kim, Young-Sik; Kwak, Yoonjin; Kim, Woo Ho; Lee, Ju-Han			Increased HOXC6 mRNA expression is a novel biomarker of gastric cancer	PLOS ONE			English	Article							PROGNOSIS; SURVIVAL	In this study, we aimed to investigate the molecular biomarkers that are pivotal for the development and progression of gastric cancer (GC). We analyzed clinical specimens using RNA sequencing to identify the target genes. We found that the expression ofHOXC6mRNA was upregulated with the progression of cancer, which was validated by quantitative real time PCR and RNAin-situhybridization. To compare the protein expression of HOXC6, we evaluated GC and normal gastric tissue samples using western blot analysis and immunohistochemistry. We detected significantly higher levels of HOXC6 in the GC tissues than in the normal controls at both mRNA and protein levels. The expression levels ofHOXC6mRNA in patients with advanced gastric cancer (AGC) were significantly higher than those in patients with early gastric cancer (EGC). Kaplan-Meier curves showed that high expression ofHOXC6mRNA is significantly associated with poor clinical prognosis. Our findings suggest thatHOXC6mRNA may be a novel biomarker and can be potentially valuable in predicting the prognosis of GC patients. Especially,HOXC6mRNAin-situhybridization may be a diagnostic tool for predicting prognosis of individual GC patients.	[Jung, Jiyoon; Jeong, Hoiseon; Oh, Hwa Eun; Choi, Jung-Woo; Lee, Eung Seok; Kim, Young-Sik; Lee, Ju-Han] Korea Univ, Ansan Hosp, Coll Med, Dept Pathol, Ansan, Gyeonggi Do, South Korea; [Jeong, Sanghoon] Korea Univ, Ansan Hosp, Coll Med, Med Sci Res Ctr, Ansan, Gyeonggi Do, South Korea; [Kwak, Yoonjin; Kim, Woo Ho] Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea; [Jung, Jiyoon] Catholic Kwandong Univ, Coll Med, Int St Marys Hosp, Dept Pathol, Incheon Metropolitan Cit, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Seoul National University Hospital; Catholic Kwandong University	Lee, JH (corresponding author), Korea Univ, Ansan Hosp, Coll Med, Dept Pathol, Ansan, Gyeonggi Do, South Korea.	repath@korea.ac.kr		Jeong, Hoiseon/0000-0002-0458-1442; Lee, Ju-Han/0000-0002-5929-5734; Jung, Jiyoon/0000-0001-9553-5283	Korea University [K1824341]	Korea University	This research was supported by a grant from the Korea University (Grant No. K1824341). http://www.korea.ac.kr/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen SW, 2016, MOL MED REP, V14, P3261, DOI 10.3892/mmr.2016.5640; Chu YH, 2019, SEMIN DIAGN PATHOL, V36, P336, DOI 10.1053/j.semdp.2019.06.004; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Du YB, 2014, J SURG RES, V188, P442, DOI 10.1016/j.jss.2014.01.017; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Gullo I, 2018, PATHOBIOLOGY, V85, P50, DOI 10.1159/000473881; Kim SG, 2018, GUT LIVER, V12, P402, DOI 10.5009/gnl17414; Kim YG, 2014, J GASTRIC CANCER, V14, P129, DOI 10.5230/jgc.2014.14.2.129; Kusano T, 2013, ANN SURG ONCOL, V20, P2290, DOI 10.1245/s10434-012-2839-8; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li PD, 2018, AGING-US, V10, P115, DOI 10.18632/aging.101363; Lin J, 2020, DIGESTIVE DIS SCI; Luo ZF, 2019, CANCERS, V11, DOI 10.3390/cancers11030323; McCabe CD, 2008, CANCER RES, V68, P1988, DOI 10.1158/0008-5472.CAN-07-5843; Moon SM, 2012, J BIOL CHEM, V287, P35678, DOI 10.1074/jbc.M112.361675; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramachandran S, 2005, ONCOGENE, V24, P188, DOI 10.1038/sj.onc.1207906; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; RUDDLE FH, 1994, ANNU REV GENET, V28, P423, DOI 10.1146/annurev.ge.28.120194.002231; Rodrigues MFSD, 2016, GENOMICS, V108, P185, DOI 10.1016/j.ygeno.2016.11.001; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang YK, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006970; Zhang Q, 2013, NEOPLASMA, V60, P439, DOI 10.4149/neo_2013_057; Zhou JY, 2019, ARTIF CELL NANOMED B, V47, P2715, DOI 10.1080/21691401.2019.1635136	26	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236811	10.1371/journal.pone.0236811	http://dx.doi.org/10.1371/journal.pone.0236811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745141	Green Published, gold			2022-12-26	WOS:000560006800006
J	Soundarapandian, MM; Juliana, CA; Chai, JH; Haslett, PA; Fitzgerald, K; De Leon, DD				Soundarapandian, Mangala M.; Juliana, Christine A.; Chai, Jinghua; Haslett, Patrick A.; Fitzgerald, Kevin; De Leon, Diva D.			Activation of Protein Kinase A (PKA) signaling mitigates congenital hyperinsulinism associated hypoglycemia in the Sur1(-/-) mouse model	PLOS ONE			English	Article							INSULIN-SECRETION; CATALYTIC SUBUNIT; GLUCAGON; KISSPEPTIN; GENE; CREB; TRANSCRIPTION; DEGRADATION; MECHANISMS; RELEASE	There is a significant unmet need for a safe and effective therapy for the treatment of children with congenital hyperinsulinism. We hypothesized that amplification of the glucagon signaling pathway could ameliorate hyperinsulinism associated hypoglycemia. In order to test this we evaluated the effects of loss of Prkar1a, a negative regulator of Protein Kinase A in the context of hyperinsulinemic conditions. With reduction of Prkar1a expression, we observed a significant upregulation of hepatic gluconeogenic genes. In wild type mice receiving a continuous infusion of insulin by mini-osmotic pump, we observed a 2-fold increase in the level of circulating ketones and a more than 40-fold increase in Kiss1 expression with reduction of Prkar1a. Loss of Prkar1a in the Sur1(-/-) mouse model of K-ATP hyperinsulinism significantly attenuated fasting induced hypoglycemia, decreased the insulin/glucose ratio, and also increased the hepatic expression of Kiss1 by more than 10-fold. Together these data demonstrate that amplification of the hepatic glucagon signaling pathway is able to rescue hypoglycemia caused by hyperinsulinism.	[Soundarapandian, Mangala M.; Haslett, Patrick A.; Fitzgerald, Kevin] Alnylam Pharmaceut, Cambridge, MA 02142 USA; [Juliana, Christine A.; Chai, Jinghua; De Leon, Diva D.] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA; [De Leon, Diva D.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Soundarapandian, MM (corresponding author), Alnylam Pharmaceut, Cambridge, MA 02142 USA.; De Leon, DD (corresponding author), Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA.; De Leon, DD (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.	msoundar@alnylam.com; deleon@email.chop.edu		Juliana, Christine/0000-0002-4314-1407	Alnylam Pharmaceuticals	Alnylam Pharmaceuticals	This study was supported by Alnylam Pharmaceuticals. https://www.alnylam.com MMS, PAH and KF work for Alnylam Pharamaceuticals; MMS, PAH and KF hold shares in Alnylam Pharmaceuticals stock; DDDL received funding from Alnylam Pharmaceuticals to conduct this study. MMS, PAH, KF and DDDL collaborated on the design, data collection, analysis, decision to publish and preparation of the manuscript. JC performed experiments and CAJ analyzed data and wrote the manuscript.	BERTHET J, 1957, J Biol Chem, V224, P463; Bowe JE, 2009, DIABETOLOGIA, V52, P855, DOI 10.1007/s00125-009-1283-1; Bowe JE, 2012, ISLETS, V4, DOI 10.4161/isl.18261; Caputo N, 2013, PEPTIDES, V45, P40, DOI 10.1016/j.peptides.2013.04.005; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Gromada J, 2004, DIABETES, V53, pS181, DOI 10.2337/diabetes.53.suppl_3.S181; Guemes M, 2015, PEDIATR CLIN N AM, V62, P1017, DOI 10.1016/j.pcl.2015.04.010; Hauge-Evans AC, 2006, DIABETOLOGIA, V49, P2131, DOI 10.1007/s00125-006-0343-z; Herrera A, 2018, J CLIN ENDOCR METAB, V103, P4365, DOI 10.1210/jc.2018-01613; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hussain K, 2005, DIABETES, V54, P2946, DOI 10.2337/diabetes.54.10.2946; Hussain MA, 2015, TRENDS ENDOCRIN MET, V26, P564, DOI 10.1016/j.tem.2015.07.008; Joshi AB, 2000, INT J PHARM, V203, P115, DOI 10.1016/S0378-5173(00)00438-5; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Laje P, 2010, PEDIATR DIABETES, V11, P142, DOI 10.1111/j.1399-5448.2009.00547.x; Leahy P, 1999, J BIOL CHEM, V274, P8813, DOI 10.1074/jbc.274.13.8813; Liu XH, 2015, ENDOCRINOLOGY, V156, P1815, DOI 10.1210/en.2014-1845; Liu Y, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.062119; Lord K, 2015, J CLIN ENDOCR METAB, V100, P4133, DOI 10.1210/jc.2015-2539; Lord Katherine, 2013, Int J Pediatr Endocrinol, V2013, P3, DOI 10.1186/1687-9856-2013-3; McGarry J., 1996, ELLENBERG RIFKINS DI, P19; MELLMAN MJ, 1992, J CLIN ENDOCR METAB, V75, P1293, DOI 10.1210/jc.75.5.1293; Nair JK, 2014, J AM CHEM SOC, V136, P16958, DOI 10.1021/ja505986a; Niswender CM, 2005, GENESIS, V43, P109, DOI 10.1002/gene.20159; QUINN PG, 1994, J BIOL CHEM, V269, P14375; Rajeev KG, 2015, CHEMBIOCHEM, V16, P903, DOI 10.1002/cbic.201500023; Schwetz TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113020; Shiota C, 2002, J BIOL CHEM, V277, P37176, DOI 10.1074/jbc.M206757200; Silvestre RA, 2008, J ENDOCRINOL, V196, P283, DOI 10.1677/JOE-07-0454; Song WJ, 2014, CELL METAB, V19, P667, DOI 10.1016/j.cmet.2014.03.005; Streeper RS, 2001, J BIOL CHEM, V276, P19111, DOI 10.1074/jbc.M101442200; Vikman J, 2009, DIABETES OBES METAB, V11, P197, DOI 10.1111/j.1463-1326.2009.01116.x; Welters A, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0367-x; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535	35	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236892	10.1371/journal.pone.0236892	http://dx.doi.org/10.1371/journal.pone.0236892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735622	gold, Green Published			2022-12-26	WOS:000569367100058
J	Yoshimura, H; Qi, HY; Kikuchi, DM; Matsui, Y; Fukushima, K; Kudo, S; Ban, K; Kusano, K; Nagano, D; Hara, M; Sato, Y; Takatsu, K; Hirata, S; Kinoshita, K				Yoshimura, Hiroto; Qi, Huiyuan; Kikuchi, Dale M.; Matsui, Yukiko; Fukushima, Kazuya; Kudo, Sai; Ban, Kazuyuki; Kusano, Keisuke; Nagano, Daisuke; Hara, Mami; Sato, Yasuhiro; Takatsu, Kiyoko; Hirata, Satoshi; Kinoshita, Kodzue			The relationship between plant-eating and hair evacuation in snow leopards (Panthera uncia)	PLOS ONE			English	Article							FEEDING-HABITS; CAT; CARNIVORES; PREY; DIET; IDENTIFICATION; FOREST; TIGER; PARK	Although most felids have an exclusive carnivore diet, the presence of plant matter in scat has been reported among various species. This indicates that there may be an adaptive significance to the conservation of plant-eating behavior in felid evolution. Some studies have hypothesized that felids consume plants for self-medication or as a source of nutrition. In addition, it is thought that plant intake helps them to excrete hairballs, however, no scientific work has confirmed these effects. Thus, the objective of this study is to investigate the relationship between plant intake and hair evacuation in felid species. We selected snow leopards (Panthera uncia) as the study species because they have longer and denser hair than other felids. The behavior of 11 captive snow leopards was observed and scat samples from eight of them and two other captive individuals were analyzed. Snow leopards evacuate hair possibly by vomiting and excreting in scats. The frequency of plant-eating and vomiting and the amount of hair and plant in scat were evaluated. We found that the frequency of vomiting was much lower than the frequency of plant-eating. In addition, there was no significant relationship between the amount of plant matter contained in scats and the amount of hair in scats. Contrary to the common assumption, our results indicate that plant intake has little effect on hair evacuation in felid species.	[Yoshimura, Hiroto; Qi, Huiyuan; Hirata, Satoshi; Kinoshita, Kodzue] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Kikuchi, Dale M.] Tokyo Inst Technol, Dept Mech Engn Sci, Tokyo, Japan; [Matsui, Yukiko; Takatsu, Kiyoko] Tama Zool Pk, Hino, Tokyo, Japan; [Fukushima, Kazuya; Kudo, Sai] Sapporo Maruyama Zoo, Sapporo, Hokkaido, Japan; [Ban, Kazuyuki] Omuta City Zoo, Omuta, Fukuoka, Japan; [Kusano, Keisuke; Nagano, Daisuke] Kumamoto City Zool & Bot Gardens, Kumamoto, Japan; [Hara, Mami; Sato, Yasuhiro] Nagoya Higashiyama Zoo, Nagoya, Aichi, Japan; [Hara, Mami; Sato, Yasuhiro] Bot Gardens, Nagoya, Aichi, Japan; [Ban, Kazuyuki] Morioka Zool Pk, Morioka, Iwate, Japan	Kyoto University; Tokyo Institute of Technology	Yoshimura, H; Kinoshita, K (corresponding author), Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan.	hrt.yoshimura@gmail.com; kinoshita.kodzue.8v@kyoto-u.ac.jp		Yoshimura, Hiroto/0000-0003-1626-0790; Kinoshita, Kodzue/0000-0002-5804-5485	JSPS KAKENHI [20H03008]; Leading Graduate Program in Primatology and Wildlife Science	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Leading Graduate Program in Primatology and Wildlife Science	Leading Graduate Program in Primatology and Wildlife Science (http://www.wildlife-science.org/index-en.html) supported logistic cost for the field work to HY. This work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (B) (20H03008) to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar Bilal M, EUR J WILDL RES; Arai H., 2006, J GEOL SOC JAPAN, V112, P439, DOI DOI 10.5575/GEOSOC.112.439; Biro Z, 2005, J ZOOL, V266, P187, DOI 10.1017/S0952836905006771; Bol S, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0987-6; Cannon M, 2013, J FELINE MED SURG, V15, P21, DOI 10.1177/1098612X12470342; Chetri M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170549; Devkota B.P., 2013, APPL ECOL ENV SCI, V1, P55, DOI DOI 10.12691/AEES-1-4-4; Edwards MS, 2001, PROCEEDINGS OF THE AZA NUTRITION ADVISORY GROUP FOURTH CONFERENCE ON ZOO AND WILDLIFE NUTRITION, P71; Fox JL, 2016, BIODIVER WORL CONS, P13, DOI 10.1016/B978-0-12-802213-9.00002-X; Freeman H.E., 1975, International Zoo Yearbook, V15, P217, DOI 10.1111/j.1748-1090.1975.tb01403.x; Hart BL, 2008, VET MED-US, V103, P648; Hart JA, 1996, AFR J ECOL, V34, P364, DOI 10.1111/j.1365-2028.1996.tb00632.x; HEMMER H, 1972, Mammalian Species, V20, P1; Herbst M, 2010, J ZOOL, V280, P403, DOI 10.1111/j.1469-7998.2009.00679.x; HOPPEDOMINIK B, 1988, NATURWISSENSCHAFTEN, V75, P49, DOI 10.1007/BF00367444; Jumabay-Uulu K, 2014, ORYX, V48, P529, DOI 10.1017/S0030605313000306; Kapfer PM, 2011, WILDLIFE BIOL, V17, P277, DOI 10.2981/10-127; Kitchener Andrew C., 2010, P83; Kubo T., 2018, BEGINNERS BOOK STAT; Lei WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139670; Mallon D, 2016, BIODIVER WORL CONS, P43, DOI 10.1016/B978-0-12-802213-9.00004-3; Martin-Fernandez JA, 2003, MATH GEOL, V35, P253, DOI 10.1023/A:1023866030544; Maskell I. E., 1993, The Waltham book of companion animal nutrition., P25; McCarthy T., 2017, IUCN RED LIST THREAT; McCarthy T, 2016, BIODIVER WORL CONS, P23, DOI 10.1016/B978-0-12-802213-9.00003-1; McCarthy TM, 2005, BIOL CONSERV, V124, P527, DOI 10.1016/j.biocon.2005.03.003; MORRIS JG, 1977, BRIT J NUTR, V37, P365, DOI 10.1079/BJN19770040; Namba S, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00672; OLI MK, 1993, J ZOOL, V231, P71, DOI 10.1111/j.1469-7998.1993.tb05354.x; Ott T, 2007, AFR ZOOL, V42, P31, DOI 10.3377/1562-7020(2007)42[31:POOTDO]2.0.CO;2; Prola L, 2010, J ANIM PHYSIOL AN N, V94, P362, DOI 10.1111/j.1439-0396.2008.00916.x; R Development Core Team, 2019, R VERS 3 6 1 LANG EN; Rocha-Mendes F, 2010, BIOTA NEOTROP, V10, P21, DOI 10.1590/S1676-06032010000400001; Sanquist M., 2002, WILD CATS WORLD; Sarasola JH, 2016, SCI REP, P6; SCHALLER GB, 1988, BIOL CONSERV, V45, P179, DOI 10.1016/0006-3207(88)90138-3; Shehzad W., 2012, PLOS ONE, V7; Shultz D., 2019, SCIENCE 80       AUG; Sueda KLC, 2008, APPL ANIM BEHAV SCI, V111, P120, DOI 10.1016/j.applanim.2007.05.018; Sugimoto T, 2006, CONSERV GENET, V7, P799, DOI 10.1007/s10592-005-9071-z; TATARA M, 1994, ECOL RES, V9, P99, DOI 10.1007/BF02347247; Wegge P, 2012, WILDLIFE BIOL, V18, P131, DOI 10.2981/11-049; Xiong M, 2016, J MAMMAL, P97	43	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236635	10.1371/journal.pone.0236635	http://dx.doi.org/10.1371/journal.pone.0236635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32736376	gold, Green Published			2022-12-26	WOS:000569367100034
J	Zhuo, Y; Gurevich, VV; Vishnivetskiy, SA; Klug, CS; Marchese, A				Zhuo, Ya; Gurevich, Vsevolod V.; Vishnivetskiy, Sergey A.; Klug, Candice S.; Marchese, Adriano			A non-GPCR-binding partner interacts with a novel surface on beta-arrestin1 to mediate GPCR signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arrestin; arrestin signaling; CXC-chemokine receptor type 4 (CXCR4); electron paramagnetic resonance (EPR); G protein-coupled receptor (GPCR); PTK2 protein-tyrosine kinase 2 (PTK2); focal adhesion kinase (FAK); bioluminescence resonance energy transfer (BRET)	FOCAL ADHESION KINASE; CRYSTAL-STRUCTURE; BETA-ARRESTIN; CONFORMATIONAL-CHANGES; RECEPTOR-BINDING; BREAST-CANCER; CHEMOKINE RECEPTORS; ADAPTER MOLECULE-1; VISUAL ARRESTIN; BONE-MARROW	The multifaceted adaptor protein beta-arr1 (beta-arrestin1) promotes activation of focal adhesion kinase (FAK) by the chemokine receptor CXCR4, facilitating chemotaxis. This function of beta-arr1 requires the assistance of the adaptor protein STAM1 (signal-transducing adaptor molecule 1) because disruption of the interaction between STAM1 and beta-arr1 reduces CXCR4-mediated activation of FAK and chemotaxis. To begin to understand the mechanism by which beta-arr1 together with STAM1 activates FAK, we used site-directed spin-labeling EPR spectroscopy-based studies coupled with bioluminescence resonance energy transfer-based cellular studies to show that STAM1 is recruited to activated beta-arr1 by binding to a novel surface on beta-arr1 at the base of the finger loop, at a site that is distinct from the receptor-binding site. Expression of a STAM1-deficient binding beta-arr1 mutant that is still able to bind to CXCR4 significantly reduced CXCL12-induced activation of FAK but had no impact on ERK-1/2 activation. We provide evidence of a novel surface at the base of the finger loop that dictates non-GPCR interactions specifying beta-arrestin-dependent signaling by a GPCR. This surface might represent a previously unidentified switch region that engages with effector molecules to drive beta-arrestin signaling.	[Zhuo, Ya; Marchese, Adriano] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Klug, Candice S.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Gurevich, Vsevolod V.; Vishnivetskiy, Sergey A.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA	Medical College of Wisconsin; Medical College of Wisconsin; Vanderbilt University	Marchese, A (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	amarchese@mcw.edu			National Institutes of Health [GM106727]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant GM106727 (to A. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alekhina O, 2016, J BIOL CHEM, V291, P26083, DOI 10.1074/jbc.M116.757138; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bonneterre J, 2016, METHOD ENZYMOL, V570, P131, DOI 10.1016/bs.mie.2015.09.003; Bornhorst JA, 2000, METHOD ENZYMOL, V326, P245; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Charest PG, 2005, EMBO REP, V6, P334, DOI 10.1038/sj.embor.7400373; Chen QY, 2018, TRENDS BIOCHEM SCI, V43, P412, DOI 10.1016/j.tibs.2018.03.005; Chen QY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01218-8; Chen Qiuyan, 2014, Handb Exp Pharmacol, V219, P205, DOI 10.1007/978-3-642-41199-1_11; Coffa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028723; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; GrayKeller MP, 1997, BIOCHEMISTRY-US, V36, P7058, DOI 10.1021/bi963110k; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Gurevich VV, 2012, CELL SIGNAL, V24, P1899, DOI 10.1016/j.cellsig.2012.05.012; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hamdan Fadi F, 2006, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0523s34; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Huang WJ, 2020, NATURE, V579, P303, DOI 10.1038/s41586-020-1953-1; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Hung CS, 2014, TUMOR BIOL, V35, P1581, DOI 10.1007/s13277-013-1218-9; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Klug CS, 2008, METHOD CELL BIOL, V84, P617, DOI 10.1016/S0091-679X(07)84020-9; Kumari P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13416; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Luttrell LM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat7650; Malik R, 2012, J BIOL CHEM, V287, P9013, DOI 10.1074/jbc.M111.336792; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marullo S, 2007, TRENDS PHARMACOL SCI, V28, P362, DOI 10.1016/j.tips.2007.06.007; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nguyen AH, 2019, NAT STRUCT MOL BIOL, V26, P1123, DOI 10.1038/s41594-019-0330-y; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Scheerert P, 2017, CURR OPIN STRUC BIOL, V45, P160, DOI 10.1016/j.sbi.2017.05.001; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Sente A, 2018, NAT STRUCT MOL BIOL, V25, P541, DOI 10.1038/s41594-018-0071-3; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shi JS, 2014, FUTURE ONCOL, V10, P749, DOI 10.2217/fon.13.193; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Staus DP, 2020, NATURE, V579, P297, DOI 10.1038/s41586-020-1954-0; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Warshaviak DT, 2013, J MAGN RESON, V232, P53, DOI 10.1016/j.jmr.2013.04.013; Yin WC, 2019, CELL RES, V29, P971, DOI 10.1038/s41422-019-0256-2; Zhan XZ, 2014, CELL SIGNAL, V26, P766, DOI 10.1016/j.cellsig.2014.01.001; Zhan Xuanzhi, 2014, Handb Exp Pharmacol, V219, P259, DOI 10.1007/978-3-642-41199-1_13; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002; Zhuo Y, 2014, J BIOL CHEM, V289, P20991, DOI 10.1074/jbc.M114.560680	78	3	3	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2020	295	41					14111	14124		10.1074/jbc.RA120.015074	http://dx.doi.org/10.1074/jbc.RA120.015074			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OG1HE	32753481	hybrid, Green Published			2022-12-26	WOS:000581643400013
J	Fu, X; Wang, J; Xie, MY; Zhao, FZ; Doughty, R				Fu, Xin; Wang, Jun; Xie, Mengyi; Zhao, Fazhu; Doughty, Russell			Increasing temperature can modify the effect of straw mulching on soil C fractions, soil respiration, and microbial community composition	PLOS ONE			English	Article							ORGANIC-CARBON FRACTIONS; BACTERIAL COMMUNITY; NITROGEN ADDITION; SENSITIVITY; INCUBATION; RESPONSES; BIOMASS; DECOMPOSITION; QUALITY; FOREST	Straw mulching has been widely adopted in dryland cropping but its effect on soil respiration and microbial communities under warming are not well understood. Soil samples were collected from a corn field with straw mulching (SM) for nine years and without straw mulching (CK), and incubated at 15 degrees C, 25 degrees C, and 35 degrees C for 60 days. Soil respiration, C fractions and bacterial and fungal community structure were measured SM had greater soil organic carbon and potential C mineralization and a similar microbial biomass carbon throughout the incubation when compared with CK. Soil respiration increased with increasing temperature and its temperature sensitivity (Q(10)) was lower with SM than CK. Similar microbial community composition was found in the soils with SM and CK before incubation. However, SM had a greater bacterial richness and the relative abundances ofProteobacteria,Acidobacteria,Nitrospirae,Planctomycetes,Bacteroidetes, andBasidiomycota, but lower relative abundances ofActinobacteria,Chloroflexi,and Ascomycotathan CK after incubation. Bacterial richness and diversity were greater at 15 degrees C and 25 degrees C than 35 degrees C, but there was no difference in fungal richness and diversity among the incubation temperatures. As temperature increased, the relative abundances ofChloroflexi,Acidobacteria, andBacteroidetesdecreased, butGemmatimonadetesandAscomycotaincreased, and were significantly correlated with soil C fractions and respiration. These findings indicated that the effect of straw mulching on soil C cycling and microbial community structure can be highly modified by increasing temperature.	[Fu, Xin; Wang, Jun; Xie, Mengyi; Zhao, Fazhu] Chinese Acad Sci & Minist Water Resources, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [Fu, Xin] Hebei Agr Univ, Coll Land & Resources, Baoding, Peoples R China; [Wang, Jun; Xie, Mengyi; Zhao, Fazhu] Northwest Univ, Coll Urban & Environm Sci, Shaanxi Key Lab Earth Surface Syst & Environm Car, Xian, Peoples R China; [Doughty, Russell] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Hebei Agricultural University; Northwest University Xi'an; California Institute of Technology	Wang, J (corresponding author), Chinese Acad Sci & Minist Water Resources, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China.; Wang, J (corresponding author), Northwest Univ, Coll Urban & Environm Sci, Shaanxi Key Lab Earth Surface Syst & Environm Car, Xian, Peoples R China.	wangj@nwu.edu.cn	Doughty, Russell/M-2499-2018; Ren, Chengjie/CAF-2259-2022; Zhao, Fazhu/CAG-5988-2022	Doughty, Russell/0000-0001-5191-2155; Zhao, Fazhu/0000-0003-4758-3277; Wang, Jun/0000-0002-8011-3149	Chinese Academy of Sciences 505 "Light of West China" Program for Introduced Talent in the West; National Natural Science Foundation of China [507 31570440, 31270484]; Key International Scientific and Technological Cooperation and Exchange Project of Shaanxi Province, China [2020KWZ-010]	Chinese Academy of Sciences 505 "Light of West China" Program for Introduced Talent in the West; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key International Scientific and Technological Cooperation and Exchange Project of Shaanxi Province, China	The study was supported by the Chinese Academy of Sciences 505 "Light of West China" Program for Introduced Talent in the West, the National Natural Science Foundation of China (Grant No. 507 31570440, 31270484), and the Key International Scientific and Technological Cooperation and Exchange Project of Shaanxi Province, China (grant number 2020KWZ-010)	Allison SD, 2009, SOIL BIOL BIOCHEM, V41, P293, DOI 10.1016/j.soilbio.2008.10.032; Birge HE, 2015, SOIL BIOL BIOCHEM, V81, P304, DOI 10.1016/j.soilbio.2014.11.028; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen YX, 2014, SCI HORTIC-AMSTERDAM, V172, P248, DOI 10.1016/j.scienta.2014.04.010; Dai SS, 2017, EUR J SOIL BIOL, V81, P69, DOI 10.1016/j.ejsobi.2017.06.010; [董立国 Dong Liguo], 2010, [生态环境学报, Ecology and Environmental Sciences], V19, P444; Dossou-Yovo ER, 2016, SOIL TILL RES, V163, P152, DOI 10.1016/j.still.2016.05.019; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fissore C, 2009, SOIL BIOL BIOCHEM, V41, P458, DOI 10.1016/j.soilbio.2008.11.004; Follett RF, 2007, SOIL SCI, V172, P189, DOI 10.1097/ss.0b013e31803403de; Fu X, 2019, APPL SOIL ECOL, V139, P64, DOI 10.1016/j.apsoil.2019.03.018; Guo LJ, 2015, BIOL FERT SOILS, V51, P65, DOI 10.1007/s00374-014-0951-6; He ZL, 2012, ISME J, V6, P259, DOI 10.1038/ismej.2011.99; Huang FY, 2019, EUR J SOIL BIOL, V92, P8, DOI 10.1016/j.ejsobi.2019.04.001; Huang ZQ, 2008, APPL SOIL ECOL, V40, P229, DOI 10.1016/j.apsoil.2008.04.009; JOERGENSEN RG, 1990, SOIL BIOL BIOCHEM, V22, P1129, DOI 10.1016/0038-0717(90)90039-3; Jozefowska A, 2017, EUR J SOIL BIOL, V80, P102, DOI 10.1016/j.ejsobi.2017.05.004; Kopittke PM, 2020, GEODERMA, V357, DOI 10.1016/j.geoderma.2019.113974; Lal R, 2008, ENERG ENVIRON SCI, V1, P86, DOI 10.1039/b809492f; Lanza G, 2016, SOIL TILL RES, V164, P18, DOI 10.1016/j.still.2016.01.005; Lee Eun-Hye, 2012, Journal of Ecology and Field Biology, V35, P1, DOI 10.5141/JEFB.2012.001; [李强 Li Qiang], 2016, [草原与草坪, Grassland and Turf], V36, P46; Li XS, 2018, RSC ADV, V8, P12588, DOI 10.1039/c8ra00708j; Liu JJ, 2017, APPL SOIL ECOL, V119, P407, DOI 10.1016/j.apsoil.2017.07.013; Liu LT, 2015, AGR FOREST METEOROL, V207, P38, DOI 10.1016/j.agrformet.2015.03.013; Liu YC, 2016, AGR FOREST METEOROL, V226, P186, DOI 10.1016/j.agrformet.2016.06.003; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo SS, 2015, EUR J SOIL BIOL, V67, P35, DOI 10.1016/j.ejsobi.2015.01.004; Ma CJ, 2017, ROM AGRIC RES, V34, P129; Meyer N, 2018, GLOBAL BIOGEOCHEM CY, V32, P306, DOI 10.1002/2017GB005644; Muller-Stover D, 2012, BIOL FERT SOILS, V48, P371, DOI 10.1007/s00374-011-0633-6; Pettersson M, 2003, FEMS MICROBIOL ECOL, V45, P13, DOI 10.1016/S0168-6496(03)00106-5; Ren CJ, 2018, FOREST ECOL MANAG, V409, P170, DOI 10.1016/j.foreco.2017.11.011; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; Suh SU, 2006, ECOL RES, V21, P405, DOI 10.1007/s11284-005-0137-7; Sun JN, 2016, SCI TOTAL ENVIRON, V569, P390, DOI 10.1016/j.scitotenv.2016.06.082; Teklay T, 2010, APPL SOIL ECOL, V46, P413, DOI 10.1016/j.apsoil.2010.09.009; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Thiessen S, 2013, SOIL BIOL BIOCHEM, V57, P739, DOI 10.1016/j.soilbio.2012.10.029; Trivedi P, 2015, SOIL BIOL BIOCHEM, V91, P169, DOI 10.1016/j.soilbio.2015.08.034; [涂纯 Tu Chun], 2012, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V18, P1103; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; Wang HH, 2020, APPL SOIL ECOL, V148, DOI 10.1016/j.apsoil.2019.103488; Wang J, 2018, SOIL SCI SOC AM J, V82, P371, DOI 10.2136/sssaj2017.11.0397; Wang QK, 2018, AGR FOREST METEOROL, V260, P240, DOI 10.1016/j.agrformet.2018.06.018; Wardle DA, 1995, SOIL BIOL BIOCHEM, V27, P1601, DOI 10.1016/0038-0717(95)00093-T; Wei H, 2015, SCI REP-UK, V5, DOI 10.1038/srep07854; Wetterstedt JAM, 2010, GLOBAL CHANGE BIOL, V16, P1806, DOI 10.1111/j.1365-2486.2009.02112.x; Whitaker J, 2014, J ECOL, V102, P1058, DOI 10.1111/1365-2745.12247; Wu YP, 2010, J SOIL SEDIMENT, V10, P223, DOI 10.1007/s11368-009-0118-5; Xiao Y, 2015, ECOL ENG, V82, P381, DOI 10.1016/j.ecoleng.2015.05.015; Yan D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05293-1; Zhao FZ, 2018, EUR J SOIL SCI, V69, P370, DOI 10.1111/ejss.12525; Zhou WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092531	54	5	6	13	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237245	10.1371/journal.pone.0237245	http://dx.doi.org/10.1371/journal.pone.0237245			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780782	Green Published, Green Accepted, gold			2022-12-26	WOS:000562664700023
J	Puppel, K; Golebiewski, M; Grodkowski, G; Solarczyk, P; Kostusiak, P; Klopcic, M; Sakowski, T				Puppel, Kamila; Golebiewski, Marcin; Grodkowski, Grzegorz; Solarczyk, Pawel; Kostusiak, Piotr; Klopcic, Maria; Sakowski, Tomasz			Use of somatic cell count as an indicator of colostrum quality	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; ESSENTIAL FATTY-ACIDS; MILK; LACTOFERRIN; LYSOZYME; MASTITIS; IMMUNITY; HEALTH; CALVES; SERUM	The impact of cow mammary gland diseases on the quality of colostrum is not conclusively defined; research results are conflicting. However, it is widely believed thatmastitislowers the level of immunoglobulins and the quality of the colostrum produced. Therefore, the aim of this study was to determine the influence of somatic cell counts (SCC) on the colostrum immunostimulating and chemical components. The experiment was conducted on an experimental organic dairy farm in which a herd of approximately 250 cows was kept in a freestall housing system, with the average performance exceeding 6,000 kg of milk per lactation. Colostrum and milk samples were taken individually from each cow seven times during the experiment: from the first to second day after calving-twice per day, and from the third to fifth day after calving-once per day. Therefore, after preliminary analyses, the cows were divided into two groups based on the cytological quality of their colostrum at the first collection: 1. SCC <= 400,000 cells/ml (good quality colostrum; GCC- 18 cows), 2. SCC >= 400,000 cells/ml (low quality colostrum; LCC- 22 cows). The study found almost double the concentration of immunoglobulins and essential fatty acids in first milking colostrum in the GCC group than in colostrum from the LCC group. In addition, an increase in the concentration of lysozyme in first milking colostrum was associated with a decrease in the concentration of immunoglobulins. In addition, the increase in the level of lysozyme was associated with a decrease in the concentration of immunoglobulins. In conclusion, the SCC of first milking colostrum can be used as an indicator of colostrum quality.	[Puppel, Kamila; Golebiewski, Marcin; Grodkowski, Grzegorz; Solarczyk, Pawel; Kostusiak, Piotr] Warsaw Univ Life Sci, Inst Anim Sci, Warsaw, Poland; [Klopcic, Maria] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Anim Sci, Magdalenka, Poland; [Sakowski, Tomasz] Univ Ljubljana, Dept Anim Sci, Domzale, Slovenia	Warsaw University of Life Sciences; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; University of Ljubljana	Sakowski, T (corresponding author), Univ Ljubljana, Dept Anim Sci, Domzale, Slovenia.	t.sakowski@ighz.pl	Sakowski, Tomasz/I-3772-2019; Kostusiak, Piotr/GSD-4915-2022; Solarczyk, Paweł/AAB-5880-2021	Sakowski, Tomasz/0000-0002-2264-4638; Kostusiak, Piotr/0000-0002-5413-0754; Solarczyk, Paweł/0000-0002-7683-4998; Puppel, Kamila/0000-0003-2909-2087	CORE Organic Co-fund 2016/17 Funding Bodies [727495]	CORE Organic Co-fund 2016/17 Funding Bodies	The partners of the ProYoungStock consortium gratefully acknowledge the financial support for this project provided by the CORE Organic Co-fund 2016/17 Funding Bodies, being partners of the Horizon 2020 ERA-Net project CORE Organic Cofund (Coordination of European Transnational Research in Organic Food and Farming systems, project ID 727495). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auldist MJ, 1998, AUST J DAIRY TECHNOL, V53, P28; Bocca C, 2007, INT J CANCER, V121, P248, DOI 10.1002/ijc.22646; Bochnak J., 2017, JAKOSC SUROW POCHODZ, P32; Brandenburg K, 2001, BIOL CHEM, V382, P1215, DOI 10.1515/BC.2001.152; Cabral RG, 2016, J DAIRY SCI, V99, P4048, DOI 10.3168/jds.2015-9868; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Crop IBM, 2019, REL IBM SPSS WIND VE; Czyewska-Dors E, 2018, YCIE WET, V93, P765; Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; Das UN, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-9; Donovan SM, 2016, J PEDIATR-US, V173, pS16, DOI 10.1016/j.jpeds.2016.02.072; Fernandes KE, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00002; FLEENOR WA, 1980, J DAIRY SCI, V63, P973, DOI 10.3168/jds.S0022-0302(80)83034-7; Fox PE, 2003, PROTEINS, V1; Grodzki H., 2011, ODCHOW CIELT JAOWEK; Gulliksen SM, 2008, J DAIRY SCI, V91, P704, DOI 10.3168/jds.2007-0450; Habing G, 2017, J DAIRY SCI, V100, P3940, DOI 10.3168/jds.2016-11969; ISO P, 2000, AN VEG FATS OILS PRE; Johnson JL, 2007, J DAIRY SCI, V90, P5189, DOI 10.3168/jds.2007-0219; Kehoe SI, 2007, J DAIRY SCI, V90, P4108, DOI 10.3168/jds.2007-0040; KEHRLI ME, 1994, J DAIRY SCI, V77, P619, DOI 10.3168/jds.S0022-0302(94)76992-7; KISZA J, 1969, Milchwissenschaft, V24, P465; Le Roux Y, 2003, VET RES, V34, P629, DOI 10.1051/vetres:2003021; Lenierowski G, 2016, PRZEM SPOYW, V70, P27, DOI DOI 10.15199/65.2016.4.5; Levieux D, 1999, J DAIRY RES, V66, P421, DOI 10.1017/S0022029999003581; Lone AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00130; Martins SV, 2015, BIOCHEM BIOPH RES CO, V458, P356, DOI 10.1016/j.bbrc.2015.01.116; Maunsell FP, 1998, J DAIRY SCI, V81, P1291, DOI 10.3168/jds.S0022-0302(98)75691-7; MCDONALD MI, 1981, LANCET, V2, P1056; Miller A, 2001, LIPIDS, V36, P1161, DOI 10.1007/s11745-001-0827-0; Morrill KM, 2012, J DAIRY SCI, V95, P3997, DOI 10.3168/jds.2011-5174; Nakanishi T, 2003, NEUROSCI LETT, V341, P135, DOI 10.1016/S0304-3940(03)00189-7; Nia EF, 2010, J ANIM PHYSIOL AN N, V94, P628, DOI 10.1111/j.1439-0396.2009.00948.x; Ochoa TJ, 2009, BIOCHIMIE, V91, P30, DOI 10.1016/j.biochi.2008.04.006; Osaka I, 2014, J DAIRY SCI, V97, P6608, DOI 10.3168/jds.2013-7571; PAULIK S, 1985, VET MED-CZECH, V30, P21; Priyadarshini S, 2002, ASIAN AUSTRAL J ANIM, V15, P895, DOI 10.5713/ajas.2002.895; Puppel K, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9121070; Puppel K, 2018, J FOOD SCI, V83, P229, DOI 10.1111/1750-3841.13988; Puppel K, 2013, J SCI FOOD AGR, V93, P2276, DOI 10.1002/jsfa.6037; Quigley JD, 1998, J DAIRY SCI, V81, P2779, DOI 10.3168/jds.S0022-0302(98)75836-9; Quigley JD, 2001, J DAIRY SCI, V84, P2059, DOI 10.3168/jds.S0022-0302(01)74650-4; Robblee ED, 2003, J DAIRY SCI, V86, P1458, DOI 10.3168/jds.S0022-0302(03)73729-1; Rubio CA, 2014, PATHOGENS, V3, P73, DOI 10.3390/pathogens3010073; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; SHUSTER DE, 1991, J DAIRY SCI, V74, P3763, DOI 10.3168/jds.S0022-0302(91)78568-8; Sordi R, 2013, INT IMMUNOPHARMACOL, V17, P283, DOI 10.1016/j.intimp.2013.06.010; Talukder MJR, 2002, J DAIRY SCI, V85, P514, DOI 10.3168/jds.S0022-0302(02)74103-9; Tortorello C.A, 2014, ENCY FOOD MICROBIOLO, P930, DOI DOI 10.1016/B978-0-12-384730-0.00241-X; TSUJI S, 1990, J DAIRY SCI, V73, P125, DOI 10.3168/jds.S0022-0302(90)78654-7; van der Strate BWA, 2001, ANTIVIR RES, V52, P225, DOI 10.1016/S0166-3542(01)00195-4; Wasowska E, 2018, J SCI FOOD AGR, V98, P5062, DOI 10.1002/jsfa.9043; Yoon BK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041114; Yoshida A, 2000, J DAIRY SCI, V83, P2211, DOI 10.3168/jds.S0022-0302(00)75104-6; Zimecki Michal, 2005, Postepy Hig Med Dosw (Online), V59, P309	56	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237615	10.1371/journal.pone.0237615	http://dx.doi.org/10.1371/journal.pone.0237615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780761	Green Published, gold			2022-12-26	WOS:000562664700033
J	Bartman, CM; Schiliro, M; Helan, M; Prakash, YS; Linden, D; Pabelick, C				Bartman, Colleen M.; Schiliro, Marta; Helan, Martin; Prakash, Y. S.; Linden, David; Pabelick, Christina			Hydrogen sulfide, oxygen, and calcium regulation in developing human airway smooth muscle	FASEB JOURNAL			English	Article						calcium; contractility; fetal airway; oxygen; prematurity	CYSTATHIONINE BETA-SYNTHASE; PHYSIOLOGICAL ROLES; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; PRETERM INFANTS; GAMMA-LYASE; HYPEROXIA; METABOLISM; H2S; SULFHYDRATION	Preterm infants can develop airway hyperreactivity and impaired bronchodilation following supplemental O-2(hyperoxia) in early life, making it important to understand mechanisms of hyperoxia effects. Endogenous hydrogen sulfide (H2S) has anti-inflammatory and vasodilatory effects with oxidative stress. There is little understanding of H2S signaling in developing airways. We hypothesized that the endogenous H2S system is detrimentally influenced by O(2)and conversely H2S signaling pathways can be leveraged to attenuate deleterious effects of O-2. Using human fetal airway smooth muscle (fASM) cells, we investigated baseline expression of endogenous H2S machinery, and effects of exogenous H2S donors NaHS and GYY4137 in the context of moderate hyperoxia, with intracellular calcium regulation as a readout of contractility. Biochemical pathways for endogenous H2S generation and catabolism are present in fASM, and are differentially sensitive to O(2)toward overall reduction in H2S levels. H2S donors have downstream effects of reducing [Ca2+](i)responses to bronchoconstrictor agonist via blunted plasma membrane Ca(2+)influx: effects blocked by O-2. However, such detrimental O(2)effects are targetable by exogenous H2S donors such as NaHS and GYY4137. These data provide novel information regarding the potential for H2S to act as a bronchodilator in developing airways in the context of oxygen exposure.	[Bartman, Colleen M.; Schiliro, Marta; Helan, Martin; Prakash, Y. S.; Pabelick, Christina] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Prakash, Y. S.; Linden, David; Pabelick, Christina] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Helan, Martin] Masaryk Univ, Dept Anesthesiol & Intens Care, Brno, Czech Republic; [Helan, Martin] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic	Mayo Clinic; Mayo Clinic; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Pabelick, C (corresponding author), Mayo Clin, Dept Anesthesiol & Perioperat Med, 4-184 W Jos SMH, Rochester, MN 55905 USA.	pabelick.christina@mayo.edu	Helan, Martin/A-4159-2018	Helan, Martin/0000-0002-9021-4947; Prakash, Y S/0000-0002-2968-224X; Bartman, Colleen/0000-0002-3624-669X	Mayo Clinic Center for Biomedical Discovery; American Heart Association [20POST35210002]; Ministry of Education, Youth and Sports of the Czech Republic [LQ1605]; NIH [T32 HL105355, R01 HL056470, R01 HL 13840, 2]	Mayo Clinic Center for Biomedical Discovery; American Heart Association(American Heart Association); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Mayo Clinic Center for Biomedical Discovery (Pabelick, Linden); American Heart Association, Grant/Award Number: 20POST35210002; Ministry of Education, Youth and Sports of the Czech Republic, Grant/Award Number: LQ1605, NPU II; NIH, Grant/Award Number: T32 HL105355, R01 HL056470, R01 HL 13840 and 2	Agrawal N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004032; Ali NKM, 2012, NEONATOLOGY, V101, P106, DOI 10.1159/000329540; Ay B, 2004, AM J PHYSIOL-LUNG C, V286, pL909, DOI 10.1152/ajplung.00317.2003; Bazhanov N, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050249; Bazhanov N, 2017, AM J RESP CELL MOL, V57, P403, DOI 10.1165/rcmb.2017-0114TR; Britt RD, 2015, AM J PHYSIOL-LUNG C, V309, pL537, DOI 10.1152/ajplung.00232.2015; Britt RD, 2015, J CELL PHYSIOL, V230, P1189, DOI 10.1002/jcp.24814; Britt RD, 2013, EXPERT REV RESP MED, V7, P515, DOI 10.1586/17476348.2013.838020; Bucci M, 2010, ARTERIOSCL THROM VAS, V30, P1998, DOI 10.1161/ATVBAHA.110.209783; Cacanyiova S, 2016, PHYSIOL RES, V65, pS273, DOI 10.33549/physiolres.933438; Chen YH, 2009, CYTOKINE, V45, P117, DOI 10.1016/j.cyto.2008.11.009; Cherian S, 2014, PAEDIATR RESPIR REV, V15, P135, DOI 10.1016/j.prrv.2012.12.003; Cole FS, 2011, PEDIATRICS, V127, P363, DOI 10.1542/peds.2010-3507; Dongo E, 2018, NITRIC OXIDE-BIOL CH, V81, P75, DOI 10.1016/j.niox.2017.10.010; Dunn WR, 2016, PHARMACOL THERAPEUT, V158, P101, DOI 10.1016/j.pharmthera.2015.12.007; Edwards MO, 2015, J ALLERGY CLIN IMMUN, V136, P581, DOI 10.1016/j.jaci.2015.05.005; Faksh A, 2016, PEDIATR RES, V79, P391, DOI 10.1038/pr.2015.232; Faller S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176649; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; Farrow KN, 2012, ANTIOXID REDOX SIGN, V17, P460, DOI 10.1089/ars.2011.4184; Filipovic MR, 2015, HANDB EXP PHARMACOL, V230, P29, DOI 10.1007/978-3-319-18144-8_2; Freeman MR, 2017, AM J PHYSIOL-LUNG C, V313, pL360, DOI 10.1152/ajplung.00580.2016; Gheibi S, 2018, BIOCHEM PHARMACOL, V149, P42, DOI 10.1016/j.bcp.2018.01.017; Guan RJ, 2020, INT IMMUNOPHARMACOL, V81, DOI 10.1016/j.intimp.2019.105979; Halvorsen T, 2005, PEDIAT ALLERG IMM-UK, V16, P487, DOI 10.1111/j.1399-3038.2005.00314.x; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hartman WR, 2012, AM J PHYSIOL-LUNG C, V303, pL711, DOI 10.1152/ajplung.00037.2012; Hilgendorff A, 2008, PEDIATR CRIT CARE ME, V9, P629, DOI 10.1097/PCC.0b013e31818d17c8; Hong J, 2018, PATHOL RES PRACT, V214, P1804, DOI 10.1016/j.prp.2018.08.008; Hu H, 2008, NEUROSCIENCE, V156, P1074, DOI 10.1016/j.neuroscience.2008.08.025; Islam JY, 2015, AM J RESP CRIT CARE, V192, P134, DOI 10.1164/rccm.201412-2142PP; Ivanciuc T, 2016, AM J RESP CELL MOL, V55, P684, DOI 10.1165/rcmb.2015-0385OC; Jackson-Weaver O, 2013, AM J PHYSIOL-HEART C, V304, pH1446, DOI 10.1152/ajpheart.00506.2012; Kanagy NL, 2017, AM J PHYSIOL-CELL PH, V312, pC537, DOI 10.1152/ajpcell.00329.2016; Kandil S, 2010, NEUROCHEM INT, V56, P611, DOI 10.1016/j.neuint.2010.01.004; Kimura H, 2015, HANDB EXP PHARMACOL, V230, P61, DOI 10.1007/978-3-319-18144-8_3; Kimura H, 2014, NITRIC OXIDE-BIOL CH, V41, P4, DOI 10.1016/j.niox.2014.01.002; Kimura H, 2014, ANTIOXID REDOX SIGN, V20, P783, DOI 10.1089/ars.2013.5309; Kiss L, 2008, LIFE SCI, V83, P589, DOI 10.1016/j.lfs.2008.08.006; Kotecha S, 2018, PEDIAT ALLERG IMM-UK, V29, P715, DOI 10.1111/pai.12957; Lavoie PM, 2010, CURR OPIN PEDIATR, V22, P134, DOI 10.1097/MOP.0b013e328336eb85; Li HD, 2013, EUR J APPL PHYSIOL, V113, P1555, DOI 10.1007/s00421-012-2584-5; Li H, 2015, J VIROL, V89, P5557, DOI 10.1128/JVI.00264-15; Li H, 2014, NEUROREPORT, V25, P358, DOI 10.1097/WNR.0000000000000090; Li N, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6492469; Lin F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00675; Linden DR, 2012, BRIT J PHARMACOL, V165, P2178, DOI 10.1111/j.1476-5381.2011.01681.x; Linden DR, 2008, J NEUROCHEM, V106, P1577, DOI 10.1111/j.1471-4159.2008.05502.x; Linden DR, 2014, ANTIOXID REDOX SIGN, V20, P818, DOI 10.1089/ars.2013.5312; Liu CX, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2070971; Liu WL, 2013, CHINESE MED J-PEKING, V126, P494, DOI 10.3760/cma.j.issn.0366-6999.20120809; Lu AZ, 2019, PFLUG ARCH EUR J PHY, V471, P1551, DOI 10.1007/s00424-019-02325-9; Madurga A, 2015, AM J PHYSIOL-LUNG C, V309, pL710, DOI 10.1152/ajplung.00134.2015; Madurga A, 2014, AM J PHYSIOL-LUNG C, V306, pL684, DOI 10.1152/ajplung.00361.2013; Martelli A, 2013, PHARMACOL RES, V70, P27, DOI 10.1016/j.phrs.2012.12.005; Martin RJ, 2013, J PEDIATR-US, V162, P443, DOI 10.1016/j.jpeds.2012.11.028; Murphy B, 2019, FASEB J, V33, P13098, DOI 10.1096/fj.201901304R; Musharaf I, 2018, PULM PHARMACOL THER, V48, P195, DOI 10.1016/j.pupt.2017.12.003; Nagao M, 2011, J GASTROINTEST SURG, V15, P12, DOI 10.1007/s11605-010-1306-8; Niu WN, 2015, ANTIOXID REDOX SIGN, V22, P350, DOI 10.1089/ars.2014.5891; O'Reilly M, 2014, NEONATOLOGY, V105, P39, DOI 10.1159/000355641; Olson KR, 2016, PHYSIOLOGY, V31, P60, DOI 10.1152/physiol.00024.2015; Olson KR, 2010, AM J PHYSIOL-REG I, V298, pR51, DOI 10.1152/ajpregu.00576.2009; Onugha H, 2015, NEONATOLOGY, V108, P65, DOI 10.1159/000380758; Pandya HC, 2006, BIOL NEONATE, V89, P211, DOI 10.1159/000089497; Parikh P, 2019, AM J RESP CELL MOL, V61, P51, DOI 10.1165/rcmb.2018-0176OC; Perry MM, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0788-x; Prakash YS, 2017, AM J RESP CRIT CARE, V195, P247, DOI 10.1164/rccm.201611-2248ST; Prakash YS, 2016, AM J PHYSIOL-LUNG C, V311, pL1113, DOI 10.1152/ajplung.00370.2016; Prakash YS, 2013, AM J PHYSIOL-LUNG C, V305, pL912, DOI 10.1152/ajplung.00259.2013; Prudova A, 2006, P NATL ACAD SCI USA, V103, P6489, DOI 10.1073/pnas.0509531103; Sathish V, 2012, EUR RESPIR J, V40, P470, DOI 10.1183/09031936.00090511; Sbodio JI, 2018, P NATL ACAD SCI USA, V115, P780, DOI 10.1073/pnas.1717877115; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Singha S, 2015, ANAL CHEM, V87, P1188, DOI 10.1021/ac503806w; Strange K, 2007, CELL CALCIUM, V42, P193, DOI 10.1016/j.ceca.2007.02.007; Strege PR, 2011, AM J PHYSIOL-GASTR L, V300, pG1105, DOI 10.1152/ajpgi.00556.2010; Sun Y, 2017, ONCOTARGET, V8, P31888, DOI 10.18632/oncotarget.16649; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Szabo C, 2017, PHARMACOL REV, V69, P497, DOI 10.1124/pr.117.014050; VINA J, 1995, AM J CLIN NUTR, V61, P1067, DOI 10.1093/ajcn/61.5.1067; Vogel ER, 2017, PEDIATR RES, V81, P376, DOI 10.1038/pr.2016.218; Vogel ER, 2015, CAN J PHYSIOL PHARM, V93, P119, DOI 10.1139/cjpp-2014-0387; Vohra PK, 2013, BBA-MOL CELL RES, V1833, P2953, DOI 10.1016/j.bbamcr.2013.07.019; Wang H, 2014, AM J PHYSIOL-LUNG C, V307, pL295, DOI 10.1152/ajplung.00208.2013; Zhang GS, 2013, AM J PATHOL, V182, P1188, DOI 10.1016/j.ajpath.2012.12.008; Zhang J, 2014, RESPIROLOGY, V19, P1165, DOI 10.1111/resp.12372; Zhou YY, 2013, CHEM COMMUN, V49, P11782, DOI 10.1039/c3cc46719h; Zimmermann KK, 2018, INFLAMMATION, V41, P249, DOI 10.1007/s10753-017-0684-4; ZLOTKIN SH, 1982, PEDIATR RES, V16, P65	91	2	2	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12991	13004		10.1096/fj.202001180R	http://dx.doi.org/10.1096/fj.202001180R		AUG 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32777143	Green Accepted			2022-12-26	WOS:000558418100001
J	Queen, D; Shen, Y; Trager, MH; Lopez, AT; Samie, FH; Lewin, JM; Niedt, GW; Geskin, LJ; Liu, L				Queen, Dawn; Shen, Yao; Trager, Megan H.; Lopez, Adriana T.; Samie, Faramarz H.; Lewin, Jesse M.; Niedt, George W.; Geskin, Larisa J.; Liu, Liang			UV biomarker genes for classification and risk stratification of cutaneous actinic keratoses and squamous cell carcinoma subtypes	FASEB JOURNAL			English	Article						actinic keratosis; squamous cell carcinoma; ultraviolet radiation	SKIN-CANCER; KERATINOCYTE; EPIDEMIOLOGY; PATHOGENESIS; PROGRESSION; RESPONSES; HISTORY; TUMOR; P53	Currently, there is no sensitive molecular test for identifying transformation-prone actinic keratoses (AKs) and aggressive squamous cell carcinoma (SCC) subtypes. Biomarker-based molecular testing represents a promising tool for risk stratifying these lesions. We evaluated the utility of a panel of ultraviolet (UV) radiation-biomarker genes in distinguishing between benign and transformation-prone AKs and SCCs. The expression of the UV-biomarker genes in 31 SCC and normal skin (NS) pairs and 10 AK/NS pairs was quantified using the NanoString nCounter system. Biomarker testing models were built using logistic regression models with leave-one-out cross validation in the training set. The best model to classify AKs versus SCCs (area under curve (AUC) 0.814, precision score 0.833, recall 0.714) was constructed using a top-ranked set of 13 UV-biomarker genes. Another model based on a 15-gene panel was developed to differentiate histologically concerning from less concerning SCCs (AUC 1, precision score 1, recall 0.714). Finally, 12 of the UV-biomarker genes were differentially expressed between AKs and SCCs, while 10 genes were uniquely expressed in the more concerning SCCs. UV-biomarker gene subsets demonstrate dynamic utility as molecular tools to classify and risk stratify AK and SCC lesions, which will complement histopathologic diagnosis to guide treatment of high-risk patients.	[Queen, Dawn] Lankenau Med Ctr, Dept Med, Philadelphia, PA USA; [Shen, Yao] Columbia Univ, Dept Syst Biol, Irving Med Ctr, New York, NY USA; [Trager, Megan H.] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA; [Lopez, Adriana T.] NYU, Dept Dermatol, New York, NY 10016 USA; [Samie, Faramarz H.; Lewin, Jesse M.; Geskin, Larisa J.; Liu, Liang] Columbia Univ, Dept Dermatol, Irving Med Ctr, New York, NY 10027 USA; [Niedt, George W.] Columbia Univ, Dept Pathol, Irving Med Ctr, New York, NY USA; [Liu, Liang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	Lankenau Medical Center; Columbia University; NewYork-Presbyterian Hospital; Columbia University; New York University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; University of Minnesota System	Liu, L (corresponding author), Univ Minnesota, Hormel Inst, Austin, MN 55912 USA.	LIU00965@umn.edu			NIH/NIAMS [K01AR064315]; Prevent Cancer Foundation; Columbia University Herbert Irving Comprehensive Cancer Center [P30 CA013696]	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Prevent Cancer Foundation; Columbia University Herbert Irving Comprehensive Cancer Center	Funding through NIH/NIAMS grant K01AR064315; the Prevent Cancer Foundation research award; the Columbia University Herbert Irving Comprehensive Cancer Center (P30 CA013696)	Bolshakov S, 2003, CLIN CANCER RES, V9, P228; Carli P, 2004, MELANOMA RES, V14, P403, DOI 10.1097/00008390-200410000-00011; Chitsazzadeh V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12601; Criscione VD, 2009, CANCER-AM CANCER SOC, V115, P2523, DOI 10.1002/cncr.24284; Dawes JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093338; Dazard JE, 2003, ONCOGENE, V22, P2993, DOI 10.1038/sj.onc.1206537; Elmets CA, 2014, J INVEST DERMATOL, V134, P2497, DOI 10.1038/jid.2014.192; Feldman SR, 2011, CUTIS, V87, P201; Glogau RG, 2000, J AM ACAD DERMATOL, V42, pS23, DOI 10.1067/mjd.2000.103339; Holmes C, 2007, AUSTRALAS J DERMATOL, V48, P67, DOI 10.1111/j.1440-0960.2007.00339.x; Karaa A, 2007, INT J DERMATOL, V46, P671, DOI 10.1111/j.1365-4632.2007.03260.x; Karia PS, 2014, J CLIN ONCOL, V32, P327, DOI 10.1200/JCO.2012.48.5326; Karia PS, 2013, J AM ACAD DERMATOL, V68, P957, DOI 10.1016/j.jaad.2012.11.037; Lebwohl M, 2003, BRIT J DERMATOL, V149, P31, DOI 10.1046/j.0366-077X.2003.05621.x; Li M, 2004, IEEE T INFORM THEORY, V50, P3250, DOI 10.1109/TIT.2004.838101; Lohmann CM, 2001, ADV ANAT PATHOL, V8, P27, DOI 10.1097/00125480-200101000-00005; Marks R, 1997, J AM ACAD DERMATOL, V36, P721, DOI 10.1016/S0190-9622(97)80324-6; Mullen JT, 2006, ANN SURG ONCOL, V13, P902, DOI 10.1245/ASO.2006.07.022; Osborne JE, 2003, BRIT J DERMATOL, V148, P252, DOI 10.1046/j.1365-2133.2003.05154.x; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; Rowert-Huber J, 2007, BRIT J DERMATOL, V156, P8, DOI 10.1111/j.1365-2133.2007.07860.x; Rogers HW, 2015, JAMA DERMATOL, V151, P1081, DOI 10.1001/jamadermatol.2015.1187; Rossi R, 2007, INT J DERMATOL, V46, P895, DOI 10.1111/j.1365-4632.2007.03166.x; Schmults CD, 2013, JAMA DERMATOL, V149, P541, DOI 10.1001/jamadermatol.2013.2139; Shen Y, 2019, CARCINOGENESIS, V40, P687, DOI 10.1093/carcin/bgy168; Shen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163054; Shulstad RM, 2010, J DERMAT NURSES ASSO, V2, P12, DOI 10.1097/JDN.0b013e3181cb5165; Skvara H, 2005, ARCH DERMATOL, V141, P155, DOI 10.1001/archderm.141.2.155; Stern RS, 2010, ARCH DERMATOL, V146, P279, DOI 10.1001/archdermatol.2010.4; Yang G, 2006, J INVEST DERMATOL, V126, P2490, DOI 10.1038/sj.jid.5700470; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	31	2	2	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					13022	13032		10.1096/fj.202001412R	http://dx.doi.org/10.1096/fj.202001412R		AUG 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32776588	Green Accepted			2022-12-26	WOS:000558416300001
J	Calvez, E; Somlor, S; Viengphouthong, S; Baliere, C; Bounmany, P; Keosenhom, S; Caro, V; Grandadam, M				Calvez, Elodie; Somlor, Somphavanh; Viengphouthong, Souksakhone; Baliere, Charlotte; Bounmany, Phaithong; Keosenhom, Sitsana; Caro, Valerie; Grandadam, Marc			Rapid genotyping protocol to improve dengue virus serotype 2 survey in Lao PDR	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; GLOBAL SPREAD; AMINO-ACID; TYPE-2; OUTBREAKS; VIRULENCE; TAIWAN	Dengue fever is one of the major public health problems in Lao PDR. Over the last decade, dengue virus (DENV) epidemics were characterized by a novel predominant serotype accompanied by at least two other serotypes. Since 2008, DENV-2 circulated at a low level in Lao PDR but its epidemiologic profile changed at the end of 2018. Indeed, the number of confirmed DENV-2 cases suddenly increased in October 2018 and DENV-2 became predominant at the country level in early 2019. We developed a Genotype Screening Protocol (GSP) to determine the origin(s) of the Lao DENV-2 and study their genetic polymorphism. With a good correlation with full envelope gene sequencing data, this molecular epidemiology tool evidence the co-circulation of two highly polymorphic DENV-2 genotypes, i.e. Asian I and Cosmopolitan genotypes, over the last five years, suggesting multiple introductions of DENV-2 in the country. GSP approach provides relevant first line information that may help countries with limited laboratory resources to reinforce their capabilities to DENV-2 and to follow the epidemics progresses and assess situations at the regional level.	[Calvez, Elodie; Somlor, Somphavanh; Viengphouthong, Souksakhone; Bounmany, Phaithong; Keosenhom, Sitsana; Grandadam, Marc] Inst Pasteur Laos, Viangchan, Laos; [Baliere, Charlotte; Caro, Valerie] Inst Pasteur, Paris, France; [Grandadam, Marc] Inst Rech Biomed Armees, Bretigny Sur Orge, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Calvez, E (corresponding author), Inst Pasteur Laos, Viangchan, Laos.	e.calvez@pasteur.la	GRANDADAM, Marc/GNP-7470-2022	CALVEZ, Elodie/0000-0002-5772-8161; BALIERE, Charlotte/0000-0002-2865-5493	Agence Francaise de Developpement [CZZ 2146 01]	Agence Francaise de Developpement	MG received funding from the Agence Francaise de Developpement grant no CZZ 2146 01 (Ecomore2 project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afreen N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004511; Ahamed SF, 2019, INT J INFECT DIS, V84, pS34, DOI 10.1016/j.ijid.2019.01.014; Akram M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0371-8; Ali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138900; Anez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027459; [Anonymous], 1994, TROP MED; Anzai S, 2004, VIRUS GENES, V29, P219, DOI 10.1023/B:VIRU.0000036382.77987.84; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Castonguay-Vanier J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006203; Chen HL, 2008, AM J TROP MED HYG, V79, P495, DOI 10.4269/ajtmh.2008.79.495; Chen WJ, 2003, INTERVIROLOGY, V46, P289, DOI 10.1159/000073208; Christenbury JG, 2010, J VIROL METHODS, V169, P202, DOI 10.1016/j.jviromet.2010.06.013; Dash PK, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-55; Dash PK, 2013, BIOCHEM BIOPH RES CO, V436, P478, DOI 10.1016/j.bbrc.2013.05.130; Dupont-Rouzeyrol M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-61; Grant D, 2011, J VIROL, V85, P7775, DOI 10.1128/JVI.00665-11; GRUENBERG A, 1988, J GEN VIROL, V69, P1391, DOI 10.1099/0022-1317-69-6-1391; Hamel R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221179; Hapuarachchi HC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1606-z; Huang JH, 2012, AM J TROP MED HYG, V87, P349, DOI 10.4269/ajtmh.2012.11-0666; Institut Pasteur du Laos, 2019, I PAST LAOS ACT REP; Institut Pasteur du Laos, 2020, I PAST LAOS ACT REP; Ito M, 2004, J CLIN MICROBIOL, V42, P5935, DOI 10.1128/JCM.42.12.5935-5937.2004; Jiang L, 2018, FRONT CELL INFECT MI, P8; Khampapongpane B, 2014, WEST PAC SURVEILL RE, V5, DOI [10.5365/wpsar.2014.5.1.001, 10.5365/WPSAR.2014.5.1.001]; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kyaw AK, 2017, EPIDEMIOL INFECT, V145, P1886, DOI 10.1017/S0950268817000735; Lambrechts L, 2011, TRENDS PARASITOL, V27, P111, DOI 10.1016/j.pt.2010.12.001; Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160; Lao M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115569; Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; LEWIS JA, 1993, VIROLOGY, V197, P216, DOI 10.1006/viro.1993.1582; Ma XZ, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-56; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011; Moore PR, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.103; Ng LC, 2015, AM J TROP MED HYG, V92, P1150, DOI 10.4269/ajtmh.14-0588; Phadungsombat J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207220; Phommanivong Viengvaly, 2016, Trop Med Health, V44, P24, DOI 10.1186/s41182-016-0020-y; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384; Shrivastava S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192672; Somlor S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189879; Soukaloun Douangdao, 2014, Southeast Asian J Trop Med Public Health, V45 Suppl 1, P113; Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033; Ty Hang TT, 2010, PLOS NEGLECT TROP D, V4; Vasilakis N, 2008, VIROLOGY, V377, P296, DOI 10.1016/j.virol.2008.04.044; Vasilakis N, 2007, J VIROL, V81, P9591, DOI 10.1128/JVI.02776-06; Warrilow D, 2002, J MED VIROL, V66, P524, DOI 10.1002/jmv.2176; Warrilow D, 2012, EMERG INFECT DIS, V18, P1850, DOI 10.3201/eid1811.120014; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Williams M, 2014, AM J TROP MED HYG, V91, P611, DOI 10.4269/ajtmh.13-0600; Wu WL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-322; Yang CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006773; Zhao H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156548	58	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237384	10.1371/journal.pone.0237384	http://dx.doi.org/10.1371/journal.pone.0237384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764809	gold, Green Published			2022-12-26	WOS:000561029000003
J	Hao, YN; Sun, YX; Liu, CZ				Hao, Ya-Nan; Sun, Yuan-Xing; Liu, Chang-Zhong			Functional morphology of antennae and sensilla ofHippodamia variegata(Coleoptera: Coccinellidae)	PLOS ONE			English	Article							VARIEGATA GOEZE COLEOPTERA; SCANNING-ELECTRON-MICROSCOPY; HIPPODAMIA-VARIEGATA; FINE-STRUCTURE; SENSORY STRUCTURES; LIFE TABLE; BEETLE; HYMENOPTERA; ULTRASTRUCTURE; PREY	The lady beetleHippodamia variegatais an important biocontrol agent of many aphids. In this study, the fine morphology of antennae as well as the typology, morphology and distribution of antennal sensilla were comprehensively examined by scanning electron microscopy. The antennal morphology of female and male are similar and consist of the scape, pedicel, and nine flagellomeres. No significant difference was detected in the length of each segment between two sexes, while the male antennae are much stronger than females. In total, six types of sensilla can be defined on antenna, including Bohm bristle, sensilla chaetica (with three subtypes), sensilla basiconica (with three subtypes), sensilla trichodea, sensilla placodea and sensilla coeloconica. It is worth noting that sensilla chaetica III distributed only on the fixed position of male antennae. In addition, the functional morphology of antennae ofH.variegatawere compared with other lady beetles from multiple perspectives. Specially, the function of sensilla were also discussed according to their morphology, location and information from previous studies.	[Hao, Ya-Nan; Sun, Yuan-Xing; Liu, Chang-Zhong] Gansu Agr Univ, Coll Plant Protect, Biocontrol Engn Lab Crop Dis & Pests Gansu Prov, Lanzhou, Peoples R China	Gansu Agricultural University	Hao, YN (corresponding author), Gansu Agr Univ, Coll Plant Protect, Biocontrol Engn Lab Crop Dis & Pests Gansu Prov, Lanzhou, Peoples R China.	haoya_nan@126.com			Scientific Research Start-up Funds for Openlyrecruited Doctors of Gansu Agricultural University [2017RCZX-08]; Special Funds for Discipline Construction of Gansu Agricultural University [GAU-XKJS2018-157]; National Natural Science Foundation of China [31960561]; National Key Research and Development Program of China [2018YFD0200405]	Scientific Research Start-up Funds for Openlyrecruited Doctors of Gansu Agricultural University; Special Funds for Discipline Construction of Gansu Agricultural University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by (1) YNH: Scientific Research Start-up Funds for Openlyrecruited Doctors of Gansu Agricultural University (Grant numbers 2017RCZX-08); (2) YNH: Special Funds for Discipline Construction of Gansu Agricultural University (Grant number GAU-XKJS2018-157); (3) YXS: National Natural Science Foundation of China (Grant number 31960561); (4) CZL: The National Key Research and Development Program of China (Grant number 2018YFD0200405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALBERSBERG YK, 1988, B ENTOMOL RES, V78, P111, DOI 10.1017/S0007485300016114; Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; Araya JE, 1997, Z PFLANZENK PFLANZEN, V104, P147; Broeckling CD, 2003, ANN ENTOMOL SOC AM, V96, P153, DOI 10.1603/0013-8746(2003)096[0153:AMOTSP]2.0.CO;2; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed., P610, DOI DOI 10.1017/CBO9780511818202.024; Chi DF, 2009, ENTOMOL NEWS, V120, P137, DOI 10.3157/021.120.0203; DAVIS EE, 1975, J COMP PHYSIOL, V96, P223, DOI 10.1007/BF00612696; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; de la Fuente ALC, 2002, MEM I OSWALDO CRUZ, V97, P1121, DOI 10.1590/S0074-02762002000800010; Fan GH, 1998, NAT ENEMIES INSECTS, V10, P187; Farhadi R, 2010, ENVIRON ENTOMOL, V39, P1586, DOI 10.1603/EN09285; Franzmann BA, 2002, AUST J ENTOMOL, V41, P375, DOI 10.1046/j.1440-6055.2002.00318.x; Gao Fang-rui, 2017, Hebei Nongye Daxue Xuebao, V40, P72; Gardiner Mary M., 2005, Great Lakes Entomologist, V38, P164; Giglio A, 2010, ACTA ZOOL-STOCKHOLM, V91, P328, DOI 10.1111/j.1463-6395.2009.00414.x; Giles KL, 2002, BIOCONTROL, V47, P1, DOI 10.1023/A:1014419623501; GORDON RD, 1987, J NEW YORK ENTOMOL S, V95, P307; Hallberg E, 1999, MICROSC RES TECHNIQ, V47, P428, DOI 10.1002/(SICI)1097-0029(19991215)47:6<428::AID-JEMT6>3.0.CO;2-P; Hamilton RM, 1999, ENVIRON ENTOMOL, V28, P812, DOI 10.1093/ee/28.5.812; Hao YN, 2019, J MORPHOL, V280, P701, DOI 10.1002/jmor.20976; Hodek I, 1973, BIOL COCCINELLIDAE; Hu F, 2009, MICRON, V40, P320, DOI 10.1016/j.micron.2008.11.001; Isberg E, 2013, J MED ENTOMOL, V50, P485, DOI 10.1603/ME12235; Isidoro N, 1998, PHYSIOL ENTOMOL, V23, P131, DOI 10.1046/j.1365-3032.1998.232066.x; JOURDAN H, 1995, INT J INSECT MORPHOL, V24, P307, DOI 10.1016/0020-7322(95)98584-Z; Keil Thomas A., 1999, P5; Khan A. A., 2008, Journal of Biological Control, V22, P291; Kim JY, 2000, ARTHROPOD STRUCT DEV, V29, P121, DOI 10.1016/S1467-8039(00)00022-0; Kontodimas DC, 2005, BIOCONTROL, V50, P223, DOI 10.1007/s10526-004-0455-7; Kuravova K, 2017, ZOOL ANZ, V266, P120, DOI 10.1016/j.jcz.2016.11.003; Lanzoni A, 2004, J APPL ENTOMOL, V128, P298, DOI 10.1111/j.1439-0418.2004.00847.x; Liu Jianwu, 2006, Journal of Northeast Forestry University, V34, P114; Liu Ping, 2013, Huanjing Kunchong Xuebao, V35, P478; Lopes O, 2002, ARTHROPOD STRUCT DEV, V31, P1, DOI 10.1016/S1467-8039(02)00011-7; MARTINI R, 1986, TISSUE CELL, V18, P143, DOI 10.1016/0040-8166(86)90013-3; Merivee E, 1999, INT J INSECT MORPHOL, V28, P41, DOI 10.1016/S0020-7322(98)00032-4; Merivee E, 2002, MICRON, V33, P429, DOI 10.1016/S0968-4328(02)00003-3; Nowinska A, 2019, ZOOMORPHOLOGY, V138, P307, DOI 10.1007/s00435-019-00446-4; Ochieng S. A., 1996, P 20 INT C ENT, P25; Ochieng SA, 2000, ARTHROPOD STRUCT DEV, V29, P231, DOI 10.1016/S1467-8039(01)00008-1; OGENGALATIGO MW, 1994, INSECT SCI APPL, V15, P55, DOI 10.1017/S1742758400016763; Onagbola EO, 2008, MICRON, V39, P526, DOI 10.1016/j.micron.2007.08.001; Pitts RJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-26; Polidori C, 2012, CR BIOL, V335, P279, DOI 10.1016/j.crvi.2012.03.008; Ren LL, 2014, MICRON, V60, P29, DOI 10.1016/j.micron.2014.01.005; Renou M, 1998, INT J INSECT MORPHOL, V27, P227, DOI 10.1016/S0020-7322(98)00014-2; Romani R, 2008, J EXP BIOL, V211, P2486, DOI 10.1242/jeb.013177; Ruschioni S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124607; Said I, 2003, J INSECT PHYSIOL, V49, P857, DOI 10.1016/S0022-1910(03)00137-9; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; Srivastava Shefali, 2003, Entomologia Sinica, V10, P271; van Baaren J, 1999, ZOOMORPHOLOGY, V119, P1, DOI 10.1007/s004350050076; Vera W, 2018, MICROSC RES TECHNIQ, V81, P590, DOI 10.1002/jemt.23014; Wang HM, 2018, ENTOMOL RES, V48, P466, DOI 10.1111/1748-5967.12296; Wang RR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194995; WCISLO WT, 1995, INT J INSECT MORPHOL, V24, P63, DOI 10.1016/0020-7322(94)E0006-B; Wei CY, 2015, FLA ENTOMOL, V98, P140, DOI 10.1653/024.098.0124; Wu XH, 2010, J PEST SCI, V83, P77, DOI 10.1007/s10340-009-0272-y; Zacharuk R.Y., 1985, COMPREHENSIVE INSECT, P1; ZACHARUK RY, 1980, ANNU REV ENTOMOL, V25, P27, DOI 10.1146/annurev.en.25.010180.000331; Zhang J, 2011, ANN ENTOMOL SOC AM, V104, P778, DOI 10.1603/AN10188; Zhu Q, 2019, INSECTS, V10, DOI 10.3390/insects10020056	62	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237452	10.1371/journal.pone.0237452	http://dx.doi.org/10.1371/journal.pone.0237452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764805	Green Published, gold			2022-12-26	WOS:000561029000073
J	Matovu, JKB; Bogart, LM; Nakabugo, J; Kagaayi, J; Serwadda, D; Wanyenze, RK; Ko, AI; Kurth, AE				Matovu, Joseph K. B.; Bogart, Laura M.; Nakabugo, Jennifer; Kagaayi, Joseph; Serwadda, David; Wanyenze, Rhoda K.; Ko, Albert I.; Kurth, Ann E.			Feasibility and acceptability of a pilot, peer-led HIV self-testing intervention in a hyperendemic fishing community in rural Uganda	PLOS ONE			English	Article							MEN; CARE; PREVENTION; PARTNERS; LINKAGE	Background Novel interventions are needed to reach young people and adult men with HIV services given the low HIV testing rates in these population sub-groups. We assessed the feasibility and acceptability of a peer-led oral HIV self-testing (HIVST) intervention in Kasensero, a hyperendemic fishing community (HIV prevalence: 37-41%) in Rakai, Uganda. Methods This study was conducted among young people (15-24 years) and adult men (25+ years) between May and August 2019. The study entailed distribution of HIVST kits by trained "peer-leaders," who were selected from existing social networks and trained in HIVST distribution processes. Peer-leaders received up to 10 kits to distribute to eligible social network members (i.e. aged 15-24 years if young people or 25+ years if adult man, not tested in the past 3 months, and HIV-negative or of unknown HIV status at enrolment). The intervention was evaluated against the feasibility benchmark of 70% of peer-leaders distributing up to 70% of the kits that they received; and the acceptability benchmark of >80% of the respondents self-testing for HIV. Results Of 298 enrolled into the study at baseline, 56.4% (n= 168) were young people (15-24 years) and 43.6% (n= 130) were adult males (25+ years). Peer-leaders received 298 kits and distributed 296 (99.3%) kits to their social network members. Of the 282 interviewed at follow-up, 98.2% (n = 277) reported that they used the HIVST kits. HIV prevalence was 7.4% (n = 21). Of the 57.1% (n = 12) first-time HIV-positives, 100% sought confirmatory HIV testing and nine of the ten (90%) respondents who were confirmed as HIV-positive were linked to HIV care within 1 week of HIV diagnosis. Conclusion Our findings show that a social network-based, peer-led HIVST intervention in a hyperendemic fishing community is highly feasible and acceptable, and achieves high linkage to HIV care among newly diagnosed HIV-positive individuals.	[Matovu, Joseph K. B.; Nakabugo, Jennifer; Serwadda, David; Wanyenze, Rhoda K.] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Matovu, Joseph K. B.] Busitema Univ, Fac Hlth Sci, Mbale, Uganda; [Bogart, Laura M.] RAND Corp, Santa Monica, CA USA; [Kagaayi, Joseph] Rakai Hlth Sci Program, Kalisizo, Uganda; [Ko, Albert I.; Kurth, Ann E.] Yale Sch Publ Hlth, New Haven, CT USA; [Kurth, Ann E.] Yale Sch Nursing, New Haven, CT USA	Makerere University; RAND Corporation; Rakai Health Sciences Program; Yale University; Yale University	Matovu, JKB (corresponding author), Makerere Univ, Sch Publ Hlth, Kampala, Uganda.; Matovu, JKB (corresponding author), Busitema Univ, Fac Hlth Sci, Mbale, Uganda.	jmatovu@musph.ac.ug	Ko, Albert/P-2343-2015	Ko, Albert/0000-0001-9023-2339	National Institutes of Health Fogarty International Center [NIH FIC D43TWO10540]; Africa Research Excellence Fund [RF-1570024-F-MATOV]	National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Africa Research Excellence Fund	This work was implemented as part of JKBM's Post-Doctoral Research Fellowship with a grant from the National Institutes of Health Fogarty International Center (NIH FIC D43TWO10540; Pls: Riley LW, Barry M, Ko Al, Madhivanan P) and another grant from the Africa Research Excellence Fund (RF-1570024-F-MATOV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi AI, 2019, J BIOSOC SCI, V51, P549, DOI 10.1017/S0021932018000330; Billioux VG, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21590; Bogart LM, 2016, AIDS BEHAV, V20, P2464, DOI 10.1007/s10461-016-1331-z; Brown W, 2016, AIDS BEHAV, V20, P2000, DOI 10.1007/s10461-016-1309-x; Camlin CS, 2016, AIDS CARE, V28, P67, DOI 10.1080/09540121.2016.1164806; Chang LW, 2016, LANCET HIV, V3, pE388, DOI 10.1016/S2352-3018(16)30034-0; Choko AT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208191; Conserve DF, 2019, AIDS CARE, V31, P169, DOI 10.1080/09540121.2018.1537466; Dyson YD, 2018, J ASSOC NURSE AIDS C, V29, P53, DOI 10.1016/j.jana.2017.11.003; Fishbein M., 1975, BELIEF ATTITUDE INTE; Fisher WA, 2003, BLACKW SER HLTH PSYC, P82, DOI 10.1002/9780470753552.ch4; Gibbs A, 2015, CULT HEALTH SEX, V17, P85, DOI 10.1080/13691058.2015.1092260; Grabowski MK, 2017, NEW ENGL J MED, V377, P2154, DOI [10.1056/NEJMoa1702150, 10.1056/nejmoa1702150]; Hatzold K, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25244; Health UMo, 2018, CONSOLIDATED GUIDELI, P1; Idele P, 2014, JAIDS-J ACQ IMM DEF, V66, pS144, DOI 10.1097/QAI.0000000000000176; Kagaayi J, 2019, LANCET HIV, V6, pE680, DOI 10.1016/S2352-3018(19)30190-0; Grabowski MK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14636-y; Knight L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1164; Korte JE, 2020, JAIDS-J ACQ IMM DEF, V84, P271, DOI 10.1097/QAI.0000000000002341; Lightfoot MA, 2018, JAIDS-J ACQ IMM DEF, V79, P38, DOI [10.1097/qai.0000000000001726, 10.1097/QAI.0000000000001726]; Lubogo M, 2019, AFR HEALTH SCI, V19, P2545, DOI 10.4314/ahs.v19i3.40; Mafigiri R, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4166-2; Maheswaran H, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0577-7; Matovu JKB, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-618; McCarty C, 2007, SOC NETWORKS, V29, P300, DOI 10.1016/j.socnet.2006.12.005; Mugisha E, 2010, J ASSOC NURSE AIDS C, V21, P503, DOI 10.1016/j.jana.2010.02.005; Musheke M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3396-z; Nabukenya AM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6027-z; Nyamhanga TM, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21812; Okoboi S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227741; SERWADDA D, 1985, LANCET, V2, P849, DOI 10.1016/S0140-6736(85)90122-9; Sileo KM, 2019, CULT HEALTH SEX, V21, P774, DOI 10.1080/13691058.2018.1516299; Skovdal M, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-13; Smith Joanna, 2011, Nurse Res, V18, P52; Tumwine C, 2019, AJAR-AFR J AIDS RES, V18, P205, DOI 10.2989/16085906.2019.1648306; Tun W, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25124; UBOS ICF, 2018, UGANDA DEMOGRAPHIC H; Uganda National Council for Science and Technology, NAT GUID RES INV HUM; UNAIDS, 2017, MEN BOYS	40	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0236141	10.1371/journal.pone.0236141	http://dx.doi.org/10.1371/journal.pone.0236141			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2FE	32764751	gold, Green Published			2022-12-26	WOS:000561029000030
J	Moreno, ACR; Nai, GA; Laurindo, CP; Gregorio, KCR; Olean-Oliveira, T; Teixeira, MFS; Seraphim, PM				Moreno, Ana Caroline Rippi; Nai, Gisele Alborghetti; Laurindo, Caroline Pancera; Gregorio, Karen Cristina Rego; Olean-Oliveira, Tiago; Teixeira, Marcos Fernando Souza; Seraphim, Patricia Monteiro			Resistance training prevents right ventricle hypertrophy in rats exposed to secondhand cigarette smoke	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; WEIGHT; EMPHYSEMA; DISEASE; ENERGY	Exposure to secondhand cigarette smoke is associated with the development of diverse diseases. Resistance training has been considered one of the most useful tools for patients with pulmonary disease, improving their quality of life. This study aimed to evaluate the effect of resistance training (RT) on the prevention of thickening of the right ventricle wall of rats exposed to secondhand cigarette smoke. Thirty-two Wistar rats were divided into four groups: Control (C), Smoker (S), Exercised (E) and Exercised Smoker (ES). The smoker groups were exposed to the smoke of four cigarettes for 30 min, twice daily, five days a week, for 16 weeks. The exercised groups climbed on a vertical ladder with progressive load, once a day, five days a week, for 16 weeks. The heart, trachea, lung, liver and gastrocnemius muscle were removed for histopathological analysis. Pulmonary emphysema (S and ESvsC and E,P< 0.0001) and pulmonary artery thickness enlargement (SvsC and E,P= 0.003, ESvsC,P= 0.003) were detected in the smoking groups. There was an increase in the right ventricle thickness in the S group compared with all other groups (P< 0.0001). An increase in resident macrophages in the liver was detected in both smoking groups compared with the C group (P= 0.002). Additionally, a relevant reduction of the diameter of the muscle fibers was detected only in ES compared with the C, S and E groups (P= 0.0002), impairing, at least in part, the muscle mass in exercised smoking rats. Therefore, it was concluded that resistance training prevented the increase of thickness of the right ventricle in rats exposed to secondhand cigarette smoke, but it may be not so beneficial for the skeletal muscle of smoking rats.	[Moreno, Ana Caroline Rippi; Laurindo, Caroline Pancera; Gregorio, Karen Cristina Rego; Olean-Oliveira, Tiago; Seraphim, Patricia Monteiro] Sao Paulo State Univ UNESP, Dept Physiotherapy, Sch Sci & Technol, Presidente Prudente, SP, Brazil; [Nai, Gisele Alborghetti] Univ Western Sao Paulo UNOESTE, Dept Pathol, Presidente Prudente, SP, Brazil; [Teixeira, Marcos Fernando Souza] Sao Paulo State Univ UNESP, Dept Chem & Biochem, Sch Sci & Technol, Presidente Prudente, SP, Brazil	Universidade Estadual Paulista; Universidade do Oeste Paulista; Universidade Estadual Paulista	Seraphim, PM (corresponding author), Sao Paulo State Univ UNESP, Dept Physiotherapy, Sch Sci & Technol, Presidente Prudente, SP, Brazil.	pm.seraphim@unesp.br	Nai, Gisele Alborghetti/M-3241-2019; Teixeira, Marcos F. S./A-2322-2009; FAPESP, CDMF/J-3591-2015	Nai, Gisele Alborghetti/0000-0003-1674-7371; Teixeira, Marcos F. S./0000-0001-9355-2143; Seraphim, Patricia/0000-0003-2145-6640; FAPESP, CDMF/0000-0002-4464-0937; Olean-Oliveira, Tiago/0000-0003-1154-740X; Rippi Moreno, Ana Caroline/0000-0002-3833-2225				Barbera JA, 2018, ARCH BRONCONEUMOL, V54, P205, DOI 10.1016/j.arbres.2017.11.014; Alencar AK, 2017, EUR J PHARM SCI, V97, P208, DOI 10.1016/j.ejps.2016.11.009; de Freitas CEA, 2015, PHOTOCHEM PHOTOBIOL, V91, P957, DOI 10.1111/php.12446; Battah KA, 2016, INT J MORPHOL, V34, P1239, DOI 10.4067/S0717-95022016000400011; Berardi A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00142; Berardi A, 2012, REV NEUROSCIENCE, V23, P645, DOI 10.1515/revneuro-2012-0054; Bhat TA, 2018, J IMMUNOL, V200, P2927, DOI 10.4049/jimmunol.1701417; Caminha GP, 2018, CLIN OTOLARYNGOL, V43, P1560, DOI 10.1111/coa.13215; Cecil TL, 2017, NICOTINE TOB RES, V19, P865, DOI 10.1093/ntr/ntx003; Ceco E, 2017, AM J RESP CELL MOL, V57, P28, DOI 10.1165/rcmb.2016-0355TR; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Kozma RD, 2014, J BRAS PNEUMOL, V40, P46, DOI 10.1590/S1806-37132014000100007; Ebersbach-Silva P, 2013, ARQ BRAS ENDOCRINOL, V57, P19, DOI 10.1590/S0004-27302013000100003; El-Zayadi AR, 2006, WORLD J GASTROENTERO, V12, P6098, DOI 10.3748/wjg.v12.i38.6098; Fouad YM, 2014, WORLD J HEPATOL, V6, P41, DOI 10.4254/wjh.v6.i1.41; Garcia BC, 2015, INT J MORPHOL, V33, P497, DOI [10.4067/S0717-95022015000200015, DOI 10.4067/S0717-95022015000200015]; Gay-Jordi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055427; Giordano J, 2017, EUR RADIOL, V27, P1631, DOI 10.1007/s00330-016-4500-6; Goodchild M, 2018, TOB CONTROL, V27, P479, DOI 10.1136/tobaccocontrol-2016-053305corr1; Gosselin N, 2003, MUSCLE NERVE, V28, P744, DOI 10.1002/mus.10491; Groennebaek T, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00713; HAYASHI M, 1977, AM REV RESPIR DIS, V115, P595; Hirasaki E, 2000, AM J PHYS ANTHROPOL, V113, P455, DOI 10.1002/1096-8644(200012)113:4<455::AID-AJPA2>3.0.CO;2-C; Hornberger TA, 2004, CAN J APPL PHYSIOL, V29, P16, DOI 10.1139/h04-002; Johnson JW, 2000, MULTIVAR BEHAV RES, V35, P1, DOI 10.1207/S15327906MBR3501_1; Kamiide Y, 2015, ENVIRON TOXICOL PHAR, V39, P864, DOI 10.1016/j.etap.2015.02.016; Lammers S, 2012, COMPR PHYSIOL, V2, P295, DOI 10.1002/cphy.c100070; Langer D, 2018, J APPL PHYSIOL, V125, P381, DOI 10.1152/japplphysiol.01078.2017; Lee HW, 2018, P NATL ACAD SCI USA, V115, pE1560, DOI 10.1073/pnas.1718185115; Leifert JA, 2008, INT J LAB HEMATOL, V30, P177, DOI 10.1111/j.1751-553X.2008.01067.x; Leite RD, 2013, METABOLISM, V62, P1477, DOI 10.1016/j.metabol.2013.05.009; Lima YC, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0391-2; Luna L.G., 1968, MANUAL HISTOLOGIC ST, P114; Maynar-Marino M, 2018, J TRACE ELEM MED BIO, V45, P136, DOI 10.1016/j.jtemb.2017.10.007; Moller S, 2013, EUR HEART J, V34, P2804, DOI 10.1093/eurheartj/eht246; Noordegraaf AV, 2017, J AM COLL CARDIOL, V69, P236, DOI 10.1016/j.jacc.2016.10.047; Pacagnelli FL, 2016, ARQ BRAS CARDIOL, V107, P33, DOI 10.5935/abc.20160083; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Ryrso CK, 2018, SCAND J MED SCI SPOR, V28, P2339, DOI 10.1111/sms.13227; Schoenfeld BJ, 2015, J STRENGTH COND RES, V29, P2954, DOI 10.1519/JSC.0000000000000958; Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791, DOI 10.1164/ajrccm.157.6.9705017; Stubbings AK, 2008, J PHYSIOL-LONDON, V586, P2637, DOI 10.1113/jphysiol.2007.149799; Chirico MTT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23425-z; Wagner PD, 2006, RESPIROLOGY, V11, P681, DOI 10.1111/j.1440-1843.2006.00939.x; Wright JL, 2002, CHEST, V121, p188S, DOI 10.1378/chest.121.5_suppl.188S; Yoon HY, 2019, RESPIROLOGY, V24, P55, DOI 10.1111/resp.13387; Zatoski WA, 2018, J HEALTH INEQUAL, V4, P18, DOI [10.5114/jhi.2018.77642, DOI 10.5114/JHI.2018.77642]	47	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0236988	10.1371/journal.pone.0236988	http://dx.doi.org/10.1371/journal.pone.0236988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764771	gold, Green Published			2022-12-26	WOS:000561029000032
J	Ghimire, PR; Akombi-Inyang, BJ; Tannous, C; Agho, KE				Ghimire, Pramesh Raj; Akombi-Inyang, Blessing J.; Tannous, Caterina; Agho, Kingsley E.			Association between obesity and miscarriage among women of reproductive age in Nepal	PLOS ONE			English	Article							BODY-MASS INDEX; LONG-TERM USE; ORAL-CONTRACEPTIVES; MATERNAL AGE; RECURRENT MISCARRIAGES; PREGNANCY; RISK; FETAL; ABNORMALITIES; OUTCOMES	Background Obesity is a major health problem in low and middle income countries (LMICs) and is associated with miscarriage. This study aims to examine the association between obesity and miscarriage among reproductive age women (15-49 years) in Nepal. Methods The combined 19160 cross-sectional pregnancy data from the Nepal Demographic and Health Survey (NDHS) for the years 2001, 2006, 2011 and 2016 was utilized. Miscarriage was defined as a spontaneous loss of pregnancy that occurred before the foetus reached 7 months of gestational age. Logistic regression analyses that adjusted for clustering, stratification and sampling weights were used to examine the association between obesity and miscarriage among women of reproductive age. Results The odds of miscarriage were 1.45 times higher (Adjusted odds ratio (AOR) = 1.45; 95%Cl: 1.06, 1.98, P = 0.021) among women with obesity. Women who did not use contraception, younger (15-19 years), and older women (35 years or more) were significantly more likely to have miscarriage. Women who smoked tobacco reported higher odds of miscarriage than women who did not smoke tobacco (AOR = 1.27; 95%Cl: 1.07,1.50, P = 0.006). Stratification of maternal smoking status by maternal Body Mass Index (BMI), after adjusting for contraception, mother age and year of survey revealed that tobacco smoking and obesity are associated with miscarriage (AOR = 1.46; 95%Cl: 1.05,2.04, P = 0.025). Conclusions Findings from this study show that obesity and tobacco smoking are associated with miscarriage. Smoking cessation, pregnancy planning and counselling on healthy weight for women of reproductive age in Nepal may help promote healthy behaviours and decrease the likelihood of miscarriage.	[Ghimire, Pramesh Raj] Ujyalo Nepal, Ratnanagar Municipality, Nepal; [Akombi-Inyang, Blessing J.] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Tannous, Caterina; Agho, Kingsley E.] Western Sydney Univ, Sch Hlth Sci, Penrith, NSW, Australia; [Agho, Kingsley E.] Univ KwaZulu Natal, African Vis Res Inst AVRI, Durban, South Africa	University of New South Wales Sydney; Western Sydney University; University of Kwazulu Natal	Ghimire, PR (corresponding author), Ujyalo Nepal, Ratnanagar Municipality, Nepal.	prameshraj@hotmail.com	Agho, Kingsley/AAW-5622-2021; Akombi-Inyang, Blessing/AAT-6507-2020	Agho, Kingsley/0000-0003-4111-3207; Akombi-Inyang, Blessing/0000-0002-6410-4154; Ghimire, Pramesh/0000-0002-7902-7294				ABDALLA HI, 1993, HUM REPROD, V8, P1512, DOI 10.1093/oxfordjournals.humrep.a138289; Patki A, 2016, J OBSTET GYN INDIA, V66, P310, DOI 10.1007/s13224-015-0682-0; An CQ, 2016, BIOMED RES-INDIA, V27, P1395; Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; Balbas BP, 2018, FAMILY PLANNING, P213; Balsells M, 2016, EUR J OBSTET GYN R B, V207, P73, DOI 10.1016/j.ejogrb.2016.10.012; Bhattacharya S, 2008, BJOG-INT J OBSTET GY, V115, P1623, DOI 10.1111/j.1471-0528.2008.01943.x; Bhattacharya S, 2009, WOMENS HEALTH, V5, P5, DOI 10.2217/17455057.5.1.5; Biggio JR, 2010, OBSTET GYNECOL, V115, P290, DOI 10.1097/AOG.0b013e3181c9b8c3; Blohm F, 2008, BJOG-INT J OBSTET GY, V115, P176, DOI 10.1111/j.1471-0528.2007.01426.x; Boots C, 2011, SEMIN REPROD MED, V29, P507, DOI 10.1055/s-0031-1293204; BOUE J, 1975, TERATOLOGY, V12, P11, DOI 10.1002/tera.1420120103; Bussen S, 1999, HUM REPROD, V14, P18, DOI 10.1093/humrep/14.1.18; CANO F, 1995, FERTIL STERIL, V64, P584, DOI 10.1016/S0015-0282(16)57797-8; Cavalcante MB, 2019, J OBSTET GYNAECOL RE, V45, P30, DOI 10.1111/jog.13799; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503; COWCHOCK FS, 1993, FERTIL STERIL, V59, P1011; Farioli A, 2010, EPIDEMIOLOGY, V21, P918, DOI 10.1097/EDE.0b013e3181e57008; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; FORD JH, 1995, HUM REPROD, V10, P1397, DOI 10.1093/HUMREP/10.6.1397; Garcia-Enguidanos A, 2005, FERTIL STERIL, V83, P1864, DOI 10.1016/j.fertnstert.2004.11.085; Ge KY, 2001, BIOMED ENVIRON SCI, V14, P53; Ghimire PR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191988; Ghimire PR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181332; Godha D, 2013, J ADOLESCENT HEALTH, V52, P552, DOI 10.1016/j.jadohealth.2013.01.021; Heinze G, 2017, TRANSPL INT, V30, P6, DOI 10.1111/tri.12895; Jellesen R, 2008, PAEDIATR PERINAT EP, V22, P334, DOI 10.1111/j.1365-3016.2008.00942.x; JOVANOVIC L, 1978, AM J OBSTET GYNECOL, V130, P274; Katz J, 2008, J ADOLESCENT HEALTH, V42, P587, DOI 10.1016/j.jadohealth.2007.11.137; Kesmodel U, 2002, ALCOHOL ALCOHOLISM, V37, P87, DOI 10.1093/alcalc/37.1.87; Khalil A, 2013, ULTRASOUND OBST GYN, V42, P634, DOI 10.1002/uog.12494; Kirk SFL, 2010, OBES REV, V11, P109, DOI 10.1111/j.1467-789X.2009.00611.x; KLINE J, 1980, LANCET, V2, P176, DOI 10.1016/S0140-6736(80)90062-8; LEVRAN D, 1991, FERTIL STERIL, V56, P1091; Li HWR, 2011, CONTRACEPTION, V83, P582, DOI 10.1016/j.contraception.2010.09.007; Lo W, 2012, J FAM COMMUNITY MED, V19, P167, DOI 10.4103/2230-8229.102316; Magnus MC, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l869; Makhlouf MA, 2014, AM J PERINAT, V31, P765, DOI 10.1055/s-0033-1358771; mark H, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.0206940 30452441, DOI 10.1371/JOURNAL.PONE.0206940 30452441]; Menasha J, 2005, GENET MED, V7, P251, DOI 10.1097/01.GIM.0000160075.96707.04; Metwally M, 2010, FERTIL STERIL, V94, P290, DOI 10.1016/j.fertnstert.2009.03.021; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Ministry of Health and Population (MOHP) [Nepal] New ERA Inc II, 2002, NEP DEM HLTH SURV 20; Ministry of Health and Population Nepal, 2007, NEP DEM HLTH SURV 20; Mishra GD, 2000, AUST NZ J PUBL HEAL, V24, P413, DOI 10.1111/j.1467-842X.2000.tb01604.x; MOHP New ERA ICF International., 2017, NEP DEM HLTH SURV 20; Nassaralla CL, 2011, J WOMENS HEALTH, V20, P169, DOI 10.1089/jwh.2010.2001; Negrato CA, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-41; NEUGEBAUER R, 1992, AM J PUBLIC HEALTH, V82, P1332, DOI 10.2105/AJPH.82.10.1332; Persson M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2563; Pineles BL, 2014, AM J EPIDEMIOL, V179, P807, DOI 10.1093/aje/kwt334; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; REGAN L, 1990, LANCET, V336, P1141, DOI 10.1016/0140-6736(90)92765-A; SACKOFF J, 1994, EPIDEMIOLOGY, V5, P422, DOI 10.1097/00001648-199407000-00008; Sudhir N, 2016, J GENET, V95, P887, DOI 10.1007/s12041-016-0713-3; Tennant PWG, 2011, HUM REPROD, V26, P1501, DOI 10.1093/humrep/der052; Thangaratinam S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2616; Upadhyay C, 2018, INT J REPROD CONTRAC, V7, P648, DOI DOI 10.18203/2320-1770.IJRCOG20180188; Vaidya A, 2010, INT J ENV RES PUB HE, V7, P2726, DOI 10.3390/ijerph7062726; 2004, LANCET LONDON ENGLAN, V363, P902	61	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236435	10.1371/journal.pone.0236435	http://dx.doi.org/10.1371/journal.pone.0236435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC2EP	32760090	gold, Green Published			2022-12-26	WOS:000561027200064
J	Harrison, JU; Baker, RE				Harrison, Jonathan U.; Baker, Ruth E.			An automatic adaptive method to combine summary statistics in approximate Bayesian computation	PLOS ONE			English	Article							MONTE-CARLO; STOCHASTIC SIMULATION; MODEL SELECTION; INFERENCE	To infer the parameters of mechanistic models with intractable likelihoods, techniques such as approximate Bayesian computation (ABC) are increasingly being adopted. One of the main disadvantages of ABC in practical situations, however, is that parameter inference must generally rely on summary statistics of the data. This is particularly the case for problems involving high-dimensional data, such as biological imaging experiments. However, some summary statistics contain more information about parameters of interest than others, and it is not always clear how to weight their contributions within the ABC framework. We address this problem by developing an automatic, adaptive algorithm that chooses weights for each summary statistic. Our algorithm aims to maximize the distance between the prior and the approximate posterior by automatically adapting the weights within the ABC distance function. Computationally, we use a nearest neighbour estimator of the distance between distributions. We justify the algorithm theoretically based on properties of the nearest neighbour distance estimator. To demonstrate the effectiveness of our algorithm, we apply it to a variety of test problems, including several stochastic models of biochemical reaction networks, and a spatial model of diffusion, and compare our results with existing algorithms.	[Harrison, Jonathan U.] Univ Warwick, Math Inst, Math Sci Bldg, Coventry, W Midlands, England; [Baker, Ruth E.] Univ Oxford, Math Inst, Andrew Wiles Bldg, Oxford, England	University of Warwick; University of Oxford	Harrison, JU (corresponding author), Univ Warwick, Math Inst, Math Sci Bldg, Coventry, W Midlands, England.	jonathan.u.harrison@warwick.ac.uk		Harrison, Jonathan/0000-0002-2748-9921	Engineering and Physical Sciences Research Council (EPSRC) [EP/G03706X/1]; Royal Society; BBSRC [BB/R00816/1]; BBSRC [BB/R000816/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Engineering and Physical Sciences Research Council (EPSRC) (grant no. EP/G03706X/1). Ruth E Baker is a Royal Society Wolfson Research Merit Award holder and a Leverhulme Research Fellow, and would also like to thank the BBSRC for funding via grant number BB/R00816/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi T, 2009, PEDIATR PULM, P359; Alquier P, 2016, STAT COMPUT, V26, P29, DOI 10.1007/s11222-014-9521-x; Andrieu C, 2010, J R STAT SOC B, V72, P269, DOI 10.1111/j.1467-9868.2009.00736.x; Andrieu C, 2009, ANN STAT, V37, P697, DOI 10.1214/07-AOS574; [Anonymous], 2016, MATLAB VERS 9 1 0 44; Barnes CP, 2012, STAT COMPUT, V22, P1181, DOI 10.1007/s11222-012-9335-7; Barthelme S, 2014, J AM STAT ASSOC, V109, P315, DOI 10.1080/01621459.2013.864178; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Bernton E, 2019, J R STAT SOC B, V81, P235, DOI 10.1111/rssb.12312; Bernton Espen, 2017, ARXIV170105146; Blum MGB, 2013, STAT SCI, V28, P189, DOI 10.1214/12-STS406; Blum MGB, 2010, STAT COMPUT, V20, P63, DOI 10.1007/s11222-009-9116-0; Daly AC, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150499; Del Moral P, 2006, J R STAT SOC B, V68, P411, DOI 10.1111/j.1467-9868.2006.00553.x; Deligiannidis G, 2018, J R STAT SOC B, V80, P839, DOI 10.1111/rssb.12280; Fearnhead P, 2012, J R STAT SOC B, V74, P419, DOI 10.1111/j.1467-9868.2011.01010.x; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Golightly A, 2011, INTERFACE FOCUS, V1, P807, DOI 10.1098/rsfs.2011.0047; GOURIEROUX C, 1993, J APPL ECONOM, V8, pS85, DOI 10.1002/jae.3950080507; Gutmann MU, 2018, STAT COMPUT, V28, P411, DOI 10.1007/s11222-017-9738-6; Hartig F, 2011, ECOL LETT, V14, P816, DOI 10.1111/j.1461-0248.2011.01640.x; Hines KE, 2015, BIOPHYS J, V108, P2103, DOI 10.1016/j.bpj.2015.03.042; Jones PJM, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/6/066001; Jung H, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1586; Lester C, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4904980; Liepe J, 2014, NAT PROTOC, V9, P439, DOI 10.1038/nprot.2014.025; Martino L, 2018, DIGIT SIGNAL PROCESS, V75, P134, DOI 10.1016/j.dsp.2018.01.004; McKinley T, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1171; Medina-Aguayo FJ, 2016, STAT COMPUT, V26, P1187, DOI 10.1007/s11222-015-9604-3; Moller J, 2006, BIOMETRIKA, V93, P451, DOI 10.1093/biomet/93.2.451; Nunes MA, 2015, R J, V7, P189; Nunes MA, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1576; Owen J, 2015, STAT COMPUT, V25, P145, DOI 10.1007/s11222-014-9524-7; Poczos B, 2012, ARXIV12020302; Poczos B., 2011, P 14 INT C ARTIFICIA, P609; Poczos B, 2012, PROC CVPR IEEE, P2989, DOI 10.1109/CVPR.2012.6248028; Prangle D, 2017, BAYESIAN ANAL, V12, P289, DOI 10.1214/16-BA1002; Price L. F., 2017, J COMPUTATIONAL GRAP; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Siegmund KD, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1374; Singh P, 2018, ARXIV180508647; Sisson SA, 2007, P NATL ACAD SCI USA, V104, P1760, DOI 10.1073/pnas.0607208104; Sisson SA., 2018, HDB APPROXIMATE BAYE; Sunnaker M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002803; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Turner BM, 2012, J MATH PSYCHOL, V56, P69, DOI 10.1016/j.jmp.2012.02.005; Warne DJ, 2020, J THEOR BIOL, V496, DOI 10.1016/j.jtbi.2020.110255; Warne DJ, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2018.0943; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Wood SN, 2010, NATURE, V466, P1102, DOI 10.1038/nature09319	52	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236954	10.1371/journal.pone.0236954	http://dx.doi.org/10.1371/journal.pone.0236954			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760106	gold, Green Published, Green Submitted			2022-12-26	WOS:000561027200053
J	Korona, D; Nightingale, D; Fabre, B; Nelson, M; Fischer, B; Johnson, G; Lees, J; Hubbard, S; Lilley, K; Russell, S				Korona, Dagmara; Nightingale, Daniel; Fabre, Bertrand; Nelson, Michael; Fischer, Bettina; Johnson, Glynnis; Lees, Jonathan; Hubbard, Simon; Lilley, Kathryn; Russell, Steven			Characterisation of protein isoforms encoded by the Drosophila Glycogen Synthase Kinase 3 gene shaggy	PLOS ONE			English	Article							ZESTE-WHITE 3; MOUSE MODELS; EXPRESSION; GSK-3-BETA; MORPHOGENESIS; GLYCOGEN-SYNTHASE-KINASE-3-BETA; PHOSPHORYLATION; MELANOGASTER; GSK3-BETA; PLATFORM	The Drosophila shaggygene (sgg,GSK-3) encodes multiple protein isoforms with serine/threonine kinase activity and is a key player in diverse developmental signalling pathways. Currently it is unclear whether different Sgg proteoforms are similarly involved in signalling or if different proteoforms have distinct functions. We used CRISPR/Cas9 genome engineering to tag eight different Sgg proteoform classes and determined their localization during embryonic development. We performed proteomic analysis of the two major proteoform classes and generated mutant lines for both of these for transcriptomic and phenotypic analysis. We uncovered distinct tissue-specific localization patterns for all of the tagged proteoforms we examined, most of which have not previously been characterised directly at the protein level, including one proteoform initiating with a non-standard codon. Collectively, this suggests complex developmentally regulated splicing of thesggprimary transcript. Further, affinity purification followed by mass spectrometric analyses indicate a different repertoire of interacting proteins for the two major proteoforms we examined, one with ubiquitous expression (Sgg-PB) and one with nervous system specific expression (Sgg-PA). Specific mutation of these proteoforms shows that Sgg-PB performs the well characterised maternal and zygotic segmentations functions of thesgglocus, while Sgg-PA mutants show adult lifespan and locomotor defects consistent with its nervous system localisation. Our findings provide new insights into the role of GSK-3 proteoforms and intriguing links with the GSK-3 alpha and GSK-3 beta proteins encoded by independent vertebrate genes. Our analysis suggests that different proteoforms generated by alternative splicing are likely to perform distinct functions.	[Korona, Dagmara; Fischer, Bettina; Johnson, Glynnis; Russell, Steven] Univ Cambridge, Dept Genet, Cambridge, England; [Nightingale, Daniel; Fabre, Bertrand; Lilley, Kathryn] Univ Cambridge, Cambridge Ctr Prote, Dept Biochem, Cambridge, England; [Nelson, Michael; Hubbard, Simon] Univ Manchester, Manchester Acad Hlth Sci Ctr Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Lees, Jonathan] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Oxford, England	University of Cambridge; University of Cambridge; University of Manchester; Oxford Brookes University	Russell, S (corresponding author), Univ Cambridge, Dept Genet, Cambridge, England.	s.russell@gen.cam.ac.uk	Lilley, Kathryn/ABF-5787-2020	Lilley, Kathryn/0000-0003-0594-6543; Fabre, Bertrand/0000-0002-8850-7185; Russell, Steven/0000-0003-0546-3031; Korona, Dagmara/0000-0002-5988-3894	BBSRC [BB/L002817/1]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	BBSRC grant (BB/L002817/1) to SH, KL and SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004325; Ainsworth C, 2000, PHILOS T ROY SOC B, V355, P931, DOI 10.1098/rstb.2000.0628; Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; [Anonymous], 2019, GEROSCIENCE; Au V, 2019, G3-GENES GENOM GENET, V9, P135, DOI 10.1534/g3.118.200778; Bauer R, 2004, MOL BIOL CELL, V15, P2992, DOI 10.1091/mbc.E04-01-0056; Bejsovec A, 2018, GENETICS, V208, P1311, DOI 10.1534/genetics.117.300157; Bhuiyan SA, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5013-2; Brennan K, 1999, CURR BIOL, V9, P707, DOI 10.1016/S0960-9822(99)80313-3; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Castillo-Quan JI, 2016, CELL REP, V15, P638, DOI 10.1016/j.celrep.2016.03.041; Chen X, 2017, DEV CELL, V43, P563, DOI 10.1016/j.devcel.2017.11.007; Choi H, 2015, J PROTEOMICS, V129, P121, DOI 10.1016/j.jprot.2015.07.036; da Rocha AM, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.128181; Dikicioglu D, 2019, FEMS YEAST RES, V19, DOI 10.1093/femsyr/foz014; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Fernandes I, 2010, DEV CELL, V18, P64, DOI 10.1016/j.devcel.2009.11.009; Gouw M, 2018, NUCLEIC ACIDS RES, V46, pD428, DOI 10.1093/nar/gkx1077; Gratz Scott J, 2015, Methods Mol Biol, V1311, P335, DOI 10.1007/978-1-4939-2687-9_22; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hikasa H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007955; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hurtado DE, 2012, J NEUROSCI, V32, P7392, DOI 10.1523/JNEUROSCI.0889-12.2012; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kaidanovich-Beilin O, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-35; Kalamegham R, 2007, MOL BIOL EVOL, V24, P732, DOI 10.1093/molbev/msl201; Kanuka H, 2005, EMBO J, V24, P3793, DOI 10.1038/sj.emboj.7600822; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Kimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003540; Korona D, 2017, J DEV BIOL, V5, DOI 10.3390/jdb5040016; Lee E, 2016, SCI REP-UK, V6, DOI 10.1038/srep29097; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Lowe N, 2014, DEVELOPMENT, V141, P3994, DOI 10.1242/dev.111054; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; NEWBY LM, 1993, GENETICS, V135, P1077; Papadopoulou D, 2004, MOL CELL BIOL, V24, P4909, DOI 10.1128/MCB.24.11.4909-4919.2004; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; PERRIMON N, 1989, DEV BIOL, V135, P287, DOI 10.1016/0012-1606(89)90180-2; Pilot-Storck F, 2010, MOL CELL PROTEOMICS, V9, P1578, DOI 10.1074/mcp.M900568-MCP200; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Rees JS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002386; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; RUEL L, 1993, NATURE, V362, P557, DOI 10.1038/362557a0; RUEL L, 1993, EMBO J, V12, P1657, DOI 10.1002/j.1460-2075.1993.tb05811.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SIEGFRIED E, 1990, NATURE, V345, P825, DOI 10.1038/345825a0; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Steitz MC, 1998, DEV BIOL, V197, P218, DOI 10.1006/dbio.1998.8884; Sundram V, 2012, J BIOL RHYTHM, V27, P183, DOI 10.1177/0748730412440667; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tress ML, 2017, TRENDS BIOCHEM SCI, V42, P98, DOI 10.1016/j.tibs.2016.08.008; Trostnikov MV, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092200; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Vashishtha V, 2018, J CANCER, V9, P1846, DOI 10.7150/jca.21248; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yang MY, 2012, DEVELOPMENT, V139, P325, DOI 10.1242/dev.074260; Yang XP, 2016, CELL, V164, P805, DOI 10.1016/j.cell.2016.01.029; Yu X, 1999, NAT CELL BIOL, V1, P144, DOI 10.1038/11064; Zhou JB, 2013, J CLIN INVEST, V123, P1821, DOI 10.1172/JCI64398	70	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236679	10.1371/journal.pone.0236679	http://dx.doi.org/10.1371/journal.pone.0236679			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760087	gold, Green Published, Green Submitted			2022-12-26	WOS:000561027200052
J	Bernardi, A; Huang, YH; Harris, B; Xiong, YG; Nandi, S; McDonald, KA; Faller, R				Bernardi, Austen; Huang, Yihan; Harris, Bradley; Xiong, Yongao; Nandi, Somen; McDonald, Karen A.; Faller, Roland			Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain	PLOS ONE			English	Article							N-LINKED GLYCANS; SIDE-CHAIN; RECEPTOR; CONFORMATIONS; AFFINITY; GROMACS	We develop fully glycosylated computational models of ACE2-Fc fusion proteins which are promising targets for a COVID-19 therapeutic. These models are tested in their interaction with a fragment of the receptor-binding domain (RBD) of the Spike Protein S of the SARS-CoV-2 virus, via atomistic molecular dynamics simulations. We see that some ACE2 glycans interact with the S fragments, and glycans are influencing the conformation of the ACE2 receptor. Additionally, we optimize algorithms for protein glycosylation modelling in order to expedite future model development. All models and algorithms are openly available.	[Bernardi, Austen; Harris, Bradley; Xiong, Yongao; Nandi, Somen; McDonald, Karen A.; Faller, Roland] Univ Calif Davis, Chem Engn, Davis, CA 95616 USA; [Huang, Yihan] Univ Calif Davis, Mat Sci & Engn, Davis, CA USA; [Nandi, Somen; McDonald, Karen A.] Univ Calif Davis, Global HealthShare Initiat, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Faller, R (corresponding author), Univ Calif Davis, Chem Engn, Davis, CA 95616 USA.	rfaller@ucdavis.edu		Bernardi, Austen/0000-0001-6217-7037; Faller, Roland/0000-0001-9946-3846; Harris, Bradley/0000-0001-9704-4656	CRAFT award (COVID-19 Research Accelerator Funding Track) by the University of California Davis; NASA [NNX17AJ31G]; NASA Space Technology Research [NNX17AJ31G]; Translational Research Institute through NASA [NNX16AO69A]	CRAFT award (COVID-19 Research Accelerator Funding Track) by the University of California Davis; NASA(National Aeronautics & Space Administration (NASA)); NASA Space Technology Research; Translational Research Institute through NASA	BH, KAM, RF, and SN are partially supported by a CRAFT award (COVID-19 Research Accelerator Funding Track) by the University of California Davis (https://covid19research.ucdavis.edu/tags/craft). YX was supported by NASA under grant or cooperative agreement award number NNX17AJ31G. KAM and SN were partially supported by NASA Space Technology Research (award number NNX17AJ31G) and by the Translational Research Institute through NASA (grant number NNX16AO69A). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author (s) and do not necessarily reflect the views of the National Aeronautics and Space Administration (NASA) or the Translational Research Institute for Space Health (TRISH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bernardi A., 2020, GLYROT; Bernardi A., 2020, MCPB GLYCAM MERGE; Bernardi A, 2019, SOFTWAREX, V10, DOI 10.1016/j.softx.2019.100241; Bernardi A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187994; Brielle ES, 2020, SARS COV 2 EXERTS DI; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case D.A., 2016, AMBER 2016, DOI DOI 10.13140/RG.2.2.27958.70729; Ceroni A, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-3; Chen Y, 2020, BIOCHEM BIOPH RES CO, V525, P135, DOI 10.1016/j.bbrc.2020.02.071; Cheng P, 2020, 11877492V1 CHEMRXIV; Ehret J, 2019, BIOTECHNOL BIOENG, V116, P816, DOI 10.1002/bit.26904; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FENOUILLET E, 1990, J VIROL, V64, P2841, DOI 10.1128/JVI.64.6.2841-2848.1990; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Figueira Thais Rezende e Silva, 2012, BMC Res Notes, V5, P185, DOI 10.1186/1756-0500-5-185; Fisher P, 2019, CELL REP, V27, P1231, DOI 10.1016/j.celrep.2019.03.107; Goffard A, 2005, J VIROL, V79, P8400, DOI 10.1128/JVI.79.13.8400-8409.2005; Goh JB, 2018, CRIT REV BIOTECHNOL, V38, P851, DOI 10.1080/07388551.2017.1416577; Grant Oliver C, 2020, bioRxiv, DOI 10.1101/2020.04.07.030445; Harbison A, 2019, GLYCOBIOLOGY; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo S, 2016, GLYCOBIOLOGY, V26, P19, DOI 10.1093/glycob/cwv083; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kruse Robert L, 2020, F1000Res, V9, P72, DOI 10.12688/f1000research.22211.2; Lei C, 2020, POTENT NEUTRALIZATIO, DOI [10.1101/2020.02.01.929976, 10.1101/2020.02.01.929976., DOI 10.1101/2020.02.01.929976]; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Lu DN, 2012, J PHYS CHEM B, V116, P390, DOI 10.1021/jp203926r; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nami B, 2020, EFFECT ACE2 INHIBITO, DOI [10.26434/chemrxiv.12159945.v1, DOI 10.26434/CHEMRXIV.12159945.V1]; Ohuchi M, 1997, J VIROL, V71, P8377, DOI 10.1128/JVI.71.11.8377-8384.1997; PARRINELLO M, 1982, J CHEM PHYS, V76, P2662, DOI 10.1063/1.443248; Petrescu AJ, 1999, GLYCOBIOLOGY, V9, P343, DOI 10.1093/glycob/9.4.343; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Shajahan A, 2020, COMPREHENSIVE CHARAC; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verdecchia P, 2020, EUR J INTERN MED; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Watanabe Y, 2020, SCIENCE, V369, P330, DOI 10.1126/science.abb9983; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Woo Hyeonuk, 2020, bioRxiv, DOI [10.1021/acs.jpcb.0c04553, 10.1101/2020.05.20.103325]; Woods Group, 2005, GLYCAM WEB; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Wrapp D, 2020, CRYO EM STRUCTURE 20; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wycoff K, 2015, PLANT BIOTECHNOL J, V13, P1078, DOI 10.1111/pbi.12441; Xiang YG, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00768; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yanaka S, 2019, ANTIBODIES, V8, DOI 10.3390/antib8030039; Zhang PQ, 2016, DRUG DISCOV TODAY, V21, P740, DOI 10.1016/j.drudis.2016.01.006; Zhang Y, 2005, COMPUT BIOL CHEM, V29, P254, DOI 10.1016/j.compbiolchem.2005.04.008	57	24	24	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0237295	10.1371/journal.pone.0237295	http://dx.doi.org/10.1371/journal.pone.0237295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756606	gold, Green Submitted, Green Published			2022-12-26	WOS:000560393300048
J	Tamura , K; Goto-Inoue, N; Miyata, K; Furuichi, Y; Fujii, NL; Manabe, Y				Tamura, Kotaro; Goto-Inoue, Naoko; Miyata, Kaede; Furuichi, Yasuro; Fujii, Nobuharu L.; Manabe, Yasuko			Effect of treatment with conditioned media derived from C2C12 myotube on adipogenesis and lipolysis in 3T3-L1 adipocytes	PLOS ONE			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; IN-VITRO EXERCISE; SKELETAL-MUSCLE; PPAR-GAMMA; PULSE STIMULATION; WHITE FAT; ADIPONECTIN; MODEL; INSULIN; PROTEIN	Regular exercise is an effective strategy that is used to prevent and treat obesity as well as type 2 diabetes. Exercise-induced myokine secretion is considered a mechanism that coordinates communication between muscles and other organs. In order to examine the possibility of novel communications from muscle to adipose tissue mediated by myokines, we treated 3T3-L1 adipocytes with C2C12 myotube electrical pulse stimulation-conditioned media (EPS-CM), using a C2C12 myotube contraction system stimulated by an electrical pulse. Continuous treatment with myotube EPS-CM promoted adipogenesis of 3T3-L1 pre-adipocytes via the upregulation of the peroxisome proliferator-activated receptor-gamma (PPAR gamma) 2 and PPAR gamma-regulated gene expression. Furthermore, our results revealed that myotube EPS-CM induces lipolysis and secretion of adiponectin in mature adipocytes. EPS-CM obtained from a C2C12 myoblast culture did not induce such changes in these genes, suggesting that contraction-induced myokine(s) secretion occurs particularly in differentiated myotubes. Thus, contraction-induced secretion of myokine(s) promotes adipogenesis and lipid metabolism in 3T3-L1 adipocytes. These findings suggest the possibility that skeletal muscle communicates to adipose tissues during exercise, probably by the intermediary of unidentified myokines.	[Tamura, Kotaro; Goto-Inoue, Naoko; Miyata, Kaede; Furuichi, Yasuro; Fujii, Nobuharu L.; Manabe, Yasuko] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, Hachioji, Tokyo, Japan; [Goto-Inoue, Naoko] Nihon Univ, Coll Bioresource Sci, Dept Marine Sci & Resources, Fujisawa, Kanagawa, Japan	Tokyo Metropolitan University; Nihon University	Fujii, NL; Manabe, Y (corresponding author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, Hachioji, Tokyo, Japan.	fujiin@tmu.ac.jp; ymanabe@tmu.ac.jp	, Nobuharu/J-2724-2014	, Nobuharu/0000-0002-0974-3033	Funding Program for World-Leading Innovative R&D on Science and Technology by the Council for Science and Technology Policy [LS102];  [19K20161];  [18H04086]	Funding Program for World-Leading Innovative R&D on Science and Technology by the Council for Science and Technology Policy; ; 	This work was supported by a Grant-in-Aid for Scientific Research to N.G-I. (19K20161) and N.L.F. (18H04086), and by a Grant-in-Aid from the Funding Program for World-Leading Innovative R&D on Science and Technology by the Council for Science and Technology Policy to N.L.F. (LS102).	Addison O, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/309570; Arimura N, 2004, J BIOL CHEM, V279, P10070, DOI 10.1074/jbc.M308522200; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Gogh IJAEV, 2015, SCI REP-UK, V5, DOI 10.1038/srep10944; Furuichi Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206146; Goto-Inoue N, 2016, MOL CELL BIOCHEM, V411, P173, DOI 10.1007/s11010-015-2579-8; Harada N, 2018, BIOCHEM BIOPH RES CO, V498, P105, DOI 10.1016/j.bbrc.2018.02.198; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Jackson RM, 2017, J BIOL CHEM, V292, P18556, DOI 10.1074/jbc.M117.791970; Jiang DQ, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0383-4; Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007; Kriketos AD, 2004, DIABETES CARE, V27, P629, DOI 10.2337/diacare.27.2.629; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lyngso D, 2002, J PHYSIOL-LONDON, V543, P379, DOI 10.1113/jphysiol.2002.021022; Manabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052592; Meyer LK, 2013, ADIPOCYTE, V2, P217, DOI 10.4161/adip.24953; Miyatake S, 2014, BIOCHEM BIOPH RES CO, V444, P496, DOI 10.1016/j.bbrc.2014.01.089; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Nikolic N, 2017, ACTA PHYSIOL, V220, P310, DOI 10.1111/apha.12830; Nishizawa H, 2004, J BIOL CHEM, V279, P19391, DOI 10.1074/jbc.C400066200; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Petersen EW, 2005, AM J PHYSIOL-ENDOC M, V288, pE155, DOI 10.1152/ajpendo.00257.2004; Quinn LS, 2009, AM J PHYSIOL-ENDOC M, V296, pE191, DOI 10.1152/ajpendo.90506.2008; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Stanford KI, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029801; Subbotina E, 2015, P NATL ACAD SCI USA, V112, P16042, DOI 10.1073/pnas.1514250112; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Wang C, 2015, ENDOCRINE, V49, P90, DOI 10.1007/s12020-014-0458-9; Wedell-Neergaard AS, 2019, CELL METAB, V29, P844, DOI 10.1016/j.cmet.2018.12.007; Whitham M, 2016, NAT REV DRUG DISCOV, V15, P719, DOI 10.1038/nrd.2016.153	38	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0237095	10.1371/journal.pone.0237095	http://dx.doi.org/10.1371/journal.pone.0237095			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3DK	32756599	gold, Green Published			2022-12-26	WOS:000560393300044
J	Totani, H; Shinjo, K; Suzuki, M; Katsushima, K; Mase, S; Masaki, A; Ito, A; Ri, M; Kusumoto, S; Komatsu, H; Ishida, T; Inagaki, H; Iida, S; Kondo, Y				Totani, Haruhito; Shinjo, Keiko; Suzuki, Miho; Katsushima, Keisuke; Mase, Shoko; Masaki, Ayako; Ito, Asahi; Ri, Masaki; Kusumoto, Shigeru; Komatsu, Hirokazu; Ishida, Takashi; Inagaki, Hiroshi; Iida, Shinsuke; Kondo, Yutaka			Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma	ONCOGENE			English	Article							LEUKEMIA-LYMPHOMA; EXPRESSION; GROWTH; LINE; IDENTIFICATION; MOGAMULIZUMAB; INVOLVEMENT; TAX	Adult T-cell leukemia/lymphoma (ATL) is an aggressive T-cell neoplasm. While ATL cells in peripheral blood (PB-ATL) are sensitive to anti-CC chemokine receptor 4 treatment, non-PB-ATLs, including lymph node ATLs (LN-ATLs), are more aggressive and resistant. We examined characteristic cytokines and growth factors that allow non-PB-ATLs to proliferate and invade compared with PB-ATLs. Protein array analysis revealed hepatocyte growth factor (HGF) and C-C motif chemokine 2 (CCL2) were significantly upregulated in non-PB-ATLs compared with PB-ATLs. The HGF membrane receptor, c-Met, was expressed in PB-ATL and non-PB-ATL cell lines, but CCR2, a CCL2 receptor, was not. Immunohistochemical analysis in clinical ATLs revealed high HGF expression in LNs, pharynx, bone marrow, and tonsils. The HGF/c-Met signaling pathway was active downstream in non-PB-ATLs. Downregulation of HGF/c-Met by siRNA or chemical inhibitors decreased in vitro and in vivo proliferation and invasion by non-PB-ATLs. Treatment with bromodomain and extra-terminal motif inhibitor suppressed HGF expression and decreased levels of histone H3 lysine 27 acetylation (H3K27Ac) and bromodomain-containing protein 4 (BRD4) binding promoter and enhancer regions, suppressing non-PB-ATL cellular growth. Our data indicate H3K27Ac/BRD4 epigenetics regulates the HGF/c-MET pathway in ATLs; targeting this pathway may improve treatment of aggressive non-PB-ATLs.	[Totani, Haruhito; Shinjo, Keiko; Suzuki, Miho; Katsushima, Keisuke; Mase, Shoko; Kondo, Yutaka] Nagoya Univ, Grad Sch Med, Div Canc Biol, Nagoya, Aichi, Japan; [Totani, Haruhito; Masaki, Ayako; Ito, Asahi; Ri, Masaki; Kusumoto, Shigeru; Komatsu, Hirokazu; Iida, Shinsuke] Nagoya City Univ, Grad Sch Med Sci, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Masaki, Ayako; Inagaki, Hiroshi] Nagoya City Univ, Grad Sch Med Sci, Dept Pathol & Mol Diagnost, Nagoya, Aichi, Japan; [Ri, Masaki] Nagoya City Univ Hosp, Dept Blood Transfus & Cell Therapy, Nagoya, Aichi, Japan; [Ishida, Takashi] Nagoya Univ, Grad Sch Med, Dept Immunol, Nagoya, Aichi, Japan	Nagoya University; Nagoya City University; Nagoya City University; Nagoya City University; Nagoya University	Kondo, Y (corresponding author), Nagoya Univ, Grad Sch Med, Div Canc Biol, Nagoya, Aichi, Japan.	ykondo@med.nagoya-u.ac.jp	katsushima, keisuke/AAD-5945-2019; 石田, 高司/GRS-3184-2022	katsushima, keisuke/0000-0001-7770-432X; 石田, 高司/0000-0002-1060-0777	Japan Society for the Promotion of Science [25290048, 19K16752]; National Cancer Center Research and Development Fund [29-A-3]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Cancer Center Research and Development Fund(National Cancer Center - Japan)	This study was performed as research program with a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (25290048, YK; 19K16752, HT) and the National Cancer Center Research and Development Fund (29-A-3, SI).	Bonanno G, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-247; Choi YL, 2007, ONCOGENE, V26, P1245, DOI 10.1038/sj.onc.1209898; Ding XS, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0922-1; Fujikawa D, 2016, BLOOD, V127, P1790, DOI 10.1182/blood-2015-08-662593; Hartmann S, 2016, CLIN CANCER RES, V22, P4005, DOI 10.1158/1078-0432.CCR-16-0951; Hieshima K, 2008, J IMMUNOL, V180, P931, DOI 10.4049/jimmunol.180.2.931; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; Imaizumi Y, 2003, CLIN CANCER RES, V9, P181; Ishida T, 2017, CANCER SCI, V108, P2022, DOI 10.1111/cas.13343; Ishida T, 2015, BRIT J HAEMATOL, V169, P672, DOI 10.1111/bjh.13338; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Kataoka K, 2015, NAT GENET, V47, P1304, DOI 10.1038/ng.3415; Katsuya H, 2015, BLOOD, V126, P2570, DOI 10.1182/blood-2015-03-632489; Kwon Y, 2015, ONCOGENE, V34, P144, DOI 10.1038/onc.2013.539; Masaki A, 2015, CLIN CANCER RES, V21, P2830, DOI 10.1158/1078-0432.CCR-14-2275; MIYOSHI I, 1980, GANN, V71, P155; Murashima A, 2019, J BIOCHEM, V166, P41, DOI 10.1093/jb/mvz007; Nakagawa M, 2018, CANCER CELL, V34, P286, DOI 10.1016/j.ccell.2018.06.014; NAOE T, 1988, CANCER GENET CYTOGEN, V34, P77, DOI 10.1016/0165-4608(88)90171-9; Oki S, 2018, EMBO REP, V19, DOI 10.15252/embr.201846255; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Onimaru Y, 2008, INT J ONCOL, V33, P697, DOI 10.3892/ijo_00000055; Oshiro A, 2006, BLOOD, V107, P4500, DOI 10.1182/blood-2005-09-3801; Piekarz RL, 2011, BLOOD, V117, P5827, DOI 10.1182/blood-2010-10-312603; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Rutella S, 2006, BLOOD, V108, P218, DOI 10.1182/blood-2005-08-3141; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; Skibinski G, 2001, EUR J CANCER, V37, P1562, DOI 10.1016/S0959-8049(01)00164-2; SUGAMURA K, 1984, INT J CANCER, V34, P221, DOI 10.1002/ijc.2910340213; Suzuki S, 2012, CANCER SCI, V103, P1764, DOI 10.1111/j.1349-7006.2012.02371.x; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; Umino A, 2011, BLOOD, V117, P5473, DOI 10.1182/blood-2010-12-327791; Xu CH, 2012, HAEMATOL-HEMATOL J, V97, P572, DOI 10.3324/haematol.2011.056101; Yamada Y, 1997, LEUKEMIA LYMPHOMA, V26, P327, DOI 10.3109/10428199709051782; Yamagishi M, 2019, CELL REP, V29, P2321, DOI 10.1016/j.celrep.2019.10.083; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yoshie O, 2002, BLOOD, V99, P1505, DOI 10.1182/blood.V99.5.1505	38	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2020	39	35					5782	5794		10.1038/s41388-020-01393-x	http://dx.doi.org/10.1038/s41388-020-01393-x		AUG 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	NF2QB	32747750				2022-12-26	WOS:000555362200001
J	Hilderbrand, RH; Keller, SR; Laperriere, SM; Santoro, AE; Cessna, J; Trott, R				Hilderbrand, Robert H.; Keller, Stephen R.; Laperriere, Sarah M.; Santoro, Alyson E.; Cessna, Jason; Trott, Regina			Microbial communities can predict the ecological condition of headwater streams	PLOS ONE			English	Article							INTEGRITY B-IBI; BIOTIC INTEGRITY; BACTERIAL COMMUNITIES; WATER CHEMISTRY; FISH; INDEX; BIOGEOGRAPHY; CATCHMENT; DIVERSITY; RIVER	Humanity's reliance on clean water and the ecosystem services provided makes identifying efficient and effective ways to assess the ecological condition of streams ever more important. We used high throughput sequencing of the 16S rRNA region to explore relationships between stream microbial communities, environmental attributes, and assessments of stream ecological condition. Bacteria and archaea in microbial community samples collected from the water column and from stream sediments during spring and summer were used to replicate standard assessments of ecological condition performed with benthic macroinvertebrate collections via the Benthic Index of Biotic Integrity (BIBI). Microbe-based condition assessments were generated at different levels of taxonomic resolution from phylum to OTU (Operational Taxonomic Units) in order to understand appropriate levels of taxonomic aggregation. Stream sediment microbial communities from both spring and summer were much better than the water column at replicating BIBI condition assessment results. Accuracies were as high as 100% on training data used to build the models and up to 80% on validation data used to assess predictions. Assessments using all OTUs usually had the highest accuracy on training data, but were lower on validation data due to overfitting. In contrast, assessments at the order-level had similar performance accuracy for validation data, and a reduced subset of orders also performed well, suggesting the method could be generalized to other watersheds. Subsets of the important orders responded similarly to environmental gradients compared to the entire community, where strong shifts in community structure occurred for known aquatic stressors such as pH, dissolved organic carbon, and nitrate nitrogen. The results suggest the stream microbes may be useful for assessing the ecological condition of streams and especially useful for stream restorations where many eukaryotic taxa have been eliminated due to prior degradation and are unable to recolonize.	[Hilderbrand, Robert H.; Keller, Stephen R.; Cessna, Jason; Trott, Regina] Univ Maryland, Appalachian Lab, Ctr Environm Sci, Frostburg, MD USA; [Laperriere, Sarah M.; Santoro, Alyson E.] Univ Maryland, Horn Point Lab, Ctr Environm Sci, Cambridge, MD USA; [Laperriere, Sarah M.; Santoro, Alyson E.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Laperriere, Sarah M.] Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90007 USA; [Keller, Stephen R.] Univ Vermont, Dept Plant Biol, Burlington, VT USA	University System of Maryland; University of Maryland Center for Environmental Science; University System of Maryland; University of Maryland Center for Environmental Science; University of California System; University of California Santa Barbara; University of Southern California; University of Vermont	Hilderbrand, RH (corresponding author), Univ Maryland, Appalachian Lab, Ctr Environm Sci, Frostburg, MD USA.	rhilderbrand@umces.edu	Hilderbrand, Robert H/H-9807-2013	Hilderbrand, Robert H/0000-0003-0923-7699	Maryland Sea Grant [NOAA(SG):NA14OAR4170090]	Maryland Sea Grant	Funding was provided by the Maryland Sea Grant (https://www.mdsg.umd.edu/) through award NOAA(SG):NA14OAR4170090 to RHH, SRK, and AES. The sponsors had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	Adams GL, 2013, GLOBAL CHANGE BIOL, V19, P3540, DOI 10.1111/gcb.12285; ANGERMEIER PL, 1995, CAN J FISH AQUAT SCI, V52, P936, DOI 10.1139/f95-093; Battin TJ, 2007, NAT REV MICROBIOL, V5, P76, DOI 10.1038/nrmicro1556; BERKMAN HE, 1986, ENVIRON MANAGE, V10, P413, DOI 10.1007/BF01867267; Besemer K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1760; Blanco S, 2010, CHEMOSPHERE, V79, P18, DOI 10.1016/j.chemosphere.2010.01.059; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Crump BC, 2007, ECOLOGY, V88, P1365, DOI 10.1890/06-0387; Crump BC, 2012, ISME J, V6, P1629, DOI 10.1038/ismej.2012.9; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ellis N, 2012, ECOLOGY, V93, P156, DOI 10.1890/11-0252.1; Fierer N, 2007, ECOLOGY, V88, P2162, DOI 10.1890/06-1746.1; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Findlay S, 2010, J N AM BENTHOL SOC, V29, P170, DOI 10.1899/09-023.1; Freund JG, 2007, ENVIRON MANAGE, V39, P707, DOI 10.1007/s00267-005-0116-3; Garcia L, 2017, FRESHW SCI, V36, P609, DOI 10.1086/693457; Good SP, 2018, WATER RESOUR RES, V54, P2424, DOI 10.1002/2017WR021974; Harding JS, 1998, P NATL ACAD SCI USA, V95, P14843, DOI 10.1073/pnas.95.25.14843; Hosen JD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01452; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Hullar MAJ, 2006, APPL ENVIRON MICROB, V72, P713, DOI 10.1128/AEM.72.1.713-722.2006; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; KARR JR, 1981, FISHERIES, V6, P21, DOI 10.1577/1548-8446(1981)006<0021:AOBIUF>2.0.CO;2; KERANS BL, 1994, ECOL APPL, V4, P768, DOI 10.2307/1942007; King RS, 2011, ECOL APPL, V21, P1659, DOI 10.1890/10-1357.1; King RS, 2010, J N AM BENTHOL SOC, V29, P998, DOI 10.1899/09-144.1; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Laperriere SM, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.00018-20; Lau KEM, 2015, FRESHWATER BIOL, V60, P1988, DOI 10.1111/fwb.12625; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lear G, 2008, FEMS MICROBIOL ECOL, V65, P463, DOI 10.1111/j.1574-6941.2008.00548.x; Liyanage CP, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9081405; Malham M, 2019, SCAND J GASTROENTERO, V54, P969, DOI 10.1080/00365521.2019.1644368; Maloney KO, 2011, FRESHWATER BIOL, V56, P611, DOI 10.1111/j.1365-2427.2010.02522.x; Masese FO, 2009, AFR J AQUAT SCI, V34, P1, DOI 10.2989/AJAS.2009.34.1.1.726; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Merritt R.W., 1996, INTRO AQUATIC INSECT; Morgan RP, 2005, J N AM BENTHOL SOC, V24, P643, DOI 10.1899/0887-3593(2005)024\\[0643:UEOSFA\\]2.0.CO;2; OSBORNE LL, 1992, CAN J FISH AQUAT SCI, V49, P671, DOI 10.1139/f92-076; Nino-Garcia JP, 2016, ISME J, V10, P1755, DOI 10.1038/ismej.2015.226; Parkyn SM, 2011, ENVIRON MANAGE, V48, P602, DOI 10.1007/s00267-011-9694-4; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Potapova M, 2005, AM FISH S S, V47, P333; RCore Team, 2020, R LANG ENV STAT COMP; Rosenberg David M., 1993, P1; Roy AH, 2003, FRESHWATER BIOL, V48, P329, DOI 10.1046/j.1365-2427.2003.00979.x; Simonin M, 2019, ENVIRON MICROBIOL, V21, P3653, DOI 10.1111/1462-2920.14694; Southerland MT, 2007, ECOL INDIC, V7, P751, DOI 10.1016/j.ecolind.2006.08.005; Southerland Mark T., 2004, Applied Herpetology, V2, P23, DOI 10.1163/1570754041231596; Stahl DA, 2012, ANNU REV MICROBIOL, V66, P83, DOI 10.1146/annurev-micro-092611-150128; Staley C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00524; Stewart JS, 2001, J AM WATER RESOUR AS, V37, P1475, DOI 10.1111/j.1752-1688.2001.tb03654.x; Stranko S, 2019, RAS3142014700; Stranko SA, 2012, RESTOR ECOL, V20, P747, DOI 10.1111/j.1526-100X.2011.00824.x; Sundermann A, 2011, ECOL APPL, V21, P1962, DOI 10.1890/10-0607.1; Tonkin JD, 2014, FRESHWATER BIOL, V59, P1843, DOI 10.1111/fwb.12387; Utz RM, 2009, ECOL INDIC, V9, P556, DOI 10.1016/j.ecolind.2008.08.008; Versar Incorporated, 2013, TR1338 VERS INC; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Wang YK, 2005, J N AM BENTHOL SOC, V24, P990, DOI 10.1899/03-028.1; Washington VJ, 2013, FRESHWATER BIOL, V58, P2277, DOI 10.1111/fwb.12208; WATSON SW, 1986, ARCH MICROBIOL, V144, P1, DOI 10.1007/BF00454947; Widdel F., 1992, PROKARYOTES, P3379, DOI DOI 10.1007/978-1-4757-2191-1_; Wright IA, 2016, HYDROBIOLOGIA, V772, P103, DOI 10.1007/s10750-016-2644-7	69	5	5	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236932	10.1371/journal.pone.0236932	http://dx.doi.org/10.1371/journal.pone.0236932			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745120	gold, Green Published			2022-12-26	WOS:000560006800005
J	Saebi, M; Xu, J; Grey, EK; Lodge, DM; Corbett, JJ; Chawla, N				Saebi, Mandana; Xu, Jian; Grey, Erin K.; Lodge, David M.; Corbett, James J.; Chawla, Nitesh			Higher-order patterns of aquatic species spread through the global shipping network	PLOS ONE			English	Article							BALLAST-WATER; MARINE INVASIONS; HOT-SPOTS; TRANSPORT; SHIPS; WORLD; RISK; ECOREGIONS; VECTORS; TIME	The introduction and establishment of nonindigenous species (NIS) through global ship movements poses a significant threat to marine ecosystems and economies. While ballast-vectored invasions have been partly addressed by some national policies and an international agreement regulating the concentrations of organisms in ballast water, biofouling-vectored invasions remain largely unaddressed. Development of additional efficient and cost-effective ship-borne NIS policies requires an accurate estimation of NIS spread risk from both ballast water and biofouling. We demonstrate that the first-order Markovian assumption limits accurate modeling of NIS spread risks through the global shipping network. In contrast, we show that higher-order patterns provide more accurate NIS spread risk estimates by revealing indirect pathways of NIS transfer using Species Flow Higher-Order Networks (SF-HON). Using the largest available datasets of non-indigenous species for Europe and the United States, we then compare SF-HON model predictions against those from networks that consider only first-order connections and those that consider all possible indirect connections without consideration of their significance. We show that not only SF-HONs yield more accurate NIS spread risk predictions, but there are important differences in NIS spread via the ballast and biofouling vectors. Our work provides information that policy-makers can use to develop more efficient and targeted prevention strategies for ship-borne NIS spread management, especially as management of biofouling is of increasing concern.	[Saebi, Mandana; Chawla, Nitesh] Univ Notre Dame, Lucy Family Inst Data & Soc, Notre Dame, IN 46556 USA; [Saebi, Mandana; Chawla, Nitesh] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Xu, Jian] Citadel LLC, Chicago, IL USA; [Grey, Erin K.] Governors State Univ, Div Sci Math & Technol, University Pk, PA USA; [Lodge, David M.] Cornell Univ, Cornell Atkins Ctr Sustainabil, Ithaca, NY USA; [Lodge, David M.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Corbett, James J.] Univ Delaware, Coll Earth Ocean & Environm, Newark, DE USA	University of Notre Dame; University of Notre Dame; Governors State University; Cornell University; Cornell University; University of Delaware	Chawla, N (corresponding author), Univ Notre Dame, Lucy Family Inst Data & Soc, Notre Dame, IN 46556 USA.; Chawla, N (corresponding author), Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA.	nchawla@nd.edu	Lodge, David Michael/AAX-1781-2021; Corbett, James J./B-3321-2009; Saebi, Mandana/ABH-9920-2020; Chawla, Nitesh/F-2690-2016	Corbett, James J./0000-0002-2588-3474; Saebi, Mandana/0000-0002-9839-9173; Grey, Erin/0000-0001-5883-0013; Chawla, Nitesh/0000-0003-3932-5956	U.S. National Science Foundation [1427157]; Army Research Laboratory [W911NF-09-2-0053]	U.S. National Science Foundation(National Science Foundation (NSF)); Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL))	This paper is based on research supported by the U.S. National Science Foundation Award number 1427157 (PIs: DM Lodge, NV Chawla, EK Grey), and the Army Research Laboratory under Cooperative Agreement Number W911NF-09-2-0053 (PI: NV Chawla). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Citadel LLC provided support in the form of salaries for author J.X. but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Andersen MC, 2004, RISK ANAL, V24, P787, DOI 10.1111/j.0272-4332.2004.00478.x; Baranova O, 2013, WORLD OCEAN ATLAS 20; Benson Austin R, 2015, Proc SIAM Int Conf Data Min, V2015, P118; Board AE, 2015, INF SYST AQ NON CRYP; Brock R, 1999, CASE STUDY EFFICACY; Burkholder JM, 2007, HARMFUL ALGAE, V6, P486, DOI 10.1016/j.hal.2006.11.006; Canning-Clode J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018026; Canning-Clode J, 2010, GLOBAL ECOL BIOGEOGR, V19, P875, DOI 10.1111/j.1466-8238.2010.00560.x; Carlton J. T., 1996, OCEANOGRAPHY, V9, P36, DOI DOI 10.5670/0CEAN0G.1996.25; Carlton James T., 2005, SCOPE, V63, P36; Carlton JT, 2001, INVASIVE SPECIES BIO, V24, P195; Chan FT, 2015, CAN J FISH AQUAT SCI, V72, P1230, DOI 10.1139/cjfas-2014-0473; Clearinghouse NBI, 2016, NBIC ONL DAT; Cofrancesco AF, 2007, TRANSFER INVASIVE SP; Coutts ADM, 2010, BIOFOULING, V26, P539, DOI 10.1080/08927014.2010.492469; Davidson IC, 2008, DIVERS DISTRIB, V14, P518, DOI 10.1111/j.1472-4642.2008.00465.x; Davidson IC, 2018, J APPL ECOL, V55, P1799, DOI 10.1111/1365-2664.13114; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Fofonoff Paul W., 2003, P152; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Freestone AL, 2013, ECOLOGY, V94, P1370, DOI 10.1890/12-1382.1; Golbeck J., 2013, ANAL SOCIAL WEB, DOI [10.1016/C2012-0-00171-8, DOI 10.1016/C2012-0-00171-8]; Grey EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27048-2; Hewitt Chad L., 2009, V204, P117; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Johnson J, 2018, ICAROB 2018: PROCEEDINGS OF THE 2018 INTERNATIONAL CONFERENCE ON ARTIFICIAL LIFE AND ROBOTICS, P1; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Keller RP, 2011, DIVERS DISTRIB, V17, P93, DOI 10.1111/j.1472-4642.2010.00696.x; Kemper A, 2010, CONTRIB MANAG SCI, P1, DOI 10.1007/978-3-7908-2367-7; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Moser CS, 2017, BIOL INVASIONS, V19, P1745, DOI 10.1007/s10530-017-1386-4; Muirhead JR, 2015, DIVERS DISTRIB, V21, P75, DOI 10.1111/ddi.12260; Murray CC, 2011, DIVERS DISTRIB, V17, P1161, DOI 10.1111/j.1472-4642.2011.00798.x; Peng HQ, 2014, CHEM-EUR J, V20, P11699, DOI 10.1002/chem.201402955; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5630; Saebi M, 2019, ARXIV190805387; SCHOENER A, 1978, ECOLOGY, V59, P367, DOI 10.2307/1936380; Scholtes I, 2016, EUR PHYS J B, V89, DOI 10.1140/epjb/e2016-60663-0; Scianni C, 2013, 2013 BIENNIAL REPORT; Seebens H, 2013, ECOL LETT, V16, P782, DOI 10.1111/ele.12111; Seebens H, 2016, P NATL ACAD SCI USA, V113, P5646, DOI 10.1073/pnas.1524427113; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; van Vuuren DP, 2017, GLOBAL ENVIRON CHANG, V42, P148, DOI 10.1016/j.gloenvcha.2016.10.009; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Williams SL, 2013, BIOSCIENCE, V63, P952, DOI 10.1525/bio.2013.63.12.8; Xu J, 2017, ARXIV171209658; Xu J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600028; Zhou DW, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P655, DOI 10.1145/3097983.3098015	53	15	16	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0220353	10.1371/journal.pone.0220353	http://dx.doi.org/10.1371/journal.pone.0220353			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735579	gold, Green Submitted, Green Published			2022-12-26	WOS:000569367100001
J	Mukherjee, M; Goswami, S				Mukherjee, Moumita; Goswami, Srikanta			Global cataloguing of variations in untranslated regions of viral genome and prediction of key host RNA binding protein-microRNA interactions modulating genome stability in SARS-CoV-2	PLOS ONE			English	Article							CELL LUNG-CANCER; CORONAVIRUS RNA; WEB SERVER; EXPRESSION; FIBROSIS; TDP-43; SITES	Background The world is going through the critical phase of COVID-19 pandemic, caused by human coronavirus, SARS-CoV-2. Worldwide concerted effort to identify viral genomic changes across different sub-types has identified several strong changes in the coding region. However, there have not been many studies focusing on the variations in the 5' and 3' untranslated regions and their consequences. Considering the possible importance of these regions in host mediated regulation of viral RNA genome, we wanted to explore the phenomenon. Methods To have an idea of the global changes in 5' and 3'-UTR sequences, we downloaded 8595 complete and high-coverage SARS-CoV-2 genome sequence information from human host in FASTA format from Global Initiative on Sharing All Influenza Data (GISAID) from 15 different geographical regions. Next, we aligned them using Clustal Omega software and investigated the UTR variants. We also looked at the putative host RNA binding protein (RBP) and microRNA binding sites in these regions by 'RBPmap' and 'RNA22 v2' respectively. Expression status of selected RBPs and microRNAs were checked in lungs tissue. Results We identified 28 unique variants in SARS-CoV-2 UTR region based on a minimum variant percentage cut-off of 0.5. Along with 241C>T change the important 5'-UTR change identified was 187A>G, while 29734G>C, 29742G>A/T and 29774C>T were the most familiar variants of 3'UTR among most of the continents. Furthermore, we found that despite the variations in the UTR regions, binding of host RBP to them remains mostly unaltered, which further influenced the functioning of specific miRNAs. Conclusion Our results, shows for the first time in SARS-Cov-2 infection, a possible cross-talk between host RBPs-miRNAs and viral UTR variants, which ultimately could explain the mechanism of escaping host RNA decay machinery by the virus. The knowledge might be helpful in developing anti-viral compounds in future.	[Mukherjee, Moumita; Goswami, Srikanta] Natl Inst Biomed Genom, Kalyani, W Bengal, India	Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG)	Goswami, S (corresponding author), Natl Inst Biomed Genom, Kalyani, W Bengal, India.	sg1@nibmg.ac.in	Mukherjee, Prof Moumita/GVS-4827-2022		National Institute of Biomedical Genomics; University Grants Commission, Government of India	National Institute of Biomedical Genomics; University Grants Commission, Government of India(University Grants Commission, India)	This study was supported by the National Institute of Biomedical Genomics to SG. MM also received a fellowship from University Grants Commission, Government of India.	[Anonymous], 2020, BIORXIV, DOI 10.1101/2020.12.22.422708, Patent No. 01.22.914473; Astuti I, 2020, DIABETES METAB SYND, V14, P407, DOI 10.1016/j.dsx.2020.04.020; Begum F., 2020, SPECIFIC MUTATIONS S; Beiter T, 2015, EXERC IMMUNOL REV, V21, P42; Bornali B., 2020, PHYLOGENETIC CLUSTER; Boudreault S, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1543; Boudreault S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161914; Breig O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059137; Chen YM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05218-0; Correia AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140248; Dasgupta T, 2012, WIRES RNA, V3, P104, DOI 10.1002/wrna.107; De novo R R., 2020, BIORXIV; Forster P, 2020, P NATL ACAD SCI USA, V117, P9241, DOI 10.1073/pnas.2004999117; Fritz D, 2007, J MOL BIOL, V371, P585, DOI 10.1016/j.jmb.2007.06.006; FUJITA T, 2017, SCI REP UK, V0007; Fung G, 2015, CELL DEATH DIFFER, V22, P2087, DOI 10.1038/cdd.2015.58; Gao CH, 2015, TUMOR BIOL, V36, P4583, DOI 10.1007/s13277-015-3103-1; Garcia-Moreno M, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1498; Gardiner AS, 2015, BIOMOLECULES, V5, P2903, DOI 10.3390/biom5042903; Gautrey HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051497; He QF, 2019, J CLIN LAB ANAL, V33, DOI 10.1002/jcla.23003; Hu RP, 2019, EUR REV MED PHARMACO, V23, P2273, DOI 10.26355/eurrev_201903_17276; Jiao YW, 2019, INT J ONCOL, V54, P845, DOI 10.3892/ijo.2019.4680; Ke RS, 2018, ONCOL LETT, V16, P3746, DOI 10.3892/ol.2018.9079; Kim HR, 2016, LUNG CANCER, V99, P57, DOI 10.1016/j.lungcan.2016.05.018; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Kuo PH, 2014, NUCLEIC ACIDS RES, V42, P4712, DOI 10.1093/nar/gkt1407; Li G, 2017, BIOMED PHARMACOTHER, V96, P1170, DOI 10.1016/j.biopha.2017.11.105; Liang YN, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0459-9; Liu XX, 2016, GENE, V576, P791, DOI 10.1016/j.gene.2015.11.009; Lu HJ, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0544-8; Madhugiri R, 2018, VIROLOGY, V517, P44, DOI 10.1016/j.virol.2017.11.025; Maitra A, 2020, J BIOSCIENCES, V45, DOI 10.1007/s12038-020-00046-1; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Neelagandan N, 2019, NUCLEIC ACIDS RES, V47, P341, DOI 10.1093/nar/gky972; Paz I, 2014, NUCLEIC ACIDS RES, V42, pW361, DOI 10.1093/nar/gku406; Saul MJ, 2019, FASEB J, V33, P6933, DOI 10.1096/fj.201802547R; SETHNA PB, 1989, P NATL ACAD SCI USA, V86, P5626, DOI 10.1073/pnas.86.14.5626; Shi ST, 2000, EMBO J, V19, P4701, DOI 10.1093/emboj/19.17.4701; Shi ST, 2005, CURR TOP MICROBIOL, V287, P95, DOI 10.1007/3-540-26765-4_4; Sokoloski Kevin J, 2006, RNA Biol, V3, P140; Tan YW, 2012, NUCLEIC ACIDS RES, V40, P5065, DOI 10.1093/nar/gks165; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Williams GD, 1999, J VIROL, V73, P8349, DOI 10.1128/JVI.73.10.8349-8355.1999; Wu XX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13498; Xie W, 2018, J CELL PHYSIOL, V233, P6615, DOI 10.1002/jcp.26274; Yang D, 2015, VIRUS RES, V206, P120, DOI 10.1016/j.virusres.2015.02.025; Yin C., 2020, GENOMICS	49	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237559	10.1371/journal.pone.0237559	http://dx.doi.org/10.1371/journal.pone.0237559			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780783	Green Submitted, gold, Green Published			2022-12-26	WOS:000562664700032
J	Sawyer, KS; Adra, N; Salz, DM; Kemppainen, MI; Ruiz, SM; Harris, GJ; Oscar-Berman, M				Sawyer, Kayle S.; Adra, Noor; Salz, Daniel M.; Kemppainen, Maaria, I; Ruiz, Susan M.; Harris, Gordon J.; Oscar-Berman, Marlene			Hippocampal subfield volumes in abstinent men and women with a history of alcohol use disorder	PLOS ONE			English	Article							COGNITIVE PERFORMANCE; SUBCORTICAL VOLUMES; CA1 SUBREGION; MATTER VOLUME; MEMORY; BRAIN; CONTEXT; ASSOCIATIONS; RETRIEVAL; TERM	Alcohol Use Disorder (AUD) has been associated with abnormalities in hippocampal volumes, but these relationships have not been fully explored with respect to sub-regional volumes, nor in association with individual characteristics such as age, gender differences, drinking history, and memory. The present study examined the impact of those variables in relation to hippocampal subfield volumes in abstinent men and women with a history of AUD. Using Magnetic Resonance Imaging at 3 Tesla, we obtained brain images from 67 participants with AUD (31 women) and 64 nonalcoholic control (NC) participants (31 women). The average duration of the most recent period of sobriety for AUD participants was 7.1 years. We used Freesurfer 6.0 to segment the hippocampus into 12 regions. These were imputed into statistical models to examine the relationships of brain volume with AUD group, age, gender, memory, and drinking history. Interactions with gender and age were of particular interest. Compared to the NC group, the AUD group had approximately 5% smaller subiculum, CA1, molecular layer, and hippocampal tail regions. Age was negatively associated with volumes for the AUD group in the subiculum and the hippocampal tail, but no significant interactions with gender were identified. The relationships for delayed and immediate memory with hippocampal tail volume differed for AUD and NC groups: Higher scores on tests of immediate and delayed memory were associated with smaller volumes in the AUD group, but larger volumes in the NC group. Length of sobriety was associated with decreasing CA1 volume in women (0.19% per year) and increasing volume size in men (0.38% per year). The course of abstinence on CA1 volume differed for men and women, and the differential relationships of subfield volumes to age and memory could indicate a distinction in the impact of AUD on functions of the hippocampal tail. These findings confirm and extend evidence that AUD, age, gender, memory, and abstinence differentially impact volumes of component parts of the hippocampus.	[Sawyer, Kayle S.; Adra, Noor; Salz, Daniel M.; Kemppainen, Maaria, I; Ruiz, Susan M.; Oscar-Berman, Marlene] VA Boston Healthcare Syst, Boston, MA 02130 USA; [Sawyer, Kayle S.; Salz, Daniel M.; Kemppainen, Maaria, I; Ruiz, Susan M.; Harris, Gordon J.; Oscar-Berman, Marlene] Boston Univ, Sch Med, Boston, MA 02118 USA; [Sawyer, Kayle S.; Adra, Noor; Salz, Daniel M.; Kemppainen, Maaria, I; Ruiz, Susan M.; Harris, Gordon J.; Oscar-Berman, Marlene] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Sawyer, Kayle S.] Sawyer Sci LLC, Boston, MA 02120 USA; [Harris, Gordon J.] Harvard Med Sch, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sawyer, KS (corresponding author), VA Boston Healthcare Syst, Boston, MA 02130 USA.; Sawyer, KS (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.; Sawyer, KS (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.; Sawyer, KS (corresponding author), Sawyer Sci LLC, Boston, MA 02120 USA.	kslays@bu.edu	Sawyer, Kayle S./H-2724-2019	Sawyer, Kayle S./0000-0001-7767-5688; Berman, Marlene Oscar/0000-0003-0100-8883; Adra, Noor/0000-0001-7214-6293	National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health US Department of Health and Human Services [R01AA07112, K05AA00219]; US Department of Veterans Affairs Clinical Science Research and Development [I01CX000326]; National Center for Advancing Translational Sciences of the National Institutes of Health US Department of Health and Human Services [1S10RR023401, 1S10RR019307, 1S10RR023043, 1UL1TR001430]	National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health US Department of Health and Human Services; US Department of Veterans Affairs Clinical Science Research and Development; National Center for Advancing Translational Sciences of the National Institutes of Health US Department of Health and Human Services	This work was supported by funds from the National Institute on Alcohol Abuse and Alcoholism (NIAAA; https://www.niaaa.nih.gov/) of the National Institutes of Health US Department of Health and Human Services under Award Numbers R01AA07112 and K05AA00219 awarded to M.O.B.; US Department of Veterans Affairs Clinical Science Research and Development (https://www.research.va.gov/services/csrd/) grant I01CX000326 awarded to M.O.B; National Center for Advancing Translational Sciences of the National Institutes of Health US Department of Health and Human Services under Award Numbers 1S10RR023401, 1S10RR019307, 1S10RR023043, and 1UL1TR001430. The funders provided support in the form of salaries for authors K.S.S., D.M.S., M.I. K., S.M.R., G.J.H., and M.O.B., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. K.S.S. is an employee of Sawyer Scientific, LLC, and this affiliation provided no funding related to the work described in this manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the U.S. Department of Veterans Affairs, or the United States Government.	Agartz I, 1999, ARCH GEN PSYCHIAT, V56, P356, DOI 10.1001/archpsyc.56.4.356; Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Allen Micah, 2019, Wellcome Open Res, V4, P63, DOI 10.12688/wellcomeopenres.15191.1; Barrientos SA, 2016, J NEUROSCI, V36, P6602, DOI 10.1523/JNEUROSCI.1107-16.2016; Bartsch T, 2011, P NATL ACAD SCI USA, V108, P17562, DOI 10.1073/pnas.1110266108; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beattie MC, 1999, ADDICT BEHAV, V24, P593, DOI 10.1016/S0306-4603(98)00120-8; Beresford TP, 2006, ALCOHOL CLIN EXP RES, V30, P1866, DOI 10.1111/j.1530-0277.2006.00223.x; Bergado JA, 2011, PROG NEUROBIOL, V94, P64, DOI 10.1016/j.pneurobio.2011.03.004; Berkers RMWJ, 2016, NEUROBIOL LEARN MEM, V134, P44, DOI 10.1016/j.nlm.2016.01.016; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Cahalan D., 1969, MONOGRAPHS RUTGERS C, V6, DOI DOI 10.1093/SF/49.2; Cardenas VA, 2005, PSYCHIAT RES-NEUROIM, V138, P115, DOI 10.1016/j.pscychresns.2005.01.002; Chanraud S, 2007, NEUROPSYCHOPHARMACOL, V32, P429, DOI 10.1038/sj.npp.1301219; Chanraud Sandra, 2014, Handb Clin Neurol, V125, P369, DOI 10.1016/B978-0-444-62619-6.00022-7; Chanraud S, 2013, CEREB CORTEX, V23, P97, DOI 10.1093/cercor/bhr381; Clark RE, 2000, J NEUROSCI, V20, P8853; Crombag HS, 2008, PHILOS T R SOC B, V363, P3233, DOI 10.1098/rstb.2008.0090; DAWSON DA, 1992, BRIT J ADDICT, V87, P119; De Santis S, 2019, JAMA PSYCHIAT, V76, P749, DOI 10.1001/jamapsychiatry.2019.0318; Durazzo TC, 2013, ALCOHOL CLIN EXP RES, V37, P1794, DOI 10.1111/acer.12140; Duvernoy H. M., 1988, HUMAN HIPPOCAMPUS AT; Eldridge LL, 2005, J NEUROSCI, V25, P3280, DOI 10.1523/JNEUROSCI.3420-04.2005; Iglesias JE, 2015, NEUROIMAGE, V115, P117, DOI 10.1016/j.neuroimage.2015.04.042; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fein G, 2006, ALCOHOL CLIN EXP RES, V30, P1538, DOI 10.1111/j.1530-0277.2006.00185.x; Fein G, 2013, NEUROIMAGE-CLIN, V3, P47, DOI 10.1016/j.nicl.2013.06.018; Foster Paul S, 2017, Brain Inform, V4, P85, DOI 10.1007/s40708-016-0054-2; Frischknecht U, 2017, ALCOHOL CLIN EXP RES, V41, P323, DOI 10.1111/acer.13308; Fung YL, 2019, J ALZHEIMERS DIS, V68, P159, DOI 10.3233/JAD-181172; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hasselmo ME, 2005, BEHAV NEUROSCI, V119, P342, DOI 10.1037/0735-7044.119.1.342; Holdnack JA, 2010, WAIS 4 CLIN USE INTE, P237; Hommer DW, 2001, AM J PSYCHIAT, V158, P198, DOI 10.1176/appi.ajp.158.2.198; Kopera M, 2012, ALCOHOL, V46, P665, DOI 10.1016/j.alcohol.2012.04.005; Krasne FB, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00041; Kuhn S, 2014, JAMA PSYCHIAT, V71, P806, DOI 10.1001/jamapsychiatry.2014.352; Laakso MP, 2000, BEHAV BRAIN RES, V109, P177, DOI 10.1016/S0166-4328(99)00172-2; Lee J, 2016, PSYCHIAT RES-NEUROIM, V258, P16, DOI 10.1016/j.pscychresns.2016.10.009; Levy W. B., 1989, COMPUTATIONAL MODELS, P243, DOI DOI 10.1016/S0079-7421(08)60113-9; Luhar RB, 2013, NEUROPSYCH DIS TREAT, V9, P1767, DOI 10.2147/NDT.S52298; Matthews DB, 1996, ALCOHOL CLIN EXP RES, V20, P404, DOI 10.1111/j.1530-0277.1996.tb01660.x; Mueller SG, 2011, NEUROIMAGE, V56, P851, DOI 10.1016/j.neuroimage.2011.03.028; Nadel L, 2013, J COGNITIVE NEUROSCI, V25, P22, DOI 10.1162/jocn_a_00313; Newmark RE, 2013, HIPPOCAMPUS, V23, P467, DOI 10.1002/hipo.22106; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; Oscar-Berman M, 2019, BRAIN RESPONSIVITY E, DOI [10.1101/496166, DOI 10.1101/496166]; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Oscar-Berman Marlene, 2014, Handb Clin Neurol, V125, P183, DOI 10.1016/B978-0-444-62619-6.00012-4; Ozsoy S, 2013, ALCOHOL, V47, P9, DOI 10.1016/j.alcohol.2012.09.002; Pandey AK, 2018, ALCOHOL CLIN EXP RES, V42, P1883, DOI 10.1111/acer.13854; PFEFFERBAUM A, 1992, ALCOHOL CLIN EXP RES, V16, P1078, DOI 10.1111/j.1530-0277.1992.tb00702.x; Pfefferbaum A, 2006, NEUROBIOL AGING, V27, P994, DOI 10.1016/j.neurobiolaging.2005.05.007; R Core Team, 2021, R LANGUAGE ENV STAT; Rivas-Grajales AM, 2018, NEUROIMAGE-CLIN, V19, P98, DOI 10.1016/j.nicl.2018.03.025; Robins LN, 2000, COMPUTERIZED DIAGNOS; Ruiz SM, 2013, J ALCOHOL DRUG DEPEN, V1, P106, DOI [10.4172/2329-6488.1000e106, DOI 10.4172/2329-6488.1000E106]; Ruiz SM, 2017, ALCOHOL ALCOHOLISM, V52, P496, DOI 10.1093/alcalc/agx016; Sameti M, 2011, ALCOHOL CLIN EXP RES, V35, P1067, DOI 10.1111/j.1530-0277.2011.01440.x; Sawyer KS, 2019, ELIFE, V8, DOI 10.7554/eLife.41723; Sawyer KS, 2018, NEUROPSYCHOPHARMACOL, V43, P1876, DOI 10.1038/s41386-018-0089-6; Sawyer KS, 2017, PSYCHIAT RES-NEUROIM, V263, P15, DOI 10.1016/j.pscychresns.2017.03.001; Sawyer KS, 2016, ALCOHOL CLIN EXP RES, V40, P1262, DOI 10.1111/acer.13074; Schultz C, 2014, FRONT NEUROL NEUROSC, V34, P6, DOI 10.1159/000360925; Seitz J, 2017, BRAIN IMAGING BEHAV, V11, P1006, DOI 10.1007/s11682-016-9579-5; Siekmeier PJ, 2007, SCHIZOPHR RES, V89, P177, DOI 10.1016/j.schres.2006.08.007; Smith DM, 2014, NEUROSCI BIOBEHAV R, V40, P52, DOI 10.1016/j.neubiorev.2014.01.005; Squire LR, 1997, PHILOS T R SOC B, V352, P1663, DOI 10.1098/rstb.1997.0148; Staples MC, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00162; SULLIVAN EV, 1995, ALCOHOL CLIN EXP RES, V19, P110, DOI 10.1111/j.1530-0277.1995.tb01478.x; Thierry AM, 2000, HIPPOCAMPUS, V10, P411, DOI 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A; Vago DR, 2008, BEHAV BRAIN RES, V189, P273, DOI 10.1016/j.bbr.2008.01.002; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Vatsalya Vatsalya, 2016, Curr Drug Abuse Rev, V9, P87, DOI 10.2174/1874473710666170125151410; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043; Wang JY, 2018, J NEUROSCI, V38, P10019, DOI 10.1523/JNEUROSCI.1267-18.2018; Wilson S, 2017, PSYCHOL MED, V47, P2288, DOI 10.1017/S0033291717000721; Zahr NM, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101764; Zironi I, 2006, BEHAV BRAIN RES, V167, P150, DOI 10.1016/j.bbr.2005.09.007	81	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0236641	10.1371/journal.pone.0236641	http://dx.doi.org/10.1371/journal.pone.0236641			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NC7KJ	32776986	Green Published, gold			2022-12-26	WOS:000561393800054
J	Jiang, GM; Han, RF; Chen, MY; Liu, R; Wu, M; Zhang, X; Ma, YB; Yuan, YP; Wang, R; Shuai, ZW; Pan, FM				Jiang, Guangming; Han, Renfang; Chen, Mengya; Liu, Rui; Wu, Meng; Zhang, Xu; Ma, Yubo; Yuan, Yaping; Wang, Ran; Shuai, Zongwen; Pan, Faming			Associations between fucosyltransferase 3 gene polymorphisms and ankylosing spondylitis: A case-control study of an east Chinese population	PLOS ONE			English	Article							SECRETOR STATUS; GEOGRAPHIC-DISTRIBUTION; DISEASE; HLA-B27; RISK; FREQUENCY; VARIANTS; INSIGHTS	Many susceptibility genes of inflammatory bowel disease (IBD) are associated with ankylosing spondylitis (AS). Fucosyltransferase 2 (FUT2) andFUT3genes are related to IBD. This study aimed to investigate whether these genes correlated with the susceptibility to AS. Questionnaires of 673 patients with AS, and peripheral blood specimens of the patients and 687 healthy controls were collected.FUT2andFUT3genes were genotyped using the SNPscan method. Frequency differences of the genes at different levels, haplotypes, and interactions were analyzed. No frequency differences were found between the cases and the controls in all the genotypes and the alleles of rs1047781, rs1800028, rs1800030, and rs812936. For rs28362459, a significant difference in allele frequencies was observed in the total participants between the groups [chi(2)= 7.515,P-corrected= 0.030; adjusted odds ratio (ORadjusted)(G/T)= 0.782; 95% confidence interval (CI), 0.650-0.941]. The frequencies of haplotypes TT (rs812936-rs28362459) (chi(2)= 5.663,P-permutation= 0.039) and TG (rs812936-rs28362459) (chi(2)= 7.456,P-permutation= 0.013) in the total participants, and TG (rs812936-rs28362459) in the female subgroup (chi(2)= 5.624,P-permutation= 0.047) showed significant differences between the cases and the controls. No frequency differences at the phenotypic level were found. Two-factor interactions were observed between rs28362459-TG and age, rs28362459-TG and sex, rs28362459 and rs1047781, and the Lewis and secretor status. Rs28362459-G was related to some aggravated symptoms of AS (allP(corrected)< 0.05). These findings indicated thatFUT3polymorphisms were associated with human predisposition to AS at the allele and haplotype level. Rs28362459-G might decrease the susceptibility to AS, but aggravate relevant symptoms.	[Jiang, Guangming; Han, Renfang; Chen, Mengya; Liu, Rui; Wu, Meng; Zhang, Xu; Ma, Yubo; Yuan, Yaping; Pan, Faming] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China; [Jiang, Guangming; Wang, Ran] Univ Sci & Technol China, Affiliated Hosp USTC 1, Div Life Sci & Med, Dept Blood Transfus, Hefei, Anhui, Peoples R China; [Jiang, Guangming; Han, Renfang; Chen, Mengya; Liu, Rui; Wu, Meng; Zhang, Xu; Ma, Yubo; Yuan, Yaping; Pan, Faming] Key Lab Anhui Med Autoimmune Dis, Hefei, Anhui, Peoples R China; [Shuai, Zongwen] Anhui Med Univ, Dept Rheumatol & Immunol, Affiliated Hosp 1, Hefei, Anhui, Peoples R China	Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University	Pan, FM (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China.; Pan, FM (corresponding author), Key Lab Anhui Med Autoimmune Dis, Hefei, Anhui, Peoples R China.	famingpan@ahmu.edu.cn	zhang, xu/AAR-6231-2021	Zhang, Xu/0000-0002-6217-6824	National Natural Science Foundation of China [81273169, 81573218, 81773514]; Scientific Research Foundation of Translational Medicine of Anhui Province [2017zhyx03]; Academic and Technical Leaders Foundation of Anhui Province [2017D140]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Translational Medicine of Anhui Province; Academic and Technical Leaders Foundation of Anhui Province	This study was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn; grant numbers: 81273169, 81573218, and 81773514; recipient: FP), the Scientific Research Foundation of Translational Medicine of Anhui Province (grant number: 2017zhyx03; recipient: FP), and the Academic and Technical Leaders Foundation of Anhui Province (grant number: 2017D140; recipient: FP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Bremander A, 2011, ARTHRIT CARE RES, V63, P550, DOI 10.1002/acr.20408; Brown MA, 2016, NAT REV RHEUMATOL, V12, P81, DOI 10.1038/nrrheum.2015.133; Carlsson B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005593; Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Costello ME, 2015, ARTHRITIS RHEUMATOL, V67, P686, DOI 10.1002/art.38967; DAMATO M, 1995, DIS MARKERS, V12, P215; GRUBB R, 1951, ACTA PATHOL MIC SC, V28, P61; Gunaydin G, 2016, VIRUS RES, V211, P64, DOI 10.1016/j.virusres.2015.10.005; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Hu DY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146557; Jin GF, 2015, AM J HUM GENET, V96, P832, DOI 10.1016/j.ajhg.2015.03.009; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; LOPEZLARREA C, 1995, TISSUE ANTIGENS, V45, P169, DOI 10.1111/j.1399-0039.1995.tb02436.x; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Maroni L, 2015, CLIN REV ALLERG IMMU, V48, P182, DOI 10.1007/s12016-014-8423-1; Mathieu A, 2008, AUTOIMMUN REV, V7, P398, DOI 10.1016/j.autrev.2008.03.013; Mathieu A, 2009, AUTOIMMUN REV, V8, P420, DOI 10.1016/j.autrev.2009.01.003; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Nanthakumar NN, 2002, FASEB J, V16, P44, DOI 10.1096/fj.02-0031fje; National Center for Biotechnology Information (NCBI), BLOOD GROUP MUT DAT; O'Rielly DD, 2016, CURR OPIN RHEUMATOL, V28, P337, DOI 10.1097/BOR.0000000000000297; Pal A, 1998, J RHEUMATOL, V25, P318; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; SHINEBAUM R, 1987, BRIT MED J, V294, P208, DOI 10.1136/bmj.294.6566.208; Smith GW, 1997, BRIT J RHEUMATOL, V36, P778; Thjodleifsson B, 2007, ARTHRITIS RHEUM-US, V56, P2633, DOI 10.1002/art.22812; Tong M, 2014, ISME J, V8, P2193, DOI 10.1038/ismej.2014.64; Tsui FWL, 2014, APPL CLIN GENET, V7, P105, DOI 10.2147/TACG.S37325; Van Praet L, 2013, ANN RHEUM DIS, V72, P414, DOI 10.1136/annrheumdis-2012-202135	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237219	10.1371/journal.pone.0237219	http://dx.doi.org/10.1371/journal.pone.0237219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764781	Green Published, gold			2022-12-26	WOS:000561029000067
J	Yamaguchi, K; Kitamura, R; Kawakami, R; Otomo, K; Nemoto, T				Yamaguchi, Kazushi; Kitamura, Ryoji; Kawakami, Ryosuke; Otomo, Kohei; Nemoto, Tomomi			In vivo two-photon microscopic observation and ablation in deeper brain regions realized by modifications of excitation beam diameter and immersion liquid	PLOS ONE			English	Article							LONG-TERM; RESOLUTION; NEURONS; NEOCORTEX; TISSUE; MAPS	In vivotwo-photon microscopy utilizing a nonlinear optical process enables, in living mouse brains, not only the visualization of morphologies and functions of neural networks in deep regions but also their optical manipulation at targeted sites with high spatial precision. Because the two-photon excitation efficiency is proportional to the square of the photon density of the excitation laser light at the focal position, optical aberrations induced by specimens mainly limit the maximum depth of observations or that of manipulations in the microscopy. To increase the two-photon excitation efficiency, we developed a method for evaluating the focal volume in living mouse brains. With this method, we modified the beam diameter of the excitation laser light and the value of the refractive index in the immersion liquid to maximize the excitation photon density at the focal position. These two modifications allowed the successful visualization of the finer structures of hippocampal CA1 neurons, as well as the intracellular calcium dynamics in cortical layer V astrocytes, even with our conventional two-photon microscopy system. Furthermore, it enabled focal laser ablation dissection of both single apical and single basal dendrites of cortical layer V pyramidal neurons. These simple modifications would enable us to investigate the contributions of single cells or single dendrites to the functions of local cortical networks.	[Yamaguchi, Kazushi; Kitamura, Ryoji; Kawakami, Ryosuke; Otomo, Kohei; Nemoto, Tomomi] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan; [Yamaguchi, Kazushi; Kitamura, Ryoji; Kawakami, Ryosuke; Otomo, Kohei; Nemoto, Tomomi] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan; [Yamaguchi, Kazushi; Otomo, Kohei; Nemoto, Tomomi] Natl Inst Nat Sci, Div Biophoton, Natl Inst Physiol Sci, Okazaki, Aichi, Japan; [Kawakami, Ryosuke] Ehime Univ, Grad Sch Med, Toon, Ehime, Japan; [Otomo, Kohei; Nemoto, Tomomi] Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst, Okazaki, Aichi, Japan; [Otomo, Kohei; Nemoto, Tomomi] Grad Sch Adv Study, Dept Physiol Sci, Hayama, Kanagawa, Japan	Hokkaido University; Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Ehime University; National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS)	Nemoto, T (corresponding author), Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan.; Nemoto, T (corresponding author), Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan.; Nemoto, T (corresponding author), Natl Inst Nat Sci, Div Biophoton, Natl Inst Physiol Sci, Okazaki, Aichi, Japan.; Nemoto, T (corresponding author), Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst, Okazaki, Aichi, Japan.; Nemoto, T (corresponding author), Grad Sch Adv Study, Dept Physiol Sci, Hayama, Kanagawa, Japan.	tn@nips.ac.jp	Nemoto, Tomomi/B-4412-2012	Nemoto, Tomomi/0000-0001-6102-1495; Otomo, Kohei/0000-0002-5322-6295				Albright TD, 2000, NEURON, V25, pS1, DOI 10.1016/S0896-6273(00)80912-5; Allegra Mascaro Anna Letizia, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00021; Binding J, 2011, OPT EXPRESS, V19, P4833, DOI 10.1364/OE.19.004833; BRENNER JF, 1976, J HISTOCHEM CYTOCHEM, V24, P100, DOI 10.1177/24.1.1254907; Choi W, 2007, NAT METHODS, V4, P717, DOI 10.1038/NMETH1078; DENK W, 1994, P NATL ACAD SCI USA, V91, P6629, DOI 10.1073/pnas.91.14.6629; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Egner A, 2006, HDB BIOL CONFOCAL MI, P404, DOI DOI 10.1007/978-0-387-45524-2_20; Esposito A, 2004, MICROSC RES TECHNIQ, V63, P12, DOI 10.1002/jemt.10425; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Go MA, 2016, SCI REP, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-8]; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Horton NG, 2013, NAT PHOTONICS, V7, P205, DOI [10.1038/nphoton.2012.336, 10.1038/NPHOTON.2012.336]; Inoue M, 2019, CELL, V177, P1346, DOI 10.1016/j.cell.2019.04.007; Jia N, 2012, P NATL ACAD SCI USA, V109, P22, DOI 10.1073/pnas.1109202108; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kawakami R, 2015, BIOMED OPT EXPRESS, V6, P891, DOI 10.1364/BOE.6.000891; Kawakami R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01014; Koho S V., 2019, BIORXIV, DOI [10.1101/563288, DOI 10.1101/563288]; Kondo M, 2017, ELIFE, V6, DOI 10.7554/eLife.26839; Lanjakornsiripan D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03940-3; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Monai H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11100; Nemoto T, 2008, MOL CELLS, V26, P113; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ouzounov DG, 2017, NAT METHODS, V14, P388, DOI 10.1038/nmeth.4183; Papouin T, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0154; Park J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10729-5; Patriarchi T, 2018, SCIENCE, V360, P1420, DOI 10.1126/science.aat4422; Peron S, 2020, NATURE, V579, P256, DOI 10.1038/s41586-020-2062-x; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Sacconi L, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2798723; Shigetomi E, 2013, J GEN PHYSIOL, V141, P633, DOI 10.1085/jgp.201210949; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tanabe A, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.12.121503; Tanabe A, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.10.101204; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Ue Y, 2018, BIOCHEM BIOPH RES CO, V500, P236, DOI 10.1016/j.bbrc.2018.04.049; Volterra A, 2014, NAT REV NEUROSCI, V15, P327, DOI 10.1038/nrn3725; Wan DS, 2000, J MICROSC-OXFORD, V197, P274, DOI 10.1046/j.1365-2818.2000.00635.x; Wang K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8276; Wang TY, 2020, ELIFE, V9, DOI 10.7554/eLife.53205; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Xie YC, 2016, J NEUROSCI, V36, P1261, DOI 10.1523/JNEUROSCI.2744-15.2016; Zipfel Warren R., 2003, Nature Biotechnology, V21, P1369, DOI 10.1038/nbt899	51	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237230	10.1371/journal.pone.0237230	http://dx.doi.org/10.1371/journal.pone.0237230			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764808	gold, Green Published			2022-12-26	WOS:000561029000028
J	Phillips, CB; Brown, K; Green, C; Toft, R; Walker, G; Broome, K				Phillips, Craig B.; Brown, Kerry; Green, Chris; Toft, Richard; Walker, Graham; Broome, Keith			Eradicating the large white butterfly from New Zealand eliminates a threat to endemic Brassicaceae	PLOS ONE			English	Article							PIERIS-RAPAE; LEPIDOPTERA; INVASIONS; DIAPAUSE; BEHAVIOR; WASPS	In May 2010 the large white butterfly,Pieris brassicaeL. (Lepidoptera: Pieridae), was discovered to have established in New Zealand. It is a Palearctic species that-due to its wide host plant range within the Brassicaceae-was regarded as a risk to New Zealand's native brassicas. New Zealand has 83 native species of Brassicaceae including 81 that are endemic, and many are threatened by both habitat loss and herbivory by other organisms. Initially a program was implemented to slow its spread, then an eradication attempt commenced in November 2012. TheP.brassicaepopulation was distributed over an area of approximately 100 km(2)primarily in urban residential gardens. The eradication attempt involved promoting public engagement and reports of sightings, including offering a bounty for a two week period, systematically searching gardens forP.brassicaeand its host plants, removing host plants, ground-based spraying of insecticide to kill eggs and larvae, searching for pupae, capturing adults with nets, and augmenting natural enemy populations. The attempt was supported by research that helped to progressively refine the eradication strategy and evaluate its performance. The last New Zealand detection ofP.brassicaeoccurred on 16 December 2014, the eradication program ceased on 4 June 2016 andP.brassicaewas officially declared eradicated from New Zealand on 22 November 2016, 6.5 years after it was first detected and 4 years after the eradication attempt commenced. This is the first species of butterfly ever to have been eradicated worldwide.	[Phillips, Craig B.] AgResearch, Biocontrol & Biosecur Grp, Lincoln, New Zealand; [Phillips, Craig B.; Walker, Graham] Better Border Biosecur Res Collaborat, Aotearoa, New Zealand; [Brown, Kerry; Green, Chris; Broome, Keith] Dept Conservat, Wellington, New Zealand; [Toft, Richard] Entecol Ltd, Nelson, New Zealand; [Walker, Graham] Plant & Food Res, Auckland, New Zealand	AgResearch - New Zealand; New Zealand Institute for Plant & Food Research Ltd	Phillips, CB (corresponding author), AgResearch, Biocontrol & Biosecur Grp, Lincoln, New Zealand.; Phillips, CB (corresponding author), Better Border Biosecur Res Collaborat, Aotearoa, New Zealand.	craig.phillips@agresearch.co.nz	Phillips, Craig B/J-7165-2013	Walker, Graham/0000-0001-7176-3919	New Zealand Department of Conservation (DOC); Vegetables New Zealand; New Zealand Ministry for Primary Industries	New Zealand Department of Conservation (DOC); Vegetables New Zealand; New Zealand Ministry for Primary Industries	Details of all costs are publicly available on-line in the Department of Conservation's 2015-16 Pieris brassicae eradication program annual report: www.doc.govt.nz/about-us/sciencepublications/conservation-publications/threats-and-impacts/animal-pests/pieris-brassicae-greatwhite-butterfly-eradication-annual-report/ Operational aspects of the eradication program were funded by the New Zealand Department of Conservation (DOC; www.doc.govt.nz). Vegetables New Zealand (www.freshvegetables.co.nz) contributed some funds to DOC to support operational aspects of the eradication program. DOC provided support in the form of salaries for authors K. Brown, CG and K. Broome, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. Vegetables New Zealand did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. RT is a the Managing Director of a commercial company EntEcol Ltd (www.entecol.co.nz) which provides technical entomological services to New Zealand clients. In the eradication program, EntEcol Ltd was contracted by DOC for RT to provide services including contributing to the TAG, preparing documents, identifying specimens, helping to develop the visual lure, and evaluating P. brassicae parasitism rates. EntEcol Ltd provided support in the form of a salary for author RT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section. The New Zealand government research institutes AgResearch (www.agresearch.co.nz) and Plant and Food Research (www.plantandfood.co.nz) are partners in a New Zealand research collaboration called Better Border Biosecurity (www.b3nz.org). The collaboration aims to help reduce the rate at which non-native insects, weeds and diseases that could harm valued New Zealand plants are becoming established in New Zealand. AgResearch provided support in the form of a salary for author CP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section. Plant and Food Research provided support in the form of a salary for author GW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section. The New Zealand Ministry for Primary Industries (www.mpi.govt.nz) provided financial support for some of the research costs of CP, GW and RT, and the New Zealand TR Ellet Agricultural Trust contributed support for some of the research costs of CP. MPI and TR Ellet Agricultural Trust did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, NAPPO PHYTOSANITARY; [Anonymous], 1963, J RES LEPIDOPTERA, V2, P127; [Anonymous], 2013, GWB HOST PLANT GUIDE, P16; BAKER RR, 1970, J ZOOL, V162, P43; Briden K, 2013, 1278224 DOCDM, P16; Brodmann J, 2008, CURR BIOL, V18, P740, DOI 10.1016/j.cub.2008.04.040; Broome K, 2005, RAT ERADICATIONS GET, P152; Brown K., 2019, Occasional Papers of the IUCN Species Survival Commission, V62, P364; Brown K, 2015, CONTROL ERADICATION, P15; Brown K, 2013, DOCDM1106615, P27; Caley P, 2019, J PEST SCI, P1; Cicconardi F, 2017, MOL ECOL, V26, P3104, DOI 10.1111/mec.14037; Clapperton BK, 1999, NEW ZEAL J ECOL, V23, P11; Clout M, ERADICATION MAMMALS, p[2006, 127]; Cromarty P.L., 2002, Occasional Papers of the IUCN Species Survival Commission, V27, P85; Curran S., 2013, MINUTES GREAT WHITE, P32; DAVIES CR, 1985, OECOLOGIA, V67, P278, DOI 10.1007/BF00384299; de Lange PJ, 2017, CONSERVATION STATUS, P82; DEMPSTER JP, 1967, J APPL ECOL, V4, P485, DOI 10.2307/2401350; Feltwell J., 1982, LARGE WHITE BUTTERFL; Funderburk J, 2016, INSECT SCI, V23, P175, DOI 10.1111/1744-7917.12250; GARDINER B O C, 1974, Journal of the Lepidopterists' Society, V28, P269; Geertsema H., 1996, Journal of the Southern African Society for Horticultural Sciences, V6, P31; Genovesi P, 2005, BIOL INVASIONS, V7, P127, DOI 10.1007/s10530-004-9642-9; Gill I, 2013, IZA J EUR LABOR STUD, V2, DOI 10.1186/2193-9012-2-19; GLARE TR, 1993, NEW ZEAL J ZOOL, V20, P95, DOI 10.1080/03014223.1993.10422867; Green K. Kappmeier, 2007, P309; Hasenbank M, 2011, NEW ZEAL J ECOL, V35, P69; Hiszczynska-Sawicka E., 2014, New Zealand Plant Protection, V67, P8; Jones HP, 2016, P NATL ACAD SCI USA, V113, P4033, DOI 10.1073/pnas.1521179113; JONES RE, 1987, J ANIM ECOL, V56, P739, DOI 10.2307/4945; Kean J, 2013, RE4002013481 AGRESEA, P15; Kean J, 2014, RE4002014579 AGRESEA, P8; KEAN JM, 2019, GLOBAL ERADICATION R; Liebhold AM, 2016, ANNU REV ENTOMOL, V61, P335, DOI 10.1146/annurev-ento-010715-023809; Mitchell AD, 2000, SYST BOT, V25, P98, DOI 10.2307/2666676; Molet T., 2011, CPHST PEST DATASHEET, P10; Muggeridge J., 1943, NEW ZEALAND JOUR SCI AND TECH, V25A, P1; Muggeridge J., 1942, NZ J SCI TECHNOLOGY, V24, P107; Myers JH, 2000, TRENDS ECOL EVOL, V15, P316, DOI 10.1016/S0169-5347(00)01914-5; Myers JH, 1998, ANNU REV ENTOMOL, V43, P471, DOI 10.1146/annurev.ento.43.1.471; Neo E, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-24; Obara Y, 2008, ZOOL SCI, V25, P1106, DOI 10.2108/zsj.25.1106; Obara Y, 2008, J EXP BIOL, V211, P3698, DOI 10.1242/jeb.021980; Pebesma E, 2018, R J, V10, P439; Philip B., 2012, BIOSECURITY RESPONSE, P29; Philip B., 2010, CONSULTATION PAPER P; Phillips C, 2014, RE4002014589 AGRESEA, P18; Phillips C, 2019, IUCN ISLAND INVASIVE, P400; Phillips C, 2013, DOCDM1307089, P31; Phillips C., 2014, RE4002014607, P13; Phillips C, 2015, R77017 DEP CONS, P19; Phillips C, 2014, 884 AGRESEARCH, P41; Phillips C, 2014, PIERIS BRASSICAE GRE, P37; Phillips C, 2013, GREAT WHITE BUTTERFL, P15; Phillips C, 2016, PIERIS BRASSICAE GRE, P20; Pluess T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048157; R Core Team, 2021, R LANGUAGE ENV STAT; Richards N. K., 2016, New Zealand Plant Protection, V69, P126; Richardson E, 2010, 2010681161 IDC, P9; Russell JC, 2016, NEW ZEAL J ECOL, V40, P197; Monteys VSI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029282; Schrouff J, 2015, 2015 INTERNATIONAL WORKSHOP ON PATTERN RECOGNITION IN NEUROIMAGING (PRNI) 2015, P81, DOI 10.1109/PRNI.2015.13; Schulz AN, 2019, BIOSCIENCE, V69, P711, DOI 10.1093/biosci/biz075; Simberloff D, 2003, WEED SCI, V51, P247, DOI 10.1614/0043-1745(2003)051[0247:EPIATO]2.0.CO;2; SIMBERLOFF D, 2002, TURNING TIDE ERADICA, P4; Simberloff D, 2009, BIOL INVASIONS, V11, P149, DOI 10.1007/s10530-008-9317-z; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; SPIETH HR, 1991, J INSECT PHYSIOL, V37, P231, DOI 10.1016/0022-1910(91)90073-9; Spieth HR, 2012, ECOL ENTOMOL, V37, P439, DOI 10.1111/j.1365-2311.2012.01385.x; Spieth HR, 2011, EUR J ENTOMOL, V108, P377, DOI 10.14411/eje.2011.047; Springenberg JT, 2016, ADV NEUR IN, V29; Stavenga DG, 2006, ARTHROPOD STRUCT DEV, V35, P307, DOI 10.1016/j.asd.2006.08.011; Suckling DM, 2014, PEST MANAG SCI, V70, P179, DOI 10.1002/ps.3670; Sullivan T, 2014, IDENTIFICATION SEMIO, P14; Tobin PC, 2014, BIOL INVASIONS, V16, P401, DOI 10.1007/s10530-013-0529-5; Tobin PC, 2011, ECOL LETT, V14, P615, DOI 10.1111/j.1461-0248.2011.01614.x; Toft R, 2012, PROPOSED ERADICATION; Toft R., 2013, ENT031, P38; Towns D, 2018, ECOLOGICAL RESTORATI, P205; Townsend AJ, 2008, NZ THREAT CLASSIFICA, V16, P2008; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Walker G, 2013, 8829 PLANT FOOD RES, P20; Walker G, 2013, 8929 PLANT FOOD RES, P11; Walker GP, 2004, N Z PLANT PROTECT-SE, P1; Walker S, 2014, J INTERACT MEDIA EDU; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479; Worner SP, 2006, J APPL ECOL, V43, P858, DOI 10.1111/j.1365-2664.2006.01202.x	88	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236791	10.1371/journal.pone.0236791	http://dx.doi.org/10.1371/journal.pone.0236791			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760094	Green Published, gold			2022-12-26	WOS:000561027200062
J	Kim, HJ; Lee, SE; Na, H; Roe, JS; Roh, JI; Lee, HW				Kim, Hye Jeong; Lee, Seung Eon; Na, Heeju; Roe, Jae-Seok; Roh, Jae-il; Lee, Han-Woong			Divergence of the PIERCE1 expression between mice and humans as a p53 target gene	PLOS ONE			English	Article							BINDING-SITES; GROWTH; IDENTIFICATION; PROGRAM; CANCER	PIERCE1, p53 induced expression 1 in Rb null cells, is a novel p53 target involved in the DNA damage response and cell cycle in mice. These facts prompted us to study the function of PIERCE1 with respect to p53-associated pathophysiology of cancer in humans. Unexpectedly, PIERCE1 did not respond to overexpression and activation of p53 in humans. In this study, we swapped p53 protein expression in human and mouse cells to find the clue of this difference between species. Human p53 expression in mouse cells upregulatedPIERCE1expression, suggesting that p53-responsive elements on thePIERCE1promoter are crucial, but not the p53 protein itself. Indeed,in silicoanalyses ofPIERCE1promoters revealed that p53-responsive elements identified in mice are not conserved in humans. Consistently, chromatin immunoprecipitation-sequencing (ChIP-seq) analyses confirmed p53 enrichment against thePIERCE1promoter region in mice, not in human cells. To complement the p53 study in mice, further promoter analyses suggested that the humanPIERCE1promoter is more similar to guinea pigs, lemurs, and dogs than to rodents. Taken together, our results confirm the differential responsiveness ofPIERCE1expression to p53 due to species differences inPIERCE1promoters. The results also show partial dissimilarity after p53 induction between mice and humans.	[Kim, Hye Jeong; Lee, Seung Eon; Na, Heeju; Roe, Jae-Seok; Roh, Jae-il; Lee, Han-Woong] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul, South Korea	Yonsei University	Roh, JI; Lee, HW (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul, South Korea.	rohjaeil@gmail.com; hwl@yonsei.ac.kr		Lee, Han-Woong/0000-0001-9515-3605; Roe, Jae-Seok/0000-0002-9994-3062	National Research Foundation of Korea (NRF) - Korean government (MEST) [2018R1A2A1A05022746, 2017R1A4A1015328]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by grants from the National Research Foundation of Korea (NRF; https://www.nrf.re.kr/eng/index) funded by the Korean government (MEST; 2018R1A2A1A05022746 and 2017R1A4A1015328) to Han-Woong Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrysik Z, 2017, GENOME RES, V27, P1645, DOI 10.1101/gr.220533.117; Assaily W, 2011, MOL CELL, V44, P491, DOI 10.1016/j.molcel.2011.08.038; Bedell MA, 1997, GENE DEV, V11, P11, DOI 10.1101/gad.11.1.11; Beroud C, 1998, NUCLEIC ACIDS RES, V26, P200, DOI 10.1093/nar/26.1.200; Broz DK, 2013, GENE DEV, V27, P1016, DOI 10.1101/gad.212282.112; Colman MS, 2000, MUTAT RES-REV MUTAT, V462, P179, DOI 10.1016/S1383-5742(00)00035-1; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Fischer M, 2019, ONCOGENE, V38, P4095, DOI 10.1038/s41388-019-0706-9; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; HARRIS CC, 1993, SCIENCE, V262, P1980, DOI 10.1126/science.8266092; Horvath MM, 2007, PLOS GENET, V3, P1284, DOI 10.1371/journal.pgen.0030127; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jin Y, 2018, MOL CELLS, V41, P684, DOI 10.14348/molcells.2018.0206; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jonas A.M., 1984, Physiologist, V27, P330; Kim Hyejeong, 2018, Lab Anim Res, V34, P257, DOI 10.5625/lar.2018.34.4.257; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lee HyunJeong, 2018, Lab Anim Res, V34, P279, DOI 10.5625/lar.2018.34.4.279; Lee TK, 2019, LAB ANIM RES, V35, DOI 10.1186/s42826-019-0022-0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Nam TW, 2019, BIOCHEM BIOPH RES CO, V514, P1087, DOI 10.1016/j.bbrc.2019.04.186; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; Park Bo Min, 2018, Lab Anim Res, V34, P264, DOI 10.5625/lar.2018.34.4.264; Perlman RL, 2016, EVOL MED PUBLIC HLTH, P170, DOI 10.1093/emph/eow014; Roe JS, 2017, CELL, V170, P875, DOI 10.1016/j.cell.2017.07.007; Roh JI, 2018, EXP ANIM TOKYO, V67, P229, DOI 10.1538/expanim.17-0123; Roh JI, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193182; Roh JI, 2014, CELL REP, V8, P991, DOI 10.1016/j.celrep.2014.07.027; Sanchez-Macedo N, 2013, CELL DEATH DIFFER, V20, P659, DOI 10.1038/cdd.2012.168; Sung YH, 2007, MOL CELLS, V24, P409; Sung YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27932; Sung YH, 2010, CANCER RES, V70, P10454, DOI 10.1158/0008-5472.CAN-10-0031; Velasco-Miguel S, 2003, DNA REPAIR, V2, P91, DOI 10.1016/S1568-7864(02)00189-1; Wong J, 2002, J BIOL CHEM, V277, P26699, DOI 10.1074/jbc.M203020200	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236881	10.1371/journal.pone.0236881	http://dx.doi.org/10.1371/journal.pone.0236881			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745107	Green Published, gold			2022-12-26	WOS:000560006800049
J	Lee, B; Yamanakkanavar, N; Choi, JY				Lee, Bumshik; Yamanakkanavar, Nagaraj; Choi, Jae Young			Automatic segmentation of brain MRI using a novel patch-wise U-net deep architecture	PLOS ONE			English	Article								Accurate segmentation of brain magnetic resonance imaging (MRI) is an essential step in quantifying the changes in brain structure. Deep learning in recent years has been extensively used for brain image segmentation with highly promising performance. In particular, the U-net architecture has been widely used for segmentation in various biomedical related fields. In this paper, we propose a patch-wise U-net architecture for the automatic segmentation of brain structures in structural MRI. In the proposed brain segmentation method, the non-overlapping patch-wise U-net is used to overcome the drawbacks of conventional U-net with more retention of local information. In our proposed method, the slices from an MRI scan are divided into non-overlapping patches that are fed into the U-net model along with their corresponding patches of ground truth so as to train the network. The experimental results show that the proposed patch-wise U-net model achieves a Dice similarity coefficient (DSC) score of 0.93 in average and outperforms the conventional U-net and the SegNet-based methods by 3% and 10%, respectively, for on Open Access Series of Imaging Studies (OASIS) and Internet Brain Segmentation Repository (IBSR) dataset.	[Lee, Bumshik; Yamanakkanavar, Nagaraj] Chosun Univ, Dept Informat & Commun Engn, Gwangju, South Korea; [Choi, Jae Young] Hankuk Univ Foreign Studies, Div Comp & Elect Syst Engn, Yongin, South Korea	Chosun University; Hankuk University Foreign Studies	Choi, JY (corresponding author), Hankuk Univ Foreign Studies, Div Comp & Elect Syst Engn, Yongin, South Korea.	jychoi@hufs.ac.kr	Yamanakkanavar, Nagaraj/ABC-9350-2020	Yamanakkanavar, Nagaraj/0000-0001-6701-1802; Lee, Bumshik/0000-0003-2482-1869	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2019R1I1A3A01058959]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2019R1I1A3A01058959).	Akkus Z, 2017, J DIGIT IMAGING, V30, P449, DOI 10.1007/s10278-017-9983-4; Andres B, 2017, IFIP ADV INF COMM TE, V499, P3, DOI 10.1007/978-3-319-56077-9_1; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; Bazin PL, 2007, IEEE T MED IMAGING, V26, P487, DOI 10.1109/TMI.2007.893283; Bernal J., 2017, DEEP CONVOLUTIONAL N; Breiman L., 2020, RANDOM FORESTS; Chollet F., 2018, KERAS PYTHON DEEP LE; Ciresan D, 2012, NIPS, V2012, P2852; Ciresan D, 2012, PROC CVPR IEEE, P3642, DOI 10.1109/CVPR.2012.6248110; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; De Brebisson A., 2015, IEEE COMPUT SOC CONF; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Feng X, 2020, FRONT COMPUT NEUROSC, V14, DOI 10.3389/fncom.2020.00025; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Jaccard P., 1912, NEW PHYTOL; Khagi B, 2018, J HEALTHC ENG, V2018, DOI 10.1155/2018/3640705; Krizhevsky A., 2012, NIPS, P1097; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lee B, 2019, IEICE T INF SYST, VE102D, P1384, DOI 10.1587/transinf.2018EDP7393; Luna M., 2019, LECT NOTES COMPUTER; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Moeskops P, 2016, IEEE T MED IMAGING, V35, P1252, DOI 10.1109/TMI.2016.2548501; Nie D, 2016, I S BIOMED IMAGING, P1342, DOI 10.1109/ISBI.2016.7493515; ozgun C., 2016, 3D U NET LEARNING DE; Pawel M., 2019, COMPUTERIZED MED IMA, V73; Ronneberger O., 2015, P MICCAI MUN GERM 5, P234, DOI DOI 10.1007/978-3-319-24574-4_28; ROTE G, 1991, INFORM PROCESS LETT, V38, P123, DOI 10.1016/0020-0190(91)90233-8; Roy S, 2012, MED IMAGE ANAL, V16, P524, DOI 10.1016/j.media.2011.12.001; Shelhamer E, 2017, IEEE T PATTERN ANAL, V39, P640, DOI 10.1109/TPAMI.2016.2572683; Srivastava R, 2010, OPT LASER ENG, V48, P626, DOI 10.1016/j.optlaseng.2009.09.012; Thompson P. M., 2000, BRAIN MAPPING DISORD, P131; Valverde S, 2015, J MAGN RESON IMAGING, V41, P93, DOI 10.1002/jmri.24517; Wang GT, 2018, IEEE T MED IMAGING, V37, P1562, DOI 10.1109/TMI.2018.2791721; Wang GT, 2016, MED IMAGE ANAL, V34, P137, DOI 10.1016/j.media.2016.04.009; Werbos P., 1975, THESIS HARVARD U; Zhang W., 2015, NEUROIMAGE; Zikic D., 2014, P MICCAI BRATS, P36, DOI DOI 10.1021/OL2032625	37	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0236493	10.1371/journal.pone.0236493	http://dx.doi.org/10.1371/journal.pone.0236493			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745102	gold, Green Published			2022-12-26	WOS:000560006800002
J	Otani, M; Aoyagi, K; Nakano, M				Otani, Masahiro; Aoyagi, Kaiki; Nakano, Masaru			Suppression of B function by chimeric repressor gene-silencing technology (CRES-T) reduces the petaloid tepal identity in transgenic Lilium sp.	PLOS ONE			English	Article							MADS-BOX GENES; FLORAL HOMEOTIC GENES; MODIFIED ABC MODEL; PI MOTIF; PISTILLATA PI; EXPRESSION; LONGIFLORUM; TRANSITION; PETUNIA; DOMAIN	Some monocotyledonous plants, including liliaceous, amaryllidaceous and iridaceous ones, produce flowers with petaloid tepals in whorls 1 and 2 organs. For explaining the molecular mechanism of two-layered petaloid tepal development, the modified ABC model has been proposed, in which B class genes are expressed in whorl 1 organs as well as in whorls 2 and 3 organs. We have previously obtained results strongly support the modified ABC model by chimeric repressor gene-silencing technology (CRES-T)-mediated suppression of B function in the liliaceous plantTricyrtissp. In the present study, we introduced a CRES-T construct derived from the B class gene ofTricyrtissp. (TrihDEFa-SRDX) intoLiliumsp. in order to examine the effect of suppressing B function on the floral organ identity. Flowers of transgenic plants did not open fully and had pale pink-colored tepals with decreased numbers of papillae on the adaxial side in whorls 1 and 2 compared with those of non-transgenic plants. No apparent morphological alterations were observed in whorls 3 and 4 organs. Both the amount of total anthocyanins and the expression levels of endogenous flavonoid biosynthesis-related genes (LhMYB12,LhbHLH2,LhCHS,LhF3H,LhF3'H,LhDFRandLhANS) decreased in whorls 1 and 2 organs of transgenic plants compared with non-transgenic plants. In addition, the expression levels of endogenous B class genes (LFDEF,LFGLOAandLFGLOB) decreased in transgenic plants and the level was negatively correlated with the degree of morphological alteration. Thus suppression of B function may reduce the identity of petaloid tepals in whorls 1 and 2 of transgenicLiliumsp.	[Otani, Masahiro; Aoyagi, Kaiki; Nakano, Masaru] Niigata Univ, Fac Agr, Nishi Ku, Niigata, Japan	Niigata University	Otani, M (corresponding author), Niigata Univ, Fac Agr, Nishi Ku, Niigata, Japan.	otani@agr.niigata-u.ac.jp		Otani, Masahiro/0000-0002-2430-0986	Ministry of Education, Culture, Sports, Science and Technology, Japan [23580037, 16380024, 15K07287]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research (Nos. 23580037, 16380024 and 15K07287 to M.N.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (URL:https://www.jsps.go.jp/english/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita Y, 2008, J HORTIC SCI BIOTECH, V83, P453, DOI 10.1080/14620316.2008.11512406; ANGENENT GC, 1993, PLANT J, V4, P101, DOI 10.1046/j.1365-313X.1993.04010101.x; Benlloch R, 2009, PLANT J, V60, P102, DOI 10.1111/j.1365-313X.2009.03939.x; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Chen MK, 2008, PLANT CELL PHYSIOL, V49, P704, DOI 10.1093/pcp/pcn046; Chen MK, 2012, J EXP BOT, V63, P941, DOI 10.1093/jxb/err323; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; Guo XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20454; Hirai M, 2007, PLANT CELL PHYSIOL, V48, P310, DOI 10.1093/pcp/pcm004; Hirai M, 2010, BREEDING SCI, V60, P110, DOI 10.1270/jsbbs.60.110; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Hoshi Y, 2004, PLANT CELL REP, V22, P359, DOI 10.1007/s00299-003-0700-z; Hsu HF, 2010, PLANT CELL PHYSIOL, V51, P1029, DOI 10.1093/pcp/pcq052; Kanemaki A, 2018, SCI HORTIC-AMSTERDAM, V240, P411, DOI 10.1016/j.scienta.2018.06.029; Kanno A, 2003, PLANT MOL BIOL, V52, P831, DOI 10.1023/A:1025070827979; Lange M, 2013, PLANT CELL, V25, P438, DOI 10.1105/tpc.112.105809; Miura K, 2019, HORTICULT J, V88, P284, DOI 10.2503/hortj.UTD-036; Nakada M, 2006, PLANT SCI, V170, P143, DOI 10.1016/j.plantsci.2005.08.021; Nakamura T, 2005, PLANT MOL BIOL, V58, P435, DOI 10.1007/s11103-005-5218-z; Nakatsuka A, 2009, SCI HORTIC-AMSTERDAM, V121, P84, DOI 10.1016/j.scienta.2009.01.008; Nonaka T, 2011, SCI HORTIC-AMSTERDAM, V129, P832, DOI 10.1016/j.scienta.2011.05.004; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Otani M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24549; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Roque E, 2013, PLANT J, V73, P663, DOI 10.1111/tpj.12068; Sage-Ono K, 2011, PLANT BIOTECHNOL-NAR, V28, P153, DOI 10.5511/plantbiotechnology.11.0119a; Sasaki K, 2010, MOL GENET GENOMICS, V284, P399, DOI 10.1007/s00438-010-0574-z; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Su CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080462; TROBNER W, 1992, EMBO J, V11, P4693, DOI 10.1002/j.1460-2075.1992.tb05574.x; Tsaftaris AS, 2006, PLANT SCI, V170, P238, DOI 10.1016/j.plantsci.2005.08.008; Tzeng TY, 2003, PLANT PHYSIOL, V133, P1091, DOI 10.1104/pp.103.026997; Tzeng TY, 2001, PLANT CELL PHYSIOL, V42, P1156, DOI 10.1093/pcp/pce151; van Doorn WG, 2003, J EXP BOT, V54, P1801, DOI 10.1093/jxb/erg213; Van Tunen A.J., 1993, FLOWERING NEWSLETTER, V16, P33; Vandenbussche M, 2004, PLANT CELL, V16, P741, DOI 10.1105/tpc.019166; Xu YF, 2006, PLANT J, V46, P54, DOI 10.1111/j.1365-313X.2006.02669.x; Yamagishi M, 2013, EUPHYTICA, V194, P325, DOI 10.1007/s10681-013-0937-8; Yamagishi M, 2010, PLANT CELL PHYSIOL, V51, P463, DOI 10.1093/pcp/pcq011; Yan XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033890	42	2	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2020	15	8							e0237176	10.1371/journal.pone.0237176	http://dx.doi.org/10.1371/journal.pone.0237176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA7OS	32745128	Green Published, gold			2022-12-26	WOS:000560006800053
J	Boff, D; Oliveira, VLS; Queiroz, CM; Galvao, I; Batista, NV; Gouwy, M; Menezes, GB; Cunha, TM; Verri, WA; Proost, P; Teixeira, MM; Amaral, FA				Boff, Daiane; Soares Oliveira, Vivian Louise; Queiroz Junior, Celso M.; Galvao, Izabela; Batista, Nathalia Vieira; Gouwy, Mieke; Menezes, Gustavo Batista; Cunha, Thiago Mattar; Verri Junior, Waldiceu Aparecido; Proost, Paul; Teixeira, Mauro Martins; Amaral, Flavio Almeida			Lipoxin A(4)impairs effective bacterial control and potentiates joint inflammation and damage caused byStaphylococcus aureusinfection	FASEB JOURNAL			English	Article						5-lipoxygenase; arthritis; inflammation	STAPHYLOCOCCUS-AUREUS; SEPTIC ARTHRITIS; LIPID MEDIATORS; DENDRITIC CELLS; RECEPTOR; RESOLUTION; SERUM; IDENTIFICATION; LEUKOTRIENES; NEUTROPHILS	Staphylococcus aureusis the main cause of septic arthritis in humans, a disease associated with high morbidity and mortality. Inflammation triggered in response to infection is fundamental to control bacterial growth but may cause permanent tissue damage. Here, we evaluated the role of Lipoxin A(4)(LXA(4)) inS aureus-induced arthritis in mice. Septic arthritis was induced byS aureusinjection into tibiofemoral joints. At different time points, we evaluated cell recruitment and bacterial load in the joint, the production of pro-inflammatory molecules, and LXA(4)in inflamed tissue and analyzed joint damage and dysfunction. LXA(4)was investigated using genetically modified mice or by pharmacological blockade of its synthesis and receptor. CD11c(+)cells were evaluated in lymph nodes by confocal microscopy and flow cytometry and dendritic cell chemotaxis using the Boyden chamber. Absence or pharmacological blockade of 5-lipoxygenase (5-LO) reduced joint inflammation and dysfunction and was associated with better control of infection at 4 to 7 days after the infection. There was an increase in LXA(4)in joints of S aureus-infected mice and administration of LXA(4)reversed the phenotype in 5-LO(-/-)mice. Blockade or absence of the LXA(4)receptor FPR2 has a phenotype similar to 5-LO(-/-)mice. Mechanistically, LXA(4)appeared to control migration and function of dendritic cells, cells shown to be crucial for adequate protective responses in the model. Thus, after the first days of infection when symptoms become evident therapies that inhibit LXA(4)synthesis or action could be useful for treatment ofS aureus-induced arthritis.	[Boff, Daiane; Soares Oliveira, Vivian Louise; Galvao, Izabela; Batista, Nathalia Vieira; Teixeira, Mauro Martins; Amaral, Flavio Almeida] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Immunopharmacol, Belo Horizonte, MG, Brazil; [Boff, Daiane; Gouwy, Mieke; Proost, Paul] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Mol Immunol, Leuven, Belgium; [Queiroz Junior, Celso M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morphol, Belo Horizonte, MG, Brazil; [Menezes, Gustavo Batista] Univ Fed Minas Gerais, Ctr Biol Gastrointestinal, Dept Morfol, Belo Horizonte, MG, Brazil; [Cunha, Thiago Mattar] Univ Sao Paulo, Ctr Res Inflammatory Dis, Fac Med Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil; [Verri Junior, Waldiceu Aparecido] Univ Estadual Londrina, Ctr Ciencias Biol, Dept Pathol Sci, Londrina, Parana, Brazil	Universidade Federal de Minas Gerais; KU Leuven; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Universidade Estadual de Londrina	Amaral, FA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Av Antonio Carlos 6627,Bloco O 4,Sala 202, Belo Horizonte, MG, Brazil.	famaral@icb.ufmg.br	Menezes, Gustavo B/B-3350-2013; WA, Verri/I-1330-2013; Cunha, Thiago M/B-7729-2012; Teixeira, Mauro M/A-4587-2008; Boff, Daiane/AAU-2149-2021; Proost, Paul/V-3052-2017; Gouwy, Mieke/I-4642-2018	WA, Verri/0000-0003-2756-9283; Cunha, Thiago M/0000-0003-1084-0065; Teixeira, Mauro M/0000-0002-6944-3008; Proost, Paul/0000-0002-0133-5545; Boff, Daiane/0000-0001-8127-916X; Soares de Oliveira, Vivian Louise/0000-0002-1798-5171; Gouwy, Mieke/0000-0002-4035-4810	MCTI \Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ 03072-15]; National Institute of Science and Technology in Dengue and Host-Microorganism Interaction-INCT Dengue [CNPq 465425/2014-3]; FAPEMIG [APQ03606-17]; Programa de Apoio a Grupos de Excelencia (PRONEX) grant by SETI/Araucaria Foundation; MCTI/ CNPq; Parana State Government [014/2017, 46.843, CNPq 427946/20182]; Fund for Scientific Research of Flanders; KU Leuven [C16/17/010]	MCTI \Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Institute of Science and Technology in Dengue and Host-Microorganism Interaction-INCT Dengue; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Programa de Apoio a Grupos de Excelencia (PRONEX) grant by SETI/Araucaria Foundation; MCTI/ CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Parana State Government; Fund for Scientific Research of Flanders(FWO); KU Leuven(KU Leuven)	MCTI vertical bar Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Grant/Award Number: APQ 03072-15; National Institute of Science and Technology in Dengue and Host-Microorganism Interaction-INCT Dengue, Grant/Award Number: CNPq 465425/2014-3 and FAPEMIG APQ03606-17; Programa de Apoio a Grupos de Excelencia (PRONEX) grant supported by SETI/Araucaria Foundation and MCTI/ CNPq and Parana State Government (agreement 014/2017, protocol 46.843), Grant/Award Number: CNPq 427946/20182:; Fund for Scientific Research of Flanders, and C1 funding (C16/17/010) of the KU Leuven	Ackermann JA, 2017, BBA-MOL CELL BIOL L, V1862, P371, DOI 10.1016/j.bbalip.2016.07.014; Balderia PG, 2015, JCR-J CLIN RHEUMATOL, V21, P196, DOI 10.1097/RHU.0000000000000249; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Bekeredjian-Ding I, 2017, CURR TOP MICROBIOL, V409, P385, DOI 10.1007/82_2015_5004; Bena S, 2012, J BIOL CHEM, V287, P24690, DOI 10.1074/jbc.M112.377101; Blaho VA, 2011, J IMMUNOL, V186, P3076, DOI 10.4049/jimmunol.1003473; Boff D, 2018, EUR J IMMUNOL, V48, P454, DOI 10.1002/eji.201747198; Broker BM, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010031; Bulloch K, 2008, J COMP NEUROL, V508, P687, DOI 10.1002/cne.21668; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Coelho FM, 2008, ARTHRITIS RHEUM-US, V58, P2329, DOI 10.1002/art.23622; Colavite PM, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-19; De Buck M, 2016, CYTOKINE GROWTH F R, V30, P55, DOI 10.1016/j.cytogfr.2015.12.010; De Buck M, 2013, BIOCHEM PHARMACOL, V85, P789, DOI 10.1016/j.bcp.2012.11.027; Dey S, 2015, J INFLAMM RES, V8, P29, DOI 10.2147/JIR.S76045; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Garcia-De La Torre I, 2009, RHEUM DIS CLIN N AM, V35, P63, DOI 10.1016/j.rdc.2009.03.001; Gobbetti T, 2014, P NATL ACAD SCI USA, V111, P18685, DOI 10.1073/pnas.1410938111; HENDERSON WR, 1994, ANN INTERN MED, V121, P684, DOI 10.7326/0003-4819-121-9-199411010-00010; Henningsson L, 2010, INFECT IMMUN, V78, P3783, DOI 10.1128/IAI.00385-10; Kennedy N, 2015, J RHEUMATOL, V42, P2392, DOI 10.3899/jrheum.150434; Khan FY, 2013, CLIN RHEUMATOL, V32, P969, DOI 10.1007/s10067-013-2211-9; Kobayashi D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09113-4; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Liang TS, 2000, BIOCHEM BIOPH RES CO, V270, P331, DOI 10.1006/bbrc.2000.2416; McGovern NN, 2011, J IMMUNOL, V186, P453, DOI 10.4049/jimmunol.1002213; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Mullen LM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0645-y; Peters-Golden M, 2001, FEBS LETT, V487, P323, DOI 10.1016/S0014-5793(00)02374-7; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Pizzolla A, 2012, J IMMUNOL, V188, P5003, DOI 10.4049/jimmunol.1103430; Proost P, 2003, EUR J IMMUNOL, V33, P3146, DOI 10.1002/eji.200324136; Queiroz CM, 2011, J IMMUNOL, V187, P3821, DOI 10.4049/jimmunol.1101195; Ross JJ, 2017, INFECT DIS CLIN N AM, V31, P203, DOI 10.1016/j.idc.2017.01.001; Sachs D, 2011, BRIT J PHARMACOL, V162, P72, DOI 10.1111/j.1476-5381.2010.00895.x; Santos PC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002390; Schindler D, 2012, AM J PATHOL, V181, P1327, DOI 10.1016/j.ajpath.2012.06.039; Schwab JM, 2006, CURR OPIN PHARMACOL, V6, P414, DOI 10.1016/j.coph.2006.02.006; Secatto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031701; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Sharba S, 2019, VIRULENCE, V10, P610, DOI 10.1080/21505594.2019.1635417; Singel KL, 2016, CLIN SCI, V130, P479, DOI 10.1042/CS20150660; Sordi R, 2013, INT IMMUNOPHARMACOL, V17, P283, DOI 10.1016/j.intimp.2013.06.010; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Weiss E, 2018, FASEB J, V32, P26, DOI 10.1096/fj.201700441R; Winkler JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep18972; Zhang Y, 2017, J LIPID RES, V58, P494, DOI 10.1194/jlr.M068882	52	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11498	11510		10.1096/fj.201802830RR	http://dx.doi.org/10.1096/fj.201802830RR		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32741032				2022-12-26	WOS:000558169200001
J	Aniort, J; Freist, M; Piraud, A; Philipponnet, C; Abdelkader, MH; Garrouste, C; Gentes, E; Pereira, B; Heng, AE				Aniort, Julien; Freist, Marine; Piraud, Aurelien; Philipponnet, Carole; Abdelkader, Mohamed Hadj; Garrouste, Cyril; Gentes, Elodie; Pereira, Bruno; Heng, Anne-Elisabeth			Circulating 20S proteasome for assessing protein energy wasting syndrome in hemodialysis patients	PLOS ONE			English	Article							MUSCLE; UBIQUITIN; SURVIVAL; MURF1	Protein energy wasting (PEW) including muscle atrophy is a common complication in chronic hemodialysis patients. The ubiquitin proteasome system (UPS) is the main proteolytic system causing muscle atrophy in chronic kidney disease and proteasome 20S is the catalytic component of the UPS. Circulating proteasome 20S (c20S proteasome) is present in the blood and its level is related to disease severity and prognosis in several disorders. We hypothesized that c20S proteasome could be related with muscle mass, other PEW criteria and their evolution in hemodialysis patients. Stable hemodialysis patients treated at our center for more than 3 months were followed over 2 years. C20S proteasome assay was performed at baseline. Biological and clinical data were collected, muscle mass was assessed by multi-frequency bio-impedancemetry, and nutritional scores were calculated at baseline, 1 year and 2 years. Hospitalizations and mortality data were collected over the 2 years. Forty-nine patients were included. At baseline, the c20S proteasome level was 0.40 [0.26-0.55] mu g/ml. Low muscle mass as defined by a lean tissue index (LTI) < 10th in accordance with the International Society of Renal Nutrition and Metabolism guidelines was observed in 36% and PEW in 62%. Increased c20S proteasome levels were related with LTI at baseline (R = 0.43, p = 0.004) and with its 2 year-variation (R = -0.56, p = 0.003). Two-year survival rate was not different between higher and lower c20S proteasome values (78.9 vs 78.4%, p = 0.98 log-rank test). C20S proteasome is not a good marker for assessing nutritional status in hemodialysis patients and predicting patient outcomes.	[Aniort, Julien; Freist, Marine; Piraud, Aurelien; Philipponnet, Carole; Abdelkader, Mohamed Hadj; Garrouste, Cyril; Heng, Anne-Elisabeth] Gabriel Montpied Univ Hosp, Nephrol Dialysis & Transplantat Dept, Clermont Ferrand, France; [Aniort, Julien; Heng, Anne-Elisabeth] Human Nutr Unit UNH, INRA, UMR 1019, St Genes Champanelle, France; [Freist, Marine] Emile Roux Hosp, Nephrol & Dialysis Dept, Le Puy En Velay, France; [Gentes, Elodie] Gabriel Montpied Univ Hosp, Clin Nutr Dept, Clermont Ferrand, France; [Pereira, Bruno] Univ Hosp Clermont Ferrand, Biostat Unit DRCI, Clermont Ferrand, France	CHU Clermont Ferrand; INRAE; CHU Clermont Ferrand; CHU Clermont Ferrand	Aniort, J (corresponding author), Gabriel Montpied Univ Hosp, Nephrol Dialysis & Transplantat Dept, Clermont Ferrand, France.; Aniort, J (corresponding author), Human Nutr Unit UNH, INRA, UMR 1019, St Genes Champanelle, France.	janiort@chu-clermontferrand.fr						Aniort J, 2019, J CACHEXIA SARCOPENI, V10, P323, DOI 10.1002/jcsm.12376; Aniort J, 2016, INT J BIOCHEM CELL B, V79, P505, DOI 10.1016/j.biocel.2016.04.006; Baker ST, 2012, EUR J CLIN NUTR, V66, P628, DOI 10.1038/ejcn.2012.3; Canaud B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093286; Cano NJM, 2009, SEMIN NEPHROL, V29, P59, DOI 10.1016/j.semnephrol.2008.10.008; Chamney PW, 2007, AM J CLIN NUTR, V85, P80, DOI 10.1093/ajcn/85.1.80; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Daugirdas J T, 1995, Adv Ren Replace Ther, V2, P295; Delanaye P, 2019, J RENAL NUTR, V29, P511, DOI 10.1053/j.jrn.2018.11.010; Depner TA, 1996, J AM SOC NEPHROL, V7, P780; Dessi M, 2009, NUTR METAB CARDIOVAS, V19, P811, DOI 10.1016/j.numecd.2009.01.009; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Dutaud D, 2002, J IMMUNOL METHODS, V260, P183, DOI 10.1016/S0022-1759(01)00555-5; Egerer K, 2002, J RHEUMATOL, V29, P2045; Esposito P, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1647-9; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Fukasawa H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121352; Heubner M, 2011, GYNECOL ONCOL, V120, P233, DOI 10.1016/j.ygyno.2010.10.014; Jakob C, 2007, BLOOD, V109, P2100, DOI 10.1182/blood-2006-04-016360; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Marcelli D, 2015, CLIN J AM SOC NEPHRO, V10, P1192, DOI 10.2215/CJN.08550814; MITCH WE, 1994, J CLIN INVEST, V93, P2127, DOI 10.1172/JCI117208; Moreau-Gaudry X, 2014, J RENAL NUTR, V24, P395, DOI 10.1053/j.jrn.2014.06.008; Niewczas MA, 2019, NAT MED, V25, P805, DOI 10.1038/s41591-019-0415-5; Polge C, 2011, FASEB J, V25, P3790, DOI 10.1096/fj.11-180968; Roth GA, 2005, EUR J CLIN INVEST, V35, P399, DOI 10.1111/j.1365-2362.2005.01508.x; Sixt SU, 2008, BBA-MOL BASIS DIS, V1782, P817, DOI 10.1016/j.bbadis.2008.06.005; Szerafin T, 2008, ANN THORAC SURG, V85, P80, DOI 10.1016/j.athoracsur.2007.06.049; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; WADA M, 1993, J LAB CLIN MED, V121, P215; Wang F, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8361237; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236948	10.1371/journal.pone.0236948	http://dx.doi.org/10.1371/journal.pone.0236948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735636	Green Published, gold			2022-12-26	WOS:000569367100064
J	Zhang, XQ; Bai, L; Guo, N; Cai, BY				Zhang, Xueqi; Bai, Li; Guo, Na; Cai, Baiyan			Transcriptomic analyses revealed the effect of Funneliformis mosseae on genes expression in Fusarium oxysporum	PLOS ONE			English	Article							TOLERANCE; TOMATO; WILT	Soybean root rot is a typical soil-borne disease that severely affects the yield of soybean. Funneliformis mosseae is one of the arbuscular mycorrhizal fungi(AMF) dominant strains in soybean continuous cropping soil. The aim of this study was to providing an experimental basis for the study of the molecular mechanism underlying the alleviation of the obstacles associated with the continuous cropping of soybean by AMF. In this study, F. mosseae was inoculated in soil planted with soybean infected with Fusarium oxysporum. The results showed that the incidence of soybean root rot was significantly reduced after inoculation with F. mosseae. In F. mosseae-treated samples, the significantly upregulated genes encoded transmembrane protein in fungal cell membrane. The significantly downregulated genes encoded some proteins, which took part in composition of essential component of fungal cell wall; hydrolyse cellulose and hemicellulose. The DEGs in each treatment were enriched in antigen processing and presentation, carbon fixation in photosynthetic organisms, glycolysis/gluconeogenesis, the MAPK signalling pathway, protein processing in the endoplasmic reticulum and RNA degradation. Inoculation with F. mosseae could in a variety of ways to promote the growth, development of soybean and improve disease resistance. Such as help fungal build barriers to the disease resistance of host plant and enhance their pathogenicity; damaging the structure of the pathogen; protect plant tissues and so on. This study provides an experimental basis for further research on the molecular mechanism underlying the alleviation of challenges associated with the continuous cropping of soybean by AMF.	[Zhang, Xueqi; Bai, Li; Guo, Na; Cai, Baiyan] Heilongjiang Univ, Coll Life Sci, Heilongjiang Prov Key Lab Ecol Restorat & Resourc, Harbin, Peoples R China; [Bai, Li; Guo, Na; Cai, Baiyan] East Univ Heilongjiang, Dept Food & Environm Engn, Harbin, Peoples R China	Heilongjiang University	Cai, BY (corresponding author), Heilongjiang Univ, Coll Life Sci, Heilongjiang Prov Key Lab Ecol Restorat & Resourc, Harbin, Peoples R China.; Cai, BY (corresponding author), East Univ Heilongjiang, Dept Food & Environm Engn, Harbin, Peoples R China.	caibaiyan@126.com			National Natural Science Foundation of China [31972502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China [grant number 31972502], grant name Study on the regulation mechanism of funneliformis moseae to promote the absorption and transport of sulfur in continuous cropping soybean soil.	Bernardo-Faura M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003795; Cao X, 2018, J HENAN AGR SCI, V47, P102; Ding ZJ, 2016, AC ANN M CHIN SOC PL; Dong HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137533; Edgar CI, 2006, AUSTRALAS PLANT PATH, V35, P581, DOI 10.1071/AP06060; [高晓敏 Gao Xiaomin], 2014, [微生物学通报, Microbiology China], V41, P2143; [郭涛 Guo Tao], 2015, [植物保护学报, Acta Phytophylacica Sinica], V42, P390; Hanazono Y, 2016, FEBS LETT, V590, P298, DOI 10.1002/1873-3468.12055; Hu YY, 2016, HUBEI AGR SCI, V55, P917; Jie WeiGuang, 2016, Soybean Science, V35, P637; Jonkers W, 2009, MOL PLANT MICROBE IN, V22, P507, DOI 10.1094/MPMI-22-5-0507; Jung S, 2003, J AM OIL CHEM SOC, V80, P1169, DOI 10.1007/s11746-003-0837-3; King BC, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-4; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li YingDe, 2018, Chinese Journal of Biological Control, V34, P598; Lin YL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187838; Liu Jia, 2018, American Journal of Plant Sciences, V9, P543; Liu X, 2019, J FORESTRY RES, V30, P483, DOI 10.1007/s11676-018-0686-6; Moroni E, 2018, J CHEM THEORY COMPUT, V14, P1033, DOI 10.1021/acs.jctc.7b00766; Orsini L, 2019, WOODHEAD PUBL SER EN, P223, DOI 10.1016/B978-0-08-102207-8.00010-2; Qian L, 2015, ACTA AGR SCAND B-S P, V65, P321, DOI 10.1080/09064710.2015.1009938; Salvioli A, 2016, ISME J, V10, P130, DOI 10.1038/ismej.2015.91; Shao HongTao, 2004, Chinese Journal of Oil Crop Sciences, V26, P74; Sharma IP, 2017, RHIZOSPHERE-NETH, V4, P25, DOI 10.1016/j.rhisph.2017.05.008; Tao LL, 2016, J ECOL, V104, P561, DOI 10.1111/1365-2745.12535; Tripathi S, 2017, MYCORRHIZA NUTR UPTA, P161; Van den Berg N, 2007, MOL PLANT PATHOL, V8, P333, DOI 10.1111/J.1364-3703.2007.00389.X; Xu XH, 2017, SCI REP-UK, V7, DOI 10.1038/srep45134; Zhang CJ, 2017, SOYB SCI, V3, P121; Zhang YB, 2004, P NATL ACAD SCI USA, V101, P10272, DOI 10.1073/pnas.0401313101; Zhu TH, 1999, FORESTRY SCI, V35, P67; Zhu Y, 2020, ROUTL RES MUS HERI A, P1, DOI 10.4324/9780429446429	32	3	5	6	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0234448	10.1371/journal.pone.0234448	http://dx.doi.org/10.1371/journal.pone.0234448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735565	Green Published, gold, Green Submitted			2022-12-26	WOS:000569367100005
J	Bajak, K; Leiss, K; Clayton, C; Erben, E				Bajak, Kathrin; Leiss, Kevin; Clayton, Christine; Erben, Esteban			A potential role for a novel ZC3H5 complex in regulating mRNA translation in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA-binding proteins; Trypanosoma brucei; translation; halfmers; posttranscriptional regulation; RNA&#8211; protein interaction; zinc finger	LIFE-CYCLE STAGES; RIBOSOME BIOGENESIS; WIDE ANALYSIS; PROTEIN; IDENTIFICATION; SUBUNIT; GENE; INSIGHTS	In Trypanosoma brucei and related kinetoplastids, gene expression regulation occurs mostly posttranscriptionally. Consequently, RNA-binding proteins play a critical role in the regulation of mRNA and protein abundance. Yet, the roles of many RNA-binding proteins are not understood. Our previous research identified the RNA-binding protein ZC3H5 as possibly involved in gene repression, but its role in controlling gene expression was unknown. We here show that ZC3H5 is an essential cytoplasmic RNA-binding protein. RNAi targeting ZC3H5 causes accumulation of precytokinetic cells followed by rapid cell death. Affinity purification and pairwise yeast two-hybrid analysis suggest that ZC3H5 forms a complex with three other proteins, encoded by genes Tb927.11.4900, Tb927.8.1500, and Tb927.7.3040. RNA immunoprecipitation revealed that ZC3H5 is preferentially associated with poorly translated, low-stability mRNAs, the 5 '-untranslated regions and coding regions of which are enriched in the motif (U/A)UAG(U/A). As previously found in high-throughput analyses, artificial tethering of ZC3H5 to a reporter mRNA or other complex components repressed reporter expression. However, depletion of ZC3H5 in vivo caused only very minor decreases in a few targets, marked increases in the abundances of very stable mRNAs, an increase in monosomes at the expense of large polysomes, and appearance of "halfmer" disomes containing two 80S subunits and one 40S subunit. We speculate that the ZC3H5 complex might be implicated in quality control during the translation of suboptimal open reading frames.	[Bajak, Kathrin; Leiss, Kevin; Clayton, Christine] Univ Heidelberg ZMBH, Zentrum Mol Biol, Heidelberg, Germany; [Bajak, Kathrin; Erben, Esteban] Deutsch Krebsforschungszentrum DKFZ, Heidelberg, Germany; [Erben, Esteban] Univ Nacl San Martin, Inst Invest Biotecnol, IIBIO, UNSAM,CONICET, San Martin, Buenos Aires, Argentina; [Bajak, Kathrin] Ctr Integrat Infect Dis Res CIID, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Erben, E (corresponding author), Deutsch Krebsforschungszentrum DKFZ, Heidelberg, Germany.; Erben, E (corresponding author), Univ Nacl San Martin, Inst Invest Biotecnol, IIBIO, UNSAM,CONICET, San Martin, Buenos Aires, Argentina.	eerben@iib.unsam.edu.ar	Erben, Esteban Daniel/AAU-5694-2020	Erben, Esteban Daniel/0000-0001-5179-7863; Clayton, Christine/0000-0002-6384-0731; Leiss, Kevin/0000-0002-5955-6076	Deutsche Forschungsgemeinshaft [Cl112/24]; State of Baden-Wurttemberg	Deutsche Forschungsgemeinshaft(German Research Foundation (DFG)); State of Baden-Wurttemberg	This work was supported by Deutsche Forschungsgemeinshaft Cl112/24 (to C. C.) and core support from the State of Baden-Wurttemberg.	Adams CC, 2002, RNA, V8, P150, DOI 10.1017/S1355838202010026; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Anand B, 2006, NUCLEIC ACIDS RES, V34, P2196, DOI 10.1093/nar/gkl178; [Anonymous], **DATA OBJECT**, DOI DOI 10.5281/ZENODO.290632; Antwi EB, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2624-3; Archer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018425; Baierlein C, 2013, MOL CELL BIOL, V33, P4811, DOI 10.1128/MCB.00873-13; Bajak K, 2020, METHODS MOL BIOL, V2116, P99, DOI 10.1007/978-1-0716-0294-2_7; Bajak K, 2020, PEERJ, V8, DOI 10.7717/peerj.8388; Becam AM, 2001, MOL GENET GENOMICS, V266, P454, DOI 10.1007/s004380100548; Benz C, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008129; Brecht M, 1998, MOL BIOCHEM PARASIT, V97, P189, DOI 10.1016/S0166-6851(98)00151-0; Castello A, 2013, NAT PROTOC, V8, P491, DOI 10.1038/nprot.2013.020; Clayton C, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190072; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dean S, 2017, TRENDS PARASITOL, V33, P80, DOI 10.1016/j.pt.2016.10.009; Droll D, 2010, FEBS LETT, V584, P1156, DOI 10.1016/j.febslet.2010.02.018; Erben ED, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004178; Fadda A, 2014, MOL MICROBIOL, V94, P307, DOI 10.1111/mmi.12764; Flegontov P, 2013, CURR BIOL, V23, P1787, DOI 10.1016/j.cub.2013.07.045; Fritz M, 2015, NUCLEIC ACIDS RES, V43, P8013, DOI 10.1093/nar/gkv731; HELSER TL, 1981, MOL CELL BIOL, V1, P51, DOI 10.1128/MCB.1.1.51; Heyer EE, 2016, CELL, V164, P757, DOI 10.1016/j.cell.2016.01.003; Jaremko D, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00475-19; Jensen BC, 2005, EUKARYOT CELL, V4, P30, DOI 10.1128/EC.4.1.30-35.2005; Jones NG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003886; Kim SJ, 2016, CELL DIV, V11, DOI 10.1186/s13008-016-0024-3; Kim TS, 2019, BMB REP, V52, P502, DOI 10.5483/BMBRep.2019.52.8.273; KOENIGMARTIN E, 1992, MOL BIOCHEM PARASIT, V55, P135, DOI 10.1016/0166-6851(92)90134-6; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lueong S, 2016, MOL MICROBIOL, V100, P457, DOI 10.1111/mmi.13328; Lukes J, 2014, MOL BIOCHEM PARASIT, V195, P115, DOI 10.1016/j.molbiopara.2014.05.007; Maier RH, 2008, BIOTECHNIQUES, V45, P235, DOI 10.2144/000112897; do Nascimento LM, 2020, J BIOL CHEM, V295, P10940, DOI 10.1074/jbc.RA120.013306; Mier P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169750; Mugo E, 2020, METHODS MOL BIOL, V2116, P295, DOI 10.1007/978-1-0716-0294-2_18; Mugo E, 2020, METHODS MOL BIOL, V2116, P285, DOI 10.1007/978-1-0716-0294-2_17; Mugo E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006560; Nascimento JD, 2018, ELIFE, V7, DOI 10.7554/eLife.32467; Park H, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000396; Prohaska K, 2009, EUKARYOT CELL, V8, P77, DOI 10.1128/EC.00234-08; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Roditi I, 1998, MOL BIOCHEM PARASIT, V91, P117, DOI 10.1016/S0166-6851(97)00195-3; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Silvester E, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006863; Singh A, 2014, NUCLEIC ACIDS RES, V42, P4652, DOI 10.1093/nar/gkt1416; Thomson E, 2013, J CELL SCI, V126, P4815, DOI 10.1242/jcs.111948; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Yu H, 2015, P NATL ACAD SCI USA, V112, P8308, DOI 10.1073/pnas.1419197112	51	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2020	295	42					14291	14304		10.1074/jbc.RA120.014346	http://dx.doi.org/10.1074/jbc.RA120.014346			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ON0UY	32763974	Green Published, hybrid			2022-12-26	WOS:000586428700005
J	Corless, EI; Bennett, B; Antony, E				Corless, Elliot I.; Bennett, Brian; Antony, Edwin			Substrate recognition induces sequential electron transfer across subunits in the nitrogenase-like DPOR complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electron transfer; chlorophyll; photosynthesis; metalloenzyme; EPR; electron transfer; nitrogenase; electron paramagnetic resonance; ATPase; cyanobacteria; DPOR; protochlorophyllide	OPERATIVE PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; CRYSTAL-STRUCTURE; BACTERIOCHLOROPHYLL BIOSYNTHESIS; L-PROTEIN; REDUCTASE; RECONSTITUTION; ENZYME	A key step in bacteriochlorophyll biosynthesis is the reduction of protochlorophyllide (Pchlide) to chlorophyllide (Chlide), catalyzed by dark-operative protochlorophyllide oxidoreductase (DPOR). DPOR is made of electron donor (BchL) and acceptor (BchNB) component proteins. BchNB is further composed of two subunits each of BchN and BchB arranged as an alpha(2)beta(2)heterotetramer with two active sites for substrate reduction. Such oligomeric architectures are found in several other electron transfer (ET) complexes, but how this architecture influences activity is unclear. Here, we describe allosteric communication between the two identical active sites inRhodobacter sphaeroidesBchNB that drives sequential and asymmetric ET. Pchlide binding to one BchNB active site initiates ET from the pre-reduced [4Fe-4S] cluster of BchNB, a process similar to the deficit spending mechanism observed in the structurally related nitrogenase complex. Pchlide binding in one active site is recognizedin transby an Asp-274 from the opposing half, which is positioned to serve as the initial proton donor. A D274A variant DPOR binds to two Pchlide molecules in the BchNB complex, but only one is bound productively, stalling Pchlide reduction in both active sites. A half-active complex combining one WT and one D274A monomer also stalled after one electron was transferred in the WT half. We propose that such sequential electron transfer in oligomeric enzymes serves as a regulatory mechanism to ensure binding and recognition of the correct substrate. The findings shed light on the functional advantages imparted by the oligomeric architecture found in many electron transfer enzymes.	[Corless, Elliot I.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA; [Corless, Elliot I.; Antony, Edwin] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Bennett, Brian] Marquette Univ, Dept Phys, Milwaukee, WI 53233 USA	Marquette University; Saint Louis University; Marquette University	Antony, E (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	edwin.antony@health.slu.edu	Antony, Edwin/AAA-3596-2021		Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0017866]; NSF Major Research Instrumentation award [CHE-1532168]; Bruker Biospin; GAANN fellowship from the Department of Education; Marquette University	Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); NSF Major Research Instrumentation award(National Science Foundation (NSF)); Bruker Biospin; GAANN fellowship from the Department of Education(US Department of Education); Marquette University	This work was supported by Department of Energy, Office of Science, Basic Energy Sciences Grant DE-SC0017866 (to E. A.). Electron paramagnetic resonance was supported by NSF Major Research Instrumentation award CHE-1532168 (to B. B.) and by Bruker Biospin. This work was also supported by a GAANN fellowship from the Department of Education and the Arthur J. Schmitt fellowship from Marquette University (to E. I. C.).	Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; Broecker MJ, 2010, J BIOL CHEM, V285, P27336, DOI 10.1074/jbc.M110.126698; Brocker MJ, 2010, J BIOL CHEM, V285, P8268, DOI 10.1074/jbc.M109.087874; Campbell MG, 2014, P NATL ACAD SCI USA, V111, pE3614, DOI 10.1073/pnas.1413763111; Corless EI, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00494-19; Danyal K, 2016, P NATL ACAD SCI USA, V113, pE5783, DOI 10.1073/pnas.1613089113; Danyal K, 2011, BIOCHEMISTRY-US, V50, P9255, DOI 10.1021/bi201003a; Duval S, 2013, P NATL ACAD SCI USA, V110, P16414, DOI 10.1073/pnas.1311218110; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; Fujita Y, 1996, PLANT CELL PHYSIOL, V37, P411, DOI 10.1093/oxfordjournals.pcp.a028962; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; HOWARD JB, 1994, ANNU REV BIOCHEM, V63, P235, DOI 10.1146/annurev.bi.63.070194.001315; Kang G, 2020, SCIENCE, V368, P424, DOI 10.1126/science.aba6794; Kondo T, 2011, FEBS LETT, V585, P214, DOI 10.1016/j.febslet.2010.11.044; Moser J, 2013, P NATL ACAD SCI USA, V110, P2094, DOI 10.1073/pnas.1218303110; Muraki N, 2010, NATURE, V465, P110, DOI 10.1038/nature08950; Nomata J, 2006, FEBS LETT, V580, P6151, DOI 10.1016/j.febslet.2006.10.014; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; Nomata J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05455; Nomata J, 2013, FEBS LETT, V587, P3142, DOI 10.1016/j.febslet.2013.07.054; Rees DC, 2000, CURR OPIN CHEM BIOL, V4, P559, DOI 10.1016/S1367-5931(00)00132-0; Reinbothe C, 2010, TRENDS PLANT SCI, V15, P614, DOI 10.1016/j.tplants.2010.07.002; Sarma R, 2008, BIOCHEMISTRY-US, V47, P13004, DOI 10.1021/bi801058r; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Yamamoto H, 2014, BIOCHEM BIOPH RES CO, V448, P200, DOI 10.1016/j.bbrc.2014.04.087	25	5	5	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2020	295	39					13630	13639		10.1074/jbc.RA120.015151	http://dx.doi.org/10.1074/jbc.RA120.015151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NY3VI	32737200	hybrid, Green Published			2022-12-26	WOS:000576321100016
J	Morello, GM; Hultgren, J; Capas-Peneda, S; Wiltshire, M; Thomas, A; Wardle-Jones, H; Brajon, S; Gilbert, C; Olsson, IAS				Morello, Gabriela M.; Hultgren, Jan; Capas-Peneda, Sara; Wiltshire, Marc; Thomas, Aurelie; Wardle-Jones, Hannah; Brajon, Sophie; Gilbert, Colin; Olsson, I. Anna S.			High laboratory mouse pre-weaning mortality associated with litter overlap, advanced dam age, small and large litters	PLOS ONE			English	Article							MICE MUS-MUSCULUS; REPRODUCTIVE-PERFORMANCE; AMMONIA LEVELS; ENERGY-INTAKE; CAGE; HOUSE; BEHAVIOR; IMPACT; LACTATION; FREQUENCY	High and variable pre-weaning mortality is a persistent problem in laboratory mouse breeding. Assuming a modest 15% mortality rate across mouse strains, means that approximately 1 million more pups are produced yearly in the EU to compensate for those which die. This paper presents the first large study under practical husbandry conditions to determine the risk factors associated with mouse pre-weaning mortality. We analysed historical records from 219,975 pups from two breeding facilities, collected as part of their management routine and including information on number of pups born and weaned per litter, parents' age and identification, and dates of birth and death of all animals. Pups were counted once in their first week of life and at weaning, and once every one or two weeks, depending on the need for cage cleaning. Dead pups were recorded as soon as these were found during the daily cage screening (without opening the cage). It was hypothesized that litter overlap (i.e. the presence of older siblings in the cage when new pups are born), a recurrent social configuration in trio-housed mice, is associated with increased newborn mortality, along with advanced dam age, large litter size, and a high number and age of older siblings in the cage. The estimated probability of pup death was two to seven percentage points higher in cages with litter overlap compared to those without. Litter overlap was associated with an increase in death of the entire litter of five and six percentage points, which represent an increase of 19% and 103% compared to non-overlapped litters in the two breeding facilities, respectively. Increased number and age of older siblings, advanced dam age, small litter size (less than four pups born) and large litter size (over 11 pups born) were associated with increased probability of pup death.	[Morello, Gabriela M.; Capas-Peneda, Sara; Brajon, Sophie; Olsson, I. Anna S.] Univ Porto, IBMC Inst Mol & Cellular Biol, Lab Anim Sci, Porto, Portugal; [Morello, Gabriela M.; Capas-Peneda, Sara; Brajon, Sophie; Olsson, I. Anna S.] Univ Porto, I3S Inst Invest & Innovat Hlth, Porto, Portugal; [Hultgren, Jan] Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Skara, Sweden; [Wiltshire, Marc; Gilbert, Colin] Babraham Inst, Cambridge, England; [Thomas, Aurelie; Wardle-Jones, Hannah] Wellcome Sanger Inst, Hinxton, Cambs, England	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Swedish University of Agricultural Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Wellcome Trust Sanger Institute	Morello, GM (corresponding author), Univ Porto, IBMC Inst Mol & Cellular Biol, Lab Anim Sci, Porto, Portugal.; Morello, GM (corresponding author), Univ Porto, I3S Inst Invest & Innovat Hlth, Porto, Portugal.	gabriela.morello@i3s.up.pt	Capas Peneda, Sara Capas/AFQ-8610-2022; Morello, Gabriela/P-1005-2017	Capas Peneda, Sara Capas/0000-0002-0167-8812; Morello, Gabriela/0000-0002-5439-969X	FCT-Fundacao para a Ciencia e a Tecnologia, I.P. [UIDB/04293/2020]; FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation (POCI), Portugal 2020; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Ensino Superior [PTDC/CVT-WEL/1202/2014 (POCI-01-0145-FEDER-016591)]	FCT-Fundacao para a Ciencia e a Tecnologia, I.P.(Portuguese Foundation for Science and Technology); FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation (POCI), Portugal 2020; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Ensino Superior(Portuguese Foundation for Science and Technology)	This work was funded by National Funds through FCT-Fundacao para a Ciencia e a Tecnologia, I.P., under the project UIDB/04293/2020 and by FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Ensino Superior in the framework of the project PTDC/CVT-WEL/1202/2014 (POCI-01-0145-FEDER-016591).	ALBERTS JR, 1978, J COMP PHYSIOL PSYCH, V92, P231, DOI 10.1037/h0077459; Auclair Y, 2014, BEHAV ECOL, V25, P1467, DOI 10.1093/beheco/aru143; Brajon S, 2019, APPL ANIM BEHAV SCI, V218, DOI 10.1016/j.applanim.2019.06.008; BRODERSON JR, 1976, AM J PATHOL, V85, P115; Capas-Peneda S, 2020, BIORXIV, DOI [10.1101/2020.02.25.964551, DOI 10.1101/2020.02.25.964551]; Castelhano-Carlos MJ, 2009, LAB ANIM-UK, V43, P311, DOI 10.1258/la.2009.0080098; Dhakal K, 2013, J DAIRY SCI, V96, P690, DOI 10.3168/jds.2012-5817; DiVincenti L, 2012, LAB ANIMAL, V41, P68, DOI 10.1038/laban0312-68; EHRET G, 1986, ANIM BEHAV, V34, P821, DOI 10.1016/S0003-3472(86)80067-7; Eskola S, 1999, LAB ANIM-UK, V33, P122, DOI 10.1258/002367799780578354; European Commission, 2020, 2019 REP STAT US AN, DOI DOI 10.21949/1504598; EVELEIGH JR, 1993, LAB ANIM, V27, P156, DOI 10.1258/002367793780810432; Ferrari M, 2019, AM NAT, V193, P106, DOI 10.1086/700567; Garner JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154966; Gaskill BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074153; Gaskill BN, 2013, APPL ANIM BEHAV SCI, V143, P110, DOI 10.1016/j.applanim.2012.10.009; Gourdine JL, 2006, J ANIM SCI, V84, P469, DOI 10.2527/2006.842469x; Hahn ME, 2005, BEHAV GENET, V35, P31, DOI 10.1007/s10519-004-0854-7; Henry KR, 2002, HEARING RES, V170, P107, DOI 10.1016/S0378-5955(02)00391-X; Inglis CA, 2004, J HOPKINS CENT ALTER, V2004, P1; Johnson MS, 2001, J EXP BIOL, V204, P1925; Konig B, 1997, NATURWISSENSCHAFTEN, V84, P95, DOI 10.1007/s001140050356; KONIG B, 1988, J ZOOL, V216, P195; Latham N, 2004, APPL ANIM BEHAV SCI, V86, P261, DOI 10.1016/j.applanim.2004.02.006; MAESTRIPIERI D, 1991, BEHAV PROCESS, V23, P223, DOI 10.1016/0376-6357(91)90052-2; Morello GM, 2019, UFAW INT AN WELF SC; Mouse phenome database at the Jackson Laboratory, PHEN MEAS JAX5 WEAN; Murray SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012418; Paul MJ, 2010, PHYSIOL BEHAV, V100, P128, DOI 10.1016/j.physbeh.2010.02.012; Potgieter FJ, 1997, J S AFR VET ASSOC, V68, P8; Rasmussen S, 2011, J AM ASSOC LAB ANIM, V50, P479; Reeb-Whitaker CK, 2001, LAB ANIM-UK, V35, P58, DOI 10.1258/0023677011911381; RUSSELL JA, 1980, J PHYSIOL-LONDON, V303, P403, DOI 10.1113/jphysiol.1980.sp013295; Russell WMS., 1959, MED J AUSTRALIA; Schmidt J, 2015, ANIM BEHAV, V101, P201, DOI 10.1016/j.anbehav.2014.12.015; Tarin JJ, 2005, BIOL REPROD, V72, P1336, DOI 10.1095/biolreprod.104.038919; Vaanholt LM, 2018, J EXP BIOL, V221; Vogelweid CM, 2011, J AM ASSOC LAB ANIM, V50, P868; Wasson K, 2017, J AM ASSOC LAB ANIM, V56, P190; Weber EM, 2013, REPROD DOMEST ANIM, V48, P292, DOI 10.1111/j.1439-0531.2012.02147.x; Weber EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161238; Weber EM, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-83; Whitaker JW, 2016, J AM ASSOC LAB ANIM, V55, P387; Wright SL, 2000, J COMP PSYCHOL, V114, P183, DOI 10.1037/0735-7036.114.2.183	44	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2020	15	8							e0236290	10.1371/journal.pone.0236290	http://dx.doi.org/10.1371/journal.pone.0236290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ND3HD	32785214	gold, Green Published, Green Submitted			2022-12-26	WOS:000561793900001
J	Stauch, BJ; Braun, V; Hanslmayr, S				Stauch, Benjamin J.; Braun, Verena; Hanslmayr, Simon			Probing the causal involvement of dlPFC in directed forgetting using rTMS-A replication study	PLOS ONE			English	Article							MEMORY; FREQUENCY; ITEM	The forgetting of previously remembered information has, for a long time, been explained by purely passive processes. This viewpoint has been challenged by the finding that humans show worse memory for specific items that they have been instructed to forget. The dorsolateral prefrontal cortex has, through imaging, lesion and brain stimulation studies, been implied in controlling such active forgetting processes. In this study, we attempted to solidify evidence for such a causal role of the dlPFC in directed forgetting by replicating an existing rTMS study (Hanslmayr S, 2012) in a preregistered within-participant design. We stimulated participants at the dlPFC (BA9) or vertex using 45s of 1Hz rTMS after instructions to forget previously remembered words in a list-method directed forgetting paradigm and tested for effects on the amount of forgotten information. Contrary to the study we were attempting to replicate, no significant increase in forgetting under dlPFC stimulation was found in our participants. However, when combining our results with the study we were attempting to replicate, dlPFC stimulation led to significantly increased directed forgetting in both studies combined. We further explored if the rTMS parameters used here and in earlier work (Hanslmayr S, 2012) influenced inhibitory processing at their time of delivery or in a more persistent manner. Unaltered incongruency and negative priming effects in a Stroop task conducted directly after stimulation suggests that our rTMS stimulation did not continue to influence inhibitory processing after the time of stimulation. As the combined evidence for increased directed forgetting due to rTMS dlPFC stimulation is still quite weak, additional replications are necessary to show that directed forgetting is indeed causally driven by an active prefrontal process.	[Stauch, Benjamin J.] Max Planck Gesell, Ernst Strungmann Inst ESI Neurosci Cooperat, Frankfurt, Germany; [Stauch, Benjamin J.] Int Max Planck Res Sch Neural Circuits, Frankfurt, Germany; [Stauch, Benjamin J.; Braun, Verena; Hanslmayr, Simon] Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England	Max Planck Society; University of Birmingham	Hanslmayr, S (corresponding author), Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England.	s.hanslmayr@bham.ac.uk	Stauch, Benjamin J./AAB-2492-2022; Hanslmayr, Simon/F-9356-2010	Stauch, Benjamin J./0000-0002-4484-813X; Hanslmayr, Simon/0000-0003-4448-2147	European Research Council [647954]; Economic and Social Research Council (ESRC) [ES/R010072/1]; Deutsche Forschungsgemeinschaft [HA 5622/1-1]; ESRC [ES/R010072/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	SH was supported by the European Research Council (grant agreement No647954, https://erc.europa.eu), the Economic and Social Research Council (ESRC grant agreement NoES/R010072/1, https://esrc.ukri.org), and Deutsche Forschungsgemeinschaft (HA 5622/1-1, https://www.dfg.de/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.	Anderson MC, 2014, TRENDS COGN SCI, V18, P279, DOI 10.1016/j.tics.2014.03.002; Aydin-Abidin S, 2006, J PHYSIOL-LONDON, V574, P443, DOI 10.1113/jphysiol.2006.108464; Basden BH, 1996, MEMORY, V4, P633, DOI 10.1080/741941000; BASDEN BH, 1993, J EXP PSYCHOL LEARN, V19, P603, DOI 10.1037/0278-7393.19.3.603; Bastos AM, 2015, NEURON, V85, P390, DOI 10.1016/j.neuron.2014.12.018; Bjork R.A., 1989, VARIETIES MEMORY CON, P309; Bjork RA, 1998, INTENTIONAL FORGETTING: INTERDISCIPLINARY APPROACHES, P453; Borenstein M, 2009, INTRO META ANAL; Braver SL, 2014, PERSPECT PSYCHOL SCI, V9, P333, DOI 10.1177/1745691614529796; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; Conway MA, 2003, CORTEX, V39, P667, DOI 10.1016/S0010-9452(08)70859-1; Freunberger R, 2009, HUM BRAIN MAPP, V30, P3417, DOI 10.1002/hbm.20766; Fuster J, 2015, PREFRONTAL CORTEX; Hanslmayr S, 2012, J NEUROSCI, V32, P14742, DOI 10.1523/JNEUROSCI.1777-12.2012; Hauswald A, 2011, SOC COGN AFFECT NEUR, V6, P450, DOI 10.1093/scan/nsq061; Jarosz AF, 2014, J PROBL SOLVING, V7, P2, DOI 10.7771/1932-6246.1167; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Ludowig E, 2010, NEUROBIOL LEARN MEM, V93, P352, DOI 10.1016/j.nlm.2009.12.001; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Pastotter B, 2012, MEM COGNITION, V40, P861, DOI 10.3758/s13421-012-0206-4; Rizio AA, 2013, J COGNITIVE NEUROSCI, V25, P297, DOI 10.1162/jocn_a_00310; Schuit E, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0048-9; Silas J, 2016, NEUROSCI LETT, V616, P166, DOI 10.1016/j.neulet.2016.01.035; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0; Thielscher A, 2011, NEUROIMAGE, V54, P234, DOI 10.1016/j.neuroimage.2010.07.061; Titz C, 2010, PSYCHOL AGING, V25, P405, DOI 10.1037/a0017225; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Viejo-Sobera R, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00462; Wylie GR, 2008, CEREB CORTEX, V18, P670, DOI 10.1093/cercor/bhm101	30	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2020	15	8							e0236287	10.1371/journal.pone.0236287	http://dx.doi.org/10.1371/journal.pone.0236287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ND3HD	32785218	gold, Green Published, Green Accepted			2022-12-26	WOS:000561793900064
J	Schouest, B; Leslie, GJ; Hoxie, JA; Maness, NJ				Schouest, Blake; Leslie, George J.; Hoxie, James A.; Maness, Nicholas J.			Tetherin downmodulation by SIVmac Nef lost with the H196Q escape variant is restored by an upstream variant	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-REPLICATION; HIV-1 NEF; VPU; INFECTION; ANTAGONISM; SERINC5; CD28; AP-2; CD4; GLYCOPROTEIN	The H(196)residue in SIVmac239 Nef is conserved across the majority of HIV and SIV isolates, lies immediately adjacent to the AP-2 (adaptor protein 2) binding di-leucine domain (ExxxLM(195)), and is critical for several described AP-2 dependent Nef functions, including the downregulation of tetherin (BST-2/CD317), CD4, and others. Surprisingly, many stocks of the closely related SIVmac251 swarm virus harbor anefallele encoding a Q(196). In SIVmac239, this variant is associated with loss of multiple AP-2 dependent functions. Publicly available sequences for SIVmac251 stocks were mined for variants linked to Q(196)that might compensate for functional defects associated with this residue. Variants were engineered into the SIVmac239 backbone and in Nef expression plasmids and flow cytometry was used to examine surface tetherin expression in primary CD4 T cells and surface CD4 expression in SupT1 cells engineered to express rhesus CD4. We found that SIVmac251 stocks that encode a Q(196)residue in Nef uniformly also encode an upstream R(191)residue. We show that R(191)restores the ability of Nef to downregulate tetherin in the presence of Q(196)and has a similar but less pronounced impact on CD4 expression. However, a published report showed Q(196)commonly evolves to H(196)in vivo, suggesting a fitness cost. R(191)may represent compensatory evolution to restore the ability to downregulate tetherin lost in viruses harboring Q(196).	[Schouest, Blake; Maness, Nicholas J.] Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA; [Leslie, George J.; Hoxie, James A.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Maness, Nicholas J.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, Hlth Sci Ctr, New Orleans, LA 70112 USA	Tulane University; University of Pennsylvania; Pennsylvania Medicine; Tulane University	Maness, NJ (corresponding author), Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA.; Maness, NJ (corresponding author), Tulane Univ, Sch Med, Dept Microbiol & Immunol, Hlth Sci Ctr, New Orleans, LA 70112 USA.	nmaness@tulane.edu		Maness, Nicholas/0000-0002-9332-7891; Schouest, Blake/0000-0002-9602-2364	NIH [P510D011104]; RO1 grant [A1138782]; P30 grant [A1045008]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RO1 grant; P30 grant	NIH provided funding for this study in the form of a base grant awarded to TNPRC (P510D011104), a RO1 grant awarded to JAH and NJM (A1138782), and a P30 grant awarded to JAH (A1045008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adland E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073117; Bell I, 2001, VIROLOGY, V283, P148, DOI 10.1006/viro.2001.0872; Brenner M, 2006, J VIROL, V80, P4469, DOI 10.1128/JVI.80.9.4469-4481.2006; Budde ML, 2012, J VIROL, V86, P7596, DOI 10.1128/JVI.00716-12; Buffalo CZ, 2019, CELL HOST MICROBE, V26, P359, DOI 10.1016/j.chom.2019.08.002; Burwitz BJ, 2014, J VIROL, V88, P3598, DOI 10.1128/JVI.03304-13; Chaudhry A, 2005, J IMMUNOL, V175, P4566, DOI 10.4049/jimmunol.175.7.4566; Chen N, 2006, EUR J IMMUNOL, V36, P278, DOI 10.1002/eji.200535487; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Del Prete GQ, 2013, J VIROL, V87, P4584, DOI 10.1128/JVI.03507-12; Del Prete GQ, 2009, J VIROL, V83, P9911, DOI 10.1128/JVI.00533-09; FOSTER JL, 1994, VIROLOGY, V201, P373, DOI 10.1006/viro.1994.1303; Friedrich TC, 2004, J VIROL, V78, P2581, DOI 10.1128/JVI.78.5.2581-2585.2004; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Goulder PJR, 1997, AIDS, V11, P536; Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964; Heigele A, 2012, J VIROL, V86, P36, DOI 10.1128/JVI.00717-11; ILYINSKII PO, 1994, J VIROL, V68, P5933, DOI 10.1128/JVI.68.9.5933-5944.1994; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Khalid M, 2012, J VIROL, V86, P4906, DOI 10.1128/JVI.06856-11; Kluge SF, 2014, CELL HOST MICROBE, V16, P639, DOI 10.1016/j.chom.2014.10.002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhl A, 2011, J INFECT DIS, V204, pS850, DOI 10.1093/infdis/jir378; Lamers SL, 2015, J VIROL, V89, P8484, DOI 10.1128/JVI.01010-15; Lauck M, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-55; Lindwasser OW, 2008, J VIROL, V82, P1166, DOI 10.1128/JVI.01874-07; Loffredo JT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001152; Lopez LA, 2012, J VIROL, V86, P5467, DOI 10.1128/JVI.06280-11; Maness NJ, 2008, J VIROL, V82, P5245, DOI 10.1128/JVI.00292-08; Matheson NJ, 2015, CELL HOST MICROBE, V18, P409, DOI 10.1016/j.chom.2015.09.003; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ren XF, 2014, ELIFE, V3, DOI 10.7554/eLife.01754; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Salgado M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-94; Sauter D, 2011, CURR HIV RES, V9, P514, DOI 10.2174/157016211798842044; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schaefer TM, 2002, VIROLOGY, V302, P106, DOI 10.1006/viro.2002.1628; Schouest B, 2018, J VIROL, V92, DOI 10.1128/JVI.01822-17; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Seki S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00267; Serra-Moreno R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003487; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Swigut T, 2001, EMBO J, V20, P1593, DOI 10.1093/emboj/20.7.1593; Swigut T, 2003, J VIROL, V77, P8116, DOI 10.1128/JVI.77.14.8116-8126.2003; Trautz B, 2016, J VIROL, V90, P10915, DOI 10.1128/JVI.01246-16; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Weiler AM, 2016, J VIROL, V90, P2119, DOI 10.1128/JVI.01975-15; Yamada E, 2018, CELL HOST MICROBE, V23, P110, DOI 10.1016/j.chom.2017.12.009; Zhang FW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002039; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	52	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0225420	10.1371/journal.pone.0225420	http://dx.doi.org/10.1371/journal.pone.0225420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764749	Green Published, gold			2022-12-26	WOS:000561029000031
J	Then, C; Thorand, B; Then, HL; Meisinger, C; Heier, M; Peters, A; Koenig, W; Rathmann, W; Bidlingmaier, M; Lechner, A; Reincke, M; Scherberich, JE; Seissler, J				Then, Cornelia; Thorand, Barbara; Then, Holger L.; Meisinger, Christa; Heier, Margit; Peters, Annette; Koenig, Wolfgang; Rathmann, Wolfgang; Bidlingmaier, Martin; Lechner, Andreas; Reincke, Martin; Scherberich, Juergen E.; Seissler, Jochen			Serum uromodulin is inversely associated with arterial hypertension and the vasoconstrictive prohormone CT-proET-1 in the population-based KORA F4 study	PLOS ONE			English	Article							TAMM-HORSFALL PROTEIN; UMOD GENE; KIDNEY; ENDOTHELIN-1; MUTATIONS; MORTALITY; ASSAY; RISK; NEPHROPATHY; VALIDATION	Objectives Uromodulin has been associated with arterial hypertension in genome-wide association studies, but data from clinical and preclinical studies are inconsistent. We here analyzed the association of serum uromodulin (sUmod) with arterial hypertension and vasoactive hormones in a population-based study. Methods In 1108 participants of the KORA F4 study aged 62-81 years, sUmod was measured and the association of sUmod with arterial hypertension was assessed using logistic regression models. The associations of sUmod with renin and aldosterone and with the vasoconstrictive prohormone C-terminal pro-endothelin-1 (CT-proET-1) were analyzed in 1079 participants and in 618 participants, respectively, using linear regression models. Results After multivariable adjustment including sex, age, eGFR, BMI, fasting glucose, current smoking, previous stroke and myocardial infarction, sUmod was inversely associated with arterial hypertension (OR 0.78; 95% CI 0.68-0.91; p = 0.001). SUmod was not significantly associated with renin and aldosterone after adjustment for sex, age and eGFR. However, sUmod was inversely associated with CT-proET-1 (beta -0.19 +/- 0.04; p < 0.001) after adjustment for sex, age, eGFR, BMI, arterial hypertension, fasting glucose, current smoking, previous stroke and myocardial infarction. The association with CT-proET-1 was stronger in participants with hypertension (beta -0.22 +/- 0.04) than in normotensive participants (beta -0.13 +/- 0.06; p for interaction hypertension = 0.003 in the model adjusted for hypertension). Conclusions SUmod was inversely associated with arterial hypertension and the vasoconstrictive prohormone CT-proET-1, suggesting direct or indirect effects of sUmod on blood pressure regulation.	[Then, Cornelia; Bidlingmaier, Martin; Lechner, Andreas; Reincke, Martin; Seissler, Jochen] LMU Munchen, Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany; [Then, Cornelia; Lechner, Andreas; Seissler, Jochen] Ludwig Maximilians Univ Munchen, Clin Cooperat Grp Diabet, Munich, Germany; [Then, Cornelia; Lechner, Andreas; Seissler, Jochen] Helmholtz Zentrum Munchen, Munich, Germany; [Then, Cornelia; Thorand, Barbara; Peters, Annette; Lechner, Andreas; Seissler, Jochen] German Ctr Diabet Res DZD, Munich, Germany; [Thorand, Barbara; Heier, Margit; Peters, Annette] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Then, Holger L.] Freie Waldorfschule Augsburg, Augsburg, Germany; [Meisinger, Christa] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Independent Res Grp Clin Epidemiol, Neuherberg, Germany; [Meisinger, Christa] Ludwig Maximilians Univ Munchen, Chair Epidemiol, UNIKAT Augsburg, Munich, Germany; [Heier, Margit] Univ Hosp Augsburg, KORA Study Ctr, Augsburg, Germany; [Peters, Annette; Koenig, Wolfgang] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Koenig, Wolfgang] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Koenig, Wolfgang] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Rathmann, Wolfgang] Heinrich Heine Univ Dusseldorf, Leibniz Inst, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Scherberich, Juergen E.] Ludwig Maximilians Univ Munchen, Teaching Hosp, Klinikum Munchen Harlaching, Munich, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Ulm University; German Heart Centre Munich; Technical University of Munich; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Munchen Klinik; University of Munich	Then, C (corresponding author), LMU Munchen, Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany.; Then, C (corresponding author), Ludwig Maximilians Univ Munchen, Clin Cooperat Grp Diabet, Munich, Germany.; Then, C (corresponding author), Helmholtz Zentrum Munchen, Munich, Germany.; Then, C (corresponding author), German Ctr Diabet Res DZD, Munich, Germany.	cornelia.then@med.uni-muenchen.de	Peters, Annette/A-6117-2011; Thorand, Barbara/B-5349-2014	Peters, Annette/0000-0001-6645-0985; Thorand, Barbara/0000-0002-8416-6440; Koenig, Wolfgang/0000-0002-2064-9603; Then, Cornelia/0000-0001-5180-1973	Virtual Diabetes Institute (Helmholtz Zentrum MOnchen); Clinical Cooperation Group Diabetes, Ludwig-Maximilians-University MOnchen; Helmholtz Zentrum MOnchen; German Diabetes Center; Federal Ministry of Health (Berlin, Germany); Ministry of Culture and Science of the state North Rhine Westphalia (Dusseldorf, Germany); Helmholtz Zentrum MOnchen -German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF); State of Bavaria; German Research Foundation (DFG) [RA-45913/3-1]; Deutsche Diabetes Gesellschaft (DDG)	Virtual Diabetes Institute (Helmholtz Zentrum MOnchen); Clinical Cooperation Group Diabetes, Ludwig-Maximilians-University MOnchen; Helmholtz Zentrum MOnchen; German Diabetes Center; Federal Ministry of Health (Berlin, Germany); Ministry of Culture and Science of the state North Rhine Westphalia (Dusseldorf, Germany); Helmholtz Zentrum MOnchen -German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF); State of Bavaria; German Research Foundation (DFG)(German Research Foundation (DFG)); Deutsche Diabetes Gesellschaft (DDG)	The study was supported by a research grant from the Virtual Diabetes Institute (Helmholtz Zentrum MOnchen) and the Clinical Cooperation Group Diabetes, Ludwig-Maximilians-University MOnchen and Helmholtz Zentrum MOnchen, and by the German Diabetes Center. The German Diabetes Center was supported by the Federal Ministry of Health (Berlin, Germany) and the Ministry of Culture and Science of the state North Rhine Westphalia (Dusseldorf, Germany). The KORA study was initiated and financed by the Helmholtz Zentrum MOnchen -German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Further support was obtained from the Deutsche Diabetes Gesellschaft (DDG) and from the German Research Foundation (DFG, grant RA-45913/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Cavallone D, 2001, BIOCHEM BIOPH RES CO, V280, P110, DOI 10.1006/bbrc.2000.4090; Dahan K, 2003, J AM SOC NEPHROL, V14, P2883, DOI 10.1097/01.ASN.0000092147.83480.B5; Delgado GE, 2017, J AM SOC NEPHROL, V28, P2201, DOI 10.1681/ASN.2016111162; Devuyst O, 2017, NAT REV NEPHROL, V13, P525, DOI 10.1038/nrneph.2017.101; Dhaun N, 2006, J AM SOC NEPHROL, V17, P943, DOI 10.1681/ASN.2005121256; Dhaun N, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001624; El-Achkar TM, 2013, AM J PHYSIOL-RENAL, V304, pF1066, DOI 10.1152/ajprenal.00543.2012; Graham LA, 2014, HYPERTENSION, V63, P551, DOI 10.1161/HYPERTENSIONAHA.113.01423; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Hixson JE, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.003831122693617, DOI 10.1371/JOURNAL.PONE.003831122693617]; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Kalani M, 2008, VASC HEALTH RISK MAN, V4, P1061, DOI 10.2147/VHRM.S3920; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2010, J AM SOC NEPHROL, V21, P337, DOI 10.1681/ASN.2009070725; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Leiherer A, 2018, J HYPERTENS, V36, P110, DOI 10.1097/HJH.0000000000001527; Leiherer A, 2017, INT J CARDIOL, V231, P6, DOI [10.1016/j.jcard.2016.12.183, 10.1016/j.ijcard.2016.12.183]; Leiherer A, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005798; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu Y, 2018, AM J PHYSIOL-RENAL, V314, pF1062, DOI 10.1152/ajprenal.00233.2017; Lynch IJ, 2015, AM J PHYSIOL-RENAL, V309, pF1026, DOI 10.1152/ajprenal.00220.2015; Manolopoulou J, 2008, J ENDOCRINOL, V196, P215, DOI 10.1677/JOE-07-0134; Meisinger C, 2011, DIABETES CARE, V34, P1648, DOI 10.2337/dc11-0118; Mo L, 2004, KIDNEY INT, V66, P1159, DOI 10.1111/j.1523-1755.2004.00867.x; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Nie MZ, 2018, J BIOL CHEM, V293, P16488, DOI 10.1074/jbc.RA118.003950; Padmanabhan S, 2014, HYPERTENSION, V64, P918, DOI 10.1161/HYPERTENSIONAHA.114.03132; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Pandit MM, 2015, AM J PHYSIOL-RENAL, V308, pF541, DOI 10.1152/ajprenal.00456.2014; Papassotiriou J, 2006, CLIN CHEM, V52, P1144, DOI 10.1373/clinchem.2005.065581; Patidar KR, 2019, AM J PHYSIOL-GASTR L, V317, pG447, DOI 10.1152/ajpgi.00158.2019; Pruijm M, 2016, CLIN J AM SOC NEPHRO, V11, P70, DOI 10.2215/CJN.04230415; Ramseyer VD, 2016, AM J PHYSIOL-RENAL, V310, pF748, DOI 10.1152/ajprenal.00473.2015; Ramseyer VD, 2011, CONTRIB NEPHROL, V172, P76, DOI 10.1159/000328686; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Risch L, 2014, CLIN CHEM LAB MED, V52, P1755, DOI 10.1515/cclm-2014-0505; Schaeffer C, 2009, MOL BIOL CELL, V20, P589, DOI 10.1091/mbc.E08-08-0876; Scherberich JE, 2018, NEPHROL DIAL TRANSPL, V33, P284, DOI 10.1093/ndt/gfw422; Seissler J, 2012, EUR J ENDOCRINOL, V167, P847, DOI 10.1530/EJE-12-0472; Steubl D, 2019, NEPHROL DIAL TRANSPL, DOI [10.1093/ndt/gfz00830903163, DOI 10.1093/NDT/GFZ00830903163]; Steubl D, 2020, NEPHROLOGY, V25, P522, DOI 10.1111/nep.13688; Steubl D, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003011; Then C, 2020, CLIN KIDNEY J, P1, DOI [10.1093/ckj/sfz15432082547, DOI 10.1093/CKJ/SFZ15432082547]; Then C, 2020, ATHEROSCLEROSIS, V297, P1, DOI 10.1016/j.atherosclerosis.2020.01.030; Then C, 2019, ENDOCR CONNECT, V8, P1363, DOI 10.1530/EC-19-0352; Then C, 2019, J CLIN ENDOCR METAB, V104, P3795, DOI 10.1210/jc.2018-02557; Tokonami N, 2018, KIDNEY INT, V94, P701, DOI 10.1016/j.kint.2018.04.021; Trudu M, 2013, NAT MED, V19, P1655, DOI 10.1038/nm.3384; Williams SE, 2009, HUM MOL GENET, V18, P2963, DOI 10.1093/hmg/ddp235; Wolf MTF, 2013, KIDNEY INT, V84, P130, DOI 10.1038/ki.2013.63; Youhanna S, 2014, NEPHROL DIAL TRANSPL, V29, P136, DOI 10.1093/ndt/gft345	53	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237364	10.1371/journal.pone.0237364	http://dx.doi.org/10.1371/journal.pone.0237364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764816	gold, Green Published			2022-12-26	WOS:000561029000059
J	Vieira, AM; Soratto, TAT; Cardinal, KM; Wagner, G; Hauptli, L; Lima, ALF; Dahlke, F; Netto, DP; Moraes, PD; Ribeiro, AML				Vieira, Alexandre Maciel; Soratto, Tatiany Aparecida Teixeira; Cardinal, Katia Maria; Wagner, Glauber; Hauptli, Lucelia; Lima, Andre Luis Ferreira; Dahlke, Fabiano; Peres Netto, Diego; Moraes, Priscila de Oliveira; Ribeiro, Andrea Machado Leal			Modulation of the intestinal microbiota of broilers supplemented with monensin or functional oils in response to challenge by Eimeria spp.	PLOS ONE			English	Article							GROWTH-PERFORMANCE; CECAL MICROFLORA; GUT HEALTH; COCCIDIOSIS; PROBIOTICS; PHYTOGENICS; CYTOKINES; POULTRY; ECOLOGY; ACIDS	The objective of this study was to evaluate the effect of supplementation with 100ppm sodium monensin or 0.15% of a blend of functional oils (cashew nut oil + castor oil) on the intestinal microbiota of broilers challenged with three differentEimeriaspp. The challenge was accomplished by inoculating broiler chicks with sporulated oocysts ofEimeria tenella,Eimeria acervulina, andEimeria maximavia oral gavage. A total of 864, day-old male broiler chicks (Cobb) were randomly assigned to six treatments (eight pens/treatment; 18 broilers/pen) in a 3 x 2 factorial arrangement, composed of three additives (control, monensin or blend), with or withoutEimeriachallenge. Intestinal contents was collected at 28 days of age for microbiota analysis by sequencing 16s rRNA in V3 and V4 regions using the Illumina MiSeq platform. Taxonomy was assigned through the SILVA database version 132, using the QIIME 2 software version 2019.1. No treatment effects (p > 0.05) were observed in the microbial richness at the family level estimated by Chao1 and the biodiversity assessed by Simpson's index, except for Shannon's index (p < 0.05). The intestinal microbiota was dominated by members of the order Clostridiales and Lactobacillales, followed by the families Ruminococcaceae, Bacteroidaceae, and Lactobacillaceae, regardless of treatment. When the controls were compared, in the challenged control group there was an increase in Erysipelotrichaceae, Lactobacillaceae, Bacteroidaceae, Streptococcaceae, and Peptostreptococcaceae, and a decrease in Ruminococcaceae. Similar results were found for a challenged group that received monensin, while the blend partially mitigated this variation. Therefore, the blend alleviated the impact of coccidiosis challenge on the microbiome of broilers compared to monensin.	[Vieira, Alexandre Maciel; Hauptli, Lucelia; Lima, Andre Luis Ferreira; Dahlke, Fabiano; Peres Netto, Diego; Moraes, Priscila de Oliveira] Univ Fed Santa Catarina, Dept Anim Sci & Rural Dev, Florianopolis, SC, Brazil; [Soratto, Tatiany Aparecida Teixeira; Wagner, Glauber] Univ Fed Santa Catarina, Ctr Biol Sci, Lab Bioinformat, Florianopolis, SC, Brazil; [Cardinal, Katia Maria; Ribeiro, Andrea Machado Leal] Univ Fed Rio Grande do Sul, Dept Anim Sci, Lab Anim Sci, Porto Alegre, RS, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal do Rio Grande do Sul	Moraes, PD (corresponding author), Univ Fed Santa Catarina, Dept Anim Sci & Rural Dev, Florianopolis, SC, Brazil.	p.agronomia@gmail.com	Soratto, Tatiany/GXH-4572-2022; RIBEIRO, Andrea/AAI-7666-2020; LIMA, ANDRE LUIS FERREIRA/AAH-2867-2019; Wagner, Glauber GW/B-2369-2013	Soratto, Tatiany/0000-0001-6263-6432; RIBEIRO, Andrea/0000-0003-0243-7946; Wagner, Glauber GW/0000-0001-5003-6595; Moraes, Priscila/0000-0001-6416-9436	FAPESC	FAPESC(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	TATS was supported by a PhD scholarship provided by FAPESC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudabos AM, 2018, J APPL ANIM RES, V46, P691, DOI 10.1080/09712119.2017.1383258; [Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; Applegate TJ, 2010, J APPL POULTRY RES, V19, P194, DOI 10.3382/japr.2010-00168; Betancourt L, 2019, POULTRY SCI, V98, P4777, DOI 10.3382/ps/pez193; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bortoluzzi C, 2019, LIVEST SCI, V228, P187, DOI 10.1016/j.livsci.2019.09.001; Chapman HD, 2010, POULTRY SCI, V89, P1788, DOI 10.3382/ps.2010-00931; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Christoff A, 2017, NEOPROSPECTA MICROBI, V25; Cross ML, 2002, MED MICROBIOL IMMUN, V191, P49, DOI 10.1007/s00430-002-0112-7; Dalloul RA, 2003, POULTRY SCI, V82, P62, DOI 10.1093/ps/82.1.62; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Carrasco JMD, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1879168; Dibner JJ, 2002, J APPL POULTRY RES, V11, P453, DOI 10.1093/japr/11.4.453; Dusa A., 2018, VENN DRAW VENN DIAGR; Fujio-Vejar S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01221; GADDE U, 2017, ANIM HEALTH RES REV, V18, P26, DOI DOI 10.1017/S1466252316000207; Gao PF, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0315-1; Geirnaert A, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv054; Gharib-Naseri K, 2019, POULTRY SCI, V98, P6422, DOI 10.3382/ps/pez480; Giannenas I, 2012, VET PARASITOL, V188, P31, DOI 10.1016/j.vetpar.2012.02.017; Hang I, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-90; Hauck R, 2017, AVIAN DIS, V61, P428, DOI 10.1637/11675-051917-review.1; Hernandez-Patlan D, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00108; Hou QC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37376; Huang T, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02309; Kiarie E, 2013, NUTR RES REV, V26, P71, DOI 10.1017/S0954422413000048; Kley M-V, 2012, EFFECT EIMERIA INFEC; Latorre JD, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00199; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lu J, 2006, J APPL POULTRY RES, V15, P145, DOI 10.1093/japr/15.1.145; M'Sadeq SA, 2015, POULTRY SCI, V94, P2434, DOI 10.3382/ps/pev219; Maassen CBM, 2000, VACCINE, V18, P2613, DOI 10.1016/S0264-410X(99)00378-3; Maki JJ, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7100376; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Moraes PO, 2019, POULTRY SCI, V98, P5456, DOI 10.3382/ps/pez345; Moraes PO, 2019, ANIMAL, V13, P2190, DOI 10.1017/S1751731119000600; Murakami AE, 2014, ASIAN AUSTRAL J ANIM, V27, P981, DOI 10.5713/ajas.2013.13449; Nagafuchi S, 1999, BIOSCI BIOTECH BIOCH, V63, P474, DOI 10.1271/bbb.63.474; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Noack S, 2019, PARASITOL RES, V118, P2009, DOI 10.1007/s00436-019-06343-5; Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608; Oksanen JF, 2010, VEGAN COMMUNITY ECOL; Onrust L, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00075; Oviedo-Rondon EO, 2010, AVIAN BIOL RES, V3, P157, DOI 10.3184/175815511X12919853724050; Pan D, 2014, GUT MICROBES, V5, P108, DOI 10.4161/gmic.26945; Perdigon G, 1999, J DAIRY SCI, V82, P1108, DOI 10.3168/jds.S0022-0302(99)75333-6; Perry M, 2019, HEATMAPS FLEXIBLE HE; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Qing XD, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0439-5; Robinson K, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090282; Rostagno HS, 2005, COMPOSICAO ALIMENTOS, V2, P186; Stanley D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00187; Stanley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104739; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Upadhaya SD, 2017, ANN ANIM SCI, V17, P929, DOI 10.1515/aoas-2016-0079; Uzal FA, 2014, FUTURE MICROBIOL, V9, P361, DOI 10.2217/fmb.13.168; VONWRIGHT A, 2012, FOOD SCI TECHNOL, P1; Vos P., 2011, BERGEYS MANUAL SYSTE, V3; Wang LL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00593; WHITEHEAD RH, 1986, GUT, V27, P1457, DOI 10.1136/gut.27.12.1457; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1; Wu SB, 2014, VET MICROBIOL, V169, P188, DOI 10.1016/j.vetmic.2014.01.007; Xavier RJ, 2000, SCIENCE, V289, P1483, DOI 10.1126/science.289.5484.1483; Yang CM, 2012, POULTRY SCI, V91, P2121, DOI 10.3382/ps.2011-02131; Zhou ZY, 2017, EXP PARASITOL, V177, P73, DOI 10.1016/j.exppara.2017.04.007	68	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0237118	10.1371/journal.pone.0237118	http://dx.doi.org/10.1371/journal.pone.0237118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764795	gold, Green Published			2022-12-26	WOS:000561029000035
J	Barha, CK; Liu-Ambrose, T				Barha, Cindy K.; Liu-Ambrose, Teresa			Sex differences in exercise efficacy: Is midlife a critical window for promoting healthy cognitive aging?	FASEB JOURNAL			English	Article						aerobic training; Alzheimer's disease; brain health; dementia	TIME PHYSICAL-ACTIVITY; OLDER-ADULTS; AEROBIC EXERCISE; LEISURE-TIME; ALZHEIMER-DISEASE; NEUROTROPHIC FACTOR; CARDIORESPIRATORY FITNESS; APOE-EPSILON-4 GENOTYPE; SYNAPTIC PLASTICITY; HIPPOCAMPAL VOLUME	Dementia is one of the most pressing health care issues of this century. As no curative treatment for dementia exists, research efforts are growing to identify effective lifestyle interventions to prevent or delay onset. One such promising strategy that promotes cognitive and brain health is engaging in physical exercise. However, current exercise recommendations are imprecise. To advance the potential of exercise as a preventative and treatment strategy, important questions regarding moderators (ie, biological sex and age) are being addressed in the literature. Biological sex is recognized as an important variable to consider in exercise efficacy on brain health, with females showing greater cognitive gains. This may be related to sex differences in underlying mechanisms. Here, we argue to better understand the sex differences in exercise efficacy, the timing of exercise intervention should also be considered. Specifically, we present the hypothesis that midlife in females is a critical window for the implementation of exercise as an early intervention to promote brain health and prevent dementia. Further, we speculate that exercise interventions targeting midlife will be of critical importance for the female brain, as females exit this period of the lifespan at greater risk for cognitive impairment. Given the potential sex differences in dementia risk and prevalence, it is imperative to assess potential sex differences in exercise efficacy as an early intervention during midlife.	[Barha, Cindy K.; Liu-Ambrose, Teresa] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada; [Barha, Cindy K.; Liu-Ambrose, Teresa] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Aging Mobil & Cognit Neurosci Lab, Vancouver, BC, Canada; [Barha, Cindy K.; Liu-Ambrose, Teresa] Univ British Columbia, Phys Act Precis Hlth Res Cluster, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Liu-Ambrose, T (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Aging Mobil & Cognit Neurosci Lab, Liu Ambrose Lab, 2215 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	teresa.ambrose@ubc.ca			Alzheimer's Association; Canada Research Chairs (Chaires de recherche du Canada); Fondation Brain Canada (Brain Canada)	Alzheimer's Association(Alzheimer's Association); Canada Research Chairs (Chaires de recherche du Canada)(Canada Research Chairs); Fondation Brain Canada (Brain Canada)	Alzheimer's Association; Canada Research Chairs (Chaires de recherche du Canada); Fondation Brain Canada (Brain Canada)	Ahlskog JE, 2011, MAYO CLIN PROC, V86, P876, DOI 10.4065/mcp.2011.0252; Allard JS, 2017, EXP GERONTOL, V87, P129, DOI 10.1016/j.exger.2016.11.001; Alzheimer's A, 2015, CHANGING TRAJECTORY; Alzheimer's Association, 2014, Alzheimers Dement, V10, pe47; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Anstey KJ, 2008, AM J GERIAT PSYCHIAT, V16, P343, DOI 10.1097/JGP.0b013e31816b72d4; Ardekani BA, 2016, J ALZHEIMERS DIS, V50, P847, DOI 10.3233/JAD-150780; Armstrong NM, 2019, AM J EPIDEMIOL, V188, P2175, DOI 10.1093/aje/kwz210; Azevedo MR, 2007, INT J PUBLIC HEALTH, V52, P8, DOI 10.1007/s00038-006-5062-1; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Barha CK, 2020, J GERONTOL A-BIOL, V75, P764, DOI 10.1093/gerona/glz093; Barha Cindy K, 2018, Brain Plast, V4, P53, DOI 10.3233/BPL-180067; Barha CK, 2017, J ALZHEIMERS DIS, V60, P1397, DOI 10.3233/JAD-170221; Barha CK, 2017, FRONT NEUROENDOCRIN, V46, P71, DOI 10.1016/j.yfrne.2017.04.002; Barha CK, 2017, FRONT NEUROENDOCRIN, V46, P86, DOI 10.1016/j.yfrne.2017.06.001; Barha CK, 2017, BRIT J SPORT MED, V51, P636, DOI 10.1136/bjsports-2016-096710; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Barnes LL, 2005, ARCH GEN PSYCHIAT, V62, P685, DOI 10.1001/archpsyc.62.6.685; Barrios H, 2013, AGING MENT HEALTH, V17, P287, DOI 10.1080/13607863.2012.747083; Bherer Louis, 2013, J Aging Res, V2013, P197326, DOI [10.1155/2013/657508, 10.1155/2013/197326]; Bove R, 2014, NEUROLOGY, V82, P222, DOI 10.1212/WNL.0000000000000033; Brinton RD, 2015, NAT REV ENDOCRINOL, V11, P393, DOI 10.1038/nrendo.2015.82; Burton NW, 2000, PREV MED, V31, P673, DOI 10.1006/pmed.2000.0763; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Chan CB, 2017, J NEUROSCI RES, V95, P328, DOI 10.1002/jnr.23863; Chang ML, 2010, J GERONTOL A-BIOL, V65, P1369, DOI 10.1093/gerona/glq152; Childs E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00161; Christie BR, 2008, NEUROMOL MED, V10, P47, DOI 10.1007/s12017-008-8033-2; Colberg SR, 2010, DIABETES CARE, V33, P2692, DOI [10.2337/dc10-1548, 10.2337/dc10-9990]; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Cooper C, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029736; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Davis JC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014387; Davis JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063031; Davis JC, 2011, BRIT J SPORT MED, V45, P470, DOI 10.1136/bjsm.2010.077990; De Marco M, 2015, BEHAV GENET, V45, P106, DOI 10.1007/s10519-014-9675-5; DeFina LF, 2013, ANN INTERN MED, V158, P162, DOI 10.7326/0003-4819-158-3-201302050-00005; Ennis GE, 2017, NEUROLOGY, V88, P371, DOI 10.1212/WNL.0000000000003537; Erickson KI, 2009, BRIT J SPORT MED, V43, P22, DOI 10.1136/bjsm.2008.052498; Erickson KI, 2019, MED SCI SPORT EXER, V51, P1242, DOI 10.1249/MSS.0000000000001936; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Etnier JL, 2007, MED SCI SPORT EXER, V39, P199, DOI 10.1249/01.mss.0000239399.85955.5e; Etnier JL, 2006, BRAIN RES REV, V52, P119, DOI 10.1016/j.brainresrev.2006.01.002; Firth J, 2018, NEUROIMAGE, V166, P230, DOI 10.1016/j.neuroimage.2017.11.007; Gardner M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40566-x; Gates N, 2013, AM J GERIAT PSYCHIAT, V21, P1086, DOI 10.1016/j.jagp.2013.02.018; Hackney Anthony C, 2006, Expert Rev Endocrinol Metab, V1, P783, DOI 10.1586/17446651.1.6.783; Haeger A, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101933; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hansson O, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0538-4; Hare BD, 2014, NEUROPSYCHOPHARMACOL, V39, P1262, DOI 10.1038/npp.2013.329; Head D, 2012, ARCH NEUROL-CHICAGO, V69, P636, DOI 10.1001/archneurol.2011.845; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Hill EE, 2008, J ENDOCRINOL INVEST, V31, P587, DOI 10.1007/BF03345606; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Howden EJ, 2015, J APPL PHYSIOL, V119, P37, DOI 10.1152/japplphysiol.00092.2015; Huang WY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184011; Hui LY, 2016, J WOMENS HEALTH, V25, P71, DOI 10.1089/jwh.2015.5214; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Karlamangla AS, 2009, AM J EPIDEMIOL, V170, P331, DOI 10.1093/aje/kwp154; Kelly ME, 2014, AGEING RES REV, V16, P12, DOI 10.1016/j.arr.2014.05.002; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000; Koran MEI, 2017, BRAIN IMAGING BEHAV, V11, P205, DOI 10.1007/s11682-016-9523-8; Krell-Roesch J, 2018, J ALZHEIMERS DIS, V63, P149, DOI 10.3233/JAD-171141; Lachman ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013297; Liu-Ambrose T, 2009, BRIT J SPORT MED, V43, P25, DOI 10.1136/bjsm.2008.055616; Liu-Ambrose T, 2018, APPL PHYSIOL NUTR ME, V43, P1105, DOI 10.1139/apnm-2018-0260; Loef M, 2013, OBESITY, V21, pE51, DOI 10.1002/oby.20037; Maass A, 2016, NEUROIMAGE, V131, P142, DOI 10.1016/j.neuroimage.2015.10.084; Martinez-Gonzalez MA, 2001, MED SCI SPORT EXER, V33, P1142, DOI 10.1097/00005768-200107000-00011; Mastorakos George, 2005, Hormones (Athens), V4, P73; Matsumoto AM, 2002, J GERONTOL A-BIOL, V57, pM76, DOI 10.1093/gerona/57.2.M76; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Middleton L, 2008, J NEUROL SCI, V269, P80, DOI 10.1016/j.jns.2007.04.054; Mielke MM, 2014, CLIN EPIDEMIOL, V6, P37, DOI 10.2147/CLEP.S37929; Mosconi L, 2017, NEUROLOGY, V89, P1382, DOI 10.1212/WNL.0000000000004425; Nagamatsu Lindsay S, 2013, J Aging Res, V2013, P861893, DOI 10.1155/2013/861893; Najar J, 2019, NEUROLOGY, V92, pE1322, DOI 10.1212/WNL.0000000000007021; Neu SC, 2017, JAMA NEUROL, V74, P1178, DOI 10.1001/jamaneurol.2017.2188; Niti M, 2008, INT PSYCHOGERIATR, V20, P237, DOI 10.1017/S1041610207006655; Northey JM, 2018, BRIT J SPORT MED, V52, P154, DOI 10.1136/bjsports-2016-096587; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Ohman H, 2014, DEMENT GERIATR COGN, V38, P347, DOI 10.1159/000365388; Otte C, 2005, PSYCHONEUROENDOCRINO, V30, P80, DOI 10.1016/j.psyneuen.2004.06.002; Palta P, 2019, ALZHEIMERS DEMENT, V15, P273, DOI 10.1016/j.jalz.2018.08.008; Podcasy JL, 2016, DIALOGUES CLIN NEURO, V18, P437; Power MC, 2018, ALZHEIMERS DEMENT, V14, P167, DOI 10.1016/j.jalz.2017.07.757; Prakash RS, 2015, ANNU REV PSYCHOL, V66, P769, DOI 10.1146/annurev-psych-010814-015249; Prince M, 2015, WORLD ALZHEIMERS REP; Ratnakumar A, 2019, ALZH DEMENT-TRCI, V5, P906, DOI 10.1016/j.trci.2019.09.004; Rettberg JR, 2014, FRONT NEUROENDOCRIN, V35, P8, DOI 10.1016/j.yfrne.2013.08.001; Rocca WA, 2007, NEUROLOGY, V69, P1074, DOI 10.1212/01.wnl.0000276984.19542.e6; Rothman SM, 2010, NEUROMOL MED, V12, P56, DOI 10.1007/s12017-009-8107-9; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Sabia S, 2012, CAN MED ASSOC J, V184, P1985, DOI 10.1503/cmaj.121080; Sanders LMJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210036; Scharfman HE, 2014, NEUROPHARMACOLOGY, V76, P696, DOI 10.1016/j.neuropharm.2013.04.029; Schubert CR, 2019, J AM GERIATR SOC, V67, P1610, DOI 10.1111/jgs.15886; Schuit AJ, 2001, MED SCI SPORT EXER, V33, P772; Seeman TE, 1997, J CLIN ENDOCR METAB, V82, P2458, DOI 10.1210/jc.82.8.2458; Sharman JE, 2015, AM J HYPERTENS, V28, P147, DOI 10.1093/ajh/hpu191; Shih IF, 2018, ALZHEIMERS DEMENT, V14, P1, DOI 10.1016/j.jalz.2017.05.005; Smith JC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00061; Smith JC, 2013, BRAIN SCI, V3, P54, DOI 10.3390/brainsci3010054; Smith JC, 2011, NEUROIMAGE, V54, P635, DOI 10.1016/j.neuroimage.2010.07.070; Sperling RA, 2013, NAT REV NEUROL, V9, P54, DOI 10.1038/nrneurol.2012.241; Stillman CM, 2020, TRENDS NEUROSCI, V43, P533, DOI 10.1016/j.tins.2020.04.010; Stillman CM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00626; Stranahan AM, 2008, NEUROMOL MED, V10, P118, DOI 10.1007/s12017-008-8027-0; Szuhany KL, 2015, J PSYCHIATR RES, V60, P56, DOI 10.1016/j.jpsychires.2014.10.003; ten Brinke LF, 2015, BRIT J SPORT MED, V49, P248, DOI 10.1136/bjsports-2013-093184; Trivino-Paredes J, 2016, FRONT NEUROENDOCRIN, V41, P23, DOI 10.1016/j.yfrne.2016.03.001; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; van Uffelen JGZ, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.044735; Verstynen Timothy D, 2012, J Aging Res, V2012, P939285, DOI 10.1155/2012/939285; Voss MW, 2013, BRAIN BEHAV IMMUN, V28, P90, DOI 10.1016/j.bbi.2012.10.021; Voss MW, 2011, J APPL PHYSIOL, V111, P1505, DOI 10.1152/japplphysiol.00210.2011; Wang YX, 2019, FRONT AGING NEUROSCI, V11, DOI [10.3389/fnagi.2019.00129, 10.3389/fnagi.2019.00259]; Weinstein AM, 2012, BRAIN BEHAV IMMUN, V26, P811, DOI 10.1016/j.bbi.2011.11.008; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; Wilson RS, 2013, NEUROLOGY, V81, P314, DOI 10.1212/WNL.0b013e31829c5e8a; Wu YT, 2017, NAT REV NEUROL, V13, P327, DOI 10.1038/nrneurol.2017.63; Yan Y, 2018, NEUROBIOL STRESS, V8, P120, DOI 10.1016/j.ynstr.2018.03.002; Yin F, 2015, NEUROBIOL AGING, V36, P2282, DOI 10.1016/j.neurobiolaging.2015.03.013; Young J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005381.pub4; Zhao LQ, 2016, NEUROBIOL AGING, V42, P69, DOI 10.1016/j.neurobiolaging.2016.02.011; Zhu N, 2014, NEUROLOGY, V82, P1339, DOI 10.1212/WNL.0000000000000310	131	13	15	2	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11329	11336		10.1096/fj.202000857R	http://dx.doi.org/10.1096/fj.202000857R		AUG 2020	8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32761860				2022-12-26	WOS:000558192800001
J	Valentine-Graves, M; Hall, E; Guest, JL; Adam, E; Valencia, R; Shinn, K; Hardee, I; Sanchez, T; Siegler, AJ; Sullivan, PS				Valentine-Graves, Mariah; Hall, Eric; Guest, Jodie Lynn; Adam, Elizabeth; Valencia, Rachel; Shinn, Kaitlin; Hardee, Isabel; Sanchez, Travis; Siegler, Aaron J.; Sullivan, Patrick Sean			At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: Post-collection acceptability of specimen collection process and patient confidence in specimens	PLOS ONE			English	Article							TESTS; RISK	Background Options to increase the ease of testing for SARS-CoV-2 infection and immune response are needed. Self-collection of diagnostic specimens at home offers an avenue to allow people to test for SARS-CoV-2 infection or immune response without traveling to a clinic or laboratory. Before this study, survey respondents indicated willingness to self-collect specimens for COVID-related tests, but hypothetical willingness can differ from post-collection acceptability after participants collect specimens. Methods 153 US adults were enrolled in a study of the willingness and feasibility of patients to self-collect three diagnostic specimens (saliva, oropharyngeal swab (OPS) and dried blood spot (DBS) card) while observed by a clinician through a telehealth session. After the specimens were collected, 148 participants participated in a survey about the acceptability of the collection, packing and shipping process, and their confidence in the samples collected for COVID-related laboratory testing. Results A large majority of participants (>84%) reported that collecting, packing and shipping of saliva, OPS, and DBS specimens were acceptable. Nearly nine in 10 (87%) reported being confident or very confident that the specimens they collected were sufficient for laboratory analysis.There were no differences in acceptability for any specimen type, packing and shipping, or confidence in samples, by gender, age, race/ethnicity, or educational level. Conclusions Self-collection of specimens for SARS-CoV-2 testing, and preparing and shipping specimens for analysis, were acceptable in a diverse group of US adults. Further refinement of materials and instructions to support self-collection of saliva, OPS and DBS specimens for COVID-related testing is needed.	[Valentine-Graves, Mariah; Hall, Eric; Guest, Jodie Lynn; Adam, Elizabeth; Valencia, Rachel; Sanchez, Travis; Sullivan, Patrick Sean] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Shinn, Kaitlin; Hardee, Isabel] Emory Univ, Sch Med, Atlanta, GA USA; [Siegler, Aaron J.] Emory Univ, Dept Behav Sci & Hlth Educ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University; Emory University; Rollins School Public Health	Sullivan, PS (corresponding author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	pssulli@emory.edu		HARDEE, ISABEL/0000-0002-8318-7522; Sullivan, Patrick Sean/0000-0002-7728-0587; Siegler, Aaron/0000-0001-5553-7540; Hall, Eric/0000-0003-0244-7458	National Institutes of Health [3R01AI143875-02S1, 3R01AI14375-02S1, R01AI143875-02S1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	AJS: National Institutes of Health 3R01AI143875-02S1 THS: National Institutes of Health R01AI143875-02S1 PSS:National Institutes of Health 3R01AI14375-02S1 NIH.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; BRESLOW N, 1970, BIOMETRIKA, V57, P579, DOI 10.2307/2334776; Colfax GN, 2002, AIDS CARE, V14, P675, DOI 10.1080/0954012021000005533a; del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1339, DOI 10.1001/jama.2020.3072; Dyer O, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1167; Greensides DR, 2003, PUBLIC HEALTH REP, V118, P531, DOI 10.1016/S0033-3549(04)50289-3; Guest JL, 2020, JMIR PUBLIC HLTH SUR, V6, DOI [10.2196/19054, DOI 10.2196/19054]; Guest JL, 2020, JMIR PUBLIC HLTH SUR, V6, P4, DOI 10.2196/19043; Hall EW, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6710; Hall EW, 2020, JMIR PREPRINTS; MacGowan RJ, 2018, AIDS BEHAV, V22, P117, DOI 10.1007/s10461-017-1932-1; Patel R, 2020, MBIO, V11, DOI 10.1128/mBio.00722-20; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; Sharfstein JM, 2020, JAMA-J AM MED ASSOC, V323, P1437, DOI 10.1001/jama.2020.3864; Siegler AJ, 2019, CLIN INFECT DIS, V68, P501, DOI 10.1093/cid/ciy529; Siegler AJ, 2020, WILLINGNESS SEEK LAB; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; Stein R, 2020, NPR; Sullivan PS, DETECTION SARS COV 2, DOI [10.2196/preprints.19054, DOI 10.2196/PREPRINTS.19054]; Thurmond VA, 2001, J NURS SCHOLARSHIP, V33, P253, DOI 10.1111/j.1547-5069.2001.00253.x; Vaismoradi M, 2016, SCIEDU PRESS; Wu Z, 2020, JAMA, V323, P1239, DOI 10.1001/jama.2020.2648	24	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2020	15	8							e0236775	10.1371/journal.pone.0236775	http://dx.doi.org/10.1371/journal.pone.0236775			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NB3DK	32756585	Green Published, Green Submitted, gold			2022-12-26	WOS:000560393300008
J	Lin, HC; Yang, CM; Chen, SN; Hsieh, YT				Lin, Hsuan-Chieh; Yang, Chung-May; Chen, San-Ni; Hsieh, Yi-Ting			Vitrectomy with internal limiting membrane peeling versus nonsurgical treatment for diabetic macular edema with massive hard exudates	PLOS ONE			English	Article							PARS-PLANA VITRECTOMY; INTRAVITREAL TRIAMCINOLONE ACETONIDE; LASER PHOTOCOAGULATION; SURGICAL REMOVAL; RETINOPATHY; MANAGEMENT; REDUCTION; INJECTION; SURGERY; EYES	Purpose To compare the anatomical and functional outcomes of severe diabetic macular edema (DME) with massive hard exudates managed by pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling or nonsurgical treatment. Methods We retrospectively reviewed 40 eyes with DME and massive hard exudates treated with either PPV with ILM peeling (vitrectomy group, 21 eyes) or nonsurgical treatment with anti-vascular endothelium growth factor (VEGF) and/or steroids (nonsurgical group, 19 eyes). Changes in best-corrected visual acuity (BCVA) and central retinal thickness (CRT) and resolution of macular hard exudates were compared between the two groups. Results After treatment, CRT decreased steadily in the vitrectomy group but fluctuated in the nonsurgical group. Compared with eyes in the nonsurgical group, eyes in the vitrectomy group had better visual improvement (P < 0.05 at 6 and 12 months and the final visit) and greater decrease in CRT (P < 0.05 at 3 and 6 months and the final visit) after adjustment for baseline BCVA. Hard exudates resolved more rapidly in the vitrectomy group than in the nonsurgical group, with 94.1% versus 47.4% eyes showing significant absorption after 6 months of the treatment (P = 0.003). In the vitrectomy group, 62% eyes did not require any further injections for treating DME after the operation. Conclusions PPV with ILM peeling resulted in rapid resolution of hard exudates with significant anatomical and functional improvement in DME with massive hard exudates.	[Lin, Hsuan-Chieh; Yang, Chung-May; Hsieh, Yi-Ting] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Lin, Hsuan-Chieh] Natl Taiwan Univ Hosp, Dept Ophthalmol, Hsinchu Branch, Hsinchu, Taiwan; [Yang, Chung-May] Natl Taiwan Univ, Sch Med, Taipei, Taiwan; [Chen, San-Ni] Changhua Christian Hosp, Dept Ophthalmol, Changhua, Taiwan; [Chen, San-Ni] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, San-Ni] Da Yeh Univ, Coll Nursing & Hlth Sci, Dept Optometry, Changhua, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Changhua Christian Hospital; Chung Shan Medical University; Da Yeh University	Hsieh, YT (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.	ythyth@gmail.com		YANG, CHUNG-MAY/0000-0003-4082-420X; Hsieh, Yi-Ting/0000-0003-2258-154X				Ashraf M, 2016, BRIT J OPHTHALMOL, V100, P1596, DOI 10.1136/bjophthalmol-2016-308388; Avci R, 2008, EYE, V22, P1099, DOI 10.1038/sj.eye.6702877; Avci R, 2006, GRAEF ARCH CLIN EXP, V244, P28, DOI 10.1007/s00417-005-0069-5; Busch C, 2019, ACTA DIABETOL, V56, P1341, DOI 10.1007/s00592-019-01416-4; Cekic Osman, 2008, International Ophthalmology, V28, P95, DOI 10.1007/s10792-007-9120-3; Ciardella AP, 2004, BRIT J OPHTHALMOL, V88, P1131, DOI 10.1136/bjo.2004.041707; Doi N, 2012, GRAEF ARCH CLIN EXP, V250, P71, DOI 10.1007/s00417-011-1777-7; Etter J, 2008, CAN J OPHTHALMOL, V43, P373, DOI 10.3129/i08-040; FERRIS FL, 1984, SURV OPHTHALMOL, V28, P452, DOI 10.1016/0039-6257(84)90227-3; Fong DS, 2018, RETINA-J RET VIT DIS, V38, P1830, DOI 10.1097/IAE.0000000000001790; Fong DS, 1997, ARCH OPHTHALMOL-CHIC, V115, P873, DOI 10.1001/archopht.1997.01100160043006; Gandorfer A, 2000, RETINA-J RET VIT DIS, V20, P126, DOI 10.1097/00006982-200003000-00003; Gupta A, 2004, AM J OPHTHALMOL, V137, P675, DOI 10.1016/j.ajo.2003.11.017; Harbour JW, 1996, AM J OPHTHALMOL, V121, P405, DOI 10.1016/S0002-9394(14)70437-4; Hartley KL, 2008, RETINA-J RET VIT DIS, V28, P410, DOI 10.1097/IAE.0b013e31816102f2; Hata Y, 2011, BRIT J OPHTHALMOL, V95, P261, DOI 10.1136/bjo.2010.190322; Ho AC, 2012, OPHTHALMOLOGY, V119, P2179, DOI 10.1016/j.ophtha.2012.07.058; Holekamp NM, 2018, AM J OPHTHALMOL, V191, P83, DOI 10.1016/j.ajo.2018.04.010; Holladay JT, 2004, J CATARACT REFR SURG, V30, P287, DOI 10.1016/j.jcrs.2004.01.014; Hsiao CC, 2020, EYE, V34, P544, DOI 10.1038/s41433-019-0549-1; Hu XY, 2018, INT J OPHTHALMOL-CHI, V11, P1848, DOI 10.18240/ijo.2018.11.18; Iglicki M, 2020, BRIT J OPHTHALMOL, V104, P666, DOI 10.1136/bjophthalmol-2019-314523; Iglicki M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200365; Ikeda T, 2000, RETINA-J RET VIT DIS, V20, P220, DOI 10.1097/00006982-200002000-00023; KAMPIK A, 1981, ARCH OPHTHALMOL-CHIC, V99, P1445, DOI 10.1001/archopht.1981.03930020319025; Khairallah M, 2005, RETINA-J RET VIT DIS, V25, P835, DOI 10.1097/00006982-200510000-00003; Kim YT, 2012, GRAEF ARCH CLIN EXP, V250, P679, DOI 10.1007/s00417-011-1888-1; Kimura T, 2005, RETINA-J RET VIT DIS, V25, P454, DOI 10.1097/00006982-200506000-00010; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1464; Kroll P, 2007, OPHTHALMOLOGICA, V221, P78, DOI 10.1159/000098253; Kumagai K, 2009, RETINA-J RET VIT DIS, V29, P464, DOI 10.1097/IAE.0b013e31819c632f; Larsson J, 2009, ACTA OPHTHALMOL, V87, P275, DOI 10.1111/j.1755-3768.2008.01245.x; LEWIS H, 1992, OPHTHALMOLOGY, V99, P753; Massin P, 2004, OPHTHALMOLOGY, V111, P218, DOI 10.1016/j.ophtha.2003.05.037; Matsunaga N, 2005, RETINA-J RET VIT DIS, V25, P311, DOI 10.1097/00006982-200504000-00010; MCDONALD HR, 1985, RETINA-J RET VIT DIS, V5, P5, DOI 10.1097/00006982-198500510-00002; Mello P, 2019, OPHTHALMOLOGICA, V241, P9, DOI 10.1159/000492132; Naito T, 2008, J MED INVESTIG, V55, P211, DOI 10.2152/jmi.55.211; Ophthalmology ICo, 2016, UPD 2017 ICO GUID DI; Otani T, 2002, AM J OPHTHALMOL, V134, P214, DOI 10.1016/S0002-9394(02)01548-9; Patel JI, 2006, RETINA-J RET VIT DIS, V26, P5, DOI 10.1097/00006982-200601000-00002; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Pendergast SD, 2000, AM J OPHTHALMOL, V130, P178, DOI 10.1016/S0002-9394(00)00472-4; Rosenblatt BJ, 2005, GRAEF ARCH CLIN EXP, V243, P20, DOI 10.1007/s00417-004-0958-z; Sakamoto T, 2011, RETINA-J RET VIT DIS, V31, P222, DOI 10.1097/IAE.0b013e3181facfa9; Schmidt-Erfurth U, 2017, OPHTHALMOLOGICA, V237, P185, DOI 10.1159/000458539; Takagi H, 1999, OPHTHALMOLOGY, V106, P249, DOI 10.1016/S0161-6420(99)90054-4; Takaya K, 2004, RETINA-J RET VIT DIS, V24, P23, DOI 10.1097/00006982-200402000-00004; Toda J, 2007, RETINA-J RET VIT DIS, V27, P764, DOI 10.1097/IAE.0b013e318030bfcd; Wells JA, 2016, OPHTHALMOLOGY, V123, P1351, DOI 10.1016/j.ophtha.2016.02.022; Yang CM, 2000, RETINA-J RET VIT DIS, V20, P121, DOI 10.1097/00006982-200002000-00003; Yanyali A, 2005, AM J OPHTHALMOL, V139, P795, DOI 10.1016/j.ajo.2004.12.017; Yoshida S, 2012, INVEST OPHTH VIS SCI, V53, P6997, DOI 10.1167/iovs.12-9671; Zur D, 2020, ACTA OPHTHALMOL, V98, pE217, DOI 10.1111/aos.14230; Zur D, 2018, OPHTHALMOLOGY, V125, P267, DOI 10.1016/j.ophtha.2017.08.031	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236867	10.1371/journal.pone.0236867	http://dx.doi.org/10.1371/journal.pone.0236867			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735583	gold, Green Published			2022-12-26	WOS:000569367100054
J	Zapolski, T; Kaminska, A; Kocki, T; Wysokinski, A; Urbanska, EM				Zapolski, Tomasz; Kaminska, Anna; Kocki, Tomasz; Wysokinski, Andrzej; Urbanska, Ewa M.			Aortic stiffness-Is kynurenic acid a novel marker? Cross-sectional study in patients with persistent atrial fibrillation	PLOS ONE			English	Article							INCREASED ARTERIAL STIFFNESS; THYROID-STIMULATING HORMONE; CHRONIC KIDNEY-DISEASE; HEART-FAILURE; RISK-FACTOR; CARDIOVASCULAR-DISEASE; CAROTID ATHEROSCLEROSIS; INDEPENDENT PREDICTOR; EJECTION FRACTION; VOLUME INDEX	Objective Although a number of modifiable and non-modifiable causes were implicated in arterial stiffness, its pathogenesis remains elusive, and very little is known about aortic elasticity in supraventricular arrhythmias. The potential role of disturbed kynurenine metabolism in the pathogenesis of cardiovascular disease has been recently suggested. Thus, we studied the correlations of aortic stiffness and echocardiographic parameters with biochemical markers and serum level of kynurenic acid (KYNA), an endothelial derivative of tryptophan, formed along the kynurenine pathway, among patients with atrial fibrillation (AF). Methods Study cohort comprised 100 patients with persistent AF (43 females/57 males). Arterial stiffness index (ASI), structural and functional indices of left atrium (LA) and left ventricle (LV) were evaluated electrocardiographically. Biochemical analyses included the measurements of serum KYNA (HPLC) and of the selected markers of lipids and glucose metabolism, thyroid status, kidney function, inflammation and coagulation. Results KYNA (beta = 0.389, P = 0.029), homocysteine (beta = 0.256, P = 0.40), total cholesterol (beta = 0.814; P = 0.044), LDL (beta = 0.663; P = 0.44), TSH (beta = 0.262, P = 0.02), fT(3) (beta = -0.333, P = 0.009), fT(4) (beta = -0.275, P = 0.043) and creatinine (beta = 0.374, P = 0.043) were independently correlated with ASI. ASI was also independently associated with LV end-systolic diameter (LVEDd; beta = 1.751, P = 0.045), midwall fractional shortening (mFS; beta = -1.266, P = 0.007), ratio mFS/end-systolic stress (mFS/ESS; beta = -0.235, P = 0.026), LV shortening fraction (FS; beta = -0.254, P = 0.017), and LA volume index (LAVI; beta = 0.944, P = 0.022). Conclusions In patients with AF, aortic stiffness correlated positively with KYNA, biochemical risk factors of atherosclerosis and with the indices of diastolic dysfunction of LV and LA. Revealed relationship between ASI and KYNA is an original observation, suggesting a potential role of disturbed kynurenine metabolism in the pathogenesis of arterial stiffening. KYNA, synthesis of which is influenced by homocysteine, emerges as a novel, non-classical factor associated with ASI in patients with AF.	[Zapolski, Tomasz; Wysokinski, Andrzej] Med Univ Lublin, Chair & Dept Cardiol, Lublin, Poland; [Kaminska, Anna] Cardiol Hlth Resort Hosp, Naleczow, Poland; [Kocki, Tomasz] Med Univ Lublin, Chair & Dept Expt & Clin Pharmacol, Lublin, Poland; [Urbanska, Ewa M.] Med Univ Lublin, Chair & Dept Expt & Clin Pharmacol, Lab Cellular & Mol Pharmacol, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Zapolski, T (corresponding author), Med Univ Lublin, Chair & Dept Cardiol, Lublin, Poland.	zapolia@wp.pl	Stefanadis, Christodoulos/ABH-2232-2020; Urbanska, Ewa/HGC-5309-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; Urbanska, Ewa/0000-0002-2704-528X; Zapolski, Tomasz/0000-0001-9808-8853; Kocki, Tomasz/0000-0002-7587-2626	Medical University in Lublin [450/16, 450/17, 450/18, 450/19, 377/17, 377/18, 377/19]	Medical University in Lublin	This work was supported by the Medical University in Lublin, DS grants No.: 450/16, 450/17, 450/18, 450/19, 377/17, 377/18, 377/19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampa M, 2018, CURR NEUROVASC RES, V15, P34, DOI 10.2174/1567202615666180326100347; Acampa M, 2017, INT J CARDIOL, V243, P466, DOI 10.1016/j.ijcard.2017.03.129; AlGhatrif M, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0523-z; Antonini-Canterin F, 2009, EUR J ECHOCARDIOGR, V10, P36, DOI 10.1093/ejechocard/jen236; Asp L, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-25; Bonarjee VVS, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00064; Boos CJ, 2020, EUR HEART J, V41, P1120, DOI 10.1093/eurheartj/ehz953; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653; Colpo GD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00778; Cremer A, 2015, J HYPERTENS, V33, P2150, DOI 10.1097/HJH.0000000000000652; Darlington LG, 2007, EUR J NEUROSCI, V26, P2211, DOI 10.1111/j.1460-9568.2007.05838.x; Esse R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040867; Eussen SJPM, 2015, INT J CARDIOL, V189, P18, DOI 10.1016/j.ijcard.2015.03.413; Filippatos GS, 2011, EUR HEART J, V32, P712, DOI 10.1093/eurheartj/ehq473; Fumagalli S, 2018, AGING CLIN EXP RES, V30, P1403, DOI 10.1007/s40520-018-0935-8; Glasser SP, 1997, AM J HYPERTENS, V10, P1175; Gumprecht J, 2019, J HUM HYPERTENS, V33, P824, DOI 10.1038/s41371-019-0279-7; Kass DA, 2005, HYPERTENSION, V46, P185, DOI 10.1161/01.HYP.0000168053.34306.d4; KNUTSEN KM, 1989, J INTERN MED, V225, P111, DOI 10.1111/j.1365-2796.1989.tb00049.x; Kontopoulos AG, 2003, CURR MED RES OPIN, V19, P22, DOI 10.1185/030079902125001290; Kotecha D, 2016, J AM COLL CARDIOL, V68, P2217, DOI 10.1016/j.jacc.2016.08.048; Kwon BJ, 2014, INT J CARDIOL, V177, P949, DOI 10.1016/j.ijcard.2014.09.200; Lambrinoudaki I, 2012, J HYPERTENS, V30, P592, DOI 10.1097/HJH.0b013e32834f5076; Lantelme P, 2008, ARCH CARDIOVASC DIS, V101, P35, DOI 10.1016/S1875-2136(08)70253-5; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Luchowski P, 2007, EUR J PHARMACOL, V563, P130, DOI 10.1016/j.ejphar.2007.02.044; Lugo-Huitron R, 2011, NEUROTOXICOL TERATOL, V33, P538, DOI 10.1016/j.ntt.2011.07.002; Maes M, 2007, NEUROENDOCRINOL LETT, V28, P826; Malaczewska J, 2016, CENT EUR J IMMUNOL, V41, P39, DOI 10.5114/ceji.2016.58815; Mo XM, 2014, J CLIN NEUROSCI, V21, P482, DOI 10.1016/j.jocn.2013.08.020; Mozos I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01058; Pai RG, 2007, CLIN CARDIOL, V30, P349, DOI 10.1002/clc.20107; Patel MR, 2005, J AM COLL CARDIOL, V46, P1606, DOI 10.1016/j.jacc.2005.08.030; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Pawlak K, 2010, ADV MED SCI-POLAND, V55, P196, DOI 10.2478/v10039-010-0015-6; Pawlak K, 2012, THROMB RES, V129, P704, DOI 10.1016/j.thromres.2011.08.016; Pitsavos C, 1998, AM HEART J, V135, P604, DOI 10.1016/S0002-8703(98)70274-1; Poormasjedi-Meibod MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091955; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Shaikh AY, 2016, HYPERTENSION, V68, P590, DOI 10.1161/HYPERTENSIONAHA.116.07650; Shi D, 2016, AGING CLIN EXP RES, V28, P653, DOI 10.1007/s40520-015-0455-8; Shimizu T, 2015, AM J PHYSIOL-HEART C, V309, pH1123, DOI 10.1152/ajpheart.00533.2015; Song P, 2017, CELL MOL LIFE SCI, V74, P2899, DOI 10.1007/s00018-017-2504-2; Stazka J, 2005, EUR J PHARMACOL, V517, P217, DOI 10.1016/j.ejphar.2005.04.048; Stazka J, 2002, EUR J PHARMACOL, V448, P133, DOI 10.1016/S0014-2999(02)01943-X; Szymona K, 2017, NEUROTOX RES, V32, P17, DOI 10.1007/s12640-017-9714-0; Tomiyama H, 2018, INT J CARDIOL, V253, P161, DOI 10.1016/j.ijcard.2017.11.022; Upala S, 2017, INT J CARDIOL, V227, P338, DOI 10.1016/j.ijcard.2016.11.073; Urbanska EM, 2014, HDB NEUROTOXICITY, V1, P421, DOI DOI 10.1007/978-1-4614-5836-4_92; Urbanska EM, 2006, PHARMACOL REP, V58, P507; Vyssoulis G, 2010, J HUM HYPERTENS, V24, P183, DOI 10.1038/jhh.2009.50; Wang J, 2015, ENDOCRINE, V50, P465, DOI 10.1007/s12020-015-0602-1; Wang QX, 2014, CIRC RES, V114, P480, DOI 10.1161/CIRCRESAHA.114.302113; Wejksza K, 2009, PHARMACOL REP, V61, P751, DOI 10.1016/S1734-1140(09)70130-6; Zapolski T, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0453-5; Zapolski T, 2013, MED SCI MONITOR, V19, P153, DOI 10.12659/MSM.883818; Zapolski T, 2013, INT J CARDIOL, V162, P253, DOI 10.1016/j.ijcard.2012.06.111; Zapolski T, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-100; Zekavat SM, 2019, CIRC-GENOM PRECIS ME, V12, DOI 10.1161/CIRCGEN.118.002453; Zhao JJ, 2017, J STROKE CEREBROVASC, V26, P2695, DOI 10.1016/j.jstrokecerebrovasdis.2016.10.012; Zhao XX, 2018, CLIN EXP HYPERTENS, V40, P487, DOI 10.1080/10641963.2017.1384486	63	8	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236413	10.1371/journal.pone.0236413	http://dx.doi.org/10.1371/journal.pone.0236413			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735567	gold, Green Published			2022-12-26	WOS:000569367100020
J	Chiang, KY; Lin, WC; Tsai, TY; Lin, CW; Huang, SJ; Huang, CY; Wu, SH; Ken, CF; Gong, HY; Chen, JY; Wu, JL				Chiang, Keng-Yu; Lin, Wen-Chun; Tsai, Tsung-Yu; Lin, Cheng-Wei; Huang, Shin-Jie; Huang, Ching-Yu; Wu, Sheng-Han; Ken, Chuian-Fu; Gong, Hong-Yi; Chen, Jyh-Yih; Wu, Jen-Leih			Dual expression of transgenic delta-5 and delta-6 desaturase in tilapia alters gut microbiota and enhances resistance toVibrio vulnificusinfection	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ANTIBACTERIAL ACTIVITY; DOCOSAHEXAENOIC ACID; INTESTINAL MICROBIOTA; OREOCHROMIS-NILOTICUS; FISH-OIL; INFLAMMATION; RESPONSES; CELLS; DHA	Omega-3 polyunsaturated fatty acids (n-3 PUFAs), such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), exhibit antibacterial and anti-inflammatory activities. Furthermore, diets rich in n-3 PUFAs are known to improve disease resistance and limit pathogen infection in commercial aquaculture fishes. In this study, we examined the effects of transgenic overexpression of n-3 PUFA biosynthesis genes on the physiological response to bacterial infection in tilapia. We first established tilapia strains with single or dual expression of salmon delta-5 desaturase and/or delta-6 desaturase and then challenged the fish withVibrio vulnificusinfection. Interestingly, our data suggest that n-3 PUFA-mediated alterations in gut microbiota may be important in determining disease outcome via effects on immune response of the host. Both liver- and muscle-specific single and dual expression of delta-5 desaturase and delta-6 desaturase resulted in higher n-3 PUFA content in transgenic fish fed with a LO basal diet. The enrichment of n-3 PUFAs in dual-transgenic fish is likely responsible for their improved survival rate and comparatively reduced expression of inflammation- and immune-associated genes afterV.vulnificusinfection. Gut microbiome analysis further revealed that dual-transgenic tilapia had high gut microbiota diversity, with low levels of inflammation-associated microbiota (i.e.,Prevotellaceae). Thus, our findings indicate that dual expression of transgenic delta-5 and delta-6 desaturase in tilapia enhances disease resistance, an effect that is associated with increased levels of n-3 PUFAs and altered gut microbiota composition.	[Chiang, Keng-Yu; Wu, Jen-Leih] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan; [Chiang, Keng-Yu; Lin, Cheng-Wei; Huang, Shin-Jie; Huang, Ching-Yu; Wu, Jen-Leih] Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan; [Lin, Wen-Chun; Tsai, Tsung-Yu; Chen, Jyh-Yih; Wu, Jen-Leih] Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Ilan, Taiwan; [Wu, Sheng-Han; Gong, Hong-Yi] Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung, Taiwan; [Ken, Chuian-Fu] Natl Changhua Univ Educ, Inst Biotechnol, Changhua, Taiwan; [Gong, Hong-Yi] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan; [Chen, Jyh-Yih] Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Jiaushi, Ilan, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan Ocean University; National Changhua University of Education; National Taiwan Ocean University; Academia Sinica - Taiwan	Wu, JL (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan.; Chen, JY (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Ilan, Taiwan.; Gong, HY (corresponding author), Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung, Taiwan.; Gong, HY (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan.; Chen, JY (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Jiaushi, Ilan, Taiwan.	hygong@mail.ntou.edu.tw; zoocjy@gate.sinica.edu.tw; jlwu@gate.sinica.edu.tw	Gong, Hong-Yi/ABE-2571-2020; Wu, Sheng-Han/ABB-7031-2021; Chen, Jyh-Yih/F-3412-2014	Gong, Hong-Yi/0000-0002-6240-0582; Chen, Jyh-Yih/0000-0001-7858-8236	Innovative Translational Agricultural Research Program (ITAR) (Academia Sinica)	Innovative Translational Agricultural Research Program (ITAR) (Academia Sinica)	Research funding for this study was partly from the academic committee members of Innovative Translational Agricultural Research Program (ITAR) (Academia Sinica) to Jyh-Yih Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu EO, 2009, PROSTAG LEUKOTR ESS, V80, P189, DOI 10.1016/j.plefa.2009.03.001; Andersen AD, 2011, J PEDIATR GASTR NUTR, V53, P303, DOI 10.1097/MPG.0b013e31821d298f; Bae Jin-Sik, 2013, J Lifestyle Med, V3, P19; Bidu C, 2018, DIABETES, V67, P1512, DOI 10.2337/db17-1488; Bilal S, 2011, BBA-MOL BASIS DIS, V1812, P1164, DOI 10.1016/j.bbadis.2011.05.002; Britz P., 2008, AFR J AQUAT SCI, V33, P103, DOI [10.2989/AJAS.2008.33.1.14.415, DOI 10.2989/AJAS.2008.33.1.14.415]; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Chen YT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23844-y; Cheng CL, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0208-1; Chung CS, 2016, SCAND J GASTROENTERO, V51, P410, DOI 10.3109/00365521.2015.1116107; Desbois AP, 2013, MAR DRUGS, V11, P4544, DOI 10.3390/md11114544; Dhople V, 2006, BBA-BIOMEMBRANES, V1758, P1499, DOI 10.1016/j.bbamem.2006.07.007; Dong JJ, 2015, GENE, V566, P23, DOI 10.1016/j.gene.2015.04.025; Emery JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057463; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frayn KN, 2006, ESSAYS BIOCHEM, V42, P89, DOI 10.1042/bse0420089; Fu GH, 2014, FISH SHELLFISH IMMUN, V40, P331, DOI 10.1016/j.fsi.2014.07.019; GEIGER M, 1993, BIOCHIM BIOPHYS ACTA, V1170, P137, DOI 10.1016/0005-2760(93)90063-F; Giatsis C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103641; Hart ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143334; Hlady WG, 1996, J INFECT DIS, V173, P1176, DOI 10.1093/infdis/173.5.1176; Innes JK, 2018, PROSTAG LEUKOTR ESS, V132, P41, DOI 10.1016/j.plefa.2018.03.004; Ji S, 2007, J PERIODONTAL RES, V42, P503, DOI 10.1111/j.1600-0765.2007.00974.x; Kohl KD, 2014, FEMS MICROBIOL ECOL, V90, P883, DOI 10.1111/1574-6941.12442; Lands B, 2012, NUTRIENTS, V4, P1338, DOI 10.3390/nu4091338; Larsen JM, 2017, IMMUNOLOGY, V151, P363, DOI 10.1111/imm.12760; Lee JM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010023; Li H, 2005, KIDNEY INT, V67, P867, DOI 10.1111/j.1523-1755.2005.00151.x; Liu HQ, 2013, NUTR RES, V33, P849, DOI 10.1016/j.nutres.2013.07.004; Liu WT, 2012, HEPATOLOGY, V56, P2268, DOI 10.1002/hep.25914; Loscher CE, 2005, J IMMUNOL, V175, P4990, DOI 10.4049/jimmunol.175.8.4990; Martinez-Rubio L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040266; Menni C, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-13722-4, 10.1038/s41598-017-10382-2]; Mil-Homens D, 2012, FEMS MICROBIOL LETT, V328, P61, DOI 10.1111/j.1574-6968.2011.02476.x; Noriega BS, 2016, CASE REP MED, V2016, DOI 10.1155/2016/3089303; Power SE, 2014, BRIT J NUTR, V111, P387, DOI 10.1017/S0007114513002560; Schincaglia GP, 2017, J DENT RES, V96, P47, DOI 10.1177/0022034516668847; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Shin SY, 2007, INT J FOOD MICROBIOL, V113, P233, DOI 10.1016/j.ijfoodmicro.2006.05.020; Solanki P, 2013, QUINTESSENCE INT, V44, P392, DOI 10.3290/j.qi.a29502; Standen BT, 2015, APPL MICROBIOL BIOT, V99, P8403, DOI 10.1007/s00253-015-6702-2; Strobel C, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-144; Sun JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep26319; Tabbaa M, 2013, NUTRIENTS, V5, P3299, DOI 10.3390/nu5083299; Tarnecki AM, 2017, J APPL MICROBIOL, V123, P2, DOI 10.1111/jam.13415; Thomas T., 2015, TRANSGENIC TECHNOLOG, P387; Wang YD, 2014, FISH SHELLFISH IMMUN, V39, P223, DOI 10.1016/j.fsi.2014.04.021; Watson H, 2018, GUT, V67, P1974, DOI 10.1136/gutjnl-2017-314968; Williams-Bey Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097957; Yu HN, 2014, ARCH MED RES, V45, P195, DOI 10.1016/j.arcmed.2014.03.008; Zhang WW, 2008, APPL ENVIRON MICROB, V74, P6254, DOI 10.1128/AEM.00109-08	51	3	4	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2020	15	7							e0236601	10.1371/journal.pone.0236601	http://dx.doi.org/10.1371/journal.pone.0236601			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MW2PD	32730353	gold, Green Published			2022-12-26	WOS:000556884700049
J	Ben, C; Wu, XJ; Takahashi-Kanemitsu, A; Knight, CT; Hayashi, T; Hatakeyama, M				Ben, Chi; Wu, Xiaojing; Takahashi-Kanemitsu, Atsushi; Knight, Christopher Takaya; Hayashi, Takeru; Hatakeyama, Masanori			Alternative splicing reverses the cell-intrinsic and cell-extrinsic pro-oncogenic potentials of YAP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hippo pathway; transcriptional repressor; YAP1; chemokine; differential splicing; SHP2; CCL2; spliceosome; RAS; tumor microenvironment; Ras protein; transcription repression	TYROSINE-PHOSPHATASE SHP-2; HIPPO PATHWAY; CONTACT INHIBITION; TUMOR-SUPPRESSOR; CANCER; DOMAIN; PROLIFERATION; INFLAMMATION; MACROPHAGES; MECHANISM	In addition to acting as a transcriptional co-activator, YAP1 directly mediates translocalization of the pro-oncogenic phosphatase SHP2 from the cytoplasm to nucleus. In the cytoplasm, SHP2 potentiates RAS-ERK signaling, which promotes cell proliferation and cell motility, whereas in the nucleus, it mediates gene regulation. As a result, elucidating the details of SHP2 trafficking is important for understanding its biological roles, including in cancer. YAP1 comprises multiple splicing isoforms defined in part by the presence (as in YAP1-2 gamma) or absence (as in YAP1-2 alpha) of a gamma-segment encoded by exon 6 that disrupts a critical leucine zipper. Although the disruptive segment is known to reduce co-activator function, it is unclear how this element impacts the physical and functional relationships between YAP1 and SHP2. To explore this question, we first demonstrated that YAP1-2 gamma cannot bind SHP2. Nevertheless, YAP1-2 gamma exhibits stronger mitogenic and motogenic activities than does YAP1-2 alpha because the YAP1-2 alpha-mediated delivery of SHP2 to the nucleus weakens cytoplasmic RAS-ERK signaling. However, YAP1-2 gamma confers lessin vivotumorigenicity than does YA1-2 alpha by recruiting tumor-inhibitory macrophages. Mechanistically, YAP1-2 gamma transactivates and the YAP1-2 alpha-SHP2 complex transrepresses the monocyte/macrophage chemoattractantCCL2. Thus, cell-intrinsic and cell-extrinsic pro-oncogenic YAP1 activities are inversely regulated by alternative splicing of exon 6. Notably, oncogenic KRAS down-regulates the SRSF3 splicing factor that prevents exon 6 skipping, thereby creating a YAP1-2 alpha-dominant situation that supports a "cold" immune microenvironment.	[Ben, Chi; Wu, Xiaojing; Takahashi-Kanemitsu, Atsushi; Knight, Christopher Takaya; Hayashi, Takeru; Hatakeyama, Masanori] Univ Tokyo, Grad Sch Med, Div Microbiol, Tokyo, Japan	University of Tokyo	Hatakeyama, M (corresponding author), Univ Tokyo, Grad Sch Med, Div Microbiol, Tokyo, Japan.	mhata@m.u-tokyo.ac.jp	HAYASHI, Takeru/AAQ-1176-2021	Wu, Xiaojing/0000-0003-1166-2029; Hayashi, Takeru/0000-0002-7881-3103; Kanemitsu, Atsushi/0000-0002-4156-9522; Hatakeyama, Masanori/0000-0001-7517-2649	Ministry of Education, Culture, Sports, Science, and Technology of Japan [16H06373, 16K15273]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas Grants 16H06373 and 16K15273 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. H.).	Alber T, 1992, CURR OPIN GENET DEV, V2, P205, DOI 10.1016/S0959-437X(05)80275-8; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Che YY, 2020, J CANCER, V11, P3502, DOI 10.7150/jca.42645; Cirit M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050975; Corbo C, 2013, BIOCHEM BIOPH RES CO, V436, P1, DOI 10.1016/j.bbrc.2013.05.027; Coulombe G, 2013, MOL CELL BIOL, V33, P2275, DOI 10.1128/MCB.00043-13; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; FARRANCE IKG, 1992, J BIOL CHEM, V267, P17234; Finch-Edmondson Megan L, 2016, Biochem Biophys Rep, V6, P24, DOI 10.1016/j.bbrep.2016.02.015; Gaffney CJ, 2012, GENE, V509, P215, DOI 10.1016/j.gene.2012.08.025; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Guo XC, 2017, GENE DEV, V31, P247, DOI 10.1101/gad.294348.116; Hatakeyama M, 2014, CELL HOST MICROBE, V15, P306, DOI 10.1016/j.chom.2014.02.008; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kamps R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020308; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Kim W, 2018, GUT, V67, P1692, DOI 10.1136/gutjnl-2017-314061; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Kubota Y, 2011, NAT CELL BIOL, V13, P282, DOI 10.1038/ncb2169; Liu Xia, 2011, J Signal Transduct, V2011, P195239, DOI 10.1155/2011/195239; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; McClellan JL, 2012, AM J PHYSIOL-GASTR L, V303, pG1087, DOI 10.1152/ajpgi.00252.2012; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Moroishi T, 2016, CELL, V167, P1525, DOI 10.1016/j.cell.2016.11.005; Moroishi T, 2015, GENE DEV, V29, P1271, DOI 10.1101/gad.262816.115; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Noe L, 2005, NUCLEIC ACIDS RES, V33, pW540, DOI 10.1093/nar/gki478; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Park HW, 2013, TRENDS PHARMACOL SCI, V34, P581, DOI 10.1016/j.tips.2013.08.006; Piva F, 2009, BIOINFORMATICS, V25, P1211, DOI 10.1093/bioinformatics/btp124; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Ruess DA, 2018, NAT MED, V24, P954, DOI 10.1038/s41591-018-0024-8; SUDOL M, 1994, ONCOGENE, V9, P2145; Sudol M, 2013, ONCOGENE, V32, P3922, DOI 10.1038/onc.2012.520; Takahashi A, 2011, MOL CELL, V43, P45, DOI 10.1016/j.molcel.2011.05.014; Tsutsumi R, 2013, DEV CELL, V26, P658, DOI 10.1016/j.devcel.2013.08.013; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065539; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao HC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-317	49	3	4	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2020	295	41					13965	13980		10.1074/jbc.RA120.013820	http://dx.doi.org/10.1074/jbc.RA120.013820			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OG1HE	32763976	hybrid, Green Published			2022-12-26	WOS:000581643400002
J	Ghodke, P; Khandagale, K; Thangasamy, A; Kulkarni, A; Narwade, N; Shirsat, D; Randive, P; Roylawar, P; Singh, I; Gawande, SJ; Mahajan, V; Solanke, A; Singh, M				Ghodke, Pranjali; Khandagale, Kiran; Thangasamy, A.; Kulkarni, Abhijeet; Narwade, Nitin; Shirsat, Dhananjay; Randive, Pragati; Roylawar, Praveen; Singh, Isha; Gawande, Suresh J.; Mahajan, Vijay; Solanke, Amolkumar; Singh, Major			Comparative transcriptome analyses in contrasting onion (Allium cepa L.) genotypes for drought stress	PLOS ONE			English	Article							ABIOTIC STRESS; GENE-EXPRESSION; WATER-STRESS; TOLERANCE; ARABIDOPSIS; TRANSPORTER; EXTRACTION; ENZYMES; PROTEIN; YIELD	Onion (Allium cepaL.) is an important vegetable crop widely grown for diverse culinary and nutraceutical properties. Being a shallow-rooted plant, it is prone to drought. In the present study, transcriptome sequencing of drought-tolerant (1656) and drought-sensitive (1627) onion genotypes was performed to elucidate the molecular basis of differential response to drought stress. A total of 123206 and 139252 transcripts (average transcript length: 690 bases) were generated after assembly for 1656 and 1627, respectively. Differential gene expression analyses revealed upregulation and downregulation of 1189 and 1180 genes, respectively, in 1656, whereas in 1627, upregulation and downregulation of 872 and 1292 genes, respectively, was observed. Genes encoding transcription factors, cytochrome P450, membrane transporters, and flavonoids, and those related to carbohydrate metabolism were found to exhibit a differential expression behavior in the tolerant and susceptible genotypes. The information generated can facilitate a better understanding of molecular mechanisms underlying drought response in onion.	[Ghodke, Pranjali; Khandagale, Kiran; Thangasamy, A.; Shirsat, Dhananjay; Randive, Pragati; Gawande, Suresh J.; Mahajan, Vijay; Singh, Major] ICAR Directorate Onion & Garl Res, Pune, Maharashtra, India; [Kulkarni, Abhijeet; Narwade, Nitin] Savitribai Phule Pune Univ, Dept Bioinformat, Pune, Maharashtra, India; [Roylawar, Praveen] SN Arts DJM Commerce & BNS Sci Coll, Sangamner, India; [Singh, Isha] Univ Coll, Sch Biomol Sci, Dublin, Ireland; [Solanke, Amolkumar] ICAR Natl Inst Plant Biotechnol, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Directorate on Onion & Garlic Research; Savitribai Phule Pune University; University College Dublin; Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB)	Ghodke, P (corresponding author), ICAR Directorate Onion & Garl Res, Pune, Maharashtra, India.	pranjali.ghodke123@gmail.com	ARUNACHALAM, THANGASAMY/AAS-7687-2020; Gawande, Suresh J./H-4180-2011; Shirsat, Dhananjay Vitthal/AAD-4668-2022; Roylawar, Praveen/GXG-9571-2022	ARUNACHALAM, THANGASAMY/0000-0002-8259-6404; Gawande, Suresh J./0000-0001-8306-0719; NARWADE, NITIN/0000-0002-1368-307X; Roylawar, Praveen/0000-0002-8511-9128; Shirsat, Dhananjay/0000-0002-3107-7460	ICAR-National Innovations on Climate Resilient Agriculture (NICRA)	ICAR-National Innovations on Climate Resilient Agriculture (NICRA)	This work was supported by ICAR-National Innovations on Climate Resilient Agriculture (NICRA)	Aarati P, 2003, PLANT SCI, V164, P25, DOI 10.1016/S0168-9452(02)00321-7; Abdelrahman M, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0378-2; Abid M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21441-7; Ahmed NU, 2015, FUNCT INTEGR GENOMIC, V15, P383, DOI 10.1007/s10142-014-0427-7; [Anonymous], 2018, INT J CURR MICROBIOL; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Basu PS, 1999, ENVIRON EXP BOT, V42, P25, DOI 10.1016/S0098-8472(99)00017-9; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Batth R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00198; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Chu XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143022; Devaiah BN, 2007, PLANT PHYSIOL, V143, P1789, DOI 10.1104/pp.106.093971; Duan FM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01909; Ebeed HT, 2018, J EXP BOT, V69, P4971, DOI 10.1093/jxb/ery266; El Balla MMA, 2013, AGR WATER MANAGE, V121, P149, DOI 10.1016/j.agwat.2013.02.002; Evangelistella C, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0828-7; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Galsurker O, 2018, J EXP BOT, V69, P4047, DOI 10.1093/jxb/ery189; Garcia ME, 2008, PLANT MOL BIOL, V67, P643, DOI 10.1007/s11103-008-9344-2; Ghodke P.H., 2018, INT J CURR MICROBIOL, V7, P3438; Gong L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128041; Gupta AK, 2005, J BIOSCIENCES, V30, P761, DOI 10.1007/BF02703574; Han J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161987; HAN JH, 2011, ARABIDOPSIBOOK AM, V0009, DOI DOI 10.3788/COL201109.090608; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Huang QJ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0644-9; Jia JB, 2017, SCI REP-UK, V7, DOI 10.1038/srep43215; Jossier M, 2009, PLANT J, V59, P316, DOI 10.1111/j.1365-313X.2009.03871.x; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kanno Y, 2012, P NATL ACAD SCI USA, V109, P9653, DOI 10.1073/pnas.1203567109; Kapilan R, 2018, BIOL RES, V51, DOI 10.1186/s40659-018-0152-0; Li HM, 2011, PLANT PHYSIOL, V156, P550, DOI 10.1104/pp.111.176214; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Y, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.017584828445484, DOI 10.1371/JOURNAL.PONE.017584828445484]; Magwanga RO, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030226; Mehra R, 2020, GENOMICS, V112, P99, DOI 10.1016/j.ygeno.2019.07.014; Nakabayashi R, 2014, PLANT J, V77, P367, DOI 10.1111/tpj.12388; Nidumukkala S, 2019, CRIT REV BIOTECHNOL, V39, P395, DOI 10.1080/07388551.2019.1566204; Osakabe Y, 2014, NEW PHYTOL, V202, P35, DOI 10.1111/nph.12613; Pandian BA, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9050454; Parmar R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43925-w; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Pelter GQ, 2004, AGR WATER MANAGE, V68, P107, DOI 10.1016/j.agwat.2004.03.010; Pinelo M, 2004, FOOD CHEM, V85, P267, DOI 10.1016/j.foodchem.2003.06.020; Potopova V, 2016, CUAD INVESTIG GEOGR, V42, P127, DOI 10.18172/cig.2924; Pratelli R, 2014, J EXP BOT, V65, P5535, DOI 10.1093/jxb/eru320; Ramanjulu S., 1997, Journal of Plant Physiology, V150, P345; Ranocha P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3625; Rao N.K.S., 2016, ABIOTIC STRESS PHYSL; Rashmi D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37039-y; Rubio-Pina JA, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue5-fulltext-10; Sairam RK, 1998, BIOL PLANTARUM, V40, P357, DOI 10.1023/A:1001009812864; Shemesh-Mayer E, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00271; Song JW, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2015.01305, 10.3389/fpls.2016.01305]; Sun XD, 2016, MOL GENET GENOMICS, V291, P647, DOI 10.1007/s00438-015-1131-6; Tao X, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01519; Tian FX, 2012, BIOL PLANTARUM, V56, P509, DOI 10.1007/s10535-012-0049-7; Tuteja N, 2015, PROTOPLASMA, V252, P1563, DOI 10.1007/s00709-015-0791-8; Van Aken O, 2013, PLANT PHYSIOL, V162, P254, DOI 10.1104/pp.113.215996; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wakchaure GC, 2018, AGR WATER MANAGE, V199, P1, DOI 10.1016/j.agwat.2017.11.026; Wang M, 2020, PLANT BIOTECHNOL J, V18, P791, DOI 10.1111/pbi.13247; Xie ZY, 2019, GENOMICS, V111, P1006, DOI 10.1016/j.ygeno.2018.05.014; Xuan T. D., 2016, AGRONOMY SUSTAINABLE, V36, P1; Yong B, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01107; Yuan JB, 2018, PEERJ, V6, DOI 10.7717/peerj.5191; ZHANG C, 2018, SCI REP UK, V0008; Zhang XJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179477; Zhu XJ, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1646-9	72	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2020	15	8							e0237457	10.1371/journal.pone.0237457	http://dx.doi.org/10.1371/journal.pone.0237457			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE5TX	32780764	Green Published, gold			2022-12-26	WOS:000562664700038
J	Srivastava, N; Tauseef, M; Amin, R; Joshi, B; Joshi, JC; Kini, V; Klomp, J; Li, W; Knezevic, N; Barbera, N; Siddiqui, S; Obukhov, A; Karginov, A; Levitan, I; Komarova, Y; Mehta, D				Srivastava, Nityanand; Tauseef, Mohammad; Amin, Ruhul; Joshi, Bhagwati; Joshi, Jagdish Chandra; Kini, Vidisha; Klomp, Jennifer; Li, Weenan; Knezevic, Nebojsa; Barbera, Nicolas; Siddiqui, Shahid; Obukhov, Alexander; Karginov, Andrei; Levitan, Irena; Komarova, Yulia; Mehta, Dolly			Noncanonical function of long myosin light chain kinase in increasing ER-PM junctions and augmentation of SOCE	FASEB JOURNAL			English	Article						endoplasmic reticulum-plasma membrane junctions; long myosin light chain kinase; store-operated calcium entry; stromal interacting molecule 1; vascular permeability	OPERATED CALCIUM-ENTRY; CA2+ ENTRY; LUNG INJURY; ACTIN CYTOSKELETON; CONFER RISK; STIM1; ACTIVATION; PHOSPHORYLATION; PERMEABILITY; GENE	Increased endothelial permeability leads to excessive exudation of plasma proteins and leukocytes in the interstitium, which characterizes several vascular diseases including acute lung injury. The myosin light chain kinase long (MYLK-L) isoform is canonically known to regulate the endothelial permeability by phosphorylating myosin light chain (MLC-P). Compared to the short MYLK isoform, MYLK-L contains an additional stretch of similar to 919 amino acid at the N-terminus of unknown function. We show that thapsigargin and thrombin-induced SOCE was markedly reduced in Mylk-L-/- endothelial cells (EC) or MYLK-L-depleted human EC. These agonists also failed to increase endothelial permeability in MYLK-L-depleted EC andMylk-L(-/-)lungs, thus demonstrating the novel role of MYLK-L-induced SOCE in increasing vascular permeability. MYLK-L augmented SOCE by increasing endoplasmic reticulum (ER)-plasma membrane (PM) junctions and STIM1 translocation to these junctions. Transduction of N-MYLK domain (amino acids 1-919 devoid of catalytic activity) into Mylk-L-/- EC rescued SOCE to the level seen in control EC in a STIM1-dependent manner. N-MYLK-induced SOCE augmented endothelial permeability without MLC-P via an actin-binding motif, DVRGLL. Liposomal-mediated delivery of N-MYLK mutant but not increment DVRGLL-N-MYLK mutant inMylk-L-/- mice rescued vascular permeability increase in response to endotoxin, indicating that targeting of DVRGLL motif within MYLK-L may limit SOCE-induced vascular hyperpermeability.	[Srivastava, Nityanand; Tauseef, Mohammad; Amin, Ruhul; Joshi, Bhagwati; Joshi, Jagdish Chandra; Kini, Vidisha; Klomp, Jennifer; Knezevic, Nebojsa; Siddiqui, Shahid; Karginov, Andrei; Komarova, Yulia; Mehta, Dolly] Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave, Chicago, IL 60612 USA; [Srivastava, Nityanand; Tauseef, Mohammad; Amin, Ruhul; Joshi, Bhagwati; Joshi, Jagdish Chandra; Kini, Vidisha; Klomp, Jennifer; Knezevic, Nebojsa; Siddiqui, Shahid; Karginov, Andrei; Komarova, Yulia; Mehta, Dolly] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA; [Tauseef, Mohammad; Mehta, Dolly] Chicago State Univ, Coll Pharm, Dept Pharmaceut Sci, Chicago, IL USA; [Li, Weenan; Obukhov, Alexander] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Barbera, Nicolas; Levitan, Irena] Univ Illinois, Dept Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Chicago State University; Indiana University System; Indiana University Bloomington; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mehta, D (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave, Chicago, IL 60612 USA.; Mehta, D (corresponding author), Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA.	dmehta@uic.edu	Joshi, JC/ABA-3242-2021; Knezevic, Nebojsa Nick/H-9921-2019; Srivastava, Nityanand/AFU-0615-2022; Obukhov, Alexander G./C-7246-2008	Joshi, JC/0000-0002-9468-3046; Knezevic, Nebojsa Nick/0000-0001-8028-1495; Klomp, Jennifer/0000-0003-1781-648X; Obukhov, Alexander G./0000-0002-3862-6004	NIH| National Heart, Lung, and Blood Institute (NHLBI) [HL84153, HL137179-01, PO1-HL60678, HL077806]	NIH| National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH| National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL84153, HL137179-01, PO1-HL60678 and HL077806	Birukov KG, 2001, J BIOL CHEM, V276, P8567, DOI 10.1074/jbc.M005270200; Blue EK, 2002, AM J PHYSIOL-CELL PH, V282, pC451, DOI 10.1152/ajpcell.00333.2001; Bogatcheva NV, 2011, J CELL PHYSIOL, V226, P3132, DOI 10.1002/jcp.22669; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Casas-Rua V, 2015, BBA-MOL CELL RES, V1853, P233, DOI 10.1016/j.bbamcr.2014.10.027; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; Chen YJ, 2017, J CELL BIOL, V216, P2011, DOI 10.1083/jcb.201606047; Christie JD, 2008, CRIT CARE MED, V36, P2794, DOI 10.1097/CCM.0b013e318186b843; Dudek S.M, 2001, J APPL PHYSIOL, V91, P1487; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; GALLAGHER PJ, 1993, J BIOL CHEM, V268, P26578; Gandhirajan RK, 2013, J CLIN INVEST, V123, P887, DOI 10.1172/JCI65647; Gao L, 2006, AM J RESP CELL MOL, V34, P487, DOI 10.1165/rcmb.2005-0404OC; Gao L, 2007, J ALLERGY CLIN IMMUN, V119, P1111, DOI 10.1016/j.jaci.2007.03.019; Garcia JGN, 1997, AM J RESP CELL MOL, V16, P489, DOI 10.1165/ajrcmb.16.5.9160829; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Hsieh TS, 2017, MOL BIOL CELL, V28, P3171, DOI 10.1091/mbc.E17-06-0377; Jing J, 2015, NAT CELL BIOL, V17, P1339, DOI 10.1038/ncb3234; Kini V, 2010, J BIOL CHEM, V285, P33082, DOI 10.1074/jbc.M110.142034; Knezevic N, 2009, J EXP MED, V206, P2761, DOI 10.1084/jem.20090652; Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534; Kudryashov DS, 1999, FEBS LETT, V463, P67, DOI 10.1016/S0014-5793(99)01591-4; Kudryashov DS, 2004, EXP CELL RES, V298, P407, DOI 10.1016/j.yexcr.2004.04.025; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lynch CD, 2011, MOL BIOL CELL, V22, P1263, DOI 10.1091/mbc.E10-08-0661; Lynch CD, 2011, CURR BIOL, V21, pR916, DOI 10.1016/j.cub.2011.10.020; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Mehta D, 2004, AM J PHYSIOL-LUNG C, V287, pL1081, DOI 10.1152/ajplung.00268.2004; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Muallem S, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaq0618; Ong HL, 2017, ADV EXP MED BIOL, V993, P159, DOI 10.1007/978-3-319-57732-6_9; Palty R, 2012, CELL, V149, P425, DOI 10.1016/j.cell.2012.01.055; Petrache I, 2003, FASEB J, V17, P407, DOI 10.1096/fj.02-0672com; Pozo-Guisado E, 2013, J CELL SCI, V126, P3170, DOI 10.1242/jcs.125054; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Reynoso R, 2007, SHOCK, V28, P589, DOI 10.1097/SHK.0b013c31804d415f; Rosado JA, 2000, J PHYSIOL-LONDON, V526, P221, DOI 10.1111/j.1469-7793.2000.t01-2-00221.x; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Rossi JL, 2007, AM J PHYSIOL-LUNG C, V292, pL1327, DOI 10.1152/ajplung.00380.2006; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Srikanth S, 2012, J PHYSIOL-LONDON, V590, P4169, DOI 10.1113/jphysiol.2012.231522; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Stolwijk JA, 2016, J BIOL CHEM, V291, P22894, DOI 10.1074/jbc.M116.756114; Sun CX, 2011, CIRCULATION, V124, P48, DOI 10.1161/CIRCULATIONAHA.110.988915; Tauseef M, 2016, FASEB J, V30, P102, DOI 10.1096/fj.15-275891; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Tinsley JH, 2000, AM J PHYSIOL-CELL PH, V279, pC1285, DOI 10.1152/ajpcell.2000.279.4.C1285; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Townsley MI, 2017, PULM CIRC, V8, DOI 10.1177/2045893217738218; van Vliet AR, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2017.1340105; Verin AD, 1998, AM J RESP CELL MOL, V19, P767, DOI 10.1165/ajrcmb.19.5.3126; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Wu SW, 2005, CIRC RES, V96, P856, DOI 10.1161/01.RES.0000163632.67282.1f; Wu SW, 2001, J CELL BIOL, V154, P1225, DOI 10.1083/jcb.200106156; WYSOLMERSKI RB, 1990, P NATL ACAD SCI USA, V87, P16, DOI 10.1073/pnas.87.1.16; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Yazbeck P, 2017, SCI REP-UK, V7, DOI 10.1038/srep42758; Yu Y, 2012, FEBS J, V279, P1485, DOI 10.1111/j.1742-4658.2012.08541.x; Yuan Y, 1997, AM J PHYSIOL-HEART C, V272, pH1437, DOI 10.1152/ajpheart.1997.272.3.H1437; Zhou YB, 2013, NAT STRUCT MOL BIOL, V20, P973, DOI 10.1038/nsmb.2625	68	2	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12805	12819		10.1096/fj.201902462RR	http://dx.doi.org/10.1096/fj.201902462RR		AUG 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32772419	Green Published			2022-12-26	WOS:000558816800001
J	Ye, CT; Yang, HY; Cheng, MS; Shultz, LD; Greiner, DL; Brehm, MA; Keck, JG				Ye, Chunting; Yang, Hongyuan; Cheng, Mingshan; Shultz, Leonard D.; Greiner, Dale L.; Brehm, Michael A.; Keck, James G.			A rapid, sensitive, and reproducible in vivo PBMC humanized murine model for determining therapeutic-related cytokine release syndrome	FASEB JOURNAL			English	Article						cytokine release syndrome; cytokine storm; humanized mouse; immune toxicity; therapeutic	MONOCLONAL-ANTIBODY TGN1412; IMMUNE-SYSTEM; MOUSE MODEL; CELL-DEVELOPMENT; MICE; TRIAL; RESPONSES; MUTATION; INNATE; ASSAYS	Immunotherapy is a powerful treatment strategy being applied to cancer, autoimmune diseases, allergies, and transplantation. Although therapeutic monoclonal antibodies (mAbs) have demonstrated significant clinical efficacy, there is also the potential for severe adverse events, including cytokine release syndrome (CRS). CRS is characterized by the rapid production of inflammatory cytokines following delivery of therapy, with symptoms ranging from mild fever to life-threating pathology and multi-organ failure. Overall there is a paucity of models to reliably and accurately predict the induction of CRS by immune therapeutics. Here, we describe the development of a humanized mouse model based on the NOD-scid IL2rg(null)(NSG) mouse to study CRS in vivo. PBMC-engrafted NSG, NSG-MHC-DKO, and NSG-SGM3 mice were used to study cytokine release in response to treatment with mAb immunotherapies. Our data show that therapeutic-stimulated cytokine release in these PBMC-based NSG models captures the variation in cytokine release between individual donors, is drug dependent, occurs in the absence of acute xeno-GVHD, highlighting the specificity of the assay, and shows a robust response following treatment with a TGN1412 analog, a CD28 superagonist. Overall our results demonstrate that PBMC-engrafted NSG models are rapid, sensitive, and reproducible platforms to screen novel therapeutics for CRS.	[Ye, Chunting; Yang, Hongyuan; Cheng, Mingshan; Keck, James G.] Jackson Lab, 1650 Santa Ana Ave, Sacramento, CA 95838 USA; [Shultz, Leonard D.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Greiner, Dale L.; Brehm, Michael A.] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Program Mol Med, Worcester, MA USA	Jackson Laboratory; Jackson Laboratory; University of Massachusetts System; University of Massachusetts Worcester	Keck, JG (corresponding author), Jackson Lab, 1650 Santa Ana Ave, Sacramento, CA 95838 USA.	james.keck@jax.org			HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01DK104218-02, DP 3DK111898]; HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI132963]; HHS \ NIH \ NIH Office of the Director (OD) [R24OD0426640]	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID); HHS \ NIH \ NIH Office of the Director (OD)	HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: U01DK104218-02 and DP 3DK111898; HHS vertical bar NIH vertical bar National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: R01 AI132963; HHS vertical bar NIH vertical bar NIH Office of the Director (OD), Grant/Award Number: R24OD0426640	Aryee KE, 2014, METHODS MOL BIOL, V1185, P267, DOI 10.1007/978-1-4939-1133-2_18; Attarwala H, 2010, J Young Pharm, V2, P332, DOI 10.4103/0975-1483.66810; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Brady JL, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.28; Brehm MA, 2019, FASEB J, V33, P3137, DOI 10.1096/fj.201800636R; CHATENOUD L, 1989, NEW ENGL J MED, V320, P1420; Christofi T, 2019, CANCERS, V11, DOI 10.3390/cancers11101472; Dougan M, 2019, ANNU REV CANC BIOL, V3, P55, DOI 10.1146/annurev-cancerbio-030518-055552; Eastwood D, 2010, BRIT J PHARMACOL, V161, P512, DOI 10.1111/j.1476-5381.2010.00922.x; Felices M, 2016, METHODS MOL BIOL, V1441, P333, DOI 10.1007/978-1-4939-3684-7_28; Finco D, 2014, CYTOKINE, V66, P143, DOI 10.1016/j.cyto.2013.12.009; Goulet DR, 2020, J PHARM SCI-US, V109, P74, DOI 10.1016/j.xphs.2019.05.031; Grimaldi C, 2016, CYTOKINE, V85, P101, DOI 10.1016/j.cyto.2016.06.006; Hall KH, 2020, PHARMACOTHERAPY, V40, P133, DOI 10.1002/phar.2354; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Jangalwe S, 2016, IMMUN INFLAMM DIS, V4, P427, DOI 10.1002/iid3.124; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; King M, 2008, CLIN IMMUNOL, V126, P303, DOI 10.1016/j.clim.2007.11.001; Lai YP, 2016, INT IMMUNOL, V28, P181, DOI 10.1093/intimm/dxv063; Malcolm SL, 2012, J IMMUNOL METHODS, V384, P33, DOI 10.1016/j.jim.2012.07.001; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; McDonald-Hyman C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa6853; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller PH, 2013, BLOOD, V121, pE1, DOI 10.1182/blood-2012-09-456566; Moote W, 2018, ALLERGY ASTHMA CL IM, V14, DOI 10.1186/s13223-018-0282-5; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; Murthy H, 2019, IMMUNOTARGETS THER, V8, P43, DOI 10.2147/ITT.S202015; Parakh Sagun, 2020, Recent Results Cancer Res, V214, P1, DOI 10.1007/978-3-030-23765-3_1; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x; Pedersen SF, 2020, J CLIN INVEST, V130, P2202, DOI 10.1172/JCI137647; Redman JM, 2015, MOL IMMUNOL, V67, P28, DOI 10.1016/j.molimm.2015.04.002; Semple KM, 2019, CTS-CLIN TRANSL SCI, V12, P283, DOI 10.1111/cts.12613; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shimabukuro-Vornhagen A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0343-9; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2019, MAMM GENOME, V30, P123, DOI 10.1007/s00335-019-09796-2; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Stebbings R, 2013, J IMMUNOTOXICOL, V10, P75, DOI 10.3109/1547691X.2012.711783; Stebbings R, 2007, J IMMUNOL, V179, P3325, DOI 10.4049/jimmunol.179.5.3325; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Vessillier S, 2015, J IMMUNOL METHODS, V424, P43, DOI 10.1016/j.jim.2015.04.020; Weaver JL, 2019, TOXICOL SCI, V169, P194, DOI 10.1093/toxsci/kfz045; Weissmuller S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149093; Wraith DC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01668; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Yan HY, 2019, TRANSL RES, V210, P43, DOI 10.1016/j.trsl.2019.04.007; Yan HY, 2019, TOXICOL APPL PHARM, V372, P57, DOI 10.1016/j.taap.2019.03.020	52	10	10	6	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12963	12975		10.1096/fj.202001203R	http://dx.doi.org/10.1096/fj.202001203R		AUG 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32772418	Bronze, Green Published			2022-12-26	WOS:000558817700001
J	Priliani, L; Oktavianthi, S; Prado, EL; Malik, SG; Shankar, AH				Priliani, Lidwina; Oktavianthi, Sukma; Prado, Elizabeth L.; Malik, Safarina G.; Shankar, Anuraj H.			Maternal biomarker patterns for metabolism and inflammation in pregnancy are influenced by multiple micronutrient supplementation and associated with child biomarker patterns and nutritional status at 9-12 years of age	PLOS ONE			English	Article							C-REACTIVE-PROTEIN; D-BINDING PROTEIN; BODY-MASS INDEX; VITAMIN-D; BIRTH-WEIGHT; INSULIN-RESISTANCE; ADIPOSE-TISSUE; SERUM LEPTIN; ADIPONECTIN; PLASMA	Maternal nutritional status influences fetal development and long-term risk for adult non-communicable diseases. However, the underlying mechanisms remain poorly understood. We examined whether biomarkers for metabolism and inflammation during pregnancy were associated with maternal health and with child biomarkers and health at 9-12 years of age in 44 maternal-child dyads from the Supplementation with Multiple Micronutrients Intervention Trial (SUMMIT, ISRCTN34151616) in Lombok, Indonesia. Archived blood for each dyad from maternal enrollment, later in pregnancy, postpartum, and from children at 9-12 years comprised 132 specimens. Multiplex microbead immunoassays were used to quantify vitamin D-binding protein (D), adiponectin (A), retinol-binding protein 4 (R), C-reactive protein (C), and leptin (L). Principal component analysis (PCA) revealed distinct variance patterns, i.e. principal components (PC), for baseline pregnancy, bp.pc1.D down arrow A down arrow R down arrow and bp.pc2.C down arrow L up arrow; combined follow-up during pregnancy and postpartum, dp-pp.pc1.D up arrow down arrow A up arrow R up arrow down arrow L down arrow and dp-pp.pc2.A up arrow C up arrow L up arrow; and children, ch.pc1.D up arrow R up arrow C up arrow and ch.pc2.D down arrow A up arrow L up arrow. Maternal multiple micronutrient (MMN) supplementation led to an association of baseline maternal bp.pc2.C down arrow L up arrow with decreased post-supplementation maternal dp-pp.pc2.A up arrow C up arrow L up arrow (p= 0.022), which was in turn associated with both increased child ch.pc1.D up arrow R up arrow C up arrow (p= 0.036) and decreased child BMI z-score (BMIZ) (p= 0.022). Further analyses revealed an association between maternal dp-pp.pc1.D up arrow down arrow A up arrow R up arrow down arrow L down arrow and increased child BMIZ (p =0.036). Child ch.pc1.D up arrow R up arrow C up arrow was associated with decreased birth weight (p =0.036) and increased child BMIZ (p= 0.002). Child ch.pc2.D down arrow A up arrow L up arrow was associated with increased child BMIZ (p= 0.005), decreased maternal height (p =0.030) and girls (p =0.002). A pattern of elevated maternal adiponectin and leptin in pregnancy was associated with increased C-reactive protein, vitamin A, and D binding proteins pattern in children, suggesting biomarkers acting in concert may have qualitative as well as quantitative influence beyond single biomarker effects. Patterns in pregnancy proximal to birth were more associated with child status. In addition, child patterns were more associated with child status, particularly child BMI. MMN supplementation affects maternal biomarker patterns of metabolism and inflammation in pregnancy, and potentially in the child. However, child nutrition conditions after birth may have a greater impact on metabolism and inflammation.	[Priliani, Lidwina; Oktavianthi, Sukma; Malik, Safarina G.] Natl Res & Innovat Agcy, Minist Res & Technol, Eijkman Inst Mol Biol, Jakarta, Indonesia; [Prado, Elizabeth L.; Shankar, Anuraj H.] Summit Inst Dev, Lombok, West Nusa Tengg, Indonesia; [Prado, Elizabeth L.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Shankar, Anuraj H.] Eijkman Inst Mol Biol, Eijkman Oxford Clin Res Unit, Jakarta, Indonesia; [Shankar, Anuraj H.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England	Eijkman Institute; University of California System; University of California Davis; Eijkman Institute; University of Oxford	Malik, SG (corresponding author), Natl Res & Innovat Agcy, Minist Res & Technol, Eijkman Inst Mol Biol, Jakarta, Indonesia.; Shankar, AH (corresponding author), Summit Inst Dev, Lombok, West Nusa Tengg, Indonesia.; Shankar, AH (corresponding author), Eijkman Inst Mol Biol, Eijkman Oxford Clin Res Unit, Jakarta, Indonesia.; Shankar, AH (corresponding author), Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England.	ina@eijkman.go.id; anuraj.shankar@ndm.ox.ac.uk		Oktavianthi, Sukma/0000-0002-5600-8111; Priliani, Lidwina/0000-0001-6304-9571; Malik, Safarina G./0000-0002-7258-2586	Indonesian Danone Institute Foundation [006/I-CG/IDIF/XI/2015]	Indonesian Danone Institute Foundation(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	Financial Disclosure This study was funded by the Indonesian Danone Institute Foundation (clsoed grant number 006/I-CG/IDIF/XI/2015) for SGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adali E, 2009, J MATERN-FETAL NEO M, V22, P873, DOI 10.1080/14767050902994622; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Barazzoni R, 2011, CLIN ENDOCRINOL, V75, P56, DOI 10.1111/j.1365-2265.2011.03990.x; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Black RE, 2001, BRIT J NUTR, V85, pS193, DOI 10.1079/BJN2000314; Block G, 2009, FREE RADICAL BIO MED, V46, P70, DOI 10.1016/j.freeradbiomed.2008.09.030; Butterworth RF, 2001, AM J CLIN NUTR, V74, P712; Carbone F, 2012, BIOCHIMIE, V94, P2082, DOI 10.1016/j.biochi.2012.05.018; Caulfield LE, 1998, AM J CLIN NUTR, V68, p499S, DOI 10.1093/ajcn/68.2.499S; Cohen SS, 2011, ANN EPIDEMIOL, V21, P86, DOI 10.1016/j.annepidem.2010.10.011; Collier CH, 2013, MATERN CHILD HLTH J, V17, P1940, DOI 10.1007/s10995-013-1220-2; Conde-Agudelo A, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.020; Coupe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030616; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dror DK, 2012, PAEDIATR PERINAT EP, V26, P55, DOI 10.1111/j.1365-3016.2012.01277.x; DUNN JT, 1993, ANN NY ACAD SCI, V678, P158; Economos CD, 2007, OBESITY, V15, P1325, DOI 10.1038/oby.2007.155; Ernst GDS, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.049; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Fleisch AF, 2007, J CLIN ENDOCR METAB, V92, P948, DOI 10.1210/jc.2006-1390; Gaillard R, 2016, OBESITY, V24, P1320, DOI 10.1002/oby.21484; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Iikuni Noriko, 2008, Current Immunology Reviews, V4, P70, DOI 10.2174/157339508784325046; Jain SK, 2015, ANTIOXID REDOX SIGN, V23, P688, DOI 10.1089/ars.2015.6320; Kaprio J, 2001, INT J OBESITY, V25, P132, DOI 10.1038/sj.ijo.0801526; Kelly KR, 2010, OBESITY, V18, P663, DOI 10.1038/oby.2009.328; Khalessi Nasrin, 2015, J Family Reprod Health, V9, P113; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Liu PH, 2008, TWIN RES HUM GENET, V11, P495, DOI 10.1375/twin.11.5.495; Loh BI, 2013, ASIA PAC J CLIN NUTR, V22, P241, DOI 10.6133/apjcn.2013.22.2.04; Long NM, 2012, J ANIM SCI, V90, P2201, DOI 10.2527/jas.2011-4343; Luo ZC, 2013, OBESITY, V21, P210, DOI 10.1002/oby.20250; Lyles Thomas E 3rd, 2006, MedGenMed, V8, P39; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Maijaliisa E, 2011, VITAM HORM, V86, P239, DOI 10.1016/B978-0-12-386960-9.00010-1; Mantzoros CS, 2010, CLIN NUTR, V29, P622, DOI 10.1016/j.clnu.2010.03.004; Fernandez-Real JM, 2008, DIABETES, V57, P1918, DOI 10.2337/db08-0041; Misra VK, 2013, OBESITY, V21, P1064, DOI 10.1002/oby.20128; Naini AE, 2016, J RES MED SCI, V21, DOI 10.4103/1735-1995.175144; Negash C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142301; Noureldeen AFH, 2014, INDIAN J CLIN BIOCHE, V29, P462, DOI 10.1007/s12291-013-0394-0; Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026; Parlee SD, 2014, BBA-MOL BASIS DIS, V1842, P495, DOI 10.1016/j.bbadis.2013.07.007; Garcia OP, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-59; Pitiphat W, 2005, AM J EPIDEMIOL, V162, P1108, DOI 10.1093/aje/kwi323; Prado EL, 2017, LANCET GLOB HEALTH, V5, pE217, DOI 10.1016/S2214-109X(16)30354-0; Prado EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032519; Priliani L, 2019, J NUTR, V149, P1309, DOI 10.1093/jn/nxz064; Prillani L, 2018, PLACENTA, V70, P1, DOI 10.1016/j.placenta.2018.08.001; Rhie YJ, 2011, J KOREAN MED SCI, V26, P797, DOI 10.3346/jkms.2011.26.6.797; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Saboori S, 2015, EUR J CLIN NUTR, V69, P867, DOI 10.1038/ejcn.2014.296; Sahu A, 2003, FRONT NEUROENDOCRIN, V24, P225, DOI 10.1016/j.yfrne.2003.10.001; Savino F, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060383; Schuster S, 2011, PEDIATR RES, V70, P633, DOI 10.1203/PDR.0b013e31823214ea; Sebayang SK, 2011, EUR J CLIN NUTR, V65, P1110, DOI 10.1038/ejcn.2011.97; Sebayang SK, 2012, TROP MED INT HEALTH, V17, P938, DOI 10.1111/j.1365-3156.2012.03039.x; Sebert S, 2011, AM J CLIN NUTR, V94, p1953S, DOI 10.3945/ajcn.110.001040; Shankar AH, 2008, LANCET, V371, P215, DOI 10.1016/S0140-6736(08)60133-6; Sowers James R, 2008, Clin Cornerstone, V9, P32, DOI 10.1016/S1098-3597(08)60026-5; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th edition.; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Tigga P.L., 2016, J ANTHR, V2016, P1, DOI [10.1155/2016/6538235, DOI 10.1155/2016/6538235]; Vaisbuch E, 2010, J PERINAT MED, V38, P129, DOI [10.1515/JPM.2009.140, 10.1515/jpm.2009.140]; Visentin S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/401595; Volberg V, 2013, PEDIATR OBES, V8, P454, DOI 10.1111/j.2047-6310.2012.00127.x; Wannamethee SG, 2007, ATHEROSCLEROSIS, V191, P418, DOI 10.1016/j.atherosclerosis.2006.04.012; Warchol M, 2014, ANN AGR ENV MED, V21, P349, DOI 10.5604/1232-1966.1108603; Weyermann M, 2006, CLIN CHEM, V52, P2095, DOI 10.1373/clinchem.2006.071019; White P, 2000, TRENDS ENDOCRIN MET, V11, P320, DOI 10.1016/S1043-2760(00)00317-9; World Health Organization, GLOB PREV VIT A DEF; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yeste D, 2010, HORM RES PAEDIAT, V73, P335, DOI 10.1159/000308165; Zaretsky MV, 2004, OBSTET GYNECOL, V103, P546, DOI 10.1097/01.AOG.0000114980.40445.83; Zhang MX, 2017, CHILD OBES, V13, P213, DOI 10.1089/chi.2016.0273; Zmora N, 2017, CELL METAB, V25, P506, DOI 10.1016/j.cmet.2017.02.006	78	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2020	15	8							e0216848	10.1371/journal.pone.0216848	http://dx.doi.org/10.1371/journal.pone.0216848			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2FE	32764747	Green Published, gold, Green Submitted			2022-12-26	WOS:000561029000009
J	Banerjee, A; Adames, N; Peccoud, J; Tyson, JJ				Banerjee, Anand; Adames, Neil; Peccoud, Jean; Tyson, John J.			A stochastic model for error correction of kinetochore-microtubule attachments in budding yeast	PLOS ONE			English	Article							CHROMOSOME BI-ORIENTATION; SPINDLE-ASSEMBLY CHECKPOINT; PROTEIN PHOSPHATASE 1; KINASE; COMPLEX; BINDING; MPS1; PHOSPHORYLATION; RECRUITMENT; DYNAMICS	To divide replicated chromosomes equally between daughter cells, kinetochores must attach to microtubules emanating from opposite poles of the mitotic spindle (biorientation). An error correction mechanism facilitates this process by destabilizing erroneous kinetochore-microtubule attachments. Here we present a stochastic model of kinetochore-microtubule attachments, via an essential protein Ndc80 in budding yeast,Saccharomyces cerevisiae. Using the model, we calculate the stochastic dynamics of a pair of sister kinetochores as they transition among different attachment states. First of all, we determine the kinase-to-phosphatase balance point that maximizes the probability of biorientation, while starting from an erroneous attachment state. We find that the balance point is sensitive to the rates of microtubule-Ndc80 dissociation and derive an approximate analytical formula that defines the balance point. Secondly, we determine the probability of transition from low-tension amphitelic to monotelic attachment and find that, despite this probability being approximately 33%, biorientation can be achieved with high probability. Thirdly, we calculate the contribution of the geometrical orientation of sister kinetochores to the probability of biorientation and show that, in the absence of geometrical orientation, the biorientation error rate is much larger than that observed in experiments. Finally, we study the coupling of the error correction mechanism to the spindle assembly checkpoint by calculating the average binding of checkpoint-related proteins to the kinetochore during the error correction process.	[Banerjee, Anand; Tyson, John J.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Banerjee, Anand; Tyson, John J.] Virginia Polytech Inst & State Univ, Acad Integrated Sci, Div Syst Biol, Blacksburg, VA 24061 USA; [Adames, Neil; Peccoud, Jean] Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA; [Peccoud, Jean] GenoFAB Inc, Ft Collins, CO 80523 USA; [Adames, Neil] New Culture Inc, San Francisco, CA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Colorado State University	Banerjee, A (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA.; Banerjee, A (corresponding author), Virginia Polytech Inst & State Univ, Acad Integrated Sci, Div Syst Biol, Blacksburg, VA 24061 USA.	anandban@vt.edu	Peccoud, Jean/A-2374-2008	Peccoud, Jean/0000-0001-7649-6127	National Institute of General Medical Sciences of the National Institutes of Health [R01GM078989]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R01GM078989, to JP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi B, 2009, GENETICS, V183, P1591, DOI 10.1534/genetics.109.109041; Aravamudhan P, 2016, MOL BIOL CELL, V27, P3405, DOI 10.1091/mbc.E16-01-0007; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Cheerambathur DK, 2017, DEV CELL, V41, P424, DOI 10.1016/j.devcel.2017.04.013; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cordeiro MH, 2018, INT J BIOCHEM CELL B, V96, P148, DOI 10.1016/j.biocel.2017.10.017; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Gay G, 2012, J CELL BIOL, V196, P757, DOI 10.1083/jcb.201107124; Gelens L, 2018, TRENDS CELL BIOL, V28, P6, DOI 10.1016/j.tcb.2017.09.005; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; HARTWELL LH, 1985, GENETICS, V110, P381; Hiruma Y, 2015, SCIENCE, V348, P1264, DOI 10.1126/science.aaa4055; Indjeian VB, 2007, CURR BIOL, V17, P1837, DOI 10.1016/j.cub.2007.09.056; Ji ZJ, 2015, SCIENCE, V348, P1260, DOI 10.1126/science.aaa4029; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; London N, 2014, GENE DEV, V28, P140, DOI 10.1101/gad.233700.113; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Munoz-Barrera M, 2014, P NATL ACAD SCI USA, V111, pE3996, DOI 10.1073/pnas.1408017111; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Pinsky BA, 2006, MOL CELL BIOL, V26, P2648, DOI 10.1128/MCB.26.7.2648-2660.2006; Pinsky BA, 2009, CURR BIOL, V19, P1182, DOI 10.1016/j.cub.2009.06.043; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Shaw SL, 1998, MOL BIOL CELL, V9, P1627, DOI 10.1091/mbc.9.7.1627; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Tanaka TU, 2010, EMBO J, V29, P4070, DOI 10.1038/emboj.2010.294; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tanaka TU, 2005, PHILOS T R SOC B, V360, P581, DOI 10.1098/rstb.2004.1612; Tubman ES, 2017, CELL SYST, V4, P645, DOI 10.1016/j.cels.2017.05.003; Vallardi G, 2017, PROG MOL SUBCELL BIO, V56, P457, DOI 10.1007/978-3-319-58592-5_19; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Zaytsev AV, 2015, MOL BIOL CELL, V26, P1829, DOI 10.1091/mbc.E14-11-1539	41	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0236293	10.1371/journal.pone.0236293	http://dx.doi.org/10.1371/journal.pone.0236293			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760074	Green Published, gold			2022-12-26	WOS:000561027200004
J	Garwain, O; Pearce, KM; Jackson, L; Carley, S; Rosati, B; Scarlata, S				Garwain, Osama; Pearce, Katherine M.; Jackson, Lela; Carley, Samuel; Rosati, Barbara; Scarlata, Suzanne			Stimulation of the G alpha q/phospholipase C beta 1 signaling pathway returns differentiated cells to a stem-like state	FASEB JOURNAL			English	Article						de-differentiation; G proteins; phospholipase C beta; RNAseq		Phospholipase C beta 1 is activated by G alpha q to generate calcium signals in response to hormones and neurotransmitters. Besides carrying out this plasma membrane function, PLC beta 1 has a cytosolic population that helps to drive the differentiation of PC12 cells by inhibiting a nuclease that promotes RNA-induced silencing (C3PO). Here, we show that down-regulating PLC beta 1 or reducing its cytosolic population by activating G alpha q to localize it to the plasma membrane returns differentiated PC12 and SK-N-SH cells to an undifferentiated state. In this state, PC12 cells have a spherical morphology, resume proliferation, and express the stem cell transcription factors nanog and Oct4. Similar changes are seen when C3PO is down-regulated. This return to a stem-like state is accompanied by shifts in multiple miR populations. Surprisingly, de-differentiation can be induced by extended stimulation of G alpha q where cells return to a spherical morphology and levels of specific miRs return to their undifferentiated values. In complementary studies, we followed the real-time hydrolysis of a fluorescent-tagged miR in cells where PLC beta 1 or C3PO were down-regulated in PC12 cells and find substantial differences in miR processing in the undifferentiated and differentiated states. Taken together, our studies suggest that PLC beta 1, through its ability to regulate C3PO and endogenous miR populations, mediates the differentiation of two types of cultured neuronal cells.	[Garwain, Osama; Pearce, Katherine M.; Jackson, Lela; Carley, Samuel; Scarlata, Suzanne] Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA; [Rosati, Barbara] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	Worcester Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Scarlata, S (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	sfscarlata@wpi.edu			NIH [GM-116187]; Richard Whitcomb Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard Whitcomb Foundation	NIH, Grant/Award Number: GM-116187; Richard Whitcomb Foundation	Aisiku O, 2011, ARCH BIOCHEM BIOPHYS, V509, P186, DOI 10.1016/j.abb.2011.02.006; Aisiku OR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015001; Alshanwani AR, 2018, IUBMB LIFE, V70, P649, DOI 10.1002/iub.1751; Benito-Gutierrez E, 2006, MOL CELL NEUROSCI, V31, P179, DOI 10.1016/j.mcn.2005.09.007; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Cao YL, 2018, MOL MED REP, V18, P5807, DOI 10.3892/mmr.2018.9573; Gao J, 2011, ONCOL LETT, V2, P1019, DOI 10.3892/ol.2011.413; Garwain O, 2018, FASEB J, V32, P2891, DOI 10.1096/fj.201701284R; Garwain O, 2016, J BIOL CHEM, V291, P22970, DOI 10.1074/jbc.M116.744953; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kamato Danielle, 2015, Front Cardiovasc Med, V2, P14, DOI 10.3389/fcvm.2015.00014; Liu WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037039; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Lyon AM, 2013, MOL PHARMACOL, V84, P488, DOI 10.1124/mol.113.087403; McCain Jack, 2013, P T, V38, P96; Milanovic M, 2018, TRENDS CELL BIOL, V28, P1049, DOI 10.1016/j.tcb.2018.09.001; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Mousavi SI, 2020, ANAL BIOCHEM, V596, DOI 10.1016/j.ab.2020.113626; Pearce KM, 2020, MOL BIOL CELL, V31, P683, DOI 10.1091/mbc.E19-09-0536; Philip F, 2016, FASEB J, V30, P1958, DOI 10.1096/fj.201500140; Philip F, 2012, FASEB J, V26, P4903, DOI 10.1096/fj.12-213934; Qifti A, 521369 BIORXIV; Sahu S, 2017, PROTEIN SCI, V26, P1807, DOI 10.1002/pro.3219; Thangaraju A, 2011, EUR J PHARMACOL, V650, P534, DOI 10.1016/j.ejphar.2010.10.054; Wang XR, 2012, ONCOL LETT, V3, P955, DOI 10.3892/ol.2012.609; Yanagi T, 2015, CELL CYCLE, V14, P463, DOI 10.1080/15384101.2015.1006539	27	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12663	12676		10.1096/fj.201902668R	http://dx.doi.org/10.1096/fj.201902668R		AUG 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32761888				2022-12-26	WOS:000558193200001
J	Noel, J; Suzukawa, K; Chavez, E; Pak, K; Wasserman, SI; Kurabi, A; Ryan, AF				Noel, Julia; Suzukawa, Keigo; Chavez, Eduardo; Pak, Kwang; Wasserman, Stephen I.; Kurabi, Arwa; Ryan, Allen F.			A kinase inhibitor screen identifies signaling pathways regulating mucosal growth during otitis media	PLOS ONE			English	Article							MIDDLE-EAR MUCOSA; NF-KAPPA-B; PROTEIN-KINASE; CELL-PROLIFERATION; EPITHELIAL-CELLS; HIPPO PATHWAY; EXPRESSION; PATHOLOGY; CHILDREN; LANGUAGE	Otitis media, the most common disease of childhood, is characterized by extensive changes in the morphology of the middle ear cavity. This includes hyperplasia of the mucosa that lines the tympanic cavity, from a simple monolayer of squamous epithelium into a greatly thickened, respiratory-type mucosa. The processes that control this response, which is critical to otitis media pathogenesis and recovery, are incompletely understood. Given the central role of protein phosphorylation in most intracellular processes, including cell proliferation and differentiation, we screened a library of kinase inhibitors targeting members of all the major families in the kinome for their ability to influence the growth of middle ear mucosal explantsin vitro. Of the 160 inhibitors, 30 were found to inhibit mucosal growth, while two inhibitors enhanced tissue proliferation. The results suggest that the regulation of infection-mediated tissue growth in the ME mucosa involves multiple cellular processes that span the kinome. While some of the pathways and processes identified have been previously implicated in mucosa hyperplasia others are novel. The results were used to generate a global model of growth regulation by kinase pathways. The potential for therapeutic applications of the results are discussed.	[Noel, Julia; Suzukawa, Keigo; Chavez, Eduardo; Pak, Kwang; Kurabi, Arwa; Ryan, Allen F.] Univ Calif San Diego, Dept Surg Otolaryngol, La Jolla, CA 92093 USA; [Wasserman, Stephen I.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Ryan, Allen F.] San Diego VA Healthcare Syst, San Diego, CA USA; [Noel, Julia] Stanford Univ, Dept Otolaryngol Head & Neck Surg, Pal Alto, CA USA; [Suzukawa, Keigo] Univ Tokyo, Dept Otolaryngol, Tokyo, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Stanford University; University of Tokyo	Ryan, AF (corresponding author), Univ Calif San Diego, Dept Surg Otolaryngol, La Jolla, CA 92093 USA.; Ryan, AF (corresponding author), San Diego VA Healthcare Syst, San Diego, CA USA.	afryan@ucsd.edu		Noel, Julia/0000-0001-9955-3315	National Institute on Deafness and Other Communication Disorders [DC000139, DC012595, DC006279, DC014801]; Veterans Affairs San Diego Healthcare System; GlaxoSmithKline foundation 11th GSK-JIAO International Award	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Veterans Affairs San Diego Healthcare System(US Department of Veterans Affairs); GlaxoSmithKline foundation 11th GSK-JIAO International Award	National Institute on Deafness and Other Communication Disorders DC000139 Dr. Allen F Ryan. National Institute on Deafness and Other Communication Disorders DC012595 Dr. Allen F Ryan. National Institute on Deafness and Other Communication Disorders DC006279 Dr Stephen I. Wasserman. National Institute on Deafness and Other Communication Disorders DC014801 Dr. Arwa Kurabi. Veterans Affairs San Diego Healthcare System Dr. Allen F Ryan. GlaxoSmithKline foundation 11th GSK-JIAO International Award Dr Julia Noel.	Ahmed S, 2014, LARYNGOSCOPE, V124, P301, DOI 10.1002/lary.24190; ANTONIADES HN, 1991, P NATL ACAD SCI USA, V88, P565, DOI 10.1073/pnas.88.2.565; Casey JR, 2010, PEDIATR INFECT DIS J, V29, P304, DOI 10.1097/INF.0b013e3181c1bc48; Chen JF, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5836143; Cho CG, 2016, INNATE IMMUN-LONDON, V22, P626, DOI 10.1177/1753425916668581; Coco A, 2010, PEDIATRICS, V125, P214, DOI 10.1542/peds.2009-1115; Daly KA, 2003, ARCH OTOLARYNGOL, V129, P517, DOI 10.1001/archotol.129.5.517; De Beer BA, 2004, ANN OTO RHINOL LARYN, V113, P438, DOI 10.1177/000348940411300604; Elden LM, 1998, J OTOLARYNGOL, V27, P9; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; FRIELPATTI S, 1982, PEDIATR INFECT DIS J, V1, P104, DOI 10.1097/00006454-198203000-00008; Furukawa M, 2007, INFECT IMMUN, V75, P2562, DOI 10.1128/IAI.01656-06; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gasparini C, 2012, CURR PHARM DESIGN, V18, P5735, DOI 10.2174/138161212803530763; Grossman Zahi, 2004, Harefuah, V143, P277; Hammaren HM, 2019, CYTOKINE, V118, P48, DOI 10.1016/j.cyto.2018.03.041; Hernandez M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1475-7; Hernandez M, 2008, J INFECT DIS, V198, P1862, DOI 10.1086/593213; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Jiao QL, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0801-5; Kaltschmidt B, 1999, ONCOGENE, V18, P3213, DOI 10.1038/sj.onc.1202657; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee HH, 2020, EXP CELL RES, V387, DOI 10.1016/j.yexcr.2019.111758; Lim DJ, 2012, ADV EXP MED BIOL, V720, P15, DOI 10.1007/978-1-4614-0254-1_2; LIM DJ, 1969, ARCH OTOLARYNGOL, V89, P835; LIM DJ, 1971, ANN OTO RHINOL LARYN, V80, P838, DOI 10.1177/000348947108000611; Liu JB, 2002, AM J RESP CELL MOL, V27, P306, DOI 10.1165/rcmb.4850; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MELHUS A, 1994, ACTA OTO-LARYNGOL, V114, P289, DOI 10.3109/00016489409126058; Melhus A, 2003, APMIS, V111, P989, DOI 10.1034/j.1600-0463.2003.1111012.x; Mills PR, 1999, AM J RESP CRIT CARE, V160, pS38, DOI 10.1164/ajrccm.160.supplement_1.11; Palacios SD, 2004, INFECT IMMUN, V72, P4662, DOI 10.1128/IAI.72.8.4662-4667.2004; Palacios SD, 2002, J INFECT DIS, V186, P1761, DOI 10.1086/345798; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Pichichero ME, 2016, PEDIATR INFECT DIS J, V35, P1027, DOI 10.1097/INF.0000000000001216; Rinaldo A, 2000, EUR ARCH OTO-RHINO-L, V257, P300, DOI 10.1007/s004050000238; Rosenfeld RM, 2004, PEDIATRICS, V113, P1412, DOI 10.1542/peds.113.5.1412; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Saito S, 2002, J BIOL CHEM, V277, P44695, DOI 10.1074/jbc.M208332200; Schilder AGM, 2017, OTOLARYNG HEAD NECK, V156, pS88, DOI 10.1177/0194599816633697; Shriberg LD, 2000, J SPEECH LANG HEAR R, V43, P100, DOI 10.1044/jslhr.4301.100; STANGERUP SE, 1994, EUR ARCH OTO-RHINO-L, V251, P399; Sun L, 1998, ONCOGENE, V16, P2095, DOI 10.1038/sj.onc.1201731; Suzukawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102739; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; TEELE DW, 1990, J INFECT DIS, V162, P685, DOI 10.1093/infdis/162.3.685; Uy Benedict, 2011, J Biomol Tech, V22, P95; Verbsky JW, 1996, J BIOL CHEM, V271, P13976, DOI 10.1074/jbc.271.24.13976; Vergison A, 2008, VACCINE, V26, pG5, DOI 10.1016/j.vaccine.2008.11.006; Wang YY, 2015, ONCOTARGET, V6, P11725, DOI 10.18632/oncotarget.3955; Yamamoto Yumi, 2001, Current Molecular Medicine (Hilversum), V1, P287; Yao W, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0046-z; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Zalcman G, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00445; Zeke A, 2016, MICROBIOL MOL BIOL R, V80, P793, DOI 10.1128/MMBR.00043-14; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	57	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2020	15	8							e0235634	10.1371/journal.pone.0235634	http://dx.doi.org/10.1371/journal.pone.0235634			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC2EP	32760078	gold, Green Published			2022-12-26	WOS:000561027200071
J	Paiva, HM; Afonso, RJM; de Oliveira, IL; Garcia, GF				Paiva, Henrique Mohallem; Magalhaes Afonso, Rubens Junqueira; de Oliveira, Igor Luppi; Garcia, Gabriele Fernandes			A data-driven model to describe and forecast the dynamics of COVID-19 transmission	PLOS ONE			English	Article							WUHAN	This paper proposes a dynamic model to describe and forecast the dynamics of the coronavirus disease COVID-19 transmission. The model is based on an approach previously used to describe the Middle East Respiratory Syndrome (MERS) epidemic. This methodology is used to describe the COVID-19 dynamics in six countries where the pandemic is widely spread, namely China, Italy, Spain, France, Germany, and the USA. For this purpose, data from the European Centre for Disease Prevention and Control (ECDC) are adopted. It is shown how the model can be used to forecast new infection cases and new deceased and how the uncertainties associated to this prediction can be quantified. This approach has the advantage of being relatively simple, grouping in few mathematical parameters the many conditions which affect the spreading of the disease. On the other hand, it requires previous data from the disease transmission in the country, being better suited for regions where the epidemic is not at a very early stage. With the estimated parameters at hand, one can use the model to predict the evolution of the disease, which in turn enables authorities to plan their actions. Moreover, one key advantage is the straightforward interpretation of these parameters and their influence over the evolution of the disease, which enables altering some of them, so that one can evaluate the effect of public policy, such as social distancing. The results presented for the selected countries confirm the accuracy to perform predictions.	[Paiva, Henrique Mohallem; de Oliveira, Igor Luppi; Garcia, Gabriele Fernandes] Fed Univ Sao Paulo UNIFESP, Inst Sci & Technol ICT, Sao Jose Dos Campos, SP, Brazil; [Magalhaes Afonso, Rubens Junqueira] Tech Univ Munich TUM, Inst Flight Syst Dynam, Dept Aerosp & Geodesy, Garching, Bavaria, Germany; [Magalhaes Afonso, Rubens Junqueira] Aeronaut Inst Technol ITA, Dept Elect Engn, Sao Jose Dos Campos, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Technical University of Munich	Paiva, HM (corresponding author), Fed Univ Sao Paulo UNIFESP, Inst Sci & Technol ICT, Sao Jose Dos Campos, SP, Brazil.	hmpaiva@unifesp.br	Afonso, Rubens Junqueira Magalhães/P-9028-2019; Paiva, Henrique Mohallem/J-2491-2016	Afonso, Rubens Junqueira Magalhães/0000-0001-9209-2253; Paiva, Henrique Mohallem/0000-0001-7081-8383; Fernandes Garcia, Gabriele/0000-0001-5816-0312; Luppi de Oliveira, Igor/0000-0002-3868-7261	Brazilian governmental agency CAPES [88881.145490/2017-01]; Alexander Von Humboldt foundation [88881.145490/2017-01]; Federal Ministry for Education and Research of Germany; Coordenacao de Aperfeicoamento de Pessoal de vel Superior - Brasil (CAPES) [001]	Brazilian governmental agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Alexander Von Humboldt foundation(Alexander von Humboldt Foundation); Federal Ministry for Education and Research of Germany; Coordenacao de Aperfeicoamento de Pessoal de vel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Dr Rubens Junqueira Magalhaes Afonso received a postdoctoral fellowship (#88881.145490/2017-01) from a joint program between the Brazilian governmental agency CAPES and the Alexander Von Humboldt foundation, from the Federal Ministry for Education and Research of Germany. This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de vel Superior - Brasil (CAPES) - Finance Code 001. The other authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; Chatterjee Kaustuv, 2020, Med J Armed Forces India, V76, P147, DOI 10.1016/j.mjafi.2020.03.022; Chen XG, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00137-4; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Fanelli D, 2020, CHAOS SOLITON FRACT, V134, DOI 10.1016/j.chaos.2020.109761; Fang YQ, 2020, J MED VIROL, V92, P645, DOI 10.1002/jmv.25750; Gill PE, 2012, IMA VOL MATH APPL, V154, P147; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guarner J, 2020, AM J CLIN PATHOL, V153, P420, DOI 10.1093/ajcp/aqaa029; Jardon-Kojakhmetov H, 2020, GEOMETRIC ANAL SIR S, P1; Khan T, 2019, CHAOS SOLITON FRACT, V124, P1, DOI 10.1016/j.chaos.2019.04.033; Kim Yunhwan, 2016, Osong Public Health Res Perspect, V7, P49, DOI 10.1016/j.phrp.2016.01.001; Lai CC, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106024; Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m641; Peng L., 2020, MEDRXIV, P1, DOI [10.1101/2020.02.16.20023465, DOI 10.1101/2020.02.16.20023465]; Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236; Shim E, 2020, INT J INFECT DIS, V93, P339, DOI 10.1016/j.ijid.2020.03.031; Tan W, 2020, CONSUMER NEWS BUSINE; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; World Health Organization, COR DIS 2019 COVID 1; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Zhao SL, 2020, QUANT BIOL, V8, P11, DOI 10.1007/s40484-020-0199-0	25	24	24	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236386	10.1371/journal.pone.0236386	http://dx.doi.org/10.1371/journal.pone.0236386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735581	Green Published, gold			2022-12-26	WOS:000569367100018
J	Pollock, LM; Perkins, B; Anand-Apte, B				Pollock, Lana M.; Perkins, Brian; Anand-Apte, Bela			Primary cilia are present on endothelial cells of the hyaloid vasculature but are not required for the development of the blood-retinal barrier	PLOS ONE			English	Article							ZEBRAFISH; PERMEABILITY; MAINTENANCE; GENES; IFT57	Endothelial cilia are found in a variety of tissues including the cranial vasculature of zebrafish embryos. Recently, endothelial cells in the developing mouse retina were reported to also possess primary cilia that are potentially involved in vascular remodeling. Fish carrying mutations in intraflagellar transport (ift) genes have disrupted cilia and have been reported to have an increased rate of spontaneous intracranial hemorrhage (ICH), potentially due to disruption of the sonic hedgehog (shh) signaling pathway. However, it remains unknown whether the endothelial cells forming the retinal microvasculature in zebrafish also possess cilia, and whether endothelial cilia are necessary for development and maintenance of the blood-retinal barrier (BRB). In the present study, we found that the endothelial cells lining the zebrafish hyaloid vasculature possess primary cilia during development. To determine whether endothelial cilia are necessary for BRB integrity, ift57, ift88, and ift172 mutants, which lack cilia, were crossed with the double-transgenic zebrafish strain Tg(l-fabp:DBP-EGFP;flk1:mCherry). This strain expresses a vitamin D-binding protein (DBP) fused to enhanced green fluorescent protein (EGFP) as a tracer in the blood plasma, while the endothelial cells forming the vasculature are tagged by mCherry. The Ift mutant fish develop a functional BRB, indicating that endothelial cilia are not necessary for early BRB integrity. Additionally, although treatment of zebrafish larvae with Shh inhibitor cyclopamine results in BRB breakdown, the Ift mutant fish were not sensitized to cyclopamine-induced BRB breakdown.	[Pollock, Lana M.; Perkins, Brian; Anand-Apte, Bela] Cleveland Clin, Dept Ophthalm Res, Cole Eye Inst, Cleveland, OH 44106 USA; [Perkins, Brian; Anand-Apte, Bela] Case Western Reserve Univ, Dept Ophthalmol, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Anand-Apte, B (corresponding author), Cleveland Clin, Dept Ophthalm Res, Cole Eye Inst, Cleveland, OH 44106 USA.; Anand-Apte, B (corresponding author), Case Western Reserve Univ, Dept Ophthalmol, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.	anandab@ccf.org		Perkins, Brian/0000-0002-9348-6542	NIH [EY016490, EY015638, EY026181, EY017037, T32EY024236, P30EY025585]; Research to Prevent Blindness Challenge Grant; Doris and Jules Stein Professorship Award from Research to Prevent Blindness; Foundation Fighting Blindness Center Grant; Cleveland Eye Bank Foundation Grant	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Challenge Grant(Research to Prevent Blindness (RPB)); Doris and Jules Stein Professorship Award from Research to Prevent Blindness; Foundation Fighting Blindness Center Grant; Cleveland Eye Bank Foundation Grant	This work was supported by NIH grants EY016490, EY015638, EY026181, EY017037, T32EY024236, P30EY025585, and a Research to Prevent Blindness Challenge Grant; a Doris and Jules Stein Professorship Award from Research to Prevent Blindness, a Foundation Fighting Blindness Center Grant, and a Cleveland Eye Bank Foundation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bell BA, 2014, EXP EYE RES, V129, P107, DOI 10.1016/j.exer.2014.10.018; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; Campbell M, 2013, ADV EXP MED BIOL, V763, P70; Cao Y, 2010, J AM SOC NEPHROL, V21, P1326, DOI 10.1681/ASN.2009091001; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Diaz-Coranguez M, 2017, EXP EYE RES, V164, P82, DOI 10.1016/j.exer.2017.07.014; Dinsmore C, 2016, EMBO REP, V17, P156, DOI 10.15252/embr.201541019; Egorova AD, 2012, DIFFERENTIATION, V83, pS56, DOI 10.1016/j.diff.2011.11.007; Eisa-Beygi S, 2018, ARTERIOSCL THROM VAS, V38, P2806, DOI 10.1161/ATVBAHA.118.311231; Goetz JG, 2014, CELL REP, V6, P799, DOI 10.1016/j.celrep.2014.01.032; Jung SH, 2016, BRIT J PHARMACOL, V173, P15, DOI 10.1111/bph.13279; Kallakuri S, 2015, J AM SOC NEPHROL, V26, P864, DOI 10.1681/ASN.2013121314; Keep RF, 2008, ACT NEUR S, V105, P73; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Krock BL, 2008, J CELL SCI, V121, P1907, DOI 10.1242/jcs.029397; Lamont RE, 2010, MECH DEVELOP, V127, P159, DOI 10.1016/j.mod.2010.02.001; Lee JM, 2007, STROKE, V38, P3289, DOI 10.1161/STROKEAHA.107.491621; Lim Yi Chung, 2015, Cilia, V4, P11, DOI 10.1186/s13630-015-0020-2; Lunt SC, 2009, DEV DYNAM, V238, P1744, DOI 10.1002/dvdy.21999; Malicki J, 1996, DEVELOPMENT, V123, P263; Mohieldin AM, 2016, CURR HYPERTENS REV, V12, P57, DOI 10.2174/1573402111666150630140615; Pollock LM, 2018, FASEB J, V32, P5674, DOI 10.1096/fj.201701469R; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; STEWART PA, 1994, J COMP NEUROL, V340, P566, DOI 10.1002/cne.903400409; Sukumaran S, 2009, VISION RES, V49, P479, DOI 10.1016/j.visres.2008.12.009; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Toda R, 2011, J PHARM SCI-US, V100, P3904, DOI 10.1002/jps.22610; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Vion AC, 2018, J CELL BIOL, V217, P1651, DOI 10.1083/jcb.201706151; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0225351	10.1371/journal.pone.0225351	http://dx.doi.org/10.1371/journal.pone.0225351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NO3EK	32735563	Green Published, Green Submitted, gold			2022-12-26	WOS:000569367100002
J	Ruangritchankul, S; Peel, NM; Hanjani, LS; Gray, LC				Ruangritchankul, Sirasa; Peel, Nancye M.; Hanjani, Leila Shafiee; Gray, Leonard C.			Drug related problems in older adults living with dementia	PLOS ONE			English	Article							POTENTIALLY INAPPROPRIATE MEDICATIONS; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; GERIATRIC SYNDROMES; PROSPECTIVE COHORT; ELDERLY-PEOPLE; ACUTE-CARE; POLYPHARMACY; PREVALENCE; HOSPITALIZATION	Background Compared with those without dementia, older patients with dementia admitted to acute care settings are at higher risk for triad combination of polypharmacy (PP), potentially inappropriate medication (PIM), and drug-drug interaction (DDI), which may consequently result in detrimental health. The aims of this research were to assess risk factors associated with triad combination of PP, PIM and DDI among hospitalized older patients with dementia, and to assess prevalence and characteristics of PP, PIM and DDI in this population. Methods In this retrospective cross-sectional study, 416 older inpatients diagnosed with dementia and referred for specialist geriatric consultation at a tertiary hospital in Brisbane, Australia during 2006-2016 were enrolled. Patients were categorized into two groups according to their exposure to the combination of PP, PIM and DDI: 'triad combination' and 'non-triad combination'. Data were collected using the interRAI Acute Care (AC) assessment instrument. Independent risk factors of exposure to the triad combination were evaluated using bivariate and multivariate logistic regression analyses. Results Overall, 181 (43.5%) were classified as triad combination group. The majority of the population took at least 1 PIM (56%) or experienced at least one potential DDI (76%). Over 75% of the participants were exposed to polypharmacy. The most common prescribed PIMs were antipsychotics, followed by benzodiazepines. The independent risk factors of the triad combination were the presence of atrial fibrillation diagnosis and higher medications use in cardiac therapy, psycholeptics and psychoanaleptics. Conclusions The exposure to triad combination of PP, PIM and DDI are common among people with dementia as a result of their vulnerable conditions and the greater risks of adverse events from medications use. This study identified the use of cardiac therapy, psycholeptics and psychoanaleptics as predictors of exposure to PP, PIM and DDI. Therefore, use of these medications should be carefully considered and closely monitored. Furthermore, comprehensive medication reviews to optimize medication prescribing should be initiated and continually implemented for this vulnerable population.	[Ruangritchankul, Sirasa; Peel, Nancye M.; Hanjani, Leila Shafiee; Gray, Leonard C.] Univ Queensland, Fac Med, Ctr Hlth Serv Res, Brisbane, Qld, Australia; [Ruangritchankul, Sirasa] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med,Div Geriatr Med, Bangkok, Thailand	University of Queensland; Mahidol University	Ruangritchankul, S (corresponding author), Univ Queensland, Fac Med, Ctr Hlth Serv Res, Brisbane, Qld, Australia.; Ruangritchankul, S (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med,Div Geriatr Med, Bangkok, Thailand.	sirasarama37@gmail.com	Hanjani, Leila Shafiee/Y-9406-2018; Peel, Nancye/F-5492-2010	Hanjani, Leila Shafiee/0000-0001-7088-9739; Peel, Nancye/0000-0002-3038-8881; Gray, Leonard/0000-0003-2141-0802				Andersen F, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-58; Andrieu S, 2002, INT J GERIATR PSYCH, V17, P422, DOI 10.1002/gps.624; [Anonymous], 2013, HEALTHCARE SERIES; Australian Commission on Safety and Quality in Health Care, 2013, EV SAF QUAL ISS ASS; Azermai M, 2012, AGEING RES REV, V11, P78, DOI 10.1016/j.arr.2011.07.002; Bail K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002770; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; Bell JS, 2012, AUST FAM PHYSICIAN, V41, P45; Beveridge LA, 2011, CLIN INTERV AGING, V6, P173, DOI 10.2147/CIA.S13423; Bickel H, 2018, DTSCH ARZTEBL INT, V115, P733, DOI 10.3238/arztebl.2018.0733; Blasco S, 2010, INTERRAI ACUTE CARE, DOI [10.1186/1472-6963-9-71, DOI 10.1186/1472-6963-9-71]; Bogetti-Salazar M, 2016, CLINICS, V71, P17, DOI 10.6061/clinics/2016(01)04; Bradshaw LE, 2013, INT J GERIATR PSYCH, V28, P681, DOI 10.1002/gps.3871; Briggs R, 2017, QJM-INT J MED, V110, P33, DOI 10.1093/qjmed/hcw114; Briggs R, 2016, QJM-INT J MED, V109, P41, DOI 10.1093/qjmed/hcv085; Brodaty H, 2012, INT PSYCHOGERIATR, V24, P1034, DOI 10.1017/S1041610211002924; Bunn F, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0192-4; Bynum JPW, 2004, J AM GERIATR SOC, V52, P187, DOI 10.1111/j.1532-5415.2004.52054.x; Carter Mary W, 2005, Am J Alzheimers Dis Other Demen, V20, P349, DOI 10.1177/153331750502000605; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Clague F, 2017, AGE AGEING, V46, P33, DOI 10.1093/ageing/afw176; Connolly S, 2015, DEMENTIA-LONDON, V14, P650, DOI 10.1177/1471301213506922; Cross AJ, 2016, DRUG AGING, V33, P37, DOI 10.1007/s40266-015-0332-3; Dementia Australia, 2017, DEM STAT VICT; Dementia Australia, 2018, DEM PREV DAT 2018 20; Department of Health, 2019, NAT FRAM ACT DEM 201; Department of Health and Ageing, 2003, UNN AV HOSP ADM OLD; Douglas IJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1227; Draper B, 2011, INT PSYCHOGERIATR, V23, P1649, DOI 10.1017/S1041610211001694; Eshetie TC, 2019, INT J GERIATR PSYCH, V34, P1498, DOI 10.1002/gps.5160; Eshetie TC, 2018, EXPERT OPIN DRUG SAF, V17, P825, DOI 10.1080/14740338.2018.1497156; Ferreira F, 2015, GERIATR GERONTOL AGI, V9, P21; Fick DM, 2019, J AM GERIATR SOC, V67, P674, DOI 10.1111/jgs.15767; Fogg C, 2018, INT J GERIATR PSYCH, V33, P1177, DOI 10.1002/gps.4919; Fong TG, 2012, ANN INTERN MED, V156, P848, DOI 10.7326/0003-4819-156-12-201206190-00005; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Gnjidic D, 2012, J CLIN EPIDEMIOL, V65, P989, DOI 10.1016/j.jclinepi.2012.02.018; Gray L, 2008, AUSTRALAS J AGEING, V27, P205, DOI 10.1111/j.1741-6612.2008.00309.x; Gray LC, 2008, J AM GERIATR SOC, V56, P536, DOI 10.1111/j.1532-5415.2007.01590.x; Gray LC, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-71; Guijarro R, 2010, NEUROEPIDEMIOLOGY, V35, P101, DOI 10.1159/000311032; Gustafsson M, 2018, PHARMACY, V6, DOI 10.3390/pharmacy6010007; Gustafsson M, 2016, EUR J CLIN PHARMACOL, V72, P1143, DOI 10.1007/s00228-016-2084-3; Gustafsson M, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-10; Guthrie B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3514; Guthrie B, 2010, AGE AGEING, V39, P637, DOI 10.1093/ageing/afq090; Gutierrez-Valencia M, 2017, GERIATR GERONTOL INT, V17, P2354, DOI 10.1111/ggi.13073; Hill J, 2005, J ALZHEIMERS DIS, V8, P43; Hoffmann F, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-190; Holt S, 2010, DTSCH ARZTEBL INT, V107, P543, DOI 10.3238/arztebl.2010.0543; Hukins D, 2019, EUR J CLIN PHARMACOL, V75, P467, DOI 10.1007/s00228-018-02612-x; ICD-10, 2016, ORG INCL SYMPT MENT; January CT, 2019, CIRCULATION, V140, pE125, DOI 10.1161/CIR.0000000000000665; Johnell K, 2015, CURR CLIN PHARMACOL, V10, P178, DOI 10.2174/1574884710666150609154741; Justin B Ng, 2013, Clin Epidemiol, V5, P135, DOI 10.2147/CLEP.S30621; Kable A, 2019, HEALTHCARE-BASEL, V7, DOI 10.3390/healthcare7010008; King B, 2006, AUSTRALAS J AGEING, V25, P20, DOI 10.1111/j.1741-6612.2006.00135.x; Koyama A, 2013, J AM GERIATR SOC, V61, P258, DOI 10.1111/jgs.12093; Kurrle S, 2012, PHYSICAL COMORBIDITIES OF DEMENTIA, P1, DOI 10.1017/CBO9780511894534; Kurrle S, 2018, PHYS COMORBIDITIES D; Lai SW, 2012, GERIATR GERONTOL INT, V12, P491, DOI 10.1111/j.1447-0594.2011.00800.x; Lai SW, 2010, MEDICINE, V89, P295, DOI 10.1097/MD.0b013e3181f15efc; Lakhan P, 2011, J AM GERIATR SOC, V59, P2001, DOI 10.1111/j.1532-5415.2011.03663.x; Lalic S, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.08.019; Laroche ML, 2007, EUR J CLIN PHARMACOL, V63, P725, DOI 10.1007/s00228-007-0324-2; Lau DT, 2010, ALZ DIS ASSOC DIS, V24, P56, DOI 10.1097/WAD.0b013e31819d6ec9; Leelakanok N, 2019, AGING MENT HEALTH, V23, P932, DOI 10.1080/13607863.2018.1468411; Liu E, 2017, J GERIATR CARDIOL, V14, P407, DOI 10.11909/j.issn.1671-5411.2017.06.009; Liu MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079812; MacDermott S, 2017, NATL ROLLOUT EVAL UA; Malone DC, 2009, AM J MANAG CARE, V15, P481; Mangoni AA, 2004, BRIT J CLIN PHARMACO, V57, P6, DOI 10.1046/j.1365-2125.2003.02007.x; Markota M, 2016, MAYO CLIN PROC, V91, P1632, DOI 10.1016/j.mayocp.2016.07.024; Mecocci P, 2005, DEMENT GERIATR COGN, V20, P262, DOI 10.1159/000087440; Brunet NM, 2014, EUR GERIATR MED, V5, P66, DOI 10.1016/j.eurger.2013.10.011; Montastruc F, 2013, EUR J CLIN PHARMACOL, V69, P1589, DOI 10.1007/s00228-013-1506-8; Mueller C, 2018, EXP GERONTOL, V106, P240, DOI 10.1016/j.exger.2018.02.011; Mukadam N, 2011, INT PSYCHOGERIATR, V23, P344, DOI 10.1017/S1041610210001717; Mukaetova-Ladinska EB, 2009, BRIT J PSYCHIAT, V195, P461, DOI 10.1192/bjp.195.5.461; Nagai M, 2010, AM J HYPERTENS, V23, P116, DOI 10.1038/ajh.2009.212; National Centre for Social and Economic Modelling, 2016, EC COST DEM AUSTR 20; National Health Service, 2011, OPT TREATM CAR PEOPL; Nicolazzo JA, 2010, THER DELIV, V1, P595, DOI 10.4155/TDE.10.41; Oesterhus R, 2017, INT J GERIATR PSYCH, V32, P183, DOI 10.1002/gps.4456; Pariente A, 2016, CNS DRUGS, V30, P1, DOI 10.1007/s40263-015-0305-4; Pariente A, 2012, ARCH INTERN MED, V172, P648, DOI 10.1001/archinternmed.2012.28; Park HY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169463; Park H, 2015, EUR J CLIN PHARMACOL, V71, P1429, DOI 10.1007/s00228-015-1955-3; Pasqualetti G, 2015, CLIN INTERV AGING, V10, P1457, DOI 10.2147/CIA.S87466; Payne RA, 2014, BRIT J CLIN PHARMACO, V77, P1073, DOI 10.1111/bcp.12292; Peron EP, 2017, ALZHEIMER DIS, p10e; Pfister B, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0157-2; Pharmaceutical Care Network Europe Foundation, 2019, PCNE CLASS V 9 0 CLA; Phelan EA, 2012, JAMA-J AM MED ASSOC, V307, P165, DOI 10.1001/jama.2011.1964; Ralph SJ, 2018, J ALZHEIMERS DIS REP, V2, P1, DOI 10.3233/ADR-170042; Redston MR, 2018, J ALZHEIMERS DIS, V61, P1639, DOI 10.3233/JAD-170842; Reeve E, 2017, EXPERT OPIN DRUG MET, V13, P651, DOI 10.1080/17425255.2017.1325873; Reynish EL, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0899-0; Richardson K, 2015, AGE AGEING, V44, P90, DOI 10.1093/ageing/afu141; Richardson K, 2011, DRUG AGING, V28, P547, DOI 10.2165/11592000-000000000-00000; Sakakibara R, 2012, NEUROL INT, V4, P52, DOI 10.4081/ni.2012.e13; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Scrutton J, 2016, DEMENTIA COMORBIDITI; Seritan AL, 2008, CURR PSYCHIAT, V7, P57; Sharma S, 2018, J AM MED DIR ASSOC, V19, P607, DOI 10.1016/j.jamda.2018.03.009; Sheehan B, 2013, AGE AGEING, V42, P786, DOI 10.1093/ageing/aft139; Shi S, 2008, EUR J CLIN PHARMACOL, V64, P183, DOI 10.1007/s00228-007-0422-1; Sinnige J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079641; Sonnerstam E, 2018, EUR J CLIN PHARMACOL, V74, P1351, DOI 10.1007/s00228-018-2514-5; Sonnerstam E, 2017, EUR J CLIN PHARMACOL, V73, P735, DOI 10.1007/s00228-017-2218-2; Staekenborg SS, 2016, J ALZHEIMERS DIS, V53, P135, DOI 10.3233/JAD-151063; Tate JA, 2014, CRIT CARE MED, V42, P1037, DOI 10.1097/CCM.0000000000000123; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Thomazi Rafael, 2018, Dement. neuropsychol., V12, P35, DOI 10.1590/1980-57642018dn12-010005; TIMMONS S, 2015, IR AGEING STUD REV, V6, P105; Timmons S, 2015, AGE AGEING, V44, P993, DOI 10.1093/ageing/afv131; Toot S, 2013, J AM MED DIR ASSOC, V14, P463, DOI 10.1016/j.jamda.2013.01.011; Travers C, 2013, J NUTR HEALTH AGING, V17, P435, DOI 10.1007/s12603-012-0439-8; Travers C, 2013, INTERN MED J, V43, P262, DOI 10.1111/j.1445-5994.2012.02962.x; Triplitt C., 2006, DIABETES SPECTR, V19, P202, DOI [10.2337/diaspect.19.4.202, DOI 10.2337/DIASPECT.19.4.202]; von Renteln-Kruse W, 2015, DTSCH ARZTEBL INT, V112, P103, DOI 10.3238/arztebl.2015.0103; Wastesson JW, 2018, EXPERT OPIN DRUG SAF, V17, P1185, DOI 10.1080/14740338.2018.1546841; Wawruch M, 2008, J CLIN PHARM THER, V33, P381, DOI 10.1111/j.1365-2710.2008.00929.x; WHO Collaborating Centre for Drug Statistics Methodology, 2019, OSLO; Wucherer D, 2017, INT PSYCHOGERIATR, V29, P1857, DOI 10.1017/S1041610217001442; Yu NW, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0530-4; Zekry D, 2009, INT J GERIATR PSYCH, V24, P283, DOI 10.1002/gps.2104; Zhao Y, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-108	128	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2020	15	7							e0236830	10.1371/journal.pone.0236830	http://dx.doi.org/10.1371/journal.pone.0236830			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NO3EK	32735592	Green Published, gold			2022-12-26	WOS:000569367100051
